PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	de Haas, EN; Bolhuis, JE; Kemp, B; Groothuis, TGG; Rodenburg, TB				de Haas, Elske N.; Bolhuis, J. Elizabeth; Kemp, Bas; Groothuis, Ton G. G.; Rodenburg, T. Bas			Parents and Early Life Environment Affect Behavioral Development of Laying Hen Chickens	PLOS ONE			English	Article							BRAIN GENE-EXPRESSION; OPEN-FIELD BEHAVIOR; YOLK STEROID-LEVELS; FEATHER-PECKING; SOCIAL TRANSMISSION; TONIC IMMOBILITY; GROUP-SIZE; PHENOTYPIC CORRELATIONS; MICROBIAL METABOLITES; OFFSPRING PHENOTYPE	Severe feather pecking (SFP) in commercial laying hens is a maladaptive behavior which is associated with anxiety traits. Many experimental studies have shown that stress in the parents can affect anxiety in the offspring, but until now these effects have been neglected in addressing the problem of SFP in commercially kept laying hens. We therefore studied whether parental stock (PS) affected the development of SFP and anxiety in their offspring. We used flocks from a brown and white genetic hybrid because genetic background can affect SFP and anxiety. As SFP can also be influenced by housing conditions on the rearing farm, we included effects of housing system and litter availability in the analysis. Forty-seven rearing flocks, originating from ten PS flocks were followed. Behavioral and physiological parameters related to anxiety and SFP were studied in the PS at 40 weeks of age and in the rearing flocks at one, five, ten and fifteen weeks of age. We found that PS had an effect on SFP at one week of age and on anxiety at one and five weeks of age. In the white hybrid, but not in the brown hybrid, high levels of maternal corticosterone, maternal feather damage and maternal whole-blood serotonin levels showed positive relations with offsprings' SFP at one week and offsprings' anxiety at one and five weeks of age. Disruption and limitation of litter supply at an early age on the rearing farms increased SFP, feather damage and fearfulness. These effects were most prominent in the brown hybrid. It appeared that hens from a brown hybrid are more affected by environmental conditions, while hens from a white hybrid were more strongly affected by parental effects. These results are important for designing measures to prevent the development of SFP, which may require a different approach in brown and white flocks.	[de Haas, Elske N.; Bolhuis, J. Elizabeth; Kemp, Bas] Wageningen Univ & Res, Dept Anim Sci, Adaptat Physiol Grp, Wageningen, Netherlands; [Groothuis, Ton G. G.] Univ Groningen, Ctr Behav & Neurosci, Groningen, Netherlands; [Rodenburg, T. Bas] Wageningen Univ & Res, Dept Anim Sci, Behav Ecol Grp, Wageningen, Netherlands	Wageningen University & Research; University of Groningen; Wageningen University & Research	de Haas, EN (corresponding author), Wageningen Univ & Res, Dept Anim Sci, Adaptat Physiol Grp, Wageningen, Netherlands.	elske.dehaas@wur.nl	Rodenburg, Bas/AAV-5612-2020; Rodenburg, Bas/D-9115-2012; Bolhuis, J. Elizabeth/P-7978-2015	Rodenburg, Bas/0000-0002-3371-1461; Bolhuis, J. Elizabeth/0000-0002-5172-7635	Division of Earth and Life Sciences with financial aid from the Netherlands Organization for Scientific Research; Ministry of Economic Affairs within the program	Division of Earth and Life Sciences with financial aid from the Netherlands Organization for Scientific Research; Ministry of Economic Affairs within the program	This work was supported by the Division of Earth and Life Sciences with financial aid from the Netherlands Organization for Scientific Research and the Ministry of Economic Affairs within the program "The Value of Animal Welfare" for the specific project named "Preventing feather pecking in laying hens: from principle to practice" (http://www.nwo.nl/en/research-and-results/research-projects/46/2300154446.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerah AM, 2007, WORLD POULTRY SCI J, V63, P439, DOI 10.1017/S0043933907001560; Bateson P, 2007, J NUTR, V137, P1060, DOI 10.1093/jn/137.4.1060; Berghof TVL, 2013, POULTRY SCI, V92, P2904, DOI 10.3382/ps.2013-03177; Bertin A, 2009, BEHAVIOUR, V146, P757, DOI 10.1163/156853909X446190; Bertin A, 2008, HORM BEHAV, V54, P396, DOI 10.1016/j.yhbeh.2008.04.012; Bilcik B, 2000, APPL ANIM BEHAV SCI, V68, P55, DOI 10.1016/S0168-1591(00)00089-7; BLOKHUIS HJ, 1986, APPL ANIM BEHAV SCI, V16, P63, DOI 10.1016/0168-1591(86)90040-7; Bolhuis JE, 2009, PHYSIOL BEHAV, V97, P470, DOI 10.1016/j.physbeh.2009.03.021; Bright A, 2008, BRIT POULTRY SCI, V49, P241, DOI 10.1080/00071660802094172; Bright A, 2009, VET REC, V164, P334, DOI 10.1136/vr.164.11.334; Brunton PJ, 2010, J NEUROENDOCRINOL, V22, P258, DOI 10.1111/j.1365-2826.2010.01969.x; Buitenhuis AJ, 2004, POULTRY SCI, V83, P1077, DOI 10.1093/ps/83.7.1077; Champagne FA, 2012, ADV GENET, V77, P33, DOI 10.1016/B978-0-12-387687-4.00002-7; Champagne FA, 2011, HORM BEHAV, V59, P277, DOI 10.1016/j.yhbeh.2011.02.011; Champagne FA, 2010, PERSPECT PSYCHOL SCI, V5, P564, DOI 10.1177/1745691610383494; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; COLLIAS NE, 1987, CONDOR, V89, P510, DOI 10.2307/1368641; Croney CC, 2007, APPL ANIM BEHAV SCI, V103, P215, DOI 10.1016/j.applanim.2006.05.023; Curley JP, 2011, HORM BEHAV, V59, P306, DOI 10.1016/j.yhbeh.2010.06.018; Davis KA, 2008, POULTRY SCI, V87, P1303, DOI 10.3382/ps.2008-00083; de Haas EN, 2013, POULTRY SCI, V92, P2259, DOI 10.3382/ps.2012-02996; de Jong IC, 2013, ANIM WELFARE, V22, P305, DOI 10.7120/09627286.22.3.305; Ebert-Zavos E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058477; Eriksen MS, 2011, J FISH BIOL, V79, P575, DOI 10.1111/j.1095-8649.2011.03036.x; FAURE JM, 1983, BIOL BEHAV, V8, P103; Fraisse F, 2006, BRIT POULTRY SCI, V47, P110, DOI 10.1080/00071660600610534; GALLUP GG, 1980, ANIM BEHAV, V28, P368, DOI 10.1016/S0003-3472(80)80045-5; Ghareeb K, 2008, BRIT POULTRY SCI, V49, P502, DOI 10.1080/00071660802290390; Ghareeb K., 2008, International Journal of Poultry Science, V7, P843; Gilani AM, 2012, APPL ANIM BEHAV SCI, V142, P42, DOI 10.1016/j.applanim.2012.09.006; Gluckman PD, 2005, TRENDS ECOL EVOL, V20, P527, DOI 10.1016/j.tree.2005.08.001; Goerlich VC, 2012, HORM BEHAV, V61, P711, DOI 10.1016/j.yhbeh.2012.03.006; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Gudsnuk KMA, 2011, CLIN PERINATOL, V38, P703, DOI 10.1016/j.clp.2011.08.005; Guibert F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2368; Guibert F, 2011, APPL ANIM BEHAV SCI, V132, P51, DOI 10.1016/j.applanim.2011.03.012; Guibert F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014069; Harlander-Matauschek A, 2007, APPL ANIM BEHAV SCI, V107, P78, DOI 10.1016/j.applanim.2006.09.022; Henriksen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023824; Henriksen R, 2011, NEUROSCI BIOBEHAV R, V35, P1484, DOI 10.1016/j.neubiorev.2011.04.010; Ho DH, 2010, J EXP BIOL, V213, P3, DOI 10.1242/jeb.019752; Hocking PM, 2001, BRIT POULTRY SCI, V42, P414, DOI 10.1080/00071660120070686; Houdelier C., 2011, PLOS ONE, V6; Huber-Eicher B, 1998, ANIM BEHAV, V55, P861, DOI 10.1006/anbe.1997.0715; HuberEicher B, 1997, ANIM BEHAV, V54, P757, DOI 10.1006/anbe.1996.0506; Hughes AL, 2010, POULTRY SCI, V89, P1858, DOI 10.3382/ps.2010-00827; Janczak AM, 2009, ACTA AGR SCAND A-AN, V59, P80, DOI 10.1080/09064700903023348; Janczak AM, 2006, APPL ANIM BEHAV SCI, V96, P69, DOI 10.1016/j.applanim.2005.04.020; Janczak AM, 2007, APPL ANIM BEHAV SCI, V107, P275, DOI 10.1016/j.applanim.2006.10.002; Janczak AM, 2007, APPL ANIM BEHAV SCI, V107, P66, DOI 10.1016/j.applanim.2006.09.016; JONES RB, 1995, BRIT POULTRY SCI, V36, P525, DOI 10.1080/00071669508417798; Kjaer JB, 2004, VET REC, V154, P556, DOI 10.1136/vr.154.18.556; Koene P, 2001, VOCALISATION DUE FRU, P95; Kops MS, 2013, BEHAV BRAIN RES, V257, P54, DOI 10.1016/j.bbr.2013.09.035; Kops MS, 2013, PHYSIOL BEHAV, V120, P77, DOI 10.1016/j.physbeh.2013.07.007; Lindqvist C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000364; Lumey LH, 2007, INT J EPIDEMIOL, V36, P1196, DOI 10.1093/ije/dym126; McAdie TM, 2002, APPL ANIM BEHAV SCI, V75, P147, DOI 10.1016/S0168-1591(01)00182-4; McAdie TM, 2000, APPL ANIM BEHAV SCI, V68, P215, DOI 10.1016/S0168-1591(00)00107-6; Meyer B, 2012, POULTRY SCI, V91, P1506, DOI 10.3382/ps.2011-01786; Meyer B, 2013, PHYSIOL BEHAV, V110, P96, DOI 10.1016/j.physbeh.2012.12.017; Mossner R, 1998, BRAIN BEHAV IMMUN, V12, P249, DOI 10.1006/brbi.1998.0532; Natt D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006405; Newberry RC, 2007, APPL ANIM BEHAV SCI, V107, P262, DOI 10.1016/j.applanim.2006.10.010; Nicol CJ, 2013, WORLD POULTRY SCI J, V69, P775, DOI 10.1017/S0043933913000809; NICOL CJ, 1995, APPL ANIM BEHAV SCI, V44, P79, DOI 10.1016/0168-1591(95)00607-T; Nicol CJ, 2001, APPL ANIM BEHAV SCI, V73, P141, DOI 10.1016/S0168-1591(01)00126-5; Richard-Yris MA, 2005, DEV PSYCHOBIOL, V46, P1, DOI 10.1002/dev.20040; Riedstra B, 2002, APPL ANIM BEHAV SCI, V77, P127, DOI 10.1016/S0168-1591(02)00031-X; Rodenburg TB, 2013, WORLD POULTRY SCI J, V69, P361, DOI 10.1017/S0043933913000354; Rodenburg TB, 2008, APPL ANIM BEHAV SCI, V110, P217, DOI 10.1016/j.applanim.2007.09.009; Rodenburg TB, 2007, APPL ANIM BEHAV SCI, V103, P205, DOI 10.1016/j.applanim.2006.05.024; Rodenburg TB, 2009, PHYSIOL BEHAV, V98, P519, DOI 10.1016/j.physbeh.2009.08.006; Rodenburg TB, 2004, BEHAV GENET, V34, P407, DOI 10.1023/B:BEGE.0000023646.46940.2d; Rodenburg TB, 2004, BEHAV PROCESS, V65, P179, DOI 10.1016/j.beproc.2003.09.003; Rogers LJ, 1995, BEHAV TRANSITIONS EA, P157; Rutherford KMD, 2012, ANIM WELFARE, V21, P419, DOI 10.7120/09627286.21.3.419; SAVORY CJ, 1995, WORLD POULTRY SCI J, V51, P215, DOI 10.1079/WPS19950016; Savory CJ, 1997, BRIT POULTRY SCI, V38, P38, DOI 10.1080/00071669708417938; Schwabl H, 1997, NATURWISSENSCHAFTEN, V84, P406, DOI 10.1007/s001140050418; SUAREZ SD, 1983, ANIM LEARN BEHAV, V11, P119, DOI 10.3758/BF03212318; SUFKA KJ, 1991, PHYSIOL BEHAV, V50, P129, DOI 10.1016/0031-9384(91)90508-L; TOLMAN CW, 1964, ANIM BEHAV, V12, P245, DOI 10.1016/0003-3472(64)90008-9; Uitdehaag KA, 2008, BEHAV PROCESS, V79, P13, DOI 10.1016/j.beproc.2008.04.004; Uitdehaag KA, 2011, POULTRY SCI, V90, P1629, DOI 10.3382/ps.2010-01292; Uitdehaag K, 2008, APPL ANIM BEHAV SCI, V109, P292, DOI 10.1016/j.applanim.2007.03.008; Uitdehaag KA, 2009, APPL ANIM BEHAV SCI, V116, P58, DOI 10.1016/j.applanim.2008.06.009; van Hierden YM, 2004, BEHAV NEUROSCI, V118, P575, DOI 10.1037/0735-7044.118.3.575; Viltart O, 2007, THESCIENTIFICWORLDJO, V7, P1493, DOI 10.1100/tsw.2007.204; Warnick JE, 2009, J PSYCHOPHARMACOL, V23, P143, DOI 10.1177/0269881108089805; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Welfare Quality Consortium, 2009, WELF QUAL ASS PROT P; Zeltner E, 2000, ANIM BEHAV, V60, P211, DOI 10.1006/anbe.2000.1453; Zimmerman PH, 2006, APPL ANIM BEHAV SCI, V101, P111, DOI 10.1016/j.applanim.2006.01.005	95	73	74	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90577	10.1371/journal.pone.0090577	http://dx.doi.org/10.1371/journal.pone.0090577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603500	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600064
J	Gage-Bouchard, EA; Devine, KA				Gage-Bouchard, Elizabeth A.; Devine, Katie A.			Examining Parents' Assessments of Objective and Subjective Social Status in Families of Children with Cancer	PLOS ONE			English	Article							SELF-RATED HEALTH; SOCIOECONOMIC-STATUS; AFRICAN-AMERICANS; RISK	Introduction: Understanding the social determinants of child health is a prominent area of research. This paper examines the measurement of socioeconomic position in a sample of families of children with cancer. Socioeconomic position is difficult to measure in pediatric health research due to sensitivity of asking about finances when research is conducted in health care delivery settings, financial volatility associated with periods of pediatric illness, and difficulty recruiting fathers to research. Methods: Caregivers of children with cancer (n = 76) completed a questionnaire that included the MacArthur Scale of Subjective Social Status (SSS). SSS was measured using two 10-rung ladders with differing referent groups: the US and respondents' communities. Respondents placed themselves on each ladder by placing an X on the rung that represented their social position in relation to the two referent groups. Individuals' SSS ratings and discrepancies in SSS ratings within couples were examined, and associations with objective social status measures were evaluated using Pearson correlations or t-tests. Results: Parents' placement on the US and community ladders was positively associated with their income, education, wealth, household savings, and household savings minus debt. On average, respondents placed themselves higher on the US ladder compared to the community ladder. There was an average intra-couple discrepancy of 1.25 rungs in partner's placements on the US ladder and a 1.56 rung difference for the community ladder. This intra-couple discrepancy was not associated with gender. Discussion: Results offer insight into the use of subjective social status measures to capture a more holistic assessment of socioeconomic position and the measurement of socioeconomic position in two-parent families.	[Gage-Bouchard, Elizabeth A.] SUNY Buffalo, Sch Publ Hlth, Dept Community Hlth & Hlth Behav, Buffalo, NY 14260 USA; [Devine, Katie A.] Rutgers State Univ, Div Populat Sci, Rutgers Canc Inst New Jersey, Dept Med, New Brunswick, NJ 08903 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Gage-Bouchard, EA (corresponding author), SUNY Buffalo, Sch Publ Hlth, Dept Community Hlth & Hlth Behav, Buffalo, NY 14260 USA.	eagage@buffalo.edu	Devine, Katie/K-1298-2019	Devine, Katie/0000-0002-1003-8905	National Institutes of Health [R21CA141165, R25CA114101, R25CA10618, P30CA072720]; NATIONAL CANCER INSTITUTE [P30CA072720, R21CA141165, R25CA114101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Institutes of Health, grants R21CA141165, R25CA114101, R25CA10618 and P30CA072720. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler N., 2007, MACARTHUR SCALE SUBJ; Adler N, 2008, SOC SCI MED, V66, P1034, DOI 10.1016/j.socscimed.2007.11.031; Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Duncan GJ, 2001, SOC SCI RES, V30, P248, DOI 10.1006/ssre.2000.0696; Gage E, 2010, CANCER NURS, V33, pE1, DOI 10.1097/NCC.0b013e3181c29583; Galobardes B, 2003, SOZ PRAVENTIV MED, V48, P70, DOI 10.1007/s000380300008; Ghaed SG, 2007, HEALTH PSYCHOL, V26, P668, DOI 10.1037/0278-6133.26.6.668; Goldman N, 2006, J CROSS-CULT GERONTO, V21, P71, DOI 10.1007/s10823-006-9020-4; Hu PF, 2005, J AM GERIATR SOC, V53, P483, DOI 10.1111/j.1532-5415.2005.53169.x; Iida H, 2013, AM J PUBLIC HEALTH, V103, P480, DOI 10.2105/AJPH.2012.300845; JACKMAN MR, 1979, PUBLIC OPIN QUART, V43, P443, DOI 10.1086/268543; JACKMAN MR, 1973, AM SOCIOL REV, V38, P569, DOI 10.2307/2094408; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Lareau Annette, 2000, QUAL SOCIOL, V23, P407, DOI DOI 10.1023/A:1005574724760; Mehta NK, 2013, SOC SCI MED, V95, P6, DOI 10.1016/j.socscimed.2012.09.011; Mitchell SJ, 2007, APPL DEV SCI, V11, P239, DOI 10.1080/10888690701762159; Ostrove JM, 2000, HEALTH PSYCHOL, V19, P613, DOI 10.1037/0278-6133.19.6.613; Singh-Manoux A, 2005, PSYCHOSOM MED, V67, P855, DOI 10.1097/01.psy.0000188434.52941.a0; Singh-Manoux A, 2003, SOC SCI MED, V56, P1321, DOI 10.1016/S0277-9536(02)00131-4; Subramanyam MA, 2012, SOC SCI MED, V74, P1146, DOI 10.1016/j.socscimed.2011.12.042; Thompson AL, 2013, SOC SCI MED, V97, P288, DOI 10.1016/j.socscimed.2012.12.007; Wolff LS, 2010, SOC SCI MED, V70, P2019, DOI 10.1016/j.socscimed.2010.02.033; Wolff LS, 2010, J HEALTH PSYCHOL, V15, P560, DOI 10.1177/1359105309354345	24	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89842	10.1371/journal.pone.0089842	http://dx.doi.org/10.1371/journal.pone.0089842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24599006	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400031
J	Lee, J; Sohn, I; Do, IG; Kim, KM; Park, SH; Park, JO; Park, YS; Lim, HY; Sohn, TS; Bae, JM; Choi, MG; Lim, DH; Min, BH; Lee, JH; Rhee, PL; Kim, JJ; Choi, DI; Choi, DI; Das, K; Tan, P; Jung, SH; Kang, WK; Kim, S				Lee, Jeeyun; Sohn, Insuk; Do, In-Gu; Kim, Kyoung-Mee; Park, Se Hoon; Park, Joon Oh; Park, Young Suk; Lim, Ho Yeong; Sohn, Tae Sung; Bae, Jae Moon; Choi, Min Gew; Lim, Do Hoon; Min, Byung Hoon; Lee, Joon Haeng; Rhee, Poong Lyul; Kim, Jae J.; Choi, Dong Il; Tan, Iain Beehuat; Das, Kakoli; Tan, Patrick; Jung, Sin Ho; Kang, Won Ki; Kim, Sung			Nanostring-Based Multigene Assay to Predict Recurrence for Gastric Cancer Patients after Surgery	PLOS ONE			English	Article							GENE-EXPRESSION; COLON-CANCER; ADENOCARCINOMA; CAPECITABINE; ASSOCIATION; DISSECTION; TISSUES; TFDP1	Despite the benefits from adjuvant chemotherapy or chemoradiotherapy, approximately one-third of stage II gastric cancer (GC) patients developed recurrences. The aim of this study was to develop and validate a prognostic algorithm for gastric cancer (GCPS) that can robustly identify high-risk group for recurrence among stage II patients. A multi-step gene expression profiling study was conducted. First, a microarray gene expression profiling of archived paraffin-embedded tumor blocks was used to identify candidate prognostic genes (N = 432). Second, a focused gene expression assay including prognostic genes was used to develop a robust clinical assay (GCPS) in stage II patients from the same cohort (N = 186). Third, a predefined cut off for the GCPS was validated using an independent stage II cohort (N = 216). The GCPS was validated in another set with stage II GC who underwent surgery without adjuvant treatment (N = 300). GCPS was developed by summing the product of Cox regression coefficients and normalized expression levels of 8 genes (LAMP5, CDC25B, CDK1, CLIP4, LTB4R2, MATN3, NOX4, TFDP1). A prospectively defined cut-point for GCPS classified 22.7% of validation cohort treated with chemoradiotherapy (N = 216) as high-risk group with 5-year recurrence rate of 58.6% compared to 85.4% in the low risk group (hazard ratio for recurrence = 3.16, p = 0.00004). GCPS also identified high-risk group among stage II patients treated with surgery only (hazard ratio = 1.77, p = 0.0053).	[Lee, Jeeyun; Park, Se Hoon; Park, Joon Oh; Park, Young Suk; Lim, Ho Yeong; Kang, Won Ki] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea; [Sohn, Insuk; Do, In-Gu; Jung, Sin Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Canc Res Inst, Seoul, South Korea; [Do, In-Gu; Kim, Kyoung-Mee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Sohn, Tae Sung; Bae, Jae Moon; Choi, Min Gew; Kim, Sung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; [Lim, Do Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Min, Byung Hoon; Lee, Joon Haeng; Rhee, Poong Lyul; Kim, Jae J.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Gastroenterol, Seoul, South Korea; [Choi, Dong Il] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Tan, Iain Beehuat; Tan, Patrick] Duke NUS Grad Med Sch Singapore, Singapore, Singapore; [Das, Kakoli; Tan, Patrick] Genome Inst Singapore, Singapore, Singapore; [Tan, Patrick] Canc Sci Inst Singapore, Singapore, Singapore	Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Kang, WK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea.	wkkang@skku.edu; sungkimm@skku.edu	Lee, Jee Yun/C-9646-2011; Lee, Jeeyun/I-7171-2015; Park, Se Hoon/GMX-1199-2022; Kim, Sung/G-4114-2014	Park, Se Hoon/0000-0001-5084-9326; Tan, Iain/0000-0003-4951-0354; Das, Kakoli/0000-0002-0990-276X; Rhee, Poong-Lyul/0000-0003-0495-5296	Samsung Medical Center	Samsung Medical Center(Samsung)	This study was supported by an Intramural grant from the Samsung Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2003, J CLIN ONCOL, V21, P241, DOI 10.1200/JCO.2003.05.044; Bang Y, 2011, J CLIN ONCOL, V29; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; Clark-Langone KM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-279; Fan JB, 2004, GENOME RES, V14, P878, DOI 10.1101/gr.2167504; Folli S, 2001, JPN J CLIN ONCOL, V31, P495, DOI 10.1093/jjco/hye107; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Kim S, 2005, INT J RADIAT ONCOL, V63, P1279, DOI 10.1016/j.ijrobp.2005.05.005; Lee J, 2012, J CLIN ONCOL, V30, P268, DOI 10.1200/JCO.2011.39.1953; Lee K, 2004, PROTEOMICS, V4, P3343, DOI 10.1002/pmic.200400960; Levi F, 2004, ANN ONCOL, V15, P338, DOI 10.1093/annonc/mdh057; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Nigro JJ, 1999, ANN SURG, V230, P433, DOI 10.1097/00000658-199909000-00015; Sohn I, 2009, BIOINFORMATICS, V25, P1775, DOI 10.1093/bioinformatics/btp322; Tan IB, 2011, GASTROENTEROLOGY, V141, P476, DOI 10.1053/j.gastro.2011.04.042; Yasui K, 2003, J HUM GENET, V48, P609, DOI 10.1007/s10038-003-0086-3; Yasui K, 2002, HEPATOLOGY, V35, P1476, DOI 10.1053/jhep.2002.33683	21	87	87	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90133	10.1371/journal.pone.0090133	http://dx.doi.org/10.1371/journal.pone.0090133			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598828	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400047
J	Luo, K; Zhang, H; Zavala, F; Biragyn, A; Espinosa, DA; Markham, RB				Luo, Kun; Zhang, Hong; Zavala, Fidel; Biragyn, Arya; Espinosa, Diego A.; Markham, Richard B.			Fusion of Antigen to a Dendritic Cell Targeting Chemokine Combined with Adjuvant Yields a Malaria DNA Vaccine with Enhanced Protective Capabilities	PLOS ONE			English	Article							CD8(+) T-CELLS; PLASMODIUM-FALCIPARUM; IMMUNE-RESPONSES; CIRCUMSPOROZOITE PROTEIN; IN-VITRO; LIVER-STAGE; IRRADIATED SPOROZOITES; IMPROVES PROTECTION; ANTIBODY-RESPONSES; EFFECTOR FUNCTIONS	Although sterilizing immunity to malaria can be elicited by irradiated sporozoite vaccination, no clinically practical subunit vaccine has been shown to be capable of preventing the approximately 600,000 annual deaths attributed to this infection. DNA vaccines offer several potential advantages for a disease that primarily affects the developing world, but new approaches are needed to improve the immunogenicity of these vaccines. By using a novel, lipid-based adjuvant, Vaxfectin, to attract immune cells to the immunization site, in combination with an antigen-chemokine DNA construct designed to target antigen to immature dendritic cells, we elicited a humoral immune response that provided sterilizing immunity to malaria challenge in a mouse model system. The chemokine, MIP3 alpha CCL20, did not significantly enhance the cellular infiltrate or levels of cytokine or chemokine expression at the immunization site but acted with Vaxfectin to reduce liver stage malaria infection by orders of magnitude compared to vaccine constructs lacking the chemokine component. The levels of protection achieved were equivalent to those observed with irradiated sporozoites, a candidate vaccine undergoing development for further large scale clinical trial. Only vaccination with the combined regimen of adjuvant and chemokine provided 80-100% protection against the development of bloodstream infection. Treating the immunization process as requiring the independent steps of 1) attracting antigen-presenting cells to the site of immunization and 2) specifically directing vaccine antigen to the immature dendritic cells that initiate the adaptive immune response may provide a rational strategy for the development of a clinically applicable malaria DNA vaccine.	[Luo, Kun; Zhang, Hong; Zavala, Fidel; Espinosa, Diego A.; Markham, Richard B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA; [Biragyn, Arya] NIA, Immunoregulat Sect, Lab Mol Biol & Immunol, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Markham, RB (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	rmarkham@jhsph.edu	Espinosa, Diego/AAT-6950-2020	Espinosa, Diego A./0000-0002-4364-5031	National Institutes of Health [AI073619]; Johns Hopkins University Malaria Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073619, R01AI044375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University Malaria Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health (Grant #AI073619) and the Johns Hopkins University Malaria Research Institute (http://malaria.jhsph.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Amante FH, 1997, PARASITE IMMUNOL, V19, P111, DOI 10.1046/j.1365-3024.1997.d01-187.x; Ambrosini E, 2005, J NEUROPATH EXP NEUR, V64, P706, DOI 10.1097/01.jnen.0000173893.01929.fc; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Biragyn A, 2004, BLOOD, V104, P1961, DOI 10.1182/blood-2004-02-0637; Biragyn A, 2002, BLOOD, V100, P1153, DOI 10.1182/blood-2002-01-0086; Biragyn A, 1999, NAT BIOTECHNOL, V17, P253, DOI 10.1038/6995; Biragyn A, 2001, J IMMUNOL, V167, P6644, DOI 10.4049/jimmunol.167.11.6644; Biragyn A, 2007, J IMMUNOL, V179, P1381, DOI 10.4049/jimmunol.179.2.1381; Bonelo A, 2000, EUR J IMMUNOL, V30, P3079, DOI 10.1002/1521-4141(200011)30:11&lt;3079::AID-IMMU3079&gt;3.0.CO;2-7; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Carvalho LH, 2001, J IMMUNOL METHODS, V252, P207, DOI 10.1016/S0022-1759(01)00331-3; CHAROENVIT Y, 1987, INFECT IMMUN, V55, P604, DOI 10.1128/IAI.55.3.604-608.1987; CHAROENVIT Y, 1990, B WORLD HEALTH ORGAN, V68, P26; CHAROENVIT Y, 1991, J IMMUNOL, V146, P1020; Cockburn IA, 2008, J IMMUNOL, V180, P64, DOI 10.4049/jimmunol.180.1.64; Cockburn IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000877; Cremel M, 2005, J LEUKOCYTE BIOL, V78, P158, DOI 10.1189/jlb.0305147; DELGIUDICE G, 1990, B WORLD HEALTH ORGAN, V68, P191; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Doolan DL, 2001, INT J PARASITOL, V31, P753, DOI 10.1016/S0020-7519(01)00184-9; Epstein JE, 2002, HUM GENE THER, V13, P1551, DOI 10.1089/10430340260201644; Finn JD, 2009, J VIROL, V83, P12027, DOI 10.1128/JVI.00593-09; Hafalla JCR, 2003, J IMMUNOL, V171, P964, DOI 10.4049/jimmunol.171.2.964; Hafalla JCR, 2002, P NATL ACAD SCI USA, V99, P11819, DOI 10.1073/pnas.182189999; Hafalla JCR, 2006, EUR J IMMUNOL, V36, P1179, DOI 10.1002/eji.200535712; Harris RC, 2012, J IMMUNOTHER, V35, P78, DOI 10.1097/CJI.0b013e31823731a4; Hartikka J, 2001, VACCINE, V19, P1911, DOI 10.1016/S0264-410X(00)00445-X; He S, 2008, J LEUKOCYTE BIOL, V84, P1549, DOI 10.1189/jlb.0708420; Hedstrom RC, 1998, INT J MOL MED, V2, P29; Hirao LA, 2008, VACCINE, V26, P440, DOI 10.1016/j.vaccine.2007.10.041; Hirao LA, 2011, J INFECT DIS, V203, P95, DOI 10.1093/infdis/jiq017; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; JAFFE RI, 1990, AM J TROP MED HYG, V42, P309, DOI 10.4269/ajtmh.1990.42.309; Kodama S, 2011, ACTA OTO-LARYNGOL, V131, P989, DOI 10.3109/00016489.2011.576429; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Lapteva N, 2010, EXPERT OPIN BIOL TH, V10, P725, DOI 10.1517/14712591003657128; Limbach K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-65; Loudon PT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011021; Luckay A, 2007, J VIROL, V81, P5257, DOI 10.1128/JVI.00055-07; Luke CJ, 1997, J INFECT DIS, V175, P91, DOI 10.1093/infdis/175.1.91; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Ma X, 2012, SCAND J IMMUNOL, V76, P521, DOI 10.1111/j.1365-3083.2012.02765.x; Rodriguez AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037801; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Nardin E, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P397; NARDIN EH, 1982, J EXP MED, V156, P20, DOI 10.1084/jem.156.1.20; Neimert-Andersson T, 2011, VACCINE, V29, P8965, DOI 10.1016/j.vaccine.2011.09.041; Nguyen-Hoai T, 2012, CANCER GENE THER, V19, P880, DOI 10.1038/cgt.2012.78; Noland GS, 2010, VACCINE, V28, P2917, DOI 10.1016/j.vaccine.2010.02.055; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Otten G, 2004, VACCINE, V22, P2489, DOI 10.1016/j.vaccine.2003.11.073; Patel V, 2010, VACCINE, V28, P4827, DOI 10.1016/j.vaccine.2010.04.064; PENNICA D, 1983, NATURE, V301, P214, DOI 10.1038/301214a0; Perales MA, 2002, CYTOKINES CELL MOL T, V7, P125, DOI 10.1080/13684730310000923; Persson C, 2002, J IMMUNOL, V169, P6681, DOI 10.4049/jimmunol.169.12.6681; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; RENIA L, 1993, J IMMUNOL, V150, P1471; Rodrigues EG, 1998, VACCINE, V16, P1812, DOI 10.1016/S0264-410X(98)00181-9; Rodrigues EG, 1997, J IMMUNOL, V158, P1268; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; Rosati M, 2009, P NATL ACAD SCI USA, V106, P15831, DOI 10.1073/pnas.0902628106; Rosenberg SA, 2003, HUM GENE THER, V14, P709, DOI 10.1089/104303403765255110; Sano G, 2001, J EXP MED, V194, P173, DOI 10.1084/jem.194.2.173; Scheiblhofer S, 2001, EUR J IMMUNOL, V31, P692, DOI 10.1002/1521-4141(200103)31:3&lt;692::AID-IMMU692&gt;3.0.CO;2-Y; SCHELLER LF, 1994, INFECT IMMUN, V62, P4844, DOI 10.1128/IAI.62.11.4844-4847.1994; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Sedegah M, 2006, VACCINE, V24, P1921, DOI 10.1016/j.vaccine.2005.10.041; Sedegah M, 2003, J IMMUNOL, V171, P3148, DOI 10.4049/jimmunol.171.6.3148; Sedegah M, 2010, VACCINE, V28, P3055, DOI 10.1016/j.vaccine.2009.10.044; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Shlapobersky M, 2012, J GEN VIROL, V93, P1305, DOI 10.1099/vir.0.040055-0; Shlapobersky M, 2009, VACCINE, V27, P6404, DOI 10.1016/j.vaccine.2009.06.087; Smith LR, 2010, VACCINE, V28, P2565, DOI 10.1016/j.vaccine.2010.01.029; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; Tsuji M, 2003, TRENDS PARASITOL, V19, P88, DOI 10.1016/S1471-4922(02)00053-3; Tsuji M, 2001, MOL IMMUNOL, V38, P433, DOI 10.1016/S0161-5890(01)00079-7; Vanderberg J, 2007, AM J PATHOL, V171, P1405, DOI 10.2353/ajpath.2007.070661; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; Veselenak RL, 2012, VACCINE, V30, P7046, DOI 10.1016/j.vaccine.2012.09.057; Vichier-Guerre S, 2003, J PEPT RES, V62, P117, DOI 10.1034/j.1399-3011.2003.00074.x; Wang RB, 1996, J IMMUNOL, V157, P4061; WANG RB, 1995, J IMMUNOL, V154, P2784; WEISS WR, 1989, J IMMUNOL, V143, P4263; Witney AA, 2001, MOL BIOCHEM PARASIT, V118, P233, DOI 10.1016/S0166-6851(01)00372-3; Wu YY, 2007, INFECT IMMUN, V75, P4357, DOI 10.1128/IAI.01660-06; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; ZAVALA F, 1991, RES IMMUNOL, V142, P654, DOI 10.1016/0923-2494(91)90144-8; ZAVALA F, 1985, SCIENCE, V228, P1436, DOI 10.1126/science.2409595; Zhao XJ, 2005, BIOMATERIALS, V26, P5048, DOI 10.1016/j.biomaterials.2004.12.003; Zheng Q, 2011, VACCINE, V29, P763, DOI 10.1016/j.vaccine.2010.11.014	94	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90413	10.1371/journal.pone.0090413	http://dx.doi.org/10.1371/journal.pone.0090413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599116	gold, Green Submitted, Green Published			2022-12-25	WOS:000332479400072
J	Shen, HX; Cao, JL; Hong, ZQ; Liu, K; Shi, J; Ding, L; Zhang, HD; Du, C; Li, Q; Zhang, ZD; Zhu, BL				Shen, Huanxi; Cao, Jinglian; Hong, Zhiqiang; Liu, Kai; Shi, Jian; Ding, Lu; Zhang, Hengdong; Du, Cheng; Li, Qian; Zhang, Zhengdong; Zhu, Baoli			A Functional Ser326Cys Polymorphism in hOGG1 Is Associated with Noise-Induced Hearing Loss in a Chinese Population	PLOS ONE			English	Article							BASE EXCISION-REPAIR; OXIDATIVE DNA-DAMAGE; GENE POLYMORPHISMS; INCREASES SUSCEPTIBILITY; OCCUPATIONAL-EXPOSURE; INNER-EAR; RISK; CANCER; WORKERS; 8-HYDROXYGUANINE	DNA damage to cochlear hair cells caused by 8-oxoguanine (8-oxoG) is essential for the development of noise-induced hearing loss (NIHL). Human 8-oxoG DNA glycosylase1 (hOGG1) is a key enzyme in the base excision repair (BER) pathway that eliminates 8-oxoG. Many epidemiological and functional studies have suggested that the hOGG1 Ser326Cys polymorphism (rs1052133) is associated with many diseases. The purpose of this investigation was to investigate whether the hOGG1 Ser326Cys polymorphism in the human BER pathway is associated with genetic susceptibility to NIHL in a Chinese population. This polymorphism was genotyped among 612 workers with NIHL and 615 workers with normal hearing. We found that individuals with the hOGG1 Cys/Cys genotype had a statistically significantly increased risk of NIHL compared with those who carried the hOGG1 Ser/Ser genotype (adjusted OR = 1.59, 95% CI = 1.13-2.25) and this increased risk was more pronounced among the workers in the 15- to 25- and >25-year noise exposure time, 85-92 dB(A) noise exposure level, ever smoking, and ever drinking groups, similar effects were also observed in a recessive model. In summary, our data suggested that the hOGG1 Cys/Cys genotype may be a genetic susceptibility marker for NIHL in the Chinese Han population.	[Shen, Huanxi; Hong, Zhiqiang; Shi, Jian; Du, Cheng] Kunshan Municipal Ctr Dis Prevent & Control, Kunshan, Peoples R China; [Shen, Huanxi; Cao, Jinglian; Ding, Lu; Zhang, Zhengdong; Zhu, Baoli] Nanjing Med Univ, Dept Environm Genom, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Cao, Jinglian; Ding, Lu; Zhang, Hengdong; Zhu, Baoli] Jiangsu Prov Ctr Dis Prevent & Control, Inst Occupat Dis Prevent, Nanjing, Jiangsu, Peoples R China; [Liu, Kai] Drum Tower Hosp Grp Nanjing, Yizheng Hosp, Dept Dis Prevent & Control, Yizheng, Peoples R China; [Zhang, Zhengdong] Nanjing Med Univ, Sch Publ Hlth, Dept Genet Toxicol, Key Lab Modern Toxicol,Minist Educ, Nanjing, Jiangsu, Peoples R China; [Li, Qian] First Peoples Hosp Kunshan, Kunshan, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zhang, ZD (corresponding author), Nanjing Med Univ, Dept Environm Genom, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Jiangsu, Peoples R China.	drzdzhang@gmail.com; zhubl@jscdc.cn	zhang, zheng/HCH-9684-2022		Jiangsu Province's Outstanding Medical Academic Leader program [LJ201130]; Natural Science Foundation of Jiangsu Province [BK2010080]; Key Program for Basic Research of Jiangsu Provincial Department of Education [08KJA330001]	Jiangsu Province's Outstanding Medical Academic Leader program; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Key Program for Basic Research of Jiangsu Provincial Department of Education	This study was mainly supported by Jiangsu Province's Outstanding Medical Academic Leader program (LJ201130), and was partly supported by Natural Science Foundation of Jiangsu Province (BK2010080), the Key Program for Basic Research of Jiangsu Provincial Department of Education (08KJA330001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bravard A, 2009, CANCER RES, V69, P3642, DOI 10.1158/0008-5472.CAN-08-3943; CHENG KC, 1992, J BIOL CHEM, V267, P166; Christmann M, 2003, TOXICOLOGY, V193, P3, DOI 10.1016/S0300-483X(03)00287-7; Collins AR, 2007, MOL ASPECTS MED, V28, P307, DOI 10.1016/j.mam.2007.05.005; Curhan SG, 2011, EAR HEARING, V32, P46, DOI 10.1097/AUD.0b013e3181f46a2f; Dahle J, 2008, CANCER LETT, V267, P18, DOI 10.1016/j.canlet.2008.03.002; Fortunato G, 2004, CLIN CHEM, V50, P2012, DOI 10.1373/clinchem.2004.037788; Goukassian D, 2000, FASEB J, V14, P1325, DOI 10.1096/fj.14.10.1325; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Hill JW, 2006, NUCLEIC ACIDS RES, V34, P1620, DOI 10.1093/nar/gkl060; Holme RH, 2004, JARO-J ASSOC RES OTO, V5, P66, DOI 10.1007/s10162-003-4021-2; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Itoh A, 2001, PUBLIC HEALTH, V115, P192; Jacono AA, 1998, HEARING RES, V117, P31, DOI 10.1016/S0378-5955(97)00214-1; Jiao XY, 2007, INT J CANCER, V121, P501, DOI 10.1002/ijc.22748; Karlsmose B, 2000, BRIT J AUDIOL, V34, P47, DOI 10.3109/03005364000000117; Kim JI, 2003, WORLD J GASTROENTERO, V9, P956; Kohno T, 1998, ONCOGENE, V16, P3219, DOI 10.1038/sj.onc.1201872; Konings A, 2009, ANN HUM GENET, V73, P215, DOI 10.1111/j.1469-1809.2008.00499.x; Konings A, 2007, HUM MOL GENET, V16, P1872, DOI 10.1093/hmg/ddm135; Konings A, 2009, EAR HEARING, V30, P151, DOI 10.1097/AUD.0b013e3181987080; Konings A, 2009, EUR J HUM GENET, V17, P329, DOI 10.1038/ejhg.2008.172; Kozel PJ, 2002, HEARING RES, V164, P231, DOI 10.1016/S0378-5955(01)00420-8; Li Q, 2011, CANCER SCI, V102, P1123, DOI 10.1111/j.1349-7006.2011.01928.x; Li XT, 2013, J OCCUP HEALTH, V55, P56, DOI 10.1539/joh.12-0242-OA; Mizoue T, 2003, OCCUP ENVIRON MED, V60, P56, DOI 10.1136/oem.60.1.56; Nakamura M, 2001, J Epidemiol, V11, P81; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P237, DOI 10.1159/000013847; Ohlemiller KK, 2000, JARO-J ASSOC RES OTO, V1, P243, DOI 10.1007/s101620010043; Okasaka T, 2009, J HUM GENET, V54, P739, DOI 10.1038/jhg.2009.108; Palmer KT, 2004, OCCUP ENVIRON MED, V61, P340, DOI 10.1136/oem.2003.009183; Pawelczyk M, 2009, ANN HUM GENET, V73, P411, DOI 10.1111/j.1469-1809.2009.00521.x; Peng T, 2003, WORLD J GASTROENTERO, V9, P2186; Popelka MM, 2000, J AM GERIATR SOC, V48, P1273, DOI 10.1111/j.1532-5415.2000.tb02601.x; Rabinowitz PM, 2002, HEARING RES, V173, P164, DOI 10.1016/S0378-5955(02)00350-7; Shen HX, 2012, J OCCUP ENVIRON MED, V54, P1157, DOI 10.1097/JOM.0b013e31825902ce; Sliwinska-Kowalska M, 2004, J OCCUP ENVIRON MED, V46, P30, DOI 10.1097/01.jom.0000105912.29242.5b; Sliwinska-Kowalska M, 2013, MUTAT RES-REV MUTAT, V752, P61, DOI 10.1016/j.mrrev.2012.11.001; Totonchy MB, 2013, BRAIN, V136, P194, DOI 10.1093/brain/aws317; Van Laer L, 2006, HUM MUTAT, V27, P786, DOI 10.1002/humu.20360; Xing DY, 2001, INT J CANCER, V95, P140, DOI 10.1002/1097-0215(20010520)95:3&lt;140::AID-IJC1024&gt;3.0.CO;2-2; Xu JF, 2002, CANCER RES, V62, P2253; Yamane A, 2004, CARCINOGENESIS, V25, P1689, DOI 10.1093/carcin/bgh166; Yang M, 2006, CELL STRESS CHAPERON, V11, P233, DOI 10.1379/CSC-192R.1	44	28	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89662	10.1371/journal.pone.0089662	http://dx.doi.org/10.1371/journal.pone.0089662			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599382	Green Submitted, Green Published, gold			2022-12-25	WOS:000332479400023
J	Zhang, Q; Jorgensen, TJD; Nielsen, PE; Mollegaard, NE				Zhang, Qiang; Jorgensen, Thomas J. D.; Nielsen, Peter E.; Mollegaard, Niels Erik			A Phosphorylation Tag for Uranyl Mediated Protein Purification and Photo Assisted Tag Removal	PLOS ONE			English	Article							RECOMBINANT PROTEINS; ESCHERICHIA-COLI; AFFINITY TAGS; FUSION PROTEINS; KINASE CK2; CLEAVAGE; CHROMATOGRAPHY; PEPTIDES; STRATEGIES; THROMBIN	Most protein purification procedures include an affinity tag fused to either the N or C-terminal end of the protein of interest as well as a procedure for tag removal. Tag removal is not straightforward and especially tag removal from the C-terminal end is a challenge due to the characteristics of enzymes available for this purpose. In the present study, we demonstrate the utility of the divalent uranyl ion in a new procedure for protein purification and tag removal. By employment of a GFP (green florescence protein) recombinant protein we show that uranyl binding to a phosphorylated C-terminal tag enables target protein purification from an E. coli extract by immobilized uranyl affinity chromatography. Subsequently, the tag can be efficiently removed by UV-irradiation assisted uranyl photocleavage. We therefore suggest that the divalent uranyl ion (UO22+) may provide a dual function in protein purification and subsequent C-terminal tag removal procedures.	[Zhang, Qiang; Nielsen, Peter E.; Mollegaard, Niels Erik] Univ Copenhagen, Dept Cellular & Mol Med, Fac Hlth Sci, Copenhagen N, Denmark; [Jorgensen, Thomas J. D.] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense M, Denmark	University of Copenhagen; University of Southern Denmark	Mollegaard, NE (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Fac Hlth Sci, Copenhagen N, Denmark.	nielsem@sund.ku.dk		/0000-0001-8771-330X; Mollegaard, Niels Erik/0000-0002-8255-3711; Jorgensen, Thomas J.D./0000-0002-7149-316X	Faculty of Health Sciences, University of Copenhagen	Faculty of Health Sciences, University of Copenhagen	Faculty of Health Sciences, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Araujo APU, 2000, BIOCHEM BIOPH RES CO, V272, P480, DOI 10.1006/bbrc.2000.2802; Arnau J, 2006, PROTEIN EXPRES PURIF, V48, P1, DOI 10.1016/j.pep.2005.12.002; Austin BP, 2011, PROTEIN EXPRES PURIF, V77, P53, DOI 10.1016/j.pep.2010.11.005; Chant A, 2005, PROTEIN EXPRES PURIF, V39, P152, DOI 10.1016/j.pep.2004.10.017; COLLINSRACIE LA, 1995, BIO-TECHNOL, V13, P982, DOI 10.1038/nbt0995-982; Duff MR, 2006, ANGEW CHEM INT EDIT, V45, P137, DOI 10.1002/anie.200502344; Fairlie WD, 2002, PROTEIN EXPRES PURIF, V26, P171; Goltermann L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010104; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Jenny RJ, 2003, PROTEIN EXPRES PURIF, V31, P1, DOI 10.1016/S1046-5928(03)00168-2; Kenig M, 2006, J CHROMATOGR A, V1101, P293, DOI 10.1016/j.chroma.2005.09.089; Kristensen LH, 2008, CHEMBIOCHEM, V9, P2377, DOI 10.1002/cbic.200800387; Lichty JJ, 2005, PROTEIN EXPRES PURIF, V41, P98, DOI 10.1016/j.pep.2005.01.019; Liew OW, 2005, PROTEIN EXPRES PURIF, V41, P332, DOI 10.1016/j.pep.2005.03.006; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; MCCLELLAND M, 1984, P NATL ACAD SCI-BIOL, V81, P983, DOI 10.1073/pnas.81.4.983; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1994, CELL MOL BIOL RES, V40, P401; MORAND K, 1993, RAPID COMMUN MASS SP, V7, P738, DOI 10.1002/rcm.1290070811; NAGAI K, 1984, NATURE, V309, P810, DOI 10.1038/309810a0; Nilsson J, 1997, PROTEIN EXPRES PURIF, V11, P1, DOI 10.1006/prep.1997.0767; Pardoux R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041922; Pedersen J, 1999, PROTEIN EXPRES PURIF, V15, P389, DOI 10.1006/prep.1999.1038; Posewitz MC, 1999, ANAL CHEM, V71, P2883, DOI 10.1021/ac981409y; Rais-Beghdadi C, 1998, APPL BIOCHEM BIOTECH, V74, P95, DOI 10.1007/BF02787176; Renzi F, 2006, ACTA CRYSTALLOGR F, V62, P298, DOI 10.1107/S1744309106006373; Roggero MA, 1997, FEBS LETT, V408, P285, DOI 10.1016/S0014-5793(97)00441-9; Sykora C, 2007, PROTEIN PEPTIDE LETT, V14, P489, DOI 10.2174/092986607780782849; TAN AK, 1995, BIOCHEMISTRY-US, V34, P5811, DOI 10.1021/bi00017a012; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; Waugh DS, 2005, TRENDS BIOTECHNOL, V23, P316, DOI 10.1016/j.tibtech.2005.03.012; Woestenenk Esmeralda A., 2004, Journal of Structural and Functional Genomics, V5, P217, DOI 10.1023/B:jsfg.0000031965.37625.0e	33	4	4	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e91138	10.1371/journal.pone.0091138	http://dx.doi.org/10.1371/journal.pone.0091138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599526	Green Submitted, Green Published, gold			2022-12-25	WOS:000332479400156
J	Amin, MT; Nawaz, M; Amin, MN; Han, M				Amin, Muhammad T.; Nawaz, Mohsin; Amin, Muhammad N.; Han, Mooyoung			Solar Disinfection of Pseudomonas aeruginosa in Harvested Rainwater: A Step towards Potability of Rainwater	PLOS ONE			English	Article							DRINKING-WATER; PLASTIC BOTTLES; INACTIVATION; SODIS; QUALITY; SIMULATION; PATHOGENS; RADIATION; MATTER; COLI	Efficiency of solar based disinfection of Pseudomonas aeruginosa (P. aeruginosa) in rooftop harvested rainwater was evaluated aiming the potability of rainwater. The rainwater samples were exposed to direct sunlight for about 8-9 hours and the effects of water temperature (degrees C), sunlight irradiance (W/m(2)), different rear surfaces of polyethylene terephthalate bottles, variable microbial concentrations, pH and turbidity were observed on P. aeruginosa inactivation at different weathers. In simple solar disinfection (SODIS), the complete inactivation of P. aeruginosa was obtained only under sunny weather conditions (>50 degrees C and >700 W/m(2)) with absorptive rear surface. Solar collector disinfection (SOCODIS) system, used to improve the efficiency of simple SODIS under mild and weak weather, completely inactivated the P. aeruginosa by enhancing the disinfection efficiency of about 20% only at mild weather. Both SODIS and SOCODIS systems, however, were found inefficient at weak weather. Different initial concentrations of P. aeruginosa and/or Escherichia coli had little effects on the disinfection efficiency except for the SODIS with highest initial concentrations. The inactivation of P. aeruginosa increased by about 10-15% by lowering the initial pH values from 10 to 3. A high initial turbidity, adjusted by adding kaolin, adversely affected the efficiency of both systems and a decrease, about 15-25%; in inactivation of P. aeruginosa was observed. The kinetics of this study was investigated by Geeraerd Model for highlighting the best disinfection system based on reaction rate constant. The unique detailed investigation of P. aeruginosa disinfection with sunlight based disinfection systems under different weather conditions and variable parameters will help researchers to understand and further improve the newly invented SOCODIS system.	[Amin, Muhammad T.; Nawaz, Mohsin] King Saud Univ, Alamoudi Water Res Chair, Riyadh, Saudi Arabia; [Amin, Muhammad N.] King Faisal Univ, Coll Engn, Dept Civil & Environm Engn, Al Hofuf Al Ahsa, Saudi Arabia; [Han, Mooyoung] Seoul Natl Univ, Civil & Environm Engn Dept, Seoul, South Korea	King Saud University; Seoul National University (SNU)	Amin, MT (corresponding author), King Saud Univ, Alamoudi Water Res Chair, Riyadh, Saudi Arabia.	mtamin@ksu.edu.sa	Amin, Muhammad Tahir/G-1525-2011; Amin, Muhammad Nasir/D-2089-2014	Amin, Muhammad Tahir/0000-0001-8283-9958; Amin, Muhammad Nasir/0000-0001-6524-4389	National Plan of Science and Technology (NPST) at King Saud University [11-WAT1875-02]	National Plan of Science and Technology (NPST) at King Saud University	Authors would like to thank and extend their sincere appreciation to the National Plan of Science and Technology (NPST) at King Saud University for the financial support through Project # 11-WAT1875-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acra A, 1984, UNICEF GUIDELINES HO; Albrechtsen HJ, 2002, WATER SCI TECHNOL, V46, P311, DOI 10.2166/wst.2002.0694; American Public Health Association, 2012, INDIAN J ENV SCI, V22nd ed.; Amin MT, 2011, DESALINATION, V276, P416, DOI 10.1016/j.desal.2011.03.076; Amin M. T., 2007, Water Science and Technology: Water Supply, V7, P185, DOI 10.2166/ws.2007.109; Amin MT, 2009, WATER RES, V43, P5225, DOI 10.1016/j.watres.2009.08.041; Amin MT, 2009, WATER SCI TECHNOL, V60, P419, DOI 10.2166/wst.2009.347; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bosshard F, 2010, ENVIRON MICROBIOL, V12, P2931, DOI 10.1111/j.1462-2920.2010.02268.x; Conroy RM, 1996, LANCET, V348, P1695, DOI 10.1016/S0140-6736(96)02309-4; Dayem AMA, 2011, DESALIN WATER TREAT, V36, P119, DOI 10.5004/dwt.2011.2227; El Ghetany HH, 2010, DESALIN WATER TREAT, V20, P11, DOI 10.5004/dwt.2010.1207; Fennema, 1996, FOOD CHEM, P879; Fisher MB, 2008, J WATER HEALTH, V6, P35, DOI 10.2166/wh.2007.005; Geeraerd AH, 2000, INT J FOOD MICROBIOL, V59, P185, DOI 10.1016/S0168-1605(00)00362-7; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; Gomez-Couso H, 2010, AM J TROP MED HYG, V82, P35, DOI 10.4269/ajtmh.2010.09-0284; Han MY, 2007, WATER SCI TECHNOL, V56, P73, DOI 10.2166/wst.2007.778; Hobbins M, 2003, J WATER SUPPLY RES T, V56, P245; Joyce TM, 1996, APPL ENVIRON MICROB, V62, P399, DOI 10.1128/AEM.62.2.399-402.1996; Kaushik R, 2012, APPL ENVIRON MICROB, V78, P2813, DOI 10.1128/AEM.07695-11; Kaushik R, 2012, ATMOS ENVIRON, V46, P131, DOI 10.1016/j.atmosenv.2011.10.013; Kehoe SC, 2001, WATER RES, V35, P1061, DOI 10.1016/S0043-1354(00)00353-5; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020; Lilya D, 2001, THESIS U IDAHO MOSCO; Lonnen J, 2005, WATER RES, V39, P877, DOI 10.1016/j.watres.2004.11.023; McGuigan KG, 1998, J APPL MICROBIOL, V84, P1138, DOI 10.1046/j.1365-2672.1998.00455.x; Miguntanna NS, 2010, DESALIN WATER TREAT, V19, P205, DOI 10.5004/dwt.2010.1886; Morais PV, 1997, APPL ENVIRON MICROB, V63, P851, DOI 10.1128/AEM.63.3.851-856.1997; National Health and Medical Reasearch Council, 2018, AUSTR COD RESP COND; Nawaz M, 2012, SCI TOTAL ENVIRON, V431, P20, DOI 10.1016/j.scitotenv.2012.05.022; Oates PM, 2003, WATER RES, V37, P47, DOI 10.1016/S0043-1354(02)00241-5; Read RH, 1997, LETT APPL MICROBIOL, V24, P276, DOI 10.1046/j.1472-765X.1997.00130.x; Rijal GK, 2001, WATER SCI TECHNOL, V43, P155, DOI 10.2166/wst.2001.0728; Rincon AG, 2004, APPL CATAL B-ENVIRON, V51, P283, DOI 10.1016/j.apcatb.2004.03.007; Schmid P, 2008, WATER RES, V42, P5054, DOI 10.1016/j.watres.2008.09.025; Sommer B, 1997, J WATER SUPPLY RES T, V46, P127; Uba BN, 2000, J WATER SUPPLY RES T, V49, P281, DOI 10.2166/aqua.2000.0024; Ubomba-Jaswa E, 2009, PHOTOCH PHOTOBIO SCI, V8, P587, DOI 10.1039/b816593a; Vialle C, 2012, WATER RESOUR MANAG, V26, P2233, DOI 10.1007/s11269-012-0012-6; Wegelin M, 2001, J WATER SUPPLY RES T, V50, P125, DOI 10.2166/aqua.2001.0012; Wegelin M., 1994, J WATER SRT AQUA, V43, P154; WHO/UNICEF Joint Monitoring Programme, 2012, PROGR DRINK WAT SAN	43	9	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90743	10.1371/journal.pone.0090743	http://dx.doi.org/10.1371/journal.pone.0090743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595188	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900143
J	Herbert, C; Shadie, AM; Bunting, MM; Tedla, N; Garthwaite, L; Freeman, A; Yoo, H; Park, SH; Kumar, RK				Herbert, Cristan; Shadie, Alexander M.; Bunting, Melissa M.; Tedla, Nicodemus; Garthwaite, Linda; Freeman, Araluen; Yoo, Hyouna; Park, Sang-Ho; Kumar, Rakesh K.			Anti-Inflammatory and Anti-Remodelling Effects of ISU201, a Modified Form of the Extracellular Domain of Human BST2, in Experimental Models of Asthma: Association with Inhibition of Histone Acetylation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC ALLERGEN CHALLENGE; STROMAL CELL ANTIGEN-2; MURINE CHRONIC ASTHMA; FACTOR-KAPPA-B; AIRWAY INFLAMMATION; MOUSE; EXACERBATION; CYTOKINE; HYPERREACTIVITY	There are few alternatives to glucocorticosteroids for treatment of asthma. We assessed the activity of a novel protein drug designated ISU201, the extracellular domain of the human cell surface protein BST2, stabilised by fusion with the Fc region of IgG, in mouse models of mild chronic asthma and an acute exacerbation of asthma. The ability of ISU201 to suppress airway inflammation and remodelling was compared with that of dexamethasone. Female BALB/c mice were systemically sensitised with ovalbumin, then received controlled low-level challenge with aerosolised ovalbumin for 6 weeks, which induced lesions of mild chronic asthma, and were treated with drugs during the final 2 weeks. Alternatively, sensitised mice received 4 weeks of chronic low-level challenge and were treated 24 and 2 hours before a final single moderate-level challenge, which triggered acute airway inflammation simulating an asthmatic exacerbation. Inflammation and remodelling were quantified, as was the expression of pro-inflammatory cytokines in bronchoalveolar lavage fluid and tissues. To identify cellular targets of ISU201, we assessed the effects of the drug on activated lymphocytes, macrophages and airway epithelial cells. In the model of mild chronic asthma, ISU201 was as effective as dexamethasone in suppressing airway inflammation and most changes of remodelling. In the model of an allergen-induced acute exacerbation of chronic asthma, ISU201 was also an effective anti-inflammatory agent, although it was less active than dexamethasone. The drug acted on multiple cellular targets, suppressing production of pro-inflammatory cytokines by lymphocytes and macrophages. ISU201 significantly reduced acetylation of histone H4 in airway epithelial cells, suggesting at least one potential mechanism of action. We conclude that in these models of asthma, ISU201 is a broad-spectrum inhibitor of both airway inflammation and remodelling. Thus, unlike drugs which target specific mediators, it could potentially be an alternative or an adjunct to glucocorticoids for the treatment of asthma.	[Herbert, Cristan; Shadie, Alexander M.; Bunting, Melissa M.; Tedla, Nicodemus; Garthwaite, Linda; Freeman, Araluen; Kumar, Rakesh K.] Univ New S Wales, Inflammat & Infect Res Ctr, Sch Med Sci, Sydney, NSW, Australia; [Yoo, Hyouna; Park, Sang-Ho] Isu Abxis Co Ltd, Seoul, South Korea	University of New South Wales Sydney	Kumar, RK (corresponding author), Univ New S Wales, Inflammat & Infect Res Ctr, Sch Med Sci, Sydney, NSW, Australia.	R.Kumar@unsw.edu.au	Kumar, Rakesh/ABD-1065-2020; Kumar, Rakesh K/J-6124-2012	Kumar, Rakesh/0000-0001-7664-0803; Kumar, Rakesh K/0000-0002-9531-8411	Australian Research Council [LP110200170]; Isu Abxis Co., Ltd.	Australian Research Council(Australian Research Council); Isu Abxis Co., Ltd.	This work was supported by an Australian Research Council Linkage Project grant (LP110200170) with Isu Abxis Co., Ltd. as the commercial partner. The Australian Research Council had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Isu Abxis Co., Ltd. supplied ISU201 as a gift to the laboratory, advised about appropriate dosage and delivery of the drug, and provided access to unpublished data. Two of the authors are employees of Isu Abxis Co., Ltd. These authors contributed to study design, decision to publish, and preparation of the manuscript.	Barnes PJ, 2010, TRENDS PHARMACOL SCI, V31, P335, DOI 10.1016/j.tips.2010.04.009; Barnes Peter J, 2009, Proc Am Thorac Soc, V6, P693, DOI 10.1513/pats.200907-071DP; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Bunting MM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/250938; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Dougherty RH, 2009, CLIN EXP ALLERGY, V39, P193, DOI 10.1111/j.1365-2222.2008.03157.x; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Foster PS, 2000, LAB INVEST, V80, P655, DOI 10.1038/labinvest.3780068; Fulkerson PC, 2005, CLIN EXP ALLERGY, V35, P1251, DOI 10.1111/j.1365-2222.2005.02354.x; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Hart LA, 1998, AM J RESP CRIT CARE, V158, P1585, DOI 10.1164/ajrccm.158.5.9706116; Herbert C, 2008, CLIN EXP ALLERGY, V38, P847, DOI 10.1111/j.1365-2222.2008.02950.x; Herbert C, 2013, DIS MODEL MECH, V6, P479, DOI 10.1242/dmm.010728; Herbert C, 2010, AM J PATHOL, V177, P1657, DOI 10.2353/ajpath.2010.100019; Holt PG, 2010, J ALLERGY CLIN IMMUN, V125, P963, DOI 10.1016/j.jaci.2010.02.011; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Korsgren M, 1997, J EXP MED, V185, P885, DOI 10.1084/jem.185.5.885; Kumar RK, 1997, EXP LUNG RES, V23, P427, DOI 10.3109/01902149709039236; Kumar RK, 2003, J PHARMACOL EXP THER, V307, P349, DOI 10.1124/jpet.103.053819; Kumar RK, 2013, MIDDLETONS ALLERGY, P986; Marks G. B., 2011, ASTHMA AUSTR 2011; MBAWUIKE IN, 1989, J LEUKOCYTE BIOL, V46, P119, DOI 10.1002/jlb.46.2.119; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Poynter ME, 2002, AM J PATHOL, V160, P1325, DOI 10.1016/S0002-9440(10)62559-X; Schneider T, 1996, J IMMUNOL METHODS, V198, P1, DOI 10.1016/0022-1759(96)00143-3; Shifren Adrian, 2012, J Allergy (Cairo), V2012, P316049, DOI 10.1155/2012/316049; Shore SA, 2003, AM J RESP CRIT CARE, V168, P910, DOI 10.1164/rccm.2307006; Siegle JS, 2006, AM J RESP CELL MOL, V35, P565, DOI 10.1165/rcmb.2006-0135OC; Swiecki M, 2012, J IMMUNOL, V188, P2488, DOI 10.4049/jimmunol.1103145; Tavano B, 2013, J IMMUNOL, V190, P2622, DOI 10.4049/jimmunol.1202391; Temelkovski J, 1998, THORAX, V53, P849, DOI 10.1136/thx.53.10.849; Tsaprouni LG, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-1; Wang W, 2010, CURR DRUG TARGETS, V11, P957, DOI 10.2174/138945010791591412; Ward C, 2002, THORAX, V57, P309, DOI 10.1136/thorax.57.4.309; Webb DC, 2000, J IMMUNOL, V165, P108, DOI 10.4049/jimmunol.165.1.108; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Yoo H, 2011, CELL IMMUNOL, V267, P23, DOI 10.1016/j.cellimm.2010.10.011	39	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90436	10.1371/journal.pone.0090436	http://dx.doi.org/10.1371/journal.pone.0090436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594933	Green Submitted, Green Published, gold			2022-12-25	WOS:000332468900110
J	Sui, HS; Yi, YL; Yao, JR; Liang, B; Sun, XS; Hu, SM; Uc, A; Nelson, DJ; Ode, KL; Philipson, LH; Engelhardt, JF; Norris, AW				Sui, Hongshu; Yi, Yaling; Yao, Jianrong; Liang, Bo; Sun, Xingshen; Hu, Shanming; Uc, Aliye; Nelson, Deborah J.; Ode, Katie Larson; Philipson, Louis H.; Engelhardt, John F.; Norris, Andrew W.			Quantifying Insulin Sensitivity and Entero-Insular Responsiveness to Hyper- and Hypoglycemia in Ferrets	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; BETA-CELL FUNCTION; HYPERGLYCEMIC CLAMP; GLUCOSE-METABOLISM; DIABETES-MELLITUS; SKELETAL-MUSCLE; HUMAN OBESITY; ORAL GLUCOSE; FATTY-ACIDS; RESISTANCE	Ferrets are an important emerging model of cystic fibrosis related diabetes. However, there is little documented experience in the use of advanced techniques to quantify aspects of diabetes pathophysiology in the ferret. Glycemic clamps are the gold standard technique to assess both insulin sensitivity and insulin secretion in humans and animal models of diabetes. We therefore sought to develop techniques for glycemic clamps in ferrets. To assess insulin sensitivity, we performed euglycemic hyperinsulinemic clamps in 5-6 week old ferrets in the anesthetized and conscious states. To assess insulin secretion, we performed hyperglycemic clamps in conscious ferrets. To evaluate responsiveness of ferret islet and entero-insular hormones to low glucose, a portion of the hyperglycemic clamps were followed by a hypoglycemic clamp. The euglycemic hyperinsulinemic clamps demonstrated insulin responsiveness in ferrets similar to that previously observed in humans and rats. The anesthetic isoflurane induced marked insulin resistance, whereas lipid emulsion induced mild insulin resistance. In conscious ferrets, glucose appearance was largely suppressed at 4 mU/kg/min insulin infusion, whereas glucose disposal was progressively increased at 4 and 20 mU/kg/min insulin. Hyperglycemic clamp induced first phase insulin secretion. Hypoglycemia induced a rapid diminishment of insulin, as well as a rise in glucagon and pancreatic polypeptide levels. The incretins GLP-1 and GIP were affected minimally by hyperglycemic and hypoglycemic clamp. These techniques will prove useful in better defining the pathophysiology in ferrets with cystic fibrosis related diabetes.	[Sui, Hongshu; Yi, Yaling; Liang, Bo; Sun, Xingshen; Engelhardt, John F.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Yao, Jianrong; Hu, Shanming; Uc, Aliye; Ode, Katie Larson; Norris, Andrew W.] Univ Iowa, Carver Coll Med, Dept Pediat, Iowa City, IA USA; [Sui, Hongshu] Taishan Med Univ, Dept Histol & Embryol, Tai An, Shandong, Peoples R China; [Nelson, Deborah J.] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; [Philipson, Louis H.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Engelhardt, John F.; Norris, Andrew W.] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA USA	University of Iowa; University of Iowa; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Chicago; University of Chicago; University of Iowa	Engelhardt, JF (corresponding author), Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA.	john-engelhardt@uiowa.edu; andrew-norris@uiowa.edu	Norris, Andrew W/O-5499-2018	Norris, Andrew W/0000-0001-8396-9543; Larson Ode, Katie/0000-0002-1086-9135; Engelhardt, John/0000-0003-2389-9277; Uc, Aliye/0000-0003-2004-5743	National Institutes of Health [R24 DK096518, R01 DK097820]; Fraternal Order of Eagles Diabetes Research Center; University of Iowa Center for Gene Therapy [DK54759]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL123482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, P30DK054759, R01DK097820, R24DK096518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fraternal Order of Eagles Diabetes Research Center; University of Iowa Center for Gene Therapy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R24 DK096518 (to J.F.E., A.W.N., D.J.N.), R01 DK097820 (to A.U. & A.W.N.), a Fraternal Order of Eagles Diabetes Research Center grant (to A.W.N.), and the University of Iowa Center for Gene Therapy (DK54759). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN A, 1994, J CLIN ENDOCR METAB, V79, P80, DOI 10.1210/jc.79.1.80; Ball RS, 2006, ILAR J, V47, P348, DOI 10.1093/ilar.47.4.348; Battezzati A, 2007, EUR J ENDOCRINOL, V156, P369, DOI 10.1530/eje.1.02344; Bell J A, 1999, Vet Clin North Am Exot Anim Pract, V2, P169; Bell JA, 1999, VET CLIN N AM EXOT A, V2, pviii; Boari A, 2010, VET RES COMMUN, V34, pS107, DOI 10.1007/s11259-010-9369-2; BODEN G, 1995, J CLIN INVEST, V96, P1261, DOI 10.1172/JCI118160; BONORA E, 1990, ACTA DIABETOL LAT, V27, P309, DOI 10.1007/BF02580935; Chen Sue, 2008, Vet Clin North Am Exot Anim Pract, V11, P107, DOI 10.1016/j.cvex.2007.09.001; Davis SN, 2000, DIABETES, V49, P1897, DOI 10.2337/diabetes.49.11.1897; DEFRONZO RA, 1978, J CLIN INVEST, V62, P204, DOI 10.1172/JCI109108; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEFRONZO RA, 1977, DIABETES, V26, P445, DOI 10.2337/diabetes.26.5.445; Hardin DS, 2008, J INVEST MED, V56, P567, DOI 10.2310/JIM.0b013e3181671788; Hardin DS, 1999, DIABETES, V48, P1082, DOI 10.2337/diabetes.48.5.1082; Hardin DS, 2001, AM J PHYSIOL-ENDOC M, V281, pE1022, DOI 10.1152/ajpendo.2001.281.5.E1022; HASEGAWA S, 1992, J VET MED SCI, V54, P583, DOI 10.1292/jvms.54.583; Hillman M, 2012, J CYST FIBROS, V11, P144, DOI 10.1016/j.jcf.2011.11.001; HOLL RW, 1995, EUR J PEDIATR, V154, P356, DOI 10.1007/s004310050303; HORBER FF, 1990, ANESTHESIOLOGY, V73, P82, DOI 10.1097/00000542-199007000-00013; Hu SM, 2012, MOL ENDOCRINOL, V26, P977, DOI 10.1210/me.2011-1253; Kim JK, 1996, DIABETES, V45, P446, DOI 10.2337/diabetes.45.4.446; KOLTERMAN OG, 1980, J CLIN INVEST, V65, P1272, DOI 10.1172/JCI109790; Kuo P, 2011, J CLIN ENDOCR METAB, V96, pE851, DOI 10.1210/jc.2010-2460; LAAGER R, 1993, J CLIN INVEST, V92, P1903, DOI 10.1172/JCI116783; LAM WF, 1993, DIGESTION, V54, P48, DOI 10.1159/000201011; LANNG S, 1993, ACTA ENDOCRINOL-COP, V128, P207, DOI 10.1530/acta.0.1280207; MORAN A, 1994, DIABETES, V43, P1020, DOI 10.2337/diabetes.43.8.1020; Olivier AK, 2012, J CLIN INVEST, V122, P3755, DOI 10.1172/JCI60610; Otis CR, 2003, COMPARATIVE MED, V53, P53; Phair KA, 2011, J AM ASSOC LAB ANIM, V50, P531; Poulsen PL, 2000, METABOLISM, V49, P1598, DOI 10.1053/meta.2000.18558; Quon BS, 2012, PAEDIATR RESPIR REV, V13, P206, DOI 10.1016/j.prrv.2012.03.005; Radike Kerstin, 2011, Diabetes Care, V34, pe43, DOI 10.2337/dc10-2286; RAKOTOAMBININA B, 1994, PEDIATR RES, V36, P667, DOI 10.1203/00006450-199411000-00024; REDMOND AOB, 1977, ACTA PAEDIATR SCAND, V66, P199, DOI 10.1111/j.1651-2227.1977.tb07833.x; ROSENTHAL KL, 1993, AM J VET RES, V54, P29; Slingerland LI, 2007, HORM METAB RES, V39, P341, DOI 10.1055/s-2007-976541; SMITH D, 1987, METABOLISM, V36, P1167, DOI 10.1016/0026-0495(87)90244-7; STATEN M, 1984, METABOLISM, V33, P132, DOI 10.1016/0026-0495(84)90125-2; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; Sun X, 2008, J CLIN INVEST, V118, P1578, DOI 10.1172/JCI34599; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; VERDONK CA, 1980, J CLIN INVEST, V65, P1119, DOI 10.1172/JCI109765; Woerle HJ, 2012, DIABETES, V61, P2349, DOI 10.2337/db11-1701; Wyre Nicole R, 2013, Vet Clin North Am Exot Anim Pract, V16, P469, DOI 10.1016/j.cvex.2013.02.003	46	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90519	10.1371/journal.pone.0090519	http://dx.doi.org/10.1371/journal.pone.0090519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594704	Green Submitted, Green Published, gold			2022-12-25	WOS:000332468900115
J	Thakur, N; Upadhyay, SK; Verma, PC; Chandrashekar, K; Tuli, R; Singh, PK				Thakur, Nidhi; Upadhyay, Santosh Kumar; Verma, Praveen C.; Chandrashekar, Krishnappa; Tuli, Rakesh; Singh, Pradhyumna K.			Enhanced Whitefly Resistance in Transgenic Tobacco Plants Expressing Double Stranded RNA of v-ATPase A Gene	PLOS ONE			English	Article							BEMISIA-TABACI; MULTIPLE CROPS; COTTON; APHID; INTERFERENCE; ALEYRODIDAE; SUPPRESSION; HOMOPTERA; HONEYDEW; BOLLWORM	Background: Expression of double strand RNA (dsRNA) designed against important insect genes in transgenic plants have been shown to give protection against pests through RNA interference (RNAi), thus opening the way for a new generation of insect-resistant crops. We have earlier compared the efficacy of dsRNAs/siRNAs, against a number of target genes, for interference in growth of whitefly (Bemisia tabaci) upon oral feeding. The v-ATPase subunit A (v-ATPaseA) coding gene was identified as a crucial target. We now report the effectiveness of transgenic tobacco plants expressing siRNA to silence v-ATPaseA gene expression for the control of whitefly infestation. Methodology/Principal Findings: Transgenic tobacco lines were developed for the expression of long dsRNA precursor to make siRNA and knock down the v-ATPaseA mRNA in whitefly. Molecular analysis and insecticidal properties of the transgenic plants established the formation of siRNA targeting the whitefly v-ATPaseA, in the leaves. The transcript level of v-ATPaseA in whiteflies was reduced up to 62% after feeding on the transgenic plants. Heavy infestation of whiteflies on the control plants caused significant loss of sugar content which led to the drooping of leaves. The transgenic plants did not show drooping effect. Conclusions/Significance: Host plant derived pest resistance was achieved against whiteflies by genetic transformation of tobacco which generated siRNA against the whitefly v-ATPaseA gene. Transgenic tobacco lines expressing dsRNA of v-ATPaseA, delivered sufficient siRNA to whiteflies feeding on them, mounting a significant silencing response, leading to their mortality. The transcript level of the target gene was reduced in whiteflies feeding on transgenic plants. The strategy can be taken up for genetic engineering of plants to control whiteflies in field crops.	[Thakur, Nidhi; Upadhyay, Santosh Kumar; Verma, Praveen C.; Chandrashekar, Krishnappa; Singh, Pradhyumna K.] Natl Bot Res Inst, Plant Mol Biol Lab, Lucknow 226001, Uttar Pradesh, India; [Thakur, Nidhi; Verma, Praveen C.; Singh, Pradhyumna K.] Acad Sci & Innovat Res, New Delhi, India; [Upadhyay, Santosh Kumar; Tuli, Rakesh] Natl Agri Food Biotechnol Inst, Dept Biotechnol, Mohali, Punjab, India; [Chandrashekar, Krishnappa] Indian Agr Res Inst, Reg Stn, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Academy of Scientific & Innovative Research (AcSIR); Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Singh, PK (corresponding author), Natl Bot Res Inst, Plant Mol Biol Lab, Lucknow 226001, Uttar Pradesh, India.	pksingh@nbri.res.in	TULI, RAKESH/AAD-3047-2021; Upadhyay, Santosh/ABD-2302-2020; Chadrashekar, K/AAX-4996-2021; Verma, Praveen C/F-9709-2010	Upadhyay, Santosh/0000-0001-6991-0502; Verma, Praveen C/0000-0002-3732-0564	DST	DST(Department of Science & Technology (India))	The authors are thankful to CSIR for providing the research facilities. We are thankful to Dr. Manjusha Srivastava (NBRI) for her kind help in performing sugar estimation. NT is thankful to CSIR for SRF support. RT is thankful to DST for JC Bose Fellowship.	Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; CANGELOSI GA, 1989, J BACTERIOL, V171, P1609, DOI 10.1128/jb.171.3.1609-1615.1989; Chassy BM, 2010, ISB NEWS REPORT; Christou P, 2006, TRENDS PLANT SCI, V11, P302, DOI 10.1016/j.tplants.2006.04.001; De Barro PJ, 2000, MOL PHYLOGENET EVOL, V16, P29, DOI 10.1006/mpev.1999.0768; Dhaliwal G. S., 2010, Indian Journal of Ecology, V37, P1; Dubey NK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-241; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FLEMING R, 1985, J ECON ENTOMOL, V78, P1179, DOI 10.1093/jee/78.6.1179; Geley S, 2004, EXP GERONTOL, V39, P985, DOI 10.1016/j.exger.2004.03.040; Ghanim M, 2007, INSECT BIOCHEM MOLEC, V37, P732, DOI 10.1016/j.ibmb.2007.04.006; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Henneberry TJ, 2000, SOUTHWEST ENTOMOL, V25, P161; Henneberry TJ, 2000, SOUTHWEST ENTOMOL, V25, P1; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jin SX, 2012, PLANT BIOTECHNOL J, V10, P313, DOI 10.1111/j.1467-7652.2011.00663.x; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Karatolos N, 2010, PEST MANAG SCI, V66, P1304, DOI 10.1002/ps.2014; Kos M, 2009, TRENDS BIOTECHNOL, V27, P621, DOI 10.1016/j.tibtech.2009.08.002; Li SJ, 2011, INSECT SCI, V18, P101, DOI 10.1111/j.1744-7917.2010.01395.x; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mlotshwa S, 2002, PLANT CELL, V14, pS289, DOI 10.1105/tpc.001677; Naimov S, 2003, PLANT BIOTECHNOL J, V1, P51, DOI 10.1046/j.1467-7652.2003.00005.x; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Porcar M, 2009, APPL ENVIRON MICROB, V75, P4897, DOI 10.1128/AEM.00686-09; Raccah B., 2009, ENCY LIFE SCI ELS, DOI 10.1002/9780470015902.A0021525.a0000760.pub2.; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Virla EG, 2010, CROP PROT, V29, P635, DOI 10.1016/j.cropro.2009.12.019; Wieczorek H, 2000, J EXP; Wieczorek H, 2009, J EXP BIOL, V212, P1611, DOI 10.1242/jeb.030007; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; YANG NS, 1990, DEV GENET, V11, P289, DOI 10.1002/dvg.1020110407; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017241	38	118	129	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e87235	10.1371/journal.pone.0087235	http://dx.doi.org/10.1371/journal.pone.0087235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595215	Green Submitted, Green Published, gold			2022-12-25	WOS:000332468900002
J	Wang, ZW; Chen, Y; Wang, YN; Xue, HD; Jin, ZY; Kong, LY; Cao, J; Li, S				Wang, Zhiwei; Chen, Yu; Wang, Yining; Xue, Huadan; Jin, Zhengyu; Kong, Lingyan; Cao, Jian; Li, Shuo			Feasibility of Low-Dose Contrast Medium High Pitch CT Angiography for the Combined Evaluation of Coronary, Head and Neck Arteries	PLOS ONE			English	Article							DUAL-SOURCE CT; COMPUTED-TOMOGRAPHY ANGIOGRAPHY; IMAGE QUALITY; DIAGNOSTIC PERFORMANCE; RADIATION-EXPOSURE; CAROTID ARTERIES; ACCURACY; PREVALENCE; STENOSIS; ATHEROSCLEROSIS	Purpose: To evaluate the image quality and radiation dose of combined heart, head, and neck CT angiography (CTA) using prospectively electrocardiography (ECG)-triggered high-pitch spiral scan protocol, compared with single coronary CTA. Materials and Methods: 151 consecutive patients were prospectively included and randomly divided into three groups. Group 1 (n = 47) underwent combined heart, neck, and head CTA using prospectively ECG-triggered high-pitch spiral (Flash) scan protocol with a single-phase intravenous injection of iodinated contrast and saline flush; Group 2 (n = 51) underwent single coronary CTA with Flash scan protocol; and Group 3 (n = 53) underwent single coronary CTA with prospective sequence scan protocol. All patients were examined on a dual source CT (Definition FLASH). The image quality was determined for each CT study. Results: Patients of scanning protocol Group 1, 2, and 3 showed no significant differences in age, sex, heart rates, and BMI. Evaluation of coronary artery image quality showed comparable results in the three scanning protocol groups on a per patient-based analysis. In group 1, image quality was found to be sufficient to be diagnostic in all arterial segments of carotid arteries. The mean dose-length product (DLP) for group 1 was 256.3 +/- 24.5 mGyxcm and was significantly higher in comparison with group 2 (93.4 +/- 19.9 mGyxcm; p<0.001). However, there was no significant difference of DLP between group 1 and group 3 (254.1 +/- 69.9 mGyxcm). Conclusions: The combined heart, neck, and head arteries scan using prospectively electrocardiography (ECG)-triggered high-pitch spiral scan protocol in 1 single examination resulted in an excellent opacification of the aorta, the carotid arteries, and the coronary arteries and provided a good image quality with low radiation dose.	[Wang, Zhiwei; Chen, Yu; Wang, Yining; Xue, Huadan; Jin, Zhengyu; Kong, Lingyan; Cao, Jian; Li, Shuo] Peking Union Med Coll Hosp, Dept Radiol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Wang, YN (corresponding author), Peking Union Med Coll Hosp, Dept Radiol, Beijing, Peoples R China.	wangyining@pumch.cn		Jin, Zhengyu/0000-0002-6179-9632	National Natural Science Fundation of China [81000629]; Beijing Nova of Science and Technology [Z121107002512072]	National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova of Science and Technology	This work was supported by the National Natural Science Fundation of China (Grant number: 81000629) and Beijing Nova of Science and Technology (Grant number: Z121107002512072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach S, 2011, JACC-CARDIOVASC IMAG, V4, P328, DOI 10.1016/j.jcmg.2011.01.012; Achenbach S, 2010, EUR HEART J, V31, P340, DOI 10.1093/eurheartj/ehp470; Alkadhi H, 2010, HEART, V96, P933, DOI 10.1136/hrt.2009.189100; Arca M, 2011, INTERN EMERG MED, V6, P571, DOI 10.1007/s11739-011-0550-6; Austen W G, 1975, Circulation, V51, P5; Bartlett ES, 2008, AM J NEURORADIOL, V29, P1677, DOI 10.3174/ajnr.A1210; Beitzke D, 2011, EUR RADIOL, V21, P2434, DOI 10.1007/s00330-011-2188-1; Bjerrum IS, 2013, INT J CARDIOVAS IMAG, V29, P301, DOI 10.1007/s10554-012-0091-8; Calvet D, 2010, CIRCULATION, V121, P1623, DOI 10.1161/CIRCULATIONAHA.109.906958; Coskun U, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-59; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Ertel D, 2009, EUR RADIOL, V19, P2357, DOI 10.1007/s00330-009-1503-6; Ferencik M, 2006, EUR J RADIOL, V57, P373, DOI 10.1016/j.ejrad.2005.12.023; Fujikawa A, 2010, NEURORADIOLOGY, V52, P291, DOI 10.1007/s00234-009-0611-y; Furtado AD, 2010, AM J NEURORADIOL, V31, P1290, DOI 10.3174/ajnr.A2075; Gaziano JM, 2001, HEART DIS TXB CARDIO, P1; Johnson KM, 2009, AM J ROENTGENOL, V192, P235, DOI 10.2214/AJR.08.1056; Johnson TRC, 2007, INVEST RADIOL, V42, P684, DOI 10.1097/RLI.0b013e31806907d0; Johnson TRC, 2007, J COMPUT ASSIST TOMO, V31, P265, DOI 10.1097/01.rct.0000236421.35761.7a; Kim JJ, 2010, AM J NEURORADIOL, V31, P91, DOI 10.3174/ajnr.A1768; Leschka S, 2009, EUR RADIOL, V19, P2896, DOI 10.1007/s00330-009-1618-9; Li AH, 2007, HEART VESSELS, V22, P297, DOI 10.1007/s00380-006-0971-8; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Moon JH, 2011, KOREAN J RADIOL, V12, P308, DOI 10.3348/kjr.2011.12.3.308; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nair SB, 2012, POSTGRAD MED J, V88, P694, DOI 10.1136/postgradmedj-2011-130214; Napoli A, 2009, EUR RADIOL, V19, P1704, DOI 10.1007/s00330-009-1342-5; Neefjes LA, 2011, RADIOLOGY, V261, P779, DOI 10.1148/radiol.11110606; Puchner S, 2009, J ENDOVASC THER, V16, P336, DOI 10.1583/08-2636.1; Sanaei-Ardekani M, 2005, CARDIOVASC REVASCULA, V6, P82, DOI 10.1016/j.carrev.2005.07.004; Scheffel H, 2006, EUR RADIOL, V16, P2739, DOI 10.1007/s00330-006-0474-0; Shuman WP, 2008, RADIOLOGY, V248, P431, DOI 10.1148/radiol.2482072192; Sommer WH, 2010, AM J ROENTGENOL, V195, P1306, DOI 10.2214/AJR.10.4416; Steinvil A, 2011, J AM COLL CARDIOL, V57, P779, DOI 10.1016/j.jacc.2010.09.047; Tublin ME, 1998, AM J ROENTGENOL, V171, P933, DOI 10.2214/ajr.171.4.9762972; Vanhoenacker PK, 2007, RADIOLOGY, V244, P419, DOI 10.1148/radiol.2442061218; Weustink AC, 2007, J AM COLL CARDIOL, V50, P786, DOI 10.1016/j.jacc.2007.04.068	37	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90268	10.1371/journal.pone.0090268	http://dx.doi.org/10.1371/journal.pone.0090268			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595301	Green Submitted, gold, Green Published			2022-12-25	WOS:000332468900087
J	Yang, M; Jiang, LX; Huang, HP; Zeng, SB; Qiu, F; Yu, M; Li, XR; Wei, S				Yang, Mei; Jiang, Lixin; Huang, Huiping; Zeng, Shengbo; Qiu, Fen; Yu, Miao; Li, Xiaorong; Wei, Sheng			Dietary Exposure to Aluminium and Health Risk Assessment in the Residents of Shenzhen, China	PLOS ONE			English	Article							UK TOTAL DIET; ALZHEIMERS-DISEASE; PARENTERAL-NUTRITION; PRETERM INFANTS; TRACE-ELEMENTS; BIOAVAILABILITY; METALS; WATER; AREA; TOXICOKINETICS	Although there are great changes of dietary in the past few decades in China, few are known about the aluminium exposure in Chinese diet. The aim of this study is to systematically evaluate the dietary aluminium intake level in residents of Shenzhen, China. A total of 853 persons from 244 household were investigated their diet by three days food records. Finally, 149 kinds of foods in 17 food groups were selected to be the most consumed foods. From them, 1399 food samples were collected from market to test aluminium concentration. High aluminium levels were found in jellyfish (median, 527.5 mg/kg), fried twisted cruller (median, 466.0 mg/kg), shell (median, 107.1 mg/kg). The Shenzhen residents' average dietary aluminium exposure was estimated at 1.263 mg/kg bw/week which is lower than the PTWI (provisional tolerable weekly intake). But 0-2 and 3-13 age groups have the highest aluminium intake exceeding the PTWI (3.356 mg/kg bw/week and 3.248 mg/kg bw/week) than other age groups. And the main dietary aluminium exposure sources are fried twisted cruller, leaf vegetables and bean products. Our study suggested that even three decades rapid economy development, children in Shenzhen still have high dietary aluminium exposure risk. How to control high dietary aluminium exposure still is a great public health challenge in Shenzhen, China.	[Yang, Mei; Jiang, Lixin; Huang, Huiping] Futian Dist Ctr Dis Control & Prevent Shenzhen, Dept Hlth Surveillance & Management, Shenzhen, Guangdong, Peoples R China; [Yang, Mei; Zeng, Shengbo; Qiu, Fen] Futian Dist Ctr Dis Control & Prevent Shenzhen, Dept Lab, Shenzhen, Guangdong, Peoples R China; [Yu, Miao; Li, Xiaorong; Wei, Sheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Wei, S (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China.	ws2008cn@gmail.com			Medical Scientific Research Foundation of Guangdong Province, China [A2012591]	Medical Scientific Research Foundation of Guangdong Province, China	This work was supported by Medical Scientific Research Foundation of Guangdong Province, China (A2012591). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnich N, 2012, FOOD CHEM TOXICOL, V50, P2432, DOI 10.1016/j.fct.2012.04.016; Aung NN, 2006, FOOD ADDIT CONTAM A, V23, P883, DOI 10.1080/02652030600699643; Bishop NJ, 1997, NEW ENGL J MED, V336, P1557, DOI 10.1056/NEJM199705293362203; Campbell A, 2002, NEPHROL DIAL TRANSPL, V17, P17, DOI 10.1093/ndt/17.suppl_2.17; China MoHo, 2009, GBT233742009 CHIN MO; Fewtrell MS, 2011, P NUTR SOC, V70, P299, DOI 10.1017/S0029665111000498; FRENCH P, 1989, FOOD CHEM TOXICOL, V27, P495, DOI 10.1016/0278-6915(89)90040-9; Gonzalez-Weller D, 2010, J AGR FOOD CHEM, V58, P10452, DOI 10.1021/jf102779t; Gupta VB, 2005, CELL MOL LIFE SCI, V62, P143, DOI 10.1007/s00018-004-4317-3; Hernandez-Sanchez A, 2013, EUR J CLIN NUTR, V67, P230, DOI 10.1038/ejcn.2012.219; Krewski D, 2007, J TOXICOL ENV HEAL B, V10, P1, DOI 10.1080/10937400701597766; Liu SQ, 2011, PREV CHRONIC DIS, V8; Nayak P, 2001, FOOD CHEM TOXICOL, V39, P587, DOI 10.1016/S0278-6915(00)00173-3; Ohno K, 2010, WATER SCI TECHNOL, V62, P2694, DOI 10.2166/wst.2010.392; Priest ND, 2004, J ENVIRON MONITOR, V6, P375, DOI 10.1039/b314329p; Rose M, 2010, FOOD ADDIT CONTAM A, V27, P1380, DOI 10.1080/19440049.2010.496794; Saiyed SM, 2005, FOOD ADDIT CONTAM A, V22, P234, DOI 10.1080/02652030500073584; Varma P P, 1999, J Assoc Physicians India, V47, P690; Wang YC, 2012, J ENVIRON SCI, V24, P690, DOI 10.1016/S1001-0742(11)60833-4; Wong WWK, 2010, FOOD ADDIT CONTAM A, V27, P457, DOI 10.1080/19440040903490112; Xu DC, 2013, ECOTOX ENVIRON SAFE, V90, P103, DOI 10.1016/j.ecoenv.2012.12.018; Yokel RA, 2006, J TOXICOL ENV HEAL B, V9, P63, DOI 10.1080/15287390500196230; Yokel RA, 2001, PHARMACOL TOXICOL, V88, P159, DOI 10.1034/j.1600-0773.2001.d01-98.x; Yokel RA, 2000, NEUROTOXICOLOGY, V21, P813; Yokel RA, 2006, TOXICOLOGY, V227, P86, DOI 10.1016/j.tox.2006.07.014; Ysart G, 1999, FOOD ADDIT CONTAM, V16, P391, DOI 10.1080/026520399283876	26	20	24	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89715	10.1371/journal.pone.0089715	http://dx.doi.org/10.1371/journal.pone.0089715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594670	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900031
J	Gonzalez-Gomez, PL; Madrid-Lopez, N; Salazar, JE; Suarez, R; Razeto-Barry, P; Mpodozis, J; Bozinovic, F; Vasquez, RA				Gonzalez-Gomez, Paulina L.; Madrid-Lopez, Natalia; Salazar, Juan E.; Suarez, Rodrigo; Razeto-Barry, Pablo; Mpodozis, Jorge; Bozinovic, Francisco; Vasquez, Rodrigo A.			Cognitive Ecology in Hummingbirds: The Role of Sexual Dimorphism and Its Anatomical Correlates on Memory	PLOS ONE			English	Article							BLACK-CAPPED CHICKADEES; FOOD-STORING BIRDS; SPATIAL MEMORY; MARSH TITS; ADAPTIVE SPECIALIZATION; HIPPOCAMPAL-FORMATION; SEASONAL-CHANGES; NEURON NUMBERS; STORED FOOD; ABILITY	In scatter-hoarding species, several behavioral and neuroanatomical adaptations allow them to store and retrieve thousands of food items per year. Nectarivorous animals face a similar scenario having to remember quality, location and replenishment schedules of several nectar sources. In the green-backed firecrown hummingbird (Sephanoides sephanoides), males are territorial and have the ability to accurately keep track of nectar characteristics of their defended food sources. In contrast, females display an opportunistic strategy, performing rapid intrusions into males territories. In response, males behave aggressively during the non-reproductive season. In addition, females have higher energetic demands due to higher thermoregulatory costs and travel times. The natural scenario of this species led us to compared cognitive abilities and hippocampal size between males and females. Males were able to remember nectar location and renewal rates significantly better than females. However, the hippocampal formation was significantly larger in females than males. We discuss these findings in terms of sexually dimorphic use of spatial resources and variable patterns of brain dimorphisms in birds.	[Gonzalez-Gomez, Paulina L.; Vasquez, Rodrigo A.] Univ Chile, Fac Ciencias, Inst Ecol & Biodiversidad, Santiago, Chile; [Razeto-Barry, Pablo] Univ Diego Portales, Vicerrectoria Acad, Santiago, Chile; [Gonzalez-Gomez, Paulina L.; Razeto-Barry, Pablo] Inst Filosofia & Ciencias Complejidad, Santiago, Chile; [Madrid-Lopez, Natalia; Salazar, Juan E.; Suarez, Rodrigo; Mpodozis, Jorge] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; [Bozinovic, Francisco] Pontificia Univ Catolica Chile, Ctr Estudios Avanzados Ecol & Biodiversidad, MIII & LINCGlobal, Dept Ecol, Santiago, Chile	Universidad de Chile; University Diego Portales; Universidad de Chile; Pontificia Universidad Catolica de Chile	Gonzalez-Gomez, PL (corresponding author), Univ Chile, Fac Ciencias, Inst Ecol & Biodiversidad, Santiago, Chile.	plgonzalezgomez@gmail.com	Suarez, Rodrigo/J-1529-2014; Suarez, Rodrigo/N-9437-2016; , Paulina/ABA-6634-2021	Suarez, Rodrigo/0000-0001-5153-5652; Suarez, Rodrigo/0000-0001-5153-5652; , Paulina/0000-0002-1219-8881; Salazar, Juan Esteban/0000-0003-1480-6761	CONICYT; FONDECYT [1130015, 1090794, 1060186];  [PFB-23-CONICYT];  [ICM-P05-002]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ; 	This work received funding from CONICYT (PGG and RS), FONDECYT 1130015 (FB) and FONDECYT 1090794, 1060186; ICM-P05-002; and PFB-23-CONICYT (RAV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astie Andrea Alejandra, 1998, Animal Cognition, V1, P77, DOI 10.1007/s100710050011; Baker HG, 1998, BIOTROPICA, V30, P559, DOI 10.1111/j.1744-7429.1998.tb00097.x; Boogert NJ, 2011, BEHAV ECOL, V22, P447, DOI 10.1093/beheco/arq173; Brown GE, 2013, BEHAV ECOL SOCIOBIOL, V67, P43, DOI 10.1007/s00265-012-1422-4; Burger DK, 2013, BEHAV BRAIN RES, V236, P131, DOI 10.1016/j.bbr.2012.08.044; Chalcoff VR, 2006, ANN BOT-LONDON, V97, P413, DOI 10.1093/aob/mcj043; Clayton NS, 1997, BEHAV PROCESS, V41, P237, DOI 10.1016/S0376-6357(97)00050-8; Costa SS, 2011, BRAIN BEHAV EVOLUT, V77, P55, DOI 10.1159/000323668; Day LB, 2011, BRAIN BEHAV EVOLUT, V77, P206, DOI 10.1159/000327046; Dunlap AS, 2006, ANIM BEHAV, V72, P401, DOI 10.1016/j.anbehav.2006.01.015; Galea LAM, 1996, J EXP BIOL, V199, P195; GAULIN SJC, 1986, AM NAT, V127, P74, DOI 10.1086/284468; Gonzalez-Gomez PL, 2011, BEHAV ECOL SOCIOBIOL, V65, P2141, DOI 10.1007/s00265-011-1222-2; Gonzalez-Gomez PL, 2011, ANIM BEHAV, V81, P1257, DOI 10.1016/j.anbehav.2011.03.014; Gonzalez-Gomez PL, 2011, AUK, V128, P36, DOI 10.1525/auk.2011.10024; Gonzalez-Gomez PL, 2009, J ORNITHOL, V150, P351, DOI 10.1007/s10336-008-0356-0; HAFTORN S, 1954, KONGELIGE NORSKE VID, V4, P1; Healy SD, 2009, BEHAV PROCESS, V80, P288, DOI 10.1016/j.beproc.2008.10.002; Healy SD, 2004, BRAIN BEHAV EVOLUT, V63, P211, DOI 10.1159/000076782; Healy SD, 1996, BEHAV BRAIN RES, V81, P61, DOI 10.1016/S0166-4328(96)00044-7; Henderson J, 2006, CURR BIOL, V16, P512, DOI 10.1016/j.cub.2006.01.054; Irwin RE, 2000, OIKOS, V91, P499, DOI 10.1034/j.1600-0706.2000.910311.x; Jones CM, 2003, BEHAV NEUROSCI, V117, P403, DOI 10.1037/0735-7044.117.3.403; KREBS JR, 1989, P NATL ACAD SCI USA, V86, P1388, DOI 10.1073/pnas.86.4.1388; Krushinskaya N.L., 1966, ZH EVOL BIOCH FISIOL, V11, P563; McKechnie AE, 2006, P ROY SOC B-BIOL SCI, V273, P931, DOI 10.1098/rspb.2005.3415; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pravosudov VV, 2013, ANNU REV ECOL EVOL S, V44, P173, DOI 10.1146/annurev-ecolsys-110512-135904; Pravosudov VV, 2010, PHILOS T R SOC B, V365, P859, DOI 10.1098/rstb.2009.0216; PRAVOSUDOV VV, 1985, ZOOL ZH, V64, P1036; Pravosudov VV, 2002, BEHAV NEUROSCI, V116, P515, DOI 10.1037//0735-7044.116.4.515; Reboreda JC, 1996, NEUROREPORT, V7, P505, DOI 10.1097/00001756-199601310-00031; Roth TC, 2010, PHILOS T R SOC B, V365, P915, DOI 10.1098/rstb.2009.0208; Roth TC, 2009, P R SOC B, V276, P401, DOI 10.1098/rspb.2008.1184; SHERRY D, 1982, Z TIERPSYCHOL, V58, P153; SHERRY DF, 1981, ANIM BEHAV, V29, P1260, DOI 10.1016/S0003-3472(81)80078-4; SHERRY DF, 1989, BEHAV NEUROSCI, V103, P308, DOI 10.1037/0735-7044.103.2.308; SHERRY DF, 1989, BRAIN BEHAV EVOLUT, V34, P308, DOI 10.1159/000116516; SHERRY DF, 1992, TRENDS NEUROSCI, V15, P298, DOI 10.1016/0166-2236(92)90080-R; Sherry DF, 1993, P NATL ACAD SCI USA, V90, P7893; SHETTLEWORTH SJ, 1982, J EXP PSYCHOL ANIM B, V8, P354, DOI 10.1037/0097-7403.8.4.354; SHETTLEWORTH SJ, 1995, BEHAV BRAIN RES NATU, P159; Smulders TV, 2010, PHILOS T R SOC B, V365, P883, DOI 10.1098/rstb.2009.0211; Smulders TV, 2000, J NEUROBIOL, V44, P414, DOI 10.1002/1097-4695(20000915)44:4<414::AID-NEU4>3.0.CO;2-I; Sokal RR, 1995, BIOMETRY; Temeles EJ, 2005, AUK, V122, P187, DOI 10.1642/0004-8038(2005)122[0187:FATEOS]2.0.CO;2; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; Ward BJ, 2012, BIOL LETTERS, V8, P657, DOI 10.1098/rsbl.2011.1180; [No title captured]	49	16	16	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90165	10.1371/journal.pone.0090165	http://dx.doi.org/10.1371/journal.pone.0090165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599049	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400052
J	Karla, S; Ruusuvirta, T; Wikgren, J				Karla, Suvi; Ruusuvirta, Timo; Wikgren, Jan			Effect of Emotional Picture Viewing on Voluntary Eyeblinks	PLOS ONE			English	Article							MODULATION; MOTIVATION; ANXIETY; FEAR	Eyeblinks, whether reflexive or voluntary, play an important role in protecting our vision. When viewing pictures, reflexive eyeblinks are known to be modulated by the emotional state induced thereby. More specifically, the hedonic valence (unpleasantness-pleasantness) induced by the picture has been shown to have a linear relationship with the amplitude of a startle blink elicited during picture viewing. This effect has been attributed to congruence between an ongoing state and task demands: an unpleasant emotional state is assumed to bias our attention towards potentially harmful stimuli, such as startle tones. However, recent research suggests that the valence-specific modulation may not be limited to the sensory parts of the reflexive pathway related to startle responses. Here, we examined the effect of emotional picture viewing on voluntary (in response to a written command) eyeblinks in adult humans. Emotional modulation of startle blinks was also evaluated. We found that when viewing unpleasant pictures, the amplitude of reflexive eyeblinks was augmented, but the amplitude of voluntary eyeblinks was unaffected. Nevertheless, the response latencies of voluntary eyeblinks were found to be delayed during the viewing of pleasant and unpleasant relative to neutral pictures. We conclude that these results support the theory that emotional experience augments sensory processing specific to potentially harmful stimuli. Further, the emotional state seems not to exert an effect on voluntarily elicited motor activity.	[Karla, Suvi; Wikgren, Jan] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland; [Karla, Suvi; Wikgren, Jan] Univ Jyvaskyla, Jyvaskyla Ctr Interdisciplinary Res, Jyvaskyla, Finland; [Ruusuvirta, Timo] Univ Turku, Dept Psychol, Turku, Finland	University of Jyvaskyla; University of Jyvaskyla; University of Turku	Karla, S (corresponding author), Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland.	suvi.karla@jyu.fi		Wikgren, Jan/0000-0002-3403-1396	University of Jyvaskyla	University of Jyvaskyla	Funding is from the University of Jyvaskyla. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, A5 U FLOR CTR RES PS; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; BONNET M, 1995, PSYCHOPHYSIOLOGY, V32, P367, DOI 10.1111/j.1469-8986.1995.tb01219.x; Bradley MM, 1996, PSYCHOPHYSIOLOGY, V33, P662, DOI 10.1111/j.1469-8986.1996.tb02362.x; BRADLEY MM, 1990, PSYCHOPHYSIOLOGY, V27, P513, DOI 10.1111/j.1469-8986.1990.tb01966.x; Coelho CM, 2010, NEUROSCI LETT, V481, P135, DOI 10.1016/j.neulet.2010.03.027; DAVIS M, 1989, ANN NY ACAD SCI, V563, P165, DOI 10.1111/j.1749-6632.1989.tb42197.x; Davis M, 1982, J NEUROSCI, V6, P175; Hawk LW, 1997, PSYCHOPHYSIOLOGY, V34, P23, DOI 10.1111/j.1469-8986.1997.tb02412.x; Kaneko K, 1999, PERCEPT MOTOR SKILL, V88, P1037, DOI 10.2466/pms.1999.88.3.1037; Karla S, 2009, BIOL PSYCHOL, V82, P208, DOI 10.1016/j.biopsycho.2009.06.008; Konagemaru S, 2012, EUR J NEUROSCI, V10, P1637; KORB DR, 1994, CORNEA, V13, P354, DOI 10.1097/00003226-199407000-00012; Lang PJ, 1998, BIOL PSYCHIAT, V44, P1248, DOI 10.1016/S0006-3223(98)00275-3; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Pereira MG, 2006, EMOTION, V6, P622, DOI 10.1037/1528-3542.6.4.622	19	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89536	10.1371/journal.pone.0089536	http://dx.doi.org/10.1371/journal.pone.0089536			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24599182	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400017
J	Zhao, Z; Li, B; Sun, HQ; Zhang, JY; Wang, YL; Chen, L; Hu, J; He, YF; Zeng, H; Zou, QM; Wu, C				Zhao, Zhuo; Li, Bin; Sun, He-Qiang; Zhang, Jin-Yong; Wang, Yi-Lin; Chen, Li; Hu, Jian; He, Ya-Fei; Zeng, Hao; Zou, Quan-Ming; Wu, Chao			Fine-Mapping of Immunodominant Linear B-Cell Epitopes of the Staphylococcus Aureus SEB Antigen Using Short Overlapping Peptides	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; ENTEROTOXIN-B; MONOCLONAL-ANTIBODIES; INFECTIONS; VACCINE; MRSA; RECEPTOR; PROTEIN	Staphylococcal enterotoxin B (SEB) is one of the most potent Staphylococcus aureus exotoxins (SEs). Due to its conserved sequence and stable structure, SEB might be a good candidate antigen for MRSA vaccines. Although cellular immune responses to SEB are well-characterized, much less is known regarding SEB-specific humoral immune responses, particularly regarding detailed epitope mapping. In this study, we utilized a recombinant nontoxic mutant of SEB (rSEB) and an AlPO4 adjuvant to immunize BALB/c mice and confirmed that rSEB can induce a high antibody level and effective immune protection against MRSA infection. Next, the antisera of immunized mice were collected, and linear B cell epitopes within SEB were finely mapped using a series of overlapping synthetic peptides. Three immunodominant B cell epitopes of SEB were screened by ELISA, including a novel epitope, SEB205-222, and two known epitopes, SEB97-114 and SEB247-261. Using truncated peptides, an ELISA was performed with peptide-KLH antisera, and the core sequence of the three immunodominant B cell epitopes were verified as SEB97-112, SEB207-222, and SEB247-257. In vitro, all of the immunodominant epitope-specific antisera (anti-SEB97-112, anti-SEB207-222 and anti-SEB247-257) were observed to inhibit SEB-induced T cell mitogenesis and cytokine production from splenic lymphocytes of BALB/c mice. The homology analysis indicated that SEB97-112 and SEB207-222 were well-conserved among different Staphylococcus aureus strains. The 3D crystal structure of SEB indicated that SEB97-112 was in the loop region inside SEB, whereas SEB207-222 and SEB247-257 were in the beta-slice region outside SEB. In summary, the fine-mapping of linear B-cell epitopes of the SEB antigen in this study will be useful to understand anti-SEB immunity against MRSA infection further and will be helpful to optimize MRSA vaccine designs that are based on the SEB antigen.	[Zhao, Zhuo; Li, Bin; Sun, He-Qiang; Zhang, Jin-Yong; Wang, Yi-Lin; Chen, Li; Zeng, Hao; Zou, Quan-Ming; Wu, Chao] Third Mil Med Univ, Natl Engn Res Ctr Immunol Prod, Dept Microbiol & Biochem Pharm, Coll Pharm, Chongqing, Peoples R China; [Hu, Jian; He, Ya-Fei] Third Mil Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Zou, QM (corresponding author), Third Mil Med Univ, Natl Engn Res Ctr Immunol Prod, Dept Microbiol & Biochem Pharm, Coll Pharm, Chongqing, Peoples R China.	qmzou2007@163.com; wuchao99261@gmail.com		Zhang, Jinyong/0000-0001-9622-5834	Natural Science Foundation of China [31300759]; national Twelfth Five Year Plan "863'' major projects of China [2012AA02A405-3]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); national Twelfth Five Year Plan "863'' major projects of China	This work was funded by the Natural Science Foundation of China (No. 31300759), and the national Twelfth Five Year Plan "863'' major projects of China (No. 2012AA02A405-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arad G, 2001, J LEUKOCYTE BIOL, V69, P921; Balali-Mood M, 2013, TOXICON, V69, P131, DOI 10.1016/j.toxicon.2013.01.005; Baum D, 1998, CELL IMMUNOL, V190, P12, DOI 10.1006/cimm.1998.1380; Bhatti AR, 1999, J MICROBIOL METH, V35, P143, DOI 10.1016/S0167-7012(98)00110-9; Birch H, 2011, CHEM WORLD-UK, V8, P21; Breuer K, 2000, ALLERGY, V55, P551, DOI 10.1034/j.1398-9995.2000.00432.x; Daum RS, 2012, CLIN INFECT DIS, V54, P560, DOI 10.1093/cid/cir828; Demei Z, 2011, CHINESE J INFECT CHE, V5, P326; DeVries AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022997; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Fluer F. S., 2012, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P99; HURLEY JM, 1995, J EXP MED, V181, P2229, DOI 10.1084/jem.181.6.2229; Inskeep TK, 2010, CLIN VACCINE IMMUNOL, V17, P1163, DOI 10.1128/CVI.00078-10; Irina VP, 2010, TOXINS, V2, P2177; Irving MB, 2001, CURR OPIN CHEM BIOL, V5, P314, DOI 10.1016/S1367-5931(00)00208-8; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; KAPPLER JW, 1992, J EXP MED, V175, P387, DOI 10.1084/jem.175.2.387; Karauzum H, 2012, J BIOL CHEM, V287, P25203, DOI 10.1074/jbc.M112.364075; Kashiwada T, 2012, INTERNAL MED, V51, P3085, DOI 10.2169/internalmedicine.51.7295; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Komatsu N, 2013, MOL IMMUNOL, V54, P465, DOI 10.1016/j.molimm.2013.01.014; Krakauer T, 2010, TOXINS, V2, P1963, DOI 10.3390/toxins2081963; Kum WWS, 2001, J INFECT DIS, V183, P1739, DOI 10.1086/320732; Landrum ML, 2012, JAMA-J AM MED ASSOC, V308, P50, DOI 10.1001/jama.2012.7139; Larkin EA, 2010, PLOS ONE, V10, P1; Lindsay CD, 2013, HUM EXP TOXICOL, V32, P606, DOI 10.1177/0960327112458941; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Nakamura A, 2012, J INFECT CHEMOTHER, V18, P90, DOI 10.1007/s10156-011-0302-6; Nishi JI, 1997, J IMMUNOL, V158, P247; Otto M, 2012, CELL MICROBIOL, V14, P1513, DOI 10.1111/j.1462-5822.2012.01832.x; Rossi RE, 2004, INT ARCH ALLERGY IMM, V133, P261, DOI 10.1159/000076833; Rusnak JM, 2004, EMERG INFECT DIS, V10, P1544, DOI 10.3201/eid1009.040250; Rux JJ, 2000, MOL THER, V1, P18, DOI 10.1006/mthe.1999.0001; Tilahun ME, 2011, PLOS ONE, V11, P1; Tilahun ME, 2011, PLOS ONE, V11, P16; Urushibata Y, 2010, CLIN VACCINE IMMUNOL, V17, P1708, DOI 10.1128/CVI.00229-10; Varshney AK, 2013, J INFECT DIS, V208, P2058, DOI 10.1093/infdis/jit421; Varshney AK, 2011, J BIOL CHEM, V286, P9737, DOI 10.1074/jbc.M110.212407	38	8	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90445	10.1371/journal.pone.0090445	http://dx.doi.org/10.1371/journal.pone.0090445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599257	gold, Green Submitted, Green Published			2022-12-25	WOS:000332479400075
J	Kim, WC; Ma, CA; Li, WM; Chohan, M; Wilson, DM; Lee, CH				Kim, Wan Cheol; Ma, Conan; Li, Wai-Ming; Chohan, Manbir; Wilson, David M., III; Lee, Chow H.			Altered Endoribonuclease Activity of Apurinic/Apyrimidinic Endonuclease 1 Variants Identified in the Human Population	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; EXCISION-REPAIR PATHWAY; DNA-REPAIR; GENETIC POLYMORPHISMS; CANCER-RISK; BREAST-CANCER; MESSENGER-RNA; APE1; APE1/REF-1; SITE	Apurinic/apyrimidinic endonuclease 1 (APE1) is the major mammalian enzyme in the DNA base excision repair pathway and cleaves the DNA phosphodiester backbone immediately 5' to abasic sites. APE1 also has 3'-5' DNA exonuclease and 3' DNA phosphodiesterase activities, and regulates transcription factor DNA binding through its redox regulatory function. The human APE1 has recently been shown to endonucleolytically cleave single-stranded regions of RNA. Towards understanding the biological significance of the endoribonuclease activity of APE1, we examined eight different amino acid substitution variants of APE1 previously identified in the human population. Our study shows that six APE1 variants, D148E, Q51H, I64V, G241R, R237A, and G306A, exhibit a 76-85% reduction in endoribonuclease activity against a specific coding region of the c-myc RNA, yet fully retain the ability to cleave apurinic/apyrimidinic DNA. We found that two APE1 variants, L104R and E126D, exhibit a unique RNase inhibitor-resistant endoribonuclease activity, where the proteins cleave c-myc RNA 3' of specific single-stranded guanosine residues. Expression of L104R and E126D APE1 variants in bacterial Origami cells leads to a 60-80% reduction in colony formation and a 1.5-fold increase in cell doubling time, whereas the other variants, which exhibit diminished endoribonuclease activity, had no effect. These data indicate that two human APE1 variants exhibit a unique endoribonuclease activity, which correlates with their ability to induce cytotoxicity or slow down growth in bacterial cells and supports the notion of their biological functionality.	[Kim, Wan Cheol; Ma, Conan; Li, Wai-Ming; Chohan, Manbir; Lee, Chow H.] Univ British Columbia, Chem Program, Prince George, BC, Canada; [Wilson, David M., III] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA	University of British Columbia; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Lee, CH (corresponding author), Univ British Columbia, Chem Program, Prince George, BC, Canada.	chow.lee@unbc.ca	Wilson, David M/AAK-5409-2021	Wilson, David M/0000-0002-8945-0395; Kim, Wan/0000-0002-6788-8986	Natural Sciences & Engineering Research Council [227158]; Intramural Research Program at the NIH, National Institute on Aging	Natural Sciences & Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Intramural Research Program at the NIH, National Institute on Aging	This research was supported by a Discovery Grant (#227158) from Natural Sciences & Engineering Research Council to CHL, and in part by the Intramural Research Program at the NIH, National Institute on Aging to DMWIII. The funders had no role in study design, decision to publish, or preparation of the manuscript.	Barnes T, 2009, NUCLEIC ACIDS RES, V37, P3946, DOI 10.1093/nar/gkp275; Berquist BR, 2008, J MOL BIOL, V379, P17, DOI 10.1016/j.jmb.2008.03.053; Chang JS, 2009, CARCINOGENESIS, V30, P78, DOI 10.1093/carcin/bgn261; Gu DY, 2009, MUTAGENESIS, V24, P507, DOI 10.1093/mutage/gep036; Hadi MZ, 2000, NUCLEIC ACIDS RES, V28, P3871, DOI 10.1093/nar/28.20.3871; Hayward C, 1999, NEUROLOGY, V52, P1899, DOI 10.1212/WNL.52.9.1899; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Illuzzi J. L., 2013, PLOS ONE, DOI [10.1371/journal.pone.0065922, DOI 10.1371/J0URNAL.P0NE.0065922]; Kim WC, 2011, J MOL BIOL, V411, P960, DOI 10.1016/j.jmb.2011.06.050; Kim Wan-Cheol, 2010, Int J Biochem Mol Biol, V1, P12; Li MX, 2014, ANTIOXID REDOX SIGN, V20, P678, DOI 10.1089/ars.2013.5492; Li WM, 2010, FEBS J, V277, P627, DOI 10.1111/j.1742-4658.2009.07488.x; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Olkowski ZL, 1998, NEUROREPORT, V9, P239, DOI 10.1097/00001756-199801260-00012; Smith BD, 2006, J MOL BIOL, V362, P459, DOI 10.1016/j.jmb.2006.07.020; Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Tomkins A, 2000, NEUROREPORT, V11, P1695, DOI 10.1097/00001756-200006050-00020; Vascotto C, 2009, MOL CELL BIOL, V29, P1834, DOI 10.1128/MCB.01337-08; Wang ML, 2010, DNA CELL BIOL, V29, P303, DOI 10.1089/dna.2009.0969; Wilson DM, 2011, MUTAT RES-FUND MOL M, V711, P100, DOI 10.1016/j.mrfmmm.2010.12.004; Zhang YW, 2006, CANCER EPIDEM BIOMAR, V15, P353, DOI 10.1158/1055-9965.EPI-05-0653	22	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90837	10.1371/journal.pone.0090837	http://dx.doi.org/10.1371/journal.pone.0090837			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595156	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500104
J	O'Neill, DG; Church, DB; McGreevy, PD; Thomson, PC; Brodbelt, DC				O'Neill, Dan G.; Church, David B.; McGreevy, Paul D.; Thomson, Peter C.; Brodbelt, Dave C.			Prevalence of Disorders Recorded in Dogs Attending Primary-Care Veterinary Practices in England	PLOS ONE			English	Article							INHERITED DISORDERS; PUREBRED DOGS; PEDIGREE DOGS; DISEASE SURVEILLANCE; COMPANION ANIMALS; ATOPIC-DERMATITIS; SELECTION BIAS; INSURANCE DATA; REFERRAL BIAS; INSURED DOGS	Purebred dog health is thought to be compromised by an increasing occurence of inherited diseases but inadequate prevalence data on common disorders have hampered efforts to prioritise health reforms. Analysis of primary veterinary practice clinical data has been proposed for reliable estimation of disorder prevalence in dogs. Electronic patient record (EPR) data were collected on 148,741 dogs attending 93 clinics across central and south-eastern England. Analysis in detail of a random sample of EPRs relating to 3,884 dogs from 89 clinics identified the most frequently recorded disorders as otitis externa (prevalence 10.2%, 95% CI: 9.1-11.3), periodontal disease (9.3%, 95% CI: 8.3-10.3) and anal sac impaction (7.1%, 95% CI: 6.1-8.1). Using syndromic classification, the most prevalent body location affected was the head-and-neck (32.8%, 95% CI: 30.7-34.9), the most prevalent organ system affected was the integument (36.3%, 95% CI: 33.9-38.6) and the most prevalent pathophysiologic process diagnosed was inflammation (32.1%, 95% CI: 29.8-34.3). Among the twenty most-frequently recorded disorders, purebred dogs had a significantly higher prevalence compared with crossbreds for three: otitis externa (P = 0.001), obesity (P = 0.006) and skin mass lesion (P = 0.033), and popular breeds differed significantly from each other in their prevalence for five: periodontal disease (P = 0.002), overgrown nails (P = 0.004), degenerative joint disease (P = 0.005), obesity (P = 0.001) and lipoma (P = 0.003). These results fill a crucial data gap in disorder prevalence information and assist with disorder prioritisation. The results suggest that, for maximal impact, breeding reforms should target commonly-diagnosed complex disorders that are amenable to genetic improvement and should place special focus on at-risk breeds. Future studies evaluating disorder severity and duration will augment the usefulness of the disorder prevalence information reported herein.	[O'Neill, Dan G.; Brodbelt, Dave C.] Univ London Royal Vet Coll, London, England; [Church, David B.] Univ London Royal Vet Coll, Small Anim Med & Surg Grp, London, England; [McGreevy, Paul D.; Thomson, Peter C.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of Sydney	O'Neill, DG (corresponding author), Univ London Royal Vet Coll, London, England.	doneill@rvc.ac.uk	Brodbelt, David C/C-6005-2009; Thomson, Peter/V-7290-2019; O'Neill, Dan Gerard/H-8351-2019	Brodbelt, David C/0000-0001-5628-4194; Thomson, Peter/0000-0003-4428-444X; O'Neill, Dan Gerard/0000-0003-1115-2723; McGreevy, Paul/0000-0001-7220-8378	RSPCA	RSPCA	This study was part of a Ph.D. study that was financially supported by the RSPCA (http://www.rspca.org.uk/sciencegroup/companionanimals). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VJ, 2010, J SMALL ANIM PRACT, V51, P512, DOI 10.1111/j.1748-5827.2010.00974.x; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Albuquerque C, 2012, VET J, V191, P299, DOI 10.1016/j.tvjl.2011.08.017; [Anonymous], 2009, VET REC, V164, P481; [Anonymous], 2013, VET REC, V172, P277; APGAW, 2009, HLTH FUT PED DOGS; Aragon CL, 2005, VET SURG, V34, P93, DOI 10.1111/j.1532-950X.2005.00016.x; Asher L, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-74; Asher L, 2009, VET J, V182, P402, DOI 10.1016/j.tvjl.2009.08.033; Bartlett PC, 2010, PREV VET MED, V94, P264, DOI 10.1016/j.prevetmed.2010.01.007; Bateson P., 2010, INDEPENDENT INQUIRY; BATT RM, 1989, J SMALL ANIM PRACT, V30, P3, DOI 10.1111/j.1748-5827.1989.tb01451.x; BBC, 2008, PED DOGS EXP; Bell J, 2012, CLIN TRUTHS PURE BRE, P22; Bellumori TP, 2013, JAVMA-J AM VET MED A, V242, P1549, DOI 10.2460/javma.242.11.1549; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bonnett BN, 2005, ACTA VET SCAND, V46, P105, DOI 10.1186/1751-0147-46-105; Brady S, 2012, VET J, V193, P522, DOI 10.1016/j.tvjl.2012.01.025; BVA/KC, 2013, HIP DYSPL SCHEM; BVA/KC, 2013, ELB SCHEM; BVA/KC, 2013, CHIAR MALF SYRING SC; BVA/KC/ISS, 2013, EYE SCHEM; Calboli FCF, 2008, GENETICS, V179, P593, DOI 10.1534/genetics.107.084954; CAWC, 2006, BREED WELF COMP AN W; Chodick G, 2007, ANN EPIDEMIOL, V17, P106, DOI 10.1016/j.annepidem.2006.06.004; Collins LM, 2010, ANIM WELFARE, V19, P67; Collins LM, 2011, VET J, V189, P147, DOI 10.1016/j.tvjl.2011.06.012; Crispin S, 2011, VET REC, V168, P53, DOI 10.1136/vr.c4949; Dank G, 2012, J SMALL ANIM PRACT, V53, P679, DOI 10.1111/j.1748-5827.2012.01296.x; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; Edney ATB., 1997, OBSERVATIONAL STUDY; Egenvall A, 1998, PREV VET MED, V36, P51, DOI 10.1016/S0167-5877(98)00073-7; Egenvall A, 2000, VET REC, V146, P519, DOI 10.1136/vr.146.18.519; Egenvall A, 2000, VET REC, V146, P551, DOI 10.1136/vr.146.19.551; Egenvall A, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-42; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Fleming JM, 2011, J VET INTERN MED, V25, P187, DOI 10.1111/j.1939-1676.2011.0695.x; Friedmann E, 2009, VET CLIN N AM-SMALL, V39, P293, DOI 10.1016/j.cvsm.2008.10.015; FROOM P, 1992, THEOR MED, V13, P255, DOI 10.1007/BF00489202; German AJ, 2003, J VET INTERN MED, V17, P8, DOI 10.1111/j.1939-1676.2003.tb01318.x; German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S; Glickman L, 2012, NATL COMPANION ANIMA; Gobar GM, 1998, J AM VET MED ASSOC, V213, P251; Gough A., 2010, BREED PREDISPOSITION; Greenland S, 2008, INT J EPIDEMIOL, V37, P430, DOI 10.1093/ije/dyn064; Group TVC, 2013, VENOM VET NOM; HEIN H. E., 1963, Journal of Small Animal Practice, V4, P457, DOI 10.1111/j.1748-5827.1963.tb01302.x; Hillier A, 2001, VET IMMUNOL IMMUNOP, V81, P147, DOI 10.1016/S0165-2427(01)00296-3; HODGMAN S. F. J., 1963, Journal of Small Animal Practice, V4, P447, DOI 10.1111/j.1748-5827.1963.tb01301.x; Houlton JEF, 2008, VET COMP ORTHOPAED, V21, P231; Hudson JI, 2005, EPIDEMIOLOGY, V16, P355, DOI 10.1097/01.ede.0000158224.50593.e3; Indrebo A, 2007, ACTA VET SCANDIN SS6, V50, pS6; Irion DN, 2003, J HERED, V94, P81, DOI 10.1093/jhered/esg004; John U, 1999, ALCOHOL ALCOHOLISM, V34, P786, DOI 10.1093/alcalc/34.5.786; Kathrani A, 2011, VET REC, V169, P635, DOI 10.1136/vr.d5380; KC, 2013, DNA SCREEN SCHEM RES; Kearsley-Fleet L, 2013, VET REC, V172, DOI 10.1136/vr.101133; Kirkwood BR, 2003, ESSENTIAL MED STAT; KNIGHT G. C., 1963, Journal of Small Animal Practice, V4, P463, DOI 10.1111/j.1748-5827.1963.tb01303.x; Leroy G, 2011, VET J, V189, P177, DOI 10.1016/j.tvjl.2011.06.016; Lewis TW, 2010, ANIM WELFARE, V19, P93; Lewis T. W., 2010, PLOS ONE, V5; Lewis TW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-16; Lewis T, 2011, VET J, V188, P73, DOI 10.1016/j.tvjl.2010.02.016; Lober WB, 2002, J AM MED INFORM ASSN, V9, P105, DOI 10.1197/jamia.M1052; Lourenco-Martins AM, 2011, VET OPHTHALMOL, V14, P248, DOI 10.1111/j.1463-5224.2011.00874.x; Lund EM, 1999, J AM VET MED ASSOC, V214, P1336; Lund EM, 1997, DEV EVALUATION MODEL; Mandl KD, 2004, J AM MED INFORM ASSN, V11, P141, DOI 10.1197/jamia.M1356; Marsella R, 2009, J INVEST DERMATOL, V129, P2351, DOI 10.1038/jid.2009.98; McGreevy PD, 2007, ANIM WELFARE, V16, P125; McGreevy PD, 1999, ANIM WELFARE, V8, P329; McMillan FD, 2001, J AM VET MED ASSOC, V219, P1204, DOI 10.2460/javma.2001.219.1204; Medivet, 2014, MED VET PARTN; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Mellersh C, 2012, MAMM GENOME, V23, P109, DOI 10.1007/s00335-011-9365-z; Mellersh CS, 1997, ADV VET MED-ACAD PR, V40, P191; Mountziaris PM, 2011, TISSUE ENG PART B-RE, V17, P393, DOI [10.1089/ten.teb.2011.0182, 10.1089/ten.TEB.2011.0182]; Murray JK, 2010, VET REC, V166, P163, DOI 10.1136/vr.b4712; Neff MW, 2006, CELL, V124, P229, DOI 10.1016/j.cell.2006.01.008; Nelson R.W., 2004, SMALL ANIMAL CLIN DI, V4th, P165; Neuber A., 2009, UK Vet: Companion Animal, V14, P56, DOI 10.1111/j.2044-3862.2009.tb00386.x; NOAH, 2013, FACTS FIG UK AN MED; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Packer RMA, 2012, ANIM WELFARE, V21, P81, DOI 10.7120/096272812X13345905673809; Page GP, 2003, AM J HUM GENET, V73, P711, DOI 10.1086/378900; Pearce N, 2007, OCCUP ENVIRON MED, V64, P562, DOI 10.1136/oem.2006.026690; Pedersen HD, 2000, CARDIOVASC RES, V47, P234, DOI 10.1016/S0008-6363(00)00113-9; Platt S, 2006, J VET INTERN MED, V20, P1355, DOI 10.1892/0891-6640(2006)20[1355:POUABD]2.0.CO;2; Powers MY, 2010, JAVMA-J AM VET MED A, V237, P532, DOI 10.2460/javma.237.5.532; Rand JS, 2004, J NUTR, V134, p2072S, DOI 10.1093/jn/134.8.2072S; Rooney N, 2008, PEDIGREE DOG BREEDIN; Rooney NJ, 2010, ANIM WELFARE, V19, P133; Rooney NJ, 2009, J VET BEHAV, V4, P180, DOI 10.1016/j.jveb.2009.06.002; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Rust MK, 2005, TRENDS PARASITOL, V21, P232, DOI 10.1016/j.pt.2005.03.010; Scott DW., 2001, MULLER KIRKS SMALL A, P996; SLATER MR, 1992, PREV VET MED, V13, P77, DOI 10.1016/0167-5877(92)90092-T; SLEATOR DD, 1983, J COMPUT SYST SCI, V26, P362, DOI 10.1016/0022-0000(83)90006-5; Smith FJD, 2003, AM J CLIN DERMATOL, V4, P347, DOI 10.2165/00128071-200304050-00005; Soll-Johanning H, 2004, DAN MED BULL, V51, P207; Starkey Mike P., 2005, Briefings in Functional Genomics & Proteomics, V4, P112; Stone AB, 2008, ZOONOSES PUBLIC HLTH, V55, P378, DOI 10.1111/j.1863-2378.2008.01129.x; Summers JF, 2010, VET J, V183, P39, DOI 10.1016/j.tvjl.2009.11.002; VetCompass, 2013, VETCOMPASS HLTH SURV; Vilson A, 2013, VET REC, V173, P116, DOI 10.1136/vr.101577; Virues-Ortega JV, 2006, J NERV MENT DIS, V194, P52, DOI 10.1097/01.nmd.0000195354.03653.63; Walsh F, 2009, FAM PROCESS, V48, P462, DOI 10.1111/j.1545-5300.2009.01296.x; Wayne RK, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P279; WILLIS M. B., 1963, Journal of Small Animal Practice, V4, P469, DOI 10.1111/j.1748-5827.1963.tb01305.x; Wilson B, 2011, VET J, V189, P160, DOI 10.1016/j.tvjl.2011.06.014; Wood JLN, 2002, PREV VET MED, V55, P95, DOI 10.1016/S0167-5877(02)00090-9	113	152	155	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90501	10.1371/journal.pone.0090501	http://dx.doi.org/10.1371/journal.pone.0090501			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594665	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500058
J	Tang, D; Zhang, JQ; Yuan, ZX; Gao, J; Wang, S; Ye, NY; Li, P; Gao, SJ; Miao, Y; Wang, DR; Jiang, KR				Tang, Dong; Zhang, Jingqiu; Yuan, Zhongxu; Gao, Jun; Wang, Sen; Ye, Nianyuan; Li, Ping; Gao, Sujun; Miao, Yi; Wang, Daorong; Jiang, Kuirong			Pancreatic Satellite Cells Derived Galectin-1 Increase the Progression and Less Survival of Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							STELLATE CELLS; CANCER CELLS; EXPRESSION; MICROENVIRONMENT; PROLIFERATION; ACTIVATION; PROTEIN; MATRIX; INVASIVENESS; METASTASIS	Background: Galectin-1, a member of carbohydrate-binding proteins with a polyvalent function on tumor progression, was found strongly expressed in pancreatic satellite cells (PSCs), which partner in crime with cancer cells and promote the development of pancreatic ductal adenocarcinoma (PDAC). We evaluated the effects of PSCs derived Galectin-1 on the progression of PDAC, as well as the tumor establishment and development in mouse xenografts. Methods: The relationship between immunohistochemistry staining intensity of Galectin-1 and clinicopathologic variables were assessed in 66 PDAC tissues, 18 chronic pancreatitis tissues and 10 normal controls. The roles of PSCs isolated from PDAC and normal pancreas on the proliferative activity, MMP2 and MMP9 expression, and the invasion of CFPAC-1 in the co-cultured system, as well as on the tumor establishment and development in mouse xenografts by mixed implanting with CFPAC-1 subcutaneously were evaluated. Results: Galectin-1 expression was gradually increased from normal pancreas (negative), chronic pancreatitis (weak) to PDAC (strong), in which Galectin-1 expression was also increased from well, moderately to poorly differentiated PDAC. Galectin-1 staining intensity of pancreatic cancer tissue was associated with increase in tumor size, lymph node metastasis, perineural invasion and differentiation and UICC stage, and served as the independent prognostic indicator of poor survival of pancreatic cancer. In vitro and in vivo experiments indicated that TGF-beta 1 upregulated Galectin-1 expression in PSCs, which could further promotes the proliferative activity, MMP2 and MMP9 expression, and invasion of pancreatic cancer cells, as well as the tumor establishment and growth. Conclusion: Galectin-1 expression in stromal cells of pancreatic cancer suggests that this protein plays a role in the promotion of cancer cells invasion and metastasis and provides a therapeutic target for the treatment of pancreatic cancer.	[Tang, Dong; Gao, Jun; Ye, Nianyuan; Li, Ping; Wang, Daorong] Yang Zhou Univ, Dept Gen Surg, Subei Peoples Hosp Jiangsu Prov, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China; [Zhang, Jingqiu; Gao, Sujun] Yang Zhou Univ, Dept Digest Syst, Subei Peoples Hosp Jiangsu Prov, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China; [Yuan, Zhongxu] Anhui 2 Prov Peoples Hosp, Dept Gen Surg, Hefei, Anhui, Peoples R China; [Wang, Sen] Nanjing Med Univ, Coll Clin Med, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Miao, Yi; Jiang, Kuirong] Nanjing Med Univ, Dept Gen Surg, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Nanjing Medical University; Nanjing Medical University	Wang, DR (corresponding author), Yang Zhou Univ, Dept Gen Surg, Subei Peoples Hosp Jiangsu Prov, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China.	daorong666@sina.com; jiangkuirong@163.com		Wang, Sen/0000-0001-7179-626X	Postdoctoral Science Foundation of China [2013M530243]; Social Development of Science and Technology Research Projects of Yangzhou City [2012123]	Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Social Development of Science and Technology Research Projects of Yangzhou City	This work is supported by Postdoctoral Science Foundation of China (No. 2013M530243) and Social Development of Science and Technology Research Projects of Yangzhou City (No. 2012123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, LANCET ONCOL, V11, P1107, DOI 10.1016/S1470-2045(10)70281-3; Ansari D, 2010, SCAND J GASTROENTERO, V45, P1022, DOI 10.3109/00365521003734174; Apte MV, 2006, J GASTROEN HEPATOL, V21, pS97, DOI 10.1111/j.1440-1746.2006.04587.x; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bektas S, 2010, PATHOL ONCOL RES, V16, P569, DOI 10.1007/s12253-010-9248-8; Berberat PO, 2001, J HISTOCHEM CYTOCHEM, V49, P539, DOI 10.1177/002215540104900414; Camby I, 2002, J NEUROPATH EXP NEUR, V61, P585, DOI 10.1093/jnen/61.7.585; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Chen R, 2012, CANCER BIOL THER, V13, P899, DOI 10.4161/cbt.20842; Chung JC, 2008, ANZ J SURG, V78, P245, DOI 10.1111/j.1445-2197.2008.04429.x; Daroqui CM, 2007, CANCER IMMUNOL IMMUN, V56, P491, DOI 10.1007/s00262-006-0208-9; Dings RPM, 2010, BIOCONJUGATE CHEM, V21, P20, DOI 10.1021/bc900287y; Fitzner B, 2005, CELL SIGNAL, V17, P1240, DOI 10.1016/j.cellsig.2004.12.012; Gerloff A, 2010, INT J ENV RES PUB HE, V7, P1093, DOI 10.3390/ijerph7031093; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; He JL, 2006, METHOD ENZYMOL, V417, P247, DOI 10.1016/S0076-6879(06)17017-2; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang XH, 2009, PANCREATOLOGY, V9, P165, DOI 10.1159/000178888; Jung EJ, 2007, INT J CANCER, V120, P2331, DOI 10.1002/ijc.22434; Juszczynski P, 2007, P NATL ACAD SCI USA, V104, P13134, DOI 10.1073/pnas.0706017104; Kikuta K, 2010, BIOCHEM BIOPH RES CO, V403, P380, DOI 10.1016/j.bbrc.2010.11.040; Kovacs-Solyom F, 2010, IMMUNOL LETT, V127, P108, DOI 10.1016/j.imlet.2009.10.003; Kuroda T, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-134; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Luo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099016; Masamune A, 2006, AM J PHYSIOL-GASTR L, V290, pG729, DOI 10.1152/ajpgi.00511.2005; Masamune A, 2005, BIOCHEM PHARMACOL, V70, P869, DOI 10.1016/j.bcp.2005.06.008; Masamune A, 2009, GUT, V58, P550, DOI 10.1136/gut.2008.154401; Masamune A, 2008, J GASTROENTEROL, V43, P352, DOI 10.1007/s00535-008-2162-0; Masamune A, 2009, CLIN GASTROENTEROL H, V7, pS48, DOI 10.1016/j.cgh.2009.07.038; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Qiu J, 2008, J CELL BIOCHEM, V104, P1054, DOI 10.1002/jcb.21691; Rabinovich GA, 2005, BRIT J CANCER, V92, P1188, DOI 10.1038/sj.bjc.6602493; Roda O, 2009, GASTROENTEROLOGY, V136, P1379, DOI 10.1053/j.gastro.2008.12.039; Satelli A, 2011, CANCER LETT, V301, P38, DOI 10.1016/j.canlet.2010.10.027; Shen JJ, 2004, CANCER RES, V64, P9018, DOI 10.1158/0008-5472.CAN-04-3262; Sioud M, 2011, SCAND J IMMUNOL, V73, P79, DOI 10.1111/j.1365-3083.2010.02491.x; Spano D, 2010, MOL MED, V16, P102, DOI 10.2119/molmed.2009.00119; Spector I, 2010, PANCREAS, V39, P1008, DOI 10.1097/MPA.0b013e3181da8aa3; Tang D, 2013, INT J CANCER, V132, P993, DOI 10.1002/ijc.27715; Tang D, 2012, INT J CANCER, V130, P2337, DOI 10.1002/ijc.26290; Thijssen VL, 2010, CANCER RES, V70, P6216, DOI 10.1158/0008-5472.CAN-09-4150; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Tripathi P, 2009, INDIAN J HEMATOL BLO, V25, P10, DOI 10.1007/s12288-009-0003-9; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Wang L, 2000, LAB INVEST, V80, P1233, DOI 10.1038/labinvest.3780131; Wu MH, 2009, MOL CANCER RES, V7, P311, DOI 10.1158/1541-7786.MCR-08-0297; Xu ZH, 2010, AM J PATHOL, V177, P2585, DOI 10.2353/ajpath.2010.090899; Xue XF, 2011, PANCREAS, V40, P832, DOI 10.1097/MPA.0b013e318217945e	55	38	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90476	10.1371/journal.pone.0090476	http://dx.doi.org/10.1371/journal.pone.0090476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595374	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500056
J	Torrado, M; Franco, D; Hernandez-Torres, F; Crespo-Leiro, MG; Iglesias-Gil, C; Castro-Beiras, A; Mikhailov, AT				Torrado, Mario; Franco, Diego; Hernandez-Torres, Francisco; Crespo-Leiro, Maria G.; Iglesias-Gil, Carmen; Castro-Beiras, Alfonso; Mikhailov, Alexander T.			Pitx2c Is Reactivated in the Failing Myocardium and Stimulates Myf5 Expression in Cultured Cardiomyocytes	PLOS ONE			English	Article							HEART-FAILURE; MUSCLE DIFFERENTIATION; CELL-PROLIFERATION; EJECTION FRACTION; INTRON RETENTION; PROGENITOR CELLS; GENE-EXPRESSION; RIEGER-SYNDROME; ATRIAL; MYOGENESIS	Background: Pitx2 (paired-like homeodomain 2 transcription factor) is crucial for heart development, but its role in heart failure (HF) remains uncertain. The present study lays the groundwork implicating Pitx2 signalling in different modalities of HF. Methodology/Principal Findings: A variety of molecular, cell-based, biochemical, and immunochemical assays were used to evaluate: (1) Pitx2c expression in the porcine model of diastolic HF (DHF) and in patients with systolic HF (SHF) due to dilated and ischemic cardiomyopathy, and (2) molecular consequences of Pitx2c expression manipulation in cardiomyocytes in vitro. In pigs, the expression of Pitx2c, physiologically downregulated in the postnatal heart, is significantly re-activated in left ventricular (LV) failing myocardium which, in turn, is associated with increased expression of a restrictive set of Pitx2 target genes. Among these, Myf5 was identified as the top upregulated gene. In vitro, forced expression of Pitx2c in cardiomyocytes, but not in skeletal myoblasts, activates Myf5 in dose-dependent manner. In addition, we demonstrate that the level of Pitx2c is upregulated in the LV-myocardium of SHF patients. Conclusions/Significance: The results provide previously unrecognized evidence that Pitx2c is similarly reactivated in postnatal/adult heart at distinct HF phenotypes and suggest that Pitx2c is involved, directly or indirectly, in the regulation of Myf5 expression in cardiomyocytes.	[Torrado, Mario; Castro-Beiras, Alfonso; Mikhailov, Alexander T.] Univ A Coruna, Inst Hlth Sci, La Coruna, Spain; [Franco, Diego; Hernandez-Torres, Francisco] Univ Jaen, Dept Expt Biol, Jaen, Spain; [Crespo-Leiro, Maria G.; Iglesias-Gil, Carmen; Castro-Beiras, Alfonso] Univ Hosp Ctr La Coruna, La Coruna, Spain	Universidade da Coruna; Universidad de Jaen; Complejo Hospitalario Universitario A Coruna	Mikhailov, AT (corresponding author), Univ A Coruna, Inst Hlth Sci, La Coruna, Spain.	a.mikhailov@udc.es	Hernandez-Torres, Francisco/P-1558-2018; IGLESIAS, CARMEN/R-4932-2016	Hernandez-Torres, Francisco/0000-0003-1343-8274; Franco, Diego/0000-0002-5669-7164; Crespo-Leiro, Maria Generosa/0000-0002-3085-167X; Mikhailov, Alexander/0000-0002-1146-4113; Torrado, Mario/0000-0001-9762-7018; IGLESIAS, CARMEN/0000-0002-3131-1181	Institute of Health Sciences; Autonomic Government of Galicia, Spain [GRC 2013/061]; Excellence Project of the Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia [CTS1416]; CNIC-T translactional grant [CNIC-T 2009/08]	Institute of Health Sciences; Autonomic Government of Galicia, Spain; Excellence Project of the Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia; CNIC-T translactional grant	ATM, MT and AC-B were supported by funds from the Institute of Health Sciences and by a grant (GRC 2013/061) from the Autonomic Government of Galicia, Spain. DF and FH-T were supported by Excellence Project of the Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia (grant # CTS1416) and a CNIC-T translactional grant (CNIC-T 2009/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammirabile G, 2012, CARDIOVASC RES, V93, P291, DOI 10.1093/cvr/cvr314; [Anonymous], EUR J HEART FAIL S; Bajard L, 2006, GENE DEV, V20, P2450, DOI 10.1101/gad.382806; BEINLICH CJ, 1995, J MOL CELL CARDIOL, V27, P273, DOI 10.1016/S0022-2828(08)80026-0; Bergmann MW, 2010, CIRC RES, V107, P1198, DOI 10.1161/CIRCRESAHA.110.223768; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Borlaug BA, 2011, CIRCULATION, V123, P2006, DOI 10.1161/CIRCULATIONAHA.110.954388; Campbell AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035822; Chinchilla A, 2011, CIRC-CARDIOVASC GENE, V4, P269, DOI 10.1161/CIRCGENETICS.110.958116; Christoffels VM, 2010, CIRC RES, V106, P240, DOI 10.1161/CIRCRESAHA.109.205419; Clause KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040725; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Crippa S, 2011, J CELL BIOL, V193, P1197, DOI 10.1083/jcb.201011099; De Keulenaer GW, 2011, CIRCULATION, V123, P1996, DOI 10.1161/CIRCULATIONAHA.110.981431; Diehl AG, 2006, INVEST OPHTH VIS SCI, V47, P1785, DOI 10.1167/iovs.05-1424; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Doetschman T, 2012, CELL TISSUE RES, V347, P203, DOI 10.1007/s00441-011-1241-3; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; Edwards JG, 1996, CIRC RES, V78, P379, DOI 10.1161/01.RES.78.3.379; Francetic T, 2011, TRANSCR-AUSTIN, V2, P109, DOI 10.4161/trns.2.3.15829; Franco D, 2003, TRENDS CARDIOVAS MED, V13, P157, DOI 10.1016/S1050-1738(03)00039-2; Franco D, 2014, TRENDS CARDIOVAS MED, V24, P23, DOI 10.1016/j.tcm.2013.06.001; Franco D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00206; Franco D, 2011, CARDIOVASC RES, V91, P223, DOI 10.1093/cvr/cvr078; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Ganga M, 2003, J BIOL CHEM, V278, P22437, DOI 10.1074/jbc.M210163200; George I, 2010, EUR J HEART FAIL, V12, P444, DOI 10.1093/eurjhf/hfq039; Hernandez-Torres F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-199; Hjalt Tord A., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010082; Hsu J, 2012, CIRC-CARDIOVASC GENE, V5, P327, DOI 10.1161/CIRCGENETICS.111.961631; Huang Y, 2009, FEBS LETT, V583, P638, DOI 10.1016/j.febslet.2009.01.028; Iwata J, 2012, J BIOL CHEM, V287, P2353, DOI 10.1074/jbc.M111.280974; Kahr PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026389; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Knopp P, 2013, DEV BIOL, V377, P293, DOI 10.1016/j.ydbio.2013.02.011; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lozano-Velasco E, 2011, DEV BIOL, V357, P165, DOI 10.1016/j.ydbio.2011.06.039; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Martinez-Fernandez S, 2006, DEV DYNAM, V235, P2930, DOI 10.1002/dvdy.20924; Mikhailov AT, 2008, INT J DEV BIOL, V52, P811, DOI 10.1387/ijdb.082655am; MINER JH, 1992, DEVELOPMENT, V114, P853; Mok GF, 2011, REPRODUCTION, V141, P301, DOI 10.1530/REP-10-0394; Murry CE, 1996, J CLIN INVEST, V98, P2209, DOI 10.1172/JCI119030; Oikonomopoulos A, 2011, CIRC RES, V109, P1363, DOI 10.1161/CIRCRESAHA.111.250282; Paylakhi SH, 2011, MOL VIS, V17, P1209; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Rios R, 2002, AM J PHYSIOL-CELL PH, V282, pC993, DOI 10.1152/ajpcell.00372.2001; Rossi A, 2006, INT J CARDIOL, V110, P386, DOI 10.1016/j.ijcard.2005.08.049; SANTERRE RF, 1993, MOL CELL BIOL, V13, P6044, DOI 10.1128/MCB.13.10.6044; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Su DM, 2013, BBA-MOL BASIS DIS, V1832, P2145, DOI 10.1016/j.bbadis.2013.07.013; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Sweetman D., 2012, SKELETAL MUSCLE MYOG, P31; Tao Y, 2014, CIRC-CARDIOVASC GENE, DOI [10.1161/CIRCGENETICS.1113.000259, DOI 10.1161/CIRCGENETICS.1113.000259]; Teo SG, 2010, EUR J ECHOCARDIOGR, V11, P38, DOI 10.1093/ejechocard/jep153; Tessari A, 2008, CIRC RES, V102, P813, DOI 10.1161/CIRCRESAHA.107.163188; Torrado M, 2004, EUR J HEART FAIL, V6, P161, DOI 10.1016/j.ejheart.2003.11.004; Torrado M, 2003, J MOL MED, V81, P566, DOI 10.1007/s00109-003-0470-7; Torrado M, 2006, FEBS LETT, V580, P4182, DOI 10.1016/j.febslet.2006.06.073; Torrado M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026392; Torrado M, 2010, EXP BIOL MED, V235, P941, DOI 10.1258/ebm.2010.010078; Torrado M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/603159; Torrado M, 2009, GENE, V440, P28, DOI 10.1016/j.gene.2009.03.017; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; Van der Heiden K, 2011, INT REV CEL MOL BIO, V290, P87, DOI 10.1016/B978-0-12-386037-8.00004-1; Venugopalan SR, 2008, HUM MOL GENET, V17, P3643, DOI 10.1093/hmg/ddn258; Wang J, 2010, P NATL ACAD SCI USA, V107, P9753, DOI 10.1073/pnas.0912585107; Yang CF, 2008, J CHIN MED ASSOC, V71, P79, DOI 10.1016/S1726-4901(08)70079-0; Zacharias AL, 2011, DEV BIOL, V349, P395, DOI 10.1016/j.ydbio.2010.10.028; Zakeri R, 2013, CIRCULATION, V128, P1085, DOI 10.1161/CIRCULATIONAHA.113.001475; Zhou YM, 2013, INT J MOL MED, V32, P827, DOI 10.3892/ijmm.2013.1463; Zu LY, 2010, J MOL CELL CARDIOL, V49, P5, DOI 10.1016/j.yjmcc.2010.02.007	74	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90561	10.1371/journal.pone.0090561	http://dx.doi.org/10.1371/journal.pone.0090561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595098	Green Submitted, Green Published, gold			2022-12-25	WOS:000332475500067
J	Zhang, ZC; Peng, XC; Li, ST; Zhang, N; Wang, Y; Wei, H				Zhang, Zhichao; Peng, Xichun; Li, Shaoting; Zhang, Ning; Wang, Yong; Wei, Hua			Isolation and Identification of Quercetin Degrading Bacteria from Human Fecal Microbes	PLOS ONE			English	Article							SP-NOV; FLAVONOIDS; METABOLISM; BIOAVAILABILITY; SURVIVAL	Quercetin has a wide range of biological properties. The gut microflora can often modulate its biological activity and their potential health effects. There still is a lack of information about gut bacteria involving in this process. The strains of gut microbes from human feces that can transform quercetin were isolated and identified by in vitro fermentation. The results showed that Escherichia coli, Stretococcus lutetiensis, Lactobacillus acidophilus, Weissella confusa, Enterococcus gilvus, Clostridium perfringens and Bacteroides fragilis have the various ability of degrading quercetin. Among them, C. perfringens and B. fragilis were discovered to have the strongest ability of degrading quercetin. Additionally, quercetin can't inhibit the growth of C. perfringens. In conclusion, many species of gut microbiota can degrade quercetin, but their ability are different.	[Zhang, Zhichao; Peng, Xichun; Li, Shaoting; Zhang, Ning; Wang, Yong] Jinan Univ, Dept Food Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Wei, Hua] Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang, Peoples R China	Jinan University; Nanchang University	Peng, XC (corresponding author), Jinan Univ, Dept Food Sci & Engn, Guangzhou, Guangdong, Peoples R China.	tpxchun@jnu.edu.cn; weihua114@live.cn	WANG, YONG/K-5715-2019; Li, Shaoting/GMX-0413-2022	WEI, HUA/0000-0003-4341-8290	National Natural Science Funds [31271849]; National Innovation Experiment Program for University Students [101055902]; State Key Laboratory of Food Science and Technology, Nanchang University [SKLF-KF-201212]	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); National Innovation Experiment Program for University Students; State Key Laboratory of Food Science and Technology, Nanchang University	The program was supported by the funds of the National Natural Science Funds (No. 31271849), National Innovation Experiment Program for University Students (No. 101055902) and the Open Project Program of State Key Laboratory of Food Science and Technology, Nanchang University (No. SKLF-KF-201212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma K, 2010, FOOD CHEM TOXICOL, V48, P1117, DOI 10.1016/j.fct.2010.02.005; Braune A, 2001, APPL ENVIRON MICROB, V67, P5558, DOI 10.1128/AEM.67.12.5558-5567.2001; Chang YZ, 2012, FOOD CHEM, V133, P445, DOI 10.1016/j.foodchem.2012.01.060; GIBSON LF, 1986, LETT APPL MICROBIOL, V3, P127, DOI 10.1111/j.1472-765X.1986.tb01565.x; Hoefel D, 2005, J APPL MICROBIOL, V99, P175, DOI 10.1111/j.1365-2672.2005.02573.x; Ishizawa K, 2011, J PHARMACOL SCI, V115, P466, DOI 10.1254/jphs.10R38FM; Jacobs DM, 2009, CURR DRUG METAB, V10, P41, DOI 10.2174/138920009787048383; KRUMHOLZ LR, 1986, ARCH MICROBIOL, V144, P8, DOI 10.1007/BF00454948; Lotito SB, 2011, FREE RADICAL BIO MED, V51, P454, DOI 10.1016/j.freeradbiomed.2011.04.032; Lu LL, 2013, BIOMED CHROMATOGR, V27, P509, DOI 10.1002/bmc.2820; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Maniatis T., 1982, MOL CLONING LAB MANU; Rasmussen SE, 2005, MOL NUTR FOOD RES, V49, P159, DOI 10.1002/mnfr.200400082; Rastmanesh R, 2011, CHEM-BIOL INTERACT, V189, P1, DOI 10.1016/j.cbi.2010.10.002; Schneider H, 1999, ARCH MICROBIOL, V171, P81, DOI 10.1007/s002030050682; Serra A, 2012, FOOD CHEM, V130, P383, DOI 10.1016/j.foodchem.2011.07.055; Setchell KDR, 2002, J NUTR, V132, P3577, DOI 10.1093/jn/132.12.3577; Tannock GW, 2012, INFLAMM BOWEL DIS, V18, P925, DOI 10.1002/ibd.21936; Tannock GW, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/954051; Walle T, 2004, FREE RADICAL BIO MED, V36, P829, DOI 10.1016/j.freeradbiomed.2004.01.002; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; WINTER J, 1989, APPL ENVIRON MICROB, V55, P1203, DOI 10.1128/AEM.55.5.1203-1208.1989; WINTER J, 1991, INT J SYST BACTERIOL, V41, P355, DOI 10.1099/00207713-41-3-355; XU X, 1995, J NUTR, V125, P2307, DOI 10.1093/jn/125.9.2307; Yoshino S, 2011, NUTRITION, V27, P847, DOI 10.1016/j.nut.2010.09.002; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	27	42	44	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90531	10.1371/journal.pone.0090531	http://dx.doi.org/10.1371/journal.pone.0090531			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594786	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500060
J	Ferraretto, X; Estellat, C; Damond, F; Longuet, P; Epelboin, S; Demailly, P; Yazbeck, C; Llabador, MA; Pasquet, B; Yazdanpanah, Y; Matheron, S; Patrat, C				Ferraretto, Xavier; Estellat, Candice; Damond, Florence; Longuet, Pascale; Epelboin, Sylvie; Demailly, Pauline; Yazbeck, Chadi; Llabador, Marie-Astrid; Pasquet, Blandine; Yazdanpanah, Yazdan; Matheron, Sophie; Patrat, Catherine			Timing of Intermittent Seminal HIV-1 RNA Shedding in Patients with Undetectable Plasma Viral Load under Combination Antiretroviral Therapy	PLOS ONE			English	Article							TREATED PATIENTS; SEMEN; INFECTION; BLOOD; COUPLES; SAMPLES; MEN	It was demonstrated that combination antiretroviral therapy (cART) reduces the HIV-1 viral load (VL) in the blood and the seminal compartment. Some studies have reported that the seminal HIV-1 VL is undetectable in individuals with an undetectable blood plasma viral load (bpVL) under cART. However, some recent studies have demonstrated that seminal HIV-1 RNA may still be detected, and potentially infectious, even in the case of an undetectable bpVL. The aim of this retrospective study was to determine the detection rate of a seminal VL and whether shedding could be intermittent over a very short time. From January 2006 to December 2011, 88 HIV-1 infected men, enrolled in an Assisted Reproduction program, provided 306 semen samples, corresponding to 177 frozen sperm samples (two samples delivered at a one-hour interval (n = 129) or one sample (n = 48)). All enrolled men were under cART, with an undetectable bpVL for more than 6 months. HIV-1 RNA was quantified in seminal plasma using a Roche COBAS Ampliprep COBAS TaqMan HIV-1 test. Seminal HIV-1 RNA was detected in 23 samples (7.5%) from 17 patients (19.3%). This detection rate was stable over years. With regards to the freezing of two samples delivered at a one-hour interval, the proportion of discordance between the first and second samples was 9.3% (12/129). Our results confirm the intermittent shedding of HIV-1 in semen. While this finding has been shown by studies examining longer time intervals, to our knowledge, this has never been demonstrated over such a short time interval.	[Ferraretto, Xavier; Demailly, Pauline; Llabador, Marie-Astrid; Patrat, Catherine] Grp Hosp Bichat Claude Bernard, Lab Biol Reprod, Paris, France; [Estellat, Candice; Pasquet, Blandine] Grp Hosp Bichat Claude Bernard, Dept Epidemiol & Rech Clin, Paris, France; [Estellat, Candice; Pasquet, Blandine] INSERM, Ctr Invest Clin Epidemiol Clin CIE 801, Paris, France; [Damond, Florence] Grp Hosp Bichat Claude Bernard, Lab Virol, Paris, France; [Damond, Florence; Demailly, Pauline; Llabador, Marie-Astrid; Yazdanpanah, Yazdan; Matheron, Sophie; Patrat, Catherine] Univ Paris 07, Paris, France; [Longuet, Pascale; Yazdanpanah, Yazdan; Matheron, Sophie] Grp Hosp Bichat Claude Bernard, Serv Malad Infect & Trop, Paris, France; [Epelboin, Sylvie; Yazbeck, Chadi] Grp Hosp Bichat Claude Bernard, Serv Gynecol Obstet, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Ferraretto, X (corresponding author), Grp Hosp Bichat Claude Bernard, Lab Biol Reprod, Paris, France.	xavier.ferraretto@gmail.com	Matheron, Sophie/D-7420-2017	Matheron, Sophie/0000-0001-7879-6553; epelboin, sylvie/0000-0001-7972-1609				Bachelot- Narquin R, 2010, J OFFICIEL REPUBLIQU; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Bujan L, 2004, AIDS, V18, P757, DOI 10.1097/00002030-200403260-00006; Bujan L, 2007, AIDS, V21, P1909, DOI 10.1097/QAD.0b013e3282703879; CAZEIN F, 2012, B EPIDEMIOLOGIQUE HE, V46, P529; Chakraborty H, 2001, AIDS, V15, P621, DOI 10.1097/00002030-200103300-00012; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dulioust E, 2010, AIDS, V24, P1595, DOI 10.1097/QAD.0b013e32833b47fc; Gupta P, 2000, J INFECT DIS, V182, P79, DOI 10.1086/315644; Halfon P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010569; Lambert-Niclot S, 2012, AIDS, V26, P971, DOI 10.1097/QAD.0b013e328352ae09; Leruez-Ville M, 2002, AIDS, V16, P486, DOI 10.1097/00002030-200202150-00023; Loutfy MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055747; Marcelin AG, 2008, AIDS, V22, P1677, DOI 10.1097/QAD.0b013e32830abdc8; Pasquier C, 2006, J MED VIROL, V78, P877, DOI 10.1002/jmv.20636; Pasquier C, 2009, J CLIN MICROBIOL, V47, P2883, DOI 10.1128/JCM.02131-08; SEMPRINI AE, 1992, LANCET, V340, P1317, DOI 10.1016/0140-6736(92)92495-2; Sheth PM, 2009, AIDS, V23, P2050, DOI 10.1097/QAD.0b013e3283303e04; Taylor S, 2001, SEX TRANSM INFECT, V77, P4, DOI 10.1136/sti.77.1.4; Vernazza P, 2008, B MED SUISSES, V89, P165; Vernazza PL, 2011, AIDS, V25, P2005, DOI 10.1097/QAD.0b013e32834a36d0; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006	22	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e88922	10.1371/journal.pone.0088922	http://dx.doi.org/10.1371/journal.pone.0088922			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594873	Green Submitted, Green Published, gold			2022-12-25	WOS:000332468900010
J	Tateishi-Karimata, H; Isono, N; Sugimoto, N				Tateishi-Karimata, Hisae; Isono, Noburu; Sugimoto, Naoki			New Insights into Transcription Fidelity: Thermal Stability of Non-Canonical Structures in Template DNA Regulates Transcriptional Arrest, Pause, and Slippage	PLOS ONE			English	Article							RNA-POLYMERASE-II; G-QUADRUPLEX STRUCTURES; CROWDING CONDITIONS; FORMING SEQUENCE; ION MOVEMENT; LOGIC GATES; ELONGATION; SITE; TERMINATION; HYDRATION	The thermal stability and topology of non-canonical structures of G-quadruplexes and hairpins in template DNA were investigated, and the effect of non-canonical structures on transcription fidelity was evaluated quantitatively. We designed ten template DNAs: A linear sequence that does not have significant higher-order structure, three sequences that form hairpin structures, and six sequences that form G-quadruplex structures with different stabilities. Templates with non-canonical structures induced the production of an arrested, a slipped, and a full-length transcript, whereas the linear sequence produced only a full-length transcript. The efficiency of production for run-off transcripts (full-length and slipped transcripts) from templates that formed the non-canonical structures was lower than that from the linear. G-quadruplex structures were more effective inhibitors of full-length product formation than were hairpin structure even when the stability of the G-quadruplex in an aqueous solution was the same as that of the hairpin. We considered that intra-polymerase conditions may differentially affect the stability of non-canonical structures. The values of transcription efficiencies of run-off or arrest transcripts were correlated with stabilities of non-canonical structures in the intra-polymerase condition mimicked by 20 wt% polyethylene glycol (PEG). Transcriptional arrest was induced when the stability of the G-quadruplex structure (-Delta G degrees(37)) in the presence of 20 wt% PEG was more than 8.2 kcal mol(-1). Thus, values of stability in the presence of 20 wt% PEG are an important indicator of transcription perturbation. Our results further our understanding of the impact of template structure on the transcription process and may guide logical design of transcription-regulating drugs.	[Tateishi-Karimata, Hisae; Isono, Noburu; Sugimoto, Naoki] Konan Univ, Frontier Inst Biomol Engn Res FIBER, Kobe, Hyogo, Japan; [Sugimoto, Naoki] Konan Univ, Fac Frontiers Innovat Res Sci & Technol FIRST, Kobe, Hyogo, Japan	Konan University; Konan University	Sugimoto, N (corresponding author), Konan Univ, Frontier Inst Biomol Engn Res FIBER, Kobe, Hyogo, Japan.	sugimoto@konan-u.ac.jp	Tateishi-Karimata, Hisae/AAH-2992-2020	Tateishi-Karimata, Hisae/0000-0001-6161-9817	Ministry of Education, Culture, Sports, Science and Technology (MEXT) Program for the Strategic Research Foundation at Private Universities, Japan; Nagase Science and Technology Foundation; Hirao Taro Foundation of the Konan University Association for Academic Research; Grants-in-Aid for Scientific Research [24750168, 26620138] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) Program for the Strategic Research Foundation at Private Universities, Japan; Nagase Science and Technology Foundation; Hirao Taro Foundation of the Konan University Association for Academic Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by the Grants-in-Aid for Scientific Research, the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Program for the Strategic Research Foundation at Private Universities (2009-2014), Japan, the Nagase Science and Technology Foundation, and the Hirao Taro Foundation of the Konan University Association for Academic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand VS, 2006, J BIOL CHEM, V281, P35677, DOI 10.1074/jbc.M608180200; Bandwar RP, 2002, J MOL BIOL, V324, P63, DOI 10.1016/S0022-2836(02)01034-3; Bassi GS, 2003, BIOCHEMISTRY-US, V42, P9980, DOI 10.1021/bi0346906; Belotserkovskii BP, 2007, J BIOL CHEM, V282, P32433, DOI 10.1074/jbc.M704618200; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Brinson RG, 2009, BIOCHEMISTRY-US, V48, P6988, DOI 10.1021/bi900357j; Broxson C, 2011, BIOCHEMISTRY-US, V50, P4162, DOI 10.1021/bi2002136; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; Chen YW, 2012, J AM CHEM SOC, V134, P13220, DOI 10.1021/ja305764d; Ditlevson JV, 2008, NUCLEIC ACIDS RES, V36, P3163, DOI 10.1093/nar/gkn136; EBBINGHAUS SW, 1993, J CLIN INVEST, V92, P2433, DOI 10.1172/JCI116850; Endoh T, 2013, ANGEW CHEM INT EDIT, V52, P5522, DOI 10.1002/anie.201300058; FUKUNAGA Y, 1982, J BIOCHEM-TOKYO, V92, P143, DOI 10.1093/oxfordjournals.jbchem.a133911; Hawryluk PJ, 2004, NUCLEIC ACIDS RES, V32, P1904, DOI 10.1093/nar/gkh505; Howe KJ, 2003, RNA, V9, P993, DOI 10.1261/rna.5390803; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; KING GC, 1986, BIOCHEMISTRY-US, V25, P36, DOI 10.1021/bi00349a006; Kobayashi K, 2011, CHEM LETT, V40, P855, DOI 10.1246/cl.2011.855; Kuzmine I, 2001, NUCLEIC ACIDS RES, V29, P2601, DOI 10.1093/nar/29.12.2601; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Li T, 2010, ANAL CHEM, V82, P7576, DOI 10.1021/ac1019446; Liu XQ, 2009, J BIOL CHEM, V284, P36262, DOI 10.1074/jbc.M109.056820; Ma Y, 2009, BIOORG MED CHEM LETT, V19, P3414, DOI 10.1016/j.bmcl.2009.05.030; MACDONALD LE, 1993, J MOL BIOL, V232, P1030, DOI 10.1006/jmbi.1993.1458; McLuckie KIE, 2011, J AM CHEM SOC, V133, P2658, DOI 10.1021/ja109474c; Miller MC, 2010, J AM CHEM SOC, V132, P17105, DOI 10.1021/ja105259m; Miyoshi D, 2003, NUCLEOS NUCLEOT NUCL, V22, P203, DOI 10.1081/NCN-120019528; Miyoshi D, 2006, J AM CHEM SOC, V128, P7957, DOI 10.1021/ja061267m; Miyoshi D, 2006, ANGEW CHEM INT EDIT, V45, P7716, DOI 10.1002/anie.200602404; Nakano S, 2004, J AM CHEM SOC, V126, P14330, DOI 10.1021/ja0463029; Nakano S, 2009, J AM CHEM SOC, V131, P16881, DOI 10.1021/ja9066628; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Podbevsek P, 2008, J AM CHEM SOC, V130, P14287, DOI 10.1021/ja8048282; Rodriguez R, 2007, ANGEW CHEM INT EDIT, V46, P5405, DOI 10.1002/anie.200605075; Rudd MD, 1996, J BIOL CHEM, V271, P21549, DOI 10.1074/jbc.271.35.21549; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sket P, 2004, ORG BIOMOL CHEM, V2, P1970, DOI 10.1039/b406815g; Smargiasso N, 2008, J AM CHEM SOC, V130, P10208, DOI 10.1021/ja801535e; Spink CH, 1999, BIOCHEMISTRY-US, V38, P496, DOI 10.1021/bi9820154; Strathern J, 2013, J BIOL CHEM, V288, P2689, DOI 10.1074/jbc.M112.429506; Tateishi-Karimata H., 2013, CURR PROTOC NUCL ACI; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Tornaletti S, 2006, CHEM RES TOXICOL, V19, P1215, DOI 10.1021/tx060103g; Torres AG, 2011, RNA, V17, P933, DOI 10.1261/rna.2533811; Toulme F, 2005, J MOL BIOL, V351, P39, DOI 10.1016/j.jmb.2005.05.052; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Tse MT, 2012, NAT REV DRUG DISCOV, V11, P674, DOI 10.1038/nrd3825; Tsuji A, 2010, J AM CHEM SOC, V132, P12464, DOI 10.1021/ja105154k; Van Horn WD, 2009, J AM CHEM SOC, V131, P8030, DOI 10.1021/ja901871n; WAGNER LA, 1990, NUCLEIC ACIDS RES, V18, P3529, DOI 10.1093/nar/18.12.3529; Wang GL, 2006, P NATL ACAD SCI USA, V103, P2677, DOI 10.1073/pnas.0511084103; Yaku H, 2013, METHODS; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	58	39	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90580	10.1371/journal.pone.0090580	http://dx.doi.org/10.1371/journal.pone.0090580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594642	gold, Green Published, Green Submitted			2022-12-25	WOS:000332468900119
J	Wang, Y; Tian, RM; Gao, ZM; Bougouffa, S; Qian, PY				Wang, Yong; Tian, Ren Mao; Gao, Zhao Ming; Bougouffa, Salim; Qian, Pei-Yuan			Optimal Eukaryotic 18S and Universal 16S/18S Ribosomal RNA Primers and Their Application in a Study of Symbiosis	PLOS ONE			English	Article							DEEP-SEA; BACTERIAL COMMUNITIES; MICROBIAL EUKARYOTES; WATER COLUMNS; COPY NUMBER; GENOME SIZE; DIVERSITY; SUBUNIT; GENES; LIFE	Eukaryotic 18S ribosomal RNA (rRNA) gene primers that feature a wide coverage are critical in detecting the composition of eukaryotic microscopic organisms in ecosystems. Here, we predicted 18S rRNA primers based on consecutive conserved sites and evaluated their coverage efficiency and scope of application to different eukaryotic groups. After evaluation, eight of them were considered as qualified 18S primers based on coverage rate. Next, we examined common conserved regions in prokaryotic 16S and eukaryotic 18S rRNA sequences to design 16S/18S universal primers. Three 16S/18S candidate primers, U515, U1390 and U1492, were then considered to be suitable for simultaneous amplification of the rRNA sequences in three domains. Eukaryotic 18S and prokaryotic 16S rRNA genes in a sponge were amplified simultaneously using universal primers U515 and U1390, and the subsequent sorting of pyrosequenced reads revealed some distinctive communities in different parts of the sample. The real difference in biodiversity between prokaryotic and eukaryotic symbionts could be discerned as the dissimilarity between OTUs was increased from 0.005 to 0.1. A network of the communities in external and internal parts of the sponge illustrated the co-variation of some unique microbes in certain parts of the sponge, suggesting that the universal primers are useful in simultaneous detection of prokaryotic and eukaryotic microbial communities.	[Wang, Yong; Tian, Ren Mao; Gao, Zhao Ming; Bougouffa, Salim; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Yong] Chinese Acad Sci, Sanya Inst Deep Sea Sci & Engn, San Ya, Hai Nan, Peoples R China	Hong Kong University of Science & Technology; Chinese Academy of Sciences; Institute of Deep-Sea Science & Engineering, CAS	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	boqianpy@ust.hk	Bougouffa, Salim/AAG-8976-2020	Bougouffa, Salim/0000-0001-9218-6452; wang, yong/0000-0003-3595-3867; Tian, Renmao/0000-0003-2151-4417; Qian, Pei-Yuan/0000-0003-4074-9078	Chinese Academy of Sciences (CAS) [XDB06010100, XDB06010200]; National Basic Research Program of China (973 Program) [2012CB417304]; Nature Science Foundation of China [U1301232]; Sanya Institute of Deep Sea Science and Engineering, CAS [SIDSSE-201206, SIDSSE-201305, SIDSSE-BR-201303]; King Abdullah University of Science and Technology [SA-C0040/UK-C0016]	Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sanya Institute of Deep Sea Science and Engineering, CAS; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	Funding: This study was supported by the "Strategic Priority Research Program" of the Chinese Academy of Sciences (CAS) (No. XDB06010100 and XDB06010200), National Basic Research Program of China (973 Program, No. 2012CB417304), the Nature Science Foundation of China (U1301232) and awards from the Sanya Institute of Deep Sea Science and Engineering, CAS (SIDSSE-201206, SIDSSE-201305) and SIDSSE-BR-201303) and from King Abdullah University of Science and Technology (SA-C0040/UK-C0016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Behnke A, 2006, APPL ENVIRON MICROB, V72, P3626, DOI 10.1128/AEM.72.5.3626-3636.2006; Biddle JF, 2012, ISME J, V6, P1018, DOI 10.1038/ismej.2011.164; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Birnstiel M L, 1971, Prog Nucleic Acid Res Mol Biol, V11, P351, DOI 10.1016/S0079-6603(08)60332-3; Blifernez-Klassen O, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2210; Bougouffa S, 2013, APPL ENVIRON MICROB, V79, P3425, DOI 10.1128/AEM.00254-13; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dawson SC, 2002, P NATL ACAD SCI USA, V99, P8324, DOI 10.1073/pnas.062169599; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Edgcomb VP, 2002, P NATL ACAD SCI USA, V99, P7658, DOI 10.1073/pnas.062186399; ELWOOD HJ, 1985, MOL BIOL EVOL, V2, P399; Ferrer M, 2012, ENVIRON MICROBIOL, V14, P268, DOI 10.1111/j.1462-2920.2011.02634.x; Gadd GM, 2010, MICROBIOL-SGM, V156, P609, DOI 10.1099/mic.0.037143-0; Giovanonni LE, 1988, J BACTERIOL, V170, P720; Huang Y, 2009, BIOINFORMATICS, V25, P1338, DOI 10.1093/bioinformatics/btp161; Huws SA, 2007, J MICROBIOL METH, V70, P565, DOI 10.1016/j.mimet.2007.06.013; Jeffery NW, 2013, GENOME, V56, P451, DOI 10.1139/gen-2012-0122; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee OO, 2009, APPL ENVIRON MICROB, V75, P3513, DOI 10.1128/AEM.00002-09; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Nonnenmann MW, 2012, J ENVIRON MONITOR, V14, P2038, DOI 10.1039/c2em30229b; Orsi W, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00341; Orsi W, 2012, ISME J, V6, P1586, DOI 10.1038/ismej.2012.7; Parfrey LW, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00153; Pawlowski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018169; Pillet L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032373; Prokopowich CD, 2003, GENOME, V46, P48, DOI [10.1139/g02-103, 10.1139/G02-103]; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Ragon M, MOL ECOL, V21, P3852; Roussel EG, 2011, FEMS MICROBIOL ECOL, V77, P647, DOI 10.1111/j.1574-6941.2011.01161.x; Sharp KH, 2012, ISME J, V6, P790, DOI 10.1038/ismej.2011.144; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stoeck T, 2006, PROTIST, V157, P31, DOI 10.1016/j.protis.2005.10.004; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088	49	59	59	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90053	10.1371/journal.pone.0090053	http://dx.doi.org/10.1371/journal.pone.0090053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594623	Green Submitted, Green Published, gold			2022-12-25	WOS:000332468900059
J	Xie, DZ; Chen, F; Lin, SY; Wang, SQ; You, CH; Monroig, O; Tocher, DR; Li, YY				Xie, Dizhi; Chen, Fang; Lin, Siyuan; Wang, Shuqi; You, Cuihong; Monroig, Oscar; Tocher, Douglas R.; Li, Yuanyou			Cloning, Functional Characterization and Nutritional Regulation of Delta 6 Fatty Acyl Desaturase in the Herbivorous Euryhaline Teleost Scatophagus Argus	PLOS ONE			English	Article							SALMON SALMO-SALAR; ACID-COMPOSITION; MARINE TELEOST; FRESH-WATER; FISH-OIL; GROWTH-PERFORMANCE; SEA BASS; EXPRESSION; ELONGASE; N-3	Marine fish are generally unable or have low ability for the biosynthesis of long-chain polyunsaturated fatty acids (LC-PUFA) from C18 PUFA precursors, with some notable exceptions including the herbivorous marine teleost Siganus canaliculatus in which such a capability was recently demonstrated. To determine whether this is a unique feature of S. canaliculatus or whether it is common to the herbivorous marine teleosts, LC-PUFA biosynthetic pathways were investigated in the herbivorous euryhaline Scatophagus argus. A putative desaturase gene was cloned and functionally characterized, and tissue expression and nutritional regulation were investigated. The full-length cDNA was 1972 bp, containing a 1338 bp open-reading frame encoding a polypeptide of 445 amino acids, which possessed all the characteristic features of fatty acyl desaturase (Fad). Functional characterization by heterologous expression in yeast showed the protein product of the cDNA efficiently converted 18:3n-3 and 18:2n-6 to 18:4n-3 and 18:3n-6, respectively, indicating Delta 6 desaturation activity. Quantitative real-time PCR showed that highest Delta 6 fad mRNA expression was detected in liver followed by brain, with lower expression in other tissues including intestine, eye, muscle, adipose, heart kidney and gill, and lowest expression in stomach and spleen. The expression of Delta 6 fad was significantly affected by dietary lipid and, especially, fatty acid composition, with highest expression of mRNA in liver of fish fed a diet with a ratio of 18: 3n-3/18:2n-6 of 1.72:1. The results indicated that S. argus may have a different LC-PUFA biosynthetic system from S. canaliculatus despite possessing similar habitats and feeding habits suggesting that LC-PUFA biosynthesis may not be common to all marine herbivorous teleosts.	[Xie, Dizhi; Chen, Fang; Lin, Siyuan; Wang, Shuqi; You, Cuihong; Li, Yuanyou] Shantou Univ, Inst Marine Biol, Shantou, Guangdong, Peoples R China; [Xie, Dizhi; Chen, Fang; Lin, Siyuan; Wang, Shuqi; You, Cuihong; Li, Yuanyou] Guangdong Prov Key Lab Marine Biotechnol, Shantou, Guangdong, Peoples R China; [Monroig, Oscar; Tocher, Douglas R.] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland	Shantou University; University of Stirling	Li, YY (corresponding author), Shantou Univ, Inst Marine Biol, Shantou, Guangdong, Peoples R China.	yyli@stu.edu.cn	Monroig, Oscar/K-9117-2014; Xie, Dizhi/AAG-9519-2019; Tocher, Douglas R/C-5652-2011	Monroig, Oscar/0000-0001-8712-0440; Tocher, Douglas R/0000-0002-8603-9410	National Natural Science Foundation of China (NSFC) [31110103913]; NSFC [41276179, 31202011, 31202012]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Major International Joint Research Project from National Natural Science Foundation of China (NSFC) (31110103913), NSFC General Projects (No. 41276179) and Youth Projects (No. 31202011, 31202012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimuddin, 2005, TRANSGENIC RES, V14, P159, DOI 10.1007/s11248-004-7435-7; Awada M, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-23; Barry Terence P., 1992, Asian Fisheries Science, V5, P163; Bell JG, 2002, J NUTR, V132, P222, DOI 10.1093/jn/132.2.222; Bell JG, 1997, LIPIDS, V32, P515, DOI 10.1007/s11745-997-0066-4; BELL JG, 1993, PROSTAG LEUKOTR ESS, V49, P665, DOI 10.1016/0952-3278(93)90075-8; Bell JG, 2001, J NUTR, V131, P1535, DOI 10.1093/jn/131.5.1535; Bell MV, 2001, LIPIDS, V36, P1153, DOI 10.1007/s11745-001-0826-1; Berry S., 2004, NUTR BULL, V29, P72, DOI DOI 10.1111/J.1467-3010.2003.00361.X; Blanchard G, 2008, AQUACULTURE, V284, P144, DOI 10.1016/j.aquaculture.2008.07.011; BRENNER R R, 1981, Progress in Lipid Research, V20, P315, DOI 10.1016/0163-7827(81)90063-1; Brouwer IA, 2006, PROG LIPID RES, V45, P357, DOI 10.1016/j.plipres.2006.02.004; Castro LFC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031950; Eilander A, 2007, PROSTAG LEUKOTR ESS, V76, P189, DOI 10.1016/j.plefa.2007.01.003; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fonseca-Madrigal J, 2006, FISH PHYSIOL BIOCHEM, V32, P317, DOI 10.1007/s10695-006-9109-2; Francis DS, 2007, J AGR FOOD CHEM, V55, P1582, DOI 10.1021/jf062153x; Gandhi V., 2002, Journal of the Marine Biological Association of India, V44, P115; Gonzalez-Rovira A, 2009, AQUACULTURE, V298, P90, DOI 10.1016/j.aquaculture.2009.10.012; Hastings N, 2004, MAR BIOTECHNOL, V6, P463, DOI 10.1007/s10126-004-3002-8; Hastings N, 2001, P NATL ACAD SCI USA, V98, P14304, DOI 10.1073/pnas.251516598; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; Izquierdo MS, 2008, FISH PHYSIOL BIOCHEM, V34, P117, DOI 10.1007/s10695-007-9152-7; Jaya-Ram A, 2011, COMP BIOCHEM PHYS A, V158, P415, DOI 10.1016/j.cbpa.2010.11.018; Kennedy SR, 2006, LIPIDS, V41, P423, DOI 10.1007/s11745-006-5116-4; Kim SH, 2011, BIOTECHNOL LETT, V33, P1185, DOI 10.1007/s10529-011-0555-2; Li YY, 2008, COMP BIOCHEM PHYS B, V151, P183, DOI 10.1016/j.cbpb.2008.06.013; Li YY, 2010, P NATL ACAD SCI USA, V107, P16840, DOI 10.1073/pnas.1008429107; Monroig O., 2011, AVANCES NUTR ACUICOL; Monroig O, 2013, AQUACULTURE, V412, P14, DOI 10.1016/j.aquaculture.2013.06.032; Monroig O, 2012, AQUACULTURE, V350, P63, DOI 10.1016/j.aquaculture.2012.04.017; Montes R, 2013, EUR J CLIN NUTR, V67, P658, DOI 10.1038/ejcn.2013.68; Morais S, 2011, AQUACULTURE, V313, P129, DOI 10.1016/j.aquaculture.2011.01.031; Muhlhausler BS, 2013, CURR OPIN ENDOCRINOL, V20, P56, DOI 10.1097/MED.0b013e32835c1ba7; Ren HT, 2013, GENE, V525, P11, DOI 10.1016/j.gene.2013.04.073; Ren HT, 2012, COMP BIOCHEM PHYS B, V163, P184, DOI 10.1016/j.cbpb.2012.05.016; Ruyter B, 2000, FISH PHYSIOL BIOCHEM, V23, P151, DOI 10.1023/A:1007893317923; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santigosa E, 2011, MAR BIOTECHNOL, V13, P22, DOI 10.1007/s10126-010-9264-4; Sargent John R., 2002, P181; Seiliez I, 2003, COMP BIOCHEM PHYS B, V135, P449, DOI 10.1016/S1096-4959(03)00111-8; Tanomman S, 2013, COMP BIOCHEM PHYS B, V166, P148, DOI 10.1016/j.cbpb.2013.07.011; Tocher DR, 2006, LIPIDS, V41, P1003, DOI 10.1007/s11745-006-5051-4; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Tocher DR, 2001, COMP BIOCHEM PHYS B, V130, P257, DOI 10.1016/S1096-4959(01)00429-8; Tocher DR, 2003, LIPIDS, V38, P723, DOI 10.1007/s11745-003-1120-y; Torrejon C, 2007, PROSTAG LEUKOTR ESS, V77, P319, DOI 10.1016/j.plefa.2007.10.014; Torstensen B.E., 2010, FISH OIL REPLACEMENT, P405, DOI 10.1201/9781439808634-c13; Vagner M, 2009, BRIT J NUTR, V101, P1452, DOI 10.1017/S0007114508088053; van der Merwe LF, 2013, AM J CLIN NUTR, V97, P45, DOI 10.3945/ajcn.112.042267; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Xu SD, 2012, AQUAC RES, V43, P1276, DOI 10.1111/j.1365-2109.2011.02931.x; Yamamoto Y, 2010, FISHERIES SCI, V76, P463, DOI 10.1007/s12562-010-0227-5; Yoshimura K., 2003, MER, V41, P82; Zheng X, 2004, COMP BIOCHEM PHYS B, V139, P269, DOI 10.1016/j.cbpc.2004.08.003; Zheng XZ, 2009, AQUACULTURE, V290, P122, DOI 10.1016/j.aquaculture.2009.02.010; Zheng XZ, 2005, BBA-MOL CELL BIOL L, V1734, P13, DOI 10.1016/j.bbalip.2005.01.006; Zheng XZ, 2005, LIPIDS, V40, P13, DOI 10.1007/s11745-005-1355-7	61	40	44	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90200	10.1371/journal.pone.0090200	http://dx.doi.org/10.1371/journal.pone.0090200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594899	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900079
J	Hale, AT; Tian, HM; Anih, E; Recio, FO; Shatat, MA; Johnson, T; Liao, XD; Ramirez-Bergeron, DL; Proweller, A; Ishikawa, M; Hamik, A				Hale, Andrew T.; Tian, Hongmei; Anih, Ejike; Recio, Fernando O., III; Shatat, Mohammad A.; Johnson, Trent; Liao, Xudong; Ramirez-Bergeron, Diana L.; Proweller, Aaron; Ishikawa, Masakazu; Hamik, Anne			Endothelial Kruppel-like Factor 4 Regulates Angiogenesis and the Notch Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Arabidopsis; ATPases; Kinetics; Molecular Motors; Myosin	INHIBITS TUMOR-GROWTH; VASCULAR MORPHOGENESIS; CELL-DIFFERENTIATION; UP-REGULATION; EXPRESSION; KLF4; BLOCKADE; GENE; ACTS; VEGF	Background: The transcription factor Kruppel-like factor 4 (KLF4) is a critical regulator of endothelial cell biology. Results: Sustained expression of endothelial KLF4 limits tumor growth by creating ineffective angiogenesis. Conclusion: KLF4 is an upstream regulator of angiogenesis in part by mediating Notch expression and activity. Significance: KLF4 regulates sprouting angiogenesis and may be a therapeutic target in regulation of tumor angiogenesis. Regulation of endothelial cell biology by the Notch signaling pathway (Notch) is essential to vascular development, homeostasis, and sprouting angiogenesis. Although Notch determines cell fate and differentiation in a wide variety of cells, the molecular basis of upstream regulation of Notch remains poorly understood. Our group and others have implicated the Kruppel-like factor family of transcription factors as critical regulators of endothelial function. Here, we show that Kruppel-like factor 4 (KLF4) is a central regulator of sprouting angiogenesis via regulating Notch. Using a murine model in which KLF4 is overexpressed exclusively in the endothelium, we found that sustained expression of KLF4 promotes ineffective angiogenesis leading to diminished tumor growth independent of endothelial cell proliferation or cell cycling effects. These tumors feature increased vessel density yet are hypoperfused, leading to tumor hypoxia. Mechanistically, we show that KLF4 differentially regulates expression of Notch receptors, ligands, and target genes. We also demonstrate that KLF4 limits cleavage-mediated activation of Notch1. Finally, we rescue Notch target gene expression and the KLF4 sprouting angiogenesis phenotype by supplementation of DLL4 recombinant protein. Identification of this hitherto undiscovered role of KLF4 implicates this transcription factor as a critical regulator of Notch, tumor angiogenesis, and sprouting angiogenesis.	[Hale, Andrew T.; Tian, Hongmei; Anih, Ejike; Recio, Fernando O., III; Shatat, Mohammad A.; Johnson, Trent; Liao, Xudong; Ramirez-Bergeron, Diana L.; Proweller, Aaron; Ishikawa, Masakazu; Hamik, Anne] Case Western Reserve Univ, Sch Med, Case Cardiovasc Res Inst, Cleveland, OH 44106 USA; [Hale, Andrew T.; Tian, Hongmei; Anih, Ejike; Recio, Fernando O., III; Shatat, Mohammad A.; Johnson, Trent; Liao, Xudong; Ramirez-Bergeron, Diana L.; Proweller, Aaron; Ishikawa, Masakazu; Hamik, Anne] Case Western Reserve Univ, Sch Med, Harrington Heart & Vasc Inst, Cleveland, OH 44106 USA; [Hale, Andrew T.; Tian, Hongmei; Anih, Ejike; Liao, Xudong; Ramirez-Bergeron, Diana L.; Proweller, Aaron; Ishikawa, Masakazu; Hamik, Anne] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Shatat, Mohammad A.] Louis Stokes Cleveland Vet Affairs Med Ctr, Div Pulm Crit Care & Sleep Med, Cleveland, OH 44106 USA; [Hamik, Anne] Louis Stokes Cleveland Vet Affairs Med Ctr, Div Cardiovasc Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Hamik, A (corresponding author), 2103 Cornell Rd, Cleveland, OH 44106 USA.	anne.hamik@case.edu		Hale, Andrew/0000-0003-3182-2966; Shatat, Mohammad/0000-0002-8715-6889	National Institutes of Health [HL083090, HL113570]; Dominic Visconsi Research Scholars' Fund;  [HL091171];  [HL096603]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091171, R01HL096597, R01HL096603, K08HL083090, R01HL113570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dominic Visconsi Research Scholars' Fund; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL083090 and HL113570, the Dominic Visconsi Research Scholars' Fund (to A. Hamik) and Grants HL091171 (to D. R-B.) and HL096603 (to A. P.).	Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; Crampton Steve P, 2007, J Vis Exp, P183, DOI 10.3791/183; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hoch M, 1998, EMBO J, V17, P5766, DOI 10.1093/emboj/17.19.5766; Hongmei D., 2011, 16 WORLD C HEART DIS; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Klaewsongkram J, 2007, J IMMUNOL, V179, P4679, DOI 10.4049/jimmunol.179.7.4679; Krebs LT, 2000, GENE DEV, V14, P1343; Kuhnert F, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-20; Lambertini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010369; Li JL, 2009, FRONT BIOSCI-LANDMRK, V14, P3094, DOI 10.2741/3438; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039663; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Niessen K, 2011, BLOOD, V118, P1989, DOI 10.1182/blood-2010-11-319129; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Overwijk W. W., 2009, CURR PROT IMMUNOL, V39; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shatat MA, 2014, AM J RESP CELL MOL, V50, P647, DOI 10.1165/rcmb.2013-0135OC; Villarreal G, 2010, BIOCHEM BIOPH RES CO, V391, P984, DOI 10.1016/j.bbrc.2009.12.002; Wang ZW, 2010, BBA-REV CANCER, V1806, P258, DOI 10.1016/j.bbcan.2010.06.001; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751; Zhang JH, 2011, J BIOL CHEM, V286, P8055, DOI 10.1074/jbc.M110.192641; Zhao X, 2002, AM J PHYSIOL-HEART C, V283, pH2371, DOI 10.1152/ajpheart.00383.2002; Zheng H, 2009, AM J PHYSIOL-GASTR L, V296, pG490, DOI 10.1152/ajpgi.90393.2008; Zhou GJ, 2012, J CLIN INVEST, V122, P4727, DOI 10.1172/JCI66056; Zimrin AB, 1996, J BIOL CHEM, V271, P32499, DOI 10.1074/jbc.271.51.32499	40	48	50	4	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					12016	12028		10.1074/jbc.M113.530956	http://dx.doi.org/10.1074/jbc.M113.530956			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24599951	hybrid, Green Published			2022-12-25	WOS:000335010600040
J	Liu, MY; Chen, KQ; Yoshimura, T; Liu, Y; Gong, WH; Le, YY; Gao, JL; Zhao, JH; Wang, JM; Wang, AM				Liu, Mingyong; Chen, Keqiang; Yoshimura, Teizo; Liu, Ying; Gong, Wanghua; Le, Yingying; Gao, Ji-Liang; Zhao, Jianhua; Wang, Ji Ming; Wang, Aimin			Formylpeptide Receptors Mediate Rapid Neutrophil Mobilization to Accelerate Wound Healing	PLOS ONE			English	Article							HOST-DEFENSE; GRO-ALPHA; IN-VIVO; MICE; INFLAMMATION; CHEMOKINES; ACCUMULATION; RECRUITMENT; MIGRATION; CXCR1/2	Wound healing is a multi-phased pathophysiological process requiring chemoattractant receptor-dependent accumulation of myeloid cells in the lesion. Two G protein-coupled formylpeptide receptors Fpr1 and Fpr2 mediate rapid neutrophil infiltration in the liver of Listeria-infected mice by sensing pathogen-derived chemotactic ligands. These receptors also recognize host-derived chemotactic peptides in inflammation and injury. Here we report the capacity of Fprs to promote the healing of sterile skin wound in mice by initiating neutrophil infiltration. We found that in normal miceneutrophils rapidly infiltrated the dermis in the wound before the production of neutrophil-specific chemokines by the injured tissue. In contrast, rapid neutrophil infiltration was markedly reduced with delayed wound closure in mice deficient in both Fprs. In addition, we detected Fpr ligand activity that chemoattracted neutrophils into the wound tissue. Our study thus demonstrates that Fprs are critical for normal healing of the sterile skin wound by mediating the first wave of neutrophil infiltration.	[Liu, Mingyong; Zhao, Jianhua] Third Mil Med Univ, Daping Hosp, Dept Spine Surg, Chongqing, Peoples R China; [Liu, Mingyong; Chen, Keqiang; Yoshimura, Teizo; Liu, Ying; Wang, Ji Ming] NCI, Mol Immunoregulat Lab, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA; [Liu, Ying] Natl Ctr Nanosci & Technol, Beijing, Peoples R China; [Gong, Wanghua] Sci Applicat Int Corp Frederick, Basic Res Program, Frederick, MD USA; [Le, Yingying] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Food Safety Res, Inst Nutr Sci, Shanghai, Peoples R China; [Gao, Ji-Liang] NIAID, Lab Mol Immunol, Bethesda, MD 20892 USA; [Wang, Aimin] Third Mil Med Univ, Ctr Orthoped, Daping Hosp, Chongqing, Peoples R China	Army Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Science Applications International Corporation (SAIC); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Army Medical University	Liu, MY (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Spine Surg, Chongqing, Peoples R China.	mingyong_liu@163.com	Le, Yingying/L-9785-2017; Gao, Ji-Liang/Y-4397-2019	Le, Yingying/0000-0002-7990-3899; Zhao, Jianhua/0000-0001-5758-3479; Yoshimura, Teizo/0000-0002-3853-2075	National Natural Science Foundation of China (NSFC) [81070981, 201111606]; National Cancer Institute (NCI), National Institutes of Health (NIH) [HHSN261200800001E]; Intramural Research Program of the NCI, NIH, United States of America; NATIONAL CANCER INSTITUTE [ZIABC010725, ZIABC010015] Funding Source: NIH RePORTER	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Cancer Institute (NCI), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NCI, NIH, United States of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported in part by the National Natural Science Foundation of China (NSFC, No. 81070981 and 201111606). This project was also funded in part with Federal funds from the National Cancer Institute (NCI), National Institutes of Health (NIH), under Contract No. HHSN261200800001E and was supported in part by the Intramural Research Program of the NCI, NIH, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandt E, 2000, J LEUKOCYTE BIOL, V67, P471, DOI 10.1002/jlb.67.4.471; Burdon PCE, 2005, BLOOD, V105, P2543, DOI 10.1182/blood-2004-08-3193; Chapman RW, 2007, J PHARMACOL EXP THER, V322, P486, DOI 10.1124/jpet.106.119040; Chen KD, 2013, J CLIN INVEST, V123, P1694, DOI 10.1172/JCI65569; Chen KQ, 2013, J BIOL CHEM, V288, P16262, DOI 10.1074/jbc.M113.450635; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Chintakuntlawar AV, 2009, J INTERF CYTOK RES, V29, P657, DOI 10.1089/jir.2009.0006; Cunha TM, 2008, BRIT J PHARMACOL, V154, P460, DOI 10.1038/bjp.2008.94; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; Engelhardt E, 1998, AM J PATHOL, V153, P1849, DOI 10.1016/S0002-9440(10)65699-4; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Gillitzer R, 1996, J INVEST DERMATOL, V107, P778, DOI 10.1111/1523-1747.ep12371803; Goebeler M, 1997, J INVEST DERMATOL, V108, P445, DOI 10.1111/1523-1747.ep12289711; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Lin Q, 2012, J INVEST DERMATOL, V132, P2085, DOI 10.1038/jid.2012.120; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; Liu Y, 2013, CANCER RES, V73, P550, DOI 10.1158/0008-5472.CAN-12-2290; Macedo L, 2007, AM J PATHOL, V171, P1774, DOI 10.2353/ajpath.2007.061048; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Monson Keith M, 2007, J Inflamm (Lond), V4, P11, DOI 10.1186/1476-9255-4-11; Reichel CA, 2006, J LEUKOCYTE BIOL, V79, P114, DOI 10.1189/jlb.0605337; Rose JJ, 2004, J BIOL CHEM, V279, P24372, DOI 10.1074/jbc.M401364200; Zhang LP, 2009, AM J PATHOL, V175, P2518, DOI 10.2353/ajpath.2009.090275; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	28	38	43	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90613	10.1371/journal.pone.0090613	http://dx.doi.org/10.1371/journal.pone.0090613			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603667	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600068
J	Chalfant, M; Bernd, KK				Chalfant, Madeleine; Bernd, Karen K.			17 beta-Estradiol Alters Rat Type-II Alveolar Cell Recovery from High Levels of Ozone	PLOS ONE			English	Article							NF-KAPPA-B; ARYL-HYDROCARBON RECEPTOR; GENE-EXPRESSION; OXIDATIVE STRESS; OXIDIZED TRYPTOPHAN; GENDER-DIFFERENCE; DOWN-REGULATION; ESTROGEN; EXPOSURE; MICE	Respiratory health is negatively impacted by exposure to ozone or to estrogens. Increasingly, individuals have simultaneous environmental exposure to both compounds. Characterizing the cellular responses stimulated by the combination of ozone and estrogens, therefore, is crucial to our complete understanding of the compounds' environmental health impacts. Our work introduces an alveolar cell culture model with defined media that provides evidence of ozone damage and determines sex hormones alter the cells' susceptibility to oxidative damage. Specifically, we investigated the individual and combined effects of environmentally relevant levels of ozone and 17 beta-estradiol on non-cancerous rat, type-II alveolar cells by examining biomarkers of cellular health and redox balance. The data reveal a complex role for 17 beta-estradiol in cellular recovery from 1 hr exposure to high ozone levels. At 0.5 hr post-ozone necrosis and inflammation markers show 17 beta-estradiol augments the detrimental effects of 350 ppb ozone, but after 24 hr of recovery, steroid treatment alters glutathione redox ratio and allows cellular proliferation.	[Chalfant, Madeleine; Bernd, Karen K.] Davidson Coll, Dept Biol, Davidson, NC 28036 USA	Davidson College	Bernd, KK (corresponding author), Davidson Coll, Dept Biol, Davidson, NC 28036 USA.	kabernd@davidson.edu	Bernd, Karen K/K-2774-2012	Bernd, Karen K/0000-0002-0743-2848	Merck Foundation; Davidson Research Initiative Grant	Merck Foundation(Merck & Company); Davidson Research Initiative Grant	This work was funded by a Merck Foundation Undergraduate Research in Biochemistry Grant (to KB) and a Davidson Research Initiative Grant (to MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, FREE RADICAL BIO MED, V39, P213, DOI 10.1016/j.freeradbiomed.2005.03.009; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Carey MA, 2007, AM J PHYSIOL-LUNG C, V293, pL272, DOI 10.1152/ajplung.00174.2007; Chang LW, 2007, CARCINOGENESIS; Cook MB, 2011, CANCER EPIDEM BIOMAR, V20, P1629, DOI 10.1158/1055-9965.EPI-11-0246; De Marinis E, 2010, NEUROSIGNALS, V18, P223, DOI 10.1159/000323906; de Torres JP, 2009, EUR RESPIR J, V33, P528, DOI 10.1183/09031936.00096108; Dhondt S, 2012, ENVIRON IMPACT ASSES, V36, P42, DOI 10.1016/j.eiar.2012.03.004; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Dougherty SM, 2006, ENDOCR-RELAT CANCER, V13, P113, DOI 10.1677/erc.1.01118; Dransfield MT, 2007, CHEST, V132, P464, DOI 10.1378/chest.07-0863; Fucic A, 2010, TOXICOL PATHOL, V38, P849, DOI 10.1177/0192623310378136; Funabashi H, 2004, TOXICOLOGY, V204, P75, DOI 10.1016/j.tox.2004.06.047; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Hamilton KL, 2004, ARTERIOSCL THROM VAS, V24, P1628, DOI 10.1161/01.ATV.0000137188.76195.fb; Ho CC, 2008, TOXICOL SCI, V104, P294, DOI 10.1093/toxsci/kfn096; Kafoury RM, 2007, ENVIRON TOXICOL, V22, P159, DOI 10.1002/tox.20246; Karlsson C, 2012, APMIS, V120, P451, DOI 10.1111/j.1600-0463.2011.02850.x; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Kosmider B, 2010, FREE RADICAL BIO MED, V48, P1513, DOI 10.1016/j.freeradbiomed.2010.02.032; Last JA, 2005, TOXICOL APPL PHARM, V208, P117, DOI 10.1016/j.taap.2005.02.001; Lin PP, 2004, TOXICOL APPL PHARM, V195, P83, DOI 10.1016/j.taap.2003.11.001; LU SC, 1991, J CLIN INVEST, V88, P260, DOI 10.1172/JCI115286; Maher TM, 2010, AM J RESP CRIT CARE, V182, P73, DOI 10.1164/rccm.200905-0674OC; Massaro D, 2007, AM J PHYSIOL-LUNG C, V293, pL222, DOI 10.1152/ajplung.00384.2006; Medina-Ramon M, 2006, AM J EPIDEMIOL, V163, P579, DOI 10.1093/aje/kwj078; Miyaguchi Chosei, 2004, Physiological Chemistry and Physics and Medical NMR, V36, P21; Nadadur SS, 2005, ENVIRON HEALTH PERSP, V113, P1717, DOI 10.1289/ehp.7413; Park GY, 2006, AM J PHYSIOL-LUNG C, V290, pL797, DOI 10.1152/ajplung.00513.2005; Porter W, 2001, J MOL ENDOCRINOL, V26, P31, DOI 10.1677/jme.0.0260031; Prokhorova S, 1998, AM J PHYSIOL-LUNG C, V275, pL1200, DOI 10.1152/ajplung.1998.275.6.L1200; Rahman I, 1999, ANTIOXID REDOX SIGN, V1, P425, DOI 10.1089/ars.1999.1.4-425; Roy D, 2007, J TOXICOL ENV HEAL B, V10, P235, DOI 10.1080/15287390600974924; Si ML, 2001, ENDOCRINE, V15, P255, DOI 10.1385/ENDO:15:3:255; Sindhu RK, 2000, J PHARMACOL EXP THER, V292, P1008; Sindhu RK, 1999, IN VITRO MOL TOXICOL, V12, P149; Singhal R, 2008, CARCINOGENESIS, V29, P227, DOI 10.1093/carcin/bgm288; Urata Y, 2006, J BIOL CHEM, V281, P13092, DOI 10.1074/jbc.M601984200; van de Wetering JK, 2004, EUR J BIOCHEM, V271, P1229, DOI 10.1111/j.1432-1033.2004.04040.x; Verma MK, 2011, J STEROID BIOCHEM, V127, P216, DOI 10.1016/j.jsbmb.2011.07.013; Wang GR, 2002, ENVIRON HEALTH PERSP, V110, P79, DOI 10.1289/ehp.0211079; Wang JR, 2006, FREE RADICAL BIO MED, V40, P1914, DOI 10.1016/j.freeradbiomed.2006.01.017; WELSHONS WV, 1988, MOL CELL ENDOCRINOL, V57, P169, DOI 10.1016/0303-7207(88)90072-X; Zhang Y, 2004, J NEUROSCI, V24, P5315, DOI 10.1523/JNEUROSCI.0913-04.2004	44	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90530	10.1371/journal.pone.0090530	http://dx.doi.org/10.1371/journal.pone.0090530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599035	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400089
J	Namba, F; Go, H; Murphy, JA; La, P; Yang, G; Sengupta, S; Fernando, AP; Yohannes, M; Biswas, C; Wehrli, SL; Dennery, PA				Namba, Fumihiko; Go, Hayato; Murphy, Jennifer A.; La, Ping; Yang, Guang; Sengupta, Shaon; Fernando, Amal P.; Yohannes, Mekdes; Biswas, Chhanda; Wehrli, Suzanne L.; Dennery, Phyllis A.			Expression Level and Subcellular Localization of Heme Oxygenase-1 Modulates Its Cytoprotective Properties in Response to Lung Injury: A Mouse Model	PLOS ONE			English	Article							CELLULAR-RESPONSES; DNA-DAMAGE; HYPEROXIA; CELLS; TOLERANCE; HEME-OXYGENASE-1; OVEREXPRESSION; SENSITIVITY; ACTIVATION; INHIBITION	Premature infants exposed to hyperoxia suffer acute and long-term pulmonary consequences. Nevertheless, neonates survive hyperoxia better than adults. The factors contributing to neonatal hyperoxic tolerance are not fully elucidated. In contrast to adults, heme oxygenase (HO)-1, an endoplasmic reticulum (ER)-anchored protein, is abundant in the neonatal lung but is not inducible in response to hyperoxia. The latter may be important, because very high levels of HO-1 overexpression are associated with significant oxygen cytotoxicity in vitro. Also, in contrast to adults, HO-1 localizes to the nucleus in neonatal mice exposed to hyperoxia. To understand the mechanisms by which HO-1 expression levels and subcellular localization contribute to hyperoxic tolerance in neonates, lung-specific transgenic mice expressing high or low levels of full-length HO-1 (cytoplasmic, HO-1-FL(H) or HO-1-FL(L)) or C-terminally truncated HO-1 (nuclear, Nuc-HO-1-TR) were generated. In HO-1-FL(L), the lungs had a normal alveolar appearance and lesser oxidative damage after hyperoxic exposure. In contrast, in HO-1-FL(H), alveolar wall thickness with type II cell hyperproliferation was observed as well worsened pulmonary function and evidence of abnormal lung cell hyperproliferation in recovery from hyperoxia. In Nuc-HO-1-TR, the lungs had increased DNA oxidative damage, increased poly (ADP-ribose) polymerase (PARP) protein expression, and reduced poly (ADP-ribose) (PAR) hydrolysis as well as reduced pulmonary function in recovery from hyperoxia. These data indicate that low cytoplasmic HO-1 levels protect against hyperoxia-induced lung injury by attenuating oxidative stress, whereas high cytoplasmic HO-1 levels worsen lung injury by increasing proliferation and decreasing apoptosis of alveolar type II cells. Enhanced lung nuclear HO-1 levels impaired recovery from hyperoxic lung injury by disabling PAR-dependent regulation of DNA repair. Lastly both high cytoplasmic and nuclear expression of HO-1 predisposed to long-term abnormal lung cellular proliferation. To maximize HO-1 cytoprotective effects, therapeutic strategies must account for the specific effects of its subcellular localization and expression levels.	[Namba, Fumihiko; Go, Hayato; Murphy, Jennifer A.; La, Ping; Yang, Guang; Sengupta, Shaon; Fernando, Amal P.; Yohannes, Mekdes; Biswas, Chhanda; Dennery, Phyllis A.] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Biswas, Chhanda; Dennery, Phyllis A.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Wehrli, Suzanne L.] Childrens Hosp Philadelphia, Small Anim Core, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Namba, F (corresponding author), Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA.	nambaf@saitama-med.ac.jp	Dennery, Phyllis/GQG-9113-2022	Dennery, Phyllis/0000-0001-5745-1855	Children's Hospital of Philadelphia; National Institutes of Health [HL-58752]; American Lung Association	Children's Hospital of Philadelphia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association	This work was supported by a grant from the Children's Hospital of Philadelphia (Lassin Funds, P. A. D.), the National Institutes of Health (HL-58752, P. A. D.), and the American Lung Association (Senior Research Training Fellowship, F.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaoui-Jamali MA, 2009, CANCER RES, V69, P8017, DOI 10.1158/0008-5472.CAN-09-0419; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; Busserolles J, 2006, INT J BIOCHEM CELL B, V38, P1510, DOI 10.1016/j.biocel.2006.03.013; CHOI AMK, 1995, AM J RESP CELL MOL, V13, P74, DOI 10.1165/ajrcmb.13.1.7598940; COONEY TP, 1982, THORAX, V37, P572, DOI 10.1136/thx.37.8.572; Cui Z, 1998, BLOOD, V91, P2326, DOI 10.1182/blood.V91.7.2326.2326_2326_2333; Degese MS, 2012, LUNG CANCER, V77, P168, DOI 10.1016/j.lungcan.2012.02.016; Deininger MH, 2000, BRAIN RES, V882, P1, DOI 10.1016/S0006-8993(00)02594-4; Dennery PA, 1996, PEDIATR RES, V40, P815, DOI 10.1203/00006450-199612000-00007; Doyle LW, 2009, SEMIN FETAL NEONAT M, V14, P391, DOI 10.1016/j.siny.2009.08.004; EMERY JL, 1960, ARCH DIS CHILD, V35, P544, DOI 10.1136/adc.35.184.544; Eustermann S, 2010, NAT STRUCT MOL BIOL, V17, P241, DOI 10.1038/nsmb.1747; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Fernandez-Gonzalez A, 2012, AM J PHYSIOL-LUNG C, V302, pL775, DOI 10.1152/ajplung.00196.2011; FRANK L, 1978, J APPL PHYSIOL, V45, P699, DOI 10.1152/jappl.1978.45.5.699; Gandini NA, 2012, EXP MOL PATHOL, V93, P237, DOI 10.1016/j.yexmp.2012.05.001; Giordano A, 2000, FEBS LETT, V487, P171, DOI 10.1016/S0014-5793(00)02217-1; Goodman AI, 1997, P SOC EXP BIOL MED, V214, P54; Gough A, 2013, EUR RESP J IN PRESS; Hara E, 1996, BIOCHEM BIOPH RES CO, V224, P153, DOI 10.1006/bbrc.1996.0999; HASS MA, 1987, AM J PHYSIOL, V253, pC66, DOI 10.1152/ajpcell.1987.253.1.C66; HOFFMAN M, 1980, TOXICOLOGY, V16, P215, DOI 10.1016/0300-483X(80)90118-3; Hwang HW, 2009, J BIOL CHEM, V284, P22672, DOI 10.1074/jbc.M109.028001; ISCHIROPOULOS H, 1989, AM J PHYSIOL, V257, pL411, DOI 10.1152/ajplung.1989.257.6.L411; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Le Rhun Y, 1998, BIOCHEM BIOPH RES CO, V245, P1; Li Volti G, 2004, BIOCHEM BIOPH RES CO, V315, P517, DOI 10.1016/j.bbrc.2004.01.090; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lin QS, 2008, FREE RADICAL BIO MED, V44, P847, DOI 10.1016/j.freeradbiomed.2007.11.012; Liu QJ, 2013, EXP BIOL MED, V238, P696, DOI 10.1177/1535370213490628; McAllister SC, 2004, BLOOD, V103, P3465, DOI 10.1182/blood-2003-08-2781; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Rushworth SA, 2008, BLOOD, V111, P3793, DOI 10.1182/blood-2007-07-104042; Sacca P, 2007, BRIT J CANCER, V97, P1683, DOI 10.1038/sj.bjc.6604081; Sass G, 2008, INT J CANCER, V123, P1269, DOI 10.1002/ijc.23695; SCHACTER BA, 1982, CANCER RES, V42, P3557; Suttner DM, 1999, AM J PHYSIOL-LUNG C, V276, pL443, DOI 10.1152/ajplung.1999.276.3.L443; Suttner DM, 1999, FASEB J, V13, P1800, DOI 10.1096/fasebj.13.13.1800; Tartier L, 2003, MUTAGENESIS, V18, P411, DOI 10.1093/mutage/geg015; Torisu-Itakura H, 2000, JPN J CANCER RES, V91, P906, DOI 10.1111/j.1349-7006.2000.tb01033.x; Tsai Jong-Rung, 2012, Cell Oncol (Dordr), V35, P461, DOI 10.1007/s13402-012-0105-5; Tsuji MH, 1999, CANCER LETT, V138, P53, DOI 10.1016/S0304-3835(98)00372-3; VREMAN HJ, 1988, ANAL BIOCHEM, V168, P31, DOI 10.1016/0003-2697(88)90006-1; West AR, 2008, J GASTROEN HEPATOL, V23, P150, DOI 10.1111/j.1440-1746.2007.05047.x; Wong P, 2011, J MED IMAG RADIAT ON, V55, P373, DOI 10.1111/j.1754-9485.2011.02285.x; Wu M, 2002, AM J RESP CRIT CARE, V166, P192, DOI 10.1164/rccm.200112-130OC; Yang G, 2004, J CLIN INVEST, V114, P669, DOI 10.1172/JCI200419300; Yang G, 2013, REDOX BIOL, V1, P234, DOI 10.1016/j.redox.2013.01.013; Yee M, 2006, AM J PHYSIOL-LUNG C, V291, pL1101, DOI 10.1152/ajplung.00126.2006; Yee M, 2009, AM J PHYSIOL-LUNG C, V297, pL641, DOI 10.1152/ajplung.00023.2009; YOSHIDA T, 1989, BIOCHEM BIOPH RES CO, V163, P1086, DOI 10.1016/0006-291X(89)92332-2; Zhuang TG, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-142	55	34	37	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90936	10.1371/journal.pone.0090936	http://dx.doi.org/10.1371/journal.pone.0090936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599172	gold, Green Published, Green Submitted			2022-12-25	WOS:000332479400147
J	Pang, F; Zha, RP; Zhao, YJ; Wang, QF; Chen, D; Zhang, ZF; Chen, TY; Yao, M; Gu, JR; He, XH				Pang, Fei; Zha, Ruopeng; Zhao, Yingjun; Wang, Qifeng; Chen, Di; Zhang, Zhenfeng; Chen, Taoyang; Yao, Ming; Gu, Jianren; He, Xianghuo			MiR-525-3p Enhances the Migration and Invasion of Liver Cancer Cells by Downregulating ZNF395	PLOS ONE			English	Article							PAPILLOMAVIRUS BINDING-FACTOR; HEPATOCELLULAR-CARCINOMA; TUMOR-CELLS; METASTASIS; MICRORNAS; OSTEOSARCOMA; TARGETS; GENES; CARCINOGENESIS; EXPRESSION	Liver cancer is one of leading causes of cancer-related deaths. A deeper mechanistic understanding of liver cancer could lead to the development of more effective therapeutic strategies. In our previous work, we screened 646 miRNAs and identified 11 that regulate liver cancer cell migration. The current study shows that miR-525-3p is frequently up-regulated in liver cancer tissues, and enhanced expression of miR-525-3p can promote liver cancer cell migration and invasion. Zinc finger protein 395 (ZNF395) is the direct functional target gene for miR-525-3p, and it is frequently down-regulated in liver cancer tissues. High expression of ZNF395 can significantly inhibit while knockdown of ZNF395 expression can markedly enhance the migration and invasion of liver cancer cells, suggesting that ZNF395 suppresses metastasis in liver cancer. Down-regulation of ZNF395 can mediate miR-525-3p induced liver cancer cell migration and invasion. In conclusion, miR-525-3p promotes liver cancer cell migration and invasion by directly targeting ZNF395, and the fact that miR-525-3p and ZNF395 both play important roles in liver cancer progression makes them potential therapeutic targets.	[Pang, Fei; Zha, Ruopeng] Fudan Univ, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Pang, Fei; Zha, Ruopeng; Zhao, Yingjun; Chen, Di; Zhang, Zhenfeng; Gu, Jianren; He, Xianghuo] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China; [Wang, Qifeng] Fudan Univ, Shanghai Canc Hosp, Shanghai 200433, Peoples R China; [Chen, Taoyang] Qi Dong Liver Canc Inst, Qi Dong, Peoples R China; [Yao, Ming] Shanghai Jiao Tong Univ, Dept Expt Pathol, Shanghai Canc Inst, Sch Med, Shanghai 200030, Peoples R China	Fudan University; Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University	He, XH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China.	xhhe@shsci.org	He, Xianghuo/I-1497-2014	He, Xianghuo/0000-0001-8872-668X	National 973 Key Basic Research Program [2013CB910504]; Shanghai Health Bureau [XYQ2011047, XBR2011039]; State Key Project for Liver Cancer [2012ZX10002-009013]	National 973 Key Basic Research Program(National Basic Research Program of China); Shanghai Health Bureau; State Key Project for Liver Cancer	This work was partially supported by grants from The National 973 Key Basic Research Program (2013CB910504), Shanghai Health Bureau (XYQ2011047, XBR2011039) and The State Key Project for Liver Cancer (2012ZX10002-009013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Boeckle S, 2002, VIROLOGY, V293, P103, DOI 10.1006/viro.2001.1231; BREEDIS C, 1954, AM J PATHOL, V30, P969; Brooks SA, 2010, ACTA HISTOCHEM, V112, P3, DOI 10.1016/j.acthis.2008.11.022; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Ding J, 2013, HEPATOLOGY, V58, P654, DOI 10.1002/hep.26378; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fatima S, 2012, ONCOGENE, V31, P4233, DOI 10.1038/onc.2011.580; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Inamura K, 2007, HUM PATHOL, V38, P702, DOI 10.1016/j.humpath.2006.11.019; Jia D, 2013, CELL RES; Jia DS, 2011, HEPATOLOGY, V54, P1227, DOI 10.1002/hep.24495; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li S, 2009, HEPATOLOGY, V49, P1194, DOI 10.1002/hep.22757; Liu ZZ, 2006, BIOORG MED CHEM LETT, V16, P1282, DOI 10.1016/j.bmcl.2005.11.069; MAREEL MM, 1993, CRIT REV ONCOGENESIS, V4, P559; MILLER FR, 1983, INVAS METAST, V3, P234; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Port M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-52; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Seo M, 2009, BIOCHEM BIOPH RES CO, V381, P153, DOI 10.1016/j.bbrc.2009.01.188; Sichtig N, 2007, ARCH BIOCHEM BIOPHYS, V464, P90, DOI 10.1016/j.abb.2007.04.017; Tsukahara T, 2008, CANCER SCI, V99, P368, DOI 10.1111/j.1349-7006.2008.00695.x; Tsukahara T, 2009, CANCER SCI, V100, P47, DOI 10.1111/j.1349-7006.2008.00991.x; Velazquez RF, 2003, HEPATOLOGY, V37, P520, DOI 10.1053/jhep.2003.50093; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang W, 2012, CARCINOGENESIS, V33, P1113, DOI 10.1093/carcin/bgs113; Wong QWL, 2010, CLIN CANCER RES, V16, P867, DOI 10.1158/1078-0432.CCR-09-1840; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Ying Q, 2011, HEPATOLOGY, V54, P2064, DOI 10.1002/hep.24614; Zha RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087665	39	34	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90867	10.1371/journal.pone.0090867	http://dx.doi.org/10.1371/journal.pone.0090867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599008	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400142
J	Rey-Santano, C; Mielgo, V; Valls-i-Soler, A; Encinas, E; Lukas, JC; Vozmediano, V; Suarez, E				Rey-Santano, Carmen; Mielgo, Victoria; Valls-i-Soler, Adolfo; Encinas, Esther; Lukas, John C.; Vozmediano, Valvanera; Suarez, Elena			Evaluation of Fentanyl Disposition and Effects in Newborn Piglets as an Experimental Model for Human Neonates	PLOS ONE			English	Article							CHEST-WALL RIGIDITY; CONTINUOUS-INFUSION FENTANYL; PATENT DUCTUS-ARTERIOSUS; PRETERM INFANTS; DOSE FENTANYL; JUVENILE PIGS; ANESTHESIA; PHARMACOKINETICS; ANALGESIA; RESPONSES	Background: Fentanyl is widely used off-label in NICU. Our aim was to investigate its cerebral, cardiovascular and pulmonary effects as well as pharmacokinetics in an experimental model for neonates. Methods: Fentanyl (5 mu g/kg bolus immediately followed by a 90 minute infusion of 3 mu g/kg/h) was administered to six mechanically ventilated newborn piglets. Cardiovascular, ventilation, pulmonary and oxygenation indexes as well as brain activity were monitored from T = 0 up to the end of experiments (T = 225-300 min). Also plasma samples for quantification of fentanyl were drawn. Results: A "reliable degree of sedation" was observed up to T = 210-240 min, consistent with the selected dosing regimen and the observed fentanyl plasma levels. Unlike cardiovascular parameters, which were unmodified except for an increasing trend in heart rate, some of the ventilation and oxygenation indexes as well as brain activity were significantly altered. The pulmonary and brain effects of fentanyl were mostly recovered from T = 210 min to the end of experiment. Conclusion: The newborn piglet was shown to be a suitable experimental model for studying fentanyl disposition as well as respiratory and cardiovascular effects in human neonates. Therefore, it could be extremely useful for further investigating the drug behaviour under pathophysiological conditions.	[Rey-Santano, Carmen; Mielgo, Victoria; Valls-i-Soler, Adolfo] Cruces Univ Hosp, Expt Neonatal Physiol Unit, BioCruces Hlth Res Inst, Baracaldo, Bizkaia, Spain; [Encinas, Esther; Lukas, John C.; Suarez, Elena] Univ Basque Country, UPV EHU, Dept Pharmacol, Fac Med, Leioa, Bizkaia, Spain; [Lukas, John C.; Vozmediano, Valvanera] Dynakin SL, Drug Modeling & Consulting, Derio, Bizkaia, Spain	Hospital Universitario Cruces; University of Basque Country	Rey-Santano, C (corresponding author), Cruces Univ Hosp, Expt Neonatal Physiol Unit, BioCruces Hlth Res Inst, Baracaldo, Bizkaia, Spain.	macarmen.reysantano@osakidetza.net		Suarez, Elena/0000-0002-6683-4847	Spanish Carlos III Health Institute [FIS 10/943, RD12/0026/0001]; Basque Country Government; INNPACTO project of the Spanish Ministry of Science and Innovation - MICINN [ITP-09000-2010-002]; European Regional Development Fund (FEDER)	Spanish Carlos III Health Institute; Basque Country Government(Basque Government); INNPACTO project of the Spanish Ministry of Science and Innovation - MICINN; European Regional Development Fund (FEDER)(European Commission)	This study was partially supported by grants from the Spanish Carlos III Health Institute: FIS 10/943 and RD12/0026/0001 (Red SAMID: Maternal, Child Health and Development Research Network, within the framework of the VI Spanish National Plan for R+D+i 2008-2012). It was also supported by a predoctoral grant to one of the authors (EE) from the Research Staff Training Program (Basque Country Government) and by an INNPACTO project of the Spanish Ministry of Science and Innovation - MICINN (ITP-09000-2010-002), which is financed by the European Regional Development Fund (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2008, PEDIATR RES, V64, P653, DOI 10.1203/PDR.0b013e318186e5dd; ANAND KJS, 1987, LANCET, V1, P62; Anzenbacher P, 1998, DRUG METAB DISPOS, V26, P56; Aranda JV, 2005, CLIN THER, V27, P877, DOI 10.1016/j.clinthera.2005.06.019; Bernet V, 2010, PEDIATR RES, V67, P650, DOI 10.1203/PDR.0b013e3181da44ba; Calvo R, 2006, CURR PHARM DESIGN, V12, P977, DOI 10.2174/138161206776055967; COLLINS C, 1985, ANESTH ANALG, V64, P1078; da Silva O, 1999, J Perinatol, V19, P120, DOI 10.1038/sj.jp.7200145; Dewhirst E, 2012, PEDIATR EMERG CARE, V28, P465, DOI 10.1097/PEC.0b013e3182535a2a; Encinas E, 2013, PEDIATR DRUGS, V15, P10; Fahnenstich H, 2000, CRIT CARE MED, V28, P836, DOI 10.1097/00003246-200003000-00037; FRIESEN RH, 1986, ANESTHESIOLOGY, V64, P238, DOI 10.1097/00000542-198602000-00018; Fritz HG, 2005, ANESTH ANALG, V100, P996, DOI 10.1213/01.ANE.0000146517.17910.54; Guinsburg R, 1996, J PEDIAT, V132, P954; HICKEY PR, 1985, ANESTH ANALG, V64, P483; Hsu Benson, 2009, WMJ, V108, P343; IRAZUZTA J, 1993, CRIT CARE MED, V21, P1001, DOI 10.1097/00003246-199307000-00013; ITOH H, 1993, CAN J VET RES, V57, P74; Kuroha M, 2001, J VET PHARMACOL THER, V24, P423, DOI 10.1046/j.1365-2885.2001.00367.x; Labroo RB, 1997, DRUG METAB DISPOS, V25, P1072; McNamara PJ, 2002, AAPS PHARMSCI, V4; Modanlou HCD, 1996, J INVEST MED, V44, P362; Norman E, 2013, PEDIATR RES, V73, P87, DOI 10.1038/pr.2012.153; Prakash Smita, 2010, J Anaesthesiol Clin Pharmacol, V26, P567; Rajan V, 1998, BIOL NEONATE, V74, P39, DOI 10.1159/000014009; ROBINSON S, 1981, ANESTH ANALG, V60, P331; ROSOW CE, 1982, ANESTHESIOLOGY, V56, P93, DOI 10.1097/00000542-198202000-00003; Roth WJ, 2013, AAPS J, V15, P763, DOI 10.1208/s12248-013-9482-6; SCHIEBER RA, 1985, ANESTHESIOLOGY, V63, P166, DOI 10.1097/00000542-198508000-00009; SCOTT JC, 1985, ANESTHESIOLOGY, V62, P234, DOI 10.1097/00000542-198503000-00005; Sen S, 2004, INTENS CARE MED, V30, P496, DOI 10.1007/s00134-003-2141-0; Smith RP, 2004, AM J OBSTET GYNECOL, V190, P836, DOI 10.1016/j.ajog.2003.09.064; Tsuji M, 1998, PEDIATR RES, V44, P591, DOI 10.1203/00006450-199810000-00020; WELLS S, 1994, HEART LUNG, V23, P196; YASTER M, 1987, ANESTHESIOLOGY, V66, P524, DOI 10.1097/00000542-198704000-00013; YASTER M, 1987, ANESTHESIOLOGY, V66, P433, DOI 10.1097/00000542-198703000-00035	36	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90728	10.1371/journal.pone.0090728	http://dx.doi.org/10.1371/journal.pone.0090728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595018	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500092
J	Brodersen, J; Chapman, BB; Nilsson, PA; Skov, C; Hansson, LA; Bronmark, C				Brodersen, Jakob; Chapman, Ben B.; Nilsson, P. Anders; Skov, Christian; Hansson, Lars-Anders; Bronmark, Christer			Fixed and Flexible: Coexistence of Obligate and Facultative Migratory Strategies in a Freshwater Fish	PLOS ONE			English	Article							PREDATION; EVOLUTION; RISK	Migration is an important event in many animal life histories, but the degree to which individual animals participate in seasonal migrations often varies within populations. The powerful ecological and evolutionary consequences of such partial migration are now well documented, but the underlying mechanisms are still heavily debated. One potential mechanism of partial migration is between-individual variation in body condition, where animals in poor condition cannot pay the costs of migration and hence adopt a resident strategy. However, underlying intrinsic traits may overrule such environmental influence, dictating individual consistency in migratory patterns. Unfortunately, field tests of individual consistency compared to the importance of individual condition on migratory propensity are rare. Here we analyse 6 years of field data on roach migration, gathered by tagging almost 3000 individual fish and monitoring their seasonal migrations over extended periods of time. Our aims were to provide a field test of the role of condition in wild fish for migratory decisions, and also to assess individual consistency in migratory tendency. Our analyses reveal that (1) migratory strategy, in terms of migration/residency, is highly consistent within individuals over time and (2) there is a positive relationship between condition and the probability of migration, but only in individuals that adopt a migratory strategy at some point during their lives. However, life-long residents do not differ in condition to migrants, hence body condition is only a good predictor of migratory tendency in fish with migratory phenotypes and not a more general determinant of migratory tendency for the population. As resident individuals can achieve very high body condition and still remain resident, we suggest that our data provides some of the first field evidence to show that both facultative and obligate strategies can co-exist within populations of migratory animals.	[Brodersen, Jakob; Chapman, Ben B.; Nilsson, P. Anders; Hansson, Lars-Anders; Bronmark, Christer] Lund Univ, Dept Biol, Lund, Sweden; [Brodersen, Jakob] EAWAG Swiss Fed Inst Aquat Sci & Technol, Ctr Ecol Evolut & Biogeochem, Dept Fish Ecol & Evolut, Kastanienbaum, Switzerland; [Skov, Christian] Tech Univ Denmark DTU, Natl Inst Aquat Resources, Silkeborg, Denmark	Lund University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Technical University of Denmark	Brodersen, J (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	jakob.brodersen@eawag.ch	Hansson, Lars-Anders/HCI-2735-2022; Skov, Christian/X-6511-2019; Nilsson, Anders/H-6836-2014	Skov, Christian/0000-0002-8547-6520; Nilsson, Anders/0000-0002-3541-9835; Hansson, Lars-Anders/0000-0002-3035-1317	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Swedish Research Council (VR); Danish Angling License Funds; FP7 Marie Curie Intra-European fellowship	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Swedish Research Council (VR)(Swedish Research Council); Danish Angling License Funds; FP7 Marie Curie Intra-European fellowship	The work was supported by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), the Swedish Research Council (VR), and the Danish Angling License Funds. BBC was funded by an FP7 Marie Curie Intra-European fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTHOLD P, 1991, TRENDS ECOL EVOL, V6, P254, DOI 10.1016/0169-5347(91)90072-6; BERTHOLD P, 1994, P ROY SOC B-BIOL SCI, V257, P311, DOI 10.1098/rspb.1994.0131; BOHL E, 1980, OECOLOGIA, V44, P368, DOI 10.1007/BF00545241; Brodersen J, 2008, ECOLOGY, V89, P1195, DOI 10.1890/07-1318.1; Brodersen J, 2011, OIKOS, V120, P1838, DOI 10.1111/j.1600-0706.2011.19433.x; Brodersen J, 2012, BIOL LETTERS, V8, P21, DOI 10.1098/rsbl.2011.0634; Bronmark C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001957; Chapman BB, 2012, J FISH BIOL, V81, P456, DOI 10.1111/j.1095-8649.2012.03342.x; Chapman BB, 2012, J FISH BIOL, V81, P479, DOI 10.1111/j.1095-8649.2012.03349.x; Chapman BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061223; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Chapman BB, 2011, ECOL LETT, V14, P871, DOI 10.1111/j.1461-0248.2011.01648.x; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; GODIN JGJ, 1994, BEHAV ECOL SOCIOBIOL, V34, P359, DOI 10.1007/BF00197006; GOTCEITAS V, 1991, BEHAV ECOL SOCIOBIOL, V29, P255, DOI 10.1007/BF00163982; Kinnerback A, 2013, NATL REGISTER SURVEY; LUNDBERG P, 1987, J THEOR BIOL, V125, P351, DOI 10.1016/S0022-5193(87)80067-X; LUNDBERG P, 1988, TRENDS ECOL EVOL, V3, P172, DOI 10.1016/0169-5347(88)90035-3; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; McNamara JM, 1998, J AVIAN BIOL, V29, P416, DOI 10.2307/3677160; Olsson IC, 2006, ECOL LETT, V9, P645, DOI 10.1111/j.1461-0248.2006.00909.x; Pulido F, 1996, P NATL ACAD SCI USA, V93, P14642, DOI 10.1073/pnas.93.25.14642; Pulido F, 2011, OIKOS, V120, P1776, DOI 10.1111/j.1600-0706.2011.19844.x; Rolshausen G, 2009, CURR BIOL, V19, P2097, DOI 10.1016/j.cub.2009.10.061; Skov C, 2005, J FISH BIOL, V67, P1195, DOI 10.1111/j.1095-8649.2005.00814.x; Skov C, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1178; Swingland IR, 1984, ECOLOGY ANIMAL MIGRA; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Wood CC, 1996, EVOLUTION, V50, P1265, DOI [10.1111/j.1558-5646.1996.tb02367.x, 10.2307/2410667]	30	38	38	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90294	10.1371/journal.pone.0090294	http://dx.doi.org/10.1371/journal.pone.0090294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594698	Green Submitted, gold, Green Published			2022-12-25	WOS:000332468900091
J	Cheng, NC; van Zandwijk, N; Reid, G				Cheng, Ngan Ching; van Zandwijk, Nico; Reid, Glen			Cilengitide Inhibits Attachment and Invasion of Malignant Pleural Mesothelioma Cells through Antagonism of Integrins alpha v beta 3 and alpha v beta 5	PLOS ONE			English	Article							PHASE-I; GLIOMA-CELLS; APOPTOSIS; ASBESTOS; CANCER; ALPHA(V)BETA(3); ANGIOGENESIS; TEMOZOLOMIDE; METASTASIS; DISTINCT	Malignant pleural mesothelioma (MPM) is an almost invariably fatal, asbestos-related malignancy arising from the mesothelial membrane lining the thoracic cavities. Despite some improvements in treatment, therapy is not considered curative and median survival following diagnosis is less than 1 year. Although still classed as a rare cancer, the incidence of MPM is increasing, and the limited progress in treating the disease makes the identification of new therapies a priority. As there is evidence for expression of the integrins alpha v beta 3 and alpha v beta 5 in MPM, there is a rationale for investigating the effects on MPM of cilengitide, a synthetic peptide inhibitor of integrin alpha v heterodimer with high specificity for alpha v beta 3 and alpha v beta 5. In mesothelial cells (MC) and 7 MPM cell lines, growth inhibition by cilengitide was associated with the expression level of its target integrins. Furthermore, cilengitide caused cell detachment and subsequent death of anoikis-sensitive cells. It also suppressed invasion of MPM cells in monolayer and three-dimensional cultures. Gene knockdown experiments indicated that these effects of cilengitide were, at least partly, due to antagonism of alpha v beta 3 and alpha v beta 5.	[Cheng, Ngan Ching; van Zandwijk, Nico; Reid, Glen] Univ Sydney, Asbestos Dis Res Inst, Concord, NSW, Australia	University of Sydney	Cheng, NC (corresponding author), Univ Sydney, Asbestos Dis Res Inst, Concord, NSW, Australia.	ngan.cheng@sydney.edu.au	van Zandwijk, Nico/E-4177-2012	van Zandwijk, Nico/0000-0002-8405-9688; Reid, Glen/0000-0001-6465-5223	Cancer Institute NSW [11/TPG/3-06]; Merck [4501161930]	Cancer Institute NSW; Merck(Merck & Company)	This study was funded by a Cancer Institute NSW grant (11/TPG/3-06) to NvZ and GR, and an investigator initiated study grant (4501161930) from Merck to GR and NvZ. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alghisi GC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004449; Barth TFE, 1997, INT J CANCER, V72, P77, DOI 10.1002/(SICI)1097-0215(19970703)72:1<77::AID-IJC12>3.0.CO;2-7; BOYLAN AM, 1995, J CLIN INVEST, V96, P1987, DOI 10.1172/JCI118246; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Byzova TV, 1998, THROMB HAEMOSTASIS, V80, P726; Cristaudo A, 2011, J THORAC ONCOL, V6, P1587, DOI 10.1097/JTO.0b013e31821e1c08; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Flores RM, 2007, J THORAC ONCOL, V2, P957, DOI 10.1097/JTO.0b013e31815608d9; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Goodman SL, 2012, BIOL OPEN, V1, P329, DOI 10.1242/bio.2012364; Hammes HP, 1996, NAT MED, V2, P529, DOI 10.1038/nm0596-529; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim YH, 2013, INT J CANC; Klominek J, 1997, INT J CANCER, V72, P1034, DOI 10.1002/(SICI)1097-0215(19970917)72:6<1034::AID-IJC19>3.0.CO;2-4; Koukoulis GK, 1997, HUM PATHOL, V28, P84, DOI 10.1016/S0046-8177(97)90284-7; Leblond P, 2013, ANTICANCER DRUGS; LECHNER JF, 1985, P NATL ACAD SCI USA, V82, P3884, DOI 10.1073/pnas.82.11.3884; MacDonald TJ, 2001, NEUROSURGERY, V48, P151, DOI 10.1097/00006123-200101000-00026; Marshall JF, 1996, SEMIN CANCER BIOL, V7, P129, DOI 10.1006/scbi.1996.0018; Maurer GD, 2009, NEURO-ONCOLOGY, V11, P747, DOI 10.1215/15228517-2009-012; Mikkelsen T, 2009, INT J CANCER, V124, P2719, DOI 10.1002/ijc.24240; Nabors LB, 2007, J CLIN ONCOL, V25, P1651, DOI 10.1200/JCO.2006.06.6514; Nisato Riccardo E., 2003, Angiogenesis, V6, P105, DOI 10.1023/B:AGEN.0000011801.98187.f2; O'Donnell PH, 2012, INVEST NEW DRUG, V30, P604, DOI 10.1007/s10637-010-9537-9; Oliveira-Ferrer L, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-86; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Reardon David A, 2011, Genes Cancer, V2, P1159, DOI 10.1177/1947601912450586; Relan V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058132; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Sigstad E, 2005, DIAGN CYTOPATHOL, V33, P325, DOI 10.1002/dc.20282; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; SMYTHE WR, 1994, ANN THORAC SURG, V57, P1395, DOI 10.1016/0003-4975(94)90090-6; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; Tentori L, 2008, ONCOL REP, V19, P1039; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; Vermorken JB, 2011, BRIT J CANCER, V104, P1691, DOI 10.1038/bjc.2011.152; Wiggins HL, 2010, BIOTECHNIQUES, V48, P120, DOI 10.2144/000113353; Zervos MD, 2008, CURR OPIN PULM MED, V14, P303, DOI 10.1097/MCP.0b013e328302851d	41	25	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90374	10.1371/journal.pone.0090374	http://dx.doi.org/10.1371/journal.pone.0090374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595274	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900101
J	Jeff, JM; Armstrong, LL; Ritchie, MD; Denny, JC; Kho, AN; Basford, MA; Wolf, WA; Pacheco, JA; Li, RL; Chisholm, RL; Roden, DM; Hayes, MG; Crawford, DC				Jeff, Janina M.; Armstrong, Loren L.; Ritchie, Marylyn D.; Denny, Joshua C.; Kho, Abel N.; Basford, Melissa A.; Wolf, Wendy A.; Pacheco, Jennifer A.; Li, Rongling; Chisholm, Rex L.; Roden, Dan M.; Hayes, M. Geoffrey; Crawford, Dana C.			Admixture Mapping and Subsequent Fine-Mapping Suggests a Biologically Relevant and Novel Association on Chromosome 11 for Type 2 Diabetes in African Americans	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ELECTRONIC MEDICAL-RECORDS; EMERGE NETWORK; RISK LOCI; VARIANT; VISUALIZATION; ANCESTRY; GENETICS; REVEALS; DISEASE	Type 2 diabetes (T2D) is a complex metabolic disease that disproportionately affects African Americans. Genome-wide association studies (GWAS) have identified several loci that contribute to T2D in European Americans, but few studies have been performed in admixed populations. We first performed a GWAS of 1,563 African Americans from the Vanderbilt Genome-Electronic Records Project and Northwestern University NUgene Project as part of the electronic Medical Records and Genomics (eMERGE) network. We successfully replicate an association in TCF7L2, previously identified by GWAS in this African American dataset. We were unable to identify novel associations at p<5.0x10(-8) by GWAS. Using admixture mapping as an alternative method for discovery, we performed a genome-wide admixture scan that suggests multiple candidate genes associated with T2D. One finding, TCIRG1, is a T-cell immune regulator expressed in the pancreas and liver that has not been previously implicated for T2D. We performed subsequent fine-mapping to further assess the association between TCIRG1 and T2D in >5,000 African Americans. We identified 13 independent associations between TCIRG1, CHKA, and ALDH3B1 genes on chromosome 11 and T2D. Our results suggest a novel region on chromosome 11 identified by admixture mapping is associated with T2D in African Americans.	[Jeff, Janina M.] Vanderbilt Univ, Charles Bronfman Inst Personalized Med, Icahn Sch Med Mt Sinai, Nashville, TN 37235 USA; [Crawford, Dana C.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [Denny, Joshua C.; Roden, Dan M.] Vanderbilt Univ, Dept Med, Div Clin Pharmacol, Nashville, TN 37235 USA; [Denny, Joshua C.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37235 USA; [Basford, Melissa A.; Roden, Dan M.] Vanderbilt Univ, Off Personalized Med, Nashville, TN 37235 USA; [Roden, Dan M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA; [Kho, Abel N.] Northwestern Univ, Div Gen Internal Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Armstrong, Loren L.; Hayes, M. Geoffrey] Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Pacheco, Jennifer A.; Chisholm, Rex L.; Hayes, M. Geoffrey] Northwestern Univ, Ctr Genet Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Wolf, Wendy A.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Li, Rongling] NHGRI, Off Populat Genom, Bethesda, MD 20892 USA; [Ritchie, Marylyn D.] Penn State Univ, Dept Biochem & Mol Biol, Ctr Syst Genom, University Pk, PA 16802 USA	Icahn School of Medicine at Mount Sinai; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Crawford, DC (corresponding author), Vanderbilt Univ, Ctr Human Genet Res, 221 Kirkland Hall, Nashville, TN 37235 USA.	crawford@chgr.mc.vanderbilt.edu	Crawford, Dana/O-5578-2019; Roden, Dan/ABD-5412-2021; Denny, Josh/AAL-3359-2021; Chisholm, Rex/B-3418-2009	Crawford, Dana/0000-0002-6437-6248; Denny, Josh/0000-0002-3049-7332; Hayes, M Geoffrey/0000-0002-4617-3981; Pacheco, Jennifer/0000-0001-8021-5818; Chisholm, Rex/0000-0002-5638-3990	NIH/NHGRI [U01HG004609, U01HG04603]; NCATS/NIH [UL1 TR000445]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007824] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004609, U01HG006378, U01HG006388, U01HG004603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178, R25GM062459] Funding Source: NIH RePORTER	NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH/NHGRI U01HG004609 (Northwestern University as part of eMERGE) and U01HG04603 (Vanderbilt University as part of eMERGE, also serving as the Administrative Coordinating Center). A portion of the dataset(s) used for the analyses described were obtained from Vanderbilt University Medical Center's BioVU which is supported by institutional funding and by the Vanderbilt CTSA grant UL1 TR000445 from NCATS/NIH. As part of the cooperative agreement, NHGRI participated in the study design, data collection and analysis, and preparation of the manuscript.	ADA, 2011, DIAB STAT; Ahlqvist E, 2011, CLIN CHEM, V57, P241, DOI 10.1373/clinchem.2010.157016; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bielinski SJ, 2011, MAYO CLIN PROC, V86, P606, DOI 10.4065/mcp.2011.0178; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Cheng CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032840; Cheng CY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000490; Crosslin DR, 2011, HUMGENET; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Denny JC, 2010, CIRCULATION, V122, P2016, DOI 10.1161/CIRCULATIONAHA.110.948828; Ding KY, 2012, MAYO CLIN PROC, V87, P461, DOI 10.1016/j.mayocp.2012.01.016; Disease NIoDaK, 2007, NAT DIAB INF PRED WH; Dumitrescu L, 2010, GENETMED; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gallego-Ortega D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007819; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gower BA, 2002, J CLIN ENDOCR METAB, V87, P2218, DOI 10.1210/jc.87.5.2218; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Herder C, 2011, EUR J CLIN INVEST, V41, P679, DOI 10.1111/j.1365-2362.2010.02454.x; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kho AN, 2012, J AM MED INFORM ASSN, V19, P212, DOI 10.1136/amiajnl-2011-000439; Kullo IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013011; Long JR, 2012, AM J EPIDEMIOL, V176, P995, DOI 10.1093/aje/kws176; Maskarinec G, 2009, ETHNIC DIS, V19, P49; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; Mozaffarian D, 2009, ARCH INTERN MED, V169, P798, DOI 10.1001/archinternmed.2009.21; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pendergrass SA, 2010, BIODATA MIN, V3, DOI 10.1186/1756-0381-3-10; Pulley J, 2010, CTS-CLIN TRANSL SCI, V3, P42, DOI 10.1111/j.1752-8062.2010.00175.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramirez de Molina A, 2008, INT J BIOCHEM CELL B, V40, P1753, DOI 10.1016/j.biocel.2008.01.013; Rasmussen-Torvik LJ, 2012, CTS-CLIN TRANSL SCI, V5, P394, DOI 10.1111/j.1752-8062.2012.00446.x; Reich D, 2009, PLOSGENET, V5; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Tandon A, 2011, GENET EPIDEMIOL, V35, P80, DOI 10.1002/gepi.20550; Tong Y, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-15; Turner SD, 2011, PLOS ONE, V6; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Yaeger R, 2008, CANCER EPIDEM BIOMAR, V17, P1329, DOI 10.1158/1055-9965.EPI-07-2505; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zuvich RL, 2011, GENET EPIDEMIOL, V35, P887, DOI 10.1002/gepi.20639	54	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e86931	10.1371/journal.pone.0086931	http://dx.doi.org/10.1371/journal.pone.0086931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595071	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900001
J	Theodore, CM; Stamps, BW; King, JB; Price, LSL; Powell, DR; Stevenson, BS; Cichewicz, RH				Theodore, Christine M.; Stamps, Blake W.; King, Jarrod B.; Price, Lauren S. L.; Powell, Douglas R.; Stevenson, Bradley S.; Cichewicz, Robert H.			Genomic and Metabolomic Insights into the Natural Product Biosynthetic Diversity of a Feral-Hog-Associated Brevibacillus laterosporus Strain	PLOS ONE			English	Article							HUMAN MICROBIOME; EVOLUTION; ACID	Bacteria associated with mammals are a rich source of microbial biodiversity; however, little is known concerning the abilities of these microbes to generate secondary metabolites. This report focuses on a bacterium isolated from the ear of a feral hog from southwestern Oklahoma, USA. The bacterium was identified as a new strain (PE36) of Brevibacillus latersporus, which was shown via genomic analysis to contain a large number of gene clusters presumably involved in secondary metabolite biosynthesis. A scale-up culture of B. latersporus PE36 yielded three bioactive compounds that inhibited the growth of methicillin-resistant Staphylococcus aureus (basiliskamides A and B and 12-methyltetradecanoic acid). Further studies of the isolate's secondary metabolome provided both new (auripyrazine) and previously-described pyrazine-containing compounds. In addition, a new peptidic natural product (auriporcine) was purified that was determined to be composed of a polyketide unit, two L-proline residues, two D-leucine residues, one L-leucine residue, and a reduced L-phenylalanine (L-phenylalanol). An examination of the genome revealed two gene clusters that are likely responsible for generating the basiliskamides and auriporcine. These combined genomic and chemical studies confirm that new and unusual secondary metabolites can be obtained from the bacterial associates of wild mammals.	[Theodore, Christine M.; King, Jarrod B.; Price, Lauren S. L.; Powell, Douglas R.; Cichewicz, Robert H.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Theodore, Christine M.; King, Jarrod B.; Price, Lauren S. L.; Stevenson, Bradley S.; Cichewicz, Robert H.] Univ Oklahoma, Inst Nat Prod Applicat & Res Technol, Nat Prod Discovery Grp, Norman, OK 73019 USA; [Stamps, Blake W.; Stevenson, Bradley S.] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Cichewicz, RH (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.	rhcichewicz@ou.edu	Stevenson, Bradley Scott/A-2786-2011; Stamps, Blake Warren/H-9781-2019; Cichewicz, Robert H/H-5233-2012	Stevenson, Bradley Scott/0000-0001-9432-9744; Stamps, Blake Warren/0000-0001-9713-9014; Cichewicz, Robert/0000-0003-0744-4117	National Institutes of Health [5R21AI101487]; Office of the Vice President for Research, University of Oklahoma, Norman Campus; Shimadzu Equipment Grant Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Vice President for Research, University of Oklahoma, Norman Campus; Shimadzu Equipment Grant Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this project was provided in part by an award from the National Institutes of Health (5R21AI101487), a Challenge Grant from the Office of the Vice President for Research, University of Oklahoma, Norman Campus, and an award through the Shimadzu Equipment Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASENSIO C, 1976, BIOCHEM BIOPH RES CO, V69, P7, DOI 10.1016/S0006-291X(76)80264-1; Barsby T, 2002, J NAT PROD, V65, P1447, DOI 10.1021/np0201321; Bhushan R, 2004, AMINO ACIDS, V27, P231, DOI 10.1007/s00726-004-0118-0; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Bythell BJ, 2010, J AM CHEM SOC, V132, P14766, DOI 10.1021/ja101556g; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; Cragg GM, 2002, TRENDS PHARMACOL SCI, V23, P404, DOI 10.1016/S0165-6147(02)02099-0; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jensen K, 2012, CHEM BIOL, V19, P329, DOI 10.1016/j.chembiol.2012.01.005; Jessup DA, 2003, ILAR J, V44, P277, DOI 10.1093/ilar.44.4.277; Joyner PM, 2010, ORG BIOMOL CHEM, V8, P5486, DOI 10.1039/c0ob00579g; Kelly MTS, 2005, Patent application, Patent No. [US 20050277779, 20050277779]; KITAHARA T, 1995, BIOSCI BIOTECH BIOCH, V59, P78, DOI 10.1271/bbb.59.78; Kochhar S, 2002, PROTEIN PROTOCOLS HD, P995; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032118; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Piel J, 2004, NAT PROD REP, V21, P519, DOI 10.1039/b310175b; Piel J, 2009, NAT PROD REP, V26, P338, DOI 10.1039/b703499g; Piel J, 2010, NAT PROD REP, V27, P996, DOI 10.1039/b816430b; Ruas-Madiedo P, 2010, J APPL MICROBIOL, V109, P2079, DOI 10.1111/j.1365-2672.2010.04839.x; Shaaban M, 2002, J NAT PROD, V65, P1660, DOI 10.1021/np020019a; Wang XR, 2012, ORG BIOMOL CHEM, V10, P2044, DOI 10.1039/c2ob06856g; Wei MQ, 2008, CANCER LETT, V259, P16, DOI 10.1016/j.canlet.2007.10.034; Yang JY, 2011, CURR OPIN CHEM BIOL, V15, P79, DOI 10.1016/j.cbpa.2010.10.025; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	29	19	20	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90124	10.1371/journal.pone.0090124	http://dx.doi.org/10.1371/journal.pone.0090124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595070	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900070
J	Wan, XB; Jiang, R; Xie, FY; Qi, ZY; Li, AJ; Ye, WJ; Hua, YJ; Zhu, YL; Zou, X; Guo, L; Mai, HQ; Guo, X; Hong, MH; Chen, MY				Wan, Xiang-Bo; Jiang, Rou; Xie, Fang-Yun; Qi, Zhen-Yu; Li, Ai-Ju; Ye, Wei-Jun; Hua, Yi-Jun; Zhu, Yu-Liang; Zou, Xiong; Guo, Ling; Mai, Hai-Qiang; Guo, Xiang; Hong, Ming-Huang; Chen, Ming-Yuan			Endoscope-Guided Interstitial Intensity-Modulated Brachytherapy and Intracavitary Brachytherapy as Boost Radiation for Primary Early T Stage Nasopharyngeal Carcinoma	PLOS ONE			English	Article							EXTERNAL-BEAM RADIATION; CANCER PATIENTS; LOCAL-CONTROL; RECURRENT; SALVAGE; REIRRADIATION; THERAPY	Background: Intracavitary brachytherapy (ICBT) is usually applied as boost radiotherapy for superficial residual of nasopharyngeal carcinoma (NPC) after primary extern-beam radiptherapy (ERT). Here, we evaluated the outcome of endoscope-guided interstitial intensity-modulated brachytherapy (IMBT) boost radiation for deep-seated residual NPC. Methodology/Principal Findings: Two hundred and thirteen patients with residual NPC who were salvaged with brachytherapy boost radiation during 2005-2009 were analyzed retrospectively. Among these patients, 171 patients had superficial residual NPC (<= 1 cm below the nasopharyngeal epithelium) were treated with ICBT boost radiation, and interstitial IMBT boost radiation was delivered to 42 patients with deep-seated residual NPC (>1 cm below the nasopharyngeal epithelium). We found that IMBT boost subgroup had a higher ratio of T2b (81.0% VS 34.5%, P<0.001) and stage II (90.5% VS 61.4%, P = 0.001) than that of ICBT boost subgroup. The dosage of external-beam radiotherapy in the nasopharyngeal (63.06 +/- 3.8 VS 62.6 +/- 64.3 Gray (Gy), P = 0.67) and regional lymph nodes (55.8 +/- 5.0 VS 57.5 +/- 5.7 Gy, P = 0.11) was comparable in both groups. For brachytherapy, IMBT subgroup had a lower boost radiation dosage than ICBT subgroup (11.0 +/- 62.9 VS 14.8 +/- 3.2 Gy, P<0.01). Though the IMBT group had deeper residual tumors and received lower boost radiation dosages, both subgroups had the similar 5-year actuarial overall survival rate (IMBT VS ICBT group: 96.8% VS 93.6%, P = 0.87), progression-free survival rate (92.4% VS 86.5%, P = 0.41) and distant metastasis-free survival rate (94.9% VS 92.7%, P = 0.64). Moreover, IMBT boost radiation subgroup had a similar local (97.4% VS 94.4%, P = 0.57) and regional (95.0% VS 97.2%, P = 0.34) control to ICBT subgroup. The acute and late toxicities rates were comparable between the both subgroups. Conclusions/Significance: IMBT boost radiation may be a promising therapeutic selection for deep-seated residual NPC.	[Wan, Xiang-Bo; Jiang, Rou; Hua, Yi-Jun; Zhu, Yu-Liang; Zou, Xiong; Guo, Ling; Mai, Hai-Qiang; Guo, Xiang; Hong, Ming-Huang; Chen, Ming-Yuan] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China; [Wan, Xiang-Bo; Jiang, Rou; Xie, Fang-Yun; Li, Ai-Ju; Ye, Wei-Jun; Hua, Yi-Jun; Zhu, Yu-Liang; Zou, Xiong; Guo, Ling; Mai, Hai-Qiang; Guo, Xiang; Hong, Ming-Huang; Chen, Ming-Yuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Wan, Xiang-Bo] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Xie, Fang-Yun; Qi, Zhen-Yu; Li, Ai-Ju; Ye, Wei-Jun] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Wan, Xiang-Bo; Jiang, Rou; Xie, Fang-Yun; Qi, Zhen-Yu; Li, Ai-Ju; Ye, Wei-Jun; Hua, Yi-Jun; Zhu, Yu-Liang; Zou, Xiong; Guo, Ling; Mai, Hai-Qiang; Guo, Xiang; Hong, Ming-Huang; Chen, Ming-Yuan] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Chen, MY (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China.	chmingy@mail.sysu.edu.cn	Chen, Ming/GVU-8412-2022		Program for Training Programme Foundation for the Talents by Sun Yat-sen University Cancer Center; New Century Excellent Talents in University [NCET-12-0562]; Sun Yat-Sen University Clinical Research 5010 Program [201310]; National Natural Science Foundation of China [81071890, 81000934, 81370060]; Guangdong Provincial Natural Science Foundation of China [S2013020012726]; Foundation for Distinguished Young Scholars of Sun Yat-sen University [13ykzd20]; Foundation for Pearl River Science & Technology Young Scholars of Guangzhou [2013J2200043]; Foundation for Outstanding Doctoral Thesis of Guangdong Province [sybzzxm201207]; National High Technology Research and Development Program of China (863 Program) [2012AA02A501]	Program for Training Programme Foundation for the Talents by Sun Yat-sen University Cancer Center; New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Sun Yat-Sen University Clinical Research 5010 Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); Foundation for Distinguished Young Scholars of Sun Yat-sen University; Foundation for Pearl River Science & Technology Young Scholars of Guangzhou; Foundation for Outstanding Doctoral Thesis of Guangdong Province; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the Program for Training Programme Foundation for the Talents by Sun Yat-sen University Cancer Center (MY Chen, 2009), New Century Excellent Talents in University (NCET-12-0562), Sun Yat-Sen University Clinical Research 5010 Program (201310), National Natural Science Foundation of China (Grants No. 81071890, No. 81000934 and No. 81370060), Guangdong Provincial Natural Science Foundation of China (S2013020012726), Foundation for Distinguished Young Scholars of Sun Yat-sen University (No. 13ykzd20), Foundation for Pearl River Science & Technology Young Scholars of Guangzhou (No. 2013J2200043), Foundation for Outstanding Doctoral Thesis of Guangdong Province (No. sybzzxm201207), and National High Technology Research and Development Program of China (863 Program, No. 2012AA02A501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan ATC, 2011, EUR J CANCER, V47, pS302, DOI 10.1016/S0959-8049(11)70179-4; Chan ATC, 2005, J CLIN ONCOL, V23, P3568, DOI 10.1200/JCO.2005.02.147; Chen Ming-Yuan, 2007, Ai Zheng, V26, P513; Chua DTT, 1998, INT J RADIAT ONCOL, V41, P379, DOI 10.1016/S0360-3016(98)00063-7; Das RK, 2004, INT J RADIAT ONCOL, V59, P1224, DOI 10.1016/j.ijrobp.2004.03.030; Greene FL PD, 2002, AJCC CANC STAGING HD, P73; Huang EY, 2013, INT J RADIAT ONCOL, V85, P123, DOI 10.1016/j.ijrobp.2012.03.045; Kovacs G, 2007, BRACHYTHERAPY, V6, P142, DOI 10.1016/j.brachy.2007.02.062; Lee AWM, 2012, ORAL ONCOL, V48, P768, DOI 10.1016/j.oraloncology.2012.02.017; Lee AWM, 1997, INT J RADIAT ONCOL, V38, P43, DOI 10.1016/S0360-3016(97)00244-7; Leung TW, 2008, INT J RADIAT ONCOL, V70, P361, DOI 10.1016/j.ijrobp.2007.06.078; Leung TW, 2000, INT J RADIAT ONCOL, V48, P1331, DOI 10.1016/S0360-3016(00)00776-8; Leung TW, 2005, CANCER, V104, P1648, DOI 10.1002/cncr.21371; Nomden CN, 2013, RADIOTHER ONCOL, V107, P69, DOI 10.1016/j.radonc.2013.04.006; Palmer AL, 2013, MED PHYS, V40, DOI 10.1118/1.4805100; Ren YF, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-165; Ren YF, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-113; Schinagl DAX, 2010, INT J RADIAT ONCOL, V78, P689, DOI 10.1016/j.ijrobp.2009.08.072; Shi CY, 2010, MED PHYS, V37, P3725, DOI 10.1118/1.3456598; Stoker SD, 2013, CURR TREAT OPTION ON, V14, P475, DOI 10.1007/s11864-013-0261-5; Sultanem K, 2000, INT J RADIAT ONCOL, V48, P711, DOI 10.1016/S0360-3016(00)00702-1; Teo PML, 2000, INT J RADIAT ONCOL, V46, P445, DOI 10.1016/S0360-3016(99)00326-0; Teo PML, 1998, INT J RADIAT ONCOL, V40, P897, DOI 10.1016/S0360-3016(97)00854-7; WANG CC, 1991, AM J CLIN ONCOL-CANC, V14, P5, DOI 10.1097/00000421-199102000-00002; Wu JX, 2013, BRACHYTHERAPY, V12, P479, DOI 10.1016/j.brachy.2012.10.004	25	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90048	10.1371/journal.pone.0090048	http://dx.doi.org/10.1371/journal.pone.0090048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595299	Green Submitted, Green Published, gold			2022-12-25	WOS:000332468900057
J	Davis, MAM; Guo, JN; Price, DH; Luse, DS				Davis, Melissa A. Mullen; Guo, Jiannan; Price, David H.; Luse, Donal S.			Functional Interactions of the RNA Polymerase II-interacting Proteins Gdown1 and TFIIF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						General Transcription Factors; RNA Polymerase II; Transcription; Transcription Elongation Factors; Transcription Initiation Factors; GRINL1A; Gdown1; POLR2M; TFIIF; Preinitiation Complex	TRANSCRIPTION INITIATION-FACTOR; PREINITIATION COMPLEX; POL-II; ELONGATION; MEDIATOR; DNA; PHOSPHORYLATION; ORGANIZATION; ARCHITECTURE; MECHANISM	Background: Gdown1 modulates pausing in early elongation but also blocks binding of the essential initiation factor TFIIF to pol II. Results: TFIIF can compete successfully with Gdown1 to support preinitiation complex assembly. Conclusion: Gdown1 cannot functionally interact with already formed preinitiation complexes. Significance: Pathways exist allowing Gdown1 to enter the transcription complex early in elongation, thus allowing Gdown1 to affect pausing. Gdown1, the substoichiometric 13th subunit of RNA polymerase II (pol II), has an important role in pausing during the initial stage of transcript elongation. However, Gdown1 quantitatively displaces the essential initiation factor TFIIF from free pol II and elongating pol II. Thus, it is not clear how or even if pol II can initiate in the presence of Gdown1. Using an in vitro transcription system with purified factors and pol II lacking Gdown1, we found that although Gdown1 is strongly inhibitory to transcription when prebound to pol II, a fraction of complexes do remain active. Surprisingly, when Gdown1 is added to complete preinitiation complexes (PICs), it does not inhibit initiation or functionally associate with the PICs. Gdown1 does associate with pol II during the early stage of transcript elongation but this association is competitive with TFIIF. By phosphorylating TFIIF, PICs can be assembled that do not retain TFIIF. Gdown1 also fails to functionally associate with these TFIIF-less PICs, but once polymerase enters transcript elongation, complexes lacking TFIIF quantitatively bind Gdown1. Our results provide a partial resolution of the paradox of the competition between Gdown1 and TFIIF for association with pol II. Although Gdown1 completely displaces TFIIF from free pol II and elongation complexes, Gdown1 does not functionally associate with the PIC. Gdown1 can enter the transcription complex immediately after initiation. Modification of TFIIF provides one pathway through which efficient Gdown1 loading can occur early in elongation, allowing downstream pausing to be regulated.	[Davis, Melissa A. Mullen; Luse, Donal S.] Cleveland Clin, Dept Mol Genet, Lerner Res Inst, Cleveland, OH 44195 USA; [Guo, Jiannan; Price, David H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Price, David H.] Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA 52242 USA	Cleveland Clinic Foundation; University of Iowa; University of Iowa	Luse, DS (corresponding author), Cleveland Clin, Dept Mol Genet, Lerner Res Inst, 9500 Euclid Ave,NE20, Cleveland, OH 44195 USA.	lused@ccf.org		Price, David/0000-0002-5597-385X	National Institutes of Health [GM35500]; National Science Foundation [1121210]; American Heart Association Postdoctoral Fellowship [12POST12040106]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association Postdoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM35500 (to D. H. P.). This work was also supported by National Science Foundation Grant 1121210 (to D. S. L.) and American Heart Association Postdoctoral Fellowship 12POST12040106 (to J. G.).	Bernecky C, 2012, J MOL BIOL, V417, P387, DOI 10.1016/j.jmb.2012.02.014; Bernecky C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000603; BURTON ZF, 1988, MOL CELL BIOL, V8, P1602, DOI 10.1128/MCB.8.4.1602; Cabart P, 2011, P NATL ACAD SCI USA, V108, P15786, DOI 10.1073/pnas.1104591108; Cabrejos ME, 2004, J CELL BIOCHEM, V93, P2, DOI 10.1002/jcb.20209; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cheng B, 2012, MOL CELL, V45, P38, DOI 10.1016/j.molcel.2011.10.022; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; FLORES O, 1989, J BIOL CHEM, V264, P8913; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Gilmour DS, 2009, CHROMOSOMA, V118, P1, DOI 10.1007/s00412-008-0182-4; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Hu X, 2006, P NATL ACAD SCI USA, V103, P9506, DOI 10.1073/pnas.0603702103; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Jishage M, 2012, MOL CELL, V45, P51, DOI 10.1016/j.molcel.2011.12.014; KEPHART DD, 1994, J BIOL CHEM, V269, P13536; KITAJIMA S, 1994, J BIOL CHEM, V269, P29970; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Lei L, 1998, MOL CELL BIOL, V18, P2130, DOI 10.1128/MCB.18.4.2130; Lewis BA, 2005, MOL CELL, V18, P471, DOI 10.1016/j.molcel.2005.04.005; Maldonado E, 1996, METHOD ENZYMOL, V274, P72; Meyer KD, 2010, NAT STRUCT MOL BIOL, V17, P753, DOI 10.1038/nsmb.1816; Murakami K, 2013, SCIENCE, V342, P709, DOI 10.1126/science.1238724; Nechaev S, 2008, CELL CYCLE, V7, P1539, DOI 10.4161/cc.7.11.6006; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; PAN GH, 1994, J BIOL CHEM, V269, P30101; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; PRICE DH, 1989, MOL CELL BIOL, V9, P1465, DOI 10.1128/MCB.9.4.1465; Roginski RS, 2004, GENOMICS, V84, P265, DOI 10.1016/j.ygeno.2004.04.004; Rossignol M, 1999, J BIOL CHEM, V274, P22387, DOI 10.1074/jbc.274.32.22387; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; SOPTA M, 1985, J BIOL CHEM, V260, P353; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; Ujvari A, 2011, J BIOL CHEM, V286, P23160, DOI 10.1074/jbc.M110.205658; Wu YM, 2012, EMBO J, V31, P3575, DOI 10.1038/emboj.2012.205; YONAHA M, 1993, NUCLEIC ACIDS RES, V21, P273, DOI 10.1093/nar/21.2.273; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	39	7	7	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11143	11152		10.1074/jbc.M113.544395	http://dx.doi.org/10.1074/jbc.M113.544395			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596085	hybrid, Green Published			2022-12-25	WOS:000334638500018
J	Sjogren, LLE; Tanabe, N; Lymperopoulos, P; Khan, NZ; Rodermel, SR; Aronsson, H; Clarke, AK				Sjogren, Lars L. E.; Tanabe, Noriaki; Lymperopoulos, Panagiotis; Khan, Nadir Z.; Rodermel, Steven R.; Aronsson, Henrik; Clarke, Adrian K.			Quantitative Analysis of the Chloroplast Molecular Chaperone ClpC/Hsp93 in Arabidopsis Reveals New Insights into Its Localization, Interaction with the Clp Proteolytic Core, and Functional Importance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chloroplast; Molecular Chaperone; Protease; Protein Degradation; Protein Translocation	ATP-DEPENDENT PROTEASE; IN-VIVO; ENVELOPE MEMBRANES; TRANSIT-PEPTIDE; PROTEINS; IDENTIFICATION; COMPLEXES; THALIANA; SUBUNIT; SYSTEM	Background: ClpC/Hsp93 is a chloroplast molecular chaperone whose function is essential for plant viability. Results: Chloroplast ClpC localized in both the stromal and envelope-membrane fractions associates with the Clp proteolytic core. Conclusion: ClpC functions primarily as the chaperone component of the chloroplast Clp protease. Significance: Learning how ClpC contributes to key functions of the Clp protease is crucial to understanding the importance of this essential enzyme for chloroplast biology. The molecular chaperone ClpC/Hsp93 is essential for chloroplast function in vascular plants. ClpC has long been held to act both independently and as the regulatory partner for the ATP-dependent Clp protease, and yet this and many other important characteristics remain unclear. In this study, we reveal that of the two near-identical ClpC paralogs (ClpC1 and ClpC2) in Arabidopsis chloroplasts, along with the closely related ClpD, it is ClpC1 that is the most abundant throughout leaf maturation. An unexpectedly large proportion of both chloroplast ClpC proteins (30% of total ClpC content) associates to envelope membranes in addition to their stromal localization. The Clp proteolytic core is also bound to envelope membranes, the amount of which is sufficient to bind to all the similarly localized ClpC. The role of such an envelope membrane Clp protease remains unclear although it appears uninvolved in preprotein processing or Tic subunit protein turnover. Within the stroma, the amount of oligomeric ClpC protein is less than that of the Clp proteolytic core, suggesting most if not all stromal ClpC functions as part of the Clp protease; a proposal supported by the near abolition of Clp degradation activity in the clpC1 knock-out mutant. Overall, ClpC appears to function primarily within the Clp protease, as the principle stromal protease responsible for maintaining homeostasis, and also on the envelope membrane where it possibly confers a novel protein quality control mechanism for chloroplast preprotein import.	[Sjogren, Lars L. E.; Tanabe, Noriaki; Lymperopoulos, Panagiotis; Khan, Nadir Z.; Aronsson, Henrik; Clarke, Adrian K.] Gothenburg Univ, Dept Biol & Environm Sci, S-40530 Gothenburg, Sweden; [Rodermel, Steven R.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA	University of Gothenburg; Iowa State University	Clarke, AK (corresponding author), Gothenburg Univ, Dept Biol & Environm Sci, Box 461, S-40530 Gothenburg, Sweden.	adrian.clarke@bioenv.gu.se	Zaman, Nadir/ABE-6560-2020	Zaman, Nadir/0000-0003-0405-2724; Lymperopoulos, Panagiotis/0000-0003-2706-3717	Swedish Research Council (VR); Stiftelsen Olle Engkvist Byggmastare	Swedish Research Council (VR)(Swedish Research Council); Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council)	This work was supported by grants from The Swedish Research Council (VR) and Stiftelsen Olle Engkvist Byggmastare (to A. K. C.).	Adam Z, 2001, PLANT PHYSIOL, V125, P1912, DOI 10.1104/pp.125.4.1912; Akita M, 1997, J CELL BIOL, V136, P983, DOI 10.1083/jcb.136.5.983; Andersson FI, 2006, J BIOL CHEM, V281, P5468, DOI 10.1074/jbc.M509661200; Andersson FI, 2009, J BIOL CHEM, V284, P13519, DOI 10.1074/jbc.M809588200; Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Aronsson H, 2011, METHODS MOL BIOL, V774, P281, DOI 10.1007/978-1-61779-234-2_17; Balsera M, 2009, J BIOL CHEM, V284, P2603, DOI 10.1074/jbc.M807134200; Block MA, 2002, EUR J BIOCHEM, V269, P240, DOI 10.1046/j.0014-2956.2001.02643.x; Bruch EM, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-57; Chou ML, 2006, J CELL BIOL, V175, P893, DOI 10.1083/jcb.200609172; Chu CC, 2012, PLANT PHYSIOL, V158, P1656, DOI 10.1104/pp.112.193300; Constan D, 2004, PLANT PHYSIOL, V136, P3605, DOI 10.1104/pp.104.052928; Desimone M, 1997, BOT ACTA, V110, P234, DOI 10.1111/j.1438-8677.1997.tb00634.x; Ellis R. John, 2005, P3, DOI 10.1017/CBO9780511546310.002; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Flores-Perez U, 2013, BBA-MOL CELL RES, V1833, P332, DOI 10.1016/j.bbamcr.2012.03.019; Froehlich JE, 2003, J PROTEOME RES, V2, P413, DOI 10.1021/pr034025j; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; GOTTESMAN S, 1990, P NATL ACAD SCI USA, V87, P3513, DOI 10.1073/pnas.87.9.3513; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; Halperin T, 2001, PLANTA, V213, P614, DOI 10.1007/s004250100527; Inaba T, 2003, J BIOL CHEM, V278, P38617, DOI 10.1074/jbc.M306367200; Jackson-Constan D, 2001, BBA-MOL CELL RES, V1541, P102, DOI 10.1016/S0167-4889(01)00148-3; Kessler F, 1996, P NATL ACAD SCI USA, V93, P7684, DOI 10.1073/pnas.93.15.7684; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Koussevitzky S, 2007, PLANT MOL BIOL, V63, P85, DOI 10.1007/s11103-006-9074-2; Kovacheva S, 2005, PLANT J, V41, P412, DOI 10.1111/j.1365-313X.2004.02307.x; Kovacheva S, 2007, PLANT J, V50, P364, DOI 10.1111/j.1365-313X.2007.03060.x; Kovacs-Bogdan E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-133; Kuroda H, 2003, NATURE, V425, P86, DOI 10.1038/nature01909; McClellan A., 2012, ELS, DOI [10.1002/9780470015902.a0020886.pub2, DOI 10.1002/9780470015902.A0020886.PUB2]; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Nakabayashi K, 1999, PLANT CELL PHYSIOL, V40, P504, DOI 10.1093/oxfordjournals.pcp.a029571; Nielsen E, 1997, EMBO J, V16, P935, DOI 10.1093/emboj/16.5.935; Nishimura K, 2013, PLANT CELL, V25, P2276, DOI 10.1105/tpc.113.112557; Olinares PDB, 2011, PLANT CELL, V23, P2348, DOI 10.1105/tpc.111.086454; Ortega J, 2002, EMBO J, V21, P4938, DOI 10.1093/emboj/cdf483; Park S, 2004, P NATL ACAD SCI USA, V101, P12765, DOI 10.1073/pnas.0402764101; Peltier JB, 2004, J BIOL CHEM, V279, P4768, DOI 10.1074/jbc.M309212200; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Randelj Olga, 2007, V390, P417; Richter S, 1999, J CELL BIOL, V147, P33, DOI 10.1083/jcb.147.1.33; Rosano GL, 2011, J BIOL CHEM, V286, P29671, DOI 10.1074/jbc.M110.211946; Rudella A, 2006, PLANT CELL, V18, P1704, DOI 10.1105/tpc.106.042861; Schwenkert S, 2011, BBA-BIOMEMBRANES, V1808, P901, DOI 10.1016/j.bbamem.2010.07.021; SHANKLIN J, 1995, PLANT CELL, V7, P1713, DOI 10.1105/tpc.7.10.1713; Shi LX, 2010, PLANT CELL, V22, P205, DOI 10.1105/tpc.109.071464; Shikanai T, 2001, PLANT CELL PHYSIOL, V42, P264, DOI 10.1093/pcp/pce031; Sjogren LLE, 2006, PLANT CELL, V18, P2635, DOI 10.1105/tpc.106.044594; Sjogren LLE, 2011, PLANT CELL, V23, P322, DOI 10.1105/tpc.110.082321; Sjogren LLE, 2004, PLANT PHYSIOL, V136, P4114, DOI 10.1104/pp.104.053835; Sokolenko A, 1998, PLANTA, V207, P286, DOI 10.1007/s004250050485; Stanne TM, 2007, J BIOL CHEM, V282, P14394, DOI 10.1074/jbc.M700275200; Stanne TM, 2009, BIOCHEM J, V417, P257, DOI 10.1042/BJ20081146; Su PH, 2010, PLANT CELL, V22, P1516, DOI 10.1105/tpc.109.071415; Tryggvesson A, 2012, BIOCHEM J, V446, P311, DOI 10.1042/BJ20120649; Vierstra RD, 1996, PLANT MOL BIOL, V32, P275, DOI 10.1007/BF00039386; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Zheng B, 2002, PHYSIOL PLANTARUM, V114, P92, DOI 10.1034/j.1399-3054.2002.1140113.x; Zheng B, 2006, PLANTA, V224, P1103, DOI 10.1007/s00425-006-0292-2	64	43	48	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11318	11330		10.1074/jbc.M113.534552	http://dx.doi.org/10.1074/jbc.M113.534552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599948	Green Published, hybrid			2022-12-25	WOS:000334638500034
J	Haas, J; Ophir, L; Barzilay, E; Yerushalmi, GM; Yung, Y; Kedem, A; Maman, E; Hourvitz, A				Haas, Jigal; Ophir, Libby; Barzilay, Eran; Yerushalmi, Gil M.; Yung, Yuval; Kedem, Alon; Maman, Ettie; Hourvitz, Ariel			GnRH Agonist vs. hCG for Triggering of Ovulation - Differential Effects on Gene Expression in Human Granulosa Cells	PLOS ONE			English	Article							OVARIAN HYPERSTIMULATION SYNDROME; ENDOTHELIAL GROWTH-FACTOR; FINAL OOCYTE MATURATION; IN-VITRO FERTILIZATION; GONADOTROPIN STIMULATION; FOLLICULAR-FLUID; EMBRYO-TRANSFER; HORMONE; WOMEN; IVF	Objective: To investigate the mRNA expression of genes related to steroidogenesis and OHSS in granulosa cells (GCs) of patients triggered with GnRH agonist compared to patients triggered with hCG. Design: Mural GCs were obtained at the time of oocyte retrieval and gene expression was analyzed using quantitative real time RT-PCR. Settings: Single center, case control study. Patient(s): 24 women who were treated with GnRH agonist or hCG for triggering of ovulation. Interventions: GC collection. Main Outcome Measure(s): The expression of genes related to steroidogenesis and OHSS in mural GCs Results: The fertilization rate was similar in the two groups. The mRNA expression of CYP19A1 (0.50 vs 1, arbitrary unit), CYP11A1 (0.6 vs. 1) and 3 beta hydroxysteroid-dehydrogenase (0.39 vs 1) was significantly lower in the GnRH group. The expression of VEGF (0.74 vs. 1) and inhibin beta B (0.38 vs 1) was lower in the GnRH analog triggered group. Conclusion: Expression of genes related to steroidogenesis is lower at the time of oocyte retrieval in patients triggered with GnRH agonist. The decreased expression of VEGF and inhibin b B in the GnRH agonist group can explain the mechanism of early OHSS prevention.	[Haas, Jigal] Chaim Sheba Med Ctr, Dept Obstet & Gynecol, Human Reprod Lab, Ramat Gan, Israel; Chaim Sheba Med Ctr, Dept Obstet & Gynecol, IVF Unit, Ramat Gan, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center	Haas, J (corresponding author), Chaim Sheba Med Ctr, Dept Obstet & Gynecol, Human Reprod Lab, Ramat Gan, Israel.	jigalh@hotmail.com	Barzilay, Eran/AAH-4433-2021	Barzilay, Eran/0000-0001-5496-4866				Agrawal R, 1999, FERTIL STERIL, V71, P287, DOI 10.1016/S0015-0282(98)00447-6; Andersen CY, 2006, HUM REPROD, V21, P2126, DOI 10.1093/humrep/del119; Babayof R, 2006, HUM REPROD, V21, P1260, DOI 10.1093/humrep/dei475; Ben-Ami I, 2011, HUM REPROD, V26, P76, DOI 10.1093/humrep/deq290; Cerrillo M, 2011, FERTIL STERIL, V95, P2517, DOI 10.1016/j.fertnstert.2010.12.054; Cerrillo M, 2009, FERTIL STERIL, V91, P1526, DOI 10.1016/j.fertnstert.2008.08.118; Conti M, 2006, MOL ENDOCRINOL, V20, P715, DOI 10.1210/me.2005-0185; Engmann L, 2006, REPROD BIOMED ONLINE, V13, P639, DOI 10.1016/S1472-6483(10)60653-0; Engmann L, 2011, FERTIL STERIL, V96, P198, DOI 10.1016/j.fertnstert.2011.04.071; Enskog A, 2001, EUR J OBSTET GYN R B, V96, P196, DOI 10.1016/S0301-2115(00)00460-7; Enskog A, 2000, HUM REPROD, V15, P532, DOI 10.1093/humrep/15.3.532; Fauser BC, 2002, J CLIN ENDOCR METAB, V87, P709, DOI 10.1210/jc.87.2.709; GONEN Y, 1990, Journal of Clinical Endocrinology and Metabolism, V71, P918; Griesinger G, 2006, HUM REPROD UPDATE, V12, P159, DOI 10.1093/humupd/dmi045; Humaidan P, 2005, HUM REPROD, V20, P1213, DOI 10.1093/humrep/deh765; Humaidan P, 2011, HUM REPROD UPDATE, V17, P510, DOI 10.1093/humupd/dmr008; Humaidan P, 2009, HUM REPROD, V24, P2389, DOI 10.1093/humrep/dep246; Humaidan P, 2011, FERTIL STERIL, V95, P2034, DOI 10.1016/j.fertnstert.2011.02.013; Humaidan P, 2010, FERTIL STERIL, V93, P847, DOI 10.1016/j.fertnstert.2008.12.042; Inoue Y, 2009, FERTIL STERIL, V91, P1035, DOI 10.1016/j.fertnstert.2008.01.014; ITSKOVITZ J, 1991, FERTIL STERIL, V56, P213; Jones SM, 2002, AM J PHYSIOL-CELL PH, V282, pC420, DOI 10.1152/ajpcell.00253.2001; Kedem-Dickman A, 2012, REPROD BIOMED ONLINE, V24, P540, DOI 10.1016/j.rbmo.2012.01.023; Kolibianakis EM, 2005, HUM REPROD, V20, P2887, DOI 10.1093/humrep/dei150; Maman E, 2012, FERTIL STERIL, V97, P592, DOI 10.1016/j.fertnstert.2011.12.027; Maman E, 2011, MOL HUM REPROD, V17, P399, DOI 10.1093/molehr/gar010; Mathur R, 2002, FERTIL STERIL, V78, P1154, DOI 10.1016/S0015-0282(02)04243-7; MCCLURE N, 1994, LANCET, V344, P235, DOI 10.1016/S0140-6736(94)93001-5; MISKIMINS WK, 1982, J CELL PHYSIOL, V112, P327, DOI 10.1002/jcp.1041120304; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Pellicer A, 1999, FERTIL STERIL, V71, P482, DOI 10.1016/S0015-0282(98)00484-1; Soares SR, 2008, HUM REPROD UPDATE, V14, P321, DOI 10.1093/humupd/dmn008; Strowitzki T, 1995, HUM REPROD, V10, P3097, DOI 10.1093/oxfordjournals.humrep.a135865; Xu FH, 2011, MOL HUM REPROD, V17, P152, DOI 10.1093/molehr/gaq089; Yung Y, 2010, MOL CELL ENDOCRINOL, V328, P104, DOI 10.1016/j.mce.2010.07.019	35	33	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90359	10.1371/journal.pone.0090359	http://dx.doi.org/10.1371/journal.pone.0090359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603682	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600048
J	ODonnell, RL; McCormick, A; Mukhopadhyay, A; Woodhouse, LC; Moat, M; Grundy, A; Dixon, M; Kaufman, A; Soohoo, S; Elattar, A; Curtin, NJ; Edmondson, RJ				ODonnell, Rachel L.; McCormick, Aiste; Mukhopadhyay, Asima; Woodhouse, Laura C.; Moat, Madeleine; Grundy, Anna; Dixon, Michelle; Kaufman, Angelika; Soohoo, San; Elattar, Ahmed; Curtin, Nicola J.; Edmondson, Richard J.			The Use of Ovarian Cancer Cells from Patients Undergoing Surgery to Generate Primary Cultures Capable of Undergoing Functional Analysis	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; EPITHELIAL-CELLS; EXPRESSION; TUMOR; HETEROGENEITY; CYTOTOXICITY; ASSAY	The use of cell lines or animal models has significant disadvantages when dealing with a set of heterogeneous diseases such as epithelial ovarian cancer. This has clinical relevance in that biomarkers developed using cell line or animal models are often not transferable to the clinical setting. In this study, we describe the development of a robust protocol for developing primary cultures of ovarian cancer which will overcome some of these difficulties. Women undergoing surgery for ovarian cancer were recruited and samples of ascites and solid tumour deposits were used to develop primary cultures. Cells were characterised using a panel of immunofluorescent antibodies prior to use in a variety of assays including functional assessment of DNA repair pathways. During the four year study period, viable cultures, confirmed to be epithelial in origin were generated from 156 of 172 (91%) cases recruited. Characterisation was carried out using a panel of antibodies including pancytokeratin, CA125, EpCAM, MOC-31, D2-40 and vimentin. Senescence occurred between the 2nd and 8th passages in all cultures except one in which spontaneous immortalization occurred. Cells could be successfully cultured even after a period of storage at 4 degrees C and cultured cells were capable of being used for a variety of applications including functional assays. Upon functional assessment there was minimal intra-tumour heterogeneity. It is therefore possible to derive viable ovarian cancer cell cultures in the majority of patients undergoing surgery. Cells cultured directly from patient cancers provide an accurate and highly diverse model.	[ODonnell, Rachel L.; Mukhopadhyay, Asima; Kaufman, Angelika; Soohoo, San] Queen Elizabeth Hosp, Northern Gynaecol Oncol Ctr, Gateshead, England; [ODonnell, Rachel L.; McCormick, Aiste; Mukhopadhyay, Asima; Woodhouse, Laura C.; Moat, Madeleine; Grundy, Anna; Dixon, Michelle; Kaufman, Angelika; Soohoo, San; Elattar, Ahmed; Curtin, Nicola J.] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Edmondson, Richard J.] Univ Manchester, Fac Inst Canc Sci, Manchester, Lancs, England	Newcastle University - UK; University of Manchester	Edmondson, RJ (corresponding author), Univ Manchester, Fac Inst Canc Sci, Manchester, Lancs, England.	richard.edmondson@manchester.ac.uk	O'Donnell, Rachel L/H-5850-2016; Elattar, Ahmed/L-3357-2019; Woodhouse, Laura/GRY-6740-2022	O'Donnell, Rachel L/0000-0002-4830-2468; Elattar, Ahmed/0000-0003-3223-0890; Curtin, Nicola/0000-0003-1369-1843; Edmondson, Richard/0000-0003-2553-4423	National Institute for Health Research [ACF-2008-01-011] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Abelson S, 2012, STEM CELLS, V30, P415, DOI 10.1002/stem.1029; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bau DT, 2007, CARCINOGENESIS, V28, P1726, DOI 10.1093/carcin/bgm109; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Dunfield Lesley D., 2002, Biol Proced Online, V4, P55; Fong MY, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-12; Hennessy BT, 2008, ADV EXP MED BIOL, V617, P23, DOI 10.1007/978-0-387-69080-3_3; HIRTE HW, 1992, GYNECOL ONCOL, V44, P223, DOI 10.1016/0090-8258(92)90046-L; Khalique L, 2007, J PATHOL, V211, P286, DOI 10.1002/path.2112; Kobel M, 2011, INT J GYNECOL PATHOL, V30, P366, DOI 10.1097/PGP.0b013e31820d20ba; Korch C, 2012, GYNECOL ONCOL, V127, P241, DOI 10.1016/j.ygyno.2012.06.017; Le Page C, 2006, BRIT J CANCER, V94, P436, DOI 10.1038/sj.bjc.6602933; Lee EC, 1991, ACT CYTOGENETICS LAB, P107; Marks A, 1999, BRIT J CANCER, V80, P569, DOI 10.1038/sj.bjc.6690393; Mukhopadhyay A, 2010, CLIN CANCER RES, V16, P2344, DOI 10.1158/1078-0432.CCR-09-2758; Ohashi A, 2005, J BIOL CHEM, V280, P14877, DOI 10.1074/jbc.M414669200; Parmar MKB, 2003, LANCET, V361, P2099; PEREZ RP, 1993, EUR J CANCER, V29A, P395, DOI 10.1016/0959-8049(93)90394-U; Rosen DG, 2005, GYNECOL ONCOL, V99, P267, DOI 10.1016/j.ygyno.2005.06.040; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; SOUHAMI RL, 1991, J NATL CANCER I, V83, P609, DOI 10.1093/jnci/83.9.609; Statistics NOf, 2011, MORT STAT DEATHS DR; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Znojek P, 2011, THESIS NEWCASTLE U	24	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90604	10.1371/journal.pone.0090604	http://dx.doi.org/10.1371/journal.pone.0090604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603616	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600067
J	Papantonopoulos, G; Takahashi, K; Bountis, T; Loos, BG				Papantonopoulos, Georgios; Takahashi, Keiso; Bountis, Tasos; Loos, Bruno G.			Artificial Neural Networks for the Diagnosis of Aggressive Periodontitis Trained by Immunologic Parameters	PLOS ONE			English	Article							DISEASE; CLASSIFICATION; MARKERS	There is neither a single clinical, microbiological, histopathological or genetic test, nor combinations of them, to discriminate aggressive periodontitis (AgP) from chronic periodontitis (CP) patients. We aimed to estimate probability density functions of clinical and immunologic datasets derived from periodontitis patients and construct artificial neural networks (ANNs) to correctly classify patients into AgP or CP class. The fit of probability distributions on the datasets was tested by the Akaike information criterion (AIC). ANNs were trained by cross entropy (CE) values estimated between probabilities of showing certain levels of immunologic parameters and a reference mode probability proposed by kernel density estimation (KDE). The weight decay regularization parameter of the ANNs was determined by 10-fold cross-validation. Possible evidence for 2 clusters of patients on cross-sectional and longitudinal bone loss measurements were revealed by KDE. Two to 7 clusters were shown on datasets of CD4/CD8 ratio, CD3, monocyte, eosinophil, neutrophil and lymphocyte counts, IL-1, IL-2, IL-4, INF-gamma and TNF-alpha level from monocytes, antibody levels against A. actinomycetemcomitans (A. a.) and P. gingivalis (P. g.). ANNs gave 90%-98% accuracy in classifying patients into either AgP or CP. The best overall prediction was given by an ANN with CE of monocyte, eosinophil, neutrophil counts and CD4/CD8 ratio as inputs. ANNs can be powerful in classifying periodontitis patients into AgP or CP, when fed by CE values based on KDE. Therefore ANNs can be employed for accurate diagnosis of AgP or CP by using relatively simple and conveniently obtained parameters, like leukocyte counts in peripheral blood. This will allow clinicians to better adapt specific treatment protocols for their AgP and CP patients.	[Papantonopoulos, Georgios] Univ Patras, Dept Math, Ctr Res & Applicat Nonlinear Syst, GR-26110 Patras, Greece; [Takahashi, Keiso] Ohu Univ, Sch Dent, Dept Conservat Dent, Fukushima, Japan; [Bountis, Tasos] Univ Patras, Dept Math, Lab Nonlinear Syst & Appl Anal, GR-26110 Patras, Greece; [Loos, Bruno G.] Univ Amsterdam, Dept Periodontol, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; [Loos, Bruno G.] Vrije Univ Amsterdam, Amsterdam, Netherlands	University of Patras; University of Patras; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Papantonopoulos, G (corresponding author), Univ Patras, Dept Math, Ctr Res & Applicat Nonlinear Syst, GR-26110 Patras, Greece.	ppntnpls@otenet.gr	Bountis, Anastasios/GRS-5915-2022; BOUNTIS, ANASTASIOS/AAR-4966-2020		University of Amsterdam; European Union (European Social Fund, ESF); Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: THALES: Investing in knowledge society through the European Social Fund	University of Amsterdam; European Union (European Social Fund, ESF)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: THALES: Investing in knowledge society through the European Social Fund(Thales Group)	The Academic Center for Dentistry Amsterdam (ACTA) (author B. G. L.) is supported in part by a grant from the University of Amsterdam for research into the focal point "Oral infections and Inflammation''. This research has been co-financed by the European Union (European Social Fund, ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: THALES: Investing in knowledge society through the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2003, ENCY SOCIAL SCI RES, P725; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Armitage GC, 2013, PERIODONTOL 2000, V62, P20, DOI 10.1111/prd.12006; Armitage GC, 2010, PERIODONTOL 2000, V53, P12, DOI 10.1111/j.1600-0757.2010.00353.x; Bartold PM, 2013, PERIODONTOL 2000, V62, P203, DOI 10.1111/j.1600-0757.2012.00450.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; De Boer PT, 2005, ANN OPER RES, V134, P19, DOI 10.1007/s10479-005-5724-z; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Graswinckel JEM, 2004, J CLIN PERIODONTOL, V31, P562, DOI 10.1111/j.1600-051X.2004.00522.x; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hall P, 2005, ANN STAT, V33, P284, DOI 10.1214/009053604000000959; Hastie T., 2009, UNSUPERVISED LEARNIN; Kebschull M, 2013, J DENT RES, V92, P1081, DOI 10.1177/0022034513506011; Kinane DF, 2001, PERIODONTOL 2000, V26, P7, DOI 10.1034/j.1600-0757.2001.2260101.x; Klnane DF L.J., 2008, CLIN PERIODONTOLOGY, V5th ed, P285; Laine ML, 2012, PERIODONTOL 2000, V58, P37, DOI 10.1111/j.1600-0757.2011.00415.x; Loos BG, 2005, PERIODONTOL 2000, V39, P53, DOI 10.1111/j.1600-0757.2005.00129.x; Loos BG, 2004, J PERIODONTOL, V75, P557, DOI 10.1902/jop.2004.75.4.557; Loos BG, 2000, J PERIODONTOL, V71, P1528, DOI 10.1902/jop.2000.71.10.1528; Mazurowski MA, 2008, NEURAL NETWORKS, V21, P427, DOI 10.1016/j.neunet.2007.12.031; Myung IJ, 2003, J MATH PSYCHOL, V47, P90, DOI 10.1016/S0022-2496(02)00028-7; Neal RM, 2006, STUD FUZZ SOFT COMP, V207, P265; Nicolis G., 2012, FDN COMPLEX SYSTEMS; Offenbacher S, 2007, J PERIODONTOL, V78, P1911, DOI 10.1902/jop.2007.060465; Papantonopoulos G, 2013, J PERIODONTOL, V84, pE29, DOI 10.1902/jop.2013.120637; Papantonopoulos G, 2013, INT J BIFURCAT CHAOS, V23, DOI 10.1142/S0218127413500569; Papantonopoulos GH, 2004, J PERIODONTOL, V75, P839, DOI 10.1902/jop.2004.75.6.839; Razzouk S, 2013, J PERIODONTOL, V84, P1266, DOI 10.1902/jop.2012.120531; Sakamoto Y., 1986, AKAIKE INFORM CRITER; Sheather SJ, 2004, STAT SCI, V19, P588, DOI 10.1214/088342304000000297; Shi HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035781; Silverman B.W., 1986, DENSITY ESTIMATION S; Simonoff J.S., 1996, SMOOTING METHODS STA, V2nd; Takahashi K, 2001, J PERIODONTOL, V72, P425, DOI 10.1902/jop.2001.72.4.425; Teles RP, 2010, J CLIN PERIODONTOL, V37, P313, DOI 10.1111/j.1600-051X.2010.01534.x; Tonetti MS, 2008, CLIN PERIODONTOLOGY, P428; van der Velden U, 2005, PERIODONTOL 2000, V39, P13, DOI 10.1111/j.1600-0757.2005.00127.x; Vose D., 2008, RISK ANAL QUANTITATI; Zhang GQP, 2000, IEEE T SYST MAN CY C, V30, P451, DOI 10.1109/5326.897072	39	27	30	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89757	10.1371/journal.pone.0089757	http://dx.doi.org/10.1371/journal.pone.0089757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603408	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600020
J	Harada, N; Tamura, S; Sugawara, Y; Togashi, J; Ishizawa, T; Kaneko, J; Aoki, T; Sakamoto, Y; Hasegawa, K; Tanaka, T; Yamashiki, N; Kokudo, N				Harada, Nobuhiro; Tamura, Sumihito; Sugawara, Yasuhiko; Togashi, Junichi; Ishizawa, Takeaki; Kaneko, Junichi; Aoki, Taku; Sakamoto, Yoshihiro; Hasegawa, Kiyoshi; Tanaka, Tomohiro; Yamashiki, Noriyo; Kokudo, Norihiro			Impact of Donor and Recipient Single Nucleotide Polymorphisms of IL28B rs8099917 in Living Donor Liver Transplantation for Hepatitis C	PLOS ONE			English	Article							ANTIVIRAL THERAPY; VIROLOGICAL RESPONSE; FIBROSIS PROGRESSION; RIBAVIRIN THERAPY; GENETIC-VARIATION; VIRUS; INTERFERON; INFECTION; GENOTYPE; ASSOCIATION	Single nucleotide polymorphisms of interleukin-28B (IL28B) rs8099917 are reported to be associated with virologic clearance in interferon-and ribavirin -based treatment for hepatitis C virus (HCV)-infected patients. We examined virologic response in accordance with IL28B polymorphisms in our living donor liver transplantation series under a preemptive interferon and RBV treatment approach. Adequate DNA samples from both the recipient and donor for the study of single nucleotide polymorphisms of IL28B were available from 96 cases and were the subjects of the present study. Various clinical factors related with virologic response including early virologic response (EVR) and sustained virologic response (SVR) were examined. Totally 51% presented with EVR and 44% achieved SVR. Presence of the major allele (TT) in either the recipient or the donor corresponded to SVR of 53% and 48%. Presence of the minor allele (TG or GG) corresponded to SVR of 26% and 32%. Multivariate analysis revealed that genotype of HCV or EVR, but not IL28B polymorphisms in either the recipient or donor, was an independent factor for achieving SVR. When virologic response to treatment was incorporated into analysis, the impact of IL28B polymorphism on virological clearance remained relative to other factors and was not significantly independent.	[Harada, Nobuhiro; Tamura, Sumihito; Sugawara, Yasuhiko; Togashi, Junichi; Kaneko, Junichi] Tokyo Univ Hosp, Div Artificial Organ & Transplantat, Tokyo 113, Japan; [Ishizawa, Takeaki; Aoki, Taku; Sakamoto, Yoshihiro; Hasegawa, Kiyoshi; Kokudo, Norihiro] Tokyo Univ Hosp, Div Hepatobiliary & Pancreat Surg, Tokyo 113, Japan; [Sugawara, Yasuhiko; Tanaka, Tomohiro; Yamashiki, Noriyo; Kokudo, Norihiro] Tokyo Univ Hosp, Organ Transplantat Serv, Tokyo 113, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Sugawara, Y (corresponding author), Tokyo Univ Hosp, Div Artificial Organ & Transplantat, Tokyo 113, Japan.	yasusuga-tky@umin.ac.jp		YAMASHIKI, Noriyo/0000-0002-9274-0000	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	The study has been supported by a Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Grants-in-aid for evolutional treatment strategies for recurrent hepatitis after liver transplantation using genome-wide analysis and Research on HIV/AIDS and Research on Measures for Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Berenguer M, 2001, J HEPATOL, V35, P666, DOI 10.1016/S0168-8278(01)00179-9; Berenguer M, 2000, J HEPATOL, V32, P673, DOI 10.1016/S0168-8278(00)80231-7; Berenguer M, 2006, LIVER TRANSPLANT, V12, P1067, DOI 10.1002/lt.20737; Bizollon T, 2007, AM J TRANSPLANT, V7, P448, DOI 10.1111/j.1600-6143.2006.01619.x; Bochud PY, 2011, J HEPATOL, V55, P980, DOI 10.1016/j.jhep.2011.01.050; Brown RS, 2005, NATURE, V436, P973, DOI 10.1038/nature04083; Carrion JA, 2007, GASTROENTEROLOGY, V132, P1746, DOI 10.1053/j.gastro.2007.03.041; Charlton MR, 2011, HEPATOLOGY, V53, P317, DOI 10.1002/hep.24074; Coto-Llerena M, 2011, AM J TRANSPLANT, V11, P1051, DOI 10.1111/j.1600-6143.2011.03491.x; Crespo G, 2013, J GASTROENTEROL, V48, P762, DOI 10.1007/s00535-012-0680-2; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Duarte-Rojo A, 2012, TRANSPLANTATION, V94, P197, DOI 10.1097/TP.0b013e3182547551; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Eurich D, 2011, LIVER TRANSPLANT, V17, P289, DOI 10.1002/lt.22235; Forman LM, 2002, GASTROENTEROLOGY, V122, P889, DOI 10.1053/gast.2002.32418; Fukuhara T, 2010, GASTROENTEROLOGY, V139, P1577, DOI 10.1053/j.gastro.2010.07.058; Garcia-Retortillo M, 2002, HEPATOLOGY, V35, P680, DOI 10.1053/jhep.2002.31773; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kawaoka T, 2012, J GASTROEN HEPATOL, V27, P1467, DOI 10.1111/j.1440-1746.2012.07129.x; Lange CM, 2011, J HEPATOL, V55, P322, DOI 10.1016/j.jhep.2010.10.037; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; McCaughan GW, 2012, J HEPATOL, V57, P1361, DOI 10.1016/j.jhep.2012.07.035; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Powers KA, 2006, LIVER TRANSPLANT, V12, P207, DOI 10.1002/lt.20572; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Sugawara Y, 2004, TRANSPLANTATION, V78, P1308, DOI 10.1097/01.TP.0000142677.12473.E5; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tamura S, 2008, J HEPATO-BILIARY-PAN, V15, P111, DOI 10.1007/s00534-007-1295-5; Tamura S, 2010, TRANSPL INT, V23, P580, DOI 10.1111/j.1432-2277.2009.01023.x; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Terrault NA, 2006, LIVER TRANSPLANT, V12, P1192, DOI 10.1002/lt.20865; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Thuluvath PJ, 2007, LIVER TRANSPLANT, V13, P719, DOI 10.1002/lt.21123; Toyoda H, 2012, J MED VIROL, V84, P61, DOI 10.1002/jmv.22272; Wang CS, 2006, AM J TRANSPLANT, V6, P1586, DOI 10.1111/j.1600-6143.2006.01362.x; Yilmaz N, 2007, LIVER TRANSPLANT, V13, P975, DOI 10.1002/lt.21117; Zeuzem S, 2009, J VIRAL HEPATITIS, V16, P75, DOI 10.1111/j.1365-2893.2008.01012.x	40	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90462	10.1371/journal.pone.0090462	http://dx.doi.org/10.1371/journal.pone.0090462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599320	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400078
J	Hong, LF; Li, XL; Luo, SH; Guo, YL; Liu, J; Zhu, CG; Qing, P; Xu, RX; Wu, NQ; Jiang, LX; Li, JJ				Hong, Li-Feng; Li, Xiao-Lin; Luo, Song-Hui; Guo, Yuan-Lin; Liu, Jun; Zhu, Cheng-Gang; Qing, Ping; Xu, Rui-Xia; Wu, Na-Qiong; Jiang, Li-Xin; Li, Jian-Jun			Relation of Leukocytes and Its Subsets Counts with the Severity of Stable Coronary Artery Disease in Patients with Diabetic Mellitus	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BLOOD-CELL COUNT; HEART-DISEASE; PROGNOSTIC VALUE; NEUTROPHIL/LYMPHOCYTE RATIO; CARDIOVASCULAR MORTALITY; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; EJECTION FRACTION; LYMPHOCYTE RATIO	Background: Both coronary artery disease (CAD) and diabetes mellitus (DM) are associated with inflammation. However, whether and which leukocytes can predict the presence and extent of CAD in patients with DM has not been investigated. The aim of the present study was to examine the association of leukocyte and its subsets counts with the severity of CAD in patients with DM. Methods and Findings: Three hundred and seventy-three diabetic patients who were scheduled for coronary angiography due to typical stable angina pectoris were enrolled in this study. They were classified into the three groups according to tertiles of Gensini score (GS, low group <8, n = 143; intermediate group 8 similar to 28, n = 109; high group >28, n = 121). The relationship between the leukocyte and its subsets counts with the severity of CAD were evaluated. The data indicated that there were significant correlations between leukocyte and neutrophil counts with GS (r = 0.154 and 0.156, respectively, all P<0.003 for Pearson's correlation). Similarly, area under the receivers operating characteristic curve of leukocyte and neutrophil counts were 0.61 and 0.60 respectively (95% CI: 0.55-0.67, all P = 0.001) for predicting high GS. Multivariate logistic regression analysis demonstrated that leukocyte count was an independent predictor for high GS patients with DM (OR = 1.20, 95% CI 1.03-1.39, P = 0.023) after adjusting for conventional risk factors of CAD. Conclusions: Compared with its subsets, leukocyte count appeared to be an independent predictor for the severity of CAD and the optimal cut-off value for predicting high GS (>28 points) was 5.0x10(9) cells/L in diabetic patients.	[Hong, Li-Feng; Li, Xiao-Lin; Guo, Yuan-Lin; Liu, Jun; Zhu, Cheng-Gang; Qing, Ping; Xu, Rui-Xia; Wu, Na-Qiong; Jiang, Li-Xin; Li, Jian-Jun] Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis,Fu Wai Hosp, Div Dyslipidemia,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Hong, Li-Feng; Luo, Song-Hui] Wuhan Univ, Div Cardiol, Hosp Wuhan 5, Wuhan 430072, Peoples R China; [Hong, Li-Feng; Luo, Song-Hui] Wuhan Univ, Affiliated Guangci Hosp, Wuhan 430072, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Wuhan University; Wuhan University	Li, JJ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis,Fu Wai Hosp, Div Dyslipidemia,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China.	lijianjun938@yahoo.com	Guo, Yuan-Lin/K-4887-2019; xu, rui/GRX-5734-2022	Guo, Yuan-Lin/0000-0002-7159-0189; 	National Natural Scientific Foundation [81070171, 81241121]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20111106110013]; Capital Special Foundation of Clinical Application Research [Z121107001012015]; Capital Health Development Fund [2011400302]; Beijing Natural Science Foundation [7131014]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Capital Special Foundation of Clinical Application Research; Capital Health Development Fund; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This article was partly supported by National Natural Scientific Foundation (81070171, 81241121), Specialized Research Fund for the Doctoral Program of Higher Education of China (20111106110013), Capital Special Foundation of Clinical Application Research (Z121107001012015), Capital Health Development Fund (2011400302), and Beijing Natural Science Foundation (7131014) awarded to Dr. Jian-Jun Li, MD, PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arain FA, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.02.020; Arbel Y, 2012, ATHEROSCLEROSIS, V225, P456, DOI 10.1016/j.atherosclerosis.2012.09.009; Avanzas P, 2004, ATHEROSCLEROSIS, V175, P151, DOI 10.1016/j.atherosclerosis.2004.03.013; Celik T, 2011, CARDIOL J, V18, P720, DOI 10.5603/CJ.2011.0044; Damman P, 2011, J AM COLL CARDIOL, V57, P29, DOI 10.1016/j.jacc.2010.06.053; Dragu R, 2008, ATHEROSCLEROSIS, V196, P405, DOI 10.1016/j.atherosclerosis.2006.11.022; FOLLAND ED, 1979, CIRCULATION, V60, P760, DOI 10.1161/01.CIR.60.4.760; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; Fowler AJ, 2013, ATHEROSCLEROSIS, V228, P44, DOI 10.1016/j.atherosclerosis.2013.02.008; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; GILLUM RF, 1993, AM HEART J, V125, P855, DOI 10.1016/0002-8703(93)90181-8; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hartaigh BO, 2012, ATHEROSCLEROSIS, V224, P161, DOI 10.1016/j.atherosclerosis.2012.04.012; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kaya A, 2013, CLIN APPL T IN PRESS; Kaya H, 2013, CLIN APPL THROMB HEM; Lee CD, 2001, AM J EPIDEMIOL, V154, P758, DOI 10.1093/aje/154.8.758; Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.056; Margolis KL, 2005, ARCH INTERN MED, V165, P500, DOI 10.1001/archinte.165.5.500; Nunez J, 2006, CURR MED CHEM, V13, P2113, DOI 10.2174/092986706777935221; Palmerini T, 2005, CIRCULATION, V112, P2332, DOI 10.1161/CIRCULATIONAHA.105.551648; Palmerini T, 2013, AM J CARDIOL; Papa A, 2008, CLIN CHIM ACTA, V395, P27, DOI 10.1016/j.cca.2008.04.019; Park CS, 2010, AM J CARDIOL, V105, P1284, DOI 10.1016/j.amjcard.2009.12.045; Rasouli M, 2007, CLIN CHIM ACTA, V377, P127, DOI 10.1016/j.cca.2006.09.009; Rasouli M, 2011, CARDIOL J, V18, P246; Sabatine MS, 2002, J AM COLL CARDIOL, V40, P1761, DOI 10.1016/S0735-1097(02)02484-1; Sahin DY, 2012, ANGIOLOGY; Sarndahl E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001056; Shantsila E, 2012, INT J CARDIOL, V155, P337, DOI 10.1016/j.ijcard.2011.12.048; Sinning JM, 2006, EUR HEART J, V27, P2962, DOI 10.1093/eurheartj/ehl362; Smit JJJ, 2008, AM J CARDIOL, V101, P446, DOI 10.1016/j.amjcard.2007.09.088; Tong PC, 2004, DIABETES CARE, V27, P216, DOI 10.2337/diacare.27.1.216; Twig G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047183; Zairis MN, 2007, ATHEROSCLEROSIS, V194, P397, DOI 10.1016/j.atherosclerosis.2006.08.008; Ziakas A, 2009, MED SCI MONITOR, V15, pCR177	36	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90663	10.1371/journal.pone.0090663	http://dx.doi.org/10.1371/journal.pone.0090663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599246	gold, Green Published, Green Submitted			2022-12-25	WOS:000332479400112
J	Xie, Q; Brackenbury, LS; Hill, DJ; Williams, NA; Qu, X; Virji, M				Xie, Qi; Brackenbury, Louise S.; Hill, Darryl J.; Williams, Neil A.; Qu, Xun; Virji, Mumtaz			Moraxella catarrhalis Adhesin UspA1-derived Recombinant Fragment rD-7 Induces Monocyte Differentiation to CD14+CD206+Phenotype	PLOS ONE			English	Article							DENDRITIC CELLS; ALTERNATIVE ACTIVATION; N-DOMAIN; NEISSERIA-MENINGITIDIS; DC-SIGN; CEACAM1; CD66A; MACROPHAGES; MOLECULE; RECEPTOR	Circulating monocytes in the bloodstream typically migrate to other tissues and differentiate into tissue resident macrophages, the process being determined by the constituents of the microenvironments encountered. These may include microbes and their products. In this study, we investigated whether Moraxella catarrhalis Ubiquitous Surface Protein A1 (UspA1), known to bind to a widely expressed human cell surface receptor CEACAM1, influences monocyte differentiation as receptor engagement has been shown to have profound effects on monocytes. We used the recombinant molecules corresponding to the regions of UspA1 which either bind (rD-7; UspA1(527-665)) or do not bind (r6-8; UspA1(659-863)) to CEACAM1 and investigated their effects on CD206, CD80 and CD86 expression on freshly isolated human CD14+ monocytes from peripheral blood mononuclear cells (PBMC). Exposure to rD-7, but not r6-8, biased monocyte differentiation towards a CD14+CD206+ phenotype, with reduced CD80 expression. Monocytes treated with rD-7 also secreted high levels of IL-1ra and chemokine IL-8 but not IL-10 or IL-12p70. The effects of rD-7 were independent of any residual endotoxin. Unexpectedly, these effects of rD-7 were also independent of its ability to bind to CEACAM1, as monocyte pre-treatment with the anti-CEACAM antibody A0115 known to inhibit rD-7 binding to the receptor, did not affect rD-7-driven differentiation. Further, another control protein rD-7/D (a mutant form of rD-7, known not to bind to CEACAMs), also behaved as the parent molecule. Our data suggest that specific regions of M. catarrhalis adhesin UspA1 may modulate inflammation during infection through a yet unknown receptor on monocytes.	[Xie, Qi; Qu, Xun] Shandong Univ, Qilu Hosp, Inst Basic Med Sci, Jinan 250100, Shandong, Peoples R China; [Brackenbury, Louise S.; Hill, Darryl J.; Williams, Neil A.; Virji, Mumtaz] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England	Shandong University; University of Bristol	Williams, NA (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.	neil.a.williams@bristol.ac.uk; quxun@sdu.edu.cn	Xie, Qi/ABC-3042-2020	Xie, Qi/0000-0002-3152-9834	National Natural Science Foundation of China [81072406, 31270971, 31100650]; Independent Innovation Foundation of Shandong University [2012TS143]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University	This work was supported by the National Natural Science Foundation of China (Nos. 81072406, 31270971, 31100650) and the Independent Innovation Foundation of Shandong University (No. 2012TS143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew D, 2000, J IMMUNOL, V165, P6889, DOI 10.4049/jimmunol.165.12.6889; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bogoevska V, 2006, GLYCOBIOLOGY, V16, P197, DOI 10.1093/glycob/cwj057; Botling J, 1995, LEUKEMIA, V9, P2034; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Brubaker RR, 2003, INFECT IMMUN, V71, P3673, DOI 10.1128/IAI.71.7.3673-3681.2003; Conners R, 2008, EMBO J, V27, P1779, DOI 10.1038/emboj.2008.101; Delneste Y, 2003, BLOOD, V101, P143, DOI 10.1182/blood-2002-04-1164; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; Fleischer J, 1996, IMMUNOLOGY, V89, P592, DOI 10.1046/j.1365-2567.1996.d01-785.x; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gerstel D, 2011, ONCOGENE, V30, P4275, DOI 10.1038/onc.2011.146; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Hallstrom T, 2011, J IMMUNOL, V186, P3120, DOI 10.4049/jimmunol.1002621; Han TH, 2009, J IMMUNOTHER, V32, P399, DOI 10.1097/CJI.0b013e31819e1773; Hill DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045452; Hill DJ, 2005, MOL MICROBIOL, V55, P1515, DOI 10.1111/j.1365-2958.2005.04487.x; Hill DJ, 2003, MOL MICROBIOL, V48, P117, DOI 10.1046/j.1365-2958.2003.03433.x; Hill DJ, 2001, MOL MICROBIOL, V39, P850, DOI 10.1046/j.1365-2958.2001.02233.x; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Hoffmann R, 2004, CELL MICROBIOL, V6, P377, DOI 10.1111/j.1462-5822.2004.00365.x; Horst AK, 2009, BLOOD, V113, P6726, DOI 10.1182/blood-2008-10-184556; Huang J, 1999, J CELL SCI, V112, P4193; Kammerer R, 2001, J IMMUNOL, V166, P6537, DOI 10.4049/jimmunol.166.11.6537; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Lobo EO, 2009, J LEUKOCYTE BIOL, V86, P205, DOI 10.1189/jlb.0109037; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; McMichael JC, 2000, VACCINE, V19, pS101, DOI 10.1016/S0264-410X(00)00287-5; Meier PS, 2002, VACCINE, V20, P1754, DOI 10.1016/S0264-410X(02)00030-0; Muller MM, 2009, J CELL BIOL, V187, P569, DOI 10.1083/jcb.200904150; N'Guessan PD, 2007, J INFECT DIS, V195, P1651, DOI 10.1086/514820; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Nouvion AL, 2009, M S-MED SCI, V25, P247, DOI 10.1051/medsci/2009253247; PEACH RJ, 1995, J BIOL CHEM, V270, P21181, DOI 10.1074/jbc.270.36.21181; Rahmoun M, 2009, J INVEST DERMATOL, V129, P671, DOI 10.1038/jid.2008.303; Riesbeck K, 2006, ACTA BIOCHIM POL, V53, P445; Rosseau S, 2005, AM J RESP CELL MOL, V32, P157, DOI 10.1165/rcmb.2004-0091OC; Rutkowski R, 2003, ARCH IMMUNOL THER EX, V51, P421; Skubitz KM, 1996, J LEUKOCYTE BIOL, V60, P106, DOI 10.1002/jlb.60.1.106; STAHL PD, 1992, CURR OPIN IMMUNOL, V4, P49, DOI 10.1016/0952-7915(92)90123-V; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Takashiba S, 1999, INFECT IMMUN, V67, P5573, DOI 10.1128/IAI.67.11.5573-5578.1999; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; van Gisbergen KPJM, 2005, FEBS LETT, V579, P6159, DOI 10.1016/j.febslet.2005.09.089; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; Wang YJ, 2010, J IMMUNOL, V185, P1822, DOI 10.4049/jimmunol.0903398; Youssef AR, 2009, INFECT IMMUN, V77, P5170, DOI 10.1128/IAI.00355-09; Yu QG, 2006, J BIOL CHEM, V281, P39179, DOI 10.1074/jbc.M608864200; Zhou CJ, 2009, ORAL ONCOL, V45, P883, DOI 10.1016/j.oraloncology.2009.03.002	56	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90999	10.1371/journal.pone.0090999	http://dx.doi.org/10.1371/journal.pone.0090999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599281	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400150
J	Zhai, CG; Cheng, J; Mujahid, H; Wang, HF; Kong, J; Yin, Y; Li, JF; Zhang, Y; Ji, XP; Chen, WQ				Zhai, Chungang; Cheng, Jing; Mujahid, Haroon; Wang, Hefeng; Kong, Jing; Yin, Yue; Li, Jifu; Zhang, Yun; Ji, Xiaoping; Chen, Wenqiang			Selective Inhibition of PI3K/Akt/mTOR Signaling Pathway Regulates Autophagy of Macrophage and Vulnerability of Atherosclerotic Plaque	PLOS ONE			English	Article							AKT; SURVIVAL; DOMAIN	Macrophage infiltration contributes to the instability of atherosclerotic plaques. In the present study, we investigated whether selective inhibition of PI3K/Akt/mTOR signaling pathway can enhance the stability of atherosclerotic plaques by activation of macrophage autophagy. In vitro study, selective inhibitors or siRNA of PI3K/Akt/mTOR pathways were used to treat the rabbit's peritoneal primary macrophage cells. Inflammation related cytokines secreted by macrophages were measured. Ultrastructure changes of macrophages were examined by transmission electron microscope. mRNA or protein expression levels of autophagy related gene Beclin 1, protein 1 light chain 3 II dots (LC3-II) or Atg5-Atg12 conjugation were assayed by quantitative RT-PCR or Western blot. In vivo study, vulnerable plaque models were established in 40 New Zealand White rabbits and then drugs or siRNA were given for 8 weeks to inhibit the PI3K/Akt/mTOR signaling pathway. Intravascular ultrasound (IVUS) was performed to observe the plaque imaging. The ultrastructure of the abdominal aortic atherosclerosis lesions were analyzed with histopathology. RT-PCR or Western blot methods were used to measure the expression levels of corresponding autophagy related molecules. We found that macrophage autophagy was induced in the presence of Akt inhibitor, mTOR inhibitor and mTOR-siRNA in vitro study, while PI3K inhibitor had the opposite role. In vivo study, we found that macrophage autophagy increased significantly and the rabbits had lower plaque rupture incidence, lower plaque burden and decreased vulnerability index in the inhibitors or siRNA treated groups. We made a conclusion that selective inhibition of the Akt/mTOR signal pathway can reduce macrophages and stabilize the vulnerable atherosclerotic plaques by promoting macrophage autophagy.	[Ji, Xiaoping] Shandong Univ, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; Shandong Univ, Chinese Minist Hlth, Qilu Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Ji, XP (corresponding author), Shandong Univ, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	jxp64@163.com; chenwenqiang33@sina.com			National Natural Science Foundation of China [30971216, 30871040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30971216, No. 30871040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt N, 2010, CELL DEATH DIFFER, V17, P1795, DOI 10.1038/cdd.2010.63; Chen WQ, 2007, AM J PHYSIOL-HEART C, V293, pH2836, DOI 10.1152/ajpheart.00472.2007; Chen WQ, 2009, BRIT J PHARMACOL, V156, P941, DOI 10.1111/j.1476-5381.2008.00102.x; Colecchia D, 2012, AUTOPHAGY, V8, P1724, DOI 10.4161/auto.21857; Greenberger S, 2011, J INVEST DERMATOL, V131, P2467, DOI 10.1038/jid.2011.300; Guo JP, 2011, J BIOL CHEM, V286, P37389, DOI 10.1074/jbc.M111.287433; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harris J, 2008, J INFECT DIS, V198, P1842, DOI 10.1086/593174; Hopkins PN, 2013, PHYSIOL REV, V93, P1317, DOI 10.1152/physrev.00004.2012; Huda R, 2013, J AUTOIMMUN, V42, P94, DOI 10.1016/j.jaut.2013.01.003; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Kang KH, 2009, TRENDS MOL MED, V15, P191, DOI 10.1016/j.molmed.2009.03.005; Kasiske BL, 2008, AM J TRANSPLANT, V8, P1384, DOI 10.1111/j.1600-6143.2008.02272.x; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li XL, 2013, INFECT IMMUN, V81, P271, DOI 10.1128/IAI.00834-12; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Martelli AM, 2010, BBA-MOL CELL RES, V1803, P991, DOI 10.1016/j.bbamcr.2010.04.005; Martinet W, 2009, CIRC RES, V104, P304, DOI 10.1161/CIRCRESAHA.108.188318; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Meijer Alfred J., 2006, Molecular Aspects of Medicine, V27, P411, DOI 10.1016/j.mam.2006.08.002; O'Garra A, 2009, NAT IMMUNOL, V10, P929, DOI 10.1038/ni0909-929; Park HJ, 2011, MOL IMMUNOL, V48, P720, DOI 10.1016/j.molimm.2010.10.020; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Razani B, 2012, CELL METAB, V15, P534, DOI 10.1016/j.cmet.2012.02.011; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Singh R., 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/282041; Sinnberg T, 2009, J INVEST DERMATOL, V129, P1500, DOI 10.1038/jid.2008.379; Subramaniam S, 2013, J NATL COMPR CANC NE, V11, P5, DOI 10.6004/jnccn.2013.0003; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Verheye S, 2007, J AM COLL CARDIOL, V49, P706, DOI 10.1016/j.jacc.2006.09.047; Williams H, 2002, ARTERIOSCL THROM VAS, V22, P788, DOI 10.1161/01.ATV.0000014587.66321.B4; You Z, 2013, FASEB J, V2; Zhong L, 2008, J CELL MOL MED, V12, P2362, DOI 10.1111/j.1582-4934.2008.00261.x	37	73	86	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90563	10.1371/journal.pone.0090563	http://dx.doi.org/10.1371/journal.pone.0090563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599185	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400093
J	Surma, M; Handy, C; Chang, J; Kapur, R; Wei, L; Shi, JJ				Surma, Michelle; Handy, Caitlin; Chang, Jiang; Kapur, Reuben; Wei, Lei; Shi, Jianjian			ROCK1 Deficiency Enhances Protective Effects of Antioxidants against Apoptosis and Cell Detachment	PLOS ONE			English	Article							RHO-ASSOCIATED KINASE; DOXORUBICIN-INDUCED CARDIOMYOPATHY; BINDING PROTEIN RHO; NADPH OXIDASE; N-ACETYLCYSTEINE; MOLECULAR-MECHANISMS; REACTIVE OXYGEN; CANCER-THERAPY; LIM-KINASE; IN-VIVO	We have recently reported that the homologous Rho kinases, ROCK1 and ROCK2, play different roles in regulating stress-induced stress fiber disassembly and cell detachment, and the ROCK1 deficiency in mouse embryonic fibroblasts (MEF) has remarkable anti-apoptotic, anti-detachment and pro-survival effects against doxorubicin, a chemotherapeutic drug. This study investigated the roles of ROCK isoforms in doxorubicin-induced reactive oxygen species (ROS) generation which is believed to be the major mechanism underlying its cytotoxicity to normal cells, and especially to cardiomyocytes. Different antioxidants have been shown to provide a protective role reported in numerous experimental studies, but clinical trials of antioxidant therapy showed insufficient benefit against the cardiac side effect. We found that both ROCK1(-/-) and ROCK2(-/-) MEFs exhibited reduced ROS production in response to doxorubicin treatment. Interestingly, only ROCK1 deficiency, but not ROCK2 deficiency, significantly enhanced the protective effects of antioxidants against doxorubicin-induced cytotoxicity. First, ROCK1 deficiency and N-acetylcysteine (an anti-oxidant) treatment synergistically reduced ROS levels, caspase activation and cell detachment. In addition, the reduction of ROS generation in ROCK1(-/-) MEFs in response to doxorubicin treatment was in part through inhibiting NADPH oxidase activity. Furthermore, ROCK1 deficiency enhanced the inhibitory effects of diphenyleneiodonium (an inhibitor of NADPH oxidase) on ROS generation and caspase 3 activation induced by doxorubicin. Finally, ROCK1 deficiency had greater protective effects than antioxidant treatment, especially on reducing actin cytoskeleton remodeling. ROCK1 deficiency not only reduced actomyosin contraction but also preserved central stress fiber stability, whereas antioxidant treatment only reduced actomyosin contraction without preserving central stress fibers. These results reveal a novel strategy to enhance the protective effect of antioxidant therapy by targeting the ROCK1 pathway to stabilize the actin cytoskeleton and boost the inhibitory effects on ROS production, apoptosis and cell detachment.	[Surma, Michelle; Handy, Caitlin; Wei, Lei; Shi, Jianjian] Indiana Univ, Sch Med, Riley Heart Res Ctr, Indianapolis, IN 46202 USA; [Surma, Michelle; Handy, Caitlin; Kapur, Reuben; Wei, Lei; Shi, Jianjian] Indiana Univ, Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Chang, Jiang] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Wei, L (corresponding author), Indiana Univ, Sch Med, Riley Heart Res Ctr, Indianapolis, IN 46202 USA.	lewei@iupui.edu; jishi@iupui.edu		Chang, Jiang/0000-0003-3707-7557	National Institutes of Health [HL107537]; American Heart Association, Midwest Affiliate [12GRNT12060525]; Riley Children's Foundation; NATIONAL CANCER INSTITUTE [R01CA173852] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077177, R01HL123953, R01HL107537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, Midwest Affiliate(American Heart Association); Riley Children's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants (HL107537), a Grant-in-Aid award from American Heart Association, Midwest Affiliate (12GRNT12060525), and by the Riley Children's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2007, J BIOL CHEM, V282, P35373, DOI 10.1074/jbc.M702175200; Aghajanian A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008045; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Brandes RP, 2005, CARDIOVASC RES, V65, P16, DOI 10.1016/j.cardiores.2004.08.007; Chang J, 2006, P NATL ACAD SCI USA, V103, P14495, DOI 10.1073/pnas.0601911103; Childs AC, 2002, CANCER RES, V62, P4592; COLOMBO R, 1990, CANCER BIOCHEM BIOPH, V11, P217; Deng SW, 2007, FREE RADICAL BIO MED, V42, P466, DOI 10.1016/j.freeradbiomed.2006.11.013; DOROSHOW JH, 1986, J BIOL CHEM, V261, P3068; DOROSHOW JH, 1981, J CLIN INVEST, V68, P1053, DOI 10.1172/JCI110328; Feng ZQ, 2010, COLLOID SURFACE B, V75, P67, DOI 10.1016/j.colsurfb.2009.08.010; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Hahmann C, 2010, CELL MOL LIFE SCI, V67, P171, DOI 10.1007/s00018-009-0189-x; Higashi M, 2003, CIRC RES, V93, P767, DOI 10.1161/01.RES.0000096650.91688.28; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kotamraju S, 2000, J BIOL CHEM, V275, P33585, DOI 10.1074/jbc.M003890200; Lemarie A, 2008, J IMMUNOL, V180, P6010, DOI 10.4049/jimmunol.180.9.6010; Leung T, 1996, MOL CELL BIOL, V16, P5313; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mali RS, 2011, CANCER CELL, V20, P357, DOI 10.1016/j.ccr.2011.07.016; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Millea PJ, 2009, AM FAM PHYSICIAN, V80, P265; Moon C, 2010, AM J RESP CRIT CARE, V181, P374, DOI 10.1164/rccm.200907-1061OC; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nisimoto Y, 1997, J BIOL CHEM, V272, P18834, DOI 10.1074/jbc.272.30.18834; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; RAJAGOPALAN S, 1988, CANCER RES, V48, P4766; Rath N, 2012, EMBO REP, V13, P900, DOI 10.1038/embor.2012.127; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Sawyer DB, 2010, PROG CARDIOVASC DIS, V53, P105, DOI 10.1016/j.pcad.2010.06.007; Shi JJ, 2013, J CARDIOVASC PHARM, V62, P341, DOI 10.1097/FJC.0b013e3182a3718f; Shi JJ, 2013, CELL CYCLE, V12, P1492, DOI 10.4161/cc.24699; Shi JJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.10; Shi J, 2011, CURR PEDIATR REV, V7, P329, DOI 10.2174/157339611796892265; Shi JJ, 2012, AM J PHYSIOL-HEART C, V302, pH1603, DOI 10.1152/ajpheart.00844.2011; Shi JJ, 2010, J MOL CELL CARDIOL, V49, P819, DOI 10.1016/j.yjmcc.2010.08.008; Shiotani S, 2007, GENE THER, V14, P1425, DOI 10.1038/sj.gt.3303000; Simunek T, 2009, PHARMACOL REP, V61, P154; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Surma M, 2011, FUTUR CARDIOL, V7, P657, DOI [10.2217/fca.11.51, 10.2217/FCA.11.51]; Tacar O, 2013, J PHARM PHARMACOL, V65, P157, DOI 10.1111/j.2042-7158.2012.01567.x; van Dalen EC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003917.pub4; Wang N, 2011, FOOD CHEM TOXICOL, V49, P2975, DOI 10.1016/j.fct.2011.06.080; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050; Zhang YW, 2009, ARCH IMMUNOL THER EX, V57, P435, DOI 10.1007/s00005-009-0051-8; Zhang YM, 2006, FASEB J, V20, P916, DOI 10.1096/fj.05-5129com; Zhao YY, 2010, CANCER RES, V70, P9287, DOI 10.1158/0008-5472.CAN-10-2664	51	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90758	10.1371/journal.pone.0090758	http://dx.doi.org/10.1371/journal.pone.0090758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595357	gold, Green Published, Green Submitted			2022-12-25	WOS:000332475500098
J	Venkatesh, GH; Manjunath, VB; Mumbrekar, KD; Negi, H; Fernandes, DJ; Sharan, K; Banerjee, S; Sadashiva, SRB				Venkatesh, Goutham Hassan; Manjunath, Vadhiraja Bejadi; Mumbrekar, Kamalesh Dattaram; Negi, Hitendra; Fernandes, Donald Jerard; Sharan, Krishna; Banerjee, Sourjya; Sadashiva, Satish Rao Bola			Polymorphisms in Radio-Responsive Genes and Its Association with Acute Toxicity among Head and Neck Cancer Patients	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; NORMAL TISSUE-REACTIONS; DNA-REPAIR GENES; BREAST-CANCER; RADIATION-THERAPY; CELLULAR RADIOSENSITIVITY; IONIZING-RADIATION; PROSTATE-CANCER; LUNG-CANCER; RADIOTHERAPY	Cellular and molecular approaches are being explored to find a biomarker which can predict the development of radiation induced acute toxicity prior to radiation therapy. SNPs in radiation responsive genes may be considered as an approach to develop tools for finding the inherited basis of clinical radiosensitivity. The current study attempts to screen single nucleotide polymorphisms/deletions in DNA damage response, DNA repair, profibrotic cytokine as well as antioxidant response genes and its predictive potential with the normal tissue adverse reactions from 183 head and neck cancer patients undergoing platinum based chemoradiotherapy or radiotherapy alone. We analysed 22 polymorphisms in 17 genes having functional relevance to radiation response. Radiation therapy induced oral mucositis and skin erythema was considered as end point for clinical radiosensitivity. Direct correlation of heterozygous and mutant alleles with acute reactions as well as haplotype correlation revealed NBN variants to be of predictive significance in analysing oral mucositis prior to radiotherapy. In addition, genetic linkage disequilibrium existed in XRCC1 polymorphisms for >grade 2 oral mucositis and skin reaction indicating the complex inheritance pattern. The current study indicates an association for polymorphism in NBN with normal tissue radiosensitivity and further warrants the replication of such studies in a large set of samples.	[Venkatesh, Goutham Hassan; Mumbrekar, Kamalesh Dattaram; Sadashiva, Satish Rao Bola] Manipal Univ, Sch Life Sci, Div Radiobiol & Toxicol, Manipal, Karnataka, India; [Negi, Hitendra] Manipal Univ, Sch Life Sci, Div Biotechnol, Manipal, Karnataka, India; [Manjunath, Vadhiraja Bejadi] Manipal Hosp, Bangalore, Karnataka, India; [Banerjee, Sourjya] Kasturba Med Coll & Hosp, Dept Radiotherapy & Oncol, Mangalore, Karnataka, India; [Fernandes, Donald Jerard; Sharan, Krishna] Kasturba Med Coll & Hosp, Shiridi SaiBaba Canc Hosp & Res Ctr, Dept Radiotherapy & Oncol, Manipal, Karnataka, India	Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal	Sadashiva, SRB (corresponding author), Manipal Univ, Sch Life Sci, Div Radiobiol & Toxicol, Manipal, Karnataka, India.	satishraomlsc@gmail.com	MUMBREKAR, KAMALESH/H-3388-2015; MUMBREKAR, KAMALESH/AAD-5791-2019	MUMBREKAR, KAMALESH/0000-0003-1888-6252; MUMBREKAR, KAMALESH/0000-0003-1888-6252; Hassan Venkatesh, Goutham/0000-0002-6520-435X; Banerjee, Sourjya/0000-0003-4710-2701; Rao Bola Sadashiva, Satish/0000-0002-9631-9731	Department of Biotechnology, Government of India [BT/01/COE/06/02/07]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Funded by Department of Biotechnology, Government of India, grant number BT/01/COE/06/02/07 (http://dbtindia.nic.in/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosone CB, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1526; Andreassen CN, 2012, RADIOTHER ONCOL, V105, P283, DOI 10.1016/j.radonc.2012.11.003; Andreassen CN, 2009, RADIOTHER ONCOL, V92, P299, DOI 10.1016/j.radonc.2009.06.015; Barnett GC, 2012, LANCET ONCOL, V13, P65, DOI 10.1016/S1470-2045(11)70302-3; Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Chang-Claude J, 2009, BRIT J CANCER, V100, P1680, DOI 10.1038/sj.bjc.6605036; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; Damaraju S, 2006, CLIN CANCER RES, V12, P2545, DOI 10.1158/1078-0432.CCR-05-2703; Giotopoulos G, 2007, BRIT J CANCER, V96, P1001, DOI 10.1038/sj.bjc.6603637; Goutham HV, 2012, INT J RADIAT ONCOL, V84, pE607, DOI 10.1016/j.ijrobp.2012.06.041; Ishikawa A, 2011, INT J RADIAT ONCOL, V81, P1144, DOI 10.1016/j.ijrobp.2010.09.012; Isomura M, 2008, CLIN CANCER RES, V14, P6683, DOI 10.1158/1078-0432.CCR-07-4389; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Guerra JLL, 2012, RADIOTHER ONCOL, V105, P299, DOI 10.1016/j.radonc.2012.08.014; Millikan RC, 2005, CANCER EPIDEM BIOMAR, V14, P2326, DOI 10.1158/1055-9965.EPI-05-0186; Parliament MB, 2010, SEMIN RADIAT ONCOL, V20, P232, DOI 10.1016/j.semradonc.2010.05.003; Popanda O, 2006, CANCER EPIDEM BIOMAR, V15, P1048, DOI 10.1158/1055-9965.EPI-06-0046; Popanda O, 2009, MUTAT RES-FUND MOL M, V667, P58, DOI 10.1016/j.mrfmmm.2008.10.014; Pratesi N, 2011, RADIOTHER ONCOL, V99, P356, DOI 10.1016/j.radonc.2011.05.062; Reuther S, 2013, INT J RADIAT ONCOL, V85, P460, DOI 10.1016/j.ijrobp.2012.01.090; Safwat A, 2002, INT J RADIAT ONCOL, V52, P198, DOI 10.1016/S0360-3016(01)02690-6; Schirmer MA, 2011, INT J RADIAT ONCOL, V79, P866, DOI 10.1016/j.ijrobp.2010.08.040; Silva J, 2012, DNA CELL BIOL, V31, P1182, DOI 10.1089/dna.2011.1562; Suga T, 2007, INT J RADIAT ONCOL, V69, P685, DOI 10.1016/j.ijrobp.2007.06.021; Trotti A, 2000, INT J RADIAT ONCOL, V47, P1, DOI 10.1016/S0360-3016(99)00558-1; Voets AM, 2012, RADIOTHER ONCOL, V105, P296, DOI 10.1016/j.radonc.2012.09.016; Werbrouck J, 2009, INT J RADIAT ONCOL, V73, P1187, DOI 10.1016/j.ijrobp.2008.08.073; West CM, 2012, GENOME MED, V3, pe52; Zackrisson B, 2003, ACTA ONCOL, V42, P443, DOI 10.1080/02841860310014886; Zschenker O, 2010, RADIOTHER ONCOL, V97, P26, DOI 10.1016/j.radonc.2010.01.016	31	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89079	10.1371/journal.pone.0089079	http://dx.doi.org/10.1371/journal.pone.0089079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594932	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500009
J	Zweytick, D; Japelj, B; Mileykovskaya, E; Zorko, M; Dowhan, W; Blondelle, SE; Riedl, S; Jerala, R; Lohner, K				Zweytick, Dagmar; Japelj, Bostjan; Mileykovskaya, Eugenia; Zorko, Mateja; Dowhan, William; Blondelle, Sylvie E.; Riedl, Sabrina; Jerala, Roman; Lohner, Karl			N-acylated Peptides Derived from Human Lactoferricin Perturb Organization of Cardiolipin and Phosphatidylethanolamine in Cell Membranes and Induce Defects in Escherichia coli Cell Division	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; ANTIMICROBIAL PEPTIDES; OUTER-MEMBRANE; PHOSPHOLIPID-COMPOSITION; BOVINE LACTOFERRICIN; AQUEOUS-SOLUTION; ACTIVE PEPTIDES; ACRIDINE-ORANGE; ANTIBIOTICS	Two types of recently described antibacterial peptides derived from human lactoferricin, either nonacylated or N-acylated, were studied for their different interaction with membranes of Escherichia coli in vivo and in model systems. Electron microscopy revealed striking effects on the bacterial membrane as both peptide types induced formation of large membrane blebs. Electron and fluorescence microscopy, however demonstrated that only the N-acylated peptides partially induced the generation of oversized cells, which might reflect defects in cell-division. Further a different distribution of cardiolipin domains on the E. coli membrane was shown only in the presence of the N-acylated peptides. The lipid was distributed over the whole bacterial cell surface, whereas cardiolipin in untreated and nonacylated peptide-treated cells was mainly located at the septum and poles. Studies with bacterial membrane mimics, such as cardiolipin or phosphatidylethanolamine revealed that both types of peptides interacted with the negatively charged lipid cardiolipin. The nonacylated peptides however induced segregation of cardiolipin into peptide-enriched and peptide-poor lipid domains, while the N-acylated peptides promoted formation of many small heterogeneous domains. Only N-acylated peptides caused additional severe effects on the main phase transition of liposomes composed of pure phosphatidylethanolamine, while both peptide types inhibited the lamellar to hexagonal phase transition. Lipid mixtures of phosphatidylethanolamine and cardiolipin revealed anionic clustering by all peptide types. However additional strong perturbation of the neutral lipids was only seen with the N-acylated peptides. Nuclear magnetic resonance demonstrated different conformational arrangement of the N-acylated peptide in anionic and zwitterionic micelles revealing possible mechanistic differences in their action on different membrane lipids. We hypothesized that both peptides kill bacteria by interacting with bacterial membrane lipids but only N-acylated peptides interact with both charged cardiolipin and zwitterionic phosphatidylethanolamine resulting in remodeling of the natural phospholipid domains in the E. coli membrane that leads to defects in cell division.	[Zweytick, Dagmar; Riedl, Sabrina; Lohner, Karl] Graz Univ, Div Biophys, Inst Mol Biosci, Graz, Austria; [Japelj, Bostjan; Zorko, Mateja; Jerala, Roman] Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia; [Mileykovskaya, Eugenia; Dowhan, William] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX USA; [Blondelle, Sylvie E.] Torrey Pines Inst Mol Studies, Dept Biochem, San Diego, CA USA; [Jerala, Roman] Ctr Excellence EN FIST, Ljubljana, Slovenia	University of Graz; National Institute of Chemistry - Slovenia; University of Texas System; University of Texas Health Science Center Houston; Torrey Pines Institute for Molecular Studies, California	Zweytick, D (corresponding author), Graz Univ, Div Biophys, Inst Mol Biosci, Graz, Austria.	dagmar.zweytick@uni-graz.at	; Jerala, Roman/H-9850-2015	Mileykovskaya, Eugenia/0000-0002-8775-4467; Zweytick, Dagmar/0000-0002-4766-7713; Jerala, Roman/0000-0002-6337-5251	EC-specific RTD Program [QLK2-CT-2002-01001]; Slovenian Research Agency; European structural funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478, R01GM020478] Funding Source: NIH RePORTER	EC-specific RTD Program; Slovenian Research Agency(Slovenian Research Agency - Slovenia); European structural funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was mainly supported by the EC-specific RTD Program Grant QLK2-CT-2002-01001. RJ, BJ and MZ were supported by the program and projects from the Slovenian Research Agency and in part by the European structural funds to the Centre of Excellence EN-FIST. The funders had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Blondelle SE, 2004, PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, P877; Brunecky R, 2005, BIOCHEMISTRY-US, V44, P16064, DOI 10.1021/bi051127+; COSTERTON JW, 1974, BACTERIOL REV, V38, P87, DOI 10.1128/MMBR.38.1.87-110.1974; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; DEVOE IW, 1973, J EXP MED, V138, P1156, DOI 10.1084/jem.138.5.1156; Epand RM, 2011, J PEPT SCI, V17, P298, DOI 10.1002/psc.1319; Epand RM, 2010, BBA-BIOMEMBRANES, V1798, P1272, DOI 10.1016/j.bbamem.2010.03.012; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Hancock REW, 1997, TRENDS MICROBIOL, V5, P37, DOI 10.1016/S0966-842X(97)81773-8; Haukland HH, 2001, FEBS LETT, V508, P389, DOI 10.1016/S0014-5793(01)03100-3; HAWROT E, 1978, J BIOL CHEM, V253, P8213; HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007; Hickel A, 2008, BBA-BIOMEMBRANES, V1778, P2325, DOI 10.1016/j.bbamem.2008.05.014; HOEKSTRA D, 1976, BIOCHIM BIOPHYS ACTA, V455, P889, DOI 10.1016/0005-2736(76)90058-4; Hunter HN, 2005, ANTIMICROB AGENTS CH, V49, P3387, DOI 10.1128/AAC.49.8.3387-3395.2005; Kadurugamuwa JL, 1997, J ANTIMICROB CHEMOTH, V40, P615, DOI 10.1093/jac/40.5.615; KATSUI N, 1982, J BACTERIOL, V151, P1523, DOI 10.1128/JB.151.3.1523-1531.1982; KNOX KW, 1966, J BACTERIOL, V92, P1206, DOI 10.1128/JB.92.4.1206-1217.1966; Koppelman CM, 2004, MOL MICROBIOL, V51, P645, DOI 10.1046/j.1365-2958.2003.03876.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lewis RNAH, 2007, BIOPHYS J, V92, P3166, DOI 10.1529/biophysj.106.094003; LIPPENS G, 1995, J BIOMOL NMR, V5, P327, DOI 10.1007/BF00211762; Lohner K, 2005, COMB CHEM HIGH T SCR, V8, P241, DOI 10.2174/1386207053764576; Lohner K, 2009, GEN PHYSIOL BIOPHYS, V28, P105, DOI 10.4149/gpb_2009_02_105; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; MACKERELL AD, 1995, J PHYS CHEM-US, V99, P1846, DOI 10.1021/j100007a011; Matsuzaki K, 1996, BIOCHEMISTRY-US, V35, P11361, DOI 10.1021/bi960016v; MAYRAND D, 1989, CAN J MICROBIOL, V35, P607, DOI 10.1139/m89-097; Mileykovskaya E, 2005, CURR OPIN MICROBIOL, V8, P135, DOI 10.1016/j.mib.2005.02.012; Mileykovskaya E, 1998, J BACTERIOL, V180, P4252, DOI 10.1128/JB.180.16.4252-4257.1998; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Mileykovskaya E., 2012, ESCHERICHIA COLI BAC, P149; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Nguyen LT, 2005, J PEPT SCI, V11, P379, DOI 10.1002/psc.629; NORRIS V, 1992, J THEOR BIOL, V154, P91, DOI 10.1016/S0022-5193(05)80190-0; PETIT JM, 1992, EUR J BIOCHEM, V209, P267, DOI 10.1111/j.1432-1033.1992.tb17285.x; Pristovsek P, 2002, J COMPUT CHEM, V23, P335, DOI 10.1002/jcc.10011; Prossnigg F, 2010, BIOPHYS CHEM, V150, P129, DOI 10.1016/j.bpc.2010.04.004; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; RIETVELD AG, 1993, J BIOL CHEM, V268, P12427; Schibli DJ, 1999, FEBS LETT, V446, P213, DOI 10.1016/S0014-5793(99)00214-8; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Shai Y, 2001, PEPTIDES, V22, P1629, DOI 10.1016/S0196-9781(01)00498-3; Smallcombe SH, 1995, J MAGN RESON SER A, V117, P295, DOI 10.1006/jmra.1995.0759; SOMEYA A, 1979, ANTIMICROB AGENTS CH, V16, P87, DOI 10.1128/AAC.16.1.87; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Tieleman DP, 2000, J PHYS CHEM B, V104, P6380, DOI 10.1021/jp001268f; Ulvatne H, 2004, FEMS MICROBIOL LETT, V237, P377, DOI 10.1016/j.femsle.2004.07.001; Vogel HJ, 2002, BIOCHEM CELL BIOL, V80, P49, DOI 10.1139/o01-213; Wadhwani P, 2012, BIOPHYS J, V103, P265, DOI 10.1016/j.bpj.2012.06.004; Wilkinson S.G., 1988, MICROBIAL LIPIDS, V1, P299; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0; Zorko M, 2009, BBA-BIOMEMBRANES, V1788, P314, DOI 10.1016/j.bbamem.2008.10.015; Zweytick D, 2006, BBA-BIOMEMBRANES, V1758, P1426, DOI 10.1016/j.bbamem.2006.02.032; Zweytick D, 2011, J BIOL CHEM, V286, P21266, DOI 10.1074/jbc.M110.195412	62	31	31	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90228	10.1371/journal.pone.0090228	http://dx.doi.org/10.1371/journal.pone.0090228			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595074	gold, Green Published, Green Submitted			2022-12-25	WOS:000332468900084
J	Benesch, MGK; Tang, XY; Maeda, T; Ohhata, A; Zhao, YY; Kok, BPC; Dewald, J; Hitt, M; Curtis, JM; McMullen, TPW; Brindley, DN				Benesch, Matthew G. K.; Tang, Xiaoyun; Maeda, Tatsuo; Ohhata, Akira; Zhao, Yuan Y.; Kok, Bernard P. C.; Dewald, Jay; Hitt, Mary; Curtis, Jonathan M.; McMullen, Todd P. W.; Brindley, David N.			Inhibition of autotaxin delays breast tumor growth and lung metastasis in mice	FASEB JOURNAL			English	Article						adipose tissue; lysophosphatidate; sphingosine 1-phosphate; syngeneic mouse model	LYSOPHOSPHATIDIC ACID; SERUM AUTOTAXIN; SPHINGOSINE 1-PHOSPHATE; LYSOPHOSPHOLIPASE-D; PHOSPHOLIPASE A(2); CANCER; EXPRESSION; MIGRATION; CHEMOTHERAPY; RESISTANCE	Autotaxin is a secreted enzyme that produces most extracellular lysophosphatidate, which stimulates 6 G-protein-coupled receptors. Lysophosphatidate promotes cancer cell survival, growth, migration, invasion, metastasis, and resistance to chemotherapy and radiotherapy. The present work investigated whether inhibiting autotaxin could decrease breast tumor growth and metastasis. We used a new autotaxin inhibitor (ONO-8430506; IC90=100 nM), which decreased plasma autotaxin activity by >60% and concentrations of unsaturated lysophosphatidates by >75% for 24 h compared with vehicle-treated mice. The effects of ONO-8430506 on tumor growth were determined in a syngeneic orthotopic mouse model of breast cancer following injection of 20,000 BALB/c mouse 4T1 or 4T1-12B cancer cells. We show for the first time that inhibiting autotaxin decreases initial tumor growth and subsequent lung metastatic nodules both by 60% compared with vehicle-treated mice. Significantly, 4T1 cells express negligible autotaxin compared with the mammary fat pad. Autotaxin activity in the fat pad of nontreated mice was increased 2-fold by tumor growth. Our results emphasize the importance of tumor interaction with its environment and the role of autotaxin in promoting breast cancer growth and metastasis. We also established that autotaxin inhibition could provide a novel therapeutic approach to blocking the adverse effects of lysophosphatidate in cancer.	[Benesch, Matthew G. K.; Tang, Xiaoyun; Kok, Bernard P. C.; Dewald, Jay; Brindley, David N.] Univ Alberta, Dept Biochem, Signal Transduct Res Grp, Edmonton, AB, Canada; [Zhao, Yuan Y.; Curtis, Jonathan M.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Hitt, Mary] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [McMullen, Todd P. W.] Univ Alberta, Mackenzie Hlth Sci Ctr, Dept Surg, Edmonton, AB, Canada; [Maeda, Tatsuo] Ono Pharmaceut Co, Explorat Res Labs, Tsukuba, Ibaraki, Japan; [Ohhata, Akira] Ono Pharmaceut Co, Med Chem Res Labs, Shimamoto, Osaka, Japan	University of Alberta; University of Alberta; University of Alberta; University of Alberta; Ono Pharmaceutical Co Ltd; Ono Pharmaceutical Co Ltd	Brindley, DN (corresponding author), Univ Alberta, Dept Biochem, Med Res Ctr, 357 Heritage, Edmonton, AB T6G 2S2, Canada.	david.brindley@ualberta.ca	Benesch, Matthew/GRF-0677-2022	Kok, Bernard/0000-0002-9073-9700; Benesch, Matthew/0000-0002-1326-684X	Vanier Canada Graduate Scholarship from the Government of Canada; Canadian Institutes of Health Research (CIHR); Alberta Innovates-Health Solutions; Killam Trust Award; Canadian Breast Cancer Foundation (CBCF); CBCF; CIHR; Alberta Cancer Foundation; Ono Pharmaceuticals	Vanier Canada Graduate Scholarship from the Government of Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Killam Trust Award; Canadian Breast Cancer Foundation (CBCF); CBCF; CIHR(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation; Ono Pharmaceuticals	The authors thank Dr. Tetsuya Sugiyama (Ono Pharmaceuticals) for many helpful discussions and facilitating collaborations. ONO-8430506 and ONO-8410506 were provided by Ono Pharmaceuticals. M.G.K.B. is the recipient of a Vanier Canada Graduate Scholarship from the Government of Canada, a Canadian Institutes of Health Research (CIHR) MD/Ph.D. Studentship, a MD/Ph.D. Studentship from Alberta Innovates-Health Solutions, and a Killam Trust Award. X.T. holds a research fellowship from the Canadian Breast Cancer Foundation (CBCF). The work was also supported by grants from the CBCF, CIHR with the Alberta Cancer Foundation, and Ono Pharmaceuticals. The authors declare the following conflicts of interest: D.N.B. received consultancy payments in 2011 from Ono Pharmaceuticals and a 2 yr research grant in 2012, which partly financed this work. T.M. and A.O. are employees of Ono Pharmaceuticals, and A.O. holds a patent on the presented ATX inhibitor. T.M. and A.O. measured ONO-8430506 concentrations in mouse plasma as illustrated in Fig. 1C. The other authors declare no conflicts of interest.	Albers HMHG, 2012, CHEM REV, V112, P2593, DOI 10.1021/cr2003213; Barbayianni E, 2013, EXPERT OPIN THER PAT, V23, P1123, DOI 10.1517/13543776.2013.796364; Bekele RT, 2012, CLIN LIPIDOL, V7, P313, DOI 10.2217/CLP.12.30; Benesch MGK, 2014, FEBS LETT, V588, P2712, DOI 10.1016/j.febslet.2014.02.009; Boucher J, 2005, DIABETOLOGIA, V48, P569, DOI 10.1007/s00125-004-1660-8; Brindley DN, 2013, BBA-MOL CELL BIOL L, V1831, P74, DOI 10.1016/j.bbalip.2012.08.015; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; Camerer E, 2009, J CLIN INVEST, V119, P1871, DOI 10.1172/JCI38575; Choi JW, 2013, BBA-MOL CELL BIOL L, V1831, P20, DOI 10.1016/j.bbalip.2012.07.015; Clair T, 2003, CANCER RES, V63, P5446; David M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009741; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; Deng W, 2007, GASTROENTEROLOGY, V132, P1834, DOI 10.1053/j.gastro.2007.03.038; Dusaulcy R, 2011, J LIPID RES, V52, P1247, DOI 10.1194/jlr.M014985; English D, 2001, CARDIOVASC RES, V49, P588, DOI 10.1016/S0008-6363(00)00230-3; Euer N, 2002, ANTICANCER RES, V22, P733; Federico L, 2012, MOL ENDOCRINOL, V26, P786, DOI 10.1210/me.2011-1229; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; Fulkerson Z, 2011, J BIOL CHEM, V286, P34654, DOI 10.1074/jbc.M111.276725; Gaetano CG, 2009, MOL CARCINOGEN, V48, P801, DOI 10.1002/mc.20524; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Houben AJS, 2013, J BIOL CHEM, V288, P510, DOI 10.1074/jbc.M112.358416; Hozumi H, 2013, LAB INVEST, V93, P508, DOI 10.1038/labinvest.2013.45; IMAMURA S, 1978, J BIOCHEM-TOKYO, V83, P677, DOI 10.1093/oxfordjournals.jbchem.a131960; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jeon YH, 2007, CANCER BIOL THER, V6, P781, DOI 10.4161/cbt.6.5.4005; Kehlen A, 2004, INT J CANCER, V109, P833, DOI 10.1002/ijc.20022; Koike S, 2009, J BIOL CHEM, V284, P33561, DOI 10.1074/jbc.M109.012716; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li H, 2010, FASEB J, V24, P4103, DOI 10.1096/fj.10-161356; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Masuda A, 2008, BRIT J HAEMATOL, V143, P60, DOI 10.1111/j.1365-2141.2008.07325.x; Morimoto T., 2012, World Patent, Patent No. [WO2012005227 A1, 2012005227]; MURATA J, 1994, J BIOL CHEM, V269, P30479; Murph MM, 2007, MOL CANCER RES, V5, P1201, DOI 10.1158/1541-7786.MCR-06-0338; Nakai Y, 2011, CLIN BIOCHEM, V44, P576, DOI 10.1016/j.clinbiochem.2011.03.128; Nakamura K, 2007, CLIN BIOCHEM, V40, P274, DOI 10.1016/j.clinbiochem.2006.10.009; Nakamura K, 2012, LIPIDS, V47, P927, DOI 10.1007/s11745-012-3691-0; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Nam SW, 2001, CANCER RES, V61, P6938; Nikitopoulou I, 2012, J EXP MED, V209, P923, DOI 10.1084/jem.20112012; Paridaens R, 2000, J CLIN ONCOL, V18, P724, DOI 10.1200/JCO.2000.18.4.724; Popnikolov NK, 2012, TUMOR BIOL, V33, P2237, DOI 10.1007/s13277-012-0485-1; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Samadi N, 2009, ONCOGENE, V28, P1028, DOI 10.1038/onc.2008.442; Samadi N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020608; Samadi N, 2011, BIOCHIMIE, V93, P61, DOI 10.1016/j.biochi.2010.08.002; Scherer M, 2010, J LIPID RES, V51, P2001, DOI 10.1194/jlr.D005322; Scherer M, 2009, CLIN CHEM, V55, P1218, DOI 10.1373/clinchem.2008.113779; Shida D, 2008, CURR DRUG TARGETS, V9, P662, DOI 10.2174/138945008785132402; So J, 2005, GYNECOL ONCOL, V97, P870, DOI 10.1016/j.ygyno.2005.03.004; Sukocheva OA, 2003, MOL ENDOCRINOL, V17, P2002, DOI 10.1210/me.2003-0119; Sukocheva O, 2009, ENDOCRINOLOGY, V150, P4484, DOI 10.1210/en.2009-0391; Sundaram Sneha, 2013, J Carcinog, V12, P19, DOI 10.4103/1477-3163.119606; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Vidot S, 2010, CELL SIGNAL, V22, P926, DOI 10.1016/j.cellsig.2010.01.017; Yang SY, 2002, CLIN EXP METASTAS, V19, P603, DOI 10.1023/A:1020950420196; Zhang RH, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-11	63	80	81	2	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2655	2666		10.1096/fj.13-248641	http://dx.doi.org/10.1096/fj.13-248641			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24599971				2022-12-25	WOS:000339883600023
J	Imamura, Y; Tomita, S; Imanishi, M; Kihira, Y; Ikeda, Y; Ishizawa, K; Tsuchiya, K; Tamaki, T				Imamura, Yuko; Tomita, Shuhei; Imanishi, Masaki; Kihira, Yoshitaka; Ikeda, Yasumasa; Ishizawa, Keisuke; Tsuchiya, Koichiro; Tamaki, Toshiaki			HIF-2 alpha/ARNT complex regulates hair development via induction of p21(Waf1/Cip1) and p27(Kip1)	FASEB JOURNAL			English	Article						hypoxia-inducible factor; cyclin-dependent kinase inhibitor; cell differentiation	INDUCIBLE FACTOR 1-ALPHA; SKIN DEVELOPMENT; BARRIER FUNCTION; DERMAL PAPILLA; STEM-CELLS; HYPOXIA; GENE; P53; HIF-1-ALPHA; EXPRESSION	The hypoxia-inducible factors HIF-1 alpha or HIF-2 alpha form heterodimeric complexes with the aryl hydrocarbon receptor nuclear translocator (ARNT). HIF-1 alpha/ARNT and HIF-2 alpha/ARNT complexes activate hypoxia-inducible genes that play critical roles in angiogenesis, anaerobic metabolism, and other processes in response to O-2 deprivation. HIF-2 alpha is known to regulate the function and/or differentiation of stem cells by activating the POU domain transcription factor Oct4; however, the precise underlying mechanism is unknown. This study examined the role of HIF-2 alpha/ARNT in hair development using conditional-knockout mice, in which Arnt was specifically deleted in keratinocytes. In wild-type mice, HIF-2 alpha and ARNT were highly expressed in the precortex above the hair matrix, an area containing differentiating stem cells. An analysis of hair size and type in these mice showed that loss of ARNT decreased the production of zigzag hairs, corresponding to reduced expression of HIF-2 alpha and induction of the mammalian cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1). The results suggest that the HIF-2 alpha/ARNT complex regulates hair follicle differentiation via induction of p21(Waf1/Cip1) and possibly p27(Kip1), as p27(Kip1) expression was not altered in ARNT knockout mice. The findings provide insight into a possible mechanism underlying hair growth disorders and can be useful for future studies on hair follicle response to insults, such as chemotherapy and ionizing radiation.	[Imamura, Yuko; Imanishi, Masaki; Kihira, Yoshitaka; Ikeda, Yasumasa; Tamaki, Toshiaki] Univ Tokushima, Grad Sch, Dept Pharmacol, Tokushima 770, Japan; [Ishizawa, Keisuke; Tsuchiya, Koichiro] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Med Pharmacol, Tokushima 770, Japan; [Imamura, Yuko] Hiroshima Univ, Grad Sch Adv Sci, Dept Mol Biotechnol, Higashihiroshima, Hiroshima 7398530, Japan; [Tomita, Shuhei] Tottori Univ, Fac Med, Div Mol Pharmacol, Yonago, Tottori 683, Japan	Tokushima University; Tokushima University; Hiroshima University; Tottori University	Imamura, Y (corresponding author), Hiroshima Univ, Grad Sch Adv Sci, Dept Mol Biotechnol, 1-3-1 Kagamiyama, Higashihiroshima, Hiroshima 7398530, Japan.	yukoima@hiroshima-u.ac.jp		Imanishi, Masaki/0000-0003-1305-5943; Ikeda, Yasumasa/0000-0003-4318-7349	Japan Society for the Promotion of Science (JSPS) for Young Scientists [21-10290]; Excellent Young Researcher Overseas Visit Program from JSPS; Grants-in-Aid for Scientific Research [25860063, 24590381] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Excellent Young Researcher Overseas Visit Program from JSPS; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a research fellowship from the Japan Society for the Promotion of Science (JSPS) for Young Scientists (21-10290) and the Excellent Young Researcher Overseas Visit Program from JSPS. The authors thank Nazumi Ishimaru and Yoshio Hayashi (Tokushima University) for providing instruments for the histological analysis, as well as David J. Mann (Imperial College London, London, UK) for his support.	Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elliott K, 1999, J INVEST DERMATOL, V113, P873, DOI 10.1046/j.1523-1747.1999.00797.x; Fels DR, 2005, TRENDS BIOCHEM SCI, V30, P426, DOI 10.1016/j.tibs.2005.06.009; Fuchs E, 2001, DEV CELL, V1, P13, DOI 10.1016/S1534-5807(01)00022-3; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; GALBRAITH DB, 1969, NATURE, V222, P288, DOI 10.1038/222288a0; Geng SM, 2006, J CELL SCI, V119, P4901, DOI 10.1242/jcs.03282; Grochot-Przeczek A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005803; Hansson LO, 2002, P NATL ACAD SCI USA, V99, P10305, DOI 10.1073/pnas.122347199; HARPER JW, 1993, CELL, V75, P805; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Ishizawa K, 2005, HYPERTENSION, V46, P1046, DOI 10.1161/01.HYP.0000172622.51973.f5; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kihira Y, 2011, INT J BIOCHEM CELL B, V43, P1602, DOI 10.1016/j.biocel.2011.07.009; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Ohtani N, 2007, P NATL ACAD SCI USA, V104, P15034, DOI 10.1073/pnas.0706949104; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rohwer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012038; Rosenberger C, 2007, J INVEST DERMATOL, V127, P2445, DOI 10.1038/sj.jid.5700874; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Sharov AA, 2006, P NATL ACAD SCI USA, V103, P18166, DOI 10.1073/pnas.0608899103; Takagi S, 2003, J CLIN INVEST, V112, P1372, DOI 10.1172/JCI200318513; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Tomita S, 2000, MOL ENDOCRINOL, V14, P1674, DOI 10.1210/me.14.10.1674; VANSCOTT EJ, 1958, J INVEST DERMATOL, V31, P281, DOI 10.1038/jid.1958.121; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Xenaki G, 2008, ONCOGENE, V27, P5785, DOI 10.1038/onc.2008.192; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	42	4	4	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2517	2524		10.1096/fj.13-244079	http://dx.doi.org/10.1096/fj.13-244079			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24599965	Bronze			2022-12-25	WOS:000339883600012
J	Xu, X; Bi, DC; Wu, XT; Wang, QQ; Wei, GB; Chi, LL; Jiang, ZD; Oda, T; Wan, M				Xu, Xu; Bi, Decheng; Wu, Xiaoting; Wang, Qingqing; Wei, Gaobin; Chi, Lianli; Jiang, Zedong; Oda, Tatsuya; Wan, Min			Unsaturated guluronate oligosaccharide enhances the antibacterial activities of macrophages	FASEB JOURNAL			English	Article						innate immunity; alginate; phagocytosis; NF-kappa B; nitric oxide	NITRIC-OXIDE SYNTHASE; CYTOKINE PRODUCTION; INNATE IMMUNITY; SEPTIC MICE; ALGINATE; PHAGOCYTOSIS; CELLS; INHIBITION; MECHANISMS; PROTECTS	Alginate from marine seaweeds is receiving continuous attention owing to its wide physiological activities. Herein, we sought to elucidate possible effects of alginate-derived polyguluronate (PG) and unsaturated guluronate oligosaccharide (GOS) on antibacterial activities of macrophages. Our results showed that, in contrast to PG, GOS markedly increased the phagocytosis of IgG-opsonized Escherichia coli and Staphylococcus aureus and further inhibited the survival of intracellular bacteria in macrophages. In line with this, GOS treatment resulted in the enhanced expression of Fc gamma receptors on macrophages. In addition, GOS activated NF-kappa B pathway, induced TNF-alpha secretion, and elevated the expression of inducible nitric oxide synthase and the production of nitric oxide. Meanwhile, GOS stimulated the production of reactive oxygen species in macrophages. Moreover, guluronate trimer to hexamer (G3-G6) in GOS exhibited significant activity that increased the bacterial phagocytosis of macrophages, with the pentamer (G5), displaying the highest activity. Finally, our in vivo results further confirmed that GOS but not PG significantly improved bacterial clearance in murine acute peritonitis. In conclusion, GOS enhances antibacterial activities of macrophages via modulating signaling pathways related to innate immunity, suggesting that GOS might be a promising therapeutic candidate to improve the host defense against bacterial infection.	[Xu, Xu; Bi, Decheng; Wu, Xiaoting; Wang, Qingqing; Wei, Gaobin] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Marine Bioresources & Ecol, Shenzhen, Peoples R China; [Chi, Lianli] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China; [Jiang, Zedong; Oda, Tatsuya] Nagasaki Univ, Fac Fisheries, Div Biochem, Nagasaki 852, Japan; [Wan, Min] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, S-17177 Stockholm, Sweden	Shenzhen University; Shandong University; Nagasaki University; Karolinska Institutet	Wan, M (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, S-17177 Stockholm, Sweden.	min.wan@ki.se	Chi, Lianli/B-9149-2015; Jiang, Zedong/G-1317-2013	Chi, Lianli/0000-0003-1126-1022; Jiang, Zedong/0000-0001-7579-3680	National Natural Science Foundation of China [31000770]; Foundation for Distinguished Young Talents in Higher Education (Guangdong, China; FDYT) [LYM10114]; Marine Biotechnology Initiative Project (Shenzhen, China); Grants-in-Aid for Scientific Research [12F02093] Funding Source: KAKEN	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Distinguished Young Talents in Higher Education (Guangdong, China; FDYT); Marine Biotechnology Initiative Project (Shenzhen, China); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Dr. Renli Zhang (Shenzhen Center for Disease Control and Prevention, Shenzen, China) for the bacteria management and technical assistance. The authors are also grateful to Mrs. Lijun Yao (Shenzhen University) for assistance with the cell culture. This work was supported financially by the National Natural Science Foundation of China (grant 31000770), Foundation for Distinguished Young Talents in Higher Education (Guangdong, China; FDYT, grant LYM10114), and the Marine Biotechnology Initiative Project (Shenzhen, China). The authors declare no conflicts of interest.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; AKIYAMA H, 1992, BIOSCI BIOTECH BIOCH, V56, P355, DOI 10.1271/bbb.56.355; Eftekharzadeh B, 2010, CARBOHYD POLYM, V79, P1063, DOI 10.1016/j.carbpol.2009.10.040; Ernst JD, 2000, CELL MICROBIOL, V2, P379, DOI 10.1046/j.1462-5822.2000.00075.x; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Gomes RN, 2013, SHOCK, V39, P63, DOI 10.1097/SHK.0b013e31827802b5; HAUG A, 1966, ACTA CHEM SCAND, V20, P183, DOI 10.3891/acta.chem.scand.20-0183; HAUG ARNE, 1965, METHOD CARBOHYD CHEM, V5, P69; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; Hollenberg SM, 2000, CIRC RES, V86, P774, DOI 10.1161/01.RES.86.7.774; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Iwamoto M, 2005, FEBS LETT, V579, P4423, DOI 10.1016/j.febslet.2005.07.007; Iwamoto Y, 2003, BIOSCI BIOTECH BIOCH, V67, P258, DOI 10.1271/bbb.67.258; Kang HJ, 2011, BIOCHEM BIOPH RES CO, V406, P449, DOI 10.1016/j.bbrc.2011.02.069; Kim AR, 2013, J BIOMAT SCI-POLYM E, V24, P1084, DOI 10.1080/09205063.2012.735100; Kohchi C, 2009, ANTICANCER RES, V29, P817; Mo SJ, 2003, ARCH PHARM RES, V26, P244, DOI 10.1007/BF02976837; MORRIS ER, 1980, CARBOHYD RES, V81, P305, DOI 10.1016/S0008-6215(00)85661-X; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Pontes GN, 2007, J PINEAL RES, V43, P365, DOI 10.1111/j.1600-079X.2007.00487.x; SCHNEEMANN M, 1993, J INFECT DIS, V167, P1358, DOI 10.1093/infdis/167.6.1358; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Tsai WC, 1997, INFECT IMMUN, V65, P1870, DOI 10.1128/IAI.65.5.1870-1875.1997; Tusi SK, 2011, BIOMATERIALS, V32, P5438, DOI 10.1016/j.biomaterials.2011.04.024; Xu X, 2003, BIOSCI BIOTECH BIOCH, V67, P2022, DOI 10.1271/bbb.67.2022; Yang D, 2009, J BIOMED MATER RES A, V90A, P411, DOI 10.1002/jbm.a.32096	27	29	31	4	37	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2645	2654		10.1096/fj.13-247791	http://dx.doi.org/10.1096/fj.13-247791			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24599964				2022-12-25	WOS:000339883600022
J	Luttermann, C; Meyers, G				Luttermann, Christine; Meyers, Gregor			Two Alternative Ways of Start Site Selection in Human Norovirus Reinitiation of Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Expression; Protein Expression; RNA Structure; RNA Viruses; Translation; Viral Protein; TURBS; Calicivirus; Norovirus; Reinitiation of Translation	TERMINATION-REINITIATION; COUPLED TRANSLATION; MESSENGER-RNA; CAPSID PROTEIN; INITIATION; VIRUS; CALICIVIRUS; EXPRESSION; CODON; IDENTIFICATION	Background: Reinitiation of translation is rare in eukaryotes and depends on specialized cis-acting RNA sequences tethering ribosomes to the reinitiation site. Results: Ribosomes can reinitiate on calicivirus RNA at different sites. Conclusion: Sites for translation reinitiation are selected either by ribosome positioning or a scanning-like process. Significance: Start site selection in prokaryotic-like translation reinitiation in eukaryotes occurs in different modes. The calicivirus minor capsid protein VP2 is expressed via termination/reinitiation. This process depends on an upstream sequence element denoted termination upstream ribosomal binding site (TURBS). We have shown for feline calicivirus and rabbit hemorrhagic disease virus that the TURBS contains three sequence motifs essential for reinitiation. Motif 1 is conserved among caliciviruses and is complementary to a sequence in the 18 S rRNA leading to the model that hybridization between motif 1 and 18 S rRNA tethers the post-termination ribosome to the mRNA. Motif 2 and motif 2* are proposed to establish a secondary structure positioning the ribosome relative to the start site of the terminal ORF. Here, we analyzed human norovirus (huNV) sequences for the presence and importance of these motifs. The three motifs were identified by sequence analyses in the region upstream of the VP2 start site, and we showed that these motifs are essential for reinitiation of huNV VP2 translation. More detailed analyses revealed that the site of reinitiation is not fixed to a single codon and does not need to be an AUG, even though this codon is clearly preferred. Interestingly, we were able to show that reinitiation can occur at AUG codons downstream of the canonical start/stop site in huNV and feline calicivirus but not in rabbit hemorrhagic disease virus. Although reinitiation at the original start site is independent of the Kozak context, downstream initiation exhibits requirements for start site sequence context known for linear scanning. These analyses on start codon recognition give a more detailed insight into this fascinating mechanism of gene expression.	[Luttermann, Christine; Meyers, Gregor] Friedrich Loeffler Inst, Inst Immunol, D-17493 Greifswald, Insel Riems, Germany	Friedrich Loeffler Institute	Luttermann, C (corresponding author), Friedrich Loeffler Inst, Inst Immunol, Sudufer 10, D-17493 Greifswald, Insel Riems, Germany.	christine.luttermann@fli.bund.de; gregor.meyers@fli.bund.de	Luttermann, Christine/L-5440-2019	Luttermann, Christine/0000-0002-6977-9900	Deutsche Forschungsgemeinschaft [Me 1367/3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant Me 1367/3 from the Deutsche Forschungsgemeinschaft.	Bertram G, 2001, MICROBIOL-SGM, V147, P255, DOI 10.1099/00221287-147-2-255; Brierley I, 2006, VIRUS RES, V119, P29, DOI 10.1016/j.virusres.2005.10.008; Chappell SA, 2006, P NATL ACAD SCI USA, V103, P9488, DOI 10.1073/pnas.0603597103; Chaudhry Y, 2006, J BIOL CHEM, V281, P25315, DOI 10.1074/jbc.M602230200; Clarke IN, 2000, J INFECT DIS, V181, pS309, DOI 10.1086/315575; Cuesta R, 2001, COLD SPRING HARB SYM, V66, P259, DOI 10.1101/sqb.2001.66.259; Daughenbaugh KF, 2003, EMBO J, V22, P2852, DOI 10.1093/emboj/cdg251; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; Dreher TW, 2006, VIROLOGY, V344, P185, DOI 10.1016/j.virol.2005.09.031; Fricke J, 2004, J VIROL, V78, P5900, DOI 10.1128/JVI.78.11.5900-5912.2004; FUTTERER J, 1993, CELL, V73, P789, DOI 10.1016/0092-8674(93)90257-Q; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; Gould PS, 2014, RNA, V20, P373, DOI 10.1261/rna.041574.113; Gould PS, 2007, J VIROL, V81, P8488, DOI 10.1128/JVI.00457-07; Gould PS, 2005, J BIOL CHEM, V280, P21972, DOI 10.1074/jbc.M502276200; GREEN KY, 2000, VIRUS TAXONOMY, P725; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; HORVATH CM, 1990, EMBO J, V9, P2639, DOI 10.1002/j.1460-2075.1990.tb07446.x; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Latorre P, 1998, MOL CELL BIOL, V18, P5021, DOI 10.1128/MCB.18.9.5021; LIM PS, 1990, J INFECT DIS, V162, P1263, DOI 10.1093/infdis/162.6.1263; Luttermann C, 2007, J BIOL CHEM, V282, P7056, DOI 10.1074/jbc.M608948200; Luttermann C, 2009, GENE DEV, V23, P331, DOI 10.1101/gad.507609; McCormick CJ, 2008, J VIROL, V82, P8917, DOI 10.1128/JVI.02362-07; Meyers G, 2003, J BIOL CHEM, V278, P34051, DOI 10.1074/jbc.M304874200; Meyers G, 2007, J VIROL, V81, P9623, DOI 10.1128/JVI.00771-07; Napthine S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008390; Park HS, 2001, CELL, V106, P723, DOI 10.1016/S0092-8674(01)00487-1; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Pestova TV, 2008, EMBO J, V27, P1060, DOI 10.1038/emboj.2008.49; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Powell ML, 2008, RNA, V14, P2394, DOI 10.1261/rna.1231008; Powell ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016822; Poyry TAA, 2007, GENE DEV, V21, P3149, DOI 10.1101/gad.439507; Rijnbrand RCA, 1996, VIROLOGY, V226, P47, DOI 10.1006/viro.1996.0626; Rohayem J, 2006, J VIROL, V80, P7060, DOI 10.1128/JVI.02195-05; Ryabova LA, 2002, PROG NUCLEIC ACID RE, V72, P1, DOI 10.1016/S0079-6603(02)72066-7; Ryabova LA, 2006, VIRUS RES, V119, P52, DOI 10.1016/j.virusres.2005.10.017; Sambrook J, 2001, MOL CLONING LAB MANU; Sarnow P, 2005, BIOCHEM SOC T, V33, P1479, DOI 10.1042/BST0331479; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510; Smith E, 2005, NUCLEIC ACIDS RES, V33, P1298, DOI 10.1093/nar/gki248; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Terenin IM, 2008, NAT STRUCT MOL BIOL, V15, P836, DOI 10.1038/nsmb.1445; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; WYATT LS, 1995, VIROLOGY, V210, P202, DOI 10.1006/viro.1995.1332; Xi QR, 2005, J VIROL, V79, P5676, DOI 10.1128/JVI.79.9.5676-5683.2005	55	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11739	11754		10.1074/jbc.M114.554030	http://dx.doi.org/10.1074/jbc.M114.554030			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24599949	Green Published, hybrid			2022-12-25	WOS:000335010600016
J	Mithu, VS; Sarkar, B; Bhowmik, D; Das, AK; Chandrakesan, M; Maiti, S; Madhu, PK				Mithu, Venus Singh; Sarkar, Bidyut; Bhowmik, Debanjan; Das, Anand Kant; Chandrakesan, Muralidharan; Maiti, Sudipta; Madhu, Perunthiruthy K.			Curcumin Alters the Salt Bridge-containing Turn Region in Amyloid beta (1-42) Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid; Drug Action; NMR; Protein Aggregation; Solid State NMR; Magic-angle Spinning; Salt Bridge	SOLID-STATE NMR; ZINC-BINDING SITE; FIBRILS IN-VITRO; ALZHEIMERS-DISEASE; EXPERIMENTAL CONSTRAINTS; CROSS-POLARIZATION; STRUCTURAL MODEL; PEPTIDES; OLIGOMERS; RAT	Background: Curcumin reduces the risk of Alzheimer disease via an unknown mechanism. Results: Curcumin-incubated A(42) aggregates retain the hairpin architecture but have disruptions in the turn region (surprising similarity with Zn2+ incubation). Conclusion: Salt bridge-containing turn region is a major determinant of morphology and toxicity. Significance: Identification of crucial structural changes provides a checkpoint for developing effective AD therapeutics. Amyloid (A) fibrillar deposits in the brain are a hallmark of Alzheimer disease (AD). Curcumin, a common ingredient of Asian spices, is known to disrupt A fibril formation and to reduce AD pathology in mouse models. Understanding the structural changes induced by curcumin can potentially lead to AD pharmaceutical agents with inherent bio-compatibility. Here, we use solid-state NMR spectroscopy to investigate the structural modifications of amyloid (1-42) (A(42)) aggregates induced by curcumin. We find that curcumin induces major structural changes in the Asp-23-Lys-28 salt bridge region and near the C terminus. Electron microscopy shows that the A(42) fibrils are disrupted by curcumin. Surprisingly, some of these alterations are similar to those reported for Zn2+ ions, another agent known to disrupt the fibrils and alter A(42) toxicity. Our results suggest the existence of a structurally related family of quasi-fibrillar conformers of A(42), which is stabilized both by curcumin and by Zn2+.</SUP	[Mithu, Venus Singh; Sarkar, Bidyut; Bhowmik, Debanjan; Das, Anand Kant; Maiti, Sudipta; Madhu, Perunthiruthy K.] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India; [Chandrakesan, Muralidharan] Seth Gordhandas Sunderdas Med Coll, Dept Biochem, Bombay 400012, Maharashtra, India; [Chandrakesan, Muralidharan] King Edward Mem Hosp, Bombay 400012, Maharashtra, India; [Madhu, Perunthiruthy K.] Tata Inst Fundamental Res, Ctr Interdisciplinary Sci, Hyderabad 500075, Andhra Pradesh, India	Tata Institute of Fundamental Research (TIFR); Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Tata Institute of Fundamental Research (TIFR); TIFR Centre for Interdisciplinary Sciences (TCIS), Hyderabad	Maiti, S (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	maiti@tifr.res.in; madhu@tifr.res.in	Das, Anand/E-4138-2016	Das, Anand/0000-0003-0740-8140; Sarkar, Bidyut/0000-0001-5023-7581; bhowmik, debanjan/0000-0002-3480-7940; Mithu, Venus Singh/0000-0003-2869-9776; Maiti, Sudipta/0000-0002-6540-7472	SERC scheme from the Department of Science and Technology of India [SR/S1/PC/27/2009]; Department of Biotechnology, Government of India [BT/53/NE/TBP/2010]	SERC scheme from the Department of Science and Technology of India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by funding under SERC scheme SR/S1/PC/27/2009 from the Department of Science and Technology of India (to P. K. M.) and Grant BT/53/NE/TBP/2010 from the Department of Biotechnology, Government of India (to S. M.).	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Danielsson J, 2007, FEBS J, V274, P46, DOI 10.1111/j.1742-4658.2006.05563.x; Esler WP, 1996, J NEUROCHEM, V66, P723; Gaggelli E, 2008, J PHYS CHEM B, V112, P100, DOI 10.1021/jp075168m; Garai K, 2007, BIOCHEMISTRY-US, V46, P10655, DOI 10.1021/bi700798b; Garai K, 2006, BIOCHEM BIOPH RES CO, V345, P210, DOI 10.1016/j.bbrc.2006.04.056; GULLION T, 1990, J MAGN RESON, V89, P479, DOI 10.1016/0022-2364(90)90331-3; Hamaguchi T, 2010, CNS NEUROSCI THER, V16, P285, DOI 10.1111/j.1755-5949.2010.00147.x; Jaroniec CP, 2001, J AM CHEM SOC, V123, P3507, DOI 10.1021/ja003266e; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Liu ZH, 2011, PHARMACOL RES, V63, P439, DOI 10.1016/j.phrs.2011.01.004; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Masuda Y, 2011, BIOORGAN MED CHEM, V19, P5967, DOI 10.1016/j.bmc.2011.08.052; METZ G, 1994, J MAGN RESON SER A, V110, P219, DOI 10.1006/jmra.1994.1208; Minicozzi V, 2008, J BIOL CHEM, V283, P10784, DOI 10.1074/jbc.M707109200; Mithu VS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050504; Mithu VS, 2011, BIOPHYS J, V101, P2825, DOI 10.1016/j.bpj.2011.10.023; Morcombe CR, 2003, J MAGN RESON, V162, P479, DOI 10.1016/S1090-7807(03)00082-X; Narlawar R, 2008, CHEMMEDCHEM, V3, P165, DOI 10.1002/cmdc.200700218; Ng TP, 2006, AM J EPIDEMIOL, V164, P898, DOI 10.1093/aje/kwj267; Noy D, 2008, J AM CHEM SOC, V130, P1376, DOI 10.1021/ja076282l; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Ono K, 2006, J NEUROCHEM, V97, P105, DOI 10.1111/j.1471-4159.2006.03707.x; Orlando RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031869; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Park SY, 2002, J NAT PROD, V65, P1227, DOI 10.1021/np010039x; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Rathore P, 2008, NEUROCHEM RES, V33, P1672, DOI 10.1007/s11064-007-9515-6; Reinke AA, 2007, CHEM BIOL DRUG DES, V70, P206, DOI 10.1111/j.1747-0285.2007.00557.x; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Singh PK, 2013, ACS CHEM NEUROSCI, V4, P393, DOI 10.1021/cn3001203; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Thakur RS, 2006, CHEM PHYS LETT, V426, P459, DOI 10.1016/j.cplett.2006.06.007; Weingarth M, 2009, CHEM PHYS LETT, V469, P342, DOI 10.1016/j.cplett.2008.12.084; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yoshiike Y, 2001, J BIOL CHEM, V276, P32293, DOI 10.1074/jbc.M010706200; Zhao LN, 2012, J PHYS CHEM B, V116, P7428, DOI 10.1021/jp3034209; Zirah S, 2006, J BIOL CHEM, V281, P2151, DOI 10.1074/jbc.M504454200	43	44	45	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11122	11131		10.1074/jbc.M113.519447	http://dx.doi.org/10.1074/jbc.M113.519447			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599958	Green Published, hybrid			2022-12-25	WOS:000334638500016
J	Nagatake, T; Fujita, H; Minato, N; Hamazaki, Y				Nagatake, Takahiro; Fujita, Harumi; Minato, Nagahiro; Hamazaki, Yoko			Enteroendocrine Cells Are Specifically Marked by Cell Surface Expression of Claudin-4 in Mouse Small Intestine	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; GASTRIC-INHIBITORY POLYPEPTIDE; FOLLICLE-ASSOCIATED EPITHELIUM; TIGHT JUNCTIONS; ENDOCRINE CELL; PEYERS-PATCHES; STEM-CELLS; GUT; INCRETIN; LOCALIZATION	Enteroendocrine cells are solitary epithelial cells scattered throughout the gastrointestinal tract and produce various types of hormones, constituting one of the largest endocrine systems in the body. The study of these rare epithelial cells has been hampered by the difficulty in isolating them because of the lack of specific cell surface markers. Here, we report that enteroendocrine cells selectively express a tight junction membrane protein, claudin-4 (Cld4), and are efficiently isolated with the use of an antibody specific for the Cld4 extracellular domain and flow cytometry. Sorted Cld4(+) epithelial cells in the small intestine exclusively expressed a chromogranin A gene (Chga) and other enteroendocrine cell-related genes (Ffar1, Ffar4, Gpr119), and the population was divided into two subpopulations based on the activity of binding to Ulex europaeus agglutinin-1 (UEA-1). A Cld4(+) UEA-1(-) cell population almost exclusively expressed glucose-dependent insulinotropic polypeptide gene (Gip), thus representing K cells, whereas a Cld4+ UEA-1(+) cell population expressed other gut hormone genes, including glucagon-like peptide 1 (Gcg), pancreatic polypeptide-like peptide with N-terminal tyrosine amide (Pyy), cholecystokinin (Cck), secretin (Sct), and tryptophan hydroxylase 1 (Tph1). In addition, we found that orally administered luminal antigens were taken up by the solitary Cld4(+) cells in the small intestinal villi, raising the possibility that enteroendocrine cells might also play a role in initiation of mucosal immunity. Our results provide a useful tool for the cellular and functional characterization of enteroendocrine cells.	[Nagatake, Takahiro; Fujita, Harumi; Minato, Nagahiro; Hamazaki, Yoko] Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan	Kyoto University	Hamazaki, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan.	hamazaki@imm.med.kyoto-u.ac.jp	Hamazaki, Y*/Q-3076-2019; Nagatake, Takahiro/AAL-1995-2020	Hamazaki, Y*/0000-0001-5866-7340; Fujita, Harumi/0000-0003-2133-845X; Nagatake, Takahiro/0000-0003-3022-9626	Ministry of Education, Culture, Science, Sports and Technology of the Japanese Government [24 3485, 24590580, 25111505, 24111008]	Ministry of Education, Culture, Science, Sports and Technology of the Japanese Government	This work was supported by grants from the Ministry of Education, Culture, Science, Sports and Technology of the Japanese Government to TN (no. 24 3485), YH(no. 24590580, no 25111505) and NM(no. 24111008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Angelow S, 2008, AM J PHYSIOL-RENAL, V295, pF867, DOI 10.1152/ajprenal.90264.2008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; BUCHAN AMJ, 1978, HISTOCHEMISTRY, V56, P37, DOI 10.1007/BF00492251; Buchert M, 2010, P NATL ACAD SCI USA, V107, P2628, DOI 10.1073/pnas.0903747107; Chu ZL, 2008, ENDOCRINOLOGY, V149, P2038, DOI 10.1210/en.2007-0966; Dhawan P, 2011, ONCOGENE, V30, P3234, DOI 10.1038/onc.2011.43; DUPRE J, 1973, J CLIN ENDOCR METAB, V37, P826, DOI 10.1210/jcem-37-5-826; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; EISSELE R, 1992, EUR J CLIN INVEST, V22, P283, DOI 10.1111/j.1365-2362.1992.tb01464.x; ELRICK H, 1964, J CLIN ENDOCR METAB, V24, P1076, DOI 10.1210/jcem-24-10-1076; Fujita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052272; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Gerbe F, 2012, CELL MOL LIFE SCI, V69, P2907, DOI 10.1007/s00018-012-0984-7; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; Hamazaki Y, 2002, J BIOL CHEM, V277, P455, DOI 10.1074/jbc.M109005200; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Kawai Y, 2011, P NATL ACAD SCI USA, V108, P4075, DOI 10.1073/pnas.1014178108; Kondoh M, 2008, DRUG DISCOV TODAY, V13, P180, DOI 10.1016/j.drudis.2007.11.005; KREYMANN B, 1987, LANCET, V2, P1300; Krug SM, 2012, ANN NY ACAD SCI, V1257, P20, DOI 10.1111/j.1749-6632.2012.06555.x; Lo D, 2004, INT IMMUNOL, V16, P91, DOI 10.1093/intimm/dxh011; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; MADARA JL, 1982, J MEMBRANE BIOL, V66, P145, DOI 10.1007/BF01868490; May CL, 2010, MOL CELL ENDOCRINOL, V323, P70, DOI 10.1016/j.mce.2009.12.009; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; MCINTYRE N, 1964, LANCET, V2, P20, DOI 10.1016/s0140-6736(64)90011-x; Mortensen K, 2003, REGUL PEPTIDES, V114, P189, DOI 10.1016/S0167-0115(03)00125-3; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Nochi T, 2004, CLIN IMMUNOL, V113, P326, DOI 10.1016/j.clim.2004.08.013; OWEN RL, 1974, GASTROENTEROLOGY, V66, P189, DOI 10.1016/s0016-5085(74)80102-2; Parker HE, 2009, DIABETOLOGIA, V52, P289, DOI 10.1007/s00125-008-1202-x; Rahner C, 2001, GASTROENTEROLOGY, V120, P411, DOI 10.1053/gast.2001.21736; Rajapaksa TE, 2010, J CONTROL RELEASE, V142, P196, DOI 10.1016/j.jconrel.2009.10.033; Rehfeld JF, 2004, HORM METAB RES, V36, P735, DOI 10.1055/s-2004-826154; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Rindi G, 2004, ANN NY ACAD SCI, V1014, P1, DOI 10.1196/annals.1294.001; SATO M, 1986, DIFFERENTIATION, V30, P211, DOI 10.1111/j.1432-0436.1986.tb00783.x; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; Tamagawa H, 2003, LAB INVEST, V83, P1045, DOI 10.1097/01.LAB.0000078741.55670.6E; Tamura A, 2008, GASTROENTEROLOGY, V134, P523, DOI 10.1053/j.gastro.2007.11.040; Terahara K, 2008, J IMMUNOL, V180, P7840, DOI 10.4049/jimmunol.180.12.7840; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Uchida H, 2010, BIOCHEM PHARMACOL, V79, P1437, DOI 10.1016/j.bcp.2010.01.010	48	28	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90638	10.1371/journal.pone.0090638	http://dx.doi.org/10.1371/journal.pone.0090638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603700	Green Submitted, Green Published, gold			2022-12-25	WOS:000332483600070
J	Randhawa, M; Sangar, V; Tucker-Samaras, S; Southall, M				Randhawa, Manpreet; Sangar, Vineet; Tucker-Samaras, Samantha; Southall, Michael			Metabolic Signature of Sun Exposed Skin Suggests Catabolic Pathway Overweighs Anabolic Pathway	PLOS ONE			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; UROCANIC ACID; NITRIC-OXIDE; UV; IRRADIATION; ACTIVATION; RADIATION	Skin chronically exposed to sun results in phenotypic changes referred as photoaging. This aspect of aging has been studied extensively through genomic and proteomic tools. Metabolites, the end product are generated as a result of biochemical reactions are often studied as a culmination of complex interplay of gene and protein expression. In this study, we focused exclusively on the metabolome to study effects from sun-exposed and sun-protected skin sites from 25 human subjects. We generated a highly accurate metabolomic signature for the skin that is exposed to sun. Biochemical pathway analysis from this data set showed that sun-exposed skin resides under high oxidative stress and the chains of reactions to produce these metabolites are inclined toward catabolism rather than anabolism. These catabolic activities persuade the skin cells to generate metabolites through the salvage pathway instead of de novo synthesis pathways. Metabolomic profile suggests catabolic pathways and reactive oxygen species operate in a feed forward fashion to alter the biology of sun exposed skin.	[Randhawa, Manpreet; Tucker-Samaras, Samantha; Southall, Michael] CPPW, Johnson & Johnson Skin Res Ctr, Skillman, NJ 08558 USA; [Sangar, Vineet] Inst Syst Biol, Seattle, WA USA	Johnson & Johnson; Johnson & Johnson USA; Institute for Systems Biology (ISB)	Randhawa, M (corresponding author), CPPW, Johnson & Johnson Skin Res Ctr, Skillman, NJ 08558 USA.	mrandha1@its.jnj.com			Johnson & Johnson Consumer Companies Inc.	Johnson & Johnson Consumer Companies Inc.(Johnson & JohnsonJohnson & Johnson USA)	This research was supported and funded by Johnson & Johnson Consumer Companies Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes VM, 2009, J DENT RES, V88, P851, DOI 10.1177/0022034509341967; Bennett MF, 2008, J INVEST DERM SYMP P, V13, P15, DOI 10.1038/jidsymp.2008.3; Besedovsky HO, 1996, ENDOCR REV, V17, P64, DOI 10.1210/er.17.1.64; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brosh S, 1984, Adv Exp Med Biol, V165 Pt A, P481; de Gruijl FR, 2001, J PHOTOCH PHOTOBIO B, V63, P19, DOI 10.1016/S1011-1344(01)00199-3; Deliconstantinos G, 1996, BIOCHEM J, V320, P997, DOI 10.1042/bj3200997; Deliconstantinos G, 1996, EXP PHYSIOL, V81, P1021, DOI 10.1113/expphysiol.1996.sp003986; El-Abaseri TB, 2006, CARCINOGENESIS, V27, P225, DOI 10.1093/carcin/bgi220; El-Abaseri TB, 2005, CANCER RES, V65, P3958, DOI 10.1158/0008-5472.CAN-04-2204; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Hanson KM, 1998, P NATL ACAD SCI USA, V95, P10576, DOI 10.1073/pnas.95.18.10576; HARMAN D, 1968, J GERONTOL, V23, P476, DOI 10.1093/geronj/23.4.476; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; Khan JA, 2007, EXPERT OPIN THER TAR, V11, P695, DOI 10.1517/14728222.11.5.695; Landmesser U, 2007, ARTERIOSCL THROM VAS, V27, P943, DOI 10.1161/01.ATV.0000258415.32883.bf; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; MOODYCLIFFE AM, 1992, IMMUNOLOGY, V77, P394; Randhawa M, 2013, MOL BIOSYST, V9, P2045, DOI 10.1039/c3mb25537a; Ratnam S, 2002, J BIOL CHEM, V277, P42912, DOI 10.1074/jbc.M206588200; SCHALLREUTER KU, 1995, J INVEST DERMATOL, V104, P953, DOI 10.1111/1523-1747.ep12606218; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 1998, CLIN DERMATOL, V16, P503, DOI 10.1016/S0738-081X(98)00023-6; Slominski Andrzej T, 2012, Adv Anat Embryol Cell Biol, V212, P1; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Zastrow L, 2009, HAUTARZT, V60, P310, DOI 10.1007/s00105-008-1628-6; Zastrow L, 2009, SKIN PHARMACOL PHYS, V22, P31, DOI 10.1159/000188083; Zhu M, 2006, CANCER LETT, V244, P220, DOI 10.1016/j.canlet.2005.12.023	30	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90367	10.1371/journal.pone.0090367	http://dx.doi.org/10.1371/journal.pone.0090367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603693	Green Submitted, gold, Green Published			2022-12-25	WOS:000332483600049
J	Venter, JA; Prins, HHT; Balfour, DA; Slotow, R				Venter, Jan A.; Prins, Herbert H. T.; Balfour, David A.; Slotow, Rob			Reconstructing Grazer Assemblages for Protected Area Restoration	PLOS ONE			English	Article							MIDDLE STONE-AGE; FORAGING BEHAVIOR; LANDSCAPE-SCALE; AFRICAN SAVANNA; HERBIVORE; FIRE; HETEROGENEITY; DIVERSITY; SELECTION; RESERVE	Protected area management agencies often struggle to reliably reconstruct grazer assemblages due to a lack of historical distribution data for their regions. Wrong predictions of grazing assemblages could potentially affect biodiversity negatively. The objective of the study was to determine how well grazing herbivores have become established since introduction to the Mkambati Nature Reserve, South Africa, how this was influenced by facilitation and competition, and how indigenous grazer assemblages can best be predicted for effective ecological restoration. Population trends of several grazing species were investigated in in order to determine how well they have become established since introduction. Five different conceivable grazing assemblages reflecting a range of approaches that are commonly encountered during conservation planning and management decision making were assessed. Species packing was used to predict whether facilitation, competition or co-existence were more likely to occur, and the species packing of the different assemblages were assessed using ANCOVA. Reconstructing a species assemblage using biogeographic and biological information provides the opportunity for a grazer assemblage that allows for facilitatory effects, which in turn leads to an ecosystem that is able to maintain its grazer assemblage structure. The strength of this approach lies in the ability to overcome the problem of depauperate grazer assemblages, resulting from a lack of historical data, by using biogeographical and biological processes, to assist in more effectively reconstructing grazer assemblages. Adaptive management of grazer assemblage restoration through reintroduction, using this approach would further mitigate management risks.	[Venter, Jan A.; Prins, Herbert H. T.; Slotow, Rob] Univ Kwazulu Natal, Sch Life Sci, Durban, South Africa; [Venter, Jan A.; Balfour, David A.] Eastern Cape Pk & Tourism Agcy, Dept Biodivers Conservat, Southernwood, East London, South Africa; [Prins, Herbert H. T.] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands	University of Kwazulu Natal; Wageningen University & Research	Venter, JA (corresponding author), Univ Kwazulu Natal, Sch Life Sci, Westville Campus, Durban, South Africa.	Jan.Venter@ecpta.co.za	Slotow, Rob/AAM-9053-2020	Prins, Herbert/0000-0003-1131-5107; Slotow, Rob/0000-0001-9469-1508	University of Kwazulu-Natal; Eastern Cape Parks and Tourism Agency	University of Kwazulu-Natal; Eastern Cape Parks and Tourism Agency	The University of Kwazulu-Natal and Eastern Cape Parks and Tourism Agency who provided funding for the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ECOLOGICAL SURVEY SE; Arsenault R, 2002, OIKOS, V97, P313, DOI 10.1034/j.1600-0706.2002.970301.x; Arsenault R, 2008, OIKOS, V117, P1711, DOI 10.1111/j.1600-0706.2008.16575.x; Atkinson IAE, 2001, BIOL CONSERV, V99, P81, DOI 10.1016/S0006-3207(00)00189-0; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; BELL RHV, 1982, ECOL STUD, V42, P193; Bernard RTF, 2006, S AFR J SCI, V102, P117; Biggs H. C., 2003, KRUGER EXPERIENCE EC, P59; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bonyongo MC, 2007, AFR J ECOL, V45, P527, DOI 10.1111/j.1365-2028.2007.00764.x; Boshoff AF, 2001, AFR ZOOL, V36, P245; Boshoff AF, 2004, C106 U PORT EL TERR; Boshoff AE, 2010, S AFR J SCI, V106, P26, DOI 10.4102/sajs.v106i1/2.116; Castley JG, 2001, S AFR J SCI, V97, P344; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Coetzee C. G., 1969, Scientific Papers Namib Desert Research Station, VNo. 40, P23; Conservation International South African National Biodiversity Institute, 2010, EC PROF MAP PO UNPUB; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Cramer MD, 2007, S AFR J WILDL RES, V37, P197, DOI 10.3957/0379-4369-37.2.197; Cromsigt JPGM, 2006, ECOLOGY, V87, P1532, DOI 10.1890/0012-9658(2006)87[1532:RPASGM]2.0.CO;2; Cromsigt JPGM, 2009, DIVERS DISTRIB, V15, P513, DOI 10.1111/j.1472-4642.2008.00554.x; D'Alonzo KT, 2004, WESTERN J NURS RES, V26, P804, DOI 10.1177/0193945904266733; de Villiers D, 2006, MKAMBATI WILD COAST; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; Drent R.H., 1987, Geobotany, V10, P131; Drescher M, 2006, AUSTRAL ECOL, V31, P76, DOI 10.1111/j.1442-9993.2006.01552.x; Drescher M, 2006, APPL ANIM BEHAV SCI, V101, P10, DOI 10.1016/j.applanim.2006.01.011; ECPB, 2009, INT RES MAN PL UNPUB; ECPB, 2010, E CAP PARKS BOARD PO; Feely JM, 2005, GUIDE NATURAL UNPUB; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Fisher Erich C., 2013, Paleoanthropology, P104; Fritz H, 2002, OECOLOGIA, V131, P620, DOI 10.1007/s00442-002-0919-3; Fryxell JM, 2005, ECOL LETT, V8, P328, DOI 10.1111/j.1461-0248.2005.00727.x; Fuhlendorf SD, 2009, CONSERV BIOL, V23, P588, DOI 10.1111/j.1523-1739.2008.01139.x; Gagnon M, 2000, J MAMMAL, V81, P490, DOI 10.1644/1545-1542(2000)081&lt;0490:DPIEAB&gt;2.0.CO;2; Gaylard A, 2011, KOEDOE, V53, DOI 10.4102/koedoe.v53i2.1005; GOODMAN PS, 1987, S AFR J WILDL RES, V17, P28; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; GRISWOLD C E, 1991, Australian Systematic Botany, V4, P73, DOI 10.1071/SB9910073; Gusset M, 2008, J APPL ECOL, V45, P100, DOI 10.1111/j.1365-2664.2007.01357.x; Hayward MW, 2009, BIODIVERS CONSERV, V18, P765, DOI 10.1007/s10531-008-9436-y; Heinen JT, 2002, ENV PRACTICE, V4, P172; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; ILLIUS AW, 1992, OECOLOGIA, V89, P428, DOI 10.1007/BF00317422; KAREIVA P, 1982, ECOLOGY, V63, P696, DOI 10.2307/1936790; Kleynhans EJ, 2011, OIKOS, V120, P591, DOI 10.1111/j.1600-0706.2010.18712.x; Klop E, 2008, GLOBAL ECOL BIOGEOGR, V17, P778, DOI 10.1111/j.1466-8238.2008.00416.x; Kramer K, 2010, ECOL MODEL, V221, P2555, DOI 10.1016/j.ecolmodel.2010.07.012; Kuemmerle T, 2012, DIVERS DISTRIB, V18, P47, DOI 10.1111/j.1472-4642.2011.00849.x; Kwazulu-Natal Nature Conservation Service, 1999, NOM PROP GREAT UNPUB; Lagendijk G, 2012, BIOTROPICA, V44, P63, DOI 10.1111/j.1744-7429.2011.00776.x; Leonard S, 2010, J APPL ECOL, V47, P876, DOI 10.1111/j.1365-2664.2010.01840.x; Linder HP, 2012, J BIOGEOGR, V39, P1189, DOI 10.1111/j.1365-2699.2012.02728.x; List R, 2007, CONSERV BIOL, V21, P1487, DOI 10.1111/j.1523-1739.2007.00810.x; May R. M., 1973, STABILITY COMPLEXITY; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; MCNAUGHTON SJ, 1976, SCIENCE, V191, P92, DOI 10.1126/science.191.4222.92; Minter L.R., 2004, ATLAS RED DATA BOOK; Mishra C, 2002, ANIM CONSERV, V5, P251, DOI 10.1017/S1367943002002305; Mucina I., 2006, STRELITZIA, V19; Mucina L., 2006, VEGETATION S AFRICA; Murray MG, 2000, OIKOS, V89, P501, DOI 10.1034/j.1600-0706.2000.890309.x; Namgail T, 2010, J ARID ENVIRON, V74, P1162, DOI 10.1016/j.jaridenv.2010.04.013; Novellie P. A., 1994, Koedoe, V37, P115; Olff H, 2002, NATURE, V415, P901, DOI 10.1038/415901a; Owen-Smith N, 2006, ECOL MONOGR, V76, P73, DOI 10.1890/04-1101; OWENSMITH N, 1987, PALEOBIOLOGY, V13, P351; Peinke D., 2007, ANN GAME ESTIM UNPUB; Plug I, 2004, S AFR J SCI, V100, P151; Pollard S, 2011, KOEDOE, V53, DOI 10.4102/koedoe.v53i2.1011; Prins H.H.T., 1998, P449; Roux DJ, 2011, DEV APPL STRATEGIC A, V53, P1; Rowe-Rowe DT, 1994, UNGULATES NATA UNPUB; SHACKLETON C M, 1992, Journal of the Grassland Society of Southern Africa, V9, P30; SHACKLETON C M, 1990, Journal of the Grassland Society of Southern Africa, V7, P265; SHACKLETON CM, 1991, BOTHALIA, V21, P91, DOI 10.4102/abc.v21i1.869; Simenstad C, 2006, ECOL ENG, V26, P27, DOI 10.1016/j.ecoleng.2005.09.007; Skead C.J., 2007, HIST INCIDENCE LARGE, V2nd Edn; SKINNER JD, 2005, MAMMALS SO AFRICAN S; Slotow R., 2001, Koedoe, V44, P85; Spear D, 2009, J ZOOL, V279, P1, DOI 10.1111/j.1469-7998.2009.00604.x; Spear Dian, 2011, Koedoe, V53, P01; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Truett Joe C., 2001, Great Plains Research, V11, P123; Uys R, 2012, NOTES NATURAL UNPUB; Van der Merwe J, 2012, AUSTRAL ECOL, V37, P401, DOI 10.1111/j.1442-9993.2011.02297.x; van Rooyen N, 2004, VEGETATION TYP UNPUB; Venter FJ, 2008, ECOSYSTEMS, V11, P173, DOI 10.1007/s10021-007-9116-x; Venter J.A., 2010, GAME CENSUS RE UNPUB; Venter JA, 2004, S AFR J WILDL RES, V34, P95; Venter JA, 2007, LARGE HERBIVOR UNPUB; VESEY-FITZGERALD DESMOND F., 1960, JOUR MAMMAL, V41, P161, DOI 10.2307/1376351; Vie J-C, 2009, WILDLIFE CHANGING WO; Waldram MS, 2008, ECOSYSTEMS, V11, P101, DOI 10.1007/s10021-007-9109-9; Watson LH, 2000, AFR J ECOL, V38, P130, DOI 10.1046/j.1365-2028.2000.00229.x; Wilmshurst JF, 2000, P ROY SOC B-BIOL SCI, V267, P345, DOI 10.1098/rspb.2000.1007; Witkowski ETF, 2001, PLANT ECOL, V152, P13, DOI 10.1023/A:1011409004004; Zavaleta ES, 2001, TRENDS ECOL EVOL, V16, P454, DOI 10.1016/S0169-5347(01)02194-2	100	14	14	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90900	10.1371/journal.pone.0090900	http://dx.doi.org/10.1371/journal.pone.0090900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603663	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600104
J	Wu, JC; Jia, HL; Li, ZR; Zhou, KL; Qin, LX; Dong, QZ; Ren, N				Wu, Jin-Cai; Jia, Hu-Liang; Li, Zhuo-Ri; Zhou, Kai-Lun; Qin, Lun-Xiu; Dong, Qiong-Zhu; Ren, Ning			Genomic Aberrations in the HTPAP Promoter Affect Tumor Metastasis and Clinical Prognosis of Hepatocellular Carcinoma	PLOS ONE			English	Article							CHROMOSOME 8P DELETION; CANCER-CELLS; EXPRESSION; RISK; ASSOCIATION; SUPPRESSOR; VARIANTS; GENE	We previously reported that the intronic tagSNP +357G/C in the metastasis suppressor HTPAP is associated with metastasis and prognosis of hepatocellular carcinoma (HCC). The aim of this study was to investigate whether SNPs in the HTPAP promoter modulate HTPAP expression and prognosis of HCC. Genomic DNA from 572 microdissected HCCs were genotyped by pyrosequencing and verified by direct sequencing. Haplotype blocks were analyzed. Reporter plasmids were constructed and transfected into HCC cell lines. Transcriptional activities of plasmids were analyzed by dual-luciferase reporter systems. HTPAP expression was measured by real-time quantitative PCR, western blots, and tissue microarrays. Invasion was assessed by Matrigel assays. The prognostic values of HTPAP promoter SNPs in HCC were evaluated by Kaplan-Meier and Cox regression analyses. We identified six SNPs, including -1053A/G and +64G/C, in the HTPAP promoter. The SNPs were in complete linkage disequilibrium, resulting in three promoter haplotypes (promoter I:-1053AA/+64GG, promoter II: -1053AG/+64GC, and promoter III: -1053GG/+64CC). Promoter I manifested the highest luciferase index (p<0.005). However, no significant difference was observed between promoters II and III. We consistently found that HTPAP mRNA and protein levels were significantly higher in promoter I than that of promoter II+III (p<0.001). Invasion was increased in HCC cells transfected with promoters II+ III compared to those transfected with promoter I (p<0.05). The HTPAP promoter II+III haplotype was associated with significantly increased metastasis compared to that of promoter I (p = 0.023). The postoperative five-year overall survival of patients with promoters II+ III was lower than that of patients with promoter I (p = 0.006). Multivariate analysis showed that the promoter II+ III haplotype was an adverse prognostic marker in HCC. The genetic variants at loci -1053 and +64 of the HTPAP promoter affect the expression of HTPAP, which might be a novel determinant and target for HCC prognosis.	[Wu, Jin-Cai; Li, Zhuo-Ri; Zhou, Kai-Lun] Nanhua Univ, Hainan Prov Peoples Hosp, Dept Hepatobiliary Surg, Haikou, Peoples R China; [Jia, Hu-Liang; Qin, Lun-Xiu; Dong, Qiong-Zhu; Ren, Ning] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R China; [Jia, Hu-Liang; Qin, Lun-Xiu; Dong, Qiong-Zhu; Ren, Ning] Fudan Univ, Ctr Canc, Inst Biomed Sci, Shanghai 200433, Peoples R China	University of South China; Fudan University; Fudan University	Dong, QZ (corresponding author), Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R China.	qiongzhudong@163.com; renning021@126.com	Wang, Nian/HDM-2087-2022	Wang, Nian/0000-0001-7743-0728; Ren, Ning/0000-0001-9776-2471	China National Key Projects for Infectious Disease [2008ZX10002-021]; "973'' State Key Basic Research Program of China [2009CB521701]; Program of Shanghai Chief Scientist [08XD14008]; National Natural Science Foundation of China [30600589, 81160310, 81260367]; Natural Science Foundation of Hainan Province [812155]; Shanghai Rising Star of Young Scientist Project [07QA14010]	China National Key Projects for Infectious Disease; "973'' State Key Basic Research Program of China(National Basic Research Program of China); Program of Shanghai Chief Scientist; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hainan Province; Shanghai Rising Star of Young Scientist Project	This work was supported by the China National Key Projects for Infectious Disease (2008ZX10002-021), the "973'' State Key Basic Research Program of China (2009CB521701), the Program of Shanghai Chief Scientist (08XD14008), the National Natural Science Foundation of China (30600589, 81160310,81260367), the Natural Science Foundation of Hainan Province (812155), and the Shanghai Rising Star of Young Scientist Project (07QA14010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059574; Chung TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033517; Dong QZ, 2013, HEPATOLOGY, V57, P1024, DOI 10.1002/hep.26103; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Jang JW, 2012, CANCER SCI, V103, P296, DOI 10.1111/j.1349-7006.2011.02170.x; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Ke AW, 2009, HEPATOLOGY, V49, P491, DOI 10.1002/hep.22639; Kong HK, 2012, J BIOL CHEM, V287, P38889, DOI 10.1074/jbc.M112.394270; Levy L, 2002, ANN NY ACAD SCI, V963, P21; Li CY, 2010, CANCER PREV RES, V3, P246, DOI 10.1158/1940-6207.CAPR-08-0228; Li Y, 2004, J CANCER RES CLIN, V130, P460, DOI 10.1007/s00432-004-0564-9; Liu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031251; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Lo PHY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061279; McLeod HL, 2013, SCIENCE, V339, P1563, DOI 10.1126/science.1234139; Nahon P, 2012, J HEPATOL, V57, P663, DOI 10.1016/j.jhep.2012.02.035; Pang JZ, 2007, CLIN CANCER RES, V13, P7363, DOI 10.1158/1078-0432.CCR-07-0593; Qin LX, 1999, CANCER RES, V59, P5662; Qin LX, 2001, J CANCER RES CLIN, V127, P482, DOI 10.1007/s004320100236; Ren N, 2006, J CANCER RES CLIN, V132, P399, DOI 10.1007/s00432-005-0049-5; Ren N, 2011, CANCER RES, V71, P3278, DOI 10.1158/0008-5472.CAN-10-3100; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Wu JC, 2010, J CANCER RES CLIN, V136, P595, DOI 10.1007/s00432-009-0695-0; Wu X, 2006, ONCOGENE, V25, P1832, DOI 10.1038/sj.onc.1209191; Zhu ZS, 2012, CANCER RES, V72, P6163, DOI 10.1158/0008-5472.CAN-12-0010	29	144	182	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90528	10.1371/journal.pone.0090528	http://dx.doi.org/10.1371/journal.pone.0090528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603412	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600060
J	Alolayan, AB; Leung, YY				Alolayan, Albraa Badr; Leung, Yiu Yan			Risk Factors of Neurosensory Disturbance following Orthognathic Surgery	PLOS ONE			English	Article							SAGITTAL SPLIT OSTEOTOMY; INFERIOR ALVEOLAR NERVE; FORT-I OSTEOTOMY; RAMUS OSTEOTOMY; SENSIBILITY; ADOLESCENTS; IMPAIRMENT; FIXATION; CHINESE; LIP	Objectives: To report the incidence of objective and subjective neurosensory disturbance (NSD) after orthognathic surgery in a major orthognathic centre in Hong Kong, and to investigate the risk factors that contributed to the incidence of NSD after orthognathic surgery. Materials and Methods: A retrospective cross-sectional study on NSD after orthognathic surgery in a local major orthognathic centre. Patients who had bimaxillary orthognathic surgery reviewed at post-operative 6 months, 12 months or 24 months were recruited to undergo neurosensory tests with subjective and 3 objective assessments. Possible risk factors of NSD including subjects' age and gender, surgical procedures and surgeons' experience were analyzed. Results: 238 patients with 476 sides were recruited. The incidences of subjective NSD after maxillary procedures were 16.2%, 13% and 9.8% at post-operative 6 months, 12 months and 24 months, respectively; the incidences of subjective NSD after mandibular procedures were 35.4%, 36.6% and 34.6% at post-operative 6 months, 12 months and 24 months, respectively. Increased age was found to be a significant risk factor of NSD after orthognathic surgery at short term (at 6 months and 12 months) but not at 24 months. SSO has a significantly higher risk of NSD when compared to VSSO. SSO in combination with anterior mandibular surgery has a higher risk of NSD when compared to VSSO in combination with anterior mandibular surgery or anterior mandibular surgery alone. Gender of patients and surgeons' experience were not found to be risk factors of NSD after orthognathic surgery. Conclusion: The incidence of NSD after maxillary and mandibular orthognathic procedures at post-operative 6 months, 12 months and 24 months was reported. Increased age was identified as a risk factor of short term post-operative NSD but not in long term (24 months or more). Specific mandibular procedures were related to higher incidence of NSD after orthognathic surgery.	[Alolayan, Albraa Badr; Leung, Yiu Yan] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Leung, YY (corresponding author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.	mikeyyleung@hku.hk		Alolayan, Albraa/0000-0001-6897-1565				August M, 1998, J ORAL MAXIL SURG, V56, P1231, DOI 10.1016/S0278-2391(98)90595-X; Bays Robert A, 2003, Oral Maxillofac Surg Clin North Am, V15, P229; Blomqvist JE, 1997, J ORAL MAXIL SURG, V55, P568, DOI 10.1016/S0278-2391(97)90486-9; Colella G, 2007, J ORAL MAXIL SURG, V65, P1707, DOI 10.1016/j.joms.2007.05.009; Essick GK, 2007, INT J ORAL MAX SURG, V36, P577, DOI 10.1016/j.ijom.2007.02.006; Gianni AB, 2002, J CRANIO MAXILL SURG, V30, P295, DOI 10.1016/S1010-5182(02)90311-2; Gu Y, 2011, AUST ORTHOD J, V27, P155; Gu Y, 2011, EUR J ORTHODONT, V33, P205, DOI 10.1093/ejo/cjq054; KARAS ND, 1990, J ORAL MAXIL SURG, V48, P124, DOI 10.1016/S0278-2391(10)80199-5; Kim YK, 2011, J ORAL MAXIL SURG, V69, P893, DOI 10.1016/j.joms.2010.10.025; Kobayashi A, 2006, J ORAL MAXIL SURG, V64, P778, DOI 10.1016/j.joms.2006.01.009; Leung YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072891; Leung YY, 2013, PLOS ONE; Nesari S, 2005, INT J ORAL MAX SURG, V34, P495, DOI 10.1016/j.ijom.2004.10.021; NISHIOKA GJ, 1987, J ORAL MAXIL SURG, V45, P20, DOI 10.1016/0278-2391(87)90081-4; Ow A, 2010, INT J ORAL MAX SURG, V39, P756, DOI 10.1016/j.ijom.2010.04.001; POSNICK JC, 1994, PLAST RECONSTR SURG, V94, P431, DOI 10.1097/00006534-199409000-00002; ROSENBERG A, 1994, J CRANIO MAXILL SURG, V22, P286, DOI 10.1016/S1010-5182(05)80078-2; Schultze-Mosgau S, 2001, J ORAL MAXIL SURG, V59, P128, DOI 10.1053/joms.2001.20480; Westermark A, 1998, BRIT J ORAL MAX SURG, V36, P425, DOI 10.1016/S0266-4356(98)90457-0; Ylikontiola L, 2000, J ORAL MAXIL SURG, V58, P1234, DOI 10.1053/joms.2000.16621	21	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e91055	10.1371/journal.pone.0091055	http://dx.doi.org/10.1371/journal.pone.0091055			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599321	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400152
J	Cordero, RR; Damiani, A; Ferrer, J; Jorquera, J; Tobar, M; Labbe, F; Carrasco, J; Laroze, D				Cordero, Raul R.; Damiani, Alessandro; Ferrer, Jorge; Jorquera, Jose; Tobar, Mario; Labbe, Fernando; Carrasco, Jorge; Laroze, David			UV Irradiance and Albedo at Union Glacier Camp (Antarctica): A Case Study	PLOS ONE			English	Article							GROUND-BASED MEASUREMENTS; SINGLE SCATTERING ALBEDO; SURFACE ALBEDO; TOTAL OZONE; ULTRAVIOLET IRRADIANCE; SPECTRAL IRRADIANCE; SNOW ALBEDO; OMI; CLIMATOLOGY; UNCERTAINTY	We report on the first spectral measurements of ultraviolet (UV) irradiance and the albedo at a Camp located in the southern Ellsworth Mountains on the broad expanse of Union Glacier (700 m altitude, 79 degrees 46' S; 82 degrees 52'W); about 1,000 km from the South Pole. The measurements were carried out by using a double monochromator-based spectroradiometer during a campaign (in December 2012) meant to weight up the effect of the local albedo on the UV irradiance. We found that the albedo measured at noon was about 0.95 in the UV and the visible part of the spectrum. This high surface reflectivity led to enhancements in the UV index under cloudless conditions of about 50% in comparison with snow free surfaces. Spectral measurements carried out elsewhere as well as estimates retrieved from the Ozone Monitoring Instrument (OMI) were used for further comparisons.	[Cordero, Raul R.; Damiani, Alessandro; Ferrer, Jorge; Jorquera, Jose; Tobar, Mario] Univ Santiago Chile, Dept Fis, Santiago, Chile; [Jorquera, Jose] Escuela Super Politecn Litoral, Guayaquil, Ecuador; [Labbe, Fernando] Univ Tecn Federico Santa Maria, Dept Ingn Mecan, Valparaiso, Chile; [Carrasco, Jorge] Direcc Meteorol Chile, Santiago, Chile; [Laroze, David] Univ Tarapaca, Inst Alta Invest, Arica, Chile	Universidad de Santiago de Chile; Escuela Superior Politecnica del Litoral; Universidad Tecnica Federico Santa Maria; Universidad de Tarapaca	Cordero, RR (corresponding author), Univ Santiago Chile, Dept Fis, Santiago, Chile.	raul.cordero@usach.cl	Carrasco, Jorge/ACG-6766-2022; Carrasco, Jorge/AAC-4799-2021; Damiani, Alessandro/X-4677-2019; Laroze, David/E-9134-2011; Cordero, Raul R/M-7979-2017; Laroze, David/Z-2852-2019; Carrasco, Jorge F/K-2949-2014	Carrasco, Jorge/0000-0003-2154-5483; Carrasco, Jorge/0000-0003-2154-5483; Damiani, Alessandro/0000-0003-3014-6193; Laroze, David/0000-0002-6487-8096; Laroze, David/0000-0002-6487-8096; Carrasco, Jorge F/0000-0003-2154-5483; Cordero, Raul R./0000-0001-7607-7993	Escuela Superior Politecnica del Litoral (Guayaquil, ECUADOR); CONICYT-REDES [Preis 130047]; CONICYT-BMBF; FONDEF [IT13I10034]; FONDECYT [Preis 1120639, 1140239, Preis 1120764]; Millennium Scientific Initiative [P10-061-F]; CEDENNA; UTA-Project [8750-12]; USACH-DICYT ASOCIATIVO; UTFSM-DGIP	Escuela Superior Politecnica del Litoral (Guayaquil, ECUADOR); CONICYT-REDES; CONICYT-BMBF(Federal Ministry of Education & Research (BMBF)); FONDEF; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Scientific Initiative; CEDENNA; UTA-Project; USACH-DICYT ASOCIATIVO; UTFSM-DGIP	Although the support of the Escuela Superior Politecnica del Litoral (Guayaquil, ECUADOR), CONICYT-REDES (Preis 130047), CONICYT-BMBF, FONDEF (IT13I10034), FONDECYT (Preis 1120639, 1140239 and Preis 1120764), Millennium Scientific Initiative (P10-061-F), CEDENNA, UTA-Project 8750-12, USACH-DICYT ASOCIATIVO, and UTFSM-DGIP, is gratefully acknowledged, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton M, 2011, ATMOS RES, V100, P83, DOI 10.1016/j.atmosres.2010.12.029; Anton M, 2010, ATMOS CHEM PHYS, V10, P5979, DOI 10.5194/acp-10-5979-2010; Aoki T, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015507; Badosa J, 2007, ATMOS CHEM PHYS, V7, P2817, DOI 10.5194/acp-7-2817-2007; Bais AF, 2005, ATMOS ENVIRON, V39, P1093, DOI 10.1016/j.atmosenv.2004.09.080; Bais AF, 2001, J GEOPHYS RES-ATMOS, V106, P12509, DOI 10.1029/2000JD900561; Balis D, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008796; Bernhard G, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004937; Bernhard G, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003450; Bernhard G, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD005857; Bernhard G, 2005, P SOC PHOTO-OPT INS, V5886, P51; Bernhard G, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007865; Bernhard G, 2010, UV RADIATION IN GLOBAL CLIMATE CHANGE, P48, DOI 10.1007/978-3-642-03313-1_3; Blumthaler M, 2009, MOCA JOINT ASS MONTR; Brandt RE, 2005, J CLIMATE, V18, P3606, DOI 10.1175/JCLI3489.1; Bromwich DH, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000363; Buchard V, 2008, ATMOS CHEM PHYS, V8, P4517, DOI 10.5194/acp-8-4517-2008; Buchard V, 2011, ATMOS MEAS TECH, V4, P1, DOI 10.5194/amt-4-1-2011; Cabrera S, 2012, J PHOTOCH PHOTOBIO B, V115, P73, DOI 10.1016/j.jphotobiol.2012.06.013; Cede A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006585; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Cordero RR, 2013, PHOTOCH PHOTOBIO SCI, V12, P1193, DOI 10.1039/c3pp25440b; Cordero RR, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/4/045104; Cordero RR, 2008, METROLOGIA, V45, P1, DOI 10.1088/0026-1394/45/1/001; Cordero RR, 2007, OPT COMMUN, V276, P44, DOI 10.1016/j.optcom.2007.04.008; Cordero RR, 2013, METROLOGIA, V50, pL1, DOI 10.1088/0026-1394/50/5/L1; Cordero RR, 2013, ANTARCT SCI, V25, P791, DOI 10.1017/S0954102013000175; Cordero RR, 2013, APPL OPTICS, V52, P6287, DOI 10.1364/AO.52.006287; Cordero RR, 2009, METROLOGIA, V46, P19, DOI 10.1088/0026-1394/46/1/003; DAHLBACK A, 1991, PLANET SPACE SCI, V39, P671, DOI 10.1016/0032-0633(91)90061-E; Damiani A, 2013, INT J REMOTE SENS, V34, P5812, DOI 10.1080/01431161.2013.796101; Damiani A, 2012, REMOTE SENS ENVIRON, V127, P162, DOI 10.1016/j.rse.2012.08.023; Douglass A, 2011, 52 GLOB OZ RES MON P; Flemming J, 2011, ATMOS CHEM PHYS, V11, P1961, DOI 10.5194/acp-11-1961-2011; Grenfell TC, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001866; GRENFELL TC, 1994, J GEOPHYS RES-ATMOS, V99, P18669, DOI 10.1029/94JD01484; Grobner J, 2000, J GEOPHYS RES-ATMOS, V105, P26991, DOI 10.1029/2000JD900395; Grobner J., 2007, REPORT PMOD WRC COST; Grobner J, 2006, METROLOGIA, V43, pS66, DOI 10.1088/0026-1394/43/2/S14; Grooss JU, 2011, ATMOS CHEM PHYS, V11, P12217, DOI 10.5194/acp-11-12217-2011; Gueymard CA, 2004, SOL ENERGY, V76, P423, DOI 10.1016/j.solener.2003.08.039; Hall A, 2004, J CLIMATE, V17, P1550, DOI 10.1175/1520-0442(2004)017&lt;1550:TROSAF&gt;2.0.CO;2; Ialongo I, 2008, ATMOS CHEM PHYS, V8, P3283, DOI 10.5194/acp-8-3283-2008; Ialongo I., 2009, ATMOS CHEM PHYS DISC, V9, P19009, DOI DOI 10.5194/acpd-9-19009-2009; Kazadzis S, 2009, ATMOS CHEM PHYS, V9, P4593, DOI 10.5194/acp-9-4593-2009; Kazadzis S, 2009, ATMOS CHEM PHYS, V9, P585, DOI 10.5194/acp-9-585-2009; Kleipool QL, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010290; Kylling A, 2000, J GEOPHYS RES-ATMOS, V105, P4949, DOI 10.1029/1999JD900304; Lenoble J, 1998, APPL OPTICS, V37, P2441, DOI 10.1364/AO.37.002441; Li SS, 2003, APPL OPTICS, V42, P5427, DOI 10.1364/AO.42.005427; Mayer B, 2005, ATMOS CHEM PHYS, V5, P1855, DOI 10.5194/acp-5-1855-2005; McKinlay AF., 1987, CIE J, P83; McPeters R, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008802; Meinander O, 2008, ATMOS CHEM PHYS, V8, P6551, DOI 10.5194/acp-8-6551-2008; Meinander O, 2013, ATMOS CHEM PHYS, V13, P3793, DOI 10.5194/acp-13-3793-2013; Meinander O., 2009, GEOPHYSICS, V45, P183; O'Byrne G, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013079; PARISH TR, 1987, NATURE, V328, P51, DOI 10.1038/328051a0; Pedersen CA, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010440; Pirazzini R, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004617; Satheesh SK, 2006, ATMOS ENVIRON, V40, P3008, DOI 10.1016/j.atmosenv.2006.01.031; Seckmeyer G., 2001, 125 WMOGAW; Smolskaia I, 2003, APPL OPTICS, V42, P1583, DOI 10.1364/AO.42.001583; STAMNES K, 1991, APPL OPTICS, V30, P4418, DOI 10.1364/AO.30.004418; Tanskanen A, 2007, ATMOS CHEM PHYS, V7, P2759, DOI 10.5194/acp-7-2759-2007; Tanskanen A, 2006, IEEE T GEOSCI REMOTE, V44, P1267, DOI 10.1109/TGRS.2005.862203; Tanskanen A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008830; Van den Broeke MR, 2004, J GLACIOL, V50, P565, DOI 10.3189/172756504781829756; Vaughan DG, 2001, SCIENCE, V293, P1777, DOI 10.1126/science.1065116; Weihs P, 2008, ATMOS CHEM PHYS, V8, P5615, DOI 10.5194/acp-8-5615-2008; Weller R, 2013, ATMOS CHEM PHYS, V13, P1579, DOI 10.5194/acp-13-1579-2013; Winton M, 2006, J CLIMATE, V19, P359, DOI 10.1175/JCLI3624.1; Wuttke S, 2006, ANN GEOPHYS-GERMANY, V24, P7, DOI 10.5194/angeo-24-7-2006; Wuttke S, 2006, J ATMOS OCEAN TECH, V23, P241, DOI 10.1175/JTECH1826.1	74	14	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90705	10.1371/journal.pone.0090705	http://dx.doi.org/10.1371/journal.pone.0090705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598906	gold, Green Submitted, Green Published			2022-12-25	WOS:000332479400122
J	Gobin, B; Moriceau, G; Ory, B; Charrier, C; Brion, R; Blanchard, F; Redini, F; Heymann, D				Gobin, Berengere; Moriceau, Gatien; Ory, Benjamin; Charrier, Celine; Brion, Regis; Blanchard, Frederic; Redini, Francoise; Heymann, Dominique			Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TYROSINE KINASE; FACTOR RECEPTOR; SOFT-TISSUE; IN-VITRO; PHASE-II; BONE; TARGET; PROLIFERATION; THERAPY	Osteosarcoma is the most common primary malignant bone tumour characterized by osteoid production and/or osteolytic lesions of bone. A lack of response to chemotherapeutic treatments shows the importance of exploring new therapeutic methods. Imatinib mesylate (Gleevec, Novartis Pharma), a tyrosine kinase inhibitor, was originally developed for the treatment of chronic myeloid leukemia. Several studies revealed that imatinib mesylate inhibits osteoclast differentiation through the M-CSFR pathway and activates osteoblast differentiation through PDGFR pathway, two key cells involved in the vicious cycle controlling the tumour development. The present study investigated the in vitro effects of imatinib mesylate on the proliferation, apoptosis, cell cycle, and migration ability of five osteosarcoma cell lines (human: MG-63, HOS; rat: OSRGA; mice: MOS-J, POS-1). Imatinib mesylate was also assessed as a curative and preventive treatment in two syngenic osteosarcoma models: MOS-J (mixed osteoblastic/osteolytic osteosarcoma) and POS-1 (undifferentiated osteosarcoma). Imatinib mesylate exhibited a dose-dependent anti-proliferative effect in all cell lines studied. The drug induced a G0/G1 cell cycle arrest in most cell lines, except for POS-1 and HOS cells that were blocked in the S phase. In addition, imatinib mesylate induced cell death and strongly inhibited osteosarcoma cell migration. In the MOS-J osteosarcoma model, oral administration of imatinib mesylate significantly inhibited the tumour development in both preventive and curative approaches. A phospho-receptor tyrosine kinase array kit revealed that PDGFR alpha, among 7 other receptors (PDFGFR beta, Axl, RYK, EGFR, EphA2 and 10, IGF1R), appears as one of the main molecular targets for imatinib mesylate. In the light of the present study and the literature, it would be particularly interesting to revisit therapeutic evaluation of imatinib mesylate in osteosarcoma according to the tyrosine-kinase receptor status of patients.	[Gobin, Berengere; Moriceau, Gatien; Ory, Benjamin; Charrier, Celine; Brion, Regis; Blanchard, Frederic; Redini, Francoise; Heymann, Dominique] INSERM, UMR 957, Nantes, France; [Gobin, Berengere; Moriceau, Gatien; Ory, Benjamin; Charrier, Celine; Brion, Regis; Blanchard, Frederic; Redini, Francoise; Heymann, Dominique] Nantes Atlantique Univ, Univ Nantes, Nantes, France; [Ory, Benjamin; Charrier, Celine; Brion, Regis; Blanchard, Frederic; Redini, Francoise; Heymann, Dominique] Equipe LIGUE Natl Canc 2012, Nantes, France; [Brion, Regis; Redini, Francoise; Heymann, Dominique] CHU Nantes, F-44035 Nantes 01, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes	Heymann, D (corresponding author), INSERM, UMR 957, Nantes, France.	dominique.heymann@univ-nantes.fr	Blanchard, Frederic/K-8018-2015; Heymann, Dominique/AAC-6014-2019; ory, benjamin r/K-8231-2015; Charrier, Céline/K-9198-2015; Blanchard, Frederic/AAS-1930-2021; REDINI, Francoise/K-7981-2015	Blanchard, Frederic/0000-0003-1055-2573; Heymann, Dominique/0000-0001-7777-0669; Blanchard, Frederic/0000-0003-1055-2573; ory, benjamin/0000-0002-2622-7356	Pharma Novartis (Rueil-Malmaison, France); Region des Pays de la Loire; INSERM	Pharma Novartis (Rueil-Malmaison, France); Region des Pays de la Loire(Region Pays de la Loire); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by a grant from Pharma Novartis (Rueil-Malmaison, France) and Berengere Gobin received a PhD fellowship from the Region des Pays de la Loire and INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison Daniel C., 2012, Sarcoma, V2012, P704872, DOI 10.1155/2012/704872; Ando Kosei, 2013, Cancers (Basel), V5, P591, DOI 10.3390/cancers5020591; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bond M, 2008, PEDIATR BLOOD CANCER, V50, P254, DOI 10.1002/pbc.21132; Chawla SP, 2012, J CLIN ONCOL, V30, P78, DOI 10.1200/JCO.2011.35.6329; Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002; Dib IE, 2006, EUR J PHARMACOL, V551, P27, DOI 10.1016/j.ejphar.2006.09.007; Fierro F, 2007, CELL PROLIFERAT, V40, P355, DOI 10.1111/j.1365-2184.2007.00438.x; Fritsche-Guenther R, 2010, HISTOPATHOLOGY, V57, P836, DOI 10.1111/j.1365-2559.2010.03713.x; Han J, 2013, BIOCHEM BIOPH RES CO, V435, P493, DOI 10.1016/j.bbrc.2013.05.019; Heymann D, 2011, IBMS BONEKEY, V8, P402, DOI DOI 10.1138/20110531; Hingorani P, 2009, CLIN CANCER RES, V15, P3416, DOI 10.1158/1078-0432.CCR-08-1657; Joliat MJ, 2002, IN VIVO, V16, P223; Kamijo A, 2002, CANCER LETT, V188, P213, DOI 10.1016/S0304-3835(02)00433-0; Kitagawa D, 2013, GENES CELLS, V18, P110, DOI 10.1111/gtc.12022; KLEIN B, 1977, INT J CANCER, V20, P112, DOI 10.1002/ijc.2910200118; Kubo T, 2008, CANCER-AM CANCER SOC, V112, P2119, DOI 10.1002/cncr.23437; Kuijjer ML, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-245; Lamoureux F, 2007, CANCER RES, V67, P7308, DOI 10.1158/0008-5472.CAN-06-4130; Lavenus S, 2011, EUR CELLS MATER, V22, P84, DOI 10.22203/eCM.v022a07; Lee JA, 2012, CANCER RES TREAT, V44, P202, DOI 10.4143/crt.2012.44.3.202; Macheda ML, 2008, CURR CANCER DRUG TAR, V8, P454, DOI 10.2174/156800908785699324; Manara MC, 2010, CLIN CANCER RES, V16, P530, DOI 10.1158/1078-0432.CCR-09-0816; Matsuo K, 2012, CELL ADHES MIGR, V6, P148, DOI 10.4161/cam.20888; McGary EC, 2002, CLIN CANCER RES, V8, P3584; McQueen P, 2011, EXPERT REV ANTICANC, V11, P1223, DOI [10.1586/era.11.94, 10.1586/ERA.11.94]; Miiji LNO, 2011, INT J CLIN EXP PATHO, V4, P775; Mohseny AB, 2011, STEM CELLS, V29, P397, DOI 10.1002/stem.596; Moriceau G, 2012, CANCER-AM CANCER SOC, V118, P750, DOI 10.1002/cncr.26336; Moriceau G, 2010, CANCER RES, V70, P10329, DOI 10.1158/0008-5472.CAN-10-0578; Nakano T, 2003, CLIN EXP METASTAS, V20, P665, DOI 10.1023/A:1027355610603; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; O'Sullivan S, 2007, J BONE MINER RES, V22, P1679, DOI 10.1359/JBMR.070719; Parkkila S, 2009, BIOORG MED CHEM LETT, V19, P4102, DOI 10.1016/j.bmcl.2009.06.002; PosthumaDeBoer J, 2013, BRIT J CANCER, V109, P2142, DOI 10.1038/bjc.2013.578; Rettew AN, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.34; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; ROSEN G, 1976, CANCER-AM CANCER SOC, V37, P1, DOI 10.1002/1097-0142(197601)37:1<1::AID-CNCR2820370102>3.0.CO;2-3; Savage DG, 2002, NEW ENGL J MED, V346, P683, DOI 10.1056/NEJMra013339; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Truitt L, 2011, BIOCHEM CELL BIOL, V89, P115, DOI [10.1139/O10-145, 10.1139/o10-145]; Vandyke K, 2010, BLOOD, V115, P766, DOI 10.1182/blood-2009-08-237404; Verweij J, 2003, EUR J CANCER, V39, P2006, DOI 10.1016/S0959-8049(02)00836-5; Winger JA, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-7; Zhang Y, 2013, INT J IMMUNOPATH PH, V26, P179, DOI 10.1177/039463201302600117	45	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90795	10.1371/journal.pone.0090795	http://dx.doi.org/10.1371/journal.pone.0090795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599309	Green Accepted, gold, Green Published			2022-12-25	WOS:000332479400132
J	Hazelton, PT; Steward, WT; Collins, SP; Gaffney, S; Morin, SF; Arnold, EA				Hazelton, Patrick T.; Steward, Wayne T.; Collins, Shane P.; Gaffney, Stuart; Morin, Stephen F.; Arnold, Emily A.			California's "Bridge to Reform'': Identifying Challenges and Defining Strategies for Providers and Policymakers Implementing the Affordable Care Act in Low-Income HIV/AIDS Care and Treatment Settings	PLOS ONE			English	Article							HIV CARE; HEALTH-INSURANCE; RYAN WHITE; SYSTEM; WAVE	Background: In preparation for full Affordable Care Act implementation, California has instituted two healthcare initiatives that provide comprehensive coverage for previously uninsured or underinsured individuals. For many people living with HIV, this has required transition either from the HIV-specific coverage of the Ryan White program to the more comprehensive coverage provided by the county-run Low-Income Health Programs or from Medicaid fee-for-service to Medicaid managed care. Patient advocates have expressed concern that these transitions may present implementation challenges that will need to be addressed if ambitious HIV prevention and treatment goals are to be achieved. Methods: 30 semi-structured, in-depth interviews were conducted between October, 2012, and February, 2013, with policymakers and providers in 10 urban, suburban, and rural California counties. Interview topics included: continuity of patient care, capacity to handle payer source transitions, and preparations for healthcare reform implementation. Study team members reviewed interview transcripts to produce emergent themes, develop a codebook, build inter-rater reliability, and conduct analyses. Results: Respondents supported the goals of the ACA, but reported clinic and policy-level challenges to maintaining patient continuity of care during the payer source transitions. They also identified strategies for addressing these challenges. Areas of focus included: gaps in communication to reach patients and develop partnerships between providers and policymakers, perceived inadequacy in new provider networks for delivering quality HIV care, the potential for clinics to become financially insolvent due to lower reimbursement rates, and increased administrative burdens for clinic staff and patients. Conclusions: California's new healthcare initiatives represent ambitious attempts to expand and improve health coverage for low-income individuals. The state's challenges in maintaining quality care and treatment for people living with HIV experiencing these transitions demonstrate the importance of setting effective policies in anticipation of full ACA implementation in 2014.	[Hazelton, Patrick T.; Steward, Wayne T.; Collins, Shane P.; Gaffney, Stuart; Morin, Stephen F.; Arnold, Emily A.] Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA 94117 USA	University of California System; University of California San Francisco	Hazelton, PT (corresponding author), Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA 94117 USA.	patrick.hazelton@ucsf.edu			California HIV/AIDS Research Centers; California HIV/AIDS Research Program (CHRP); CHRP [RP11-SF-021]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	California HIV/AIDS Research Centers; California HIV/AIDS Research Program (CHRP); CHRP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was conducted under the auspices of the California HIV/AIDS Research Centers, two university-community partnerships funded by the California HIV/AIDS Research Program (CHRP) that are intended to increase the use of systematic investigations to inform HIV policymaking. The center in Northern California consists of the University of California, San Francisco (UCSF); the San Francisco AIDS Foundation; and Project Inform. The center in Southern California consists of the University of California, Los Angeles; AIDS Project Los Angeles, and the Los Angeles Gay and Lesbian Center. The data collection activities and analyses described in this paper were supported by the CHRP funding awarded to UCSF (RP11-SF-021; PI: Wayne T. Steward). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bindman AB, 2011, NEW ENGL J MED, V364, P1487, DOI 10.1056/NEJMp1014109; California Budget Project, 2013, EXP HOR KEY FACTS ME; California Department of Healthcare Services (DHCS), 2011, CAL BRIDG REF DEM LO; Chen RY, 2006, CLIN INFECT DIS, V42, P1003, DOI 10.1086/500453; Crowley JS, 2013, UPDATE R WHITE HIV A; Darling H, 2010, HEALTH AFFAIR, V29, P1220, DOI 10.1377/hlthaff.2010.0422; Decker SL, 2012, HEALTH AFFAIR, V31, P1673, DOI 10.1377/hlthaff.2012.0294; Donnelly A, 2012, HLTH CARE REFORM CAL; Flynn M, 2012, HEALTHCARE REFORM MA; Gallant JE, 2011, CLIN INFECT DIS, V53, P1043, DOI 10.1093/cid/cir689; Health Resource and Services Administration (HRSA), 2011, HIV AIDS PROGR R WHI; Health Resources and Services Administration (HRSA), 2013, WHAT AR FED QUAL HLT; Health Resources and Services Administration (HRSA), 2014, 340B DRUG PRIC PROGR; Hoang T, 2009, MED CARE, V47, P560, DOI 10.1097/MLR.0b013e31819432a0; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSSING QUALITY CHA; Kaiser Family Foundation, 2012, MED TO MED FEE IND; Kaiser Family Foundation, 2013, NAV IN PERS ASS PROG; Kates J., 2014, ASSESSING IMPACT AFF; Kates J., 2011, MEDICAID HIV NATL AN; Lefert A, 2013, NATL ADAP MONITORING; Leibowitz AA, 2013, JAIDS-J ACQ IMM DEF, V64, pS62, DOI 10.1097/01.qai.0000435254.49553.24; Martin EG, 2012, JAIDS-J ACQ IMM DEF, V60, P72, DOI 10.1097/QAI.0b013e31824c0dd4; McDonough JE, 2006, HEALTH AFFAIR, V25, pW420, DOI 10.1377/hlthaff.25.w420; Moore RD, 2012, CLIN INFECT DIS, V55, P1242, DOI 10.1093/cid/cis654; National Alliance of State & Territorial AIDS Directors, 2013, HLTH REF ISS BRIEF P; Ojikutu B, 2013, AIDS CARE; Parham Hopson D, 2011, CALIFORNIA WAIVER LE; Pourat N, 2012, HEALTH AFFAIR, V31, P1717, DOI 10.1377/hlthaff.2012.0545; Riley ED, 2011, AIDS CARE, V23, P822, DOI 10.1080/09540121.2010.538660; Ryan B, 2011, POZ              SEP, P42; Saag MS, 2009, AIDS READ, V19, P166; San Francisco HIV Health Care Reform Task Force Harder+Company Community Research, 2013, HIV SERV ORG PLANN C; Shepherd J, 2013, MINNESOTA J LAW SCI; Sherer R, 2012, SEX TRANSM INFECT, V88, P106, DOI 10.1136/sextrans-2011-050160; Strauss AL, 1998, BASICS QUALITATIVE R, V2nd; The Center for Medicaid and CHIP Services (CMCS), 2014, HLTH HOM	36	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90306	10.1371/journal.pone.0090306	http://dx.doi.org/10.1371/journal.pone.0090306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24599337	gold, Green Submitted, Green Published			2022-12-25	WOS:000332479400061
J	Lin, TY; Chu, YY; Yang, YC; Hsu, SW; Liu, ST; Chang, LK				Lin, Ting-Yu; Chu, Ya-Yun; Yang, Ya-Chun; Hsu, Shih-Wei; Liu, Shih-Tung; Chang, Li-Kwan			MCAF1 and Rta-Activated BZLF1 Transcription in Epstein-Barr Virus	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; IMMEDIATE-EARLY PROTEIN; SWITCH GENE BZLF1; LYTIC CYCLE; EPITHELIAL-CELLS; BMLF1 PROMOTER; BRLF1; EBV; BINDING; TRANSACTIVATORS	Epstein-Barr virus (EBV) expresses two transcription factors, Rta and Zta, which are involved in the transcriptional activation of EBV lytic genes. This study sought to elucidate the mechanism by which Rta activates transcription of the Zta-encoding gene, BZLF1, through the ZII element in the gene promoter. In a DNA affinity precipitation assay, ATF2 was found to associate with an Rta-interacting protein, MCAF1, at the ZII element. The interaction between Rta, MCAF1, and ATF2 at the same site in the ZII region was further verified in vivo by chromatin immunoprecipitation assay. The complex appears to be crucial for the activation of BZLF1 transcription, as the overexpression of two ATF2-dominant negative mutants, or the introduction of MCAF1 siRNA into 293T cells, were both found to substantially reduce Rta-mediated transcription levels of BZLF1. Moreover, this study also found that the Rta-MCAF1-ATF2 complex binds to a typical AP-1 binding sequence on the promoter of BMRF2, a key viral gene for EBV infection. Mutation of this sequence decreased Rta-mediated promoter activity significantly. Taken together, these results indicate a critical role for MCAF1 in AP-1-dependent Rta activation of BZLF1 transcription.	[Lin, Ting-Yu; Chu, Ya-Yun; Yang, Ya-Chun; Chang, Li-Kwan] Natl Taiwan Univ, Dept Biochem Sci & Technol, Coll Life Sci, Taipei 10764, Taiwan; [Hsu, Shih-Wei; Liu, Shih-Tung] Chang Gung Univ, Dept Microbiol & Immunol, Mol Genet Lab, Tao Yuan, Taiwan	National Taiwan University; Chang Gung University	Chang, LK (corresponding author), Natl Taiwan Univ, Dept Biochem Sci & Technol, Coll Life Sci, Taipei 10764, Taiwan.	changlk@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013		National Health Research Institute [NHRI-EX102-10030BI]	National Health Research Institute(National Health Research Institutes - Taiwan)	This work was supported by National Health Research Institute (Grant NHRI-EX102-10030BI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AL, 2000, J VIROL, V74, P1224, DOI 10.1128/JVI.74.3.1224-1233.2000; Bergbauer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001114; Bhende PM, 2004, NAT GENET, V36, P1099, DOI 10.1038/ng1424; Chang LK, 2008, J MOL BIOL, V379, P231, DOI 10.1016/j.jmb.2008.04.011; Chang LK, 2010, NUCLEIC ACIDS RES, V38, P4687, DOI 10.1093/nar/gkq243; Chang LK, 2005, NUCLEIC ACIDS RES, V33, P6528, DOI 10.1093/nar/gki956; Chang LK, 2000, NUCLEIC ACIDS RES, V28, P3918, DOI 10.1093/nar/28.20.3918; Chang LK, 2004, J BIOL CHEM, V279, P38803, DOI 10.1074/jbc.M405470200; Chang PJ, 1998, J VIROL, V72, P5128, DOI 10.1128/JVI.72.6.5128-5136.1998; CHEVALLIERGRECO A, 1986, EMBO J, V5, P3243, DOI 10.1002/j.1460-2075.1986.tb04635.x; DAVIES AH, 1991, J VIROL, V65, P6838, DOI 10.1128/JVI.65.12.6838-6844.1991; De Graeve F, 2000, ONCOGENE, V19, P1807, DOI 10.1038/sj.onc.1203492; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; FIXMAN ED, 1992, J VIROL, V66, P5030, DOI 10.1128/JVI.66.8.5030-5039.1992; FLEMINGTON E, 1990, J VIROL, V64, P1217, DOI 10.1128/JVI.64.3.1217-1226.1990; FLEMINGTON E, 1990, J VIROL, V64, P1227, DOI 10.1128/JVI.64.3.1227-1232.1990; Fujita N, 2003, MOL CELL BIOL, V23, P2834, DOI 10.1128/MCB.23.8.2834-2843.2003; GRUFFAT H, 1990, NUCLEIC ACIDS RES, V18, P6835, DOI 10.1093/nar/18.23.6835; GRUFFAT H, 1992, J VIROL, V66, P46, DOI 10.1128/JVI.66.1.46-52.1992; Hinuma Y, 1967, J Virol, V1, P1045; HOLLEYGUTHRIE EA, 1990, J VIROL, V64, P3753, DOI 10.1128/JVI.64.8.3753-3759.1990; Huang J, 2006, J VIROL, V80, P1098, DOI 10.1128/JVI.80.3.1098-1109.2006; Karlsson QH, 2008, BIOCHEM SOC T, V36, P637, DOI 10.1042/BST0360637; KENNEY S, 1989, J VIROL, V63, P3878, DOI 10.1128/JVI.63.9.3878-3883.1989; Lee YH, 2008, J GEN VIROL, V89, P2437, DOI 10.1099/vir.0.2008/003897-0; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; Liu CN, 1996, J VIROL, V70, P2545, DOI 10.1128/JVI.70.4.2545-2555.1996; Lu CC, 2006, VIROLOGY, V345, P358, DOI 10.1016/j.virol.2005.09.064; LUKA J, 1979, VIROLOGY, V94, P228, DOI 10.1016/0042-6822(79)90455-0; QUINLIVAN EB, 1993, NUCLEIC ACIDS RES, V21, P1999, DOI 10.1093/nar/21.8.1999; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; RUF IK, 1995, J VIROL, V69, P7648, DOI 10.1128/JVI.69.12.7648-7657.1995; SCHEPERS A, 1993, EMBO J, V12, P3921, DOI 10.1002/j.1460-2075.1993.tb06070.x; Speck SH, 1997, TRENDS MICROBIOL, V5, P399, DOI 10.1016/S0966-842X(97)01129-3; Sun CC, 2007, J VIROL, V81, P13566, DOI 10.1128/JVI.01055-07; Uchimura Y, 2006, J BIOL CHEM, V281, P23180, DOI 10.1074/jbc.M602280200; Wang YCJ, 1997, VIROLOGY, V227, P323, DOI 10.1006/viro.1996.8326; Xiao JQ, 2008, VIROLOGY, V370, P430, DOI 10.1016/j.virol.2007.09.012; Yang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054075	39	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90698	10.1371/journal.pone.0090698	http://dx.doi.org/10.1371/journal.pone.0090698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598729	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400119
J	Murgatroyd, C; Spengler, D				Murgatroyd, Chris; Spengler, Dietmar			Polycomb Binding Precedes Early-Life Stress Responsive DNA Methylation at the Avp Enhancer	PLOS ONE			English	Article							TRANSCRIPTIONAL REPRESSION; MECP2; BRAIN; HYPOTHALAMUS; LINEAGE; CELLS; AXIS; CPG	Early-life stress (ELS) in mice causes sustained hypomethylation at the downstream Avp enhancer, subsequent overexpression of hypothalamic Avp and increased stress responsivity. The sequence of events leading to Avp enhancer methylation is presently unknown. Here, we used an embryonic stem cell-derived model of hypothalamic-like differentiation together with in vivo experiments to show that binding of polycomb complexes (PcG) preceded the emergence of ELS-responsive DNA methylation and correlated with gene silencing. At the same time, PcG occupancy associated with the presence of Tet proteins preventing DNA methylation. Early hypothalamic-like differentiation triggered PcG eviction, DNA-methyltransferase recruitment and enhancer methylation. Concurrently, binding of the Methyl-CpG-binding and repressor protein MeCP2 increased at the enhancer although Avp expression during later stages of differentiation and the perinatal period continued to increase. Overall, we provide evidence of a new role of PcG proteins in priming ELS-responsive DNA methylation at the Avp enhancer prior to epigenetic programming consistent with the idea that PcG proteins are part of a flexible silencing system during neuronal development.	[Murgatroyd, Chris; Spengler, Dietmar] Max Planck Inst Psychiat, Munich, Germany; [Murgatroyd, Chris] Manchester Metropolitan Univ, Manchester M15 6BH, Lancs, England	Max Planck Society; Manchester Metropolitan University	Murgatroyd, C (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	c.murgatroyd@mmu.ac.uk		Murgatroyd, Chris/0000-0002-6885-7794				Bettscheider Marc, 2011, BMC Res Notes, V4, P314, DOI 10.1186/1756-0500-4-314; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Engelmann M, 2004, FRONT NEUROENDOCRIN, V25, P132, DOI 10.1016/j.yfrne.2004.09.001; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Goncharova Nadezhda D, 2013, Front Endocrinol (Lausanne), V4, P26, DOI 10.3389/fendo.2013.00026; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Hoffmann A, 2014, NEUROSCIENCE, V264, P64, DOI 10.1016/j.neuroscience.2012.04.003; KARIM MA, 1980, J ANAT, V130, P341; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kurian JR, 2007, EPIGENETICS, V2, P173, DOI 10.4161/epi.2.3.4841; Lees-Murdock DJ, 2003, GENOMICS, V82, P230, DOI 10.1016/S0888-7543(03)00105-8; Lynch MD, 2012, EMBO J, V31, P317, DOI 10.1038/emboj.2011.399; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Murgatroyd C, 2012, METHODS MOL BIOL, V809, P135, DOI 10.1007/978-1-61779-376-9_9; Murgatroyd C, 2011, STRESS, V14, P581, DOI 10.3109/10253890.2011.602146; Murgatroyd C, 2010, AGING-US, V2, P107; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Negishi M, 2007, BIOCHEM BIOPH RES CO, V353, P992, DOI 10.1016/j.bbrc.2006.12.166; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Sweatt JD, 2013, NEURON, V80, P624, DOI 10.1016/j.neuron.2013.10.023; Szabo NE, 2009, J NEUROSCI, V29, P6989, DOI 10.1523/JNEUROSCI.1089-09.2009; Szarek E, 2010, MOL CELL ENDOCRINOL, V323, P115, DOI 10.1016/j.mce.2010.04.002; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wissing S, 2012, HUM MOL GENET, V21, P208, DOI 10.1093/hmg/ddr455; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485	35	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90277	10.1371/journal.pone.0090277	http://dx.doi.org/10.1371/journal.pone.0090277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599304	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400059
J	Onwuamah, CK; Ekama, SO; Audu, RA; Ezechi, OC; Poirier, MC; Odeigah, PGC				Onwuamah, Chika K.; Ekama, Sabdat O.; Audu, Rosemary A.; Ezechi, Oliver C.; Poirier, Miriam C.; Odeigah, Peter G. C.			Exposure of Allium cepa Root Cells to Zidovudine or Nevirapine Induces Cytogenotoxic Changes	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; HUMAN LYMPHOBLASTOID-CELLS; UNINFECTED CHILDREN BORN; HIV-INFECTED WOMEN; IN-VITRO EXPOSURE; PERINATAL EXPOSURE; UTERO EXPOSURE; TRANSMISSION; GENOTOXICITY; CARCINOMA	Antiretroviral drugs have proved useful in the clinical management of HIV-infected persons, though there are concerns about the effects of exposure to these DNA-reactive drugs. We investigated the potential of the plant model Allium cepa root tip assay to demonstrate the cytogenotoxicity of zidovudine and nevirapine and as a replace-reduce-refine programme amenable to resource-poor research settings. Cells mitotic index were determined in squashed root cells from Allium cepa bulbs exposed to zidovudine or nevirapine for 48 hr. The concentration of zidovudine and nevirapine inhibiting 50% root growth after 96 hr exposure was 65.0 mu M and 92.5 mu M respectively. Root length of all antiretroviral-exposed roots after 96 hr exposure was significantly shorter than the unexposed roots while additional root growth during a subsequent 48 hr recovery period in the absence of drug was not significantly different. By ANOVA, there was a significant association between percentage of cells in mitosis and zidovudine dose (p = 0.004), but not nevirapine dose (p = 0.68). Chromosomal aberrations such as sticky chromosomes, chromatin bridges, multipolar mitoses and binucleated cells were observed in root cells exposed to zidovudine and nevirapine for 48 hr. The most notable chromosomal aberration was drug-related increases in sticky chromosomes. Overall, the study showed inhibition in root length growth, changes in the mitotic index, and the induction of chromosomal aberrations in Allium bulbs treated for 96 hr or 48 hr with zidovudine and nevirapine. The study reveals generalized cytogenotoxic damage induced by exposure to zidovudine and nevirapine, and further show that the two compounds differ in their effects on mitosis and the types of chromosomal aberrations induced.	[Onwuamah, Chika K.; Audu, Rosemary A.] Nigerian Inst Med Res, Human Virol Lab, Lagos, Nigeria; [Ekama, Sabdat O.; Ezechi, Oliver C.] Nigerian Inst Med Res, Div Clin Sci, Lagos, Nigeria; [Poirier, Miriam C.] NCI, Carcinogen DNA Interact Sect, LCBG, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Odeigah, Peter G. C.] Univ Lagos, Dept Cell Biol & Genet, Lagos, Nigeria	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Lagos	Onwuamah, CK (corresponding author), Nigerian Inst Med Res, Human Virol Lab, Lagos, Nigeria.	chikaonwuamah@yahoo.com	Onwuamah, Chika Kingsley/ABB-9926-2020; Audu, Rosemary A/G-1726-2017	Onwuamah, Chika Kingsley/0000-0002-5111-1822; Audu, Rosemary A/0000-0002-0330-5219; EKAMA, SABDAT/0000-0003-4395-419X	Intramural research program of the Centre for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; NATIONAL CANCER INSTITUTE [ZIABC010770] Funding Source: NIH RePORTER	Intramural research program of the Centre for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was self-sponsored by Dr Onwuamah as part of his doctoral research. Dr Poirier also provided some reagents and she is supported by the Intramural research program of the Centre for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briand N, 2006, PEDIATR INFECT DIS J, V25, P325, DOI 10.1097/01.inf.0000207398.10466.0d; Bulterys M, 2000, J ACQ IMMUN DEF SYND, V25, P261, DOI 10.1097/00126334-200011010-00009; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Culnane M, 1999, JAMA-J AM MED ASSOC, V281, P151, DOI 10.1001/jama.281.2.151; ENNEVER FK, 1988, MUTAT RES, V205, P99, DOI 10.1016/0165-1218(88)90013-4; Escobar PA, 2007, ENVIRON MOL MUTAGEN, V48, P330, DOI 10.1002/em.20285; FISKESJO G, 1985, HEREDITAS, V102, P99, DOI 10.1111/j.1601-5223.1985.tb00471.x; Foster C, 2008, J ANTIMICROB CHEMOTH, V61, P8, DOI 10.1093/jac/dkm411; Fretheim A, 2006, ANTIRETROVIRAL DRUGS; Landriscina M, 2005, J CLIN ENDOCR METAB, V90, P5663, DOI 10.1210/jc.2005-0367; Lipshultz SE, 2011, J AM COLL CARDIOL, V57, P76, DOI 10.1016/j.jacc.2010.08.620; Odeigah PGC, 1997, HEREDITAS, V126, P161, DOI 10.1111/j.1601-5223.1997.00161.x; Olivero OA, 2005, MUTAGENESIS, V20, P139, DOI 10.1093/mutage/gei019; Paul ME, 2005, PEDIATR INFECT DIS J, V24, P46, DOI 10.1097/01.inf.0000148879.83854.7e; Stefanidis K, 2008, GYNECOL ONCOL, V111, P344, DOI 10.1016/j.ygyno.2008.08.006; Torres SM, 2007, ENVIRON MOL MUTAGEN, V48, P224, DOI 10.1002/em.20264; Walker VE, 2007, ENVIRON MOL MUTAGEN, V48, P159, DOI 10.1002/em.20296; Witt KL, 2007, ENVIRON MOL MUTAGEN, V48, P322, DOI 10.1002/em.20266	18	6	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90296	10.1371/journal.pone.0090296	http://dx.doi.org/10.1371/journal.pone.0090296			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599327	gold, Green Submitted, Green Published			2022-12-25	WOS:000332479400060
J	Taya, K; Nakayama, EE; Shioda, T				Taya, Kahoru; Nakayama, Emi E.; Shioda, Tatsuo			Moderate Restriction of Macrophage-Tropic Human Immunodeficiency Virus Type 1 by SAMHD1 in Monocyte-Derived Macrophages	PLOS ONE			English	Article							T-CELL-LINE; HIV-1 ENTRY; MONONUCLEAR PHAGOCYTES; DENDRITIC CELLS; AIDS VIRUS; INFECTION; REPLICATION; RECEPTOR; FUSION; VECTORS	Macrophage-tropic human immunodeficiency virus type 1 (HIV-1) strains are able to grow to high titers in human monocyte-derived macrophages. However, it was recently reported that cellular protein SAMHD1 restricts HIV-1 replication in human cells of the myeloid lineage, including monocyte-derived macrophages. Here we show that degradation of SAMHD1 in monocyte-derived macrophages was associated with moderately enhanced growth of the macrophage-tropic HIV-1 strain. SAMHD1 degradation was induced by treating target macrophages with vesicular stomatitis virus glycoprotein-pseudotyped human immunodeficiency virus type 2 (HIV-2) particles containing viral protein X. For undifferentiated monocytes, HIV-2 particle treatment allowed undifferentiated monocytes to be fully permissive for productive infection by the macrophage-tropic HIV-1 strain. In contrast, untreated monocytes were totally resistant to HIV-1 replication. These results indicated that SAMHD1 moderately restricts even a macrophage-tropic HIV-1 strain in monocyte-derived macrophages, whereas the protein potently restricts HIV-1 replication in undifferentiated monocytes.	[Taya, Kahoru; Nakayama, Emi E.; Shioda, Tatsuo] Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan	Osaka University	Shioda, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan.	shioda@biken.osaka-u.ac.jp		ying mei, zhong shan/0000-0002-0477-0980	Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research [23390111] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, and by a grant from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; BERGAMINI A, 1994, BLOOD, V84, P3405; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Berson JF, 1996, J VIROL, V70, P6288, DOI 10.1128/JVI.70.9.6288-6295.1996; Cashin K, 2011, J VIROL, V85, P10699, DOI 10.1128/JVI.05510-11; CHENGMAYER C, 1988, SCIENCE, V240, P80, DOI 10.1126/science.2832945; CHENGMAYER C, 1987, P NATL ACAD SCI USA, V84, P3526, DOI 10.1073/pnas.84.10.3526; CHENGMAYER C, 1989, P NATL ACAD SCI USA, V86, P8575, DOI 10.1073/pnas.86.21.8575; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Diget EA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/208412; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Goujon C, 2008, J VIROL, V82, P12335, DOI 10.1128/JVI.01181-08; Gruber A, 2000, BLOOD, V96, P1327, DOI 10.1182/blood.V96.4.1327.h8001327_1327_1333; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Kedzierska K, 2000, AIDS, V14, P1739, DOI 10.1097/00002030-200008180-00008; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lapham CK, 1999, NAT MED, V5, P303, DOI 10.1038/6523; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MATSUDA S, 1995, AIDS RES HUM RETROV, V11, P1031, DOI 10.1089/aid.1995.11.1031; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Nomaguchi M, 2013, MICROBES INFECT, V15, P319, DOI 10.1016/j.micinf.2013.01.005; OBRIEN WA, 1990, NATURE, V348, P69, DOI 10.1038/348069a0; Pauls E, 2013, J IMMUNOL, V190, P4736, DOI 10.4049/jimmunol.1203226; Peters PJ, 2007, J NEUROIMMUNE PHARM, V2, P32, DOI 10.1007/s11481-006-9042-2; SHIODA T, 1992, P NATL ACAD SCI USA, V89, P9434, DOI 10.1073/pnas.89.20.9434; SHIODA T, 1991, NATURE, V349, P167, DOI 10.1038/349167a0; Tan PH, 2005, BLOOD, V105, P3824, DOI 10.1182/blood-2004-10-3880; Tokunaga K, 2001, J VIROL, V75, P6776, DOI 10.1128/JVI.75.15.6776-6785.2001; Welbourn S, 2013, J VIROL, V87, P11516, DOI 10.1128/JVI.01642-13; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005	46	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90969	10.1371/journal.pone.0090969	http://dx.doi.org/10.1371/journal.pone.0090969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599229	Green Submitted, gold, Green Published			2022-12-25	WOS:000332479400148
J	Vighi, M; Borrell, A; Crespo, EA; Oliveira, LR; Simoes-Lopes, PC; Flores, PAC; Garcia, NA; Aguilar, A				Vighi, Morgana; Borrell, Asuncion; Crespo, Enrique A.; Oliveira, Larissa R.; Simoes-Lopes, Paulo C.; Flores, Paulo A. C.; Garcia, Nestor A.; Aguilar, Alejandro			Stable Isotopes Indicate Population Structuring in the Southwest Atlantic Population of Right Whales (Eubalaena australis)	PLOS ONE			English	Article							PENINSULA VALDES; FOOD-WEB; MOVEMENTS; FRACTIONATION; ECOLOGY; TISSUES	From the early 17th century to the 1970s southern right whales, Eubalaena australis, were subject to intense exploitation along the Atlantic coast of South America. Catches along this coast recorded by whalers originally formed a continuum from Brazil to Tierra del Fuego. Nevertheless, the recovery of the population has apparently occurred fragmentarily, and with two main areas of concentration, one off southern Brazil (Santa Catarina) and another off central Argentina (Peninsula Valdes). This pattern suggests some level of heterogeneity amongst the population, which is apparently contradicted by records that traced individuals moving throughout the whole geographical extension covered by the species in the Southwest Atlantic. To test the hypothesis of the potential occurrence of discrete subpopulations exploiting specific habitats, we investigated N, C and O isotopic values in 125 bone samples obtained from whaling factories operating in the early 1970s in southern Brazil (n = 72) and from contemporary and more recent strandings occurring in central Argentina (n = 53). Results indicated significant differences between the two sampling areas, being delta C-13 and delta O-18 values significantly higher in samples from southern Brazil than in those from central Argentina. This variation was consistent with isotopic baselines from the two areas, indicating the occurrence of some level of structure in the Southwest Atlantic right whale population and equally that whales more likely feed in areas commonly thought to exclusively serve as nursing grounds. Results aim at reconsidering of the units currently used in the management of the southern right whale in the Southwest Atlantic Ocean. In the context of the current die-off affecting the species in Peninsula Valdes, these results also highlight the necessity to better understand movements of individuals and precisely identify their feeding areas.	[Vighi, Morgana; Borrell, Asuncion; Aguilar, Alejandro] Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain; [Vighi, Morgana; Borrell, Asuncion; Aguilar, Alejandro] Univ Barcelona, Fac Biol, IRBio, Barcelona, Spain; [Crespo, Enrique A.; Garcia, Nestor A.] Natl Univ Patagonia, Lab Marine Mammals, Ctr Nacl Patagon CENPAT CONICET, Puerto Madryn, Argentina; [Oliveira, Larissa R.] Univ Vale Rio Sinos UNISINOS, Sao Leopoldo, Brazil; [Simoes-Lopes, Paulo C.] Univ Fed Santa Catarina, Ctr Biol Sci, Dept Ecol & Zool, BR-88010970 Florianopolis, SC, Brazil; [Flores, Paulo A. C.] MMA, ICMBio, CMA, Ctr Nacl Pesquisa & Conservacao Mamiferos Aquat, BR-88053700 Jurere Florianopolis, MG, Brazil; [Flores, Paulo A. C.] Study Grp Aquat Mammals Rio Grande Sul GEMARS, Imbe, Brazil	University of Barcelona; University of Barcelona; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade do Vale do Rio dos Sinos (Unisinos); Universidade Federal de Santa Catarina (UFSC)	Vighi, M (corresponding author), Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain.	morgana.vighi@gmail.com	Simões-Lopes, P. C./AAC-8562-2020; Vighi, Morgana/B-7982-2015; Borrell, Asunción/B-8257-2009; Simões-Lopes, P. C./I-9501-2012; Aguilar, Alex/L-1283-2014	Simões-Lopes, P. C./0000-0002-7338-3669; Borrell, Asunción/0000-0002-6714-0724; Simões-Lopes, P. C./0000-0002-7338-3669; Aguilar, Alex/0000-0002-5751-2512; Oliveira, Larissa/0000-0002-5735-3697	Fundacion BBVA [BIOCON08-194/09]; Agencia de Gestio d'Ajuts Universitaris I de Recerca (AGAUR) of the Catalunya Government	Fundacion BBVA; Agencia de Gestio d'Ajuts Universitaris I de Recerca (AGAUR) of the Catalunya Government	Fundacion BBVA funded this research as part of the project "Efectos de la explotacion humana sobre depredadores apicales y la estructura de la red trofica del Mar Argentino durante los ultimos 6000 anos" (BIOCON08-194/09 2009-2011). Funding of MV's PhD project was granted by a FI scholarship of the Agencia de Gestio d'Ajuts Universitaris I de Recerca (AGAUR) of the Catalunya Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2001, Journal of Cetacean Research and Management Special Issue, V2, P1; Berzin AA, 2008, MAR FISH REV, V70, P1; Best PB, 1996, MAR BIOL, V124, P483, DOI 10.1007/BF00351030; BEST PB, 1993, MAR MAMMAL SCI, V9, P227, DOI 10.1111/j.1748-7692.1993.tb00451.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Born EW, 2003, J MARINE SYST, V43, P1, DOI 10.1016/S0924-7963(03)00085-X; Borrell A, 2012, RAPID COMMUN MASS SP, V26, P1596, DOI 10.1002/rcm.6267; Bowen GJ, 2010, ANNU REV EARTH PL SC, V38, P161, DOI 10.1146/annurev-earth-040809-152429; Carroll E, 2011, MAR ECOL PROG SER, V432, P257, DOI 10.3354/meps09145; Clapham PJ, 2008, MAR MAMMAL SCI, V24, P183, DOI 10.1111/j.1748-7692.2007.00175.x; Clementz MT, 2001, OECOLOGIA, V129, P461, DOI 10.1007/s004420100745; Cooke J. G., 2001, Journal of Cetacean Research and Management Special Issue, P125; Crawford K, 2008, MAMMAL REV, V38, P87, DOI 10.1111/j.1365-2907.2008.00120.x; de Oliveira Santos Marcos Cesar, 2001, Journal of Cetacean Research and Management Special Issue, V2, P153; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; Ellis M, 1969, BALEIA BRASIL COLONI; FRY B, 1988, LIMNOL OCEANOGR, V33, P1182, DOI 10.4319/lo.1988.33.5.1182; Gimenez J, 2013, RAPID COMMUN MASS SP, V27, P1801, DOI 10.1002/rcm.6633; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Greig Antonio B., 2001, Journal of Cetacean Research and Management Special Issue, V2, P157; Groch Karina R., 2005, Latin American Journal of Aquatic Mammals, V4, P41; Hart AB, 2006, WHALING FALKLAND ISL; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; Hoffmeyer MS, 2010, REV BIOL MAR OCEANOG, V45, P131; International Engineering Alliance, 2013, IDF DIABETES ATLAS, P1; International Union for Conservation of Nature, 2012, IUCN RED LIST THREAT; International Whaling Commission, 2011, J CETACEAN RES MAN S, V12, P367; International Whaling Commission, 2011, WORKSH SO RIGHT WHAL; International Whaling Commission, 2013, WORKSH SO RIGHT WHAL; International Whaling Commission, 2012, J CETACEAN RES MAN S, V13, P154; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jacob U, 2005, MAR ECOL PROG SER, V287, P251, DOI 10.3354/meps287251; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; KENNEY RD, 1995, CONT SHELF RES, V15, P385, DOI 10.1016/0278-4343(94)00053-P; KNOWLTON AR, 1992, MAR MAMMAL SCI, V8, P397, DOI 10.1111/j.1748-7692.1992.tb00054.x; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Leaper R, 2006, BIOL LETTERS, V2, P289, DOI 10.1098/rsbl.2005.0431; MATTHEWS L. HARRISON, 1932, DISCOVERY REPTS [GOVERNMENT DEPENDENCIES FALKLAND ISLS], V5, P467; MATTHEWS L. HARRISON, 1938, DISCOVERY REPTS [GOVT DEPENDENCIES FALKLAND ISLANDS], V17, P169; McMahon KW, 2013, LIMNOL OCEANOGR, V58, P697, DOI 10.4319/lo.2013.58.2.0697; Mermoz J.F., 1980, International Whaling Commission Report of the Commission, P183; Mermoz JF, 1980, NATURAL HIST WHALES, V30, P183; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Patenaude NJ, 2007, J HERED, V98, P147, DOI 10.1093/jhered/esm005; Payne R., 1990, REPORT INT WHALING C, P271; Pontalti Monica, 2011, Biotemas, V24, P109, DOI 10.5007/2175-7925.2011v24n2p109; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Richards R, 2009, NEW ZEAL J ZOOL, V36, P447, DOI 10.1080/03014223.2009.9651477; Riofrio-Lazo M, 2013, RAPID COMMUN MASS SP, V27, P1076, DOI 10.1002/rcm.6556; Rowntree Victoria J., 2001, Journal of Cetacean Research and Management Special Issue, V2, P133; Rowntree VJ, 1998, MAR MAMMAL SCI, V14, P99, DOI 10.1111/j.1748-7692.1998.tb00693.x; Simoes-Lopes P. C., 1992, P 3 REUN TRAB EXP MA, P62; Sironi M., 2009, SC61BRG19 INT WHAL C; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Tonnessen JN., 1982, HIST MODERN WHALING; Tormosov DD, 1998, BIOL CONSERV, V86, P185, DOI 10.1016/S0006-3207(98)00008-1; TOWNSEND CHARLES HASKINS, 1935, ZOOLOGICA [NEW YORK], V19, P1; Valenzuela LO, 2009, MOL ECOL, V18, P782, DOI 10.1111/j.1365-294X.2008.04069.x; WHITEHEAD H, 1982, CAN J ZOOL, V60, P2203, DOI 10.1139/z82-282; Whitehead H., 1981, NEW TECHNIQUES ASSES, P189; YOSHIDA N, 1991, J GEOPHYS RES-OCEANS, V96, P815, DOI 10.1029/90JC01580	63	18	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90489	10.1371/journal.pone.0090489	http://dx.doi.org/10.1371/journal.pone.0090489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598539	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400081
J	Walentowicz, P; Krintus, M; Sadlecki, P; Grabiec, M; Mankowska-Cyl, A; Sokup, A; Walentowicz-Sadlecka, M				Walentowicz, Pawel; Krintus, Magdalena; Sadlecki, Pawel; Grabiec, Marek; Mankowska-Cyl, Aneta; Sokup, Alina; Walentowicz-Sadlecka, Malgorzata			Serum Inhibin A and Inhibin B Levels in Epithelial Ovarian Cancer Patients	PLOS ONE			English	Article							ACTIVIN; BETAGLYCAN; BETA; ANTAGONISM; MECHANISMS; SECRETION; SURVIVAL; TARGET; CELLS	The aim: of our study was to examine serum inhibin A and inhibin B concentrations in ovarian cancer patients in relation to clinicopathological features and 5-year survival. Material and Methods: We enrolled 90 epithelial ovarian cancer patients in our study, aged 45-81 years, who underwent optimal cytoreductive surgery. In all patients, serum inhibin A and inhibin B concentrations were measured using a two-step sandwich type enzyme immunoassay before surgery. Results: In the group of patients with ovarian cancer median serum concentration of inhibin A was 3.87 pg/mL (0.96-10.09) and inhibin B was 13.9 pg/mL (5.1-45.0). Median concentrations of inhibin A and B in relation to FIGO stage and histological subtype did not differ significantly. Inhibin A levels were significantly higher in patients with lower grading (G1 and G2) in comparison to those with higher grade G3 (p = 0.001). There were no differences in inhibin B concentrations in relation to grading. The Kaplan-Meier analyses demonstrated no differences in survival rate in relation to inhibin A levels, while there was a stepwise impairment of 5-years survival with increased inhibin B level. In the group of patients with inhibin B levels higher than 20 pg/ml the survival rate was lower (p = 0,00625, log-rank test). Conclusion: 1. Higher inhibin A serum levels were found in patients with highly differentiated ovarian carcinoma compared to the group of patients with a poorly differentiated cancer, which may confirm the influence of inhibin A on cell proliferation processes. 2. A significant importance of inhibin B was demonstrated in the prediction of death within less than a five year period. The probability of survival in patients featuring high inhibin B levels was lower with statistical significance. This may indicate the need for further studies on how to block the inhibin B activation pathway in the ovarian carcinoma therapy.	[Walentowicz, Pawel; Sadlecki, Pawel; Grabiec, Marek; Walentowicz-Sadlecka, Malgorzata] Nicholas Copernicus Univ, L Rydygier Coll Med Bydgoszcz, Dept Obstet & Gynecol, Bydgoszcz, Poland; [Krintus, Magdalena; Mankowska-Cyl, Aneta] Nicholas Copernicus Univ, L Rydygier Coll Med Bydgoszcz, Dept Lab Med, Bydgoszcz, Poland; [Sokup, Alina] Nicholas Copernicus Univ, Dept Gastroenterol Angiol & Internal Dis, Dr J Biziel Univ Hosp, Bydgoszcz, Poland	Nicolaus Copernicus University; Nicolaus Copernicus University; Nicolaus Copernicus University	Walentowicz-Sadlecka, M (corresponding author), Nicholas Copernicus Univ, L Rydygier Coll Med Bydgoszcz, Dept Obstet & Gynecol, Bydgoszcz, Poland.	walentowiczm@cm.umk.pl	Sadlecki, Pawel/AAB-6993-2021; Sadłecki, Paweł/I-5728-2014; Mankowska-Cyl, Aneta/P-5575-2015; Sokup, Alina/M-5222-2014; Krintus, Magdalena/H-9419-2014; Sadlecki, Pawel/AAB-5046-2021	Sadlecki, Pawel/0000-0001-8355-2553; Sadłecki, Paweł/0000-0001-8355-2553; Mankowska-Cyl, Aneta/0000-0002-1049-9824; Sokup, Alina/0000-0002-7470-6706; Krintus, Magdalena/0000-0003-2627-7473; Walentowicz, Pawel/0000-0002-7748-343X				Antenos M, 2007, MOL ENDOCRINOL, V21, P1670, DOI 10.1210/me.2007-0050; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; CHEIFETZ S, 1988, J BIOL CHEM, V263, P17225; Delfino KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058608; Deregowski V, 2002, BIOCHEM PHARMACOL, V64, P873, DOI 10.1016/S0006-2952(02)01151-6; Farnworth PG, 2006, ENDOCRINOLOGY, V147, P3462, DOI 10.1210/en.2006-0023; FINDLAY JK, 1987, BAILLIERE CLIN ENDOC, V1, P223, DOI 10.1016/S0950-351X(87)80060-5; Gatza CE, 2010, CELL SIGNAL, V22, P1163, DOI 10.1016/j.cellsig.2010.01.016; Hernandez L, 2010, CANCER RES, V70, P4005, DOI 10.1158/0008-5472.CAN-09-3912; Hirschhorn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043459; Kisielewski R, 2013, GINEKOL POL, V84, P293; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; LEVERSHA LJ, 1987, J ENDOCRINOL, V113, P213, DOI 10.1677/joe.0.1130213; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Makanji Y, 2008, J BIOL CHEM, V283, P16743, DOI 10.1074/jbc.M801045200; Makanji Y, 2007, ENDOCRINOLOGY, V148, P2309, DOI 10.1210/en.2006-1612; Makanji Y, 2011, VITAM HORM, V85, P299, DOI 10.1016/B978-0-12-385961-7.00014-7; Makanji Y, 2009, ENDOCRINOLOGY, V150, P4784, DOI 10.1210/en.2008-1783; Mason AJ, 1996, MOL ENDOCRINOL, V10, P1055, DOI 10.1210/me.10.9.1055; Park Y, 2011, CLIN BIOCHEM, V44, P884, DOI 10.1016/j.clinbiochem.2011.04.011; Pfeiffer RM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001492; Quartuccio SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065067; Rachidi SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057911; Robertson DM, 2009, J CLIN ENDOCR METAB, V94, P138, DOI 10.1210/jc.2008-1684; Sharma A, 2013, ULTRASOUND OBST GYN, V42, P472, DOI 10.1002/uog.12447; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sohn I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054089; Son DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051116; Stenvers KL, 2012, MOL CELL ENDOCRINOL, V359, P1, DOI 10.1016/j.mce.2012.03.001; Theriault BL, 2011, CANCER LETT, V313, P108, DOI 10.1016/j.canlet.2011.08.033; Tournier I, 2014, HUM MUTAT, V35, P294, DOI 10.1002/humu.22489; Walentowicz-Sadlecka M, 2012, CLIN BIOCHEM, V45, P1568, DOI 10.1016/j.clinbiochem.2012.07.110; Walton KL, 2012, MOL CELL ENDOCRINOL, V359, P2, DOI 10.1016/j.mce.2011.06.030; Wiater E, 2009, MOL ENDOCRINOL, V23, P1033, DOI 10.1210/me.2009-0021; Zhang W, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002975; Zhao BX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071071	37	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90575	10.1371/journal.pone.0090575	http://dx.doi.org/10.1371/journal.pone.0090575			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599287	gold, Green Submitted, Green Published			2022-12-25	WOS:000332479400096
J	Dagar, S; Nagar, S; Goel, M; Cherukuri, P; Dhingra, NK				Dagar, Sushma; Nagar, Saumya; Goel, Manvi; Cherukuri, Pitchaiah; Dhingra, Narender K.			Loss of Photoreceptors Results in Upregulation of Synaptic Proteins in Bipolar Cells and Amacrine Cells	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; RD10 MOUSE MODEL; HETEROGENEOUS DISTRIBUTION; DEVELOPMENTAL EXPRESSION; ECTOPIC SYNAPTOGENESIS; VESICLE PROTEINS; VISUAL FUNCTION; ROYAL-COLLEGE; MUTANT MOUSE; DEGENERATION	Deafferentation is known to cause significant changes in the postsynaptic neurons in the central nervous system. Loss of photoreceptors, for instance, results in remarkable morphological and physiological changes in bipolar cells and horizontal cells. Retinal ganglion cells (RGCs), which send visual information to the brain, are relatively preserved, but show aberrant firing patterns, including spontaneous bursts of spikes in the absence of photoreceptors. To understand how loss of photoreceptors affects the circuitry presynaptic to the ganglion cells, we measured specific synaptic proteins in two mouse models of retinal degeneration. We found that despite the nearly total loss of photoreceptors, the synaptophysin protein and mRNA levels in retina were largely unaltered. Interestingly, the levels of synaptophysin in the inner plexiform layer (IPL) were higher, implying that photoreceptor loss results in increased synaptophysin in bipolar and/or amacrine cells. The levels of SV2B, a synaptic protein expressed by photoreceptors and bipolar cells, were reduced in whole retina, but increased in the IPL of rd1 mouse. Similarly, the levels of syntaxin-I and synapsin-I, synaptic proteins expressed selectively by amacrine cells, were higher after loss of photoreceptors. The upregulation of syntaxin-I was evident as early as one day after the onset of photoreceptor loss, suggesting that it did not require any massive or structural remodeling, and therefore is possibly reversible. Together, these data show that loss of photoreceptors results in increased synaptic protein levels in bipolar and amacrine cells. Combined with previous reports of increased excitatory and inhibitory synaptic currents in RGCs, these results provide clues to understand the mechanism underlying the aberrant spiking in RGCs.	[Dagar, Sushma; Nagar, Saumya; Goel, Manvi; Cherukuri, Pitchaiah; Dhingra, Narender K.] Natl Brain Res Ctr, Gurgaon, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Dhingra, NK (corresponding author), Natl Brain Res Ctr, Gurgaon, Haryana, India.	naren@nbrc.ac.in	Goel, Manvi/T-3148-2019	Goel, Manvi/0000-0003-2049-5605; Nagar, Saumya/0000-0002-9111-477X	National Brain Research Centre; Department of Biotechnology, Government of India [BT/PR6410/Med/14/801/2005, BT/PR6615/Med/14/857/2005]; Council of Scientific and Industrial Research, Government of India [09/821(0035)/2011-EMR-I]	National Brain Research Centre; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by National Brain Research Centre and Grants BT/PR6410/Med/14/801/2005 and BT/PR6615/Med/14/857/2005 to NKD from the Department of Biotechnology, Government of India. SD was supported by a research fellowship (09/821(0035)/2011-EMR-I) from the Council of Scientific and Industrial Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaratnasingam C, 2009, INVEST OPHTH VIS SCI, V50, P2824, DOI 10.1167/iovs.08-3206; Barhoum R, 2008, NEUROSCIENCE, V155, P698, DOI 10.1016/j.neuroscience.2008.06.042; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; Brandstatter JH, 1996, J COMP NEUROL, V370, P1, DOI 10.1002/(SICI)1096-9861(19960617)370:1<1::AID-CNE1>3.0.CO;2-7; Chow AY, 2001, IEEE T NEUR SYS REH, V9, P86, DOI 10.1109/7333.918281; Chua J, 2009, J COMP NEUROL, V514, P473, DOI 10.1002/cne.22029; Claes E, 2004, INVEST OPHTH VIS SCI, V45, P2039, DOI 10.1167/iovs.03-0741; Cuenca N, 2005, EUR J NEUROSCI, V22, P1057, DOI 10.1111/j.1460-9568.2005.04300.x; DEITCH JS, 1984, J COMP NEUROL, V229, P66, DOI 10.1002/cne.902290106; Dhingra A, 2012, J NEUROSCI, V32, P11343, DOI 10.1523/JNEUROSCI.1436-12.2012; Dhingra NK, 1997, DEV BRAIN RES, V102, P267, DOI 10.1016/S0165-3806(97)00085-0; DRAGER UC, 1978, J COMP NEUROL, V180, P85, DOI 10.1002/cne.901800107; Freed MA, 2003, NEURON, V38, P89, DOI 10.1016/S0896-6273(03)00166-1; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Goel M, 2012, NEUROSCIENCE, V225, P152, DOI 10.1016/j.neuroscience.2012.08.066; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HERROLD KM, 1967, ARCH OPHTHALMOL-CHIC, V78, P650, DOI 10.1001/archopht.1967.00980030652017; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Horch HW, 2009, INSECT MOL BIOL, V18, P483, DOI 10.1111/j.1365-2583.2009.00891.x; Humayun MS, 2003, VISION RES, V43, P2573, DOI 10.1016/S0042-6989(03)00457-7; Jain V, 2012, J COMP NEUROL, V520, P742, DOI 10.1002/cne.22765; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; Kihara AH, 2008, NEUROSCIENCE, V151, P995, DOI 10.1016/j.neuroscience.2007.09.088; Kim HY, 2007, AM J PHYSIOL-RENAL, V293, pF1238, DOI 10.1152/ajprenal.00151.2007; Kirkeby S, 2005, J IMMUNOL METHODS, V301, P102, DOI 10.1016/j.jim.2005.04.006; KITZES LM, 1995, J COMP NEUROL, V353, P341, DOI 10.1002/cne.903530303; Kurpius D, 2006, GLIA, V54, P58, DOI 10.1002/glia.20355; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Lazzell DR, 2004, J BIOL CHEM, V279, P52124, DOI 10.1074/jbc.M407502200; Lo FS, 2002, J NEUROPHYSIOL, V88, P794, DOI 10.1152/jn.2002.88.2.794; Machida S, 2008, INVEST OPHTH VIS SCI, V49, P442, DOI 10.1167/iovs.07-0291; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; MANDELL JW, 1990, NEURON, V5, P19, DOI 10.1016/0896-6273(90)90030-J; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Marchena M, 2011, EXP EYE RES, V93, P607, DOI 10.1016/j.exer.2011.07.010; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Margolis DJ, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/507037; Mazzoni F, 2008, J NEUROSCI, V28, P14282, DOI 10.1523/JNEUROSCI.4968-08.2008; Menzler J, 2011, J NEUROSCI, V31, P2280, DOI 10.1523/JNEUROSCI.4238-10.2011; Morgans CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005230; MURASHIMA YL, 1990, J NEUROCHEM, V54, P893, DOI 10.1111/j.1471-4159.1990.tb02335.x; Nagar S, 2009, NEUROSCIENCE, V160, P517, DOI 10.1016/j.neuroscience.2009.02.056; Nambu H, 1997, PATHOL INT, V46, P874; Park SJ, 2004, CELL TISSUE RES, V315, P407, DOI 10.1007/s00441-003-0844-8; Peng YW, 2003, NEUROSCIENCE, V119, P813, DOI 10.1016/S0306-4522(03)00153-2; Peng YW, 2000, NAT NEUROSCI, V3, P1121, DOI 10.1038/80639; Phillips MJ, 2010, J COMP NEUROL, V518, P2071, DOI 10.1002/cne.22322; Pu ML, 2006, INVEST OPHTH VIS SCI, V47, P3579, DOI 10.1167/iovs.05-1450; Puthussery T, 2009, EUR J NEUROSCI, V29, P1533, DOI 10.1111/j.1460-9568.2009.06728.x; Sakai T, 2009, INVEST OPHTH VIS SCI, V50, P4402, DOI 10.1167/iovs.09-3458; Sherry DM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-54; Specht D, 2007, EUR J NEUROSCI, V26, P2506, DOI 10.1111/j.1460-9568.2007.05886.x; Stasheff SF, 2008, J NEUROPHYSIOL, V99, P1408, DOI 10.1152/jn.00144.2007; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; Strettoi E, 2003, VISION RES, V43, P867, DOI 10.1016/S0042-6989(02)00594-1; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Trenholm S, 2012, J PHYSL; Varela C, 2003, VISION RES, V43, P879, DOI 10.1016/S0042-6989(02)00493-5; von Kriegstein K, 1999, EUR J NEUROSCI, V11, P1335, DOI 10.1046/j.1460-9568.1999.00542.x; Wan QF, 2010, NEURON, V66, P884, DOI 10.1016/j.neuron.2010.05.010; Wang MM, 2003, J COMP NEUROL, V460, P106, DOI 10.1002/cne.10636; WESTENBROEK RE, 1988, J COMP NEUROL, V274, P334, DOI 10.1002/cne.902740304; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Yazulla S, 1997, VISION RES, V37, P3471, DOI 10.1016/S0042-6989(96)00223-4	66	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90250	10.1371/journal.pone.0090250	http://dx.doi.org/10.1371/journal.pone.0090250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595229	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500039
J	Jackson, A; Li, KL; Zhu, XP				Jackson, Alan; Li, Ka-Loh; Zhu, Xiaoping			Semi-Quantitative Parameter Analysis of DCE-MRI Revisited: Monte-Carlo Simulation, Clinical Comparisons, and Clinical Validation of Measurement Errors in Patients with Type 2 Neurofibromatosis	PLOS ONE			English	Article							CONTRAST-ENHANCED MRI; NORMAL PERIPHERAL ZONE; MAGNETIC-RESONANCE; BREAST-CANCER; PROSTATE-CANCER; GD-DTPA; NEOADJUVANT CHEMOTHERAPY; ANTIVASCULAR THERAPIES; IMAGING MEASUREMENTS; MICROVESSEL DENSITY	Purpose: To compare semi-quantitative (SQ) and pharmacokinetic (PK) parameters for analysis of dynamic contrast enhanced MR data (DCE-MRI) and investigate error-propagation in SQ parameters. Methods: Clinical data was collected from five patients with type 2-neurofibromatosis (NF2) receiving anti-angiogenic therapy for rapidly growing vestibular schwannoma (VS). There were 7 VS and 5 meningiomas. Patients were scanned prior to therapy and at days 3 and 90 of treatment. Data was collected using a dual injection technique to permit direct comparison of SQ and PK parameters. Monte Carlo modeling was performed to assess potential measurement errors in SQ parameters in persistent, washout, and weakly enhancing tissues. The simulation predictions for five semi-quantitative parameters were tested using the clinical DCE-MRI data. Results: In VS, SQ parameters and K-trans showed close correlation and demonstrated similar therapy induced reductions. In meningioma, only the denoised Signal Enhancement Ratio (R-se1/se2(DN)) showed a significant therapy induced reduction (p<0.05). Simulation demonstrated: 1) Precision of SQ metrics normalized to the pre-contrast-baseline values (MSErel and Sigma MSErel) is improved by use of an averaged value from multiple baseline scans; 2) signal enhancement ratio R-mse1/mse2 shows considerable susceptibility to noise; 3) removal of outlier values to produce a new parameter, R-mse1/mse2(DN), improves precision and sensitivity to therapy induced changes. Direct comparison of in-vivo analysis with Monte Carlo simulation supported the simulation predicted error distributions of semi-quantitative metrics. Conclusion: PK and SQ parameters showed similar sensitivity to anti-angiogenic therapy induced changes in VS. Modeling studies confirmed the benefits of averaging baseline signal from multiple images for normalized SQ metrics and demonstrated poor noise tolerance in the widely used signal enhancement ratio, which is corrected by removal of outlier values.	[Jackson, Alan; Li, Ka-Loh; Zhu, Xiaoping] Univ Manchester, Wolfson Mol Imaging Ctr, Manchester, Lancs, England	University of Manchester	Jackson, A (corresponding author), Univ Manchester, Wolfson Mol Imaging Ctr, Manchester, Lancs, England.	alan.jackson@manchester.ac.uk	Zhu, Xiaoping/AAO-2711-2021	Zhu, Xiaoping/0000-0002-4351-121X; JACKSON, ALAN/0000-0002-1623-0383	Manchester Cancer Research Centre; Cancer Research UK [16465, 18097] Funding Source: researchfish	Manchester Cancer Research Centre; Cancer Research UK(Cancer Research UK)	This study was locally funded by the Manchester Cancer Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akisik MF, 2010, RADIOLOGY, V256, P441, DOI 10.1148/radiol.10091733; Arasu VA, 2011, ACAD RADIOL, V18, P716, DOI 10.1016/j.acra.2011.02.008; Asselin MC, 2012, EUR J CANCER, V48, P447, DOI 10.1016/j.ejca.2011.12.025; Balvay D, 2005, MAGNET RESON MED, V54, P868, DOI 10.1002/mrm.20650; Bolouri MS, 2013, RADIOLOGY, V269, P353, DOI 10.1148/radiol.13130058; Bone B, 2003, ACTA RADIOL, V44, P373, DOI 10.1034/j.1600-0455.2003.00080.x; Brown J, 2000, MAGN RESON IMAGING, V18, P765, DOI 10.1016/S0730-725X(00)00167-3; Buadu LD, 1996, RADIOLOGY, V200, P639, DOI 10.1148/radiology.200.3.8756909; Buckler AJ, 2011, RADIOLOGY, V259, P875, DOI 10.1148/radiol.10100800; Buckley DL, 2002, MAGN RESON MED, V47, P601, DOI 10.1002/mrm.10080; De Lussanet QG, 2005, INT J RADIAT ONCOL, V63, P1309, DOI 10.1016/j.ijrobp.2005.04.052; Dyke JP, 2003, RADIOLOGY, V228, P271, DOI 10.1148/radiol.2281011651; El Khouli RH, 2009, AM J ROENTGENOL, V193, pW295, DOI 10.2214/AJR.09.2483; Engelbrecht MR, 2003, RADIOLOGY, V229, P248, DOI 10.1148/radiol.2291020200; Esserman Laura, 1999, Breast J, V5, P13, DOI 10.1046/j.1524-4741.1999.005001013.x; Evelhoch J, 2005, CANCER RES, V65, P7041, DOI 10.1158/0008-5472.CAN-05-0674; Evelhoch JL, 1999, JMRI-J MAGN RESON IM, V10, P254, DOI 10.1002/(SICI)1522-2586(199909)10:3<254::AID-JMRI5>3.0.CO;2-9; Evelhoch JL, 2000, ISMRM 8 SCI M DENV, P1439; Ferl GZ, 2010, MAGN RESON MED, V63, P1366, DOI 10.1002/mrm.22335; FLICKINGER FW, 1993, MAGN RESON IMAGING, V11, P617, DOI 10.1016/0730-725X(93)90002-U; Flickinger FW, 1990, RADIOLOGY, V174, P491; Florie J, 2006, AM J ROENTGENOL, V186, P1384, DOI 10.2214/AJR.04.1454; Fritz-Hansen T, 1998, MAGNET RESON MED, V40, P922, DOI 10.1002/mrm.1910400619; Furman-Haran E, 2002, J COMPUT ASSIST TOMO, V26, P376, DOI 10.1097/00004728-200205000-00012; Galbraith SM, 2002, NMR BIOMED, V15, P132, DOI 10.1002/nbm.731; GRIBBESTAD IS, 1994, JMRI-J MAGN RESON IM, V4, P477, DOI 10.1002/jmri.1880040339; Hattangadi J, 2008, AM J ROENTGENOL, V190, P1630, DOI 10.2214/AJR.07.2533; Ikeda O, 1999, ACTA RADIOL, V40, P585, DOI 10.3109/02841859909175592; Jansen SA, 2007, RADIOLOGY, V245, P684, DOI 10.1148/radiol.2453062061; Jansen SA, 2011, J MAGN RESON IMAGING, V33, P1382, DOI 10.1002/jmri.22567; KAISER WA, 1989, RADIOLOGY, V170, P681, DOI 10.1148/radiology.170.3.2916021; Karahaliou A, BR J RADIOL, V83, P296; Koh TS, 2011, MAGN RESON MED, V65, P250, DOI 10.1002/mrm.22596; Kuhl CK, 1999, RADIOLOGY, V211, P101, DOI 10.1148/radiology.211.1.r99ap38101; Kuhl CK, 2000, J MAGN RESON IMAGING, V12, P965, DOI 10.1002/1522-2586(200012)12:6<965::AID-JMRI23>3.0.CO;2-1; Lavini C, 2011, J MAGN RESON IMAGING, V34, P1303, DOI 10.1002/jmri.22742; Lavini C, 2009, MAGN RESON IMAGING, V27, P62, DOI 10.1016/j.mri.2008.05.012; Leach MO, 2012, EUR RADIOL, V22, P1451, DOI 10.1007/s00330-012-2446-x; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; Leach MO, 2003, BRIT J RADIOL, V76, pS87, DOI 10.1259/bjr/15917261; Levman J, 2008, IEEE T MED IMAGING, V27, P688, DOI 10.1109/TMI.2008.916959; Li KL, 2008, RADIOLOGY, V248, P79, DOI 10.1148/radiol.2481070846; Li KL, 2007, MAGN RESON MED, V58, P572, DOI 10.1002/mrm.21361; Li KL, 2012, MAGN RESON MED, V68, P452, DOI 10.1002/mrm.23252; Li KL, 2003, MAGNET RESON MED, V50, P1286, DOI 10.1002/mrm.10652; MILLARD S.P., 2000, ENV STAT S PLUS; Narang J, 2011, NEURO-ONCOLOGY, V13, P1037, DOI 10.1093/neuonc/nor075; O'Connor JPB, 2011, BRIT J RADIOL, V84, pS112, DOI 10.1259/bjr/55166688; O'Connor JPB, 2012, NAT REV CLIN ONCOL, V9, P167, DOI 10.1038/nrclinonc.2012.2; Padhani AR, 2000, CLIN RADIOL, V55, P99, DOI 10.1053/crad.1999.0327; Partridge SC, 2010, J MAGN RESON IMAGING, V32, P1124, DOI 10.1002/jmri.22362; Rouviere O, 2003, EUR RADIOL, V13, P931, DOI 10.1007/s00330-002-1617-6; Schabel MC, 2008, PHYS MED BIOL, V53, P2345, DOI 10.1088/0031-9155/53/9/010; Sourbron SP, 2011, MAGN RESON MED, V66, P735, DOI 10.1002/mrm.22861; Su MY, 2003, J MAGN RESON IMAGING, V18, P467, DOI 10.1002/jmri.10380; Tofts PS, 2011, BRIT J RADIOL, V84, pS213, DOI 10.1259/bjr/74316620; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Tuncbilek N, 2004, ABDOM IMAGING, V29, P166, DOI 10.1007/s00261-003-0090-2; Vokurka EA, 2002, AM J NEURORADIOL, V23, P459; Warren R, 2006, MAGN RESON IMAGING, V24, P917, DOI 10.1016/j.mri.2006.03.004; Waterton JC, 2012, EUR J CANCER, V48, P409, DOI 10.1016/j.ejca.2011.11.037; Williams TC, 2007, RADIOLOGY, V244, P94, DOI 10.1148/radiol.2441060634; Zahra MA, 2009, INT J RADIAT ONCOL, V74, P766, DOI 10.1016/j.ijrobp.2008.08.023; Zelhof B, 2009, BJU INT, V104, P621, DOI 10.1111/j.1464-410X.2009.08457.x; Zhang XM, 2008, J MAGN RESON IMAGING, V27, P1309, DOI 10.1002/jmri.21378; Zhu XP, 2000, J MAGN RESON IMAGING, V11, P575, DOI 10.1002/1522-2586(200006)11:6<575::AID-JMRI2>3.0.CO;2-1	66	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90300	10.1371/journal.pone.0090300	http://dx.doi.org/10.1371/journal.pone.0090300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594707	Green Submitted, Green Published, gold			2022-12-25	WOS:000332475500041
J	Reid, JL; Mendenhall, CD; Rosales, JA; Zahawi, RA; Holl, KD				Reid, J. Leighton; Mendenhall, Chase D.; Abel Rosales, J.; Zahawi, Rakan A.; Holl, Karen D.			Landscape Context Mediates Avian Habitat Choice in Tropical Forest Restoration	PLOS ONE			English	Article							SEED DISPERSAL; RAIN-FOREST; ECOLOGICAL RESTORATION; ECOSYSTEM SERVICES; FRUGIVOROUS BIRDS; DEGRADED LANDS; TREE ISLANDS; PATCH SIZE; BIODIVERSITY; CONSERVATION	Birds both promote and prosper from forest restoration. The ecosystem functions birds perform can increase the pace of forest regeneration and, correspondingly, increase the available habitat for birds and other forest-dependent species. The aim of this study was to learn how tropical forest restoration treatments interact with landscape tree cover to affect the structure and composition of a diverse bird assemblage. We sampled bird communities over two years in 13 restoration sites and two old-growth forests in southern Costa Rica. Restoration sites were established on degraded farmlands in a variety of landscape contexts, and each included a 0.25-ha plantation, island treatment (trees planted in patches), and unplanted control. We analyzed four attributes of bird communities including frugivore abundance, nectarivore abundance, migrant insectivore richness, and compositional similarity of bird communities in restoration plots to bird communities in old-growth forests. All four bird community variables were greater in plantations and/or islands than in control treatments. Frugivore and nectarivore abundance decreased with increasing tree cover in the landscape surrounding restoration plots, whereas compositional similarity to old-growth forests was greatest in plantations embedded in landscapes with high tree cover. Migrant insectivore richness was unaffected by landscape tree cover. Our results agree with previous studies showing that increasing levels of investment in active restoration are positively related to bird richness and abundance, but differences in the effects of landscape tree cover on foraging guilds and community composition suggest that trade-offs between biodiversity conservation and bird-mediated ecosystem functioning may be important for prioritizing restoration sites.	[Reid, J. Leighton; Holl, Karen D.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA; [Mendenhall, Chase D.] Stanford Univ, Ctr Conservat Biol, Dept Biol, Stanford, CA 94305 USA; [Abel Rosales, J.; Zahawi, Rakan A.] Org Trop Studies, San Vito De Coto Brus, Costa Rica	University of California System; University of California Santa Cruz; Stanford University	Reid, JL (corresponding author), Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA.	j.leighton.reid@gmail.com	Zahawi, Rakan/N-1028-2014	Zahawi, Rakan/0000-0002-5678-2967	US National Science Foundation [NSF-DEB 0918112]; University of California Santa Cruz Open Access Fund	US National Science Foundation(National Science Foundation (NSF)); University of California Santa Cruz Open Access Fund	Financial support was provided by the US National Science Foundation (NSF-DEB 0918112 and graduate fellowships to J.L.R. and C.D.M.), Peter and Helen Bing, Ralph and Louise Haberfield, the Moore Family Foundation, the Koret Foundation, the Mertz Gilmore Foundation, and the Winslow Foundation. Funding for Open Access provided by the University of California Santa Cruz Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aide TM, 1994, RESTOR ECOL, V2, P219, DOI [10.1111/j.1526-100X.1994.tb00054.x, DOI 10.1111/J.1526-100X.1994.TB00054.X]; American Ornithologists Union, 1998, CHECK LIST N AM BIRD, V7th; Arriagada RA, 2012, LAND ECON, V88, P382, DOI 10.3368/le.88.2.382; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Blake JG, 2001, AUK, V118, P304, DOI 10.1642/0004-8038(2001)118[0304:BAISGA]2.0.CO;2; Brancalion PHS., 2012, UNASYLVA, V63, P41, DOI DOI 10.1007/S13398-014-0173-7.2; Burnham K. P., 1998, MODEL SELECTION INFE; Catterall CP, 2012, BIOL CONSERV, V146, P53, DOI 10.1016/j.biocon.2011.10.033; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Cole RJ, 2010, ECOL APPL, V20, P1255, DOI 10.1890/09-0714.1; Cole RJ, 2009, BIOTROPICA, V41, P319, DOI 10.1111/j.1744-7429.2009.00490.x; DaSilva JMC, 1996, CONSERV BIOL, V10, P491, DOI 10.1046/j.1523-1739.1996.10020491.x; de la Pena-Domene M, 2013, ECOL APPL, V23, P1124, DOI 10.1890/12-1728.1; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Dixon KW, 2009, SCIENCE, V325, P571, DOI 10.1126/science.1176295; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Duncan RS, 1999, ECOL APPL, V9, P998, DOI 10.1890/1051-0761(1999)009[0998:SDAPFS]2.0.CO;2; Edwards DP, 2010, CONSERV LETT, V3, P313, DOI 10.1111/j.1755-263X.2010.00143.x; Fink RD, 2009, RESTOR ECOL, V17, P479, DOI 10.1111/j.1526-100X.2008.00383.x; Freeman AND, 2009, EMU, V109, P331, DOI 10.1071/MU09089; Galindo-Gonzalez J, 2000, CONSERV BIOL, V14, P1693, DOI [10.1046/j.1523-1739.2000.99072.x, 10.1111/j.1523-1739.2000.99072.x]; Garcia D, 2012, P ROY SOC B-BIOL SCI, V279, P3106, DOI 10.1098/rspb.2012.0175; Gardner TA, 2012, BIOL CONSERV, V154, P61, DOI 10.1016/j.biocon.2011.11.018; Gelman A., 2007, ANAL METHODS SOCIAL, DOI 10.1017/CBO9780511790942; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Graham LLB, 2012, RESTOR ECOL, V20, P631, DOI 10.1111/j.1526-100X.2011.00805.x; Grainger MJ, 2011, RESTOR ECOL, V19, P111, DOI 10.1111/j.1526-100X.2009.00630.x; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; GUEVARA S, 1993, VEGETATIO, V108, P319; Harvey CA, 2010, CONSERV LETT, V3, P53, DOI 10.1111/j.1755-263X.2009.00086.x; Hill JK, 2004, J APPL ECOL, V41, P744, DOI 10.1111/j.0021-8901.2004.00926.x; Holdridge L. R., 1971, Forest environments in tropical life zones: a pilot study.; Holl KD, 1999, BIOTROPICA, V31, P229, DOI 10.1111/j.1744-7429.1999.tb00135.x; Holl KD, 1998, RESTOR ECOL, V6, P253, DOI 10.1046/j.1526-100X.1998.00638.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hutto R.L., 1985, P455; Huxel GR, 1999, RESTOR ECOL, V7, P309, DOI 10.1046/j.1526-100X.1999.72024.x; Ibarra-Macias A, 2011, BIOL CONSERV, V144, P703, DOI 10.1016/j.biocon.2010.08.006; Ingle NR, 2003, OECOLOGIA, V134, P251, DOI 10.1007/s00442-002-1081-7; Jansen A, 2005, RESTOR ECOL, V13, P275, DOI 10.1111/j.1526-100X.2005.00035.x; Karp DS, 2013, ECOL LETT, V16, P1339, DOI 10.1111/ele.12173; Karp DS, 2011, P NATL ACAD SCI USA, V108, P21134, DOI 10.1073/pnas.1118276108; Lindell CA, 2013, RESTOR ECOL, V21, P515, DOI 10.1111/j.1526-100X.2012.00905.x; Lindell CA, 2013, SUSTAINABILITY-BASEL, V5, P1177, DOI 10.3390/su5031177; Lindell CA, 2012, BIRD CONSERV INT, V22, P94, DOI 10.1017/S0959270911000177; Lindenmayer DB, 2010, BIOL CONSERV, V143, P289, DOI 10.1016/j.biocon.2009.10.010; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; Maechler M., 2011, LME4 LINEAR MIXED EF; MARRA PP, 1993, AUK, V110, P565, DOI 10.2307/4088420; Mason NWH, 2012, BIOL CONSERV, V155, P157, DOI 10.1016/j.biocon.2012.05.019; Mendenhall CD, 2013, CONSERV LETT, V6, P125, DOI 10.1111/j.1755-263X.2012.00302.x; Mendenhall CD, 2012, BIOL CONSERV, V151, P32, DOI 10.1016/j.biocon.2012.01.069; Mendenhall CD, 2011, P NATL ACAD SCI USA, V108, P16313, DOI 10.1073/pnas.1111687108; Montague-Drake RM, 2009, BIOL CONSERV, V142, P2896, DOI 10.1016/j.biocon.2009.07.009; Moore RP, 2008, ECOL LETT, V11, P960, DOI 10.1111/j.1461-0248.2008.01196.x; Moran C, 2004, OECOLOGIA, V141, P584, DOI 10.1007/s00442-004-1685-1; Morrison EB, 2012, ECOL APPL, V22, P1526, DOI 10.1890/11-1118.1; Morrison EB, 2010, J APPL ECOL, V47, P130, DOI 10.1111/j.1365-2664.2009.01743.x; Munro Nicola T., 2007, Ecological Management & Restoration, V8, P199, DOI 10.1111/j.1442-8903.2007.00368.x; Munro NT, 2011, RESTOR ECOL, V19, P223, DOI 10.1111/j.1526-100X.2010.00703.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; O'Dea N, 2007, BIODIVERS CONSERV, V16, P1131, DOI 10.1007/s10531-006-9095-9; Oksanen J., 2017, R PACKAGE VERSION 26; Ortega-Alvarez Ruben, 2012, Ecological Restoration, V30, P116, DOI 10.3368/er.30.2.116; Parrotta JA, 1997, FOREST ECOL MANAG, V99, P21, DOI 10.1016/S0378-1127(97)00192-8; Pearman PB, 2002, ECOL MONOGR, V72, P19, DOI 10.1890/0012-9615(2002)072[0019:TSOCSH]2.0.CO;2; Pejchar L, 2008, BIOL CONSERV, V141, P536, DOI 10.1016/j.biocon.2007.11.008; Phelps J, 2012, BIOL CONSERV, V154, P53, DOI 10.1016/j.biocon.2011.12.031; R Core Team, 2021, R LANG ENV STAT COMP; Redo DJ, 2012, P NATL ACAD SCI USA, V109, P8839, DOI 10.1073/pnas.1201664109; Reid JL, 2013, RESTOR ECOL, V21, P153, DOI 10.1111/j.1526-100X.2012.00922.x; Reid JL, 2012, BIOTROPICA, V44, P350, DOI 10.1111/j.1744-7429.2011.00814.x; Reid JL, 2008, J TROP ECOL, V24, P685, DOI 10.1017/S0266467408005415; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Rickert E., 2005, THESIS EVERGREEN STA; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Robinson W. D., 2010, Open Environmental Sciences, V4, P21, DOI 10.2174/1876325101004010021; Ruiz-Gutierrez V, 2010, J APPL ECOL, V47, P621, DOI 10.1111/j.1365-2664.2010.01811.x; Ruiz-Jaen MC, 2005, RESTOR ECOL, V13, P569, DOI 10.1111/j.1526-100X.2005.00072.x; Schwartz MW, 2000, OECOLOGIA, V122, P297, DOI 10.1007/s004420050035; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Seligson M, 1980, PEASANTS COSTA RICA; SER, 2022, US; Shiels AB, 2003, RESTOR ECOL, V11, P457, DOI 10.1046/j.1526-100X.2003.rec0269.x; Sodhi NS, 2007, J ORNITHOL, V148, pS305, DOI 10.1007/s10336-007-0180-y; Stiles F.G., 1989, GUIDE BIRDS COSTA RI; Stouffer PC, 2009, DIVERS DISTRIB, V15, P88, DOI 10.1111/j.1472-4642.2008.00497.x; Tambosi LR, 2014, RESTOR ECOL, V22, P169, DOI 10.1111/rec.12049; Traveset Anna, 2002, P339, DOI 10.1079/9780851995250.0339; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Van Bael SA, 2008, ECOLOGY, V89, P928, DOI 10.1890/06-1976.1; Vellend M, 2003, ECOLOGY, V84, P1158, DOI 10.1890/0012-9658(2003)084[1158:HLIROP]2.0.CO;2; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Webb TJ, 2006, P ROY SOC B-BIOL SCI, V273, P757, DOI 10.1098/rspb.2005.3364; WHITTAKER RJ, 1994, J BIOGEOGR, V21, P245, DOI 10.2307/2845528; Wunderle JM, 1997, FOREST ECOL MANAG, V99, P223, DOI 10.1016/S0378-1127(97)00208-9; Young TP, 2000, BIOL CONSERV, V92, P73, DOI 10.1016/S0006-3207(99)00057-9; Zahawi RA, 2006, ECOL APPL, V16, P464, DOI 10.1890/1051-0761(2006)016[0464:TFRTIA]2.0.CO;2; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3	102	37	38	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90573	10.1371/journal.pone.0090573	http://dx.doi.org/10.1371/journal.pone.0090573			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595233	gold, Green Submitted, Green Published			2022-12-25	WOS:000332475500069
J	Robson, K; Alizart, M; Martin, J; Nagel, R				Robson, Kathryn; Alizart, Michelle; Martin, Jarad; Nagel, Robyn			Coeliac Patients Are Undiagnosed at Routine Upper Endoscopy	PLOS ONE			English	Article							DUODENAL BIOPSY; DISEASE; DIAGNOSIS; PREVALENCE; SCREEN	Background and Aims: Two out of three patients with Coeliac Disease (CD) in Australia are undiagnosed. This prospective clinical audit aimed to determine how many CD patients would be undiagnosed if duodenal biopsy had only been performed if the mucosa looked abnormal or the patient presented with typical CD symptoms. Methods: All eligible patients presenting for upper gastrointestinal endoscopy (OGD) in a regional center from 2004-2009 underwent prospective analysis of presenting symptoms and duodenal biopsy. Clinical presentations were defined as either Major (diarrhea, weight loss, iron deficiency, CD family history or positive celiac antibodies-Ab) or Minor Clinical Indicators (CI) to duodenal biopsy (atypical symptoms). Newly diagnosed CD patients had follow up celiac antibody testing. Results: Thirty-five (1.4%) new cases of CD were identified in the 2,559 patients biopsied at upper endoscopy. Almost a quarter (23%) of cases presented with atypical symptoms. There was an inverse relationship between presentation with Major CI's and increasing age (<16, 16-59 and >60: 100%, 81% and 50% respectively, p = 0.03); 28% of newly diagnosed CD patients were aged over 60 years. Endoscopic appearance was a useful diagnostic tool in only 51% (18/35) of CD patients. Coeliac antibodies were positive in 34/35 CD patients (sensitivity 97%). Conclusions: Almost one quarter of new cases of CD presented with atypical symptoms and half of the new cases had unremarkable duodenal mucosa. At least 10% of new cases of celiac disease are likely to be undiagnosed at routine upper endoscopy, particularly patients over 60 years who more commonly present atypically. All new CD patients could be identified in this study by performing pre-operative celiac antibody testing on all patients presenting for OGD and proceeding to biopsy only positive antibody patients and those presenting with either Major CI or abnormal duodenal mucosa for an estimated cost of AUS$4,629 and AUS$3,710 respectively.	[Robson, Kathryn; Alizart, Michelle; Nagel, Robyn] Medici Med Ctr, Toowoomba Gastroenterol Clin, Toowoomba, Qld, Australia; [Martin, Jarad] St Andrews Hosp, Radiat Oncol Queensland, Toowoomba, Qld, Australia; [Nagel, Robyn] Univ Queensland, Rural Sch Med, Toowoomba, Qld, Australia	University of Queensland	Nagel, R (corresponding author), Medici Med Ctr, Toowoomba Gastroenterol Clin, Toowoomba, Qld, Australia.	robynnagel@tgclinic.com.au	; nagel, robyn/J-7991-2014	Martin, Jarad/0000-0002-4929-0278; nagel, robyn/0000-0001-8389-2718				Abdulkarim AS, 2003, ALIMENT PHARM THER, V17, P987, DOI 10.1046/j.1365-2036.2003.01442.x; Anderson RP, 2008, INTERN MED J, V38, P790, DOI 10.1111/j.1445-5994.2008.01741.x; Bassen MS, 2009, J GASTROENTEROL H S2, V24, pA228; Burgell KR, 2008, J GASTROENTEROL H S4, V23, pA176; Burger JPW, 2013, NETH J MED, V71, P308; Collin P, 2005, GASTROENTEROLOGY, V128, pS104, DOI 10.1053/j.gastro.2005.02.021; Duggan JM, 2004, MED J AUSTRALIA, V180, P524, DOI 10.5694/j.1326-5377.2004.tb06058.x; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; Fasano A, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3592; HANKEY GL, 1994, GUT, V35, P65, DOI 10.1136/gut.35.1.65; Hopper AD, 2007, BMJ-BRIT MED J, V334, P729, DOI 10.1136/bmj.39133.668681.BE; Hovell CJ, 2001, MED J AUSTRALIA, V175, P247, DOI 10.5694/j.1326-5377.2001.tb143555.x; Johnson MW, 2008, NAT CLIN PRACT GASTR, V5, P697, DOI 10.1038/ncpgasthep1281; Jones S, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-24; Leeds JS, 2008, BRIT MED BULL, V88, P157, DOI 10.1093/bmb/ldn044; Lohi S, 2009, ANN MED, V41, P508, DOI 10.1080/07853890903036199; Olds G, 2002, GASTROINTEST ENDOSC, V56, P407, DOI 10.1067/mge.2002.127412; Pais WP, 2008, GASTROINTEST ENDOSC, V67, P1082, DOI 10.1016/j.gie.2007.10.015; Rashtak S, 2009, GASTROENTEROL CLIN N, V38, P433, DOI 10.1016/j.gtc.2009.06.005; Shamir R, 2007, J GASTROEN HEPATOL, V22, P532, DOI 10.1111/j.1440-1746.2006.04728.x; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119	22	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90552	10.1371/journal.pone.0090552	http://dx.doi.org/10.1371/journal.pone.0090552			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595045	gold, Green Published			2022-12-25	WOS:000332475500066
J	Bonomo, LDF; Silva, DN; Boasquivis, PF; Paiva, FA; Guerra, JFD; Martins, TAF; Torres, AGD; de Paula, ITBR; Caneschi, WL; Jacolot, P; Grossin, N; Tessier, FJ; Boulanger, E; Silva, ME; Pedrosa, ML; Oliveira, RD				Bonomo, Larissa de Freitas; Silva, David Nunes; Boasquivis, Patricia Ferreira; Paiva, Franciny Aparecida; da Costa Guerra, Joyce Ferreira; Faria Martins, Talita Alves; de Jesus Torres, Alvaro Gustavo; Borges Raposo de Paula, Igor Thadeu; Caneschi, Washington Luiz; Jacolot, Philippe; Grossin, Nicolas; Tessier, Frederic J.; Boulanger, Eric; Silva, Marcelo Eustaquio; Pedrosa, Maria Lucia; Oliveira, Riva de Paula			Acai (Euterpe oleracea Mart.) Modulates Oxidative Stress Resistance in Caenorhabditis elegans by Direct and Indirect Mechanisms	PLOS ONE			English	Article							AMAZONIAN PALM BERRY; LIFE-SPAN EXTENSION; ANTIOXIDANT PROPERTIES; FACTOR SKN-1; RICH FRUIT; IN-VITRO; PULP; FLAVONOIDS; ACRYLAMIDE; EXTRACT	Acai (Euterpe oleracea Mart.) has recently emerged as a promising source of natural antioxidants. Despite its claimed pharmacological and nutraceutical value, studies regarding the effects of acai in vivo are limited. In this study, we use the Caenorhabditis elegans model to evaluate the in vivo antioxidant properties of acai on an organismal level and to examine its mechanism of action. Supplementation with acai aqueous extract (AAE) increased both oxidative and osmotic stress resistance independently of any effect on reproduction and development. AAE suppressed bacterial growth, but this antimicrobial property did not influence stress resistance. AAE-increased stress resistance was correlated with reduced ROS production, the prevention of sulfhydryl (SH) level reduction and gcs-1 activation under oxidative stress conditions. Our mechanistic studies indicated that AAE promotes oxidative stress resistance by acting through DAF-16 and the osmotic stress response pathway OSR-1/UNC-43/SEK-1. Finally, AAE increased polyglutamine protein aggregation and decreased proteasome activity. Our findings suggest that natural compounds available in AAE can improve the antioxidant status of a whole organism under certain conditions by direct and indirect mechanisms.	[Bonomo, Larissa de Freitas; Silva, David Nunes; Boasquivis, Patricia Ferreira; Paiva, Franciny Aparecida; da Costa Guerra, Joyce Ferreira; Borges Raposo de Paula, Igor Thadeu; Caneschi, Washington Luiz; Silva, Marcelo Eustaquio; Pedrosa, Maria Lucia; Oliveira, Riva de Paula] Univ Fed Ouro Preto, Nucl Pesquisa Ciencias Biol, Ouro Preto, Brazil; [Pedrosa, Maria Lucia] Univ Fed Ouro Preto, Dept Ciencias Biol, Ouro Preto, Brazil; [Faria Martins, Talita Alves; de Jesus Torres, Alvaro Gustavo; Oliveira, Riva de Paula] Univ Fed Ouro Preto, Dept Biodiversidade Evolucao & Meio Ambiente, Ouro Preto, Brazil; [Jacolot, Philippe; Tessier, Frederic J.] Inst Polytech LaSalle Beauvais, Beauvais, France; [Grossin, Nicolas; Boulanger, Eric] Univ Lille 2, Fac Med Pole Rech, Lille, France; [Silva, Marcelo Eustaquio] Univ Fed Ouro Preto, Dept Alimentos, Ouro Preto, Brazil	Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; UniLaSalle; Universite de Lille - ISITE; Universite de Lille; Universidade Federal de Ouro Preto	Oliveira, RD (corresponding author), Univ Fed Ouro Preto, Nucl Pesquisa Ciencias Biol, Ouro Preto, Brazil.	rivaoliveira@nupeb.ufop.br	Tessier, Frederic J/G-3729-2018	Tessier, Frederic J/0000-0001-8096-5715; Paiva, Franciny Aparecida/0000-0002-2052-1079; de Paula Oliveira, Riva/0000-0002-6092-6142; BOULANGER, Eric/0000-0002-5204-2849; Ferreira Boasquivis, Patricia/0000-0002-6811-9978; Magalhaes, Talita/0000-0003-2818-369X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [473015/2008 0]; Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) [CBBAPQ- 01153-08, CBB-PPM-00491-10]; Universidade Federal de Ouro Preto (UFOP); CAPES; CNPq; FAPEMIG; UFOP	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Universidade Federal de Ouro Preto (UFOP); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); UFOP	This work received financial support from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Process 473015/2008 0), Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG Process CBBAPQ- 01153-08 and CBB-PPM-00491-10) and Universidade Federal de Ouro Preto (UFOP). Research fellowships were sponsored by CAPES (Bonomo, L. F.; Boasquivis, P. F.; de Paula, I. T. B. R; Guerra, J.F.C.), CNPq (Oliveira, R. P., Pedrosa, M. L., Silva, M. E.), FAPEMIG (Paiva, F. A.; Silva, D.N.) and UFOP (Caneschi, W. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Boulanger E, 2007, KIDNEY INT, V71, P126, DOI 10.1038/sj.ki.5002016; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; BRENNER S, 1974, GENETICS, V77, P71; Buchter C, 2013, INT J MOL SCI, V14, P11895, DOI 10.3390/ijms140611895; Choe KP, 2007, FEBS J, V274, P5782, DOI 10.1111/j.1742-4658.2007.06098.x; Guerra JFD, 2011, J CLIN BIOCHEM NUTR, V49, P188, DOI 10.3164/jcbn.11-02; Del Pozo-Insfran D, 2004, J AGR FOOD CHEM, V52, P1539, DOI 10.1021/jf035189n; Garigan D, 2002, GENETICS, V161, P1101; Gems D, 2000, J GERONTOL A-BIOL, V55, pB215, DOI 10.1093/gerona/55.5.B215; Girones-Vilaplana A, 2012, J AGR FOOD CHEM, V60, P6571, DOI 10.1021/jf300873k; Giusti MM, 2001, CURRENT PROTOCOLS FO; Gonzalez-Manzano S, 2012, J AGR FOOD CHEM, V60, P8911, DOI 10.1021/jf3004256; Gordon A, 2012, FOOD CHEM, V133, P256, DOI 10.1016/j.foodchem.2011.11.150; Grunz G, 2012, MECH AGEING DEV, V133, P1, DOI 10.1016/j.mad.2011.11.005; Guha S, 2013, AGE, V35, P1559, DOI 10.1007/s11357-012-9459-x; Hasegawa K, 2004, TOXICOL LETT, V152, P183, DOI 10.1016/j.toxlet.2004.04.037; Hasegawa K, 2008, TOXICOL SCI, V101, P215, DOI 10.1093/toxsci/kfm276; Hasegawa K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011194; Heinrich M, 2011, PHYTOCHEM LETT, V4, P10, DOI 10.1016/j.phytol.2010.11.005; Hogan S, 2010, FOOD CHEM, V118, P208, DOI 10.1016/j.foodchem.2009.04.099; Honzel D, 2008, J AGR FOOD CHEM, V56, P8319, DOI 10.1021/jf800401d; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Ishikado A, 2012, FREE RADIC BIOL MED; Jensen GS, 2008, J AGR FOOD CHEM, V56, P8326, DOI 10.1021/jf8016157; Jensen GS, 2011, J MED FOOD, V14, P702, DOI 10.1089/jmf.2010.0150; Kampkotter A, 2007, PHARMACOL RES, V55, P139, DOI 10.1016/j.phrs.2006.11.006; Kampkotter A, 2008, COMP BIOCHEM PHYS B, V149, P314, DOI 10.1016/j.cbpb.2007.10.004; Kampkotter A, 2007, TOXICOLOGY, V234, P113, DOI 10.1016/j.tox.2007.02.006; Kang J, 2011, FOOD CHEM, V128, P152, DOI 10.1016/j.foodchem.2011.03.011; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Lamitina T, 2006, P NATL ACAD SCI USA, V103, P12173, DOI 10.1073/pnas.0602987103; Liedo P, 2012, EXP GERONTOL, V47, P536, DOI 10.1016/j.exger.2012.05.001; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Montiel-Davalos A, 2010, TOXICOL IN VITRO, V24, P135, DOI 10.1016/j.tiv.2009.08.004; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; MunizMiret N, 1996, FOREST ECOL MANAG, V87, P163, DOI 10.1016/S0378-1127(96)03825-X; Murphy CT, 2006, EXP GERONTOL, V41, P910, DOI 10.1016/j.exger.2006.06.040; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Noratto GD, 2011, J AGR FOOD CHEM, V59, P7999, DOI 10.1021/jf201056x; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Pietsch K, 2009, BIOGERONTOLOGY, V10, P565, DOI 10.1007/s10522-008-9199-6; Reisner K, 2011, J BIOCHEM MOL TOXIC, V25, P269, DOI 10.1002/jbt.20386; Rufino MDM, 2011, FOOD RES INT, V44, P2100, DOI 10.1016/j.foodres.2010.09.011; Schauss AG, 2006, J AGR FOOD CHEM, V54, P8604, DOI 10.1021/jf0609779; Schauss AG, 2006, J AGR FOOD CHEM, V54, P8598, DOI 10.1021/jf060976g; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Shi YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039515; Solomon A, 2004, GENETICS, V167, P161, DOI 10.1534/genetics.167.1.161; Song J, 2013, FOOD CHEM TOXICOL, V58, P306, DOI 10.1016/j.fct.2013.05.003; Spada PDS, 2009, J MED FOOD, V12, P1084, DOI 10.1089/jmf.2008.0236; Sun XP, 2010, EXP GERONTOL, V45, P243, DOI 10.1016/j.exger.2010.01.008; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Udani JK, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-45; Wheeler JM, 2006, GENETICS, V174, P1327, DOI 10.1534/genetics.106.059089; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; Wu ZX, 2002, CELL MOL BIOL, V48, P725; Xue YL, 2011, J AGR FOOD CHEM, V59, P5927, DOI 10.1021/jf104798n; Yu YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009339	61	34	37	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89933	10.1371/journal.pone.0089933	http://dx.doi.org/10.1371/journal.pone.0089933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594796	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900048
J	Kong, XY; Xu, XF; Yan, YH; Guo, FF; Li, J; Hu, YL; Zhou, HJ; Xun, QY				Kong, Xiangyi; Xu, XiaoFeng; Yan, Yuhua; Guo, Feifei; Li, Jian; Hu, Yali; Zhou, Huaijun; Xun, Qingying			Estrogen Regulates the Tumour Suppressor MiRNA-30c and Its Target Gene, MTA-1, in Endometrial Cancer	PLOS ONE			English	Article							GROWTH-FACTOR; MICRORNA EXPRESSION; MESSENGER-RNAS; RECEPTOR; CELLS; ADENOCARCINOMA; PROLIFERATION; CARCINOMA; BETA	MicroRNA-30c (miR-30c) has been reported to be a tumour suppressor in endometrial cancer (EC). We demonstrate that miR-30c is down-regulated in EC tissue and is highly expressed in estrogen receptor (ER)-negative HEC-1-B cells. MiR-30c directly inhibits MTA-1 expression and functions as a tumour suppressor via the miR-30c-MTA-1 signalling pathway. Furthermore, miR-30c is decreased upon E-2 treatment in both ER-positive Ishikawa and ER-negative HEC-1-B cells. Taken together, our results suggest that miR-30c is an important deregulated miRNA in EC and might serve as a potential biomarker and novel therapeutic target for EC.	[Kong, Xiangyi; Xu, XiaoFeng; Yan, Yuhua; Guo, Feifei; Li, Jian; Hu, Yali; Zhou, Huaijun] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Gynecol & Obstet, Nanjing 210008, Jiangsu, Peoples R China; [Xun, Qingying] Southeast Univ, Coll Med, Dept Physiol, Nanjing, Jiangsu, Peoples R China; [Hu, Yali] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Reprod Med Ctr, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Southeast University - China; Nanjing University	Zhou, HJ (corresponding author), Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Gynecol & Obstet, Nanjing 210008, Jiangsu, Peoples R China.	zhouhj2007@126.com; xqyzhou@126.com			Six Talent Summit Project of Jiangsu Province Personnel bureau [WSW-021]	Six Talent Summit Project of Jiangsu Province Personnel bureau	This work was supported by Six Talent Summit Project of Jiangsu Province Personnel bureau (WSW-021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Balasenthil S, 2006, HUM PATHOL, V37, P656, DOI 10.1016/j.humpath.2006.01.024; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Bockhorn J, 2013, BREAST CANCER RES TR, V137, P373, DOI 10.1007/s10549-012-2346-4; Boren T, 2008, GYNECOL ONCOL, V110, P206, DOI 10.1016/j.ygyno.2008.03.023; Bridge G, 2012, BLOOD, V120, P5063, DOI 10.1182/blood-2012-04-423004; Busacca S, 2010, AM J RESP CELL MOL, V42, P312, DOI 10.1165/rcmb.2009-0060OC; CHARNOCKJONES DS, 1993, BIOL REPROD, V48, P1120, DOI 10.1095/biolreprod48.5.1120; Chen XY, 2012, CANCER LETT, V314, P41, DOI 10.1016/j.canlet.2011.09.014; Da Sacco L, 2013, INT J MOL SCI, V14, P480, DOI 10.3390/ijms14010480; Du B, 2011, WORLD J GASTROENTERO, V17, P1219, DOI 10.3748/wjg.v17.i9.1219; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Eitan R, 2009, GYNECOL ONCOL, V114, P253, DOI 10.1016/j.ygyno.2009.04.024; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Goparaju CM, 2011, ONCOGENE, V30, P2767, DOI 10.1038/onc.2010.643; Guo Jigang, 2010, Cancer Biol Ther, V9, P446, DOI 10.4161/cbt.9.6.10894; He YQ, 2012, EXP MOL MED, V44, P723, DOI 10.3858/emm.2012.44.12.079; Heinzelmann J, 2011, WORLD J UROL, V29, P367, DOI 10.1007/s00345-010-0633-4; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Jia W, 2011, MOL CANCER RES, V9, P1732, DOI 10.1158/1541-7786.MCR-11-0245; Joglekar MV, 2009, ISLETS, V1, P137, DOI 10.4161/isl.1.2.9578; Karas RH, 2001, CIRC RES, V89, P534, DOI 10.1161/hh1801.097239; Klinge CM, 2012, TRENDS ENDOCRIN MET, V23, P223, DOI 10.1016/j.tem.2012.03.002; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lee H, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-174; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Li S, 2012, BREAST CANCER RES TR, V136, P77, DOI 10.1007/s10549-012-2166-6; Li XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029350, 10.1371/journal.pone.0051199]; Masuda M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-S1-S2; Nothnick WB, 2010, REPROD SCI, V17, P987, DOI 10.1177/1933719110377472; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Patel N, 2011, BIOCHEM J, V434, P473, DOI 10.1042/BJ20101585; Rodriguez-Gonzalez FG, 2011, BREAST CANCER RES TR, V127, P43, DOI 10.1007/s10549-010-0940-x; Sorbe Bengt, 2012, ISRN Obstet Gynecol, V2012, P325790, DOI 10.5402/2012/325790; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Tanic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038847; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wang G, 2010, INT UROL NEPHROL, V42, P95, DOI 10.1007/s11255-009-9584-3; Wang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046888; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Wu YJ, 2011, CANCER-AM CANCER SOC, V117, P3989, DOI 10.1002/cncr.25944; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017; Zhang R, 2012, CANCER LETT, V314, P155, DOI 10.1016/j.canlet.2011.09.027; Zhang YS, 2012, J BIOL CHEM, V287, P41514, DOI 10.1074/jbc.M112.404871; Zhao J, 2013, ARTERIOSCL THROM VAS, V33, P257, DOI 10.1161/ATVBAHA.112.300200; Zhou HJ, 2012, ONCOL REP, V27, P807, DOI 10.3892/or.2011.1574	47	50	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90810	10.1371/journal.pone.0090810	http://dx.doi.org/10.1371/journal.pone.0090810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595016	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900148
J	Li, B; Li, R; Zhang, C; Bian, HJ; Wang, F; Xiao, J; Liu, SW; Yi, W; Zhang, MX; Wang, SX; Zhang, Y; Su, GH; Ji, XP				Li, Bin; Li, Rui; Zhang, Chun; Bian, Hong-jun; Wang, Fu; Xiao, Jie; Liu, Shan-wen; Yi, Wei; Zhang, Ming-xiang; Wang, Shuang-xi; Zhang, Yun; Su, Guo-hai; Ji, Xiao-ping			MicroRNA-7a/b Protects against Cardiac Myocyte Injury in Ischemia/Reperfusion by Targeting Poly(ADP-Ribose) Polymerase	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; INDUCED APOPTOSIS; DOWN-REGULATION; H9C2 CELLS; GROWTH; CARDIOMYOCYTES; CANCER; RECEPTOR; HEART; INHIBITORS	Objectives: MicroRNA-7 (miR-7) is highly connected to cancerous cell proliferation and metastasis. It is also involved in myocardial ischemia-reperfusion (I/R) injury and is upregulated in cardiomyocyte under simulated I/R (SI/R). We aimed to investigate the role of miR-7 during myocardial I/R injury in vitro and in vivo and a possible gene target. Methods and Results: Real-time PCR revealed that miR-7a/b expression was upregulated in H9c2 cells after SI/R. Flow cytometry showed SI/R-induced cell apoptosis was decreased with miR-7a/b mimic transfection but increased with miR-7a/b inhibitor in H9c2 cells. In a rat cardiac I/R injury model, infarct size determination and TUNEL assay revealed that miR-7a/b mimic decreased but miR-7a/b inhibitor increased cardiac infarct size and cardiomyocyte apoptosis as compared with controls. We previously identified an important gene connected with cell apoptosis -- poly(ADP-ribose) polymerase (PARP) -- as a candidate target for miR-7a/b and verified the target by luciferase reporter activity assay and western blot analysis. Conclusions: miR-7a/b is sensitive to I/R injury and protects myocardial cells against I/R-induced apoptosis by negatively regulating PARP expression in vivo and in vitro. miR-7a/b may provide a new therapeutic approach for treatment of myocardial I/R injury. Poly(ADP-ribose) polymerase.	[Li, Bin; Li, Rui; Wang, Fu; Xiao, Jie; Liu, Shan-wen; Zhang, Ming-xiang; Wang, Shuang-xi; Zhang, Yun; Ji, Xiao-ping] Shandong Univ, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China; [Li, Bin; Li, Rui; Wang, Fu; Xiao, Jie; Liu, Shan-wen; Zhang, Ming-xiang; Wang, Shuang-xi; Zhang, Yun; Ji, Xiao-ping] Shandong Univ, Chinese Minist Hlth, Dept Cardiol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Li, Bin; Su, Guo-hai] Shandong Univ, Jinan Cent Hosp, Dept Hlth care, Jinan 250100, Shandong, Peoples R China; [Zhang, Chun] Laizhou Peoples Hosp, Dept Cardiol, Laizhou, Shandong, Peoples R China; [Bian, Hong-jun] Shandong Univ, Shandong Prov Hosp, Dept Emergency, Jinan 250100, Shandong, Peoples R China; [Liu, Shan-wen] Linyi Peoples Hosp, Dept Emergency, Linyi, Shandong, Peoples R China; [Yi, Wei] Shandong Univ, Sch Mech Engn, Jinan 250100, Shandong, Peoples R China; [Yi, Wei] Shandong Univ, Engn Training Ctr, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Shandong University	Su, GH (corresponding author), Shandong Univ, Jinan Cent Hosp, Dept Hlth care, Jinan 250100, Shandong, Peoples R China.	guohaisu@medmail.com.cn; jixiaoping1964@hotmail.com	Yi, Weiming/ABD-7435-2020		National Natural Science Foundation of China [81070087]; National 973 Basic Research Program of China [2012CB722406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China)	This work was supported by the the National Natural Science Foundation of China [81070087], and the National 973 Basic Research Program of China [2012CB722406]. the URL of any funder's website:http://isisn.nsfc.gov.cn/egrantweb/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Callis TE, 2008, TRENDS MOL MED, V14, P254, DOI 10.1016/j.molmed.2008.03.006; Chakrabarti M, 2012, BRAIN RES, V1454, P1, DOI 10.1016/j.brainres.2012.03.017; Choi JY, 2007, BIOCHEM BIOPH RES CO, V352, P366, DOI 10.1016/j.bbrc.2006.11.036; Duan HJ, 1996, J BIOL CHEM, V271, P16720, DOI 10.1074/jbc.271.28.16720; Duex JE, 2011, J BIOL CHEM, V286, P25377, DOI 10.1074/jbc.M111.222760; Ekhterae D, 1999, CIRC RES, V85, pE70; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fleury S, 2003, CIRCULATION, V107, P2375, DOI 10.1161/01.CIR.0000065598.46411.EF; Ji ES, 2004, ACTA PHARMACOL SIN, V25, P306; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Latronico MVG, 2007, CIRC RES, V101, P1225, DOI 10.1161/CIRCRESAHA.107.163147; Liu JH, 2008, AM J PHYSIOL-HEART C, V295, pH1956, DOI 10.1152/ajpheart.00407.2008; Mohanty Ipseeta, 2006, BMC Complement Altern Med, V6, P3, DOI 10.1186/1472-6882-6-3; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Qi JN, 2012, FEBS LETT, V586, P1201, DOI 10.1016/j.febslet.2012.03.011; Qin YJ, 2012, INT J MED SCI, V9, P413, DOI 10.7150/ijms.4514; Rai K, 2011, MOL CANCER THER, V10, P1720, DOI 10.1158/1535-7163.MCT-11-0220; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Tang YH, 2009, INT HEART J, V50, P377, DOI 10.1536/ihj.50.377; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Villa P, 1997, TRENDS BIOCHEM SCI, V22, P388, DOI 10.1016/S0968-0004(97)01107-9; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang JX, 2011, NAT MED, V17, P71, DOI 10.1038/nm.2282; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Xiao J, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-35; Xiong SD, 2011, INT J BIOL SCI, V7, P805, DOI 10.7150/ijbs.7.805; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Ye YM, 2010, CARDIOVASC RES, V87, P535, DOI 10.1093/cvr/cvq053; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007; Zhao YJ, 2009, CHINESE MED J-PEKING, V122, P1322, DOI 10.3760/cma.j.issn.0366-6999.2009.11.016; Zhou HZ, 2006, AM J PHYSIOL-HEART C, V291, pH714, DOI 10.1152/ajpheart.00823.2005	40	49	63	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90096	10.1371/journal.pone.0090096	http://dx.doi.org/10.1371/journal.pone.0090096			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594984	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900067
J	Pinz, S; Unser, S; Brueggemann, S; Besl, E; Al-Rifai, N; Petkes, H; Amslinger, S; Rascle, A				Pinz, Sophia; Unser, Samy; Brueggemann, Susanne; Besl, Elisabeth; Al-Rifai, Nafisah; Petkes, Hermina; Amslinger, Sabine; Rascle, Anne			The Synthetic alpha-Bromo-2 ',3,4,4 '-Tetramethoxychalcone (alpha-Br-TMC) Inhibits the JAK/STAT Signaling Pathway	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; DNA-BINDING ACTIVITY; NF-KAPPA-B; TRANSACTIVATION DOMAIN; LEUKEMIA-CELLS; CONSTITUTIVE ACTIVATION; SERINE PHOSPHORYLATION; HEMATOPOIETIC-CELLS; STAT5 ACTIVATION; GENE-EXPRESSION	Signal transducer and activator of transcription STAT5 and its upstream activating kinase JAK2 are essential mediators of cytokine signaling. Their activity is normally tightly regulated and transient. However, constitutive activation of STAT5 is found in numerous cancers and a driving force for malignant transformation. We describe here the identification of the synthetic chalcone alpha-Br-2',3,4,4'-tetramethoxychalcone (alpha-Br-TMC) as a novel JAK/STAT inhibitor. Using the non-transformed IL-3-dependent B cell line Ba/F3 and its oncogenic derivative Ba/F3-1*6 expressing constitutively activated STAT5, we show that alpha-Br-TMC targets the JAK/STAT pathway at multiple levels, inhibiting both JAK2 and STAT5 phosphorylation. Moreover, alpha-Br-TMC alters the mobility of STAT5A/B proteins in SDS-PAGE, indicating a change in their post-translational modification state. These alterations correlate with a decreased association of STAT5 and RNA polymerase II with STAT5 target genes in chromatin immunoprecipitation assays. Interestingly, expression of STAT5 target genes such as Cis and c-Myc was differentially regulated by alpha-Br-TMC in normal and cancer cells. While both genes were inhibited in IL-3-stimulated Ba/F3 cells, expression of the oncogene c-Myc was down-regulated and that of the tumor suppressor gene Cis was up-regulated in transformed Ba/F3-1* 6 cells. The synthetic chalcone alpha-Br-TMC might therefore represent a promising novel anticancer agent for therapeutic intervention in STAT5-associated malignancies.	[Pinz, Sophia; Unser, Samy; Brueggemann, Susanne; Besl, Elisabeth; Rascle, Anne] Univ Regensburg, Inst Immunol, Signaling Res Grp Stat5, D-93053 Regensburg, Germany; [Al-Rifai, Nafisah; Petkes, Hermina; Amslinger, Sabine] Univ Regensburg, Inst Organ Chem, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg	Amslinger, S (corresponding author), Univ Regensburg, Inst Organ Chem, D-93053 Regensburg, Germany.	sabine.amslinger@chemie.uni-regensburg.de; anne.rascle@klinik.uni-regensburg.de	Al-Rifai, Nafisah/AAW-8832-2021; Rascle, Anne/AAC-1904-2019; Amslinger, Sabine/H-9072-2015	Al-Rifai, Nafisah/0000-0003-3128-052X; Rascle, Anne/0000-0001-7464-8545; Amslinger, Sabine/0000-0001-6588-3658; /0000-0001-8613-0655	Deutsche Forschungsgemeinschaft [RA 2010/2-1]; Deutsche Krebshilfe [109750]; Fonds der Chemischen Industrie; DAAD	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the Deutsche Forschungsgemeinschaft (Grant No. RA 2010/2-1 to AR), the Deutsche Krebshilfe (Grant No. 109750 to AR), institutional research funds (Foerderlinie C to AR), the Fonds der Chemischen Industrie (Liebig scholarship to SA) and the DAAD (Doctoral scholarship to NA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rifai N, 2013, CHEM-EUR J, V19, P15384, DOI 10.1002/chem.201302117; Amslinger S, 2013, ORG BIOMOL CHEM, V11, P549, DOI 10.1039/c2ob27163j; Amslinger S, 2010, CHEMMEDCHEM, V5, P351, DOI 10.1002/cmdc.200900499; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Batovska DI, 2010, CURR CLIN PHARMACOL, V5, P1, DOI 10.2174/157488410790410579; Beuvink I, 2000, J BIOL CHEM, V275, P10247, DOI 10.1074/jbc.275.14.10247; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Butturini E, 2013, FREE RADIC BIOL MED; Butturini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020174; Chim CS, 2004, BLOOD, V103, P4630, DOI 10.1182/blood-2003-06-2007; de Groot RP, 1999, BLOOD, V94, P1108, DOI 10.1182/blood.V94.3.1108.415k07_1108_1112; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Elliott J, 2008, BIOCHEM SOC T, V36, P464, DOI 10.1042/BST0360464; Evrot E, 2013, CLIN CANCER RES, V19, P6230, DOI 10.1158/1078-0432.CCR-13-0905; Fujihara M, 1998, J IMMUNOL, V161, P3659; Funakoshi-Tago M, 2008, BIOCHEM PHARMACOL, V76, P1681, DOI 10.1016/j.bcp.2008.09.012; Garcon L, 2006, BLOOD, V108, P1551, DOI 10.1182/blood-2005-10-009514; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Gryder BE, 2012, FUTURE MED CHEM, V4, P505, DOI [10.4155/FMC.12.3, 10.4155/fmc.12.3]; Guerini V, 2008, LEUKEMIA, V22, P740, DOI 10.1038/sj.leu.2405049; Hanan EJ, 2012, J MED CHEM, V55, P10090, DOI 10.1021/jm3012239; Hayakawa F, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.63; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; Ioannidis S, 2011, J MED CHEM, V54, P262, DOI 10.1021/jm1011319; Jatiani Shashidhar S, 2010, Genes Cancer, V1, P331, DOI 10.1177/1947601910371337; John S, 1999, MOL CELL BIOL, V19, P1910; Kim BH, 2013, BIOCHEM PHARMACOL, V86, P950, DOI 10.1016/j.bcp.2013.08.009; Kraus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037207; Levitzki A, 2006, ANNU REV BIOCHEM, V75, P93, DOI 10.1146/annurev.biochem.75.103004.142657; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Litterst CM, 2003, J BIOL CHEM, V278, P45340, DOI 10.1074/jbc.M303644200; Liu CB, 1999, J BIOL CHEM, V274, P6342, DOI 10.1074/jbc.274.10.6342; Liu YC, 2007, LIFE SCI, V80, P1420, DOI 10.1016/j.lfs.2006.12.040; Liu Yongbo, 2012, J Exp Ther Oncol, V10, P1; Lord JD, 2000, J IMMUNOL, V164, P2533, DOI 10.4049/jimmunol.164.5.2533; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Luo C, 2004, DRUG DISCOV TODAY, V9, P268, DOI 10.1016/S1359-6446(03)03014-9; Ma L, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.6; Ma L, 2010, P NATL ACAD SCI USA, V107, P19314, DOI 10.1073/pnas.1010253107; Mamoon NM, 2007, BIOCHEMISTRY-US, V46, P14810, DOI 10.1021/bi701118u; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Muller J, 2008, CHEMBIOCHEM, V9, P723, DOI 10.1002/cbic.200700701; Muller J, 2008, ANAL BIOCHEM, V375, P249, DOI 10.1016/j.ab.2008.01.017; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; Nelson Erik A, 2012, Genes Cancer, V3, P503, DOI 10.1177/1947601912466555; Nelson EA, 2011, ONCOTARGET, V2, P518; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; Nieborowska-Skorska M, 1999, J EXP MED, V189, P1229, DOI 10.1084/jem.189.8.1229; Niwa Y, 2005, ONCOGENE, V24, P6406, DOI 10.1038/sj.onc.1208788; Nosaka T, 2002, EXP HEMATOL, V30, P697, DOI 10.1016/S0301-472X(02)00808-1; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Pandey MK, 2009, MOL PHARMACOL, V75, P525, DOI 10.1124/mol.108.052548; Paukku K, 2004, CYTOKINE GROWTH F R, V15, P435, DOI 10.1016/j.cytogfr.2004.09.001; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; Pietschmann K, 2012, MOL CANCER THER, V11, P2373, DOI 10.1158/1535-7163.MCT-12-0129; Quintas-Cardama A, 2013, CLIN CANCER RES, V19, P1933, DOI 10.1158/1078-0432.CCR-12-0284; Rascle A, 2003, NUCLEIC ACIDS RES, V31, P6882, DOI 10.1093/nar/gkg907; Rascle A, 2003, MOL CELL BIOL, V23, P4162, DOI 10.1128/MCB.23.12.4162-4173.2003; Rascle A, 2009, EXP CELL RES, V315, P76, DOI 10.1016/j.yexcr.2008.10.012; Roskoski R, 2003, BIOCHEM BIOPH RES CO, V309, P709, DOI 10.1016/j.bbrc.2003.08.055; Santos FPS, 2011, BLOOD REV, V25, P53, DOI 10.1016/j.blre.2010.10.004; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Simmler C, 2013, J AGR FOOD CHEM, V61, P2146, DOI 10.1021/jf304445p; Nguyen TV, 2012, MOL CELL, V45, P210, DOI 10.1016/j.molcel.2011.12.026; Townsend DM, 2008, CANCER RES, V68, P2870, DOI 10.1158/0008-5472.CAN-07-5957; Nguyen T, 2011, CLIN CANCER RES, V17, P3219, DOI 10.1158/1078-0432.CCR-11-0234; Valentino L, 2006, BIOCHEM PHARMACOL, V71, P713, DOI 10.1016/j.bcp.2005.12.017; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; Wang YC, 2009, BLOOD, V114, P5024, DOI 10.1182/blood-2009-05-222133; Ward AC, 2000, BLOOD, V95, P19; Warsch W, 2013, BLOOD, V122, P2167, DOI 10.1182/blood-2013-02-485573; Weber A, 2005, ONCOGENE, V24, P6699, DOI 10.1038/sj.onc.1208818; Weber A, 2013, PHARMACEUTICALS, V6, P960, DOI 10.3390/ph6080960; Wieczorek M, 2012, CYTOKINE GROWTH F R, V23, P293, DOI 10.1016/j.cytogfr.2012.06.005; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Yamashita H, 1998, J BIOL CHEM, V273, P30218, DOI 10.1074/jbc.273.46.30218; Yang J, 2010, MOL CANCER THER, V9, P3386, DOI 10.1158/1535-7163.MCT-10-0416; Zhang Q, 2005, P NATL ACAD SCI USA, V102, P6948, DOI 10.1073/pnas.0501959102	86	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90275	10.1371/journal.pone.0090275	http://dx.doi.org/10.1371/journal.pone.0090275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595334	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900088
J	Purkey, MT; Li, J; Mentch, F; Grant, SFA; Desrosiers, M; Hakonarson, H; Toskala, E				Purkey, Michael T.; Li, Jin; Mentch, Frank; Grant, Struan F. A.; Desrosiers, Martin; Hakonarson, Hakon; Toskala, Elina			Genetic Variation in Genes Encoding Airway Epithelial Potassium Channels Is Associated with Chronic Rhinosinusitis in a Pediatric Population	PLOS ONE			English	Article							BASOLATERAL K+ CHANNELS; CYSTIC-FIBROSIS; LARGE-CONDUCTANCE; CL-SECRETION; INCREASED PREVALENCE; MOLECULAR DIVERSITY; CFTR POTENTIATOR; ANION SECRETION; G-PROTEIN; EXPRESSION	Background: Apical potassium channels regulate ion transport in airway epithelial cells and influence air surface liquid (ASL) hydration and mucociliary clearance (MCC). We sought to identify whether genetic variation within genes encoding airway potassium channels is associated with chronic rhinosinusitis (CRS). Methods: Single nucleotide polymorphism (SNP) genotypes for selected potassium channels were derived from data generated on the Illumnia HumanHap550 BeadChip or Illumina Human610-Quad BeadChip for 828 unrelated individuals diagnosed with CRS and 5,083 unrelated healthy controls from the Children's Hospital of Philadelphia (CHOP). Statistical analysis was performed with set-based tests using PLINK, and corrected for multiple testing. Results: Set-based case control analysis revealed the gene KCNMA1 was associated with CRS in our Caucasian subset of the cohort (598 CRS cases and 3,489 controls; p = 0.022, based on 10,000 permutations). In addition there was borderline evidence that the gene KCNQ5 (p = 0.0704) was associated with the trait in our African American subset of the cohort (230 CRS cases and 1,594 controls). In addition to the top significant SNPs rs2917454 and rs6907229, imputation analysis uncovered additional genetic variants in KCNMA1 and in KCNQ5 that were associated with CRS. Conclusions: We have implicated two airway epithelial potassium channels as novel susceptibility loci in contributing to the pathogenesis of CRS.	[Purkey, Michael T.] Hosp Univ Penn, Dept Otorhinolaryngol, Philadelphia, PA 19104 USA; [Li, Jin; Mentch, Frank; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Desrosiers, Martin] McGill Univ, Montreal Gen Hosp, Dept Otolaryngol, Montreal, PQ H3G 1A4, Canada; [Hakonarson, Hakon] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Toskala, Elina] Temple Univ, Dept Otolaryngol, Philadelphia, PA 19122 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; McGill University; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	Hakonarson@email.chop.edu; Elina.Toskala@tuhs.temple.edu			Institute Development Funds	Institute Development Funds	This work was supported by the Institute Development Funds to The Center for Applied Genomics and an Adele S. and Daniel S. Kubert Estate gift to the Center for Applied Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Bardou O, 2009, AM J PHYSIOL-LUNG C, V296, pL145, DOI 10.1152/ajplung.90525.2008; Bernard K, 2003, J MEMBRANE BIOL, V196, P15, DOI 10.1007/s00232-003-0621-3; Chadwick LH, 2012, EPIGENOMICS-UK, V4, P317, DOI [10.2217/epi.12.18, 10.2217/EPI.12.18]; Chorev Michal, 2012, Frontiers in Genetics, V3, P55, DOI 10.3389/fgene.2012.00055; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Cohen NA, 2006, OTOLARYNG HEAD NECK, V134, P601, DOI 10.1016/j.otohns.2005.11.042; COOK DI, 1989, J MEMBRANE BIOL, V110, P139, DOI 10.1007/BF01869469; Cowley EA, 2002, J PHYSIOL-LONDON, V538, P747, DOI 10.1113/jphysiol.2001.013300; Delagranda A, 2008, RHINOLOGY, V46, P125; Derendorf H, 2008, ALLERGY, V63, P1292, DOI 10.1111/j.1398-9995.2008.01750.x; Deshane J, 2010, J BIOL CHEM, V285, P16476, DOI 10.1074/jbc.M109.058586; Doring F, 1998, J NEUROSCI, V18, P8625; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Greisner WA, 1996, ALLERGY ASTHMA PROC, V17, P283, DOI 10.2500/108854196778662192; Harvey PR, 2011, AM J RESP CELL MOL, V45, P592, DOI 10.1165/rcmb.2010-0484OC; Hollenhorst MI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/174306; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hsu J, 2013, J ALLERGY CLIN IMMUN, V131, P977, DOI 10.1016/j.jaci.2013.01.028; Inglis SK, 2007, AM J PHYSIOL-LUNG C, V292, pL1304, DOI 10.1152/ajplung.00424.2006; Jovanovic S, 2003, AM J RESP CELL MOL, V28, P363, DOI 10.1165/rcmb.2002-0101OC; Kennedy DW, 2012, INT FORUM ALLERGY RH, V2, P93, DOI 10.1002/alr.21043; Kennedy DW, 2004, ANN OTO RHINOL LARYN, V113, P6, DOI 10.1177/00034894041130S503; Leroy C, 2006, AM J PHYSIOL-LUNG C, V291, pL1207, DOI 10.1152/ajplung.00376.2005; LOCKEY RF, 1973, ANN INTERN MED, V78, P57, DOI 10.7326/0003-4819-78-1-57; Lusk RP, 1997, OTOLARYNG HEAD NECK, V117, pS53, DOI 10.1016/S0194-5998(97)70008-1; Mall M, 2003, PEDIATR RES, V53, P608, DOI 10.1203/01.PDR.0000057204.51420.DC; Mall M, 2000, AM J RESP CELL MOL, V23, P283, DOI 10.1165/ajrcmb.23.3.4060; Manzanares D, 2011, J BIOL CHEM, V286, P19830, DOI 10.1074/jbc.M110.185074; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Monaghan AS, 1997, PFLUG ARCH EUR J PHY, V433, P294; Moser SL, 2008, J MEMBRANE BIOL, V221, P153, DOI 10.1007/s00232-008-9093-9; O'Grady SM, 2003, AM J PHYSIOL-LUNG C, V284, pL689, DOI 10.1152/ajplung.00256.2002; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Ooi EH, 2010, OTOLARYNG CLIN N AM, V43, P473, DOI 10.1016/j.otc.2010.02.020; Oomen Karin P Q, 2012, Int J Otolaryngol, V2012, P789572, DOI 10.1155/2012/789572; Ott CJ, 2009, J CELL MOL MED, V13, P680, DOI 10.1111/j.1582-4934.2008.00621.x; Plummer HK, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-104; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raman V, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e13; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ridge FPG, 1997, BBA-BIOMEMBRANES, V1327, P249, DOI 10.1016/S0005-2736(97)00073-4; RIORDAN JR, 1989, SCIENCE, V245, P1066; SAKAKURA Y, 1985, CLIN OTOLARYNGOL, V10, P79, DOI 10.1111/j.1365-2273.1985.tb01171.x; Sakuma T, 1998, PHARMACOL TOXICOL, V83, P16, DOI 10.1111/j.1600-0773.1998.tb01436.x; Sayegh R, 1999, J BIOL CHEM, V274, P12431, DOI 10.1074/jbc.274.18.12431; Scohy S, 2000, NUCLEIC ACIDS RES, V28, P3743, DOI 10.1093/nar/28.19.3743; Soler ZM, 2009, OTOLARYNG HEAD NECK, V141, P454, DOI 10.1016/j.otohns.2009.06.085; Tan BK, 2010, CURR OPIN OTOLARYNGO, V18, P21, DOI 10.1097/MOO.0b013e3283350053; Teng SY, 2003, BIOCHEM BIOPH RES CO, V303, P808, DOI 10.1016/S0006-291X(03)00433-9; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Verschuren JJW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056262; Verschuren JJW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042401; Wang XJ, 2005, ARCH OTOLARYNGOL, V131, P237, DOI 10.1001/archotol.131.3.237; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhao KQ, 2012, AM J PHYSIOL-LUNG C, V302, pL4, DOI 10.1152/ajplung.00102.2011	58	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89329	10.1371/journal.pone.0089329	http://dx.doi.org/10.1371/journal.pone.0089329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595210	gold, Green Submitted, Green Published			2022-12-25	WOS:000332468900015
J	Sarker, AH; Chatterjee, A; Williams, M; Lin, S; Havel, C; Jacob, P; Boldogh, I; Hazra, TK; Talbot, P; Hang, B				Sarker, Altaf H.; Chatterjee, Arpita; Williams, Monique; Lin, Sabrina; Havel, Christopher; Jacob, Peyton, III; Boldogh, Istvan; Hazra, Tapas K.; Talbot, Prudence; Hang, Bo			NEIL2 Protects against Oxidative DNA Damage Induced by Sidestream Smoke in Human Cells	PLOS ONE			English	Article							CILIARY BEAT FREQUENCY; TOBACCO-SMOKE; LUNG-CANCER; CIGARETTE-SMOKE; IN-VITRO; REPAIR; GLYCOSYLASE; RISK; EXPOSURE; IDENTIFICATION	Secondhand smoke (SHS) is a confirmed lung carcinogen that introduces thousands of toxic chemicals into the lungs. SHS contains chemicals that have been implicated in causing oxidative DNA damage in the airway epithelium. Although DNA repair is considered a key defensive mechanism against various environmental attacks, such as cigarette smoking, the associations of individual repair enzymes with susceptibility to lung cancer are largely unknown. This study investigated the role of NEIL2, a DNA glycosylase excising oxidative base lesions, in human lung cells treated with sidestream smoke (SSS), the main component of SHS. To do so, we generated NEIL2 knockdown cells using siRNA-technology and exposed them to SSS-laden medium. Representative SSS chemical compounds in the medium were analyzed by mass spectrometry. An increased production of reactive oxygen species (ROS) in SSS-exposed cells was detected through the fluorescent detection and the induction of HIF-1 alpha. The long amplicon-quantitative PCR (LA-QPCR) assay detected significant dose-dependent increases of oxidative DNA damage in the HPRT gene of cultured human pulmonary fibroblasts (hPF) and BEAS-2B epithelial cells exposed to SSS for 24 h. These data suggest that SSS exposure increased oxidative stress, which could contribute to SSS-mediated toxicity. siRNA knockdown of NEIL2 in hPF and HEK 293 cells exposed to SSS for 24 h resulted in significantly more oxidative DNA damage in HPRT and POLB than in cells with control siRNA. Taken together, our data strongly suggest that decreased repair of oxidative DNA base lesions due to an impaired NEIL2 expression in non-smokers exposed to SSS would lead to accumulation of mutations in genomic DNA of lung cells over time, thus contributing to the onset of SSS-induced lung cancer.	[Sarker, Altaf H.; Hang, Bo] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Dept Canc & DNA Damage Responses, Berkeley, CA 94720 USA; [Chatterjee, Arpita; Boldogh, Istvan; Hazra, Tapas K.] Univ Texas Med Branch, Div Pulm & Crit Care Med, Galveston, TX 77555 USA; [Williams, Monique; Lin, Sabrina; Talbot, Prudence] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Havel, Christopher; Jacob, Peyton, III] Univ Calif San Francisco, Med Ctr, Dept Med, San Francisco Gen Hosp, San Francisco, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California Riverside; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Sarker, AH (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Dept Canc & DNA Damage Responses, Berkeley, CA 94720 USA.	AHSarker@lbl.gov; Bo_Hang@lbl.gov	Classen, Scott/AAY-8176-2020; Talbot, Prue/AAY-3896-2021; Chatterjee, Arpita/GPS-9141-2022		California Tobacco-Related Disease Research Program (TRDRP), under the U.S. Department of Energy [19XT-0070, DE-AC02-05CH11231]; National Institutes of Health [CA63503, CA092584, S10 RR026437, P30 DA012393]; TRDRP Consortium on Thirdhand Smoke [20PT-0184]; Flight Attendant Medical Research Institute Bland Lane Center of Excellence on Secondhand Smoke; NATIONAL CANCER INSTITUTE [R01CA063503, P01CA092584] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA012393] Funding Source: NIH RePORTER	California Tobacco-Related Disease Research Program (TRDRP), under the U.S. Department of Energy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TRDRP Consortium on Thirdhand Smoke; Flight Attendant Medical Research Institute Bland Lane Center of Excellence on Secondhand Smoke; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Dr. Bo Hang was supported by the Grant 19XT-0070 (to B. H.) from the California Tobacco-Related Disease Research Program (TRDRP), under the U.S. Department of Energy Contract no. DE-AC02-05CH11231. Dr. Altaf Sarker was supported by National Institutes of Health Grants CA63503 and CA092584 (Dr. Priscilla K. Cooper. PI). Instrumentation and analytical chemistry at UCSF were supported by the TRDRP Consortium on Thirdhand Smoke, 20PT-0184 (Dr. Neal L. Benowitz, PI), the Flight Attendant Medical Research Institute Bland Lane Center of Excellence on Secondhand Smoke (Dr. Rita F. Redberg, PI), and the National Institutes of Health, S10 RR026437 (to Dr. P.J.) and P30 DA012393 (Dr. Reese T. Jones, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhakat KK, 2006, MOL CELL BIOL, V26, P1654, DOI 10.1128/MCB.26.5.1654-1665.2006; Delaney S, 2012, FREE RADICAL RES, V46, P420, DOI 10.3109/10715762.2011.653968; Dey S, 2012, DNA REPAIR, V11, P570, DOI 10.1016/j.dnarep.2012.03.005; Dizdaroglu M, 2012, CANCER LETT, V327, P26, DOI 10.1016/j.canlet.2012.01.016; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Feng Z, 2006, JNCI-J NATL CANCER I, V94, P1527; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Hang B, 2006, DNA REPAIR GENETIC I, P23; Hang B, 2013, MUTAGENESIS, V28, P381, DOI 10.1093/mutage/get013; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Howard DJ, 1998, ARCH BIOCHEM BIOPHYS, V352, P293, DOI 10.1006/abbi.1998.0605; Husgafvel-Pursiainen K, 2004, MUTAT RES-REV MUTAT, V567, P427, DOI 10.1016/j.mrrev.2004.06.004; Izzotti A, 1999, CARCINOGENESIS, V20, P1499, DOI 10.1093/carcin/20.8.1499; Jacob P, 2013, CHEM RES TOXICOL, V26, P1615, DOI 10.1021/tx400094y; Janik J, 2011, MUTAT RES-FUND MOL M, V709-10, P21, DOI 10.1016/j.mrfmmm.2011.02.009; Jung SN, 2008, CARCINOGENESIS, V29, P713, DOI 10.1093/carcin/bgn032; Kaufmann R. B., 2010, Morbidity and Mortality Weekly Report, V59, P1141; Knoll M, 1998, REPROD TOXICOL, V12, P57, DOI 10.1016/S0890-6238(97)00100-7; KNOLL M, 1995, BIOL REPROD, V53, P29, DOI 10.1095/biolreprod53.1.29; Lin CH, 2012, J EPIDEMIOL, V22, P537, DOI 10.2188/jea.JE20120048; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Matt GE, 2011, ENVIRON HEALTH PERSP, V119, P1218, DOI 10.1289/ehp.1103500; National Cancer Institute, 2004, CANC PROGR REP 2003; Paz-Elizur T, 2003, J NATL CANCER I, V95, P1312, DOI 10.1093/jnci/djg033; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Roszkowski K, 2011, MED SCI MONITOR, V17, pCR329, DOI 10.12659/MSM.881805; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Sarker AH, 1998, J MOL BIOL, V282, P761, DOI 10.1006/jmbi.1998.2042; Smith CJ, 2003, FOOD CHEM TOXICOL, V41, P807, DOI 10.1016/S0278-6915(03)00021-8; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; U.S. Department of Health and Human Services, 2010, REP SURG GEN TOB SMO; US Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; Wei W, 2012, MOL BIOL REP, V39, P11249, DOI 10.1007/s11033-012-2035-8; Zhai XD, 2008, CLIN CANCER RES, V14, P4345, DOI 10.1158/1078-0432.CCR-07-5282; Zhong DY, 2012, GENET MOL RES, V11, P3490, DOI 10.4238/2012.September.26.4	37	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90261	10.1371/journal.pone.0090261	http://dx.doi.org/10.1371/journal.pone.0090261			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595271	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900086
J	Wang, MH; Wang, WP; Zhang, P; Xiao, JJ; Wang, JG; Huang, CQ				Wang, Minghua; Wang, Weiping; Zhang, Ping; Xiao, Juanjuan; Wang, Jianguo; Huang, Chaoqun			Discrimination of the Expression of Paralogous microRNA Precursors That Share the Same Major Mature Form	PLOS ONE			English	Article							HOST GENES; MIR-17-92 CLUSTER; MIRNA; IDENTIFICATION; PROLIFERATION; TRANSCRIPTION; DIFFERENTIATION; COEXPRESSION; HNF-1-ALPHA; DROSOPHILA	Background: MicroRNAs (miRNAs) are a class of small non-coding RNAs generated from endogenous transcripts that form hairpin structures. The hairpin precursor is processed into two mature miRNAs that form major/minor duplexes. Mature miRNAs regulate gene expression by cleaving mRNA or repressing protein translation. Numerous miRNAs have been discovered via deep sequencing. Many miRNAs are produced from multiple genome sites. These miRNAs are grouped into paralogous families of miRNAs that generate the same major mature form within organisms. Currently, no method of distinguishing the expression of these miRNAs is available. Results: In the present study, strategies were developed to discriminate and quantify the expression of paralogous miRNA precursors. First, paralogous miRNA precursors that were differentially expressed in tissues were identified through analysis of the coexpression scores of their major and minor forms based on deep sequencing data. Then the precursors were identified by monitoring the expression of their host gene or minor form using real-time PCR. Finally, precursors were identified by assessing the expression of clusters of miRNA members. These approaches were used to distinguish miR-128-1 and miR-128-2 as well as miR-194-1 and miR-194-2. The mechanism of transcription related to the differential expression of miR-194-1 and miR-194-2 was also investigated. Conclusion: This is the first report to distinguish paralogous miRNA copies by analyzing the expression of major-minor pairs, the host gene, and miRNA clusters. Discriminating paralogous precursors can provide useful information for investigating the mechanisms that regulate miRNA gene expression under different physiological and pathological conditions.	[Wang, Minghua; Wang, Weiping; Zhang, Ping; Xiao, Juanjuan; Wang, Jianguo] Soochow Univ, Coll Med, Dept Biochem & Mol Biol, Suzhou, Jiangsu, Peoples R China; [Huang, Chaoqun] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA	Soochow University - China; Oklahoma State University System; Oklahoma State University - Stillwater	Wang, MH (corresponding author), Soochow Univ, Coll Med, Dept Biochem & Mol Biol, Suzhou, Jiangsu, Peoples R China.	mhwang@suda.edu.cn; chaoqunhuang89@yahoo.com			National Natural Science Foundation of China [81071957]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grant from the National Natural Science Foundation of China (Grant 81071957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Biasiolo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023854; Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Castellano L, 2013, NUCLEIC ACIDS RES, V41, P3339, DOI 10.1093/nar/gks1474; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Furlotte NA, 2011, BIOINFORMATICS, V27, pI288, DOI 10.1093/bioinformatics/btr221; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Griffiths-Jones S, 2011, EMBO REP, V12, P172, DOI 10.1038/embor.2010.191; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; He CJ, 2012, NUCLEIC ACIDS RES, V40, P4002, DOI 10.1093/nar/gkr1312; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Hu HY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-413; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kuchenbauer F, 2011, BLOOD, V118, P3350, DOI 10.1182/blood-2010-10-312454; Kuehn H, 2008, CURR PROTOC BIOINFOR, P12, DOI [10.1002/0471250953.bi0712-22, DOI 10.1002/0471250953.BI0712-22]; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li SC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S13; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Liang S, 2006, PHYSIOL GENOMICS, V26, P158, DOI 10.1152/physiolgenomics.00313.2005; Makova KD, 2003, GENOME RES, V13, P1638, DOI 10.1101/gr.1133803; Marco A, 2012, RNA BIOL, V9, P242, DOI 10.4161/rna.19160; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Pan JB, 2012, BIOINFORMATICS, V28, P1544, DOI 10.1093/bioinformatics/bts169; Pereira V, 2009, GENETICS, V183, P1597, DOI 10.1534/genetics.109.110247; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ryazansky SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-371; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Shomron N, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/594678; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; WU GD, 1994, J BIOL CHEM, V269, P17080; Xiang R, 2012, BRAZ J MED BIOL RES, V45, P131, DOI 10.1590/S0100-879X2012007500007; Yu G, 2012, J SURG ONCOL, V106, P232, DOI 10.1002/jso.22138; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595; Yu XP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-79; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034688	38	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90591	10.1371/journal.pone.0090591	http://dx.doi.org/10.1371/journal.pone.0090591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594692	Green Submitted, Green Published, gold			2022-12-25	WOS:000332468900121
J	Whitesell, TR; Kennedy, RM; Carter, AD; Rollins, EL; Georgijevic, S; Santoro, MM; Childs, SJ				Whitesell, Thomas R.; Kennedy, Regan M.; Carter, Alyson D.; Rollins, Evvi-Lynn; Georgijevic, Sonja; Santoro, Massimo M.; Childs, Sarah J.			An alpha-Smooth Muscle Actin (acta2/alpha sma) Zebrafish Transgenic Line Marking Vascular Mural Cells and Visceral Smooth Muscle Cells	PLOS ONE			English	Article							SONIC HEDGEHOG; TIE2 RECEPTOR; IN-VIVO; PDGF-B; PERICYTES; EXPRESSION; ANGIOGENESIS; MATURATION; STABILITY; CADHERIN	Mural cells of the vascular system include vascular smooth muscle cells (SMCs) and pericytes whose role is to stabilize and/or provide contractility to blood vessels. One of the earliest markers of mural cell development in vertebrates is alpha smooth muscle actin (acta2; alpha sma), which is expressed by pericytes and SMCs. In vivo models of vascular mural cell development in zebrafish are currently lacking, therefore we developed two transgenic zebrafish lines driving expression of GFP or mCherry in acta2-expressing cells. These transgenic fish were used to trace the live development of mural cells in embryonic and larval transgenic zebrafish. acta2:EGFP transgenic animals show expression that largely mirrors native acta2 expression, with early pan-muscle expression starting at 24 hpf in the heart muscle, followed by skeletal and visceral muscle. At 3.5 dpf, expression in the bulbus arteriosus and ventral aorta marks the first expression in vascular smooth muscle. Over the next 10 days of development, the number of acta2:EGFP positive cells and the number of types of blood vessels associated with mural cells increases. Interestingly, the mural cells are not motile and remain in the same position once they express the acta2:EGFP transgene. Taken together, our data suggests that zebrafish mural cells develop relatively late, and have little mobility once they associate with vessels.	[Whitesell, Thomas R.; Kennedy, Regan M.; Carter, Alyson D.; Rollins, Evvi-Lynn; Georgijevic, Sonja; Childs, Sarah J.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Whitesell, Thomas R.; Kennedy, Regan M.; Carter, Alyson D.; Rollins, Evvi-Lynn; Georgijevic, Sonja; Childs, Sarah J.] Univ Calgary, Smooth Muscle Res Grp, Calgary, AB, Canada; [Santoro, Massimo M.] Univ Leuven KU Leuven, VIB Vesalius Res Ctr, Louvain, Belgium	University of Calgary; University of Calgary; Flanders Institute for Biotechnology (VIB); KU Leuven	Childs, SJ (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	schilds@ucalgary.ca	Childs, Sarah/AAG-5111-2021	Childs, Sarah/0000-0003-2261-580X; SANTORO, Massimo Mattia/0000-0003-4605-5085	National Science and Engineering Research Council [RGPIN/312496-2009]; Heart and Stroke Foundation of Alberta, Nunavut and NWT [M06092]; Alberta Innovates [201400188] Funding Source: researchfish	National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Alberta, Nunavut and NWT; Alberta Innovates	This work was supported by grants to SJC from the National Science and Engineering Research Council (RGPIN/312496-2009) and the Heart and Stroke Foundation of Alberta, Nunavut and NWT (M06092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JJ, 2010, GENESIS, V48, P457, DOI 10.1002/dvg.20638; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Crump JG, 2004, DEVELOPMENT, V131, P5703, DOI 10.1242/dev.01444; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Georgijevic S, 2007, DEV DYNAM, V236, P1623, DOI 10.1002/dvdy.21165; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Gittenberger-de Groot AC, 1999, ARTERIOSCL THROM VAS, V19, P1589; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Grimes AC, 2006, DEV BIOL, V290, P265, DOI 10.1016/j.ydbio.2005.11.042; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hu N, 2000, ANAT REC, V260, P148, DOI 10.1002/1097-0185(20001001)260:2<148::AID-AR50>3.0.CO;2-X; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Huang JB, 2010, CIRC RES, V106, P583, DOI 10.1161/CIRCRESAHA.109.207852; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Killian ECO, 2009, DEV BIOL, V333, P161, DOI 10.1016/j.ydbio.2009.06.031; Kim J, 2010, P NATL ACAD SCI USA, V107, P17206, DOI 10.1073/pnas.0915016107; Korn J, 2002, J COMP NEUROL, V442, P78, DOI 10.1002/cne.1423; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lamont RE, 2010, MECH DEVELOP, V127, P159, DOI 10.1016/j.mod.2010.02.001; Lauter G, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-10; Lavine KJ, 2008, J CLIN INVEST, V118, P2404, DOI 10.1172/JCI34561; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Le V. P., 2012, J VIS EXP; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu J, 2007, P NATL ACAD SCI USA, V104, P13990, DOI 10.1073/pnas.0700825104; Liu J, 2012, DEV BIOL, V363, P95, DOI 10.1016/j.ydbio.2011.12.022; Mack CP, 1999, CIRC RES, V84, P852; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Miano JM, 2006, ZEBRAFISH, V3, P455, DOI 10.1089/zeb.2006.3.455; Mundell NA, 2011, DEVELOPMENT, V138, P641, DOI 10.1242/dev.054718; Nielsen CM, 2010, DEV BIOL, V340, P430, DOI 10.1016/j.ydbio.2010.01.032; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Passman JN, 2008, P NATL ACAD SCI USA, V105, P9349, DOI 10.1073/pnas.0711382105; Patan S, 1998, MICROVASC RES, V56, P1, DOI 10.1006/mvre.1998.2081; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Proulx K, 2010, DEV BIOL, V348, P34, DOI 10.1016/j.ydbio.2010.08.036; Renard M, 2010, EUR J HUM GENET, V18, P895, DOI 10.1038/ejhg.2010.45; Roman BL, 2002, DEVELOPMENT, V129, P3009; Santoro MM, 2009, MECH DEVELOP, V126, P638, DOI 10.1016/j.mod.2009.06.1080; Seiler C, 2010, DEV DYNAM, V239, P2806, DOI 10.1002/dvdy.22420; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; von Tell D, 2006, EXP CELL RES, V312, P623, DOI 10.1016/j.yexcr.2005.10.019; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Wang WD, 2011, DEV BIOL, V360, P173, DOI 10.1016/j.ydbio.2011.09.019; Wasteson P, 2008, DEVELOPMENT, V135, P1823, DOI 10.1242/dev.020958; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Zeng L, 2009, P NATL ACAD SCI USA, V106, P17793, DOI 10.1073/pnas.0903693106	55	60	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90590	10.1371/journal.pone.0090590	http://dx.doi.org/10.1371/journal.pone.0090590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594685	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900120
J	Kornilov, P; Peretz, A; Lee, Y; Son, K; Lee, JH; Refaeli, B; Roz, N; Rehavi, M; Choi, S; Attali, B				Kornilov, Polina; Peretz, Asher; Lee, Yoonji; Son, Karam; Lee, Jin Hee; Refaeli, Bosmat; Roz, Netta; Rehavi, Moshe; Choi, Sun; Attali, Bernard			Promiscuous gating modifiers target the voltage sensor of K(v)7.2, TRPV1, and H(v)1 cation channels	FASEB JOURNAL			English	Article						vanilloid; capsaicin; KCNQ	GATED ION CHANNELS; DEPENDENT K+ CHANNEL; POTASSIUM CHANNELS; TARANTULA TOXINS; DOMAIN; DETERMINANTS; SENSITIVITY; ACTIVATION; DISEASE; LIPIDS	Some of the fascinating features of voltage-sensing domains (VSDs) in voltage-gated cation channels (VGCCs) are their modular nature and adaptability. Here we examined the VSD sensitivity of different VGCCs to 2 structurally related nontoxin gating modifiers, NH17 and NH29, which stabilize K(v)7.2 potassium channels in the closed and open states, respectively. The effects of NH17 and NH29 were examined in Chinese hamster ovary cells transfected with transient receptor potential vanilloid 1 (TRPV1) or K(v)7.2 channels, as well as in dorsal root ganglia neurons, using the whole-cell patch-clamp technique. NH17 and NH29 exert opposite effects on TRPV1 channels, operating, respectively, as an activator and a blocker of TRPV1 currents (EC50 and IC50 values ranging from 4 to 40 mu M). Combined mutagenesis, electrophysiology, structural homology modeling, molecular docking, and molecular dynamics simulation indicate that both compounds target the VSDs of TRPV1 channels, which, like vanilloids, are involved in pi-pi stacking, H-bonding, and hydrophobic interactions. Reflecting their promiscuity, the drugs also affect the lone VSD proton channel mV-SOP. Thus, the same gating modifier can promiscuously interact with different VGCCs, and subtle differences at the VSD-ligand interface will dictate whether the gating modifier stabilizes channels in either the closed or the open state.	[Kornilov, Polina; Peretz, Asher; Refaeli, Bosmat; Roz, Netta; Rehavi, Moshe; Attali, Bernard] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Tel Aviv, Israel; [Lee, Yoonji; Son, Karam; Lee, Jin Hee; Choi, Sun] Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, Natl Leading Res Lab Mol Modeling & Drug Design, Seoul, South Korea; [Lee, Yoonji; Son, Karam; Lee, Jin Hee; Choi, Sun] Ewha Womans Univ, Global Top Res Program 5, Seoul, South Korea	Tel Aviv University; Sackler Faculty of Medicine; Ewha Womans University; Ewha Womans University	Attali, B (corresponding author), Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Aviv, Israel.	sunchoi@ewha.ac.kr; battali@post.tau.ac.il	Choi, Sun/AAQ-9407-2020; LEE, YOONJI/AAU-7878-2021	LEE, YOONJI/0000-0002-2494-5792; Choi, Sun/0000-0002-7669-7954	Deutsch-Israelische Projektkooperation (DIP) fund (Deutsche Forschungsgemeinschaft) [AT 119/1-1]; Israel Science Foundation (ISF) [488/09]; National Leading Research Laboratory (NLRL) program - Ministry of Education, Science, and Technology (MEST) [2011-0028885]; National Research Foundation (NRF) of Korea	Deutsch-Israelische Projektkooperation (DIP) fund (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Israel Science Foundation (ISF)(Israel Science Foundation); National Leading Research Laboratory (NLRL) program - Ministry of Education, Science, and Technology (MEST); National Research Foundation (NRF) of Korea(National Research Foundation of Korea)	The authors thank Dr. David Julius (University of California-San Francisco, San Francisco, CA, USA) for rTRPV1 and cTRPV1 cDNA clones, Dr. Yasushi Okamura (Osaka Univer-sity, Osaka, Japan) for the mVSOP clone, and the Korea Institute of Science and Technology Information (KISTI) Supercomputing Center (Yusong, Korea) for providing computing resources. This work was supported by the Deutsch-Israelische Projektkooperation (DIP) fund (Deutsche Forschungsgemeinschaft, AT 119/1-1) and the Israel Science Foundation (ISF; 488/09 to B.A.) and the National Leading Research Laboratory (NLRL) program (2011-0028885 to S.C.) funded by the Ministry of Education, Science, and Technology (MEST) and the National Research Foundation (NRF) of Korea. The authors declare no conflicts of interest.	Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Ashcroft FM, 2000, ION CHANNELS DIS; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Chou MZ, 2004, BIOCHEMISTRY-US, V43, P2501, DOI 10.1021/bi035981h; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Krepkiy D, 2012, J MOL BIOL, V423, P632, DOI 10.1016/j.jmb.2012.07.015; Lee JH, 2011, J COMPUT AID MOL DES, V25, P317, DOI 10.1007/s10822-011-9421-5; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317, DOI 10.1152/physrev.1999.79.4.1317; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; Milescu M, 2013, J GEN PHYSIOL, V141, P203, DOI 10.1085/jgp.201210914; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Nau C., 2008, V182, P85, DOI 10.1007/978-3-540-74806-9_4; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Peretz A, 2010, P NATL ACAD SCI USA, V107, P15637, DOI 10.1073/pnas.0911294107; Peretz A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001332; Phillips E, 2004, J BIOL CHEM, V279, P17165, DOI 10.1074/jbc.M313328200; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Swartz KJ, 2004, NAT REV NEUROSCI, V5, P905, DOI 10.1038/nrn1559; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Zhang XF, 2011, J GEN PHYSIOL, V138, P341, DOI 10.1085/jgp.201110618	37	10	10	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2591	2602		10.1096/fj.14-250647	http://dx.doi.org/10.1096/fj.14-250647			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24599966				2022-12-25	WOS:000339883600018
J	Kurt, TD; Jiang, L; Bett, C; Eisenberg, D; Sigurdson, CJ				Kurt, Timothy D.; Jiang, Lin; Bett, Cyrus; Eisenberg, David; Sigurdson, Christina J.			A Proposed Mechanism for the Promotion of Prion Conversion Involving a Strictly Conserved Tyrosine Residue in the beta(2)-alpha (2) Loop of PrPC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Infectious Diseases; Neurodegenerative Diseases; Prions; Protein Aggregation; (2)-(2) Loop; TSE; Steric Zipper; Transmissible Spongiform Encephalopathy	CHRONIC WASTING DISEASE; BETA-2-ALPHA-2 LOOP; NATURAL SCRAPIE; CYCLIC AMPLIFICATION; NMR STRUCTURE; HAMSTER PRP; PROTEIN PRP; TRANSMISSION; SHEEP; PROPAGATION	Background: Single residue differences can block conversion of the cellular prion protein (PrP) to the pathogenic conformation. Results: Prion conversion was reduced by non-aromatic amino acids at PrP position 169 in the (2)-(2) loop. Conclusion: The conserved tyrosine side chain at PrP position 169 promotes efficient prion formation. Significance: These findings are consistent with a steric zipper model of prion conversion. The transmission of infectious prions into different host species requires compatible prion protein (PrP) primary structures, and even one heterologous residue at a pivotal position can block prion infection. Mapping the key amino acid positions that govern cross-species prion conversion has not yet been possible, although certain residue positions have been identified as restrictive, including residues in the (2)-(2) loop region of PrP. To further define how (2)-(2) residues impact conversion, we investigated residue substitutions in PrPC using an in vitro prion conversion assay. Within the (2)-(2) loop, a tyrosine residue at position 169 is strictly conserved among mammals, and transgenic mice expressing mouse PrP having the Y169G, S170N, and N174T substitutions resist prion infection. To better understand the structural requirements of specific residues for conversion initiated by mouse prions, we substituted a diverse array of amino acids at position 169 of PrP. We found that the substitution of glycine, leucine, or glutamine at position 169 reduced conversion by approximate to 75%. In contrast, replacing tyrosine 169 with either of the bulky, aromatic residues, phenylalanine or tryptophan, supported efficient prion conversion. We propose a model based on a requirement for tightly interdigitating complementary amino acid side chains within specific domains of adjacent PrP molecules, known as steric zippers, to explain these results. Collectively, these studies suggest that an aromatic residue at position 169 supports efficient prion conversion.	[Kurt, Timothy D.; Bett, Cyrus; Sigurdson, Christina J.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Kurt, Timothy D.; Bett, Cyrus; Sigurdson, Christina J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Jiang, Lin; Eisenberg, David] UCLA, Howard Hughes Med Inst, Dept Energy, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Jiang, Lin; Eisenberg, David] UCLA, Inst Mol Biol, Los Angeles, CA 90095 USA; [Sigurdson, Christina J.] Univ Calif Davis, Dept Pathol Immunol & Microbiol, Davis, CA 95616 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Davis	Sigurdson, CJ (corresponding author), Univ Calif San Diego, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	csigurdson@ucsd.edu			National Institutes of Health [NS076896, NS069566, U54AI0359, AG029430]; Morris Animal Foundation Fellowship [D13ZO-419]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076896, R01NS069566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029430] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD017863] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Morris Animal Foundation Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants NS076896, NS069566, and U54AI0359 (to C. J. S.) and AG029430 (to D. E.). This work was also supported by Morris Animal Foundation Fellowship D13ZO-419 (to T. D. K.).	Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; Apostol MI, 2011, BIOCHEMISTRY-US, V50, P2456, DOI 10.1021/bi101803k; Apostol MI, 2010, J BIOL CHEM, V285, P29671, DOI 10.1074/jbc.C110.158303; Atarashi R, 2006, J VIROL, V80, P7854, DOI 10.1128/JVI.00424-06; Baeten LA, 2007, J WILDLIFE DIS, V43, P309, DOI 10.7589/0090-3558-43.2.309; BELT PBGM, 1995, J GEN VIROL, V76, P509, DOI 10.1099/0022-1317-76-3-509; Bett C, 2012, FASEB J, V26, P2868, DOI 10.1096/fj.11-200923; Bons N, 1996, CR ACAD SCI III-VIE, V319, P733; Christen B, 2013, P NATL ACAD SCI USA, V110, P8549, DOI 10.1073/pnas.1306178110; Christen B, 2012, J MOL BIOL, V423, P496, DOI 10.1016/j.jmb.2012.08.011; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; Damberger FF, 2011, P NATL ACAD SCI USA, V108, P17308, DOI 10.1073/pnas.1106325108; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Geoghegan JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000535; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Heisey DM, 2010, J VIROL, V84, P210, DOI 10.1128/JVI.00560-09; Hunter N, 1997, VET REC, V141, P137, DOI 10.1136/vr.141.6.137; HUNTER N, 1993, J GEN VIROL, V74, P1025, DOI 10.1099/0022-1317-74-6-1025; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Karapetyan YE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005730; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KIRKWOOD JK, 1994, VET REC, V135, P296, DOI 10.1136/vr.135.13.296; Kreeger TJ, 2006, J WILDLIFE DIS, V42, P640, DOI 10.7589/0090-3558-42.3.640; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kurt TD, 2014, J NEUROSCI, V34, P1022, DOI 10.1523/JNEUROSCI.4636-13.2014; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Mackay GA, 2011, INT J MOL EPIDEMIOL, V2, P217; Mays CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018047; Ministry of Agriculture Fisheries and Food, 2000, BOV SPONG ENC GREAT, P71; Mitchell GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039055; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Pastore A, 2007, PRION, V1, P185, DOI 10.4161/pri.1.3.5281; Perez DR, 2010, J MOL BIOL, V400, P121, DOI 10.1016/j.jmb.2010.04.066; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; Perrott MR, 2013, J GEN VIROL, V94, P432, DOI 10.1099/vir.0.046110-0; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; PRIOLA SA, 1995, J VIROL, V69, P7754, DOI 10.1128/JVI.69.12.7754-7758.1995; Priola SA, 2001, J VIROL, V75, P4673, DOI 10.1128/JVI.75.10.4673-4680.2001; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schatzl HM, 1997, J MOL BIOL, V265, P257, DOI 10.1006/jmbi.1996.0791; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; TAYLOR DM, 1993, DEV BIOL STAND, V80, P215; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Yokoyama T, 2011, NEUROSCI LETT, V498, P119, DOI 10.1016/j.neulet.2011.04.072	53	28	29	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10660	10667		10.1074/jbc.M114.549030	http://dx.doi.org/10.1074/jbc.M114.549030			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24596090	Green Published, hybrid			2022-12-25	WOS:000334226400036
J	Brogan, AJ; Talbird, SE; Thompson, JR; Miller, JD; Rubin, J; Deniz, B				Brogan, Anita J.; Talbird, Sandra E.; Thompson, James R.; Miller, Jeffrey D.; Rubin, Jaime; Deniz, Baris			Cost-effectiveness of Telaprevir Combination Therapy for Chronic Hepatitis C	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; ALPHA-2B PLUS RIBAVIRIN; UNITED-STATES; INITIAL TREATMENT; VIRUS-INFECTION; LIVER FIBROSIS; FOLLOW-UP; INTERFERON-ALPHA-2B; PEGINTERFERON; DISEASE	Objective: To explore the expected long-term health and economic outcomes of telaprevir (TVR) plus peginterferon alfa-2a and ribavirin (PR), a regimen that demonstrated substantially increased sustained virologic response (SVR) compared with PR alone in adults with chronic genotype 1 hepatitis C virus (HCV) and compensated liver disease in the Phase III studies ADVANCE (treatment-naive patients) and REALIZE (relapsers, partial responders, and null responders to previous PR treatment). Study Design: A decision-analytic model was developed to assess the cost-effectiveness of TVR+PR vs. PR in the United States (US). Methods: Patients first moved through the 72-week decision-tree treatment phase of the model and then entered the cyclic Markov post-treatment phase. Clinical data (patient characteristics, SVR rates, and adverse event rates and durations) were obtained from ADVANCE and REALIZE. Health-state transition probabilities, drug and other costs (in 2012/2013 US dollars), and utility values were obtained from the trials, published studies, and publicly available sources. Outcomes were discounted at 3% per year. Results: Regardless of treatment history, patients receiving TVR+PR were projected to experience fewer liver-disease complications, more life-years, and more quality-adjusted life-years (QALYs) than patients receiving PR. In prior relapsers, TVR+PR was dominant, with lower total medical costs and more QALYs. For the other patient subgroups, incremental costs per QALY gained were between $16,778 (treatment-naive patients) and $34,279 (prior null responders). Extensive sensitivity analyses confirmed robust model results. Conclusions: At standard willingness-to-pay thresholds, TVR+PR represents a cost-effective treatment option compared with PR alone for patients with chronic genotype 1 HCV and compensated liver disease in the US. Future analyses are needed to compare TVR+PR with all existing HCV treatment options.	[Brogan, Anita J.; Talbird, Sandra E.; Thompson, James R.] RTI Hlth Solut, Res Triangle Pk, NC 27709 USA; [Miller, Jeffrey D.] RTI Hlth Solut, Waltham, MA USA; [Rubin, Jaime; Deniz, Baris] Vertex Pharmaceut Inc, Cambridge, MA USA	Research Triangle Institute; Research Triangle Institute; Vertex Pharmaceuticals	Brogan, AJ (corresponding author), RTI Hlth Solut, Res Triangle Pk, NC 27709 USA.	abrogan@rti.org		Talbird, Sandra/0000-0003-4719-3703; Brogan, Anita/0000-0002-9003-994X	Vertex Pharmaceuticals Incorporated	Vertex Pharmaceuticals Incorporated(Vertex Pharmaceuticals)	Funding for this study was provided to RTI Health Solutions by Vertex Pharmaceuticals Incorporated. Baris Deniz and Jaime Rubin are current or former employees of Vertex Pharmaceuticals Incorporated and provided ideas and support for the study design, data collection, and manuscript development. Anita Brogan, Sandra Talbird, James Thompson, and Jeffrey Miller are current or former employees of RTI Health Solutions, an independent research organization, and maintained independent scientific control over the study, including final study design, data collection and analysis, interpretation of results, and preparation of the manuscript. All authors jointly decided to publish the manuscript.	[Anonymous], 2011, HEP C; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bennett WG, 1997, ANN INTERN MED, V127, P855, DOI 10.7326/0003-4819-127-10-199711150-00001; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Brogan AJ, 2012, PODIUM PRESENTATION; Brogan A, 2010, PHARMACOECONOMICS, V28, P129, DOI 10.2165/11587490-000000000-00000; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; But DYK, 2008, WORLD J GASTROENTERO, V14, P1652, DOI 10.3748/wjg.14.1652; Camma C, 2004, HEPATOLOGY, V39, P333, DOI 10.1002/hep.20073; Camma C, 2009, J HEPATOL, V51, P675, DOI 10.1016/j.jhep.2009.06.018; Centers for Disease Control and Prevention, 2011, HEP C INF HLTH PROF; Centers for Medicare and Medicaid Services, 2012, MED MED CLIN LAB FEE; Centers for Medicare and Medicaid Services, 2012, MED MED PHYS SCHED 2; Darbinian JA, 2010, 61 ANN M AM ASS STUD; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Davis KL, 2011, J CLIN GASTROENTEROL, V45, pE17, DOI 10.1097/MCG.0b013e3181e12c09; Druyts Eric, 2013, Clin Epidemiol, V5, P173, DOI 10.2147/CLEP.S44273; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gold MR, 1996, COST EFFECTIVENESS H; Grieve R, 2006, GUT, V55, P1332, DOI 10.1136/gut.2005.064774; Hornberger J, 2006, J CLIN VIROL, V36, P283, DOI 10.1016/j.jcv.2006.04.008; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Liu S, 2012, ANN INTERN MED, V156, P279, DOI 10.7326/0003-4819-156-4-201202210-00005; Liu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026783; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McAdam-Marx C, 2011, J MANAGE CARE PHARM, V17, P531, DOI 10.18553/jmcp.2011.17.7.531; McHutchison JG, 2005, AM J MANAG CARE, V11, pS286; Minino A.M., 2011, NATL VITAL STAT REPO, V59; Nainan OV, 2006, GASTROENTEROLOGY, V131, P478, DOI 10.1053/j.gastro.2006.06.007; National Cancer Institute (NCI), 2009, FAST STATS INT TOOL; Poynard T, 2000, HEPATOLOGY, V32, P1131, DOI 10.1053/jhep.2000.19347; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Saab S, 2010, LIVER TRANSPLANT, V16, P748, DOI 10.1002/lt.22072; Salomon JA, 2003, JAMA-J AM MED ASSOC, V290, P228, DOI 10.1001/jama.290.2.228; Sax PE, 2005, JAIDS-J ACQ IMM DEF, V39, P69, DOI 10.1097/01.qai.0000160406.08924.a2; Sherman KE, 2011, HEPATOLOGY, V54, p485A; Spackman DE, 2008, PHARMACOECONOMICS, V26, P937, DOI 10.2165/00019053-200826110-00006; Sullivan SD, 2004, AM J GASTROENTEROL, V99, P1490, DOI 10.1111/j.1572-0241.2004.30286.x; Thein HH, 2009, J VIRAL HEPATITIS, V16, P802, DOI 10.1111/j.1365-2893.2009.01136.x; Thein HH, 2005, AM J GASTROENTEROL, V100, P643, DOI 10.1111/j.1572-0241.2005.40976.x; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Thuluvath PJ, 2010, AM J TRANSPLANT, V10, P1003, DOI 10.1111/j.1600-6143.2010.03037.x; Townsend R, 2011, VALUE HEALTH, V14, P1068, DOI 10.1016/j.jval.2011.06.006; US Bureau of Labor Statistics (BLS), 2012, CONS PRIC IND ALL UR; US Department of Veterans Affairs (USDVA), 2010, NAT HEP C PROGR OFF; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; Vertex Pharmaceuticals Incorporated, 2012, INCIVEK TEL FILM COA; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562; Wong JB, 2003, AM J GASTROENTEROL, V98, P2354, DOI 10.1111/j.1572-0241.2003.t01-1-08735.x; Wright K, 2003, SIDE EFFECT MANAGEME, P6; Younossi Z, 2012, J HEPATOL, V56, pS462, DOI 10.1016/S0168-8278(12)61181-7; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	57	16	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90295	10.1371/journal.pone.0090295	http://dx.doi.org/10.1371/journal.pone.0090295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603445	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600041
J	Noble, AJ; McCrone, P; Seed, PT; Goldstein, LH; Ridsdale, L				Noble, Adam J.; McCrone, Paul; Seed, Paul T.; Goldstein, Laura H.; Ridsdale, Leone			Clinical- and Cost-Effectiveness of a Nurse Led Self-Management Intervention to Reduce Emergency Visits by People with Epilepsy	PLOS ONE			English	Article							QUALITY-OF-LIFE; CARE; QUESTIONNAIRE; DEPARTMENTS; POPULATION; DEPRESSION; KNOWLEDGE; SERVICES; ANXIETY; EUROPE	People with chronic epilepsy (PWE) often make costly, and clinically unnecessary emergency department (ED) visits. Some do it frequently. No studies have examined interventions to reduce them. An intervention delivered by an epilepsy nurse specialist (ENS) might reduce visits. The rationale is it may optimize patients' self-management skills and knowledge of appropriate ED use. We examined such an intervention's clinical-and cost-effectiveness. Eighty-five adults with epilepsy were recruited from three London EDs with similar catchment populations. Forty-one PWE recruited from two EDs received treatment-as-usual (TAU) and formed the comparison group. The remaining 44 PWE were recruited from the ED of a hospital that had implemented a new ENS service for PWE attending ED. These participants formed the intervention group. They were offered 2 one-to-one sessions with an ENS, plus TAU. Participants completed questionnaires on health service use and psychosocial well-being at baseline, 6- and 12-month follow-up. Covariates were identified and adjustments made. Sixty-nine (81%) participants were retained at follow-up. No significant effect of the intervention on ED visits at 12 months or on other outcomes was found. However, due to less time as inpatients, the average service cost for intervention participants over follow-up was less than for TAU participants' (adjusted difference 558 pound, 95% CI, -2409 pound, 648) pound. Covariates most predictive of subsequent ED visits were patients' baseline feelings of stigmatization due to epilepsy and low confidence in managing epilepsy. The intervention did not lead to a reduction in ED use, but did not cost more, partly because those receiving the intervention had shorter hospital admissions. Our findings on long-term ED predictors clarifies what causes ED use, and suggests that future interventions might focus more on patients' perceptions of stigma and on their confidence in managing epilepsy. If addressed, ED visits might be reduced and efficiency-savings generated.	[Noble, Adam J.] Univ Liverpool, Inst Psychol Hlth & Soc, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England; [Noble, Adam J.; Ridsdale, Leone] Kings Coll London, Inst Psychiat, Dept Clin Neurosci, London WC2R 2LS, England; [McCrone, Paul] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Seed, Paul T.] Kings Coll London, Div Womens Hlth, London WC2R 2LS, England; [Goldstein, Laura H.] Kings Coll London, Inst Psychiat, Dept Psychol, London WC2R 2LS, England	University of Liverpool; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London	Noble, AJ (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England.	adam.noble@liv.ac.uk	; Seed, Paul T/C-4435-2008; Goldstein, Laura/E-7817-2010	McCrone, Paul/0000-0001-7001-4502; Seed, Paul T/0000-0001-7904-7933; Noble, Adam/0000-0002-8070-4352; Goldstein, Laura/0000-0001-9387-3035; Ridsdale, Leone/0000-0002-2234-2859	National Institute for Health Research (NIHR) Health Services and Delivery Research (HSR) programme [08/1808/247]; NIHR Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust; NIHR Dementia Biomedical Research Unit at King's College London; National Institute for Health Research [08/1815/234] Funding Source: researchfish	National Institute for Health Research (NIHR) Health Services and Delivery Research (HSR) programme(National Institute for Health Research (NIHR)); NIHR Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust; NIHR Dementia Biomedical Research Unit at King's College London; National Institute for Health Research(National Institute for Health Research (NIHR))	The project was supported by funding from the National Institute for Health Research (NIHR) Health Services and Delivery Research (HS&R) programme (08/1808/247) and the NIHR Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views and opinions expressed are those of the authors and do not necessarily reflect those of the HS&DR programme, NIHR, NHS or the Department of Health.	Amiel S, 2002, BRIT MED J, V325, P746, DOI 10.1136/bmj.325.7367.746; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; BAKER GA, 1993, EPILEPSY RES, V16, P65, DOI 10.1016/0920-1211(93)90041-5; Baker GA, 1998, SEIZURE-EUR J EPILEP, V7, P201, DOI 10.1016/S1059-1311(98)80036-8; Bautista RED, 2008, EPILEPSY RES, V79, P120, DOI 10.1016/j.eplepsyres.2008.01.003; Beecham J, 1992, MEASURING MENTAL HLT, P163; Bradley P., 2009, COCHRANE DB SYST REV, V2008; Casado V, 2011, NEUROLOGIA, V26, P233, DOI 10.1016/j.nrl.2010.07.033; Cramer JA, 1996, EPILEPSIA, V37, P577, DOI 10.1111/j.1528-1157.1996.tb00612.x; Curtis L., 2010, UNIT COSTS HLTH SOCI; Department of Health, 2012, CAS STUD 2 EM ADM EP; Department of Health, 2010, NHS REF COSTS 2009 1; DiIorio C, 1996, NURS RES, V45, P211, DOI 10.1097/00006199-199607000-00004; Dolan P, 1995, SOCIAL TARIFF EUROQO; Elhai JD, 2008, PSYCHIAT RES, V160, P129, DOI 10.1016/j.psychres.2007.07.003; Faught E, 2008, NEUROLOGY, V71, P1572, DOI 10.1212/01.wnl.0000319693.10338.b9; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Fraser RT, 2011, EPILEPSY BEHAV, V20, P291, DOI 10.1016/j.yebeh.2010.10.010; HART YM, 1995, EPILEPSY RES, V21, P51, DOI 10.1016/0920-1211(95)00008-X; Helde G, 2005, EPILEPSY BEHAV, V7, P451, DOI 10.1016/j.yebeh.2005.06.008; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Jacoby A, 1998, EPILEPSIA, V39, P776, DOI 10.1111/j.1528-1157.1998.tb01164.x; JARVIE S, 1993, SEIZURE, V2, P179, DOI 10.1016/S1059-1311(05)80125-6; Kitson A, 2000, SERVICES PATIENTS EP; Mills N, 1999, SEIZURE-EUR J EPILEP, V8, P1; National Institute for Health and Care Excellence, 2012, MEAS EFF COST EFF QA; National Society for Epilepsy, 2012, DIAL 999; Ndiapi Njankouo, 2011, INT SCI C HARDWOOD P; NHS Right Care, 2010, NHS ATL VAR HEALTHC; Noble AJ, 2013, J NEUROL, V260, P1022, DOI 10.1007/s00415-012-6749-2; Noble AJ, 2012, EPILEPSIA, V53, P1820, DOI 10.1111/j.1528-1167.2012.03586.x; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Parmar MK, 1995, SURVIVAL ANAL PRACTI, P193; Pearson M, 2012, NATL AUDIT SEIZURE M; Public Health England, 2010, PROF LOC HLTH; Pugliatti M, 2007, EPILEPSIA, V48, P2224; Ramaratnam S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002029.pub3; Ridsdale L, 2000, EPILEPSIA, V41, P1014, DOI 10.1111/j.1528-1157.2000.tb00287.x; Ridsdale L, 1999, BRIT J GEN PRACT, V49, P285; Ridsdale L, 1997, BRIT MED J, V314, P120, DOI 10.1136/bmj.314.7074.120; Ridsdale L, 2012, EPILEPSY BEHAV, V25, P529, DOI 10.1016/j.yebeh.2012.09.034; Royl G, 2010, NERVENARZT, V81, P1226, DOI 10.1007/s00115-010-3020-x; Tan JH, 2005, SEIZURE-EUR J EPILEP, V14, P464, DOI 10.1016/j.seizure.2005.07.010; Tapp S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003000.pub2; Tatum WO, 2008, EPILEPSY RES, V82, P156, DOI 10.1016/j.eplepsyres.2008.07.017; Taylor J, 2011, EPILEPSY BEHAV, V21, P255, DOI 10.1016/j.yebeh.2011.04.002; Thapar A, 2009, EPILEPSY BEHAV, V14, P134, DOI 10.1016/j.yebeh.2008.09.004; The Health and Social Care Information Centre, 2010, DIS PREV QUAL O UTC; The Health and Social Care Information Centre, 2011, INP STAT 2010 11 PRI; WAGNER AK, 1995, QUAL LIFE RES, V4, P115, DOI 10.1007/BF01833606; Warren E, 1998, EVALUATION NURSE SPE; WILBY J, 2005, HLTH TECHNOLOGY ASSE, V9; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	54	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90789	10.1371/journal.pone.0090789	http://dx.doi.org/10.1371/journal.pone.0090789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4ID	24603669	Green Published, gold			2022-12-25	WOS:000332483600086
J	Vattay, G; Kauffman, S; Niiranen, S				Vattay, Gabor; Kauffman, Stuart; Niiranen, Samuli			Quantum Biology on the Edge of Quantum Chaos	PLOS ONE			English	Article							LYAPUNOV EXPONENTS; SPECTRA	We give a new explanation for why some biological systems can stay quantum coherent for a long time at room temperature, one of the fundamental puzzles of quantum biology. We show that systems with the right level of complexity between chaos and regularity can increase their coherence time by orders of magnitude. Systems near Critical Quantum Chaos or Metal-Insulator Transition (MIT) can have long coherence times and coherent transport at the same time. The new theory tested in a realistic light harvesting system model can reproduce the scaling of critical fluctuations reported in recent experiments. Scaling of return probability in the FMO light harvesting complex shows the signs of universal return probability decay observed at critical MIT. The results may open up new possibilities to design low loss energy and information transport systems in this Poised Realm hovering reversibly between quantum coherence and classicality.	[Vattay, Gabor] Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary; [Kauffman, Stuart] Univ Vermont, Vermont Complex Syst Ctr, Burlington, VT USA; [Niiranen, Samuli] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland	Eotvos Lorand University; University of Vermont; Tampere University	Vattay, G (corresponding author), Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary.	vattay@elte.hu	Vattay, Gabor/Q-4266-2019; Vattay, Gabor/G-9638-2017	Vattay, Gabor/0000-0002-0919-9429	Lockheed-Martin grant [026703]; Hungarian National Science Foundation [OTKA 77779]	Lockheed-Martin grant; Hungarian National Science Foundation	This work has been partially supported by Lockheed-Martin grant no. 026703 and Hungarian National Science Foundation grant OTKA 77779. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSHULER BL, 1988, ZH EKSP TEOR FIZ+, V94, P343; BOHIGAS O, 1984, PHYS REV LETT, V52, P1, DOI 10.1103/PhysRevLett.52.1; Collini E, 2010, NATURE, V463, P644, DOI 10.1038/nature08811; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; Evangelou SN, 2000, PHYS REV LETT, V84, P1643, DOI 10.1103/PhysRevLett.84.1643; Evangelou SN, 2001, PHYSICA B, V296, P62, DOI 10.1016/S0921-4526(00)00780-8; EVANGELOU SN, 1993, J PHYS A-MATH GEN, V26, pL1243, DOI 10.1088/0305-4470/26/23/010; Franco MI, 2011, P NATL ACAD SCI USA, V108, P3797, DOI 10.1073/pnas.1012293108; Gauger EM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.040503; Gong JB, 1999, PHYS REV E, V60, P1643, DOI 10.1103/PhysRevE.60.1643; Jacquod P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.150403; Kauffman SA, 2012, ONCE FUTURE TURING C; Lichtenberg A., 1992, REGUL CHAOTIC DYN, V2; LINDBLAD G, 1976, COMMUN MATH PHYS, V48, P119, DOI 10.1007/BF01608499; Lloyd S, 2011, J PHYS CONF SER, V302, DOI 10.1088/1742-6596/302/1/012037; MacKay RS., 1993, RENORMALISATION AREA; Olson JM, 2004, PHOTOSYNTH RES, V80, P181, DOI 10.1023/B:PRES.0000030428.36950.43; Panitchayangkoon G, 2011, P NATL ACAD SCI USA, V108, P20908, DOI 10.1073/pnas.1105234108; Panitchayangkoon G, 2010, P NATL ACAD SCI USA, V107, P12766, DOI 10.1073/pnas.1005484107; Pattanayak AK, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.014103; Pattanayak AK, 1999, PHYS REV LETT, V83, P4526, DOI 10.1103/PhysRevLett.83.4526; Pattanayak AK, 1996, PHYS REV LETT, V77, P59, DOI 10.1103/PhysRevLett.77.59; Pattanayak AK, 1997, PHYS REV E, V56, P5174, DOI 10.1103/PhysRevE.56.5174; PRIGODIN VN, 1993, PHYS REV LETT, V70, P2932, DOI 10.1103/PhysRevLett.70.2932; Reichl L. E., 2004, TRANSITION CHAOS CON, DOI 10.1007/978-1-4757-4350-0; SHKLOVSKII BI, 1993, PHYS REV B, V47, P11487, DOI 10.1103/PhysRevB.47.11487; ZUREK WH, 1995, PHYSICA D, V83, P300, DOI 10.1016/0167-2789(94)00271-Q; ZUREK WH, 1993, PHYS REV LETT, V70, P1187, DOI 10.1103/PhysRevLett.70.1187	28	25	25	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89017	10.1371/journal.pone.0089017	http://dx.doi.org/10.1371/journal.pone.0089017			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603620	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600008
J	Bodner, M; Patera, J; Szajewska, M				Bodner, Mark; Patera, Jiri; Szajewska, Marzena			Breaking of Icosahedral Symmetry: C-60 to C-70	PLOS ONE			English	Article							FULLERENES; C70; C60	We describe the existence and structure of large fullerenes in terms of symmetry breaking of the C-60 molecule. Specifically, we describe the existence of C-70 in terms of breaking of the icosahedral symmetry of C-60 by the insertion into its middle of an additional H-2 decagon. The surface of C-70 is formed by 12 regular pentagons and 25 regular hexagons. All 105 edges of C-70 are of the same length. It should be noted that the structure of the molecules is described in exact coordinates relative to the non-orthogonal icosahedral bases. This symmetry breaking process can be readily applied, and could account for and describe other larger cage cluster fullerene molecules, as well as more complex higher structures such as nanotubes.	[Bodner, Mark; Patera, Jiri] MIND Res Inst, Irvine, CA 92617 USA; [Patera, Jiri; Szajewska, Marzena] Univ Montreal, Ctr Rech Math, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Bodner, M (corresponding author), MIND Res Inst, Irvine, CA 92617 USA.	mbodner@mindresearch.net; patera@crm.umontreal.ca; m.szajewska@math.uwb.edu.pl	Szajewska, Marzena/AAM-9802-2021	Szajewska, Marzena/0000-0003-4664-6619	Natural Sciences and Engineering Research Council of Canada; MITACS	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); MITACS	Partial support from the Natural Sciences and Engineering Research Council of Canada and MITACS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJIE H, 1990, J PHYS CHEM-US, V94, P8630, DOI 10.1021/j100387a004; [Anonymous], PURE APPL CHEM, V74, P629; BETHUNE DS, 1990, CHEM PHYS LETT, V174, P219, DOI 10.1016/0009-2614(90)85335-A; CHAMPAGNE B, 1995, CAN J PHYS, V73, P566, DOI 10.1139/p95-084; Chen L., 1998, FIELDS I MONOGRAPHS, V10, P135; CURL RF, 1988, SCIENCE, V242, P1017, DOI 10.1126/science.242.4881.1017; FOWLER PW, 1992, NATURE, V355, P428, DOI 10.1038/355428a0; GUO T, 1995, J PHYS CHEM-US, V99, P10694, DOI 10.1021/j100027a002; KERNER R, 1994, COMP MATER SCI, V2, P500, DOI 10.1016/0927-0256(94)90080-9; KROTO HW, 1987, NATURE, V329, P529, DOI 10.1038/329529a0; MCELVANY SW, 1992, ACCOUNTS CHEM RES, V25, P162, DOI 10.1021/ar00015a010; MCKENZIE DR, 1992, NATURE, V355, P622, DOI 10.1038/355622a0; Pisanski T, 1977, GLAS MAT, V12, P233; Powell WH, 2002, PURE APPL CHEM, V74, P629, DOI 10.1351/pac200274040629; RAGHAVACHARI K, 1991, J PHYS CHEM-US, V95, P5768, DOI 10.1021/j100168a013; SMALLEY RE, 1992, ACCOUNTS CHEM RES, V25, P98, DOI 10.1021/ar00015a001; TAYLOR R, 1990, J CHEM SOC CHEM COMM, P1423, DOI 10.1039/c39900001423; Terrones H, 1997, J PHYS CHEM SOLIDS, V58, P1789, DOI 10.1016/S0022-3697(97)00067-X; Terrones M, 2002, STRUCT CHEM, V13, P373, DOI 10.1023/A:1015880427362; Weaver JH, 1994, SOLID STATE PHYS, V48, P1, DOI 10.1016/S0081-1947(08)60577-9	20	7	7	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e84079	10.1371/journal.pone.0084079	http://dx.doi.org/10.1371/journal.pone.0084079			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599292	gold, Green Submitted, Green Published			2022-12-25	WOS:000332479400002
J	Fuentes, E; Caballero, J; Alarcon, M; Rojas, A; Palomo, I				Fuentes, Eduardo; Caballero, Julio; Alarcon, Marcelo; Rojas, Armando; Palomo, Ivan			Chlorogenic Acid Inhibits Human Platelet Activation and Thrombus Formation	PLOS ONE			English	Article							P-SELECTIN EXPRESSION; PROTEIN-KINASE-A; ADENOSINE RECEPTOR; INCREASES; THERAPY; ASPIRIN; DOCKING; BINDING; COFFEE	Background: Chlorogenic acid is a potent phenolic antioxidant. However, its effect on platelet aggregation, a critical factor in arterial thrombosis, remains unclear. Consequently, chlorogenic acid-action mechanisms in preventing platelet activation and thrombus formation were examined. Methods and Results: Chlorogenic acid in a dose-dependent manner (0.1 to 1 mmol/L) inhibited platelet secretion and aggregation induced by ADP, collagen, arachidonic acid and TRAP-6, and diminished platelet firm adhesion/aggregation and platelet-leukocyte interactions under flow conditions. At these concentrations chlorogenic acid significantly decreased platelet inflammatory mediators (sP-selectin, sCD40L, CCL5 and IL-1 beta) and increased intraplatelet cAMP levels/PKA activation. Interestingly, SQ22536 (an adenylate cyclase inhibitor) and ZM241385 (a potent A(2A) receptor antagonist) attenuated the antiplatelet effect of chlorogenic acid. Chlorogenic acid is compatible to the active site of the adenosine A(2A) receptor as revealed through molecular modeling. In addition, chlorogenic acid had a significantly lower effect on mouse bleeding time when compared to the same dose of aspirin. Conclusions: Antiplatelet and antithrombotic effects of chlorogenic acid are associated with the A(2A) receptor/adenylate cyclase/cAMP/PKA signaling pathway.	[Fuentes, Eduardo; Alarcon, Marcelo; Palomo, Ivan] Univ Talca, Dept Clin Biochem & Immunohematol, Interdisciplinary Excellence Res Program Hlth Agi, Fac Hlth Sci, Talca, Chile; [Fuentes, Eduardo; Alarcon, Marcelo; Palomo, Ivan] CONICYT Reg, CEAP, Gore Maule, Talca, Chile; [Caballero, Julio] Univ Talca, Fac Engn Bioinformat, Ctr Bioinformat & Mol Simulat, Talca, Chile; [Rojas, Armando] Catholic Univ Maule, Fac Med, Biomed Res Labs, Talca, Chile	Universidad de Talca; Universidad de Talca; Universidad Catolica del Maule	Fuentes, E (corresponding author), Univ Talca, Dept Clin Biochem & Immunohematol, Interdisciplinary Excellence Res Program Hlth Agi, Fac Hlth Sci, Talca, Chile.	edfuentes@utalca.cl; ipalomo@utalca.cl	Rojas, Armando/D-2647-2014; Palomo, Iván/I-4321-2018; Caballero, Julio/G-3654-2014; Alarcon, Marcelo A/I-5016-2018	Caballero, Julio/0000-0003-0182-1444; Alarcon, Marcelo A/0000-0001-7596-5382; Rojas, Armando/0000-0001-9911-7142; Fuentes Quinteros, Eduardo/0000-0003-0099-4108; Palomo, Ivan/0000-0002-9618-8778	CONICYT [REGIONAL/GORE MAULE/CEAP/R09I2001]; Interdisciplinary Excellence Research Program on Healthy Aging (PIEIES); Fondecyt, Chile [1130216]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Interdisciplinary Excellence Research Program on Healthy Aging (PIEIES); Fondecyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was funded by the CONICYT REGIONAL/GORE MAULE/CEAP/R09I2001, Interdisciplinary Excellence Research Program on Healthy Aging (PIEIES), and supported by grant no. 1130216 (I. P., M. G., R. M., M. A., J.C.) from Fondecyt, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CW, 2001, CHEST, V119, p300S, DOI 10.1378/chest.119.1_suppl.300S; Albers GW, 2001, STROKE, V32, P2948, DOI 10.1161/hs1201.100829; Amin RP, 2013, J COMPLEMENT INTEGR, V10, P1; [Anonymous], 2003, INT CARD DIS STAT; Appeldoorn CCM, 2005, CIRCULATION, V111, P106, DOI 10.1161/01.CIR.0000151307.10576.02; Aukrust P, 1999, CIRCULATION, V100, P614, DOI 10.1161/01.CIR.100.6.614; Badimon L, 2012, EUR HEART J-ACUTE CA, V1, P60, DOI 10.1177/2048872612441582; Barrett NE, 2008, BRIT J PHARMACOL, V154, P918, DOI 10.1038/bjp.2008.151; Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444; Bijak M, 2013, PHYTOTHER RES, V27, P71, DOI 10.1002/ptr.4682; Conant Carolyn G, 2009, J Vis Exp, DOI 10.3791/1644; DECLERCK F, 1976, THROMB RES, V8, P179, DOI 10.1016/0049-3848(76)90261-9; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Enomoto Y, 2011, INT J MOL MED, V27, P695, DOI 10.3892/ijmm.2011.637; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; FROJMOVIC M, 1991, BIOPHYS J, V59, P815, DOI 10.1016/S0006-3495(91)82294-9; Fuentes Eduardo, 2013, Evid Based Complement Alternat Med, V2013, P609714, DOI 10.1155/2013/609714; Fuentes E, 2013, MOLECULES, V18, P11526, DOI 10.3390/molecules180911526; Hwang SJ, 2013, INFLAMM RES, V2013, P1; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jensen BO, 2004, BLOOD, V104, P2775, DOI 10.1182/blood-2004-03-1058; Ji XB, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-44; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Karunanidhi A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/392058; LARANJINHA JAN, 1994, BIOCHEM PHARMACOL, V48, P487, DOI 10.1016/0006-2952(94)90278-X; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Libersan D, 2003, THROMB HAEMOSTASIS, V89, P310, DOI 10.1055/s-0037-1613448; Loyau S, 2012, ARTERIOSCL THROM VAS, V32, P778, DOI 10.1161/ATVBAHA.111.241067; MARKS DC, 1992, LEUKEMIA RES, V16, P1165, DOI 10.1016/0145-2126(92)90114-M; Martins PAD, 2006, J LEUKOCYTE BIOL, V79, P499, DOI 10.1189/jlb.0605318; Martins PD, 2004, ARTERIOSCL THROM VAS, V24, P193, DOI 10.1161/01.ATV.0000106320.40933.E5; Massberg Steffen, 2003, Semin Vasc Med, V3, P147; Meng SX, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/702196, 10.1155/2013/801457]; Merten M, 2000, CIRCULATION, V102, P1931, DOI 10.1161/01.CIR.102.16.1931; Munoz C, 2012, J MOL GRAPH MODEL, V32, P39, DOI 10.1016/j.jmgm.2011.10.005; NARDINI M, 1995, FREE RADICAL BIO MED, V19, P541, DOI 10.1016/0891-5849(95)00052-Y; Nurden AT, 2011, THROMB HAEMOSTASIS, V105, pS13, DOI 10.1160/THS10-11-0720; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Olthof MR, 2001, AM J CLIN NUTR, V73, P532; Onate B, 2012, FASEB J, V26, P4327, DOI 10.1096/fj.12-207217; Plaza M, 2008, TRENDS FOOD SCI TECH, V19, P31, DOI 10.1016/j.tifs.2007.07.012; Przyklenk K, 2007, LASER MED SCI, V22, P42, DOI 10.1007/s10103-006-0410-1; Raju NC, 2012, CURR OPIN CARDIOL, V27, P499, DOI 10.1097/HCO.0b013e328356ae95; Serebruany VL, 2004, AM J HEMATOL, V75, P40, DOI 10.1002/ajh.10451; WALTER U, 1993, ADV EXP MED BIOL, V344, P237; Wang YL, 2014, MULTIMED TOOLS APPL, V73, P7, DOI 10.1007/s11042-012-1267-x; Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655; World Health Organization, 2004, WHO PUBL DEF ATL GLO; Yang D, 2010, J THROMB HAEMOST, V8, P817, DOI 10.1111/j.1538-7836.2010.03769.x	49	66	72	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90699	10.1371/journal.pone.0090699	http://dx.doi.org/10.1371/journal.pone.0090699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598787	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400120
J	Herod, MR; Salim, O; Skilton, RJ; Prince, CA; Ward, VK; Lambden, PR; Clarke, IN				Herod, Morgan R.; Salim, Omar; Skilton, Rachel J.; Prince, Cynthia A.; Ward, Vernon K.; Lambden, Paul R.; Clarke, Ian N.			Expression of the Murine Norovirus (MNV) ORF1 Polyprotein Is Sufficient to Induce Apoptosis in a Virus-Free Cell Model	PLOS ONE			English	Article							NORWALK-LIKE VIRUS; RNA-SYNTHESIS; NONSTRUCTURAL POLYPROTEIN; SUBSTRATE-SPECIFICITY; REPLICATION COMPLEX; STRUCTURAL BASIS; CLEAVAGE SITES; CAPSID PROTEIN; INFECTED-CELLS; POLYMERASE	Investigations into human norovirus infection, replication and pathogenesis, as well as the development of potential antiviral agents, have been restricted by the lack of a cell culture system for human norovirus. To date, the optimal cell culture surrogate virus model for studying human norovirus biology is the murine norovirus (MNV). In this report we generate a tetracycline-regulated, inducible eukaryotic cell system expressing the entire MNV ORF1 polyprotein. Once induced, the MNV ORF1 polyprotein was faithfully processed to the six mature non-structural proteins that predominately located to a discrete perinuclear region, as has been observed in active MNV infection. Furthermore, we found that expression of the ORF1 polyprotein alone was sufficient to induce apoptosis, characterised by caspase-9 activation and survivin down-regulation. This cell line provides a valuable new tool for studying MNV ORF1 non-structural protein function, screening for potential antiviral agents and acts as a proof-of-principle for such systems to be developed for human noroviruses.	[Herod, Morgan R.; Salim, Omar; Skilton, Rachel J.; Prince, Cynthia A.; Lambden, Paul R.; Clarke, Ian N.] Univ Southampton, Mol Microbiol Grp, Southampton, Hants, England; [Ward, Vernon K.] Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin, New Zealand	University of Southampton; University of Otago	Clarke, IN (corresponding author), Univ Southampton, Mol Microbiol Grp, Southampton, Hants, England.	I.N.Clarke@soton.ac.uk		Clarke, Ian/0000-0002-4938-1620; Ward, Vernon/0000-0001-8692-5116; Herod, Morgan/0000-0002-8626-6787	Wellcome Trust [086112]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust, programme grant number 086112 entitled Replication of Noroviruses: Determinants of Tropism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias A, 2012, JOVE-J VIS EXP, DOI 10.3791/4145; Baker ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030534; Belliot G, 2003, J VIROL, V77, P10957, DOI 10.1128/JVI.77.20.10957-10974.2003; Belliot G, 2008, VIROLOGY, V374, P33, DOI 10.1016/j.virol.2007.12.028; Blakeney SJ, 2003, VIROLOGY, V308, P216, DOI 10.1016/S0042-6822(03)00004-7; Bok K, 2009, J VIROL, V83, P3647, DOI 10.1128/JVI.02028-08; Bu WM, 2008, J VIROL, V82, P5340, DOI 10.1128/JVI.00135-08; Chang KO, 2007, J VIROL, V81, P12111, DOI 10.1128/JVI.00560-07; Chang KO, 2006, VIROLOGY, V353, P463, DOI 10.1016/j.virol.2006.06.006; Chang KO, 2009, J VIROL, V83, P8587, DOI 10.1128/JVI.00005-09; Choi JM, 2008, P NATL ACAD SCI USA, V105, P9175, DOI 10.1073/pnas.0803275105; Ettayebi K, 2003, J VIROL, V77, P11790, DOI 10.1128/JVI.77.21.11790-11797.2003; Furman LM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-139; Glass PJ, 2000, J VIROL, V74, P6581, DOI 10.1128/JVI.74.14.6581-6591.2000; Hardy ME, 1996, VIRUS GENES, V12, P287; Hardy ME, 2002, VIRUS RES, V89, P29, DOI 10.1016/S0168-1702(02)00114-4; Hyde JL, 2012, J VIROL, V86, P4110, DOI 10.1128/JVI.05784-11; Hyde JL, 2010, VIROLOGY, V406, P138, DOI 10.1016/j.virol.2010.06.047; Hyde JL, 2009, J VIROL, V83, P9709, DOI 10.1128/JVI.00600-09; JIANG X, 1993, VIROLOGY, V195, P51, DOI 10.1006/viro.1993.1345; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; LAMBDEN PR, 1993, SCIENCE, V259, P516, DOI 10.1126/science.8380940; Liu BL, 1996, J VIROL, V70, P2605, DOI 10.1128/JVI.70.4.2605-2610.1996; Liu BL, 1999, J GEN VIROL, V80, P291, DOI 10.1099/0022-1317-80-2-291; McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413; Moradpour D, 1998, HEPATOLOGY, V28, P192, DOI 10.1002/hep.510280125; Moradpour D, 1996, VIROLOGY, V222, P51, DOI 10.1006/viro.1996.0397; Muhaxhiri Z, 2013, J VIROL, V87, P4281, DOI 10.1128/JVI.02869-12; Nakamura K, 2005, J VIROL, V79, P13685, DOI 10.1128/JVI.79.21.13685-13693.2005; Ng KKS, 2004, J BIOL CHEM, V279, P16638, DOI 10.1074/jbc.M400584200; Papafragkou E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063485; Pfister T, 2001, J VIROL, V75, P1611, DOI 10.1128/JVI.75.4.1611-1619.2001; Rohayem J, 2006, J VIROL, V80, P7060, DOI 10.1128/JVI.02195-05; Sharp TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013130; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; Subba-Reddy CV, 2012, J VIROL, V86, P10138, DOI 10.1128/JVI.01208-12; Subba-Reddy CV, 2011, J VIROL, V85, P13027, DOI 10.1128/JVI.06191-11; Vongpunsawad S, 2013, J VIROL, V87, P4818, DOI 10.1128/JVI.03508-12; Ward VK, 2007, P NATL ACAD SCI USA, V104, P11050, DOI 10.1073/pnas.0700336104; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992; Zamyatkin DF, 2008, J BIOL CHEM, V283, P7705, DOI 10.1074/jbc.M709563200	42	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90679	10.1371/journal.pone.0090679	http://dx.doi.org/10.1371/journal.pone.0090679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599381	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000332479400117
J	Moon, AM; Stauffer, AM; Schwindinger, WF; Sheridan, K; Firment, A; Robishaw, JD				Moon, Anne M.; Stauffer, Anna M.; Schwindinger, William F.; Sheridan, Kathy; Firment, Ashley; Robishaw, Janet D.			Disruption of G-Protein gamma(5) Subtype Causes Embryonic Lethality in Mice	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEINS; CONGENITAL HEART-DISEASE; ARTERIAL POLE; COUPLED RECEPTORS; ALPHA-SUBUNIT; HUMAN GENOME; RAT-BRAIN; 2ND HEART; PROLIFERATION; ACTIVATION	Heterotrimeric G-proteins modulate many processes essential for embryonic development including cellular proliferation, migration, differentiation, and survival. Although most research has focused on identifying the roles of the various alpha subtypes, there is growing recognition that similarly divergent beta gamma dimers also regulate these processes. In this paper, we show that targeted disruption of the mouse Gng5 gene encoding the gamma(5) subtype produces embryonic lethality associated with severe head and heart defects. Collectively, these results add to a growing body of data that identify critical roles for the gamma subunits in directing the assembly of functionally distinct G-alpha beta gamma trimers that are responsible for regulating diverse biological processes. Specifically, the finding that loss of the G-gamma(5) subtype is associated with a reduced number of cardiac precursor cells not only provides a causal basis for the mouse phenotype but also raises the possibility that G-beta gamma(5) dependent signaling contributes to the pathogenesis of human congenital heart problems.	[Moon, Anne M.; Stauffer, Anna M.; Schwindinger, William F.; Sheridan, Kathy; Firment, Ashley; Robishaw, Janet D.] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA		Robishaw, JD (corresponding author), Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA.	jrobishaw@geisinger.edu		moon, anne/0000-0002-9090-1093	National Institutes of Health [NS 080083]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS080083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by a National Institutes of Health R03 grant NS 080083 awarded to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AHMAD W, 1995, CYTOGENET CELL GENET, V71, P44, DOI 10.1159/000134059; Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Asano T, 2001, J NEUROCHEM, V79, P1129, DOI 10.1046/j.1471-4159.2001.00662.x; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Bordeaux JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036559; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Chen YB, 2013, CELL RES, V23, P186, DOI 10.1038/cr.2013.10; Chin AJ, 2012, MECH DEVELOP, V129, P75, DOI 10.1016/j.mod.2012.05.005; Cook LA, 2006, MOL CELL PROTEOMICS, V5, P671, DOI 10.1074/mcp.M500223-MCP200; Cook LA, 1998, BIOCHEMISTRY-US, V37, P12280, DOI 10.1021/bi980230e; Delcourt N, 2007, TRENDS PHARMACOL SCI, V28, P602, DOI 10.1016/j.tips.2007.09.007; Frank DU, 2002, DEVELOPMENT, V129, P4591; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Grimes AC, 2006, DEV BIOL, V290, P265, DOI 10.1016/j.ydbio.2005.11.042; HANSEN CA, 1994, J CELL BIOL, V126, P811, DOI 10.1083/jcb.126.3.811; Hurowitz EH, 2000, DNA RES, V7, P111, DOI 10.1093/dnares/7.2.111; Ilagan R, 2006, DEVELOPMENT, V133, P2435, DOI 10.1242/dev.02408; Jeong SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068781; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kelly RG, 2012, CURR TOP DEV BIOL, V100, P33, DOI 10.1016/B978-0-12-387786-4.00002-6; Koval A, 2012, DRUG DISCOV TODAY, V17, P1316, DOI 10.1016/j.drudis.2012.07.007; Krejci P, 2009, HUM MUTAT, V30, P1245, DOI 10.1002/humu.21067; Kusters DM, 2012, EXPERT REV CARDIOVAS, V10, P363, DOI [10.1586/erc.11.196, 10.1586/ERC.11.196]; L'Hote D, 2007, GENETICS, V176, P1907, DOI 10.1534/genetics.107.072157; Leung T, 2006, BLOOD, V108, P160, DOI 10.1182/blood-2005-09-3706; Li F, 2013, J NEUROSCI, V33, P7975, DOI 10.1523/JNEUROSCI.5563-12.2013; Lobanova ES, 2008, J NEUROSCI, V28, P3510, DOI 10.1523/JNEUROSCI.0338-08.2008; Mikelis CM, 2013, J BIOL CHEM, V288, P12232, DOI 10.1074/jbc.M112.428599; Mittal A, 2010, MECH DEVELOP, V127, P472, DOI 10.1016/j.mod.2010.08.005; Morishita R, 1999, J NEUROCHEM, V73, P2369, DOI 10.1046/j.1471-4159.1999.0732369.x; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Nakajima K, 2011, DEVELOPMENT, V138, P1771, DOI 10.1242/dev.059295; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Ofori B, 2007, BRIT J CLIN PHARMACO, V64, P496, DOI 10.1111/j.1365-2125.2007.02905.x; Okae H, 2010, DEV DYNAM, V239, P1089, DOI 10.1002/dvdy.22256; Park EJ, 2008, DEVELOPMENT, V135, P3599, DOI 10.1242/dev.025437; Park EJ, 2006, DEVELOPMENT, V133, P2419, DOI 10.1242/dev.02367; Plummer NW, 2012, P NATL ACAD SCI USA, V109, P21366, DOI 10.1073/pnas.1219810110; Pyne NJ, 2011, TRENDS PHARMACOL SCI, V32, P443, DOI 10.1016/j.tips.2011.04.002; Robishaw Janet D, 2012, Subcell Biochem, V63, P181, DOI 10.1007/978-94-007-4765-4_10; Robishaw JD, 2004, CURR OPIN CELL BIOL, V16, P206, DOI 10.1016/j.ceb.2004.02.007; Rosen H, 2013, ANNU REV BIOCHEM, V82, P637, DOI 10.1146/annurev-biochem-062411-130916; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwindinger WF, 2004, MOL CELL BIOL, V24, P7758, DOI 10.1128/MCB.24.17.7758-7768.2004; Schwindinger WF, 2003, J BIOL CHEM, V278, P6575, DOI 10.1074/jbc.M211132200; Schwindinger WF, 2012, J BIOL CHEM, V287, P7121, DOI 10.1074/jbc.M111.308395; Schwindinger WF, 2010, J BIOL CHEM, V285, P29787, DOI 10.1074/jbc.M110.142620; Schwindinger WF, 2009, AM J PHYSIOL-REG I, V297, pR1494, DOI 10.1152/ajpregu.00308.2009; Shen F, 2013, MOL PHARMACOL, V83, P691, DOI 10.1124/mol.112.082511; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Subbaiah VK, 2011, BIOCHEM J, V439, P195, DOI 10.1042/BJ20110903; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Walsh CT, 2008, MOL INTERV, V8, P165, DOI 10.1124/mi.8.4.8; Wang HY, 2006, CELL SIGNAL, V18, P934, DOI 10.1016/j.cellsig.2005.12.008; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Winking H, 2004, CYTOGENET GENOME RES, V105, P251, DOI 10.1159/000078196; Yi P, 2008, DEV CELL, V15, P704, DOI 10.1016/j.devcel.2008.10.001; Yi P, 2006, SCIENCE, V313, P1301, DOI 10.1126/science.1127704; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715; Zhang JH, 2011, J NEUROCHEM, V119, P544, DOI 10.1111/j.1471-4159.2011.07457.x	61	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90970	10.1371/journal.pone.0090970	http://dx.doi.org/10.1371/journal.pone.0090970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599258	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400149
J	Shi, Y; Liu, C; Liu, X; Tang, DG; Wang, JC				Shi, Yang; Liu, Can; Liu, Xin; Tang, Dean G.; Wang, Junchen			The microRNA miR-34a Inhibits Non-Small Cell Lung Cancer (NSCLC) Growth and the CD44(hi) Stem-Like NSCLC Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; SIDE POPULATION; EXPRESSION; METASTASIS; APOPTOSIS; MIRNAS; LINES; CYCLE	Lung cancer is among the most lethal malignancies with a high metastasis and recurrence rate, which is probably due to the existence of lung cancer stem cells (CSCs). CSCs in many tumors including non-small cell lung cancer (NSCLC) have been identified using adhesion molecular CD44, either individually or in combination with other marker(s). MicroRNAs (miRNAs) regulate both normal stem cells and CSCs and dysregulation of miRNAs has been implicated in tumorigenesis. Recently, miR-34a was found to be downregulated in NSCLC cells but the biological functions of miR-34a in regulating NSCLC cell behavior have not been extensively studied. Here we show that transfection of synthetic miR-34a, but not the negative control (NC) miRNA oligonucleotides (oligos) in three NSCLC cell lines, i.e., A549, H460, and H1299, inhibited their holoclone formation, clonogenic expansion, and tumor regeneration in vivo. Furthermore, the lentiviral vector-mediated overexpression of miR-34a in purified CD44(hi) H460 cells also inhibited tumor outgrowth. In contrast, expression of miR-34a antagomirs (i.e., antisense oligos) in the CD44(lo) H460 cells promoted tumor development. Our study shows that miR-34a is a negative regulator of the tumorigenic properties of NSCLC cells and CD44(hi) lung CSCs, and establishes a strong rationale for developing miR-34a as a novel therapeutic agent against NSCLC.	[Shi, Yang; Wang, Junchen] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Pathol, Shanghai 200092, Peoples R China; [Shi, Yang; Liu, Can; Liu, Xin; Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Shi, Yang; Tang, Dean G.; Wang, Junchen] Tongji Univ, Sch Med, Shanghai East Hosp, Canc Stem Cell Inst,Res Ctr Translat Med, Shanghai 200092, Peoples R China	Tongji University; University of Texas System; UTMD Anderson Cancer Center; Tongji University	Wang, JC (corresponding author), Tongji Univ, Sch Med, Shanghai East Hosp, Dept Pathol, Shanghai 200092, Peoples R China.	jeancwangdfyy@gmail.com	Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174	National Natural Science Foundation of China [81141096, 81372512]; Key Project Fund of Shanghai Science and Technology association, China [05119554]; NIH [R01-CA155693]; Department of Defense [PC120817]; CPRIT [RP120380]; MDACC Center for Cancer Epigenetics; RNA Center-Laura & John Arnold Foundation; DOD [PC121553]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project Fund of Shanghai Science and Technology association, China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); CPRIT; MDACC Center for Cancer Epigenetics; RNA Center-Laura & John Arnold Foundation; DOD(United States Department of Defense)	This study was supported by the National Natural Science Foundation of China(Grant No. 81141096 and Grant No. 81372512) and the Key Project Fund of Shanghai Science and Technology association, China (Grant No. 05119554) to J. Wang, and NIH (R01-CA155693), Department of Defense (PC120817), CPRIT (RP120380), and the MDACC Center for Cancer Epigenetics and RNA Center-Laura & John Arnold Foundation grants to DG. Tang. C. Liu was supported, in part, by a DOD post-doctoral fellowship (PC121553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandi N, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-55; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Chen F, 2012, J BIOCHEM MOL TOXIC, V26, P79, DOI 10.1002/jbt.20412; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Das B, 2008, STEM CELLS, V26, P1818, DOI 10.1634/stemcells.2007-0724; Di Martino MT, 2012, CLIN CANCER RES, V18, P6260, DOI 10.1158/1078-0432.CCR-12-1708; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Duan WM, 2013, J RADIAT RES, V54, P611, DOI 10.1093/jrr/rrs136; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Garofalo M, 2011, ANNU REV PHARMACOL, V51, P25, DOI 10.1146/annurev-pharmtox-010510-100517; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kumar B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037601; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Li LS, 2013, CLIN EXP MED, V13, P109, DOI 10.1007/s10238-012-0186-5; Liu C, 2012, CANCER RES, V72, P3393, DOI 10.1158/0008-5472.CAN-11-3864; Liu C, 2011, CANCER RES, V71, P5950, DOI 10.1158/0008-5472.CAN-11-1035; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Pang RTK, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-25; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Sell S, 2010, AM J PATHOL, V176, P2584, DOI 10.2353/ajpath.2010.091064; Shi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033358; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Tang DG, 2012, CELL RES, V22, P457, DOI 10.1038/cr.2012.13; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang X, 2013, CANCER BIOTHER RADIO, V28, P45, DOI 10.1089/cbr.2012.1218; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Yan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033778; Yang S, 2013, ONCOGENE, V32, P4294, DOI 10.1038/onc.2012.432; Zhao HE, 2013, ONCOL REP, V29, P1027, DOI 10.3892/or.2013.2234	34	97	104	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90022	10.1371/journal.pone.0090022	http://dx.doi.org/10.1371/journal.pone.0090022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595209	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500030
J	Al-Ansari, MM; Aboussekhra, A				Al-Ansari, Mysoon M.; Aboussekhra, Abdelilah			Caffeine Mediates Sustained Inactivation of Breast Cancer-Associated Myofibroblasts via Up-Regulation of Tumor Suppressor Genes	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CELL MOTILITY; FIBROBLASTS; EXPRESSION; PROTEIN; PTEN; ANGIOGENESIS; COFFEE; TEA	Background: Active cancer-associated fibroblasts (CAFs) or myofibroblasts play important roles not only in the development and progression of breast carcinomas, but also in their prognosis and treatment. Therefore, targeting these cells through suppressing their supportive procarcinogenic paracrine effects is mandatory for improving the current therapies that are mainly targeting tumor cells. To this end, we investigated the effect of the natural and pharmacologically safe molecule, caffeine, on CAF cells and their various procarcinogenic effects. Methodology/Principal Findings: We have shown here that caffeine up-regulates the tumor suppressor proteins p16, p21, p53 and Cav-1, and reduces the expression/secretion of various cytokines (IL-6, TGF-beta, SDF-1 and MMP-2), and down-regulates alpha-SMA. Furthermore, caffeine suppressed the migratory/invasiveness abilities of CAF cells through PTEN-dependent Akt/Erk1/2 inactivation. Moreover, caffeine reduced the paracrine pro-invasion/-migration effects of CAF cells on breast cancer cells. These results indicate that caffeine can inactivate breast stromal myofibroblasts. This has been confirmed by showing that caffeine also suppresses the paracrine pro-angiogenic effect of CAF cells through down-regulating HIF-1 alpha and its downstream effector VEGF-A. Interestingly, these effects were sustained in absence of caffeine. Conclusion/Significance: The present findings provide a proof of principle that breast cancer myofibroblasts can be inactivated, and thereby caffeine may provide a safe and effective prevention against breast tumor growth/recurrence through inhibition of the procarcinogenic effects of active stromal fibroblasts.	[Al-Ansari, Mysoon M.] King Saud Univ, Fac Sci & Med Studies, Dept Microbiol, Riyadh, Saudi Arabia; [Aboussekhra, Abdelilah] King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, Riyadh 11211, Saudi Arabia	King Saud University; King Faisal Specialist Hospital & Research Center	Aboussekhra, A (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, Riyadh 11211, Saudi Arabia.	aboussekhra@kfshrc.edu.sa	Al-Ansari, Mysoon M/X-3875-2018; Al-Ansari, Mysoon/K-1915-2013	Al-Ansari, Mysoon M/0000-0002-2501-691X; Al-Ansari, Mysoon/0000-0002-2501-691X	KFSH&RC (King Faisal Specialist Hospital & Research Center)	KFSH&RC (King Faisal Specialist Hospital & Research Center)	This work was supported by KFSH&RC (King Faisal Specialist Hospital & Research Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel EL, 2007, EUR J CANCER PREV, V16, P446, DOI 10.1097/01.cej.0000243850.59362.73; Aboussekhra A, 2011, INT J DEV BIOL, V55, P841, DOI 10.1387/ijdb.113362aa; Al-Ansari MM, 2013, ONCOGENE, V32, P2356, DOI 10.1038/onc.2012.270; Al-Ansari MM, 2012, NEOPLASIA, V14, P1269, DOI 10.1593/neo.121632; Al-Mohanna MA, 2007, NUCLEIC ACIDS RES, V35, P223, DOI 10.1093/nar/gkl1075; Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Berra E, 2000, CANCER METAST REV, V19, P139, DOI 10.1023/A:1026506011458; BLANCHARD J, 1983, EUR J CLIN PHARMACOL, V24, P93, DOI 10.1007/BF00613933; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Bode AM, 2007, CANCER LETT, V247, P26, DOI 10.1016/j.canlet.2006.03.032; Conney AH, 2007, TOXICOL APPL PHARM, V224, P209, DOI 10.1016/j.taap.2006.11.001; D'Anello L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-300; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Farhang Ghahremani M, 2013, CELL DEATH DIFFER, V20, P888, DOI 10.1038/cdd.2013.12; Foukas LC, 2002, J BIOL CHEM, V277, P37124, DOI 10.1074/jbc.M202101200; Franco OE, 2010, SEMIN CELL DEV BIOL, V21, P33, DOI 10.1016/j.semcdb.2009.10.010; Ganmaa D, 2008, INT J CANCER, V122, P2071, DOI 10.1002/ijc.23336; Hashimoto T, 2004, CANCER RES, V64, P3344, DOI 10.1158/0008-5472.CAN-03-3453; Hawsawi NM, 2008, CANCER RES, V68, P2717, DOI 10.1158/0008-5472.CAN-08-0192; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Ku BM, 2011, MOL CELLS, V31, P275, DOI 10.1007/s10059-011-0027-5; LELO A, 1986, CLIN PHARMACOL THER, V39, P54, DOI 10.1038/clpt.1986.10; Li H, 2013, ANAT CELL BIOL, V46, P57, DOI 10.5115/acb.2013.46.1.57; Lou YR, 1999, NUTR CANCER, V33, P146, DOI 10.1207/S15327914NC330205; Merdzhanova G, 2010, ONCOGENE, V29, P5392, DOI 10.1038/onc.2010.281; Merighi S, 2007, MOL PHARMACOL, V72, P395, DOI 10.1124/mol.106.032920; Milanini J, 1998, J BIOL CHEM, V273, P18165, DOI 10.1074/jbc.273.29.18165; Miwa S, 2011, INT J ONCOL, V39, P465, DOI 10.3892/ijo.2011.1051; Moskovits N, 2006, CANCER RES, V66, P10671, DOI 10.1158/0008-5472.CAN-06-2323; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Okano JI, 2008, BASIC CLIN PHARMACOL, V102, P543, DOI 10.1111/j.1742-7843.2008.00231.x; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pinto MP, 2010, CANCER RES, V70, P2655, DOI 10.1158/0008-5472.CAN-09-4373; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; Saiki S, 2011, AUTOPHAGY, V7, P176, DOI 10.4161/auto.7.2.14074; Shimoda M, 2010, SEMIN CELL DEV BIOL, V21, P19, DOI 10.1016/j.semcdb.2009.10.002; Skinner HD, 2004, J BIOL CHEM, V279, P45643, DOI 10.1074/jbc.M404097200; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Wang FS, 2004, J BIOL CHEM, V279, P10331, DOI 10.1074/jbc.M308013200; Weng LP, 2001, HUM MOL GENET, V10, P605, DOI 10.1093/hmg/10.6.605; WOLFROM DM, 1991, BREAST CANCER RES TR, V19, P269, DOI 10.1007/BF01961163; Xin H, 2012, MOL CANCER RES, V10, P108, DOI 10.1158/1541-7786.MCR-11-0435; Yang HY, 2004, CLIN EXP METASTAS, V21, P719, DOI 10.1007/s10585-004-8251-4; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033	46	26	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90907	10.1371/journal.pone.0090907	http://dx.doi.org/10.1371/journal.pone.0090907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595168	Green Submitted, Green Published, gold			2022-12-25	WOS:000332468900157
J	Kluver, N; Ortmann, J; Paschke, H; Renner, P; Ritter, AP; Scholz, S				Kluever, Nils; Ortmann, Julia; Paschke, Heidrun; Renner, Patrick; Ritter, Axel P.; Scholz, Stefan			Transient Overexpression of adh8a Increases Allyl Alcohol Toxicity in Zebrafish Embryos	PLOS ONE			English	Article							DEVELOPMENTAL TOXICITY; ALTERNATIVE METHOD; LIFE STAGES; ASSAY; METABOLISM; ACTIVATION; PREDICTION; RERIO; TERM	Fish embryos are widely used as an alternative model to study toxicity in vertebrates. Due to their complexity, embryos are believed to more resemble an adult organism than in vitro cellular models. However, concerns have been raised with respect to the embryo's metabolic capacity. We recently identified allyl alcohol, an industrial chemical, to be several orders of magnitude less toxic to zebrafish embryo than to adult zebrafish (embryo LC50 = 478 mg/L vs. fish LC50 = 0.28 mg/L). Reports on mammals have indicated that allyl alcohol requires activation by alcohol dehydrogenases (Adh) to form the highly reactive and toxic metabolite acrolein, which shows similar toxicity in zebrafish embryos and adults. To identify if a limited metabolic capacity of embryos indeed can explain the low allyl alcohol sensitivity of zebrafish embryos, we compared the mRNA expression levels of Adh isoenzymes (adh5, adh8a, adh8b and adhfe1) during embryo development to that in adult fish. The greatest difference between embryo and adult fish was found for adh8a and adh8b expression. Therefore, we hypothesized that these genes might be required for allyl alcohol activation. Microinjection of adh8a, but not adh8b mRNA led to a significant increase of allyl alcohol toxicity in embryos similar to levels reported for adults (LC50 = 0.42 mg/L in adh8a mRNA-injected embryos). Furthermore, GC/MS analysis of adh8a-injected embryos indicated a significant decline of internal allyl alcohol concentrations from 0.23-58 ng/embryo to levels below the limit of detection (<4.6 mu g/L). Injection of neither adh8b nor gfp mRNA had an impact on internal allyl alcohol levels supporting that the increased allyl alcohol toxicity was mediated by an increase in its metabolization. These results underline the necessity to critically consider metabolic activation in the zebrafish embryo. As demonstrated here, mRNA injection is one useful approach to study the role of candidate enzymes involved in metabolization.	[Kluever, Nils; Ortmann, Julia; Renner, Patrick; Scholz, Stefan] UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany; [Paschke, Heidrun; Ritter, Axel P.] UFZ Helmholtz Ctr Environm Res, Dept Analyt Chem, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Kluver, N (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany.	nils.kluever@ufz.de	Scholz, Stefan/B-7776-2014; Klüver, Nils/D-8678-2015	Scholz, Stefan/0000-0002-6990-4716; 	CEFIC-LRI/DEFRA-UK (European Chemical Industry Council Long-range Research Initiative/ Department for Environment, Food and Rural Affairs); Federal Ministry of Education and Research (BMBF) GenDarT2 [PTJ-BIO/0315190]	CEFIC-LRI/DEFRA-UK (European Chemical Industry Council Long-range Research Initiative/ Department for Environment, Food and Rural Affairs); Federal Ministry of Education and Research (BMBF) GenDarT2(Federal Ministry of Education & Research (BMBF))	This work was partially supported by a CEFIC-LRI/DEFRA-UK (European Chemical Industry Council Long-range Research Initiative/ Department for Environment, Food and Rural Affairs) research grant and by the Federal Ministry of Education and Research (BMBF) GenDarT2 [PTJ-BIO/0315190]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton W, 2010, XENOBIOTICA, V40, P547, DOI 10.3109/00498254.2010.493960; Ali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021076; [Anonymous], 2006, ISO15088; ATZORI L, 1989, Drug Metabolism and Drug Interactions, V7, P295; Auerbach SS, 2008, TOXICOLOGY, V253, P79, DOI 10.1016/j.tox.2008.08.014; BORENFREUND E, 1987, CANCER LETT, V34, P243, DOI 10.1016/0304-3835(87)90173-X; Brannen KC, 2010, BIRTH DEFECTS RES B, V89, P66, DOI 10.1002/bdrb.20223; Busquet F, 2008, TOXICOL SCI, V104, P177, DOI 10.1093/toxsci/kfn065; Cai J, 2009, CHEM RES TOXICOL, V22, P708, DOI 10.1021/tx800465m; Clements R.G., 1994, EPA748R93002 OFF POL, V7403; Cowan-Ellsberry CE, 2008, CHEMOSPHERE, V70, P1804, DOI 10.1016/j.chemosphere.2007.08.030; Embry MR, 2010, AQUAT TOXICOL, V97, P79, DOI 10.1016/j.aquatox.2009.12.008; Escher BI, 2011, CHEM RES TOXICOL, V24, P1134, DOI 10.1021/tx200114y; FLOURIOT G, 1993, J CELL SCI, V105, P407; Geiger DLB L. T., 1990, ACUTE TOXICITIES ORG; GOLDSTEIN JA, 1993, ENVIRON HEALTH PERSP, V100, P169, DOI 10.2307/3431523; Gustafson AL, 2012, REPROD TOXI IN PRESS; Henn K, 2011, COMP BIOCHEM PHYS C, V153, P91, DOI 10.1016/j.cbpc.2010.09.003; Hoke RA, 2005, ENVIRON TOXICOL CHEM, V24, P2677, DOI 10.1897/04-506R.1; Knobel M, 2012, ENVIRON SCI TECHNOL, V46, P9690, DOI 10.1021/es301729q; Kramer NI, 2009, TOXICOL IN VITRO, V23, P1372, DOI 10.1016/j.tiv.2009.07.029; Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006; Madden JC, 2006, EXPERT OPIN DRUG MET, V2, P545, DOI 10.1517/17425255.2.4.545; NAGEL R, 1991, ECOTOX ENVIRON SAFE, V21, P157, DOI 10.1016/0147-6513(91)90017-J; Padilla S, 2012, REPROD TOXI IN PRESS; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reimers MJ, 2006, NEUROTOXICOL TERATOL, V28, P497, DOI 10.1016/j.ntt.2006.05.007; Reimers MJ, 2004, J BIOL CHEM, V279, P38303, DOI 10.1074/jbc.M401165200; Reimers MJ, 2004, NEUROTOXICOL TERATOL, V26, P769, DOI 10.1016/j.ntt.2004.06.012; Russom CL, 1997, ENVIRON TOXICOL CHEM, V16, P948, DOI 10.1002/etc.5620160514; Schirmer K, 2008, AQUAT TOXICOL, V90, P128, DOI 10.1016/j.aquatox.2008.08.005; Selderslaghs IWT, 2012, REPROD TOXICOL, V33, P142, DOI 10.1016/j.reprotox.2011.08.003; Selderslaghs IWT, 2009, REPROD TOXICOL, V28, P308, DOI 10.1016/j.reprotox.2009.05.004; Spielmann H, 2006, ATLA-ALTERN LAB ANIM, V34, P527, DOI 10.1177/026119290603400504; Strahle U, 2012, REPROD TOXICOL, V33, P128, DOI 10.1016/j.reprotox.2011.06.121; Tanneberger K, 2013, ENVIRON SCI TECHNOL, V47, P1110, DOI 10.1021/es303505z; Tao T, 2009, J GENET GENOMICS, V36, P325, DOI 10.1016/S1673-8527(08)60121-6; Weigt S, 2011, TOXICOLOGY, V281, P25, DOI 10.1016/j.tox.2011.01.004	38	17	17	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90619	10.1371/journal.pone.0090619	http://dx.doi.org/10.1371/journal.pone.0090619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594943	Green Submitted, Green Published, gold			2022-12-25	WOS:000332468900125
J	Maeda, R; Suzuki, H; Tanaka, Y; Tamura, T				Maeda, Ryo; Suzuki, Hidefumi; Tanaka, Yuta; Tamura, Taka-aki			Interaction between Transactivation Domain of p53 and Middle Part of TBP-Like Protein (TLP) Is Involved in TLP-Stimulated and p53-Activated Transcription from the p21 Upstream Promoter	PLOS ONE			English	Article							TATA-BINDING PROTEIN; DNA-DAMAGE; ACTIVATION DOMAIN; TUMOR SUPPRESSION; CELL-CYCLE; IN-VIVO; GENE; DIFFERENTIATION; TLP/TRF2/TLF; EXPRESSION	TBP-like protein (TLP) is involved in transcriptional activation of an upstream promoter of the human p21 gene. TLP binds to p53 and facilitates p53-activated transcription from the upstream promoter. In this study, we clarified that in vitro affinity between TLP and p53 is about one-third of that between TBP and p53. Extensive mutation analyses revealed that the TLP-stimulated function resides in transcription activating domain 1 (TAD1) in the N-terminus of p53. Among the mutants, #22.23, which has two amino acid substitutions in TAD1, exhibited a typical mutant phenotype. Moreover, #22.23 exhibited the strongest mutant phenotype for TLP-binding ability. It is thus thought that TLP-stimulated and p53-dependent transcriptional activation is involved in TAD1 binding of TLP. #22.23 had a decreased transcriptional activation function, especially for the upstream promoter of the endogenous p21 gene, compared with wild-type p53. This mutant did not facilitate p53-dependent growth repression and etoposide-mediated cell-death as wild-type p53 does. Moreover, mutation analysis revealed that middle part of TLP, which is requited for p53 binding, is involved in TLP-stimulated and p53-dependent promoter activation and cell growth repression. These results suggest that activation of the p21 upstream promoter is mediated by interaction between specific regions of TLP and p53.	[Maeda, Ryo; Suzuki, Hidefumi; Tanaka, Yuta; Tamura, Taka-aki] Chiba Univ, Dept Biol, Grad Sch Sci, Chiba, Japan	Chiba University	Tamura, T (corresponding author), Chiba Univ, Dept Biol, Grad Sch Sci, Chiba, Japan.	ttamura@faculty.chiba-u.jp	Suzuki, Hidefumi/GRR-9474-2022		JSPS KAKENHI [24570193]; Grants-in-Aid for Scientific Research [24570193] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant Number 24570193. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Berk AJ, 2000, CELL, V103, P5, DOI 10.1016/S0092-8674(00)00098-2; Bryant GO, 1996, GENE DEV, V10, P2491, DOI 10.1101/gad.10.19.2491; Chong JA, 2005, MOL CELL BIOL, V25, P2632, DOI 10.1128/MCB.25.7.2632-2643.2005; D'Alessio JA, 2009, MOL CELL, V36, P924, DOI 10.1016/j.molcel.2009.12.011; David WM, 1999, ONCOGENE, V18, P7666; Davidson I, 2003, TRENDS BIOCHEM SCI, V28, P391, DOI 10.1016/S0968-0004(03)00117-8; Deato MDE, 2008, MOL CELL, V32, P96, DOI 10.1016/j.molcel.2008.09.009; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hochheimer A, 2002, NATURE, V420, P439, DOI 10.1038/nature01167; HORIKOSHI N, 1995, MOL CELL BIOL, V15, P227, DOI 10.1128/MCB.15.1.227; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Li AG, 2007, MOL CELL, V28, P408, DOI 10.1016/j.molcel.2007.09.006; LIU X, 1993, MOL CELL BIOL, V13, P3291, DOI 10.1128/MCB.13.6.3291; McLure KG, 1998, EMBO J, V17, P3342, DOI 10.1093/emboj/17.12.3342; Muller M, 2006, DRUG RESIST UPDATE, V9, P288, DOI 10.1016/j.drup.2007.01.001; Nakadai T, 2004, J BIOL CHEM, V279, P7447, DOI 10.1074/jbc.M305412200; Ohbayashi T, 2001, BIOCHEM BIOPH RES CO, V285, P616, DOI 10.1006/bbrc.2001.5217; Ohbayashi T, 2003, NUCLEIC ACIDS RES, V31, P2127, DOI 10.1093/nar/gkg315; Ohbayashi T, 1999, NUCLEIC ACIDS RES, V27, P750, DOI 10.1093/nar/27.3.750; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Persengiev SP, 2003, P NATL ACAD SCI USA, V100, P14887, DOI 10.1073/pnas.2036440100; Radhakrishnan SK, 2006, ONCOGENE, V25, P1812, DOI 10.1038/sj.onc.1209195; Reina JH, 2007, GENE DEV, V21, P2855, DOI 10.1101/gad.1623207; SETO E, 1992, P NATL ACAD SCI USA, V89, P12028, DOI 10.1073/pnas.89.24.12028; Shimada M, 2003, MOL CELL BIOL, V23, P4107, DOI 10.1128/MCB.23.12.4107-4120.2003; Shiraishi S, 2007, J BIOL CHEM, V282, P9017, DOI 10.1074/jbc.M611513200; Shiraishi S, 2009, GENE, V436, P115, DOI 10.1016/j.gene.2009.01.016; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Suenaga Y, 2009, J BIOL CHEM, V284, P35433, DOI 10.1074/jbc.M109.050047; Suzuki H, 2012, J BIOL CHEM, V287, P19792, DOI 10.1074/jbc.M112.369629; Tanaka Y, 2007, BIOCHEM BIOPH RES CO, V352, P21, DOI 10.1016/j.bbrc.2006.10.175; Teichmann M, 1999, P NATL ACAD SCI USA, V96, P13720, DOI 10.1073/pnas.96.24.13720; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; TRUANT R, 1993, J BIOL CHEM, V268, P2284; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145	47	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90190	10.1371/journal.pone.0090190	http://dx.doi.org/10.1371/journal.pone.0090190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594805	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900078
J	Merida, S; Sancho-Tello, M; Navea, A; Almansa, I; Muriach, M; Bosch-Morell, F				Merida, Salvador; Sancho-Tello, Maria; Navea, Amparo; Almansa, Inmaculada; Muriach, Maria; Bosch-Morell, Francisco			An Anti-Interleukin-2 Receptor Drug Attenuates T-Helper 1 Lymphocytes-Mediated Inflammation in an Acute Model of Endotoxin-Induced Uveitis	PLOS ONE			English	Article							REGULATORY T-CELLS; ANTIBODY DACLIZUMAB; AQUEOUS-HUMOR; NITRIC-OXIDE; IFN-GAMMA; EXPRESSION; CYTOKINES; INDUCTION; MACROPHAGES; GLUTATHIONE	The aim of the present study was to evaluate the anti-inflammatory efficacy of Daclizumab, an anti-interleukin-2 receptor drug, in an experimental uveitis model upon a subcutaneous injection of lipopolysaccharide into Lewis rats, a valuable model for ocular acute inflammatory processes. The integrity of the blood-aqueous barrier was assessed 24 h after endotoxin-induced uveitis by evaluating two parameters: cell count and protein concentration in aqueous humors. The histopathology of all the ocular structures (cornea, lens, sclera, choroid, retina, uvea, and anterior and posterior chambers) was also considered. Enzyme-linked immunosorbent assays of the aqueous humor samples were performed to quantify the levels of the different chemokine and cytokine proteins. Similarly, a biochemical analysis of oxidative stress-related markers was also assessed. The inflammation observed in the anterior chamber of the eyes when Daclizumab was administered with endotoxin was largely prevented since the aqueous humor protein concentration substantially lowered concomitantly with a significant reduction in the uveal and vitreous histopathological grading. Th1 lymphocytes-related cytokines, such as Interleukin-2 and Interferon-gamma, also significantly reduced with related anti-oxidant systems recovery. Daclizumab treatment in endotoxin-induced uveitis reduced Th1 lymphocytes-related cytokines, such as Interleukin-2 and Interferon gamma, by about 60-70% and presented a preventive role in endotoxin-induced oxidative stress. This antioxidant protective effect of Daclizumab may be related to several of the observed Daclizumab effects in our study, including IL-6 cytokine regulatory properties and a substantial concomitant drop in INF gamma. Concurrently, Daclizumab treatment triggered a significant reduction in both the uveal histopathological grading and protein concentration in aqueous humors, but not in cellular infiltration.	[Merida, Salvador; Almansa, Inmaculada; Bosch-Morell, Francisco] Univ CEU Cardenal Herrera, Inst Ciencias Biomed, Valencia, Spain; [Sancho-Tello, Maria] Univ Valencia, Dept Patol, Valencia, Spain; [Navea, Amparo; Bosch-Morell, Francisco] Fdn Fomento Invest Sanitaria & Biomed Comunitat V, Valencia, Spain; [Muriach, Maria] Univ Jaume 1, Unidad Predept Med, Castellon De La Plana, Spain	Universidad CEU Cardenal Herrera; University of Valencia; Universitat Jaume I	Bosch-Morell, F (corresponding author), Univ CEU Cardenal Herrera, Inst Ciencias Biomed, Valencia, Spain.	fbosch@uch.ceu.es	Sancho-Tello, Maria/F-8566-2016; Sancho-Tello, Maria/AAA-1304-2019; Morell, Francisco Bosch/AAA-8355-2019; Almansa, Inma/K-8869-2014; Navea, Amparo/D-4577-2009; Muriach, María/AAB-2003-2019; Almansa, Inmaculada/F-4183-2016	Sancho-Tello, Maria/0000-0002-7080-2979; Sancho-Tello, Maria/0000-0002-7080-2979; Morell, Francisco Bosch/0000-0002-8681-9230; Almansa, Inma/0000-0001-8085-3377; Navea, Amparo/0000-0002-9856-5370; Almansa, Inmaculada/0000-0001-8085-3377; Muriach, Maria/0000-0002-6525-0073	Fundacion San Pablo [PRUCHB06/09, PRCEU-UCH 13/07]; Copernicus Santander Programme of the Universidad CEU Cardenal Herrera; Mutua Madrilena Institution	Fundacion San Pablo; Copernicus Santander Programme of the Universidad CEU Cardenal Herrera; Mutua Madrilena Institution	The work was supported in part by Grant no. PRUCHB06/09 and PRCEU-UCH 13/07 from the Fundacion San Pablo to FBM and the Copernicus Santander Programme of the Universidad CEU Cardenal Herrera. The last corrections of the work (revision process) have been supported by Mutua Madrilena Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bosch-Morell F, 2002, FREE RADICAL BIO MED, V33, P669, DOI 10.1016/S0891-5849(02)00954-1; Bosch-Morell F, 1999, FREE RADICAL BIO MED, V26, P1383, DOI 10.1016/S0891-5849(98)00335-9; Bousquet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049036; Busse D, 2010, P NATL ACAD SCI USA, V107, P3058, DOI 10.1073/pnas.0812851107; Cano M, 2010, VISION RES, V50, P652, DOI 10.1016/j.visres.2009.08.018; Caspi R. R., 2006, DRUG DISCOV TODAY, V3, P3; Chang JH, 2005, SURV OPHTHALMOL, V50, P364, DOI 10.1016/j.survophthal.2005.04.003; Chen W, 2009, MOL VIS, V15, P619; DEVOS AF, 1994, INVEST OPHTH VIS SCI, V35, P3873; Field MG, 2011, EXP EYE RES, V93, P548, DOI 10.1016/j.exer.2011.06.023; Foxman EF, 2002, J IMMUNOL, V168, P2483, DOI 10.4049/jimmunol.168.5.2483; Garcia-Bermudez M, 2012, PLOS ONE, V7; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Heiligenhaus A, 2010, GRAEF ARCH CLIN EXP, V248, P1531, DOI 10.1007/s00417-010-1485-8; HERBORT CP, 1988, GRAEF ARCH CLIN EXP, V226, P553, DOI 10.1007/BF02169204; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Ilieva I, 2004, EXP EYE RES, V79, P181, DOI 10.1016/j.exer.2004.03.009; Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McDyer JF, 2002, J IMMUNOL, V169, P2736, DOI 10.4049/jimmunol.169.5.2736; Merida S, 2013, FREE RADICAL RES, V47, P593, DOI 10.3109/10715762.2013.805882; Mullen JC, 2007, J HEART LUNG TRANSPL, V26, P504, DOI 10.1016/j.healun.2007.01.032; Nussenblatt RB, 2005, OPHTHALMOLOGY, V112, P764, DOI 10.1016/j.ophtha.2004.12.034; Nussenblatt RB, 1999, P NATL ACAD SCI USA, V96, P7462, DOI 10.1073/pnas.96.13.7462; Omari KM, 2009, AM J PATHOL, V174, P164, DOI 10.2353/ajpath.2009.080350; Ooi KGJ, 2006, CLIN MED RES, V4, P294, DOI 10.3121/cmr.4.4.294; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Rao NA, 2000, PROG RETIN EYE RES, V19, P41, DOI 10.1016/S1350-9462(99)00003-8; Rech AJ, 2009, ANN NY ACAD SCI, V1174, P99, DOI 10.1111/j.1749-6632.2009.04939.x; REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9; REEM GH, 1984, SCIENCE, V225, P429, DOI 10.1126/science.6429853; RICHARD MJ, 1992, J CHROMATOGR-BIOMED, V577, P9, DOI 10.1016/0378-4347(92)80593-F; Romero MJ, 1998, FREE RADICAL BIO MED, V25, P993, DOI 10.1016/S0891-5849(98)00118-X; ROSENBAUM JT, 1980, NATURE, V286, P611, DOI 10.1038/286611a0; Sasaki M, 2009, INVEST OPHTH VIS SCI, V50, P1433, DOI 10.1167/iovs.08-2493; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Sen HN, 2009, AM J OPHTHALMOL, V148, P696, DOI 10.1016/j.ajo.2009.06.003; Sijssens KM, 2007, EXP EYE RES, V85, P443, DOI 10.1016/j.exer.2007.06.011; Smith JR, 1998, IMMUNOL CELL BIOL, V76, P497, DOI 10.1046/j.1440-1711.1998.00783.x; Snyder JT, 2007, BLOOD, V109, P5399, DOI 10.1182/blood-2006-12-062943; Steinke JW, 2006, J ALLERGY CLIN IMMUN, V117, pS441, DOI 10.1016/j.jaci.2005.07.001; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Sutherland DER, 2001, ANN SURG, V233, P463, DOI 10.1097/00000658-200104000-00003; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Totemeyer S, 2006, J IMMUNOL, V176, P4804, DOI 10.4049/jimmunol.176.8.4804; Trinh L, 2008, MOL VIS, V14, P2428; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vincenti F, 1998, NEW ENGL J MED, V338, P161, DOI 10.1056/NEJM199801153380304; Wruck CJ, 2011, J BIOL CHEM, V286, P4493, DOI 10.1074/jbc.M110.162008; Wuest SC, 2011, NAT MED, V17, P604, DOI 10.1038/nm.2365; Xu YZ, 2010, MOL VIS, V16, P1689; Yeh S, 2008, J AUTOIMMUN, V31, P91, DOI 10.1016/j.jaut.2008.05.001; Zhang WJ, 2007, P NATL ACAD SCI USA, V104, P4077, DOI 10.1073/pnas.0700305104	62	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90216	10.1371/journal.pone.0090216	http://dx.doi.org/10.1371/journal.pone.0090216			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595020	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900082
J	Kolli, N; Garman, SC				Kolli, Nilima; Garman, Scott C.			Proteolytic Activation of Human Cathepsin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycoprotein Structure; Lysosomal Glycoproteins; Protease; Proteolytic Enzymes; X-ray Crystallography	LYSOSOMAL PROTECTIVE PROTEIN; 3-DIMENSIONAL STRUCTURE; INSECT CELLS; GLYCOSYLATION; NEURAMINIDASE; INHIBITORS; TRANSPORT; SUGGESTS; COMPLEX; DOMAIN	Background: The human lysosomal protease cathepsin A requires proteolytic activation. Results: The crystal structure of mature and active cathepsin A reveals its mechanism of activation. Conclusion: Removal of a 3.3-kDa peptide (by unidentified proteases) allows substrate access to the active site. Significance: The results revise a 2-decades-old model of cathepsin A activation by proteolysis and subsequent conformational change. Galactosialidosis is a human lysosomal storage disease caused by deficiency in the multifunctional lysosomal protease cathepsin A (also known as protective protein/cathepsin A, PPCA, catA, HPP, and CTSA; EC 3.4.16.5). Previous structural work on the inactive precursor human cathepsin A (zymogen) led to a two-stage model for activation, where proteolysis of a 1.6-kDa excision peptide is followed by a conformational change in a blocking peptide occluding the active site. Here we present evidence for an alternate model of activation of human cathepsin A, needing only cleavage of a 3.3-kDa excision peptide to yield full enzymatic activity, with no conformational change required. We present x-ray crystallographic, mass spectrometric, amino acid sequencing, enzymatic, and cellular data to support the cleavage-only activation model. The results clarify a longstanding question about the mechanism of cathepsin A activation and point to new avenues for the design of mechanism-based inhibitors of the enzyme.	[Kolli, Nilima; Garman, Scott C.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Kolli, Nilima; Garman, Scott C.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Garman, SC (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 710 North Pleasant St, Amherst, MA 01003 USA.	garman@biochem.umass.edu	Kolli, nilima/AAC-9038-2020	Kolli, nilima/0000-0001-5012-5344	National Center for Research Resources at the National Institutes of Health [RR-15301]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076877] Funding Source: NIH RePORTER	National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Rinat Abzalimov of the University of Massachusetts Amherst mass spectrometry center for the mass spectroscopy measurements and Igor Kourinov and the staff of the Advanced Photon Source Northeastern Collaborative Access Team beamlines, which are supported by Award RR-15301 from the National Center for Research Resources at the National Institutes of Health.	Birkus G, 2011, ANTIMICROB AGENTS CH, V55, P2166, DOI 10.1128/AAC.01603-10; Bonten EJ, 2000, J BIOL CHEM, V275, P37657, DOI 10.1074/jbc.M007380200; BONTEN EJ, 1995, J BIOL CHEM, V270, P26441, DOI 10.1074/jbc.270.44.26441; BULLOCK TL, 1994, BIOCHEMISTRY-US, V33, P11127, DOI 10.1021/bi00203a009; Cayot P, 1997, ANAL BIOCHEM, V249, P184, DOI 10.1006/abio.1997.2161; Cornish-Bowden A., 2004, FUNDAMENTALS ENZYME, P213; Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002; d'Azzo A., 2001, METABOLIC MOL BASES, V3, P3811; Dojima T, 2009, J BIOTECHNOL, V143, P27, DOI 10.1016/j.jbiotec.2009.06.013; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENDRIZZI JA, 1994, BIOCHEMISTRY-US, V33, P11106, DOI 10.1021/bi00203a007; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; GALJART NJ, 1991, J BIOL CHEM, V266, P14754; Gouveia R, 2010, J BIOTECHNOL, V145, P130, DOI 10.1016/j.jbiotec.2009.10.018; Haque A, 2008, CNS NEUROL DISORD-DR, V7, P270, DOI 10.2174/187152708784936653; Hiraiwa M, 1999, CELL MOL LIFE SCI, V56, P894, DOI 10.1007/s000180050482; ITOH K, 1995, J BIOL CHEM, V270, P515, DOI 10.1074/jbc.270.2.515; ITOH K, 1993, J BIOL CHEM, V268, P1180; JACKMAN HL, 1992, J BIOL CHEM, V267, P2872; Jackman HL, 2002, HYPERTENSION, V39, P976, DOI 10.1161/01.HYP.0000017283.67962.02; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MORREAU H, 1992, J BIOL CHEM, V267, P17949; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OLESEN K, 1995, BIOCHEMISTRY-US, V34, P15689, DOI 10.1021/bi00048a013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PSHEZHETSKY AV, 1995, ANAL BIOCHEM, V230, P303, DOI 10.1006/abio.1995.1478; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; RUDENKO G, 1995, STRUCTURE, V3, P1249, DOI 10.1016/S0969-2126(01)00260-X; Rudenko G, 1998, P NATL ACAD SCI USA, V95, P621, DOI 10.1073/pnas.95.2.621; Rudenko G, 1996, ACTA CRYSTALLOGR D, V52, P923, DOI 10.1107/S0907444996004702; Ruf S, 2013, FUTURE MED CHEM, V5, P399, DOI [10.4155/FMC.13.24, 10.4155/fmc.13.24]; Ruf S, 2012, J MED CHEM, V55, P7636, DOI 10.1021/jm300663n; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; van der Spoel A, 1998, EMBO J, V17, P1588, DOI 10.1093/emboj/17.6.1588; van der Spoel A, 1997, AM J HUM GENET, V61, pA27; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wittlin S, 1999, EUR J BIOCHEM, V265, P384, DOI 10.1046/j.1432-1327.1999.00747.x	38	15	15	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11592	11600		10.1074/jbc.M113.524280	http://dx.doi.org/10.1074/jbc.M113.524280			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24599961	Green Published, hybrid			2022-12-25	WOS:000335010600003
J	Date, DA; Burrows, AC; Summers, MK				Date, Dipali A.; Burrows, Amy C.; Summers, Matthew K.			Phosphorylation Regulates the p31Comet-Mitotic Arrest-deficient 2 ( Mad2) Interaction to Promote Spindle Assembly Checkpoint ( SAC) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Cell Division; Mitosis; Protein Complexes; Protein Phosphorylation; Anaphase-promoting Complex; Mad2; Mitotic Checkpoint Complex; p31Comet; Spindle Assembly Checkpoint	MITOTIC CHECKPOINT; COMPLEX; BINDING; CDC20; P31(COMET); ACTIVATION; PROTEIN; INHIBITION; BUBR1; UBIQUITINATION	Background: p31(Comet) antagonizes the SAC effector Mad2 to promote mitotic progression. Results: p31(Comet) phosphorylation modulates binding to Mad2. Conclusion: Phosphorylation attenuates binding of Mad2 by p31(Comet) to promote SAC activity. Significance: Our study provides the first description of p31(Comet) regulation and new insight into the control of SAC activity. The spindle assembly checkpoint (SAC) ensures the faithful segregation of the genome during mitosis by ensuring that sister chromosomes form bipolar attachments with microtubules of the mitotic spindle. p31(Comet) is an antagonist of the SAC effector Mad2 and promotes silencing of the SAC and mitotic progression. However, p31(Comet) interacts with Mad2 throughout the cell cycle. We show that p31(Comet) binds Mad2 solely in an inhibitory manner. We demonstrate that attenuating the affinity of p31(Comet) for Mad2 by phosphorylation promotes SAC activity in mitosis. Specifically, phosphorylation of Ser-102 weakens p31(Comet)-Mad2 binding and enhances p31(Comet)-mediated bypass of the SAC. Our results provide the first evidence for regulation of p31(Comet) and demonstrate a previously unknown event controlling SAC activity.	[Date, Dipali A.; Burrows, Amy C.; Summers, Matthew K.] Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Summers, MK (corresponding author), Lerner Res Inst, Dept Canc Biol, 9500 Euclid Ave,NB40, Cleveland, OH 44195 USA.	summerm@ccf.org			Lerner Research Institute; American Cancer Society [IRG-91-022-15]; Ohio Cancer Research Associates; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	Lerner Research Institute; American Cancer Society(American Cancer Society); Ohio Cancer Research Associates; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by seed funds form the Lerner Research Institute, American Cancer Society Grant IRG-91-022-15, and pilot funds from the Ohio Cancer Research Associates (to M. K. S.).	De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Fava LL, 2011, EMBO J, V30, P3322, DOI 10.1038/emboj.2011.239; Hagan RS, 2011, MOL BIOL CELL, V22, P4236, DOI 10.1091/mbc.E11-03-0216; Jia LY, 2011, MOL BIOL CELL, V22, P4227, DOI 10.1091/mbc.E11-05-0389; Kim S, 2010, P NATL ACAD SCI USA, V107, P19772, DOI 10.1073/pnas.1009000107; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Luo XL, 2000, NAT STRUCT BIOL, V7, P224; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Mariani L, 2012, CURR BIOL, V22, P1900, DOI 10.1016/j.cub.2012.08.028; Miniowitz-Shemtov S, 2012, P NATL ACAD SCI USA, V109, P8056, DOI 10.1073/pnas.1204081109; Miniowitz-Shemtov S, 2010, P NATL ACAD SCI USA, V107, P5351, DOI 10.1073/pnas.1001875107; Nezi L, 2006, J CELL BIOL, V174, P39, DOI 10.1083/jcb.200602109; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Summers MK, 2008, MOL CELL, V31, P544, DOI 10.1016/j.molcel.2008.07.014; Teichner A, 2011, P NATL ACAD SCI USA, V108, P3187, DOI 10.1073/pnas.1100023108; Tipton AR, 2011, J BIOL CHEM, V286, P21173, DOI 10.1074/jbc.M111.238543; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Varetti G, 2011, MOL CELL, V44, P710, DOI 10.1016/j.molcel.2011.11.014; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048	28	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11367	11373		10.1074/jbc.M113.520841	http://dx.doi.org/10.1074/jbc.M113.520841			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596092	hybrid, Green Published			2022-12-25	WOS:000334638500038
J	Senning, EN; Collins, MD; Stratiievska, A; Ufret-Vincenty, CA; Gordon, SE				Senning, Eric N.; Collins, Marcus D.; Stratiievska, Anastasiia; Ufret-Vincenty, Carmen A.; Gordon, Sharona E.			Regulation of TRPV1 Ion Channel by Phosphoinositide (4,5)-Bisphosphate THE ROLE OF MEMBRANE ASYMMETRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ion Channels; Membrane; Membrane Lipids; Phosphoinositides; Phospholipid; PI(4; 5)P-2; TRPV1	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CA2+-DEPENDENT DESENSITIZATION; CAPSAICIN RECEPTOR; LIPIDS; ACTIVATION; BINDS	Background: Whether phosphoinositide 4,5-bisphosphate (PI(4,5)P-2) activates or inhibits TRPV1 is controversial. Results: PI(4,5)P-2 in the intracellular leaflet activates TRPV1, whereas PI(4,5)P-2 in the extracellular leaflet inhibits TRPV1. Conclusion: Inhibition by PI(4,5)P-2 in the extracellular leaflet may explain previous findings that TRPV1 reconstituted into PI(4,5)P-2-containing liposomes is inhibited. Significance: PI(4,5)P-2 in the physiologically relevant leaflet (the intracellular leaflet) of the membrane activates TRPV1. Membrane asymmetry is essential for generating second messengers that act in the cytosol and for trafficking of membrane proteins and membrane lipids, but the role of asymmetry in regulating membrane protein function remains unclear. Here we show that the signaling lipid phosphoinositide 4,5-bisphosphate (PI(4,5)P-2) has opposite effects on the function of TRPV1 ion channels depending on which leaflet of the cell membrane it resides in. We observed potentiation of capsaicin-activated TRPV1 currents by PI(4,5)P-2 in the intracellular leaflet of the plasma membrane but inhibition of capsaicin-activated currents when PI(4,5)P-2 was in both leaflets of the membrane, although much higher concentrations of PI(4,5)P-2 in the extracellular leaflet were required for inhibition compared with the concentrations of PI(4,5)P-2 in the intracellular leaflet that produced activation. Patch clamp fluorometry using a synthetic PI(4,5)P-2 whose fluorescence reports its concentration in the membrane indicates that PI(4,5)P-2 must incorporate into the extracellular leaflet for its inhibitory effects to be observed. The asymmetry-dependent effect of PI(4,5)P-2 may resolve the long standing controversy about whether PI(4,5)P-2 is an activator or inhibitor of TRPV1. Our results also underscore the importance of membrane asymmetry and the need to consider its influence when studying membrane proteins reconstituted into synthetic bilayers.	[Gordon, Sharona E.] Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Stratiievska, Anastasiia] Int Ctr Mol Physiol, Bogomoletz Inst Physiol, Lab Biophys Ion Channels, Dept Gen Physiol Nervous Syst, UA-01024 Kiev, Ukraine	University of Washington; University of Washington Seattle; National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology	Gordon, SE (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	seg@uw.edu		Collins, Marcus/0000-0002-2342-8056	NIGMS, National Institutes of Health [R01GM100718]; NEI, National Institutes of Health [R01EY017564, P30EY001730]; National Center for Research Resources, National Institutes of Health [S10RR025429]; NIDDK, National Institutes of Health [P30DK017047, T32EY007031, T32HL007312]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025429] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY001730, T32EY007031, R01EY017564] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100718] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMS, National Institutes of Health Grant R01GM100718; by NEI, National Institutes of Health Grants R01EY017564 and P30EY001730; by the National Center for Research Resources, National Institutes of Health Grant S10RR025429; and by NIDDK, National Institutes of Health Grants P30DK017047, T32EY007031, and T32HL007312.	Bai JN, 1997, BIOCHEMISTRY-US, V36, P8840, DOI 10.1021/bi970145r; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Cheng H, 2007, J NEUROCHEM, V101, P57, DOI 10.1111/j.1471-4159.2006.04342.x; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Collins MD, 2013, JOVE-J VIS EXP, DOI 10.3791/50227; Collins MD, 2013, BIOPHYS J, V105, P2485, DOI 10.1016/j.bpj.2013.09.035; Dahim M, 2002, BIOPHYS J, V83, P1511, DOI 10.1016/S0006-3495(02)73921-0; DEVAUX PF, 1992, ANNU REV BIOPH BIOM, V21, P417, DOI 10.1146/annurev.bb.21.060192.002221; DOWNES P, 1982, CELL CALCIUM, V3, P467, DOI 10.1016/0143-4160(82)90031-8; GARRETT RJB, 1975, BIOCHIM BIOPHYS ACTA, V382, P58; GASCARD P, 1991, BIOCHIM BIOPHYS ACTA, V1069, P27, DOI 10.1016/0005-2736(91)90100-M; GASCARD P, 1993, BIOCHEM SOC T, V21, P253, DOI 10.1042/bst0210253; Gordon-Shaag A, 2008, CHANNELS, V2, P125, DOI 10.4161/chan.2.2.6026; Jung J, 1999, J NEUROSCI, V19, P529; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Lukacs V, 2013, J BIOL CHEM, V288, P35003, DOI 10.1074/jbc.M113.520288; Mercado J, 2010, J NEUROSCI, V30, P13338, DOI 10.1523/JNEUROSCI.2108-10.2010; Nasuhoglu C, 2002, ANAL BIOCHEM, V301, P243, DOI 10.1006/abio.2001.5489; Ozato-Sakurai N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023567; PEITZSCH RM, 1995, BIOPHYS J, V68, P729, DOI 10.1016/S0006-3495(95)80253-5; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Wenk MR, 2003, NAT BIOTECHNOL, V21, P813, DOI 10.1038/nbt837; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Zheng Jie, 2003, Sci STKE, V2003, pPL7, DOI 10.1126/stke.2003.176.pl7	32	37	37	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					10999	11006		10.1074/jbc.M114.553180	http://dx.doi.org/10.1074/jbc.M114.553180			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599956	Green Published, hybrid			2022-12-25	WOS:000334638500006
J	Aylagas, E; Borja, A; Rodriguez-Ezpeleta, N				Aylagas, Eva; Borja, Angel; Rodriguez-Ezpeleta, Naiara			Environmental Status Assessment Using DNA Metabarcoding: Towards a Genetics Based Marine Biotic Index (gAMBI)	PLOS ONE			English	Article							OXIDASE SUBUNIT-I; COMMUNITY; HABITATS; PRIMERS; HEALTH; AMBI	Marine ecosystem protection and conservation initiatives rely on the assessment of ecological integrity and health status of marine environments. The AZTI's Marine Biotic Index (AMBI), which consists on using macroinvertebrate diversity as indicator of ecosystem health, is used worldwide for this purpose. Yet, this index requires taxonomic assignment of specimens, which typically involves a time and resource consuming visual identification of each sample. DNA barcoding or metabarcoding are potential harmonized, faster and cheaper alternatives for species identification, although the suitability of these methods for easing the implementation of the AMBI is yet to be evaluated. Here, we analyze the requirements for the implementation of a genetics based AMBI (gAMBI), and show, using available sequence data, that information about presence/absence of the most frequently occurring species provides accurate AMBI values. Our results set the basics for the implementation of the gAMBI, which has direct implications for a faster and cheaper marine monitoring and health status assessment.	[Aylagas, Eva; Borja, Angel; Rodriguez-Ezpeleta, Naiara] AZTI Tecnalia, Div Marine Res, Sukarrieta, Bizkaia, Spain	AZTI	Rodriguez-Ezpeleta, N (corresponding author), AZTI Tecnalia, Div Marine Res, Sukarrieta, Bizkaia, Spain.	nrodriguez@azti.es	Rodriguez-Ezpeleta, Naiara/B-7138-2014; Borja, Angel/I-3665-2018	Rodriguez-Ezpeleta, Naiara/0000-0001-6735-6755; Borja, Angel/0000-0003-1601-2025	Fundacion Centros Tecnologicos through an Inaki Goenaga doctoral grant; DEVOTES (DEVelopment Of innovative Tools for understanding marine biodiversity and assessing good Environmental Status); European Union [308392]; Basque Water Agency (URA)	Fundacion Centros Tecnologicos through an Inaki Goenaga doctoral grant; DEVOTES (DEVelopment Of innovative Tools for understanding marine biodiversity and assessing good Environmental Status); European Union(European Commission); Basque Water Agency (URA)	Eva Aylagas is supported by the Fundacion Centros Tecnologicos through an Inaki Goenaga doctoral grant. This manuscript is a result of the project DEVOTES (DEVelopment Of innovative Tools for understanding marine biodiversity and assessing good Environmental Status) funded by the European Union under the 7th Framework Program 'The Ocean of Tomorrow' Theme (grant agreement no. 308392), (http://www.devotes-project.eu), and also supported by the Basque Water Agency (URA), through a Convention with AZTI-Tecnalia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; Borja A, 2008, ECOLOGICAL INDICATOR, V8, P6; Borja A, 2013, MAR POLLUT BULL, V68, P1, DOI 10.1016/j.marpolbul.2013.01.041; Borja A, 2011, MAR POLLUT BULL, V62, P889, DOI 10.1016/j.marpolbul.2011.03.031; Borja A, 2009, HYDROBIOLOGIA, V633, P181, DOI 10.1007/s10750-009-9881-y; Borja A, 2009, MAR POLLUT BULL, V59, P54, DOI 10.1016/j.marpolbul.2008.11.010; Bourlat SJ, 2013, MARINE POLLUTION B; Cameron S, 2006, SYST BIOL, V55, P844, DOI 10.1080/10635150600960079; CBD, 2000, 5 C PART CONV BIOD N; Claudet J, 2010, BIOL CONSERV, V143, P2195, DOI 10.1016/j.biocon.2010.06.004; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; da Silva JM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028233, 10.1371/journal.pone.0019449]; de Jonge VN, 2006, MAR POLLUT BULL, V53, P5, DOI 10.1016/j.marpolbul.2005.11.026; Diaz RJ, 2004, J ENVIRON MANAGE, V73, P165, DOI 10.1016/j.jenvman.2004.06.004; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frolov S, 2013, HARMFUL ALGAE, V21-22, P1, DOI 10.1016/j.hal.2012.11.001; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Hardy Sarah Mincks, 2011, Marine Biodiversity, V41, P195, DOI 10.1007/s12526-010-0056-x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ji Y, 2013, ECOL LETT; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Machida JR, 2012, PLOS ONE, P7; Machida JR, 2010, PLOS ONE, V5, P6; Markmann M, 2005, PHILOS T R SOC B, V360, P1917, DOI 10.1098/rstb.2005.1723; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W; Muxika I, 2012, ECOL INDIC, V12, P96, DOI 10.1016/j.ecolind.2011.04.030; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Pinto R, 2009, ECOL INDIC, V9, P1, DOI 10.1016/j.ecolind.2008.01.005; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Porazinska DL, 2010, MOL ECOL RESOUR, V10, P666, DOI 10.1111/j.1755-0998.2009.02819.x; Prosser SWJ, 2013, MOL ECOLOGY RESOURCE; Ranasinghe JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040875; Taberlet P, 2012, MOL ECOL, V21, P6; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; UNCLOS, 1982, UN CONV LAW SEA SIGN, P202; Valenca APMC, 2012, MAR POLLUT BULL, V64, P1809, DOI 10.1016/j.marpolbul.2012.06.003; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Warwick RM, 2010, MAR POLLUT BULL, V60, P554, DOI 10.1016/j.marpolbul.2009.11.009; Yang CX, 2013, SCI CHINA LIFE SCI, V56, P73, DOI 10.1007/s11427-012-4423-7; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x	47	105	111	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90529	10.1371/journal.pone.0090529	http://dx.doi.org/10.1371/journal.pone.0090529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603433	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600061
J	Ferrer, CP; McMunn, A; Dommarco, JAR; Brunner, EJ				Ferrer, Carolina Perez; McMunn, Anne; Rivera Dommarco, Juan A.; Brunner, Eric J.			Educational Inequalities in Obesity among Mexican Women: Time-Trends from 1988 to 2012	PLOS ONE			English	Article							BODY-MASS-INDEX; SOCIOECONOMIC-STATUS; UNITED-STATES; DEVELOPING-COUNTRIES; US ADULTS; HEALTH; PREVALENCE; OVERWEIGHT; INCOME; WEIGHT	Background: Obesity is one of the leading causes of global morbidity and mortality. Trends in educational inequalities in obesity prevalence among Mexican women have not been analysed systematically to date. Methods: Data came from four nationally representative surveys (1988, 1999, 2006, and 2012) of a total of 51 220 nonpregnant women aged 20 to 49. Weight and height were measured during home visits. Education level (higher education, high school, secondary, primary or less) was self-reported. We analysed trends in relative and absolute educational inequalities in obesity prevalence separately for urban and rural areas. Results: Nationally, age-standardised obesity prevalence increased from 9.3% to 33.7% over 25 years to 2012. Obesity prevalence was inversely associated with education level in urban areas at all survey waves. In rural areas, obesity prevalence increased markedly but there was no gradient with education level at any survey. The relative index of inequality in urban areas declined over the period (2.87 (95%CI: 1.94, 4.25) in 1988, 1.55 (95%CI: 1.33, 1.80) in 2012, trend p<0.001). Obesity increased 5.92 fold (95%CI: 4.03, 8.70) among urban women with higher education in the period 1988-2012 compared to 3.23 fold (95%CI: 2.88, 3.63) for urban women with primary or no education. The slope index of inequality increased in urban areas from 1988 to 2012. Over 0.5 M cases would be avoided if the obesity prevalence of women with primary or less education was the same as for women with higher education. Conclusions: The expected inverse association between education and obesity was observed in urban areas of Mexico. The declining trend in relative educational inequalities in obesity was due to a greater increase in obesity prevalence among higher educated women. In rural areas there was no social gradient in the association between education level and obesity across the four surveys.	[Ferrer, Carolina Perez; McMunn, Anne; Brunner, Eric J.] UCL, Res Dept Epidemiol & Publ Hlth, London, England; [Rivera Dommarco, Juan A.] Inst Nacl Salud Publ, Ctr Invest Nutr & Salud, Cuernavaca, Morelos, Mexico	University of London; University College London; Instituto Nacional de Salud Publica	Ferrer, CP (corresponding author), UCL, Res Dept Epidemiol & Publ Hlth, London, England.	carolina.perez.10@ucl.ac.uk	Perez-Ferrer, Carolina/K-6262-2019; Brunner, Eric/H-2114-2011	Brunner, Eric/0000-0002-0595-4474; Perez Ferrer, Carolina/0000-0003-4732-3555; McMunn, Anne/0000-0003-3237-9345	Mexican Council for Science and Technology (CONACyT) [309252]; European Research Council [ERC-2011-StG_20101124]; Economic and Social Research Council [ES/J019119/1]; ESRC [ES/J019119/1, ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1] Funding Source: researchfish	Mexican Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); European Research Council(European Research Council (ERC)European Commission); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Carolina Perez Ferrer is funded by a PhD scholarship (grant no 309252) from the Mexican Council for Science and Technology (CONACyT). Further information about this grant is available from http://www.conacyt.gob.mx/FormacionCapitalHumano/Becas/Extranjero/Paginas/default.aspx. Anne McMunn is supported by the European Research Council (grant no ERC-2011-StG_20101124) and the Economic and Social Research Council (grant no ES/J019119/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitsi-Selmi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039507; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bleich S, 2008, ANNU REV PUBL HEALTH, V29, P273, DOI 10.1146/annurev.publhealth.29.020907.090954; Bolling C., 1999, Choices. The Magazine of Food, Farm, and Resources Issues, P33; Buttenheim AM, 2010, GLOB PUBLIC HEALTH, V5, P413, DOI 10.1080/17441690902756062; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Clark SE, 2012, INT J OCCUP ENV HEAL, V18, P53, DOI 10.1179/1077352512Z.0000000007; Colchero MA, 2012, SOC SCI MED, V75, P120, DOI 10.1016/j.socscimed.2012.01.010; Creighton MJ, 2011, SOC SCI MED, V72, P685, DOI 10.1016/j.socscimed.2010.12.006; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Drewnowski A, 2009, NUTR REV, V67, pS36, DOI 10.1111/j.1753-4887.2009.00157.x; Ernst ND, 1997, J AM DIET ASSOC, V97, pS47, DOI 10.1016/S0002-8223(97)00729-3; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Hawkes C, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-4; Hiyoshi A, 2013, J EPIDEMIOL COMMUN H, V67, P960, DOI 10.1136/jech-2013-202608; Instituto Nacional de Estadistica y Geografia, 2011, EST PROP INT MUJ; Instituto Nacional de Estadistica y Geografia, 2012, DEM POBL; Jones-Smith JC, 2012, INT J OBESITY, V36, P866, DOI 10.1038/ijo.2011.134; Jones-Smith JC, 2012, INT J OBESITY, V36, P1114, DOI 10.1038/ijo.2011.179; Jones-Smith JC, 2011, AM J EPIDEMIOL, V173, P667, DOI 10.1093/aje/kwq428; Khang YH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-66; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Martorell R, 1998, J NUTR, V128, P1464, DOI 10.1093/jn/128.9.1464; Martorell R, 2000, EUR J CLIN NUTR, V54, P247, DOI 10.1038/sj.ejcn.1600931; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Monteiro C, 2004, INT J OBESITY, V28, P1181, DOI 10.1038/sj.ijo.0802716; Monteiro CA, 2000, EUR J CLIN NUTR, V54, P342, DOI 10.1038/sj.ejcn.1600960; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Monteiro CA, 2007, AM J PUBLIC HEALTH, V97, P1808, DOI 10.2105/AJPH.2006.099630; Olaiz G, 2006, ENCUESTA NACL SALUD; Pezzini M, 2007, OECD RURAL POLICY RE; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Resano-Perez E, 2003, SALUD PUBLICA MEXICO, V45, pS558; Rivera JA, 2004, NUTR REV, V62, pS149, DOI 10.1111/j.1753-4887.2004.tb00086.x; Romero-Martinez M, 2013, SALUD PUBLICA MEXICO, V55, pS332, DOI 10.21149/spm.v55s2.5132; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; Sassi F., 2010, OBESITY EC PREVENTIO; Sepulveda-Amor J, 1990, Gac Med Mex, V126, P207; Shaw M, 2007, HDB INEQUALITY SOCIO; Shields Margot, 2006, Health Rep, V17, P53; Singh GK, 2011, J COMMUN HEALTH, V36, P94, DOI 10.1007/s10900-010-9287-9; Smith KV, 2007, SOC SCI MED, V65, P1372, DOI 10.1016/j.socscimed.2007.05.023; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001235, 10.1371/journal.pmed.1001242]; Szklo M., 2007, EPIDEMIOLOGY BASICS; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Yoo S, 2010, PREV MED, V51, P460, DOI 10.1016/j.ypmed.2010.10.004; Zhang Q, 2004, OBES RES, V12, P1622, DOI 10.1038/oby.2004.202	56	17	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90195	10.1371/journal.pone.0090195	http://dx.doi.org/10.1371/journal.pone.0090195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24599098	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400054
J	Klos, KS; Warmka, JK; Drachenberg, DM; Chang, L; Luxton, GWG; Leung, CT; Schwertfeger, KL; Wattenberg, EV				Klos, Kristine S.; Warmka, Janel K.; Drachenberg, Disa M.; Chang, Liang; Luxton, G. W. Gant; Leung, Cheuk T.; Schwertfeger, Kathryn L.; Wattenberg, Elizabeth V.			Building Bridges toward Invasion: Tumor Promoter Treatment Induces a Novel Protein Kinase C-Dependent Phenotype in MCF10A Mammary Cell Acini	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; CANCER; ACTIVATION; ALPHA; DIFFERENTIATION; PROLIFERATION; ONCOGENESIS; GF-109203X; INHIBITOR; COMPLEX	The potent tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) alters many cellular processes through activation of its receptor protein kinase C (PKC), including gene expression, cell cycle, and the regulation of cell morphology, raising an important question for developing targeted methods to prevent cancer: which effects of TPA are crucial for carcinogenesis? To address this question, we studied TPA action in the 3-dimensional (3D) MCF10A human breast epithelial cell system, which models important features of in vivo epithelial tissue including growth constraints, structural organization of cells, and establishment of a basement membrane. MCF10A cells, which are immortalized but nontumorigenic, form hollow, spheroid structures in 3D culture referred to as acini. The development of normal acini requires the tight spatiotemporal regulation of cellular proliferation, polarization, apoptosis, and growth arrest. Treatment of MCF10A acini with TPA caused the appearance of multi-acinar structures. Surprisingly, this phenotype did not involve an increase in cell number or major changes in cell death, and polarization. Instead, live cell and confocal microscopy revealed that TPA stimulates MCF10A acini to aggregate. TPA induces the PKC-dependent production of actin-based protrusions, which leads to the formation of cellular bridges between acini, the clustering of acini, and allows cells to move into adjacent acini. During this process, the integrity of the laminin V basement membrane is disrupted, while E-cadherin-based cell-cell contacts remain intact. Altogether, our results show that under the biochemical and structural constraints of epithelial tissue, as modeled by the 3D MCF10A system, TPA induces a novel PKC-dependent phenotype that resembles local invasion. Of the many effects caused by TPA, these studies highlight the aggressive production of actin-based cellular protrusions as a potentially important event along the pathway to carcinogenesis.	[Klos, Kristine S.; Warmka, Janel K.; Drachenberg, Disa M.; Chang, Liang; Wattenberg, Elizabeth V.] Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN 55455 USA; [Luxton, G. W. Gant] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Leung, Cheuk T.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Schwertfeger, Kathryn L.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Schwertfeger, Kathryn L.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wattenberg, EV (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN 55455 USA.	watte004@umn.edu		Chang, Liang/0000-0002-5653-3004; Luxton, GW Gant/0000-0002-6180-8906; Leung, Cheuk/0000-0002-5838-5535	University of Minnesota Academic Health Center Faculty Research Development Program; University of Minnesota Cancer Center, Translational Breast Cancer Research Award	University of Minnesota Academic Health Center Faculty Research Development Program; University of Minnesota Cancer Center, Translational Breast Cancer Research Award	This research was supported by a grant from the University of Minnesota Academic Health Center Faculty Research Development Program and a University of Minnesota Cancer Center, Translational Breast Cancer Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita Y, 2008, FEBS J, V275, P3995, DOI 10.1111/j.1742-4658.2008.06557.x; Bacus S S, 2000, Breast Dis, V11, P63; BELETSKY IP, 1990, J IMMUNOL METHODS, V134, P201, DOI 10.1016/0022-1759(90)90381-5; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Breitkreutz D, 2007, J CANCER RES CLIN, V133, P793, DOI 10.1007/s00432-007-0280-3; Chen J, 2013, EXP CELL RES, V319, P1357, DOI 10.1016/j.yexcr.2013.03.021; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; DIAMOND L, 1978, LIFE SCI, V23, P1979, DOI 10.1016/0024-3205(78)90229-1; Goel G, 2007, INT J TOXICOL, V26, P279, DOI 10.1080/10915810701464641; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HEIKKILA J, 1993, BIOCHEM BIOPH RES CO, V197, P1185, DOI 10.1006/bbrc.1993.2602; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Rafn B, 2012, MOL CELL, V45, P764, DOI 10.1016/j.molcel.2012.01.029; SOULE HD, 1990, CANCER RES, V50, P6075; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Tan M, 2006, ONCOGENE, V25, P3286, DOI 10.1038/sj.onc.1209361; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; WAYS DK, 1995, J CLIN INVEST, V95, P1906, DOI 10.1172/JCI117872; Wrobel CN, 2004, J CELL BIOL, V165, P263, DOI 10.1083/jcb.200309102; Wu-Zhang AX, 2013, BIOCHEM J, V452, P195, DOI 10.1042/BJ20130220; Yuspa SH, 1998, J DERMATOL SCI, V17, P1, DOI 10.1016/S0923-1811(97)00071-6	32	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90722	10.1371/journal.pone.0090722	http://dx.doi.org/10.1371/journal.pone.0090722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599099	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400126
J	Shackell, NL; Ricard, D; Stortini, C				Shackell, Nancy L.; Ricard, Daniel; Stortini, Christine			Thermal Habitat Index of Many Northwest Atlantic Temperate Species Stays Neutral under Warming Projected for 2030 but Changes Radically by 2060	PLOS ONE			English	Article							CLIMATE-CHANGE; ECOLOGICAL RESPONSES; RANGE SHIFTS; IMPACTS; UNCERTAINTY; MODELS; BIODIVERSITY; PATTERNS; NICHE; SHELF	Global scale forecasts of range shifts in response to global warming have provided vital insight into predicted species redistribution. We build on that insight by examining whether local warming will affect habitat on spatiotemporal scales relevant to regional agencies. We used generalized additive models to quantify the realized habitat of 46 temperate/boreal marine species using 41+ years of survey data from 35 degrees N-48 degrees N in the Northwest Atlantic. We then estimated change in a "realized thermal habitat index" under short-term (2030) and long-term (2060) warming scenarios. Under the 2030 scenario similar to 10% of species will lose realized thermal habitat at the national scale (USA and Canada) but planktivores are expected to lose significantly in both countries which may result in indirect changes in their predators' distribution. In contrast, by 2060 in Canada, the realized habitat of 76% of species will change (55% will lose, 21% will gain) while in the USA, the realized habitat of 85% of species will change (65% will lose, 20% will gain). If all else were held constant, the ecosystem is projected to change radically based on thermal habitat alone. The magnitude of the 2060 warming projection (similar to 1.5-3 degrees C) was observed in 2012 affirming that research is needed on effects of extreme "weather" in addition to increasing mean temperature. Our approach can be used to aggregate at smaller spatial scales where temperate/boreal species are hypothesized to have a greater loss at similar to 40 degrees N. The uncertainty associated with climate change forecasts is large, yet resource management agencies still have to address climate change. How? Since many fishery agencies do not plan beyond 5 years, a logical way forward is to incorporate a "realized thermal habitat index" into the stock assessment process. Over time, decisions would be influenced by the amount of suitable thermal habitat, in concert with gradual or extreme warming.	[Shackell, Nancy L.] Fisheries & Oceans Canada, Bedford Inst Oceanog, Dept Fisheries & Oceans, Oceans & Ecosyst Sci Div, Dartmouth, NS B2Y 4A2, Canada; [Ricard, Daniel] Biol Ctr AS CR Vvi, Inst Hydrobiol, Ceske Budejovice, Czech Republic; [Stortini, Christine] Dalhousie Univ, Sch Resource & Environm Studies, Halifax, NS, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Dalhousie University	Shackell, NL (corresponding author), Fisheries & Oceans Canada, Bedford Inst Oceanog, Dept Fisheries & Oceans, Oceans & Ecosyst Sci Div, POB 1006, Dartmouth, NS B2Y 4A2, Canada.	nancy.shackell@dfo-mpo.gc.ca	Ricard, Daniel/G-1814-2014; Shackell, Nancy L/AAF-8209-2019	Shackell, Nancy L/0000-0001-5128-948X	Fisheries and Oceans Canada's Aquatic Climate Change Adaptation Services Program (ACCASP)	Fisheries and Oceans Canada's Aquatic Climate Change Adaptation Services Program (ACCASP)	NLS, DR and CS were supported by Fisheries and Oceans Canada's Aquatic Climate Change Adaptation Services Program (ACCASP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Beale CM, 2012, PHILOS T R SOC B, V367, P247, DOI 10.1098/rstb.2011.0178; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Chen DL, 2006, ADV ATMOS SCI, V23, P54, DOI 10.1007/s00376-006-0006-5; Cheung WWL, 2011, ICES J MAR SCI, V68, P1008, DOI 10.1093/icesjms/fsr012; Cheung William W.L., 2008, University of British Columbia Fisheries Centre Research Reports, V16, P1; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Choi J, 2012, 2012024 DFO CAN SCI, V2012; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Franco AMA, 2006, GLOBAL CHANGE BIOL, V12, P1545, DOI 10.1111/j.1365-2486.2006.01180.x; Frank KT, 2006, ECOL LETT, V9, P1096, DOI 10.1111/j.1461-0248.2006.00961.x; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Fronzek S, 2011, NAT HAZARD EARTH SYS, V11, P2981, DOI 10.5194/nhess-11-2981-2011; Gaston K., 2008, PATTERN PROCESS MACR; Gritti ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068823; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hale R, 2011, OIKOS, V120, P661, DOI 10.1111/j.1600-0706.2010.19469.x; Hare JA, 2012, ICES J MAR SCI, V69, P1753, DOI 10.1093/icesjms/fss160; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hebert D, 2013, 2013058 DFO CAN SCI, V2013; Helmuth B, 2005, ANNU REV PHYSIOL, V67, P177, DOI 10.1146/annurev.physiol.67.040403.105027; Hulme PE, 2005, J APPL ECOL, V42, P784, DOI 10.1111/j.1365-2664.2005.01082.x; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Kearney M, 2006, OIKOS, V115, P186, DOI 10.1111/j.2006.0030-1299.14908.x; Link JS, 2011, FISH FISH, V12, P461, DOI 10.1111/j.1467-2979.2010.00398.x; Loder J, 2013, CAN TECH REP HYDROGR, V292; Loder J. W., 2013, CAN TECH REP HYDROGR, V286; McCay BJ, 2012, NAT CLIM CHANGE, V2, P840, DOI 10.1038/nclimate1765; Niiranen S, 2013, GLOBAL CHANGE BIOL, V19, P3327, DOI 10.1111/gcb.12309; Nye JA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1420; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Pinsky ML, 2012, CLIMATIC CHANGE, V115, P883, DOI 10.1007/s10584-012-0599-x; Planque B, 2010, J MARINE SYST, V79, P403, DOI 10.1016/j.jmarsys.2008.12.018; R Core Team, 2012, R LANG ENV STAT COMP; Russell BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046554; Seo C, 2009, BIOL LETTERS, V5, P39, DOI 10.1098/rsbl.2008.0476; Shackell NL, 2007, MAR ECOL PROG SER, V336, P235, DOI 10.3354/meps336235; Shackell NL, 2012, ICES J MAR SCI, V69, P151, DOI 10.1093/icesjms/fsr195; Shackell NL, 2010, P ROY SOC B-BIOL SCI, V277, P1353, DOI 10.1098/rspb.2009.1020; Sherman K, 2014, OCEAN COAST MANAGE, V90, P38, DOI 10.1016/j.ocecoaman.2013.06.008; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Tuszynski J., 2012, CATOOLS TOOLS MOVING; UNESCO/IOC, 2012, NE FISH SCI CTR BOTT; UNESCO/IOC, 2012, DFO MAR RES VESS TRA; Wake DB, 2009, P NATL ACAD SCI USA, V106, P19631, DOI 10.1073/pnas.0911097106; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	53	35	38	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90662	10.1371/journal.pone.0090662	http://dx.doi.org/10.1371/journal.pone.0090662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599187	gold, Green Published, Green Submitted			2022-12-25	WOS:000332479400111
J	Tarazon, E; Rosello-Lleti, E; Rivera, M; Ortega, A; Molina-Navarro, MM; Trivino, JC; Lago, F; Gonzalez-Juanatey, JR; Orosa, P; Montero, JA; Salvador, A; Portoles, M				Tarazon, Estefania; Rosello-Lleti, Esther; Rivera, Miguel; Ortega, Ana; Micaela Molina-Navarro, Maria; Carlos Trivino, Juan; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose; Orosa, Placido; Anastasio Montero, Jose; Salvador, Antonio; Portoles, Manuel			RNA Sequencing Analysis and Atrial Natriuretic Peptide Production in Patients with Dilated and Ischemic Cardiomyopathy	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; CHRONIC HEART-FAILURE; B-TYPE; GUIDELINE UPDATE; GENE-EXPRESSION; ESC GUIDELINES; PLASMA; CORIN; DIAGNOSIS; VENTRICLES	Background: The atrium is the major site of ANP synthesis, which has been said to increase in heart failure as a result of increased production in the left ventricular (LV) myocardium. This is a key issue related to its diagnostic and prognostic capabilities. We aimed to evaluate protein levels of proANP and ANP and the enzymes that cleave the natriuretic peptides, corin and furin, in the LV tissue of heart transplant patients with dilated (DCM) and ischemic (ICM) cardiomyopathy compared with control donors (CNT). We also evaluate mRNA levels of ANP gene (NPPA) by RNA sequencing in the same tissue. Methods and Results: Seventy-three human LV tissue samples from ICM (n = 30) and DCM (n = 33) patients and CNT (n = 10) were analyzed by Western blot and RNA sequencing. Comparing protein levels according to etiology, neither DCM nor ICM showed levels of proANP or ANP different from those of CNT. However, NPPA was increased in both groups compared to CNT (DCM 32 fold, p<0.0001; ICM 10 fold, p<0.0001). Corin (but not furin) was elevated in the ICM group compared to CNT (112 +/- 24 vs. 100 +/- 7, p<0.05), and its level was inversely related with LV ejection fraction (LVEF) (r = -0.399, p<0.05). Conclusions: Patients present with elevated levels of NPPA but not of proANP or ANP proteins in LV tissue, which may be due to posttranscripcional regulation of NPPA or different pathways for ANP secretion between the atrium and ventricle. Moreover, there are differences between DCM and ICM in corin levels, indicating that a different molecular mechanism may exist that converge in this syndrome. Further, LV concentration of corin is inversely related to LVEF in ICM.	[Tarazon, Estefania; Rosello-Lleti, Esther; Rivera, Miguel; Ortega, Ana; Micaela Molina-Navarro, Maria; Portoles, Manuel] Inst Invest Sanitaria Hosp Univ La Fe, Cardiocirculatory Unit, Valencia, Spain; [Carlos Trivino, Juan] Sistemas Genom, Valencia, Spain; [Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Dept Cardiol, Cellular & Mol Cardiol Res Unit, Santiago De Compostela, Spain; [Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Inst Biomed Res, Santiago De Compostela, Spain; [Orosa, Placido] Hosp San Francesc de Borja, Cardiol Unit, Gandia, Spain; [Anastasio Montero, Jose] Hosp Univ La Fe, Serv Cirugia Cardiovasc, Valencia, Spain; [Salvador, Antonio] Hosp Univ La Fe, Dept Cardiol, Heart Failure & Transplantat Unit, Valencia, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe	Portoles, M (corresponding author), Inst Invest Sanitaria Hosp Univ La Fe, Cardiocirculatory Unit, Valencia, Spain.	portoles_man@gva.es	Tarazón, Estefanía/D-6950-2017; PORTOLES, MANUEL/B-4789-2009; Ortega, Ana AO/D-3027-2017; Roselló Lletí, Esther/ABG-8503-2020; Ortega, Ana/AAG-5941-2020; Roselló-Lletí, Esther/B-2695-2017	Tarazón, Estefanía/0000-0003-3466-2558; PORTOLES, MANUEL/0000-0002-4415-7160; Ortega, Ana AO/0000-0002-9763-0505; Roselló Lletí, Esther/0000-0003-2627-6104; Ortega, Ana/0000-0002-9763-0505; Roselló-Lletí, Esther/0000-0003-2627-6104; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388; , Micaela/0000-0002-2103-0351	National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III'' [RETICS 12/0042/0003, PI10/00275]	National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III''	This work was supported by grants from the National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III'' [RETICS 12/0042/0003, Project PI10/00275]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arora P, 2013, J CLIN INVEST, V123, P3378, DOI 10.1172/JCI67383; BLOCH KD, 1986, CELL, V47, P695, DOI 10.1016/0092-8674(86)90512-X; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Cortes R, 2007, HEART, V93, P957, DOI 10.1136/hrt.2006.096891; Cortes R, 2006, EUR J HEART FAIL, V8, P621, DOI 10.1016/j.ejheart.2005.11.011; Cortes R, 2012, INT J CARDIOL, V158, P199, DOI 10.1016/j.ijcard.2011.01.014; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Dickstein K, 2010, EUR J HEART FAIL, V12, P1143, DOI [10.1093/eurjhf/hfq192, 10.1093/europace/euq392]; Dong NZ, 2010, CIRC-HEART FAIL, V3, P207, DOI 10.1161/CIRCHEARTFAILURE.109.903849; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Ibebuogu UN, 2011, CIRC-HEART FAIL, V4, P114, DOI 10.1161/CIRCHEARTFAILURE.109.895581; Ichiki T, 2013, AM J PHYSIOL-REG I, V304, pR102, DOI 10.1152/ajpregu.00233.2012; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu P, 2003, CAN J CARDIOL, V19, P347; Macrae Duncan J, 2007, Proc Am Thorac Soc, V4, P176, DOI 10.1513/pats.200701-011GC; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008847; Mooney M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061088; NELESEN RA, 1992, CIRCULATION, V86, P463, DOI 10.1161/01.CIR.86.2.463; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; Rivera M, 2005, EUR J HEART FAIL, V7, P1168, DOI 10.1016/j.ejheart.2005.04.003; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosello-Lleti E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031189; Ruskoaho H, 2003, ENDOCR REV, V24, P341, DOI 10.1210/er.2003-0006; SAITO Y, 1987, BIOCHEM BIOPH RES CO, V148, P211, DOI 10.1016/0006-291X(87)91097-7; Semenov AG, 2010, CLIN CHEM, V56, P1166, DOI 10.1373/clinchem.2010.143883; Seronde MF, 2013, INT J CARDIOL, V168, P3404, DOI 10.1016/j.ijcard.2013.04.164; TAKAHASHI T, 1992, CIRC RES, V71, P9, DOI 10.1161/01.RES.71.1.9; Tarazon E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048957; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; TSUCHIMOCHI H, 1988, CIRCULATION, V78, P920, DOI 10.1161/01.CIR.78.4.920; Waldo SW, 2008, J AM COLL CARDIOL, V51, P1874, DOI 10.1016/j.jacc.2007.12.051; Winters AL, 2005, ANAL BIOCHEM, V346, P43, DOI 10.1016/j.ab.2005.07.041; Wu QY, 2009, KIDNEY INT, V75, P142, DOI 10.1038/ki.2008.418; Zolty R, 2008, CLIN BIOCHEM, V41, P1255, DOI 10.1016/j.clinbiochem.2008.05.008	36	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90157	10.1371/journal.pone.0090157	http://dx.doi.org/10.1371/journal.pone.0090157			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599027	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400051
J	Vasquez-Limeta, A; Wagstaff, KM; Ortega, A; Crouch, DH; Jans, DA; Cisneros, B				Vasquez-Limeta, Alejandra; Wagstaff, Kylie M.; Ortega, Arturo; Crouch, Dorothy H.; Jans, David A.; Cisneros, Bulmaro			Nuclear Import of beta-Dystroglycan Is Facilitated by Ezrin-Mediated Cytoskeleton Reorganization	PLOS ONE			English	Article							ACTIN CYTOSKELETON; ERM PROTEINS; LOCALIZATION; DYSTROPHIN; CELLS; TRANSLOCATION; TRANSPORT; MUSCLE; AJUBA; ORGANIZATION	The beta-dystroglycan (beta-DG) protein has the ability to target to multiple sites in eukaryotic cells, being a member of diverse protein assemblies including the transmembranal dystrophin-associated complex, and a nuclear envelope-localised complex that contains emerin and lamins A/C and B1. We noted that the importin alpha 2/beta 1-recognised nuclear localization signal (NLS) of beta-DG is also a binding site for the cytoskeletal-interacting protein ezrin, and set out to determine whether ezrin binding might modulate beta-DG nuclear translocation for the first time. Unexpectedly, we found that ezrin enhances rather than inhibits beta-DG nuclear translocation in C2C12 myoblasts. Both overexpression of a phosphomimetic activated ezrin variant (Ez-T567D) and activation of endogenous ezrin through stimulation of the Rho pathway resulted in both formation of actin-rich surface protrusions and significantly increased nuclear translocation of beta-DG as shown by quantitative microscopy and subcellular fractionation/Western analysis. In contrast, overexpression of a nonphosphorylatable inactive ezrin variant (Ez-T567A) or inhibition of Rho signaling, decreased nuclear translocation of beta-DG concomitant with a lack of cell surface protrusions. Further, a role for the actin cytoskeleton in ezrin enhancement of beta-DG nuclear translocation was implicated by the observation that an ezrin variant lacking its actin-binding domain failed to enhance nuclear translocation of beta-DG, while disruption of the actin cytoskeleton led to a reduction in beta-DG nuclear localization. Finally, we show that ezrin-mediated cytoskeletal reorganization enhances nuclear translocation of the cytoplasmic but not the transmembranal fraction of beta-DG. This is the first study showing that cytoskeleton reorganization can modulate nuclear translocation of beta-DG, with the implication that b-DG can respond to cytoskeleton-driven changes in cell morphology by translocating from the cytoplasm to the nucleus to orchestrate nuclear processes in response to the functional requirements of the cell.	[Vasquez-Limeta, Alejandra; Ortega, Arturo; Cisneros, Bulmaro] Inst Politecn Nacl CINVESTAV IPN, Ctr Invest & Estudios Avanzados, Dept Genet & Biol Mol, Mexico City, DF, Mexico; [Wagstaff, Kylie M.; Jans, David A.] Monash Univ, Nucl Signalling Lab, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Crouch, Dorothy H.] Univ Dundee, Sch Dent, Dundee, Scotland	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Monash University; University of Dundee	Jans, DA (corresponding author), Monash Univ, Nucl Signalling Lab, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	david.jans@monash.edu; bcisnero@cinvestav.mx	Ortega, Arturo/A-2282-2008; Vásquez Limeta, Alejandra/AIE-1291-2022	Ortega, Arturo/0000-0002-9594-8114; Vásquez Limeta, Alejandra/0000-0002-2504-6270; Wagstaff, Kylie/0000-0003-4791-1410; Jans, David/0000-0001-5115-4745	CONACyT (Mexico) [128418]; National Health and Medical Research Council (Australia) [APP1002486];  [203589]	CONACyT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); 	This work was supported by: CONACyT (Mexico); Contract grant number 128418 to BC, and scholarship for PhD studies, Contract number 203589 was granted to AVL; and the National Health and Medical Research Council (Australia); Contract grant number APP1002486 to DAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyanathan K, 2007, CANCER RES, V67, P9097, DOI 10.1158/0008-5472.CAN-07-2987; Baliga BC, 2003, J BIOL CHEM, V278, P4899, DOI 10.1074/jbc.M211512200; Batchelor CL, 2004, EXP CELL RES, V296, P208, DOI 10.1016/j.yexcr.2004.02.010; Batchelor CL, 2007, CELL CYCLE, V6, P353, DOI 10.4161/cc.6.3.3819; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Fazal F, 2007, J BIOL CHEM, V282, P3940, DOI 10.1074/jbc.M608074200; Fuentes-Mera L, 2006, EXP CELL RES, V312, P3023, DOI 10.1016/j.yexcr.2006.06.002; Gonzalez-Ramirez R, 2008, J CELL BIOCHEM, V105, P735, DOI 10.1002/jcb.21870; Henry MD, 1996, CURR OPIN CELL BIOL, V8, P625, DOI 10.1016/S0955-0674(96)80103-7; Higginson JR, 2008, INT J BIOCHEM CELL B, V40, P892, DOI 10.1016/j.biocel.2007.10.019; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; Ilsley JL, 2001, CELL SIGNAL, V13, P625, DOI 10.1016/S0898-6568(01)00188-7; Kanungo J, 2000, MOL BIOL CELL, V11, P3299, DOI 10.1091/mbc.11.10.3299; Kim JH, 2010, J BIOL CHEM, V285, P9995, DOI 10.1074/jbc.M109.061671; Kumeta Masahiro, 2012, Int J Cell Biol, V2012, P494902, DOI 10.1155/2012/494902; Lara-Chacon B, 2010, J CELL BIOCHEM, V110, P706, DOI 10.1002/jcb.22581; Martinez-Vieyra IA, 2013, BBA-MOL CELL RES, V1833, P698, DOI 10.1016/j.bbamcr.2012.11.019; Mathew G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02792; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Montoya-Durango DE, 2008, J BIOL CHEM, V283, P32056, DOI 10.1074/jbc.M802320200; Moore CJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-3; Oppizzi ML, 2008, TRAFFIC, V9, P2063, DOI 10.1111/j.1600-0854.2008.00822.x; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Pouton CW, 2007, ADV DRUG DELIVER REV, V59, P698, DOI 10.1016/j.addr.2007.06.010; Rivier F, 1999, J MUSCLE RES CELL M, V20, P305, DOI 10.1023/A:1005426920070; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Sotgia F, 2003, BIOCHEMISTRY-US, V42, P7110, DOI 10.1021/bi0271289; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Spence HJ, 2004, HUM MOL GENET, V13, P1657, DOI 10.1093/hmg/ddh170; Thompson O, 2010, J CELL SCI, V123, P118, DOI 10.1242/jcs.047902; Villarreal-Silva M, 2009, NEUROCHEMICAL RES; Wagstaff KM, 2006, ANAL BIOCHEM, V348, P49, DOI 10.1016/j.ab.2005.10.029; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Wang YN, 2010, J BIOL CHEM, V285, P38720, DOI 10.1074/jbc.M110.158659; Xiao CY, 1996, J BIOL CHEM, V271, P6451, DOI 10.1074/jbc.271.11.6451; Zh LX, 2007, AM J PHYSIOL-CELL PH, V293, pC874, DOI 10.1152/ajpcell.00111.2007	36	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90629	10.1371/journal.pone.0090629	http://dx.doi.org/10.1371/journal.pone.0090629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599031	Green Submitted, gold, Green Published			2022-12-25	WOS:000332479400106
J	Zabala, J; Zuberogoitia, I				Zabala, Jabi; Zuberogoitia, Inigo			Individual Quality Explains Variation in Reproductive Success Better than Territory Quality in a Long-Lived Territorial Raptor	PLOS ONE			English	Article							BREEDING PERFORMANCE; HABITAT HETEROGENEITY; POPULATION REGULATION; TAWNY OWLS; BROOD-SIZE; AGE; DIET; SELECTION; ECOLOGY; WEATHER	Evolution by natural selection depends on the relationship between individual traits and fitness. Variation in individual fitness can result from habitat (territory) quality and individual variation. Individual quality and specialization can have a deep impact on fitness, yet in most studies on territorial species the quality of territory and individuals are confused. We aimed to determine if variation in breeding success is better explained by territories, individual quality or a combination of both. We analysed the number of fledglings and the breeding quality index (the difference between the number of fledglings of an individual/breeding pair and the average number of fledglings of the monitored territories in the same year) as part of a long term (16 years) peregrine falcon (Falco peregrinus) monitoring program with identification of individuals. Using individual and territory identities as correlates of quality, we built Generalised Linear Models with Mixed effects, in which random factors depicted different hypotheses for sources of variation (territory/individual quality) in the reproductive success of unique breeding pairs, males and females, and assessed their performance. Most evidence supported the hypothesis that variation in breeding success is explained by individual identity, particularly male identity, rather than territory. There is also some evidence for inter year variations in the breeding success of females and a territory effect in the case of males. We argue that, in territorial species, individual quality is a major source of variation in breeding success, often masked by territory. Future ecological and conservation studies on habitat use should consider and include the effect of individuals, in order to avoid misleading results.	[Zuberogoitia, Inigo] Icarus Estudios Medioambientales, Logrono, Spain; [Zuberogoitia, Inigo] Soc Ciencias Aranzadi, Dept Ornithol, Donostia San Sebastian, Spain			jzabalaalbizua@yahoo.com	Iñigo, Zuberogoitia/H-5062-2019; Zabala, Jabi/B-8157-2009	Zabala, Jabi/0000-0002-1425-1594; Zuberogoitia, Inigo/0000-0002-8945-7386	Fhe Agriculture and the Environment Departments of the Diputacion Foral de Bizkaia	Fhe Agriculture and the Environment Departments of the Diputacion Foral de Bizkaia	This work was supported by Fhe Agriculture and the Environment Departments of the Diputacion Foral de Bizkaia provided partial funding for field work some of the seasons. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2012, LME4 LINEAR MIXED EF; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.2307/3802723, DOI 10.2307/3802723]; Cam E, 2000, J ANIM ECOL, V69, P380, DOI 10.1046/j.1365-2656.2000.00400.x; Cam E, 2002, AM NAT, V159, P96, DOI 10.1086/324126; Cardador L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033375; Carrete M, 2006, OIKOS, V112, P680, DOI 10.1111/j.0030-1299.2006.14528.x; Carrete M, 2008, OIKOS, V117, P1115, DOI 10.1111/j.0030-1299.2008.16968.x; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Crawley MJ., 2007, R BOOK; Crone EE, 2001, EVOLUTION, V55, P2611; Espie RHM, 2004, IBIS, V146, P623, DOI 10.1111/j.1474-919x.2004.00294.x; Ferrer M, 2003, AUK, V120, P180, DOI 10.1642/0004-8038(2003)120[0180:AATEOF]2.0.CO;2; Ferrer M, 1996, ECOLOGY, V77, P69, DOI 10.2307/2265655; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Forsman D, 1999, RAPTORS EUROPE MIDDL; Germain RR, 2014, ECOLOGY IN PRESS; GOODBURN SF, 1991, IBIS, V133, P85, DOI 10.1111/j.1474-919X.1991.tb04815.x; HOGSTEDT G, 1980, SCIENCE, V210, P1148, DOI 10.1126/science.210.4474.1148; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Katzner TE, 2005, IBIS, V147, P576, DOI 10.1111/j.1474-919X.2005.00443.x; KORPIMAKI E, 1988, J ANIM ECOL, V57, P1027, DOI 10.2307/5109; Kruger O, 2012, J ANIM ECOL, V81, P330, DOI 10.1111/j.1365-2656.2011.01904.x; Kruger O, 2001, OIKOS, V93, P260, DOI 10.1034/j.1600-0706.2001.930209.x; Margalida A, 2014, ECOLOGICAL IN PRESS; Margalida A, 2012, IBIS, V154, P184, DOI 10.1111/j.1474-919X.2011.01189.x; Margalida A, 2008, ARDEA, V96, P173, DOI 10.5253/078.096.0203; Margalida A, 2009, IBIS, V151, P235; Martin TE, 1998, ECOLOGY, V79, P656, DOI 10.1890/0012-9658(1998)079[0656:AMPOCS]2.0.CO;2; Martinez JE, 2008, ORNIS FENNICA, V85, P13; McGraw JB, 1996, AM NAT, V147, P47, DOI 10.1086/285839; Millon A, 2011, J ANIM ECOL, V80, P968, DOI 10.1111/j.1365-2656.2011.01842.x; NEWTON I, 1991, IBIS, V133, P76, DOI 10.1111/j.1474-919X.1991.tb07671.x; Newton I, 1989, LIFETIME REPROD BIRD; Newton I, 2013, BIRD POPUL; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Olsen J, 2003, EMU, V103, P127, DOI 10.1071/MU02013; Pagan I, 2009, J ZOOL, V279, P36, DOI 10.1111/j.1469-7998.2009.00587.x; Pinheiro J, 2012, LME LINEAR NONLINEAR; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; R Core Team, 2021, R LANG ENV STAT COMP; Rodriguez C, 2003, J ANIM ECOL, V72, P793, DOI 10.1046/j.1365-2656.2003.00757.x; Sasvari L, 2002, FOLIA ZOOL, V51, P113; Sasvari L, 2000, ACTA OECOL, V21, P267, DOI 10.1016/S1146-609X(00)01080-8; Sergio F, 2003, J ANIM ECOL, V72, P857, DOI 10.1046/j.1365-2656.2003.00758.x; Steenhof K, 1997, J ANIM ECOL, V66, P350, DOI 10.2307/5981; Wiens J.A., 1989, ECOLOGY BIRD COMMUNI, V1; Zabala J, 2011, MAR POLLUT BULL, V62, P109, DOI 10.1016/j.marpolbul.2010.09.004; Zar JH, 1999, BIOSTATISTCAL ANAL; Zuberogoitia I, 2008, ANIM CONSERV, V11, P313, DOI 10.1111/j.1469-1795.2008.00184.x; Zuberogoitia I, 2002, HALCION PEREGRINO; Zuberogoitia I, 2014, MUNIBE, V61, P117; Zuberogoitia I, 2009, J ORNITHOL, V150, P95, DOI 10.1007/s10336-008-0321-y; Zuberogoitia I, 2013, J ORNITHOL, V154, P73, DOI 10.1007/s10336-012-0872-9; Zuur Alain F., 2009, P1	57	30	30	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90254	10.1371/journal.pone.0090254	http://dx.doi.org/10.1371/journal.pone.0090254			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599280	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400058
J	Zimmermann, M; Armeanu-Ebinger, S; Bossow, S; Lampe, J; Smirnow, I; Schenk, A; Lange, S; Weiss, TS; Neubert, W; Lauer, UM; Bitzer, M				Zimmermann, Martina; Armeanu-Ebinger, Sorin; Bossow, Sascha; Lampe, Johanna; Smirnow, Irina; Schenk, Andrea; Lange, Sebastian; Weiss, Thomas S.; Neubert, Wolfgang; Lauer, Ulrich M.; Bitzer, Michael			Attenuated and Protease-Profile Modified Sendai Virus Vectors as a New Tool for Virotherapy of Solid Tumors	PLOS ONE			English	Article							TARGETED ONCOLYTIC POXVIRUS; C-PROTEINS; HOST-CELL; CANCER; ACTIVATION; DEFECTS; THERAPY; FUSION; GENERATION; INHIBITION	Multiple types of oncolytic viruses are currently under investigation in clinical trials. To optimize therapeutic outcomes it is believed that the plethora of different tumor types will require a diversity of different virus types. Sendai virus (SeV), a murine parainfluenza virus, displays a broad host range, enters cells within minutes and already has been applied safely as a gene transfer vector in gene therapy patients. However, SeV spreading naturally is abrogated in human cells due to a lack of virus activating proteases. To enable oncolytic applications of SeV we here engineered a set of novel recombinant vectors by a two-step approach: (i) introduction of an ubiquitously recognized cleavage-motive into SeV fusion protein now enabling continuous spreading in human tissues, and (ii) profound attenuation of these rSeV by the knockout of viral immune modulating accessory proteins. When employing human hepatoma cell lines, newly generated SeV variants now reached high titers and induced a profound tumor cell lysis. In contrast, virus release from untransformed human fibroblasts or primary human hepatocytes was found to be reduced by about three log steps in a time course experiment which enables the cumulation of kinetic differences of the distinct phases of viral replication such as primary target cell infection, target cell replication, and progeny virus particle release. In a hepatoma xenograft animal model we found a tumor-specific spreading of our novel recombinant SeV vectors without evidence of biodistribution into non-malignant tissues. In conclusion, we successfully developed novel tumor-selective oncolytic rSeV vectors, constituting a new tool for virotherapy of solid tumors being ready for further preclinical and clinical development to address distinct tumor types.	[Zimmermann, Martina; Smirnow, Irina; Schenk, Andrea; Lauer, Ulrich M.; Bitzer, Michael] Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany; [Armeanu-Ebinger, Sorin] Univ Childrens Hosp, Tubingen, Germany; [Bossow, Sascha] Natl Ctr Tumor Dis, Dept Translat Oncol, Heidelberg, Germany; [Lampe, Johanna] Inst Mol Med Finland FIMM, Helsinki, Finland; [Lange, Sebastian] Tech Univ Munich, Med Klin, Klinikum Rechts Isar, D-80290 Munich, Germany; [Weiss, Thomas S.] Univ Regensburg Hosp, Ctr Liver Cell Res, Dept Pediat & Adolescent Med, Regensburg, Germany; [Neubert, Wolfgang] Max Planck Inst Biochem, Dept Mol Virol, D-82152 Martinsried, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Technical University of Munich; University of Regensburg; Max Planck Society	Bitzer, M (corresponding author), Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany.	michael.bitzer@uni-tuebingen.de	Lange, Sebastian/S-4635-2019; Weiss, Thomas S./G-3989-2012	Lange, Sebastian/0000-0003-0406-1401; Weiss, Thomas S./0000-0003-0336-0581	Deutsche Forschungsgemeinschaft [SFB 773, BI 669/3-6]; Federal Ministry for Education and Research of Germany [BMBF 01GU0506, 01GU0806]; Deutsche Forschungsgemeinschaft; Tuebingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry for Education and Research of Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University	This work was supported by grants from the Deutsche Forschungsgemeinschaft SFB 773 (B3) and BI 669/3-6, and from the Federal Ministry for Education and Research of Germany (BMBF 01GU0506 & 01GU0806). The authors acknowledge additional support by the "Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armeanu S, 2008, CLIN CANCER RES, V14, P3520, DOI 10.1158/1078-0432.CCR-07-4744; Berchtold S, 2013, J VIROL, V87, P3484, DOI 10.1128/JVI.02106-12; Bitzer M, 2003, Z GASTROENTEROL, V41, P667; Bitzer M, 2003, J GENE MED, V5, P543, DOI 10.1002/jgm.426; Bitzer M, 2003, MOL THER, V7, P210, DOI 10.1016/S1525-0016(02)00052-7; Bitzer M, 1999, J VIROL, V73, P702, DOI 10.1128/JVI.73.1.702-708.1999; Blechacz B, 2006, HEPATOLOGY, V44, P1465, DOI 10.1002/hep.21437; Bourke MG, 2011, CANCER TREAT REV, V37, P618, DOI 10.1016/j.ctrv.2010.12.003; Breitbach CJ, 2011, NATURE, V477, P99, DOI 10.1038/nature10358; Cattaneo R, 2008, NAT REV MICROBIOL, V6, P529, DOI 10.1038/nrmicro1927; Chen NG, 2012, ADV VIROL, V2012, DOI 10.1155/2012/320206; Fontana JM, 2008, IMMUNOL REV, V225, P46, DOI 10.1111/j.1600-065X.2008.00669.x; Galanis E, 2010, CANC RES; Garcin D, 1999, J VIROL, V73, P6559, DOI 10.1128/JVI.73.8.6559-6565.1999; Gotoh B, 1999, FEBS LETT, V459, P205, DOI 10.1016/S0014-5793(99)01241-7; Haddad D, 2012, J NUCL MED, V53, P1933, DOI 10.2967/jnumed.112.105056; Hasegawa Y, 2010, MOL THER, V18, P1778, DOI 10.1038/mt.2010.138; Hawkins LK, 2002, LANCET ONCOL, V3, P17, DOI 10.1016/S1470-2045(01)00618-0; Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914; Kato A, 2004, J VIROL, V78, P7443, DOI 10.1128/JVI.78.14.7443-7454.2004; Kelly E, 2007, MOL THER, V15, P651, DOI 10.1038/sj.mt.6300108; Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983; KIDO H, 1992, J BIOL CHEM, V267, P13573; Kinoh H, 2004, GENE THER, V11, P1137, DOI 10.1038/sj.gt.3302272; Kinoh H, 2009, GENE THER, V16, P392, DOI 10.1038/gt.2008.167; Komatsu T, 2004, VIROLOGY, V325, P137, DOI 10.1016/j.virol.2004.04.025; Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009; Kurotani A, 1998, GENES CELLS, V3, P111, DOI 10.1046/j.1365-2443.1998.00170.x; Latorre P, 1998, J VIROL, V72, P5984, DOI 10.1128/JVI.72.7.5984-5993.1998; Laurie SA, 2006, CLIN CANCER RES, V12, P2555, DOI 10.1158/1078-0432.CCR-05-2038; Lech PJ, 2010, EXPERT REV VACCINES, V9, P1275, DOI 10.1586/ERV.10.124; Lemken ML, 2007, INT J ONCOL, V30, P1153; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; LINGE C, 1995, CANCER RES, V55, P4099; Markwell M A, 1984, Adv Exp Med Biol, V174, P369; MARKWELL MAK, 1980, P NATL ACAD SCI-BIOL, V77, P5693, DOI 10.1073/pnas.77.10.5693; MARKWELL MAK, 1981, P NATL ACAD SCI-BIOL, V78, P5406, DOI 10.1073/pnas.78.9.5406; Marozin S, 2008, MOL THER, V16, P1789, DOI 10.1038/mt.2008.201; Naik S, 2009, EXPERT OPIN BIOL TH, V9, P1163, DOI 10.1517/14712590903170653; Park BH, 2008, LANCET ONCOL, V9, P533, DOI 10.1016/S1470-2045(08)70107-4; Patel MR, 2013, TRANSL RES, V161, P355, DOI 10.1016/j.trsl.2012.12.010; Persano L, 2009, CARCINOGENESIS, V30, P851, DOI 10.1093/carcin/bgp052; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Slobod KS, 2004, VACCINE, V22, P3182, DOI 10.1016/j.vaccine.2004.01.053; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Straehle L, 2007, J VIROL, V81, P12227, DOI 10.1128/JVI.01300-07; Stritzker J, 2013, P NATL ACAD SCI USA, V110, P3316, DOI 10.1073/pnas.1216916110; Takeuchi K, 2001, GENES CELLS, V6, P545, DOI 10.1046/j.1365-2443.2001.00442.x; Villar E, 2006, GLYCOCONJUGATE J, V23, P5, DOI 10.1007/s10719-006-5433-0; Wiegand MA, 2007, J VIROL, V81, P13835, DOI 10.1128/JVI.00914-07; Yonemitsu Y, 2013, MOL THER, V21, P707, DOI 10.1038/mt.2012.279; Yoshida A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049968	52	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90508	10.1371/journal.pone.0090508	http://dx.doi.org/10.1371/journal.pone.0090508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598703	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400083
J	Reddy, PS; Kishor, PBK; Seiler, C; Kuhlmann, M; Eschen-Lippold, L; Lee, J; Reddy, MK; Sreenivasulu, N				Reddy, Palakolanu Sudhakar; Kishor, Polavarapu B. Kavi; Seiler, Christiane; Kuhlmann, Markus; Eschen-Lippold, Lennart; Lee, Justin; Reddy, Malireddy K.; Sreenivasulu, Nese			Unraveling Regulation of the Small Heat Shock Proteins by the Heat Shock Factor HvHsfB2c in Barley: Its Implications in Drought Stress Response and Seed Development	PLOS ONE			English	Article							ALPHA-CRYSTALLIN DOMAIN; ORYZA-SATIVA L.; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; SUBCELLULAR-LOCALIZATION; MOLECULAR CHAPERONES; EXPRESSION ANALYSIS; ABIOTIC STRESS; I-TASSER; GENE	The rapid increase in heat shock proteins upon exposure to damaging stresses and during plant development related to desiccation events reveal their dual importance in plant development and stress tolerance. Genome-wide sequence survey identified 20 non-redundant small heat shock proteins (sHsp) and 22 heat shock factor (Hsf) genes in barley. While all three major classes (A, B, C) of Hsfs are localized in nucleus, the 20 sHsp gene family members are localized in different cell organelles like cytoplasm, mitochondria, plastid and peroxisomes. Hsf and sHsp members are differentially regulated during drought and at different seed developmental stages suggesting the importance of chaperone role under drought as well as seed development. In silico cis-regulatory motif analysis of Hsf promoters showed an enrichment with abscisic acid responsive cis-elements (ABRE), implying regulatory role of ABA in mediating transcriptional response of HvsHsf genes. Gene regulatory network analysis identified HvHsfB2c as potential central regulator of the seed-specific expression of several HvsHsps including 17.5CI sHsp. These results indicate that HvHsfB2c is co-expressed in the central hub of small Hsps and therefore it may be regulating the expression of several HvsHsp subclasses HvHsp16.88-CI, HvHsp17.5-CI and HvHsp17.7-CI. The in vivo relevance of binding specificity of HvHsfB2C transcription factor to HSE-element present in the promoter of HvSHP17.5-CI under heat stress exposure is confirmed by gel shift and LUC-reporter assays. Further, we isolated 477 bp cDNA from barley encoding a 17.5 sHsp polypeptide, which was predominantly upregulated under drought stress treatments and also preferentially expressed in developing seeds. Recombinant HvsHsp17.5-CI protein was expressed in E. coli and purified to homogeneity, which displayed in vitro chaperone activity. The predicted structural model of HvsHsp17.5-CI protein suggests that the alpha-crystallin domain is evolutionarily highly conserved.	[Reddy, Palakolanu Sudhakar; Kishor, Polavarapu B. Kavi; Seiler, Christiane; Kuhlmann, Markus; Sreenivasulu, Nese] Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany; [Kishor, Polavarapu B. Kavi] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India; [Kuhlmann, Markus; Sreenivasulu, Nese] Interdisciplinary Ctr Crop Plant Res, Res Grp Abiot Stress Genom, Halle, Germany; [Eschen-Lippold, Lennart; Lee, Justin] Leibniz Inst Plant Biochem IPB, Halle, Germany; [Reddy, Malireddy K.] Int Ctr Genet Engn & Biotechnol, New Delhi, India	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Osmania University; Leibniz Institut fur Pflanzenbiochemie; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Sreenivasulu, N (corresponding author), Int Rice Res Inst, Grain Qual & Nutr Ctr, Manila, Philippines.	srinivas@ipk-gatersleben.de	Lee, Justin/B-6096-2012; Sreenivasulu, Nese/E-8600-2011; Eschen-Lippold, Lennart/I-5098-2016	Lee, Justin/0000-0001-8269-7494; Sreenivasulu, Nese/0000-0002-3998-038X; Eschen-Lippold, Lennart/0000-0001-8907-6922; Kavi Kishor, Polavarapu/0000-0002-9587-7547; Kuhlmann, Markus/0000-0003-3104-0825	IB-BMBF [IND 09/526]; Ministry of Education, SaxonyAnhalt; Germany Academic Exchange programme (DAAD) [A/11/94309]	IB-BMBF; Ministry of Education, SaxonyAnhalt; Germany Academic Exchange programme (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The authors work in the NS laboratory has been supported by grants from the IB-BMBF (IND 09/526) and from the Ministry of Education, SaxonyAnhalt. PSR acknowledges the Leibniz-DAAD post doctoral fellowship award (Number: A/11/94309) from Germany Academic Exchange programme (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almoguera C, 2002, J BIOL CHEM, V277, P43866, DOI 10.1074/jbc.M207330200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Basha E, 2010, J BIOL CHEM, V285, P11489, DOI 10.1074/jbc.M109.074088; Begum T, 2013, MECH DEVELOP, V130, P54, DOI 10.1016/j.mod.2012.05.008; Busch W, 2005, PLANT J, V41, P1, DOI 10.1111/j.1365-313X.2004.02272.x; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Chauhan H, 2012, PLANT CELL ENVIRON, V35, P1912, DOI 10.1111/j.1365-3040.2012.02525.x; Chauhan H, 2011, MOL GENET GENOMICS, V286, P171, DOI 10.1007/s00438-011-0638-8; Close TJ, 2004, PLANT PHYSIOL, V134, P960, DOI 10.1104/pp.103.034462; De Bodt S, 2012, NEW PHYTOL, V195, P707, DOI 10.1111/j.1469-8137.2012.04184.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hong SW, 2001, PLANT J, V27, P25, DOI 10.1046/j.1365-313x.2001.01066.x; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Ikeda M, 2011, PLANT PHYSIOL, V157, P1243, DOI 10.1104/pp.111.179036; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kotak S, 2004, PLANT J, V39, P98, DOI 10.1111/j.1365-313X.2004.02111.x; Kotak S, 2007, PLANT CELL, V19, P182, DOI 10.1105/tpc.106.048165; Kuhlmann M, 2003, J BIOL CHEM, V278, P8786, DOI 10.1074/jbc.M210292200; LEE GJ, 1995, J BIOL CHEM, V270, P10432, DOI 10.1074/jbc.270.18.10432; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lin YX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-76; Lohmann C, 2004, MOL GENET GENOMICS, V271, P11, DOI 10.1007/s00438-003-0954-8; Long TA, 2008, ANNU REV CELL DEV BI, V24, P81, DOI 10.1146/annurev.cellbio.24.110707.175408; Low D, 2000, PLANTA, V211, P575, DOI 10.1007/s004250000315; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; Matsumoto T, 2011, PLANT PHYSIOL, V156, P20, DOI 10.1104/pp.110.171579; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Mittal D, 2009, PLANT PHYSIOL BIOCH, V47, P785, DOI 10.1016/j.plaphy.2009.05.003; Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200; Mutwil M, 2011, PLANT CELL, V23, P895, DOI 10.1105/tpc.111.083667; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nover L, 2001, CELL STRESS CHAPERON, V6, P177, DOI 10.1379/1466-1268(2001)006<0177:AATHST>2.0.CO;2; Prandl R, 1996, PLANT MOL BIOL, V31, P157, DOI 10.1007/BF00020615; Puigderrajols P, 2002, J EXP BOT, V53, P1445, DOI 10.1093/jexbot/53.373.1445; Rana RM, 2012, J EXP BOT, V63, P6003, DOI 10.1093/jxb/ers245; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; Reddy PS, 2012, MOL BIOL REP, V39, P7163, DOI 10.1007/s11033-012-1548-5; Reddy PS, 2011, GENE, V474, P29, DOI 10.1016/j.gene.2010.12.004; Ren YJ, 2012, PLANT CELL ENVIRON, V35, P770, DOI 10.1111/j.1365-3040.2011.02450.x; Rojas A, 1999, PLANT J, V20, P601, DOI 10.1046/j.1365-313X.1999.00635.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sarkar NK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-393; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Siddique M, 2003, CELL STRESS CHAPERON, V8, P381, DOI 10.1379/1466-1268(2003)008<0381:THSPHR>2.0.CO;2; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Sreenivasulu N, 2008, PLANT PHYSIOL, V146, P1738, DOI 10.1104/pp.107.111781; Sreenivasulu N, 2006, PLANT J, V47, P310, DOI 10.1111/j.1365-313X.2006.02789.x; Sreenivasulu N, 2013, ANNU REV PLANT BIOL, V64, P189, DOI 10.1146/annurev-arplant-050312-120215; Sreenivasulu N, 2012, GENE, V506, P265, DOI 10.1016/j.gene.2012.06.076; Stamler R, 2005, J MOL BIOL, V353, P68, DOI 10.1016/j.jmb.2005.08.025; STRAUB PF, 1994, PLANT MOL BIOL, V26, P617, DOI 10.1007/BF00013748; Sun CW, 1997, PLANT J, V11, P1017, DOI 10.1046/j.1365-313X.1997.11051017.x; Sun WN, 2001, PLANT J, V27, P407, DOI 10.1046/j.1365-313X.2001.01107.x; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; von Koskull-Doring P, 2007, TRENDS PLANT SCI, V12, P452, DOI 10.1016/j.tplants.2007.08.014; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Waters ER, 2008, CELL STRESS CHAPERON, V13, P127, DOI 10.1007/s12192-008-0023-7; Waters ER, 2013, J EXP BOT, V64, P391, DOI 10.1093/jxb/ers355; Wehmeyer N, 2000, PLANT PHYSIOL, V122, P1099, DOI 10.1104/pp.122.4.1099; Wehmeyer N, 1996, PLANT PHYSIOL, V112, P747, DOI 10.1104/pp.112.2.747; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	64	44	48	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89125	10.1371/journal.pone.0089125	http://dx.doi.org/10.1371/journal.pone.0089125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594978	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000332475500010
J	Sikulu, MT; Majambere, S; Khatib, BO; Ali, AS; Hugo, LE; Dowell, FE				Sikulu, Maggy T.; Majambere, Silas; Khatib, Bakar O.; Ali, Abdullah S.; Hugo, Leon E.; Dowell, Floyd E.			Using a Near-Infrared Spectrometer to Estimate the Age of Anopheles Mosquitoes Exposed to Pyrethroids	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; CUTICULAR HYDROCARBONS; GAMBIAE COMPLEX; MALARIA; IDENTIFICATION; CULICIDAE; SPECTROSCOPY; POPULATIONS; RESISTANCE; NETS	We report on the accuracy of using near-infrared spectroscopy (NIRS) to predict the age of Anopheles mosquitoes reared from wild larvae and a mixed age-wild adult population collected from pit traps after exposure to pyrethroids. The mosquitoes reared from wild larvae were estimated as <7 or >= 7 d old with an overall accuracy of 79%. The age categories of Anopheles mosquitoes that were not exposed to the insecticide papers were predicted with 78% accuracy whereas the age categories of resistant, susceptible and mosquitoes exposed to control papers were predicted with 82%, 78% and 79% accuracy, respectively. The ages of 85% of the wild-collected mixed-age Anopheles were predicted by NIRS as <= 8 d for both susceptible and resistant groups. The age structure of wild-collected mosquitoes was not significantly different for the pyrethroid-susceptible and pyrethroid-resistant mosquitoes (P = 0.210). Based on these findings, NIRS chronological age estimation technique for Anopheles mosquitoes may be independent of insecticide exposure and the environmental conditions to which the mosquitoes are exposed.	[Sikulu, Maggy T.; Hugo, Leon E.] QIMR Berghofer Med Res Inst, Mosquito Control Lab, Brisbane, Qld, Australia; [Sikulu, Maggy T.] Griffith Univ, Environm Futures Ctr, Brisbane, Qld 4111, Australia; [Sikulu, Maggy T.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania; [Majambere, Silas] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Majambere, Silas; Khatib, Bakar O.; Ali, Abdullah S.] Minist Hlth & Social Welf, Zanzibar Malaria Control Programme, Zanzibar, Tanzania; [Dowell, Floyd E.] ARS, Engn & Wind Eros Res Unit, USDA, Ctr Grain & Anim Hlth Res, Manhattan, KS USA	QIMR Berghofer Medical Research Institute; Griffith University; Ifakara Health Institute; Liverpool School of Tropical Medicine; University of Liverpool; United States Department of Agriculture (USDA)	Sikulu, MT (corresponding author), QIMR Berghofer Med Res Inst, Mosquito Control Lab, Brisbane, Qld, Australia.	maggy.sikulu@qimrberghofer.edu.au	Hugo, R. Leon E/O-3013-2018; Sikulu-Lord, Maggy/L-8158-2017	Hugo, R. Leon E/0000-0002-6767-9850; Sikulu-Lord, Maggy/0000-0002-9346-2970	CDC	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by a CDC cooperative agreement grant awarded to Ifakara Health Institute to support the NIRS work. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beier JC, 1998, ANNU REV ENTOMOL, V43, P519, DOI 10.1146/annurev.ento.43.1.519; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Caputo B, 2005, J MASS SPECTROM, V40, P1595, DOI 10.1002/jms.961; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Cook PE, 2010, INSECT MOL BIOL, V19, P745, DOI 10.1111/j.1365-2583.2010.01034.x; Desena ML, 1999, J MED ENTOMOL, V36, P811, DOI 10.1093/jmedent/36.6.811; Desena ML, 1999, J MED ENTOMOL, V36, P824, DOI 10.1093/jmedent/36.6.824; DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13; Dowell FE, 2011, AM J TROP MED HYG, V85, P1093, DOI 10.4269/ajtmh.2011.11-0438; GILLIES MT, 1965, B ENTOMOL RES, V56, P237, DOI 10.1017/S0007485300056339; Glunt KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024968; Haji KA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-82; Hugo LE, 2006, AM J TROP MED HYG, V74, P462, DOI 10.4269/ajtmh.2006.74.462; Hugo LE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000608; Jones CM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-24; LINES JD, 1991, MED VET ENTOMOL, V5, P261, DOI 10.1111/j.1365-2915.1991.tb00550.x; MAGESA SM, 1991, ACTA TROP, V49, P97, DOI 10.1016/0001-706X(91)90057-Q; Mayagaya VS, 2009, AM J TROP MED HYG, V81, P622, DOI 10.4269/ajtmh.2009.09-0192; MNZAVA AEP, 1986, ACTA TROP, V43, P277; Ntamatungiro AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-298; Polovodova V., 1949, MED PARASITOL, V28, P352; Rajatileka S, 2011, T ROY SOC TROP MED H, V105, P247, DOI 10.1016/j.trstmh.2011.01.009; ROBERT V, 1991, B WORLD HEALTH ORGAN, V69, P735; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Sikulu M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-186; Sikulu M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-49; Wang MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069439; Wang MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013359; WHO, 1998, B WHO	29	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90657	10.1371/journal.pone.0090657	http://dx.doi.org/10.1371/journal.pone.0090657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594705	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000332475500084
J	Vaessen, MJ; Jansen, JFA; Braakman, HMH; Hofman, PAM; De Louw, A; Aldenkamp, AP; Backes, WH				Vaessen, Maarten J.; Jansen, Jacobus F. A.; Braakman, Hilde M. H.; Hofman, Paul A. M.; De Louw, Anton; Aldenkamp, Albert P.; Backes, Walter H.			Functional and Structural Network Impairment in Childhood Frontal Lobe Epilepsy	PLOS ONE			English	Article							BRAIN NETWORKS; MODULAR ORGANIZATION; COMMUNITY STRUCTURE; COGNITIVE DECLINE; CONNECTIVITY; DIFFUSION; CHILDREN; ABNORMALITIES; EFFICIENCY	In childhood frontal lobe epilepsy (FLE), cognitive impairment and educational underachievement are serious, well-known co-morbidities. The broad scale of affected cognitive domains suggests wide-spread network disturbances that not only involves, but also extends beyond the frontal lobe. In this study we have investigated whole brain connectional properties of children with FLE in relation to their cognitive impairment and compared them with healthy controls. Functional connectivity (FC) of the networks was derived from dynamic fluctuations of resting state fMRI and structural connectivity (SC) was obtained from fiber tractograms of diffusion weighted MRI. The whole brain network was characterized with graph theoretical metrics and decomposed into modules. Subsequently, the graph metrics and the connectivity within and between modules were related to cognitive performance. Functional network disturbances in FLE were related to increased clustering, increased path length, and stronger modularity compared to healthy controls, which was accompanied by stronger within- and weaker between-module functional connectivity. Although structural path length and clustering appeared normal in children with FLE, structural modularity increased with stronger cognitive impairment. It is concluded that decreased coupling between large-scale functional network modules is a hallmark for impaired cognition in childhood FLE.	[Vaessen, Maarten J.; Jansen, Jacobus F. A.; Hofman, Paul A. M.; Backes, Walter H.] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands; [Vaessen, Maarten J.; Braakman, Hilde M. H.; Hofman, Paul A. M.; De Louw, Anton; Aldenkamp, Albert P.] Epilepsy Ctr Kempenhaeghe, Dept Res & Dev, Heeze, Netherlands; [Vaessen, Maarten J.; Jansen, Jacobus F. A.; Braakman, Hilde M. H.; Hofman, Paul A. M.; Aldenkamp, Albert P.; Backes, Walter H.] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Braakman, Hilde M. H.; Aldenkamp, Albert P.] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Vaessen, MJ (corresponding author), Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands.	m.vaessen@gmail.com	Jansen, Jacobus F.A./C-4098-2009	Jansen, Jacobus F.A./0000-0002-5271-8060	Dutch National Epilepsy Foundation (NEF)	Dutch National Epilepsy Foundation (NEF)	This work was supported by the Dutch National Epilepsy Foundation (NEF, http://www.epilepsiefonds.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Aldenkamp AP, 2004, CHILD NEUROPSYCHOL, V10, P297, DOI 10.1080/09297040490909341; Alexander-Bloch A, 2012, NEUROIMAGE, V59, P3889, DOI 10.1016/j.neuroimage.2011.11.035; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; Bonilha L, 2012, J NEUROL NEUROSUR PS, V83, P903, DOI 10.1136/jnnp-2012-302476; Braakman HMH, 2012, EUR J PAEDIATR NEURO, V16, P707, DOI 10.1016/j.ejpn.2012.05.003; Braakman HMH, 2011, EPILEPSIA, V52, P849, DOI 10.1111/j.1528-1167.2011.03057.x; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Ethofer T, 2011, NEUROIMAGE, V55, P411, DOI 10.1016/j.neuroimage.2010.11.033; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Ghosh SS, 2010, NEUROIMAGE, V53, P85, DOI 10.1016/j.neuroimage.2010.05.075; Ginestet CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021570; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johansen-Berg H, 2011, NEUROIMAGE; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Lancichinetti A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00336; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; MANFORD M, 1992, NEUROLOGY, V42, P1911; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Pereira FRS, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-66; Powell HWR, 2007, NEUROIMAGE, V36, P209, DOI 10.1016/j.neuroimage.2007.02.028; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Pravata E, 2011, AM J NEURORADIOL, V32, P532, DOI 10.3174/ajnr.A2311; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stadlbauer A, 2008, RADIOLOGY, V247, P179, DOI 10.1148/radiol.2471070707; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Telesford Qawi K, 2010, Front Neuroinform, V4, P117, DOI 10.3389/fninf.2010.00117; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011; Vaessen M, 2011, EPILEPSIA, V52, P166; Vaessen MJ, 2013, CEREB CORTEX, V23, P1997, DOI 10.1093/cercor/bhs186; Vaessen MJ, 2012, CEREB CORTEX, V22, P2139, DOI 10.1093/cercor/bhr298; Vaessen MJ, 2011, ABNORMAL MODUL UNPUB; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vlooswijk MCG, 2011, NEUROLOGY, V77, P938, DOI 10.1212/WNL.0b013e31822cfc2f; Vlooswijk MCG, 2010, NEUROLOGY, V75, P395, DOI 10.1212/WNL.0b013e3181ebdd3e; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Widjaja E, 2013, AM J NEURORADIOL, V34, P2386, DOI 10.3174/ajnr.A3608; Xue KQ, 2014, EPILEPSY RES, V108, P125, DOI 10.1016/j.eplepsyres.2013.10.002; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	60	40	41	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90068	10.1371/journal.pone.0090068	http://dx.doi.org/10.1371/journal.pone.0090068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594874	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500033
J	Zambelli, VO; Fernandes, ACD; Gutierrez, VP; Ferreira, JCB; Parada, CA; Mochly-Rosen, D; Cury, Y				Zambelli, Vanessa Olzon; de Oliveira Fernandes, Ana Carolina; Gutierrez, Vanessa Pacciari; Batista Ferreira, Julio Cesar; Parada, Carlos Amilcar; Mochly-Rosen, Daria; Cury, Yara			Peripheral Sensitization Increases Opioid Receptor Expression and Activation by Crotalphine in Rats	PLOS ONE			English	Article							PROTEIN-KINASE-C; TERRIFICUS SNAKE-VENOM; DORSAL-ROOT GANGLIA; PRIMARY AFFERENT; SPINAL-CORD; UP-REGULATION; KAPPA; INFLAMMATION; DELTA; ANTINOCICEPTION	Inflammation enhances the peripheral analgesic efficacy of opioid drugs, but the mechanisms involved in this phenomenon have not been fully elucidated. Crotalphine (CRP), a peptide that was first isolated from South American rattlesnake C.d. terrificus venom, induces a potent and long-lasting anti-nociceptive effect that is mediated by the activation of peripheral opioid receptors. Because the high efficacy of CRP is only observed in the presence of inflammation, we aimed to elucidate the mechanisms involved in the CRP anti-nociceptive effect induced by inflammation. Using real-time RT-PCR, western blot analysis and ELISA assays, we demonstrate that the intraplantar injection of prostaglandin E2 (PGE(2)) increases the mRNA and protein levels of the mu-and kappa-opioid receptors in the dorsal root ganglia (DRG) and paw tissue of rats within 3 h of the injection. Using conformation state-sensitive antibodies that recognize activated opioid receptors, we show that PGE(2), alone does not increase the activation of these opioid receptors but that in the presence of PGE(2), the activation of specific opioid receptors by CRP and selective mu-and kappa-opioid receptor agonists (positive controls) increases. Furthermore, PGE2 down-regulated the expression and activation of the delta-opioid receptor. CRP increased the level of activated mitogen-activated protein kinases in cultured DRG neurons, and this increase was dependent on the activation of protein kinase C zeta. This CRP effect was much more prominent when the cells were pretreated with PGE(2). These results indicate that the expression and activation of peripheral opioid receptors by opioid-like drugs can be up- or down-regulated in the presence of an acute injury and that acute tissue injury enhances the efficacy of peripheral opioids.	[Zambelli, Vanessa Olzon; de Oliveira Fernandes, Ana Carolina; Gutierrez, Vanessa Pacciari; Cury, Yara] Inst Butantan, Lab Especial Dor & Sinalizacao, Sao Paulo, Brazil; [Batista Ferreira, Julio Cesar] Univ Sao Paulo, Inst Ciencias Biomed, Dept Anat, BR-05508 Sao Paulo, Brazil; [Parada, Carlos Amilcar] Inst Biociencias UNICAMP, Dept Fisiol & Biofis, Campinas, SP, Brazil; [Mochly-Rosen, Daria] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA	Instituto Butantan; Universidade de Sao Paulo; Stanford University	Cury, Y (corresponding author), Inst Butantan, Lab Especial Dor & Sinalizacao, Sao Paulo, Brazil.	yara.cury@butantan.gov.br	Ferreira, Julio Cesar Batista/I-3177-2012; Ferreira, Julio Cesar Batista/AEU-0494-2022; Parada, Carlos Amilcar/C-3974-2012; Ferreira, Julio/L-4687-2019; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Zambelli, Vanessa O/C-2716-2013	Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Amilcar Parada, Carlos/0000-0001-5209-8853; Zambelli, Vanessa/0000-0003-0890-9561; Mochly-Rosen, Daria/0000-0002-6691-8733	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP) [07/03404-4, 07/00135-2]; Instituto Nacional de Ciencia e Tecnologia em Toxinologia (INCTTOX PROGRAM) of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [573790/2008-6]; FAPESP [2008/57898-0]; CAPES/CNPq [301508/2008-9, 305345/2011-7]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA011147] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Ciencia e Tecnologia em Toxinologia (INCTTOX PROGRAM) of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by funds from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP, grant numbers 07/03404-4, 07/00135-2), Instituto Nacional de Ciencia e Tecnologia em Toxinologia (INCTTOX PROGRAM) of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant number 573790/2008-6)/FAPESP (grant number 2008/57898-0) and CAPES/CNPq, grant numbers 301508/2008-9 and 305345/2011-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarante LH, 2002, EUR J PHARMACOL, V454, P19, DOI 10.1016/S0014-2999(02)02275-6; ANTONIJEVIC I, 1995, J NEUROSCI, V15, P165; Belcheva MM, 1998, J NEUROCHEM, V70, P635; Belcheva MM, 2005, J BIOL CHEM, V280, P27662, DOI 10.1074/jbc.M502593200; BERRA E, 1993, CELL, V74, P555, DOI 10.1016/0092-8674(93)80056-K; Bohn LM, 2000, J NEUROCHEM, V74, P564, DOI 10.1046/j.1471-4159.2000.740564.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruchas MR, 2008, NEUROREPORT, V19, P1417, DOI 10.1097/WNR.0b013e32830dd655; Bruchas MR, 2007, J BIOL CHEM, V282, P29803, DOI 10.1074/jbc.M705540200; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Bruchas MR, PSYCHOPHARMACOLOGY B, V210, P137; Cahill CM, 2003, PAIN, V101, P199, DOI 10.1016/S0304-3959(02)00333-0; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Connor M, 1999, CLIN EXP PHARMACOL P, V26, P493, DOI 10.1046/j.1440-1681.1999.03049.x; Cunha TM, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-10; Cunha TM, 2010, P NATL ACAD SCI USA, V107, P4442, DOI 10.1073/pnas.0914733107; Decaillot FM, 2003, NAT STRUCT BIOL, V10, P629, DOI 10.1038/nsb950; FERREIRA SH, 1981, PROSTAGLANDINS, V21, P789, DOI 10.1016/0090-6980(81)90235-5; Furst S, 2005, J PHARMACOL EXP THER, V312, P609, DOI 10.1124/jpet.104.075176; Gendron L, 2007, NEUROSCIENCE, V150, P807, DOI 10.1016/j.neuroscience.2007.09.060; Granados-Soto V, 1997, EUR J PHARMACOL, V340, P177, DOI 10.1016/S0014-2999(97)01399-X; Gupta A, 2006, J BIOL CHEM; Gutierrez VP, 2008, EUR J PHARMACOL, V594, P84, DOI 10.1016/j.ejphar.2008.07.053; Gutierrez VP, BEHAV PHARM, V23, P14; HASSAN AHS, 1993, NEUROSCIENCE, V55, P185, DOI 10.1016/0306-4522(93)90465-R; Ji YP, 2007, J PAIN, V8, P494, DOI 10.1016/j.jpain.2007.01.006; Konno K, 2008, PEPTIDES; Kreibich AS, 2004, J NEUROSCI, V24, P6686, DOI 10.1523/JNEUROSCI.1706-04.2004; Kwong K, 2005, J PHYSIOL-LONDON, V564, P437, DOI 10.1113/jphysiol.2004.078725; Law BK, 2000, J BIOL CHEM, V275, P38261, DOI 10.1074/jbc.M005545200; Lecat S, 2002, J BIOL CHEM, V277, P42034, DOI 10.1074/jbc.M203606200; Lomas LM, 2007, PSYCHOPHARMACOLOGY, V191, P273, DOI 10.1007/s00213-006-0663-1; Maekawa K, 1996, PAIN, V64, P365, DOI 10.1016/0304-3959(95)00132-8; Melief EJ, 2010, P NATL ACAD SCI USA, V107, P11608, DOI 10.1073/pnas.1000751107; Mousa SA, 2001, J NEUROIMMUNOL, V115, P71, DOI 10.1016/S0165-5728(01)00271-5; Mousa SA, 2002, J NEUROIMMUNOL, V126, P5, DOI 10.1016/S0165-5728(02)00049-8; Nunez S, 2007, NEUROSCIENCE, V146, P1346, DOI 10.1016/j.neuroscience.2007.02.024; Obara I, 2009, PAIN, V141, P283, DOI 10.1016/j.pain.2008.12.006; Pacheco DF, 2005, LIFE SCI, V78, P54, DOI 10.1016/j.lfs.2005.04.032; Picolo G, 2004, LIFE SCI, V75, P559, DOI [10.1016/S0024-3205(04)00292-9, 10.1016/j.lfs.2003.12.024]; Picolo G, 1998, TOXICON, V36, P223, DOI 10.1016/S0041-0101(97)00048-2; Picolo G, 2000, EUR J PHARMACOL, V391, P55, DOI 10.1016/S0014-2999(99)00934-6; Puehler W, 2004, NEUROSCIENCE, V129, P473, DOI 10.1016/j.neuroscience.2004.06.086; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P209; Sachs D, 2004, P NATL ACAD SCI USA, V101, P3680, DOI 10.1073/pnas.0308382101; SCHAFER M, 1995, EUR J PHARMACOL, V279, P165, DOI 10.1016/0014-2999(95)00150-J; SELLEY DE, 1993, MOL PHARMACOL, V44, P731; Shaqura MA, 2004, J PHARMACOL EXP THER, V308, P712, DOI 10.1124/jpet.103.057257; Southall MD, 2001, J BIOL CHEM, V276, P16083, DOI 10.1074/jbc.M011408200; STEIN C, 1993, ANESTH ANALG, V76, P182; STEIN C, 1989, J PHARMACOL EXP THER, V248, P1269; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Velazquez KT, 2007, PHARMACOL RES, V55, P578, DOI 10.1016/j.phrs.2007.04.006; von Banchet GS, 2003, BRIT J PHARMACOL, V139, P672, DOI 10.1038/sj.bjp.0705278; Zhou L, 1998, J PHARMACOL EXP THER, V286, P1000; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zollner C, 2003, MOL PHARMACOL, V64, P202, DOI 10.1124/mol.64.2.202	58	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90576	10.1371/journal.pone.0090576	http://dx.doi.org/10.1371/journal.pone.0090576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594607	gold, Green Published, Green Submitted			2022-12-25	WOS:000332475500070
J	Calil, IL; Zarpelon, AC; Guerrero, ATG; Alves, JC; Ferreira, SH; Cunha, FQ; Cunha, TM; Verri, WA				Calil, Igor L.; Zarpelon, Ana C.; Guerrero, Ana T. G.; Alves-Filho, Jose C.; Ferreira, Sergio H.; Cunha, Fernando Q.; Cunha, Thiago M.; Verri, Waldiceu A., Jr.			Lipopolysaccharide Induces Inflammatory Hyperalgesia Triggering a TLR4/MyD88-Dependent Cytokine Cascade in the Mice Paw	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; MOUSE MACROPHAGES; IMMUNE-RESPONSE; KAPPA-B; HYPERNOCICEPTION; EXPRESSION; INNATE; CELLS	Inflammatory pain can be triggered by different stimuli, such as trauma, radiation, antigen and infection. In a model of inflammatory pain caused by infection, injection in the mice paw of lipopolysaccharide (LPS), a Toll-like receptor 4 (TLR4) agonist, produces mechanical hyperalgesia. We identify here the TLR4 linked signaling pathways that elicit this response. Firstly, LPS paw injection in wild type (WT) mice produced mechanical hyperalgesia that was not altered in TRIF-/- mice. On the other hand, this response was absent in TLR4 mutant and MyD88 null mice and reduced in TNFR1 null mice. Either an IL-1 receptor antagonist, anti-KC/CXCL1 antibody, indomethacin or guanethidine injection also lessened this response. Moreover, LPS-induced time dependent increases in TNF-alpha, KC/CXCL1 and IL-1 beta expression in the mice paw, which were absent in TLR4 mutant and MyD88 null mice. Furthermore, in TNFR1 deficient mice, the LPS-induced rises in KC/CXCL1 and IL-1 beta release were less than in their wild type counterpart. LPS also induced increase of myeloperoxidase activity in the paw skin, which was inhibited in TLR4 mutant and MyD88 null mice, and not altered in TRIF-/- mice. These results suggest that LPS-induced inflammatory pain in mice is solely dependent on the TLR4/MyD88 rather than the TLR4/TRIF signaling pathway. This pathway triggers pronociceptive cytokine TNF-alpha release that in turn mediates rises in KC/CXCL1 and IL-1 beta expression. Finally, these cytokines might be involved in stimulating production of directly-acting hyperalgesic mediators such as prostaglandins and sympathomimetic amine.	[Calil, Igor L.; Alves-Filho, Jose C.; Ferreira, Sergio H.; Cunha, Fernando Q.; Cunha, Thiago M.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Sao Paulo, Brazil; [Zarpelon, Ana C.; Verri, Waldiceu A., Jr.] Univ Estadual Londrina, Ctr Ciencias Biol, Dept Patol, Londrina, Parana, Brazil; [Guerrero, Ana T. G.] FIOCRUZ Mato Grosso Sul, Campo Grande, MS, Brazil	Universidade de Sao Paulo; Universidade Estadual de Londrina; Fundacao Oswaldo Cruz	Cunha, TM (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Sao Paulo, Brazil.	thicunha@usp.br; waldiceujr@yahoo.com.br	Alves-Filho, Jose Carlos/B-5814-2008; Cunha, Thiago M/B-7729-2012; Cunha, Fernando Q/M-3090-2014; WA, Verri/I-1330-2013	Alves-Filho, Jose Carlos/0000-0002-9918-8714; Cunha, Thiago M/0000-0003-1084-0065; WA, Verri/0000-0003-2756-9283; Cunha, Fernando Queiroz/0000-0003-4755-1670	Sao Paulo Research Foundation (FAPESP) [2011/19670-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Ministerio da Ciencia, Tecnologia e Inovacao (MCTI); SETI/Fundacao Araucaria; Parana State Government	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio da Ciencia, Tecnologia e Inovacao (MCTI); SETI/Fundacao Araucaria; Parana State Government	This work was supported by Grants 2011/19670-0 from Sao Paulo Research Foundation (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Ministerio da Ciencia, Tecnologia e Inovacao (MCTI), SETI/Fundacao Araucaria and Parana State Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, CR BIOL, V327, P581, DOI 10.1016/j.crvi.2004.04.002; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Beutler B, 2004, NAT REV IMMUNOL, V4, P498, DOI 10.1038/nri1401; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Casagrande R, 2006, J PHOTOCH PHOTOBIO B, V84, P21, DOI 10.1016/j.jphotobiol.2006.01.006; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; CUNHA FQ, 1992, BRIT J PHARMACOL, V107, P660, DOI 10.1111/j.1476-5381.1992.tb14503.x; Cunha TM, 2008, EUR J PHARMACOL, V590, P127, DOI 10.1016/j.ejphar.2008.05.048; Cunha TM, 2008, J LEUKOCYTE BIOL, V83, P824, DOI 10.1189/jlb.0907654; Cunha TM, 2007, EUR J PHARMACOL, V573, P221, DOI 10.1016/j.ejphar.2007.07.007; Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018; Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Endale M, 2013, IMMUNOBIOLOGY, V218, P1452, DOI 10.1016/j.imbio.2013.04.019; FERREIRA SH, 1988, NATURE, V334, P698, DOI 10.1038/334698a0; Ferreira SH, 1997, BRIT J PHARMACOL, V121, P883, DOI 10.1038/sj.bjp.0701211; Gais P, 2010, J IMMUNOL, V184, P5842, DOI 10.4049/jimmunol.0902456; Gandhapudi SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056855; Guerrero ATG, 2008, J LEUKOCYTE BIOL, V83, P122, DOI 10.1189/jlb.0207123; HANDWERKER HO, 1976, PFLUG ARCH EUR J PHY, V365, P221, DOI 10.1007/BF01067022; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Keck S, 2011, J IMMUNOL, V186, P5478, DOI 10.4049/jimmunol.1000458; Loiarro M, 2013, CL LYMPH MYELOM LEUK, V13, P222, DOI 10.1016/j.clml.2013.02.003; Lorenzetti BB, 2002, EUR CYTOKINE NETW, V13, P456; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; MELLER ST, 1994, NEUROPHARMACOLOGY, V33, P1471, DOI 10.1016/0028-3908(94)90051-5; Motta EM, 2009, PEPTIDES, V30, P918, DOI 10.1016/j.peptides.2009.01.011; Needham BD, 2013, P NATL ACAD SCI USA, V110, P1464, DOI 10.1073/pnas.1218080110; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Perl E R, 1976, Prog Brain Res, V43, P263; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Shen H, 2003, J IMMUNOL, V170, P1443, DOI 10.4049/jimmunol.170.3.1443; Shinya K, 2012, J VIROL, V86, P6055, DOI 10.1128/JVI.00365-12; Sugama S, 2009, J NEUROIMMUNOL, V207, P24, DOI 10.1016/j.jneuroim.2008.11.007; Valerio DA, 2009, BRIT J PHARMACOL, V158, P558, DOI 10.1111/j.1476-5381.2009.00325.x; Verri WA, 2008, P NATL ACAD SCI USA, V105, P2723, DOI 10.1073/pnas.0712116105; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001	38	73	77	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90013	10.1371/journal.pone.0090013	http://dx.doi.org/10.1371/journal.pone.0090013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595131	gold, Green Published, Green Submitted			2022-12-25	WOS:000332468900055
J	Peterson, DS; Pickett, KA; Duncan, R; Perlmutter, J; Earhart, GM				Peterson, Daniel S.; Pickett, Kristen A.; Duncan, Ryan; Perlmutter, Joel; Earhart, Gammon M.			Gait-Related Brain Activity in People with Parkinson Disease with Freezing of Gait	PLOS ONE			English	Article							SUPRASPINAL LOCOMOTOR CONTROL; MOTOR IMAGERY; PEDUNCULOPONTINE NUCLEUS; BILATERAL COORDINATION; CLINICAL-ASSESSMENT; MENTAL-IMAGERY; WALKING; PATHOPHYSIOLOGY; CONNECTIVITY; ACTIVATION	Approximately 50% of people with Parkinson disease experience freezing of gait, described as a transient inability to produce effective stepping. Complex gait tasks such as turning typically elicit freezing more commonly than simple gait tasks, such as forward walking. Despite the frequency of this debilitating and dangerous symptom, the brain mechanisms underlying freezing remain unclear. Gait imagery during functional magnetic resonance imaging permits investigation of brain activity associated with locomotion. We used this approach to better understand neural function during gait-like tasks in people with Parkinson disease who experience freezing-"FoG+" and people who do not experience freezing-"FoG-". Nine FoG+ and nine FoG- imagined complex gait tasks (turning, backward walking), simple gait tasks (forward walking), and quiet standing during measurements of blood oxygen level dependent (BOLD) signal. Changes in BOLD signal (i.e. beta weights) during imagined walking and imagined standing were analyzed across FoG+ and FoG- groups in locomotor brain regions including supplementary motor area, globus pallidus, putamen, mesencephalic locomotor region, and cerebellar locomotor region. Beta weights in locomotor regions did not differ for complex tasks compared to simple tasks in either group. Across imagined gait tasks, FoG+ demonstrated significantly lower beta weights in the right globus pallidus with respect to FoG-. FoG+ also showed trends toward lower beta weights in other right-hemisphere locomotor regions (supplementary motor area, mesencephalic locomotor region). Finally, during imagined stand, FoG+ exhibited lower beta weights in the cerebellar locomotor region with respect to FoG-. These data support previous results suggesting FoG+ exhibit dysfunction in a number of cortical and subcortical regions, possibly with asymmetric dysfunction towards the right hemisphere.	[Peterson, Daniel S.; Pickett, Kristen A.; Duncan, Ryan; Perlmutter, Joel; Earhart, Gammon M.] Washington Univ, Program Phys Therapy, St Louis, MO 63130 USA; [Pickett, Kristen A.; Perlmutter, Joel; Earhart, Gammon M.] Washington Univ, Dept Neurol, St Louis, MO USA; [Perlmutter, Joel; Earhart, Gammon M.] Washington Univ, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Earhart, GM (corresponding author), Washington Univ, Program Phys Therapy, St Louis, MO 63130 USA.	earhartg@wusm.wustl.edu		Pickett, Kristen/0000-0002-4889-6817; Peterson, Daniel/0000-0002-4639-6544	National Institutes of Health [R01 NS077959, UL1 TR000448, TL1 TR000449, NS41509, NS075321, 2T32 HD007434-18]; American Parkinson Disease Association (APDA); APDA Center for Advanced PD Research at Washington University; Greater St. Louis APDA; Parkinson Study Group; Parkinson's Disease Foundation's Advancing Parkinson's Treatments Innovations Grant; Barnes Jewish Hospital Foundation Elliot Stein Endowment and Parkinson Disease research fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007434] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000449, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077959, R01NS075321, R01NS041509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Parkinson Disease Association (APDA); APDA Center for Advanced PD Research at Washington University; Greater St. Louis APDA; Parkinson Study Group; Parkinson's Disease Foundation's Advancing Parkinson's Treatments Innovations Grant; Barnes Jewish Hospital Foundation Elliot Stein Endowment and Parkinson Disease research fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health [R01 NS077959 to GE; UL1 TR000448, sub-award TL1 TR000449 to DP; NS41509, NS075321, and UL1 TR000448 to JP; and 2T32 HD007434-18 to KP]; the American Parkinson Disease Association (APDA) [to JP], the APDA Center for Advanced PD Research at Washington University [to JP and GE], the Greater St. Louis APDA [to GE and JP], the Parkinson Study Group [to KP], the Parkinson's Disease Foundation's Advancing Parkinson's Treatments Innovations Grant [to KP], and the Barnes Jewish Hospital Foundation Elliot Stein Endowment and Parkinson Disease research fund [to JP]. Funding agencies had no involvement in the study design; collection, analysis or interpretation of data; writing of the report; and the decision to submit the article for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amboni M, 2008, MOVEMENT DISORD, V23, P395, DOI 10.1002/mds.21850; Amboni M, 2010, MOVEMENT DISORD, V25, P800, DOI 10.1002/mds.23033; Bakker M, 2008, NEUROIMAGE, V41, P998, DOI 10.1016/j.neuroimage.2008.03.020; Bartels AL, 2003, J CLIN NEUROSCI, V10, P584, DOI 10.1016/S0967-5868(03)00192-9; Bartels AL, 2008, MOVEMENT DISORD, V23, pS461, DOI 10.1002/mds.21912; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Bruck A, 2006, MOVEMENT DISORD, V21, P958, DOI 10.1002/mds.20855; Courtine G, 2003, EUR J NEUROSCI, V18, P191, DOI 10.1046/j.1460-9568.2003.02737.x; Cremers J, 2012, MOVEMENT DISORD, V27, P1498, DOI 10.1002/mds.25139; Cremers J, 2012, HUM BRAIN MAPP, V33, P873, DOI 10.1002/hbm.21255; de Lange FP, 2005, J COGNITIVE NEUROSCI, V17, P97, DOI 10.1162/0898929052880039; DeArmond SJ, 1989, STRUCTURE HUMAN BRAI; Deiber MP, 1998, NEUROIMAGE, V7, P73, DOI 10.1006/nimg.1997.0314; Fling BW, 2013, BRAIN; Giladi N, 2001, NEUROLOGY, V56, P1712, DOI 10.1212/WNL.56.12.1712; Giladi N, 2008, MOVEMENT DISORD, V23, pS423, DOI 10.1002/mds.21927; Godde B, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00139; Gray P, 2000, J Neurosci Nurs, V32, P222; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; Hanakawa T, 1999, BRAIN, V122, P1271, DOI 10.1093/brain/122.7.1271; Hashimoto T, 2006, PARKINSONISM RELAT D, V12, pS55, DOI 10.1016/j.parkreldis.2006.05.017; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Immisch I, 2001, NEUROIMAGE, V14, P674, DOI 10.1006/nimg.2001.0856; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; Jahn K, 2010, RESTOR NEUROL NEUROS, V28, P105, DOI 10.3233/RNN-2010-0506; Jahn K, 2008, PROG BRAIN RES, V171, P353, DOI 10.1016/S0079-6123(08)00652-3; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; Jenkinson N, 2009, MOVEMENT DISORD, V24, P319, DOI 10.1002/mds.22189; Karachi C, 2010, J CLIN INVEST, V120, P2745, DOI 10.1172/JCI42642; Karimi M, 2008, BRAIN, V131, P2710, DOI 10.1093/brain/awn179; Kerr GK, 2010, NEUROLOGY, V75, P116, DOI 10.1212/WNL.0b013e3181e7b688; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; la Fougere C, 2010, NEUROIMAGE, V50, P1589, DOI 10.1016/j.neuroimage.2009.12.060; Lewis SJG, 2009, PARKINSONISM RELAT D, V15, P333, DOI 10.1016/j.parkreldis.2008.08.006; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Malouin Francine, 2007, J Neurol Phys Ther, V31, P20; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Moore O, 2007, MOVEMENT DISORD, V22, P2192, DOI 10.1002/mds.21659; Mori S, 1999, J NEUROPHYSIOL, V82, P290, DOI 10.1152/jn.1999.82.1.290; Mori S, 2004, PROG BRAIN RES, V143, P341, DOI 10.1016/S0079-6123(03)43033-1; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; Morris ME, 2006, PHYS THER, V86, P1426, DOI 10.2522/ptj.20050277; Nieuwboer A, 2009, GAIT POSTURE, V30, P459, DOI 10.1016/j.gaitpost.2009.07.108; Pahapill PA, 2000, BRAIN, V123, P1767, DOI 10.1093/brain/123.9.1767; Peterson DS, 2012, PARKINSONISM RELAT D, V18, P1022, DOI 10.1016/j.parkreldis.2012.05.019; Pickett KA, 2012, J PARKINSON DIS, V2, P19, DOI 10.3233/JPD-2012-11045; Plotnik M, 2008, MOVEMENT DISORD, V23, pS444, DOI 10.1002/mds.21984; Plotnik M, 2008, EUR J NEUROSCI, V27, P1999, DOI 10.1111/j.1460-9568.2008.06167.x; Porro CA, 1996, J NEUROSCI, V16, P7688; Prodoehl J, 2010, MOVEMENT DISORD, V25, P2035, DOI 10.1002/mds.23360; Racette BA, 1999, AM J MED GENET, V88, P539, DOI 10.1002/(SICI)1096-8628(19991015)88:5<539::AID-AJMG19>3.3.CO;2-J; Schaafsma JD, 2003, EUR J NEUROL, V10, P391, DOI 10.1046/j.1468-1331.2003.00611.x; Schweder PM, 2010, NEUROREPORT, V21, P914, DOI 10.1097/WNR.0b013e32833ce5f1; Shine JM, 2013, BRAIN, V136, P1204, DOI 10.1093/brain/awt049; Snijders AH, 2012, PARKINSONISM RELAT D, V18, P149, DOI 10.1016/j.parkreldis.2011.09.006; Snijders AH, 2011, BRAIN, V134, P59, DOI 10.1093/brain/awq324; Spildooren J, 2010, MOVEMENT DISORD, V25, P2563, DOI 10.1002/mds.23327; Spraker MB, 2010, HUM BRAIN MAPP, V31, P1928, DOI 10.1002/hbm.20987; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Talairach J., 1998, COPLANAR STEREOTAXIC; Tessitore A, 2012, PARKINSONISM RELAT D, V18, P781, DOI 10.1016/j.parkreldis.2012.03.018; Thevathasan W, 2012, BRAIN, V135, P1446, DOI 10.1093/brain/aws039; Vereeck L, 2008, INT J AUDIOL, V47, P67, DOI 10.1080/14992020701689688; Wagner J, 2008, EXP BRAIN RES, V191, P247, DOI 10.1007/s00221-008-1520-8; Wai YY, 2012, PARKINSONISM RELAT D, V18, P537, DOI 10.1016/j.parkreldis.2012.02.004; Wang CH, 2008, J NEURAL TRANSM, V115, P1149, DOI 10.1007/s00702-008-0058-z; Woosley T, 2008, BRAIN ATLAS VISUAL G; Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360; Zrinzo L, 2008, Br J Neurosurg, V22 Suppl 1, pS19, DOI 10.1080/02688690802448426; Zrinzo L, 2011, J NEURAL TRANSM, V118, P1487, DOI 10.1007/s00702-011-0639-0; Zwergal A, 2012, NEUROBIOL AGING, V33, P1073, DOI 10.1016/j.neurobiolaging.2010.09.022	73	75	78	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90634	10.1371/journal.pone.0090634	http://dx.doi.org/10.1371/journal.pone.0090634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595265	gold, Green Submitted, Green Published			2022-12-25	WOS:000332468900127
J	Vistnes, M; Aronsen, JM; Lunde, IG; Sjaastad, I; Carlson, CR; Christensen, G				Vistnes, Maria; Aronsen, Jan Magnus; Lunde, Ida G.; Sjaastad, Ivar; Carlson, Cathrine R.; Christensen, Geir			Pentosan Polysulfate Decreases Myocardial Expression of the Extracellular Matrix Enzyme ADAMTS4 and Improves Cardiac Function In Vivo in Rats Subjected to Pressure Overload by Aortic Banding	PLOS ONE			English	Article							HEART-FAILURE; ENDOTHELIAL GLYCOCALYX; INTERSTITIAL EDEMA; HEPARAN-SULFATE; KEY ROLES; VERSICAN; ATHEROSCLEROSIS; AGGRECANASE-1; METALLOPROTEINASES; INFLAMMATION	Background: We hypothesized that cleavage of the extracellular matrix (ECM) proteoglycans versican and aggrecan by ADAMTS (a disintegrin and metalloprotease with thrombospondin motifs) proteases, which contributes to stress-induced ECM-reorganization in atherogenesis and osteoarthritis, also play a role in heart failure development. Objectives: The primary objective was to identify alterations in expression of ADAMTS versicanases and aggrecanases during development of heart failure, while evaluation of the effects of in vivo modulation of relevant changes in ADAMTS activity constituted the secondary objective. Methods: Myocardial levels of versican, aggrecan, and their ADAMTS cleaving proteases were examined in Wistar rats six weeks after aortic banding (AB), and versican and selected ADAMTS versicanases were further analyzed in neonatal cardiomyocytes (NCM) and cardiac fibroblasts (NFB) after stimulation by inflammatory mediators. Based on the initial findings, ADAMTS4 was selected the most promising therapeutic target. Thus, rats with AB were treated with pentosan polysulfate (PPS), a polysaccharide with known ADAMTS4-inhibitory properties, and effects on versican fragmentation, left ventricular function and geometry were evaluated. Results: We discovered that myocardial mRNA and protein levels of ADAMTS1 and -4, and mRNA levels of versican, aggrecan, and ADAMTS8 increased after AB, and TNF-alpha and IL-1 beta synergistically increased mRNA of versican and ADAMTS4 in NCM and NFB and secretion of ADAMTS4 from NCM. Furthermore, PPS-treatment improved systolic function, demonstrated by an improved fractional shortening (vehicle 48 +/- 3% versus PPS 60 +/- 1%, p<0.01) after AB. Following PPS-treatment, we observed an similar to 80% reduction in myocardial ADAMTS4 mRNA (p = 0.03), and similar to 50% reduction in the extracellular amount of the p150 versican fragments (p = 0.05), suggesting reduced versicanase activity. Conclusions: Our findings suggest that AB induces an increase in myocardial ADAMTS4 versicanase activity, and that PPS-treatment improved systolic function in the pressure-overloaded heart, holding promise as a novel therapeutic agent in heart failure.	[Vistnes, Maria; Aronsen, Jan Magnus; Lunde, Ida G.; Sjaastad, Ivar; Carlson, Cathrine R.; Christensen, Geir] Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway; [Vistnes, Maria; Aronsen, Jan Magnus; Lunde, Ida G.; Sjaastad, Ivar; Carlson, Cathrine R.; Christensen, Geir] Univ Oslo, Oslo, Norway; [Vistnes, Maria; Aronsen, Jan Magnus; Lunde, Ida G.; Sjaastad, Ivar; Carlson, Cathrine R.; Christensen, Geir] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Vistnes, Maria; Aronsen, Jan Magnus; Lunde, Ida G.; Sjaastad, Ivar; Carlson, Cathrine R.; Christensen, Geir] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Aronsen, Jan Magnus] Bjorknes Coll, Oslo, Norway; [Lunde, Ida G.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Harvard University; Harvard Medical School	Vistnes, M (corresponding author), Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway.	r.m.vistnes@medisin.uio.no	Lunde, Ida Gjervold/ABN-5567-2022	Lunde, Ida Gjervold/0000-0001-9502-6841; Vistnes, Maria/0000-0002-6243-0626	University of Oslo; Anders Jahre's Fund for the Promotion of Science; Kristian Gerhard Jebsen foundation; South-Eastern Norway Regional Health Authority; Research Council of Norway, Norway; Simon Fougner Hartmanns Family Fund, Denmark	University of Oslo; Anders Jahre's Fund for the Promotion of Science; Kristian Gerhard Jebsen foundation; South-Eastern Norway Regional Health Authority; Research Council of Norway, Norway(Research Council of Norway); Simon Fougner Hartmanns Family Fund, Denmark	This work was supported by University of Oslo, Anders Jahre's Fund for the Promotion of Science (www.unifor.no/Fund.aspx?site = 1&fund = 290), the Kristian Gerhard Jebsen foundation (www.stiftkgj.no), the South-Eastern Norway Regional Health Authority (www.helse-sorost.no), the Research Council of Norway (www.forskningsradet.no), Norway, and the Simon Fougner Hartmanns Family Fund, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Boyle A, 2007, J CARD FAIL, V13, P133, DOI 10.1016/j.cardfail.2006.10.015; Brooks WW, 2010, GENOMICS, V95, P84, DOI 10.1016/j.ygeno.2009.12.002; Cattaruzza S, 2002, J BIOL CHEM, V277, P47626, DOI 10.1074/jbc.M206521200; Chan CK, 2010, J CELL BIOCHEM, V111, P585, DOI 10.1002/jcb.22744; Didangelos A, 2012, J BIOL CHEM, V287, P19341, DOI 10.1074/jbc.C112.350785; Dongaonkar RM, 2010, CARDIOVASC RES, V87, P331, DOI 10.1093/cvr/cvq145; Dorman Gyorgy, 2007, Recent Pat Cardiovasc Drug Discov, V2, P186, DOI 10.2174/157489007782418964; Fomovsky GM, 2010, J MOL CELL CARDIOL, V48, P490, DOI 10.1016/j.yjmcc.2009.08.003; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Hashimoto G, 2001, FEBS LETT, V494, P192, DOI 10.1016/S0014-5793(01)02323-7; Hudson MP, 2006, J AM COLL CARDIOL, V48, P15, DOI 10.1016/j.jacc.2006.02.055; Kenagy RD, 2005, J HISTOCHEM CYTOCHEM, V53, P131, DOI 10.1369/jhc.4A6493.2005; Lockhart M, 2011, BIRTH DEFECTS RES A, V91, P535, DOI 10.1002/bdra.20810; Lunde IG, 2012, PHYSIOL GENOMICS, V44, P162, DOI 10.1152/physiolgenomics.00016.2011; Miserocchi G, 2001, NEWS PHYSIOL SCI, V16, P66; Miyata N, 2010, CLIN EXP HYPERTENS, V32, P511, DOI 10.3109/10641963.2010.496511; Nickel JC, 2005, UROLOGY, V65, P654, DOI 10.1016/j.urology.2004.10.071; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rodriguez-Manzaneque JC, 2000, J BIOL CHEM, V275, P33471, DOI 10.1074/jbc.M002599200; RUBBOLI A, 1994, AM J PHYSIOL, V267, pH1054, DOI 10.1152/ajpheart.1994.267.3.H1054; Salter RC, 2010, J MOL MED, V88, P1203, DOI 10.1007/s00109-010-0654-x; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Schuchman EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054459; Shioi T, 1997, CIRC RES, V81, P664; Shiomi T, 2010, PATHOL INT, V60, P477, DOI 10.1111/j.1440-1827.2010.02547.x; Sjaastad I, 2000, J APPL PHYSIOL, V89, P1445, DOI 10.1152/jappl.2000.89.4.1445; Spinale FG, 2013, CIRC RES, V112, P195, DOI 10.1161/CIRCRESAHA.112.266882; Strand ME, 2013, FEBS J, V280, P2228, DOI 10.1111/febs.12161; Takizawa M, 2008, FEBS LETT, V582, P2945, DOI 10.1016/j.febslet.2008.07.036; Tanhehco EJ, 1999, J CARDIOVASC PHARM, V34, P153, DOI 10.1097/00005344-199907000-00024; TorreAmione G, 1996, CIRCULATION, V93, P704, DOI 10.1161/01.CIR.93.4.704; Troeberg L, 2008, FASEB J, V22, P3515, DOI 10.1096/fj.08-112680; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; Verma P, 2011, J CELL BIOCHEM, V112, P3507, DOI 10.1002/jcb.23298; Waehre A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018668; Wagsater D, 2008, ATHEROSCLEROSIS, V196, P514, DOI 10.1016/j.atherosclerosis.2007.05.018; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Wu J, 2011, LAB INVEST, V91, P1459, DOI 10.1038/labinvest.2011.93; Zanin MKB, 1999, ANAT RECORD, V256, P366; Zha YP, 2010, BIOMED PHARMACOTHER, V64, P160, DOI 10.1016/j.biopha.2009.09.012	41	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89621	10.1371/journal.pone.0089621	http://dx.doi.org/10.1371/journal.pone.0089621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595230	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900026
J	Kan, W; Adjobo-Hermans, M; Burroughs, M; Faibis, G; Malik, S; Tall, GG; Smrcka, AV				Kan, Wei; Adjobo-Hermans, Merel; Burroughs, Michael; Faibis, Guy; Malik, Sundeep; Tall, Gregory G.; Smrcka, Alan V.			M3 Muscarinic Receptor Interaction with Phospholipase C beta(3) Determines Its Signaling Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein-coupled Receptors (GPCR); G Proteins; Phosphatidylinositol Signaling; Phospholipase C; Protein-Protein Interactions; Scaffolding	PROTEIN-COUPLED RECEPTOR; HETEROTRIMERIC G-PROTEINS; MUSCARINIC ACETYLCHOLINE-RECEPTOR; RECTIFYING POTASSIUM CHANNELS; FORM STABLE COMPLEXES; G-ALPHA-Q; LIVING CELLS; STRUCTURAL BASIS; TERNARY COMPLEX; GAMMA-SUBUNITS	Background: Scaffolding of signaling proteins to GPCRs may increase signaling efficiency and spatial fidelity. Results: Phospholipase C (PLC) 3 binding directly to M3 muscarinic receptor intracellular loops involves a non-canonical PDZ interaction. Conclusion: M3 muscarinic receptor binding to PLC3 optimizes interactions with substrate and G protein activator. Significance: Scaffolding of PLC enzymes to GPCRs may be important for spatial signal specificity and efficacy. Phospholipase C (PLC) enzymes are activated by G protein-coupled receptors through receptor-catalyzed guanine nucleotide exchange on G heterotrimers containing G(q) family G proteins. Here we report evidence for a direct interaction between M3 muscarinic receptor (M3R) and PLC3. Both expressed and endogenous M3R interacted with PLC in coimmunoprecipitation experiments. Stimulation of M3R with carbachol significantly increased this association. Expression of M3R in CHO cells promoted plasma membrane localization of YFP-PLC3. Deletion of the PLC3 C terminus or deletion of the PLC3 PDZ ligand inhibited coimmunoprecipitation with M3R and M3R-dependent PLC3 plasma membrane localization. Purified PLC3 bound directly to glutathione S-transferase (GST)-fused M3R intracellular loops 2 and 3 (M3Ri2 and M3Ri3) as well as M3R C terminus (M3R/H8-CT). PLC3 binding to M3Ri3 was inhibited when the PDZ ligand was removed. In assays using reconstituted purified components in vitro, M3Ri2, M3Ri3, and M3R/H8-CT potentiated G(q)-dependent but not G-dependent PLC3 activation. Disruption of key residues in M3Ri3N and of the PDZ ligand in PLC3 inhibited M3Ri3-mediated potentiation. We propose that the M3 muscarinic receptor maximizes the efficiency of PLC3 signaling beyond its canonical role as a guanine nucleotide exchange factor for G.	[Kan, Wei; Burroughs, Michael; Faibis, Guy; Malik, Sundeep; Tall, Gregory G.; Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Aab Inst Cardiovasc Res, Rochester, NY 14642 USA; [Adjobo-Hermans, Merel] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6525 GA Nijmegen, Netherlands	University of Rochester; University of Rochester; University of Rochester; Radboud University Nijmegen	Smrcka, AV (corresponding author), Univ Rochester, 601 Elmwood Ave, Rochester, NY 14642 USA.	alan_smrcka@urmc.rochester.edu	Adjobo-Hermans, Merel/AAN-5989-2020; Adjobo-Hermans, M.J.W./L-4170-2015	Adjobo-Hermans, Merel/0000-0002-5947-2876; Adjobo-Hermans, M.J.W./0000-0002-5947-2876; Kan, Wei/0000-0002-6830-6714	National Institutes of Health [GM053536]; American Heart Association Predoctoral Fellowship [10PRE3490032]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088242, R01GM053536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM053536 (to A. V. S.). This work was also supported by American Heart Association Predoctoral Fellowship 10PRE3490032 (to W. K.).	Adjobo-Hermans MJW, 2013, CELL SIGNAL, V25, P255, DOI 10.1016/j.cellsig.2012.09.022; Benians A, 2003, J BIOL CHEM, V278, P10851, DOI 10.1074/jbc.M212299200; Bonacci TM, 2005, J BIOL CHEM, V280, P10174, DOI 10.1074/jbc.M412514200; Chan P, 2011, J BIOL CHEM, V286, P2625, DOI 10.1074/jbc.M110.178897; Choi JW, 2010, CELL SIGNAL, V22, P1153, DOI 10.1016/j.cellsig.2010.03.010; Daulat AM, 2007, MOL CELL PROTEOMICS, V6, P835, DOI 10.1074/mcp.M600298-MCP200; David M, 2006, CELL SIGNAL, V18, P2172, DOI 10.1016/j.cellsig.2006.05.014; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Harden TK, 2011, CHEM REV, V111, P6120, DOI 10.1021/cr200209p; Hein P, 2009, N-S ARCH PHARMACOL, V379, P435, DOI 10.1007/s00210-008-0383-7; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Hwang JI, 2005, J BIOL CHEM, V280, P12467, DOI 10.1074/jbc.M410740200; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kim JK, 2012, J BIOL CHEM, V287, P21012, DOI 10.1074/jbc.M111.337865; Kim JK, 2011, ADV ENZYME REGUL, V51, P138, DOI 10.1016/j.advenzreg.2010.10.004; Klenk C, 2010, J BIOL CHEM, V285, P30355, DOI 10.1074/jbc.M110.114900; Lavine N, 2002, J BIOL CHEM, V277, P46010, DOI 10.1074/jbc.M205035200; Lehmann DM, 2007, METHOD ENZYMOL, V434, P29, DOI 10.1016/S0076-6879(07)34003-2; Li B, 2007, NAT METHODS, V4, P169, DOI 10.1038/nmeth990; Lyon AM, 2013, MOL PHARMACOL, V84, P488, DOI 10.1124/mol.113.087403; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; MUMBY SM, 1991, METHOD ENZYMOL, V195, P215; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Oh YS, 2004, MOL CELL BIOL, V24, P5069, DOI 10.1128/MCB.24.11.5069-5079.2004; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; PANG IH, 1990, J BIOL CHEM, V265, P18707; Patowary S, 2013, BIOCHEM J, V452, P303, DOI 10.1042/BJ20121902; Philip F, 2010, CURR BIOL, V20, P1327, DOI 10.1016/j.cub.2010.06.013; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Singer AU, 2002, NAT STRUCT BIOL, V9, P32, DOI 10.1038/nsb731; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; STERNWEIS PC, 1992, TRENDS BIOCHEM SCI, V17, P502, DOI 10.1016/0968-0004(92)90340-F; Suh PG, 2001, BIOCHEM BIOPH RES CO, V288, P1, DOI 10.1006/bbrc.2001.5710; van Huizen R, 1998, EMBO J, V17, P2285, DOI 10.1093/emboj/17.8.2285; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; WU DQ, 1993, J BIOL CHEM, V268, P3704; Wu GY, 2000, J BIOL CHEM, V275, P9026, DOI 10.1074/jbc.275.12.9026; Wu GY, 1998, J BIOL CHEM, V273, P7197, DOI 10.1074/jbc.273.13.7197; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487; Zeng FY, 1999, J NEUROCHEM, V72, P2404, DOI 10.1046/j.1471-4159.1999.0722404.x	51	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11206	11218		10.1074/jbc.M113.538546	http://dx.doi.org/10.1074/jbc.M113.538546			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596086	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000334638500024
J	Zhao, J; Fu, Y; Liu, CC; Shinohara, M; Nielsen, HM; Dong, Q; Kanekiyo, T; Bu, GJ				Zhao, Jing; Fu, Yuan; Liu, Chia-Chen; Shinohara, Mitsuru; Nielsen, Henrietta M.; Dong, Qiang; Kanekiyo, Takahisa; Bu, Guojun			Retinoic Acid Isomers Facilitate Apolipoprotein E Production and Lipidation in Astrocytes through the Retinoid X Receptor/Retinoic Acid Receptor Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid; ApoE; Cholesterol; Retinoid; Retinoic Acid	UNION-OF-PHARMACOLOGY; A-BETA CLEARANCE; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; AMYLOID DEPOSITION; CHOLESTEROL EFFLUX; MEMORY DEFICITS; TYPE-4 ALLELE; APOE LEVELS; ABCA1	Background: Apolipoprotein E (apoE) isoforms influence the risk for Alzheimer disease (AD). Results: All-trans-retinoic acid (RA), 9-cis-RA, and 13-cis-RA were identified as compounds that increase apoE expression and lipidation in astrocytes. Conclusion: RA isomers are effective modulators of apoE production through the retinoid X receptor (RXR) and RA receptor (RAR). Significance: RXR/RAR agonists can be explored for AD therapy. Apolipoprotein E (apoE) is the major cholesterol transport protein in the brain. Among the three human APOE alleles (APOE2, APOE3, and APOE4), APOE4 is the strongest genetic risk factor for late-onset Alzheimer disease (AD). The accumulation of amyloid- (A) is a central event in AD pathogenesis. Increasing evidence demonstrates that apoE isoforms differentially regulate AD-related pathways through both A-dependent and -independent mechanisms; therefore, modulating apoE secretion, lipidation, and function might be an attractive approach for AD therapy. We performed a drug screen for compounds that modulate apoE production in immortalized astrocytes derived from apoE3-targeted replacement mice. Here, we report that retinoic acid (RA) isomers, including all-trans-RA, 9-cis-RA, and 13-cis-RA, significantly increase apoE secretion to approximate to 4-fold of control through retinoid X receptor (RXR) and RA receptor. These effects on modulating apoE are comparable with the effects recently reported for the RXR agonist bexarotene. Furthermore, all of these compounds increased the expression of the cholesterol transporter ABCA1 and ABCG1 levels and decreased cellular uptake of A in an apoE-dependent manner. Both bexarotene and 9-cis-RA promote the lipidation status of apoE, in which 9-cis-RA promotes a stronger effect and exhibits less cytotoxicity compared with bexarotene. Importantly, we showed that oral administration of bexarotene and 9-cis-RA significantly increases apoE, ABCA1, and ABCG1 levels in mouse brains. Taken together, our results demonstrate that RXR/RA receptor agonists, including several RA isomers, are effective modulators of apoE secretion and lipidation and may be explored as potential drugs for AD therapy.	[Zhao, Jing; Dong, Qiang] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200032, Peoples R China; [Zhao, Jing; Fu, Yuan; Liu, Chia-Chen; Shinohara, Mitsuru; Nielsen, Henrietta M.; Kanekiyo, Takahisa; Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Liu, Chia-Chen; Bu, Guojun] Xiamen Univ, Inst Neurosci, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361005, Fujian, Peoples R China	Fudan University; Mayo Clinic; Xiamen University	Bu, GJ (corresponding author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	bu.guojun@mayo.edu	Fu, Yuan/AAO-6040-2020; Nielsen, Henrietta M/B-1746-2013	Fu, Yuan/0000-0003-2293-814X; Zhao, Jing/0000-0002-4520-6307; Nielsen, Henrietta M/0000-0001-9664-7068	National Institutes of Health [R01AG046205, R01AG035355, R01AG027924, P01AG030128, P01NS074969]; Alzheimer's Drug Discovery Foundation; Alzheimer's Association New Investigator Research Grant; Mayo Clinic Center for Regenerative Medicine Career Development Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031784, R01AG046205, R01AG035355, R01AG027924, P01AG030128, RF1AG046205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Drug Discovery Foundation; Alzheimer's Association New Investigator Research Grant; Mayo Clinic Center for Regenerative Medicine Career Development Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AG046205, R01AG035355, R01AG027924, P01AG030128, and P01NS074969 (to G. B.). This work was also supported by a grant from the Alzheimer's Drug Discovery Foundation, Alzheimer's Association New Investigator Research Grant, and Mayo Clinic Center for Regenerative Medicine Career Development Award (to T. K.).	Ahlemeyer B, 2000, NEUROCHEM INT, V36, P1, DOI 10.1016/S0197-0186(99)00101-1; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Blaner WS, 2001, J AM ACAD DERMATOL, V45, pS129, DOI 10.1067/mjd.2001.113714; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chen J, 2011, J PHARMACOL EXP THER, V338, P870, DOI 10.1124/jpet.111.182196; Cocco S, 2002, NEUROSCIENCE, V115, P475, DOI 10.1016/S0306-4522(02)00423-2; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Cruchaga C, 2012, HUM MOL GENET, V21, P4558, DOI 10.1093/hmg/dds296; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Ding Y, 2008, J NEUROSCI, V28, P11622, DOI 10.1523/JNEUROSCI.3153-08.2008; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Fagan AM, 1999, J BIOL CHEM, V274, P30001, DOI 10.1074/jbc.274.42.30001; Fagan AM, 2000, ANN NEUROL, V48, P201, DOI 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X; Fan JJ, 2009, BIOFACTORS, V35, P239, DOI 10.1002/biof.37; Fitz NF, 2013, SCIENCE, V340, DOI 10.1126/science.1235809; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Grant W B, 1999, J Alzheimers Dis, V1, P197; Groot PHE, 2005, J LIPID RES, V46, P2182, DOI 10.1194/jlr.M500116-JLR200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Idres N, 2002, J BIOL CHEM, V277, P31491, DOI 10.1074/jbc.M205016200; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Karten B, 2006, J BIOL CHEM, V281, P4049, DOI 10.1074/jbc.M508915200; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Koldamova R, 2010, BBA-MOL CELL BIOL L, V1801, P824, DOI 10.1016/j.bbalip.2010.02.010; Koldamova RP, 2003, J BIOL CHEM, V278, P13244, DOI 10.1074/jbc.M300044200; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; KRUL ES, 1988, J LIPID RES, V29, P1309; LaClair KD, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-18; Li J, 2012, J BIOL CHEM, V287, P44593, DOI 10.1074/jbc.M112.420224; Liraz O, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-16; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Liu CC, 2009, J BIOL CHEM, V284, P15299, DOI 10.1074/jbc.M807285200; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; Maden M, 2003, DEV DYNAM, V226, P237, DOI 10.1002/dvdy.10222; Manelli AM, 2004, J MOL NEUROSCI, V23, P235, DOI 10.1385/JMN:23:3:235; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; Nielsen HM, 2010, GLIA, V58, P1235, DOI 10.1002/glia.21004; Oram JF, 2001, J LIPID RES, V42, P1173; Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7; Price AR, 2013, SCIENCE, V340, DOI 10.1126/science.1234089; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; Reitz C, 2004, ARCH NEUROL-CHICAGO, V61, P705, DOI 10.1001/archneur.61.5.705; Shen H, 2009, J NEUROSCI RES, V87, P545, DOI 10.1002/jnr.21865; Shudo K, 2009, CURR ALZHEIMER RES, V6, P302, DOI 10.2174/156720509788486581; Song HS, 2009, BIOCHEM BIOPH RES CO, V388, P400, DOI 10.1016/j.bbrc.2009.08.020; Stratman NC, 2005, CHEM PHYS LIPIDS, V137, P52, DOI 10.1016/j.chemphyslip.2005.06.005; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tafti M, 2007, ARCH NEUROL-CHICAGO, V64, P1706, DOI 10.1001/archneur.64.12.1706; Tesseur I, 2013, SCIENCE, V340, DOI 10.1126/science.1233937; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Trommer BL, 2005, NEUROBIOL DIS, V18, P75, DOI 10.1016/j.nbd.2004.08.011; Vakeva L, 2012, ACTA DERM-VENEREOL, V92, P258, DOI 10.2340/00015555-1359; Vance JE, 2010, BBA-MOL CELL BIOL L, V1801, P806, DOI 10.1016/j.bbalip.2010.02.007; Veeraraghavalu K, 2013, SCIENCE, V340, DOI 10.1126/science.1235505; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Wahrle SE, 2005, J BIOL CHEM, V280, P43236, DOI 10.1074/jbc.M508780200; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Wahrle SE, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-7; Walter J, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-34; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang Y, 2006, MOL CANCER THER, V5, P1060, DOI 10.1158/1535-7163.MCT-05-0322; Weinstein D. E., 2001, CURR PROTOC NEUROSCI, DOI [10. 1002/0471142301. ns0305s00, DOI 10.1002/0471142301. NS0305S00]; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	73	47	47	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11282	11292		10.1074/jbc.M113.526095	http://dx.doi.org/10.1074/jbc.M113.526095			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599963	hybrid, Green Published			2022-12-25	WOS:000334638500031
J	Hu, JCC; Hu, YY; Lu, YH; Smith, CE; Lertlam, R; Wright, JT; Suggs, C; McKee, MD; Beniash, E; Kabir, ME; Simmer, JP				Hu, Jan C. -C.; Hu, Yuanyuan; Lu, Yuhe; Smith, Charles E.; Lertlam, Rangsiyakorn; Wright, John Timothy; Suggs, Cynthia; McKee, Marc D.; Beniash, Elia; Kabir, M. Enamul; Simmer, James P.			Enamelin Is Critical for Ameloblast Integrity and Enamel Ultrastructure Formation	PLOS ONE			English	Article							AMELOGENIN; PHENOTYPE; BIOMINERALIZATION; NONAMELOGENIN; EXPRESSION; PROTEINS; MUTATION; RESCUE; ROLES	Mutations in the human enamelin gene cause autosomal dominant hypoplastic amelogenesis imperfecta in which the affected enamel is thin or absent. Study of enamelin knockout NLS-lacZ knockin mice revealed that mineralization along the distal membrane of ameloblast is deficient, resulting in no true enamel formation. To determine the function of enamelin during enamel formation, we characterized the developing teeth of the Enam(-/-) mice, generated amelogenin-driven enamelin transgenic mouse models, and then introduced enamelin transgenes into the Enam(-/-) mice to rescue enamel defects. Mice at specific stages of development were subjected to morphologic and structural analysis using beta-galactosidase staining, immunohistochemistry, and transmission and scanning electron microscopy. Enamelin expression was ameloblast-specific. In the absence of enamelin, ameloblasts pathology became evident at the onset of the secretory stage. Although the aggregated ameloblasts generated matrix-containing amelogenin, they were not able to create a well-defined enamel space or produce normal enamel crystals. When enamelin is present at half of the normal quantity, enamel was thinner with enamel rods not as tightly arranged as in wild type suggesting that a specific quantity of enamelin is critical for normal enamel formation. Enamelin dosage effect was further demonstrated in transgenic mouse lines over expressing enamelin. Introducing enamelin transgene at various expression levels into the Enam(-/-) background did not fully recover enamel formation while a medium expresser in the Enam(+/-) background did. Too much or too little enamelin abolishes the production of enamel crystals and prism structure. Enamelin is essential for ameloblast integrity and enamel formation.	[Hu, Jan C. -C.; Hu, Yuanyuan; Lu, Yuhe; Smith, Charles E.; Lertlam, Rangsiyakorn; Kabir, M. Enamul; Simmer, James P.] Univ Michigan, Sch Dent, Dent Res Lab, Ann Arbor, MI 48109 USA; [Smith, Charles E.] McGill Univ, Dept Anat & Cell Biol, Facil Electron Microscopy Res, Montreal, PQ, Canada; [Smith, Charles E.] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Wright, John Timothy; Suggs, Cynthia] Univ N Carolina, Dent Res Ctr, Chapel Hill, NC 27599 USA; [McKee, Marc D.] McGill Univ, Fac Dent, Montreal, PQ, Canada; [McKee, Marc D.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Beniash, Elia] Univ Pittsburgh, Dept Oral Biol, Sch Dent Med, Pittsburgh, PA USA	University of Michigan System; University of Michigan; McGill University; McGill University; University of North Carolina; University of North Carolina Chapel Hill; McGill University; McGill University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hu, JCC (corresponding author), Univ Michigan, Sch Dent, Dent Res Lab, Ann Arbor, MI 48109 USA.	janhu@umich.edu	McKee, Marc D/E-2187-2011; Wright, John Timothy/AAX-5755-2020; Hu, Jan C-C./F-5679-2015	McKee, Marc D/0000-0001-8349-965X; Hu, Jan C-C./0000-0002-9294-0248; Simmer, James/0000-0002-7192-6105	United States Public Health Service Research from the National Institute of Dental and Craniofacial Research of the National Institutes of Health [DE011301, DE019622]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011301, R56DE011301, R29DE011301] Funding Source: NIH RePORTER	United States Public Health Service Research from the National Institute of Dental and Craniofacial Research of the National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by United States Public Health Service Research Grants DE011301 and DE019622 from the National Institute of Dental and Craniofacial Research of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan AHL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/246861; Chan HL, 2013, J PERIODONTOL, V7, P7; Chun YHP, 2010, J DENT RES, V89, P1414, DOI 10.1177/0022034510379223; Dohi N, 1998, CELL TISSUE RES, V293, P313, DOI 10.1007/s004410051123; Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gibson CW, 2011, EUR J ORAL SCI, V119, P70, DOI 10.1111/j.1600-0722.2011.00882.x; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Hatakeyama J, 2009, J DENT RES, V88, P318, DOI 10.1177/0022034509334749; Hu JCC, 2008, J BIOL CHEM, V283, P10858, DOI 10.1074/jbc.M710565200; Hu JCC, 2011, EUR J ORAL SCI, V119, P329, DOI 10.1111/j.1600-0722.2011.00860.x; Masuya H, 2005, HUM MOL GENET, V14, P575, DOI 10.1093/hmg/ddi054; Meredith RW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000634; Newbrun E, 1960, AUST DENT J, V5, P210, DOI DOI 10.1111/J.1834-7819.1960.TB01939.X; Ozdemir D, 2005, J DENT RES, V84, P1036, DOI 10.1177/154405910508401113; Rajpar MH, 2001, HUM MOL GENET, V10, P1673, DOI 10.1093/hmg/10.16.1673; Sheehan D.C., 1980, THEORY PRACTICE HIST; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; Simmer JP, 2012, INT J ORAL SCI, V4, P129, DOI 10.1038/ijos.2012.59; Suzuki S, 2009, MATRIX BIOL, V28, P221, DOI 10.1016/j.matbio.2009.03.006; TANABE T, 1990, CALCIFIED TISSUE INT, V46, P205, DOI 10.1007/BF02555046; UCHIDA T, 1991, ARCH HISTOL CYTOL, V54, P527, DOI 10.1679/aohc.54.527; Wazen RM, 2009, MATRIX BIOL, V28, P292, DOI 10.1016/j.matbio.2009.04.004; WITKOP CJ, 1988, J ORAL PATHOL MED, V17, P547, DOI 10.1111/j.1600-0714.1988.tb01332.x; Wright JT, 2009, CELLS TISSUES ORGANS, V189, P224, DOI 10.1159/000151378; Yuan Q, 2013, J BONE MINER RES, V27	26	43	45	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89303	10.1371/journal.pone.0089303	http://dx.doi.org/10.1371/journal.pone.0089303			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603688	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000332483600010
J	Huang, CM; Chen, QY; Lin, JX; Zheng, CH; Li, P; Xie, JW; Wang, JB; Lu, J				Huang, Chang-Ming; Chen, Qi-Yue; Lin, Jian-Xian; Zheng, Chao-Hui; Li, Ping; Xie, Jian-Wei; Wang, Jia-Bin; Lu, Jun			Laparoscopic Spleen-Preserving Splenic Hilar Lymphadenectomy Performed by Following the Perigastric Fascias and the Intrafascial Space for Advanced Upper-Third Gastric Cancer	PLOS ONE			English	Article							LYMPH-NODE DISSECTION; TOTAL GASTRECTOMY; RADICAL SURGERY; SPLENECTOMY; PRESERVATION; SURVIVAL	Background: Laparoscopic spleen-preserving Splenic hilar lymphadenectomy (LSPL) is required in laparoscopy-assisted total gastrectomy for advanced proximal gastric cancer. However, it is considerably difficult and risk in clinical practice. Thus, we explore the application of LSPL performed by following the perigastric fascias and the intrafascial space in D2 radical gastrectomy for advanced upper-third gastric cancer. Methods: From July 2010 to December 2012, 109 patients with T2-3 upper-third gastric cancer underwent LSPL. Of these patients, 55 underwent classic LSPL (classic group), and the remaining 54 patients underwent LSPL performed by following the fascias and intrafascial space (fascia group). Clinicopathologic characteristics and intraoperative and postoperative variables were compared between the two groups. Results: There were no significant differences in clinicopathological characteristics between the two groups (P>0.05). All of the operations were successful without conversion to laparotomy. The operation time, mean splenic hilar lymph node (LN) dissection time, mean total blood loss and mean blood loss from splenic hilar LN dissection were significantly lower in the fascia group than in the classic group (P<0.05), whereas the times to first flatus, fluid diet and soft diet and the duration of hospital stay were similar in both groups. The mean number of harvested LNs (No. 10 and No. 11d) was slightly higher in the fascia group, but the difference was not significant. No significant difference in morbidity was found between the fascia group and the classic group (9.3% vs. 10.9%, P>0.05). At a median follow-up of 12 months(range 5 to 35 months), none of the patients had died or experienced recurrent or metastatic disease. Conclusion: LSPL performed by following the fascias and intrafascial space is an optimal and safe technique based on anatomical logic, and it reduces the difficulties associated with LSPL, making it easier to master and allowing its widespread adoption.	[Huang, Chang-Ming; Chen, Qi-Yue; Lin, Jian-Xian; Zheng, Chao-Hui; Li, Ping; Xie, Jian-Wei; Wang, Jia-Bin; Lu, Jun] Fujian Med Univ, Union Hosp, Dept Gastr Surg, Fuzhou, Fujian Province, Peoples R China	Fujian Medical University	Huang, CM (corresponding author), Fujian Med Univ, Union Hosp, Dept Gastr Surg, Fuzhou, Fujian Province, Peoples R China.	hcmlr2002@163.com	Zheng, Chao-hui/HGE-3348-2022; Li, Ping/GYV-4914-2022	Zheng, Chao-hui/0000-0001-8680-3127; 	National Key Clinical Specialty Discipline Construction program of China [[2012]649]	National Key Clinical Specialty Discipline Construction program of China	Sponsored by National Key Clinical Specialty Discipline Construction program of China (No. [2012]649). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bo T, 2013, J GASTROINTESTINAL S, P1; Borghi F, 2002, WORLD J SURG, V26, P1139, DOI 10.1007/s00268-002-6346-0; BRUNSCHWIG A, 1948, CANCER, V1, P427, DOI 10.1002/1097-0142(194809)1:3<427::AID-CNCR2820010308>3.0.CO;2-G; Csendes A, 2002, SURGERY, V131, P401, DOI 10.1067/msy.2002.121891; Gullino D, 2000, Minerva Chir, V55, P721; HEALD RJ, 1986, LANCET, V1, P1479; HEALD RJ, 1982, BRIT J SURG, V69, P613, DOI 10.1002/bjs.1800691019; Hyung WJ, 2008, J AM COLL SURGEONS, V207, pE6, DOI 10.1016/j.jamcollsurg.2008.04.027; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Jia-Bin Wang, 2012, World J Surg Oncol, V10, P241, DOI 10.1186/1477-7819-10-241; Liang JT, 2011, SURG ENDOSC, V25, P935, DOI 10.1007/s00464-010-1264-y; Moore KL., 2008, DEV HUMAN CLIN ORIEN; Okabe Hiroshi, 2010, J Am Coll Surg, V211, pe1, DOI 10.1016/j.jamcollsurg.2010.04.006; Sakuramoto S, 2009, SURG ENDOSC, V23, P2416, DOI 10.1007/s00464-009-0371-0; Shinohara T, 2013, SURG ENDOSC, V27, P286, DOI 10.1007/s00464-012-2442-x; Sobin L, 2009, TNM CLASSIFICATION M; Song J, 2010, ANN SURG ONCOL, V17, P1777, DOI 10.1245/s10434-010-0932-4; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Tanimura S, 2005, SURG ENDOSC, V19, P1177, DOI 10.1007/s00464-004-8936-4; Uyama Ichiro, 1999, Gastric Cancer, V2, P230, DOI 10.1007/s101200050069; VOLPE CM, 1995, J AM COLL SURGEONS, V181, P56; WAGNER PK, 1991, BRIT J SURG, V78, P825, DOI 10.1002/bjs.1800780719; Yao XX, 2011, HEPATO-GASTROENTEROL, V58, P1067; Yu W, 2006, BRIT J SURG, V93, P559, DOI 10.1002/bjs.5353; Zhang CH, 2007, ANN SURG ONCOL, V14, P1312, DOI 10.1245/s10434-006-9190-x	26	9	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90345	10.1371/journal.pone.0090345	http://dx.doi.org/10.1371/journal.pone.0090345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603610	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600046
J	Jenner, W; Motwani, M; Veighey, K; Newson, J; Audzevich, T; Nicolaou, A; Murphy, S; MacAllister, R; Gilroy, DW				Jenner, William; Motwani, Madhur; Veighey, Kristin; Newson, Justine; Audzevich, Tatsiana; Nicolaou, Anna; Murphy, Sharon; MacAllister, Raymond; Gilroy, Derek W.			Characterisation of Leukocytes in a Human Skin Blister Model of Acute Inflammation and Resolution	PLOS ONE			English	Article							LIPID MEDIATORS; BLOOD MONOCYTES; FC-GAMMA; EOSINOPHILS; SUBSET; IMMUNE; TUBERCULOSIS; PERITONITIS; EXPRESSION; INSIGHTS	There is an increasing need to understand the leukocytes and soluble mediators that drive acute inflammation and bring about its resolution in humans. We therefore carried out an extensive characterisation of the cantharidin skin blister model in healthy male volunteers. A novel fluorescence staining protocol was designed and implemented, which facilitated the identification of cell populations by flow cytometry. We observed that at the onset phase, 24 h after blister formation, the predominant cells were CD16(hi)/CD66b(+) PMNs followed by HLA-DR+/CD14(+) monocytes/macrophages, CD11c(+) and CD141(+) dendritic cells as well as Siglec-8(+) eosinophils. CD3(+) T cells, CD19(+) B cells and CD56(+) NK cells were also present, but in comparatively fewer numbers. During resolution, 72 h following blister induction, numbers of PMNs declined whilst the numbers of monocyte/macrophages remain unchanged, though they upregulated expression of CD16 and CD163. In contrast, the overall numbers of dendritic cells and Siglec-8(+) eosinophils increased. Post hoc analysis of these data revealed that of the inflammatory cytokines measured, TNF-alpha but not IL-1 beta or IL-8 correlated with increased PMN numbers at the onset. Volunteers with the greatest PMN infiltration at onset displayed the fastest clearance rates for these cells at resolution. Collectively, these data provide insight into the cells that occupy acute resolving blister in humans, the soluble mediators that may control their influx as well as the phenotype of mononuclear phagocytes that predominate the resolution phase. Further use of this model will improve our understanding of the evolution and resolution of inflammation in humans, how defects in these over-lapping pathways may contribute to the variability in disease longevity/chronicity, and lends itself to the screen of putative anti-inflammatory or pro-resolution therapies.	[Jenner, William; Motwani, Madhur; Veighey, Kristin; Newson, Justine; Audzevich, Tatsiana; MacAllister, Raymond; Gilroy, Derek W.] UCL, Div Med, Ctr Clin Pharmacol & Therapeut, London, England; [Nicolaou, Anna; Murphy, Sharon] Univ Manchester, Manchester Pharm Sch, Fac Med & Human Sci, Manchester, Lancs, England	University of London; University College London; University of Manchester	Gilroy, DW (corresponding author), UCL, Div Med, Ctr Clin Pharmacol & Therapeut, London, England.	d.gilroy@ucl.ac.uk	Gilroy, Derek W/C-2588-2009; Nicolaou, Anna/D-4025-2018; Gilroy, Derek/AAP-7227-2020	Nicolaou, Anna/0000-0002-1314-413X; Gilroy, Derek/0000-0003-3476-0844	British Heart Foundation; Wellcome Trust; British Heart Foundation [FS/10/44/28294] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	This work was funded by the British Heart Foundation (WJ, RM) and The Wellcome Trust (DWG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles D, 2012, CYTOM PART A, V81A, P823, DOI 10.1002/cyto.a.22104; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bedner E, 1999, CYTOMETRY, V36, P77, DOI 10.1002/(SICI)1097-0320(19990501)36:1<77::AID-CYTO10>3.3.CO;2-6; Cash JL, 2009, METHOD ENZYMOL, V461, P379, DOI 10.1016/S0076-6879(09)05417-2; Castano D, 2011, TUBERCULOSIS, V91, P348, DOI 10.1016/j.tube.2011.04.002; Colville-Nash Paul, 2003, Methods Mol Biol, V225, P181; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Day RM, 2001, J IMMUNOL METHODS, V257, P213, DOI 10.1016/S0022-1759(01)00467-7; DRANSFIELD I, 1994, J IMMUNOL, V153, P1254; Evans BJ, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/780502; FINGERLE G, 1993, BLOOD, V82, P3170; Fulkerson PC, 2013, NAT REV DRUG DISCOV, V12, P117, DOI 10.1038/nrd3838; Gabor Miklos, 2003, Methods Mol Biol, V225, P129; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hepburn AL, 2004, RHEUMATOLOGY, V43, P547, DOI 10.1093/rheumatology/keh112; Isobe Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00270; Jenner WJ GD, 2012, J R SOC MED CARDIO, V1; Kuhns DB, 1992, DYNAMICS CELLULAR HU; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lugo-Villarino G, 2013, EUR J IMMUNOL, V43, P327, DOI 10.1002/eji.201243256; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; Masoodi M, 2008, RAPID COMMUN MASS SP, V22, P75, DOI 10.1002/rcm.3331; Masoodi M, 2006, RAPID COMMUN MASS SP, V20, P3023, DOI 10.1002/rcm.2697; Moore Adrian R, 2003, Methods Mol Biol, V225, P123; Morris T, 2010, P NATL ACAD SCI USA, V107, P8842, DOI 10.1073/pnas.1000373107; Phong HDD, 2011, BRIT J CLIN PHARMACO, V72, P912, DOI 10.1111/j.1365-2125.2011.04020.x; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; VANE JR, 1995, INFLAMM RES, V44, P1, DOI 10.1007/BF01630479; Vanham G, 1996, CLIN EXP IMMUNOL, V103, P30, DOI 10.1046/j.1365-2249.1996.907600.x; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; ZIEGLERHEITBROCK HWL, 1993, EUR J IMMUNOL, V23, P2053, DOI 10.1002/eji.1830230902; Zimmermann HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011049	35	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89375	10.1371/journal.pone.0089375	http://dx.doi.org/10.1371/journal.pone.0089375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603711	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600012
J	Chen, ZR; Lei, XQ; Zhang, BZ; Yang, LX; Zhang, HJ; Zhang, JY; Li, Y; Zheng, W; Tian, Y; Liu, JW; Zheng, TL				Chen, Zhangran; Lei, Xueqian; Zhang, Bangzhou; Yang, Luxi; Zhang, Huajun; Zhang, Jingyan; Li, Yi; Zheng, Wei; Tian, Yun; Liu, Jingwen; Zheng, Tianling			First Report of Pseudobodo sp, a New Pathogen for a Potential Energy-Producing Algae: Chlorella vulgaris Cultures	PLOS ONE			English	Article							ALGICIDAL BACTERIUM; RED-TIDE; PARAMECIUM-BURSARIA; MARINE BACTERIUM; RNA; INFECTS; VIRUS; DINOFLAGELLATE; PREDATION; STRAIN	Chlorella vulgaris, is a kind of single-celled green algae, which could serve as a potential source of food and energy because of its photosynthetic efficiency. In our study, a pathogenic organism targeting C. vulgaris was discovered. The algae-lytic activity relates to a fraction from lysates of infected C. vulgaris that was blocked upon filtration through a 3 mm filter. 18S rRNA gene sequence analysis revealed that it shared 99.0% homology with the protist Pseudobodo tremulans. Scanning electron microscope analysis showed that Pseudobodo sp. KD51 cells were approximately 4-5 mm long, biflagellate with an anterior collar around the anterior part of the cell in unstressed feeding cells. Besides the initial host, Pseudobodo sp. KD51 could also kill other algae, indicating its relatively wide predatory spectrum. Heat stability, pH and salinity tolerance experiments were conducted to understand their effects on its predatory activities, and the results showed that Pseudobodo sp. KD51 was heat-sensitive, and pH and salinity tolerant.	[Chen, Zhangran; Lei, Xueqian; Zhang, Bangzhou; Yang, Luxi; Zhang, Huajun; Zhang, Jingyan; Li, Yi; Zheng, Wei; Tian, Yun; Zheng, Tianling] Xiamen Univ, Sch Life Sci, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Chen, Zhangran; Lei, Xueqian; Zhang, Bangzhou; Yang, Luxi; Zhang, Huajun; Zhang, Jingyan; Li, Yi; Zheng, Wei; Tian, Yun; Zheng, Tianling] Xiamen Univ, Sch Life Sci, Minist Educ Coastal & Wetland Ecosyst, Key Lab, Xiamen, Peoples R China; [Chen, Zhangran; Zheng, Tianling] Xiamen Univ, ShenZhen Res Inst, Shenzhen, Peoples R China; [Liu, Jingwen] Jimei Univ, Bioengn Coll, Xiamen, Peoples R China	Xiamen University; Xiamen University; Xiamen University; Jimei University	Liu, JW (corresponding author), Jimei Univ, Bioengn Coll, Xiamen, Peoples R China.	lljjww16@163.com; wshwzh@xmu.edu.cn	Zhang, Bangzhou/CAG-9625-2022		National Nature Science Foundation of China [41376119, 40930847]; public science and technology research funds projects of ocean [201305016, 201305022]; science and technology innovation funds of Shenzhen [JCYJ20120615161239998]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); public science and technology research funds projects of ocean; science and technology innovation funds of Shenzhen	This work was financially supported by the National Nature Science Foundation of China (41376119, 40930847), public science and technology research funds projects of ocean (201305016, 201305022) and science and technology innovation funds of Shenzhen (JCYJ20120615161239998). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Arndt H, 2003, MAR ECOL PROG SER, V256, P45, DOI 10.3354/meps256045; Asif MH, 2000, PLANT MOL BIOL REP, V18, P109, DOI 10.1007/BF02824018; Bubeck JA, 2005, J GEN VIROL, V86, P2871, DOI 10.1099/vir.0.81068-0; Cai WW, 2011, APPL ENVIRON MICROB, V77, P7837, DOI 10.1128/AEM.05783-11; CARON DA, 1991, MAR ECOL PROG SER, V76, P205, DOI 10.3354/meps076205; Castberg T, 2002, J PHYCOL, V38, P767, DOI 10.1046/j.1529-8817.2002.02015.x; Collet P, 2011, BIORESOURCE TECHNOL, V102, P207, DOI 10.1016/j.biortech.2010.06.154; Corno G, 2006, APPL ENVIRON MICROB, V72, P78, DOI 10.1128/AEM.72.1.78-86.2006; Demirbas A, 2010, GREEN ENERGY TECHNOL, P1, DOI 10.1007/978-1-84996-050-2; FENCHEL T, 1982, MAR ECOL PROG SER, V8, P211, DOI 10.3354/meps008211; Gonzalez-Moreno S, 1997, PHYSIOL PLANTARUM, V101, P777, DOI 10.1034/j.1399-3054.1997.1010414.x; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Happe T, 2002, TRENDS PLANT SCI, V7, P246, DOI 10.1016/S1360-1385(02)02274-4; Hoshina R, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-222; Jeong HJ, 1999, J EUKARYOT MICROBIOL, V46, P69, DOI 10.1111/j.1550-7408.1999.tb04586.x; Jeong HJ, 2005, AQUAT MICROB ECOL, V41, P131, DOI 10.3354/ame041131; Jeong HJ, 2004, J EUKARYOT MICROBIOL, V51, P563, DOI 10.1111/j.1550-7408.2004.tb00292.x; Jeong SY, 2003, TETRAHEDRON LETT, V44, P8005, DOI 10.1016/j.tetlet.2003.08.115; Kahrstrom CT, 2013, NATURE REV MICROBIOL; Kang M, 2005, MOL PLANT PATHOL, V6, P213, DOI 10.1111/j.1364-3703.2005.00281.x; Karpov SA, 2000, PROTISTOLOGY, V1, P100; Kim JD, 2009, MAR BIOTECHNOL, V11, P463, DOI 10.1007/s10126-008-9167-9; Kim MJ, 2008, J APPL PHYCOL, V20, P1069, DOI 10.1007/s10811-008-9312-x; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kim YS, 2009, J MICROBIOL, V47, P9, DOI 10.1007/s12275-008-0141-z; Kodama Y, 2012, ENVIRON MICROBIOL, V14, P2800, DOI 10.1111/j.1462-2920.2012.02793.x; Kodani S, 2002, J APPL PHYCOL, V14, P109, DOI 10.1023/A:1019533414018; Lee SO, 2000, APPL ENVIRON MICROB, V66, P4334, DOI 10.1128/AEM.66.10.4334-4339.2000; Lee YJ, 2008, HARMFUL ALGAE, V7, P154, DOI 10.1016/j.hal.2007.06.004; LEWIS MA, 1990, ECOTOX ENVIRON SAFE, V20, P123, DOI 10.1016/0147-6513(90)90052-7; Liang J-w, 2009, ENV SCI TECHNOLOGY, V32, P019; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Mu RM, 2007, J ENVIRON SCI-CHINA, V19, P1336, DOI 10.1016/S1001-0742(07)60218-6; O'Kelly CJ, 1998, EUR J PROTISTOL, V34, P369, DOI 10.1016/S0932-4739(98)80006-0; OKelly CJ, 1996, EUR J PROTISTOL, V32, P216, DOI 10.1016/S0932-4739(96)80021-6; Pedersen MF, 2003, MAR ECOL PROG SER, V260, P33, DOI 10.3354/meps260033; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181; Radakovits R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1688; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Roberts EC, 2011, J PLANKTON RES, V33, P603, DOI 10.1093/plankt/fbq118; Rose JM, 2007, LIMNOL OCEANOGR, V52, P886, DOI 10.4319/lo.2007.52.2.0886; Roth PB, 2008, HARMFUL ALGAE, V7, P682, DOI 10.1016/j.hal.2008.02.002; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Shannon SP, 2007, MICROB ECOL, V53, P66, DOI 10.1007/s00248-006-9140-y; Sharif Hossain A. B. M., 2008, American Journal of Biochemistry and Biotechnology, V4, P250; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Shirai Y, 2008, APPL ENVIRON MICROB, V74, P4022, DOI 10.1128/AEM.00509-08; Su JQ, 2011, BIOL CONTROL, V56, P132, DOI 10.1016/j.biocontrol.2010.10.004; Su RQ, 2007, HARMFUL ALGAE, V6, P799, DOI 10.1016/j.hal.2007.04.004; SUTTLE CA, 1991, APPL ENVIRON MICROB, V57, P721, DOI 10.1128/AEM.57.3.721-726.1991; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan HY, 2013, J EUKARYOT MICROBIOL, V60, P98, DOI 10.1111/jeu.12011; Tillmann U, 2004, J EUKARYOT MICROBIOL, V51, P156, DOI 10.1111/j.1550-7408.2004.tb00540.x; Tokusoglu O, 2003, J FOOD SCI, V68, P1144, DOI 10.1111/j.1365-2621.2003.tb09615.x; Tomaru Y, 2008, AQUAT MICROB ECOL, V50, P103, DOI 10.3354/ame01170; Turner JT, 2006, ECOL STU AN, V189, P259, DOI 10.1007/978-3-540-32210-8_20; Wang B, 2011, HARMFUL ALGAE; Wang H, 2012, APPL ENVIRON MICROB, V78, P1445, DOI 10.1128/AEM.06474-11; Wang WR, 2013, BIORESOURCE TECHNOL, V136, P24, DOI 10.1016/j.biortech.2013.03.075; Xu Y, 2011, J HAZARD TOXIC RADIO, V15, P21, DOI 10.1061/(ASCE)HZ.1944-8376.0000053; Yu J, 2013, APPL MICROBIOL BIOT, V97, P9825, DOI 10.1007/s00253-013-5294-y; Zhang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063018; Zheng XW, 2013, APPL MICROBIOL BIOT, V97, P9207, DOI 10.1007/s00253-012-4617-8	66	22	22	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89571	10.1371/journal.pone.0089571	http://dx.doi.org/10.1371/journal.pone.0089571			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599263	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400019
J	Ruiz-Sola, MA; Arbona, V; Gomez-Cadenas, A; Rodriguez-Concepcion, M; Rodriguez-Villalon, A				Aguila Ruiz-Sola, M.; Arbona, Vicent; Gomez-Cadenas, Aurelio; Rodriguez-Concepcion, Manuel; Rodriguez-Villalon, Antia			A Root Specific Induction of Carotenoid Biosynthesis Contributes to ABA Production upon Salt Stress in Arabidopsis	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; SYNTHASE GENE FAMILY; ABIOTIC STRESS; ACCUMULATION; PATHWAYS; CAROTENOGENESIS; EXPRESSION; THALIANA; SIGNAL; AAO3	Abscisic acid (ABA) is a hormone that plays a vital role in mediating abiotic stress responses in plants. Salt exposure induces the synthesis of ABA through the cleavage of carotenoid precursors (xanthophylls), which are found at very low levels in roots. Here we show that de novo ABA biosynthesis in salt-treated Arabidopsis thaliana roots involves an organ-specific induction of the carotenoid biosynthetic pathway. Upregulation of the genes encoding phytoene synthase (PSY) and other enzymes of the pathway producing ABA precursors was observed in roots but not in shoots after salt exposure. A pharmacological block of the carotenoid pathway substantially reduced ABA levels in stressed roots, confirming that an increase in carotenoid accumulation contributes to fuel hormone production after salt exposure. Treatment with exogenous ABA was also found to upregulate PSY expression only in roots, suggesting an organ-specific feedback regulation of the carotenoid pathway by ABA. Taken together, our results show that the presence of high concentrations of salt in the growth medium rapidly triggers a root-specific activation of the carotenoid pathway, probably to ensure a proper supply of ABA precursors required for a sustained production of the hormone.	[Aguila Ruiz-Sola, M.; Rodriguez-Concepcion, Manuel; Rodriguez-Villalon, Antia] CSIC IRTA UAB UB, CRAG, Barcelona, Spain; [Arbona, Vicent; Gomez-Cadenas, Aurelio] Univ Jaume 1, Dept Ciencies Agr & Med Nat, Castellon de La Plana, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; Universitat Jaume I	Rodriguez-Concepcion, M (corresponding author), CSIC IRTA UAB UB, CRAG, Barcelona, Spain.	manuel.rodriguez@cragenomica.es; antia.rodriguezvillalon@unil.ch	Rodriguez-Concepcion, Manuel/I-7229-2015; Arbona, Vicent/K-1748-2015; Ruiz-Sola, M. Aguila/B-4889-2019; Gomez-Cadenas, Aurelio/K-6084-2012	Rodriguez-Concepcion, Manuel/0000-0002-1280-2305; Arbona, Vicent/0000-0003-2232-106X; Ruiz-Sola, M. Aguila/0000-0002-2281-6700; Gomez-Cadenas, Aurelio/0000-0002-4598-2664; Rodriguez-Villalon, Antia/0000-0001-8962-1353	Spanish Direccion General de Investigacion (DGI) [BIO2008-00432, BIO2011-23680]; DGI [AGL2010-22195-C03-01]; Consolider program [CSD2007-00036]; FPI fellowship; EC FP7 project TiMet; Generalitat de Catalunya [2009SGR-26]	Spanish Direccion General de Investigacion (DGI)(Spanish Government); DGI; Consolider program(Spanish Government); FPI fellowship(Spanish Government); EC FP7 project TiMet; Generalitat de Catalunya(Generalitat de Catalunya)	The work was mainly funded by research grants BIO2008-00432 and BIO2011-23680 from the Spanish Direccion General de Investigacion (DGI) to MRC. DGI also provided funding through research grant AGL2010-22195-C03-01 to AGC, the Consolider program (CSD2007-00036), and a FPI fellowship to ARS. Additional funding was provided by EC FP7 project TiMet. The Generalitat de Catalunya provided a FI fellowship to ARV and support grants (2009SGR-26 and XRB program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango J, 2010, PLANTA, V232, P1251, DOI 10.1007/s00425-010-1250-6; Barrero JM, 2006, PLANT CELL ENVIRON, V29, P2000, DOI 10.1111/j.1365-3040.2006.01576.x; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Durgbanshi A, 2005, J AGR FOOD CHEM, V53, P8437, DOI 10.1021/jf050884b; Endo A, 2008, PLANT PHYSIOL, V147, P1984, DOI 10.1104/pp.108.116632; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Gonzalez-Garcia MP, 2011, DEVELOPMENT, V138, P849, DOI 10.1242/dev.057331; Hirschberg J, 2001, CURR OPIN PLANT BIOL, V4, P210, DOI 10.1016/S1369-5266(00)00163-1; Howitt CA, 2006, PLANT CELL ENVIRON, V29, P435, DOI 10.1111/j.1365-3040.2005.01492.x; Jia WS, 2002, J EXP BOT, V53, P2201, DOI 10.1093/jxb/erf079; Jiang F, 2008, J EXP BOT, V59, P37, DOI 10.1093/jxb/erm127; Koiwai H, 2004, PLANT PHYSIOL, V134, P1697, DOI 10.1104/pp.103.036970; LeonKloosterziel KM, 1996, PLANT J, V10, P655, DOI 10.1046/j.1365-313X.1996.10040655.x; Li FQ, 2008, PLANT PHYSIOL, V147, P1334, DOI 10.1104/pp.108.122119; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Li FQ, 2009, PLANT SIGNAL BEHAV, V4, P208, DOI 10.4161/psb.4.3.7798; Lindgren LO, 2003, PLANT PHYSIOL, V132, P779, DOI 10.1104/pp.102.017053; Maass D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006373; Meier S, 2011, BMC SYSTBIOL, V5, P77; Nambara E, 1998, PLANT CELL PHYSIOL, V39, P853, DOI 10.1093/oxfordjournals.pcp.a029444; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Rodriguez-Concepcion M, 2004, PLANT CELL, V16, P144, DOI 10.1105/tpc.016204; Rodriguez-Villalon A, 2009, PLANT J, V60, P424, DOI 10.1111/j.1365-313X.2009.03966.x; Ruiz-Sola M Aguila, 2012, Arabidopsis Book, V10, pe0158, DOI 10.1199/tab.0158; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; Toledo-Ortiz G, 2010, P NATL ACAD SCI USA, V107, P11626, DOI 10.1073/pnas.0914428107; Van Norman JM, 2007, PLANT J, V49, P619, DOI 10.1111/j.1365-313X.2006.02982.x; Welsch R, 2003, PLANTA, V216, P523, DOI 10.1007/s00425-002-0885-3; Welsch R, 2008, PLANT PHYSIOL, V147, P367, DOI 10.1104/pp.108.117028; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453	37	71	72	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90765	10.1371/journal.pone.0090765	http://dx.doi.org/10.1371/journal.pone.0090765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595399	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500099
J	Chen, XL; Chen, TW; Zhang, XM; Li, ZL; Zeng, NL; Li, T; Wang, D; Li, J; Fang, ZJ; Li, H; Chen, J; Liu, J; Xu, GH; Ren, J; Wu, JL; Li, CP				Chen, Xiao-li; Chen, Tian-wu; Zhang, Xiao-ming; Li, Zhen-lin; Zeng, Nan-lin; Li, Ting; Wang, Dan; Li, Jie; Fang, Zhi-jia; Li, Hang; Chen, Jia; Liu, Jun; Xu, Guo-hui; Ren, Jing; Wu, Jian-lin; Li, Chun-ping			Quantitative Assessment of the Presence and Severity of Cirrhosis in Patients with Hepatitis B Using Right Liver Lobe Volume and Spleen Size Measured at Magnetic Resonance Imaging	PLOS ONE			English	Article							PORTAL HEMODYNAMICS; COMPUTED-TOMOGRAPHY; PROGNOSIS; FIBROSIS; HYPERSPLENISM; MRI	Objective: To determine whether right liver lobe volume (RV) and spleen size measured utilizing magnetic resonance (MR) imaging could identify the presence and severity of cirrhosis in patients with hepatitis B. Methods: Two hundred and five consecutive patients with clinically confirmed diagnosis of cirrhosis due to hepatitis B and 40 healthy control individuals were enrolled in this study and underwent abdominal triphasic enhanced scans using MR imaging. Spleen maximal width (W), thickness (T) and length (L), together with RV and spleen volume (SV), were measured utilizing MR imaging. Spleen multidimensional index (SI) was obtained by multiplying previously acquired parameters WxTxL. Then statistical assessment was performed to evaluate the ability of these parameters, including RV, SV, RV/SV and SI, to identify the presence of cirrhosis and define Child-Pugh class of this disease. Results: SV and SI tended to increase (r = 0.557 and 0.622, respectively; all P<0.001), and RV and RV/SV tended to decrease (r = -0.749 and -0.699, respectively; all P<0.001) with increasing Child-Pugh class of cirrhosis. All the parameters, including RV, SV, RV/SV and SI, might be the indicators used to discriminate the patients with liver cirrhosis from the control group, and to distinguish these patients between Child-Pugh class A and B, between B and C, and between A and C (area under receiver operating characteristic curve [AUC] = 0.609-0.975, all P<0.05). Among these parameters, RV/SV was the best noninvasive factor for the discrimination of liver cirrhosis between Child-Pugh class A and B (AUC = 0.725), between A and C (AUC = 0.975), and between B and C (AUC = 0.876), while SI was the best variable to distinguish the cirrhosis patients from the control group (AUC = 0.960, P<0.05). Conclusion: RV/SV should be used to identify the severity of cirrhosis, while SI can be recommended to determine the presence of this disease.	[Chen, Xiao-li; Chen, Tian-wu; Zhang, Xiao-ming; Zeng, Nan-lin; Li, Ting; Wang, Dan; Li, Jie; Li, Hang; Li, Chun-ping] North Sichuan Med Coll, Affiliated Hosp, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China; [Chen, Xiao-li; Chen, Tian-wu; Zhang, Xiao-ming; Zeng, Nan-lin; Li, Ting; Wang, Dan; Li, Jie; Li, Hang; Li, Chun-ping] North Sichuan Med Coll, Affiliated Hosp, Dept Radiol, Nanchong, Sichuan, Peoples R China; [Chen, Xiao-li; Xu, Guo-hui; Ren, Jing] Sichuan Canc Hosp & Inst, Dept Radiol, Chengdu, Sichuan, Peoples R China; [Chen, Xiao-li; Xu, Guo-hui; Ren, Jing] Second Peoples Hosp Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Li, Zhen-lin; Fang, Zhi-jia] Sichuan Univ, West China Hosp, Dept Radiol, Chengdu, Sichuan, Peoples R China; [Chen, Jia] Sichuan Acad Med Sci, Dept Ultrasonog, Chengdu, Sichuan, Peoples R China; [Chen, Jia] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Liu, Jun] Cent S Univ, Xiangya Hosp 2, Dept Radiol, Changsha, Hunan, Peoples R China; [Wu, Jian-lin] Dalian Univ, Affiliated Zhongshan Hosp, Dept Radiol, Dalian 116012, Liaoning, Peoples R China	North Sichuan Medical University; North Sichuan Medical University; Sichuan University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Central South University; Dalian University	Chen, TW (corresponding author), North Sichuan Med Coll, Affiliated Hosp, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China.	chentw@aliyun.com; cjr.wujianlin@vip.163.com	Zhang, Xiao Ming/H-7104-2019	Zhang, Xiao Ming/0000-0001-5327-8506	National Natural Science Foundation of China [81050033]; Key Projects in the Sichuan Province Science and Technology Pillar Program [2011SZ0237]; Science Foundation for Distinguished Young Scholars of Sichuan Province in China [2010JQ0039]; Key Science and Technology Project of Chinese Ministry of Public Health [2014114]; Natural Science Key Project of North Sichuan Medical College [CBY12-A-ZD03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the Sichuan Province Science and Technology Pillar Program; Science Foundation for Distinguished Young Scholars of Sichuan Province in China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Science and Technology Project of Chinese Ministry of Public Health; Natural Science Key Project of North Sichuan Medical College	This study was supported by the National Natural Science Foundation of China (Grant No. 81050033), the Key Projects in the Sichuan Province Science and Technology Pillar Program (Grant No. 2011SZ0237), the Science Foundation for Distinguished Young Scholars of Sichuan Province in China (Grant No. 2010JQ0039), the Key Science and Technology Project of Chinese Ministry of Public Health (Grant No. 2014114), and the Natural Science Key Project of North Sichuan Medical College (Grant No. CBY12-A-ZD03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JJ, 1997, RADIOLOGY, V202, P1; Chen XL, 2013, J MAGN RESON IMAGING, V38, P540, DOI 10.1002/jmri.24007; Durand F, 2005, J HEPATOL, V42, pS100, DOI 10.1016/j.jhep.2004.11.015; FISHER MR, 1985, J CLIN GASTROENTEROL, V7, P173, DOI 10.1097/00004836-198504000-00012; HOEFS JC, 1995, HEPATOLOGY, V22, P1113, DOI 10.1016/0270-9139(95)90617-7; Ito K, 1999, AM J ROENTGENOL, V173, P591, DOI 10.2214/ajr.173.3.10470885; Li H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079681; Liu P, 2009, WORLD J GASTROENTERO, V15, P3298, DOI 10.3748/wjg.15.3298; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Mazonakis M, 2002, J MAGN RESON IMAGING, V15, P557, DOI 10.1002/jmri.10109; Murata Y, 2008, J GASTROENTEROL, V43, P632, DOI 10.1007/s00535-008-2202-9; Nagula S, 2006, J HEPATOL, V44, P111, DOI 10.1016/j.jhep.2005.07.036; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Rezai P, 2011, AM J ROENTGENOL, V196, P367, DOI 10.2214/AJR.10.4453; Rustogi R, 2012, J MAGN RESON IMAGING, V35, P1356, DOI 10.1002/jmri.23585; Suarez MS, 2008, TRANSPL P, V40, P2965, DOI 10.1016/j.transproceed.2008.08.110; Saygili OB, 2005, EUR J RADIOL, V54, P400, DOI 10.1016/j.ejrad.2004.08.001; Shah SHA, 1996, AM J GASTROENTEROL, V91, P2580; Shi BM, 2005, WORLD J GASTROENTERO, V11, P708, DOI 10.3748/wjg.v11.i5.708; Talwalkar JA, 2008, HEPATOLOGY, V47, P332, DOI 10.1002/hep.21972; Tan KC, 2008, RADIOLOGY, V248, P317, DOI 10.1148/radiol.2481051024; Taouli B, 2009, AM J ROENTGENOL, V193, P14, DOI 10.2214/AJR.09.2601; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; Wehler M, 2001, HEPATOLOGY, V34, P255, DOI 10.1053/jhep.2001.26522; WITTE CL, 1974, GASTROENTEROLOGY, V67, P498; Zhou L, 2014, J MAGN RESON IMAGING, V39, P872, DOI 10.1002/jmri.24248; Zhou L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083697; Zhou XP, 2007, AM J ROENTGENOL, V189, pW153, DOI 10.2214/AJR.07.2181	28	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89973	10.1371/journal.pone.0089973	http://dx.doi.org/10.1371/journal.pone.0089973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594920	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500028
J	Fu, XH; Duan, YM; Liu, YT; Cai, C; Meng, FL; Zhou, JQ				Fu, Xiao-Hong; Duan, Yi-Min; Liu, Yu-Ting; Cai, Chen; Meng, Fei-Long; Zhou, Jin-Qiu			Telomere Recombination Preferentially Occurs at Short Telomeres in Telomerase-Null Type II Survivors	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST TELOMERES; REPLICATION; DNA; ELONGATION; SENESCENCE; MAINTENANCE; PROTEIN; TEL1P; POLYMERASES	In telomerase negative yeast cells, Rad52-dependent recombination is activated to maintain telomeres. This recombination-mediated telomere elongation usually involves two independent pathways, type I and type II, and leads to generation of type I and type II survivors. It remains elusive whether the recombination-mediated telomere elongation prefers to take place on shorter or longer telomeres. In this study, we exploited the de novo telomere addition system to examine the telomere recombination event in telomerase negative cells. We show that recombination preferentially occurs on shorter rather than longer telomeres in both pre-survivors and established type II survivors. In type II survivors, the short VII-L telomeres could invade either terminal TG(1-3) sequence or short tracts of TG(1-3) sequence in subtelomeric Y'-X and Y'-Y' junction to initiate recombination. Unexpectedly, short VII-L telomere recombination still takes place in type II survivors lacking either Rad50 or Rad59, which are required for type II survivor generation in senescing telomerase-null cells. Our results support the notion that Rad50 and Rad59 are not essential for the maintenance of type II survivors once established.	[Fu, Xiao-Hong; Duan, Yi-Min; Liu, Yu-Ting; Meng, Fei-Long; Zhou, Jin-Qiu] Chinese Acad Sci, Shanghai Inst Biol Sci, Univ Chinese Acad Sci, State Key Lab Mol Biol,Shanghai Inst Biochem & Ce, Shanghai, Peoples R China; [Cai, Chen] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University	Zhou, JQ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Univ Chinese Acad Sci, State Key Lab Mol Biol,Shanghai Inst Biochem & Ce, Shanghai, Peoples R China.	jqzhou@sibcb.ac.cn		Meng, Feilong/0000-0003-0333-6872	National Natural Science Foundation of China [31230040, 31221001]; Ministry of Science and Technology of China [2013CB910403, 2011CB966301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from National Natural Science Foundation of China (31230040 and 31221001) and Ministry of Science and Technology of China (2013CB910403 and 2011CB966301) to J-QZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneric M, 2007, EMBO REP, V8, P1080, DOI 10.1038/sj.embor.7401082; Bianchi A, 2007, CELL, V128, P1051, DOI 10.1016/j.cell.2007.01.041; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; CHAN CSM, 1983, CELL, V33, P563, DOI 10.1016/0092-8674(83)90437-3; Chang M, 2011, NAT STRUCT MOL BIOL, V18, P451, DOI 10.1038/nsmb.2034; Chen QJ, 2001, MOL CELL BIOL, V21, P1819, DOI 10.1128/MCB.21.5.1819-1827.2001; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Forstemann K, 2000, NUCLEIC ACIDS RES, V28, P2690, DOI 10.1093/nar/28.14.2690; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hector RE, 2007, MOL CELL, V27, P851, DOI 10.1016/j.molcel.2007.08.007; Hu Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003208; Hughes TR, 2000, CURR BIOL, V10, P809, DOI 10.1016/S0960-9822(00)00562-5; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Kozak ML, 2010, EMBO J, V29, P158, DOI 10.1038/emboj.2009.314; Le S, 1999, GENETICS, V152, P143; Lendvay TS, 1996, GENETICS, V144, P1399; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; McEachern MJ, 2001, MOL CELL, V7, P695, DOI 10.1016/S1097-2765(01)00215-5; Meng FL, 2009, EMBO J, V28, P1466, DOI 10.1038/emboj.2009.92; Natarajan S, 2002, MOL CELL BIOL, V22, P4512, DOI 10.1128/MCB.22.13.4512-4521.2002; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; Reddel RR, 2001, RADIAT RES, V155, P194, DOI 10.1667/0033-7587(2001)155[0194:ALOTIH]2.0.CO;2; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Steiner BR, 1996, P NATL ACAD SCI USA, V93, P2817, DOI 10.1073/pnas.93.7.2817; Straatman KR, 2007, CHROMOSOME RES, V15, P1033, DOI 10.1007/s10577-007-1178-2; Teng SC, 2000, MOL CELL, V6, P947, DOI 10.1016/S1097-2765(05)00094-8; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Topcu Z, 2005, P NATL ACAD SCI USA, V102, P3348, DOI 10.1073/pnas.0408770102; Tsai YL, 2002, MOL CELL BIOL, V22, P5679, DOI 10.1128/MCB.22.16.5679-5687.2002; Wellinger RJ, 2010, FEBS LETT, V584, P3734, DOI 10.1016/j.febslet.2010.06.031; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; ZAKIAN VA, 1988, MOL CELL BIOL, V8, P2257, DOI 10.1128/MCB.8.5.2257; Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141	40	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90644	10.1371/journal.pone.0090644	http://dx.doi.org/10.1371/journal.pone.0090644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594632	gold, Green Published, Green Submitted			2022-12-25	WOS:000332468900128
J	Kaur, S; Harjai, K; Chhibber, S				Kaur, Sandeep; Harjai, Kusum; Chhibber, Sanjay			Bacteriophage Mediated Killing of Staphylococcus aureus In Vitro on Orthopaedic K Wires in Presence of Linezolid Prevents Implant Colonization	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; SUBINHIBITORY CONCENTRATIONS; FUSIDIC ACID; DRUG-RELEASE; INFECTION; VANCOMYCIN; PENETRATION; PNEUMONIAE; GENTAMICIN; BONE	Background: Infections of bone and joint tissues following arthroplasty surgeries remain a major challenge in orthopaedic settings. Methicillin resistant Staphylococcus aureus (MRSA) is recognised as an established pathogen in such infections. Combination therapy using linezolid and bacteriophage impregnated in biopolymer was investigated in the present study as an alternative strategy to prevent MRSA colonisation on the orthopaedic implant surface. Methodology: Coating of stainless steel orthopaedic grade K-wires was achieved using hydroxypropylmethlycellulose (HPMC) mixed with phage alone, linezolid alone and phage and linezolid together. The potential of these agents to inhibit adhesion of S. aureus (MRSA) 43300 on K-wires was assessed. Coated and naked wires were analysed by scanning electron microscopy (SEM) and fluorescent staining. Result: Significant reduction in bacterial adhesion was achieved on phage/linezolid wires in comparison to naked as well as HPMC coated wires. However, maximum reduction in bacterial adherence (similar to 4 log cycles) was observed on the wires coated with phage-linezolid combination. The frequency of emergence of resistant mutants was also negligible in presence of both the agents. Conclusion: This study provides evidence to confirm that local delivery system employing linezolid (a potent protein synthesis inhibitor) along with a broad spectrum lytic bacteriophage (capable of self-multiplication) is able to attack the adhered as well as surrounding bacteria present near the implant site. Unlike other antibiotic based therapies, this combination has the potential to significantly restrict the emergence of resistant mutants, thus paving the way for effective treatment of MRSA associated infection of medical implants.	[Kaur, Sandeep; Harjai, Kusum; Chhibber, Sanjay] Panjab Univ, Dept Microbiol, Chandigarh 160014, India	Panjab University	Chhibber, S (corresponding author), Panjab Univ, Dept Microbiol, Chandigarh 160014, India.	sanjaychhibber8@gmail.com	Kaur, Sandeep/T-1863-2019	Kaur, Sandeep/0000-0003-3146-1611				Abedon ST, 2010, CURR PHARM BIOTECHNO, V11, P28, DOI 10.2174/138920110790725410; ALDERMAN D A, 1984, International Journal of Pharmaceutical Technology and Product Manufacture, V5, P1; Alfadhel M, 2011, INT J PHARMACEUT, V416, P280, DOI 10.1016/j.ijpharm.2011.07.006; Ambrose CG, 2004, CLIN ORTHOP RELAT R, P293, DOI 10.1097/01.blo.0000126303.41711.a2; Azeredo J, 2008, CURR PHARM BIOTECHNO, V9, P261, DOI 10.2174/138920108785161604; Bedi MS, 2009, WORLD J MICROB BIOT, V25, P1145, DOI 10.1007/s11274-009-9991-8; Bernardo K, 2004, ANTIMICROB AGENTS CH, V48, P546, DOI 10.1128/AAC.48.2.546-555.2004; Billon A, 2005, J MICROENCAPSUL, V22, P841, DOI 10.1080/02652040500162790; Calhoun JH, 1997, CLIN ORTHOP RELAT R, P206; Carlton Richard M., 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P267; Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062, DOI 10.1177/039139880502801103; Cowsar DR, 1974, ADV EXP MED BIOL, V47, P1; Dhand Abhay, 2012, F1000 Med Rep, V4, P4, DOI 10.3410/M4-4; Djurkovic S, 2005, ANTIMICROB AGENTS CH, V49, P1225, DOI 10.1128/AAC.49.3.1225-1228.2005; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Duckworth DH, 2002, BIODRUGS, V16, P57, DOI 10.2165/00063030-200216010-00006; Fines M, 2000, J ANTIMICROB CHEMOTH, V45, P797, DOI 10.1093/jac/45.6.797; FORD JL, 1987, INT J PHARM, V40, P223, DOI 10.1016/0378-5173(87)90172-4; Gemmell CG, 2002, J ANTIMICROB CHEMOTH, V50, P665, DOI 10.1093/jac/dkf192; Gollwitzer H, 2003, J ANTIMICROB CHEMOTH, V51, P585, DOI 10.1093/jac/dkg105; Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074; Grohs P, 2003, ANTIMICROB AGENTS CH, V47, P418, DOI 10.1128/AAC.47.1.418-420.2003; Herrmann DJ, 2008, EXPERT REV ANTI-INFE, V6, P825, DOI 10.1586/14787210.6.6.825; Hickok NJ, 2012, ADV DRUG DELIVER REV, V64, P1165, DOI 10.1016/j.addr.2012.03.015; Kalicke T, 2006, J ORTHOP RES, V24, P1622, DOI 10.1002/jor.20193; Kaur S, 2012, APPL ENVIRON MICROB, V78, P8227, DOI 10.1128/AEM.02371-12; Kumari S, 2011, J MED MICROBIOL, V60, P205, DOI 10.1099/jmm.0.018580-0; Kutateladze M, 2010, TRENDS BIOTECHNOL, V28, P591, DOI 10.1016/j.tibtech.2010.08.001; Kutscha-Lissberg F, 2003, ANTIMICROB AGENTS CH, V47, P3964, DOI 10.1128/AAC.47.12.3964-3966.2003; Langley R, 2003, J MED MICROBIOL, V52, P483, DOI 10.1099/jmm.0.05099-0; Lee BJ, 1999, INT J PHARM, V188, P71, DOI 10.1016/S0378-5173(99)00204-5; Loc-Carrillo Catherine, 2011, Bacteriophage, V1, P111; Lovering AM, 2002, J ANTIMICROB CHEMOTH, V50, P73, DOI 10.1093/jac/dkf066; McMillan D.J., 2011, J BIOMED SCI ENG, V4, P535, DOI [10.4236/jbise.2011.48069, DOI 10.4236/JBISE.2011.48069]; Moellering RC, 2003, ANN INTERN MED, V138, P135, DOI 10.7326/0003-4819-138-2-200301210-00015; Neut D, 2001, J ANTIMICROB CHEMOTH, V47, P885, DOI 10.1093/jac/47.6.885; O'Neill AJ, 2001, J ANTIMICROB CHEMOTH, V47, P647, DOI 10.1093/jac/47.5.647; Partridge SR, 2011, FEMS MICROBIOL REV, V35, P820, DOI 10.1111/j.1574-6976.2011.00277.x; Patel SA, 2012, INT J PHARM RES, V4; PHAM AT, 1994, PHARMACEUT RES, V11, P1379, DOI 10.1023/A:1018975318805; Pradhan R, 2008, MUSET, V1, P55; Puapermpoonsiri U, 2010, INT J PHARMACEUT, V389, P168, DOI 10.1016/j.ijpharm.2010.01.034; Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4; Rana B, 2002, J ANTIMICROB CHEMOTH, V50, P747, DOI 10.1093/jac/dkf207; Raschke MJ, 2004, UNFALLCHIRURG, V107, P653, DOI 10.1007/s00113-004-0828-5; Sakoulas G, 2008, CLIN INFECT DIS, V46, pS360, DOI 10.1086/533592; Salgado CD, 2007, CLIN ORTHOP RELAT R, P48, DOI 10.1097/BLO.0b013e3181123d4e; Skurnik M, 2006, INT J MED MICROBIOL, V296, P5, DOI 10.1016/j.ijmm.2005.09.002; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Sulakvelidze A, 2001, ANN MED, V33, P507, DOI 10.3109/07853890108995959; Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001; Tenover FC, 2007, CLIN INFECT DIS, V44, P1208, DOI 10.1086/513203; Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8; Tweden KS, 1997, J HEART VALVE DIS, V6, P553; Verheust C., 2010, APPL BIOSAF, V15, P32, DOI [10.1177/153567601001500106, DOI 10.1177/153567601001500106]; Walls RJ, 2008, J BONE JOINT SURG BR, V90B, P292, DOI 10.1302/0301-620X.90B3.20155; WAN AT, 1991, CLIN CHEM, V37, P1683; Wayne PA, 2006, M7A7 CLIN LAB STAND; Widmer AF, 2001, CLIN INFECT DIS, V33, pS94, DOI 10.1086/321863; Wiederhold NP, 2005, J ANTIMICROB CHEMOTH, V55, P792, DOI 10.1093/jac/dki106	61	41	41	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90411	10.1371/journal.pone.0090411	http://dx.doi.org/10.1371/journal.pone.0090411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594764	gold, Green Submitted, Green Published			2022-12-25	WOS:000332468900106
J	Saia, S; Amato, G; Frenda, AS; Giambalvo, D; Ruisi, P				Saia, Sergio; Amato, Gaetano; Frenda, Alfonso Salvatore; Giambalvo, Dario; Ruisi, Paolo			Influence of Arbuscular Mycorrhizae on Biomass Production and Nitrogen Fixation of Berseem Clover Plants Subjected to Water Stress	PLOS ONE			English	Article							MEDICAGO-SATIVA; FUNGI; DROUGHT; ACCUMULATION; INOCULATION; RHIZOBIUM; FREQUENCY; REGROWTH; ALFALFA; GROWTH	Several studies, performed mainly in pots, have shown that arbuscular mycorrhizal symbiosis can mitigate the negative effects of water stress on plant growth. No information is available about the effects of arbuscular mycorrhizal symbiosis on berseem clover growth and nitrogen (N) fixation under conditions of water shortage. A field experiment was conducted in a hilly area of inner Sicily, Italy, to determine whether symbiosis with AM fungi can mitigate the detrimental effects of drought stress (which in the Mediterranean often occurs during the late period of the growing season) on forage yield and symbiotic N-2 fixation of berseem clover. Soil was either left under water stress (i.e., rain-fed conditions) or the crop was well-watered. Mycorrhization treatments consisted of inoculation of berseem clover seeds with arbuscular mycorrhizal spores or suppression of arbuscular mycorrhizal symbiosis by means of fungicide treatments. Nitrogen biological fixation was assessed using the N-15-isotope dilution technique. Arbuscular mycorrhizal symbiosis was able to mitigate the negative effect of water stress on berseem clover grown in a typical semiarid Mediterranean environment. In fact, under water stress conditions, arbuscular mycorrhizal symbiosis resulted in increases in total biomass, N content, and N fixation, whereas no effect of crop mycorrhization was observed in the well-watered treatment.	[Saia, Sergio; Amato, Gaetano; Frenda, Alfonso Salvatore; Giambalvo, Dario; Ruisi, Paolo] Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy	University of Palermo	Ruisi, P (corresponding author), Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy.	paolo.ruisi@unipa.it	Amato, Gaetano/E-1105-2011; Saia, Sergio/K-7535-2012; Amato, Gaetano/AAT-2213-2020; Frenda, Alfonso Salvatore/AAP-4426-2020; Ruisi, Paolo/L-9337-2015	Amato, Gaetano/0000-0003-0660-7594; Saia, Sergio/0000-0001-5465-8500; Amato, Gaetano/0000-0003-0660-7594; Frenda, Alfonso Salvatore/0000-0002-2393-4936; Giambalvo, Dario/0000-0003-0267-698X; Ruisi, Paolo/0000-0002-5807-6986	Regione Siciliana (Italy) Project SI.CO.BIO.S.	Regione Siciliana (Italy) Project SI.CO.BIO.S.	This study was funded by Regione Siciliana (Italy) Project SI.CO.BIO.S. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato G, 2013, AGRON J, V105, P1222, DOI 10.2134/agronj2013.0038; Antunes PM, 2006, SOIL BIOL BIOCHEM, V38, P1234, DOI 10.1016/j.soilbio.2005.09.016; Auge RM, 2001, MYCORRHIZA, V11, P3, DOI 10.1007/s005720100097; Avice JC, 1997, PLANT SOIL, V188, P189, DOI 10.1023/A:1004291801023; Azcon R, 2001, CAN J BOT, V79, P1175, DOI 10.1139/cjb-79-10-1175; AZCON R, 1988, BIOL FERT SOILS, V7, P28, DOI 10.1007/BF00260728; Barea JM, 2005, NITROGEN FIXATION IN AGRICULTURE, FORESTRY, ECOLOGY, AND THE ENVIRONMENT, P199, DOI 10.1007/1-4020-3544-6_10; Barea Jose-Miguel, 2008, V7, P143; Chalk PM, 2006, SOIL BIOL BIOCHEM, V38, P2944, DOI 10.1016/j.soilbio.2006.05.005; FRIED M, 1977, PLANT SOIL, V47, P713, DOI 10.1007/BF00011042; GAHOONIA TS, 1994, PLANT SOIL, V159, P213, DOI 10.1007/BF00009283; GANRY F, 1982, PLANT SOIL, V68, P321, DOI 10.1007/BF02197937; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; Giambalvo D, 2011, CROP SCI, V51, P1808, DOI 10.2135/cropsci2010.05.0271; Giambalvo D, 2011, PLANT SOIL, V342, P379, DOI 10.1007/s11104-010-0703-9; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Goicoechea N, 1998, J PLANT PHYSIOL, V153, P706, DOI 10.1016/S0176-1617(98)80224-1; HASAN N, 1987, Indian Journal of Nematology, V17, P184; Jayne B, 2013, MYCORRHIZA IN PRESS, DOI [10.1007/s00572-013-0515-x, DOI 10.1007/S00572-013-0515-X.PUBLISHED]; Jung SC, 2012, J CHEM ECOL, V38, P651, DOI 10.1007/s10886-012-0134-6; Kubikova E, 2001, J PLANT PHYSIOL, V158, P1227, DOI 10.1078/0176-1617-00441; Lambers H, 2008, TRENDS ECOL EVOL, V23, P95, DOI 10.1016/j.tree.2007.10.008; Lekberg Y, 2005, NEW PHYTOL, V168, P189, DOI 10.1111/j.1469-8137.2005.01490.x; Marulanda A, 2003, PHYSIOL PLANTARUM, V119, P526, DOI 10.1046/j.1399-3054.2003.00196.x; Meuriot F, 2004, ANN BOT-LONDON, V94, P311, DOI 10.1093/aob/mch144; Miller MH, 2000, CAN J PLANT SCI, V80, P47, DOI 10.4141/P98-130; Olesniewicz KS, 1999, NEW PHYTOL, V142, P133, DOI 10.1046/j.1469-8137.1999.00372.x; PATTERSON NA, 1990, SYMBIOSIS, V8, P9; Pellegrino E, 2011, SOIL BIOL BIOCHEM, V43, P367, DOI 10.1016/j.soilbio.2010.11.002; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Porcel R, 2004, J EXP BOT, V55, P1743, DOI 10.1093/jxb/erh188; RuizLozano JM, 1995, PHYSIOL PLANTARUM, V95, P472, DOI 10.1111/j.1399-3054.1995.tb00865.x; Saia S, 2014, J AGR SCI-CAMBRIDGE, V152, P370, DOI 10.1017/S002185961300004X; SAS Institute, 2008, SAS STAT 9 2 US GUID; Schweiger PF, 2001, SOIL BIOL BIOCHEM, V33, P1231, DOI 10.1016/S0038-0717(01)00028-1; Shokri S., 2009, Journal of Agronomy, V8, P79; Smith SE, 2010, PLANT SOIL, V326, P3, DOI 10.1007/s11104-009-9981-5; UDAIYAN K, 1995, BIOL FERT SOILS, V20, P275, DOI 10.1007/BF00336090; Vietz FG., 1972, WATER DEFICITS PLANT, VIll, P217, DOI DOI 10.1139/CGJ-2014-0090	39	42	44	4	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90738	10.1371/journal.pone.0090738	http://dx.doi.org/10.1371/journal.pone.0090738			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595111	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900142
J	Saitou, K; Lees, JN; Tordoff, MG				Saitou, Katsuyoshi; Lees, John N.; Tordoff, Michael G.			Taste Hedonics Influence the Disposition of Fat by Modulating Gastric Emptying in Rats	PLOS ONE			English	Article							CEPHALIC PHASE RESPONSES; CARDIOVASCULAR-DISEASE; ORAL-STIMULATION; BITTER TASTE; HUMANS; SECRETION; GUSTDUCIN; GLUCOSE; TRIGLYCERIDES; METABOLISM	We investigated how preferred and nonpreferred tastes influence the disposition of fat. Adult male Sprague Dawley rats were infused with 5 ml of 20% intralipid through an intragastric catheter and with 0.3 ml of a taste solution through an intraoral catheter. At 120 min postinfusion, plasma concentrations of fat fuels (triglycerides and non-esterified fatty acids) were either unchanged or slightly higher after rats tasted a preferred sweet taste solution (0.125% saccharin +3% glucose) than after they tasted water. They were markedly lower after rats tasted a non-preferred solution-either a bitter solution (0.15% quinine hydrochloride) or a sweet solution that had previously been the conditioned stimulus for lithium-induced taste aversion. The distribution of C-14-triolein mixed with the gastric load was determined at 4 h postinfusion. Rats that received a non-preferred bitter taste had significantly more C-14 remaining in the stomach than did those that received a preferred sweet taste. These results suggest that taste hedonics-either unconditioned or conditioned aversive tastes-influence fat disposition by altering gastric emptying.	[Saitou, Katsuyoshi; Lees, John N.; Tordoff, Michael G.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Saitou, Katsuyoshi] Kao Corp, Hlth Care Food Res Labs, Tokyo, Japan	Monell Chemical Senses Center; KAO Corporation	Saitou, K (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	saitou.katsuyoshi@kao.co.jp		Tordoff, Michael/0000-0003-1977-9520	Kao Corporation (Tokyo, Japan)	Kao Corporation (Tokyo, Japan)	Financial support for this study was provided by Kao Corporation (Tokyo, Japan; http://www.kao.com/jp/en/corp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah L, 1997, AM J CLIN NUTR, V65, P737, DOI 10.1093/ajcn/65.3.737; Alipour A, 2008, ATHEROSCLEROSIS SUPP, V9, P39, DOI 10.1016/j.atherosclerosissup.2008.05.007; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Bartoshuk LM, 1977, DRINKING BEHAVIOR, P317; Chan DC, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0309-9; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Chavez-Jauregui RN, 2010, GASTROENTEROLOGY, V139, P1538, DOI 10.1053/j.gastro.2010.05.002; FLYNN FW, 1991, BEHAV NEUROSCI, V105, P933, DOI 10.1037/0735-7044.105.6.933; Garcia-Bailo B, 2009, OMICS, V13, P69, DOI 10.1089/omi.2008.0031; Glendinning JI, 2008, PHYSIOL BEHAV, V93, P757, DOI 10.1016/j.physbeh.2007.11.029; Inui-Yamamoto C, 2009, PHYSIOL BEHAV, V96, P717, DOI 10.1016/j.physbeh.2009.01.013; Iwatsuki K, 2012, J PHARMACOL SCI, V118, P123, DOI 10.1254/jphs.11R08CP; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Mattes RD, 2002, J NUTR, V132, P3656, DOI 10.1093/jn/132.12.3656; Mattes RD, 2011, PHYSIOL BEHAV, V105, P27, DOI 10.1016/j.physbeh.2011.02.016; Mattes RD, 2009, CHEMOSENS PERCEPT, V2, P180, DOI 10.1007/s12078-009-9062-4; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Mora S, 2008, CIRCULATION, V118, P993, DOI 10.1161/CIRCULATIONAHA.108.777334; NAIM M, 1978, PHYSIOL BEHAV, V20, P563, DOI 10.1016/0031-9384(78)90248-2; POWLEY TL, 1985, AM J CLIN NUTR, V42, P991, DOI 10.1093/ajcn/42.5.991; RAMIREZ I, 1985, AM J PHYSIOL, V248, pR459, DOI 10.1152/ajpregu.1985.248.4.R459; Robertson MD, 2002, AM J CLIN NUTR, V75, P505, DOI 10.1093/ajcn/75.3.505; Robertson MD, 2003, GUT, V52, P834, DOI 10.1136/gut.52.6.834; Robertson MD, 2002, AM J CLIN NUTR, V76, P71, DOI 10.1093/ajcn/76.1.71; ROSENSTEIN D, 1988, CHILD DEV, V59, P1555, DOI 10.1111/j.1467-8624.1988.tb03683.x; Smeets PAM, 2010, NUTR REV, V68, P643, DOI 10.1111/j.1753-4887.2010.00334.x; Spector AC, 2009, CURR OPIN NEUROBIOL, V19, P370, DOI 10.1016/j.conb.2009.07.014; Steiner JE, 2001, NEUROSCI BIOBEHAV R, V25, P53, DOI 10.1016/S0149-7634(00)00051-8; Teff KL, 2011, PHYSIOL BEHAV, V103, P44, DOI 10.1016/j.physbeh.2011.01.012; Tittelbach TJ, 2001, J AM COLL NUTR, V20, P485, DOI 10.1080/07315724.2001.10719057; Tonosaki K, 2007, BIOMED RES-TOKYO, V28, P79, DOI 10.2220/biomedres.28.79; VALENSTEIN ES, 1967, SCIENCE, V157, P552, DOI 10.1126/science.157.3788.552; Wicks D, 2005, EUR J GASTROEN HEPAT, V17, P961, DOI 10.1097/00042737-200509000-00012	35	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90717	10.1371/journal.pone.0090717	http://dx.doi.org/10.1371/journal.pone.0090717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595359	gold, Green Published, Green Submitted			2022-12-25	WOS:000332468900136
J	Tian, XL; Zhang, Y; Gu, SY; Fan, YC; Sun, Q; Zhang, B; Yan, SH; Xu, WB; Ma, XE; Wang, WR				Tian, Xiaoling; Zhang, Yong; Gu, Suyi; Fan, Yaochun; Sun, Qiang; Zhang, Bo; Yan, Shaohong; Xu, Wenbo; Ma, Xueen; Wang, Wenrui			New Coxsackievirus B4 Genotype Circulating in Inner Mongolia Autonomous Region, China	PLOS ONE			English	Article							HUMAN-ENTEROVIRUS-B; VACCINE-DERIVED POLIOVIRUS; MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; FREQUENT RECOMBINATION; SHANDONG PROVINCE; HAND; FOOT; EVOLUTION; OUTBREAK	Hand, foot, and mouth disease (HFMD) surveillance was initiated in the Inner Mongolia Autonomous Region of China in 2007, a crucial scrutiny for monitoring the prevalence of enterovirus serotypes associated with HFMD patients. However, this surveillance mostly focused on enterovirus 71 (EV-A71) and coxsackievirus A16; therefore, information on other enterovirus serotypes is limited. To identify the other circulating enterovirus serotypes in the HFMD outbreaks in Inner Mongolia in 2010, clinical samples from HFMD patients were investigated. Six coxsackievirus B4 (CVB4) strains were isolated and phylogenetic analyses of VP1 sequences were performed. Full-length genome sequences of two representative CVB4 isolates were acquired and similarity plot and bootscanning analyses were performed. The phylogenetic dendrogram indicated that all CVB4 strains could be divided into 5 genotypes (Genotypes I-V) with high bootstrap support (90-100%). The CVB4 prototype strain (JVB) was the sole member of genotype I. CVB4 strains belonging to genotype II, which were once common in Europe and the Americas, seemingly disappeared and gave way to genotype III and IV strains, which appear to be the dominant circulating strains in the world. All Chinese CVB4 strains belonged to Genotype V, a newly identified genotype supported by a high bootstrap value (100%), and are circulating only in mainland of China. Intertypic recombination occurred in the Chinese CVB4 strains with novel unknown serotype EV-B donor sequences. Two Chinese CVB4 strains had a virulent residue at position 129 of VP1, and one strain also had a virulent residue at position 16 of VP4. Increased surveillance is needed to monitor the emergence of new genetic lineages of enteroviruses in areas that are often associated with large-scale outbreaks. In addition, continued monitoring of enteroviruses by clinical surveillance and genetic characterization should be enhanced.	[Tian, Xiaoling; Gu, Suyi; Fan, Yaochun; Yan, Shaohong; Ma, Xueen; Wang, Wenrui] Inner Mongolia Ctr Dis Control & Prevent, Hohhot City, Inner Mongolia, Peoples R China; [Zhang, Yong; Sun, Qiang; Zhang, Bo; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China; [Zhang, Yong; Sun, Qiang; Zhang, Bo; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Minist Hlth Key Lab Med Virol, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, WR (corresponding author), Inner Mongolia Ctr Dis Control & Prevent, Hohhot City, Inner Mongolia, Peoples R China.	wr821@163.com		Zhang, Yong/0000-0002-2692-5437	Inner Mongolia Autonomous Region science and technology department [20120404]; Inner Mongolia Autonomous Region medical and health research project [2010016]	Inner Mongolia Autonomous Region science and technology department; Inner Mongolia Autonomous Region medical and health research project	The authors received support through the following grants: 1. Inner Mongolia Autonomous Region science and technology department project (grant no. 20120404); 2. Inner Mongolia Autonomous Region medical and health research project (grant no. 2010016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apisarnthanarak A, 2005, CLIN INFECT DIS, V41, P1361, DOI 10.1086/497076; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; CAGGANA M, 1993, J VIROL, V67, P4797, DOI 10.1128/JVI.67.8.4797-4803.1993; Chen P, 2013, J MED VIROL, V85, P483, DOI 10.1002/jmv.23478; Chu PY, 2009, J CLIN VIROL, V45, P16, DOI 10.1016/j.jcv.2009.02.012; Gu R, 2012, VIROLOGY, V427, P135, DOI 10.1016/j.virol.2012.02.009; He YQ, 2013, J CLIN MICROBIOL, V51, P3560, DOI 10.1128/JCM.01231-13; Hu YF, 2012, J VIROL, V86, P10901, DOI 10.1128/JVI.01808-12; Hu YF, 2012, J INFECTION, V65, P189, DOI 10.1016/j.jinf.2012.03.021; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Lindberg AM, 2003, J GEN VIROL, V84, P1223, DOI 10.1099/vir.0.18971-0; Lu QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052073; Lukashev AN, 2005, J GEN VIROL, V86, P3281, DOI 10.1099/vir.0.81264-0; MINOR PD, 1990, CURR TOP MICROBIOL, V161, P121; Mirand A, 2012, CLIN MICROBIOL INFEC, V18, pE110, DOI 10.1111/j.1469-0691.2012.03789.x; Mulders MN, 2000, J GEN VIROL, V81, P803, DOI 10.1099/0022-1317-81-3-803; Oberste AS, 2007, VIRUS RES, V128, P34, DOI 10.1016/j.virusres.2007.04.001; Oberste MS, 2004, J VIROL, V78, P855, DOI 10.1128/JVI.78.2.855-867.2004; RAMSINGH AI, 1995, J VIROL, V69, P7278, DOI 10.1128/JVI.69.11.7278-7281.1995; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Sun Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055480; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084233; Wang JT, 2012, ARCH VIROL, V157, P1593, DOI 10.1007/s00705-012-1332-9; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Zhang J, 2011, BIOMED ENVIRON SCI, V24, P214, DOI 10.3967/0895-3988.2011.03.002; Zhang Y, 2013, BIOMED ENVIRON SCI, V26, P875, DOI 10.3967/bes2013.015; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2010, J INFECT DIS, V202, P1780, DOI 10.1086/657410; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037206; Zhu Z, 2007, BIOMED ENVIRON SCI, V20, P321	33	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90379	10.1371/journal.pone.0090379	http://dx.doi.org/10.1371/journal.pone.0090379			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595311	Green Submitted, gold, Green Published			2022-12-25	WOS:000332468900102
J	Walls, RL; Deck, J; Guralnick, R; Baskauf, S; Beaman, R; Blum, S; Bowers, S; Buttigieg, PL; Davies, N; Endresen, D; Gandolfo, MA; Hanner, R; Janning, A; Krishtalka, L; Matsunaga, A; Midford, P; Morrison, N; Tuama, EO; Schildhauer, M; Smith, B; Stucky, BJ; Thomer, A; Wieczorek, J; Whitacre, J; Wooley, J				Walls, Ramona L.; Deck, John; Guralnick, Robert; Baskauf, Steve; Beaman, Reed; Blum, Stanley; Bowers, Shawn; Buttigieg, Pier Luigi; Davies, Neil; Endresen, Dag; Gandolfo, Maria Alejandra; Hanner, Robert; Janning, Alyssa; Krishtalka, Leonard; Matsunaga, Andrea; Midford, Peter; Morrison, Norman; Tuama, Eamonn O.; Schildhauer, Mark; Smith, Barry; Stucky, Brian J.; Thomer, Andrea; Wieczorek, John; Whitacre, Jamie; Wooley, John			Semantics in Support of Biodiversity Knowledge Discovery: An Introduction to the Biological Collections Ontology and Related Ontologies	PLOS ONE			English	Article							INTEGRATION; ANNOTATION; LANGUAGE; NETWORK	The study of biodiversity spans many disciplines and includes data pertaining to species distributions and abundances, genetic sequences, traitmeasurements, and ecological niches, complemented by information on collection and measurement protocols. A review of the current landscape of metadata standards and ontologies in biodiversity science suggests that existing standards such as the Darwin Core terminology are inadequate for describing biodiversity data in a semantically meaningful and computationally useful way. Existing ontologies, such as the Gene Ontology and others in the Open Biological and Biomedical Ontologies (OBO) Foundry library, provide a semantic structure but lack many of the necessary terms to describe biodiversity data in all its dimensions. In this paper, we describe the motivation for and ongoing development of a new Biological Collections Ontology, the Environment Ontology, and the Population and Community Ontology. These ontologies share the aim of improving data aggregation and integration across the biodiversity domain and can be used to describe physical samples and sampling processes (for example, collection, extraction, and preservation techniques), as well as biodiversity observations that involve no physical sampling. Together they encompass studies of: 1) individual organisms, including voucher specimens from ecological studies and museum specimens, 2) bulk or environmental samples (e.g., gut contents, soil, water) that include DNA, other molecules, and potentially many organisms, especially microbes, and 3) survey-based ecological observations. We discuss how these ontologies can be applied to biodiversity use cases that span genetic, organismal, and ecosystem levels of organization. We argue that if adopted as a standard and rigorously applied and enriched by the biodiversity community, these ontologies would significantly reduce barriers to data discovery, integration, and exchange among biodiversity resources and researchers.	[Walls, Ramona L.] Univ Arizona, iPlant Collaborat, Tucson, AZ 85721 USA; [Deck, John] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Guralnick, Robert; Stucky, Brian J.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Guralnick, Robert] Univ Colorado, CU Museum Nat Hist, Boulder, CO 80309 USA; [Baskauf, Steve] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Beaman, Reed] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Blum, Stanley] Calif Acad Sci, San Francisco, CA 94118 USA; [Bowers, Shawn] Gonzaga Univ, Spokane, WA 99258 USA; [Buttigieg, Pier Luigi] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Davies, Neil] Univ Calif Berkeley, Gump South Pacific Res Stn, Moorea, France; [Endresen, Dag] Univ Oslo, Nat Hist Museum, GBIF Norway, Oslo, Norway; [Gandolfo, Maria Alejandra] Cornell Univ, Dept Plant Biol, LH Bailey Hortorium, Ithaca, NY USA; [Hanner, Robert] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Janning, Alyssa] Univ Arizona, Sch Informat Resources & Lib Sci, Tucson, AZ USA; [Krishtalka, Leonard] Univ Kansas, Biodivers Inst & Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Matsunaga, Andrea] Univ Florida, Gainesville, FL USA; [Midford, Peter] Univ Kansas, Lawrence, KS 66045 USA; [Morrison, Norman] Univ Manchester, Sch Comp Sci, BioVeL Project, Manchester, Lancs, England; [Tuama, Eamonn O.] GBIF Secretariat, Copenhagen, Denmark; [Schildhauer, Mark] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; [Smith, Barry] SUNY Buffalo, Dept Philosophy, Buffalo, NY 14260 USA; [Thomer, Andrea] Univ Illinois, Grad Sch Lib & Informat Sci, Urbana, IL USA; [Wieczorek, John] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Whitacre, Jamie] Smithsonian Inst, Informat Branch, Informat Technol Off, Natl Museum Nat Hist, Washington, DC 20560 USA; [Wooley, John] Univ Calif San Diego, La Jolla, CA 92093 USA	University of Arizona; University of California System; University of California Berkeley; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Vanderbilt University; State University System of Florida; University of Florida; California Academy of Sciences; Gonzaga University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Oslo; Cornell University; University of Guelph; University of Arizona; University of Kansas; State University System of Florida; University of Florida; University of Kansas; University of Manchester; National Center for Ecological Analysis & Synthesis; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Berkeley; Smithsonian Institution; Smithsonian National Museum of Natural History; University of California System; University of California San Diego	Walls, RL (corresponding author), Univ Arizona, iPlant Collaborat, Tucson, AZ 85721 USA.	rwalls@iplantcollaborative.org	Smith, Barry/A-9525-2011; Midford, Peter E./B-5946-2008; Baskauf, Steven J/V-2630-2018; Davies, Neil/E-5863-2012; Endresen, Dag/G-1284-2010	Smith, Barry/0000-0003-1384-116X; Midford, Peter E./0000-0001-6512-3296; Baskauf, Steven J/0000-0003-4365-3135; Davies, Neil/0000-0001-8085-5014; Endresen, Dag/0000-0002-2352-5497; Thomer, Andrea/0000-0001-6238-3498; Morrison, Norman/0000-0003-1604-1512; Deck, John/0000-0002-5905-1617; Matsunaga, Andrea/0000-0001-9036-5895; Buttigieg, Pier Luigi/0000-0002-4366-3088; Schildhauer, Mark/0000-0003-0632-7576	US National Science Foundation (NSF) [DBI-0840989, IIS-1255035, DBI: 0956371, 0956350, 0956426, DBI-0851313]; National Institutes of Health (NIH) [U54 HG004028]; European Commission [287589, 283359];  [DBI-0735191]; Direct For Biological Sciences [1062148, 1115210, 1062193, 0956426] Funding Source: National Science Foundation; Division Of Environmental Biology [0956350] Funding Source: National Science Foundation; Div Of Biological Infrastructure [0840989, 1062271, 1062200] Funding Source: National Science Foundation; Div Of Information & Intelligent Systems [1255035] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004028] Funding Source: NIH RePORTER	US National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We gratefully acknowledge the support from the US National Science Foundation (NSF - http://www.nsf.gov/) through the following grants: Research Coordination Network for Genomic Standards Consortium (DBI-0840989), EAGER: An Interoperable Information Infrastructure for Biodiversity Research (IIS-1255035), Collaborative Research: BiSciCol Tracker: Towards a tagging and tracking infrastructure for biodiversity science collections (DBI: 0956371, 0956350, 0956426), Collaborative Research: Data Integration for Repository Services in Biodiversity Informatics (DBI-0851313), and the National Institutes of Health (NIH - http://www.nih.gov/) through a grant to the National Center for Biomedical Ontology (U54 HG004028). RW is supported by DBI-0735191 (The iPlant Collaborative). PLB is supported by the European Commission under Grant Agreement no 287589 (MicroB3). NM is supported by the European Commission 7th Framework Programme (FP7) as part of its e-Infrastructures activity (Grant no. 283359, BioVeL). Any opinions, findings, conclusions, or recommendations expressed in this report are those of the participants and do not necessarily represent the official views, opinions, or policy of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arp R., 2008, NATURE P, V2, P1, DOI [10101/npre.2008.1941.1, DOI 10.1038/NPRE.2008.1941.1]; Ashburner M, 2001, GENOME RES, V11, P1425; Bada M, 2012, KR MED SERIES; BASKAUF S. J., 2010, BIODIVERSITY INFORM, V7, P17; Beach J, 2010, STRATEGIC PLAN ESTAB; BEACH JH, 1993, ADVANCES IN COMPUTER METHODS FOR SYSTEMATIC BIOLOGY, P241; BERENDSOHN WG, 1995, TAXON, V44, P207, DOI 10.2307/1222443; BIEN project team, 2009, CYB INT BOT INF NETW; Bizer C, 2009, INT J SEMANT WEB INF, V5, P1, DOI 10.4018/jswis.2009081901; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Brinkman Ryan R, 2010, J Biomed Semantics, V1 Suppl 1, pS7, DOI 10.1186/2041-1480-1-S1-S7; Buttigieg PL, J BIOMEDICA IN PRESS; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Catapano T, 2011, RECOMMENDATIONS USE; Ceusters W, 2007, INT J MED INFORM, V76, pS326, DOI 10.1016/j.ijmedinf.2007.02.003; Check E, 2006, NATURE, V439, P378, DOI 10.1038/439378a; Cowell LG, 2010, INFECTIOUS DISEASE INFORMATICS, P373, DOI 10.1007/978-1-4419-1327-2_19; Davies N, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-5; Davies N, 2012, NATURE, V481, P145, DOI 10.1038/481145a; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Deans AR, 2012, TRENDS ECOL EVOL, V27, P78, DOI 10.1016/j.tree.2011.11.007; Deck J, 2013, STAND GENOMIC SCI, V8, P352, DOI 10.4056/sigs.3907833; Eilbeck K, 2004, COMP FUNCT GENOM, V5, P642, DOI 10.1002/cfg.446; Field D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001088; Fisher BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001787; Franz NM, 2009, SYST BIODIVERS, V7, P5, DOI 10.1017/S147720000800282X; Franz Nico M., 2010, Biodiversity Informatics, V7, P45; GEOFFROY M, 2003, SCHRIFTENREIHE VEGET, V39, P5; Gkoutos GV, 2012, INT REV NEUROBIOL, V103, P69, DOI 10.1016/B978-0-12-388408-4.00004-6; Grenon P, 2004, SPAT COGN COMPUT, V4, P69, DOI [10.1207/s15427633scc0401_5, DOI 10.1207/S15427633SCC0401_5]; HAENDEL MA, 2008, COMPUT BIOL SER, V6, P327; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Hardisty A, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-16; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holetschek J, 2012, PLANT BIOSYST, V146, P771, DOI 10.1080/11263504.2012.740085; Horridge M, 2006, P 2006 OWL EXP DIR W; Hrebicek, 2009, P EUR C ENV OPP SEIS, P606; Imam Fahim T., 2012, Frontiers in Genetics, V3, P111, DOI 10.3389/fgene.2012.00111; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kelling S, 2009, BIOSCIENCE, V59, P613, DOI 10.1525/bio.2009.59.7.12; Kennedy J, 2005, TAXONOMIC CONCEPT TR; Kennedy J, 2006, P TAX DAT WORK GROUP; Kottmann R, 2008, OMICS, V12, P115, DOI 10.1089/omi.2008.0A10; Lapp Hilmar, 2011, Bulletin of the American Society for Information Science and Technology, V37, P38, DOI 10.1002/bult.2011.1720370411; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Madin JS, 2008, TRENDS ECOL EVOL, V23, P159, DOI 10.1016/j.tree.2007.11.007; MicroB3, 2012, DEL 4 2 BEST PRACT E; Parr CS, 2012, TRENDS ECOL EVOL, V27, P94, DOI 10.1016/j.tree.2011.11.001; Patterson DJ, 2010, TRENDS ECOL EVOL, V25, P686, DOI 10.1016/j.tree.2010.09.004; Penev L, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.50.538; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Pyle RL, 2008, ZOOTAXA, P3, DOI 10.11646/zootaxa.1671.1.2; Robbins RJ, 2012, STAND GENOMIC SCI, V7, P159, DOI 10.4056/sigs.3156511; Scholes RJ, 2012, CURR OPIN ENV SUST, V4, P139, DOI 10.1016/j.cosust.2011.12.005; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Stoltzfus Arlin, 2012, BMC Res Notes, V5, P574, DOI 10.1186/1756-0500-5-574; Tiffin N, 2005, NUCLEIC ACIDS RES, V33, P1544, DOI 10.1093/nar/gki296; Tuama EO, 2012, STAND GENOMIC SCI, V7, P166, DOI 10.4056/sigs.3166513; United Nations, 1992, CONV BIOL DIV OP SIG; Vasilevsky N, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar067; Webb C, 2011, P TAX DAT WORK GROUP; Wieczorek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029715; Wooley JC, 2009, STAND GENOMIC SCI, V1, P87, DOI 10.4056/sigs.26218; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823	66	80	82	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89606	10.1371/journal.pone.0089606	http://dx.doi.org/10.1371/journal.pone.0089606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595056	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900024
J	Kolmus, K; Van Troys, M; Van Wesemael, K; Ampe, C; Haegeman, G; Tavernier, J; Gerlo, S				Kolmus, Krzysztof; Van Troys, Marleen; Van Wesemael, Karlien; Ampe, Christophe; Haegeman, Guy; Tavernier, Jan; Gerlo, Sarah			beta-Agonists Selectively Modulate Proinflammatory Gene Expression in Skeletal Muscle Cells via Non-Canonical Nuclear Crosstalk Mechanisms	PLOS ONE			English	Article							NF-KAPPA-B; HISTONE H3 PHOSPHORYLATION; NECROSIS-FACTOR-ALPHA; BINDING PROTEIN CREB; TNF-ALPHA; TRANSCRIPTIONAL ACTIVITY; IL-6 EXPRESSION; CAMP; ACETYLATION; ACTIVATION	The proinflammatory cytokine Tumour Necrosis Factor (TNF)-alpha is implicated in a variety of skeletal muscle pathologies. Here, we have investigated how in vitro cotreatment of skeletal muscle C2C12 cells with b-agonists modulates the TNF-alpha-induced inflammatory program. We observed that C2C12 myotubes express functional TNF receptor 1 (TNF-R1) and beta 2 adrenoreceptors (beta 2-ARs). TNF-alpha activated the canonical Nuclear Factor-kappa B (NF-kappa B) pathway and Mitogen-Activated Protein Kinases (MAPKs), culminating in potent induction of NF-kappa B-dependent proinflammatory genes. Cotreatment with the beta-agonist isoproterenol potentiated the expression of inflammatory mediators, including Interleukin-6 (IL-6) and several chemokines. The enhanced production of chemotactic factors upon TNF-alpha/isoproterenol cotreatment was also suggested by the results from migrational analysis. Whereas we could not explain our observations by cytoplasmic crosstalk, we found that TNF-R1-and beta 2-AR-induced signalling cascades cooperate in the nucleus. Using the IL-6 promoter as a model, we demonstrated that TNF-alpha/isoproterenol cotreatment provoked phosphorylation of histone H3 at serine 10, concomitant with enhanced promoter accessibility and recruitment of the NF-kappa B p65 subunit, cAMP-response element-binding protein (CREB), CREB-binding protein (CBP) and RNA polymerase II. In summary, we show that b-agonists potentiate TNF-alpha action, via nuclear crosstalk, that promotes chromatin relaxation at selected gene promoters. Our data warrant further study into the mode of action of beta-agonists and urge for caution in their use as therapeutic agents for muscular disorders.	[Kolmus, Krzysztof; Tavernier, Jan; Gerlo, Sarah] Univ Ghent VIB, Dept Med Prot Res, B-9052 Ghent, Belgium; [Kolmus, Krzysztof; Van Troys, Marleen; Ampe, Christophe; Tavernier, Jan; Gerlo, Sarah] Univ Ghent, Fac Med & Hlth Sci, Dept Biochem, B-9000 Ghent, Belgium; [Van Wesemael, Karlien; Haegeman, Guy] Univ Ghent, Fac Sci, Dept Physiol, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University	Gerlo, S (corresponding author), Univ Ghent VIB, Dept Med Prot Res, B-9052 Ghent, Belgium.	Sarah.Gerlo@vib-ugent.be	Tavernier, Jan/AAG-3636-2019	Christophe, Ampe/0000-0002-8554-3594; Van Troys, Marleen/0000-0003-4283-8103	Fund For Scientific Research Flanders (FWO) [KaN1.5.223.13N]; GROUP-ID Ghent University Multidisciplinary Research Platform	Fund For Scientific Research Flanders (FWO)(FWO); GROUP-ID Ghent University Multidisciplinary Research Platform	This work is supported by the Fund For Scientific Research Flanders (FWO)(KaN1.5.223.13N, a postdoctoral fellowship to SG and a doctoral fellowship to KK). In addition this work is funded by the GROUP-ID Ghent University Multidisciplinary Research Platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avni D, 2010, MOL IMMUNOL, V47, P1396, DOI 10.1016/j.molimm.2010.02.015; Baouz S, 2005, INT IMMUNOL, V17, P1473, DOI 10.1093/intimm/dxh325; Bhatnagar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013262; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clayton AL, 2003, FEBS LETT, V546, P51, DOI 10.1016/S0014-5793(03)00451-4; Corti S, 2001, EXP CELL RES, V268, P36, DOI 10.1006/excr.2001.5267; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; De Paepe B, 2007, ANN NY ACAD SCI, V1109, P441, DOI 10.1196/annals.1398.050; Dempsey PW, 2003, CYTOKINE GROWTH F R, V14, P193, DOI 10.1016/S1359-6101(03)00021-2; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Farmer P, 2000, AM J PHYSIOL-LUNG C, V279, pL675, DOI 10.1152/ajplung.2000.279.4.L675; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Frost RA, 2004, AM J PHYSIOL-ENDOC M, V286, pE809, DOI 10.1152/ajpendo.00560.2003; Gavrilyuk V, 2002, J BIOL CHEM, V277, P29662, DOI 10.1074/jbc.M203256200; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hinkle RT, 2002, MUSCLE NERVE, V25, P729, DOI 10.1002/mus.10092; Holmqvist PH, 2013, TRANSCR-AUSTIN, V4, P18, DOI 10.4161/trns.22601; Kaur M, 2008, AM J PHYSIOL-LUNG C, V295, pL505, DOI 10.1152/ajplung.00046.2008; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Li YP, 2001, CURR OPIN RHEUMATOL, V13, P483, DOI 10.1097/00002281-200111000-00005; Lu Q, 2003, J BIOL CHEM, V278, P15727, DOI 10.1074/jbc.M300546200; Lynch GS, 2008, PHYSIOL REV, V88, P729, DOI 10.1152/physrev.00028.2007; Mayr BM, 2001, P NATL ACAD SCI USA, V98, P10936, DOI 10.1073/pnas.191152098; McManus KJ, 2001, BIOCHEM CELL BIOL, V79, P253, DOI 10.1139/bcb-79-3-253; Monroy MA, 2001, J BIOL CHEM, V276, P40721, DOI 10.1074/jbc.M103615200; Mourkioti F, 2008, J MOL MED, V86, P747, DOI 10.1007/s00109-008-0308-4; Nedachi T, 2009, AM J PHYSIOL-ENDOC M, V297, pE866, DOI 10.1152/ajpendo.00104.2009; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Peterson JM, 2008, INT REV IMMUNOL, V27, P375, DOI 10.1080/08830180802302389; Porter JD, 2003, NEUROMUSCULAR DISORD, V13, P223, DOI 10.1016/S0960-8966(02)00242-0; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; Ryall JG, 2002, AM J PHYSIOL-REG I, V283, pR1386, DOI 10.1152/ajpregu.00324.2002; Salvador LM, 2001, J BIOL CHEM, V276, P40146, DOI 10.1074/jbc.M106710200; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Shimada M, 2010, J BIOL CHEM, V285, P9390, DOI 10.1074/jbc.M109.057745; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Smale ST, 2012, IMMUNOL REV, V246, P193, DOI 10.1111/j.1600-065X.2011.01091.x; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Spooren A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/275892; Spooren A, 2010, CELL SIGNAL, V22, P871, DOI 10.1016/j.cellsig.2010.01.018; Spurlock DM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-320; Steensberg A, 2001, AM J PHYSIOL-CELL PH, V281, pC1001; Sundar IK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031378; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Warren GL, 2004, AM J PHYSIOL-CELL PH, V286, pC1031, DOI 10.1152/ajpcell.00467.2003; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Ye RD, 2000, AM J PHYSIOL-LUNG C, V279, pL615, DOI 10.1152/ajplung.2000.279.4.L615; Yoon JH, 2011, J PROTEOME RES, V10, P5315, DOI 10.1021/pr200573b; Zador E, 2001, MUSCLE NERVE, V24, P1058, DOI 10.1002/mus.1110; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	65	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90649	10.1371/journal.pone.0090649	http://dx.doi.org/10.1371/journal.pone.0090649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603712	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600071
J	Al Faraj, A; Shaik, AS; Pureza, MA; Alnafea, M; Halwani, R				Al Faraj, Achraf; Shaik, Asma Sultana; Pureza, Mary Angeline; Alnafea, Mohammad; Halwani, Rabih			Preferential Macrophage Recruitment and Polarization in LPS-Induced Animal Model for COPD: Noninvasive Tracking Using MRI	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; IN-VITRO; DENDRITIC CELLS; CHEMOKINE MDC; INFLAMMATION; MONOCYTES; EXPRESSION; PLASTICITY; RESOLUTION; INFECTION	Noninvasive imaging of macrophages activity has raised increasing interest for diagnosis of chronic obstructive respiratory diseases (COPD), which make them attractive vehicles to deliver contrast agents for diagnostic or drugs for therapeutic purposes. This study was designed to monitor and evaluate the migration of differently polarized M1 and M2 iron labeled macrophage subsets to the lung of a LPS-induced COPD animal model and to assess their polarization state once they have reached the inflammatory sites in the lung after intravenous injection. Ex vivo polarized bone marrow derived M1 or M2 macrophages were first efficiently and safely labeled with amine-modified PEGylated dextran-coated SPIO nanoparticles and without altering their polarization profile. Their biodistribution in abdominal organs and their homing to the site of inflammation in the lung was tracked for the first time using a free-breathing non-invasive MR imaging protocol on a 4.7T magnet after their intravenous administration. This imaging protocol was optimized to allow both detection of iron labeled macrophages and visualization of inflammation in the lung. M1 and M2 macrophages were successfully detected in the lung starting from 2 hours post injection with no variation in their migration profile. Quantification of cytokines release, analysis of surface membrane expression using flow cytometry and immunohistochemistry investigations confirmed the successful recruitment of injected iron labeled macrophages in the lung of COPD mice and revealed that even with a continuum switch in the polarization profile of M1 and M2 macrophages during the time course of inflammation a balanced number of macrophage subsets predominate.	[Al Faraj, Achraf; Shaik, Asma Sultana; Alnafea, Mohammad] King Saud Univ, Dept Radiol Sci, Coll Appl Med Sci, Mol & Cellular Imaging Lab, Riyadh, Saudi Arabia; [Pureza, Mary Angeline; Halwani, Rabih] King Saud Univ, Coll Med, Asthma Res Chair, Riyadh 11461, Saudi Arabia; [Pureza, Mary Angeline; Halwani, Rabih] King Saud Univ, Coll Med, Prince Naif Ctr Immunol Res, Riyadh 11461, Saudi Arabia	King Saud University; King Saud University; King Saud University	Al Faraj, A (corresponding author), King Saud Univ, Dept Radiol Sci, Coll Appl Med Sci, Mol & Cellular Imaging Lab, Riyadh, Saudi Arabia.	aalfaraj@ksu.edu.sa	Al Faraj, Achraf/B-1351-2012; Halwani, Rabih/AAN-1568-2021; shaik, Asma Sultana/E-1284-2016; Faraj, Achraf Al/M-9476-2019	Al Faraj, Achraf/0000-0002-8943-1354; Halwani, Rabih/0000-0002-6516-7771; Faraj, Achraf Al/0000-0002-8943-1354	NPST Program, King Saud University [11-MED1773]	NPST Program, King Saud University(King Saud University)	This work was supported by the NPST Program, King Saud University, Project Number 11-MED1773. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Faraj A, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1797-9; Al Faraj A, 2013, CONTRAST MEDIA MOL I, V8, P193, DOI 10.1002/cmmi.1516; Bamrungsap S, 2012, NANOMEDICINE-UK, V7, P1253, DOI [10.2217/NNM.12.87, 10.2217/nnm.12.87]; Barnes Peter J, 2004, COPD, V1, P59, DOI 10.1081/COPD-120028701; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Boorsma CE, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/769214; Cai QY, 2012, NANOMED-NANOTECHNOL, V8, P365, DOI 10.1016/j.nano.2011.06.019; Cecilio CA, 2011, BRAZ J MED BIOL RES, V44, P671, DOI [10.1590/S0100-879X2011007500067, 10.1590/S0100-879X2011000700010]; Chen ZP, 2009, NANOSCALE RES LETT, V4, P204, DOI 10.1007/s11671-008-9226-1; Ebner B, 2010, CIRC-CARDIOVASC IMAG, V3, P202, DOI 10.1161/CIRCIMAGING.109.902312; Engberink RDO, 2007, RADIOLOGY, V243, P467, DOI 10.1148/radiol.2432060120; Frankenberger M, 2011, MOL MED, V17, P762, DOI 10.2119/molmed.2010.00202; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Global Initiative for Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Godiska R, 1997, J EXP MED, V185, P1595, DOI 10.1084/jem.185.9.1595; Hardison SE, 2010, AM J PATHOL, V176, P774, DOI 10.2353/ajpath.2010.090634; Hauger O, 2007, EUR RADIOL, V17, P2898, DOI 10.1007/s00330-007-0660-8; Herold S, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00065; Lee JS, 2006, RADIOLOGY, V241, P142, DOI 10.1148/radiol.2403051156; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Lum H, 2001, AM J PHYSIOL-CELL PH, V280, pC719; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Redente EF, 2010, J LEUKOCYTE BIOL, V88, P159, DOI 10.1189/jlb.0609378; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Saito S, 2012, INT J NANOMED, V7, P5415, DOI 10.2147/IJN.S33709; Schweiger C, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-28; Singh N, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5358; Soenen SJ, 2012, METHOD ENZYMOL, V509, P195, DOI 10.1016/B978-0-12-391858-1.00011-3; Soenen SJH, 2010, NANOMEDICINE-UK, V5, P1261, DOI 10.2217/NNM.10.106; Strobel K, 2012, MAGN RESON MED, V68, P1924, DOI 10.1002/mrm.24180; Tang KS, 2011, MAGN RESON MED, V65, P1564, DOI 10.1002/mrm.22843; Tyler DJ, 2007, J MAGN RESON IMAGING, V25, P279, DOI 10.1002/jmri.20851; Vazquez-Tello A, 2012, INT ARCH ALLERGY IMM, V157, P406, DOI 10.1159/000329527; Vulcano M, 2001, EUR J IMMUNOL, V31, P812, DOI 10.1002/1521-4141(200103)31:3<812::AID-IMMU812>3.0.CO;2-L; Wang YXJ, 2011, QUANT IMAGING MED SU, V1, P35, DOI 10.3978/j.issn.2223-4292.2011.08.03; Wouters Emiel F M, 2009, Proc Am Thorac Soc, V6, P638, DOI 10.1513/pats.200907-073DP; Yamashita U, 2002, CRIT REV IMMUNOL, V22, P105; Ying S, 2008, J IMMUNOL, V181, P2790, DOI 10.4049/jimmunol.181.4.2790; Yu SS, 2012, INT J NANOMED, V7, P799, DOI 10.2147/IJN.S28531; Zheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063967; Zhu XM, 2012, INT J NANOMED, V7, P953, DOI 10.2147/IJN.S28316	42	27	27	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90829	10.1371/journal.pone.0090829	http://dx.doi.org/10.1371/journal.pone.0090829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598763	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400138
J	Jonsdottir, K; Assmus, J; Slewa, A; Gudlaugsson, E; Skaland, I; Baak, JPA; Janssen, EAM				Jonsdottir, Kristin; Assmus, Joerg; Slewa, Aida; Gudlaugsson, Einar; Skaland, Ivar; Baak, Jan P. A.; Janssen, Emiel A. M.			Prognostic Value of Gene Signatures and Proliferation in Lymph-Node-Negative Breast Cancer	PLOS ONE			English	Article							21-GENE RECURRENCE SCORE; ESTROGEN-RECEPTOR; PROSPECTIVE MULTICENTER; EXPRESSION; CHEMOTHERAPY; VALIDATION; INDEX; MICROARRAY; PREDICTOR; MARKERS	Introduction: The overall survival rate is good for lymph-node-negative breast cancer patients, but they still suffer from serious over-and some undertreatments. Prognostic and predictive gene signatures for node-negative breast cancer have a high number of genes related to proliferation. The prognostic value of gene sets from commercial gene-expression assays were compared with proliferation markers. Methods: Illumina WG6 mRNA microarray analysis was used to examine 94 fresh-frozen tumour samples from node-negative breast cancer patients. The patients were divided into low-and high-risk groups for distant metastasis based on the MammaPrint-related genes, and into low-, intermediate-and high-risk groups based on the recurrence score algorithm with genes included in Oncotype DX. These data were then compared to proliferation status, as measured by the mitotic activity index, the expressions of phosphohistone H3 (PPH3), and Ki67. Results: Kaplan-Meier survival analysis for distant-metastasis-free survival revealed that patients with weak and strong PPH3 expressions had 14-year survival rates of 87% (n = 45), and 65% (n = 49, p = 0.014), respectively. Analysis of the MammaPrint classification resulted in 14-year survival rates of 80% (n = 45) and 71% (n = 49, p = 0.287) for patients with low and high risks of recurrence, respectively. The Oncotype DX categorization yielded 14-year survival rates of 83% (n = 18), 79% (n = 42) and 68% (n = 34) for those in the low-, intermediate-and high-risk groups, respectively (p = 0.52). Supervised hierarchical cluster analysis for distant-metastasis-free survival in the subgroup of patients with strong PPH3 expression revealed that the genes involved in Notch signalling and cell adhesion were expressed at higher levels in those patients with distant metastasis. Conclusion: This pilot study indicates that proliferation has greater prognostic value than the expressions of either MammaPrint- or Oncotype-DX-related genes. Furthermore, in the subgroup of patients with high proliferation, Notch signalling pathway genes appear to be expressed at higher levels in patients who develop distant metastasis.	[Jonsdottir, Kristin; Slewa, Aida; Gudlaugsson, Einar; Skaland, Ivar; Baak, Jan P. A.; Janssen, Emiel A. M.] Stavanger Univ Hosp, Dept Pathol, Stavanger, Norway; [Assmus, Joerg] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway; [Baak, Jan P. A.] Free Univ Amsterdam, Amsterdam, Netherlands	Stavanger University Hospital; University of Bergen; Haukeland University Hospital; Vrije Universiteit Amsterdam	Janssen, EAM (corresponding author), Stavanger Univ Hosp, Dept Pathol, Stavanger, Norway.	emiel.janssen@sus.no	Janssen, Emiel A.M./AAM-2357-2020		Helse Vest, Norway [911450]; Folke Hermansen Foundation; Stavanger University Hospital research department	Helse Vest, Norway; Folke Hermansen Foundation; Stavanger University Hospital research department	Kristin Jonsdottir has a grant from Helse Vest (no: 911450) (http://www.helse-vest.no/english/Sider/side.aspx), Norway and the study received financial support from the Folke Hermansen Foundation (2010) (http://www.folke-fondet.org/index.html) and the Stavanger University Hospital research department (2009-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2005, J CLIN ONCOL, V23, P2996, DOI 10.1200/JCO.2005.08.046; [Anonymous], 2003, WHO CLASSIFICATION T; Baak JPA, 2006, J CLIN PATHOL, V59, P1017, DOI 10.1136/jcp.2005.027839; Baak JPA, 2007, EUR J CANCER, V43, P527, DOI 10.1016/j.ejca.2006.10.001; Baak JPA, 2009, BREAST CANCER RES TR, V115, P241, DOI 10.1007/s10549-008-0126-y; Baak JPA, 2005, J CLIN ONCOL, V23, P5993, DOI 10.1200/JCO.2005.05.511; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Desmedt C, 2006, CELL CYCLE, V5, P2198, DOI 10.4161/cc.5.19.3254; Dontu G, 2004, TRENDS ENDOCRIN MET, V15, P193, DOI 10.1016/j.tem.2004.05.011; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elloumi F, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-54; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Git A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2109; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gudlaugsson E, 2012, HISTOPATHOLOGY; Habel LA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1412; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Haughian JM, 2012, P NATL ACAD SCI USA, V109, P2742, DOI 10.1073/pnas.1106509108; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Janssen EAM, 2009, CELL ONCOL, V31, P335, DOI 10.3233/CLO-2009-0479; Kelly CM, 2010, CANCER-AM CANCER SOC, V116, P5161, DOI 10.1002/cncr.25269; Knauer M, 2010, BREAST CANCER RES TR, V120, P655, DOI 10.1007/s10549-010-0814-2; Lo SS, 2010, J CLIN ONCOL, V28, P1671, DOI 10.1200/JCO.2008.20.2119; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; NICHOLSON RI, 1991, EUR J CANCER, V27, P908, DOI 10.1016/0277-5379(91)90145-4; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Niikura N, 2012, CANCER SCI, V103, P1508, DOI 10.1111/j.1349-7006.2012.02319.x; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Sahebjam S, 2011, BRIT J CANCER, V105, P1342, DOI 10.1038/bjc.2011.402; Sanchez-Navarro I, 2010, BIOTECHNIQUES, V48, P389, DOI 10.2144/000113388; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Simmons MJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3321; Skaland I, 2007, MODERN PATHOL, V20, P1307, DOI 10.1038/modpathol.3800972; Skaland I, 2009, BREAST CANCER RES TR, V114, P39, DOI 10.1007/s10549-008-9980-x; Starmans MHW, 2008, BRIT J CANCER, V99, P1884, DOI 10.1038/sj.bjc.6604746; Sun B, 2011, BREAST J, V17, P172, DOI 10.1111/j.1524-4741.2010.01049.x; Tian S, 2010, BIOMARK INSIGHTS, V5, P129, DOI 10.4137/BMI.S6184; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5; Williams DJ, 2011, APPL IMMUNOHISTO M M, V19, P431, DOI 10.1097/PAI.0b013e318206d23d; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Wolf I, 2008, CANCER-AM CANCER SOC, V112, P731, DOI 10.1002/cncr.23225; Yao K, 2011, INT J SURG PATHOL, V19, P607, DOI 10.1177/1066896910362080	56	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90642	10.1371/journal.pone.0090642	http://dx.doi.org/10.1371/journal.pone.0090642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599057	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400107
J	Sengupta, N; Ghosh, S; Vasaikar, SV; Gomes, J; Basu, A				Sengupta, Nabonita; Ghosh, Sourish; Vasaikar, Suhas V.; Gomes, James; Basu, Anirban			Modulation of Neuronal Proteome Profile in Response to Japanese Encephalitis Virus Infection	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; QUANTITATIVE PROTEOMICS; SYSTEMS BIOLOGY; IDENTIFICATION; PROTEINS; RNA; CYTOSCAPE; INTERACTS; VIMENTIN; PLATFORM	In this study we have reported the in vivo proteomic changes during Japanese Encephalitis Virus (JEV) infection in combination with in vitro studies which will help in the comprehensive characterization of the modifications in the host metabolism in response to JEV infection. We performed a 2-DE based quantitative proteomic study of JEV-infected mouse brain as well as mouse neuroblastoma (Neuro2a) cells to analyze the host response to this lethal virus. 56 host proteins were found to be differentially expressed post JEV infection (defined as exhibiting >= 1.5-fold change in protein abundance upon JEV infection). Bioinformatics analyses were used to generate JEV-regulated host response networks which reported that the identified proteins were found to be associated with various cellular processes ranging from intracellular protein transport, cellular metabolism and ER stress associated unfolded protein response. JEV was found to invade the host protein folding machinery to sustain its survival and replication inside the host thereby generating a vigorous unfolded protein response, subsequently triggering a number of pathways responsible for the JEV associated pathologies. The results were also validated using a human cell line to correlate them to the human response to JEV. The present investigation is the first report on JEV-host interactome in in vivo model and will be of potential interest for future antiviral research in this field.	[Sengupta, Nabonita; Ghosh, Sourish; Basu, Anirban] Natl Brain Res Ctr, Manesar, Haryana, India; [Vasaikar, Suhas V.; Gomes, James] Indian Inst Technol Delhi, Kusuma Sch Biol Sci, New Delhi, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Sengupta, N (corresponding author), Natl Brain Res Ctr, Manesar, Haryana, India.	nabonita.s@gmail.com	Vasaikar, Suhas/AAJ-5885-2020; Ghosh, Sourish/AAL-7250-2021	Ghosh, Sourish/0000-0001-8438-9487; Basu, Anirban/0000-0002-5200-2054; Vasaikar, Suhas/0000-0001-9763-3899	Department of Biotechnology; Research Associateship from Indian Council of Medical Research	Department of Biotechnology; Research Associateship from Indian Council of Medical Research	This work was supported by the core grant from the Department of Biotechnology, to the National Brain Research Centre. NS is the recipient of Research Associateship from Indian Council of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BLACKSHEAR PJ, 1984, METHOD ENZYMOL, V104, P237; Byun K, 2012, ANAT CELL BIOL, V45, P47, DOI 10.5115/acb.2012.45.1.47; Chiou CT, 2003, J GEN VIROL, V84, P2795, DOI 10.1099/vir.0.19201-0; Coombs KM, 2010, J VIROL, V84, P10888, DOI 10.1128/JVI.00431-10; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Das S, 2011, VIRUS RES, V160, P404, DOI 10.1016/j.virusres.2011.06.001; Das S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008134; De Mees C, 2006, MOL CELL BIOL, V26, P2012, DOI 10.1128/MCB.26.5.2012-2018.2006; Freudenburg W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052408; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Glaser V, 2010, NEUROTOXICOLOGY, V31, P454, DOI 10.1016/j.neuro.2010.05.012; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hauler F, 2012, P NATL ACAD SCI USA, V109, P19733, DOI 10.1073/pnas.1210659109; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Jaag HM, 2011, J VIROL, V85, P243, DOI 10.1128/JVI.01749-10; Jin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052909; Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katoh H, 2011, J VIROL, V85, P10976, DOI 10.1128/JVI.00846-11; Kaushik DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032270; Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]; Koh WL, 2005, EMERG INFECT DIS, V11, P629, DOI 10.3201/eid1104.041076; Kumar B, 2013, PROTEOMICS, V13, P89, DOI 10.1002/pmic.201200227; KUMAR R, 1990, INDIAN J MED RES-A, V91, P321; Kurihara LJ, 2001, HUM MOL GENET, V10, P1963, DOI 10.1093/hmg/10.18.1963; Lee JW, 2011, J PROTEOME RES, V10, P4522, DOI 10.1021/pr200338d; Liang JJ, 2011, CELL MICROBIOL, V13, P1358, DOI 10.1111/j.1462-5822.2011.01624.x; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mishra MK, 2009, NEUROCHEM INT, V54, P464, DOI 10.1016/j.neuint.2009.01.022; Mkrtchian S, 1998, EUR J BIOCHEM, V251, P304, DOI 10.1046/j.1432-1327.1998.2510304.x; Munday DC, 2012, PROTEOMICS, V12, P666, DOI 10.1002/pmic.201100488; Navratil V, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-13; Pastorino B, 2009, MOL CELL PROTEOMICS, V8, P1623, DOI 10.1074/mcp.M800565-MCP200; Pattanakitsakul S, 2007, J PROTEOME RES, V6, P4592, DOI 10.1021/pr070366b; Diniz JAP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001733; Russo A, 2011, NUCLEIC ACIDS RES, V39, P7576, DOI 10.1093/nar/gkr461; Samad MA, 2007, FEBS LETT, V581, P3283, DOI 10.1016/j.febslet.2007.06.024; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sengupta N, INFECT IMMUNITY, V78, P3957; Sengupta N, 2010, INFECT IMMUN, V78, P3957, DOI 10.1128/IAI.00374-10; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan SL, 2007, NAT BIOTECHNOL, V25, P1383, DOI 10.1038/nbt1207-1383; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x; Tsukumo Y, 2007, J BIOL CHEM, V282, P29264, DOI 10.1074/jbc.M705038200; Tulsawani R, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-125; Turano C, 2011, CELL MOL BIOL LETT, V16, P539, DOI 10.2478/s11658-011-0022-z; Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05; Vasaikar SV, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-3; Wang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002507; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Yang SH, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-40; Zhang LK, 2013, J PROTEOME RES, V12, P2666, DOI 10.1021/pr400011k; Zhou ST, 2011, SCI CHINA LIFE SCI, V54, P502, DOI 10.1007/s11427-011-4177-7	58	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90211	10.1371/journal.pone.0090211	http://dx.doi.org/10.1371/journal.pone.0090211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599148	gold, Green Submitted, Green Published			2022-12-25	WOS:000332479400055
J	Wang, LJ; Wang, DB; Fei, XC; Ruan, M; Chai, WM; Xu, L; Li, XX				Wang, Lijun; Wang, Dengbin; Fei, Xiaochun; Ruan, Mei; Chai, Weimin; Xu, Lin; Li, Xiaoxiao			A Rim-Enhanced Mass with Central Cystic Changes on MR Imaging: How to Distinguish Breast Cancer from Inflammatory Breast Diseases?	PLOS ONE			English	Article							ADJACENT VESSEL SIGN; DUCTAL CARCINOMA; FEATURES; ANGIOGENESIS; MASTITIS; LESIONS; BENIGN; TISSUE	Objective: To evaluate the capacity of magnetic resonance imaging (MRI) to distinguish breast cancer from inflammatory breast diseases manifesting as a rim-enhanced mass with central cystic changes. Materials and Methods: Forty cases of breast cancer and 52 of inflammatory breast diseases showing a rim-enhanced mass with central cystic changes were retrospectively reviewed. All cases underwent dynamic contrast-enhanced MRI and 31 of them underwent diffusion-weighted imaging (DWI). Morphological features, dynamic parameters and apparent diffusion coefficient (ADC) values were comparatively analyzed using univariate analysis and binary logistic regression analysis. Results: Breast cancer had a significantly thicker wall than the inflammatory breast diseases (P<0.001) while internal enhancing septa were more common in inflammatory breast diseases (P = 0.003). On DWI, 86.7% of breast cancers demonstrate a peripheral hyperintensity whereas 93.8% of inflammatory breast diseases had a central hyperintensity (P<0.001). Compared to the inflammatory breast diseases, breast cancers had a lower ADC value for the wall (1.09x10(-3) mm(2)/s vs 1.42x10(-3) mm(2)/s, P<0.001) and a higher ADC value for the central part (1.94x10(-3) mm(2)/s vs 1.05x10(-3) mm(2)/s, P<0.001). Conclusions: Both breast cancer and inflammatory breast diseases could present as a rim-enhanced mass with central cystic changes on MRI. Integrated analysis of the MR findings can allow for an accurate differential diagnosis.	[Wang, Lijun; Wang, Dengbin; Ruan, Mei; Xu, Lin; Li, Xiaoxiao] Shanghai Jiao Tong Univ Sch Med, Xinhua Hosp, Dept Radiol, Shanghai, Peoples R China; [Fei, Xiaochun] Shanghai Jiao Tong Univ Sch Med, Ruijin Hosp, Dept Pathol, Shanghai, Peoples R China; [Chai, Weimin] Shanghai Jiao Tong Univ Sch Med, Ruijin Hosp, Dept Radiol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, DB (corresponding author), Shanghai Jiao Tong Univ Sch Med, Xinhua Hosp, Dept Radiol, Shanghai, Peoples R China.	dbwang8@aliyun.com			National Natural Science Foundation of China; Program of Shanghai Municipal Health Outstanding Discipline Leader [NSFC 81171389, NSFC 81371621, XBR 2013110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Municipal Health Outstanding Discipline Leader	This study was funded by the National Natural Science Foundation of China and the Program of Shanghai Municipal Health Outstanding Discipline Leader (NSFC 81171389, NSFC 81371621, and XBR 2013110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MS, 2012, JCPSP-J COLL PHYSICI, V22, P428, DOI 07.2012/JCPSP.428431; American College of Radiology, 2003, ACR BREAST IM REP DA; Bian XW, 2004, INT IMMUNOPHARMACOL, V4, P1537, DOI 10.1016/j.intimp.2004.07.017; Buadu LD, 1997, J COMPUT ASSIST TOMO, V21, P421, DOI 10.1097/00004728-199705000-00016; Dietzel M, 2010, KOREAN J RADIOL, V11, P178, DOI 10.3348/kjr.2010.11.2.178; Dursun M, 2012, RADIOL MED, V117, P529, DOI 10.1007/s11547-011-0733-2; Ferron S, 2012, J RADIOL DIAGN INTER, V93, P93, DOI 10.1016/j.jradio.2011.11.002; Gupta C, 2006, PATHOL RES PRACT, V202, P465, DOI 10.1016/j.prp.2006.01.006; Han M, 2012, AM J ROENTGENOL, V199, P921, DOI 10.2214/AJR.11.7895; Kurz KD, 2010, EUR J RADIOL, V76, P195, DOI 10.1016/j.ejrad.2009.07.036; Liu HQ, 2011, J MAGN RESON IMAGING, V33, P1369, DOI 10.1002/jmri.22464; Luciani A, 2004, AM J ROENTGENOL, V182, P1059, DOI 10.2214/ajr.182.4.1821059; Mansour SM, 2012, EGYPT J RADIOL NUC M, V43, P487, DOI 10.1016/j.ejrnm.2012.04.004; Orguc S, 2012, SINGAP MED J, V53, P737; Renz DM, 2008, EUR RADIOL, V18, P2370, DOI 10.1007/s00330-008-1029-3; Uematsu T, 2013, BREAST CANC IN PRESS; Uematsu T, 2012, BREAST CANCER-TOKYO, V19, P289, DOI 10.1007/s12282-012-0346-1; Uematsu T, 2011, JPN J RADIOL, V29, P609, DOI 10.1007/s11604-011-0612-8; Unal O, 2011, EUR J RADIOL, V77, P490, DOI 10.1016/j.ejrad.2009.08.025; Velasco M, 2005, AM J ROENTGENOL, V184, P1274, DOI 10.2214/ajr.184.4.01841274; Yamaguchi R, 2008, PATHOL INT, V58, P26, DOI 10.1111/j.1440-1827.2007.02184.x; Yoshihara E, 2013, BREAST, V22, P357, DOI 10.1016/j.breast.2012.09.003; Youk JH, 2012, EUR RADIOL, V22, P1724, DOI 10.1007/s00330-012-2425-2	23	9	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90355	10.1371/journal.pone.0090355	http://dx.doi.org/10.1371/journal.pone.0090355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598845	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400067
J	Zevnik, B; Uyttersprot, NC; Perez, AV; Bothe, GWM; Kern, H; Kauselmann, G				Zevnik, Branko; Uyttersprot, Nathalie C.; Perez, Ana V.; Bothe, Gerald W. M.; Kern, Heidrun; Kauselmann, Gunther			C57BL/6N Albino/Agouti Mutant Mice as Embryo Donors for Efficient Germline Transmission of C57BL/6 ES Cells	PLOS ONE			English	Article							IMPROVED GENERATION; BALB/C BLASTOCYSTS; STEM-CELLS; MOUSE; ESTABLISHMENT; GENE; LINE; TYROSINASE	We generated C57BL/6NTac mice carrying a tyrosinase loss-of function mutation and a reversion of the nonagouti locus to agouti. This strain has a high superovulation response, allows visual detection of chimeric coat color contribution of C57BL/6 ES-cells and provides a simplified breeding format that generates black G1 offspring of pure inbred C57BL/6 background in one step, providing the ideal host for genetically manipulated C57BL/6 ES cells.	[Zevnik, Branko] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Uyttersprot, Nathalie C.; Kern, Heidrun; Kauselmann, Gunther] TaconicArtemis GmbH, Cologne, Germany; [Perez, Ana V.; Bothe, Gerald W. M.] Taconic, Hudson, NY USA	University of Cologne	Zevnik, B (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany.	branko.zevnik@uk-koeln.de	Zevnik, Branko/AAB-7853-2020	Zevnik, Branko/0000-0001-7845-9522	Taconic (NY, USA)	Taconic (NY, USA)	This work has been funded by Taconic (NY, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Cheng J, 2004, GENESIS, V39, P100, DOI 10.1002/gene.20031; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Fielder TJ, 2012, TRANSGENIC RES; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Kern Heidrun, 2009, V530, P187, DOI 10.1007/978-1-59745-471-1_10; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; KWON BS, 1989, J INVEST DERMATOL, V93, P589, DOI 10.1111/1523-1747.ep12319693; LEDERMANN B, 1991, EXP CELL RES, V197, P254, DOI 10.1016/0014-4827(91)90430-3; Lemckert FA, 1997, NUCLEIC ACIDS RES, V25, P917, DOI 10.1093/nar/25.4.917; Nagy A., 2003, MANIPULATING MOUSE E; Ohta H, 2009, HUM REPROD, V24, P775, DOI 10.1093/humrep/den456; Pacholczyk G, 2008, BIOTECHNIQUES, V44, P413, DOI 10.2144/000112706; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Ryder E, 2013, GENESIS, V51, P523, DOI 10.1002/dvg.22398; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Schoonjans L, 2003, STEM CELLS, V21, P90, DOI 10.1634/stemcells.21-1-90; Schuster-Gossler K, 2001, BIOTECHNIQUES, V31, P1022, DOI 10.2144/01315st01; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; YOKOYAMA T, 1990, NUCLEIC ACIDS RES, V18, P7293, DOI 10.1093/nar/18.24.7293	22	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90570	10.1371/journal.pone.0090570	http://dx.doi.org/10.1371/journal.pone.0090570			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599260	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400095
J	Calvo-Polanco, M; Sanchez-Romera, B; Aroca, R				Calvo-Polanco, Monica; Sanchez-Romera, Beatriz; Aroca, Ricardo			Mild Salt Stress Conditions Induce Different Responses in Root Hydraulic Conductivity of Phaseolus vulgaris Over-Time	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL SYMBIOSIS; WATER TRANSPORT; GENE-EXPRESSION; AQUAPORIN EXPRESSION; SALINITY STRESS; COLLECTING DUCT; OSMOTIC-STRESS; ABSCISIC-ACID; MEMBRANE; MECHANISMS	Plants respond to salinity by altering their physiological parameters in order to maintain their water balance. The reduction in root hydraulic conductivity is one of the first responses of plants to the presence of salt in order to minimize water stress. Although its regulation has been commonly attributed to aquaporins activity, osmotic adjustment and the toxic effect of Na+ and Cl- have also a main role in the whole process. We studied the effects of 30 mM NaCl on Phaseolus vulgaris plants after 9 days and found different responses in root hydraulic conductivity over-time. An initial and final reduction of root hydraulic conductivity, stomatal conductance, and leaf water potential in response to NaCl was attributed to an initial osmotic shock after 1 day of treatment, and to the initial symptoms of salt accumulation within the plant tissues after 9 days of treatment. After 6 days of NaCl treatment, the increase in root hydraulic conductivity to the levels of control plants was accompanied by an increase in root fructose content, and with the intracellular localization of root plasma membrane aquaporins (PIP) to cortex cells close to the epidermis and to cells surrounding xylem vessels. Thus, the different responses of bean plants to mild salt stress over time may be connected with root fructose accumulation, and intracellular localization of PIP aquaporins.	[Calvo-Polanco, Monica; Sanchez-Romera, Beatriz; Aroca, Ricardo] CSIC, Estn Expt Zaidin, Dept Soil Microbiol & Symbiot Syst, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Calvo-Polanco, M (corresponding author), CSIC, Estn Expt Zaidin, Dept Soil Microbiol & Symbiot Syst, Granada, Spain.	monica.calvo@eez.csic.es	Aroca, Ricardo/K-5268-2014; Sánchez, Beatriz/AAH-9291-2019; Calvo-Polanco, Monica/AAN-9952-2020	Aroca, Ricardo/0000-0003-2402-2063; Calvo-Polanco, Monica/0000-0002-0813-0921; Sanchez Romera, Beatriz/0000-0002-0204-2330	Ministry of Economy and Competitiveness of Spain [AGL2011-25403]; Junta de Andalucia [P10-CVI-5920]	Ministry of Economy and Competitiveness of Spain(Spanish Government); Junta de Andalucia(Junta de Andalucia)	We would like to thank the Ministry of Economy and Competitiveness of Spain(Juan de la Cierva Program and AGL2011-25403 project) and Junta de Andalucia (P10-CVI-5920 project) for research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRE P, 1993, AM J PHYSIOL, V265, pF461, DOI 10.1152/ajprenal.1993.265.3.F461; Aroca R, 2005, PLANT PHYSIOL, V137, P341, DOI 10.1104/pp.104.051045; Aroca R, 2001, PLANT PHYSIOL BIOCH, V39, P1067, DOI 10.1016/S0981-9428(01)01335-3; Aroca R, 2007, NEW PHYTOL, V173, P808, DOI 10.1111/j.1469-8137.2006.01961.x; Aroca R, 2006, ANN BOT-LONDON, V98, P1301, DOI 10.1093/aob/mcl219; Aroca R, 2012, J EXP BOT, V63, P43, DOI 10.1093/jxb/err266; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Benabdellah K, 2009, PLANT MOL BIOL, V70, P647, DOI 10.1007/s11103-009-9497-7; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Boursiac Y, 2008, PLANT J, V56, P207, DOI 10.1111/j.1365-313X.2008.03594.x; Bramley H, 2009, PLANT PHYSIOL, V150, P348, DOI 10.1104/pp.108.134098; Chen T, 2011, PLANT SIGNAL BEHAV, V6, P10; Cho YH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001263; Cho YH, 2007, PLANT SIGNAL BEHAV, V2, P123, DOI 10.4161/psb.2.2.3894; COLMER TD, 1995, PLANT PHYSIOL, V108, P1715, DOI 10.1104/pp.108.4.1715; Diatloff E, 2001, J PLANT NUTR, V24, P75, DOI 10.1081/PLN-100000313; ECHEVARRIA M, 1994, P NATL ACAD SCI USA, V91, P10997, DOI 10.1073/pnas.91.23.10997; Evelin H, 2009, ANN BOT-LONDON, V104, P1263, DOI 10.1093/aob/mcp251; FLOWERS TJ, 1986, AUST J PLANT PHYSIOL, V13, P75, DOI 10.1071/PP9860075; Gambetta GA, 2013, PLANT PHYSIOL, V163, P1254, DOI 10.1104/pp.113.221283; Gao YX, 2010, PLANT SOIL, V331, P193, DOI 10.1007/s11104-009-0245-1; Guo L, 2006, CELL RES, V16, P277, DOI 10.1038/sj.cr.7310035; Hachez C, 2006, PLANT MOL BIOL, V62, P305, DOI 10.1007/s11103-006-9022-1; Henzler T, 1999, PLANTA, V210, P50, DOI 10.1007/s004250050653; Hewitt EJ, 1952, COMMONW AGR BUR; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Horie T, 2011, PLANT CELL PHYSIOL, V52, P663, DOI 10.1093/pcp/pcr027; ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269; Javot H, 2003, PLANT CELL, V15, P509, DOI 10.1105/tpc.008888; JESCHKE WD, 1985, J PLANT PHYSIOL, V121, P211, DOI 10.1016/S0176-1617(85)80055-9; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; KAY R, 1987, SCIENCE, V236, P1299, DOI 10.1126/science.236.4806.1299; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Lee SH, 2010, PLANT CELL ENVIRON, V33, P769, DOI 10.1111/j.1365-3040.2009.02103.x; Liu T, 2001, PLANT GROWTH REGUL, V33, P13, DOI 10.1023/A:1010687711334; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ruiz-Lozano JM, 2012, J EXP BOT, V63, P4033, DOI 10.1093/jxb/ers126; Martinez-Ballesta MDC, 2006, PLANT BIOLOGY, V8, P535, DOI 10.1055/s-2006-924172; Marulanda A, 2010, PLANTA, V232, P533, DOI 10.1007/s00425-010-1196-8; Montero E, 1998, PLANT CELL ENVIRON, V21, P54, DOI 10.1046/j.1365-3040.1998.00249.x; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; MUNNS R, 1984, AUST J PLANT PHYSIOL, V11, P497, DOI 10.1071/PP9840497; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Muries B, 2011, MOL BIOSYST, V7, P1322, DOI 10.1039/c0mb00285b; Park W, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-142; Peterson RL, 2009, TEACHING PLANT ANATO; Postaire O, 2010, PLANT PHYSIOL, V152, P1418, DOI 10.1104/pp.109.145326; Quintero JM, 2001, J EXP BOT, V52, P99, DOI 10.1093/jexbot/52.354.99; Rahnama A, 2010, FUNCT PLANT BIOL, V37, P255, DOI 10.1071/FP09148; Rook F, 1998, PLANT J, V15, P253, DOI 10.1046/j.1365-313X.1998.00205.x; Ruiz-Lozano JM, 2001, NEW PHYTOL, V151, P493, DOI 10.1046/j.0028-646x.2001.00196.x; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Schachtman DP, 2008, TRENDS PLANT SCI, V13, P281, DOI 10.1016/j.tplants.2008.04.003; Shavrukov Y, 2013, J EXP BOT, V64, P119, DOI 10.1093/jxb/ers316; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Steudle E, 1998, J EXP BOT, V49, P775, DOI 10.1093/jexbot/49.322.775; Sutka M, 2011, PLANT PHYSIOL, V155, P1264, DOI 10.1104/pp.110.163113; Thompson AJ, 2007, PLANT PHYSIOL, V143, P1905, DOI 10.1104/pp.106.093559; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P525, DOI 10.4161/psb.3.8.6186; Wan XC, 2010, ACTA BIOCH BIOPH SIN, V42, P351, DOI 10.1093/abbs/gmq029; Wen K, 2005, PHYTOPATHOLOGY, V95, P345, DOI 10.1094/PHYTO-95-0345; Yang HM, 2005, J INTEGR PLANT BIOL, V47, P1159, DOI 10.1111/j.1744-7909.2005.00146.x; Zhou Y, 2007, PLANT CELL ENVIRON, V30, P1566, DOI 10.1111/j.1365-3040.2007.01732.x	66	31	34	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90631	10.1371/journal.pone.0090631	http://dx.doi.org/10.1371/journal.pone.0090631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595059	Green Submitted, gold, Green Published			2022-12-25	WOS:000332475500077
J	Chong, YP; Park, KH; Kim, ES; Kim, MN; Kim, SH; Lee, SO; Choi, SH; Jeong, JY; Woo, JH; Kim, YS				Chong, Yong Pil; Park, Ki-Ho; Kim, Eun Sil; Kim, Mi-Na; Kim, Sung-Han; Lee, Sang-Oh; Choi, Sang-Ho; Jeong, Jin-Yong; Woo, Jun Hee; Kim, Yang Soo			Association of Mannose-Binding Lectin 2 Gene Polymorphisms with Persistent Staphylococcus aureus Bacteremia	PLOS ONE			English	Article							RISK-FACTORS; INFECTION; DEFICIENCY; OUTCOMES; PROTEIN; RESISTANCE; GENOTYPE; PROMOTER; IMMUNITY; LEVEL	Objectives: Mannose-binding lectin (MBL) is an important component of innate immunity. Structural and promoter polymorphisms in the MBL2 gene that are responsible for low MBL levels are associated with susceptibility to infectious diseases. The objective of this study was to investigate the association of serum MBL levels and MBL2 polymorphisms with persistent Staphylococcus aureus bacteremia (SAB) in adult Korean patients. Methods: We conducted a case-control study nested in a prospective cohort of patients with SAB. The study compared 41 patients with persistent bacteremia (>= 7 days) and 46 patients with resolving bacteremia (<3 days). In each subject, we genotyped six single-nucleotide polymorphisms in the promoter region (alleles H/L, X/Y, and P/Q) and exon 1 (alleles A/B, A/C, and A/D) of the MBL2 gene and measured serum MBL concentrations. We also compared MBL2 genotypes between SAB patients and healthy people. Results: Patients with persistent bacteremia were significantly more likely to have low/deficient MBL-producing genotypes and resultant low serum MBL levels, than were patients with resolving bacteremia (P = 0.019 and P = 0.012, respectively). Independent risk factors for persistent bacteremia were metastatic infection (adjusted odds ratio [aOR], 34.7; 95% confidence interval [CI], 12.83-196.37; P = 0.003), methicillin resistance (aOR, 4.10; 95% CI, 3.19-29.57; P = 0.025), and low/deficient MBL-producing genotypes (aOR, 7.64; 95% CI, 4.12-63.39; P = 0.003). Such genotypes were significantly more common in patients with persistent bacteremia than in healthy people (OR, 2.09; 95% CI, 1.03-4.26; P = 0.040). Conclusions: This is the first demonstration of an association of low MBL levels and MBL2 polymorphisms responsible for low or deficient MBL levels with persistent SAB. A combination of factors, including clinical and microbiological characteristics and host defense factors such as MBL levels, may together contribute to the development of persistent SAB.	[Chong, Yong Pil; Kim, Sung-Han; Lee, Sang-Oh; Choi, Sang-Ho; Woo, Jun Hee; Kim, Yang Soo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea; [Kim, Mi-Na] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul, South Korea; [Park, Ki-Ho] Kyung Hee Univ, Sch Med, Kyung Hee Univ Hosp, Div Infect Dis,Dept Internal Med, Seoul, South Korea; [Chong, Yong Pil; Kim, Eun Sil; Jeong, Jin-Yong; Kim, Yang Soo] Univ Ulsan, Coll Med, Ctr Antimicrobial Resistance & Microbial Genet, Seoul, South Korea; [Jeong, Jin-Yong] Univ Ulsan, Coll Med, Asan Inst Life Sci, Asan Med Ctr, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Kyung Hee University; Kyung Hee University Hospital; University of Ulsan; University of Ulsan	Kim, YS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea.	yskim@amc.seoul.kr	Lee, Sang-Oh/AGV-5413-2022; Chong, Yong Pil/AAB-2623-2021	Lee, Sang-Oh/0000-0003-1381-8787; Choi, Sang-Ho/0000-0002-4972-4531	Korea Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea [A120964]	Korea Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea	This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea (grant number: A120964). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouwman LH, 2006, HUM IMMUNOL, V67, P247, DOI 10.1016/j.humimm.2006.02.030; Casanova JL, 2004, J EXP MED, V199, P1295, DOI 10.1084/jem.20040537; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chong YP, 2013, MEDICINE, V92, P98, DOI 10.1097/MD.0b013e318289ff1e; CHOW JW, 1991, ANN INTERN MED, V115, P585, DOI 10.7326/0003-4819-115-8-585; Fowler VG, 2004, J INFECT DIS, V190, P1140, DOI 10.1086/423145; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Gomi K, 2004, CHEST, V126, P95, DOI 10.1378/chest.126.1.95; Hawkins C, 2007, ARCH INTERN MED, V167, P1861, DOI 10.1001/archinte.167.17.1861; Huh JW, 2009, CRIT CARE, V13, DOI 10.1186/cc8157; Im CH, 2012, RHEUMATOL INT, V32, P2251, DOI 10.1007/s00296-011-1939-2; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Kars M, 2005, EUR J CLIN INVEST, V35, P531, DOI 10.1111/j.1365-2362.2005.01521.x; Khatib R, 2006, SCAND J INFECT DIS, V38, P7, DOI 10.1080/00365540500372846; Khatib R, 2009, SCAND J INFECT DIS, V41, P4, DOI 10.1080/00365540802441711; Kim J, 2009, CLIN EXP RHEUMATOL, V27, pS13; Kullar R, 2011, CLIN INFECT DIS, V52, P975, DOI 10.1093/cid/cir124; Lee SG, 2005, MOL IMMUNOL, V42, P969, DOI 10.1016/j.molimm.2004.09.036; Lin SH, 2010, J ANTIMICROB CHEMOTH, V65, P1792, DOI 10.1093/jac/dkq188; Lozano F, 2005, TISSUE ANTIGENS, V66, P131, DOI 10.1111/j.1399-0039.2005.00436.x; MADSEN HO, 1995, J IMMUNOL, V155, P3013; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Neth O, 2002, J IMMUNOL, V169, P4430, DOI 10.4049/jimmunol.169.8.4430; Ou XT, 2011, J INFECT DIS, V203, P1686, DOI 10.1093/infdis/jir152; Park SY, 2013, INFECTION, V41, P111, DOI 10.1007/s15010-012-0348-0; Seidl K, 2011, ANTIMICROB AGENTS CH, V55, P575, DOI 10.1128/AAC.01028-10; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; Smithson A, 2007, CLIN VACCINE IMMUNOL, V14, P256, DOI 10.1128/CVI.00400-06; Steffensen R, 2000, J IMMUNOL METHODS, V241, P33, DOI 10.1016/S0022-1759(00)00198-8; Takahashi K, 2005, CLIN INFECT DIS, V41, pS440, DOI 10.1086/431987; Takahashi K, 2005, INFECT IMMUN, V73, P8188, DOI 10.1128/IAI.73.12.8188-8193.2005; Ziegler C, 2011, EMBO MOL MED, V3, P652, DOI 10.1002/emmm.201100173	33	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89139	10.1371/journal.pone.0089139	http://dx.doi.org/10.1371/journal.pone.0089139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595015	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500011
J	Fan, QH; Yu, R; Huang, WX; Cui, XX; Luo, BH; Zhang, LY				Fan, Qiu-Hong; Yu, Rong; Huang, Wei-Xian; Cui, Xi-Xi; Luo, Bing-Hui; Zhang, Li-Yuan			The has-miR-526b Binding-Site rs8506G > A Polymorphism in the lincRNA-NR_024015 Exon Identified by GWASs Predispose to Non-Cardia Gastric Cancer Risk	PLOS ONE			English	Article							LONG NONCODING RNAS; BREAST-CANCER; GENE; EPIDEMIOLOGY; ASSOCIATION; TRANSCRIPTS; METASTASIS; CARCINOMA; LINCRNAS; REVEALS	Gastric cancer including the cardia and non-cardia types is the second frequent cause of cancer-related deaths worldwide. A subset of non-cardia gastric cancer genetic susceptibility loci have been addressed among Asian through genome-wide association studies (GWASs). This study was to evaluate the effects of single nucleotide polymorphisms (SNPs) of long intergenic non-coding RNAs (lincRNAs) on non-cardia gastric cancer susceptibility in Chinese populations. We selected long intergenic noncoding RNAs (lincRNAs) located in non-cardia gastric cancer risk-related loci and identified 10 SNPs located within lincRNA exonic regions. We examined whether genetic polymorphisms in lincRNAs exons are associated with non-cardia gastric cancer risk in 438 non-cardia gastric cancer patients and 727 control subjects in Chinese populations using logistic regression. Functional relevance was further examined by biochemical assays. We found that lincRNA-NR_024015 rs8506AA carrier was significantly associated with risk of non-cardia gastric cancer (adjusted odds ratio [OR] = 1.56, 95% CI = 1.03-2.39, compared with the rs8506 AG or GG genotype. Further stratification analysis showed that the risk effect was more pronounced in subgroups of smokers (P = 0.001). Biochemical analysis demonstrated that the G to A base change at rs8506G>A disrupts the binding site for has-miR-526b, thereby influencing the transcriptional activity of lincRNA-NR_024015 and affecting cell proliferation. Our present study established a robust association between the rs8506G>A polymorphism in the lincRNA-NR_024015 exon and the risk of non-cardia gastric cancer.	[Fan, Qiu-Hong; Cui, Xi-Xi; Luo, Bing-Hui; Zhang, Li-Yuan] Soochow Univ, Affiliated Hosp 2, Dept Radiotherapy & Oncol, Suzhou, Peoples R China; [Yu, Rong] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou Municipal Hosp, Dept Oncol, Suzhou, Peoples R China; [Huang, Wei-Xian] Wu Jiang First Peoples Hosp, Dept Gastrointestinal Surg, Suzhou, Peoples R China	Soochow University - China; Nanjing Medical University	Zhang, LY (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Radiotherapy & Oncol, Suzhou, Peoples R China.	zhangliyuan126@126.com		Zhang, Liyuan/0000-0002-7469-1743	Suzhou Social Development Fund Project, Jiangsu Province's Key Medical Department [SS08047]	Suzhou Social Development Fund Project, Jiangsu Province's Key Medical Department	This study was supported by the Suzhou Social Development Fund Project (SS08047), Jiangsu Province's Key Medical Department in 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung CC, 2011, HUM GENET, V130, P59, DOI 10.1007/s00439-011-1030-9; de Martel C, 2013, GASTROENTEROL CLIN N, V42, P219, DOI 10.1016/j.gtc.2013.01.003; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Jiang L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3225; Jiang L, 2011, BREAST CANCER RES TR, V126, P487, DOI 10.1007/s10549-010-1094-6; Jin GF, 2011, CARCINOGENESIS, V32, P1655, DOI 10.1093/carcin/bgr187; Kelley JR, 2003, J CLIN EPIDEMIOL, V56, P1, DOI 10.1016/S0895-4356(02)00534-6; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luo JH, 2006, HEPATOLOGY, V44, P1012, DOI 10.1002/hep.21328; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x; Morrison LE, 2007, GENE CHROMOSOME CANC, V46, P397, DOI 10.1002/gcc.20419; Nupponen NN, 2001, CANCER METAST REV, V20, P155, DOI 10.1023/A:1015557308033; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Smedley D, 2000, GENE CHROMOSOME CANC, V28, P121, DOI 10.1002/(SICI)1098-2264(200005)28:1<121::AID-GCC14>3.0.CO;2-O; Song X, 2002, P NATL ACAD SCI USA, V99, P6269, DOI 10.1073/pnas.092112199; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Valenti V, 2011, J SURG ONCOL, V104, P124, DOI 10.1002/jso.21947; Wang F, 2008, FEBS LETT, V582, P1919, DOI 10.1016/j.febslet.2008.05.012; Wu H, 2013, CARCINOGENESIS; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zheng J, 2012, CARCINOGENESIS, V33, P2409, DOI 10.1093/carcin/bgs307; Zheng J, 2012, INT J CANCER, V130, P1981, DOI 10.1002/ijc.26253	39	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90008	10.1371/journal.pone.0090008	http://dx.doi.org/10.1371/journal.pone.0090008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595048	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500029
J	Ji, H; Gu, Q; Chen, LL; Xu, K; Ling, X; Bao, CJ; Tang, FY; Qi, X; Wu, YQ; Ai, J; Shen, GY; Dong, DJ; Yu, HY; Huang, M; Cao, Q; Xu, Y; Zhao, W; Xu, YT; Xia, Y; Chen, SH; Yang, GL; Gu, CL; Xie, GX; Zhu, YF; Zhu, FC; Zhou, MH				Ji, Hong; Gu, Qin; Chen, Li-ling; Xu, Ke; Ling, Xia; Bao, Chang-jun; Tang, Fen-yang; Qi, Xian; Wu, Ying-qiu; Ai, Jing; Shen, Gu-yu; Dong, Dan-jiang; Yu, Hui-yan; Huang, Mao; Cao, Quan; Xu, Ying; Zhao, Wei; Xu, Yang-ting; Xia, Yu; Chen, Shan-hui; Yang, Gen-lin; Gu, Cai-ling; Xie, Guo-xiang; Zhu, Ye-fei; Zhu, Feng-cai; Zhou, Ming-hao			Epidemiological and Clinical Characteristics and Risk Factors for Death of Patients with Avian Influenza A H7N9 Virus Infection from Jiangsu Province, Eastern China	PLOS ONE			English	Article							H5N1; HUMANS; IMMUNITY; ILLNESS	Background: A novel avian influenza A (H7N9) virus has caused great morbidity as well as mortality since its emergence in Eastern China in February 2013. However, the possible risk factors for death are not yet fully known. Methods and Findings: Patients with H7N9 virus infection between March 1 and August 14, 2013 in Jiangsu province were enrolled. Data were collected with a standard form. Mean or percentage was used to describe the features, and Fisher's exact test or t-test test was used to compare the differences between fatal and nonfatal cases with H7N9 virus infection. A total of 28 patients with H7N9 virus infection were identified among whom, nine (32.1%) died. The median age of fatal cases was significant higher than nonfatal cases (P<0.05). Patients with older age were more strongly associated with increased odds of death (OR = 30.0; 95% CI, 2.85-315.62). Co-morbidity with chronic lung disease and hypertension were risk factors for mortality (OR = 14.40; 95% CI, 1.30-159.52, OR = 6.67; 95% CI, 1.09-40.43, respectively). Moreover, the presence of either bilateral lung inflammation or pulmonary consolidation on chest imaging on admission was related with fatal outcome (OR = 7.00; 95% CI, 1.10-44.61). Finally, dynamic monitoring showed that lymphopenia was more significant in fatal group than in nonfatal group from day 11 to week five (P<0.05). The decrease in oxygenation indexes were observed in most cases and more significantly in fatal cases after week three (P<0.05), and the value of nearly all fatal cases were below 200 mmHg during our evaluation period. Conclusions: Among cases with H7N9 virus infection, increased age accompanied by co-morbidities was the risk of death. The severity of lung infection at admission, the persistence of lymphocytopenia, and the extended duration of lower oxygenation index all contributed to worsened outcomes of patients with H7N9 virus infection.	[Ji, Hong; Xu, Ke; Bao, Chang-jun; Tang, Fen-yang; Qi, Xian; Ai, Jing; Yu, Hui-yan; Zhu, Ye-fei] Jiangsu Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Gu, Qin; Dong, Dan-jiang] Nanjing Drum Tower Hosp, Dept Crit Care Med, Nanjing, Jiangsu, Peoples R China; [Chen, Li-ling; Xia, Yu] Suzhou Municipal Ctr Dis Control & Prevent, Suzhou, Jiangsu, Peoples R China; [Ling, Xia; Chen, Shan-hui] Wuxi Municipal Ctr Dis Control & Prevent, Wuxi, Jiangsu, Peoples R China; [Wu, Ying-qiu; Xu, Ying; Gu, Cai-ling] Soochow Univ, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China; [Shen, Gu-yu; Yang, Gen-lin] Nanjing Med Univ, Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China; [Huang, Mao; Cao, Quan] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhao, Wei] Second Hosp Nanjing, Nanjing, Jiangsu, Peoples R China; [Xu, Yang-ting; Xie, Guo-xiang] Nanjing Municipal Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Zhu, Feng-cai; Zhou, Ming-hao] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; Nanjing University; Soochow University - China; Jiangnan University; Nanjing Medical University; Nanjing Medical University; Jiangsu Provincial Center for Disease Control & Prevention	Bao, CJ (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.	bao2000_cn@163.com; zmh@jscdc.cn	zhou, minghao/GZA-7244-2022; Xie, Guoxiang/F-3022-2016	Xie, Guoxiang/0000-0002-0951-4150	Jiangsu Province Health Development Project with Science and Education [ZX201109, RC2011085]; Natural Science Foundation of China [81373055]; Jiangsu Province Science and Technology Support Program [BE2012769]; National Ministry of Science and Technology [KJYJ-2013-01-02]; 10th Summit of Six Top Talents of Jiangsu Province	Jiangsu Province Health Development Project with Science and Education; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Science and Technology Support Program; National Ministry of Science and Technology; 10th Summit of Six Top Talents of Jiangsu Province	This study was funded by Jiangsu Province Health Development Project with Science and Education (ZX201109 and RC2011085); Natural Science Foundation of China (No. 81373055); Jiangsu Province Science and Technology Support Program (social development: BE2012769); National Ministry of Science and Technology Emergency Research Project on human infection with avian influenza H7N9 virus (No. KJYJ-2013-01-02). M. H. Zhou and Y.F. Zhu are partly supported by Jiangsu Province Health Development Project with Science and Education (ZX201109 and RC2011085). C.J. Bao is partly supported by Natural Science Foundation of China (No. 81373055), Jiangsu Province Science and Technology Support Program (social development: BE2012769), and the 10th Summit of Six Top Talents of Jiangsu Province. F.Y. Tang is supported by National Ministry of Science and Technology Emergency Research Project on human infection with avian influenza H7N9 virus (No. KJYJ-2013-01-02). The contents of this article are solely the responsibility of the authors and do not necessarily represent the views of the Jiangsu Provincial Centers for Disease Control and Prevention or other organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Adisasmito W, 2010, J INFECT DIS, V202, P1154, DOI 10.1086/656316; Bermejo-Martin JF, 2013, J INFECT DEV COUNTR, V7, P497, DOI 10.3855/jidc.3810; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Commission CNHaFP, DIAGN TREATM PROT HU; Cowling BJ, 2013, EUROSURVEILLANCE, V18, P2; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guan Y, 2013, J INFECT DEV COUNTR, V7, P302, DOI 10.3855/jidc.3675; Hien ND, 2009, EMERG INFECT DIS, V15, P19, DOI 10.3201/eid1501.080073; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V309, P2086, DOI 10.1001/jama.2013.6086; Lee EH, 2010, CLIN INFECT DIS, V50, P1498, DOI 10.1086/652446; Liu S, 2013, J INFECT, DOI 10.1016; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Lu S, 2013, EMERG INFECT DIS, V19; Mei Z, 2013, EMERG INFECT DIS, V19, P1179, DOI 10.3201/eid1907.130523; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Nicoll A., 2008, EURO SURVEILL, V13; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Shinde V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014809; Smallman-Raynor M, 2007, EMERG INFECT DIS, V13, P510, DOI 10.3201/eid1303.060849; WHO/GIP, 2003, CUM NUMB CONF HUM CA; Wong SSY, 2006, CHEST, V129, P156, DOI 10.1378/chest.129.1.156; Wongsurakiat P, 2004, CHEST, V125, P2011, DOI 10.1378/chest.125.6.2011; World Health Organization, FREQ ASK QUEST HUM I; Wu H, 2013, N ENGL J MED; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985	32	30	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89581	10.1371/journal.pone.0089581	http://dx.doi.org/10.1371/journal.pone.0089581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595034	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500018
J	Poissonnier, L; Villain, G; Soncin, F; Mattot, V				Poissonnier, Loic; Villain, Gaelle; Soncin, Fabrice; Mattot, Virginie			Egfl7 Is Differentially Expressed in Arteries and Veins during Retinal Vascular Development	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; MICRORNA MIR-126; ANGIOGENESIS; INTEGRITY; MIGRATION; DEATH; GENE; VEGF; MICE; CNS	The vasculature of the central nervous system (CNS) is composed of vascular endothelial and mural cells which interact closely with glial cells and neurons. The development of the CNS vascularisation is a unique process which requires the contribution of specific regulators in addition to the classical angiogenic factors. The egfl7 gene is mainly detected in endothelial cells during physiological and pathological angiogenesis. Egfl7 codes for a secreted protein which predominantly accumulates into the extracellular space where it controls vascular elastin deposition or the Notch pathway. Egfl7 is the host gene of the microRNA miR126 which is also expressed in endothelial cells and which plays major functions during blood vessel development. While the expression of egfl7 and that of miR126 were well described in endothelial cells during development, their pattern of expression during the establishment of the CNS vasculature is still unknown. By analysing the expression of egfl7 and miR126 during mouse retina vascularisation, we observed that while expression of miR126 is detected in all endothelia, egfl7 is initially expressed in all endothelial cells and then is progressively restricted to veins and to their neighbouring capillaries. The recruitment of mural cells around retina arteries coincides with the down-regulation of egfl7 in the arterial endothelial cells, suggesting that this recruitment could be involved in the loss of egfl7 expression in arteries. However, the expression pattern of egfl7 is similar when mural cell recruitment is prevented by the injection of a PDGFR beta blocking antibody, suggesting that vessel maturation is not responsible for egfl7 down-regulation in retinal arteries.	[Poissonnier, Loic; Villain, Gaelle; Soncin, Fabrice; Mattot, Virginie] Univ Lille Nord France, CNRS, Inst Biol Lille, UMR8161, Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Mattot, V (corresponding author), Univ Lille Nord France, CNRS, Inst Biol Lille, UMR8161, Lille, France.	virginie.mattot@ibl.fr	SONCIN, Fabrice/A-1475-2009	SONCIN, Fabrice/0000-0001-6312-0673	Fondation pour la Recherche Medicale (FRM Regionale Comite Nord-Pas de Calais); Association pour la Recherche sur le Cancer (ARC) [5071]; Comite du Nord de la ligue Nationale contre le Cancer; Canceropole Nord-Ouest; ARC PhD student fellowship	Fondation pour la Recherche Medicale (FRM Regionale Comite Nord-Pas de Calais); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Comite du Nord de la ligue Nationale contre le Cancer; Canceropole Nord-Ouest; ARC PhD student fellowship	This work was supported by Fondation pour la Recherche Medicale (FRM Regionale Comite Nord-Pas de Calais 2009; VM), Association pour la Recherche sur le Cancer (ARC #5071; VM), Comite du Nord de la ligue Nationale contre le Cancer (VM) and Canceropole Nord-Ouest (VM). LP is supported by ARC PhD student fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiwala MV, 2010, CIRCULATION, V122, pS156, DOI 10.1161/CIRCULATIONAHA.109.927715; Bell ML, 2010, MOL CELL BIOL, V30, P1937, DOI 10.1128/MCB.01370-09; Claxton S, 2005, DEV DYNAM, V233, P822, DOI 10.1002/dvdy.20407; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Eichmann A, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006551; Fantin A, 2013, NAT PROTOC, V8, P418, DOI 10.1038/nprot.2013.015; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fitch MJ, 2004, DEV DYNAM, V230, P316, DOI 10.1002/dvdy.20063; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lelievre E, 2008, EMBO J, V27, P1658, DOI 10.1038/emboj.2008.103; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Nichol D, 2010, BLOOD, V116, P6133, DOI 10.1182/blood-2010-03-274860; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Ruhrberg C, 2013, CELL MOL LIFE SCI, V70, P1675, DOI 10.1007/s00018-013-1277-5; Schmidt M, 2007, DEVELOPMENT, V134, P2913, DOI 10.1242/dev.002576; Schmidt MHH, 2009, NAT CELL BIOL, V11, P873, DOI 10.1038/ncb1896; Soncin F, 2003, EMBO J, V22, P5700, DOI 10.1093/emboj/cdg549; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Tam SJ, 2012, DEV CELL, V22, P403, DOI 10.1016/j.devcel.2011.11.018; Uemura A, 2002, J CLIN INVEST, V110, P1619, DOI 10.1172/JCI200215621; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wong Andrew D, 2013, Front Neuroeng, V6, P7, DOI 10.3389/fneng.2013.00007; Xu D, 2008, AM J PHYSIOL-LUNG C, V294, pL17, DOI 10.1152/ajplung.00178.2007	29	8	8	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90455	10.1371/journal.pone.0090455	http://dx.doi.org/10.1371/journal.pone.0090455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595089	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500052
J	Wang, CH; Chang, RW; Ko, YH; Tsai, PR; Wang, SS; Chen, YS; Ko, WJ; Chang, CY; Young, TH; Chang, KC				Wang, Chih-Hsien; Chang, Ru-Wen; Ko, Ya-Hui; Tsai, Pi-Ru; Wang, Shoei-Shen; Chen, Yih-Sharng; Ko, Wen-Je; Chang, Chun-Yi; Young, Tai-Horng; Chang, Kuo-Chu			Prevention of Arterial Stiffening by Using Low-Dose Atorvastatin in Diabetes Is Associated with Decreased Malondialdehyde	PLOS ONE			English	Article							LIPID-DERIVED MALONDIALDEHYDE; PLACEBO-CONTROLLED TRIAL; OXIDATIVE STRESS; VASCULAR COMPLICATIONS; END-PRODUCTS; NITRIC-OXIDE; FATTY-ACIDS; TIME DOMAIN; MELLITUS; SYSTEM	Introduction: Without affecting the lipid profile, a low-dose treatment with atorvastatin contributes to the reduction of oxidative stress, inflammation, and adverse cardiovascular events in diabetes. In this study, we investigated whether low-dose atorvastatin exerts any beneficial effect on vascular dynamics in streptozotocin (STZ)-induced diabetes in male Wistar rats. Methods: Diabetes was induced using a single tail-vein injection of STZ at 55 mg kg(-1). The diabetic rats were treated daily with atorvastatin (10 mg kg(-1) by oral gavage) for 6 weeks. They were also compared with untreated age-matched diabetic controls. Arterial wave reflection was derived using the impulse response function of the filtered aortic input impedance spectra. A thiobarbituric acid reactive substances measurement was used to estimate the malondialdehyde content. Results: The high plasma level of total cholesterol in the diabetic rats did not change in response to this low-dose treatment with atorvastatin. Atorvastatin resulted in a significant increase of 15.4% in wave transit time and a decrease of 33.5% in wave reflection factor, suggesting that atorvastatin may attenuate the diabetes-induced deterioration in systolic loads imposed on the heart. This was in parallel with its lowering of malondialdehyde content in plasma and aortic walls in diabetes. Atorvastatin therapy also prevented the diabetes-related cardiac hypertrophy, as evidenced by the diminished ratio of left ventricular weight to body weight. Conclusion: These findings indicate that low-dose atorvastatin might protect diabetic vasculature against diabetes-associated deterioration in aorta stiffness and cardiac hypertrophy, possibly through its decrease of lipid oxidation-derived malondialdehyde.	[Wang, Chih-Hsien; Wang, Shoei-Shen; Chen, Yih-Sharng] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Wang, Chih-Hsien] Natl Taiwan Univ Hosp, Dept Surg, Hsin Chu Branch, Hsinchu, Taiwan; [Chang, Ru-Wen; Tsai, Pi-Ru; Ko, Wen-Je] Natl Taiwan Univ Hosp, Dept Surg & Traumatol, Taipei, Taiwan; [Wang, Chih-Hsien; Ko, Ya-Hui; Chang, Kuo-Chu] Natl Taiwan Univ, Dept Physiol, Coll Med, Taipei 10764, Taiwan; [Chang, Chun-Yi] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Young, Tai-Horng] Natl Taiwan Univ, Inst Biomed Engn, Coll Med & Engn, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chang, KC (corresponding author), Natl Taiwan Univ, Dept Physiol, Coll Med, Taipei 10764, Taiwan.	kcchang1008@ntu.edu.tw		WANG, CHIH-HSIEN/0000-0003-3214-6867; CHANG, KUO-CHU/0000-0002-4421-5711; Chen, Yih-Sharng/0000-0003-3846-8162; Wang, Shoei-Shen/0000-0003-3201-4143	National Science Council of Taiwan [NSC 101-2320-B-002-021-MY2]; National Taiwan University Hospital, Hsin-Chu Branch [HCH-101-19]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital, Hsin-Chu Branch	This study was supported by grants from the National Science Council of Taiwan (NSC 101-2320-B-002-021-MY2) and National Taiwan University Hospital, Hsin-Chu Branch (HCH-101-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2003, J HYPERTENS, V21, P3, DOI 10.1097/00004872-200301000-00002; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; BEUGE JA, 1978, METHOD ENZYMOL, V52, P302; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chang KC, 2003, EXP BIOL MED, V228, P70, DOI 10.1177/153537020322800110; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2003, LANCET, V361, P2005; COX RH, 1974, J APPL PHYSIOL, V36, P381, DOI 10.1152/jappl.1974.36.3.381; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Guyton AC, 1992, HUMAN PHYSL MECH DIS, P115; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; JAUHIAINEN M, 1986, J BIOL CHEM, V261, P7032; Jinnouchi Y, 2006, CLIN EXP MED, V6, P191, DOI 10.1007/s10238-006-0115-6; Laufs U, 2003, EUR J CLIN PHARMACOL, V58, P719, DOI 10.1007/s00228-002-0556-0; LAXMINARAYAN S, 1978, IEEE T BIO-MED ENG, V25, P177, DOI 10.1109/TBME.1978.326244; Liu A, 1986, AM J PHYSIOL, V251, pH588; Lykkesfeldt J, 2007, CLIN CHIM ACTA, V380, P50, DOI 10.1016/j.cca.2007.01.028; Milnor W.R., 1989, HEMODYNAMICS, V2nd Edn; MITCHELL GF, 1994, AM J PHYSIOL-HEART C, V267, pH1907, DOI 10.1152/ajpheart.1994.267.5.H1907; Nichols W., 2005, MCDONALDS BLOOD FLOW, V5th; OKABE H, 1980, CLIN CHEM, V26, P1540; Oram JF, 2004, FRONT BIOSCI-LANDMRK, V9, P1240, DOI 10.2741/1300; Pieper GM, 1999, DIABETOLOGIA, V42, P204, DOI 10.1007/s001250051140; Riad A, 2007, EUR J PHARMACOL, V569, P204, DOI 10.1016/j.ejphar.2007.04.065; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Shanmugam N, 2008, DIABETES, V57, P879, DOI 10.2337/db07-1204; SIPKEMA P, 1980, CARDIOVASC RES, V14, P270, DOI 10.1093/cvr/14.5.270; Slatter DA, 1999, J BIOL CHEM, V274, P19661, DOI 10.1074/jbc.274.28.19661; Slatter DA, 2000, DIABETOLOGIA, V43, P550, DOI 10.1007/s001250051342; TOMLINSON KC, 1992, PHARMACOL REV, V44, P103; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; WESTERHOF N, 1972, CARDIOVASC RES, V6, P648, DOI 10.1093/cvr/6.6.648; Williamson JR, 1989, DIABETES MELLITUS PA, P142; Yamagishi S, 2006, CURR PHARM DESIGN, V12, P1549, DOI 10.2174/138161206776389796; ZATZ R, 1986, AM J MED, V80, P443, DOI 10.1016/0002-9343(86)90719-9	38	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90471	10.1371/journal.pone.0090471	http://dx.doi.org/10.1371/journal.pone.0090471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595201	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500054
J	Deetman, PE; Bakker, SJL; Kwakernaak, AJ; Navis, G; Dullaart, RPF				Deetman, Petronella E.; Bakker, Stephan J. L.; Kwakernaak, Arjan J.; Navis, Gerjan; Dullaart, Robin P. F.		PREVEND Study Grp	The Relationship of the Anti-Oxidant Bilirubin with Free Thyroxine Is Modified by Insulin Resistance in Euthyroid Subjects	PLOS ONE			English	Article							SERUM BILIRUBIN; METABOLIC SYNDROME; THYROID-HORMONE; HEPATIC TRANSPORT; HEME OXYGENASE-1; RISK; ASSOCIATION; FAILURE; PATHWAY; GLUCOSE	Background: The strong anti-oxidative properties of bilirubin largely explain its cardioprotective effects. Insulin resistance is featured by low circulating bilirubin. Thyroid hormone affects both bilirubin generation and its biliary transport, but it is unknown whether circulating bilirubin is associated with thyroid function in euthyroid subjects. Aim is to determine relationships of bilirubin with TSH, free T-4 and free T-3 in euthyroid subjects without type 2 diabetes mellitus (T2DM), and to assess whether such a relationship would be modified by the degree of insulin resistance. Methods: Total bilirubin, TSH, free T-4, free T-3, glucose, insulin, lipids and transaminases were measured in 1854 fasting euthyroid subjects without T2DM, recruited from the general population (PREVEND cohort). Insulin resistance was assessed by homeostasis model assessment. Results: Bilirubin was positively related to free T-4 (beta = 0.116, P<0.001) and free T-3 (beta = 0.078, P = 0.001), but bilirubin was unrelated to TSH. The relationship of bilirubin with free T-4 was modified by insulin resistance with a larger effect in more insulin resistant individuals (adjusted for age and sex: beta = 0.043, P = 0.056 for interaction; additionally adjusted for smoking, alcohol intake, transaminases and total cholesterol (beta = 0.044, P = 0.044 for interaction). The association of bilirubin with free T-4 was also modified by high density lipoprotein cholesterol (age- and sex-adjusted: beta = 0.040, P = 0.072). Conclusions: Low bilirubin relates to low free T-4 in euthyroid non-diabetic subjects. Low normal free T-4 may particularly confer low bilirubin in more insulin resistant individuals.	[Deetman, Petronella E.; Bakker, Stephan J. L.; Kwakernaak, Arjan J.; Navis, Gerjan; Dullaart, Robin P. F.; PREVEND Study Grp] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9700 AB Groningen, Netherlands	University of Groningen	Deetman, PE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9700 AB Groningen, Netherlands.	p.e.deetman@umcg.nl	de Zeeuw, Dick/E-9080-2014; Bakker, Stephan J. L./J-4023-2015	de Zeeuw, Dick/0000-0003-3434-7777; Bakker, Stephan J. L./0000-0003-3356-6791; Stolk, Ronald/0000-0002-0518-1205; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921	Dutch Kidney Foundation [E.033]; Dade Behring; Ausam; Roche; Abbott; Dutch Heart Foundation [2001-005]	Dutch Kidney Foundation; Dade Behring; Ausam; Roche(Roche Holding); Abbott(Abbott Laboratories); Dutch Heart Foundation(Netherlands Heart Foundation)	The Dutch Kidney Foundation supported the infrastructure of the PREVEND program from 1997 to 2003 (Grant E.033). The University Medical Center Groningen supported the infrastructure from 2003 to 2006. Dade Behring, Ausam, Roche, and Abbott financed laboratory equipment and reagents by which various laboratory determinations could be performed. The Dutch Heart Foundation supported studies on lipid metabolism (Grant 2001-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggeli IK, 2011, ENDOCRINOLOGY, V152, P1274, DOI 10.1210/en.2010-1319; Ajja R, 2011, AM J CARDIOL, V108, P1438, DOI 10.1016/j.amjcard.2011.06.067; Bao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012371; Chan KH, 2013, DIABETOLOGIA, V56, P724, DOI 10.1007/s00125-012-2818-4; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Deetman PE, 2013, THYROID IN PRESS; Deetman PE, 2012, TRANSPL INT, V25, P876, DOI 10.1111/j.1432-2277.2012.01515.x; Dullaart RPF, 2012, CLIN CHIM ACTA, V414, P161, DOI 10.1016/j.cca.2012.08.029; Duntas LH, 2002, THYROID, V12, P287, DOI 10.1089/10507250252949405; Ferder L, 2006, CURR HYPERTENS REP, V8, P191, DOI 10.1007/s11906-006-0050-7; GARTNER LM, 1972, AM J PHYSIOL, V222, P1091, DOI 10.1152/ajplegacy.1972.222.5.1091; Harrison EM, 2006, FEBS J, V273, P2345, DOI 10.1111/j.1742-4658.2006.05224.x; Heima NE, 2013, EUR J ENDOCRINOL, V168, P59, DOI 10.1530/EJE-12-0375; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; Katsiki N, 2013, DIABETOLOGIA, V56, P683, DOI 10.1007/s00125-013-2840-1; Kraemer HC, 2004, INT J METH PSYCH RES, V13, P141, DOI 10.1002/mpr.170; Li F, 2011, MOL CELL ENDOCRINOL, V339, P54, DOI 10.1016/j.mce.2011.03.019; Lu M, 2005, J NEUROSCI METH, V143, P209, DOI 10.1016/j.jneumeth.2004.10.002; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Muscogiuri G, 2008, CURR VASC PHARMACOL, V6, P301, DOI 10.2174/157016108785909715; Novotny L, 2003, EXP BIOL MED, V228, P568, DOI 10.1177/15353702-0322805-29; Oda E, 2013, ACTA DIABETOL, V50, P417, DOI 10.1007/s00592-012-0447-5; Ong KL, 2011, ATHEROSCLEROSIS, V219, P728, DOI 10.1016/j.atherosclerosis.2011.07.094; Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Roos A, 2007, J CLIN ENDOCR METAB, V92, P491, DOI 10.1210/jc.2006-1718; Selvin S., 1996, STAT ANAL EPIDEMIOLO; Shieh G, 2011, BRIT J MATH STAT PSY, V64, P462, DOI 10.1111/j.2044-8317.2010.02002.x; SMITH TJ, 1991, BIOCHIM BIOPHYS ACTA, V1075, P119, DOI 10.1016/0304-4165(91)90240-H; TISDALE WA, 1959, AM J MED, V26, P214, DOI 10.1016/0002-9343(59)90310-9; Triolo M, 2013, CLIN ENDOCRINOL, V79, P416, DOI 10.1111/cen.12138; TUNON MJ, 1991, J HEPATOL, V13, P71, DOI 10.1016/0168-8278(91)90866-A; VANSTEENBERGEN W, 1989, HEPATOLOGY, V9, P314, DOI 10.1002/hep.1840090225; Varin R, 2000, CIRCULATION, V102, P351; Vitek L, 2007, ADV CLIN CHEM, V43, P1, DOI 10.1016/S0065-2423(06)43001-8; Vitek L, 2006, CEREBROVASC DIS, V21, P408, DOI 10.1159/000091966; Vitek L, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00055; Wassen FWJS, 2000, J ENDOCRINOL, V165, P599, DOI 10.1677/joe.0.1650599; Zelle DM, 2011, KIDNEY INT, V79, P686, DOI 10.1038/ki.2010.503	41	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90886	10.1371/journal.pone.0090886	http://dx.doi.org/10.1371/journal.pone.0090886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595410	gold, Green Published, Green Submitted			2022-12-25	WOS:000332468900154
J	Hashimoto, DT; Senhorini, JA; Foresti, F; Martinez, P; Porto-Foresti, F				Hashimoto, Diogo Teruo; Senhorini, Jose Augusto; Foresti, Fausto; Martinez, Paulino; Porto-Foresti, Fabio			Genetic Identification of F1 and Post-F1 Serrasalmid Juvenile Hybrids in Brazilian Aquaculture	PLOS ONE			English	Article							LEPORINUS-MACROCEPHALUS; CLARIAS-MACROCEPHALUS; FISH HYBRIDS; DIPLOID EGGS; CUTTHROAT; MARKERS; HYBRIDIZATION; MANAGEMENT; CATFISH; INTROGRESSION	Juvenile fish trade monitoring is an important task on Brazilian fish farms. However, the identification of juvenile fish through morphological analysis is not feasible, particularly between interspecific hybrids and pure species individuals, making the monitoring of these individuals difficult. Hybrids can be erroneously identified as pure species in breeding facilities, which might reduce production on farms and negatively affect native populations due to escapes or stocking practices. In the present study, we used a multi-approach analysis (molecular and cytogenetic markers) to identify juveniles of three serrasalmid species (Colossoma macropomum, Piaractus mesopotamicus and Piaractus brachypomus) and their hybrids in different stocks purchased from three seed producers in Brazil. The main findings of this study were the detection of intergenus backcrossing between the hybrid female patinga (P. mesopotamicus x P. brachypomus) x C. macropomum and the occurrence of one hybrid triploid individual. This atypical specimen might result from automixis, a mechanism that produces unreduced gametes in some organisms. Moreover, molecular identification indicated that hybrid individuals are traded as pure species or other types of interspecific hybrids, particularly post-F1 individuals. These results show that serrasalmid fish genomes exhibit high genetic heterogeneity, and multi-approach methods and regulators could improve the surveillance of the production and trade of fish species and their hybrids, thereby facilitating the sustainable development of fish farming.	[Hashimoto, Diogo Teruo] Univ Estadual Paulista, UNESP, Ctr Aquicultura, Jaboticabal, SP, Brazil; [Senhorini, Jose Augusto] Inst Chico Mendes Conservacao Biodiversidade, Ctr Pesquisa & Gestao Recursos Pesqueiros Contine, Pirassununga, SP, Brazil; [Foresti, Fausto] Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Morfol, Botucatu, SP, Brazil; [Martinez, Paulino] Univ Santiago de Compostela, Fac Vet, Dept Genet, Lugo, Spain; [Porto-Foresti, Fabio] Univ Estadual Paulista, UNESP, Fac Ciencias, Dept Ciencias Biol, Bauru, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Santiago de Compostela; Universidade Estadual Paulista	Hashimoto, DT (corresponding author), Univ Estadual Paulista, UNESP, Ctr Aquicultura, Campus Jaboticabal, Jaboticabal, SP, Brazil.	diogo@caunesp.unesp.br	Hashimoto, Diogo Teruo/A-4377-2013; Porto-Foresti, Fabio/AAC-4797-2020; Gómez, ACUIGEN/ABD-5337-2020; Augusto, José Senhorini/S-2419-2016; Martínez, Paulino/K-8636-2014; Hashimoto, Diogo Teruo/AAP-7423-2020; Calado, Leonardo/H-1346-2016	Porto-Foresti, Fabio/0000-0001-8845-3845; Augusto, José Senhorini/0000-0002-5120-448X; Martínez, Paulino/0000-0001-8438-9305; Hashimoto, Diogo Teruo/0000-0002-8808-2498; Calado, Leonardo/0000-0003-2328-5267	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [481823/2011-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq number 481823/2011-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Almeida-Toledo L.F., 1996, Boletim Tecnico do CEPTA, V9, P31; Almeida-Toledo LF, 1987, SELECTION HYBRIDIZAT, V1; Amish SJ, 2012, MOL ECOL RESOUR, V12, P653, DOI 10.1111/j.1755-0998.2012.03157.x; Angienda PO, 2011, CONSERV GENET, V12, P243, DOI 10.1007/s10592-010-0136-2; Arai K, 2013, CYTOGENET GENOME RES, V140, P226, DOI 10.1159/000353301; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; BARTLEY DM, 1991, COPEIA, P854, DOI 10.2307/1446416; Bartley DM, 2000, REV FISH BIOL FISHER, V10, P325, DOI 10.1023/A:1016691725361; Boecklen WJ, 1997, ECOLOGY, V78, P2611, DOI 10.1890/0012-9658(1997)078[2611:GAOHZN]2.0.CO;2; Calcagnotto D, 1999, AQUACULTURE, V174, P51, DOI 10.1016/S0044-8486(99)00005-8; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; do Prado FD, 2012, FISH RES, V125, P300, DOI 10.1016/j.fishres.2012.02.030; do Prado FD, 2011, AQUAC RES, V42, P1890, DOI 10.1111/j.1365-2109.2010.02777.x; Docker MF, 2003, MOL ECOL, V12, P3515, DOI 10.1046/j.1365-294X.2003.02000.x; Flores Nava A., 2007, FAO Fisheries Technical Paper, P91; Food and Agriculture Organization, 2010, The State of World Fisheries and Aquaculture, 2010; FORESTI F, 1981, CYTOGENET CELL GENET, V31, P137, DOI 10.1159/000131639; Godinho H. P., 2007, Revista Brasileira de Reproducao Animal, V31, P351; Gomelsky B, 2003, AQUAT LIVING RESOUR, V16, P408, DOI 10.1016/S0990-7440(03)00085-8; Gomes F, 2012, AN ACAD BRAS CIENC, V84, P89; Gomes L. C., 2010, ESPECIES NATIVAS PIS, P175; Hallerman E., 2008, FAO Fisheries and Aquaculture Technical Paper, P47; Hashimoto DT, 2011, CYTOGENET GENOME RES, V134, P64, DOI 10.1159/000323512; Hashimoto DT, 2009, CYTOGENET GENOME RES, V124, P151, DOI 10.1159/000207523; Hashimoto DT, 2012, REV AQUACULT, V4, P108, DOI 10.1111/j.1753-5131.2012.01067.x; Hashimoto DT, 2013, AQUAC RES, V44, P876, DOI 10.1111/j.1365-2109.2012.03092.x; Hashimoto DT, 2011, AQUACULTURE, V321, P49, DOI 10.1016/j.aquaculture.2011.08.018; Hashimoto DT, 2010, AQUACULTURE, V298, P346, DOI 10.1016/j.aquaculture.2009.11.015; Hashimoto DT, 2009, GENETICA, V137, P135, DOI 10.1007/s10709-009-9366-y; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Hu HongLang, 2007, FAO Fisheries Technical Paper, P185; IBAMA, 2007, EST PESC 2007 BRAS G; Itono M, 2007, J EXP ZOOL PART A, V307A, P35, DOI 10.1002/jez.a.344; Lamatsch DK, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P399, DOI 10.1007/978-90-481-2770-2_19; Lampert KP, 2007, CURR BIOL, V17, P1948, DOI 10.1016/j.cub.2007.09.064; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Mair GC, 2007, ENV RISK ASSESS GENE, V3, P209, DOI 10.1079/9781845932961.0209; Mair GC, 2007, ASSESSMENT FRESHWATE, P519; Martino G, 2002, CIVA 2002 COMUNICACI, P688; Martins C., 2004, FOCUS GENOME RES, P289; Mia MY, 2005, AQUACULTURE, V247, P267, DOI 10.1016/j.aquaculture.2005.02.018; Na-Nakorn U, 2004, AQUACULTURE, V240, P145, DOI 10.1016/j.aquaculture.2004.08.001; Nirchio M, 2003, CARYOLOGIA, V56, P405, DOI 10.1080/00087114.2003.10589351; Orsi ML, 1999, REV BRAS ZOOL, V16, P557; Paiva MP, 2002, REPRESAS PEIXES NATI; PENDAS AM, 1994, CYTOGENET CELL GENET, V67, P31, DOI 10.1159/000133792; Porto-Foresti F, 2013, J APPL ICHTHYOL, V29, P643, DOI 10.1111/jai.12092; Porto-Foresti F, 2008, GENET MOL BIOL, V31, P195, DOI 10.1590/S1415-47572008000200005; Pullin RSV, 1988, INT CTR LIV AQ RES M; Senanan W, 2004, AQUACULTURE, V235, P167, DOI 10.1016/j.aquaculture.2003.08.020; Shimizu Y, 2000, ZOOL SCI, V17, P951, DOI 10.2108/zsj.17.951; Suplicy F. M., 2007, FAO Fisheries Technical Paper, P129; Toledo-Filho SA, 1994, CADERNOS ICTIOGENETI, V2; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/NMETH.2023, 10.1038/nmeth.2023]; Yang F, 1999, GENOMICS, V62, P189, DOI 10.1006/geno.1999.5989; Young WP, 2001, MOL ECOL, V10, P921, DOI 10.1046/j.1365-294X.2001.01247.x	57	29	30	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89902	10.1371/journal.pone.0089902	http://dx.doi.org/10.1371/journal.pone.0089902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594674	gold, Green Published, Green Submitted			2022-12-25	WOS:000332468900044
J	Wilding, C; Bell, K; Beck, S; Funke, S; Pfeiffer, N; Grus, FH				Wilding, Corina; Bell, Katharina; Beck, Sabine; Funke, Sebastian; Pfeiffer, Norbert; Grus, Franz H.			gamma-Synuclein Antibodies Have Neuroprotective Potential on Neuroretinal Cells via Proteins of the Mitochondrial Apoptosis Pathway	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; ALPHA-SYNUCLEIN; OPTIC-NERVE; MEDIATED ENDOCYTOSIS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MYASTHENIA-GRAVIS; GLAUCOMA PATIENTS; MEDICAL PROGRESS; LEWY BODIES	The family of synuclein proteins (alpha, beta and gamma) are related to neurodegenerative disease e.g. Parkinson disease and Morbus Alzheimer. Additionally, a connection between gamma-synuclein and glaucoma, a neurodegenerative disease characterized by a progressive loss of retinal ganglion cells, which finally leads to blindness, exists. The reason for the development of glaucoma is still unknown. Recent studies evaluating the participation of immunological components, demonstrate complex changed antibody reactivities in glaucoma patients in comparison to healthy people, showing not only upregulations (e.g. alpha-fodrin antibody) but also down-regulations (e.g. gamma-synuclein antibody) of antibodies in glaucoma patients. Up-regulated antibodies could be auto-aggressive, but the role of down-regulated antibodies is still unclear. Previous studies show a significant influence of the serum and the antibodies of glaucoma patients on protein expression profiles of neuroretinal cells. The aim of this study was to investigate the effect of gamma-synuclein antibody on the viability and reactive oxygen species levels of a neuroretinal cell line (RGC-5) as well as their interaction with cellular proteins. We found a protective effect of gamma-synuclein antibody resulting in an increased viability (up to 15%) and decreased reactive oxygen species levels (up to -12%) of glutamate and oxidative stressed RGC-5. These can be traced back to anti-apoptotic altered protein expressions in the mitochondrial apoptosis pathway indicated by mass spectrometry and validated by microarray analysis such as active caspase 3, bcl-2 associated-x-protein, S100A4, voltage-dependent anion channel, extracellular-signal-regulated-kinase (down-regulated) and baculoviral IAP repeat-containing protein 6, phosphorylated extracellular-signal-regulated-kinase (up-regulated). These changed protein expression are triggered by the gamma-synuclein antibody internalization of RGC-5 we could see in immunohistochemical stainings. These findings let us assume a novel physiological function of gamma-synuclein antibodies and give insights in the role of autoantibodies in glaucoma. We hypothesize that the down-regulation of autoantibodies found in glaucoma patients lead to a loss of protective autoimmunity.	[Wilding, Corina; Bell, Katharina; Beck, Sabine; Funke, Sebastian; Pfeiffer, Norbert; Grus, Franz H.] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Grus, FH (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Dept Ophthalmol, D-55122 Mainz, Germany.	grus@eye-research.org	Bell, Katharina/T-5802-2019; Pfeiffer, Norbert/AAO-7586-2020		Forschungsschwerpunkt Translationale Neurowissenschaften Mainz	Forschungsschwerpunkt Translationale Neurowissenschaften Mainz	Forschungsschwerpunkt Translationale Neurowissenschaften Mainz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamus G, 1998, J AUTOIMMUN, V11, P523, DOI 10.1006/jaut.1998.0221; ALARCONSEGOVIA D, 1978, NATURE, V271, P67, DOI 10.1038/271067a0; Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; Bell K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046910; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Charest-Morin X, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00122; Congdon EE, 2013, J BIOL CHEM, V288, P35452, DOI 10.1074/jbc.M113.491001; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; Du Y, 2001, NEUROLOGY, V57, P801, DOI 10.1212/WNL.57.5.801; Fewou SN, 2012, J CLIN INVEST, V122, P1037, DOI 10.1172/JCI59110; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; FUKUOKA SI, 1991, NUCLEIC ACIDS RES, V19, P6961, DOI 10.1093/nar/19.24.6961; GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0; GRAUS YMF, 1993, IMMUNOL RES, V12, P78, DOI 10.1007/BF02918370; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Grus FH, 2006, INVEST OPHTH VIS SCI, V47, P968, DOI 10.1167/iovs.05-0685; Gutteridge Ian F, 2000, Clin Exp Optom, V83, P161; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Iglesias-Bartolome R, 2009, BBA-BIOMEMBRANES, V1788, P2526, DOI 10.1016/j.bbamem.2009.09.018; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Ji JZ, 2005, VISION RES, V45, P169, DOI 10.1016/j.visres.2004.08.008; Joachim SC, 2008, GRAEF ARCH CLIN EXP, V246, P573, DOI 10.1007/s00417-007-0737-8; Joachim SC, 2007, CURR EYE RES, V32, P501, DOI 10.1080/02713680701375183; Klettner AK, 2009, GRAEF ARCH CLIN EXP, V247, P1601, DOI 10.1007/s00417-009-1136-0; Kohler H, 2003, SCAND J IMMUNOL, V58, P285, DOI 10.1046/j.1365-3083.2003.01314.x; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Kuida K, 2000, INT J BIOCHEM CELL B, V32, P121, DOI 10.1016/S1357-2725(99)00024-2; Kumarswamy R, 2009, MITOCHONDRION, V9, P1, DOI 10.1016/j.mito.2008.10.003; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Maurage CA, 2003, ANN NEUROL, V54, P542, DOI 10.1002/ana.10730; MCINTOSH LP, 1985, BIOCHEMISTRY-US, V24, P4806, DOI 10.1021/bi00339a014; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Ninkina N, 2009, HUM MOL GENET, V18, P1779, DOI 10.1093/hmg/ddp090; Papachroni KK, 2007, J NEUROCHEM, V101, P749, DOI 10.1111/j.1471-4159.2006.04365.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; Saha AR, 2000, EUR J NEUROSCI, V12, P3073, DOI 10.1046/j.1460-9568.2000.00210.x; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Surgucheva I, 2002, J NEUROSCI RES, V68, P97, DOI 10.1002/jnr.10198; Surgucheva I, 2008, J MOL NEUROSCI, V35, P267, DOI 10.1007/s12031-008-9074-6; Surgucheva I, 2008, J BIOL CHEM, V283, P36377, DOI 10.1074/jbc.M806660200; Surgucheva I, 2008, MOL VIS, V14, P1540; Surguchov A, 2001, J NEUROSCI RES, V65, P68, DOI 10.1002/jnr.1129; Surguchov A, 2001, CELL MOTIL CYTOSKEL, V49, P218, DOI 10.1002/cm.1035; Tajeddine N, 2008, ONCOGENE, V27, P4221, DOI 10.1038/onc.2008.63; Tezel G, 2000, J NEUROSCI, V20, P3552, DOI 10.1523/JNEUROSCI.20-10-03552.2000; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; WAX MB, 1994, AM J OPHTHALMOL, V117, P561, DOI 10.1016/S0002-9394(14)70059-5; Yanase K, 1997, J CLIN INVEST, V100, P25, DOI 10.1172/JCI119517; Yang XJ, 2008, INVEST OPHTH VIS SCI, V49, P2483, DOI 10.1167/iovs.07-1344; Yuan SP, 2008, FASEB J, V22, P2809, DOI 10.1096/fj.08-107417; Zalewska R, 2008, MED SCI MONITOR, V14, pBR274; Zhou Y, 2005, MOL THER, V12, P402, DOI 10.1016/j.ymthe.2005.04.004	60	21	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90737	10.1371/journal.pone.0090737	http://dx.doi.org/10.1371/journal.pone.0090737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595072	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900141
J	Lawton, RJ; de Nys, R; Skinner, S; Paul, NA				Lawton, Rebecca J.; de Nys, Rocky; Skinner, Stephen; Paul, Nicholas A.			Isolation and Identification of Oedogonium Species and Strains for Biomass Applications	PLOS ONE			English	Article							FRESH-WATER ALGAE; SEQUENCES; CLASSIFICATION; TEMPERATURE; RECOVERY; RDNA	Freshwater macroalgae from the genus Oedogonium have recently been targeted for biomass applications; however, strains of Oedogonium for domestication have not yet been identified. Therefore, the objective of this study was to compare the performance of isolates of Oedogonium collected from multiple geographic locations under varying environmental conditions. We collected and identified wild-type isolates of Oedogonium from three geographic locations in Eastern Australia, then measured the growth of these isolates under a range of temperature treatments corresponding to ambient conditions in each geographic location. Our sampling identified 11 isolates of Oedogonium that could be successfully maintained under culture conditions. It was not possible to identify most isolates to species level using DNA barcoding techniques or taxonomic keys. However, there were considerable genetic and morphological differences between isolates, strongly supporting each being an identifiable species. Specific growth rates of species were high (>26% day(-1)) under 7 of the 9 temperature treatments (average tested temperature range: 20.9-27.7 degrees C). However, the variable growth rates of species under lower temperature treatments demonstrated that some were better able to tolerate lower temperatures. There was evidence for local adaptation under lower temperature treatments (winter conditions), but not under higher temperature treatments (summer conditions). The high growth rates we recorded across multiple temperature treatments for the majority of species confirm the suitability of this diverse genus for biomass applications and the domestication of Oedogonium.	[Lawton, Rebecca J.; de Nys, Rocky; Paul, Nicholas A.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Skinner, Stephen] Molonglo Catchment Grp, Fyshwick, Australia	James Cook University	Lawton, RJ (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	rebecca.lawton@jcu.edu.au	Paul, Nicholas/B-6496-2009; Lawton, Rebecca/E-5711-2014; de Nys, Rocky/D-6741-2012; Lawton, Rebecca/A-6149-2012	Lawton, Rebecca/0000-0001-6296-6415; de Nys, Rocky/0000-0003-3869-4928; Paul, Nicholas/0000-0002-9275-1535	Australian Government through the Australian Renewable Energy Agency; Advanced Manufacturing Cooperative Research Centre (AMCRC); Australian Government's Cooperative Research Centre Scheme	Australian Government through the Australian Renewable Energy Agency(Australian Renewable Energy Agency (ARENA)); Advanced Manufacturing Cooperative Research Centre (AMCRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research is supported by the Australian Government through the Australian Renewable Energy Agency and the Advanced Manufacturing Cooperative Research Centre (AMCRC), funded through the Australian Government's Cooperative Research Centre Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten WMJ, 2010, BIOFUELS-UK, V1, P91, DOI 10.4155/BFS.09.4; Anderson MJ, 2008, PERMANCOVA PRIMER GU; BAKKER FT, 1995, J MOL EVOL, V40, P640, DOI 10.1007/BF00160512; Bird MI, 2012, GCB BIOENERGY, V4, P61, DOI 10.1111/j.1757-1707.2011.01109.x; Cole AJ, 2014, GCB BIOENERGY, V6, P637, DOI 10.1111/gcbb.12097; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DAVISON IR, 1991, J PHYCOL, V27, P2, DOI 10.1111/j.0022-3646.1991.00002.x; Eggert A., 2012, SEAWEED BIOL, P47, DOI [10.1007/978-3-642-28451-9_3, DOI 10.1007/978-3-642-28451-9_3]; Evenson RE, 2003, SCIENCE, V300, P758, DOI 10.1126/science.1078710; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harper JT, 2001, CAH BIOL MAR, V42, P25; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kebede-Westhead E, 2006, J APPL PHYCOL, V18, P41, DOI 10.1007/s10811-005-9012-8; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lawton RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077344; Lawton RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064168; Lewis SH, 2007, ALGAE AUSTR BATRACHO; Lobban CS, 2000, SEAWEED ECOLOGY PHYS, P366; Mei H, 2007, PLANT SYST EVOL, V265, P179, DOI 10.1007/s00606-007-0523-4; MINORSKY PV, 1989, PLANT CELL ENVIRON, V12, P119, DOI 10.1111/j.1365-3040.1989.tb01924.x; Mulbry W, 2008, BIORESOURCE TECHNOL, V99, P8137, DOI 10.1016/j.biortech.2008.03.073; Paul NA, 2012, AQUACULTURE: FARMING AQUATIC ANIMALS AND PLANTS, 2ND EDITION, P268; RAVEN JA, 1988, NEW PHYTOL, V110, P441, DOI 10.1111/j.1469-8137.1988.tb00282.x; Ross AB, 2008, BIORESOURCE TECHNOL, V99, P6494, DOI 10.1016/j.biortech.2007.11.036; Saunders RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036470; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silva PHD, 2008, AQUACULTURE, V284, P74, DOI 10.1016/j.aquaculture.2008.07.035; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Yan J, 2012, GCB BIOENERGY, V4, P49, DOI 10.1111/j.1757-1707.2011.01108.x	32	39	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90223	10.1371/journal.pone.0090223	http://dx.doi.org/10.1371/journal.pone.0090223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603705	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000332483600031
J	Merino, JJ; Arce, C; Naddaf, A; Bellver-Landete, V; Oset-Gasque, MJ; Gonzalez, MP				Joaquin Merino, Jose; Arce, Carmen; Naddaf, Ahmad; Bellver-Landete, Victor; Jesus Oset-Gasque, Maria; Pilar Gonzalez, Maria			The Nitric Oxide Donor SNAP-Induced Amino Acid Neurotransmitter Release in Cortical Neurons. Effects of Blockers of Voltage-Dependent Sodium and Calcium Channels	PLOS ONE			English	Article							LOWER ESOPHAGEAL SPHINCTER; RAT ANOCOCCYGEUS MUSCLE; S-NITROSYLATION; GLUTAMATE RELEASE; EVOKED RELEASE; NERVOUS-SYSTEM; PROTEIN-KINASE; GABA RELEASE; MODULATION; TRANSMISSION	Background: The discovery that nitric oxide (NO) functions as a signalling molecule in the nervous system has radically changed the concept of neuronal communication. NO induces the release of amino acid neurotransmitters but the underlying mechanisms remain to be elucidated. Findings: The aim of this work was to study the effect of NO on amino acid neurotransmitter release (Asp, Glu, Gly and GABA) in cortical neurons as well as the mechanism underlying the release of these neurotransmitters. Cortical neurons were stimulated with SNAP, a NO donor, and the release of different amino acid neurotransmitters was measured by HPLC. The involvement of voltage dependent Na+ and Ca2+ channels as well as cGMP in its mechanism of action was evaluated. Conclusions: Our results indicate that NO induces release of aspartate, glutamate, glycine and GABA in cortical neurons and that this release is inhibited by ODQ, an inhibitor of soluble guanylate cyclase. Thus, the NO effect on amino acid neurotransmission could be mediated by cGMP formation in cortical neurons. Our data also demonstrate that the Na+ and Ca2+ voltage-dependent calcium channels are involved in the NO effects on cortical neurons.	[Joaquin Merino, Jose; Arce, Carmen; Bellver-Landete, Victor; Jesus Oset-Gasque, Maria; Pilar Gonzalez, Maria] Univ Complutense Madrid, Fac Farm, Dept Bioquim & Biol Mol 2, E-28040 Madrid, Spain; [Joaquin Merino, Jose; Arce, Carmen; Bellver-Landete, Victor; Jesus Oset-Gasque, Maria; Pilar Gonzalez, Maria] Univ Complutense Madrid, IUIN, Madrid, Spain; [Naddaf, Ahmad] Isra Univ, Fac Pharm, Amman, Jordan	Complutense University of Madrid; Complutense University of Madrid; Isra University	Merino, JJ (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Bioquim & Biol Mol 2, E-28040 Madrid, Spain.	josem2005@yahoo.es; pilarg@ucm.es	Oset Gasque, María Jesús/I-1072-2015	Oset Gasque, María Jesús/0000-0002-7223-0222	"Ministry of Science and Innovation, Spain" (MICINN) [SAF2010-20337]; UCM (Complutense University of Madrid, Spain)-Santander [GR35/10-B]; Cienporciennatural Company	"Ministry of Science and Innovation, Spain" (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); UCM (Complutense University of Madrid, Spain)-Santander; Cienporciennatural Company	This study was supported by respective grants from "Ministry of Science and Innovation, Spain" (MICINN) (SAF2010-20337), UCM (Complutense University of Madrid, Spain)-Santander (GR35/10-B), and Cienporciennatural Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern GP, 2002, TRENDS NEUROSCI, V25, P510, DOI 10.1016/S0166-2236(02)02254-3; Artinian L, 2012, EUR J NEUROSCI, V36, P3333, DOI 10.1111/j.1460-9568.2012.08260.x; BARNETTE MS, 1990, EUR J PHARMACOL, V182, P363, DOI 10.1016/0014-2999(90)90295-H; Bartus K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057292; Bellamy TC, 2002, P NATL ACAD SCI USA, V99, P507, DOI 10.1073/pnas.012368499; Beltran B, 1999, BRIT J PHARMACOL, V127, P1603, DOI 10.1038/sj.bjp.0702717; Bieda MC, 1999, J NEUROPHYSIOL, V81, P3092, DOI 10.1152/jn.1999.81.6.3092; BOECKXSTAENS GE, 1993, BRIT J PHARMACOL, V109, P1079, DOI 10.1111/j.1476-5381.1993.tb13732.x; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; Currie DA, 2006, DEV DYNAM, V235, P1668, DOI 10.1002/dvdy.20732; Drapier JC, 1996, BIOESSAYS, V18, P549, DOI 10.1002/bies.950180706; Engelmann M, 2002, NEUROSCI LETT, V324, P252, DOI 10.1016/S0304-3940(02)00211-2; Figueroa S, 2006, J NEUROSCI RES, V83, P441, DOI 10.1002/jnr.20739; Figueroa S, 2005, BRAIN RES, V1034, P25, DOI 10.1016/j.brainres.2004.11.024; Gallo EF, 2011, J NEUROSCI, V31, P6947, DOI 10.1523/JNEUROSCI.0374-11.2011; Gao YS, 2010, PFLUG ARCH EUR J PHY, V459, P829, DOI 10.1007/s00424-009-0773-9; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; GUSTAFSSON LE, 1990, BIOCHEM BIOPH RES CO, V173, P106, DOI 10.1016/S0006-291X(05)81028-9; HANBAUER I, 1992, NEUROREPORT, V3, P409, DOI 10.1097/00001756-199205000-00008; Hirooka K, 2000, J NEUROPHYSIOL, V83, P198, DOI 10.1152/jn.2000.83.1.198; HORN T, 1994, AM J PHYSIOL, V266, P306; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jin XG, 2011, J BIOL CHEM, V286, P33190, DOI 10.1074/jbc.M111.270967; Kiss JP, 2001, TRENDS NEUROSCI, V24, P211, DOI 10.1016/S0166-2236(00)01745-8; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; KURIYAMA K, 1995, JPN J PHARMACOL, V69, P1, DOI 10.1254/jjp.69.1; Lane P., 2001, SCI STKE, V86, pre1; LI CG, 1989, CLIN EXP PHARMACOL P, V16, P933, DOI 10.1111/j.1440-1681.1989.tb02404.x; LI CG, 1989, EUR J PHARMACOL, V168, P107, DOI 10.1016/0014-2999(89)90640-7; Lopez E, 2001, NEUROCHEM INT, V39, P283, DOI 10.1016/S0197-0186(01)00035-3; MARQUEZ FJ, 1986, J CHROMATOGR, V380, P275, DOI 10.1016/S0378-4347(00)83656-7; MartinezMartos JM, 1997, BRAIN RES BULL, V43, P441; MEFFERT MK, 1994, NEURON, V12, P1235, DOI 10.1016/0896-6273(94)90440-5; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Moncada S, 1997, PHARMACOL REV, V49, P137; Mongin AA, 1998, BIOCHEMISTRY-MOSCOW+, V63, P662; MONTAGUE PR, 1994, SCIENCE, V263, P973, DOI 10.1126/science.7508638; OHKUMA S, 1995, J NEUROCHEM, V65, P1109; Pieper AA, 2000, P NATL ACAD SCI USA, V97, P1845, DOI 10.1073/pnas.97.4.1845; Reaume Christopher J., 2009, V191, P423, DOI 10.1007/978-3-540-68964-5_18; REISER G, 1990, EUR J BIOCHEM, V189, P547, DOI 10.1111/j.1432-1033.1990.tb15521.x; SEGAL M, 1983, J NEUROPHYSIOL, V50, P1249, DOI 10.1152/jn.1983.50.6.1249; SEGIETH J, 1995, NEUROSCI LETT, V200, P101, DOI 10.1016/0304-3940(95)12088-L; Sistiaga A, 1997, EUR J PHARMACOL, V321, P247, DOI 10.1016/S0014-2999(96)00937-5; SORKIN LS, 1993, NEUROREPORT, V4, P479, DOI 10.1097/00001756-199305000-00004; TORPHY TJ, 1986, AM J PHYSIOL, V251, pG786, DOI 10.1152/ajpgi.1986.251.6.G786; Tozer AJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032256; TURNER TJ, 1992, SCIENCE, V258, P310, DOI 10.1126/science.1357749; WAGGONER AS, 1979, ANNU REV BIOPHYS BIO, V8, P47, DOI 10.1146/annurev.bb.08.060179.000403; WALAAS SI, 1991, PHARMACOL REV, V43, P299; Wang JQ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00164; Waterman SA, 1996, J NEUROSCI, V16, P4155; Xue L, 2000, P NATL ACAD SCI USA, V97, P1851, DOI 10.1073/pnas.97.4.1851; Yoshimura N, 2001, J NEUROPHYSIOL, V86, P304, DOI 10.1152/jn.2001.86.1.304	57	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90703	10.1371/journal.pone.0090703	http://dx.doi.org/10.1371/journal.pone.0090703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598811	gold, Green Accepted, Green Published			2022-12-25	WOS:000332479400121
J	Kolby, JE				Kolby, Jonathan E.			Presence of the Amphibian Chytrid Fungus Batrachochytrium dendrobatidis in Native Amphibians Exported from Madagascar	PLOS ONE			English	Article							POPULATION DECLINES; RANA-CATESBEIANA; CHYTRIDIOMYCOSIS; TRADE; EMERGENCE; DISEASE; FROGS; TIME	The emerging infectious disease chytridiomycosis is driven by the spread of amphibian chytrid fungus (Batrachochytrium dendrobatidis, Bd), a highly virulent pathogen threatening global amphibian biodiversity. Although pandemic in distribution, previous intensive field surveys have failed to detect Bd in Madagascar, a biodiversity hotspot home to hundreds of endemic amphibian species. Due to the presence of Bd in nearby continental Africa and the ecological crisis that can be expected following establishment in Madagascar, enhanced surveillance is imperative. I sampled 565 amphibians commercially exported from Madagascar for the presence of Bd upon importation to the USA, both to assist early detection efforts and demonstrate the conservation potential of wildlife trade disease surveillance. Bd was detected in three animals via quantitative PCR: a single Heterixalus alboguttatus, Heterixalus betsileo, and Scaphiophryne spinosa. This is the first time Bd has been confirmed in amphibians from Madagascar and presents an urgent call to action. Our early identification of pathogen presence prior to widespread infection provides the necessary tools and encouragement to catalyze a swift, targeted response to isolate and eradicate Bd from Madagascar. If implemented before establishment occurs, an otherwise likely catastrophic decline in amphibian biodiversity may be prevented.	James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Hlth Res Grp 1, Townsville, Qld 4811, Australia	James Cook University	Kolby, JE (corresponding author), James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Hlth Res Grp 1, Townsville, Qld 4811, Australia.	jonathan.kolby@my.jcu.edu.au	Kolby, Jonathan/GWZ-3092-2022; Kolby, Jonathan/GWV-5557-2022		James Cook University Australian Postgraduate Research Scholarship	James Cook University Australian Postgraduate Research Scholarship	Jonathan Kolby was supported by a James Cook University Australian Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreone F, 2008, PLOS BIOL, V6, P943, DOI 10.1371/journal.pbio.0060118; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Boyle DG, 2003, DIS AQUAT ORGAN, V56, P59, DOI 10.3354/dao056059; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Crottini A, 2011, NORTH-WEST J ZOOL, V7, P346; Daszak P, 2004, HERPETOL J, V14, P201; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher Matthew C., 2007, Fungal Biology Reviews, V21, P2, DOI 10.1016/j.fbr.2007.02.002; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Garland S, 2010, DIS AQUAT ORGAN, V92, P113, DOI 10.3354/dao02053; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Lotters S., 2011, BIODIVERSITY HOTSPOT, P255; Nichols DK, 2001, J WILDLIFE DIS, V37, P1; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Richards-Hrdlicka KL, 2013, DIS AQUAT ORGAN, V102, P169, DOI 10.3354/dao02552; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; Skerratt LF, 2008, DIS AQUAT ORGAN, V80, P85, DOI 10.3354/dao01923; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Vredenburg VT, 2012, HERPETOLOGY NOTES, V5, P507, DOI DOI 10.1186/1756-0500-5-507; Webb R, 2007, DIS AQUAT ORGAN, V74, P13, DOI 10.3354/dao074013; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Weldon Che, 2008, Museo Regionale di Scienze Naturali Monografie (Turin), V45, P95	31	15	19	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89660	10.1371/journal.pone.0089660	http://dx.doi.org/10.1371/journal.pone.0089660			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599336	Green Accepted, gold, Green Published			2022-12-25	WOS:000332479400022
J	Luna-Gomes, T; Filardy, AA; Rocha, JDB; Decote-Ricardo, D; LaRocque-de-Freitas, IF; Morrot, A; Bozza, PT; Castro-Faria-Neto, HC; DosReis, GA; Nunes, MP; Freire-de-Lima, CG				Luna-Gomes, Tatiana; Filardy, Alessandra A.; Rocha, Juliana Dutra B.; Decote-Ricardo, Debora; LaRocque-de-Freitas, Isabel Ferreira; Morrot, Alexandre; Bozza, Patricia T.; Castro-Faria-Neto, Hugo C.; DosReis, George A.; Nunes, Marise P.; Freire-de-Lima, Celio G.			Neutrophils Increase or Reduce Parasite Burden in Trypanosoma cruzi-Infected Macrophages, Depending on Host Strain: Role of Neutrophil Elastase	PLOS ONE			English	Article							APOPTOTIC CELLS; LEISHMANIA-MAJOR; MONOCLONAL-ANTIBODY; NITRIC-OXIDE; PHAGOCYTOSIS; MICE; RECOGNITION; GENERATION; DEPLETION; DRIVES	Neutrophils are involved in the initial steps of most responses to pathogens and are essential components of the innate immune response. Due to the ability to produce and release various soluble mediators, neutrophils may participate in the regulation of the inflammatory response. Little is known about the role of neutrophils during protozoan infections including infection by Trypanosoma cruzi. In the present study we investigated the importance of inflammatory neutrophils on macrophage activation and T. cruzi replication in vitro, in cells obtained from BALB/c mice and C57Bl/6 mice. Co-cultures of BALB/c apoptotic or live neutrophils with infected peritoneal macrophages resulted in increased replication of the parasites and in the production of TGF-beta and PGE(2). The treatment with anti-TGF-beta neutralizing antibody and COX inhibitor blocked the parasite replication in vitro. On the other hand, co-cultures of T. cruzi infected macrophages with live neutrophils isolated from C57BL/6 mice resulted in decreased number of trypomastigotes in culture and increased production of TNF-alpha and NO. The addition of anti-TNF-alpha neutralizing antibody or elastase inhibitor resulted in the abolishment of macrophage microbicidal effect and increased parasite replication. Addition of elastase to infected macrophages reduced the replication of the parasites, and on the other hand, addition of a selective inhibitor of iNOS increased parasite growth, suggesting the role of NO in this system. Our findings reveal that neutrophils may regulate T. cruzi experimental infection and determine susceptibility and resistance to infection.	[Luna-Gomes, Tatiana; Filardy, Alessandra A.; Rocha, Juliana Dutra B.; DosReis, George A.; Freire-de-Lima, Celio G.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Decote-Ricardo, Debora; LaRocque-de-Freitas, Isabel Ferreira] Univ Fed Rural Rio de Janeiro, Inst Vet, Rio De Janeiro, Brazil; [Morrot, Alexandre] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil; [Bozza, Patricia T.; Castro-Faria-Neto, Hugo C.; Nunes, Marise P.] Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Freire-de-Lima, CG (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.	celio@biof.ufrj.br	de Lima, Celio Geraldo Freire/A-9057-2012; Filardy, Alessandra/AAH-6034-2020; Bozza, Patricia T./AAM-4537-2021; Bozza, Patricia T./AAE-2933-2021; Decote-Ricardo, Debora/O-6480-2019	Filardy, Alessandra/0000-0003-4098-3235; Bozza, Patricia T./0000-0001-8349-9529; DosReis, George/0000-0002-8924-4727	Brazilian National Research Council (CNPq); Rio de Janeiro State Science Foundation (FAPERJ)	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Science Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Brazilian National Research Council (CNPq) and Rio de Janeiro State Science Foundation (FAPERJ). The funders had no the role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Abdallah DSA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00382; Appelberg R, 2007, TRENDS MICROBIOL, V15, P87, DOI 10.1016/j.tim.2006.11.009; Bliss SK, 1999, J IMMUNOL, V163, P2081; Chen L, 2001, EUR J IMMUNOL, V31, P265, DOI 10.1002/1521-4141(200101)31:1<265::AID-IMMU265>3.3.CO;2-C; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; D'Avila H, 2011, J INFECT DIS, V204, P951, DOI 10.1093/infdis/jir432; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Carmo EVD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013815; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Fadok VA, 2001, SEMIN IMMUNOL, V13, P365, DOI 10.1006/smim.2001.0333; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Fu LM, 2003, INT J TUBERC LUNG D, V7, P1027; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; Gregory SH, 2002, J LEUKOCYTE BIOL, V72, P239; HASLETT C, 1994, PHILOS T ROY SOC B, V345, P327, DOI 10.1098/rstb.1994.0113; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hoffmann PR, 2005, J IMMUNOL, V174, P1393, DOI 10.4049/jimmunol.174.3.1393; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Ji YS, 2013, EXP PARASITOL, V133, P70, DOI 10.1016/j.exppara.2012.10.013; KUDO C, 1993, J IMMUNOL, V150, P3728; KWON NS, 1989, J BIOL CHEM, V264, P20496; Laskay T, 2003, TRENDS MICROBIOL, V11, P210, DOI 10.1016/S0966-842X(03)00075-1; Lopes MF, 2000, IMMUNOL TODAY, V21, P489, DOI 10.1016/S0167-5699(00)01713-8; Meyer-Hoffert U, 2009, FRONT BIOSCI-LANDMRK, V14, P3409, DOI 10.2741/3462; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Patel VA, 2012, J BIOL CHEM, V287, P13761, DOI 10.1074/jbc.M112.350843; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Ribeiro-Gomes FL, 2006, PARASITOLOGY, V132, pS61, DOI 10.1017/S0031182006000862; Ribeiro-Gomes FL, 2004, J IMMUNOL, V172, P4454, DOI 10.4049/jimmunol.172.7.4454; Ribeiro-Gomes FL, 2007, J IMMUNOL, V179, P3988, DOI 10.4049/jimmunol.179.6.3988; Romani L, 1997, J IMMUNOL, V158, P2356; Savill J, 1997, BRIT MED BULL, V53, P491; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0; Zhang Y, 2010, J INTERF CYTOK RES, V30, P113, DOI 10.1089/jir.2010.0004	39	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90582	10.1371/journal.pone.0090582	http://dx.doi.org/10.1371/journal.pone.0090582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599360	Green Submitted, gold, Green Published			2022-12-25	WOS:000332479400098
J	Negrete, L; Colpo, KD; Brusa, F				Negrete, Lisandro; Colpo, Karine D.; Brusa, Francisco			Land Planarian Assemblages in Protected Areas of the Interior Atlantic Forest: Implications for Conservation	PLOS ONE			English	Article							SUBTROPICAL DECIDUOUS FOREST; MAN-INDUCED DISTURBANCE; FLATWORM PLATYHELMINTHES; COMMUNITY COMPOSITION; TRICLADIDA; TERRICOLA; BIODIVERSITY; DIVERSITY; GEOPLANIDAE; ARAUCARIA	Land planarians are an interesting group of free-living flatworms that can be useful as bioindicators because of their high sensitivity to environmental changes and low dispersal capacity. In this study, we describe and compare assemblages of land planarians from areas with different conservation degrees of the Interior Atlantic Forest (Misiones, Argentina), and assess factors that could be related to their abundance and richness. Eight sites were tracked in search of land planarians in Reserva de Vida Silvestre Urugua-i (RVSU) and Campo Anexo Manuel Belgrano (CAMB). Diurnal and nocturnal surveys were performed in each site along nine sampling campaigns. We collected 237 individuals belonging to 18 species of the subfamily Geoplaninae. All sites were dominated by Geoplana sp. 1 and Pasipha hauseri. The richness estimators showed that there would be more species in RVSU than in CAMB. The abundance and richness of land planarians was high during the night and after rainfalls, suggesting an increased activity of flatworms under such conditions. The abundance and richness of land planarians were also related to the conservation condition of the sites. Disturbed sites showed less abundance and richness, and were segregated from non-disturbed ones by nmMDS analysis. Beta diversity between sites was higher than expected, indicating that the species turnover between sites contributed more to the total richness (gamma diversity) than the alpha diversity.	[Negrete, Lisandro; Brusa, Francisco] Univ Nacl La Plata, Fac Ciencias Nat & Museo, Div Zool Invertebrados, La Plata, Buenos Aires, Argentina; [Colpo, Karine D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Lab Biol Reprod & Crecimiento Crustaceos Decapodo, Buenos Aires, DF, Argentina; [Negrete, Lisandro; Colpo, Karine D.; Brusa, Francisco] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	National University of La Plata; Museo La Plata; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Brusa, F (corresponding author), Univ Nacl La Plata, Fac Ciencias Nat & Museo, Div Zool Invertebrados, La Plata, Buenos Aires, Argentina.	fbrusa@fcnym.unlp.edu.ar	Brusa, Francisco/N-1250-2019	Brusa, Francisco/0000-0003-2206-1560; Colpo, Karine/0000-0003-4513-8620; Negrete, Lisandro/0000-0003-3398-6606	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas); Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT) [PICT 2007-01287]; UNLP (Universidad Nacional de La Plata) [11/N600]	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT)(ANPCyTFONCyT); UNLP (Universidad Nacional de La Plata)(National University of La Plata)	This work was financed by CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas), Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT) PICT 2007-01287, and UNLP (Universidad Nacional de La Plata) 11/N600. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carbonari FA, 2009, ENCUENTROS LATINOAM, P49; Antunes M, 2012, PEDOBIOLOGIA, V55, P25, DOI 10.1016/j.pedobi.2011.09.010; Antunes Michelle Bicalho, 2008, Neotropical Biology and Conservation, V3, P34; Baptista VA, 2010, BELG J ZOOL, V140, P83; Baptista Vanessa A., 2006, Iheringia, Sér. Zool., V96, P293, DOI 10.1590/S0073-47212006000300004; Baptista VD, 2010, BIOTA NEOTROP, V10, P247, DOI 10.1590/S1676-06032010000200027; Carbayo F, 2002, BIODIVERS CONSERV, V11, P1091, DOI 10.1023/A:1015865005604; Carbayo F, 2001, BELG J ZOOL, V131, P223; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chao A, 2000, STAT SINICA, V10, P227; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Colwell RK., 2013, STAT ESTIMATION SPEC; Colwell RK, 1996, BIODIVERSITY MEASURE, P101; De Castro A., 2005, ACTA BIOL LEOPOLDENS, V27, P147; Di Bitetti M.S., 2003, VISION BIODIVERSIDAD; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Feinsinger P., 2001, DESIGNING FIELD STUD; Fick IA, 2006, INVERTEBR BIOL, V125, P306, DOI 10.1111/j.1744-7410.2006.00062.x; Fonseca CR, 2009, BIOL CONSERV, V142, P1209, DOI 10.1016/j.biocon.2009.02.017; Froelich C. G., 1955, Boletim da Faculdade de Filosofia Ciencias e Letras Universidade de Sao Paulo Zoologica, V20, P263; Galindo-Leal C, 2003, STATE HOTS, P3; Giraudo AR, 2003, STATE HOTS, P160; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kawaguti S, 1932, MEM FS AGR TAIHOKU I, V7, P15; Leal-Zanchet AM, 2011, INVERTEBR BIOL, V130, P25, DOI 10.1111/j.1744-7410.2010.00215.x; Magurran A. E., 2004, MEASURING BIOL DIVER; Moreno CE, 2011, REV MEX BIODIVERS, V82, P1249, DOI 10.22201/ib.20078706e.2011.4.745; Morrone Juan J., 2001, M&T Manuales y Tesis SEA, V3, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Negrete L, 2014, ZOOTAXA, V 3753, P177, DOI 10.11646/zootaxa.3753.2.7; Negrete L, 2012, STUD NEOTROP FAUNA E, V47, P227, DOI 10.1080/01650521.2012.735071; OGREN RE, 1995, HYDROBIOLOGIA, V305, P105, DOI 10.1007/BF00036370; Pfeiffer Martin, 2012, PLoS One, V7, pe40729, DOI 10.1371/journal.pone.0040729; Prasniski MET, 2009, ZOOLOGIA-CURITIBA, V26, P606, DOI 10.1590/S1984-46702009005000011; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Romeis B., 1989, MIKROSKOPISCHE TECHN; Sluys R, 1998, PEDOBIOLOGIA, V42, P490; Sluys R, 1999, BIODIVERS CONSERV, V8, P1663, DOI 10.1023/A:1008994925673; Terrace T. E., 1996, Transactions of the Royal Society of South Australia, V120, P177; TERRACE TE, 1994, J AUST ENTOMOL SOC, V33, P371; Veech JA., 2009, PARTITION SOFTWARE H; Winsor Leigh, 2004, P227, DOI 10.1079/9780851993195.0227	46	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90513	10.1371/journal.pone.0090513	http://dx.doi.org/10.1371/journal.pone.0090513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598934	gold, Green Published, Green Submitted			2022-12-25	WOS:000332479400087
J	Willcox, JM; Summerlee, AJS				Willcox, Jordan M.; Summerlee, Alastair J. S.			Relaxin Protects Astrocytes from Hypoxia In Vitro	PLOS ONE			English	Article							BOVINE HEART-MITOCHONDRIA; NF-KAPPA-B; NITRIC-OXIDE; SUPEROXIDE ANION; OXIDATIVE STRESS; ISCHEMIA-REPERFUSION; ANTIOXIDANT DEFENSE; RADICAL GENERATION; CEREBRAL-ISCHEMIA; ARTERY-OCCLUSION	The peptide relaxin has recently been shown to protect brain tissues from the detrimental effects of ischemia. To date, the mechanisms for this remain unclear. In order to investigate the neuroprotective mechanisms by which relaxin may protect the brain, we investigated the possibility that relaxin protects astrocytes from hypoxia or oxygen/glucose deprivation (OGD). Cultured astrocytes were pre-treated with either relaxin-2 or relaxin-3 and exposed to OGD for 24 or 48 hours. Following OGD exposure, viability assays showed that relaxin-treated cells exhibited a higher viability when compared to astrocytes that experienced OGD-alone. Next, to test whether relaxin reduced the production of reactive oxygen species (ROS) astrocytes were exposed to the same conditions as the previous experiment and a commercially available ROS detection kit was used to detect ROS production. Astrocytes that were treated with relaxin-2 and relaxin-3 showed a marked decrease in ROS production when compared to control astrocytes that were exposed only to OGD. Finally, experiments were performed to determine whether or not the mitochondrial membrane potential was affected by relaxin treatment during 24 hour OGD. Mitochondrial membrane potential was higher in astrocytes that were treated with relaxin-2 and relaxin-3 compared to untreated OGD-alone astrocytes. Taken together, these data present novel findings that show relaxin protects astrocytes from ischemic conditions through the reduction of ROS production and the maintenance of mitochondrial membrane potential.	[Willcox, Jordan M.; Summerlee, Alastair J. S.] Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Willcox, JM (corresponding author), Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	jwillcox@uoguelph.ca			University of Guelph; NSERC; Ontario Graduate Scholarship	University of Guelph; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	The authors wish to acknowledge funding from the University of Guelph and NSERC to AJS Summerlee. JM Willcox received salary support from an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoulnik AI, 2007, ADV EXP MED BIOL, V612, P49; Amantea D, 2009, INT REV NEUROBIOL, V85, P363, DOI 10.1016/S0074-7742(09)85025-3; Bani D, 1998, HYPERTENSION, V31, P1240, DOI 10.1161/01.HYP.31.6.1240; Bani D, 1998, AM J PATHOL, V152, P1367; BANISACCHI T, 1995, BRIT J PHARMACOL, V116, P1589, DOI 10.1111/j.1476-5381.1995.tb16377.x; Barja G, 1999, J BIOENERG BIOMEMBR, V31, P347, DOI 10.1023/A:1005427919188; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Bathgate RAD, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P679; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Cadenas S, 2000, BIOCHEM J, V351, P307, DOI 10.1042/0264-6021:3510307; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cheung NS, 1998, NEUROPHARMACOLOGY, V37, P1419, DOI 10.1016/S0028-3908(98)00123-3; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; Danielson LA, 1999, J CLIN INVEST, V103, P525, DOI 10.1172/JCI5630; Das A, 2010, CANCER-AM CANCER SOC, V116, P164, DOI 10.1002/cncr.24699; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Ginsberg MD, 1997, AM J NEURORADIOL, V18, P1435; Grishko VI, 1999, NUCLEIC ACIDS RES, V27, P4510, DOI 10.1093/nar/27.22.4510; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Haugaard-Jonsson LM, 2008, J BIOL CHEM, V283, P23811, DOI 10.1074/jbc.M800489200; Haugaard-Jonsson LM, 2009, ANN NY ACAD SCI, V1160, P27, DOI 10.1111/j.1749-6632.2008.03805.x; Ho TY, 2007, J LEUKOCYTE BIOL, V81, P1303, DOI 10.1189/jlb.0906556; Hollensworth SB, 2000, FREE RADICAL BIO MED, V28, P1161, DOI 10.1016/S0891-5849(00)00214-8; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Cosen-Binker LI, 2006, WORLD J GASTROENTERO, V12, P1558; Ivell R, 2011, MOL HUM REPROD, V17, P71, DOI 10.1093/molehr/gaq086; Jordan Joaquin, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P98; KAUR H, 1994, ANAL BIOCHEM, V220, P11, DOI 10.1006/abio.1994.1291; Liu D, 1999, MOL BRAIN RES, V68, P29, DOI 10.1016/S0169-328X(99)00063-7; Martin LJ, 1997, ANN NEUROL, V42, P335, DOI 10.1002/ana.410420310; Masini E, 1997, ENDOCRINOLOGY, V138, P4713, DOI 10.1210/en.138.11.4713; Masini E, 1996, INFLAMM RES, V45, pS27, DOI 10.1007/BF03354073; Masini E, 2006, BRIT J PHARMACOL, V148, P1124, DOI 10.1038/sj.bjp.0706811; MCLENNAN H, 1976, CAN J PHYSIOL PHARM, V54, P70, DOI 10.1139/y76-011; Murley JS, 2001, FREE RADICAL BIO MED, V30, P1426, DOI 10.1016/S0891-5849(01)00554-8; OBERLEY LW, 1987, ARCH BIOCHEM BIOPHYS, V254, P69, DOI 10.1016/0003-9861(87)90082-8; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; SCHURR A, 1988, SCIENCE, V240, P1326, DOI 10.1126/science.3375817; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; SHANK RP, 1984, J NEUROCHEM, V42, P1153, DOI 10.1111/j.1471-4159.1984.tb12724.x; SONNEWALD U, 1991, NEUROSCI LETT, V128, P235, DOI 10.1016/0304-3940(91)90268-X; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; SUMMERLEE AJS, 1984, NATURE, V309, P372, DOI 10.1038/309372a0; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Tsan MF, 2001, AM J PHYSIOL-CELL PH, V280, pC1422; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; van der Westhuizen ET, 2007, MOL PHARMACOL, V71, P1618, DOI 10.1124/mol.106.032763; WESTERGAARD N, 1993, J NEUROSCI RES, V35, P540, DOI 10.1002/jnr.490350510; Wilson BC, 2006, NEUROSCI LETT, V393, P160, DOI 10.1016/j.neulet.2005.09.059; Wilson BC, 2005, ANN NY ACAD SCI, V1041, P223, DOI 10.1196/annals.1282.035; Wilson BC, 2009, ANN NY ACAD SCI, V1160, P265, DOI 10.1111/j.1749-6632.2008.03806.x; Wilson JX, 1997, CAN J PHYSIOL PHARM, V75, P1149, DOI 10.1139/cjpp-75-10-11-1149; Ying WH, 2000, NEUROREPORT, V11, P1385, DOI 10.1097/00001756-200005150-00007; Ying WH, 2000, J CEREBR BLOOD F MET, V20, P359, DOI 10.1097/00004647-200002000-00018; YUDKOFF M, 1990, J NEUROCHEM, V55, P137, DOI 10.1111/j.1471-4159.1990.tb08831.x; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972	60	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90864	10.1371/journal.pone.0090864	http://dx.doi.org/10.1371/journal.pone.0090864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598861	gold, Green Submitted, Green Published			2022-12-25	WOS:000332479400140
J	Lai, CW; Chen, HL; Lin, KY; Liu, FC; Chong, KY; Cheng, WTK; Chen, CM				Lai, Cheng-Wei; Chen, Hsiao-Ling; Lin, Ken-Yo; Liu, Fang-Chueh; Chong, Kowit-Yu; Cheng, Winston T. K.; Chen, Chuan-Mu			FTSJ2, a Heat Shock-Inducible Mitochondrial Protein, Suppresses Cell Invasion and Migration	PLOS ONE			English	Article							ESCHERICHIA-COLI; MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; PICHIA-PASTORIS; FAT DIGESTION; RNA; EXPRESSION; METHYLATION; GROWTH; SPB1P	Ribosomal RNA large subunit methyltransferase J (RrmJ), an Escherichia coli heat shock protein, is responsible for 2'-O-ribose methylation in 23S rRNA. In mammals, three close homologs of RrmJ have been identified and have been designated as FTSJ1, FTSJ2 and FTSJ3; however, little is known about these genes. In this study, we characterized the mammalian FTSJ2, which was the most related protein to RrmJ in a phylogenetic analysis that had similar amino acid sequence features and tertiary protein structures of RrmJ. FTSJ2 was first identified in this study as a nucleus encoded mitochondrial protein that preserves the heat shock protein character in mammals in which the mRNA expressions was increased in porcine lung tissues and A549 cells after heat shock treatment. In addition, a recent study in non-small cell lung cancer (NSCLC) suggested that the FTSJ2 gene is located in a novel oncogenic locus. However, our results demonstrate that the expression of FTSJ2 mRNA was decreased in the more invasive subline (CL1-5) of the lung adenocarcinoma cells (CL1) compared with the less invasive subline (CL1-0), and overexpression of FTSJ2 resulted in the inhibition of cell invasion and migration in the rhabdomyosarcoma cell (TE671). In conclusion, our findings indicate that mammalian FTSJ2 is a mitochondrial ortholog of E. coli RrmJ and conserves the heat shock protein properties. Moreover, FTSJ2 possesses suppressive effects on the invasion and migration of cancer cells.	[Lai, Cheng-Wei; Lin, Ken-Yo; Liu, Fang-Chueh; Chen, Chuan-Mu] Natl Chung Hsing Univ, Dept Life Sci, Agr Biotechnol Ctr, iEGG Ctr, Taichung 40227, Taiwan; [Chen, Hsiao-Ling] Da Yeh Univ, Dept Bioresources, Changhua, Taiwan; [Liu, Fang-Chueh] Council Agr, Livestock Res Inst, Dept Anim Nutr, Tainan, Taiwan; [Chong, Kowit-Yu] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Cheng, Winston T. K.] Tunghai Univ, Dept Anim Sci & Biotechnol, Taichung 40704, Taiwan	National Chung Hsing University; Da Yeh University; Taiwan Livestock Research Institute; Chang Gung University; Tunghai University	Chen, CM (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Agr Biotechnol Ctr, iEGG Ctr, Taichung 40227, Taiwan.	chchen1@dragon.nchu.edu.tw	Chen, Chuan-Mu/K-7049-2013	Chen, Chuan-Mu/0000-0003-2461-9150; Chong, Kowit Yu/0000-0003-0974-0673	National Science Council [NSC-98-2313-b-005-012]; Ministry of Education, Taiwan, Republic of China [ATU-101-s0508]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Republic of China(Ministry of Education, Taiwan)	This research was supported by grant NSC-98-2313-b-005-012 from the National Science Council and was partly supported by the Ministry of Education, Taiwan, Republic of China, under the aiming top university plan (ATU-101-s0508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANG D, 1991, J BIOL CHEM, V266, P24233; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; Blanchard SC, 2001, P NATL ACAD SCI USA, V98, P3720, DOI 10.1073/pnas.051608498; Bonnerot C, 2003, MOL CELL, V12, P1309, DOI 10.1016/S1097-2765(03)00435-0; Bugl H, 2000, MOL CELL, V6, P349, DOI 10.1016/S1097-2765(00)00035-6; Caldas T, 2000, J BIOL CHEM, V275, P16414, DOI 10.1074/jbc.M001854200; Caldas T, 2000, BIOCHEM BIOPH RES CO, V271, P714, DOI 10.1006/bbrc.2000.2702; Campbell JM, 2008, GENOME, V51, P1032, DOI 10.1139/G08-086; Chang TP, 2010, CANCER RES, V70, P1656, DOI 10.1158/0008-5472.CAN-09-2453; Chen HL, 2010, BIOMETALS, V23, P543, DOI 10.1007/s10534-010-9298-0; Cheng ZY, 2013, ANTIOXID REDOX SIGN, V19, P240, DOI 10.1089/ars.2013.5255; Choi I, 2013, GLIA, V61, P800, DOI 10.1002/glia.22475; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Feder M, 2003, GENE, V302, P129, DOI 10.1016/S0378-1119(02)01097-1; Freude K, 2004, AM J HUM GENET, V75, P305, DOI 10.1086/422507; Hager J, 2002, J BIOL CHEM, V277, P41978, DOI 10.1074/jbc.M205423200; Hodel AE, 1998, MOL CELL, V1, P443, DOI 10.1016/S1097-2765(00)80044-1; Huang JT, 2013, J VIROL, V87, P4994, DOI 10.1128/JVI.02526-12; Kang R, 2014, ONCOGENE, V33, P567, DOI 10.1038/onc.2012.631; Kressler D, 1999, NUCLEIC ACIDS RES, V27, P4598, DOI 10.1093/nar/27.23.4598; Lapeyre B, 2005, TOP CURR GENET, V12, P263, DOI 10.1007/b105433; Lapeyre B, 2004, MOL CELL, V16, P663, DOI 10.1016/j.molcel.2004.10.022; Lee HW, 2013, VIRCHOWS ARCH, V463, P489, DOI 10.1007/s00428-013-1461-x; Lin CS, 2012, INT J MOL SCI, V13, P11228, DOI 10.3390/ijms130911228; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu FC, 2010, J AGR FOOD CHEM, V58, P3322, DOI 10.1021/jf903439q; Liu FC, 2008, BIOTECHNOL PROGR, V24, P1333, DOI 10.1002/btpr.46; Morello LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029174; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; OGURA T, 1991, RES MICROBIOL, V142, P279, DOI 10.1016/0923-2508(91)90041-8; Pintard L, 2002, EMBO J, V21, P1139, DOI 10.1093/emboj/21.5.1139; Pintard L, 2002, EMBO J, V21, P1811, DOI 10.1093/emboj/21.7.1811; Pintard L, 2000, MOL CELL BIOL, V20, P1370, DOI 10.1128/MCB.20.4.1370-1381.2000; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Radosevic-Stasic Biserka, 2012, Curr Aging Sci, V5, P254; Richmond CS, 1999, NUCLEIC ACIDS RES, V27, P3821, DOI 10.1093/nar/27.19.3821; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Siegelin MD, 2013, CANCER LETT, V333, P133, DOI 10.1016/j.canlet.2013.01.045; Simabuco FM, 2012, J PROTEOME RES, V11, P3112, DOI 10.1021/pr201106n; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsai SW, 2013, J ORTHOP RES, V31, P125, DOI 10.1002/jor.22180; Tung YT, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/319247; Tung YT, 2013, J DAIRY SCI, V96, P2095, DOI 10.3168/jds.2012-6153; Verschuure P, 2003, EUR J CELL BIOL, V82, P523, DOI 10.1078/0171-9335-00337; VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0; Wang HM, 2000, EMBO J, V19, P317, DOI 10.1093/emboj/19.3.317; Widerak M, 2005, GENE, V347, P109, DOI 10.1016/j.gene.2004.12.025; Wu H, 2009, PDB ID 2NYU; YANG D, 1985, P NATL ACAD SCI USA, V82, P4443, DOI 10.1073/pnas.82.13.4443; Yang XK, 2012, CANCER LETT, V321, P137, DOI 10.1016/j.canlet.2012.01.030; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494	51	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90818	10.1371/journal.pone.0090818	http://dx.doi.org/10.1371/journal.pone.0090818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595062	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500103
J	Mi, YN; Ping, NN; Xiao, X; Zhu, YB; Liu, J; Cao, YX				Mi, Yan-Ni; Ping, Na-Na; Xiao, Xue; Zhu, Yan-Bing; Liu, Jing; Cao, Yong-Xiao			The Severe Adverse Reaction to Vitamin K-1 Injection Is Anaphylactoid Reaction but Not Anaphylaxis	PLOS ONE			English	Article							IDIOSYNCRATIC DRUG-REACTIONS; PHYTONADIONE VITAMIN-K-1; ANIMAL-MODELS; BEAGLE DOGS; HYPERSENSITIVITY; POLYSORBATE-80; DEGRANULATION	The severe adverse reaction to vitamin K-1 injection is always remarkable and is thought to result from anaphylaxis. Paradoxically, however, some patients administered vitamin K-1 injection for the first time have adverse reactions. Using beagle dogs, the present study tested the hypothesis that the response to vitamin K-1 is an anaphylactoid reaction. The results showed that serious anaphylaxis-like symptoms appeared in beagle dogs after the administration of vitamin K-1 injection for the first time. The plasma histamine concentration increased, and blood pressure decreased sharply. After sensitization, dogs were challenged with vitamin K-1 injection and displayed the same degree of symptoms as prior to sensitization. However, when the vitamin K-1 injection-sensitized dogs were challenged with a vitamin K-1-fat emulsion without solubilizers such asTween-80, the abnormal reactions did not occur. Furthermore, there was no significant change in the plasma immunoglobulin E concentration after vitamin K-1 challenge. Following treatment with vitamin K-1 injection, the release of histamine and beta-hexosaminidase by rat basophilic leukemia-2H3 cells as well as the rate of apoptosis increased. The Tween-80 group displayed results similar to those observed following vitamin K-1 injection in vivo. However, the dogs in the vitamin K-1-fat emulsion group did not display any abnormal behavior or significant change in plasma histamine. Additionally, degranulation and apoptosis did not occur in rat basophilic leukemia-2H3 cells. Our results indicate that the adverse reaction induced by vitamin K-1 injection is an anaphylactoid reaction, not anaphylaxis. Vitamin K-1 injection induces the release of inflammatory factors via a non-IgE-mediated immune pathway, for which the trigger may be the solubilizer.	[Mi, Yan-Ni; Ping, Na-Na; Xiao, Xue; Zhu, Yan-Bing; Liu, Jing; Cao, Yong-Xiao] Xi An Jiao Tong Univ, Coll Med, Dept Pharmacol, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University	Cao, YX (corresponding author), Xi An Jiao Tong Univ, Coll Med, Dept Pharmacol, Xian 710049, Shaanxi, Peoples R China.	yxy@xjtu.edu.cn			Shaanxi province science and technology research and development programs of China [2012SP2-06]	Shaanxi province science and technology research and development programs of China	This work was supported by the Shaanxi province science and technology research and development programs of China (2012SP2-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coors EA, 2005, ANN ALLERG ASTHMA IM, V95, P593, DOI 10.1016/S1081-1206(10)61024-1; Fiore LD, 2001, J THROMB THROMBOLYS, V11, P175, DOI 10.1023/A:1011237019082; Funaba M, 2003, CELL BIOL INT, V27, P879, DOI 10.1016/S1065-6995(03)00177-X; He Ping, 2012, Zhongguo Zhong Yao Za Zhi, V37, P1880; Huang FH, 2010, ACTA PHARMACOL SIN, V31, P849, DOI 10.1038/aps.2010.63; Liang Aihua, 2010, Zhongguo Zhong Yao Za Zhi, V35, P2328; MARTIN JC, 1991, MED J AUSTRALIA, V155, P851, DOI 10.5694/j.1326-5377.1991.tb94070.x; Na HJ, 2005, J ETHNOPHARMACOL, V101, P43, DOI 10.1016/j.jep.2005.03.026; Ng WN, 2012, ADV PHARMACOL, V63, P81, DOI 10.1016/B978-0-12-398339-8.00003-3; Nishikawa H, 2011, TOXICOL APPL PHARM, V252, P228, DOI 10.1016/j.taap.2011.02.011; Pereira SP, 1998, PHARMACOEPIDEM DR S, V7, P173, DOI 10.1002/(SICI)1099-1557(199805/06)7:3<173::AID-PDS343>3.0.CO;2-8; Qiu SD, 2013, INT IMMUNOPHARMACOL, V15, P144, DOI 10.1016/j.intimp.2012.10.021; Riegert-Johnson DL, 2002, ANN ALLERG ASTHMA IM, V89, P400, DOI 10.1016/S1081-1206(10)62042-X; Riegert-Johnson DL, 2001, BONE MARROW TRANSPL, V28, P1176, DOI 10.1038/sj.bmt.1703305; SFDA PRC, 2011, AL REG SER ALL REACT; Shenton JM, 2004, CHEM-BIOL INTERACT, V150, P53, DOI 10.1016/j.cbi.2004.09.001; Sommer S, 2002, CONTACT DERMATITIS, V46, P94, DOI 10.1034/j.1600-0536.2002.460206.x; Sousa Tatiana, 2010, Dermatol Online J, V16, P16; Sun Wei-wei, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P90; Sun Weiwei, 2011, Zhongguo Zhong Yao Za Zhi, V36, P1874; Van der Meer J, 1968, Thromb Diath Haemorrh Suppl, V29, P1; Vo TS, 2011, CARBOHYD POLYM, V84, P649, DOI 10.1016/j.carbpol.2010.12.046; Wang ZG, 2012, J TRADIT CHIN MED, V32, P641, DOI 10.1016/S0254-6272(13)60085-0; Wang Zhiguo, 2011, Zhongguo Zhong Yao Za Zhi, V36, P1842; Wang Zhiguo, 2011, Zhongguo Zhong Yao Za Zhi, V36, P1870; WEISS RB, 1990, J CLIN ONCOL, V8, P1263, DOI 10.1200/JCO.1990.8.7.1263; Wilkins K, 2000, J Cutan Med Surg, V4, P164; Yang G-H, 2009, CHIN J CLIN RATIONAL, V2	28	29	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90199	10.1371/journal.pone.0090199	http://dx.doi.org/10.1371/journal.pone.0090199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594861	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500037
J	Peng, XR; Liu, T; Shi, CY; Zhang, LQ; Wang, Y; Zhao, WY; Jiang, LH; Wu, MC; Zhang, Y; Qian, QJ				Peng, Xinrong; Liu, Tao; Shi, Chuanyin; Zhang, Liqing; Wang, Ying; Zhao, Wuyang; Jiang, Lihua; Wu, Mengchao; Zhang, Yong; Qian, Qijun			Germline Transmission of an Embryonic Stem Cell Line Derived from BALB/c Cataract Mice	PLOS ONE			English	Article							SELF-RENEWAL; CONGENITAL CATARACT; GROUND-STATE; MOUSE STRAIN; INHIBITORS; CULTURE; GENE; GSK3	Mice embryonic stem (ES) cells have enabled the generation of mouse strains with defined mutation(s) in their genome for putative disease loci analysis. In the study of cataract, the complex genetic background of this disease and lack of long-term self-renewal ES cells have hampered the functional researches of cataract-related genes. In this study, we aimed to establish ES cells from inherited cataract mice (BALB/C-Cat/Cat). Embryos of cataract mice were cultured in chemical-defined N2B27 medium with the presence of two small molecules PD0325901 and CHIR99021 (2i) and an ES cell line (named EH-BES) was successfully established. EH-BES showed long-term self-renewal in 2i medium and maintained capacity of germline transmission. Most importantly, the produced chimera and offspring developed congenital cataract as well. Flow cytometry assay revealed that EH-BES are homogeneous in expression of Oct4 and Rex1in 2i medium, which may account for their self-renewal ability. With long-term self-renewal ability and germline-competent, EH-BES cell line can facilitate genetic and functional researches of cataract-related genes and better address mechanisms of cataract.	[Peng, Xinrong; Zhang, Yong] Northwest Agr & Forestry Univ, Coll Vet Med, Xianyang, Shanxi, Peoples R China; [Peng, Xinrong; Liu, Tao; Shi, Chuanyin; Wang, Ying; Jiang, Lihua; Wu, Mengchao; Qian, Qijun] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China; [Zhang, Liqing; Zhao, Wuyang; Qian, Qijun] Zhejiang Sci Tech Univ, Xinyuan Inst Med & Biotechnol, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Northwest A&F University - China; Naval Medical University; Zhejiang Sci-Tech University	Zhang, Y (corresponding author), Northwest Agr & Forestry Univ, Coll Vet Med, Xianyang, Shanxi, Peoples R China.	zhangyong1956@nwsuaf.edu.cn; qianqj@sino-gene.cn	Wang, Ying/AAY-4117-2021	Wang, Ying/0000-0002-1819-294X	National Science Fund for distinguished Yong Scholar [30925037]; National Natural Science Foundation of China [81071850]; National High Technology Research and Development Program 863 [2012AA020806]; National Significant Science and Technology Special Projects of New Drugs Creation [2011ZX09102-010-02]	National Science Fund for distinguished Yong Scholar; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); National Significant Science and Technology Special Projects of New Drugs Creation	This work was supported by the National Science Fund for distinguished Yong Scholar (No. 30925037), National Natural Science Foundation of China (No. 81071850), National High Technology Research and Development Program 863 (No. 2012AA020806) and National Significant Science and Technology Special Projects of New Drugs Creation (No. 2011ZX09102-010-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Craig JE, 2008, MOL VIS, V14, P721; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; LEITER EH, 1985, CURR TOP MICROBIOL, V122, P78; Li L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012624; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; MATSUZAWA A, 1988, EXP EYE RES, V47, P705, DOI 10.1016/0014-4835(88)90038-3; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nakamura T, 1998, BIOCHEM BIOPH RES CO, V248, P22, DOI 10.1006/bbrc.1998.8900; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; NobenTrauth N, 1996, TRANSGENIC RES, V5, P487, DOI 10.1007/BF01980214; Pelton TA, 2002, J CELL SCI, V115, P329; Peng XR, 2013, CELL REPROGRAM, V15, P179, DOI 10.1089/cell.2012.0065; Santana A, 2011, ARQ BRAS OFTALMOL, V74, P136, DOI 10.1590/S0004-27492011000200016; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Wang J, 2007, CHINESE MED J-PEKING, V120, P820, DOI 10.1097/00029330-200705010-00015; YASUMURA Y, 1966, CANCER RES, V26, P529; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhao WX, 2012, MOLECULES, V17, P6196, DOI 10.3390/molecules17066196	29	0	0	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90707	10.1371/journal.pone.0090707	http://dx.doi.org/10.1371/journal.pone.0090707			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595217	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500089
J	Sletten, T; Kostas, M; Bober, J; Sorensen, V; Yadollahi, M; Olsnes, S; Tomala, J; Otlewski, J; Zakrzewska, M; Wiedlocha, A				Sletten, Torunn; Kostas, Michal; Bober, Joanna; Sorensen, Vigdis; Yadollahi, Mandana; Olsnes, Sjur; Tomala, Justyna; Otlewski, Jacek; Zakrzewska, Malgorzata; Wiedlocha, Antoni			Nucleolin Regulates Phosphorylation and Nuclear Export of Fibroblast Growth Factor 1 (FGF1)	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; RIBOSOMAL-PROTEIN L26; CELL-CYCLE ARREST; INTRACELLULAR PROTEIN; EXOGENOUS FGF1; WEB SERVER; TRANSLOCATION; CYTOSOL; BINDING; SEQUENCE	Extracellular fibroblast growth factor 1 (FGF1) acts through cell surface tyrosine kinase receptors, but FGF1 can also act directly in the cell nucleus, as a result of nuclear import of endogenously produced, non-secreted FGF1 or by transport of extracellular FGF1 via endosomes and cytosol into the nucleus. In the nucleus, FGF1 can be phosphorylated by protein kinase C delta (PKC delta), and this event induces nuclear export of FGF1. To identify intracellular targets of FGF1 we performed affinity pull-down assays and identified nucleolin, a nuclear multifunctional protein, as an interaction partner of FGF1. We confirmed a direct nucleolin-FGF1 interaction by surface plasmon resonance and identified residues of FGF1 involved in the binding to be located within the heparin binding site. To assess the biological role of the nucleolin-FGF1 interaction, we studied the intracellular trafficking of FGF1. In nucleolin depleted cells, exogenous FGF1 was endocytosed and translocated to the cytosol and nucleus, but FGF1 was not phosphorylated by PKC delta or exported from the nucleus. Using FGF1 mutants with reduced binding to nucleolin and a FGF1-phosphomimetic mutant, we showed that the nucleolin-FGF1 interaction is critical for the intranuclear phosphorylation of FGF1 by PKC delta and thereby the regulation of nuclear export of FGF1.	[Sletten, Torunn; Sorensen, Vigdis; Yadollahi, Mandana; Olsnes, Sjur; Wiedlocha, Antoni] Oslo Univ Hosp, Dept Biochem, Inst Canc Res, Norwegian Radium Hosp, Oslo, Norway; [Sletten, Torunn; Sorensen, Vigdis; Yadollahi, Mandana; Olsnes, Sjur; Wiedlocha, Antoni] Univ Oslo, Fac Med, Ctr Canc Biomed, N-0316 Oslo, Norway; [Bober, Joanna; Otlewski, Jacek; Zakrzewska, Malgorzata] Univ Wroclaw, Dept Prot Engn, Fac Biotechnol, PL-50138 Wroclaw, Poland; [Kostas, Michal; Tomala, Justyna] Univ Wroclaw, Dept Prot Biotechnol, Fac Biotechnol, PL-50138 Wroclaw, Poland	University of Oslo; University of Oslo; University of Wroclaw; University of Wroclaw	Zakrzewska, M (corresponding author), Univ Wroclaw, Dept Prot Engn, Fac Biotechnol, PL-50138 Wroclaw, Poland.	malgorzata.zakrzewska@uni.wroc.pl; antoni.wiedlocha@rr-research.no		Bober, Joanna/0000-0002-8588-0486; Zakrzewska, Malgorzata/0000-0001-8214-1533	Norway through the Norwegian Financial Mechanism within the Polish-Norwegian Research Fund [PNRF-87-AI-1/07]; Polish Ministry of Science and Higher Education [0627/IP1/2011/71]; Norwegian Cancer Society	Norway through the Norwegian Financial Mechanism within the Polish-Norwegian Research Fund; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grant PNRF-87-AI-1/07 from Norway through the Norwegian Financial Mechanism within the Polish-Norwegian Research Fund, and by the Polish Ministry of Science and Higher Education (grant 0627/IP1/2011/71) and the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bhatt P, 2012, FEBS J, V279, P370, DOI 10.1111/j.1742-4658.2011.08430.x; Bonnet H, 1996, J BIOL CHEM, V271, P24781, DOI 10.1074/jbc.271.40.24781; Bossard C, 2003, NAT CELL BIOL, V5, P433, DOI 10.1038/ncb979; Bouleau S, 2005, ONCOGENE, V24, P7839, DOI 10.1038/sj.onc.1208932; Brand TM, 2011, DISCOV MED, V12, P419; BURGESS WH, 1991, ANN NY ACAD SCI, V638, P89, DOI 10.1111/j.1749-6632.1991.tb49020.x; Chandra M, 2012, MOL CELL BIOL, V32, P2183, DOI 10.1128/MCB.00320-12; Chen J, 2012, J BIOL CHEM, V287, P16467, DOI 10.1074/jbc.M112.349274; Daniely Y, 2002, MOL CELL BIOL, V22, P6014, DOI 10.1128/MCB.22.16.6014-6022.2002; Di Segni A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002310; Fu Y, 2009, BIOCHEMISTRY-US, V48, P11655, DOI 10.1021/bi901265z; Ginisty H, 1999, J CELL SCI, V112, P761; Greco A, 2012, J VIROL, V86, P1449, DOI 10.1128/JVI.06194-11; Haugsten EM, 2008, MOL BIOL CELL, V19, P3390, DOI 10.1091/mbc.E07-12-1219; Hong SK, 2009, P NATL ACAD SCI USA, V106, P2230, DOI 10.1073/pnas.0812880106; IMAMURA T, 1990, SCIENCE, V249, P1567, DOI 10.1126/science.1699274; IMAMURA T, 1992, J BIOL CHEM, V267, P5676; Jans DA, 1998, BIOESSAYS, V20, P400, DOI 10.1002/(SICI)1521-1878(199805)20:5<400::AID-BIES7>3.0.CO;2-R; Klingenberg O, 2000, J BIOL CHEM, V275, P11972, DOI 10.1074/jbc.275.16.11972; Klingenberg O, 2000, J CELL SCI, V113, P1827; Klingenberg O, 1999, J BIOL CHEM, V274, P18081, DOI 10.1074/jbc.274.25.18081; Kolpakova E, 1998, BIOCHEM J, V336, P213, DOI 10.1042/bj3360213; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Liang H, 2006, NUCLEIC ACIDS RES, V34, pW382, DOI 10.1093/nar/gkl272; Malecki J, 2002, EMBO J, V21, P4480, DOI 10.1093/emboj/cdf472; Meunier S, 2009, TRAFFIC, V10, P1765, DOI 10.1111/j.1600-0854.2009.00985.x; Mizukoshi E, 1999, BIOCHEM J, V343, P461, DOI 10.1042/0264-6021:3430461; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Nilsen T, 2007, J BIOL CHEM, V282, P26245, DOI 10.1074/jbc.M611234200; Olsnes S, 2003, PHYSIOL REV, V83, P163, DOI 10.1152/physrev.00021.2002; Ornitz DM, 2001, GENOME BIOL, V2; Planque Nathalie, 2006, Cell Commun Signal, V4, P7, DOI 10.1186/1478-811X-4-7; Qin S, 2007, BIOINFORMATICS, V23, P3386, DOI 10.1093/bioinformatics/btm434; Renaud F, 1996, J BIOL CHEM, V271, P2801, DOI 10.1074/jbc.271.5.2801; Rodriguez-Enfedaque A, 2009, BBA-MOL CELL RES, V1793, P1719, DOI 10.1016/j.bbamcr.2009.09.010; Saxena A, 2006, ONCOGENE, V25, P7274, DOI 10.1038/sj.onc.1209714; Sheng Z, 2005, MOL CELL BIOL, V25, P9419, DOI 10.1128/MCB.25.21.9419-9426.2005; Skjerpen CS, 2002, J BIOL CHEM, V277, P23864, DOI 10.1074/jbc.M112193200; Skjerpen CS, 2002, EMBO J, V21, P4058, DOI 10.1093/emboj/cdf402; Song N, 2012, ANGIOGENESIS, V15, P697, DOI 10.1007/s10456-012-9284-y; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Sorensen V, 2008, MOL CELL BIOL, V28, P4129, DOI 10.1128/MCB.02117-07; Sorensen V, 2006, J CELL SCI, V119, P4332, DOI 10.1242/jcs.03209; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Svitel J, 2003, BIOPHYS J, V84, P4062, DOI 10.1016/S0006-3495(03)75132-7; Tajrishi Marjan M, 2011, Commun Integr Biol, V4, P267, DOI 10.4161/cib.4.3.14884; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Wesche J, 2005, BIOCHEMISTRY-US, V44, P6071, DOI 10.1021/bi047403m; WIEDLOCHA A, 1994, CELL, V76, P1039, DOI 10.1016/0092-8674(94)90381-6; Wiedlocha A, 2005, MOL BIOL CELL, V16, P794; Wiedlocha A, 2004, CURR TOP MICROBIOL, V286, P45; Yang Chonglin, 2009, Mol Cell Pharmacol, V1, P130; Zakrzewska M, 2005, J MOL BIOL, V352, P860, DOI 10.1016/j.jmb.2005.07.066; Zakrzewska M, 2011, EXP CELL RES, V317, P1005, DOI 10.1016/j.yexcr.2011.01.003; Zakrzewska M, 2009, J BIOL CHEM, V284, P25388, DOI 10.1074/jbc.M109.001289; Zhen Y, 2012, TRAFFIC, V13, P650, DOI 10.1111/j.1600-0854.2012.01341.x	58	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90687	10.1371/journal.pone.0090687	http://dx.doi.org/10.1371/journal.pone.0090687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595027	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000332475500086
J	Dang, YY; Liu, B; Xu, P; Zhu, PY; Zhai, YM; Liu, MY; Ye, XY				Dang, Yongyan; Liu, Bei; Xu, Peng; Zhu, Pingya; Zhai, Yimiao; Liu, Mingyao; Ye, Xiyun			Gpr48 Deficiency Induces Polycystic Kidney Lesions and Renal Fibrosis in Mice by Activating Wnt Signal Pathway	PLOS ONE			English	Article							DOWN-REGULATION; TGF-BETA; INTERSTITIAL FIBROSIS; DISEASE; LGR4; INHIBITION; EXPRESSION; INDUCTION; CANCER; INJURY	G protein-coupled receptor 48 (Gpr48/Lgr4) is essential to regulate the development of multiple tissues in mice. The notion that Gpr48 functions in renal development prompted us to investigate the relation between Gpr48 and renal diseases. Using a Gpr48 knockout mice model, we observed that 66.7% Gpr48 null mice developed polycystic lesions in the kidney, while no cysts were observed in the kidneys of wild-type mice. Polycystic kidney disease 1 (PKD1) and PKD2 expressions were also markedly decreased in the Gpr48 knockout mice. Abnormal expressions of exra-cellular matrix protein lead to the progression of polycystic kidney disease and the formation of renal fibrosis in the Gpr48 null mice. The expressions of several Wnt molecules and its receptors were increased and marked beta-catenin nuclear accumulation was observed in the Gpr48 null mice. The inhibitors of Wnt/beta-catenin signal pathway such as GSK3 beta and axin2 were loss of function. The Wnt/PCP signaling pathway is also activated in Gpr48 null mice. However, TGF-beta expression and phosphorylated Smad2/3 levels were not altered. Collectively, our results showed that Gpr48 null mice are at a greater risk of suffering from polycystic lesions and renal fibrosis. Moreover, the formation of polycystic lesions and renal fibrosis induced by Gpr48 deficiency involves the activation of Wnt signaling pathway but not the TGF-beta/Smad pathway.	[Liu, Mingyao] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China; E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University	Liu, MY (corresponding author), E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China.	mliu@lm.bio.ecnu.edu; xyye@bio.ecnu.edu.cn		Liu, Mingyao/0000-0001-7339-5048	National Natural Science Foundation of China [81272226]; Key Science and Technology Projects from the Science and Technology Commission of Shanghai Municipality [13JC1405102]; Research Fund for the Doctoral Program of Higher Education [20100076120007]; National Basic Research Program of China [2012CB910400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Projects from the Science and Technology Commission of Shanghai Municipality; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (No. 81272226), Key Science and Technology Projects from the Science and Technology Commission of Shanghai Municipality (13JC1405102), Research Fund for the Doctoral Program of Higher Education (No. 20100076120007) and National Basic Research Program of China (2012CB910400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzing T, 2007, J AM SOC NEPHROL, V18, P1389, DOI 10.1681/ASN.2006121355; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Chia IV, 2005, MOL CELL BIOL, V25, P4371, DOI 10.1128/MCB.25.11.4371-4376.2005; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; Hao S, 2011, J AM SOC NEPHROL, V22, P1642, DOI 10.1681/ASN.2010101079; Hassane S, 2010, J PATHOL, V222, P21, DOI 10.1002/path.2734; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Iglesias DM, 2007, AM J PHYSIOL-RENAL, V293, pF494, DOI 10.1152/ajprenal.00416.2006; Jin C, 2008, INVEST OPHTH VIS SCI, V49, P4245, DOI 10.1167/iovs.08-1860; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Lancaster MA, 2010, TRENDS MOL MED, V16, P349, DOI 10.1016/j.molmed.2010.05.004; Li JH, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014252.37680.E4; Lyons JP, 2009, MECH DEVELOP, V126, P142, DOI 10.1016/j.mod.2008.11.007; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Mohri Y, 2008, DEV DYNAM, V237, P2235, DOI 10.1002/dvdy.21639; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Obermuller N, 2001, AM J PHYSIOL-RENAL, V280, pF540, DOI 10.1152/ajprenal.2001.280.3.F540; Okada H, 2000, KIDNEY INT, V58, P587, DOI 10.1046/j.1523-1755.2000.00205.x; Okada S, 2003, DIABETES, V52, P2586, DOI 10.2337/diabetes.52.10.2586; Omori S, 2006, J AM SOC NEPHROL, V17, P1604, DOI 10.1681/ASN.2004090800; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Pulkkinen Kaisa, 2008, Organogenesis, V4, P55; Qian LH, 2011, P NATL ACAD SCI USA, V108, P8692, DOI 10.1073/pnas.1100328108; Rao VH, 2003, KIDNEY INT, V63, P1736, DOI 10.1046/j.1523-1755.2003.00939.x; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Song HP, 2008, J BIOL CHEM, V283, P36687, DOI 10.1074/jbc.M800721200; Spiegelberg BD, 2007, CURR OPIN GENET DEV, V17, P40, DOI 10.1016/j.gde.2006.12.002; Surendran K, 2002, AM J PHYSIOL-RENAL, V282, pF431, DOI 10.1152/ajprenal.0009.2001; Tan JH, 2006, CANCER RES, V66, P2320, DOI 10.1158/0008-5472.CAN-05-2700; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Wuthrich RP, 1999, NEPHROL DIAL TRANSPL, V14, P2554, DOI 10.1093/ndt/14.11.2554; Yamashita R, 2009, DEV DYNAM, V238, P993, DOI 10.1002/dvdy.21900; Zhang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026533	37	9	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89835	10.1371/journal.pone.0089835	http://dx.doi.org/10.1371/journal.pone.0089835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595031	gold, Green Published, Green Submitted			2022-12-25	WOS:000332468900039
J	Frenzel, D; Gluck, JM; Brener, O; Oesterhelt, F; Nagel-Steger, L; Willbold, D				Frenzel, Daniel; Glueck, Julian M.; Brener, Oleksandr; Oesterhelt, Filipp; Nagel-Steger, Luitgard; Willbold, Dieter			Immobilization of Homogeneous Monomeric, Oligomeric and Fibrillar A beta Species for Reliable SPR Measurements	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; PEPTIDE; PROTEINS; AGGREGATION; DEMENTIA; BRAIN; ASSAY	There is strong evidence that the amyloid-beta peptide (Ab) plays a central role in the pathogenesis of Alzheimer's disease (AD). In this context, a detailed quantitative description of the interactions with different Ab species is essential for characterization of physiological and artificial ligands. However, the high aggregation propensity of Ab in concert with its susceptibility to structural changes due to even slight changes in solution conditions has impeded surface plasmon resonance (SPR) studies with homogeneous Ab conformer species. Here, we have adapted the experimental procedures to state-of-the-art techniques and established novel approaches to reliably overcome the aforementioned challenges. We show that the application of density gradient centrifugation (DGC) for sample purification and the use of a single chain variable fragment (scFv) of a monoclonal antibody directed against the amino-terminus of Ab allows reliable SPR measurements and quality control of the immobilized Ab aggregate species at any step throughout the experiment.	[Frenzel, Daniel; Glueck, Julian M.; Brener, Oleksandr; Nagel-Steger, Luitgard; Willbold, Dieter] Forschungszentrum Julich, ICS 6 Struct Biochem, D-52425 Julich, Germany; [Brener, Oleksandr; Oesterhelt, Filipp; Nagel-Steger, Luitgard; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf	Willbold, D (corresponding author), Forschungszentrum Julich, ICS 6 Struct Biochem, D-52425 Julich, Germany.	D.Willbold@fz-juelich.de	Nagel-Steger, Luitgard/H-6415-2013; Willbold, Dieter/A-6280-2013	Nagel-Steger, Luitgard/0000-0001-5232-2149; Willbold, Dieter/0000-0002-0065-7366; Brener, Oleksandr/0000-0001-9771-7515				Amijee H, 2012, BIOCHEMISTRY-US, V51, P8338, DOI 10.1021/bi300415v; Bruggink KA, 2013, ANAL BIOCHEM, V433, P112, DOI 10.1016/j.ab.2012.09.014; Cannon MJ, 2004, ANAL BIOCHEM, V328, P67, DOI 10.1016/j.ab.2004.01.014; Dornieden S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059820; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; FORD T, 1994, ANAL BIOCHEM, V220, P360, DOI 10.1006/abio.1994.1350; Gluck JM, 2011, ANAL BIOCHEM, V408, P46, DOI 10.1016/j.ab.2010.08.028; GREEN NM, 1963, BIOCHEM J, V89, P585, DOI 10.1042/bj0890585; Gulland A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2604; Johansson AS, 2006, FEBS J, V273, P2618, DOI 10.1111/j.1742-4658.2006.05263.x; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Milligan CE, 2000, NAT MED, V6, P385, DOI 10.1038/74644; Muller-Schiffmann A, 2010, ANGEW CHEM INT EDIT, V49, P8743, DOI 10.1002/anie.201004437; Nagel-Steger L, 2010, EUR BIOPHYS J BIOPHY, V39, P415, DOI 10.1007/s00249-009-0416-2; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SCHMIDT ML, 1994, EXP NEUROL, V130, P311, DOI 10.1006/exnr.1994.1209; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; Stine WB, 1996, J PROTEIN CHEM, V15, P193, DOI 10.1007/BF01887400; Stravalaci M, 2012, J BIOL CHEM, V287, P27796, DOI 10.1074/jbc.M111.334979; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Wang-Dietrich L, 2013, J ALZHEIMERS DIS, V34, P985, DOI 10.3233/JAD-122047; Wood SJ, 1996, J MOL BIOL, V256, P870, DOI 10.1006/jmbi.1996.0133; Xia N, 2010, ANAL CHEM, V82, P10151, DOI 10.1021/ac102257m	24	10	10	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89490	10.1371/journal.pone.0089490	http://dx.doi.org/10.1371/journal.pone.0089490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594736	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900019
J	Kang, PC; Wan, M; Huang, P; Li, CL; Wang, ZD; Zhong, XY; Hu, ZL; Tai, S; Cui, YF				Kang, Pengcheng; Wan, Ming; Huang, Peng; Li, Chunlong; Wang, Zhidong; Zhong, Xiangyu; Hu, Zhanliang; Tai, Sheng; Cui, Yunfu			The Wnt Antagonist sFRP1 as a Favorable Prognosticator in Human Biliary Tract Carcinoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; BETA-CATENIN; ABERRANT METHYLATION; TARGET GENES; EXPRESSION; CHOLANGIOCARCINOMA; PROGRESSION; INHIBITION; PATHWAYS; MUTATION	Inactivation of Secreted Frizzled-Related wProtein-1 (SFRP1) and overexpression of beta-catenin play important roles in the development and progression of a wide range of malignancies. We sought to determine whether the expression of SFRP1 and beta-catenin correlates with clinicopathologic parameters in human biliary tract cancer (BTC) and to evaluate the potential roles of these proteins as prognostic indicators. The expression of SFRP1 and beta-catenin in 78 patients with BTC and 36 control patients as investigated by immunohistochemistry. A wide variety of statistical parameters were assessed to determine the association between these proteins and the occurrence, clinical features, and overall survival rate in BTC. SFRP1 and beta-catenin had an inverse correlation (r = -0.636, P<0.0001) as assessed by Spearman rank analysis, with 52 (66.7%) of the BTC samples negative for SFRP1 expression and 53 (68.0%) positive for beta-catenin expression. Expression of each protein was associated with the histological type and lymph node invasion of BTC. A significantly poorer overall survival rate was observed for patients with low SFRP1 expression (P< 0.0001) or high beta-catenin expression (P = 0.007). SFRP1 expression (P<0.0001), beta-catenin expression (P<0.01) and histological type (P<0.01) were correlated with overall survival rate as assessed by univariate analysis; while multivariate analysis suggested that SFRP1 (hazard ratio, 10.514; 95% confidence intervals, 2.381-39.048; P<0.0001) may serve as an independent prognostic factor for BTC. Collectively, these results demonstrate that SFRP1 is a favorable prognostic factor for human BTC and that its expression inversely correlates with that of beta-catenin.	[Kang, Pengcheng; Wan, Ming; Huang, Peng; Li, Chunlong; Wang, Zhidong; Zhong, Xiangyu; Hu, Zhanliang; Tai, Sheng; Cui, Yunfu] Harbin Med Univ, Affiliated Hosp 2, Dept Hepatopancreatobiliary Surg, Harbin, Peoples R China	Harbin Medical University	Cui, YF (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Hepatopancreatobiliary Surg, Harbin, Peoples R China.	yfcui777@hotmail.com		cui, yunfu/0000-0001-7393-1680	National Natural Science Foundation of China [81170426]; Heilongjiang Province Science and Technology Preferred Projects [297]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Province Science and Technology Preferred Projects	This study was supported by the National Natural Science Foundation of China (no. 81170426) and Heilongjiang Province Science and Technology Preferred Projects (2011, no. 297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen K, 2012, EPIGENETICS-US, V7, P1249, DOI 10.4161/epi.22191; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Byun T, 2005, J CLIN PATHOL, V58, P515, DOI 10.1136/jcp.2004.018598; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Caldwell GM, 2004, CANCER RES, V64, P883, DOI 10.1158/0008-5472.CAN-03-1346; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Figueras J, 2000, NEW ENGL J MED, V342, P663; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; FRAUMENI JF, 1996, CANC EPIDEMIOLOGY PR, P794; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Goeppert B, 2014, HEPATOLOGY, V59, P544, DOI 10.1002/hep.26721; Hsing AW, 1998, INT J CANCER, V75, P368, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;368::AID-IJC7&gt;3.0.CO;2-0; Huang J, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-126; Jarnagin WR, 2004, SEMIN LIVER DIS, V24, P189, DOI 10.1055/s-2004-828895; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Klopocki E, 2004, INT J ONCOL, V25, P641; Lee AY, 2004, ONCOGENE, V23, P6672, DOI 10.1038/sj.onc.1207881; Lodygin D, 2005, CANCER RES, V65, P4218, DOI 10.1158/0008-5472.CAN-04-4407; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Malhi H, 2006, J HEPATOL, V45, P856, DOI 10.1016/j.jhep.2006.09.001; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Marsit CJ, 2005, CANCER RES, V65, P7081, DOI 10.1158/0008-5472.CAN-05-0267; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Stoehr R, 2004, LAB INVEST, V84, P465, DOI 10.1038/labinvest.3700068; Sun X, 2013, CELL SIGNAL, V25, P2805, DOI 10.1016/j.cellsig.2013.09.006; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Suzuki M, 2007, CLIN CANCER RES, V13, P6087, DOI 10.1158/1078-0432.CCR-07-0591; Takada T, 2004, CANCER SCI, V95, P741, DOI 10.1111/j.1349-7006.2004.tb03255.x; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Ugolini F, 2001, ONCOGENE, V20, P5810, DOI 10.1038/sj.onc.1204706; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; Wong CM, 2001, CANCER-AM CANCER SOC, V92, P136, DOI 10.1002/1097-0142(20010701)92:1<136::AID-CNCR1301>3.0.CO;2-R; Xi S, 2010, PLOS ONE, V29, P5; Yan D, 2001, P NATL ACAD SCI USA, V98, P3802, DOI 10.1073/pnas.071041898; You J, 2013, PLOS ONE, V18, P8; Zong YW, 2011, INT J BIOCHEM CELL B, V43, P257, DOI 10.1016/j.biocel.2010.06.020; Zou HZ, 2005, INT J CANCER, V116, P584, DOI 10.1002/ijc.21045	39	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90308	10.1371/journal.pone.0090308	http://dx.doi.org/10.1371/journal.pone.0090308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594839	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900093
J	Pfortmueller, CA; Marti, M; Kunz, M; Lindner, G; Exadaktylos, AK				Pfortmueller, Carmen A.; Marti, Mariana; Kunz, Mirco; Lindner, Gregor; Exadaktylos, Aristomenis K.			Injury Severity and Mortality of Adult Zebra Crosswalk and Non-Zebra Crosswalk Road Crossing Accidents: A Cross-Sectional Analysis	PLOS ONE			English	Article							PEDESTRIANS; BEHAVIOR; DRIVERS; CRASHES; SPEED; RISK	Principals: Over a million people worldwide die each year from road traffic injuries and more than 10 million sustain permanent disabilities. Many of these victims are pedestrians. The present retrospective study analyzes the severity and mortality of injuries suffered by adult pedestrians, depending on whether they used a zebra crosswalk. Methods: Our retrospective data analysis covered adult patients admitted to our emergency department (ED) between 1 January 2000 and 31 December 2012 after being hit by a vehicle while crossing the road as a pedestrian. Patients were identified by using a string term. Medical, police and ambulance records were reviewed for data extraction. Results: A total of 347 patients were eligible for study inclusion. Two hundred and three (203; 58.5%) patients were on a zebra crosswalk and 144 (41.5%) were not. The mean ISS (injury Severity Score) was 12.1 (SD 14.7, range 1-75). The vehicles were faster in non-zebra crosswalk accidents (47.7 km/n, versus 41.4 km/h, p<0.027). The mean ISS score was higher in patients with non-zebra crosswalk accidents; 14.4 (SD 16.5, range 1-75) versus 10.5 (SD13.14, range 1-75) (p<0.019). Zebra crosswalk accidents were associated with less risk of severe injury (OR 0.61, 95% CI 0.38-0.98, p<0.042). Accidents involving a truck were associated with increased risk of severe injury (OR 3.53, 95% CI 1.21-10.26, p<0.02). Conclusion: Accidents on zebra crosswalks are more common than those not on zebra crosswalks. The injury severity of non-zebra crosswalk accidents is significantly higher than in patients with zebra crosswalk accidents. Accidents involving large vehicles are associated with increased risk of severe injury. Further prospective studies are needed, with detailed assessment of motor vehicle types and speed.	[Pfortmueller, Carmen A.; Lindner, Gregor] Univ Hosp Bern, Univ Dept Gen Internal Med, CH-3010 Bern, Switzerland; [Pfortmueller, Carmen A.; Marti, Mariana; Lindner, Gregor; Exadaktylos, Aristomenis K.] Univ Bern, Bern, Switzerland; [Marti, Mariana; Exadaktylos, Aristomenis K.] Univ Hosp Bern, Univ Dept Emergency Med, CH-3010 Bern, Switzerland; [Kunz, Mirco] Kantonsspital Winterthur, Dept Anesthesiol, Winterthur, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern	Pfortmueller, CA (corresponding author), Univ Hosp Bern, Univ Dept Gen Internal Med, CH-3010 Bern, Switzerland.	cpfortmueller@gmail.com	Lindner, Gregor/AAR-6761-2020	Lindner, Gregor/0000-0001-5551-8227; Pfortmueller, Carmen/0000-0003-0326-2770				[Anonymous], 2002, PEDESTRIAN AFETY NEW; [Anonymous], 1996, 136 U LUND, P136; [Anonymous], 1988, EVALUATION EFFECTIVE; BFU, 2012, STAT 2012; BFU, 2004, SICH SCHUL BFU SAF T; Bunn F., 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003110, DOI 10.1002/14651858.CD003110]; Duperrex O, 2002, BRIT MED J, V324, P1129, DOI 10.1136/bmj.324.7346.1129; Hamed MM, 2001, SAFETY SCI, V38, P63, DOI 10.1016/S0925-7535(00)00058-8; Herms BF, 1972, 406 HIGHW RES BOARD, P406; KALLINEN M, 1995, SPORTS MED, V20, P41, DOI 10.2165/00007256-199520010-00004; Koepsell T, 2002, JAMA-J AM MED ASSOC, V288, P2136, DOI 10.1001/jama.288.17.2136; Moudon AV, 2011, ACCIDENT ANAL PREV, V43, P11, DOI 10.1016/j.aap.2009.12.008; Muhammad M, 2009, MAKING ROADS SAFE PE; Rothman L, 2012, INJURY PREV, V18, P365, DOI 10.1136/injuryprev-2011-040246; Roudsari BS, 2004, INJURY PREV, V10, P154, DOI 10.1136/ip.2003.003814; Scaramuzza G, 1997, SICHERHEITSTECHNISCH; Tefft BC, 2013, ACCIDENT ANAL PREV, V50, P871, DOI 10.1016/j.aap.2012.07.022; Thompson JP, 2013, ACCIDENT ANAL PREV, V50, P768, DOI 10.1016/j.aap.2012.06.028; Tidwell JE, 1995, TRANSPORT RES REC, V1502, P119; Tobey H.N., 1983, TRANSPORT RES REC, P31; Varhelyi A, 1998, ACCIDENT ANAL PREV, V30, P731, DOI 10.1016/S0001-4575(98)00026-8	21	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90835	10.1371/journal.pone.0090835	http://dx.doi.org/10.1371/journal.pone.0090835			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4CT	24595100	Green Published, gold			2022-12-25	WOS:000332468900151
J	Sztiller-Sikorska, M; Koprowska, K; Majchrzak, K; Hartman, M; Czyz, M				Sztiller-Sikorska, Malgorzata; Koprowska, Kamila; Majchrzak, Kinga; Hartman, Mariusz; Czyz, Malgorzata			Natural Compounds' Activity against Cancer Stem-Like or Fast-Cycling Melanoma Cells	PLOS ONE			English	Article							SIDE-POPULATION CELLS; CYTOTOXIN ILLUDIN-M; HEPATOCELLULAR-CARCINOMA; IN-VIVO; MALIGNANT-MELANOMA; SIGNALING PATHWAY; HSP90 INHIBITORS; SELF-RENEWAL; TUMOR-GROWTH; LUNG-CANCER	Background: Accumulating evidence supports the concept that melanoma is highly heterogeneous and sustained by a small subpopulation of melanoma stem-like cells. Those cells are considered as responsible for tumor resistance to therapies. Moreover, melanoma cells are characterized by their high phenotypic plasticity. Consequently, both melanoma stem-like cells and their more differentiated progeny must be eradicated to achieve durable cure. By reevaluating compounds in heterogeneous melanoma populations, it might be possible to select compounds with activity not only against fast-cycling cells but also against cancer stem-like cells. Natural compounds were the focus of the present study. Methods: We analyzed 120 compounds from The Natural Products Set II to identify compounds active against melanoma populations grown in an anchorage-independent manner and enriched with cells exerting self-renewing capacity. Cell viability, cell cycle arrest, apoptosis, gene expression, clonogenic survival and label-retention were analyzed. Findings: Several compounds efficiently eradicated cells with clonogenic capacity and nanaomycin A, streptonigrin and toyocamycin were effective at 0.1 mu M. Other anti-clonogenic but not highly cytotoxic compounds such as bryostatin 1, siomycin A, illudin M, michellamine B and pentoxifylline markedly reduced the frequency of ABCB5 (ATP-binding cassette, sub-family B, member 5)-positive cells. On the contrary, treatment with maytansine and colchicine selected for cells expressing this transporter. Maytansine, streptonigrin, toyocamycin and colchicine, even if highly cytotoxic, left a small subpopulation of slow-dividing cells unaffected. Compounds selected in the present study differentially altered the expression of melanocyte/melanoma specific microphthalmia-associated transcription factor (MITF) and proto-oncogene c-MYC. Conclusion: Selected anti-clonogenic compounds might be further investigated as potential adjuvants targeting melanoma stem-like cells in the combined anti-melanoma therapy, whereas selected cytotoxic but not anti-clonogenic compounds, which increased the frequency of ABCB5-positive cells and remained slow-cycling cells unaffected, might be considered as a tool to enrich cultures with cells exhibiting melanoma stem cell characteristics.	[Sztiller-Sikorska, Malgorzata; Koprowska, Kamila; Majchrzak, Kinga; Hartman, Mariusz; Czyz, Malgorzata] Med Univ Lodz, Dept Mol Biol Canc, Lodz, Poland	Medical University Lodz	Czyz, M (corresponding author), Med Univ Lodz, Dept Mol Biol Canc, Lodz, Poland.	malgorzata.czyz@umed.lodz.pl	Sztiller-Sikorska, Malgorzata Magdalena/S-9581-2016; /S-9995-2016; Czyz, Malgorzata/AAD-1869-2020; Koprowska, Kamila/J-8550-2012	Czyz, Malgorzata/0000-0002-8279-4742; Majchrzak, Kinga/0000-0001-5978-7782; Hartman, Mariusz/0000-0002-2231-3740; Sztiller-Sikorska, Malgorzata/0000-0001-5827-7959	National Science Centre [2011/01/B/NZ4/04921]	National Science Centre(National Science Centre, Poland)	Funding: This work was financially supported by a grant 2011/01/B/NZ4/04921 from the National Science Centre. The Natural Products Set II was provided at no cost by the US National Cancer Institute (NCI, http://www.dtp.nci.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akunuru S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.93; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Blanc V, 2011, CLIN CANCER RES, V17, P6448, DOI 10.1158/1078-0432.CCR-11-0485; Blum R H, 1978, Cancer Clin Trials, V1, P113; Bolzan AD, 2001, MUTAT RES-REV MUTAT, V488, P25, DOI 10.1016/S1383-5742(00)00062-4; BORDEN EC, 1982, AM J CLIN ONCOL-CANC, V5, P417, DOI 10.1097/00000421-198208000-00012; Bragado P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029974; Burris HA, 2011, J CLIN ONCOL, V29, P398, DOI 10.1200/JCO.2010.29.5865; Cassady JM, 2004, CHEM PHARM BULL, V52, P1, DOI 10.1248/cpb.52.1; Caulfield T, 2011, J STRUCT BIOL, V176, P185, DOI 10.1016/j.jsb.2011.07.015; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chartrain M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036762; Chen GJ, 2007, J CELL BIOCHEM, V101, P1492, DOI 10.1002/jcb.21265; Chen XM, 2012, TOXICOL IN VITRO, V26, P649, DOI 10.1016/j.tiv.2012.01.024; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Czyz M, 2013, CANCER BIOL THER, V14, P135, DOI 10.4161/cbt.22952; D'incalci M, 2007, CURR PHARM DESIGN, V13, P2744, DOI 10.2174/138161207781757097; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dua P, 2006, CANCER CHEMOTH PHARM, V58, P195, DOI 10.1007/s00280-005-0155-8; Elliott AM, 2009, MOL CANCER RES, V7, P79, DOI 10.1158/1541-7786.MCR-08-0235; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Frenzel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027988; Garate M, 2010, FREE RADICAL BIO MED, V48, P1601, DOI 10.1016/j.freeradbiomed.2010.03.003; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gavriil M, 2009, MOL CARCINOGEN, V48, P678, DOI 10.1002/mc.20550; Goding CR, 2011, ONCOGENE, V30, P2304, DOI 10.1038/onc.2010.641; Gomez-Cabrero A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073607; Gu JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062839; Hallett RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033976; Haq R, 2013, P NATL ACAD SCI USA, V110, P4321, DOI 10.1073/pnas.1205575110; He KJ, 2011, MOL CANCER THER, V10, P938, DOI 10.1158/1535-7163.MCT-10-1120; Helm F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077375; Hermann PC, 2010, SEMIN CANCER BIOL, V20, P77, DOI 10.1016/j.semcancer.2010.03.004; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Jain M, 2010, CHEMOTHERAPY, V56, P82, DOI 10.1159/000298823; Kamran MZ, 2013, BIOMED PHARMACOTHER, V67, P399, DOI 10.1016/j.biopha.2013.03.020; Kamran MZ, 2012, BIOMED PHARMACOTHER, V66, P617, DOI 10.1016/j.biopha.2012.03.006; Kiburu IN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037371; Kilarski WW, 2012, ANGIOGENESIS, V15, P643, DOI 10.1007/s10456-012-9287-8; Knauer S, 2009, ANTI-CANCER DRUG, V20, P676, DOI 10.1097/CAD.0b013e32832e056a; Koprowska K, 2013, ANTI-CANCER DRUG, V24, P835, DOI 10.1097/CAD.0b013e3283635a04; Kuck D, 2010, MOL CANCER THER, V9, P3015, DOI 10.1158/1535-7163.MCT-10-0609; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Leder K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014366; Lewis AM, 2005, MOL CARCINOGEN, V43, P215, DOI 10.1002/mc.20107; Lin ZY, 2013, LIFE SCI, V93, P323, DOI 10.1016/j.lfs.2013.07.002; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; MCMORRIS TC, 1990, CHEM RES TOXICOL, V3, P574, DOI 10.1021/tx00018a013; Murphy GF, 2014, MOL ASPECTS MED, V39, P33, DOI 10.1016/j.mam.2013.10.003; Nakano I, 2011, NEURO-ONCOLOGY, V13, P622, DOI 10.1093/neuonc/nor023; Park S, 2011, BBA-GEN SUBJECTS, V1810, P1340, DOI 10.1016/j.bbagen.2011.06.023; Perego M, 2010, J INVEST DERMATOL, V130, P1877, DOI 10.1038/jid.2010.69; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Rabindran SK, 2000, CANCER RES, V60, P47; Ramgolam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018784; Ri M, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.26; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Saez-Ayala M, 2013, CANCER CELL, V24, P105, DOI 10.1016/j.ccr.2013.05.009; Sawanyawisuth K, 2007, ACTA ONCOL, V46, P378, DOI 10.1080/02841860600871061; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schobert R, 2008, BIOORGAN MED CHEM, V16, P8592, DOI 10.1016/j.bmc.2008.08.015; Sheen IS, 2005, WORLD J GASTROENTERO, V11, P771, DOI 10.3748/wjg.v11.i6.771; Shukla V, 2003, CANCER BIOTHER RADIO, V18, P559, DOI 10.1089/108497803322287637; Singh S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-73; Sinnberg T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023429; SKOUFIAS DA, 1992, BIOCHEMISTRY-US, V31, P738, DOI 10.1021/bi00118a015; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; SUHADOLN.RJ, 1967, BIOCHIM BIOPHYS ACTA, V149, P41, DOI 10.1016/0005-2787(67)90689-2; Sztiller-Sikorska M, 2012, MELANOMA RES, V22, P215, DOI 10.1097/CMR.0b013e3283531317; TAVITIAN A, 1969, BIOCHIM BIOPHYS ACTA, V179, P50, DOI 10.1016/0005-2787(69)90121-X; Theron T, 2000, INT J RADIAT BIOL, V76, P1197, DOI 10.1080/09553000050134438; Thurber AE, 2011, ONCOGENE, V30, P3036, DOI 10.1038/onc.2011.33; Toyomura K, 2012, J TOXICOL SCI, V37, P1049, DOI 10.2131/jts.37.1049; Valkenburg Kenneth C, 2011, Cancers (Basel), V3, P2050, DOI 10.3390/cancers3022050; van der Kraan AGJ, 2013, BIOCHEM J, V451, P235, DOI 10.1042/BJ20121626; Zhai JM, 2013, DIGEST DIS SCI, V58, P1934, DOI 10.1007/s10620-013-2663-4; Zhao D, 2011, CELL IMMUNOL, V271, P392, DOI 10.1016/j.cellimm.2011.08.007	80	38	39	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90783	10.1371/journal.pone.0090783	http://dx.doi.org/10.1371/journal.pone.0090783			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595456	Green Submitted, gold, Green Published			2022-12-25	WOS:000332468900146
J	Wahlstrom, H; Lewerin, SS; Sundstrom, K; Ivarsson, S				Wahlstrom, Helene; Lewerin, Susanna Sternberg; Sundstrom, Kristian; Ivarsson, Sofie			Estimation of the Expected Change in Domestic Human Salmonella Cases in Sweden in 2010, Given a Hypothetical Relaxation of the Current Salmonella Control Programme	PLOS ONE			English	Article							COUNTRIES	The Swedish salmonella control programme has been very successful in reducing the number of salmonella infections in both humans and animals. However, the costs for the control have increased and it has thus been questioned if the control measures could be relaxed and, if so, what effect this would have on human and animal health. The aim of the present study is to evaluate the expected effects on human health of a relaxation of the Swedish control i.e. a substitution of the present programme with a programme similar to the ones present in Denmark or the Netherlands. Data from the year 2010 was used to illustrate this. It was assumed that the domestic exposure to salmonella would then become the same in Sweden as it was in Denmark or the Netherlands in that year. As official statistics on the number of reported salmonella cases are not comparable across European countries, data from five different sources were used to try to obtain comparable estimates of the domestic salmonella exposure in the three countries. The study shows that the number of reported domestic human salmonella cases in Sweden in 2010 would increase by approximately 900 to 2 400 cases in the Danish scenarios and 6 400 to 8 400 in the Dutch scenarios. Although uncertainty exists, it was concluded that the number of reported domestic salmonella cases would increase substantially in Sweden in case of a relaxation of the current control programme.	[Wahlstrom, Helene] Natl Vet Inst, Zoonosis Ctr, S-75007 Uppsala, Sweden; [Lewerin, Susanna Sternberg] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Sundstrom, Kristian] Lund Univ, Inst Food & Agr Econ, Lund, Sweden; [Ivarsson, Sofie] Swedish Inst Communicable Dis Control, Dept Preparedness, Solna, Sweden	National Veterinary Institute SVA; Swedish University of Agricultural Sciences; Lund University; Swedish Institute for Infectious Disease Control	Wahlstrom, H (corresponding author), Natl Vet Inst, Zoonosis Ctr, S-75007 Uppsala, Sweden.	helene.wahlstrom@sva.se	Lewerin, Susanna Sternberg/C-1621-2015	Lewerin, Susanna Sternberg/0000-0001-7907-8377				[Anonymous], 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.134r; [Anonymous], 2010, ANN REPORT ZOONOSES; [Anonymous], 2011, SURVEILLANCE ZOONOTI; de Jong B, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-4; EFSA, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.135r; EFSA, 2007, EFSA J, V97; EFSA, 2007, EFSA J, V98, P1; EFSA, 2009, EFSA J, V7; Engvall A, 1994, EC SWEDISH SALMONELL; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; Falkenhorst G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-523; Haagsma JA, 2013, EPIDEMIOL INFECT, V141, P1625, DOI 10.1017/S0950268812002166; Havelaar A, 2012, EPIDEMIOLOGY INFECT, V1, P1; Pires SM, 2011, ESTIMATION RELATIVE; RIVM, 2010, RIJKS VOLKSG MIL RIV; Smittskyddsinstitutet, 2011, SMITTSK EP ARSR 2010; Sundstrom K, 2010, FOLKHALSA DJURHALSA, V2010, P106; Wahlstrom H, 2011, EPIDEMIOL INFECT, V139, P1246, DOI 10.1017/S0950268810002293	18	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89833	10.1371/journal.pone.0089833	http://dx.doi.org/10.1371/journal.pone.0089833			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594989	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900038
J	Fan, Z; Jiang, GF; Liu, YX; He, QX; Blanchard, B				Fan, Zhou; Jiang, Guo-Fang; Liu, Yu-Xiang; He, Qi-Xin; Blanchard, Benjamin			Population Explosion in the Yellow-Spined Bamboo Locust Ceracris kiangsu and Inferences for the Impact of Human Activity	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; MITOCHONDRIAL-DNA; GENETIC-STRUCTURE; MOLECULAR EVIDENCE; COMPARATIVE PHYLOGEOGRAPHY; ENTOMOPATHOGENIC FUNGUS; AFLP; INSECT; POLYMORPHISM; DIVERSITY	Geographic distance and geographical barriers likely play a considerable role in structuring genetic variation in species, although some migratory species may have less phylogeographic structure on a smaller spatial scale. Here, genetic diversity and the phylogenetic structure among geographical populations of the yellow-spined bamboo locust, Ceracris kiangsu, were examined with 16S rDNA and amplified fragment length polymorphisms (AFLPs). In this study, no conspicuous phylogeographical structure was discovered from either Maximum parsimony (MP) and Neighbor-joining (NJ) phylogenetic analyses. The effect of geographical isolation was not conspicuous on a large spatial scale. At smaller spatial scales local diversity of some populations within mountainous areas were detected using Nei's genetic distance and AMOVA. There is a high level of genetic diversity and a low genetic differentiation among populations in the C. kiangsu of South and Southeast China. Our analyses indicate that C. kiangsu is a monophyletic group. Our results also support the hypothesis that the C. kiangsu population is in a primary differentiation stage. Given the mismatch distribution, it is likely that a population expansion in C. kiangsu occurred about 0.242 Ma during the Quaternary interglaciation. Based on historical reports, we conjecture that human activities had significant impacts on the C. kiangsu gene flow.	[Fan, Zhou; Jiang, Guo-Fang; Liu, Yu-Xiang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Jiang, Guo-Fang; He, Qi-Xin; Blanchard, Benjamin] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Nanjing Normal University; University of Michigan System; University of Michigan	Jiang, GF (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China.	cnjgf1208@163.com	Jiang, Guo-Fang/I-5236-2019	Jiang, Guo-Fang/0000-0003-0164-0950	National Natural Sciences Foundation of China [30670257, 30970339]; Nanjing Normal University Innovative Team Project [0319PM0902]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Normal University Innovative Team Project; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants from the National Natural Sciences Foundation of China (Nos. 30670257, 30970339, http://www.nsfc.gov.cn/) to Guo-Fang Jiang, Nanjing Normal University Innovative Team Project (No. 0319PM0902), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern RG, 2009, MOL ECOL, V18, P343, DOI 10.1111/j.1365-294X.2008.04034.x; Apple LJ, 2010, MOL ECOL, V19, P1365; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Arrigo N, 2011, MOL PHYLOGENET EVOL, V58, P33, DOI 10.1016/j.ympev.2010.11.009; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Ayoub NA, 2004, MOL ECOL, V13, P3453, DOI 10.1111/j.1365-294X.2004.02335.x; Balint M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031872; Bamboo Research Group Forestry Department of Henan Municipal Agricultural and Forestry Bureau, 1976, CHINESE FOREST SCI, P7; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; Borer M, 2010, MOL PHYLOGENET EVOL, V57, P703, DOI 10.1016/j.ympev.2010.08.017; Chen B, 2011, HEREDITY, V106, P241, DOI 10.1038/hdy.2010.58; Chen Y, 2007, METALLOGENIC SYSTEM, P1; Comes HP, 2003, TAXON, V52, P451, DOI 10.2307/3647445; COOPER SJB, 1995, MOL ECOL, V4, P49, DOI 10.1111/j.1365-294X.1995.tb00191.x; De Moura PA, 2011, BMC GENET, V12, P1471; Devi UK, 2007, MYCOL RES, V111, P716, DOI 10.1016/j.mycres.2007.03.003; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fu YX, 1997, GENETICS, V147, P915; Fuentes-Contreras E, 2008, J ECON ENTOMOL, V101, P190, DOI 10.1603/0022-0493(2008)101[190:PGSOCM]2.0.CO;2; Galbreath KE, 2004, MOL ECOL, V13, P135, DOI 10.1046/j.1365-294X.2004.02026.x; Garcia JT, 2011, MOL PHYLOGENET EVOL, V61, P671, DOI 10.1016/j.ympev.2011.07.017; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Henan Native Fresh Food Company, 1978, J HENAN AGR U, P16; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hollingsworth PM, 2004, HEREDITY, V92, P490, DOI 10.1038/sj.hdy.6800445; Hrbek T, 2005, ANIM CONSERV, V8, P297, DOI 10.1017/S1367943005002210; Manrique-Poyato MI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059041, 10.1371/journal.pone.0083712]; Inoue MK, 2009, BIODIVERSITY OTTAWA, V10, P2; [姜石生 JIANG Shisheng], 2011, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V31, P115; Kambhampati S, 1995, INSECT MOL BIOL, V4, P233, DOI 10.1111/j.1365-2583.1995.tb00028.x; Kingman J.F.C., 1980, CBMS-NSF Regional Conference Series in Applied Mathematics, P1; Knowles LL, 2005, MOL ECOL, V14, P4023, DOI 10.1111/j.1365-294X.2005.02711.x; Knowles LL, 2000, EVOLUTION, V54, P1337, DOI 10.1111/j.0014-3820.2000.tb00566.x; Koblmuller S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-7; Kosman E, 2005, MOL ECOL, V14, P415, DOI 10.1111/j.1365-294X.2005.02416.x; Kronforst MR, 2008, P ROY SOC B-BIOL SCI, V275, P493, DOI 10.1098/rspb.2007.1378; Lanave C, 2002, NUCLEIC ACIDS RES, V30, P174, DOI 10.1093/nar/30.1.174; Li SH, 2009, MOL ECOL, V18, P622, DOI 10.1111/j.1365-294X.2008.04028.x; Li T, 2011, GENETICA, V139, P511, DOI 10.1007/s10709-011-9573-1; Li XS, 2010, J INSECT CONSERV, V14, P257, DOI 10.1007/s10841-009-9254-x; Liu JW, 2006, ORIENT INSECTS, V40, P153, DOI 10.1080/00305316.2006.10417467; Lohse K, 2010, MOL ECOL, V30, P1365; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Magri D, 2010, QUATERN INT, V219, P145, DOI 10.1016/j.quaint.2009.10.032; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; Mendelson TC, 2005, NATURE, V433, P375, DOI 10.1038/433375a; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Mopper S, 1996, TRENDS ECOL EVOL, V11, P235, DOI 10.1016/0169-5347(96)10036-7; Morgan K, 2011, MOL ECOL, V20, P4533, DOI 10.1111/j.1365-294X.2011.05268.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1978, GENETICS, V89, P583; Nei M., 2000, MOL EVOLUTION PHYLOG; Ortego J, 2010, MOL ECOL, V19, P472, DOI 10.1111/j.1365-294X.2009.04512.x; Pang JF, 2003, MOL PHYLOGENET EVOL, V27, P398, DOI 10.1016/S1055-7903(03)00019-8; Peterson MA, 1998, AM NAT, V152, P428, DOI 10.1086/286180; Poggio CE, 2002, J PROSTHET DENT, V87, P688, DOI 10.1067/mpr.2002.126421; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D., 2003, CURRENT PROTOCOLS BI; Pritchard JK, 2000, GENETICS, V155, P945; Qu YH, 2009, MOL PHYLOGENET EVOL, V51, P312, DOI 10.1016/j.ympev.2009.01.013; Quek SP, 2010, P NATL ACAD SCI USA, V107, P7365, DOI 10.1073/pnas.0911572107; Rand DM, 1996, CONSERV BIOL, V10, P665, DOI 10.1046/j.1523-1739.1996.10020665.x; Roehrdanz R.L., 1993, Insect Molecular Biology, V2, P89, DOI 10.1111/j.1365-2583.1993.tb00129.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosetti N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040807; ROZAS J, 2005, DNASP DNA SEQUENCE P; Rudh A, 2007, MOL ECOL, V16, P4284, DOI 10.1111/j.1365-294X.2007.03479.x; Russell AL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-88; Scheffer SJ, 2007, MOL ECOL, V16, P2627, DOI 10.1111/j.1365-294X.2007.03303.x; Schonswetter P, 2004, J BIOGEOGR, V31, P1673, DOI 10.1111/j.1365-2699.2004.01103.x; Shen K, 2009, J INSECT PHYSIOL, V55, P78, DOI 10.1016/j.jinsphys.2008.10.011; Shen L, 2002, ACTA ECOLOGY SINICA, V22, P1985; Shreve SM, 2011, MOL ECOL, V20, P4433, DOI 10.1111/j.1365-294X.2011.05298.x; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; TAJIMA F, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P37; TAJIMA F, 1989, GENETICS, V123, P597; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teng ZQ, 2007, INSECT SCI, V14, P193, DOI 10.1111/j.1744-7917.2007.00143.x; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Arana MV, 2010, MOL PHYLOGENET EVOL, V54, P941, DOI 10.1016/j.ympev.2009.11.007; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wright S, 1943, GENETICS, V28, P114; Xuan WJ, 2009, EUR J ENTOMOL, V106, P663, DOI 10.14411/eje.2009.082; Yeh F.C., 1999, MICROSOFT WINDOWS BA; Yeh WB, 2004, ANN ENTOMOL SOC AM, V97, P613, DOI 10.1603/0013-8746(2004)097[0613:GDOLAC]2.0.CO;2; Yi CL, 2005, QUATERNARY SCI, V25, P611; Yu HP, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0145; Yu HP, 2011, ENTOMOL EXP APPL, V138, P71, DOI 10.1111/j.1570-7458.2010.01076.x; Yu HP, 2010, PHYSIOL ENTOMOL, V35, P379, DOI 10.1111/j.1365-3032.2010.00755.x; Yu HP, 2010, J INSECT BEHAV, V23, P472, DOI 10.1007/s10905-010-9230-z; Yu XW, 2003, FOREST HUMANKIND, V10, P50; Yu ZD, 2011, WORLD BAMBOO RATTAN, V9, P43; Zamoum T, 2005, HEREDITY, V94, P630, DOI 10.1038/sj.hdy.6800673; Zhan XJ, 2011, MOL ECOL, V20, P3014, DOI 10.1111/j.1365-294X.2011.05144.x; Zhang CS, 2007, MOL BIOTECHNOL, V36, P23, DOI 10.1007/s12033-007-0022-4; Zhang DX, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-144; Zhang DX, 1997, INSECT MOL BIOL, V6, P143, DOI 10.1111/j.1365-2583.1997.tb00082.x; Zhang MW, 2009, MOLECULAR PHYLOGENET, V54, P47; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x; Zhang XM, 2010, WORLD BAMBOO RATTAN, V8, P34; Zheng Z. M., 1998, FAUNA SINICA INSECTA; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x; Zou YG, 2006, J FUJIAN FORESTRY SC, V33, P192	110	9	11	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89873	10.1371/journal.pone.0089873	http://dx.doi.org/10.1371/journal.pone.0089873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603526	gold, Green Published			2022-12-25	WOS:000332483600025
J	Lourenco, BH; Cardoso, MA				Lourenco, Barbara H.; Cardoso, Marly A.		ACTION Study Team	C-Reactive Protein Concentration Predicts Change in Body Mass Index during Childhood	PLOS ONE			English	Article							MIDDLE-AGED ADULTS; WEIGHT-GAIN; LIFE-COURSE; INFLAMMATION; HEALTH; NUTRITION; CHILDREN; DISEASE; MARKERS; OBESITY	Objective: Inflammation may constitute an underlying mechanism for increased risk of developing chronic diseases in later years, but few prospective studies have assessed the influence of low-grade inflammation on body weight gain, particularly among children in low-to middle-income settings with lower prevalence of overweight and obesity. We aimed to investigate whether C-reactive protein (CRP), as a biomarker of low-grade inflammation, predicts changes in body mass index-for-age z scores (BAZ) during childhood. Methods: A population-based longitudinal study was conducted in the Brazilian Amazon among children aged <= 10 years in 2007, with follow-up visits in 2009 and 2012. Outcome was annual change in BAZ. As the main exposure of interest, CRP concentrations were divided into four categories, with values <1 mg/L divided in tertiles plus a fourth category with values ranging from 1 to 10 mg/L. Children were simultaneously screened for iron and vitamin A deficiencies, diarrhea, and wheezing. We used mixed-effect linear regression models to measure the effect of CRP concentrations on annual BAZ change and linear regression models to explore CRP predictors at baseline. Results: At baseline, 1007 children had CRP and anthropometric data [ mean (SD) age: 5.3 (2.9) years; 50.9% male, 84.5% mulatto/mixed-race, 14.0% at risk for overweight or obesity, 4.8% stunted]; 737 were successfully followed up. Morbidities and nutritional deficiencies were widespread. Among participants aged >5 years, children in the highest tertile of CRP <1 mg/L at baseline, regarded as an indicator of low-grade inflammation, had a 0.04 z/y higher gain in BAZ (95% CI: 0.01, 0.09 z/y) during follow-up. CRP was positively associated with household poverty and worse nutritional indicators. Conclusions: We found evidence of a role for low-grade inflammation in predicting annual BAZ gain among children aged >5 years.	[Lourenco, Barbara H.] Univ Sao Paulo, Publ Hlth Nutr Program, Sch Publ Hlth, Sao Paulo, Brazil; [Cardoso, Marly A.] Univ Sao Paulo, Dept Nutr, Sch Publ Hlth, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Cardoso, MA (corresponding author), Univ Sao Paulo, Dept Nutr, Sch Publ Hlth, Sao Paulo, Brazil.	marlyac@usp.br	Lourenco, Barbara/H-8291-2012; Cardoso, Marly Augusto/B-8010-2013	Lourenco, Barbara/0000-0002-2006-674X; Cardoso, Marly Augusto/0000-0003-0973-3908	Brazilian National Counsel of Technological and Scientific Development, CNPq [551359/2001-3, 502937/2003-3, 307728/2006-4, 470573/2007-4]; Sao Paulo Research Foundation, FAPESP [2007/53042-1]; FAPESP [2008/57796-3]; Organization of American States [20100656]	Brazilian National Counsel of Technological and Scientific Development, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Organization of American States	This study was funded by the Brazilian National Counsel of Technological and Scientific Development, CNPq (Grant nos. 551359/2001-3, 502937/2003-3, 307728/2006-4, and 470573/2007-4) and the Sao Paulo Research Foundation, FAPESP (Grant no. 2007/53042-1). BHL received PhD scholarships from the FAPESP (Grant no. 2008/57796-3) and the Organization of American States (BR Self Grad 2010/11, ID 20100656). The views expressed in this paper are those of the authors and not necessarily those of any funding agencies or others whose support is acknowledged. The funders had no influence on the study design, data collection, analysis or interpretation, decision to publish, or preparation of the manuscript.	Aeberli I, 2006, AM J CLIN NUTR, V84, P748, DOI 10.1093/ajcn/84.4.748; [Anonymous], 2009, WHO GLOBAL DATABASE; Augusto RA, 2013, PUBLIC HEALTH NUTR, V16, P256; Barros FC, 2010, REV SAUDE PUBL, V44, P1, DOI 10.1590/S0034-89102010000100001; Cardoso MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036341; Chen K, 2006, NAT MED, V12, P425, DOI 10.1038/nm1372; Cobayashi F, 2014, PUBLIC HEALTH NUTR, V17, P551, DOI 10.1017/S1368980013000190; Danese A, 2007, P NATL ACAD SCI USA, V104, P1319, DOI 10.1073/pnas.0610362104; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; DeBoer MD, 2012, NUTR REV, V70, P642, DOI 10.1111/j.1753-4887.2012.00543.x; Dewey KG, 2011, MATERN CHILD NUTR, V7, P129, DOI 10.1111/j.1740-8709.2011.00357.x; Duncan BB, 2000, OBES RES, V8, P279, DOI 10.1038/oby.2000.33; Egger G, 2009, OBES REV, V10, P237, DOI 10.1111/j.1467-789X.2008.00542.x; Engstrom G, 2003, DIABETES, V52, P2097, DOI 10.2337/diabetes.52.8.2097; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; Gomes LF, 2004, ANTIOXID REDOX SIGN, V6, P237, DOI 10.1089/152308604322899305; Holz T, 2010, OBESITY, V18, P2347, DOI 10.1038/oby.2010.73; Howe LD, 2013, J EPIDEMIOL COMMUN H, V67, P358, DOI 10.1136/jech-2012-201892; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Lakshmy R, 2011, INT J EPIDEMIOL, V40, P102, DOI 10.1093/ije/dyq121; Lam QLK, 2007, CELL MOL IMMUNOL, V4, P1; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Lourenco BH, 2015, MATERN CHILD NUTR, V11, P240, DOI 10.1111/mcn.12005; Margolis R, 2010, ADV LIFE COURSE RES, V15, P132, DOI 10.1016/j.alcr.2010.10.001; Maslova E, 2009, FOOD NUTR BULL, V30, P103, DOI 10.1177/156482650903000201; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Muniz PT, 2007, CAD SAUDE PUBLICA, V23, P1283, DOI 10.1590/S0102-311X2007000600004; Nazmi A, 2009, AM J HUM BIOL, V21, P192, DOI 10.1002/ajhb.20852; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012; Scagliusi FB, 2011, CAD SAUDE PUBLICA, V27, P2196; Skinner AC, 2010, PEDIATRICS, V125, pE801, DOI 10.1542/peds.2009-2182; Slopen N, 2013, PSYCHONEUROENDOCRINO, V38, P188, DOI 10.1016/j.psyneuen.2012.05.013; STRACK AM, 1995, AM J PHYSIOL-REG I, V268, pR142, DOI 10.1152/ajpregu.1995.268.1.R142; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tanner J.H., 1962, GROWTH ADOLESCENTS; Tzoulaki I, 2008, EUR HEART J, V29, P1049, DOI 10.1093/eurheartj/ehn105; WHO, 2006, ACTA PAEDIATR, P76, DOI DOI 10.1111/J.1651-2227.2006.TB02378.X; World Health Organization Centers for Disease Control and Prevention, 2007, ASS IR STAT POP; Zhu JH, 2000, AM J CARDIOL, V85, P140, DOI 10.1016/S0002-9149(99)00653-0	40	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90357	10.1371/journal.pone.0090357	http://dx.doi.org/10.1371/journal.pone.0090357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603645	Green Submitted, gold, Green Published			2022-12-25	WOS:000332483600047
J	Manichaikul, A; Rich, SS; Perry, H; Yeboah, J; Law, M; Davis, M; Parker, M; Ragosta, M; Connelly, JJ; McNamara, CA; Taylor, AM				Manichaikul, Ani; Rich, Stephen S.; Perry, Heather; Yeboah, Joseph; Law, Michelle; Davis, Molly; Parker, Matthew; Ragosta, Michael; Connelly, Jessica J.; McNamara, Coleen A.; Taylor, Angela M.			A Functionally Significant Polymorphism in ID3 Is Associated with Human Coronary Pathology	PLOS ONE			English	Article							BINDING INHIBITOR ID3; T-CELLS; INTRAVASCULAR ULTRASOUND; SJOGRENS-SYNDROME; ARTERY-DISEASE; MOUSE MODEL; ATHEROSCLEROSIS; MICE; 12/15-LIPOXYGENASE; DIFFERENTIATION	Aims: We previously identified association between the ID3 SNP rs11574 and carotid intima-media thickness in the Diabetes Heart Study, a predominantly White diabetic population. The nonsynonymous SNP rs11574 results in an amino acid substitution in the C-terminal region of ID3, attenuating the dominant negative function of ID3 as an inhibitor of basic HLH factor E12-mediated transcription. In the current investigation, we characterize the association between the functionally significant polymorphism in ID3, rs11574, with human coronary pathology. Methods and Results: The Multi-Ethnic Study of Atherosclerosis (MESA) is a longitudinal study of subclinical cardiovascular disease, including non-Hispanic White (n = 2,588), African American (n = 2,560) and Hispanic (n = 2,130) participants with data on coronary artery calcium (CAC). The Coronary Assessment in Virginia cohort (CAVA) included 71 patients aged 30-80 years, undergoing a medically necessary cardiac catheterization and intravascular ultrasound (IVUS) at the University of Virginia. ID3 SNP rs11574 risk allele was associated with the presence of CAC in MESA Whites (P = 0.017). In addition, the risk allele was associated with greater atheroma burden and stenosis in the CAVA cohort (P = 0.003, P = 0.04 respectively). The risk allele remained predictive of atheroma burden in multivariate analysis (Model 1: covariates age, gender, and LDL, regression coefficient = 9.578, SE = 3.657, p = 0.0110; Model 2: covariates Model 1, presence of hypertension, presence of diabetes, regression coefficient = 8.389, SE = 4.788, p = 0.0163). Conclusions: We present additional cohorts that demonstrate association of ID3 SNP rs11574 directly with human coronary artery pathology as measured by CAC and IVUS: one a multiethnic, relatively healthy population with low levels of diabetes and the second a predominantly White population with a higher incidence of T2DM referred for cardiac catheterization.	[Manichaikul, Ani; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Manichaikul, Ani] Univ Virginia, Dept Publ Hlth Sci, Div Biostat & Epidemiol, Charlottesville, VA USA; [Perry, Heather; Law, Michelle; Davis, Molly; Parker, Matthew; Connelly, Jessica J.; McNamara, Coleen A.; Taylor, Angela M.] Univ Virginia, Cardiovasc Res Ctr, Charlottesville, VA 22903 USA; [Yeboah, Joseph] Wake Forest Univ Hlth Sci, Dept Internal Med Cardiol, Winston Salem, NC USA; [Law, Michelle; Ragosta, Michael; Connelly, Jessica J.; McNamara, Coleen A.; Taylor, Angela M.] Univ Virginia, Dept Med, Div Cardiovasc Med, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; Wake Forest University; Wake Forest University School of Medicine; University of Virginia	Taylor, AM (corresponding author), Univ Virginia, Cardiovasc Res Ctr, Charlottesville, VA 22903 USA.	amt6b@virginia.edu		Manichaikul, Ani/0000-0002-5998-795X; Taylor, Angela/0000-0003-4927-4320; Rich, Stephen/0000-0003-3872-7793	NIH [P01 HL55798, R01 HL096447, R01 HL107490, K23HL093118-04]; Pfizer Preventive Cardiology Award; National Heart, Lung, and Blood Institute (NHLBI) [N01-HC-95159, N01-HC-95169, RR-024156]; NHLBI [N02-HL-6-4278];  [R01HL071051];  [R01HL071205];  [R01HL071250];  [R01HL071251];  [R01HL071252];  [R01HL071258];  [R01HL071259]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159, N01HC095169] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071259, R01HL071250, R01HL071252, R01HL064278, P01HL055798, R01HL071251, R01HL107490, T32HL007355, R01HL096447, R01HL071051, R01HL136098, K23HL093118, R01HL071258, R01HL071205] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Preventive Cardiology Award; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The CAVA study was supported by NIH P01 HL55798 (CAM), NIH R01 HL096447 (CAM), NIH R01 HL107490 (CAM), K23HL093118-04 (AMT), Pfizer Preventive Cardiology Award (AMT). The funders of the CAVA study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MESA and the MESA SHARe project are conducted and supported by contracts N01-HC-95159 through N01-HC-95169 and RR-024156 from the National Heart, Lung, and Blood Institute (NHLBI). Funding for MESA SHARe genotyping was provided by NHLBI Contract N02-HL-6-4278. MESA Family is conducted and supported in collaboration with MESA investigators; support is provided by grants and contracts R01HL071051, R01HL071205, R01HL071250, R01HL071251, R01HL071252, R01HL071258, R01HL071259. The funders (NHLBI) had a significant role in design and data collection for the MESA study. The funders had no role in analysis, decision to publish, or preparation of the manuscript.	Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Calvert PA, 2011, JACC-CARDIOVASC IMAG, V4, P894, DOI 10.1016/j.jcmg.2011.05.005; Campbell KA, 2012, CIRC RES, V110, P889, DOI 10.1161/CIRCRESAHA.111.263186; Chan L, 1994, CARDIOL REV, V2, P130, DOI DOI 10.1097/00045415-199405000-00003; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Deliri H, 2011, ARTERIOSCL THROM VAS, V31, P110, DOI 10.1161/ATVBAHA.110.212068; Doran AC, 2012, CIRC RES, V110, pE1, DOI 10.1161/CIRCRESAHA.111.256438; Doran AC, 2010, CIRC RES, V106, P1303, DOI 10.1161/CIRCRESAHA.109.210294; Guo ZL, 2011, IMMUNOL LETT, V135, P34, DOI 10.1016/j.imlet.2010.09.009; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Ji Y, 2011, NAT IMMUNOL, V12, P1230, DOI 10.1038/ni.2153; Jones-Mason ME, 2012, IMMUNITY, V36, P348, DOI 10.1016/j.immuni.2012.02.010; KEYS A, 1986, AM J EPIDEMIOL, V124, P903, DOI 10.1093/oxfordjournals.aje.a114480; Lahoute C, 2011, NAT REV CARDIOL, V8, P348, DOI 10.1038/nrcardio.2011.62; Li HM, 2004, IMMUNITY, V21, P551, DOI 10.1016/j.immuni.2004.08.013; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lipinski MJ, 2012, ARTERIOSCL THROM VAS, V32, P2855, DOI 10.1161/ATVBAHA.112.300352; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; Mahlios J, 2011, MOL IMMUNOL, V49, P227, DOI 10.1016/j.molimm.2011.08.012; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Morris-Rosenfeld S, 2013, EXPERT REV CLIN IMMU; NICHAMAN MZ, 1975, AM J EPIDEMIOL, V102, P491, DOI 10.1093/oxfordjournals.aje.a112187; Nicholls SJ, 2010, J AM COLL CARDIOL, V55, P2399, DOI 10.1016/j.jacc.2010.02.026; Perry HM, 2013, ARTERIOSCL THROM VAS, V33, P2771, DOI 10.1161/ATVBAHA.113.302571; Ragosta M, 2011, J CARDIOVASC TRANSL, V4, P385, DOI 10.1007/s12265-011-9274-2; Taylor AM, 2005, ARTERIOSCL THROM VAS, V25, P2069, DOI 10.1161/01.ATV.0000178992.40088.f2; Tsimikas S, 2007, J LIPID RES, V48, P425, DOI 10.1194/jlr.M600361-JLR200; Wang Q, 2004, AM J HUM GENET, V74, P262, DOI 10.1086/381560; Welch CL, 2001, P NATL ACAD SCI USA, V98, P7946, DOI 10.1073/pnas.141239098; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	34	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90222	10.1371/journal.pone.0090222	http://dx.doi.org/10.1371/journal.pone.0090222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603695	gold, Green Submitted, Green Published			2022-12-25	WOS:000332483600030
J	Zou, MY; Guo, FF; Li, XZ; Zhao, J; Qu, YB				Zou, Mouyong; Guo, Fenfen; Li, Xuezhi; Zhao, Jian; Qu, Yinbo			Enhancing Production of Alkaline Polygalacturonate Lyase from Bacillus subtilis by Fed-Batch Fermentation	PLOS ONE			English	Article							PECTATE LYASE; DEGRADING ENZYMES; PECTIN LYASE; PURIFICATION; INHIBITION; SUBSTRATE; KINETICS; METHANOL; FIBERS; GENE	Alkaline polygalacturonate lyase (PGL, EC 4.2.2.2) is an enzyme used in many industries. We developed a fed-batch fermentation process that combines the enzymatic pretreatment of the carbon source with controlling the pH of the fermentative broth to enhance the PGL production from Bacillus subtilis 7-3-3 to decrease the production cost. Maintaining the fermentation broth at pH 6.5 prior to feeding with ammonia and at pH 6.0 after feeding significantly improved PGL activity (743.5 U mL(-1)) compared with the control (202.5 U mL(-1)). The average PGL productivity reached 19.6 U mL(-1) h(-1) after 38 h of fermentation. The crude PGL was suitable for environmentally friendly ramie enzymatic degumming.	[Zou, Mouyong; Guo, Fenfen; Li, Xuezhi; Zhao, Jian; Qu, Yinbo] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China	Shandong University	Li, XZ (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	lixz@sdu.edu.cn; zhaojian@sdu.edu.cn			National High Technology Research and Development Program of China [2012AA022203B]; National Natural Sciences Foundation of China [31170107]; Natural Sciences Foundation of Shandong Province [ZR2010CM023]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported by grants from the National High Technology Research and Development Program of China (No. 2012AA022203B)(http:// www.863.gov.cn), the National Natural Sciences Foundation of China (31170107)(http://www.nsfc.gov.cn/Portal0/default152.htm), and the Natural Sciences Foundation of Shandong Province (ZR2010CM023)(http://www.sdnsf.gov.cn/portal/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY MJ, 1992, J BIOTECHNOL, V23, P257, DOI 10.1016/0168-1656(92)90074-J; Basu S, 2009, J IND MICROBIOL BIOT, V36, P239, DOI 10.1007/s10295-008-0490-y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruhlmann F, 2000, J BIOTECHNOL, V76, P43, DOI 10.1016/S0168-1656(99)00175-3; COOPER RM, 1975, PHYSIOL PLANT PATHOL, V5, P135, DOI 10.1016/0048-4059(75)90017-X; DEAN RA, 1989, PLANT CELL, V1, P275, DOI 10.1105/tpc.1.3.275; FEDER J, 1970, BIOCHEMISTRY-US, V9, P2784, DOI 10.1021/bi00816a005; FUJII M, 1983, J BACTERIOL, V154, P831, DOI 10.1128/JB.154.2.831-837.1983; Gummadi S. N., 2006, American Journal of Food Technology, V1, P19; Guo FF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/212315; Herron SR, 2000, P NATL ACAD SCI USA, V97, P8762, DOI 10.1073/pnas.97.16.8762; HONG J, 1986, BIOTECHNOL BIOENG, V28, P1421, DOI 10.1002/bit.260280916; Hoondal GS, 2002, APPL MICROBIOL BIOT, V59, P409, DOI 10.1007/s00253-002-1061-1; Hossain MZ, 1996, ENZYME MICROB TECH, V18, P95, DOI 10.1016/0141-0229(95)00071-2; Kapoor M, 2000, PROCESS BIOCHEM, V36, P467, DOI 10.1016/S0032-9592(00)00238-7; Kilonzo PA, 2004, BIOCHEM ENG J, V17, P27, DOI 10.1016/S1369-703X(03)00121-9; Klug-Santner BG, 2006, J BIOTECHNOL, V121, P390, DOI 10.1016/j.jbiotec.2005.07.019; Matsumoto T, 2002, BIOCHEM ENG J, V12, P175, DOI 10.1016/S1369-703X(02)00075-X; MCCONN JD, 1964, J BIOL CHEM, V239, P3706; Moo-Young M, 2011, COMPREHENSIVE BIOTEC, P515; PAZLAROVA J, 1984, APPL MICROBIOL BIOT, V20, P331, DOI 10.1007/BF00270595; Qureshi MS, 2010, J IND MICROBIOL BIOT, V37, P323, DOI 10.1007/s10295-009-0677-x; SAID S, 1991, WORLD J MICROB BIOT, V7, P607, DOI 10.1007/BF00452841; Song JJ, 2010, THESIS SHANDONG U JI; Songpim M., 2010, OPEN BIOL J, V3, P1; TSUYUMU S, 1984, PHYSIOL PLANT PATHOL, V24, P291, DOI 10.1016/0048-4059(84)90003-1; van Niel EWJ, 2003, BIOTECHNOL BIOENG, V81, P255, DOI 10.1002/bit.10463; Wang B, 2007, BOT STUD, V48, P173; Wang Y, 2009, BIORESOURCE TECHNOL, V100, P1343, DOI 10.1016/j.biortech.2008.07.049; Wang ZH, 2010, BIORESOURCE TECHNOL, V101, P1318, DOI 10.1016/j.biortech.2009.09.025; Yadav S, 2009, PROCESS BIOCHEM, V44, P1, DOI 10.1016/j.procbio.2008.09.012; Zhang JJ, 2013, BIORESOURCE TECHNOL, V146, P543, DOI 10.1016/j.biortech.2013.07.129; Zhao Z, 2003, IND MICROBIOLOGY, V2, P003; Zheng LS, 2001, BIORESOURCE TECHNOL, V78, P89, DOI 10.1016/S0960-8524(00)00154-1; ZUCKER M, 1970, J BACTERIOL, V104, P13, DOI 10.1128/JB.104.1.13-18.1970	35	13	15	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90392	10.1371/journal.pone.0090392	http://dx.doi.org/10.1371/journal.pone.0090392			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603713	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600051
J	Churin, Y; Roderfeld, M; Stiefel, J; Wurger, T; Schroder, D; Matono, T; Mollenkopf, HJ; Montalbano, R; Pompaiah, M; Reifenberg, K; Zahner, D; Ocker, M; Gerlich, W; Glebe, D; Roeb, E				Churin, Yuri; Roderfeld, Martin; Stiefel, Johannes; Wuerger, Tilman; Schroeder, Dirk; Matono, Tomomitsu; Mollenkopf, Hans-Joachim; Montalbano, Roberta; Pompaiah, Malvika; Reifenberg, Kurt; Zahner, Daniel; Ocker, Matthias; Gerlich, Wolfram; Glebe, Dieter; Roeb, Elke			Pathological Impact of Hepatitis B Virus Surface Proteins on the Liver Is Associated with the Host Genetic Background	PLOS ONE			English	Article							LARGE ENVELOPE POLYPEPTIDE; C-JUN; KAPPA-B; MOUSE; EXPRESSION; INFECTION; STRESS; HEPATOCARCINOGENESIS; PATHOGENESIS; ACTIVATION	Background: While the immune pathogenesis caused by hepatitis B virus (HBV) infection has been studied extensively, little is known about direct pathogenic effects of HBV surface proteins. Here, we have investigated pathological cellular effects of HBV surface protein expression in the liver of transgenic mice with different genetic background. Methods: The impact of HBV surface protein expression on the liver was studied in two mouse strains, BALB/c and C57BL/6. Histology and hydroxyproline assays were performed to investigate liver morphology and fibrosis. Gene expression and signaling were analyzed by microarray, qPCR and Western blotting. Results: Expression of HBV surface proteins in the liver of transgenic mice induced activation of protein kinase-like endoplasmic reticulum kinase (PERK) and eukaryotic initiation factor 2 alpha (eIF2 alpha) phosphorylation. Phosphorylation of eIF2 alpha resulted in activation of the ER stress markers glucose regulated protein (GRP) 78 and pro-apoptotic C/EBP homologous protein (CHOP) in transgenic mice on BALB/c genetic background leading to stronger liver injury and fibrosis in comparison with transgenic mice on C57BL/6 background. Hepatic stellate cells represented the main collagen-producing liver cells in HBV transgenic mice. The key regulators of hepatocyte proliferation, transcription factors c-Jun and STAT3 were activated in HBV transgenic mice. Tumour incidence in transgenic mice was strain-and sex-dependent. Conclusions: Extent of liver injury, fibrosis, and tumour development induced by hepatic HBV surface protein expression considerably depends on host genetic background.	[Churin, Yuri; Roderfeld, Martin; Stiefel, Johannes; Wuerger, Tilman; Schroeder, Dirk; Matono, Tomomitsu; Roeb, Elke] Univ Giessen, Dept Gastroenterol, D-35390 Giessen, Germany; [Mollenkopf, Hans-Joachim] Max Planck Inst Infekt Biol, Core Facil Microarray, D-10117 Berlin, Germany; [Montalbano, Roberta; Ocker, Matthias] Univ Marburg, Inst Surg Res, Marburg, Germany; [Pompaiah, Malvika] Max Planck Inst Infekt Biol, Dept Mol Biol, D-10117 Berlin, Germany; [Reifenberg, Kurt] Johannes Gutenberg Univ Mainz, Cent Lab Anim Facil, D-55122 Mainz, Germany; [Zahner, Daniel] Univ Giessen, Div Anim Welf & Ethol, D-35390 Giessen, Germany; [Gerlich, Wolfram; Glebe, Dieter] Univ Giessen, Inst Med Virol, Natl Reference Ctr Hepatitis B & Viruses D, D-35390 Giessen, Germany	Justus Liebig University Giessen; Max Planck Society; Philipps University Marburg; Max Planck Society; Johannes Gutenberg University of Mainz; Justus Liebig University Giessen; Justus Liebig University Giessen	Roeb, E (corresponding author), Univ Giessen, Dept Gastroenterol, D-35390 Giessen, Germany.	elke.roeb@innere.med.uni-giessen.de	Mollenkopf, Hans-Joachim/AAH-2500-2019; , Martin/AHD-5202-2022	, Martin/0000-0002-3232-1277; Mollenkopf, Hans-Joachim/0000-0003-1167-4783; Ocker, Matthias/0000-0001-8263-6288	Deutsche Forschungsgemeinschaft [RO 957/7-1, RO 957/8-1]; ZooMAP (Bundesministerium fur Bildung und Forschung, BMBF); von-Behring-Roentgen Foundation; University Medical Center Giessen and Marburg (UKGM) [10/2012 GI]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ZooMAP (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF)); von-Behring-Roentgen Foundation; University Medical Center Giessen and Marburg (UKGM)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (RO 957/7-1 and RO 957/8-1), ZooMAP (Bundesministerium fur Bildung und Forschung, BMBF), the von-Behring-Roentgen Foundation and the University Medical Center Giessen and Marburg (10/2012 GI, UKGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobrovnikova-Marjon E, ONCOGENE, V29, P3881; Boigk G, 1997, HEPATOLOGY, V26, P643, DOI 10.1053/jhep.1997.v26.pm0009303494; Chisari FV, 2010, PATHOL BIOL, V58, P258, DOI 10.1016/j.patbio.2009.11.001; CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8; CHISARI FV, 1987, P NATL ACAD SCI USA, V84, P6909, DOI 10.1073/pnas.84.19.6909; CHISARI FV, 1986, J VIROL, V60, P880, DOI 10.1128/JVI.60.3.880-887.1986; DAVIES SE, 1991, HEPATOLOGY, V13, P150, DOI 10.1002/hep.1840130122; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; DRAGANI TA, 1990, CARCINOGENESIS, V11, P953, DOI 10.1093/carcin/11.6.953; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Glebe D, 2003, J VIROL, V77, P9511, DOI 10.1128/JVI.77.17.9511-9521.2003; Glebe D, 2013, SEMIN LIVER DIS, V33, P103, DOI 10.1055/s-0033-1345717; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Jin ZX, 2011, HEPATOLOGY, V53, P219, DOI 10.1002/hep.23983; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; LAU JYN, 1991, HEPATOLOGY, V14, P416, DOI 10.1002/hep.1840140303; LAU JYN, 1992, GASTROENTEROLOGY, V102, P956, DOI 10.1016/0016-5085(92)90182-X; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Machida K, 2010, HEPATOLOGY, V52, P480, DOI 10.1002/hep.23697; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Meuleman P, 2006, J VIROL, V80, P2797, DOI 10.1128/JVI.80.6.2797-2807.2006; Min LH, 2012, NAT CELL BIOL, V14, P1203, DOI 10.1038/ncb2590; Naoumov NV, GASTROENTEROLOGY, P1248; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Palacios RS, 2008, LAB INVEST, V88, P1192, DOI 10.1038/labinvest.2008.91; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pol S, 2013, LIVER INT, V33, P182, DOI 10.1111/liv.12055; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Reece ST, 2010, J CLIN INVEST, V120, P3365, DOI 10.1172/JCI42796; Roderfeld M, 2010, HEPATOLOGY, V51, P267, DOI 10.1002/hep.23274; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schonthal Axel H, 2012, Front Biosci (Schol Ed), V4, P412; Shi ZD, 1997, P NATL ACAD SCI USA, V94, P10663, DOI 10.1073/pnas.94.20.10663; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Sohlenius-Sternbeck AK, 2006, TOXICOL IN VITRO, V20, P1582, DOI 10.1016/j.tiv.2006.06.003; Spano D, 2008, J PROTEOME RES, V7, P2642, DOI 10.1021/pr7006522; Sugiyama M, 2009, GASTROENTEROLOGY, V136, P652, DOI 10.1053/j.gastro.2008.10.048; Wang HC, 2005, HEPATOLOGY, V41, P761, DOI 10.1002/hep.20615; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Xu ZC, 1997, J VIROL, V71, P7387, DOI 10.1128/JVI.71.10.7387-7392.1997; Zheng YY, 2007, HEPATOLOGY, V45, P16, DOI 10.1002/hep.21445	46	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90608	10.1371/journal.pone.0090608	http://dx.doi.org/10.1371/journal.pone.0090608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594856	gold, Green Submitted, Green Published			2022-12-25	WOS:000332475500073
J	Sun, YM; Li, FH; Sun, Z; Zhang, XJ; Li, SH; Zhang, CS; Xiang, JH				Sun, Yumiao; Li, Fuhua; Sun, Zheng; Zhang, Xiaojun; Li, Shihao; Zhang, Chengsong; Xiang, Jianhai			Transcriptome Analysis of the Initial Stage of Acute WSSV Infection Caused by Temperature Change	PLOS ONE			English	Article							WHITE-SPOT-SYNDROME; SYNDROME VIRUS WSSV; SHRIMP PENAEUS-JAPONICUS; CELL-CYCLE ARREST; WATER TEMPERATURE; LITOPENAEUS-VANNAMEI; IMMUNE-RESPONSE; GENE-EXPRESSION; APOPTOSIS; REPLICATION	White spot syndrome virus (WSSV) is the most devastating virosis threatening the shrimp culture industry worldwide. Variations of environmental factors in shrimp culture ponds usually lead to the outbreak of white spot syndrome (WSS). In order to know the molecular mechanisms of WSS outbreak induced by temperature variation and the biological changes of the host at the initial stage of WSSV acute infection, RNA-Seq technology was used to analyze the differentially expressed genes (DEGs) in shrimp with a certain amount of WSSV cultured at 18 degrees C and shrimp whose culture temperature were raised to 25 degrees C. To analyze whether the expression changes of the DEGs were due to temperature rising or WSSV proliferation, the expression of selected DEGs was analyzed by real-time PCR with another shrimp group, namely Group T, as control. Group T didn't suffer WSSV infection but was subjected to temperature rising in parallel. At the initial stage of WSSV acute infection, DEGs related to energy production were up-regulated, whereas most DEGs related to cell cycle and positive regulation of cell death and were down-regulated. Triose phosphate isomerase, enolase and alcohol dehydrogenase involved in glycosis were up-regulated, while pyruvate dehydrogenase, citrate synthase and isocitrate dehydrogenase with NAD as the coenzyme involved in TCA pathway were down-regulated. Also genes involved in host DNA replication, including DNA primase, DNA topoisomerase and DNA polymerase showed down-regulated expression. Several interesting genes including crustin genes, acting binding or inhibiting protein genes, a disintegrin and metalloproteinase domain-containing protein 9 (ADAM9) gene and a GRP 78 gene were also analyzed. Understanding the interactions between hosts and WSSV at the initial stage of acute infection will not only help to get a deep insight into the pathogenesis of WSSV but also provide clues for therapies.	[Sun, Yumiao; Li, Fuhua; Sun, Zheng; Zhang, Xiaojun; Li, Shihao; Zhang, Chengsong; Xiang, Jianhai] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS	Li, FH (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	fhli@qdio.ac.cn	Zhang, Chengsong/E-2211-2014; zhang, jin/GXV-9154-2022; xiang, jianhai/A-4767-2012	xiang, jianhai/0000-0001-5395-7787; Sun, Zheng/0000-0002-8537-8576	Major State Basic Research Development Program [2012CB114403]; National High Tech Research and Development Program [2012AA10A404, 2012AA092205]; National Natural Science Foundation Program [31072203]	Major State Basic Research Development Program(National Basic Research Program of China); National High Tech Research and Development Program(National High Technology Research and Development Program of China); National Natural Science Foundation Program(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Major State Basic Research Development Program (2012CB114403), National High Tech Research and Development Program (2012AA10A404, 2012AA092205), National Natural Science Foundation Program (31072203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony SP, 2011, IMMUNOBIOLOGY, V216, P184, DOI 10.1016/j.imbio.2010.05.030; Arockiaraj J, 2013, FISH SHELLFISH IMMUN, V34, P109, DOI 10.1016/j.fsi.2012.10.009; Braunagel SC, 1998, VIROLOGY, V244, P195, DOI 10.1006/viro.1998.9097; Bresnahan WA, 1996, VIROLOGY, V224, P150, DOI 10.1006/viro.1996.0516; Broemer M, 2009, TRENDS CELL BIOL, V19, P130, DOI 10.1016/j.tcb.2009.01.004; Chen CJ, 2004, J VIROL, V78, P5658, DOI 10.1128/JVI.78.11.5658-5669.2004; Chen IT, 2011, J VIROL, V85, P12919, DOI 10.1128/JVI.05385-11; Chen KY, 2009, FISH SHELLFISH IMMUN, V27, P460, DOI 10.1016/j.fsi.2009.06.018; Chen YH, 2011, MOL IMMUNOL, V48, P793, DOI 10.1016/j.molimm.2010.11.020; Chou HY, 1995, DIS AQUAT ORGAN, V23, P165, DOI 10.3354/dao023165; Chowdhury IH, 2003, VIROLOGY, V305, P371, DOI 10.1006/viro.2002.1777; Clavero-Salas A, 2007, FISH SHELLFISH IMMUN, V23, P459, DOI 10.1016/j.fsi.2007.01.010; CLEM RJ, 1993, J VIROL, V67, P3730, DOI 10.1128/JVI.67.7.3730-3738.1993; De Bolle L, 2004, FEBS LETT, V560, P25, DOI 10.1016/S0014-5793(04)00035-3; Du HH, 2006, DIS AQUAT ORGAN, V71, P175, DOI 10.3354/dao071175; Du HH, 2008, AQUACULTURE, V277, P149, DOI 10.1016/j.aquaculture.2008.03.003; Eto K, 2002, J BIOL CHEM, V277, P17804, DOI 10.1074/jbc.M200086200; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; FENWICK ML, 1978, J GEN VIROL, V41, P37, DOI 10.1099/0022-1317-41-1-37; Galvan-Alvarez D, 2012, J INVERTEBR PATHOL, V111, P60, DOI 10.1016/j.jip.2012.06.005; Gao HA, 2011, AQUACULTURE, V312, P26, DOI 10.1016/j.aquaculture.2010.12.022; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Granja CB, 2003, DIS AQUAT ORGAN, V54, P73, DOI 10.3354/dao054073; Guan YQ, 2003, J INVERTEBR PATHOL, V83, P257, DOI 10.1016/S0022-2011(03)00068-5; GUIR J, 1971, J GEN VIROL, V12, P293, DOI 10.1099/0022-1317-12-3-293; Hauton C, 2006, MOL IMMUNOL, V43, P1490, DOI 10.1016/j.molimm.2005.07.029; Hay S, 2002, J GEN VIROL, V83, P1547, DOI 10.1099/0022-1317-83-7-1547; He F, 2006, J VIROL, V80, P3884, DOI 10.1128/JVI.80.8.3884-3892.2006; He F, 2009, J GEN VIROL, V90, P1483, DOI 10.1099/vir.0.008912-0; He NH, 2005, ANTIVIR RES, V66, P39, DOI 10.1016/j.antiviral.2004.12.010; Huang XD, 2010, VIROLOGY, V406, P176, DOI 10.1016/j.virol.2010.06.046; Jiravanichpaisal P, 2004, FISH SHELLFISH IMMUN, V17, P265, DOI 10.1016/j.fsi.2004.03.010; Koyama AH, 2000, MICROBES INFECT, V2, P1111, DOI 10.1016/S1286-4579(00)01265-X; Leu JH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-120; Leu JH, 2013, FISH SHELLFISH IMMUN, V34, P1011, DOI 10.1016/j.fsi.2012.05.030; Leu JH, 2010, DEV COMP IMMUNOL, V34, P1068, DOI 10.1016/j.dci.2010.05.010; Li DF, 2007, VIROLOGY, V368, P122, DOI 10.1016/j.virol.2007.06.027; Liberman E, 1999, J VIROL, V73, P3718, DOI 10.1128/JVI.73.5.3718-3722.1999; Lin YR, 2011, J VIROL, V85, P3517, DOI 10.1128/JVI.01973-10; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Liu WJ, 2007, J VIROL, V81, P1461, DOI 10.1128/JVI.01880-06; Luan W, 2009, MOL BIOL REP, V36, P289, DOI 10.1007/s11033-007-9178-z; Ma Y, 2009, MOL CELL PROTEOMICS, V8, P2582, DOI 10.1074/mcp.M900180-MCP200; Moser JR, 2012, AQUACULTURE, V326, P9, DOI 10.1016/j.aquaculture.2011.10.033; Oidtmann B, 2011, TRANSBOUND EMERG DIS, V14; Ou DSC, 2011, CELL RES, V21, P642, DOI 10.1038/cr.2011.10; Pan D, 2005, DEV COMP IMMUNOL, V29, P103, DOI 10.1016/j.dci.2004.07.001; Pongsomboon S, 2011, FISH SHELLFISH IMMUN, V30, P439, DOI 10.1016/j.fsi.2010.10.015; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Reyes A, 2007, DEV COMP IMMUNOL, V31, P23, DOI 10.1016/j.dci.2006.05.003; Robalino J, 2009, VET IMMUNOL IMMUNOP, V128, P110, DOI 10.1016/j.vetimm.2008.10.329; Sritunyalucksana K, 2006, J VIROL, V80, P10734, DOI 10.1128/JVI.00349-06; Sun YM, 2013, ACTA OCEANOL SIN, V32, P52, DOI 10.1007/s13131-013-0261-0; Sun YM, 2013, AQUACULTURE, V376, P124, DOI 10.1016/j.aquaculture.2012.11.014; van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002; Wali A, 1999, EXP MOL PATHOL, V66, P31, DOI 10.1006/exmp.1999.2249; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Wang ZM, 2004, BIOCHEM BIOPH RES CO, V325, P899, DOI 10.1016/j.bbrc.2004.09.224; Wati S, 2009, J VIROL, V83, P12871, DOI 10.1128/JVI.01419-09; Withyachumnarnkul B, 2003, DIS AQUAT ORGAN, V53, P167, DOI 10.3354/dao053167; Xie XX, 2005, VIROLOGY, V336, P93, DOI 10.1016/j.virol.2005.03.011; Xu H, 2009, FISH SHELLFISH IMMUN, V26, P414, DOI 10.1016/j.fsi.2009.01.001; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001; You XX, 2010, AQUACULTURE, V305, P133, DOI 10.1016/j.aquaculture.2010.04.024; Zhi B, 2011, MAR BIOTECHNOL, V13, P575, DOI 10.1007/s10126-010-9328-5; Zhou M, 2001, BIOCHEM BIOPH RES CO, V280, P574, DOI 10.1006/bbrc.2000.4155	66	19	19	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90732	10.1371/journal.pone.0090732	http://dx.doi.org/10.1371/journal.pone.0090732			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595043	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500093
J	Wang, LQ; Luo, HH; Chen, XH; Jiang, Y; Huang, QB				Wang, Liqun; Luo, Haihua; Chen, Xiaohuan; Jiang, Yong; Huang, Qiaobing			Functional Characterization of S100A8 and S100A9 in Altering Monolayer Permeability of Human Umbilical Endothelial Cells	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; CARBOXYLATED GLYCANS; SCAVENGER RECEPTOR; SIGNALING PATHWAY; EXPRESSION; MACROPHAGES; BARRIER; KINASE; ROLES; MRP14	S100A8, S100A9 and S100A8/A9 complexes have been known as important endogenous damage-associated molecular pattern (DAMP) proteins. But the pathophysiological roles of S100A8, S100A9 and S100A8/A9 in cardiovascular diseases are incompletely explained. In this present study, the effects of homo S100A8, S100A9 and their hetero-complex S100A8/A9 on endothelial barrier function were tested respectively in cultured human umbilical venous endothelial cells (HUVECs). The involvement of TLR4 and RAGE were observed by using inhibitor of TLR4 and blocking antibody of RAGE. The clarification of different MAPK subtypes in S100A8/A9-induced endothelial response was implemented by using specific inhibitors. The calcium-dependency was detected in the absence of Ca2+ or in the presence of gradient-dose Ca2+. The results showed that S100A8, S100A9 and S100A8/A9 could induce F-actin and ZO-1 disorganization in HUVECs and evoked the increases of HUVEC monolayer permeability in a dose- and time-dependent manner. The effects of S100A8, S100A9 and S100A8/A9 on endothelial barrier function depended on the activation of p38 and ERK1/2 signal pathways through receptors TLR4 and RAGE. Most importantly, we revealed the preference of S100A8 on TLR4 and S100A9 on RAGE in HUVECs. The results also showed the calcium dependency in S100A8- and S100A9-evoked endothelial response, indicating that calcium dependency on formation of S100A8 or A9 dimmers might be the prerequisite for this endothelial functional alteration.	[Wang, Liqun; Huang, Qiaobing] Southern Med Univ, Key Lab Shock & Microcirculat Res Guangdong, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Luo, Haihua; Chen, Xiaohuan; Jiang, Yong] Southern Med Univ, Key Lab Funct Prote Guangdong Prov, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Jiang, Y (corresponding author), Southern Med Univ, Key Lab Funct Prote Guangdong Prov, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China.	jiang48231@163.com; bing@smu.edu.cn			National Key Basic Research (973) Program of China [2011CB510200]; National Natural Science Foundation of China [81030055, 30971201, 81170297]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT0731]; NSFC-Guangdong Joint Fund [U0632004]	National Key Basic Research (973) Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); NSFC-Guangdong Joint Fund	This work was supported by National Key Basic Research (973) Program of China (No. 2011CB510200 to Y.J.), National Natural Science Foundation of China (No. 81030055; No. 30971201, No. 81170297), Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) (No. IRT0731 to Y.J.) and NSFC-Guangdong Joint Fund (No. U0632004 to Y.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CL, 2009, DIABETES OBES METAB, V11, P480, DOI 10.1111/j.1463-1326.2008.00987.x; Andonegui G, 2009, J CLIN INVEST, V119, P1921, DOI 10.1172/JCI36411; Bhattacharjee R, 2012, CHEST, V141, P682, DOI 10.1378/chest.11-1777; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Borbiev T, 2004, AM J PHYSIOL-LUNG C, V287, pL911, DOI 10.1152/ajplung.00372.2003; Ehlermann P, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-6; Fontaine M, 2011, CRIT CARE MED, V39, P2684, DOI 10.1097/CCM.0b013e3182282a40; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; Hunter MJ, 1998, J BIOL CHEM, V273, P12427, DOI 10.1074/jbc.273.20.12427; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kerkhoff C, 2001, BIOCHEMISTRY-US, V40, P241, DOI 10.1021/bi001791k; LAU W, 1995, J CLIN INVEST, V95, P1957, DOI 10.1172/JCI117879; Legrand P, 2001, J BIOL CHEM, V276, P3581, DOI 10.1074/jbc.M002667200; Lim SY, 2011, ANTIOXID REDOX SIGN, V15, P2235, DOI 10.1089/ars.2010.3641; Lu Y, 2012, AMINO ACIDS, V43, P2125, DOI 10.1007/s00726-012-1298-7; Luo T, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0342-4; Mohammad G, 2013, EXP EYE RES, V107, P101, DOI 10.1016/j.exer.2012.12.009; Mukherjee TK, 2005, BBA-MOL CELL RES, V1744, P213, DOI 10.1016/j.bbamcr.2005.03.007; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Oh CD, 2000, J BIOL CHEM, V275, P5613, DOI 10.1074/jbc.275.8.5613; Patabendige A, 2013, BRAIN RES, V1521, P1, DOI 10.1016/j.brainres.2012.06.057; Perera C, 2010, IMMUNOL CELL BIOL, V88, P41, DOI 10.1038/icb.2009.88; Rammes A, 1997, J BIOL CHEM, V272, P9496; Rauvala H, 2010, BBA-GENE REGUL MECH, V1799, P164, DOI 10.1016/j.bbagrm.2009.11.012; Riehl A, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-12; Robinson MJ, 2002, J BIOL CHEM, V277, P3658, DOI 10.1074/jbc.M102950200; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Sakaguchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023132; Schelbergen RFP, 2012, ARTHRITIS RHEUM-US, V64, P1477, DOI 10.1002/art.33495; Shimizu K, 2011, CIRCULATION, V124, P2920, DOI 10.1161/CIRCULATIONAHA.110.009910; Spirig R, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/181394; Srikrishna G, 2001, J IMMUNOL, V166, P4678, DOI 10.4049/jimmunol.166.7.4678; Srikrishna G, 2012, J INNATE IMMUN, V4, P31, DOI 10.1159/000330095; Stocca A, 2012, ATHEROSCLEROSIS, V221, P325, DOI 10.1016/j.atherosclerosis.2012.01.036; Strupat K, 2000, J AM SOC MASS SPECTR, V11, P780, DOI 10.1016/S1044-0305(00)00150-1; Sunahori K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1939; Tang BMP, 2009, CRIT CARE MED, V37, P882, DOI 10.1097/CCM.0b013e31819b52fd; TEIGELKAMP S, 1991, J BIOL CHEM, V266, P13462; Turovskaya O, 2008, CARCINOGENESIS, V29, P2035, DOI 10.1093/carcin/bgn188; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Viemann D, 2007, BLOOD, V109, P2453, DOI 10.1182/blood-2006-08-040444; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang Y, 2011, AM J PHYSIOL-HEART C, V300, pH1743, DOI 10.1152/ajpheart.01335.2008; Wu W, 2011, SHOCK, V35, P618, DOI 10.1097/SHK.0b013e31820e041f	45	50	50	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90472	10.1371/journal.pone.0090472	http://dx.doi.org/10.1371/journal.pone.0090472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595267	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900111
J	Zhou, QY; Wang, W; He, XY; Zhu, XY; Shen, YY; Yu, Z; Wang, XX; Qi, XC; Zhang, X; Fan, MJ; Dai, Y; Yang, SX; Yan, QF				Zhou, Qiyin; Wang, Wei; He, Xiangyu; Zhu, Xiaoyu; Shen, Yaoyao; Yu, Zhe; Wang, Xuexiang; Qi, Xuchen; Zhang, Xuan; Fan, Mingjie; Dai, Yu; Yang, Shuxu; Yan, Qingfeng			Mechanistic Study on the Nuclear Modifier Gene MSS1 Mutation Suppressing Neomycin Sensitivity of the Mitochondrial 15S rRNA C1477G Mutation Saccharomyces cerevisiae	PLOS ONE			English	Article							PAROMOMYCIN-RESISTANCE MUTATION; GLYCOLYTIC GENES; TRANSCRIPTIONAL ACTIVATION; PHENOTYPIC-EXPRESSION; PROTEIN; METABOLISM; OVEREXPRESSION; PATHOGENESIS; RESPIRATION; MUTANTS	The phenotypic manifestation of mitochondrial DNA (mtDNA) mutations can be modulated by nuclear genes and environmental factors. However, neither the interaction among these factors nor their underlying mechanisms are well understood. The yeast Saccharomyces cerevisiae mtDNA 15S rRNA C1477G mutation (P-R) corresponds to the human 12S rRNA A1555G mutation. Here we report that a nuclear modifier gene mss1 mutation suppresses the neomycin-sensitivity phenotype of a yeast C1477G mutant in fermentable YPD medium. Functional assays show that the mitochondrial function of the yeast C1477G mutant was impaired severely in YPD medium with neomycin. Moreover, the mss1 mutation led to a significant increase in the steady-state level of HAP5 (heme activated protein), which greatly up-regulated the expression of glycolytic transcription factors RAP1, GCR1, and GCR2 and thus stimulated glycolysis. Furthermore, the high expression of the key glycolytic enzyme genes HXK2, PFK1 and PYK1 indicated that enhanced glycolysis not only compensated for the ATP reduction from oxidative phosphorylation (OXPHOS) in mitochondria, but also ensured the growth of the mss1(P-R) mutant in YPD medium with neomycin. This study advances our understanding of the phenotypic manifestation of mtDNA mutations.	[Zhou, Qiyin; Wang, Wei; He, Xiangyu; Zhu, Xiaoyu; Shen, Yaoyao; Yu, Zhe; Wang, Xuexiang; Zhang, Xuan; Fan, Mingjie; Dai, Yu; Yan, Qingfeng] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Qi, Xuchen; Yang, Shuxu] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Dai, Yu] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Yan, QF (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	qfyan@zju.edu.cn	yan, qing/GZN-2287-2022; Fan, Mingjie/GZM-9365-2022	Yu, Zhe/0000-0002-6908-6135; Fan, Mingjie/0000-0002-2930-9998	National Basic Research Program of China [2012CB966800D, 2014CB943001]; National Natural Science Foundation of China [30971599/C060503]; Program for New Century Excellent Talents in University [NCET-06-0526]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Basic Research Program of China (Grant NO. 2012CB966800D, 2014CB943001), the National Natural Science Foundation of China (Grant NO. 30971599/C060503) and the Program for New Century Excellent Talents in University (Grant NO. NCET-06-0526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER DM, 1991, P NATL ACAD SCI USA, V88, P1968, DOI 10.1073/pnas.88.5.1968; Blom J, 2000, APPL ENVIRON MICROB, V66, P1970, DOI 10.1128/AEM.66.5.1970-1973.2000; Bourges I, 2009, J MOL BIOL, V387, P1081, DOI 10.1016/j.jmb.2009.02.039; Bregeon D, 2001, GENE DEV, V15, P2295, DOI 10.1101/gad.207701; Chambers A, 1995, CURR GENET, V29, P1, DOI 10.1007/BF00313187; Colby G, 1998, J BIOL CHEM, V273, P27945, DOI 10.1074/jbc.273.43.27945; DECOSTER E, 1993, J MOL BIOL, V232, P79, DOI 10.1006/jmbi.1993.1371; Deminoff SJ, 2001, GENETICS, V158, P133; Diaz-Ruiz R, 2009, BBA-REV CANCER, V1796, P252, DOI 10.1016/j.bbcan.2009.07.003; Duenas-Sanchez R, 2010, INT J FOOD MICROBIOL, V143, P150, DOI 10.1016/j.ijfoodmicro.2010.08.009; DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; Guan MX, 2011, MITOCHONDRION, V11, P237, DOI 10.1016/j.mito.2010.10.006; Hao WS, 2010, J BIOL CHEM, V285, P12647, DOI 10.1074/jbc.M109.084194; He XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081490; KUTZLEB R, 1973, MOL GEN GENET, V125, P91, DOI 10.1007/BF00292984; LI M, 1982, J BIOL CHEM, V257, P5921; Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; McNabb DS, 2005, EUKARYOT CELL, V4, P1829, DOI 10.1128/EC.4.11.1829-1839.2005; Menon BB, 2005, P NATL ACAD SCI USA, V102, P5749, DOI 10.1073/pnas.0501768102; Mizuno T, 2004, YEAST, V21, P851, DOI 10.1002/yea.1123; Ozalp VC, 2010, J BIOL CHEM, V285, P37579, DOI 10.1074/jbc.M110.155119; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Qiu JZ, 1998, NUCLEIC ACIDS RES, V26, P3077, DOI 10.1093/nar/26.13.3077; Raghevendran V, 2006, J BIOL CHEM, V281, P12308, DOI 10.1074/jbc.M512972200; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Sasaki H, 2005, YEAST, V22, P111, DOI 10.1002/yea.1198; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Schuurmans JM, 2008, FEMS YEAST RES, V8, P26, DOI 10.1111/j.1567-1364.2007.00309.x; SERAPHIN B, 1987, P NATL ACAD SCI USA, V84, P6810, DOI 10.1073/pnas.84.19.6810; Sherman F., 1983, METHODS YEAST GENETI; Suhane S, 2013, BIOL OPEN, V2, P295, DOI 10.1242/bio.20133244; Uemura H, 1997, GENETICS, V147, P521; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Wang XJ, 2007, FEBS LETT, V581, P4228, DOI 10.1016/j.febslet.2007.07.067; Wang XJ, 2010, J MOL BIOL, V395, P1038, DOI 10.1016/j.jmb.2009.12.002; Wang XJ, 2009, MITOCHONDRION, V9, P180, DOI 10.1016/j.mito.2009.01.010; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yan QF, 2005, J BIOL CHEM, V280, P29151, DOI 10.1074/jbc.M504247200; Zhang CK, 2012, FASEB J, V26, P4914, DOI 10.1096/fj.12-206532; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	45	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90336	10.1371/journal.pone.0090336	http://dx.doi.org/10.1371/journal.pone.0090336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595024	gold, Green Published, Green Submitted			2022-12-25	WOS:000332468900096
J	Lee, LTO; Ng, SYL; Chu, JYS; Sekar, R; Harikumar, KG; Miller, LJ; Chow, BKC				Lee, Leo T. O.; Ng, Stephanie Y. L.; Chu, Jessica Y. S.; Sekar, Revathi; Harikumar, Kaleeckal G.; Miller, Laurence J.; Chow, Billy K. C.			Transmembrane peptides as unique tools to demonstrate the in vivo action of a cross-class GPCR heterocomplex	FASEB JOURNAL			English	Article						secretin; angiotensin II; in vivo analysis	PROTEIN-COUPLED RECEPTORS; II TYPE-1 RECEPTOR; ANGIOTENSIN-II; SECRETIN RECEPTOR; CRYSTAL-STRUCTURE; AT(1) RECEPTOR; OLIGOMERIZATION; HETERODIMERS; ANTAGONIST; ACTIVATION	Angiotensin (ANGII) and secretin (SCT) share overlapping, interdependent osmoregulatory functions in brain, where SCT peptide/receptor function is required for ANGII action, yet the molecular basis is unknown. Since receptors for these peptides (AT1aR, SCTR) are coexpressed in osmoregulatory centers, a possible mechanism is formation of a cross-class receptor heterocomplex. Here, we demonstrate such a complex and its functional importance to modulate signaling. Association of AT1aR with SCTR reduced ability of SCT to stimulate cyclic adenosine monophosphate (cAMP), with signaling augmented in presence of ANGII or constitutively active AT1aR. Several transmembrane (TM) peptides of these receptors were able to affect their conformation within complexes, reducing receptor BRET signals. AT1aR TM1 affected only formation and activity of the heterocomplex, without effect on homomers of either receptor, and reduced SCT-stimulated cAMP responses in cells expressing both receptors. This peptide was active in vivo by injection into mouse lateral ventricle, thereby suppressing water-drinking behavior after hyperosmotic shock, similar to SCTR knockouts. This supports the interpretation that active conformation of AT1aR is a key modulator of cAMP responses induced by SCT stimulation of SCTR. The SCTR/AT1aR complex is physiologically important, providing differential signaling to SCT in settings of hyperosmolality or food intake, modulated by differences in levels of ANGII.	[Lee, Leo T. O.; Ng, Stephanie Y. L.; Chu, Jessica Y. S.; Sekar, Revathi; Chow, Billy K. C.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Harikumar, Kaleeckal G.; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ USA	University of Hong Kong; Mayo Clinic; Mayo Clinic Phoenix	Chow, BKC (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	bkcc@hku.hk	Sekar, Revathi/AAE-9642-2022; Lee, Leo T.O./AAB-1581-2021; Sekar, Revathi/AFE-8105-2022; Chow, Billy/D-3064-2009	Sekar, Revathi/0000-0002-6787-7742; Chow, Billy/0000-0003-3390-0307; Harikumar, Kaleeckal/0000-0003-0411-5334	Hong Kong Government RGC [770212M, CRFHKU6/CRF/11G, HKU 764812M, HKU 765011M]; U.S. National Institutes of Health [DK046577]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046577, R01DK046577] Funding Source: NIH RePORTER	Hong Kong Government RGC; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Hong Kong Government RGC grants 770212M (to L.T.O.L.) and CRFHKU6/CRF/11G, HKU 764812M and HKU 765011M (to B.K.C.C.), and U.S. National Institutes of Health grant DK046577 (to L.J.M.).	AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; AbdAlla S, 2005, J MOL NEUROSCI, V26, P185, DOI 10.1385/JMN:26:2-3:185; Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Bock A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2028; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Canals M, 2006, J BIOL CHEM, V281, P16757, DOI 10.1074/jbc.M601121200; Chu JYS, 2007, MOL CELL BIOL, V27, P2499, DOI 10.1128/MCB.01088-06; Chu JYS, 2011, KIDNEY INT, V79, P280, DOI 10.1038/ki.2010.397; Dong MQ, 2010, BIOORG MED CHEM LETT, V20, P6040, DOI 10.1016/j.bmcl.2010.08.062; Fanelli F, 2011, CHEM REV, V111, pPR438, DOI 10.1021/cr100437t; Gao F, 2009, MOL PHARMACOL, V76, P264, DOI 10.1124/mol.109.055756; Gonzalez AD, 2012, NEUROSCIENCE, V226, P489, DOI 10.1016/j.neuroscience.2012.08.039; GRAY MA, 1988, J MEMBRANE BIOL, V105, P131, DOI 10.1007/BF02009166; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Harikumar KG, 2006, BIOCHEMISTRY-US, V45, P14706, DOI 10.1021/bi061107n; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Lee VHY, 2010, FASEB J, V24, P5024, DOI 10.1096/fj.10-165399; Lisenbee CS, 2006, BIOCHEMISTRY-US, V45, P8216, DOI 10.1021/bi060494y; Lyngso C, 2009, MOL CELL ENDOCRINOL, V302, P203, DOI 10.1016/j.mce.2008.09.018; MAGGIO R, 1993, P NATL ACAD SCI USA, V90, P3103, DOI 10.1073/pnas.90.7.3103; Mancia F, 2008, EMBO REP, V9, P363, DOI 10.1038/embor.2008.27; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Nikiforovich GV, 2005, J PEPT RES, V66, P236, DOI 10.1111/j.1399-3011.2005.00293.x; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Paxinos G, 2012, MOUSE BRAIN STEREOTA; Quitterer U, 2011, BIOCHEM BIOPH RES CO, V409, P544, DOI 10.1016/j.bbrc.2011.05.041; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Walker JKL, 1999, J BIOL CHEM, V274, P31515, DOI 10.1074/jbc.274.44.31515; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yan LP, 2010, J BIOL CHEM, V285, P2227, DOI 10.1074/jbc.M109.077180	36	35	36	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2632	2644		10.1096/fj.13-246868	http://dx.doi.org/10.1096/fj.13-246868			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24599969	Green Published			2022-12-25	WOS:000339883600021
J	Scalzo, RL; Peltonen, GL; Binns, SE; Shankaran, M; Giordano, GR; Hartley, DA; Klochak, AL; Lonac, MC; Paris, HLR; Szallar, SE; Wood, LM; Peelor, FF; Holmes, WE; Hellerstein, MK; Bell, C; Hamilton, KL; Miller, BF				Scalzo, Rebecca L.; Peltonen, Garrett L.; Binns, Scott E.; Shankaran, Mahalakshmi; Giordano, Gregory R.; Hartley, Dylan A.; Klochak, Anna L.; Lonac, Mark C.; Paris, Hunter L. R.; Szallar, Steve E.; Wood, Lacey M.; Peelor, Frederick F., III; Holmes, William E.; Hellerstein, Marc K.; Bell, Christopher; Hamilton, Karyn L.; Miller, Benjamin F.			Greater muscle protein synthesis and mitochondrial biogenesis in males compared with females during sprint interval training	FASEB JOURNAL			English	Article						stable isotope; sex differences; deuterium oxide; exercise	HUMAN SKELETAL-MUSCLE; HIGH-INTENSITY INTERVAL; BETA-ADRENERGIC STIMULATION; RESISTANCE EXERCISE; SYNTHESIS RATES; SHORT-TERM; AEROBIC EXERCISE; HEAVY-WATER; CALORIE RESTRICTION; HEALTHY-ADULTS	Improved endurance exercise performance in adult humans after sprint interval training (SIT) has been attributed to mitochondrial biogenesis. However, muscle protein synthesis (MPS) and mitochondrial biogenesis during SIT have not been measured, nor have sex-specific differences. We hypothesized that males and females would have similar rates of MPS, mitochondrial biogenesis, and synthesis of individual proteins during SIT. Deuterium oxide (D2O) was orally administered to 21 adults [11 male, 10 female; mean age, 23+/-1 yr; body mass index (BMI), 22.8+/-0.6 kg/m(2); mean+/- SE] for 4 wk, to measure protein synthesis rates while completing 9 sessions of 4-8 bouts of 30 s duration on a cycle ergometer separated by 4 min of active recovery. Samples of the vastus lateralis were taken before and 48 h after SIT. SIT increased maximum oxygen uptake (VO2max, males 43.4+/-2.1-44.0+/-2.3; females 39.5+/-0.9 - 42.5+/-1.3 ml/kg/min; P = 0.002). MPS was greater in the males than in the females in the mixed (similar to 150%; P < 0.001), cytosolic (similar to 135%; P = 0.038), and mitochondrial (similar to 135%; P = 0.056) fractions. The corresponding ontological clusters of individual proteins were significantly greater in the males than in the females (all P<0.00001). For the first time, we document greater MPS and mitochondrial biogenesis during SIT in males than in females and describe the synthetic response of individual proteins in humans during exercise training.	[Scalzo, Rebecca L.; Peltonen, Garrett L.; Binns, Scott E.; Giordano, Gregory R.; Hartley, Dylan A.; Klochak, Anna L.; Lonac, Mark C.; Paris, Hunter L. R.; Szallar, Steve E.; Wood, Lacey M.; Peelor, Frederick F., III; Bell, Christopher; Hamilton, Karyn L.; Miller, Benjamin F.] Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA; [Shankaran, Mahalakshmi; Holmes, William E.; Hellerstein, Marc K.] KineMed Inc, Emeryville, CA USA; [Hellerstein, Marc K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	Colorado State University; University of California System; University of California Berkeley	Miller, BF (corresponding author), Colorado State Univ, Dept Hlth & Exercise Sci, 201 Moby B Complex, Ft Collins, CO 80523 USA.	benjamin.f.miller@colostate.edu		Miller, Benjamin/0000-0003-1647-0122	Office of Naval Research [N00014-10-1-0247]	Office of Naval Research(Office of Naval Research)	The authors thank Dr. M. Colangelo (KineMed) for assistance with the statistical analysis of proteomics data. The Office of Naval Research (N00014-10-1-0247) supported this study.	Astorino TA, 2011, EUR J APPL PHYSIOL, V111, P1279, DOI 10.1007/s00421-010-1741-y; Bartlett JD, 2012, J APPL PHYSIOL, V112, P1135, DOI 10.1152/japplphysiol.01040.2011; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Burgomaster KA, 2006, J APPL PHYSIOL, V100, P2041, DOI 10.1152/japplphysiol.01220.2005; Busch R, 2006, BBA-GEN SUBJECTS, V1760, P730, DOI 10.1016/j.bbagen.2005.12.023; Carter SL, 2001, CAN J PHYSIOL PHARM, V79, P386, DOI 10.1139/cjpp-79-5-386; Drake JC, 2013, J GERONTOL A-BIOL, V68, P1493, DOI 10.1093/gerona/glt047; Dreyer HC, 2010, ACTA PHYSIOL, V199, P71, DOI 10.1111/j.1748-1716.2010.02074.x; Esbjornsson M, 2009, ACTA PHYSIOL, V197, P107, DOI 10.1111/j.1748-1716.2009.01994.x; Fanara P, 2004, J BIOL CHEM, V279, P49940, DOI 10.1074/jbc.M409660200; Fuentes T, 2012, EUR J APPL PHYSIOL, V112, P1917, DOI 10.1007/s00421-011-2164-0; Fujita S, 2007, AM J PHYSIOL-ENDOC M, V292, pE77, DOI 10.1152/ajpendo.00173.2006; Gasier HG, 2011, ACTA PHYSIOL, V201, P381, DOI 10.1111/j.1748-1716.2010.02183.x; Gasier HG, 2012, METABOLISM, V61, P153, DOI 10.1016/j.metabol.2011.07.001; Gasier HG, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-31; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gibala MJ, 2009, J APPL PHYSIOL, V106, P929, DOI 10.1152/japplphysiol.90880.2008; Harber MP, 2010, AM J PHYSIOL-REG I, V299, pR1254, DOI 10.1152/ajpregu.00348.2010; Hartman JW, 2006, APPL PHYSIOL NUTR ME, V31, P557, DOI 10.1139/h06-031; Henderson GC, 2009, FASEB J, V23, P631, DOI 10.1096/fj.08-117200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jacobs RA, 2013, J APPL PHYSIOL, V115, P785, DOI 10.1152/japplphysiol.00445.2013; Jahn LA, 1999, J CLIN ENDOCR METAB, V84, P1007, DOI 10.1210/jc.84.3.1007; Kasumov T, 2013, AM J PHYSIOL-HEART C, V304, pH1201, DOI 10.1152/ajpheart.00933.2012; Kim PL, 2005, J PHYSIOL-LONDON, V568, P283, DOI 10.1113/jphysiol.2005.093708; Liljedahl ME, 1996, EUR J APPL PHYSIOL O, V74, P375, DOI 10.1007/s004210050089; Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010; MacDougall JD, 1998, J APPL PHYSIOL, V84, P2138, DOI 10.1152/jappl.1998.84.6.2138; Miller BF, 2013, J GERONTOL A-BIOL, V68, P530, DOI 10.1093/gerona/gls219; Miller BF, 2012, AM J PHYSIOL-ENDOC M, V302, pE496, DOI 10.1152/ajpendo.00578.2011; Miller BF, 2012, AGING CELL, V11, P150, DOI 10.1111/j.1474-9726.2011.00769.x; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Niklas P, 2010, EUR J APPL PHYSIOL, V110, P597, DOI 10.1007/s00421-010-1544-1; Parise G, 2001, J APPL PHYSIOL, V91, P1041, DOI 10.1152/jappl.2001.91.3.1041; Pikosky MA, 2006, J NUTR, V136, P379, DOI 10.1093/jn/136.2.379; Price JC, 2012, MOL CELL PROTEOMICS, V11, P1801, DOI 10.1074/mcp.M112.021204; Price JC, 2012, ANAL BIOCHEM, V420, P73, DOI 10.1016/j.ab.2011.09.007; Richards JC, 2010, J PHYSIOL-LONDON, V588, P2961, DOI 10.1113/jphysiol.2010.189886; Richards JC, 2010, MED SCI SPORT EXER, V42, P739, DOI 10.1249/MSS.0b013e3181bcab6c; Robinson MM, 2011, FASEB J, V25, P3240, DOI 10.1096/fj.11-186437; Robinson MM, 2011, AM J PHYSIOL-REG I, V301, pR327, DOI 10.1152/ajpregu.00160.2011; Robinson MM, 2010, AM J PHYSIOL-REG I, V298, pR25, DOI 10.1152/ajpregu.00524.2009; Serpiello FR, 2012, MED SCI SPORT EXER, V44, P827, DOI 10.1249/MSS.0b013e318240067e; Short KR, 2004, AM J PHYSIOL-ENDOC M, V286, pE92, DOI 10.1152/ajpendo.00366.2003; Smith GI, 2011, J APPL PHYSIOL, V110, P480, DOI 10.1152/japplphysiol.00125.2010; Smith GI, 2009, J APPL PHYSIOL, V107, P1308, DOI 10.1152/japplphysiol.00348.2009; Weber CL, 2002, J APPL PHYSIOL, V92, P1795, DOI 10.1152/japplphysiol.00546.2001; West DWD, 2012, J APPL PHYSIOL, V112, P1805, DOI 10.1152/japplphysiol.00170.2012; Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916	51	93	94	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2705	2714		10.1096/fj.13-246595	http://dx.doi.org/10.1096/fj.13-246595			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24599968				2022-12-25	WOS:000339883600028
J	Peyrot, SM; Nachtergaele, S; Luchetti, G; Mydock-McGrane, LK; Fujiwara, H; Scherrer, D; Jallouk, A; Schlesinger, PH; Ory, DS; Covey, DF; Rohatgi, R				Peyrot, Sara M.; Nachtergaele, Sigrid; Luchetti, Giovanni; Mydock-McGrane, Laurel K.; Fujiwara, Hideji; Scherrer, David; Jallouk, Andrew; Schlesinger, Paul H.; Ory, Daniel S.; Covey, Douglas F.; Rohatgi, Rajat			Tracking the Subcellular Fate of 20( S)-Hydroxycholesterol with Click Chemistry Reveals a Transport Pathway to the Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Imaging; Lipids; Lysosomes; Signaling; Trafficking; Oxysterol	CELLULAR CHOLESTEROL HOMEOSTASIS; OXYSTEROL-BINDING PROTEINS; PICK C1 DISEASE; IN-VIVO; LIVING CELLS; ENDOPLASMIC-RETICULUM; STROMAL CELLS; MEMBRANE; STEROL; TRAFFICKING	Background: Oxysterols are a class of emerging signaling molecules whose cell biology is poorly understood. Results: A click chemistry-based imaging strategy shows that 20(S)-hydroxycholesterol accumulates in Golgi membranes in a process that depends on ATP and lysosome function. Conclusion: 20(S)-Hydroxycholesterol is transported through a vesicular pathway to the Golgi. Significance: Specific transport pathways may regulate the oxysterol content of cellular membranes. Oxysterols, oxidized metabolites of cholesterol, are endogenous small molecules that regulate lipid metabolism, immune function, and developmental signaling. Although the cell biology of cholesterol has been intensively studied, fundamental questions about oxysterols, such as their subcellular distribution and trafficking pathways, remain unanswered. We have therefore developed a useful method to image intracellular 20(S)-hydroxycholesterol with both high sensitivity and spatial resolution using click chemistry and fluorescence microscopy. The metabolic labeling of cells with an alkynyl derivative of 20(S)-hydroxycholesterol has allowed us to directly visualize this oxysterol by attaching an azide fluorophore through cyclo-addition. Unexpectedly, we found that this oxysterol selectively accumulates in the Golgi membrane using a pathway that is sensitive to ATP levels, temperature, and lysosome function. Although previous models have proposed nonvesicular pathways for the rapid equilibration of oxysterols between membranes, direct imaging of oxysterols suggests that a vesicular pathway is responsible for differential accumulation of oxysterols in organelle membranes. More broadly, clickable alkynyl sterols may represent useful tools for sterol cell biology, both to investigate the functions of these important lipids and to decipher the pathways that determine their cellular itineraries.	[Peyrot, Sara M.; Rohatgi, Rajat] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Nachtergaele, Sigrid; Luchetti, Giovanni; Rohatgi, Rajat] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Mydock-McGrane, Laurel K.; Covey, Douglas F.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Jallouk, Andrew; Schlesinger, Paul H.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Covey, Douglas F.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Covey, Douglas F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Fujiwara, Hideji; Scherrer, David; Ory, Daniel S.] Washington Univ, Sch Med, Diabet Cardiovasc Res Ctr, St Louis, MO 63110 USA; [Covey, Douglas F.] Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO 63110 USA	Stanford University; Stanford University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Rohatgi, R (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	rrohatgi@stanford.edu			National Institutes of Health [GM47969, HL67773, 5 T32 HL007275]; Stand Up to Cancer Innovation Award from the American Association for Cancer Research; National Science Foundation Graduate Research Fellowship; NATIONAL CANCER INSTITUTE [R00CA129174] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067773, T32HL007275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276, P01GM047969, R01GM106078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up to Cancer Innovation Award from the American Association for Cancer Research; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM47969 and HL67773 (to D. F. C.), HL67773 (to D. S. O.), and Training Grant 5 T32 HL007275 (to L. K. M.). This work was also supported by a Stand Up to Cancer Innovation Award from the American Association for Cancer Research (to R. R.) and by a National Science Foundation Graduate Research Fellowship (to S. N.).	Abi-Mosleh L, 2009, P NATL ACAD SCI USA, V106, P19316, DOI 10.1073/pnas.0910916106; Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104; Bernardin A, 2010, BIOCONJUGATE CHEM, V21, P583, DOI 10.1021/bc900564w; Bielska AA, 2012, TRENDS ENDOCRIN MET, V23, P99, DOI 10.1016/j.tem.2011.12.002; Bjorkhem I, 2002, J CLIN INVEST, V110, P725, DOI 10.1172/JCI200216388; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chang PV, 2012, CHEM COMMUN, V48, P8864, DOI 10.1039/c2cc31845h; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Choudhury A, 2004, MOL BIOL CELL, V15, P4500, DOI 10.1091/mbc.E04-05-0432; Christian AE, 1997, J LIPID RES, V38, P2264; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; DUNN WA, 1980, J BIOL CHEM, V255, P5971; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Gale SE, 2009, J BIOL CHEM, V284, P1755, DOI 10.1074/jbc.M807210200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Hofmann K, 2014, J LIPID RES, V55, P583, DOI 10.1194/jlr.D044727; Holtta-Vuori M, 2008, TRAFFIC, V9, P1839, DOI 10.1111/j.1600-0854.2008.00801.x; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Jao CY, 2009, P NATL ACAD SCI USA, V106, P15332, DOI 10.1073/pnas.0907864106; Jiang XT, 2011, J LIPID RES, V52, P1435, DOI 10.1194/jlr.D015735; Kim WK, 2010, J BONE MINER RES, V25, P782, DOI 10.1359/jbmr.091024; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; LANGE Y, 1995, J LIPID RES, V36, P1092; Laughlin ST, 2009, P NATL ACAD SCI USA, V106, P12, DOI 10.1073/pnas.0811481106; LeBlanc MA, 2010, J BIOL CHEM, V285, P33875, DOI 10.1074/jbc.M110.147264; Lin YY, 2003, J STEROID BIOCHEM, V85, P57, DOI 10.1016/S0960-0760(03)00137-7; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Marks DL, 2002, TRENDS CELL BIOL, V12, P605, DOI 10.1016/S0962-8924(02)02399-1; MARSH M, 1983, CELL, V32, P931, DOI 10.1016/0092-8674(83)90078-8; Massey JB, 2006, BIOCHEMISTRY-US, V45, P10747, DOI 10.1021/bi060540u; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; McIntosh TJ, 2006, ANNU REV BIOPH BIOM, V35, P177, DOI 10.1146/annurev.biophys.35.040405.102022; Meaney S, 2002, J LIPID RES, V43, P2130, DOI 10.1194/jlr.M200293-JLR200; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Millard EE, 2000, J BIOL CHEM, V275, P38445, DOI 10.1074/jbc.M003180200; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Nachtergaele S, 2013, ELIFE, V2, DOI 10.7554/eLife.01340; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; Olkkonen VM, 2009, MOL ASPECTS MED, V30, P123, DOI 10.1016/j.mam.2009.02.004; Olsen BN, 2009, J AM CHEM SOC, V131, P4854, DOI 10.1021/ja8095224; PENTCHEV PG, 1986, J BIOL CHEM, V261, P2772; Pipalia NH, 2007, TRAFFIC, V8, P130, DOI 10.1111/j.1600-0854.2006.00513.x; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; ROBERTS KD, 1969, BIOCHEMISTRY-US, V8, P1259, DOI 10.1021/bi00831a061; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Russell DW, 2000, BBA-MOL CELL BIOL L, V1529, P126, DOI 10.1016/S1388-1981(00)00142-6; Sacchetti P, 2009, CELL STEM CELL, V5, P409, DOI 10.1016/j.stem.2009.08.019; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; SCHATTNER A, 1991, POSTGRAD MED J, V67, P223, DOI 10.1136/pgmj.67.785.223; Steck TL, 2010, TRENDS CELL BIOL, V20, P680, DOI 10.1016/j.tcb.2010.08.007; THEUNISSEN JJH, 1986, BIOCHIM BIOPHYS ACTA, V860, P66, DOI 10.1016/0005-2736(86)90499-2; Uchida Y, 2011, P NATL ACAD SCI USA, V108, P15846, DOI 10.1073/pnas.1109101108; Urano Y, 2008, P NATL ACAD SCI USA, V105, P16513, DOI 10.1073/pnas.0807450105; Varnai P, 2006, BBA-MOL CELL BIOL L, V1761, P957, DOI 10.1016/j.bbalip.2006.03.019; Yamakoshi H, 2012, J AM CHEM SOC, V134, P20681, DOI 10.1021/ja308529n; Yi TS, 2012, IMMUNITY, V37, P535, DOI 10.1016/j.immuni.2012.06.015; Zaccolo M, 2000, NAT CELL BIOL, V2, P25, DOI 10.1038/71345	72	17	17	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11095	11110		10.1074/jbc.M113.540351	http://dx.doi.org/10.1074/jbc.M113.540351			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596093	Green Published, hybrid			2022-12-25	WOS:000334638500014
J	Sor-suwan, S; Jariyapan, N; Roytrakul, S; Paemanee, A; Phumee, A; Phattanawiboon, B; Intakhan, N; Chanmol, W; Bates, PA; Saeung, A; Choochote, W				Sor-suwan, Sriwatapron; Jariyapan, Narissara; Roytrakul, Sittiruk; Paemanee, Atchara; Phumee, Atchara; Phattanawiboon, Benjarat; Intakhan, Nuchpicha; Chanmol, Wetpisit; Bates, Paul A.; Saeung, Atiporn; Choochote, Wej			Identification of Salivary Gland Proteins Depleted after Blood Feeding in the Malaria Vector Anopheles campestris-like Mosquitoes (Diptera: Culicidae)	PLOS ONE			English	Article							IMMUNO-EPIDEMIOLOGIC TOOL; PLATELET-AGGREGATION; FEMALE MOSQUITO; TRANSCRIPTOME; EXPOSURE; PEPTIDE; GAMBIAE; EXPRESSION; EVOLUTION; ABUNDANT	Malaria sporozoites must invade the salivary glands of mosquitoes for maturation before transmission to vertebrate hosts. The duration of the sporogonic cycle within the mosquitoes ranges from 10 to 21 days depending on the parasite species and temperature. During blood feeding salivary gland proteins are injected into the vertebrate host, along with malaria sporozoites in the case of an infected mosquito. To identify salivary gland proteins depleted after blood feeding of female Anopheles campestris-like, a potential malaria vector of Plasmodium vivax in Thailand, two-dimensional gel electrophoresis and nano-liquid chromatography-mass spectrometry techniques were used. Results showed that 19 major proteins were significantly depleted in three to four day-old mosquitoes fed on a first blood meal. For the mosquitoes fed the second blood meal on day 14 after the first blood meal, 14 major proteins were significantly decreased in amount. The significantly depleted proteins in both groups included apyrase, 5'-nucleotidase/apyrase, D7, D7-related 1, short form D7r1, gSG6, antiplatelet protein, serine/threonine-protein kinase rio3, putative sil1, cyclophilin A, hypothetical protein Phum_PHUM512530, AGAP007618-PA, and two non-significant hit proteins. To our knowledge, this study presents for the first time the salivary gland proteins that are involved in the second blood feeding on the day corresponding to the transmission period of the sporozoites to new mammalian hosts. This information serves as a basis for future work concerning the possible role of these proteins in the parasite transmission and the physiological processes that occur during the blood feeding.	[Sor-suwan, Sriwatapron; Jariyapan, Narissara; Phattanawiboon, Benjarat; Intakhan, Nuchpicha; Chanmol, Wetpisit; Saeung, Atiporn; Choochote, Wej] Chiang Mai Univ, Fac Med, Dept Parasitol, Chiang Mai 50000, Thailand; [Roytrakul, Sittiruk; Paemanee, Atchara] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand; [Phumee, Atchara] Chulalongkorn Univ, Fac Med, Dept Parasitol, Bangkok 10330, Thailand; [Bates, Paul A.] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England	Chiang Mai University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University; Lancaster University	Jariyapan, N (corresponding author), Chiang Mai Univ, Fac Med, Dept Parasitol, Chiang Mai 50000, Thailand.	narsuwan@mail.med.cmu.ac.th	Chanmol, Wetpisit/AFV-0649-2022; PHUMEE, ATCHARA/AAG-4881-2020	PHUMEE, ATCHARA/0000-0001-8243-7406; Saeung, Atiporn/0000-0003-3550-5992; Bates, Paul/0000-0001-6861-5421; Paemanee, Atchara/0000-0001-9206-3153	Thailand Research Fund [PHD/0149/2551, RMU5180011]; Faculty of Medicine Endowment Fund, Chiang Mai University	Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Medicine Endowment Fund, Chiang Mai University	The authors sincerely thank the Thailand Research Fund through the Royal Golden Jubilee Ph.D. program (PHD/0149/2551), the Thailand Research Fund (RMU5180011 to NJ), and the Faculty of Medicine Endowment Fund, Chiang Mai University, for financial support in this research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arca B, 2002, INSECT MOL BIOL, V11, P47, DOI 10.1046/j.0962-1075.2001.00309.x; Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; Beier JC, 1998, ANNU REV ENTOMOL, V43, P519, DOI 10.1146/annurev.ento.43.1.519; Boisson B, 2006, FEBS LETT, V580, P1988, DOI 10.1016/j.febslet.2006.02.069; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2004, INSECT MOL BIOL, V13, P73, DOI 10.1111/j.1365-2583.2004.00463.x; Calvo E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-57; Cazares-Raga FE, 2007, INSECT MOL BIOL, V16, P187, DOI 10.1111/j.1365-2583.2006.00712.x; CHOOCHOTE W, 1983, Southeast Asian Journal of Tropical Medicine and Public Health, V14, P204; Choumet V, 2007, PROTEOMICS, V7, P3384, DOI 10.1002/pmic.200700334; Das S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-566; Fontaine A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-614; GOLENDA CF, 1995, J MED ENTOMOL, V32, P300, DOI 10.1093/jmedent/32.3.300; Gross TL, 2009, J MED ENTOMOL, V46, P496, DOI 10.1603/033.046.0313; Isawa H, 2007, INSECT BIOCHEM MOLEC, V37, P466, DOI 10.1016/j.ibmb.2007.02.002; JAMES AA, 1991, MOL BIOCHEM PARASIT, V44, P245, DOI 10.1016/0166-6851(91)90010-4; Jaresitthikunchai J, 2009, P 2 BIOCH MOL BIOL C, P29; Jariyapan N, 2006, J MED ENTOMOL, V43, P867, DOI 10.1603/0022-2585(2006)43[867:AGAGPI]2.0.CO;2; Jariyapan N, 2012, PARASITOL RES, V111, P1239, DOI 10.1007/s00436-012-2958-y; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kim Se-Joo, 2003, Korean Journal of Entomology, V33, P267; Lanfrancotti A, 2002, FEBS LETT, V517, P67, DOI 10.1016/S0014-5793(02)02578-4; Lombardo F, 2009, INSECT BIOCHEM MOLEC, V39, P457, DOI 10.1016/j.ibmb.2009.04.006; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Phumee A, 2011, ASIAN BIOMED, V5, P353, DOI 10.5372/1905-7415.0502.046; Poinsignon A, 2010, TROP MED INT HEALTH, V15, P1198, DOI 10.1111/j.1365-3156.2010.02611.x; Poinsignon A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-198; Poinsignon A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002472; Raghavendra K, 2011, PARASITOL RES, V108, P757, DOI 10.1007/s00436-010-2232-0; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Rizzo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017980; ROSSIGNOL PA, 1984, AM J TROP MED HYG, V33, P17, DOI 10.4269/ajtmh.1984.33.17; Simons FER, 2001, INT ARCH ALLERGY IMM, V124, P403, DOI 10.1159/000053771; Siriyasatien Padet, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P64; Soliman Mohamed A., 1999, Journal of the Egyptian Society of Parasitology, V29, P619; Sor-suwan S, 2013, PARASITOL RES, V112, P1065, DOI 10.1007/s00436-012-3233-y; Sun DF, 2006, PLATELETS, V17, P178, DOI 10.1080/09537100500460234; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thangamani S, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-34; Thongsahuan S, 2011, MEM I OSWALDO CRUZ, V106, P105, DOI 10.1590/S0074-02762011000100017; Thongsahuan S, 2009, MEM I OSWALDO CRUZ, V104, P558, DOI 10.1590/S0074-02762009000400004; Valenzuela JG, 2003, INSECT BIOCHEM MOLEC, V33, P717, DOI 10.1016/S0965-1748(03)00067-5; Valenzuela JG, 2002, INSECT MOL BIOL, V11, P149, DOI 10.1046/j.1365-2583.2002.00319.x; Wasinpiyamongkol L, 2010, PROTEOMICS, V10, P1906, DOI 10.1002/pmic.200900626; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Yoshida S, 2008, BLOOD, V111, P2007, DOI 10.1182/blood-2007-06-097824	48	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90809	10.1371/journal.pone.0090809	http://dx.doi.org/10.1371/journal.pone.0090809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599352	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000332479400134
J	Jaquet, A; Horo, A; Ekouevi, DK; Toure, B; Coffie, PA; Effi, B; Lenaud, S; Messou, E; Minga, A; Sasco, AJ; Dabis, F				Jaquet, Antoine; Horo, Apollinaire; Ekouevi, Didier K.; Toure, Badian; Coffie, Patrick A.; Effi, Benjamin; Lenaud, Severin; Messou, Eugene; Minga, Albert; Sasco, Annie J.; Dabis, Francois		IeDEA West Africa Collaboration	Risk Factors for Cervical Intraepithelial Neoplasia in HIV-Infected Women on Antiretroviral Treatment in Cote d'Ivoire, West Africa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; POSITIVE WOMEN; CANCER; LESIONS; PREVALENCE; PREDICTORS; SPECTRUM; THERAPY; ZAMBIA	Background: Facing the dual burden of invasive cervical cancer and HIV in sub-Saharan Africa, the identification of preventable determinants of Cervical Intraepithelial Neoplasia (CIN) in HIV-infected women is of paramount importance. Methods: A cervical cancer screening based on visual inspection methods was proposed to HIV-infected women in care in Abidjan, Cote d'Ivoire. Positively screened women were referred for a colposcopy to a gynaecologist who performed directed biopsies. Results: Of the 2,998 HIV-infected women enrolled, 132 (4.4%) CIN of any grade (CIN+) were identified. Women had been followed-up for a median duration of three years [IQR: 1-5] and 76% were on antiretroviral treatment (ART). Their median most recent CD4 count was 452 [IQR: 301-621] cells/mm(3). In multivariate analysis, CIN+ was associated with a most recent CD4 count >350 cells/mm(3) (OR: 0.3; 95% CI: 0.2-0.6) or >= 200-350 cells/mm(3) (OR 0.6; 95% CI 0.4-1.0) (Ref: <200 cells/mm(3) CD4) (p<10(-4)). Conclusions: The presence of CIN+ is less common among HIV-infected women with limited or no immune deficiency. Despite the potential impact of immunological recovery on the reduction of premalignant cervical lesions through the use of ART, cervical cancer prevention, including screening and vaccination remains a priority in West Africa while ART is rolled-out.	[Jaquet, Antoine; Ekouevi, Didier K.; Sasco, Annie J.; Dabis, Francois] Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Jaquet, Antoine; Ekouevi, Didier K.; Sasco, Annie J.; Dabis, Francois] INSERM, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Horo, Apollinaire; Toure, Badian] Ctr Hops Univ CHU Yopougon, Serv Gynecol Obstet, Abidjan, Cote Ivoire; [Ekouevi, Didier K.; Coffie, Patrick A.; Lenaud, Severin] CHU Treichville, Programme PACCI, Abidjan, Cote Ivoire; [Effi, Benjamin] CHU Treichville, Serv Anatomopathol, Abidjan, Cote Ivoire; [Messou, Eugene] ACONDA, CePReF, Abidjan, Cote Ivoire; [Minga, Albert] Ctr Med Suivi Donneurs Sang CNTS PRIMO CI, Abidjan, Cote Ivoire	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Jaquet, A (corresponding author), Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France.	antoine.jaquet@isped.u-bordeaux2.fr	EKOUEVI, Didier K/E-7960-2014; Leroy, Valeriane/AAO-5175-2020; Ostergaard, Lars/AAA-3020-2020; Leroy, Valeriane/GQB-1102-2022; Adebamowo, Clement/C-8778-2011; Jaquet, Antoine/T-2794-2019; DABIS, FRANCOIS/S-9298-2019; Leroy, Valeriane/F-8129-2013; Wejse, Christian/C-8468-2014	Leroy, Valeriane/0000-0003-3542-8616; Ostergaard, Lars/0000-0003-2459-0511; Leroy, Valeriane/0000-0003-3542-8616; Adebamowo, Clement/0000-0002-6571-2880; Jaquet, Antoine/0000-0002-3426-9492; DABIS, FRANCOIS/0000-0002-1614-8857; Leroy, Valeriane/0000-0003-3542-8616; Wejse, Christian/0000-0002-2534-2942; Gottlieb, Geoffrey/0000-0002-5749-481X	National Cancer Institute (NCI); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH), as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) [U01AI069919]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069919] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH), as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The National Cancer Institute (NCI), the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) and the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH), as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) under Award Number U01AI069919. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjorlolo-Johnson G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-242; Agaba PA, 2009, INT J GYNECOL OBSTET, V107, P99, DOI 10.1016/j.ijgo.2009.06.006; Anastos K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013525; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Arbyn M, 2008, INT J CANCER, V123, P153, DOI 10.1002/ijc.23489; De Vuyst H, 2012, BRIT J CANCER, V107, P1624, DOI 10.1038/bjc.2012.441; Ferlay J, 2013, IARC CANCERBASE; Fife KH, 2009, JAIDS-J ACQ IMM DEF, V51, P274, DOI 10.1097/QAI.0b013e3181a97be5; Firnhaber C, 2010, CANCER CAUSE CONTROL, V21, P433, DOI 10.1007/s10552-009-9475-z; Hawes SE, 2003, J INFECT DIS, V188, P555, DOI 10.1086/376996; Horo A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-237; Huchko MJ, 2014, INT J CANCER, V134, P740, DOI 10.1002/ijc.28401; Jaquet A, 2012, BRIT J CANCER, V107, P556, DOI 10.1038/bjc.2012.299; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; La Ruche G, 1998, CANCER-AM CANCER SOC, V82, P2401, DOI 10.1002/(SICI)1097-0142(19980615)82:12&lt;2401::AID-CNCR14&gt;3.3.CO;2-H; Mbulaiteye SM, 2006, INT J CANCER, V118, P985, DOI 10.1002/ijc.21443; Minkoff H, 2010, J INFECT DIS, V201, P681, DOI 10.1086/650467; Munoz N, 2002, LANCET, V359, P1093, DOI 10.1016/S0140-6736(02)08151-5; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Parham GP, 2006, GYNECOL ONCOL, V103, P1017, DOI 10.1016/j.ygyno.2006.06.015; Sahasrabuddhe VV, 2007, BRIT J CANCER, V96, P1480, DOI 10.1038/sj.bjc.6603737; Sahasrabuddhe VV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008634; Sankaranarayanan R, 2003, PRACTICAL MANUAL VIS, P1; Simen-Kapeu A, 2009, CANCER CAUSE CONTROL, V20, P163, DOI 10.1007/s10552-008-9230-x; Stein L, 2008, INT J CANCER, V122, P2260, DOI 10.1002/ijc.23391; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; de Andrade ACV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018297	27	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90625	10.1371/journal.pone.0090625	http://dx.doi.org/10.1371/journal.pone.0090625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595037	gold, Green Published, Green Submitted			2022-12-25	WOS:000332475500076
J	Claessen, JHL; Sanyal, S; Ploegh, HL				Claessen, Jasper H. L.; Sanyal, Sumana; Ploegh, Hidde L.			The Chaperone BAG6 Captures Dislocated Glycoproteins in the Cytosol	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; N-GLYCANASE; DEGRADATION; ELIMINATION; PROTEASOME; TURNOVER; PEPTIDE; ER	Secretory and membrane (glyco) proteins are subject to quality control in the endoplasmic reticulum (ER) to ensure that only functional proteins reach their destination. Proteins deemed terminally misfolded and hence functionally defective may be dislocated to the cytosol, where the proteasome degrades them. What we know about this process stems mostly from overexpression of tagged misfolded proteins, or from situations where viruses have hijacked the quality control machinery to their advantage. We know of only very few endogenous substrates of ER quality control, most of which are degraded as part of a signaling pathway, such as Insig-1, but such examples do not necessarily represent terminally misfolded proteins. Here we show that endogenous dislocation clients are captured specifically in association with the cytosolic chaperone BAG6, or retrieved en masse via their glycan handle.	[Claessen, Jasper H. L.; Sanyal, Sumana; Ploegh, Hidde L.] MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Ploegh, HL (corresponding author), MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02139 USA.	ploegh@wi.mit.edu	Sanyal, Sumana/AAF-5155-2020; Sanyal, Sumana/I-7975-2013	Sanyal, Sumana/0000-0002-6230-5366	Boehringer Ingelheim Fonds; NIH [RO1 AI087879, RO1 AI033456]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087879, R01AI033456] Funding Source: NIH RePORTER	Boehringer Ingelheim Fonds(Boehringer Ingelheim); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JHLC was supported by a fellowship from the Boehringer Ingelheim Fonds. HLP receives funding from the NIH (RO1 AI087879 and RO1 AI033456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Chen X, 2011, J CELL BIOL, V192, P825, DOI 10.1083/jcb.201008090; Claessen JHL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028542; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Leichner GS, 2009, MOL BIOL CELL, V20, P3330, DOI 10.1091/mbc.E08-09-0953; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Sanyal S, 2012, J BIOL CHEM, V287, P23594, DOI 10.1074/jbc.M112.365312; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Spooner RA, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-26; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Tortorella D, 1998, J CELL BIOL, V142, P365, DOI 10.1083/jcb.142.2.365; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Xu Y, 2013, J BIOL CHEM, V288, P18068, DOI 10.1074/jbc.M112.449199	24	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90204	10.1371/journal.pone.0090204	http://dx.doi.org/10.1371/journal.pone.0090204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594942	Green Submitted, Green Published, gold			2022-12-25	WOS:000332468900080
J	Huynen, L; Lambert, DM				Huynen, Leon; Lambert, David M.			Complex Species Status for Extinct Moa (Aves: Dinornithiformes) from the Genus Euryapteryx	PLOS ONE			English	Article							ANCIENT DNA; SUBSTITUTIONS	The exact species status of New Zealand's extinct moa remains unknown. In particular, moa belonging to the genus Euryapteryx have been difficult to classify. We use the DNA barcoding sequence on a range of Euryapteryx samples in an attempt to resolve the species status for this genus. We obtained mitochondrial control region and the barcoding region from Cytochrome Oxidase Subunit I (COI) from a number of new moa samples and use available sequences from previous moa phylogenies and eggshell data to try and clarify the species status of Euryapteryx. Using the COI barcoding region we show that species status in Euryapteryx is complex with no clear separation between various individuals. Eggshell, soil, and bone data suggests that a Euryapteryx subspecies likely exists on New Zealand's North Island and can be characterized by a single mitochondrial control region SNP. COI divergences between Euryapteryx individuals from the south of New Zealand's South Island and those from the Far North of the North Island exceed 1.6% and are likely to represent separate species. Individuals from other areas of New Zealand were unable to be clearly separated based on COI differences possibly as a result of repeated hybridisation events. Despite the accuracy of the COI barcoding region to determine species status in birds, including that for the other moa genera, for moa from the genus Euryapteryx, COI barcoding fails to provide a clear result, possibly as a consequence of repeated hybridisation events between these moa. A single control region SNP was identified however that segregates with the two general morphological variants determined for Euryapteryx; a smaller subspecies restricted to the North Island of New Zealand, and a larger subspecies, found on both New Zealand's North and South Island.	[Lambert, David M.] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; Griffith Univ, Sch Biomol & Phys Sci, Nathan, Qld 4111, Australia	Griffith University; Griffith University	Lambert, DM (corresponding author), Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia.	D.Lambert@griffith.edu.au		Lambert, David/0000-0002-5821-3637	Australian Research Council [DP110101364]	Australian Research Council(Australian Research Council)	This work was carried out with support from the Australian Research Council (Grant number DP110101364; The molecular evolution of wings in ratites). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AJ, 2005, P NATL ACAD SCI USA, V102, P8257, DOI 10.1073/pnas.0409435102; Bunce M, 2003, NATURE, V425, P172, DOI 10.1038/nature01871; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; Burbidge ML, 2003, CONSERV GENET, V4, P167, DOI 10.1023/A:1023386506067; Cooper A, 2000, SCIENCE, V289, P1139; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Huynen L, 2003, NATURE, V425, P175, DOI 10.1038/nature01838; Huynen L, 2010, P NATL ACAD SCI USA, V107, P16201, DOI 10.1073/pnas.0914096107; Kerr KCR, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-29; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lambert DM, 2005, J HERED, V96, P279, DOI 10.1093/jhered/esi035; Oskam CL, 2011, J ARCHAEOL SCI, V38, P2589, DOI 10.1016/j.jas.2011.05.006; Rawlence NJ, 2009, P ROY SOC B-BIOL SCI, V276, P3395, DOI 10.1098/rspb.2009.0755; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Waugh J, 2008, BIOESSAYS, V30, P92, DOI 10.1002/bies.20698; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Worthy TH, 2012, NEW ZEAL J ZOOL, V39, P87, DOI 10.1080/03014223.2012.665060; WORTHY TH, 2002, LOST WORLD MOA	20	0	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90212	10.1371/journal.pone.0090212	http://dx.doi.org/10.1371/journal.pone.0090212			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594991	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900081
J	Janson, IA; Kong, YP; Putnam, AJ				Janson, Isaac A.; Kong, Yen P.; Putnam, Andrew J.			Nanotopographic Substrates of Poly (Methyl Methacrylate) Do Not Strongly Influence the Osteogenic Phenotype of Mesenchymal Stem Cells In Vitro	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX; BONE-FORMATION; SURFACE-FEATURES; DIFFERENTIATION; ADHESION; COLLAGEN; ACTIVATION; BEHAVIOR; MINERALIZATION	The chemical, mechanical, and topographical features of the extracellular matrix (ECM) have all been documented to influence cell adhesion, gene expression, migration, proliferation, and differentiation. Topography plays a key role in the architecture and functionality of various tissues in vivo, thus raising the possibility that topographic cues can be instructive when incorporated into biomaterials for regenerative applications. In the literature, there are discrepancies regarding the potential roles of nanotopography to enhance the osteogenic phenotype of mesenchymal stem cells (MSC). In this study, we used thin film substrates of poly(methyl methacrylate) (PMMA) with nanoscale gratings to investigate the influence of nanotopography on the osteogenic phenotype of MSCs, focusing in particular on their ability to produce mineral similar to native bone. Topography influenced focal adhesion size and MSC alignment, and enhanced MSC proliferation after 14 days of culture. However, the osteogenic phenotype was minimally influenced by surface topography. Specifically, alkaline phosphatase (ALP) expression was not increased on nanotopographic films, nor was calcium deposition improved after 21 days in culture. Ca:P ratios were similar to native mouse bone on films with gratings of 415 nm width and 200 nm depth (G415) and 303 nm width and 190 nm depth (G303). Notably, all surfaces had Ca: P ratios significantly lower than G415 films. Collectively, these data suggest that, PMMA films with nanogratings are poor drivers of an osteogenic phenotype.	[Janson, Isaac A.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Kong, Yen P.; Putnam, Andrew J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Putnam, AJ (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	putnam@umich.edu	Putnam, Andrew J./E-8643-2010	Putnam, Andrew J./0000-0002-1262-4377; Janson, Isaac/0000-0002-8862-7785	University of Michigan	University of Michigan(University of Michigan System)	This work was funded by start-up funds from the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allori AC, 2008, TISSUE ENG PART B-RE, V14, P275, DOI 10.1089/ten.teb.2008.0083; Biggs MJP, 2007, J ORTHOP RES, V25, P273, DOI 10.1002/jor.20319; Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049; Bigi A, 1997, J INORG BIOCHEM, V68, P45, DOI 10.1016/S0162-0134(97)00007-X; Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y; BURSTONE MS, 1958, J NATL CANCER I, V21, P523; CASSELLA JP, 1992, BONE MINER, V17, P123, DOI 10.1016/0169-6009(92)90722-P; Chung JY, 2007, SOFT MATTER, V3, P1163, DOI 10.1039/b705112c; Coyer SR, 2012, J CELL SCI, V125, P5110, DOI 10.1242/jcs.108035; Cunningham JJ, 2002, ANN BIOMED ENG, V30, P927, DOI 10.1114/1.1500408; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Denis FA, 2005, SMALL, V1, P984, DOI 10.1002/smll.200500116; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; FARLEY JR, 1986, METABOLISM, V35, P563, DOI 10.1016/0026-0495(86)90016-8; Gao LC, 2007, LANGMUIR, V23, P3762, DOI 10.1021/la062634a; Gao LC, 2009, LANGMUIR, V25, P7249, DOI 10.1021/la901416m; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hermitte L, 2004, J COLLOID INTERF SCI, V272, P82, DOI 10.1016/j.jcis.2003.08.055; Hirvi JT, 2007, LANGMUIR, V23, P7724, DOI 10.1021/la700558v; Huebsch N, 2011, MECHANOBIOLOGY OF CELL-CELL AND CELL-MATRIX INTERACTIONS, P23, DOI 10.1007/978-1-4419-8083-0_3; Jaberi J, 2013, J ORAL MAXIL SURG, V71, pE81, DOI 10.1016/j.joms.2012.09.023; Kerschnitzki M, 2011, J STRUCT BIOL, V173, P303, DOI 10.1016/j.jsb.2010.11.014; Khang D, 2012, BIOMATERIALS, V33, P5997, DOI 10.1016/j.biomaterials.2012.05.005; Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974; Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/jbmr.081240, 10.1359/JBMR.081240]; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107; Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042; Kim J, 2013, BIOMATERIALS, V34, P7257, DOI 10.1016/j.biomaterials.2013.06.029; Koh LB, 2010, PHYS CHEM CHEM PHYS, V12, P10301, DOI 10.1039/c001747g; Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022; Krause U, 2011, METHODS MOL BIOL, V698, P215, DOI 10.1007/978-1-60761-999-4_17; Kuhn LT, 2008, CALCIFIED TISSUE INT, V83, P146, DOI 10.1007/s00223-008-9164-z; Kulangara K, 2012, BIOMATERIALS, V33, P4998, DOI 10.1016/j.biomaterials.2012.03.053; Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110; Kusumaatmaja H, 2008, LANGMUIR, V24, P7299, DOI 10.1021/la800649a; Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034; Leroy F, 2012, J CHEM THEORY COMPUT, V8, P3724, DOI 10.1021/ct300089j; Lewis G, 2011, J BIOMED MATER RES B, V98B, P171, DOI 10.1002/jbm.b.31835; Li D, 2012, ACS SYM SER, V1120, P301; Li W, 2008, J PHYS CHEM B, V112, P7234, DOI 10.1021/jp712019y; Lim JY, 2008, BIOMATERIALS, V29, P1776, DOI 10.1016/j.biomaterials.2007.12.026; Liu YJ, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/46/465302; Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]; OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815; Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012; Prockop DJ, 2008, MESENCHYMAL STEM CEL; Prodanov L, 2013, BIOMATERIALS, V34, P2920, DOI 10.1016/j.biomaterials.2013.01.027; Prodanov L, 2010, BIOMATERIALS, V31, P7758, DOI 10.1016/j.biomaterials.2010.06.050; Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007; Rao MS, 2001, MECH AGEING DEV, V122, P713, DOI 10.1016/S0047-6374(01)00224-X; Rao RR, 2012, ACTA BIOMATER, V8, P1560, DOI 10.1016/j.actbio.2012.01.001; Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017; Salasznyk RM, 2007, J CELL BIOCHEM, V100, P499, DOI 10.1002/jcb.21074; Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z; Ter Brugge PJ, 2002, TISSUE ENG, V8, P321, DOI 10.1089/107632702753725076; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]; Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y; Wang PY, 2012, J MATER SCI-MATER M, V23, P3015, DOI 10.1007/s10856-012-4748-6; Watari S, 2012, BIOMATERIALS, V33, P128, DOI 10.1016/j.biomaterials.2011.09.058; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098; Wood JA, 2012, EXP CELL RES, V318, P2438, DOI 10.1016/j.yexcr.2012.06.022; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058; Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037; Yong X, 2009, LANGMUIR, V25, P5045, DOI 10.1021/la804025h; You MH, 2010, BIOMACROMOLECULES, V11, P1856, DOI 10.1021/bm100374n; Zhao Y, 2007, LANGMUIR, V23, P6212, DOI 10.1021/la0702077	73	21	21	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90719	10.1371/journal.pone.0090719	http://dx.doi.org/10.1371/journal.pone.0090719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594848	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900137
J	Wei, HW; Lu, XT; Lu, FM; Han, XG				Wei, Hai-Wei; Lu, Xiao-Tao; Lu, Fu-Mei; Han, Xing-Guo			Effects of Nitrogen Addition and Fire on Plant Nitrogen Use in a Temperate Steppe	PLOS ONE			English	Article							USE EFFICIENCY; NUTRIENT RESORPTION; TERRESTRIAL ECOSYSTEMS; MINERAL-NUTRITION; AVAILABILITY; PRODUCTIVITY; LIMITATION; DEPOSITION; GRASSLAND; LEAF	Plant nitrogen (N) use strategies have great implications for primary production and ecosystem nutrient cycling. Given the increasing atmospheric N deposition received by most of the terrestrial ecosystems, understanding the responses of plant N use would facilitate the projection of plant-mediated N cycling under global change scenarios. The effects of N deposition on plant N use would be affected by both natural and anthropogenic disturbances, such as prescribed fire in the grassland. We examined the effects of N addition (5.25 g N m(-2) yr(-1)) and prescribed fire (annual burning) on plant N concentrations and N use characters at both species and community levels in a temperate steppe of northern China. We found that N addition and fire independently affected soil N availability and plant N use traits. Nitrogen addition increased aboveground net primary productivity (ANPP), inorganic N, and N uptake, decreased N response efficiency (NRE), but did not affect biomass-weighed N concentrations at community level. Prescribed fire did not change the community level N concentrations, but largely decreased N uptake efficiency and NRE. At the species level, the effects of N addition and fire on plant N use were species-specific. The divergent responses of plant N use at community and species levels to N addition and fire highlight the importance of the hierarchical responses of plant N use at diverse biological organization levels to the alteration of soil N availability. This study will improve our understanding of the responses of plant-mediated N cycling to global change factors and ecosystem management strategies in the semiarid grasslands.	[Wei, Hai-Wei; Lu, Xiao-Tao; Han, Xing-Guo] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Wei, Hai-Wei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Lu, Fu-Mei; Han, Xing-Guo] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Botany, CAS	Lu, XT (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	lvxiaotao@iae.ac.cn	Han, Xingguo/K-7552-2016; Lu (ü), Xiao-Tao/B-3905-2008	Han, Xingguo/0000-0002-1836-975X; Lu (ü), Xiao-Tao/0000-0001-5571-1895	National Natural Science Foundation of China [41273094, 41173086, 31170433]; State Key Laboratory of Forest and Soil Ecology [LFSE2013-13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Forest and Soil Ecology	This research was supported by the National Natural Science Foundation of China (41273094, 41173086, and 31170433) and the State Key Laboratory of Forest and Soil Ecology (LFSE2013-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; AERTS R, 1994, ECOLOGY, V75, P2362, DOI 10.2307/1940890; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; BLAIR JM, 1990, ECOLOGY, V71, P1976, DOI 10.2307/1937606; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bowles ML, 2013, ECOL APPL, V23, P464, DOI 10.1890/12-0808.1; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Bradshaw SD, 2011, TRENDS PLANT SCI, V16, P405, DOI 10.1016/j.tplants.2011.05.005; BRIDGHAM SD, 1995, AM NAT, V145, P1, DOI 10.1086/285725; Britton AJ, 2008, ENVIRON POLLUT, V156, P409, DOI 10.1016/j.envpol.2008.01.029; CHAPIN FS, 1986, AM NAT, V127, P48, DOI 10.1086/284466; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Cole L, 2008, SOIL BIOL BIOCHEM, V40, P505, DOI 10.1016/j.soilbio.2007.09.018; Cui QA, 2010, PLANT SOIL, V334, P209, DOI 10.1007/s11104-010-0375-5; Freschet GT, 2010, NEW PHYTOL, V186, P879, DOI 10.1111/j.1469-8137.2010.03228.x; Heisler JL, 2004, ECOLOGY, V85, P2245, DOI 10.1890/03-0574; Hirose T, 2011, OECOLOGIA, V166, P863, DOI 10.1007/s00442-011-1942-z; Iversen CM, 2010, ECOLOGY, V91, P693, DOI 10.1890/09-0064.1; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Keuter A, 2013, PLANT SOIL, V364, P193, DOI 10.1007/s11104-012-1344-y; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Lu XT, 2012, J ARID ENVIRON, V78, P154, DOI 10.1016/j.jaridenv.2011.11.008; Lu XT, 2012, J ECOL, V100, P144, DOI 10.1111/j.1365-2745.2011.01881.x; Lu XT, 2012, OECOLOGIA, V168, P301, DOI 10.1007/s00442-011-2097-7; Lu XT, 2011, ECOL ENG, V37, P534, DOI 10.1016/j.ecoleng.2010.12.013; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Neary DG, 1999, FOREST ECOL MANAG, V122, P51, DOI 10.1016/S0378-1127(99)00032-8; OJIMA DS, 1994, BIOGEOCHEMISTRY, V24, P67, DOI 10.1007/BF02390180; OLear HA, 1996, SOIL BIOL BIOCHEM, V28, P323, DOI 10.1016/0038-0717(95)00138-7; Pastor J, 1999, OECOLOGIA, V118, P50, DOI 10.1007/s004420050702; Perakis SS, 2007, PLANT ECOL, V191, P209, DOI 10.1007/s11258-006-9238-9; Pilkington MG, 2007, J ECOL, V95, P1195, DOI 10.1111/j.1365-2745.2007.01292.x; Reich PB, 2001, ECOLOGY, V82, P1703; Reich PB, 1997, ECOLOGY, V78, P335, DOI 10.1890/0012-9658(1997)078[0335:NMAPIH]2.0.CO;2; SHAVER GR, 1984, ECOLOGY, V65, P1491, DOI 10.2307/1939129; VITOUSEK P, 1982, AM NAT, V119, P553, DOI 10.1086/283931; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wallenda T, 1998, NEW PHYTOL, V139, P169, DOI 10.1046/j.1469-8137.1998.00176.x; Wan SQ, 2001, ECOL APPL, V11, P1349, DOI 10.2307/3060925; Watson PJ, 2009, AUSTRAL ECOL, V34, P218, DOI 10.1111/j.1442-9993.2008.01924.x; Yasumura Y, 2002, FUNCT ECOL, V16, P826, DOI 10.1046/j.1365-2435.2002.00691.x; Yuan ZY, 2006, OECOLOGIA, V148, P564, DOI 10.1007/s00442-006-0409-0; Yuan ZY, 2005, J INTEGR PLANT BIOL, V47, P539, DOI 10.1111/j.1744-7909.2005.00006.x; Zhou LS, 2009, SOIL BIOL BIOCHEM, V41, P796, DOI 10.1016/j.soilbio.2009.01.019	45	4	5	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90057	10.1371/journal.pone.0090057	http://dx.doi.org/10.1371/journal.pone.0090057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594654	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900060
J	Shi, YX; Zhao, G; Kong, W				Shi, Yixin; Zhao, Guang; Kong, Wei			Genetic Analysis of Riboswitch-mediated Transcriptional Regulation Responding to Mn2(+) in Salmonella	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Magnesium; Manganese; Riboswitch; Transcription Regulation; Transcription Termination; 5-Untranslated Region	ENTERICA SEROVAR TYPHIMURIUM; ION-INDUCED CLEAVAGES; LEAD BINDING-SITES; ESCHERICHIA-COLI; MANGANESE TRANSPORT; BACILLUS-SUBTILIS; MN2+ TRANSPORTER; NRAMP PROTEINS; RNA; MNTH	Background: Divalent cation binding to riboswitch RNAs regulates expression of their transporter genes in bacteria. Results: Mn2+ interacts with Salmonella riboswitches characterized from Mn2+ transporter mntH and Mg2+ transporter mgtA to modulate transcription of the downstream coding region. Conclusion: Specific riboswitches control gene expression in response to Mn2+ in bacteria. Significance: This is the discovery of a Mn2+ riboswitch. Riboswitches are a class of cis-acting regulatory RNAs normally characterized from the 5-UTR of bacterial transcripts that bind a specific ligand to regulate expression of associated genes by forming alternative conformations. Here, we present a riboswitch that contributes to transcriptional regulation through sensing Mn2+ in Salmonella typhimurium. We characterized a 5-UTR (UTR1) from the mntH locus encoding a Mn2+ transporter, which forms a Rho-independent terminator to implement transcription termination with a high Mn2+ selectivity both in vivo and in vitro. Nucleotide substitutions that cause disruption of the terminator interfere with the regulatory function of UTR1. RNA probing analyses outlined a specific UTR1 conformation that favors the terminator structure in Mn2+-replete condition. Switch sequence GCUAUG can alternatively base pair duplicated hexanucleotide CAUAGC to form either a pseudoknot or terminator stem. Mn2+, but not Mg2+, and Ca2+, can enhance cleavage at specific nucleotides in UTR1. We conclude that UTR1 is a riboswitch that senses cytoplasmic Mn2+ and therefore participates in Mn2+-responsive mntH regulation in Salmonella. This riboswitch domain is also conserved in several Gram-negative enteric bacteria, indicating that this Mn2+-responsive mechanism could have broader implications in bacterial gene expression. Additionally, a high level of cytoplasmic Mn2+ can down-regulate transcription of the Salmonella Mg2+ transporter mgtA locus in a Mg2+ riboswitch-dependent manner. On the other hand, these two types of cation riboswitches do not share similarity at the primary or secondary structural levels. Taken together, characterization of Mn2+-responsive riboswitches should expand the scope of RNA regulatory elements in response to inorganic ions.	[Shi, Yixin; Zhao, Guang; Kong, Wei] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA; [Shi, Yixin] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Shi, YX (corresponding author), Arizona State Univ, Sch Life Sci, POB 874501, Tempe, AZ 85287 USA.	yixin.shi@asu.edu	SHI, YIXIN/M-5751-2019; zhao, guang/E-4702-2013	zhao, guang/0000-0003-0002-5972	State Key Laboratory of Pharmaceutical Biotechnology at Nanjing University, China [KF-GW-201202]	State Key Laboratory of Pharmaceutical Biotechnology at Nanjing University, China	This study was supported in part by Open Research Grant KF-GW-201202 from the State Key Laboratory of Pharmaceutical Biotechnology at Nanjing University, China (to Y. S.).	Agranoff DD, 1998, MOL MICROBIOL, V28, P403, DOI 10.1046/j.1365-2958.1998.00790.x; Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; Bowman JC, 2012, CURR OPIN STRUC BIOL, V22, P262, DOI 10.1016/j.sbi.2012.04.006; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; CIESIOLKA J, 1989, EUR J BIOCHEM, V186, P71, DOI 10.1111/j.1432-1033.1989.tb15179.x; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEUEL TF, 1974, J BIOL CHEM, V249, P257; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Ferre-D'Amare AR, 2011, METAL IONS LIFE SCI, V9, P141, DOI 10.1039/978184973251200141; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Garst AD, 2011, COLD SPRING HARB PER, V3; Govoni G, 1998, INFLAMM RES, V47, P277, DOI 10.1007/s000110050330; Haemig HAH, 2004, J MEMBRANE BIOL, V201, P97, DOI 10.1007/s00232-004-0711-x; Henkin TM, 2008, GENE DEV, V22, P3383, DOI 10.1101/gad.1747308; Hollands K, 2012, P NATL ACAD SCI USA, V109, P5376, DOI 10.1073/pnas.1112211109; Ikeda JS, 2005, J BACTERIOL, V187, P912, DOI 10.1128/JB.187.3.912-922.2005; KAJITANI M, 1983, NUCLEIC ACIDS RES, V11, P671, DOI 10.1093/nar/11.3.671; Kehres DG, 2000, MOL MICROBIOL, V36, P1085, DOI 10.1046/j.1365-2958.2000.01922.x; Kehres DG, 2003, FEMS MICROBIOL REV, V27, P263, DOI 10.1016/S0168-6445(03)00052-4; Kehres DG, 2002, J BACTERIOL, V184, P3151, DOI 10.1128/JB.184.12.3151-3158.2002; Kehres DG, 2002, J BACTERIOL, V184, P3159, DOI 10.1128/JB.184.12.3159-3166.2002; Kong W, 2008, J BIOL CHEM, V283, P16612, DOI 10.1074/jbc.M800547200; Liu MF, 2004, P NATL ACAD SCI USA, V101, P6911, DOI 10.1073/pnas.0401929101; Makui H, 2000, MOL MICROBIOL, V35, P1065, DOI 10.1046/j.1365-2958.2000.01774.x; MARCINIEC T, 1989, FEBS LETT, V243, P293, DOI 10.1016/0014-5793(89)80148-6; Miller JH., 1972, EXPT MOL GENETICS; NELSON DL, 1971, J BIOL CHEM, V246, P3042; Nevo Y, 2006, BBA-MOL CELL RES, V1763, P609, DOI 10.1016/j.bbamcr.2006.05.007; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Park SY, 2010, CELL, V142, P737, DOI 10.1016/j.cell.2010.07.046; Patzer SI, 2001, J BACTERIOL, V183, P4806, DOI 10.1128/JB.183.16.4806-4813.2001; Portnoy ME, 2002, BIOCHEM J, V362, P119, DOI 10.1042/bj3620119; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Que Q, 2000, MOL MICROBIOL, V35, P1454, DOI 10.1046/j.1365-2958.2000.01811.x; Serganov A, 2012, CURR OPIN STRUC BIOL, V22, P279, DOI 10.1016/j.sbi.2012.04.005; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; TABOR S, 1989, P NATL ACAD SCI USA, V86, P4076, DOI 10.1073/pnas.86.11.4076; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; WRZESINSKI J, 1995, FEBS LETT, V374, P62, DOI 10.1016/0014-5793(95)01077-R; Zaharik ML, 2004, INFECT IMMUN, V72, P5522, DOI 10.1128/IAI.72.9.5522-5525.2004; Zhao G, 2011, EMBO J, V30, P1485, DOI 10.1038/emboj.2011.66; Zhao G, 2008, P NATL ACAD SCI USA, V105, P20924, DOI 10.1073/pnas.0807071106	45	16	16	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11353	11366		10.1074/jbc.M113.517516	http://dx.doi.org/10.1074/jbc.M113.517516			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596096	Green Published, hybrid			2022-12-25	WOS:000334638500037
J	He, R; Aluko, RE; Ju, XR				He, Rong; Aluko, Rotimi E.; Ju, Xing-Rong			Evaluating Molecular Mechanism of Hypotensive Peptides Interactions with Renin and Angiotensin Converting Enzyme	PLOS ONE			English	Article							ACE INHIBITORY PEPTIDE; PROTEIN HYDROLYSATE; EGG-WHITE; IDENTIFICATION; PURIFICATION; CALMODULIN; DISCOVERY; BINDING; DESIGN; DRUGS	Our previous study showed that three rapeseed protein-derived peptides (TF, LY and RALP) inhibited the in vitro activities of angiotensin converting enzyme (ACE) and renin. Oral administration of these peptides to spontaneously hypertensive rats led to reductions in systolic blood pressure. In the present work, we examined the potential molecular mechanisms responsible for the ACE-and renin-inhibitory activities of these peptides. Enzyme inhibition kinetics showed competitive, non-competitive and mixed-type peptide-dependent inhibition of renin and ACE activities. Intrinsic fluorescence intensity data showed that LY and RALP have stronger binding effects on ACE molecule compared to that of TF. LY and RALP showed the highest inhibition of ACE and renin activities, respectively. Circular dichroism data showed that the inhibitory mechanism involved extensive peptide-dependent reductions in alpha-helix and beta-sheet fractions of ACE and renin protein conformations. Molecular docking studies confirmed that the higher renin-inhibitory activity of RALP may be due to formation of several hydrogen bonds (H-bonds) with the enzyme's active site residues. The rapeseed peptides inhibited renin and ACE activities mostly through binding to enzyme active site or non-active sites and forming extensive H-bonds that distorted the normal configuration required for catalysis. Data presented from this work could enhance development of highly potent antihypertensive natural peptides or peptidomimetics.	[He, Rong; Ju, Xing-Rong] Nanjing Univ Finance & Econ, Coll Food Sci & Engn, Nanjing, Jiangsu, Peoples R China; [He, Rong; Ju, Xing-Rong] Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Peoples R China; [He, Rong; Aluko, Rotimi E.] Univ Manitoba, Dept Human Nutr Sci, Winnipeg, MB, Canada; [He, Rong; Aluko, Rotimi E.] Univ Manitoba, Richardson Ctr Funct Foods & Nutraceut, Winnipeg, MB, Canada	Nanjing University of Finance & Economics; Jiangnan University; University of Manitoba; University of Manitoba	Ju, XR (corresponding author), Nanjing Univ Finance & Econ, Coll Food Sci & Engn, Nanjing, Jiangsu, Peoples R China.	xingrongju@163.com	he, rong/V-5127-2019	he, rong/0000-0002-3341-9786	National Natural Science Foundation of China [31271930, 31101338]; Natural Sciences and Engineering Research Council of Canada (NSERC)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this work was supported by the National Natural Science Foundation of China (Grant No. 31271930 and 31101338). The research program of Dr. R.E. Aluko is funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) through a Discovery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CB, 2012, PROCESS BIOCHEM, V47, P2240, DOI 10.1016/j.procbio.2012.08.019; Bonanni L, 2012, THER ADV CHRONIC DIS, V3, P173, DOI 10.1177/2040622312446244; Brew K, 2003, TRENDS PHARMACOL SCI, V24, P391, DOI 10.1016/S0165-6147(03)00196-2; Connelly KA, 2013, CARDIOVASC THER, V31, P84, DOI 10.1111/j.1755-5922.2011.00292.x; Daien V, 2012, AM J HYPERTENS, V25, P126, DOI 10.1038/ajh.2011.180; Du L, 2013, J FUNCT FOODS, V5, P475, DOI 10.1016/j.jff.2012.12.003; Girgih AT, 2011, J AM OIL CHEM SOC, V88, P1767, DOI 10.1007/s11746-011-1841-9; He R, 2013, J FUNCT FOODS, V5, P781, DOI 10.1016/j.jff.2013.01.024; Jao CL, 2012, BIOMEDICINE-TAIWAN, V2, P130, DOI 10.1016/j.biomed.2012.06.005; Jimsheena VK, 2010, PEPTIDES, V31, P1165, DOI 10.1016/j.peptides.2010.02.022; Katayama K, 2004, J AGR FOOD CHEM, V52, P771, DOI 10.1021/jf0350865; Ko SC, 2012, PROCESS BIOCHEM, V47, P2005, DOI 10.1016/j.procbio.2012.07.015; Kobayashi Y, 2008, J BIOSCI BIOENG, V106, P310, DOI 10.1263/jbb.106.310; Li H, 2006, INT J FOOD SCI NUTR, V57, P178, DOI 10.1080/09637480600659144; Memarpoor-Yazdi M, 2012, INT J PEPT RES THER, V18, P353, DOI 10.1007/s10989-012-9311-2; Natesh R, 2004, BIOCHEMISTRY-US, V43, P8718, DOI 10.1021/bi049480n; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Oliva RV, 2012, MANAGING KIDNEY HEAR, P59; Omoni AO, 2006, MOL NUTR FOOD RES, V50, P958, DOI 10.1002/mnfr.200600041; Pan DD, 2012, FOOD CHEM, V130, P121, DOI 10.1016/j.foodchem.2011.07.011; Pina AS, 2009, J MOL RECOGNIT, V22, P162, DOI 10.1002/jmr.905; Rahuel J, 2000, CHEM BIOL, V7, P493, DOI 10.1016/S1074-5521(00)00134-4; Schmid FX., 1989, SPECTRAL METHODS CHA, P251; SIELECKI AR, 1989, SCIENCE, V243, P1346, DOI 10.1126/science.2493678; Tanzadehpanah H, 2013, INNOV FOOD SCI EMERG, V18, P212, DOI 10.1016/j.ifset.2013.02.002; Thangapandian S, 2011, EUR J MED CHEM, V46, P2469, DOI 10.1016/j.ejmech.2011.03.035; Valika AA, 2013, HEART FAIL REV, V18, P135, DOI 10.1007/s10741-011-9295-6; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	28	48	50	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91051	10.1371/journal.pone.0091051	http://dx.doi.org/10.1371/journal.pone.0091051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603692	Green Submitted, Green Published, gold			2022-12-25	WOS:000332483600125
J	Sutton, JE; Buset, M; Keller, M				Sutton, Jennifer E.; Buset, Melanie; Keller, Mikayla			Navigation Experience and Mental Representations of the Environment: Do Pilots Build Better Cognitive Maps?	PLOS ONE			English	Article							SPATIAL ABILITIES; INDIVIDUAL-DIFFERENCES; TAXI DRIVERS; KNOWLEDGE	A number of careers involve tasks that place demands on spatial cognition, but it is still unclear how and whether skills acquired in such applied experiences transfer to other spatial tasks. The current study investigated the association between pilot training and the ability to form a mental survey representation, or cognitive map, of a novel, ground-based, virtual environment. Undergraduate students who were engaged in general aviation pilot training and controls matched to the pilots on gender and video game usage freely explored a virtual town. Subsequently, participants performed a direction estimation task that tested the accuracy of their cognitive map representation of the town. In addition, participants completed the Object Perspective Test and rated their spatial abilities. Pilots were significantly more accurate than controls at estimating directions but did not differ from controls on the Object Perspective Test. Locations in the town were visited at a similar rate by the two groups, indicating that controls' relatively lower accuracy was not due to failure to fully explore the town. Pilots' superior performance is likely due to better online cognitive processing during exploration, suggesting the spatial updating they engage in during flight transfers to a non-aviation context.	[Sutton, Jennifer E.; Buset, Melanie; Keller, Mikayla] Brescia Univ Coll, Dept Psychol, London, ON, Canada	Western University (University of Western Ontario)	Sutton, JE (corresponding author), Brescia Univ Coll, Dept Psychol, London, ON, Canada.	jennifer.sutton@uwo.ca			Brescia University College	Brescia University College	Funding for this research was provided by a grant from Brescia University College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GL, 1996, INTELLIGENCE, V22, P327, DOI 10.1016/S0160-2896(96)90026-4; ARETZ AJ, 1991, HUM FACTORS, V33, P85, DOI 10.1177/001872089103300107; Bennett ATD, 1996, J EXP BIOL, V199, P219; Blade MF, 1955, PSYCHOL MONOGR-GEN A, V69, P1; Carretta TR, 2000, AFRLHEWPTR20000116 D; Casner S.M., 2005, INT J APPL AVIAT STU, V5, P153; Chen XL, 2011, PSYCHON B REV, V18, P985, DOI 10.3758/s13423-011-0134-5; DROR IE, 1993, J APPL PSYCHOL, V78, P763, DOI 10.1037/0021-9010.78.5.763; Golledge RG, 1999, WAYFINDING BEHAVIOR, P5; Hegarty M, 2006, INTELLIGENCE, V34, P151, DOI 10.1016/j.intell.2005.09.005; Hegarty M, 2004, INTELLIGENCE, V32, P175, DOI 10.1016/j.intell.2003.12.001; Hegarty M, 2002, INTELLIGENCE, V30, P425, DOI 10.1016/S0160-2896(02)00116-2; Hegarty M, 2009, LEARN INDIVID DIFFER, V19, P61, DOI 10.1016/j.lindif.2008.04.006; Ishikawa T, 2006, COGNITIVE PSYCHOL, V52, P93, DOI 10.1016/j.cogpsych.2005.08.003; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maguire EA, 2006, HIPPOCAMPUS, V16, P1091, DOI 10.1002/hipo.20233; Montello DR, 2004, HUMAN SPATIAL MEMORY: REMEMBERING WHERE, P251; Montello DR, 2005, CAMBRIDGE HDB VISUOS, P257, DOI DOI 10.1017/CBO9780511610448.008; Montello DR, 1998, SPATIAL TEMPORAL REA, P143, DOI DOI 10.1088/1748-6041/6/2/025001; National Transportation Safety Board, 2010, NTSBSS1001; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Siegel A W, 1975, Adv Child Dev Behav, V10, P9, DOI 10.1016/S0065-2407(08)60007-5; Spence I, 2010, REV GEN PSYCHOL, V14, P92, DOI 10.1037/a0019491; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Transport Canada, 2012, CAN AV REG 4; United States Department of Transportation Federal Aviation Administration, 2008, FAAH808325A US DEP T; Uttal DH, 2013, PSYCHOL BULL, V139, P352, DOI 10.1037/a0028446; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005; Wolbers T, 2010, TRENDS COGN SCI, V14, P138, DOI 10.1016/j.tics.2010.01.001; Woollett K, 2011, CURR BIOL, V21, P2109, DOI 10.1016/j.cub.2011.11.018; Woollett K, 2010, J ENVIRON PSYCHOL, V30, P565, DOI 10.1016/j.jenvp.2010.03.003	31	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90058	10.1371/journal.pone.0090058	http://dx.doi.org/10.1371/journal.pone.0090058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4ID	24603608	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600027
J	Yeh, KW; Lee, CM; Chang, CJ; Lin, YJ; Huang, JL				Yeh, Kuo-Wei; Lee, Chi-Ming; Chang, Chee-Jen; Lin, Yu-Jr; Huang, Jing-Long			Lipid Profiles Alter from Pro-Atherogenic into Less Atherogenic and Proinflammatory in Juvenile Idiopathic Arthritis Patients Responding to Anti TNF-alpha Treatment	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; ACTIVE RHEUMATOID-ARTHRITIS; CARDIOVASCULAR-DISEASE; RISK-FACTORS; ETANERCEPT; PLASMA; ASSOCIATION; CHILDREN; THERAPY; SAFETY	Objective: Dyslipidemia with higher inflammatory states, disease activity, and longer disease duration in juvenile idiopathic arthritis (JIA) patients seemed to increase the risks of atherosclerosis. Tumor necrosis factor-alpha (TNF-alpha) receptor blocking agent etanercept has been proven to be effective in JIA. However, data about the correlation of anti-inflammatory treatment on lipid profiles and atherogenic index in JIA patients remains limited. This study aimed to investigate the longitudinal changes on lipid profiles and atherogenic index in JIA patients after etanercept treatment. Methods: Twenty-three patients diagnosed with JIA (polyarticular type n = 7; oligoarticular type, n = 2; systemic type, n = 10, Enthesitis-related arthritis = 4) received treatment with etanercept during the period 2004-012 in a medical center. We measured their serum lipid profiles at baseline and 2, 4, 6, 12 months later, and determined whether there were differences in complete blood counts, inflammatory mediators, lipid levels and atherogenic indices between patients who had inactive disease (responders) and those who were poor responders (non-responders) to etanercept treatment. Results: Analysis of dynamic change in total JIA patients before and after TNF inhibitor therapy showed modest increases in hemoglobin levels (P = 0.02) and decreases in WBC counts, Platelet and CRP levels progressively (p = 0.002, p = 0.006 and p = 0.006, respectively). Twelve of the 23 patients achieved inactive disease status (responders) after 12-months of treatment. In responders, compared to non-responders, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) increased significantly (P = 0.007, P = 0.044, P<0.001), whereas triglyceride and atherogenic index (TC/HDL-C ratio) significantly decreased (P = 0.04, P = 0.01, respectively) after etanercept treatment. Conclusion: Disease severity was associated with triglyceride level, atherogenic index and was inversely associated with total cholesterol, HDL-C, and LDL-C levels and can be improved substantially by using anti TNF-alpha treatment. Such treatment may have a beneficial effect on the cardiovascular risk in patients with JIA.	[Yeh, Kuo-Wei; Lee, Chi-Ming; Huang, Jing-Long] Chang Gung Mem Hosp Linkou, Dept Pediat, Div Allergy Asthma & Rheumatol, Tao Yuan, Taiwan; [Yeh, Kuo-Wei; Lee, Chi-Ming; Huang, Jing-Long] Chang Gung Univ, Tao Yuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Chang, Chee-Jen; Lin, Yu-Jr] Chang Gung Mem Hosp Linkuo, Biostat Ctr Clin Res, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Huang, JL (corresponding author), Chang Gung Mem Hosp Linkou, Dept Pediat, Div Allergy Asthma & Rheumatol, Tao Yuan, Taiwan.	long@adm.cgmh.org.tw	Yeh, Kuo-Wei/V-3725-2019	Huang, Jing-Long/0000-0001-9280-920X; Chang, Chee Jen/0000-0002-7725-7555; Huang, Jing-Long/0000-0002-3530-7753	Chang Gung Memorial Hospital	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by a research grant from Chang Gung Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no grant or additional financial support from pharmaceutical accepted to perform the study.	Bakkaloglu A, 1996, CLIN RHEUMATOL, V15, P341, DOI 10.1007/BF02230355; BALLANTYNE CM, 2000, J CLIN ENDOCR METAB, V85, P2089; Beukelman T, 2011, ARTHRIT CARE RES, V63, P465, DOI 10.1002/acr.20460; DELEURAN BW, 1992, ARTHRITIS RHEUM, V35, P1170, DOI 10.1002/art.1780351009; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Garrison L, 1999, ANN RHEUM DIS, V58, P65, DOI 10.1136/ard.58.2008.i65; Goncalves Marcela, 2007, Pediatr Rheumatol Online J, V5, P2, DOI 10.1186/1546-0096-5-2; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Horneff G, 2009, ANN RHEUM DIS, V68, P519, DOI 10.1136/ard.2007.087593; Huang Jing-Long, 2012, Chang Gung Med J, V35, P1; ILOWITE NT, 1989, J PEDIATR-US, V114, P823, DOI 10.1016/S0022-3476(89)80148-9; Jamnitski A, 2010, ANN RHEUM DIS, V69, P1929, DOI 10.1136/ard.2009.127597; Kaplan MJ, 2009, NAT REV RHEUMATOL, V5, P208, DOI 10.1038/nrrheum.2009.29; Marangoni RG, 2011, CLINICS, V66, P1549, DOI 10.1590/S1807-59322011000900007; Millan J, 2009, VASC HEALTH RISK MAN, V5, P757; Naranjo A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2383; Otten MH, 2011, JAMA-J AM MED ASSOC, V306, P2340, DOI 10.1001/jama.2011.1671; Petty RE, 2004, J RHEUMATOL, V31, P390; Petty Ross E., 1998, Journal of Rheumatology, V25, P1991; Popa C, 2005, ANN RHEUM DIS, V64, P303, DOI 10.1136/ard.2004.023119; Popa C, 2007, ANN RHEUM DIS, V66, P1503, DOI 10.1136/ard.2006.066191; Prakken B, 2011, LANCET, V377, P2138, DOI 10.1016/S0140-6736(11)60244-4; Rodriguez-Moran M, 2013, DIABETES VASC DIS RE, V10, P17, DOI 10.1177/1479164112440713; Shen CC, 2013, SEMIN ARTHRITIS RHEU, V42, P590, DOI 10.1016/j.semarthrit.2012.10.002; Tselepis AD, 1999, ARTHRITIS RHEUM-US, V42, P373, DOI 10.1002/1529-0131(199902)42:2<373::AID-ANR21>3.0.CO;2-3; Twisk JWR, 2004, EUR J EPIDEMIOL, V19, P769, DOI 10.1023/B:EJEP.0000036572.00663.f2; van Eijk IC, 2009, ARTHRITIS RHEUM-US, V60, P1324, DOI 10.1002/art.24492; Vermont CL, 2005, CRIT CARE MED, V33, P1610, DOI 10.1097/01.CCM.0000171272.50888.AD; Wallace CA, 2004, J RHEUMATOL, V31, P2290; Woo P, 1998, BAILLIERE CLIN RHEUM, V12, P219, DOI 10.1016/S0950-3579(98)80016-2; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	31	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90757	10.1371/journal.pone.0090757	http://dx.doi.org/10.1371/journal.pone.0090757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603504	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600082
J	Yeste, M; Estrada, E; del Alamo, MMR; Bonet, S; Rigau, T; Rodriguez-Gil, JE				Yeste, Marc; Estrada, Efren; Rivera del Alamo, Maria-Montserat; Bonet, Sergi; Rigau, Teresa; Rodriguez-Gil, Joan-Enric			The Increase in Phosphorylation Levels of Serine Residues of Protein HSP70 during Holding Time at 17 degrees C Is Concomitant with a Higher Cryotolerance of Boar Spermatozoa	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; THAWING INDUCES ALTERATIONS; SPERM DNA FRAGMENTATION; PLASMA-MEMBRANE; FLOW-CYTOMETRY; HEAT-SHOCK-PROTEIN-70 HSP-70; NUCLEOPROTEIN STRUCTURE; MAMMALIAN SPERMATOZOA; REDUCED GLUTATHIONE; BOVINE SPERMATOZOA	Boar-sperm cryopreservation is not usually performed immediately after semen collection, but rather a holding time (HT) of 4 h-30 h at 17 degrees C is spent before starting this procedure. Taking this into account, the aim of this study was to go further in-depth into the mechanisms underlying the improving effects of HT at 17 degrees C on boar-sperm cryotolerance by evaluating the effects of two different HTs (3 h and 24 h) on overall boar-sperm function and survival before and after cryopreservation. Given that phospho/dephosphorylation mechanisms are of utmost importance in the overall regulation of sperm function, the phosphorylation levels of serine residues (pSer) in 30 different sperm proteins after a 3 h-or 24 h-HT period were also assessed. We found that a HT of 24 h contributed to a higher sperm resistance to freeze-thawing procedures, whereas mini-array protein analyses showed that a HT of 24 h induced a significant (P<0.05) increase in pSer (from 100.0 +/- 1.8 arbitrary units in HT 3 h to 150.2 +/- 5.1 arbitrary units in HT 24 h) of HSP70 and, to a lesser extent, in protein kinases GSK3 and total TRK and in the cell-cycle regulatory protein CDC2/CDK1. In the case of HSP70, this increase was confirmed through immunoprecipation analyses. Principal component and multiple regression analyses indicated that a component explaining a percentage of variance higher than 50% in sperm cryotolerance was significantly correlated with pSer levels in HSP70. In addition, from all the parameters evaluated before freeze-thawing, only pSer levels in HSP70 resulted to be able to predict sperm cryotolerance. In conclusion, our results suggest that boar spermatozoa modulate its function during HT, at least partially, by changes in pSer levels of proteins like HSP70, and this is related to a higher cryotolerance.	[Yeste, Marc; Estrada, Efren; Rivera del Alamo, Maria-Montserat; Rigau, Teresa; Rodriguez-Gil, Joan-Enric] Autonomous Univ Barcelona, Fac Vet Med, Dept Anim Med & Surg, Unit Anim Reprod, Barcelona, Spain; [Bonet, Sergi] Univ Girona, Inst Food & Agr Technol, Dept Biol, TechnoSperm, Girona, Spain	Autonomous University of Barcelona; Universitat de Girona	Yeste, M (corresponding author), Autonomous Univ Barcelona, Fac Vet Med, Dept Anim Med & Surg, Unit Anim Reprod, Barcelona, Spain.	marc.yeste@uab.cat	Rodriguez-Gil, Joan E./F-8748-2016; Bonet, Sergi/AAA-9768-2020; Yeste, Marc/G-5945-2012; Bonet, Sergi/P-5026-2015	Rodriguez-Gil, Joan E./0000-0002-1112-9884; Bonet, Sergi/0000-0002-5125-7274; Yeste, Marc/0000-0002-2209-340X; Bonet, Sergi/0000-0002-5125-7274; Rigau Mas, Teresa/0000-0002-2688-0275	Spanish Ministry of Economy and Competitivity [AGL-2008-01792GAN]; Post-doctoral JdC fellowship [JCI-2010-08620]	Spanish Ministry of Economy and Competitivity(Spanish Government); Post-doctoral JdC fellowship	This research has been supported by Project AGL-2008-01792GAN of the Spanish Ministry of Economy and Competitivity and by Post-doctoral JdC fellowship (JCI-2010-08620) granted to Marc Yeste. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio IM, 2007, REPRODUCTION, V134, P435, DOI 10.1530/REP-06-0388; Aquila S, 2004, J CLIN ENDOCR METAB, V89, P1443, DOI 10.1210/jc.2003-031681; Ball BA, 2001, AM J VET RES, V62, P508, DOI 10.2460/ajvr.2001.62.508; Baumber J, 2003, J ANDROL, V24, P621; Bilodeau JF, 2000, MOL REPROD DEV, V55, P282, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;282::AID-MRD6&gt;3.0.CO;2-7; Bohring C, 2001, MOL HUM REPROD, V7, P113, DOI 10.1093/molehr/7.2.113; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitbart H, 1999, REV REPROD, V4, P151; Casas I, 2010, THERIOGENOLOGY, V74, P940, DOI 10.1016/j.theriogenology.2010.04.021; Casas I, 2009, THERIOGENOLOGY, V72, P930, DOI 10.1016/j.theriogenology.2009.07.001; Cole JA, 2011, J ANDROL, V32, P402, DOI 10.2164/jandrol.110.010702; de Lamirande E, 2002, MOL HUM REPROD, V8, P124, DOI 10.1093/molehr/8.2.124; Dun MD, 2012, HUM REPROD UPDATE, V18, P420, DOI 10.1093/humupd/dms009; Enciso M, 2006, THERIOGENOLOGY, V65, P308, DOI 10.1016/j.theriogenology.2005.05.044; Erata GO, 2008, FERTIL STERIL, V90, P322, DOI 10.1016/j.fertnstert.2007.06.021; Eriksson BM, 2001, THERIOGENOLOGY, V55, P1593, DOI 10.1016/S0093-691X(01)00505-2; Estrada E, 2014, ANDROLOGY-US, V2, P88, DOI 10.1111/j.2047-2927.2013.00144.x; Fernandez-Novell JM, 2011, REPROD FERT DEVELOP, V23, P468, DOI 10.1071/RD10120; Flesch FM, 2000, BBA-REV BIOMEMBRANES, V1469, P197, DOI 10.1016/S0304-4157(00)00018-6; Flores E, 2008, THERIOGENOLOGY, V69, P1083, DOI 10.1016/j.theriogenology.2008.01.022; Flores E, 2011, THERIOGENOLOGY, V76, P1450, DOI 10.1016/j.theriogenology.2011.05.039; Fraser L, 2010, REPROD DOMEST ANIM, V45, pE155, DOI 10.1111/j.1439-0531.2009.01537.x; GARNER DL, 1995, BIOL REPROD, V53, P276, DOI 10.1095/biolreprod53.2.276; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Grunewald S, 2005, ARCH ANDROLOGY, V51, P449, DOI 10.1080/014850190947813; Guthrie HD, 2006, J ANIM SCI, V84, P2089, DOI 10.2527/jas.2005-766; Guthrie HD, 2005, THERIOGENOLOGY, V63, P396, DOI 10.1016/j.theriogenology.2004.09.020; Harrison RAP, 2004, MOL REPROD DEV, V67, P337, DOI 10.1002/mrd.20028; Harrison RAP, 1996, MOL REPROD DEV, V45, P378, DOI 10.1002/(SICI)1098-2795(199611)45:3&lt;378::AID-MRD16&gt;3.0.CO;2-V; Huang SY, 2000, ANIM REPROD SCI, V63, P231, DOI 10.1016/S0378-4320(00)00175-5; Ibrahim NM, 2000, J ANDROL, V21, P887; Ibrahim NM, 2001, J ANDROL, V22, P863; Jha KN, 2006, MOL HUM REPROD, V12, P781, DOI 10.1093/molehr/gal085; Johnson LA, 2000, ANIM REPROD SCI, V62, P143, DOI 10.1016/S0378-4320(00)00157-3; Jungnickel MK, 2007, DEV BIOL, V304, P116, DOI 10.1016/j.ydbio.2006.12.023; Kadirvel G, 2009, ANIM REPROD SCI, V116, P244, DOI 10.1016/j.anireprosci.2009.02.003; Kim SH, 2010, THERIOGENOLOGY, V73, P282, DOI 10.1016/j.theriogenology.2009.09.011; Kim S, 2011, ANIM REPROD SCI, V124, P118, DOI 10.1016/j.anireprosci.2011.01.014; KotziasBandeira E, 1997, DEUT TIERARZTL WOCH, V104, P302; Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623; Linke K, 2003, ANTIOXID REDOX SIGN, V5, P425, DOI 10.1089/152308603768295168; Martin G, 2007, HUM REPROD, V22, P380, DOI 10.1093/humrep/del399; Matwee C, 2001, MOL HUM REPROD, V7, P829, DOI 10.1093/molehr/7.9.829; Muino-Blanco T, 2008, REPROD DOMEST ANIM, V43, P18, DOI 10.1111/j.1439-0531.2008.01228.x; Naaby-Hansen S, 2010, J REPROD IMMUNOL, V84, P32, DOI 10.1016/j.jri.2009.09.006; Nagy S, 2003, BIOL REPROD, V68, P1828, DOI 10.1095/biolreprod.102.011445; Naz Rajesh K, 2004, Reprod Biol Endocrinol, V2, P75, DOI 10.1186/1477-7827-2-75; NAZ RK, 1994, MOL REPROD DEV, V39, P397; NAZ RK, 1993, BIOL REPROD, V48, P720, DOI 10.1095/biolreprod48.4.720; Oliva R, 2006, HUM REPROD UPDATE, V12, P417, DOI 10.1093/humupd/dml009; Paasch U, 2004, FERTIL STERIL, V81, P802, DOI 10.1016/j.fertnstert.2003.09.030; Petrunkina AM, 2010, THERIOGENOLOGY, V73, P995, DOI 10.1016/j.theriogenology.2009.12.006; PURSEL VG, 1975, J ANIM SCI, V40, P99, DOI 10.2527/jas1975.40199x; Rath D, 2009, Soc Reprod Fertil Suppl, V66, P51; Silva PFN, 2006, THERIOGENOLOGY, V65, P958, DOI 10.1016/j.theriogenology.2005.09.010; Spinaci M, 2005, MOL REPROD DEV, V72, P534, DOI 10.1002/mrd.20367; Suzuki T, 2010, REPRODUCTION, V139, P847, DOI 10.1530/REP-08-0366; TAMULI MK, 1994, VET REC, V135, P160, DOI 10.1136/vr.135.7.160; Tardif S, 2001, BIOL REPROD, V65, P784, DOI 10.1095/biolreprod65.3.784; Thundathil J, 2002, MOL HUM REPROD, V8, P811, DOI 10.1093/molehr/8.9.811; Travert C, 2009, GYNECOL OBSTET FERTI, V37, P523, DOI 10.1016/j.gyobfe.2009.04.004; Urner F, 2003, REPRODUCTION, V125, P17, DOI 10.1530/rep.0.1250017; Vallorani C, 2010, ANIM REPROD SCI, V122, P58, DOI 10.1016/j.anireprosci.2010.07.007; Vijayaraghavan Srinivasan, 2007, Soc Reprod Fertil Suppl, V63, P111; Visconti PE, 2009, P NATL ACAD SCI USA, V106, P667, DOI 10.1073/pnas.0811895106; Volpe S, 2008, REPROD DOMEST ANIM, V43, P385, DOI 10.1111/j.1439-0531.2007.00918.x; Westendorf P, 1975, Dtsch Tierarztl Wochenschr, V82, P261; Yeste M, 2008, ANIM REPROD SCI, V108, P180, DOI 10.1016/j.anireprosci.2007.08.008; Yeste M, 2013, REPROD FERT DEVELOP, V25, P1036, DOI 10.1071/RD12230; Yeste M, 2013, THERIOGENOLOGY, V79, P929, DOI 10.1016/j.theriogenology.2013.01.008; Yeste M, 2010, ANIM REPROD SCI, V119, P265, DOI 10.1016/j.anireprosci.2010.02.011	71	52	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90887	10.1371/journal.pone.0090887	http://dx.doi.org/10.1371/journal.pone.0090887			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603527	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600101
J	Cotoia, A; Scrima, R; Gefter, JV; Piccoli, C; Cinnella, G; Dambrosio, M; Fink, MP; Capitanio, N				Cotoia, Antonella; Scrima, Rosella; Gefter, Julia V.; Piccoli, Claudia; Cinnella, Gilda; Dambrosio, Michele; Fink, Mitchell P.; Capitanio, Nazzareno			p-Hydroxyphenylpyruvate, an Intermediate of the Phe/Tyr Catabolism, Improves Mitochondrial Oxidative Metabolism under Stressing Conditions and Prolongs Survival in Rats Subjected to Profound Hemorrhagic Shock	PLOS ONE			English	Article							RINGERS ETHYL PYRUVATE; FLUID RESUSCITATION; VOLUME; MODEL; METHYL-2-ACETAMIDOACRYLATE; ACID	The aim of this study was to test the effect of a small volume administration of p-hydroxyphenylpyruvate (pHPP) in a rat model of profound hemorrhagic shock and to assess a possible metabolic mechanism of action of the compound. The results obtained show that hemorrhaged rats treated with 2-4% of the estimated blood volume of pHPP survived significantly longer (p<0.001) than rats treated with vehicle. In vitro analysis on cultured EA.hy 926 cells demonstrated that pHPP improved cell growth rate and promoted cell survival under stressing conditions. Moreover, pHPP stimulated mitochondria-related respiration under ATP-synthesizing conditions and exhibited antioxidant activity toward mitochondria-generated reactive oxygen species. The compound effects reported in the in vitro and in vivo analyses were obtained in the same millimolar concentration range. These data disclose pHPP as an efficient energetic substrates-supplier to the mitochondrial respiratory chain as well as an antioxidant supporting the view that the compound warrants further evaluation as a therapeutic agent.	[Cotoia, Antonella; Cinnella, Gilda; Dambrosio, Michele] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy; [Scrima, Rosella; Piccoli, Claudia; Capitanio, Nazzareno] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy; [Gefter, Julia V.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Fink, Mitchell P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg & Anesthesiol, Los Angeles, CA 90095 USA	University of Foggia; University of Foggia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Capitanio, N (corresponding author), Univ Foggia, Dept Clin & Expt Med, Foggia, Italy.	nazzareno.capitanio@unifg.it	Cinnella, Gilda/O-2987-2016	Cinnella, Gilda/0000-0001-9864-2893; Cotoia, Antonella/0000-0002-0154-0418	Defense Advanced Research Projects Agency (DARPA), University of Pittsburgh, USA; Departments of Anesthesiology and Clinical and Experimental Medicine, University of Foggia, Italy	Defense Advanced Research Projects Agency (DARPA), University of Pittsburgh, USA; Departments of Anesthesiology and Clinical and Experimental Medicine, University of Foggia, Italy	This study was financed by Defense Advanced Research Projects Agency (DARPA), University of Pittsburgh, USA, and by local grants of the Departments of Anesthesiology and Clinical and Experimental Medicine, University of Foggia, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett-Guerrero E, 2009, J CARDIOTHOR VASC AN, V23, P324, DOI 10.1053/j.jvca.2008.08.005; Cairns C B, 2001, Curr Opin Crit Care, V7, P437, DOI 10.1097/00075198-200112000-00011; Cotton BA, 2011, J TRAUMA, V70, pS30, DOI [10.1097/TA.0b013e31821a55a, 10.1097/TA.0b013e31821a55af]; DICKSON AJ, 1981, FEBS LETT, V127, P28, DOI 10.1016/0014-5793(81)80333-X; Dubick MA, 2003, J TRAUMA, V54, pS43, DOI 10.1097/01.TA.0000064514.42470.3B; Famili A, 2013, MOL VIS, V19, P1304; Fink MP, 2007, CRIT CARE MED, V35, pS461, DOI 10.1097/01.CCM.0000279192.96303.E7; Graham J M, 2001, Curr Protoc Cell Biol, VChapter 3, DOI [10.1002/0471143030.cb0305s06, 10.1002/0471143030.cb0303s04, 10.1002/0471143030.cb0304s04]; Kao KK, 2010, BIOCHEM PHARMACOL, V80, P151, DOI 10.1016/j.bcp.2010.03.007; Kaufman S, 1999, P NATL ACAD SCI USA, V96, P3160, DOI 10.1073/pnas.96.6.3160; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kim SW, 2011, MOL PHARMACOL, V79, P220, DOI 10.1124/mol.110.067520; Kuznetsov AV, 2011, ANAL BIOANAL CHEM, V400, P2383, DOI 10.1007/s00216-011-4764-2; Lantum HBM, 2003, TOXICOL SCI, V74, P192, DOI 10.1093/toxsci/kfg104; Leelahavanichkul A, 2008, AM J PHYSIOL-RENAL, V295, pF1825, DOI 10.1152/ajprenal.90442.2008; Macias CA, 2005, CRIT CARE MED, V33, pA32, DOI 10.1097/00003246-200512002-00122; Macias CA, 2007, ANN SURG, V245, P305, DOI 10.1097/01.sla.0000236626.57752.8e; McSwain NE, 2011, J TRAUMA, V70, pS2, DOI 10.1097/TA.0b013e31821b201d; Mulier KE, 2005, SHOCK, V23, P248, DOI 10.1097/01.shk.0000153353.58341.ff; OWENS TM, 1995, J TRAUMA, V39, P200, DOI 10.1097/00005373-199508000-00004; PEITZMAN AB, 1995, CURR PROB SURG, V32, P930; Probst RJ, 2006, J AM ASSOC LAB ANIM, V45, P49; Riddez L, 2002, SHOCK, V17, P377, DOI 10.1097/00024382-200205000-00006; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Sappington PL, 2005, BIOCHEM PHARMACOL, V70, P1579, DOI 10.1016/j.bcp.2005.08.015; Shah KJ, 2002, SHOCK, V18, P242, DOI 10.1097/00024382-200209000-00007; Tawadrous ZS, 2002, SHOCK, V17, P473, DOI 10.1097/00024382-200206000-00006; Taylor JH, 2004, SHOCK, V21, P58, DOI 10.1097/01.shk.0000101674.49265.93; Varma SD, 1998, FREE RADICAL RES, V28, P131, DOI 10.3109/10715769809065799; Yang R, 2002, AM J PHYSIOL-REG I, V283, pR1263, DOI 10.1152/ajpregu.00278.2002	31	9	10	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90917	10.1371/journal.pone.0090917	http://dx.doi.org/10.1371/journal.pone.0090917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599095	Green Published, Green Accepted, gold			2022-12-25	WOS:000332479400145
J	Liu, HS; Liao, J; Jiang, WX; Wang, W				Liu, Huasheng; Liao, Jian; Jiang, Weixiong; Wang, Wei			Changes in Low-Frequency Fluctuations in Patients with Antisocial Personality Disorder Revealed by Resting-State Functional MRI	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; DECISION-MAKING; FRONTAL-LOBE; CRIMINAL PSYCHOPATHS; SOCIAL COGNITION; BEHAVIOR; EMOTION; BRAIN; ABNORMALITIES; ASSOCIATION	Antisocial Personality Disorder (APD) is a personality disorder that is most commonly associated with the legal and criminal justice systems. The study of the brain in APD has important implications in legal contexts and in helping ensure social stability. However, the neural contribution to the high prevalence of APD is still unclear. In this study, we used resting-state functional magnetic resonance imaging (fMRI) to investigate the underlying neural mechanisms of APD. Thirty-two healthy individuals and thirty-five patients with APD were recruited. The amplitude of low-frequency fluctuations (ALFF) was analyzed for the whole brain of all subjects. Our results showed that APD patients had a significant reduction in the ALFF in the right orbitofrontal cortex, the left temporal pole, the right inferior temporal gyrus, and the left cerebellum posterior lobe compared to normal controls. We observed that the right orbitofrontal cortex had a negative correlation between ALFF values and MMPI psychopathic deviate scores. Alterations in ALFF in these specific brain regions suggest that APD patients may be associated with abnormal activities in the fronto-temporal network. We propose that our results may contribute in a clinical and forensic context to a better understanding of APD.	[Liu, Huasheng; Liao, Jian; Jiang, Weixiong; Wang, Wei] Cent S Univ, Xiangya Hosp 3, Dept Radiol, Changsha, Hunan, Peoples R China; [Liu, Huasheng; Jiang, Weixiong] Cent S Univ, Biomed Engn Lab, Sch Geosci & Info Phys, Changsha, Hunan, Peoples R China; [Jiang, Weixiong] Hunan First Normal Univ, Dept Informat Sci & Engn, Changsha, Hunan, Peoples R China	Central South University; Central South University; Hunan First Normal University	Wang, W (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Radiol, Changsha, Hunan, Peoples R China.	cjr.wangwei@vip.163.com			Education Ministry for the Development of Liberal Arts and Social Sciences [13YJCZH068, 2013GK1024]; Science and Technology Plan Funded of Hunan Province [2013GK1024, 2009JT3014]; National Education Department Key Laboratory [cqu-moekl-br-2011-3, 2012QNZT161]	Education Ministry for the Development of Liberal Arts and Social Sciences; Science and Technology Plan Funded of Hunan Province; National Education Department Key Laboratory	This study was supported by Education Ministry for the Development of Liberal Arts and Social Sciences (NO. 13YJCZH068, NO: 2013GK1024), Science and Technology Plan Funded of Hunan Province (NO: 2009JT3014, NO: 2013GK1024), and the National Education Department Key Laboratory (NO: cqu-moekl-br-2011-3, NO: 2012QNZT161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anckarsater H, 2007, PSYCHIAT RES-NEUROIM, V156, P87, DOI 10.1016/j.pscychresns.2006.12.008; Barkataki I, 2006, BEHAV BRAIN RES, V169, P239, DOI 10.1016/j.bbr.2006.01.009; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Berthoz S, 2002, BRAIN, V125, P1696, DOI 10.1093/brain/awf190; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Cohen MX, 2005, COGNITIVE BRAIN RES, V23, P61, DOI 10.1016/j.cogbrainres.2005.01.010; Craig MC, 2009, MOL PSYCHIATR, V14, P946, DOI 10.1038/mp.2009.40; de Oliveira-Souza R, 2008, NEUROIMAGE, V40, P1202, DOI 10.1016/j.neuroimage.2007.12.054; Di X, 2013, FRONTIERS HUMAN NEUR, V7; Eronen M, 1996, PSYCHIAT SERVICES; Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1; Goldstein RZ, 2005, PSYCHIAT RES-NEUROIM, V138, P13, DOI 10.1016/j.pscychresns.2004.10.002; Green S, 2010, NEUROIMAGE, V52, P1720, DOI 10.1016/j.neuroimage.2010.05.038; Gregory S, 2012, ARCH GEN PSYCHIAT; Kiehl KA, 2004, PSYCHIAT RES-NEUROIM, V130, P27, DOI 10.1016/S0925-4927(03)00106-9; Kumari V, 2005, BEHAV BRAIN RES, V158, P159, DOI 10.1016/j.bbr.2004.08.021; Lilienfeld S. O., 2006, HDB PSYCHOPATHY, P107; Lucantonio F, 2012, NAT NEUROSCI, V15, P358, DOI 10.1038/nn.3014; Miller BL, 1997, BRIT J PSYCHIAT, V170, P150, DOI 10.1192/bjp.170.2.150; Muller JL, 2008, PSYCHIAT RES-NEUROIM, V163, P213, DOI 10.1016/j.pscychresns.2007.08.010; Muller JL, 2008, BEHAV SCI LAW, V26, P131, DOI 10.1002/bsl.796; Narayan VM, 2007, AM J PSYCHIAT, V164, P1418, DOI 10.1176/appi.ajp.2007.06101631; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Olson IR, 2013, SOC COGN AFFECT NEUR, V8, P123, DOI 10.1093/scan/nss119; Potegal M, 2012, BEHAV BRAIN RES, V231, P386, DOI 10.1016/j.bbr.2011.10.049; Raine A, 2000, ARCH GEN PSYCHIAT, V57, P119, DOI 10.1001/archpsyc.57.2.119; Raine A, 2011, MOL PSYCHIATR, V16, P227, DOI 10.1038/mp.2009.136; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Ross LA, 2010, NEUROIMAGE, V49, P3452, DOI 10.1016/j.neuroimage.2009.11.012; Sarkar S, 2013, PSYCHOL MED, V43, P401, DOI 10.1017/S003329171200116X; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Schneider F, 2000, NEUROPSYCHOBIOLOGY, V42, P192, DOI 10.1159/000026693; Seguin JR, 2004, BRAIN COGNITION, V55, P185, DOI 10.1016/s0278-2626(03)00273-2; Sellbom M, 2007, PSYCHOL ASSESSMENT, V19, P430, DOI 10.1037/1040-3590.19.4.430; Shimony JS, 2009, ACAD RADIOL, V16, P578, DOI 10.1016/j.acra.2009.02.001; Skipper LM, 2011, NEUROPSYCHOLOGIA, V49, P3419, DOI 10.1016/j.neuropsychologia.2011.07.033; Sundram F, 2012, CORTEX, V48, P216, DOI 10.1016/j.cortex.2011.06.005; Tang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060652; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; Wagner U, 2011, CEREB CORTEX, V21, P2461, DOI 10.1093/cercor/bhr016; Wen XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063691; Widiger T. A, 1995, DSM 4 PERSONALITY DI, P103; Xuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030570; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Zahn R, 2007, P NATL ACAD SCI USA, V104, P6430, DOI 10.1073/pnas.0607061104; Zahn R, 2009, BRAIN, V132, P604, DOI 10.1093/brain/awn343; Zahn R, 2009, CEREB CORTEX, V19, P276, DOI 10.1093/cercor/bhn080	49	18	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89790	10.1371/journal.pone.0089790	http://dx.doi.org/10.1371/journal.pone.0089790			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598769	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400027
J	Ma, YW; Shen, B; Zhang, X; Lu, YD; Chen, W; Ma, J; Huang, XX; Zhang, LF				Ma, Yuanwu; Shen, Bin; Zhang, Xu; Lu, Yingdong; Chen, Wei; Ma, Jing; Huang, Xingxu; Zhang, Lianfeng			Heritable Multiplex Genetic Engineering in Rats Using CRISPR/Cas9	PLOS ONE			English	Article							ONE-STEP GENERATION; KNOCKOUT RATS; EMBRYO MICROINJECTION; DNA CLEAVAGE; CAS SYSTEMS; HUMAN-CELLS; GENOME; NUCLEASES; IMMUNITY; MICE	The CRISPR/Cas9 system has been proven to be an efficient gene-editing tool for genome modification of cells and organisms. Multiplex genetic engineering in rat holds a bright future for the study of complex disease. Here, we show that this system enables the simultaneous disruption of four genes (ApoE, B2m, Prf1, and Prkdc) in rats in one-step, by co-injection of Cas9 mRNA and sgRNAs into fertilized eggs. We further observed the gene modifications are germline transmittable, and confirmed the off-target mutagenesis and mosaicism are rarely detected by comprehensive analysis. Thus, the CRISPR/Cas9 system makes it possible to efficiently and reliably generate gene knock-out rats.	[Ma, Yuanwu; Zhang, Xu; Lu, Yingdong; Chen, Wei; Ma, Jing; Zhang, Lianfeng] Chinese Acad Med Sci, Inst Lab Anim Sci, Minist Hlth, Key Lab Human Dis Comparat Med, Beijing 100730, Peoples R China; [Shen, Bin; Huang, Xingxu] Nanjing Univ, Nanjing Biomed Res Inst, Key Lab Model Anim Dis Study, MOE,Model Anim Res Ctr,Natl Resource Ctr Mutant M, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Nanjing University	Huang, XX (corresponding author), Nanjing Univ, Nanjing Biomed Res Inst, Key Lab Model Anim Dis Study, MOE,Model Anim Res Ctr,Natl Resource Ctr Mutant M, Nanjing, Jiangsu, Peoples R China.	xingxuhuang@mail.nju.edu.cn; zhanglf@cnilas.org	Shen, Bin/ABD-5084-2021	Shen, Bin/0000-0002-8946-8448; huang, xingxu/0000-0001-8934-1247; Ma, Yuanwu/0000-0002-1882-1777	National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BA139B02, 2009CB918700]; Youth Foundation of CAMS PUMC [2012J25]	National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Youth Foundation of CAMS PUMC	The present work was supported in part by the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2012BA139B02, 2009CB918700) and the Youth Foundation of CAMS & PUMC (2012J25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Brown AJ, 2013, NAT METHODS, V10, P638, DOI 10.1038/nmeth.2516; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hamra FK, 2010, NATURE, V467, P161, DOI 10.1038/467161a; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	24	74	88	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89413	10.1371/journal.pone.0089413	http://dx.doi.org/10.1371/journal.pone.0089413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598943	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400012
J	Peters, VE				Peters, Valerie E.			Intercropping with Shrub Species That Display a 'Steady-State' Flowering Phenology as a Strategy for Biodiversity Conservation in Tropical Agroecosystems	PLOS ONE			English	Article							TREEFALL GAPS; EUGLOSSINE BEES; DIVERSITY; FOREST; POLLINATION; PATTERNS; HUMMINGBIRDS; UNDERSTOREY; TREELET; SYSTEMS	Animal species in the Neotropics have evolved under a lower spatiotemporal patchiness of food resources compared to the other tropical regions. Although plant species with a steady-state flowering/fruiting phenology are rare, they provide predictable food resources and therefore may play a pivotal role in animal community structure and diversity. I experimentally planted a supplemental patch of a shrub species with a steady-state flowering/fruiting phenology, Hamelia patens Jacq., into coffee agroforests to evaluate the contribution of this unique phenology to the structure and diversity of the flower-visiting community. After accounting for the higher abundance of captured animals in the coffee agroforests with the supplemental floral resources, species richness was 21% higher overall in the flower-visiting community in these agroforests compared to control agroforests. Coffee agroforests with the steady-state supplemental floral patch also had 31% more butterfly species, 29% more hummingbird species, 65% more wasps and 85% more bees than control coffee agroforests. The experimental treatment, together with elevation, explained 57% of the variation in community structure of the flower-visiting community. The identification of plant species that can support a high number of animal species, including important ecosystem service providers, is becoming increasingly important for restoration and conservation applications. Throughout the Neotropics plant species with a steady-state flowering/fruiting phenology can be found in all aseasonal forests and thus could be widely tested and suitable species used throughout the tropics to manage for biodiversity and potentially ecosystem services involving beneficial arthropods.	[Peters, Valerie E.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Peters, VE (corresponding author), Miami Univ, Dept Biol, Oxford, OH 45056 USA.	petersve@miamioh.edu			EarthWatch Institute; Andrew W. Mellon Foundation	EarthWatch Institute; Andrew W. Mellon Foundation	Funding for this study was provided by the EarthWatch Institute (www.earthwatch.org) and the Andrew W. Mellon Foundation (www.mellon.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN JD, 1983, ECOLOGY, V64, P274, DOI 10.2307/1937075; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; BAKER GH, 1963, SCIENCE, V139, P877, DOI 10.1126/science.139.3558.877; Bawa KS, 2003, AM J BOT, V90, P877, DOI 10.3732/ajb.90.6.877; Borrell BJ, 2005, BIOTROPICA, V37, P664, DOI 10.1111/j.1744-7429.2005.00084.x; Chauhan S, 2009, INT J PLANT REPROD B, V1, P63; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; COLWELL RK, 1995, BIOTROPICA, V27, P206, DOI 10.2307/2388996; Dalling JW, 2002, J ECOL, V90, P714, DOI 10.1046/j.1365-2745.2002.00706.x; DEVRIES PJ, 1997, BUTTERFLIES COSTA RI, V2; DeVries PJ, 1987, BUTTERFLIES COSTA RI; Diekotter T, 2013, INSECT CONSERV DIVER, V6, P607, DOI 10.1111/icad.12015; Dixon KW, 2009, SCIENCE, V325, P571, DOI 10.1126/science.1176295; FEINSINGER P, 1978, ECOL MONOGR, V48, P269, DOI 10.2307/2937231; FLEMING TH, 1987, ANNU REV ECOL SYST, V18, P91, DOI 10.1146/annurev.ecolsys.18.1.91; Fleming TH, 2008, J BIOGEOGR, V35, P764, DOI 10.1111/j.1365-2699.2007.01833.x; GENTRY A H, 1974, Biotropica, V6, P64, DOI 10.2307/2989698; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Greenberg R, 2008, ECOLOGY, V89, P913, DOI 10.1890/07-1578.1; Halvorsen R, 2009, LANDSCAPE ECOL, V24, P851, DOI 10.1007/s10980-009-9363-7; Hernandez SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065101; Hopwood JL, 2008, BIOL CONSERV, V141, P2632, DOI 10.1016/j.biocon.2008.07.026; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; Kang H, 2003, AM J BOT, V90, P865, DOI 10.3732/ajb.90.6.865; Kinnaird MF, 2005, TROPICAL FRUITS AND FRUGIVORES: THE SEARCH FOR STRONG INTERACTORS, P155, DOI 10.1007/1-4020-3833-X_9; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; KOPTUR S, 1988, J TROP ECOL, V4, P323, DOI 10.1017/S0266467400002984; Lasso E, 2003, BIOTROPICA, V35, P57; LEVEY DJ, 1987, OECOLOGIA, V74, P203, DOI 10.1007/BF00379360; LEVEY DJ, 1990, J TROP ECOL, V6, P409, DOI 10.1017/S026646740000479X; Menz MHM, 2011, TRENDS PLANT SCI, V16, P4, DOI 10.1016/j.tplants.2010.09.006; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; Milton K, 2005, TROPICAL FRUITS AND FRUGIVORES: THE SEARCH FOR STRONG INTERACTORS, P5, DOI 10.1007/1-4020-3833-X_2; Newstrom L. E., 1994, P142; NEWSTROM LE, 1994, BIOTROPICA, V26, P141, DOI 10.2307/2388804; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; OPLER PA, 1980, J ECOL, V68, P167, DOI 10.2307/2259250; Peres CA, 2000, J TROP ECOL, V16, P287, DOI 10.1017/S0266467400001413; Perfecto I, 2005, ECOL ECON, V54, P435, DOI 10.1016/j.ecolecon.2004.10.009; Peters VE, 2013, INSECT CONSERV DIVER, V6, P45, DOI 10.1111/j.1752-4598.2012.00189.x; Peters VE, 2013, BIOTROPICA, V45, P102, DOI 10.1111/j.1744-7429.2012.00891.x; Peters VE, 2010, J ANIM ECOL, V79, P824, DOI 10.1111/j.1365-2656.2010.01699.x; Philpott SM, 2011, AGR ECOSYST ENV; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; R Core Team, 2022, R LANG ENV STAT COMP; Russell KN, 2005, BIOL CONSERV, V124, P133, DOI 10.1016/j.biocon.2005.01.022; Sakai S, 2000, J TROP ECOL, V16, P337, DOI 10.1017/S0266467400001449; Sakai S, 2001, POPUL ECOL, V43, P77, DOI 10.1007/PL00012018; Scheper J, 2013, ECOL LETT, V16, P912, DOI 10.1111/ele.12128; Schnitzer SA, 2001, ECOLOGY, V82, P913, DOI 10.1890/0012-9658(2001)082[0913:TGATMO]2.0.CO;2; Stevenson P, 2005, TROPICAL FRUITS FRUG, P155; STILES FG, 1975, ECOLOGY, V56, P285, DOI 10.2307/1934961; Terborgh J., 1986, CONSERVATION BIOL SC, P330; THOMAS CD, 1986, BIOTROPICA, V18, P161, DOI 10.2307/2388759; Wunderle JM, 2005, IBIS, V147, P109, DOI 10.1111/j.1474-919x.2005.00382.x	56	4	4	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90510	10.1371/journal.pone.0090510	http://dx.doi.org/10.1371/journal.pone.0090510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598826	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400085
J	Taylor, CM; Coffey, PL; DeLay, BD; Dively, GP				Taylor, Christopher M.; Coffey, Peter L.; DeLay, Bridget D.; Dively, Galen P.			The Importance of Gut Symbionts in the Development of the Brown Marmorated Stink Bug, Halyomorpha halys (Stal)	PLOS ONE			English	Article							VERTICAL TRANSMISSION; PLATASPID STINKBUG; BACTERIA; HEMIPTERA; HETEROPTERA; INSECTS; CAPSULE	The invasive brown marmorated stink bug, Halyomorpha halys (Stal), has become a severe agricultural pest and nuisance problem since its introduction in the U. S. Research is being conducted to understand its biology and to find management solutions. Its symbiotic relationship with gut symbionts is one aspect of its biology that is not understood. In the family Pentatomidae, the reliance on gut symbionts for successful development seems to vary depending on the species of stink bug. This research assessed the role of gut symbionts in the development, survivorship, and fecundity of H. halys. We compared various fitness parameters of nymphs and adults reared from surface sterilized and untreated egg masses during two consecutive generations under laboratory conditions. Results provided direct evidence that H. halys is negatively impacted by the prevention of vertical transmission of its gut symbionts and that this impact is significant in the first generation and manifests dramatically in the subsequent generation. Developmental time and survivorship of treated cohorts in the first generation were significantly affected during third instar development through to the adult stage. Adults from the sterilized treatment group exhibited longer pre-oviposition periods, produced fewer egg masses, had significantly smaller clutch sizes, and the hatch rate and survivorship of those eggs were significantly reduced. Observations following hatch of surface sterilized eggs also revealed significant effects on wandering behavior of the first instars. The second generation progeny from adults of the sterilized cohorts showed significantly lower survival to adulthood, averaging only 0.3% compared to 20.8% for the control cohorts. Taken together, results demonstrate that H. halys is heavily impacted by deprival of its gut symbionts. Given the economic status of this invasive pest, further investigations may lead to management tactics that disrupt this close symbiotic relationship in the biology of H. halys.	[Taylor, Christopher M.; Coffey, Peter L.; DeLay, Bridget D.; Dively, Galen P.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Taylor, CM (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	cmjtaylor3@gmail.com	DeLay, Bridget/AAM-1497-2020	DeLay, Bridget/0000-0003-1354-1407	United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) Specialty Crop Research Initiative (SCRI) [2011-51181-30937]	United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) Specialty Crop Research Initiative (SCRI)	Grant: United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) Specialty Crop Research Initiative (SCRI) # 2011-51181-30937: Biology, Ecology, and Management of Brown Marmorated Stink Bug in orchard Crops, Small Fruit, Grapes, Vegetables and Ornamentals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE Y, 1995, JPN J APPL ENTOMOL Z, V39, P109, DOI 10.1303/jjaez.39.109; [Anonymous], IS BMSB STAT BY STAT; Baumann P, 1997, ANTON LEEUW INT J G, V72, P39, DOI 10.1023/A:1000239108771; Buchner P, 1965, ENDOSYMBIONTS ANIMAL; Dasch GA, 1984, BERGEYS MANUAL SYSTE, V1, P811; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Fukatsu T, 2002, APPL ENVIRON MICROB, V68, P389, DOI 10.1128/AEM.68.1.389-396.2002; Glasgow H, 1914, BIOL BULL-US, V26, P101, DOI 10.2307/1536004; Hamilton George C., 2009, American Entomologist, V55, P19; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Hosokawa T, 2005, FEMS MICROBIOL ECOL, V54, P471, DOI 10.1016/j.femsec.2005.06.002; Hosokawa T, 2008, BIOL LETTERS, V4, P45, DOI 10.1098/rsbl.2007.0510; Hosokawa T, 2012, APPL ENVIRON MICROB, V78, P4758, DOI 10.1128/AEM.00867-12; Hosokawa T, 2012, ANIM BEHAV, V83, P293, DOI 10.1016/j.anbehav.2011.11.006; Kaiwa N, 2011, ZOOL SCI, V28, P169, DOI 10.2108/zsj.28.169; Kaiwa N, 2010, APPL ENVIRON MICROB, V76, P3486, DOI 10.1128/AEM.00421-10; Kashima T, 2006, J INSECT PHYSIOL, V52, P816, DOI 10.1016/j.jinsphys.2006.05.003; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kikuchi Y, 2012, APPL ENTOMOL ZOOL, V47, P1, DOI 10.1007/s13355-011-0081-7; Kikuchi Y, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-2; Kuhar T.P., 2012, PLANT HLTH PROG, V13, P41, DOI [10.1094/PHP-2012-0523-01-BR, DOI 10.1094/PHP-2012-0523-01-BR]; Lauzon CR, 2009, ANN ENTOMOL SOC AM, V102, P85, DOI 10.1603/008.102.0109; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; Leskey Tracy C., 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/535062; Lockwood JA, 1998, ENVIRON ENTOMOL, V14, P562; Moran NA, 1998, BIOSCIENCE, V48, P295, DOI 10.2307/1313356; Nielsen AL, 2008, ENVIRON ENTOMOL, V37, P348, DOI 10.1603/0046-225X(2008)37[348:DREALT]2.0.CO;2; Prado SS, 2006, ANN ENTOMOL SOC AM, V99, P577, DOI 10.1603/0013-8746(2006)99[577:VTOAPC]2.0.CO;2; Prado SS, 2010, APPL ENVIRON MICROB, V76, P1261, DOI 10.1128/AEM.02034-09; Prado SS, 2009, ENTOMOL EXP APPL, V132, P21, DOI 10.1111/j.1570-7458.2009.00863.x; Prado SS, 2009, CURR MICROBIOL, V58, P64, DOI 10.1007/s00284-008-9267-9; Prado Simone Souza, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/269473; Schorr H., 1957, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V45, P561, DOI 10.1007/BF00399596	34	72	77	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90312	10.1371/journal.pone.0090312	http://dx.doi.org/10.1371/journal.pone.0090312			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598598	gold, Green Published, Green Submitted			2022-12-25	WOS:000332479400063
J	Tu, XB; Li, ZH; Wang, J; Huang, XB; Yang, JW; Fan, CB; Wu, HH; Wang, QL; Zhang, ZH				Tu, Xiongbing; Li, Zhihong; Wang, Jie; Huang, Xunbing; Yang, Jiwen; Fan, Chunbin; Wu, Huihui; Wang, Qinglei; Zhang, Zehua			Improving the Degree-Day Model for Forecasting Locusta migratoria manilensis (Meyen) (Orthoptera: Acridoidea)	PLOS ONE			English	Article							CALCULATING TEMPERATURE-DEPENDENCE; LONG-TIME PERIODS; GROWTH; COLEOPTERA; SURVIVAL; WEIGHT	The degree-day (DD) model is an important tool for forecasting pest phenology and voltinism. Unfortunately, the DD model is inaccurate, as is the case for the Oriental migratory locust. To improve the existing DD model for this pest, we first studied locust development in seven growth chambers, each of which simulated the complete growing-season climate of a specific region in China (Baiquan, Chengde, Tumotezuoqi, Wenan, Rongan, Qiongzhong, or Qiongshan). In these seven treatments, locusts completed 0.95, 1, 1.1, 2.2, 2.95, 3.95, and 4.95 generations, respectively. Hence, in the Baiquan (700), Rongan (2400), Qiongzhong (3200), and Qiongshan (2400) treatments, the final generation were unable to lay eggs. In a second experiment, we reared locusts for a full generation in growth chambers, at different constant temperatures. This experiment provided two important findings. First, temperatures between 32 and 42 degrees C did not influence locust development rate. Hence, the additional heat provided by temperatures above 32 degrees C did not add to the total heat units acquired by the insects, according to the traditional DD model. Instead, temperatures above 32 degrees C represent overflow heat, and can not be included when calculating total heat acquired during development. We also noted that females raised at constant 21 degrees C failed to oviposit. Hence, temperatures lower than 21 degrees C should be deducted when calculating total heat acquired during adult development. Using our experimental findings, we next micmiked 24-h temperature curve and constructed a new DD model based on a 24-h temperature integral calculation. We then compared our new model with the traditional DD model, results showed the DD deviation was 166 heat units in Langfang during 2011. At last we recalculated the heat by our new DD model, which better predicted the results from our first growth chamber experiment.	[Tu, Xiongbing; Wang, Jie; Huang, Xunbing; Wu, Huihui; Zhang, Zehua] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Tu, Xiongbing; Li, Zhihong] China Agr Univ, Coll Agron & Biotechnol, Dept Entomol, Beijing 100094, Peoples R China; [Yang, Jiwen; Fan, Chunbin] Tianjin Binhai New Area Dagang Agr Serv Ctr, Tianjin, Peoples R China; [Wang, Qinglei] Cangzhou Acad Agr & Forestry Sci Hebei, Cangzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; China Agricultural University	Zhang, ZH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	lgbcc@263.net		Zehua, Zhang/0000-0002-0648-8954	earmarked fund for China Agriculture Research System [CARS-35-07]; Special Fund for Agro-scientific Research in the Public Interest [201003079]	earmarked fund for China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest	This article was supported by the earmarked fund for China Agriculture Research System (CARS-35-07) and the Special Fund for Agro-scientific Research in the Public Interest, 201003079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKONOR JB, 1988, INSECT SCI APPL, V9, P625, DOI 10.1017/S1742758400005117; ALLEN JC, 1976, ENVIRON ENTOMOL, V5, P388, DOI 10.1093/ee/5.3.388; [Anonymous], 1991, BIOL MIGRATORY LOCUS; Arnold CY, 1960, AM SOC HORTICULTURAL, V76, P682; BASKERVILLE GL, 1969, ECOLOGY, V50, P514, DOI 10.2307/1933912; BEGON M, 1983, ECOL ENTOMOL, V8, P361, DOI 10.1111/j.1365-2311.1983.tb00516.x; Briere JF, 1998, ENVIRON ENTOMOL, V27, P94, DOI 10.1093/ee/27.1.94; Chappell M.A., 1990, P143; Chen YL, 2007, MAIN LOCUST ECOLOGIC, P82; Chen Yong-Lin, 2000, Entomological Knowledge, V37, P50; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Davidson J., 1942, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V20, P233, DOI 10.1038/icb.1942.39; de Reaumur R, 1735, MEMOIRE ACAD SCI PAR; DUDLEY B., 1964, Transactions of the Royal Entomological Society of London, V116, P115; Eizenberg H, 2005, WEED SCI, V53, P37, DOI 10.1614/WS-04-018R1; Feng CH, 2011, PLANT PROTECTION THE, P68; Frouz J, 2002, J ECON ENTOMOL, V95, P699, DOI 10.1603/0022-0493-95.4.699; Hamilton A. G., 1950, Transactions of the Royal Entomological Society of London, V101, P1; HAMILTON ANDREW G., 1936, TRANS ROY ENT SOC LONDON, V85, P1; Heinrich B., 1993, HOT BLOODED INSECTS; HIGLEY LG, 1986, ENVIRON ENTOMOL, V15, P999, DOI 10.1093/ee/15.5.999; Jong G. de, 2009, Phenotypic plasticity of insects: mechanisms and consequences, P523; Kontodimas DC, 2004, ENVIRON ENTOMOL, V33, P1, DOI 10.1603/0046-225X-33.1.1; LIN YU, 1959, ACTA ENT SINICA, V9, P423; Lischke H, 1997, AGR FOREST METEOROL, V86, P169, DOI 10.1016/S0168-1923(97)00015-4; Lischke H, 1997, ECOL MODEL, V98, P105, DOI 10.1016/S0304-3800(96)01907-2; LUDWIG DANIEL, 1928, PHYSIOL ZOOL, V1, P358; MA S. C., 1958, ACTA ENT SINICA, V8, P1; Ma S.J, 1965, STUDY DISTRIBUTION M; Mohsen M, 2007, EUROPE J ENTOMOLOGY, V104, P631; Mu J. Y., 1987, Acta Phytophylactica Sinica, V14, P169; Nicholas M, 1949, J AM STAT ASSOC, V44, P335; Popov GB, 1959, ECOLOGY, V66, P1084; Pradhan S., 1945, Proceedings of the National Institute of Sciences of India, V11, P74; PRUESS KP, 1983, ENVIRON ENTOMOL, V12, P613, DOI 10.1093/ee/12.3.613; SCHOOLFIELD RM, 1981, J THEOR BIOL, V88, P719, DOI 10.1016/0022-5193(81)90246-0; Shi Pei-Jian, 2011, Chinese Journal of Applied Entomology, V48, P1149; Son Y, 2005, AGR FOREST ENTOMOL, V7, P201, DOI 10.1111/j.1461-9555.2005.00260.x; Stauffer Timothy W., 1997, P231; Tu XB, 2010, THESIS CHINESE ACAD; Tu Xiongbing, 2012, Journal of Orthoptera Research, V21, P133, DOI 10.1665/034.021.0201; UVAROV B. P., 1931, TRANS ENT SOC [LONDON], V79, P1; UVAROV B. P., 1936, Bulletin of Entomological Research, V27, P91, DOI 10.1017/S0007485300058144; Uvarov B. P., 1977, GRASSHOPPERS LOCUSTS, V2; Uvarov BP, 1966, GRASSHOPPERS LOCUSTS, V1; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; WANG JY, 1960, ECOLOGY, V41, P785, DOI 10.2307/1931815; Watanabe N, 1981, DIS INSECT PEST OBSE, V2, P39; [徐兴奎 XU Xing-Kui], 2009, [生态学报, Acta Ecologica Sinica], V29, P6042; YANG V. L., 1959, ACTA ENT SINICA, V9, P137; [昝庆安 Zan Qingan], 2010, [云南农业大学学报, Journal of Yunnan Agricultural University], V25, P476; Zhang XX, 1979, PEST FORECAST PRINCI, P1; Zhang XX, 2002, INSECT ECOLOGY FOREC, P1; Zhou Y, 1980, HIST CHINESE ENTOMOL, P55; Zhu EL, 1999, OCCURRENCE MANAGEMEN, P5	55	9	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89523	10.1371/journal.pone.0089523	http://dx.doi.org/10.1371/journal.pone.0089523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599091	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400015
J	Xue, WW; Liu, HX; Yao, XJ				Xue, Weiwei; Liu, Huanxiang; Yao, Xiaojun			Molecular Modeling Study on the Allosteric Inhibition Mechanism of HIV-1 Integrase by LEDGF/p75 Binding Site Inhibitors	PLOS ONE			English	Article							CONFORMATIONAL-CHANGES; DYNAMICS SIMULATIONS; COMBINING DOCKING; RESP METHODOLOGY; FREE-ENERGIES; FORCE-FIELD; PROTEINS; INSIGHTS; DNA; RALTEGRAVIR	HIV-1 integrase (IN) is essential for the integration of viral DNA into the host genome and an attractive therapeutic target for developing antiretroviral inhibitors. LEDGINs are a class of allosteric inhibitors targeting LEDGF/p75 binding site of HIV-1 IN. Yet, the detailed binding mode and allosteric inhibition mechanism of LEDGINs to HIV-1 IN is only partially understood, which hinders the structure-based design of more potent anti-HIV agents. A molecular modeling study combining molecular docking, molecular dynamics simulation, and binding free energy calculation were performed to investigate the interaction details of HIV-1 IN catalytic core domain (CCD) with two recently discovered LEDGINs BI-1001 and CX14442, as well as the LEDGF/p75 protein. Simulation results demonstrated the hydrophobic domain of BI-1001 and CX14442 engages one subunit of HIV-1 IN CCD dimer through hydrophobic interactions, and the hydrophilic group forms hydrogen bonds with HIV-1 IN CCD residues from other subunit. CX14442 has a larger tert-butyl group than the methyl of BI-1001, and forms better interactions with the highly hydrophobic binding pocket of HIV-1 IN CCD dimer interface, which can explain the stronger affinity of CX14442 than BI-1001. Analysis of the binding mode of LEDGF/p75 with HIV-1 IN CCD reveals that the LEDGF/p75 integrase binding domain residues Ile365, Asp366, Phe406 and Val408 have significant contributions to the binding of the LEDGF/p75 to HIV1-IN. Remarkably, we found that binding of BI-1001 and CX14442 to HIV-1 IN CCD induced the structural rearrangements of the 140 s loop and oration displacements of the side chains of the three conserved catalytic residues Asp64, Asp116, and Glu152 located at the active site. These results we obtained will be valuable not only for understanding the allosteric inhibition mechanism of LEDGINs but also for the rational design of allosteric inhibitors of HIV-1 IN targeting LEDGF/p75 binding site.	[Xue, Weiwei; Yao, Xiaojun] Lanzhou Univ, Dept Chem, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China; [Liu, Huanxiang] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China; [Yao, Xiaojun] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China	Lanzhou University; Lanzhou University; Macau University of Science & Technology	Yao, XJ (corresponding author), Lanzhou Univ, Dept Chem, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China.	xjyao@lzu.edu.cn	; Xue, Weiwei/C-7461-2016	Liu, Huanxiang/0000-0002-9284-3667; Xue, Weiwei/0000-0002-3285-0574	National Natural Science Foundation of China [21175063]; Program for Changjiang Scholars and Innovative Research Team in University [PCSIRT: IRT1137]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (Grant No 21175063) and the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT: IRT1137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mawsawi LQ, 2011, CHEMMEDCHEM, V6, P228, DOI 10.1002/cmdc.201000443; Allingham JS, 1999, J MOL BIOL, V289, P1195, DOI 10.1006/jmbi.1999.2837; Alonso H, 2006, MED RES REV, V26, P531, DOI 10.1002/med.20067; [Anonymous], 2008, AMBER 10; [Anonymous], 2009, PRIM VERS 2 1; [Anonymous], 2009, LIGPREP VERS 2 3; [Anonymous], 2009, GLID VERS 5 5; [Anonymous], 2009, EP VERS 2 0; Asante-Appiah E, 1999, ADV VIRUS RES, V52, P351, DOI 10.1016/S0065-3527(08)60306-1; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Busschots K, 2009, MOL BIOSYST, V5, P21, DOI 10.1039/b810306b; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Christ F, 2013, VIROLOGY, V435, P102, DOI 10.1016/j.virol.2012.09.033; Christ F, 2012, ANTIMICROB AGENTS CH, V56, P4365, DOI 10.1128/AAC.00717-12; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Cui W, 2010, J CHEM INF MODEL, V50, P380, DOI 10.1021/ci900404p; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Luca L, 2012, J CHEM INF MODEL, V52, P3245, DOI 10.1021/ci300361e; DeJesus E, 2006, JAIDS-J ACQ IMM DEF, V43, P1, DOI 10.1097/01.qai.0000233308.82860.2f; Du L, 2008, BIOCHEM BIOPH RES CO, V375, P139, DOI 10.1016/j.bbrc.2008.07.139; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; ENGELMAN A, 1994, J VIROL, V68, P5911, DOI 10.1128/JVI.68.9.5911-5917.1994; Fox T, 1998, J PHYS CHEM B, V102, P8070, DOI 10.1021/jp9717655; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Greenwald J, 1999, BIOCHEMISTRY-US, V38, P8892, DOI 10.1021/bi9907173; Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T; Hare S, 2009, VIRUSES-BASEL, V1, P780, DOI 10.3390/v1030780; Hou TJ, 2008, J MOL BIOL, V376, P1201, DOI 10.1016/j.jmb.2007.12.054; Hu GP, 2012, J MED CHEM, V55, P10108, DOI 10.1021/jm301226a; Hu GP, 2012, J MOL MODEL, V18, P4995, DOI 10.1007/s00894-012-1494-0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Kessl JJ, 2009, MOL PHARMACOL, V76, P824, DOI 10.1124/mol.109.058883; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; Koelsch KK, 2009, CURR OPIN HIV AIDS, V4, P518, DOI 10.1097/COH.0b013e328331b526; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KUKOLJ G, 1995, GENE DEV, V9, P2556, DOI 10.1101/gad.9.20.2556; Liu H., 2009, MOL PHARM, V7, P75; Marchand C, 2012, EXPERT OPIN INV DRUG, V21, P901, DOI 10.1517/13543784.2012.685653; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Quashie PK, 2013, CURR OPIN INFECT DIS, V26, P43, DOI 10.1097/QCO.0b013e32835ba81c; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schrijvers R, 2012, 19 INT AIDS C; Schrodinger, 2009, MAESTR VERS 9 0; SCHUPBACH J, 1984, SCIENCE, V224, P503, DOI 10.1126/science.6200937; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Tintori C, 2010, PROTEINS, V78, P3396, DOI 10.1002/prot.22847; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534; U. S. Food and Drug Administration, 2013, FDA APPR NEW DRUG TR; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Xu L, 2012, MOL BIOSYST, V8, P2260, DOI 10.1039/c2mb25146a; Xue WW, 2013, J CHEM INF MODEL, V53, P210, DOI 10.1021/ci300541c; Xue WW, 2012, MOL BIOSYST, V8, P2753, DOI 10.1039/c2mb25157d; Xue WW, 2012, MOL BIOSYST, V8, P2135, DOI 10.1039/c2mb25114k; Xue WW, 2012, J COMPUT CHEM, V33, P527, DOI 10.1002/jcc.22887; Yang Y, 2012, MOL BIOSYST, V8, P2106, DOI 10.1039/c2mb25042j; Yang Y, 2011, J CHEM INF MODEL, V51, P3235, DOI 10.1021/ci200159g; Zhao YX, 2010, J CHEM INF MODEL, V50, P1633, DOI 10.1021/ci1002119	67	15	16	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90799	10.1371/journal.pone.0090799	http://dx.doi.org/10.1371/journal.pone.0090799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599328	gold, Green Published, Green Submitted			2022-12-25	WOS:000332479400133
J	Butt, AM; Nasrullah, I; Tong, YG				Butt, Azeem Mehmood; Nasrullah, Izza; Tong, Yigang			Genome-Wide Analysis of Codon Usage and Influencing Factors in Chikungunya Viruses	PLOS ONE			English	Article							ESCHERICHIA-COLI; PATTERNS; BIAS; EXPRESSION; GENES; REEMERGENCE; DROSOPHILA; EVOLUTION; HOST; CPG	Chikungunya virus (CHIKV) is an arthropod-borne virus of the family Togaviridae that is transmitted to humans by Aedes spp. mosquitoes. Its genome comprises a 12 kb single-strand positive-sense RNA. In the present study, we report the patterns of synonymous codon usage in 141 CHIKV genomes by calculating several codon usage indices and applying multivariate statistical methods. Relative synonymous codon usage (RSCU) analysis showed that the preferred synonymous codons were G/C and A-ended. A comparative analysis of RSCU between CHIKV and its hosts showed that codon usage patterns of CHIKV are a mixture of coincidence and antagonism. Similarity index analysis showed that the overall codon usage patterns of CHIKV have been strongly influenced by Pan troglodytes and Aedes albopictus during evolution. The overall codon usage bias was low in CHIKV genomes, as inferred from the analysis of effective number of codons (ENC) and codon adaptation index (CAI). Our data suggested that although mutation pressure dominates codon usage in CHIKV, patterns of codon usage in CHIKV are also under the influence of natural selection from its hosts and geography. To the best of our knowledge, this is first report describing codon usage analysis in CHIKV genomes. The findings from this study are expected to increase our understanding of factors involved in viral evolution, and fitness towards hosts and the environment.	[Butt, Azeem Mehmood] Univ Punjab, Ctr Excellence Mol Biol CEMB, Lahore, Pakistan; [Nasrullah, Izza] Quaid I Azam Univ, Fac Biol Sci, Dept Biochem, Islamabad, Pakistan; [Tong, Yigang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	University of Punjab; Quaid I Azam University; Beijing Institute of Microbiology & Epidemiology	Tong, YG (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	tong62035@gmail.com	Butt, Azeem Mehmood/B-6249-2014	Butt, Azeem Mehmood/0000-0001-5897-6848; Tong, Yigang/0000-0002-8503-8045	National Hi-Tech Research and Development (863) Program of China [2012AA022-003]; China Mega-Project on Major Drug Development [2011ZX09401-023]; China Mega-Project on Infectious Disease Prevention [2013ZX10004-605, 2013ZX10004-607, 2013ZX10004-217, 2011ZX10004-001]	National Hi-Tech Research and Development (863) Program of China; China Mega-Project on Major Drug Development; China Mega-Project on Infectious Disease Prevention	This research was supported by grants from the National Hi-Tech Research and Development (863) Program of China (No. 2012AA022-003), China Mega-Project on Major Drug Development (No. 2011ZX09401-023), and China Mega-Project on Infectious Disease Prevention (No. 2013ZX10004-605, No. 2013ZX10004-607, No. 2013ZX10004-217, and No. 2011ZX10004-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JW, 2006, VIRUS GENES, V33, P15, DOI 10.1007/s11262-005-0035-7; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Chen YH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/406342; Cheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074109; Chiusano ML, 2000, GENE, V261, P63, DOI 10.1016/S0378-1119(00)00521-7; Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384; Dorn A, 2008, CURR OPIN MOL THER, V10, P10; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; Greenacre M.J., 1984, THEORY APPL CORRES A; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Gu WJ, 2004, VIRUS RES, V101, P155, DOI 10.1016/j.virusres.2004.01.006; Hassan Sameer, 2009, Advances in Bioinformatics, V2009, P316936, DOI 10.1155/2009/316936; Hu JS, 2011, INFECT GENET EVOL, V11, P2098, DOI 10.1016/j.meegid.2011.08.025; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; Jupp P. G., 1988, The arboviruses: epidemiology and ecology. Volume II., P137; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 1997, P NATL ACAD SCI USA, V94, P10227, DOI 10.1073/pnas.94.19.10227; Kumar NP, 2008, J GEN VIROL, V89, P1945, DOI 10.1099/vir.0.83628-0; Liu YS, 2011, INFECT GENET EVOL, V11, P1168, DOI 10.1016/j.meegid.2011.02.018; Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282; Ma JJ, 2013, J ANIM VET ADV, V12, P88; MARIN A, 1989, NUCLEIC ACIDS RES, V17, P6181; Moratorio G, 2013, INFECT GENET EVOL, V14, P396, DOI 10.1016/j.meegid.2013.01.001; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; Sanchez G, 2003, J VIROL, V77, P452, DOI 10.1128/JVI.77.1.452-459.2003; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shi SL, 2013, VIRUS GENES, V46, P10, DOI 10.1007/s11262-012-0818-6; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tao P, 2009, VIRUS GENES, V38, P104, DOI 10.1007/s11262-008-0296-z; Tatarinova TV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-308; Theamboonlers A, 2009, JPN J INFECT DIS, V62, P303; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; Van der Linden MG, 2006, EXTREMOPHILES, V10, P479, DOI 10.1007/s00792-006-0533-0; Wang M, 2011, ARCH VIROL, V156, P153, DOI 10.1007/s00705-010-0848-0; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zhang ZC, 2013, ARCH VIROL, V158, P145, DOI 10.1007/s00705-012-1480-y; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]; Zhou H, 2005, ARCH VIROL, V150, P1591, DOI 10.1007/s00705-005-0510-4; Zhou JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077239	52	124	129	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90905	10.1371/journal.pone.0090905	http://dx.doi.org/10.1371/journal.pone.0090905			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595095	gold, Green Submitted, Green Published			2022-12-25	WOS:000332475500112
J	Palazzo, C; Ravaud, JF; Papelard, A; Ravaud, P; Poiraudeau, S				Palazzo, Clemence; Ravaud, Jean-Francois; Papelard, Agathe; Ravaud, Philippe; Poiraudeau, Serge			The Burden of Musculoskeletal Conditions	PLOS ONE			English	Article							ICF CORE SETS; LOW-BACK-PAIN; RHEUMATOID-ARTHRITIS; PREVALENCE; DISABILITY; DISEASES; IMPACT; EPIDEMIOLOGY	Objective: Despite the burden of rheumatic and musculoskeletal diseases (RMDs), these conditions probably deserve more attention from public health authorities in several countries including developed ones. We assessed their contribution to disability. Methods: Data on disabilities associated with RMDs were extracted from the national 2008-2009 Disability-Health Survey of 29,931 subjects representative of the population in France. We used the core set of disability categories for RMDs of the World Health Organization's International Classification of Functioning, Disability and Health for analysis. Diagnosis and disabilities were self-reported. We assessed the risk of disability associated with RMDs using odds ratios (ORs) and the societal impact of RMDs using the average attributable fraction (AAF). Results: Overall 27.7% (about 17.3 million people) (95% CI 26.9-28.4%) of the population reported having RMDs. The most prevalent RMDs were low back pain (12.5%, 12.1-13.1) and osteoarthritis (12.3%, 11.8-12.7). People reporting osteoarthritis were more disabled in walking (adjusted OR 1.9, 1.7-2.2) than those without. People reporting inflammatory arthritis were more limited in activities of daily living (from 1.4, 1.2-1.8 for walking to 2.1, 1.5-2.9 for moving around). From a societal perspective, osteoarthritis was the main contributor to activity limitations (AAF 22% for walking difficulties). Changing jobs was mainly attributed to neck pain (AAF 13%) and low back pain (11.5%). Conclusion: RMDs are highly prevalent and significantly affect activity limitations and participation restrictions. More effort is needed to improve care and research in this field.	[Palazzo, Clemence; Ravaud, Philippe; Poiraudeau, Serge] INSERM, U1153, Paris, France; [Palazzo, Clemence; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75181 Paris, France; [Palazzo, Clemence; Ravaud, Philippe; Poiraudeau, Serge] Univ Paris 05, PRES Sorbonne Paris Cite, Paris, France; [Palazzo, Clemence; Papelard, Agathe; Poiraudeau, Serge] Hop Cochin, AP HP, Serv Reeduc & Readaptat Appareil Locomoteur & Pat, F-75674 Paris, France; [Ravaud, Jean-Francois; Papelard, Agathe; Poiraudeau, Serge] INSERM, Inst Federatif Rech Handicap, Paris, France; [Ravaud, Jean-Francois] INSERM, U988, Villejuif, France; [Ravaud, Jean-Francois] CNRS, UMR 8211, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite Paris Cite	Palazzo, C (corresponding author), INSERM, U1153, Paris, France.	clemence.palazzo@cch.aphp.fr	ravaud, philippe/C-1694-2009; POIRAUDEAU, SERGE/P-5301-2016; RAVAUD, Jean-François/F-7190-2013	RAVAUD, Jean-François/0000-0003-3959-4195; Ravaud, Philippe/0000-0001-8264-9206; Poiraudeau, Serge/0000-0002-1988-9124	Head Office of Research, Studies, Evaluation and Statistics (DREES) of the Social Affairs Ministry of France [PA 11/R 10100LL]; Pfizer	Head Office of Research, Studies, Evaluation and Statistics (DREES) of the Social Affairs Ministry of France; Pfizer(Pfizer)	The Head Office of Research, Studies, Evaluation and Statistics (DREES) of the Social Affairs Ministry of France (contract PA 11/R 10100LL), Pfizer. The Head Office of Research, Studies, Evaluation and Statistics (DREES) of the Social Affairs Ministry of France and Pfizer had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Baumeister H, 2010, J CLIN EPIDEMIOL, V63, P558, DOI 10.1016/j.jclinepi.2009.08.009; Boonen A, 2005, ANN RHEUM DIS, V64, P396, DOI 10.1136/ard.2003.019711; Buchbinder R, 2001, SPINE, V26, P2535, DOI 10.1097/00007632-200112010-00005; Castro-Sanchez AM, 2012, PAIN MED, V13, P1639, DOI 10.1111/j.1526-4637.2012.01523.x; Chopra A, 2013, RHEUMATOLOGY, V52, P1925, DOI 10.1093/rheumatology/ket222; Cieza A, 2004, J REHABIL MED, V36, P69, DOI 10.1080/16501960410016037; Cieza A, 2004, J REHABIL MED, V36, P81, DOI 10.1080/16501960410016028; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; EIDE GE, 1995, J CLIN EPIDEMIOL, V48, P645, DOI 10.1016/0895-4356(94)00161-I; European Commision, 2007, HLTH EUR UN SPEC EUR; Gebhardt C, 2010, J REHABIL MED, V42, P780, DOI 10.2340/16501977-0599; Guo HR, 1999, AM J PUBLIC HEALTH, V89, P1029, DOI 10.2105/AJPH.89.7.1029; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Knight M, 2001, J PUBLIC HEALTH MED, V23, P179, DOI 10.1093/pubmed/23.3.179; Krishnan E, 2012, ANN RHEUM DIS, V71, P213, DOI 10.1136/annrheumdis-2011-200354; Kwok WY, 2011, ANN RHEUM DIS, V70, P334, DOI 10.1136/ard.2010.133603; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; Nikolaus S, 2013, ARTHRITIS CARE RES H, V17; Nuesch E, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1165; Palazzo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044994; Picavet HSJ, 2003, ANN RHEUM DIS, V62, P644, DOI 10.1136/ard.62.7.644; Ruckinger S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-7; Schwarzkopf SR, 2008, CLIN RHEUMATOL, V27, P1355, DOI 10.1007/s10067-008-0916-y; Song J, 2006, ARTHRIT RHEUM-ARTHR, V55, P248, DOI 10.1002/art.21842; Stucki G, 2005, ANN RHEUM DIS, V64, P664, DOI 10.1136/ard.2003.019356; The European Musculoskeletal Conditions Surveillance and Information Network, 2012, MUSC HLTH STAT EUR V; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wolfe F, 2010, J RHEUMATOL, V37, P305, DOI 10.3899/jrheum.090781; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646	30	119	122	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90633	10.1371/journal.pone.0090633	http://dx.doi.org/10.1371/journal.pone.0090633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595187	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500078
J	Patrone, M; Carinhas, N; Sousa, MQ; Peixoto, C; Ciferri, C; Carfi, A; Alves, PM				Patrone, Marco; Carinhas, Nuno; Sousa, Marcos Q.; Peixoto, Cristina; Ciferri, Claudio; Carfi, Andrea; Alves, Paula M.			Enhanced Expression of Full-Length Human Cytomegalovirus Fusion Protein in Non-Swelling Baculovirus-Infected Cells with a Minimal Fed-Batch Strategy	PLOS ONE			English	Article							SIMPLEX-VIRUS 1; GLYCOPROTEIN COMPLEX GB; ENDOTHELIAL-CELLS; VACCINE; GROWTH; ENTRY; HERPESVIRUSES; PREVENTION; GP55-116; EFFICACY	Human cytomegalovirus congenital infection represents an unmet medical issue and attempts are ongoing to develop an effective vaccine. The virion fusion players of this enveloped virus are the natural targets to achieve this goal and to develop novel anti-viral therapies. The secreted ectodomain of the viral fusion factor glycoprotein B (gB) has been exploited so far as an alternative to the cumbersome expression of the wild type trans-membrane protein. In the soluble form, gB showed encouraging but limited potential as antigen candidate calling for further efforts. Here, the exhaustive evaluation of the Baculovirus/insect cell expression system has been coupled to an orthogonal screening for expression additives to produce full-length gB. In detail, rapamycin was found to prolong gB intracellular accumulation while inhibiting the infection-induced cell swelling. Not obvious to predict, this inhibition did not affect Baculovirus growth, revealing that the virus-induced cell size increase is a dispensable side phenotype. In parallel, a feeding strategy for the limiting nutrient cysteine has been set up which improved gB stability. This multi-modal scheme allowed the production of full-length, mutation-free gB in the milligram scale. The recombinant full-length gB obtained was embedded into a stable mono-dispersed particle substantially larger than the protein trimer itself, according to the reported association of this protein with detergent-resistant lipid domains.	[Patrone, Marco; Carinhas, Nuno; Sousa, Marcos Q.; Peixoto, Cristina; Alves, Paula M.] iBET, Oeiras, Portugal; [Carinhas, Nuno; Alves, Paula M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Ciferri, Claudio; Carfi, Andrea] Novartis Vaccines & Diagnost, Cambridge, MA USA	Universidade Nova de Lisboa; Novartis	Patrone, M (corresponding author), Ist Sci San Raffaele, I-20132 Milan, Italy.	patrone.marco@hsr.it	Alves, Paula M/C-1070-2008; Patrone, Marco/M-5672-2013; Peixoto, Cristina/K-8945-2014	Alves, Paula M/0000-0003-1445-3556; Patrone, Marco/0000-0002-5164-2877; Peixoto, Cristina/0000-0002-0995-6637	Marie Curie post-doctoral grant SHerpA [251982]; EU project ComplexINC [270089]; Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/80514/2011]	Marie Curie post-doctoral grant SHerpA; EU project ComplexINC; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was partially supported by the Marie Curie post-doctoral grant SHerpA to M. P. (FP7-PEOPLE-2009-IEF, grant agreement No 251982) and EU project ComplexINC to P. M. A. (FP7/2007-2013, grant agreement No 270089, www.complexinc.eu). N.C. acknowledges Fundacao para a Ciencia e a Tecnologia (FCT) for his fellowship grant (SFRH/BPD/80514/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PRIORITIES NATL VACC; [Anonymous], 2000, VACCINES 21 CENTURY; Atanasiu D, 2010, J VIROL, V84, P12292, DOI 10.1128/JVI.01700-10; Backovic M, 2009, CURR OPIN STRUC BIOL, V19, P189, DOI 10.1016/j.sbi.2009.02.012; Backovic M, 2009, P NATL ACAD SCI USA, V106, P2880, DOI 10.1073/pnas.0810530106; Balcarcel RR, 2001, BIOTECHNOL BIOENG, V76, P1, DOI 10.1002/bit.1020; Bender FC, 2003, J VIROL, V77, P9542, DOI 10.1128/JVI.77.17.9542-9552.2003; Britt W, 2008, CURR TOP MICROBIOL, V325, P417; BRITT WJ, 1992, J VIROL, V66, P6747, DOI 10.1128/JVI.66.11.6747-6754.1992; BRITT WJ, 1989, J VIROL, V63, P403, DOI 10.1128/JVI.63.1.403-410.1989; Carinhas N, 2010, METAB ENG, V12, P39, DOI 10.1016/j.ymben.2009.08.008; Chauvin C., 2013, ONCOGENE, DOI 10.1038/onc.2012.606; Dempsey AF, 2012, VACCINE, V30, P4060, DOI 10.1016/j.vaccine.2012.04.011; Dollery SJ, 2011, J VIROL, V85, P9964, DOI 10.1128/JVI.05291-11; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Fernandes F, 2013, EXPERT REV VACCINES, V12, P225, DOI [10.1586/ERV.12.153, 10.1586/erv.12.153]; Hahn G, 2004, J VIROL, V78, P10023, DOI 10.1128/JVI.78.18.10023-10033.2004; Hahn G, 2002, J VIROL, V76, P9551, DOI 10.1128/JVI.76.18.9551-9555.2002; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Lopper M, 2002, J VIROL, V76, P6073, DOI 10.1128/JVI.76.12.6073-6082.2002; Martin S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002894; Monteiro F, 2013, BIOTECHNOL IN PRESS; Pass RF, 1999, J INFECT DIS, V180, P970, DOI 10.1086/315022; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; Patrone M, 2007, J VIROL, V81, P11479, DOI 10.1128/JVI.00788-07; Radford KM, 1997, BIOTECHNOL BIOENG, V56, P32, DOI 10.1002/(SICI)1097-0290(19971005)56:1<32::AID-BIT4>3.0.CO;2-W; Ryckman BJ, 2008, J VIROL, V82, P60, DOI 10.1128/JVI.01910-07; Schleiss MR, 2003, J VIROL METHODS, V108, P59, DOI 10.1016/S0166-0934(02)00258-6; Sharma S, 2013, VIROLOGY, V435, P239, DOI 10.1016/j.virol.2012.09.024; Silverman JL, 2013, J VIROL, V87, P10139, DOI 10.1128/JVI.01760-13; Silverman JL, 2012, J VIROL, V86, P8171, DOI 10.1128/JVI.00932-12; Strive T, 2002, J VIROL, V76, P1252, DOI 10.1128/JVI.76.3.1252-1264.2002; Treanor JJ, 2011, VACCINE, V29, P7733, DOI 10.1016/j.vaccine.2011.07.128; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102	37	9	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90753	10.1371/journal.pone.0090753	http://dx.doi.org/10.1371/journal.pone.0090753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595278	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500096
J	Peng, YL; Gao, XF; Li, RY; Cao, GX				Peng, Yulan; Gao, Xinfen; Li, Renyuan; Cao, Guoxing			Transcriptome Sequencing and De Novo Analysis of Youngia japonica Using the Illumina Platform	PLOS ONE			English	Article							SSR MARKERS; TOOL; ANNOTATION; DIVERGENCE; ASTERACEAE; DISCOVERY; GENOMICS; PLANTS; WHEAT; GENE	Youngia japonica, a weed species distributed worldwide, has been widely used in traditional Chinese medicine. It is an ideal plant for studying the evolution of Asteraceae plants because of its short life history and abundant source. However, little is known about its evolution and genetic diversity. In this study, de novo transcriptome sequencing was conducted for the first time for the comprehensive analysis of the genetic diversity of Y. japonica. The Y. japonica transcriptome was sequenced using Illumina paired-end sequencing technology. We produced 21,847,909 high-quality reads for Y. japonica and assembled them into contigs. A total of 51,850 unigenes were identified, among which 46,087 were annotated in the NCBI non-redundant protein database and 41,752 were annotated in the Swiss-Prot database. We mapped 9,125 unigenes onto 163 pathways using the Kyoto Encyclopedia of Genes and Genomes Pathway database. In addition, 3,648 simple sequence repeats (SSRs) were detected. Our data provide the most comprehensive transcriptome resource currently available for Y. japonica. C-4 photosynthesis unigenes were found in the biological process of Y. japonica. There were 5596 unigenes related to defense response and 1344 ungienes related to signal transduction mechanisms (10.95%). These data provide insights into the genetic diversity of Y. japonica. Numerous SSRs contributed to the development of novel markers. These data may serve as a new valuable resource for genomic studies on Youngia and, more generally, Cichoraceae.	[Peng, Yulan; Gao, Xinfen] Chinese Acad Sci, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Peng, Yulan; Gao, Xinfen] Chinese Acad Sci, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Li, Renyuan; Cao, Guoxing] Sichuan Agr Univ, Forest Coll, Yaan, Sichuan, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Sichuan Agricultural University	Peng, YL (corresponding author), Chinese Acad Sci, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China.	pengyl@cib.ac.cn; xfgao@cib.ac.cn	peng, yu/GXW-2071-2022	gao, xin fen/0000-0002-5703-1639	National Natural Science Foundation for Young Scholars [31000096]; Knowledge Innovation Project of Chinese Academy of Sciences [Y1B2041100]; 12th Five-year Plan Project of the National Science and Technology of China [2011BAC09B04-04-02]; Sichuan Province Science and technology Project [2013NZ0037]	National Natural Science Foundation for Young Scholars; Knowledge Innovation Project of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); 12th Five-year Plan Project of the National Science and Technology of China; Sichuan Province Science and technology Project	This study was supported by the National Natural Science Foundation for Young Scholars (Grant No. 31000096), the Knowledge Innovation Project of Chinese Academy of Sciences (Grant No. Y1B2041100), the 12th Five-year Plan Project of the National Science and Technology of China (Grant No. 2011BAC09B04-04-02) and Sichuan Province Science and technology Project (No. 2013NZ0037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABC0CK E. B., 1937, CARNEGIE INST WASHINGTON PUBL, V484, P1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; De Cremer K, 2013, PLANT CELL ENVIRON, V36, P1992, DOI 10.1111/pce.12106; Dlugosch KM, 2013, G3-GENES GENOM GENET, V3, P359, DOI 10.1534/g3.112.003871; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guggisberg A, 2013, NEW PHYTOL, V199, P595, DOI 10.1111/nph.12258; Hong, 2011, FLORA CHINA, V20-21, P195; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Nakamura K, 2012, MOL PHYLOGENET EVOL, V63, P486, DOI 10.1016/j.ympev.2012.01.023; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ooi LSM, 2004, J ETHNOPHARMACOL, V94, P117, DOI 10.1016/j.jep.2004.05.004; Peng C.I, 1998, DIGITAL FLORA TAIWAN, V4; Raven P.H., 1992, BIOL PLANTS; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Scaglione D, 2012, PLANT BIOTECHNOL J, V10, P956, DOI 10.1111/j.1467-7652.2012.00725.x; TAIZ L, 1991, PLANT PHYSL; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Varshney RK, 2005, PLANT SCI, V168, P195, DOI 10.1016/j.plantsci.2004.08.001; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Xie QL, 2004, THESIS SW JIAOTONG U; Yae E, 2009, CHEM PHARM BULL, V57, P719, DOI 10.1248/cpb.57.719; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu JK, 2004, MOL GENET GENOMICS, V271, P742, DOI 10.1007/s00438-004-1027-3	34	24	24	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90636	10.1371/journal.pone.0090636	http://dx.doi.org/10.1371/journal.pone.0090636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595283	gold, Green Published, Green Submitted			2022-12-25	WOS:000332475500079
J	Taina, M; Sipola, P; Muuronen, A; Hedman, M; Mustonen, P; Kantanen, AM; Jakala, P; Vanninen, R				Taina, Mikko; Sipola, Petri; Muuronen, Antti; Hedman, Marja; Mustonen, Pirjo; Kantanen, Anne-Mari; Jakala, Pekka; Vanninen, Ritva			Determinants of Left Atrial Appendage Volume in Stroke Patients without Chronic Atrial Fibrillation	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; ACUTE ISCHEMIC-STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; PERICARDIAL FAT; SINUS RHYTHM; CARDIOVASCULAR-DISEASE; CRYPTOGENIC STROKE; VENTRICULAR VOLUME; THROMBUS FORMATION; RISK	Background: Left atrial appendage (LAA) volume has been shown to be increased in patients with acute cryptogenic stroke. Atrial fibrillation (AF) is a well-recognized risk factor but it is not the only one associated with LAA enlargement. The aim of the study was to clarify the multifactorial etiology of LAA enlargement in cardiogenic stroke/TIA patients without AF. Methods: Altogether 149 patients with suspected cardioembolic stroke/TIA (47 females; mean age 61 years) underwent cardiac CT. Diagnosed AF on admittance was an exclusion criteria but 24-hour Holter ambulatory ECG revealed paroxysmal AF (PAF) in 20 patients. Body surface area adjusted LAA volume was evaluated. Eighteen different variables were registered including general characteristics, definite and potential causal risk factors for ischemic stroke/TIA, clinical echoparameters and CT based cardiac volumetric and adipose tissue measurements. A stepwise linear regression analysis was performed to achieve a model adjusted for the number of predictors of LAA volume increase. Results: In linear regression analysis, the best model accounted for 30% of the variability in LAA volume, including PAF (19%) and enlarged left atrial volume (6%), enlarged left ventricle end-systolic diameter (3%) and decreased pericardial adipose tissue (2%). No multi-colinearity between variables was observed. In addition to PAF, no other definitive or potential causal risk factors could account for the LAA volume in these patients. Conclusions: LAA volume increase seems to be poorly associated with currently known stroke/TIA risk factors, except for AF. Targeting more comprehensive ECG monitoring for stroke patients with increased LAA volume should be considered.	[Taina, Mikko; Sipola, Petri; Muuronen, Antti; Vanninen, Ritva] Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland; [Taina, Mikko; Kantanen, Anne-Mari; Jakala, Pekka] Univ Eastern Finland, Neurol Unit, Inst Clin Med, Kuopio, Finland; [Taina, Mikko; Sipola, Petri; Muuronen, Antti; Hedman, Marja; Vanninen, Ritva] Univ Eastern Finland, Radiol Unit, Inst Clin Med, Kuopio, Finland; [Hedman, Marja] Kuopio Univ Hosp, Ctr Heart, SF-70210 Kuopio, Finland; [Mustonen, Pirjo] Keski Suomi Cent Hosp, Dept Cardiol, Jyvaskyla, Finland; [Kantanen, Anne-Mari; Jakala, Pekka] Kuopio Univ Hosp, NeuroCtr, SF-70210 Kuopio, Finland	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Central Finland Central Hospital; Kuopio University Hospital; University of Eastern Finland	Taina, M (corresponding author), Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland.	Mikko.Taina@kuh.fi			Kuopio University Hospital [5063519]	Kuopio University Hospital	This study was supported by the Kuopio University Hospital (grant number 5063519 - URL: http://www.psshp.fi/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Agmon Y, 2002, CIRCULATION, V105, P27, DOI 10.1161/hc0102.101776; Anselmino M, 2011, J CARDIOVASC ELECTR, V22, P1, DOI 10.1111/j.1540-8167.2010.01853.x; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bakalli A, 2013, J CLIN ULTRASOUND, V41, P38, DOI 10.1002/jcu.21953; Beinart R, 2011, J CARDIOVASC ELECTR, V22, P10, DOI 10.1111/j.1540-8167.2010.01854.x; BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; Bonita R, 1999, TOB CONTROL, V8, P156, DOI 10.1136/tc.8.2.156; COULSHED N, 1970, BRIT HEART J, V32, P26; Di Tullio MR, 1999, STROKE, V30, P2019, DOI 10.1161/01.STR.30.10.2019; DiTomasso D, 2010, ATHEROSCLEROSIS, V208, P531, DOI 10.1016/j.atherosclerosis.2009.08.015; Fox CS, 2009, CIRCULATION, V119, P1586, DOI 10.1161/CIRCULATIONAHA.108.828970; FROHLICH ED, 1992, NEW ENGL J MED, V327, P998, DOI 10.1056/NEJM199210013271406; GRAHAM TP, 1973, CIRCULATION, V47, P144, DOI 10.1161/01.CIR.47.1.144; Greif M, 2013, CLIN RES CARDIOL, V102, P555, DOI 10.1007/s00392-013-0566-1; Halliday A, 2004, LANCET, V363, P1491; Handke M, 2005, AM J CARDIOL, V96, P1342, DOI 10.1016/j.amjcard.2005.06.085; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Heist EK, 2006, HEART RHYTHM, V3, P1313, DOI 10.1016/j.hrthm.2006.07.022; Ito T, 1998, AM J CARDIOL, V81, P1056, DOI 10.1016/S0002-9149(98)00011-3; Jickling GC, 2012, STROKE, V43, P2036, DOI 10.1161/STROKEAHA.111.648725; Kizer JR, 2005, STROKE, V36, P2533, DOI 10.1161/01.STR.0000190005.09442.ad; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Langman J., 2003, LANGMANS MED EMBRYOL, P223; Lawes CMM, 2004, DIABETES CARE, V27, P2836; Lawes CMM, 2004, STROKE, V35, P776, DOI 10.1161/01.STR.0000116869.64771.5A; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Loh E, 1997, NEW ENGL J MED, V336, P251, DOI 10.1056/NEJM199701233360403; Mahilmaran Asha, 2004, Indian Heart J, V56, P293; MILLER JT, 1988, AM HEART J, V116, P1048, DOI 10.1016/0002-8703(88)90158-5; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Nucifora G, 2011, CIRC-CARDIOVASC IMAG, V4, P514, DOI 10.1161/CIRCIMAGING.111.963892; Okuyama H, 2006, CIRC J, V70, P971, DOI 10.1253/circj.70.971; Ozer N, 2005, J AM SOC ECHOCARDIOG, V18, P1362, DOI 10.1016/j.echo.2005.03.023; POLLICK C, 1991, CIRCULATION, V84, P223, DOI 10.1161/01.CIR.84.1.223; Rodriguez-Yanez M, 2013, NEUROLOGY, V81, P444, DOI 10.1212/WNL.0b013e31829d8773; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Sipola P, 2013, CEREBROVASC DIS, V35, P521, DOI 10.1159/000350734; Taina M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079519; Thanassoulis G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P345, DOI 10.1161/CIRCEP.109.912055; Therkelsen SK, 2005, J CARDIOVASC MAGN R, V7, P465, DOI 10.1081/JCMR-200053618; Walker DT, 2012, J INTERV CARD ELECTR, V34, P173, DOI 10.1007/s10840-011-9638-1; Wong CX, 2011, J AM COLL CARDIOL, V57, P1745, DOI 10.1016/j.jacc.2010.11.045	44	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90903	10.1371/journal.pone.0090903	http://dx.doi.org/10.1371/journal.pone.0090903			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595515	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500111
J	Cucak, H; Mayer, C; Tonnesen, M; Thomsen, LH; Grunnet, LG; Rosendahl, A				Cucak, Helena; Mayer, Christopher; Tonnesen, Morten; Thomsen, Lise Hoj; Grunnet, Lars Groth; Rosendahl, Alexander			Macrophage Contact Dependent and Independent TLR4 Mechanisms Induce beta-Cell Dysfunction and Apoptosis in a Mouse Model of Type 2 Diabetes	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; TOLL-LIKE RECEPTORS; FATTY-ACID; INNATE IMMUNITY; ADIPOSE-TISSUE; OBESITY; INFLAMMATION; EXPRESSION; DB/DB; TOLL-LIKE-RECEPTOR-4	Type 2 diabetes (T2D) is evolving into a global disease and patients have a systemic low-grade inflammation, yet the role of this inflammation is still not established. One plausible mechanism is enhanced expression and activity of the innate immune system. Therefore, we evaluated the expression and the function of the toll-like receptor 4 (TLR4) on pancreatic beta-cells in primary mouse islets and on the murine beta-cell line MIN6 in the presence or absence of macrophages. Diabetic islets have 40% fewer TLR4 positive beta-cells, but twice the number of TLR4 positive macrophages as compared to healthy islets. Healthy and diabetic islets respond to a TLR4 challenge with enhanced production of cytokines (5-10-fold), while the TLR4 negative beta-cell line MIN6 fails to produce cytokines. TLR4 stimulation induces beta-cell dysfunction in mouse islets, measured as reduced glucose stimulated insulin secretion. Diabetic macrophages from 4-months old mice have acquired a transient enhanced capacity to produce cytokines when stimulated with LPS. Interestingly, this is lost in 6-months old diabetic mice. TLR4 activation alone does not induce apoptosis in islets or MIN-6 cells. In contrast, macrophages mediate TLR4-dependent cell-contact dependent (3-fold) as well as cell-contact independent (2-fold) apoptosis of both islets and MIN-6 cells. Importantly, diabetic macrophages have a significantly enhanced capacity to induce beta-cell apoptosis compared to healthy macrophages. Taken together, the TLR4 responsiveness is elevated in the diabetic islets and mainly mediated by newly recruited macrophages. The TLR4 positive macrophages, in both a cell-contact dependent and independent manner, induce apoptosis of beta-cells in a TLR4 dependent fashion and TLR4 activation directly induces beta-cell dysfunction. Thus, targeting either the TLR4 pathway or the macrophages provides a novel attractive treatment regime for T2D.	[Cucak, Helena; Mayer, Christopher; Tonnesen, Morten; Thomsen, Lise Hoj; Rosendahl, Alexander] Hagedorn Res Inst, Dept Diabet Complicat Biol, Malov, Denmark; [Grunnet, Lars Groth] Dept Incretin & Islet Biol, Malov, Denmark	Novo Nordisk; Hagedorn Research Institute	Rosendahl, A (corresponding author), Hagedorn Res Inst, Dept Diabet Complicat Biol, Malov, Denmark.	AXRD@novonordisk.com			NovoNordisk foundation	NovoNordisk foundation(Novo Nordisk Foundation)	The study was funded through a post-doc grant from the NovoNordisk foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo J, 2012, DIABETES, V61, P2851, DOI 10.2337/db12-0134; Amyot J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036200; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bell E, 2009, NAT REV IMMUNOL, V9, P532, DOI 10.1038/nri2608; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Boyle JJ, 2001, ARTERIOSCL THROM VAS, V21, P1402, DOI 10.1161/hq0901.094279; CHAN TM, 1981, DIABETES, V30, P211, DOI 10.2337/diab.30.3.211; Chanchamroen S, 2009, INFECT IMMUN, V77, P456, DOI 10.1128/IAI.00503-08; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Chou DHC, 2010, ACS CHEM BIOL, V5, P729, DOI 10.1021/cb100129d; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; COLEMAN DL, 1982, DIABETES, V31, P1; Collier JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022485; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Cucak H, 2013, J LEUKOC BIOL; Donath MY, 2010, TRENDS ENDOCRIN MET, V21, P261, DOI 10.1016/j.tem.2009.12.010; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Flavin MP, 1997, NEUROSCIENCE, V80, P437, DOI 10.1016/S0306-4522(97)00078-X; Garay-Malpartida HM, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-18; Goldberg A, 2007, FASEB J, V21, P2840, DOI 10.1096/fj.06-7910com; HERBERG L, 1977, METABOLISM, V26, P59, DOI 10.1016/0026-0495(77)90128-7; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ikejima S, 2005, DIABETES, V54, P182, DOI 10.2337/diabetes.54.1.182; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; Ladefoged M, 2012, APMIS; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; MANDRUPPOULSEN T, 1985, ALLERGY, V40, P424, DOI 10.1111/j.1398-9995.1985.tb02681.x; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Orr JS, 2012, DIABETES, V61, P2718, DOI 10.2337/db11-1595; Park S, 2009, INFECT IMMUN, V77, P1008, DOI 10.1128/IAI.00976-08; Radin MS, 2008, DIABETOLOGIA, V51, P336, DOI 10.1007/s00125-007-0861-3; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Vives-Pi M, 2003, CLIN EXP IMMUNOL, V133, P208, DOI 10.1046/j.1365-2249.2003.02211.x; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yang YH, 2012, CANCER RES, V72, P5219, DOI 10.1158/0008-5472.CAN-12-1463; Zhou YP, 1996, DIABETES, V45, P580, DOI 10.2337/diabetes.45.5.580; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zykova SN, 2000, DIABETES, V49, P1451, DOI 10.2337/diabetes.49.9.1451	49	26	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90685	10.1371/journal.pone.0090685	http://dx.doi.org/10.1371/journal.pone.0090685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594974	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900133
J	Fujita, K; Okai, T; Hosono, T				Fujita, Kazuhiko; Okai, Takaaki; Hosono, Takashi			Oxygen Metabolic Responses of Three Species of Large Benthic Foraminifers with Algal Symbionts to Temperature Stress	PLOS ONE			English	Article							CLIMATE-CHANGE; MARGINOPORA-VERTEBRALIS; OCEAN ACIDIFICATION; CORAL-REEFS; BEARING FORAMINIFERA; NORTHWEST PACIFIC; PHOTOSYSTEM-II; ZOOXANTHELLAE; FUTURE; PHOTOSYNTHESIS	Water temperature affects the physiology of large benthic foraminifers (LBFs) with algal symbionts dwelling in coral reef environments. However, the detailed physiological responses of LBF holobionts to temperature ranges occurring in their habitats are not known. We report net oxygen (O-2) production and respiration rates of three LBF holobionts (Baculogypsina sphaerulata and Calcarina gaudichaudii hosting diatom symbionts, and Amphisorus kudakajimensis hosting dinoflagellate symbionts) measured in the laboratory at water temperatures ranging from 5 degrees C to 45 degrees C in 2.5 degrees C or 5 degrees C intervals and with light saturation levels of similar to 500 mu mol m(-2) s(-1). In addition, the recovery of net O-2 production and respiration rates after exposure to temperature stress was assessed. The net O-2 production and respiration rates of the three LBF holobionts peaked at similar to 30 degrees C, indicating their optimal temperature for a short exposure period. At extreme high temperatures (>= 40 degrees C), the net O-2 production rates of all three LBF holobionts declined to less than zero and the respiration rates slightly decreased, indicating that photosynthesis of algal symbionts was inactivated. At extreme low temperatures (<= 10 degrees C for two calcarinid species and <= 5 degrees C for A. kudakajimensis), the net O-2 production and respiration rates were near zero, indicating a weakening of holobiont activity. After exposure to extreme high or low temperature, the net O-2 production rates did not recover until the following day, whereas the respiration rates recovered rapidly, suggesting that a longer time (days) is required for recovery from damage to the photosystem by temperature stress compared to the respiration system. These results indicate that the oxygen metabolism of LBF holobionts can generally cope well with conditions that fluctuate diurnally and seasonally in their habitats. However, temporal heat and cold stresses with high light levels may induce severe damage to algal symbionts and also damage to host foraminifers.	[Fujita, Kazuhiko; Okai, Takaaki] Univ Ryukyus, Dept Phys & Earth Sci, Nishihara, Okinawa 90301, Japan; [Hosono, Takashi] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Tokyo 113, Japan	University of the Ryukyus; University of Tokyo	Fujita, K (corresponding author), Univ Ryukyus, Dept Phys & Earth Sci, Nishihara, Okinawa 90301, Japan.	fujitaka@sci.u-ryukyu.ac.jp		Kazuhiko, Fujita/0000-0002-9833-007X	JSPS KAKENHI [17740341]; JST/JICA SATREPS [0808918]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST/JICA SATREPS(Japan Science & Technology Agency (JST))	This work was supported by JSPS KAKENHI (17740341) and JST/JICA SATREPS (0808918, PI: H. Kayanne). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Doo SS, 2012, J EXP MAR BIOL ECOL, V430, P63, DOI 10.1016/j.jembe.2012.06.025; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Fujita K, 2004, J FORAMIN RES, V34, P169, DOI 10.2113/34.3.169; Fujita K, 2000, MAR MICROPALEONTOL, V38, P267, DOI 10.1016/S0377-8398(99)00042-0; Fujita K, 2008, J FORAMIN RES, V38, P117, DOI 10.2113/gsjfr.38.2.117; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; HALLOCK P, 1995, J FORAMIN RES, V25, P280, DOI 10.2113/gsjfr.25.3.280; Hill R, 2004, PHOTOSYNTH RES, V82, P59, DOI 10.1023/B:PRES.0000040444.41179.09; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hohenegger J, 2004, J FORAMIN RES, V34, P9, DOI 10.2113/0340009; Hohenegger J., 2011, LARGE FORAMINIFERA G; Hohenegger J, 2006, MAR MICROPALEONTOL, V61, P4, DOI 10.1016/j.marmicro.2006.05.007; Hohenegger Johann, 1994, Marine Ecology, V15, P291, DOI 10.1111/j.1439-0485.1994.tb00059.x; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kirk J.T.O., 2011, LIGHT PHOTOSYNTHESIS; Kohler-Rink S, 2001, OPHELIA, V55, P111; Langer MR, 2000, MICROPALEONTOLOGY, V46, P105; Lee JJ, 2006, SYMBIOSIS, V42, P63; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Momigliano P, 2013, MAR ECOL PROG SER, V491, P33, DOI 10.3354/meps10465; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raja R, 2005, MAR MICROPALEONTOL, V58, P31, DOI 10.1016/j.marmicro.2005.08.001; Reymond CE, 2011, MAR ECOL PROG SER, V435, P97, DOI 10.3354/meps09172; Sakai K., 1981, P 4 INT COR REEF S M, V2, P763; Saraswati PK, 2004, MAR MICROPALEONTOL, V50, P339, DOI 10.1016/S0377-8398(03)00099-9; Saxby T, 2003, MAR ECOL PROG SER, V248, P85, DOI 10.3354/meps248085; Schmidt C, 2011, LIMNOL OCEANOGR, V56, P1587, DOI 10.4319/lo.2011.56.5.1587; Sheppard CRC, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198566359.001.0001; Sinutok S, 2013, MAR ECOL PROG SER, V478, P127, DOI 10.3354/meps10187; Sinutok S, 2011, LIMNOL OCEANOGR, V56, P1200, DOI 10.4319/lo.2011.56.4.1200; Smith DJ, 2005, GLOBAL CHANGE BIOL, V11, P1, DOI 10.1111/j.1529-8817.2003.00895.x; Talge HK, 2003, J EUKARYOT MICROBIOL, V50, P324, DOI 10.1111/j.1550-7408.2003.tb00143.x; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Uthicke S, 2012, CORAL REEFS, V31, P401, DOI 10.1007/s00338-011-0851-2; Uthicke S, 2012, GLOBAL CHANGE BIOL, V18, P2781, DOI 10.1111/j.1365-2486.2012.02715.x; van Dam JW, 2012, MAR POLLUT BULL, V65, P373, DOI 10.1016/j.marpolbul.2011.08.008; van Dam JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033900; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Weinmann AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062182; Williams DE, 2004, MAR BIOL, V145, P641, DOI 10.1007/s00227-004-1351-5; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Ziegler M, 2011, J EXP MAR BIOL ECOL, V407, P70, DOI 10.1016/j.jembe.2011.07.009; ZMIRI A, 1974, J PROTOZOOL, V21, P133, DOI 10.1111/j.1550-7408.1974.tb03626.x	47	26	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90304	10.1371/journal.pone.0090304	http://dx.doi.org/10.1371/journal.pone.0090304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594773	gold, Green Published, Green Submitted			2022-12-25	WOS:000332468900092
J	Hou, PP; Zhang, R; Liu, YF; Feng, J; Wang, W; Wu, YL; Ding, JP				Hou, Panpan; Zhang, Rong; Liu, Yongfeng; Feng, Jing; Wang, Wei; Wu, Yingliang; Ding, Jiuping			Physiological Role of Kv1.3 Channel in T Lymphocyte Cell Investigated Quantitatively by Kinetic Modeling	PLOS ONE			English	Article							ADRENAL CHROMAFFIN CELLS; GATED POTASSIUM CHANNEL; C-TYPE INACTIVATION; K+ CHANNEL; AUTOIMMUNE-DISEASES; CALCIUM INFLUX; RHEUMATOID-ARTHRITIS; JURKAT LYMPHOBLASTS; THERAPEUTIC TARGET; VOLUME REGULATION	Kv1.3 channel is a delayed rectifier channel abundant in human T lymphocytes. Chronic inflammatory and autoimmune disorders lead to the over-expression of Kv1.3 in T cells. To quantitatively study the regulatory mechanism and physiological function of Kv1.3 in T cells, it is necessary to have a precise kinetic model of Kv1.3. In this study, we firstly established a kinetic model capable to precisely replicate all the kinetic features for Kv1.3 channels, and then constructed a T-cell model composed of ion channels including Ca2+-release activated calcium (CRAC) channel, intermediate K+ (IK) channel, TASK channel and Kv1.3 channel for quantitatively simulating the changes in membrane potentials and local Ca2+ signaling messengers during activation of T cells. Based on the experimental data from current-clamp recordings, we successfully demonstrated that Kv1.3 dominated the membrane potential of T cells to manipulate the Ca2+ influx via CRAC channel. Our results revealed that the deficient expression of Kv1.3 channel would cause the less Ca2+ signal, leading to the less efficiency in secretion. This was the first successful attempt to simulate membrane potential in non-excitable cells, which laid a solid basis for quantitatively studying the regulatory mechanism and physiological role of channels in non-excitable cells.	[Hou, Panpan; Zhang, Rong; Liu, Yongfeng; Wang, Wei; Ding, Jiuping] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Hubei, Peoples R China; [Feng, Jing; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Liu, Yongfeng] Xinxiang Med Univ, Sch Publ Hlth, Xinxiang, Henan, Peoples R China	Huazhong University of Science & Technology; Wuhan University; Xinxiang Medical University	Wu, YL (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	ylwu@whu.edu.cn; jpding@mail.hust.edu.cn	Hou, Panpan/Q-2941-2019; Feng, Jing/C-1729-2018; Liu, Yongfeng/ABG-1361-2020	Feng, Jing/0000-0001-6726-7912; Liu, Yongfeng/0000-0002-8649-7892; Hou, Panpan/0000-0001-7694-2262	National Basic Research Program of China [2010CB529800]; National Science Foundation of China [30971179, 31170814]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (2010CB529800), the National Science Foundation of China (30971179, 31170814). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Anangi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052965; Bajnok A, 2013, CYTOM PART A, V83A, P287, DOI 10.1002/cyto.a.22256; BEELER GW, 1977, J PHYSIOL-LONDON, V268, P177, DOI 10.1113/jphysiol.1977.sp011853; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Cabado AG, 1999, LIFE SCI, V64, P681, DOI 10.1016/S0024-3205(98)00610-9; Cahalan M D, 1988, Soc Gen Physiol Ser, V43, P281; CAHALAN MD, 1985, J PHYSIOL-LONDON, V358, P197, DOI 10.1113/jphysiol.1985.sp015548; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; CAI YC, 1992, DNA CELL BIOL, V11, P163, DOI 10.1089/dna.1992.11.163; CHANDY KG, 1990, EUR J IMMUNOL, V20, P747; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; DEUTSCH C, 1993, P NATL ACAD SCI USA, V90, P10036, DOI 10.1073/pnas.90.21.10036; DEUTSCH C, 1988, RENAL PHYSIOL BIOCH, V11, P260; EKEBERG O, 1991, BIOL CYBERN, V65, P81, DOI 10.1007/BF00202382; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Gocke AR, 2012, J IMMUNOL, V188, P5877, DOI 10.4049/jimmunol.1103095; GRISSMER S, 1993, J GEN PHYSIOL, V102, P601, DOI 10.1085/jgp.102.4.601; GRISSMER S, 1990, P NATL ACAD SCI USA, V87, P9411, DOI 10.1073/pnas.87.23.9411; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Levy DI, 1996, BIOPHYS J, V70, P798, DOI 10.1016/S0006-3495(96)79619-4; LEWIS RS, 1993, J GEN PHYSIOL, V101, P801, DOI 10.1085/jgp.101.6.801; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; MALTSEV VA, 1992, CELL SIGNAL, V4, P697, DOI 10.1016/0898-6568(92)90050-I; MALTSEV VA, 1990, IMMUNOL LETT, V26, P277, DOI 10.1016/0165-2478(90)90159-N; Marek N, 2010, HUM IMMUNOL, V71, P666, DOI 10.1016/j.humimm.2010.05.002; MAROM S, 1994, BIOPHYS J, V67, P579, DOI 10.1016/S0006-3495(94)80517-X; Meuth SG, 2008, J BIOL CHEM, V283, P14559, DOI 10.1074/jbc.M800637200; Naraghi M, 1997, J NEUROSCI, V17, P6961; Nicolaou SA, 2007, J IMMUNOL, V179, P346, DOI 10.4049/jimmunol.179.1.346; Numata T, 2007, AM J PHYSIOL-CELL PH, V292, pC460, DOI 10.1152/ajpcell.00367.2006; PAHAPILL PA, 1992, J PHYSIOL-LONDON, V445, P407, DOI 10.1113/jphysiol.1992.sp018931; Panyi G, 2006, CURR PHARM DESIGN, V12, P2199, DOI 10.2174/138161206777585120; PANYI G, 1995, BIOPHYS J, V69, P896, DOI 10.1016/S0006-3495(95)79963-5; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; RANDRIAMAMPITA C, 1991, CELL CALCIUM, V12, P313, DOI 10.1016/0143-4160(91)90005-Y; Rashid MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078712; ROSS PE, 1995, J GEN PHYSIOL, V106, P415, DOI 10.1085/jgp.106.3.415; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; SARKADI B, 1990, BIOCHIM BIOPHYS ACTA, V1027, P130, DOI 10.1016/0005-2736(90)90076-Z; SARKADI B, 1990, MOL IMMUNOL, V27, P1297, DOI 10.1016/0161-5890(90)90034-W; Sun L, 2009, BIOPHYS J, V97, P1832, DOI 10.1016/j.bpj.2009.06.042; Toldi G, 2013, IMMUNOBIOLOGY, V218, P311, DOI 10.1016/j.imbio.2012.05.013; Varga Z, 2010, IMMUNOL LETT, V130, P19, DOI 10.1016/j.imlet.2009.12.015; VERHEUGEN JAH, 1995, J GEN PHYSIOL, V105, P765, DOI 10.1085/jgp.105.6.765; VERHEUGEN JAH, 1995, CELL CALCIUM, V17, P287, DOI 10.1016/0143-4160(95)90075-6; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035208; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7	55	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89975	10.1371/journal.pone.0089975	http://dx.doi.org/10.1371/journal.pone.0089975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594979	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900051
J	Ihssen, J; Schubert, M; Thony-Meyer, L; Richter, M				Ihssen, Julian; Schubert, Mark; Thoeny-Meyer, Linda; Richter, Michael			Laccase Catalyzed Synthesis of Iodinated Phenolic Compounds with Antifungal Activity	PLOS ONE			English	Article							TRAMETES-VERSICOLOR; IODIDE OXIDATION; WOOD DECAY; MULTICOPPER OXIDASE; MASS-SPECTROMETRY; GREEN CHEMISTRY; POSTIA-PLACENTA; FUNGAL LACCASE; LIGNIN; BIOCATALYSTS	Iodine is a well known antimicrobial compound. Laccase, an oxidoreductase which couples the one electron oxidation of diverse phenolic and non-phenolic substrates to the reduction of oxygen to water, is capable of oxidizing unreactive iodide to reactive iodine. We have shown previously that laccase-iodide treatment of spruce wood results in a wash-out resistant antimicrobial surface. In this study, we investigated whether phenolic compounds such as vanillin, which resembles substructures of softwood lignin, can be directly iodinated by reacting with laccase and iodide, resulting in compounds with antifungal activity. HPLC-MS analysis showed that vanillin was converted to iodovanillin by laccase catalysis at an excess of potassium iodide. No conversion of vanillin occurred in the absence of enzyme. The addition of redox mediators in catalytic concentrations increased the rate of iodide oxidation ten-fold and the yield of iodovanillin by 50%. Iodinated phenolic products were also detected when o-vanillin, ethyl vanillin, acetovanillone and methyl vanillate were incubated with laccase and iodide. At an increased educt concentration of 0.1 M an almost one to one molar ratio of iodide to vanillin could be used without compromising conversion rate, and the insoluble iodovanillin product could be recovered by simple centrifugation. The novel enzymatic synthesis procedure fulfills key criteria of green chemistry. Biocatalytically produced iodovanillin and iodo-ethyl vanillin had significant growth inhibitory effects on several wood degrading fungal species. For Trametes versicolor, a species causing white rot of wood, almost complete growth inhibition and a partial biocidal effect was observed on agar plates. Enzymatic tests indicated that the iodinated compounds acted as enzyme responsive, antimicrobial materials.	[Ihssen, Julian; Thoeny-Meyer, Linda; Richter, Michael] Swiss Fed Labs Mat Sci & Technol, Empa, Lab Biomat, St Gallen, Switzerland; [Schubert, Mark] Swiss Fed Labs Mat Sci & Technol, Empa, Lab Appl Wood Mat, St Gallen, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Ihssen, J (corresponding author), Swiss Fed Labs Mat Sci & Technol, Empa, Lab Biomat, St Gallen, Switzerland.	julian.ihssen@empa.ch		Schubert, Mark/0000-0002-6900-0370	Empa, Swiss Federal Laboratories for Materials Science and Technology	Empa, Swiss Federal Laboratories for Materials Science and Technology	This study was funded internally by Empa, Swiss Federal Laboratories for Materials Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimurthy S, 2003, TETRAHEDRON LETT, V44, P5099, DOI 10.1016/S0040-4039(03)01144-4; Al-Adham ISI, 1998, J IND MICROBIOL BIOT, V21, P6, DOI 10.1038/sj.jim.2900554; Anastas P, 2010, CHEM SOC REV, V39, P301, DOI 10.1039/b918763b; Baier G, 2013, BIOMACROMOLECULES, V14, P1103, DOI 10.1021/bm302003m; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Borrelli F, 2004, EUR J ORG CHEM, V2004, P3227, DOI 10.1002/ejoc.200400181; Camarero S, 2005, APPL ENVIRON MICROB, V71, P1775, DOI 10.1128/AEM.71.4.1775-1784.2005; Deng YH, 2011, BIOMACROMOLECULES, V12, P1116, DOI 10.1021/bm101449b; Fernandez-Sanchez C, 2002, BIOELECTROCHEMISTRY, V58, P149, DOI 10.1016/S1567-5394(02)00119-6; Gitchaiwat A, 2013, J APPL POLYM SCI, V128, P371, DOI 10.1002/app.37675; GRIBBLE GW, 1992, J NAT PROD, V55, P1353, DOI 10.1021/np50088a001; Grover N, 2012, ENZYME MICROB TECH, V50, P271, DOI 10.1016/j.enzmictec.2012.01.006; Hammel KE, 2002, ENZYME MICROB TECH, V30, P445, DOI 10.1016/S0141-0229(02)00011-X; Herpoel I, 2000, FEMS MICROBIOL LETT, V183, P301, DOI 10.1016/S0378-1097(99)00616-3; Hoegger PJ, 2006, FEBS J, V273, P2308, DOI 10.1111/j.1742-4658.2006.05247.x; Hofrichter M, 2006, APPL MICROBIOL BIOT, V71, P276, DOI 10.1007/s00253-006-0417-3; Iniesta J, 2008, ARCH BIOCHEM BIOPHYS, V474, P1, DOI 10.1016/j.abb.2008.02.032; Intra A, 2005, ADV SYNTH CATAL, V347, P973, DOI 10.1002/adsc.200505043; Kiiskinen LL, 2004, J APPL MICROBIOL, V97, P640, DOI 10.1111/j.1365-2672.2004.02348.x; Kulys J, 2005, BIOTECHNOL BIOENG, V92, P124, DOI 10.1002/bit.20610; Lahtinen M, 2013, ORG BIOMOL CHEM, V11, P5454, DOI 10.1039/c3ob40783g; Marjasvaara A, 2008, J MASS SPECTROM, V43, P470, DOI 10.1002/jms.1332; Martorana A, 2013, J MOL CATAL B-ENZYM, V97, P203, DOI 10.1016/j.molcatb.2013.08.013; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; Mizrahi B, 2007, J PHARM SCI-US, V96, P3144, DOI 10.1002/jps.20876; Nishimura RT, 2010, J CHEM EDUC, V87, P526, DOI 10.1021/ed8001607; PEPPER JM, 1953, CAN J CHEM, V31, P476, DOI 10.1139/v53-064; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Ratto M, 2004, HOLZFORSCHUNG, V58, P440, DOI 10.1515/HF.2004.067; Xavier AMRB, 2007, ELECTRON J BIOTECHN, V10, P444, DOI 10.2225/vol10-issue3-fulltext-1; Reiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065633; Rekuc A, 2010, BIORESOURCE TECHNOL, V101, P2076, DOI 10.1016/j.biortech.2009.11.077; Riva S, 2006, TRENDS BIOTECHNOL, V24, P219, DOI 10.1016/j.tibtech.2006.03.006; Russell A. D., 1996, UNDERSTANDING ANTIBA; Said SS, 2012, EUR J PHARM BIOPHARM, V80, P85, DOI 10.1016/j.ejpb.2011.08.007; Schubert M, 2012, J BIOTECHNOL, V161, P429, DOI 10.1016/j.jbiotec.2012.08.003; Schubert M, 2012, APPL ENVIRON MICROB, V78, P7267, DOI 10.1128/AEM.01856-12; Seki M, 2013, ENVIRON SCI TECHNOL, V47, P390, DOI 10.1021/es303228n; Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082; Shimamoto YS, 2011, ENVIRON SCI TECHNOL, V45, P2086, DOI 10.1021/es1032162; Stalpers J.A, 1978, IDENTIFICATION WOOD; Suzuki M, 2012, APPL ENVIRON MICROB, V78, P3941, DOI 10.1128/AEM.00084-12; Tao JH, 2009, CURR OPIN CHEM BIOL, V13, P43, DOI 10.1016/j.cbpa.2009.01.018; Voda K, 2003, INT BIODETER BIODEGR, V51, P51, DOI 10.1016/S0964-8305(02)00075-6; Wagner C, 2009, J NAT PROD, V72, P540, DOI 10.1021/np800651m; Wei DS, 2010, APPL ENVIRON MICROB, V76, P2091, DOI 10.1128/AEM.02929-09; Witayakran S, 2009, ADV SYNTH CATAL, V351, P1187, DOI 10.1002/adsc.200800775; Wohlgemuth R, 2010, CURR OPIN BIOTECH, V21, P713, DOI 10.1016/j.copbio.2010.09.016; Wymelenberg AV, 2010, APPL ENVIRON MICROB, V76, P3599, DOI 10.1128/AEM.00058-10; Xu F, 1996, APPL BIOCHEM BIOTECH, V59, P221, DOI 10.1007/BF02783566; Xu F, 1998, BIOCHEM J, V334, P63, DOI 10.1042/bj3340063; Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u; Zelzer M, 2013, BIOMATER SCI-UK, V1, P11, DOI 10.1039/c2bm00041e	53	39	41	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89924	10.1371/journal.pone.0089924	http://dx.doi.org/10.1371/journal.pone.0089924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594755	Green Published, gold			2022-12-25	WOS:000332468900047
J	Liang, J; Wang, Y; Li, HY; Liu, XK; Qiu, QQ; Qi, L				Liang, Jun; Wang, Yu; Li, Hongyan; Liu, Xuekui; Qiu, Qinqin; Qi, Lu			Combination of Diabetes Risk Factors and Hepatic Steatosis in Chinese: The Cardiometabolic Risk in Chinese (CRC) Study	PLOS ONE			English	Article							FATTY LIVER-DISEASE; METABOLIC SYNDROME; DIAGNOSTIC-ACCURACY; INSULIN-RESISTANCE; NATURAL-HISTORY; PREVALENCE; EPIDEMIOLOGY; MELLITUS; SCORE; ASSOCIATION	Aims: Hepatic steatosis has been related to insulin resistance and increased diabetes risk. We assessed whether combination of diabetes risk factors, evaluated by the Finnish Diabetes Risk Score, was associated with risk of hepatic steatosis in an apparently healthy Chinese population. Research Design and Methods: The study samples were from a community-based health examination survey in central China. In total 1,780 men and women (18-64 y) were included in the final analyses. Hepatic steatosis was diagnosed by ultrasonography. We created combination of diabetes risk factors score on basis of age, Body Mass Index, waist circumference, physical activity at least 4 h a week, daily consumption of fruits, berries or vegetables, history of antihypertensive drug treatment, history of high blood glucose. The total risk score is a simple sum of the individual weights, and values range from 0 to 20. Results: Hepatic steatosis was present 18% in the total population. In multivariate models, the odds ratios of hepatic steatosis were 1.20 (95% CI 1.15-1.25) in men and 1.25 (95% CI 1.14-1.37) in women by each unit increase in the combination of diabetes risk factors score, after adjustment for blood pressure, liver enzymes, plasma lipids, and fasting glucose. The area under the receiver operating characteristic curve for hepatic steatosis was 0.78 (95% CI 0.76-0.80), 0.76 in men (95% CI 0.74-0.78) and 0.83 (95% CI 0.79-0.87) in women. Conclusions: Our data suggest that combination of major diabetes risk factors was significantly related to risk of hepatic steatosis in Chinese adults.	[Liang, Jun; Liu, Xuekui] Southeast Univ, Xuzhou Inst Med Sci, Xuzhou Inst Diabet,Xuzhou Med Coll,Affiliated Hos, Dept Endocrinol,Xuzhou Cent Hosp,Xuzhou Clin Sch, Xuzhou, Jiangsu, Peoples R China; [Wang, Yu; Li, Hongyan; Qiu, Qinqin] Xuzhou Med Coll, Xuzhou, Jiangsu, Peoples R China; [Qi, Lu] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Qi, Lu] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Qi, Lu] Harvard Univ, Sch Med, Boston, MA USA	Southeast University - China; Xuzhou Medical University; Xuzhou Medical University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Liang, J (corresponding author), Southeast Univ, Xuzhou Inst Med Sci, Xuzhou Inst Diabet,Xuzhou Med Coll,Affiliated Hos, Dept Endocrinol,Xuzhou Cent Hosp,Xuzhou Clin Sch, Xuzhou, Jiangsu, Peoples R China.	mwlj521@163.com; nhlqi@channing.harvard.edu			National Institutes of Health (NIH) [DK091718, HL071981]; American Heart Association; Boston Obesity Nutrition Research Center [DK46200]; Jiangsu Health International Exchange Program; Xuzhou Medical Leading Talent Grant & Xuzhou Science and Technology Board Foundation Grant [XF11C067]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091718, P30DK046200] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Boston Obesity Nutrition Research Center; Jiangsu Health International Exchange Program; Xuzhou Medical Leading Talent Grant & Xuzhou Science and Technology Board Foundation Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Qi's research is supported by National Institutes of Health (NIH) grants DK091718, HL071981, the American Heart Association Scientist Development Award, and the Boston Obesity Nutrition Research Center (DK46200). Dr. Liang's research was sponsored by Jiangsu Health International Exchange Program and supported by Xuzhou Medical Leading Talent Grant & Xuzhou Science and Technology Board Foundation Grant (XF11C067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67; Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Angulo P, 2007, ALIMENT PHARM THER, V25, P883, DOI 10.1111/j.1365-2036.2007.03246.x; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; Bohte AE, 2011, EUR RADIOL, V21, P87, DOI 10.1007/s00330-010-1905-5; Bugianesi E, 2010, CURR PHARM DESIGN, V16, P1941, DOI 10.2174/138161210791208875; Carvalho JAM, 2011, ANN MED, V43, P487, DOI 10.3109/07853890.2011.554428; Falck-Ytter Y, 2001, SEMIN LIVER DIS, V21, P17, DOI 10.1055/s-2001-12926; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Kelley DE, 2003, AM J PHYSIOL-ENDOC M, V285, pE906, DOI 10.1152/ajpendo.00117.2003; Laaksonen DE, 2002, AM J EPIDEMIOL, V156, P1070, DOI 10.1093/aje/kwf145; Li ZZ, 2014, J GASTROEN HEPATOL, V29, P42, DOI 10.1111/jgh.12428; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lonardo A, 1997, ITAL J GASTROENTEROL, V29, P351; Lorenzo C, 2003, DIABETES CARE, V26, P3153, DOI 10.2337/diacare.26.11.3153; Preiss D, 2008, CLIN SCI, V115, P141, DOI 10.1042/CS20070402; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Schwarz PEH, 2009, J CLIN ENDOCR METAB, V94, P920, DOI 10.1210/jc.2007-2427; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Targher G, 2007, DIABETES CARE, V30, P2119, DOI 10.2337/dc07-0349; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Zelber-Sagi S, 2006, LIVER INT, V26, P856, DOI 10.1111/j.1478-3231.2006.01311.x	27	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90101	10.1371/journal.pone.0090101	http://dx.doi.org/10.1371/journal.pone.0090101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595017	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900068
J	Tarapore, P; Ying, J; Ouyang, B; Burke, B; Bracken, B; Ho, SM				Tarapore, Pheruza; Ying, Jun; Ouyang, Bin; Burke, Barbara; Bracken, Bruce; Ho, Shuk-Mei			Exposure to Bisphenol A Correlates with Early-Onset Prostate Cancer and Promotes Centrosome Amplification and Anchorage-Independent Growth In Vitro	PLOS ONE			English	Article							CHROMOSOME INSTABILITY; EXPRESSION; CARCINOGENESIS; MICROTUBULES; VARIABILITY; ESTROGENS; RESPONSES; TUBULIN; TARGETS; BINDING	Human exposure to bisphenol A (BPA) is ubiquitous. Animal studies found that BPA contributes to development of prostate cancer, but human data are scarce. Our study examined the association between urinary BPA levels and Prostate cancer and assessed the effects of BPA on induction of centrosome abnormalities as an underlying mechanism promoting prostate carcinogenesis. The study, involving 60 urology patients, found higher levels of urinary BPA (creatinine-adjusted) in Prostate cancer patients (5.74 mu g/g [95% CI; 2.63, 12.51]) than in non-Prostate cancer patients (1.43 mu g/g [95% CI; 0.70, 2.88]) (p = 0.012). The difference was even more significant in patients <65 years old. A trend toward a negative association between urinary BPA and serum PSA was observed in Prostate cancer patients but not in non-Prostate cancer patients. In vitro studies examined centrosomal abnormalities, microtubule nucleation, and anchorage-independent growth in four Prostate cancer cell lines (LNCaP, C4-2, 22Rv1, PC-3) and two immortalized normal prostate epithelial cell lines (NPrEC and RWPE-1). Exposure to low doses (0.01-100 nM) of BPA increased the percentage of cells with centrosome amplification two- to eight-fold. Dose responses either peaked or reached the plateaus with 0.1 nM BPA exposure. This low dose also promoted microtubule nucleation and regrowth at centrosomes in RWPE-1 and enhanced anchorage-independent growth in C4-2. These findings suggest that urinary BPA level is an independent prognostic marker in Prostate cancer and that BPA exposure may lower serum PSA levels in Prostate cancer patients. Moreover, disruption of the centrosome duplication cycle by low-dose BPA may contribute to neoplastic transformation of the prostate.	[Tarapore, Pheruza; Ying, Jun; Ouyang, Bin; Ho, Shuk-Mei] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Tarapore, Pheruza; Ying, Jun; Ouyang, Bin; Ho, Shuk-Mei] Univ Cincinnati, Coll Med, Ctr Environm Genet, Cincinnati, OH USA; [Tarapore, Pheruza; Ouyang, Bin; Ho, Shuk-Mei] Univ Cincinnati, Coll Med, Cincinnati Canc Ctr, Cincinnati, OH USA; [Burke, Barbara; Bracken, Bruce] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45267 USA; [Ho, Shuk-Mei] Cincinnati Veteran Affairs Hosp Med Ctr, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Ho, SM (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA.	shuk-mei.ho@uc.edu	Tarapore, Pheruza/A-8876-2013	Tarapore, Pheruza/0000-0003-0911-3661	National Institutes of Health [P30-ES006096, U01-ES019480, U01-ES020988]; Veterans Administration Merit Award [I01-BX000675]; University of Cincinnati; Congressionally Directed Medical Research Program Department of Defense Award [PC094619]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, U01ES020988, U01ES019480] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000675] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Merit Award; University of Cincinnati; Congressionally Directed Medical Research Program Department of Defense Award; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by grants from the National Institutes of Health (P30-ES006096, U01-ES019480, U01-ES020988), a Veterans Administration Merit Award (I01-BX000675), an internal funding source from the University of Cincinnati to SMH and PT, and a Congressionally Directed Medical Research Program Department of Defense Award (PC094619) to PT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, CANC FACTS FIG; [Anonymous], 2013, SEER CANC STAT REV; Avidor-Reiss T, 2013, CURR OPIN CELL BIOL, V25, P72, DOI 10.1016/j.ceb.2012.10.016; Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; Brownlee CW, 2013, CELL MOL LIFE SCI, V70, P1021, DOI 10.1007/s00018-012-1102-6; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Carroll PE, 1999, ONCOGENE, V18, P1935, DOI 10.1038/sj.onc.1202515; Carwile JL, 2011, ENVIRON RES, V111, P825, DOI 10.1016/j.envres.2011.05.014; Chan JY, 2011, INT J BIOL SCI, V7, P1122, DOI 10.7150/ijbs.7.1122; Cheung CHA, 2011, EXPERT OPIN THER PAT, V21, P857, DOI 10.1517/13543776.2011.574614; Darshan MS, 2011, CANCER RES, V71, P6019, DOI 10.1158/0008-5472.CAN-11-1417; Davis JN, 2000, INT J ONCOL, V16, P1091; De Coster S, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/713696; De Flora S, 2011, TOXICOL SCI, V122, P45, DOI 10.1093/toxsci/kfr096; Dekant W, 2008, TOXICOL APPL PHARM, V228, P114, DOI 10.1016/j.taap.2007.12.008; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Derouiche S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-54; Donohue KM, 2013, J ALLERGY CLIN IMMUN, V131, P736, DOI 10.1016/j.jaci.2012.12.1573; Duan B, 2013, INT J CLIN ONCOL, V18, P492, DOI 10.1007/s10147-012-0408-6; Ehrlich S, 2012, HUM REPROD, V27, P3583, DOI 10.1093/humrep/des328; Erickson BE, 2008, CHEM ENG NEWS, V86, P36, DOI 10.1021/cen-v086n022.p036; Fiege H., 2002, ULLMANNS ENCY IND CH; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Geens T, 2012, FOOD CHEM TOXICOL, V50, P3725, DOI 10.1016/j.fct.2012.07.059; George O, 2008, ACS CHEM BIOL, V3, P167, DOI 10.1021/cb700210u; Gorlov IP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-599; Guay A T, 2000, Endocr Pract, V6, P132; Heidenreich A, 2014, EUR UROL, V65, P467, DOI 10.1016/j.eururo.2013.11.002; Hess-Wilson JK, 2007, ENVIRON HEALTH PERSP, V115, P1646, DOI 10.1289/ehp.10283; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Jenkins S, 2011, ENVIRON HEALTH PERSP, V119, P1604, DOI 10.1289/ehp.1103850; Keri RA, 2007, REPROD TOXICOL, V24, P240, DOI 10.1016/j.reprotox.2007.06.008; Korzeniewski N, 2013, EXPERT OPIN THER TAR, V17, P43, DOI 10.1517/14728222.2013.731396; Lam YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009075; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lee HH, 2008, ENDOCR-RELAT CANCER, V15, P765, DOI 10.1677/ERC-07-0213; Lehmann L, 2004, CHEM-BIOL INTERACT, V147, P273, DOI 10.1016/j.cbi.2004.01.005; Ling HB, 2012, CELL CYCLE, V11, P3779, DOI 10.4161/cc.21985; Lingle WL, 2005, ADV EXP MED BIOL, V570, P393, DOI 10.1007/1-4020-3764-3_14; Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605; Matsushima A, 2008, BIOCHEM BIOPH RES CO, V373, P408, DOI 10.1016/j.bbrc.2008.06.050; Mobley JA, 2003, CANCER EPIDEM BIOMAR, V12, P775; Morgentaler A, 2006, UROLOGY, V68, P1263, DOI 10.1016/j.urology.2006.08.1058; Nomura H, 2009, PROSTATE CANCER P D, V12, P375, DOI 10.1038/pcan.2009.20; Okada H, 2008, ENVIRON HEALTH PERSP, V116, P32, DOI 10.1289/ehp.10587; Ouyang B, 2009, J UROLOGY, V181, P2508, DOI 10.1016/j.juro.2009.01.110; Padmanabhan V, 2008, J PERINATOL, V28, P258, DOI 10.1038/sj.jp.7211913; Pfeiffer E, 1997, MUTAT RES-GEN TOX EN, V390, P21, DOI 10.1016/S0165-1218(96)00161-9; Prins GS, 2011, REPROD TOXICOL, V31, P1, DOI 10.1016/j.reprotox.2010.09.009; Prins Gail S, 2008, Fertil Steril, V89, pe41, DOI 10.1016/j.fertnstert.2007.12.023; Qin XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036711; Rhoden EL, 2008, J UROLOGY, V179, P1741, DOI 10.1016/j.juro.2008.01.045; Rogers JA, 2013, MOL IMMUNOL, V53, P421, DOI 10.1016/j.molimm.2012.09.013; Safe SH, 2002, ENVIRON HEALTH PERSP, V110, P925, DOI 10.1289/ehp.02110s6925; Schoffski P, 2009, ONCOLOGIST, V14, P559, DOI 10.1634/theoncologist.2009-0010; Sheng ZG, 2012, TOXICOL APPL PHARM, V259, P133, DOI 10.1016/j.taap.2011.12.018; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; STAVNEZER E, 1981, J VIROL, V39, P920, DOI 10.1128/JVI.39.3.920-934.1981; Tang WY, 2012, ENDOCRINOLOGY, V153, P42, DOI 10.1210/en.2011-1308; Tarapore P, 2012, CELL CYCLE, V11, P2931, DOI 10.4161/cc.21396; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Townsend MK, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-80; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; Walker CL, 2012, NAT REV CANCER, V12, P479, DOI 10.1038/nrc3220; Watson CS, 2005, STEROIDS, V70, P364, DOI 10.1016/j.steroids.2005.03.002; WHO (World Health Organization), 1996, BIOL MON CHEM EXP WO; Xi W, 2011, REPROD TOXICOL, V31, P409, DOI 10.1016/j.reprotox.2010.12.002; Ye XY, 2011, ENVIRON HEALTH PERSP, V119, P983, DOI 10.1289/ehp.1002701; Zhang ZF, 2011, ENVIRON SCI TECHNOL, V45, P7044, DOI 10.1021/es200976k; Zhu ML, 2010, CANCER RES, V70, P7992, DOI 10.1158/0008-5472.CAN-10-0585	72	75	80	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90332	10.1371/journal.pone.0090332	http://dx.doi.org/10.1371/journal.pone.0090332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594937	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900094
J	Frei, R; Roduit, C; Bieli, C; Loeliger, S; Waser, M; Scheynius, A; van Hage, M; Pershagen, G; Doekes, G; Riedler, J; von Mutius, E; Sennhauser, F; Akdis, CA; Braun-Fahrlander, C; Lauener, RP				Frei, Remo; Roduit, Caroline; Bieli, Christian; Loeliger, Susanne; Waser, Marco; Scheynius, Annika; van Hage, Marianne; Pershagen, Goran; Doekes, Gert; Riedler, Josef; von Mutius, Erika; Sennhauser, Felix; Akdis, Cezmi A.; Braun-Fahrlaender, Charlotte; Lauener, Roger P.		PARSIFAL Study Team	Expression of Genes Related to Anti-Inflammatory Pathways Are Modified Among Farmers' Children	PLOS ONE			English	Article							CLASS-SWITCH RECOMBINATION; SCHOOL-AGE-CHILDREN; RURAL LIFE-STYLE; INNATE IMMUNITY; ATOPIC SENSITIZATION; ALLERGIC DISEASES; HAY-FEVER; T-CELLS; TRANSCRIPTION FACTOR; HYGIENE HYPOTHESIS	Background: The hygiene hypothesis states that children exposed to higher loads of microbes such as farmers' children suffer less from allergies later in life. Several immunological mechanisms underpinning the hygiene hypothesis have been proposed such as a shift in T helper cell balance, T regulatory cell activity, or immune regulatory mechanisms induced by the innate immunity. Objective: To investigate whether the proposed immunological mechanisms for the hygiene hypotheses are found in farmers' children. Methods: We assessed gene expression levels of 64 essential markers of the innate and adaptive immunity by quantitative real-time PCR in white blood cells in 316 Swiss children of the PARSIFAL study to compare farmers' to non-farmers' expressions and to associate them to the prevalence of asthma and rhinoconjunctivitis, total and allergen-specific IgE in serum, and expression of Ce germ-line transcripts. Results: We found enhanced expression of genes of the innate immunity such as IRAK-4 and RIPK1 and enhanced expression of regulatory molecules such as IL-10, TGF-beta, SOCS4, and IRAK-2 in farmers' children. Furthermore, farmers' children expressed less of the T(H)1 associated cytokine IFN-gamma while T(H)2 associated transcription factor GATA3 was enhanced. No significant associations between the assessed immunological markers and allergic diseases or sensitization to allergens were observed. Conclusion: Farmers' children express multiple increased innate immune response and immune regulatory molecules, which may contribute to the mechanisms of action of the hygiene hypothesis.	[Frei, Remo; Akdis, Cezmi A.] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland; [Frei, Remo; Roduit, Caroline; Loeliger, Susanne; Akdis, Cezmi A.; Lauener, Roger P.] Christine Kuhne Ctr Allergy Res & Educ, Zurich, Switzerland; [Roduit, Caroline; Bieli, Christian; Loeliger, Susanne; Sennhauser, Felix] Univ Zurich, Childrens Hosp, Zurich, Switzerland; [Waser, Marco; Braun-Fahrlaender, Charlotte] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Waser, Marco; Braun-Fahrlaender, Charlotte] Univ Basel, Basel, Switzerland; [Scheynius, Annika] Karolinska Inst, Translat Immunol Unit, Dept Med Solna, Stockholm, Sweden; [Scheynius, Annika; van Hage, Marianne] Univ Hosp, Stockholm, Sweden; [van Hage, Marianne] Karolinska Inst, Clin Immunol & Allergy Unit, Dept Med Solna, Stockholm, Sweden; [Pershagen, Goran] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Doekes, Gert] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Riedler, Josef] Childrens Hosp Schwarzach, Schwarzach, Austria; [von Mutius, Erika] Univ Munich, Dr von Hauner Childrens Hosp, Munich, Germany; [Lauener, Roger P.] Kantonsspital St Gallen, St Gallen, Switzerland	Swiss Institute of Allergy & Asthma Research; University of Zurich; University Children's Hospital Zurich; University of Zurich; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Utrecht University; University of Munich	Frei, R (corresponding author), Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland.	remo.frei@siaf.uzh.ch	Akdis, Cezmi/AAV-4844-2020; Roduit, Caroline/S-4928-2017; van Hage, Marianne/A-9678-2017; riedler, josef/AAQ-4666-2020; Lauener, Roger P/O-8612-2016; Frei, Remo/AAI-9180-2020; Bieli, Christian/F-7209-2014	Akdis, Cezmi/0000-0001-8020-019X; van Hage, Marianne/0000-0003-3091-1596; Lauener, Roger P/0000-0002-8412-606X; von Mutius, Erika/0000-0002-8893-4515; Pershagen, Goran/0000-0002-9701-1130; Roduit, Caroline/0000-0002-5988-0570; Bieli, Christian/0000-0002-2128-6082	European Union [QLRT 1999-013]; Swiss National Science Foundation [2-100324]; Christine Kuhne - Center for Allergy Research and Education (CK-Care) in Davos	European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Christine Kuhne - Center for Allergy Research and Education (CK-Care) in Davos	Supported by grants from the European Union QLRT 1999-013, from the Swiss National Science Foundation 2-100324, and by the Christine Kuhne - Center for Allergy Research and Education (CK-Care) in Davos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alfven T, 2006, ALLERGY, V61, P414, DOI 10.1111/j.1398-9995.2005.00939.x; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bieli C, 2008, ALLERGY, V63, P1633, DOI 10.1111/j.1398-9995.2008.01744.x; Bieli C, 2007, J ALLERGY CLIN IMMUN, V120, P1308, DOI 10.1016/j.jaci.2007.07.034; Braun-Fahrlander C, 1999, CLIN EXP ALLERGY, V29, P28, DOI 10.1046/j.1365-2222.1999.00479.x; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Ege MJ, 2007, J ALLERGY CLIN IMMUN, V119, P1140, DOI 10.1016/j.jaci.2007.01.037; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Eyerich K, 2013, ALLERGY, V68, P974, DOI 10.1111/all.12184; Felliet H, 2004, CURR OPIN GASTROEN, V20, P560; Filipiak B, 2001, CLIN EXP ALLERGY, V31, P1829, DOI 10.1046/j.1365-2222.2001.01246.x; Flannery S, 2010, BIOCHEM PHARMACOL, V80, P1981, DOI 10.1016/j.bcp.2010.06.020; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Frei R, 2012, ALLERGY, V67, P451, DOI 10.1111/j.1398-9995.2011.02783.x; Frei R, 2013, J ALLERGY CLIN IMMUN, V132, P194, DOI 10.1016/j.jaci.2013.01.013; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jiang H, 2006, NEW ENGL J MED, V354, P1166, DOI 10.1056/NEJMra055446; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; Lauener RP, 2002, LANCET, V360, P465, DOI 10.1016/S0140-6736(02)09641-1; Lee SY, 2012, INT ARCH ALLERGY IMM, V158, P168, DOI 10.1159/000330820; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Loss G, 2012, J ALLERGY CLIN IMMUN, V130, P523, DOI 10.1016/j.jaci.2012.05.049; Loss G, 2011, J ALLERGY CLIN IMMUN, V128, P766, DOI 10.1016/j.jaci.2011.07.048; Macpherson AJ, 2002, NAT IMMUNOL, V3, P798, DOI 10.1038/ni0902-798; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Marshall AL, 2004, DIABETIC MED, V21, P1035, DOI 10.1111/j.1464-5491.2004.01282.x; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; Mrabet-Dahbi S, 2010, ALLERGY, V65, P1351, DOI 10.1111/j.1398-9995.2010.02452.x; Ng LG, 2005, MOL IMMUNOL, V42, P763, DOI 10.1016/j.molimm.2004.06.041; Pfefferle PI, 2008, J ALLERGY CLIN IMMUN, V122, P711, DOI 10.1016/j.jaci.2008.06.035; Rebane A, 2012, J ALLERGY CLIN IMMUN, V129, P1297, DOI 10.1016/j.jaci.2012.02.020; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Riedler J, 2000, CLIN EXP ALLERGY, V30, P194, DOI 10.1046/j.1365-2222.2000.00799.x; Roduit C, 2011, J ALLERGY CLIN IMMUN, V127, P179, DOI 10.1016/j.jaci.2010.10.010; Rosenlund H, 2009, PEDIATRICS, V123, P771, DOI 10.1542/peds.2008-0013; Sheikh A, 2003, J ALLERGY CLIN IMMUN, V111, P131, DOI 10.1067/mai.2003.8; Soyka MB, 2012, IMMUNOTHERAPY-UK, V4, P389, DOI [10.2217/IMT.12.10, 10.2217/imt.12.10]; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Ublagger E, 2005, CLIN EXP ALLERGY, V35, P1033, DOI 10.1111/j.1365-2222.2005.02308.x; Wickman M, 2002, PEDIATR ALLERGY IMMU, V13, P11, DOI 10.1034/j.1399-3038.13.s.15.10.x; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zeller S, 2009, J ALLERGY CLIN IMMUN, V124, P278, DOI 10.1016/j.jaci.2009.05.015; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zimmermann M, 2011, J ALLERGY CLIN IMMUN, V127, P200, DOI 10.1016/j.jaci.2010.11.005	56	28	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91097	10.1371/journal.pone.0091097	http://dx.doi.org/10.1371/journal.pone.0091097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603716	Green Published, gold, Green Accepted			2022-12-25	WOS:000332483600128
J	Laxminarayan, R; Reif, J; Malani, A				Laxminarayan, Ramanan; Reif, Julian; Malani, Anup			Incentives for Reporting Disease Outbreaks	PLOS ONE			English	Article							MENINGOCOCCAL MENINGITIS; HAJJ PILGRIMS; INFLUENZA; AFRICA	Background: Countries face conflicting incentives to report infectious disease outbreaks. Reports of outbreaks can prompt other countries to impose trade and travel restrictions, which has the potential to discourage reporting. However, reports can also bring medical assistance to contain the outbreak, including access to vaccines. Methods: We compiled data on reports of meningococcal meningitis to the World Health Organization (WHO) from 54 African countries between 1966 and 2002, a period is marked by two events: first, a large outbreak reported from many countries in 1987 associated with the Hajj that resulted in more stringent requirements for meningitis vaccination among pilgrims; and second, another large outbreak in Sub-Saharan Africa in 1996 that led to a new international mechanism to supply vaccines to countries reporting a meningitis outbreak. We used fixed-effects regression modeling to statistically estimate the effect of external forcing events on the number of countries reporting cases of meningitis to WHO. Findings: We find that the Hajj vaccination requirements started in 1988 were associated with reduced reporting, especially among countries with relatively fewer cases reported between 1966 and 1979. After the vaccine provision mechanism was in place in 1996, reporting among countries that had previously not reported meningitis outbreaks increased. Interpretation: These results indicate that countries may respond to changing incentives to report outbreaks when they can do so. In the long term, these incentives are likely to be more important than surveillance assistance in prompt reporting of outbreaks.	[Laxminarayan, Ramanan; Malani, Anup] Ctr Dis Dynam Econ & Policy, Washington, DC 20036 USA; [Laxminarayan, Ramanan] Princeton Univ, Princeton, NJ 08544 USA; [Laxminarayan, Ramanan] Publ Hlth Fdn India, Inst Area, New Delhi, India; [Malani, Anup] Univ Chicago, Sch Law, Chicago, IL 60637 USA; [Malani, Anup] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Reif, Julian] Univ Illinois, Dept Finance, Champaign, IL USA; [Reif, Julian] Univ Illinois, Inst Govt & Publ Affairs, Champaign, IL USA	Princeton University; Public Health Foundation of India; University of Chicago; University of Chicago; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Laxminarayan, R (corresponding author), Ctr Dis Dynam Econ & Policy, Washington, DC 20036 USA.	Ramanan@cddep.org	Laxminarayan, Ramanan/ABD-5050-2021	Malani, Anup/0000-0002-2594-5778	Health Grand Challenges Program at Princeton University	Health Grand Challenges Program at Princeton University	Ramanan Laxminarayan was supported by the Health Grand Challenges Program at Princeton University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlGahtani YM, 1995, EPIDEMIOL INFECT, V115, P399, DOI 10.1017/S0950268800058556; [Anonymous], 2008, LANCET INFECT DIS, V8, P1; Baker MG, 2006, EMERG INFECT DIS, V12, P1058; Central Intelligence Agency, 2009, WORLD FACTB 2009; El Bashir H, 2007, LANCET, V369, P1343, DOI 10.1016/S0140-6736(07)60625-4; ElBushra HE, 1995, E AFR MED J, V72, P715; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; French Howard W., 1996, NY TIMES; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Malani A, 2011, J HUM RESOUR, V46, P176; Memish ZA, 2002, CLIN INFECT DIS, V34, P84, DOI 10.1086/323403; Normile D, 2010, SCIENCE, V330, P435, DOI 10.1126/science.330.6003.435; NOVELLI VM, 1987, LANCET, V2, P863; Teyssou R, 2007, VACCINE, V25, pA3, DOI 10.1016/j.vaccine.2007.04.032; World Health Organization, 2013, WHO VACC PREV DIS MO	16	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90290	10.1371/journal.pone.0090290	http://dx.doi.org/10.1371/journal.pone.0090290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603414	Green Submitted, Green Published, gold			2022-12-25	WOS:000332483600040
J	Starha, P; Hosek, J; Vanco, J; Dvorak, Z; Suchy, P; Popa, I; Prazanova, G; Travnicek, Z				Starha, Pavel; Hosek, Jan; Vanco, Jan; Dvorak, Zdenek; Suchy, Pavel, Jr.; Popa, Igor; Prazanova, Gabriela; Travnicek, Zdenek			Pharmacological and Molecular Effects of Platinum(II) Complexes Involving 7-Azaindole Derivatives	PLOS ONE			English	Article							IN-VITRO CYTOTOXICITY; CISPLATIN RESISTANCE; CRYSTAL-STRUCTURE; CARRIER LIGANDS; ANTICANCER; CELL; OXALIPLATIN; CANCER; AGENTS; DNA	The in vitro antitumour activity studies on a panel of human cancer cell lines (A549, HeLa, G-361, A2780, and A2780R) and the combined in vivo and ex vivo antitumour testing on the L1210 lymphocytic leukaemia model were performed on the cis-[PtCl2(naza)2] complexes (1-3) involving the 7-azaindole derivatives (naza). The platinum(II) complexes showed significantly higher in vitro cytotoxic effects on cell-based models, as compared with cisplatin, and showed the ability to avoid the acquired resistance of the A2780R cell line to cisplatin. The in vivo testing of the complexes (applied at the same dose as cisplatin) revealed their positive effect on the reduction of cancerous tissues volume, even if it is lower than that of cisplatin, however, they also showed less serious adverse effects on the healthy tissues and the health status of the treated mice. The results of ex vivo assays revealed that the complexes 1-3 were able to modulate the levels of active forms of caspases 3 and 8, and the transcription factor p53, and thus activate the intrinsic (mitochondrial) pathway of apoptosis. The pharmacological observations were supported by both the histological and immunohistochemical evaluation of isolated cancerous tissues. The applicability of the prepared complexes and their fate in biological systems, characterized by the hydrolytic stability and the thermodynamic aspects of the interactions with cysteine, reduced glutathione, and human serum albumin were studied by the mass spectrometry and isothermal titration calorimetric experiments.	[Starha, Pavel; Hosek, Jan; Vanco, Jan; Popa, Igor; Travnicek, Zdenek] Palacky Univ, Dept Inorgan Chem, Reg Ctr Adv Technol & Mat, Fac Sci, CR-77147 Olomouc, Czech Republic; [Dvorak, Zdenek] Palacky Univ, Fac Sci, Dept Cell Biol & Genet, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic; [Suchy, Pavel, Jr.; Prazanova, Gabriela] Univ Vet & Pharmaceut Sci Brno, Fac Pharm, Dept Human Pharmacol & Toxicol, Brno, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; University of Veterinary Sciences Brno	Travnicek, Z (corresponding author), Palacky Univ, Dept Inorgan Chem, Reg Ctr Adv Technol & Mat, Fac Sci, CR-77147 Olomouc, Czech Republic.	zdenek.travnicek@upol.cz	Starha, Pavel/H-3902-2016; Suchy, Pavel/A-6632-2009; Vanco, Jan/H-2705-2013; Hosek, Jan/B-6274-2009	Suchy, Pavel/0000-0002-6277-2749; Vanco, Jan/0000-0003-3351-1192; Hosek, Jan/0000-0003-0975-1671; Starha, Pavel/0000-0003-0422-045X; Travnicek, Zdenek/0000-0002-5890-7874; Dvorak, Zdenek/0000-0002-3938-3585	Czech Science Foundation [GACR P207/11/0841]; Operational Program Research and Development for Innovations - European Regional Development Fund [CZ.1.05/2.1.00/03.0058]; Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.07/2.3.00/20.0017]; Palacky University in Olomouc [PrF_2013_015]; University of Veterinary and Pharmaceutical Sciences Brno [IGA VFU 82/2012/FaF]	Czech Science Foundation(Grant Agency of the Czech Republic); Operational Program Research and Development for Innovations - European Regional Development Fund; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Palacky University in Olomouc; University of Veterinary and Pharmaceutical Sciences Brno	The authors acknowledge funding from the Czech Science Foundation (GACR P207/11/0841), Operational Program Research and Development for Innovations - European Regional Development Fund (CZ.1.05/2.1.00/03.0058), Operational Program Education for Competitiveness - European Social Fund (CZ.1.07/2.3.00/20.0017) of the Ministry of Education, Youth and Sports of the Czech Republic, Palacky University in Olomouc (PrF_2013_015), and University of Veterinary and Pharmaceutical Sciences Brno (IGA VFU 82/2012/FaF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; AKAZA H, 1992, CANCER CHEMOTH PHARM, V31, P187, DOI 10.1007/BF00685546; [Anonymous], 2010, US Patent, Patent No. [H.J. Dyke, S. Price, K. Williams, 20100216768]; Brown SD, 2012, DALTON T, V41, P11330, DOI 10.1039/c2dt31313h; Carland M, 2010, J INORG BIOCHEM, V104, P815, DOI 10.1016/j.jinorgbio.2010.03.011; Carreira M, 2012, J INORG BIOCHEM, V116, P204, DOI 10.1016/j.jinorgbio.2012.06.017; Chauhan P, 2009, IMMUNOBIOLOGY, V214, P197, DOI 10.1016/j.imbio.2008.07.012; Cheve G, 2012, MEDCHEMCOMM, V3, P788, DOI 10.1039/c2md20104f; de Mier-Vinue J, 2008, J MED CHEM, V51, P424, DOI 10.1021/jm070844u; Esposito BP, 2002, COORDIN CHEM REV, V232, P137, DOI 10.1016/S0010-8545(02)00049-8; Galanski M, 2004, EUR J MED CHEM, V39, P707, DOI 10.1016/j.ejmech.2004.04.003; Gong JG, 1999, NATURE, V399, P806; HARRAP KR, 1985, CANCER TREAT REV, V12, P21, DOI 10.1016/0305-7372(85)90015-5; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Holford J, 1998, ANTI-CANCER DRUG DES, V13, P1; Holford J, 1998, BRIT J CANCER, V77, P366, DOI 10.1038/bjc.1998.59; Hong S, 2012, J MED CHEM, V55, P5337, DOI 10.1021/jm3002982; Hua H, 2011, CELL MOL LIFE SCI, V68, P3853, DOI 10.1007/s00018-011-0763-x; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kelland LR, 2000, PLATINUM BASED DRUGS; KIDANI Y, 1978, J MED CHEM, V21, P1315, DOI 10.1021/jm00210a029; Komeda S, 2013, METALLOMICS, V5, P461, DOI 10.1039/c3mt00040k; Margiotta N, 2010, J MED CHEM, V53, P5144, DOI 10.1021/jm100429r; McKeage MJ, 2001, EXPERT OPIN INV DRUG, V10, P119, DOI 10.1517/13543784.10.1.119; Muchova T, 2013, J BIOL INORG CHEM, V18, P579, DOI 10.1007/s00775-013-1003-7; Nagle PS, 2012, J MED CHEM, V55, P4397, DOI 10.1021/jm300296f; Pierce LT, 2012, EUR J MED CHEM, V56, P292, DOI 10.1016/j.ejmech.2012.08.002; Pogozhev D, 2013, POLYHEDRON, V52, P1329, DOI 10.1016/j.poly.2012.06.009; Quirante J, 2011, J INORG BIOCHEM, V105, P1720, DOI 10.1016/j.jinorgbio.2011.09.021; REEDIJK J, 1987, PURE APPL CHEM, V59, P181, DOI 10.1351/pac198759020181; Reedijk J, 1999, CHEM REV, V99, P2499, DOI 10.1021/cr980422f; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Ruiz J, 2010, DALTON T, V39, P3290, DOI 10.1039/b920854b; Salemi G, 2009, NEUROL SCI, V30, P361, DOI 10.1007/s10072-009-0090-2; Sharp SY, 2002, EUR J CANCER, V38, P2309, DOI 10.1016/S0959-8049(02)00244-7; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Spuches AM, 2005, INORG CHEM, V44, P2964, DOI 10.1021/ic048694q; Starha P, 2012, J INORG BIOCHEM, V115, P57, DOI 10.1016/j.jinorgbio.2012.05.006; Starha P, 2012, POLYHEDRON, V33, P404, DOI 10.1016/j.poly.2011.11.059; TALHOUK RS, 1991, DEVELOPMENT, V112, P439; Timerbaev AR, 2006, CHEM REV, V106, P2224, DOI 10.1021/cr040704h; Travnicek Z, 2011, J INORG BIOCHEM, V105, P937, DOI 10.1016/j.jinorgbio.2011.04.002; Tsoureas N, 2011, DALTON T, V40, P951, DOI 10.1039/c0dt01148g; Vrzal R, 2010, J INORG BIOCHEM, V104, P1130, DOI 10.1016/j.jinorgbio.2010.07.002; W.H. Organization, 2009, WORLD HLTH STAT 2009; Wheate NJ, 2010, DALTON T, V39, P8113, DOI 10.1039/c0dt00292e; Xu G, 2011, EUR J MED CHEM, V46, P356, DOI 10.1016/j.ejmech.2010.11.025; Yamori T, 2003, CANCER CHEMOTH PHARM, V52, pS74, DOI 10.1007/s00280-003-0649-1; Zhang BZ, 2008, J AM SOC NEPHROL, V19, P923, DOI 10.1681/ASN.2007090982	51	29	30	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90341	10.1371/journal.pone.0090341	http://dx.doi.org/10.1371/journal.pone.0090341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603594	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600045
J	Clark, RW; Schuett, GW; Repp, RA; Amarello, M; Smith, CF; Herrmann, HW				Clark, Rulon W.; Schuett, Gordon W.; Repp, Roger A.; Amarello, Melissa; Smith, Charles F.; Herrmann, Hans-Werner			Mating Systems, Reproductive Success, and Sexual Selection in Secretive Species: A Case Study of the Western Diamond-Backed Rattlesnake, Crotalus atrox	PLOS ONE			English	Article							MICROSATELLITE LOCI; MULTIPLE PATERNITY; BODY-SIZE; GENOTYPING ERRORS; GENETIC-EVIDENCE; HOME-RANGE; SNAKES; POPULATION; VIPERIDAE; SERPENTES	Long-term studies of individual animals in nature contribute disproportionately to our understanding of the principles of ecology and evolution. Such field studies can benefit greatly from integrating the methods of molecular genetics with traditional approaches. Even though molecular genetic tools are particularly valuable for species that are difficult to observe directly, they have not been widely adopted. Here, we used molecular genetic techniques in a 10-year radio-telemetric investigation of the western diamond-backed rattlesnake (Crotalus atrox) for an analysis of its mating system and to measure sexual selection. Specifically, we used microsatellite markers to genotype 299 individuals, including neonates from litters of focal females to ascertain parentage using full-pedigree likelihood methods. We detected high levels of multiple paternity within litters, yet found little concordance between paternity and observations of courtship and mating behavior. Larger males did not father significantly more offspring, but we found evidence for size-specific male-mating strategies, with larger males guarding females for longer periods in the mating seasons. Moreover, the spatial proximity of males to mothers was significantly associated with reproductive success. Overall, our field observations alone would have been insufficient to quantitatively measure the mating system of this population of C. atrox, and we thus urge more widespread adoption of molecular tools by field researchers studying the mating systems and sexual selection of snakes and other secretive taxa.	[Clark, Rulon W.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Schuett, Gordon W.] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Schuett, Gordon W.] Georgia State Univ, Ctr Behav Neurosci, Atlanta, GA 30303 USA; [Schuett, Gordon W.; Smith, Charles F.] Copperhead Inst, Spartanburg, SC USA; [Schuett, Gordon W.; Smith, Charles F.] Chiricahua Desert Museum, Rodeo, NM USA; [Repp, Roger A.] Natl Opt Astron Observ, Tucson, AZ 85726 USA; [Amarello, Melissa] Social Snakes, Tucson, AZ USA; [Smith, Charles F.] Wofford Coll, Dept Biol, Spartanburg, SC USA; [Herrmann, Hans-Werner] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA	California State University System; San Diego State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; National Optical Astronomy Observatory; University of Arizona	Clark, RW (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	rclark@mail.sdsu.edu; gwschuett@yahoo.com		Amarello, Melissa/0000-0002-1596-5476	Arizona State University; Zoo Atlanta; Georgia State University; San Diego State University	Arizona State University; Zoo Atlanta; Georgia State University; San Diego State University	Arizona State University, Zoo Atlanta, Georgia State University, San Diego State University, and David L. Hardy Sr, funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge RD, 2002, HERPETOL MONOGR, V16, P1, DOI 10.1655/0733-1347(2002)016[0001:EOTMSI]2.0.CO;2; Amarello M, 2010, J ARID ENVIRON, V74, P1443, DOI 10.1016/j.jaridenv.2010.05.019; Andersson Malte, 1994; ARNOLD SJ, 1994, AM NAT, V143, P317, DOI 10.1086/285606; Avise JC, 2011, P NATL ACAD SCI USA, V108, P11512, DOI 10.1073/pnas.1109216108; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Beaupre SJ, 1998, COPEIA, P40, DOI 10.2307/1447700; Birkhead TR, 1998, SPERM COMPETITION SE; Blank S, 2001, RESAMPLING STATS; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Blouin-Demers G, 2005, ANIM BEHAV, V69, P225, DOI 10.1016/j.anbehav.2004.03.012; Blouin-Demers G, 2002, J ZOOL, V256, P1, DOI 10.1017/S0952836902000018; Bonnet X, 2002, TRENDS ECOL EVOL, V17, P1, DOI 10.1016/S0169-5347(01)02381-3; Booth W, 2012, BIOL LETTERS, V8, P983, DOI 10.1098/rsbl.2012.0666; Booth W, 2011, BIOL J LINN SOC, V104, P934, DOI 10.1111/j.1095-8312.2011.01782.x; Brown DE., 1994, BIOTIC COMMUNITIES S; Brown GP, 1999, BEHAV ECOL SOCIOBIOL, V47, P9, DOI 10.1007/s002650050644; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Campbell J. A., 2004, VENOMOUS REPTILES W; Castoe TA, 2007, MOL PHYLOGENET EVOL, V42, P193, DOI 10.1016/j.ympev.2006.07.002; Clark RW, 2012, ANIM BEHAV, V84, P183, DOI 10.1016/j.anbehav.2012.04.029; Clark RW, 2006, COPEIA, P181; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; DeNardo DF, 2011, REPROD BIOL PHYLOGEN, V9, P265; DeWoody JA, 2005, J WILDLIFE MANAGE, V69, P1400, DOI 10.2193/0022-541X(2005)69[1400:MATTSO]2.0.CO;2; Dewsbury DA, 2005, INTEGR COMP BIOL, V45, P831, DOI 10.1093/icb/45.5.831; DeYoung RW, 2005, J WILDLIFE MANAGE, V69, P1362, DOI 10.2193/0022-541X(2005)69[1362:TMTGTI]2.0.CO;2; Dibattista JD, 2008, MOL ECOL, V17, P783, DOI 10.1111/j.1365-294X.2007.03623.x; Dorcas Michael E., 2009, P5; Dubey S, 2009, ANIM BEHAV, V77, P177, DOI 10.1016/j.anbehav.2008.09.037; Duvall D, 1997, ANIM BEHAV, V54, P329, DOI 10.1006/anbe.1996.0418; Duvall David, 1992, P321; Duvall David, 1993, P165; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Epple A. E., 1995, PLANTS ARIZONA; Fisher DO, 1999, ANIM BEHAV, V58, P121, DOI 10.1006/anbe.1999.1119; FITCH H S, 1981, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Gibbs HL, 2001, J HERED, V92, P173, DOI 10.1093/jhered/92.2.173; Gibbs HL, 1998, J HERED, V89, P169, DOI 10.1093/jhered/89.2.169; GILLINGHAM JC, 1983, J HERPETOL, V17, P265, DOI 10.2307/1563829; Goldberg CS, 2003, MOL ECOL NOTES, V3, P539, DOI 10.1046/j.1471-8286.2003.00503.x; Goldberg Stephen R., 2007, Bulletin of the Maryland Herpetological Society, V43, P103; Graham SP, 2008, GEN COMP ENDOCR, V159, P226, DOI 10.1016/j.ygcen.2008.09.002; GRAVES BM, 1993, J HERPETOL, V27, P33, DOI 10.2307/1564902; GRAVES BM, 1995, HERPETOLOGICAL MONOGRAPHS, NO 9, 1995, P102; Greene Harry W., 2002, P179; Greene HW, 2005, TRENDS ECOL EVOL, V20, P23, DOI 10.1016/j.tree.2004.11.005; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Harrison HB, 2013, MOL ECOL, V22, P1158, DOI 10.1111/mec.12138; Holycross AT, 2002, MOL ECOL NOTES, V2, P537, DOI 10.1046/j.1471-8286.2002.00310.x; IMS RA, 1988, EVOL ECOL, V2, P338, DOI 10.1007/BF02207565; Jellen BC, 2011, REPROD BIOL PHYLOGEN, V9, P619; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; King Richard B., 2009, P78; KLAUBER L. M., 1972, RATTLESNAKES THEIR H, V2nd; Kokko H, 2007, EVOLUTION, V61, P1162, DOI 10.1111/j.1558-5646.2007.00090.x; Kvarnemo C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0042; Lukoschek V, 2011, J HERED, V102, P347, DOI 10.1093/jhered/esr017; MADSEN T, 1993, AM NAT, V141, P167, DOI 10.1086/285467; MADSEN T, 1993, ANIM BEHAV, V45, P491, DOI 10.1006/anbe.1993.1060; Mock CJ, 1996, J CLIMATE, V9, P1111, DOI 10.1175/1520-0442(1996)009<1111:CCASVO>2.0.CO;2; Munguia-Vega A, 2009, MOL ECOL RESOUR, V9, P1267, DOI 10.1111/j.1755-0998.2009.02661.x; Nowak EM, 2008, BIOL REV, V83, P601, DOI 10.1111/j.1469-185X.2008.00056.x; Oyler-McCance SJ, 2005, MOL ECOL NOTES, V5, P452, DOI 10.1111/j.1471-8286.2005.00961.x; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Parker GA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0335; Parker Joshua M., 2012, Herpetological Review, V43, P658; Phillips S.J., 2000, NATURAL HIST SONORAN; Pizzari T, 2013, PHILOS T R SOC B, V368, DOI [10.1111/j.1420-9101.2011.02271.x, DOI 10.1111/J.1420-9101.2011.02271.X]; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Pozarowski K, 2012, CONSERV GENET RESOUR, V4, P955, DOI 10.1007/s12686-012-9682-x; PRESTT I, 1971, J ZOOL, V164, P373; PRICE AH, 1988, SOUTHWEST NAT, V33, P370, DOI 10.2307/3671770; Prosser MR, 2002, BEHAV ECOL, V13, P800, DOI 10.1093/beheco/13.6.800; REINERT HK, 1982, COPEIA, P702, DOI 10.2307/1444674; Reinert Howard K., 1992, P185; Reiserer RS, 2008, J ZOOL, V274, P277, DOI 10.1111/j.1469-7998.2007.00383.x; Repp RA, 2008, SOUTHWEST NAT, V53, P108, DOI 10.1894/0038-4909(2008)53[108:WDRCAS]2.0.CO;2; Repp Roger A., 2009, Herpetological Review, V40, P353; Rivas JA, 2005, J COMP PSYCHOL, V119, P447, DOI 10.1037/0735-7036.119.4.447; Rosen PC, 2002, TEX J SCI, V54, P347; Row JR, 2006, COPEIA, P797, DOI 10.1643/0045-8511(2006)6[797:KANAEO]2.0.CO;2; Schmoll T, 2011, J ORNITHOL, V152, P265, DOI 10.1007/s10336-011-0683-4; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schuett GW, 2013, J ZOOL, V289, P101, DOI 10.1111/j.1469-7998.2012.00969.x; Schuett GW, 2011, J ZOOL, V284, P105, DOI 10.1111/j.1469-7998.2010.00786.x; Schuett Gordon W., 1992, P169; Schuett Gordon W., 2004, Herpetological Review, V35, P328; Schuett Gordon W., 2001, Acta Ethologica, V4, P31, DOI 10.1007/s102110100043; Schuett GW, 1997, ANIM BEHAV, V54, P213, DOI 10.1006/anbe.1996.0417; Sever DM, 2002, J EXP ZOOL, V292, P187, DOI 10.1002/jez.1154; Shine R, 2005, ANIM BEHAV, V70, P387, DOI 10.1016/j.anbehav.2005.04.001; SHINE R, 1994, COPEIA, P326; SHUSTER SM, 2003, MG BEH ECOL, pR7; Shuster SM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0046; Simonov E, 2011, ACTA HERPETOL, V6, P289; Spencer C.L., 2008, BIOL RATT, P55; Taylor EN, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 3: REPTILES, P355; Taylor EN, 2005, J EXP ZOOL PART A, V303A, P598, DOI 10.1002/jez.a.189; Trimbos KB, 2009, J ORNITHOL, V150, P915, DOI 10.1007/s10336-009-0422-2; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; Ursenbacher S, 2009, J HERED, V100, P365, DOI 10.1093/jhered/esn104; Walling CA, 2010, MOL ECOL, V19, P1914, DOI 10.1111/j.1365-294X.2010.04604.x; Wang JL, 2010, MOL ECOL, V19, P5061, DOI 10.1111/j.1365-294X.2010.04865.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Weatherhead PJ, 2002, BEHAV ECOL, V13, P808, DOI 10.1093/beheco/13.6.808; Wright LI, 2013, BEHAV ECOL, V24, P1022, DOI 10.1093/beheco/art003; Wusterbarth TL, 2010, HERPETOL CONSERV BIO, V5, P86; Zamudio KR, 2000, P NATL ACAD SCI USA, V97, P14427, DOI 10.1073/pnas.011544998; Zar J. H., 1996, BIOSTATISTICAL ANAL	111	32	34	0	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90616	10.1371/journal.pone.0090616	http://dx.doi.org/10.1371/journal.pone.0090616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598810	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400102
J	De Souza, CP; Hashmi, SB; Osmani, AH; Osmani, SA				De Souza, Colin P.; Hashmi, Shahr B.; Osmani, Aysha H.; Osmani, Stephen A.			Application of a New Dual Localization-Affinity Purification Tag Reveals Novel Aspects of Protein Kinase Biology in Aspergillus nidulans	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; SEPTATION INITIATION NETWORK; DNA-REPLICATION; MITOTIC CHECKPOINT; CELL-CYCLE; SEPTUM FORMATION; GLOBAL ANALYSIS; FISSION YEAST; NIMA KINASE; TRANSCRIPTION FACTOR	Filamentous fungi occupy critical environmental niches and have numerous beneficial industrial applications but devastating effects as pathogens and agents of food spoilage. As regulators of essentially all biological processes protein kinases have been intensively studied but how they regulate the often unique biology of filamentous fungi is not completely understood. Significant understanding of filamentous fungal biology has come from the study of the model organism Aspergillus nidulans using a combination of molecular genetics, biochemistry, cell biology and genomic approaches. Here we describe dual localization-affinity purification (DLAP) tags enabling endogenous N or C-terminal protein tagging for localization and biochemical studies in A. nidulans. To establish DLAP tag utility we endogenously tagged 17 protein kinases for analysis by live cell imaging and affinity purification. Proteomic analysis of purifications by mass spectrometry confirmed association of the CotA and NimX(Cdk1) kinases with known binding partners and verified a predicted interaction of the SldA(Bub1/R1) spindle assembly checkpoint kinase with SldB(Bub3). We demonstrate that the single TOR kinase of A. nidulans locates to vacuoles and vesicles, suggesting that the function of endomembranes as major TOR cellular hubs is conserved in filamentous fungi. Comparative analysis revealed 7 kinases with mitotic specific locations including An-Cdc7 which unexpectedly located to mitotic spindle pole bodies (SPBs), the first such localization described for this family of DNA replication kinases. We show that the SepH septation kinase locates to SPBs specifically in the basal region of apical cells in a biphasic manner during mitosis and again during septation. This results in gradients of SepH between G1 SPBs which shift along hyphae as each septum forms. We propose that SepH regulates the septation initiation network (SIN) specifically at SPBs in the basal region of G1 cells and that localized gradients of SIN activity promote asymmetric septation.	[De Souza, Colin P.; Hashmi, Shahr B.; Osmani, Aysha H.; Osmani, Stephen A.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	Ohio State University	Osmani, SA (corresponding author), Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA.	osmani.2@osu.edu	Osmani, Stephen A./AAS-3904-2021		NIH [P01 GM068087-08S1, GM042564]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087, R01GM042564] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants P01 GM068087-08S1 and GM042564 from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenza JF, 2012, MOL BIOL CELL, V23, P1889, DOI 10.1091/mbc.E11-11-0925; Abenza JF, 2009, TRAFFIC, V10, P57, DOI 10.1111/j.1600-0854.2008.00848.x; Agromayor M, 2013, TRENDS CELL BIOL, V23, P433, DOI 10.1016/j.tcb.2013.04.006; Anaya P, 1998, GENE, V211, P323, DOI 10.1016/S0378-1119(98)00115-2; Andersen MR, 2008, P NATL ACAD SCI USA, V105, P4387, DOI 10.1073/pnas.0709964105; Apostolaki A, 2012, MOL MICROBIOL, V84, P530, DOI 10.1111/j.1365-2958.2012.08042.x; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Arnaud MB, 2010, NUCLEIC ACIDS RES, V38, pD420, DOI 10.1093/nar/gkp751; Arratia-Quijada J, 2012, EUKARYOT CELL, V11, P1132, DOI 10.1128/EC.00101-12; Bachewich C, 2005, MOL MICROBIOL, V55, P572, DOI 10.1111/j.1365-2958.2004.04404.x; Bailis JM, 2003, NAT CELL BIOL, V5, P1111, DOI 10.1038/ncb1069; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Borkovich KA, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P1; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Bruno KS, 2001, MOL MICROBIOL, V42, P3, DOI 10.1046/j.1365-2958.2001.02605.x; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; CLUTTERBUCK AJ, 1970, J GEN MICROBIOL, V60, P133, DOI 10.1099/00221287-60-1-133; De Souza CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058008; De Souza CP, 2011, EMBO J, V30, P2648, DOI 10.1038/emboj.2011.176; De Souza CP, 2009, MOL BIOL CELL, V20, P2146, DOI 10.1091/mbc.E08-08-0878; De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050; De Souza CPC, 1999, MOL BIOL CELL, V10, P3661, DOI 10.1091/mbc.10.11.3661; Efimov VP, 1998, GENETICS, V149, P101; Egan MJ, 2012, J CELL BIOL; Feoktistova A, 2012, MOL BIOL CELL; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Garcia-Cortes JC, 2009, J CELL BIOL, V186, P739, DOI 10.1083/jcb.200902116; Goldman G. H., 2008, ASPERGILLI GENOMICS; Goya A, 2011, CYTOSKELETON, V68, P69, DOI 10.1002/cm.20500; Grallert A, 2004, GENE DEV, V18, P1007, DOI 10.1101/gad.296204; Grallert A, 2012, NAT CELL BIOL, V14, P738, DOI 10.1038/ncb2514; Greer YE, 2011, CELL CYCLE, V10, P2605, DOI 10.4161/cc.10.16.16386; Guertin DA, 2000, EMBO J, V19, P1803, DOI 10.1093/emboj/19.8.1803; HARRIS SD, 1994, GENETICS, V136, P517; Harris SD, 2001, CURR OPIN MICROBIOL, V4, P736, DOI 10.1016/S1369-5274(01)00276-4; Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745; Hernandez-Rodriguez Y, 2012, EUKARYOT CELL, V11, P311, DOI 10.1128/EC.05164-11; Hofmann AF, 2000, GENETICS, V154, P1577; Horio T, 2005, MOL BIOL CELL, V16, P918, DOI 10.1091/mbc.E04-09-0798; Hossain M, 2012, GENE DEV, V26, P1797, DOI 10.1101/gad.197178.112; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; James SW, 1999, J CELL SCI, V112, P1313; Johns SA, 2006, MOL GENET GENOMICS, V275, P593, DOI 10.1007/S00438-006-0113-0; Johnson AE, 2013, CURR BIOL, V23, P1920, DOI 10.1016/j.cub.2013.07.077; Johnson AE, 2012, CYTOSKELETON, V69, P686, DOI 10.1002/cm.21044; Judelson HS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-700; Kafadar KA, 2003, GENE DEV, V17, P2698, DOI 10.1101/gad.1140603; KIM JS, 1993, PROTEIN SCI, V2, P348; Kim JM, 2006, GENETICS, V173, P685, DOI 10.1534/genetics.105.054304; Kim JM, 2009, MOL BIOL CELL, V20, P2874, DOI 10.1091/mbc.E08-12-1177; Kimata Y, 2011, CURR OPIN CELL BIOL, V23, P135, DOI 10.1016/j.ceb.2010.10.008; Knockleby JW, 2010, CELL CYCLE, V9, P4487, DOI 10.4161/cc.9.22.14047; Konzack S, 2005, MOL BIOL CELL, V16, P497, DOI 10.1091/mbc.E04-02-0083; KORNSTEIN LB, 1992, GENE, V113, P75, DOI 10.1016/0378-1119(92)90671-B; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lara-Rojas F, 2011, MOL MICROBIOL, V80, P436, DOI 10.1111/j.1365-2958.2011.07581.x; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Liu HL, 2010, EUKARYOT CELL, V9, P831, DOI 10.1128/EC.00032-10; Liu HL, 2009, MOL BIOL CELL, V20, P616, DOI 10.1091/mbc.E08-06-0628; Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435; Lusk CP, 2007, TRAFFIC, V8, P647, DOI 10.1111/j.1600-0854.2007.00559.x; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Markina-Inarrairaegui A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067154; Martin-Castellanos C, 2000, MOL BIOL CELL, V11, P543, DOI 10.1091/mbc.11.2.543; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Miller CT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000498; Montembault E, 2007, J CELL BIOL, V179, P601, DOI 10.1083/jcb.200703133; Morozov IY, 2010, MOL MICROBIOL, V76, P503, DOI 10.1111/j.1365-2958.2010.07118.x; MORRIS NR, 1975, GENET RES, V26, P237, DOI 10.1017/S0016672300016049; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Natsume T, 2013, MOL CELL, V50, P661, DOI 10.1016/j.molcel.2013.05.011; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Nayak T, 2010, J CELL BIOL, V190, P317, DOI 10.1083/jcb.201002105; OSMANI AH, 1994, J CELL SCI, V107, P1519; Osmani AH, 2006, MOL BIOL CELL, V17, P4946, DOI 10.1091/mbc.E06-07-0657; OSMANI SA, 1988, CELL, V53, P237, DOI 10.1016/0092-8674(88)90385-6; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; Ovechkina Y, 2003, MOL BIOL CELL, V14, P2192, DOI 10.1091/mbc.e02-10-0641; Park G, 2011, EUKARYOT CELL, V10, P1553, DOI 10.1128/EC.05140-11; Pei Y, 2006, MOL CELL BIOL, V26, P777, DOI 10.1128/MCB.26.3.777-788.2006; Penalva Miguel A, 2012, Cell Logist, V2, P2; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Reyes-Dominguez Y, 2010, MOL MICROBIOL, V76, P1376, DOI 10.1111/j.1365-2958.2010.07051.x; RICHARDS FREDERIC M., 1955, COMPT REND TRAV LAB CARLSBERG SER CHIM, V29, P322; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Seiler S, 2010, MOL MICROBIOL, V78, P1058, DOI 10.1111/j.1365-2958.2010.07392.x; Shen KF, 2013, MOL BIOL CELL, V24, P3842, DOI 10.1091/mbc.E13-07-0422; Shi J, 2008, FUNGAL GENET BIOL, V45, P1570, DOI 10.1016/j.fgb.2008.08.011; Si HY, 2010, GENETICS, V185, P166, DOI 10.1534/genetics.110.114165; Sibthorp C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-847; Sohrmann M, 1998, GENE DEV, V12, P84, DOI 10.1101/gad.12.1.84; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Sturgill TW, 2008, EUKARYOT CELL, V7, P1819, DOI 10.1128/EC.00088-08; Suelmann R, 1997, MOL MICROBIOL, V25, P757, DOI 10.1046/j.1365-2958.1997.5131873.x; Suijkerbuijk SJE, 2012, DEV CELL, V22, P1321, DOI 10.1016/j.devcel.2012.03.009; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Taheri-Talesh N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031218; Takahashi TS, 2008, GENE DEV, V22, P1894, DOI 10.1101/gad.1683308; Takeshita N, 2007, FUNGAL GENET BIOL, V44, P1205, DOI 10.1016/j.fgb.2007.03.006; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Ukil L, 2008, EUKARYOT CELL, V7, P2087, DOI 10.1128/EC.00278-08; Valbuena N, 2012, J CELL SCI, V125, P1920, DOI 10.1242/jcs.094219; van der Waal MS, 2012, EXP CELL RES, V318, P1407, DOI 10.1016/j.yexcr.2012.03.015; Vanrobays E, 2001, EMBO J, V20, P4204, DOI 10.1093/emboj/20.15.4204; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Wakabayashi M, 2010, FUNGAL GENET BIOL, V47, P809, DOI 10.1016/j.fgb.2010.05.010; Wang CF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002460; Wang XS, 2001, J BIOL CHEM, V276, P26559, DOI 10.1074/jbc.M101083200; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Westfall PJ, 2002, MOL BIOL CELL, V13, P110, DOI 10.1091/mbc.01-06-0312; Wong KH, 2008, FUNGAL GENET BIOL, V45, P728, DOI 10.1016/j.fgb.2007.12.009; Wu L, 1998, J CELL BIOL, V141, P1575, DOI 10.1083/jcb.141.7.1575; Xiong Y, 2009, J CELL SCI; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004; YE XS, 1995, EMBO J, V14, P986, DOI 10.1002/j.1460-2075.1995.tb07079.x; Ye XS, 1997, J BIOL CHEM, V272, P33384, DOI 10.1074/jbc.272.52.33384; Zhang J, 2011, J CELL BIOL, V193, P1245, DOI 10.1083/jcb.201011022; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zyss D, 2011, J CELL BIOL, V195, P781, DOI 10.1083/jcb.201106025	131	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90911	10.1371/journal.pone.0090911	http://dx.doi.org/10.1371/journal.pone.0090911			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599037	Green Submitted, Green Published, gold			2022-12-25	WOS:000332479400143
J	Siekmans, K; Receveur, O; Haddad, S				Siekmans, Kendra; Receveur, Olivier; Haddad, Slim			Can an Integrated Approach Reduce Child Vulnerability to Anaemia? Evidence from Three African Countries	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; HEMOGLOBIN CONCENTRATION; NUTRITIONAL-STATUS; YOUNG-CHILDREN; RISK-FACTORS; MALARIA; IRON; SUPPLEMENTATION; HEALTH; PREVALENCE	Addressing the complex, multi-factorial causes of childhood anaemia is best done through integrated packages of interventions. We hypothesized that due to reduced child vulnerability, a "buffering" of risk associated with known causes of anaemia would be observed among children living in areas benefiting from a community-based health and nutrition program intervention. Cross-sectional data on the nutrition and health status of children 24-59 mo (N = 2405) were obtained in 2000 and 2004 from program evaluation surveys in Ghana, Malawi and Tanzania. Linear regression models estimated the association between haemoglobin and immediate, underlying and basic causes of child anaemia and variation in this association between years. Lower haemoglobin levels were observed in children assessed in 2000 compared to 2004 (difference -3.30 g/L), children from Tanzania (-9.15 g/L) and Malawi (-2.96 g/L) compared to Ghana, and the youngest (24-35 mo) compared to oldest age group (48-59 mo; -5.43 g/L). Children who were stunted, malaria positive and recently ill also had lower haemoglobin, independent of age, sex and other underlying and basic causes of anaemia. Despite ongoing morbidity, risk of lower haemoglobin decreased for children with malaria and recent illness, suggesting decreased vulnerability to their anaemia-producing effects. Stunting remained an independent and unbuffered risk factor. Reducing chronic undernutrition is required in order to further reduce child vulnerability and ensure maximum impact of anaemia control programs. Buffering the impact of child morbidity on haemoglobin levels, including malaria, may be achieved in certain settings.	[Siekmans, Kendra] HealthBridge, Ottawa, ON, Canada; [Receveur, Olivier] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Haddad, Slim] Univ Montreal, Univ Montreal Hosp Res Ctr CRCHUM, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Siekmans, K (corresponding author), HealthBridge, Ottawa, ON, Canada.	ksiekmans@healthbridge.ca		Siekmans, Kendra/0000-0002-3116-2278	Canadian International Development Agency; World Vision Canada	Canadian International Development Agency; World Vision Canada	The MICAH program was funded by the Canadian International Development Agency and World Vision Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agho KE, 2008, J HEALTH POPUL NUTR, V26, P200; Barros FC, 2010, REV SAUDE PUBL, V44, P1, DOI 10.1590/S0034-89102010000100001; Bates I, 2004, LANCET INFECT DIS, V4, P267, DOI 10.1016/S1473-3099(04)01002-3; Bates L, 2004, LANCET INFECT DIS, V4, P368, DOI 10.1016/S1473-3099(04)01047-3; Berti PR, 2010, INT J EPIDEMIOL, V39, P613, DOI 10.1093/ije/dyp389; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Brooker S, 1999, T ROY SOC TROP MED H, V93, P240, DOI 10.1016/S0035-9203(99)90007-X; Cercamondi CI, 2010, AM J CLIN NUTR, V92, P1385, DOI 10.3945/ajcn.2010.30051; CHAMBERS R, 1989, IDS BULL-I DEV STUD, V20, P1, DOI 10.1111/j.1759-5436.1989.mp20002001.x; Cornet M, 1998, AM J TROP MED HYG, V58, P606, DOI 10.4269/ajtmh.1998.58.606; Custodio E, 2008, FOOD NUTR BULL, V29, P49, DOI 10.1177/156482650802900106; Delacollette C, 1996, B WORLD HEALTH ORGAN, V74, P423; Desai MR, 2005, AM J TROP MED HYG, V72, P47, DOI 10.4269/ajtmh.2005.72.47; Dewey KG, 2009, FOOD NUTR BULL, V30, pS187, DOI 10.1177/15648265090302S201; Drakeley CJ, 2005, J INFECT DIS, V191, P1589, DOI 10.1086/429669; Ekvall H, 2003, CURR OPIN HEMATOL, V10, P108, DOI 10.1097/00062752-200303000-00002; Eliades MJ, 2006, AM J TROP MED HYG, V75, P622, DOI 10.4269/ajtmh.2006.75.622; Ezeamama AE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000245; Foote EM, 2013, AM J TROP MED HYG, V88, P757, DOI 10.4269/ajtmh.12-0560; Friedman JF, 2005, AM J TROP MED HYG, V73, P698, DOI 10.4269/ajtmh.2005.73.698; Galea S, 2005, SOC SCI MED, V60, P2417, DOI 10.1016/j.socscimed.2004.11.028; Green HK, 2011, PARASITOLOGY, V138, P1534, DOI 10.1017/S0031182011001016; Haldar Kasturi, 2009, Hematology Am Soc Hematol Educ Program, P87, DOI 10.1182/asheducation-2009.1.87; Holtz TH, 2003, T ROY SOC TROP MED H, V97, P491, DOI 10.1016/S0035-9203(03)80003-2; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; Magalhaes RJS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000438; Mason J, 2013, LANCET GLOB HEALTH, V1, pE4, DOI 10.1016/S2214-109X(13)70009-3; McElroy PD, 1999, AM J TROP MED HYG, V61, P932, DOI 10.4269/ajtmh.1999.61.932; Nestel P., 2002, ADJUSTING HEMOGLOBIN; Ngnie-Teta I, 2007, FOOD NUTR BULL, V28, P76, DOI 10.1177/156482650702800109; Onis M. de, 2006, Acta Paediatrica, V95, P76; Osorio MM, 2004, BRIT J NUTR, V91, P307, DOI 10.1079/BJN20031042; Payne LG, 2007, J NUTR, V137, P1455, DOI 10.1093/jn/137.6.1455; Pedro M. R. A., 2004, Food and Nutrition Bulletin, V25, P319; Ratledge C, 2007, FOOD NUTR BULL, V28, pS515, DOI 10.1177/15648265070284S405; Ronald LA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-105; Ruel MT, 2008, LANCET, V371, P588, DOI 10.1016/S0140-6736(08)60271-8; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Schellenberg D, 2003, B WORLD HEALTH ORGAN, V81, P581; Shrimpton R, 2009, FOOD NUTR BULL, V30, pS556, DOI 10.1177/15648265090304S410; Sirima SB, 2003, TROP MED INT HEALTH, V8, P133, DOI 10.1046/j.1365-3156.2003.00997.x; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Stoltzfus RJ, 2007, FOOD NUTR BULL, V28, pS572, DOI 10.1177/15648265070284S410; Stoltzfus RJ, 2000, J NUTR, V130, P1724, DOI 10.1093/jn/130.7.1724; Thurnham DI, 2007, NUTR ANEMIA; UNICEF, 1995, MON PROGR GOALS WORL; UNICEF, 1990, STRAT IMPR NUTR CHIL; World Vision Canada, 2006, WORLD VIS TANZ MICAH; World Vision Canada, 2006, WORLD VIS MAL MICAH; World Vision Canada, 2006, WORLD VIS GHAN MICAH	51	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90108	10.1371/journal.pone.0090108	http://dx.doi.org/10.1371/journal.pone.0090108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598692	Green Published, gold			2022-12-25	WOS:000332479400045
J	Wang, JM; Zhang, T; Du, J; Cui, S; Yang, F; Jin, Q				Wang, Jianmin; Zhang, Ting; Du, Jiang; Cui, Sheng; Yang, Fan; Jin, Qi			Anti-Enterovirus 71 Effects of Chrysin and Its Phosphate Ester	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; ALDOSE REDUCTASE; MOUTH-DISEASE; IN-VITRO; MOLECULAR EPIDEMIOLOGY; ANTIVIRAL ACTIVITY; WESTERN-AUSTRALIA; PROTEIN; VIRUS; INHIBITION	Enterovirus 71 (EV71) can cause severe disease and even lead to death in children, and an effective antiviral drug is currently unavailable. The anti-EV71 effect of chrysin (5,7-dihydroxyflavone), a natural flavonoid commonly found in many plants, was tested in this report. By using the predicting program Autodock 4.0 and an in vitro protease inhibition assay, we found that chrysin could suppress viral 3C(pro) activity. Replication of viral RNA and production of viral capsid protein and the infectious virion were strongly inhibited by chrysin, without noticeable cytotoxicity. Cytopathic effects on cells were also prevented. Diisopropyl chrysin-7-yl phosphate (CPI), the phosphate ester for chrysin, was generated through a simplified Atheron-Todd reaction to achieve stronger anti-viral activity. CPI was also able to bind with and inhibit viral 3C(pro) activity in vitro. As expected, CPI demonstrated more potent antiviral activity against EV71.	[Yang, Fan] Chinese Acad Med Sci, Inst Pathogen Biol, Key Lab Syst Biol Pathogens, MOH, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, F (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, Key Lab Syst Biol Pathogens, MOH, Beijing 100730, Peoples R China.	ymf129@163.com; zdsys@vip.sina.com	wang, jian/GVS-0711-2022; Zhang, Ting/S-8215-2019; Sheng, CUI/M-6405-2013; Cui, Sheng/AAQ-1721-2020	Sheng, CUI/0000-0001-6329-3582; 	National Science and Technology Major Project of China [2013ZX10004-601, 2011ZX10004-001, 2013ZX10004-101]	National Science and Technology Major Project of China	The work was supported by the National Science and Technology Major Project of China, project No. 2013ZX10004-601, No. 2011ZX10004-001 and No. 2013ZX10004-101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chen Xiao-lan, 2007, Yaoxue Xuebao, V42, P396; Chen XL, 2004, ANAL CHEM, V76, P211, DOI 10.1021/ac035027q; Chu PY, 2001, ARCH VIROL, V146, P589, DOI 10.1007/s007050170164; Cui S, 2011, J MOL BIOL, V408, P449, DOI 10.1016/j.jmb.2011.03.007; Fernandez M, 2005, BIOORGAN MED CHEM, V13, P3269, DOI 10.1016/j.bmc.2005.02.038; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; HARRIS KS, 1992, J VIROL, V66, P7481, DOI 10.1128/JVI.66.12.7481-7489.1992; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; Hu YC, 2003, BIOTECHNOL LETT, V25, P919, DOI 10.1023/A:1024071514438; Hung HC, 2010, J ANTIMICROB CHEMOTH, V65, P676, DOI 10.1093/jac/dkp502; Hwang YC, 2006, APPL ENVIRON MICROB, V72, P3710, DOI 10.1128/AEM.72.5.3710-3715.2006; Johari J, 2012, INT J MOL SCI, V13, P16785, DOI 10.3390/ijms131216785; Jung HA, 2012, CHEM-BIOL INTERACT, V197, P110, DOI 10.1016/j.cbi.2012.04.004; Kuo CJ, 2008, BIOORGAN MED CHEM, V16, P7388, DOI 10.1016/j.bmc.2008.06.015; Lei XB, 2013, J VIROL, V87, P1690, DOI 10.1128/JVI.01855-12; Lei XB, 2011, J VIROL, V85, P8811, DOI 10.1128/JVI.00447-11; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li ML, 2002, VIROLOGY, V293, P386, DOI 10.1006/viro.2001.1310; Li ZH, 2008, J INFECT DIS, V197, P854, DOI 10.1086/527326; Liao Hung-Tsai, 2001, Acta Paediatrica Taiwanica, V42, P27; Liu AL, 2008, BIOORGAN MED CHEM, V16, P7141, DOI 10.1016/j.bmc.2008.06.049; Lyu SY, 2005, ARCH PHARM RES, V28, P1293, DOI 10.1007/BF02978215; Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Mercader AG, 2008, BIOORGAN MED CHEM, V16, P7470, DOI 10.1016/j.bmc.2008.06.004; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Nolan MA, 2003, NEUROLOGY, V60, P1651, DOI 10.1212/01.WNL.0000066810.62490.FF; Parsley TB, 1997, RNA, V3, P1124; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Tan CW, 2013, J VIROL, V87, P611, DOI 10.1128/JVI.02226-12; Wang JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052954; Wang JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038035; Weng KF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000593; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560; Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030259	44	41	46	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89668	10.1371/journal.pone.0089668	http://dx.doi.org/10.1371/journal.pone.0089668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598537	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400024
J	Chen, YJ; Wang, YH; Wang, CZ; Ho, ML; Kuo, PL; Huang, MH; Chen, CH				Chen, Yi-Jen; Wang, Yan-Hsiung; Wang, Chau-Zen; Ho, Mei-Ling; Kuo, Po-Lin; Huang, Mao-Hsiung; Chen, Chia-Hsin			Effect of Low Level Laser Therapy on Chronic Compression of the Dorsal Root Ganglion	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RAT SCIATIC-NERVE; FACTOR-ALPHA; NUCLEUS PULPOSUS; SENSORY NEURONS; MESSENGER-RNA; 780 NM; HYPERALGESIA; IRRADIATION; ALLODYNIA	Dorsal root ganglia (DRG) are vulnerable to physical injury of the intervertebral foramen, and chronic compression of the DRG (CCD) an result in nerve root damage with persistent morbidity. The purpose of this study was to evaluate the effects of low level laser therapy (LLLT) on the DRG in a CCD model and to determine the mechanisms underlying these effects. CCD rats had L-shaped stainless-steel rods inserted into the fourth and fifth lumbar intervertebral foramen, and the rats were then subjected to 0 or 8 J/cm(2) LLLT for 8 consecutive days following CCD surgery. Pain and heat stimuli were applied to test for hyperalgesia following CCD. The levels of TNF-alpha, IL-1 beta and growth-associated protein-43 (GAP-43) messenger RNA (mRNA) expression were measured via real-time PCR, and protein expression levels were analyzed through immunohistochemical analyses. Our data indicate that LLLT significantly decreased the tolerable sensitivity to pain and heat stimuli in the CCD groups. The expression levels of the pro-inflammatory cytokines TNF-alpha and IL-1 beta were increased following CCD, and we found that these increases could be reduced by the application of LLLT. Furthermore, the expression of GAP-43 was enhanced by LLLT. In conclusion, LLLT was able to enhance neural regeneration in rats following CCD and improve rat ambulatory behavior. The therapeutic effects of LLLT on the DRG during CCD may be exerted through suppression of the inflammatory response and induction of neuronal repair genes. These results suggest potential clinical applications for LLLT in the treatment of compression-induced neuronal disorders.	[Chen, Yi-Jen; Huang, Mao-Hsiung; Chen, Chia-Hsin] Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Yi-Jen; Kuo, Po-Lin] Kaohsiung Med Univ, Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Wang, Yan-Hsiung; Wang, Chau-Zen; Ho, Mei-Ling] Kaohsiung Med Univ, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Wang, Yan-Hsiung] Kaohsiung Med Univ, Sch Dent, Coll Dent Med, Kaohsiung, Taiwan; [Wang, Chau-Zen; Ho, Mei-Ling] Kaohsiung Med Univ, Dept Physiol, Coll Med, Kaohsiung, Taiwan; [Ho, Mei-Ling] Kaohsiung Med Univ, Grad Inst Med, Sch Med, Kaohsiung, Taiwan; [Kuo, Po-Lin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Huang, Mao-Hsiung] Kaohsiung Med Univ, Sch Med, Dept Phys Med & Rehabil, Fac Med, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Municipal Tatung Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital	Chen, CH (corresponding author), Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan.	chchen@kmu.edu.tw	Wang, Yan-Hsiung/ABD-4004-2020	Wang, Yan-Hsiung/0000-0001-8161-7472; Chen, Yi-Jen/0000-0002-5178-2335; Chen, Chia-Hsin/0000-0002-6557-9848; Ho, Mei-Ling/0000-0001-8064-8488	National Health Research Institutes [NHRI-EX 102-9914EC]; National Science Council [NSC97-2314-B-037-004-MY3]; Kaohsiung Medical University [KMU-Q098007, KMU-Q098025, KMU-Q099018]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University	This study was supported by a grant from the National Health Research Institutes (NHRI-EX 102-9914EC), a grant from the National Science Council (NSC97-2314-B-037-004-MY3) and grants from the Kaohsiung Medical University (KMU-Q098007, KMU-Q098025 and KMU-Q099018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa RI, 2010, LASER MED SCI, V25, P423, DOI 10.1007/s10103-009-0750-8; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chow RT, 2007, J PERIPHER NERV SYST, V12, P28, DOI 10.1111/j.1529-8027.2007.00114.x; Camara CND, 2011, ACTA CIR BRAS, V26, P12, DOI 10.1590/S0102-86502011000100004; Grava ALD, 2012, EUR SPINE J, V21, P537, DOI 10.1007/s00586-011-2027-8; Gigo-Benato D, 2005, MUSCLE NERVE, V31, P694, DOI 10.1002/mus.20305; Gigo-Benato D, 2010, LASER SURG MED, V42, P673, DOI 10.1002/lsm.20978; Gilchrist Russel V, 2002, Pain Physician, V5, P372; Gu XP, 2007, BRAIN RES, V1174, P39, DOI 10.1016/j.brainres.2007.08.030; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Ho ML, 2009, EUR J CLIN INVEST, V39, P296, DOI 10.1111/j.1365-2362.2009.02092.x; Hsieh YL, 2012, J COMP NEUROL, V520, P2903, DOI 10.1002/cne.23072; Hu SJ, 1998, PAIN, V77, P15, DOI 10.1016/S0304-3959(98)00067-0; Jimbo K, 1998, NEUROSCI LETT, V240, P93, DOI 10.1016/S0304-3940(97)00935-X; Liu B, 2002, J NEUROPHYSIOL, V88, P1393, DOI 10.1152/jn.2002.88.3.1393; Mohammed IFR, 2007, PHOTOMED LASER SURG, V25, P107, DOI 10.1089/pho.2006.1090; Ozaktay AC, 2002, EUR SPINE J, V11, P467, DOI 10.1007/s00586-002-0430-x; Rochkind S, 2007, PHOTOMED LASER SURG, V25, P436, DOI 10.1089/pho.2007.2093; Rothman SM, 2009, J PAIN, V10, P90, DOI 10.1016/j.jpain.2008.07.008; RYDEVIK BL, 1989, SPINE, V14, P574, DOI 10.1097/00007632-198906000-00004; Schaeffer V, 2010, PROG NEUROBIOL, V92, P33, DOI 10.1016/j.pneurobio.2010.04.009; Schafers M, 2003, J NEUROSCI, V23, P2517; Shin DH, 2003, NEUROSCI LETT, V344, P71, DOI 10.1016/S0304-3940(03)00354-9; Snyder SK, 2002, LASER SURG MED, V31, P216, DOI 10.1002/lsm.10098; Song XJ, 1999, J NEUROPHYSIOL, V82, P3347, DOI 10.1152/jn.1999.82.6.3347; VANDERZEE CEEM, 1989, J NEUROSCI, V9, P3505; Watanabe K, 2007, SPINE, V32, P1265, DOI 10.1097/BRS.0b013e318059aef8; Watanabe K, 2011, EUR SPINE J, V20, P1877, DOI 10.1007/s00586-011-1854-y; Wu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054067, 10.1371/journal.pone.0067644]; Yamashita M, 2008, SPINE, V33, P1836, DOI 10.1097/BRS.0b013e31817bab2a; Zhang JM, 2000, J NEUROPHYSIOL, V84, P798, DOI 10.1152/jn.2000.84.2.798	31	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89894	10.1371/journal.pone.0089894	http://dx.doi.org/10.1371/journal.pone.0089894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594641	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500027
J	Donati, V; Feltrin, F; Hendriksen, RS; Svendsen, CA; Cordaro, G; Garcia-Fernandez, A; Lorenzetti, S; Lorenzetti, R; Battisti, A; Franco, A				Donati, Valentina; Feltrin, Fabiola; Hendriksen, Rene S.; Svendsen, Christina Aaby; Cordaro, Gessica; Garcia-Fernandez, Aurora; Lorenzetti, Serena; Lorenzetti, Raniero; Battisti, Antonio; Franco, Alessia			Extended-Spectrum-Beta-Lactamases, AmpC Beta-Lactamases and Plasmid Mediated Quinolone Resistance in Klebsiella spp. from Companion Animals in Italy	PLOS ONE			English	Article							ESCHERICHIA-COLI; PNEUMONIAE CLONE; MULTIPLEX PCR; DETERMINANTS QNR; GENES; PREVALENCE; ENTEROBACTERIACEAE; AAC(6')-IB-CR; OUTBREAK; IDENTIFICATION	We report the genetic characterization of 15 Klebsiella pneumoniae (KP) and 4 isolates of K. oxytoca (KO) from clinical cases in dogs and cats and showing extended-spectrum cephalosporin (ESC) resistance. Extended spectrum beta-lactamase (ESBL) and AmpC genes, plasmid-mediated quinolone resistance (PMQR) and co-resistances were investigated. Among KP isolates, ST101 clone was predominant (8/15, 53%), followed by ST15 (4/15, 27%). ST11 and ST340, belonging to Clonal Complex (CC) 11, were detected in 2012 (3/15, 20%). MLST on KP isolates corresponded well with PFGE results, with 11 different PFGE patterns observed, including two clusters of two (ST340) and four (ST101) indistinguishable isolates, respectively. All isolates harbored at least one ESBL or AmpC gene, all carried on transferable plasmids (IncR, IncFII, IncI1, IncN), and 16/19 were positive for PMQR genes (qnr family or aac(6')-Ib-cr). The most frequent ESBL was CTX-M-15 (11/19, 58%), detected in all KP ST101, in one KP ST15 and in both KP ST340. bla(CTX-M-15) was carried on IncR plasmids in all but one KP isolate. All KP ST15 isolates harbored different ESC resistance genes and different plasmids, and presented the non-transferable bla(SHV-28) gene, in association with bla(CTX-M-15), bla(CTX-M-1) (on IncR, or on IncN), bla(SHV-2a) (on IncR) or bla(CMY-2) genes (on IncI1). KO isolates were positive for bla(CTX-M-9) gene (on IncHI2), or for the bla(SHV-12) and bla(DHA-1) genes (on IncL/M). They were all positive for qnr genes, and one also for the aac(6')-Ib-cr gene. All Klebsiella isolates showed multiresistance towards aminoglycosides, sulfonamides, tetracyclines, trimethoprim and amphenicols, mediated by strA/B, aadA2, aadB, ant (2")-Ia, aac(6')-Ib, sul, tet, dfr and cat genes in various combinations. The emergence in pets of multidrug-resistant Klebsiella with ESBL, AmpC and PMQR determinants, poses further and serious challenges in companion animal therapy and raise concerns for possible bidirectional transmission between pets and humans, especially at household level.	[Donati, Valentina; Feltrin, Fabiola; Cordaro, Gessica; Lorenzetti, Serena; Lorenzetti, Raniero; Battisti, Antonio; Franco, Alessia] Ist Zooprofilatt Sperimentale Regioni Lazio & Tos, Rome, Italy; [Hendriksen, Rene S.; Svendsen, Christina Aaby] Tech Univ Denmark, Natl Food Inst DTU Food, DK-2800 Lyngby, Denmark; [Garcia-Fernandez, Aurora] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy	Technical University of Denmark; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS)	Battisti, A (corresponding author), Ist Zooprofilatt Sperimentale Regioni Lazio & Tos, Rome, Italy.	antonio.battisti@izslt.it	García-Fernández, Aurora/K-2560-2016; Battisti, Antonio/AAQ-9243-2021	García-Fernández, Aurora/0000-0002-5070-6154; Battisti, Antonio/0000-0003-1308-199X; Aaby Svendsen, Christina/0000-0002-2532-6854; Franco, Alessia/0000-0001-6968-973X; Hendriksen, Rene S./0000-0003-2934-8214				ARLET G, 1995, FEMS MICROBIOL LETT, V134, P203, DOI 10.1111/j.1574-6968.1995.tb07938.x; Boccia D, 2005, Ann Ig, V17, P95; Briales A, 2012, INT J ANTIMICROB AG, V39, P431, DOI 10.1016/j.ijantimicag.2011.12.009; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Carter G., 2004, ESSENTIALS VET BACTE; Cattoir V, 2007, J ANTIMICROB CHEMOTH, V60, P394, DOI 10.1093/jac/dkm204; Cavaco LM, 2009, ANTIMICROB AGENTS CH, V53, P603, DOI 10.1128/AAC.00997-08; Cavaco LM, 2008, MICROB DRUG RESIST, V14, P163, DOI 10.1089/mdr.2008.0821; Chowdhury PR, 2011, ANTIMICROB AGENTS CH, V55, P3140, DOI 10.1128/AAC.01529-10; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; Coelho A, 2010, INT J ANTIMICROB AG, V36, P73, DOI 10.1016/j.ijantimicag.2010.03.005; D'Andrea MM, 2013, INT J MED MICROBIOL; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Durmaz R, 2009, JPN J INFECT DIS, V62, P372; Fontana C, 2005, J CLIN MICROBIOL, V43, P615, DOI 10.1128/JCM.43.2.615-619.2005; Fontana C, 2010, BMC RES NOTES, V23, P3; Frank T, 2007, J ANTIMICROB CHEMOTH, V59, P742, DOI 10.1093/jac/dkl538; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Garcia-Fernandez A, 2012, ANTIMICROB AGENTS CH, V56, P2143, DOI 10.1128/AAC.05308-11; Garcia-Fernandez A, 2010, ANTIMICROB AGENTS CH, V54, P4178, DOI 10.1128/AAC.01301-09; Haenni M, 2012, J ANTIMICROB CHEMOTH, V67, P770, DOI 10.1093/jac/dkr527; Hidalgo L, 2013, ANTIMICROB AGENTS CH, V57, P4532, DOI 10.1128/AAC.00491-13; Hujer AM, 2002, J CLIN MICROBIOL, V40, P1947, DOI 10.1128/JCM.40.6.1947-1957.2002; Jemima SA, 2009, INDIAN J MED MICROBI, V27, P51; Jonas D, 2004, RES MICROBIOL, V155, P17, DOI 10.1016/j.resmic.2003.09.011; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Lavilla S, 2008, J ANTIMICROB CHEMOTH, V61, P291, DOI 10.1093/jac/dkm448; Lavollay M, 2006, ANTIMICROB AGENTS CH, V50, P2433, DOI 10.1128/AAC.00150-06; Ma JY, 2009, ANTIMICROB AGENTS CH, V53, P519, DOI 10.1128/AAC.00886-08; Mammina C, 2012, EUROSURVEILLANCE, V17, P9; Mammina C, 2012, INT J ANTIMICROB AG, V39, P543, DOI 10.1016/j.ijantimicag.2012.02.012; Migliavacca R, 2013, NEW MICROBIOL, V36, P109; Miro E, 2010, J ANTIMICROB CHEMOTH, V65, P661, DOI 10.1093/jac/dkp504; Nielsen JB, 2011, EUR J CLIN MICROBIOL, V30, P773, DOI 10.1007/s10096-011-1153-x; Ode T, 2009, INT J ANTIMICROB AG, V34, P347, DOI 10.1016/j.ijantimicag.2009.05.007; Osterblad M, 2012, J ANTIMICROB CHEMOTH, V67, P2860, DOI 10.1093/jac/dks299; Park CH, 2006, ANTIMICROB AGENTS CH, V50, P3953, DOI 10.1128/AAC.00915-06; Paterson DL, 2003, ANTIMICROB AGENTS CH, V47, P3554, DOI 10.1128/AAC.47.11.3554-3560.2003; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Perichon B, 2007, ANTIMICROB AGENTS CH, V51, P2464, DOI 10.1128/AAC.00143-07; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Qi Y, 2011, J ANTIMICROB CHEMOTH, V66, P307, DOI 10.1093/jac/dkq431; Quinn P.J., 2004, CLIN VET MICROBIOLOG; Roberts DE, 2000, J VET DIAGN INVEST, V12, P168, DOI 10.1177/104063870001200215; Roh KH, 2008, YONSEI MED J, V49, P53, DOI 10.3349/ymj.2008.49.1.53; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Vo ATT, 2007, VET MICROBIOL, V124, P248, DOI 10.1016/j.vetmic.2007.04.027; Voulgari E, 2013, J ANTIMICROB CHEMOTH, V68, P84, DOI 10.1093/jac/dks356; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI 10.1093/jac/dki412; Yang JY, 2011, MICROB DRUG RESIST, V17, P363, DOI 10.1089/mdr.2011.0034; Yu VL, 2007, EMERG INFECT DIS, V13, P986, DOI 10.3201/eid1307.070187	54	67	68	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90564	10.1371/journal.pone.0090564	http://dx.doi.org/10.1371/journal.pone.0090564			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595207	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500068
J	Li, GC; Xie, RS; Zhu, XP; Mao, YL; Liu, SX; Jiao, HM; Yan, H; Xiong, K; Ji, MC				Li, Guocai; Xie, Rushan; Zhu, Xiaoping; Mao, Yanli; Liu, Shuangxi; Jiao, Hongmei; Yan, Hua; Xiong, Kun; Ji, Mingchun			Antibodies with Higher Bactericidal Activity Induced by a Neisseria gonorrhoeae Rmp Deletion Mutant Strain	PLOS ONE			English	Article							GONOCOCCAL PILUS VACCINE; OUTER-MEMBRANE PROTEIN; REPLICON PARTICLES; IMMUNE-RESPONSES; MICE; IMMUNIZATION; PEPTIDE; EPITOPE; TRANSMISSION; CULTIVATION	Neisseria gonorrhoeae (N. gonorrhoeae) outer membrane protein reduction modifiable protein (Rmp) has strong immunogenicity. However, anti-Rmp antibodies block rather than preserve the antibacterial effects of protective antibodies, which hampers the development of vaccines for gonococcal infections. We herein constructed an Rmp deletion mutant strain of N. gonorrhoeae by gene homologous recombination. The 261-460 nucleotide residues of Rmp gene amplified from N. gonorrhoeae WHO-A strain were replaced with a kanamycin-resistant Kan gene amplified from pET-28a. The resultant hybridized DNA was transformed into N. gonorrhoeae WHO-A strain. PCR was used to screen the colonies in which wild-type Rmp gene was replaced with a mutant gene fragment. Western blotting revealed that the Rmp deletion mutant strain did not express Rmp protein. Rmp deletion did not alter the morphological and Gram staining properties of the mutant strain that grew slightly more slowly than the wild-type one. Rmp gene mutated stably throughout 25 generations of passage. Antibody-mediated complement-dependent cytotoxicity assay indicated that the antibodies induced by the mutant strain had evidently higher bactericidal activities than those induced by the wild-type strain. Further modification of the Rmp deletion mutant strain is still required in the development of novel live attenuated vaccines for gonorrhea by Opa genes deletion or screening of phenotypic variant strains that do not express Opa proteins.	[Li, Guocai; Mao, Yanli; Liu, Shuangxi; Jiao, Hongmei; Yan, Hua; Ji, Mingchun] Yangzhou Univ, Sch Med, Dept Pathogen Biol & Immunol, Yangzhou, Jiangsu, Peoples R China; [Li, Guocai; Mao, Yanli; Liu, Shuangxi; Jiao, Hongmei] Yangzhou Univ, Jiangsu Key Lab Zoonosis, Yangzhou, Jiangsu, Peoples R China; [Xie, Rushan] Heze Med Coll, Dept Pathogen Biol, Heze, Shandong, Peoples R China; [Zhu, Xiaoping] Yangzhou Univ, Clin Testing Ctr, Coll Clin Med, Yangzhou, Jiangsu, Peoples R China; [Xiong, Kun] Cent S Univ, Dept Anatomyand Neurobiol, Sch Basic Med Sci, Changsha, Hunan, Peoples R China	Yangzhou University; Yangzhou University; Yangzhou University; Central South University	Li, GC (corresponding author), Yangzhou Univ, Sch Med, Dept Pathogen Biol & Immunol, Yangzhou, Jiangsu, Peoples R China.	gcli@yzu.edu.cn; xiongkun2001@163.com	Li, Guocai/HGC-9680-2022		National Natural Science Foundation of China [31100652]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (31100652). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barh Debmalya, 2009, In Silico Biology, V9, P225, DOI 10.3233/ISB-2009-0399; BOSLEGO JW, 1991, VACCINE, V9, P154, DOI 10.1016/0264-410X(91)90147-X; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; BROSSAY L, 1993, J IMMUNOL, V151, P234; CARTWRIGHT CP, 1994, J CLIN MICROBIOL, V32, P1825, DOI 10.1128/JCM.32.7.1825-1826.1994; Chen CC, 2011, J BACTERIOL, V193, P1788, DOI 10.1128/JB.00007-11; Chung GT, 2008, J BACTERIOL, V190, P6035, DOI 10.1128/JB.00566-08; Cole JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008108; De Seta F, 2012, GIORN ITAL DERMAT V, V147, P423; del Rio Carlos, 2012, Morbidity and Mortality Weekly Report, V61, P590; Ding J, 2010, J IMMUNOL, V184, P2814, DOI 10.4049/jimmunol.0902125; GOTSCHLICH EC, 1986, J EXP MED, V164, P868, DOI 10.1084/jem.164.3.868; GOTSCHLICH EC, 1987, J EXP MED, V165, P471, DOI 10.1084/jem.165.2.471; Gulati S, 1996, J INFECT DIS, V174, P1238, DOI 10.1093/infdis/174.6.1238; Hansen JK, 2007, INFECT IMMUN, V75, P4138, DOI 10.1128/IAI.02015-06; Hauck CR, 2003, CURR OPIN MICROBIOL, V6, P43, DOI 10.1016/S1369-5274(03)00004-3; HECKELS JE, 1990, VACCINE, V8, P225, DOI 10.1016/0264-410X(90)90050-V; Javanbakht M., 2007, Morbidity and Mortality Weekly Report, V56, P222; JUDD RC, 1982, INFECT IMMUN, V37, P622, DOI 10.1128/IAI.37.2.622-631.1982; Klotman ME, 2008, J IMMUNOL, V180, P6176, DOI 10.4049/jimmunol.180.9.6176; Li GC, 2011, CLIN VACCINE IMMUNOL, V18, P1817, DOI 10.1128/CVI.05245-11; LYTTON EJ, 1986, J EXP MED, V164, P1749, DOI 10.1084/jem.164.5.1749; MCCHESNEY D, 1982, INFECT IMMUN, V36, P1006, DOI 10.1128/IAI.36.3.1006-1012.1982; MCDADE RL, 1980, J BACTERIOL, V141, P1183, DOI 10.1128/JB.141.3.1183-1191.1980; Ngampasutadol J, 2006, VACCINE, V24, P157, DOI 10.1016/j.vaccine.2005.07.065; Pantelic M, 2005, INFECT IMMUN, V73, P4171, DOI 10.1128/IAI.73.7.4171-4179.2005; Plante M, 1999, INFECT IMMUN, V67, P2855, DOI 10.1128/IAI.67.6.2855-2861.1999; Plante M, 2000, J INFECT DIS, V182, P848, DOI 10.1086/315801; PLUMMER FA, 1993, J CLIN INVEST, V91, P339, DOI 10.1172/JCI116190; Price GA, 2005, INFECT IMMUN, V73, P3945, DOI 10.1128/IAI.73.7.3945-3953.2005; RICE PA, 1986, J EXP MED, V164, P1735, DOI 10.1084/jem.164.5.1735; RICE PA, 1994, ANN NY ACAD SCI, V730, P7, DOI 10.1111/j.1749-6632.1994.tb44234.x; SIEGEL M, 1982, J INFECT DIS, V145, P300, DOI 10.1093/infdis/145.3.300; Takei M, 2005, J CLIN MICROBIOL, V43, P4321, DOI 10.1128/JCM.43.9.4321-4327.2005; Thomas CE, 2006, INFECT IMMUN, V74, P1612, DOI 10.1128/IAI.74.3.1612-1620.2006; TRAMONT EC, 1981, J CLIN INVEST, V68, P881, DOI 10.1172/JCI110343; Voges M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-117; WETZLER LM, 1989, J EXP MED, V169, P2199, DOI 10.1084/jem.169.6.2199; WHO, 2012, GLOB INC PREV SEL CU; WONG TP, 1981, INFECT IMMUN, V34, P739, DOI 10.1128/IAI.34.3.739-745.1981; Zhu W, 2004, VACCINE, V22, P660, DOI 10.1016/j.vaccine.2003.08.036; Zhu WY, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00124; Zhu WY, 2005, INFECT IMMUN, V73, P7558, DOI 10.1128/IAI.73.11.7558-7568.2005	43	3	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90525	10.1371/journal.pone.0090525	http://dx.doi.org/10.1371/journal.pone.0090525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594737	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500059
J	Ni, W; Lin, N; He, H; Zhu, JX; Zhang, YJ				Ni, Wensi; Lin, Ning; He, Hua; Zhu, Jianxing; Zhang, Yongjun			Lipopolysaccharide Induces Up-Regulation of TGF-alpha through HDAC2 in a Rat Model of Bronchopulmonary Dysplasia	PLOS ONE			English	Article							HISTONE DEACETYLASE ACTIVITY; LUNG INFLAMMATION; PULMONARY; HYPEROXIA; CYTOKINES; INTERLEUKIN-6; THEOPHYLLINE; EXPRESSION; BIRTH; EGF	Bronchopulmonary dysplasia (BPD) is characterized by alveolar simplification with decreased alveolar number and increased airspace. Previous studies suggested that transforming growth factor-alpha (TGF-alpha) may contribute to arrested alveolar development in BPD. Histone deacetylases (HDACs) control cellular signaling and gene expression. HDAC2 is crucial for suppression of inflammatory gene expression. Here we investigated whether HDAC2 was involved in the arrest of alveolarization, as well as the ability of HDAC2 to regulate TGF-alpha expression in a rat model of BPD induced by intra-amniotic injection of lipopolysaccharide (LPS). Results showed that LPS exposure led to a suppression of both HDAC1 and HDAC2 expression and activity, induced TGF-alpha expression, and disrupted alveolar morphology. Mechanistic studies showed that overexpression of HDAC2, but not HDAC1, suppressed LPS-induced TGF-alpha expression. Moreover, the HDAC inhibitor TSA or downregulation of HDAC2 by siRNA both significantly increased TGF-alpha expression in cultured myofibroblasts. Finally, preservation of HDAC activity by theophylline treatment improved alveolar development and attenuated TGF-alpha release. Together, these findings indicate that attenuation of TGF-alpha-mediated effects in the lung by enhancing HDAC2 may have a therapeutic effect on treating BPD.	[Ni, Wensi; Lin, Ning; He, Hua; Zhu, Jianxing; Zhang, Yongjun] Shanghai Jiao Tong Univ, Sch Med, XinHua Hosp, Shanghai 200030, Peoples R China; [Zhang, Yongjun] MOE, Shanghai, Peoples R China; [Zhang, Yongjun] Shanghai Key Lab Childrens Environm Hlth, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zhang, YJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, XinHua Hosp, Shanghai 200030, Peoples R China.	zhangyongjun@sjtu.edu.cn			Shanghai Natural Science Foundation [11ZR1423800]; National Natural Science Foundation of China [81270729]	Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Shanghai Natural Science Foundation (No. 11ZR1423800) and National Natural Science Foundation of China (No. 81270729 to Y. Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambalavanan N, 2009, PEDIATRICS, V123, P1132, DOI 10.1542/peds.2008-0526; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Brunmeir R, 2009, INT J DEV BIOL, V53, P275, DOI 10.1387/ijdb.082649rb; Cao L, 2009, AM J PHYSIOL-LUNG C, V296, pL726, DOI 10.1152/ajplung.90405.2008; Choi CW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035250500404085; Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8; Deng H, 2000, AM J RESP CRIT CARE, V162, P2316, DOI 10.1164/ajrccm.162.6.9911020; DiCamillo SJ, 2006, AM J PHYSIOL-LUNG C, V291, pL232, DOI 10.1152/ajplung.00530.2005; Husain AN, 1998, HUM PATHOL, V29, P710, DOI 10.1016/S0046-8177(98)90280-5; Ingram JL, 2006, CURR MOL MED, V6, P409, DOI 10.2174/156652406777435426; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Ito K, 2002, AM J RESP CRIT CARE, V166, P392, DOI 10.1164/rccm.2110060; Ito K, 2002, P NATL ACAD SCI USA, V99, P8921, DOI 10.1073/pnas.132556899; Jobe AH, 2001, RESP RES, V2, P27, DOI 10.1186/rr35; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Jobe Alan H, 2003, Semin Neonatol, V8, P9, DOI 10.1016/S1084-2756(02)00188-4; Kramer OH, 2009, TRENDS PHARMACOL SCI, V30, P647, DOI 10.1016/j.tips.2009.09.007; Kramer EL, 2007, AM J PHYSIOL-LUNG C, V293, pL314, DOI 10.1152/ajplung.00354.2006; Lei WW, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.21; Li HP, 2012, AM J PHYSIOL-LUNG C, V302, pL569, DOI 10.1152/ajplung.00217.2011; Li LL, 2012, INT IMMUNOPHARMACOL, V13, P15, DOI 10.1016/j.intimp.2012.03.001; Londhe VA, 2011, PEDIATR RES, V69, P371, DOI 10.1203/PDR.0b013e318211c917; Lordan JL, 2002, J IMMUNOL, V169, P407, DOI 10.4049/jimmunol.169.1.407; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Perl AKT, 2009, AM J PHYSIOL-LUNG C, V297, pL299, DOI 10.1152/ajplung.00008.2009; Prince LS, 2005, DEV DYNAM, V233, P553, DOI 10.1002/dvdy.20362; Speer CP, 2001, BIOL NEONATE, V79, P205; Sun XW, 2012, CAN J PHYSIOL PHARM, V90, P895, DOI [10.1139/Y2012-079, 10.1139/y2012-079]; Szulakowski P, 2006, AM J RESP CRIT CARE, V174, P41, DOI 10.1164/rccm.200505-725OC; Van Marter LJ, 2002, J PEDIATR-US, V140, P171, DOI 10.1067/mpd.2002.121381; Vigushin DM, 2001, CLIN CANCER RES, V7, P971; Viscardi RM, 2004, PEDIATR RES, V55, P1009, DOI 10.1203/01.pdr.0000127015.60185.8a; Waheed S, 2002, EXP LUNG RES, V28, P361, DOI 10.1080/01902140290091994; Wang Y, 2013, DEV CELL, V24, P345, DOI 10.1016/j.devcel.2013.01.012; Yamada M, 2005, J HISTOCHEM CYTOCHEM, V53, P735, DOI 10.1369/jhc.4A6483.2005; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P825, DOI 10.1016/S0002-9378(97)70276-X; Zhang J, 2011, CYTOKINE, V54, P289, DOI 10.1016/j.cyto.2011.02.018; Zhu LC, 2012, PEDIATR PULM, V47, P264, DOI 10.1002/ppul.21540	40	10	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e91083	10.1371/journal.pone.0091083	http://dx.doi.org/10.1371/journal.pone.0091083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595367	gold, Green Submitted, Green Published			2022-12-25	WOS:000332475500114
J	Perera, ND; Sheean, RK; Scott, JW; Kemp, BE; Horne, MK; Turner, BJ				Perera, Nirma D.; Sheean, Rebecca K.; Scott, John W.; Kemp, Bruce E.; Horne, Malcolm K.; Turner, Bradley J.			Mutant TDP-43 Deregulates AMPK Activation by PP2A in ALS Models	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN-KINASE; CALORIC RESTRICTION; TRANSGENIC MICE; MOTOR-NEURONS; DEGENERATION; MITOCHONDRIA; INDUCTION; PATHWAYS; MOUSE	Bioenergetic abnormalities and metabolic dysfunctionoccur in amyotrophic lateral sclerosis (ALS) patients and genetic mouse models. However, whether metabolic dysfunction occurs earlyin ALS pathophysiology linked to different ALS genes remains unclear. Here, we investigatedAMP-activated protein kinase (AMPK) activation, which is a key enzyme induced by energy depletion and metabolic stress, inneuronal cells and mouse models expressing mutantsuperoxide dismutase 1 (SOD1) or TAR DNA binding protein 43 (TDP-43) linked to ALS.AMPKphosphorylation was sharply increased in spinal cords of transgenic SOD1(G93A) mice at disease onset and accumulated incytoplasmic granules in motor neurons, but not in presymptomatic mice. AMPK phosphorylation also occurred in peripheraltissues, liver and kidney, in SOD1(G93A) mice at disease onset, demonstrating that AMPK activation occurs late and is not restricted to motor neurons. Conversely, AMPK activity was drastically diminished in spinal cords and brains of presymptomatic and symptomatictransgenic TDP-43(A315T) mice and motor neuronal cells expressing different TDP-43 mutants. We show that mutant TDP-43 induction of the AMPK phosphatase, protein phosphatase 2A (PP2A), is associated with AMPK inactivation in these ALS models. Furthermore, PP2A inhibition by okadaic acid reversed AMPK inactivation by mutant TDP-43 in neuronal cells. Our results suggest that mutant SOD1 and TDP-43 exert contrasting effects on AMPK activation which may reflect key differences in energy metabolism and neurodegeneration in spinal cords of SOD1(G93A) and TDP-43(A315T) mice. While AMPK activation in motor neurons correlateswith progressionin mutant SOD1-mediated disease, AMPK inactivation mediated by PP2Ais associated withmutant TDP-43-linked ALS.	[Perera, Nirma D.; Sheean, Rebecca K.; Horne, Malcolm K.; Turner, Bradley J.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Perera, Nirma D.; Sheean, Rebecca K.; Horne, Malcolm K.; Turner, Bradley J.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia; [Scott, John W.; Kemp, Bruce E.] Univ Melbourne, St Vincents Inst, Melbourne, Vic, Australia; [Scott, John W.; Kemp, Bruce E.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; University of Melbourne	Turner, BJ (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia.	bradley.turner@florey.edu.au	Kemp, Bruce/G-9602-2019; Scott, John W/P-1170-2018; Perera, Nirma/AAK-8871-2021; Horne, Malcolm/AAL-5214-2020; Scott, John W/AAA-2676-2021; Kemp, Bruce E/L-2633-2014	Kemp, Bruce/0000-0001-6735-5082; Scott, John W/0000-0002-1896-9798; Perera, Nirma/0000-0002-7695-6290; Horne, Malcolm/0000-0001-9427-2100; Scott, John W/0000-0002-1896-9798; Kemp, Bruce E/0000-0001-6735-5082; Turner, Bradley/0000-0001-6580-7655	Australian National Health and Medical Research Council [1008910]; MND Research Institute of Australia; Bethlehem Griffiths Research Foundation; Victorian Government through the Operational Infrastructure Scheme; Australian Postgraduate Award Scholarship	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); MND Research Institute of Australia; Bethlehem Griffiths Research Foundation; Victorian Government through the Operational Infrastructure Scheme; Australian Postgraduate Award Scholarship	This work was supported by the Australian National Health and Medical Research Council (Project Grant 1008910), MND Research Institute of Australia (Mick Rodger Benalla and Susie Harris Memorial Fund MND Research Grants), Bethlehem Griffiths Research Foundation and Victorian Government through the Operational Infrastructure Scheme. N.P. is supported by an Australian Postgraduate Award Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8; Browne SE, 2006, NEUROBIOL DIS, V22, P599, DOI 10.1016/j.nbd.2006.01.001; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; Desport JC, 1999, NEUROLOGY, V53, P1059, DOI 10.1212/WNL.53.5.1059; Desport JC, 2001, AM J CLIN NUTR, V74, P328; Dodge JC, 2013, P NATL ACAD SCI USA, V110, P10812, DOI 10.1073/pnas.1308421110; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Esmaeili MA, 2013, INT J EXP PATHOL, V94, P56, DOI 10.1111/iep.12006; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Ferraiuolo L, 2011, BRAIN, V134, P2627, DOI 10.1093/brain/awr193; Funalot B, 2009, AMYOTROPH LATERAL SC, V10, P113, DOI 10.1080/17482960802295192; Garcia-Haro L, 2010, FASEB J, V24, P5080, DOI 10.1096/fj.10-166306; Guo YS, 2012, BRAIN RES, V1460, P88, DOI 10.1016/j.brainres.2012.04.003; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hamadeh MJ, 2006, MUSCLE NERVE, V34, P709, DOI 10.1002/mus.20630; Kaneb HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024189; Kong JM, 1998, J NEUROSCI, V18, P3241; Li J, 2010, J CEREBR BLOOD F MET, V30, P480, DOI 10.1038/jcbfm.2009.255; Lim MA, 2012, J NEUROSCI, V32, P1123, DOI 10.1523/JNEUROSCI.6554-10.2012; Meyerowitz J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-57; Patel BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009386; Ravnskjaer K, 2006, J MOL ENDOCRINOL, V36, P289, DOI 10.1677/jme.1.01965; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Shaw PJ, 2000, J NEUROL, V247, P17; Soo KY, 2009, J NEUROCHEM, V108, P578, DOI 10.1111/j.1471-4159.2008.05799.x; Stallings NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071793; Turner BJ, 2005, J NEUROSCI, V25, P108, DOI 10.1523/JNEUROSCI.4253-04.2005; Vaisman N, 2009, J NEUROL SCI, V279, P26, DOI 10.1016/j.jns.2008.12.027; Voss M, 2011, CELL SIGNAL, V23, P114, DOI 10.1016/j.cellsig.2010.08.010; Wang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013096; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106	33	37	37	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90449	10.1371/journal.pone.0090449	http://dx.doi.org/10.1371/journal.pone.0090449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595038	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500050
J	Parashar, A; Gade, SK; Potnuru, M; Madhavan, N; Manoj, KM				Parashar, Abhinav; Gade, Sudeep Kumar; Potnuru, Mahesh; Madhavan, Nandita; Manoj, Kelath Murali			The Curious Case of Benzbromarone: Insight into Super-Inhibition of Cytochrome P450	PLOS ONE			English	Article							METABOLISM; SPECIFICITY; MOLECULES; KINETICS; P4502C9	Cytochrome P450 (CYP) family of redox enzymes metabolize drugs and xenobiotics in liver microsomes. Isozyme CYP2C9 is reported to be inhibited by benzbromarone (BzBr) and this phenomenon was hitherto explained by classical active-site binding. Theoretically, it was impossible to envisage the experimentally derived sub-nM K-i for an inhibitor, when supra-nM enzyme and 10X K-M substrate concentrations were employed. We set out to find a more plausible explanation for this highly intriguing "super-inhibition'' phenomenon. In silico docking of various BzBr analogs with known crystal structure of CYP2C9 did not provide any evidence in support of active-site based inhibition hypothesis. Experiments tested the effects of BzBr and nine analogs on CYPs in reconstituted systems of lab-purified proteins, complex baculosomes & crude microsomal preparations. In certain setups, BzBr and its analogs could even enhance reactions, which cannot be explained by an active site hypothesis. Generally, it was seen that Ki became smaller by orders of magnitude, upon increasing the dilution order of BzBr analogs. Also, it was seen that BzBr could also inhibit other CYP isozymes like CYP3A4, CYP2D6 and CYP2E1. Further, amphipathic derivatives of vitamins C & E (scavengers of diffusible reactive oxygen species or DROS) effectively inhibited CYP2C9 reactions in different reaction setups. Therefore, the inhibition of CYP activity by BzBr analogs (which are also surface-active redox agents) is attributed to catalytic scavenging of DROS at phospholipid interface. The current work expands the scope of interpretations of inhibitions in redox enzymes and ushers in a new cellular biochemistry paradigm that small amounts of DROS may be obligatorily required in routine redox metabolism for constructive catalytic roles.	[Manoj, Kelath Murali] PSG Inst Adv Studies, Biotechnol & Healthcare Div, REDOx Lab, Peelamedu, Tamil Nadu, India; [Parashar, Abhinav; Gade, Sudeep Kumar] VIT Univ, Sch Biosci & Technol, Vellore, Tamil Nadu, India; [Potnuru, Mahesh; Madhavan, Nandita] IIT Madras, Dept Chem, Chennai, Tamil Nadu, India	Vellore Institute of Technology; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Manoj, KM (corresponding author), PSG Inst Adv Studies, Biotechnol & Healthcare Div, REDOx Lab, Peelamedu, Tamil Nadu, India.	satyamjayatu@yahoo.com	Parashar, Abhinav/G-2921-2019	Parashar, Abhinav/0000-0003-4229-0248	DBT, Govt. of India [BT/PR/15226/BRB/10/905/2011]; TRR Research Grant from SASTRA University, Thanjavur, Tamil Nadu	DBT, Govt. of India(Department of Biotechnology (DBT) India); TRR Research Grant from SASTRA University, Thanjavur, Tamil Nadu	The research was funded by research grant BT/PR/15226/BRB/10/905/2011 from DBT, Govt. of India. (http://dbtindia.nic.in/index.asp) and TRR Research Grant from SASTRA University, Thanjavur, Tamil Nadu (http://www.sastra.edu/index.php?option = com_content&view = article&id = 1270&Itemid = 632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew D, 2011, BIOCHEM BIOPH RES CO, V415, P646, DOI 10.1016/j.bbrc.2011.10.128; Blanksby SJ, 2007, ANGEW CHEM INT EDIT, V46, P4948, DOI 10.1002/anie.200700219; Bort R, 1999, BIOCHEM PHARMACOL, V58, P787, DOI 10.1016/S0006-2952(99)00167-7; Chance B, 1943, J CELL COMPAR PHYSL, V22, P33, DOI 10.1002/jcp.1030220104; Chang T K, 1998, Methods Mol Biol, V107, P147; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; De Grey ADNJ, 2002, DNA CELL BIOL, V21, P251, DOI 10.1089/104454902753759672; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dickmann LJ, 2004, MOL PHARMACOL, V65, P842, DOI 10.1124/mol.65.4.842; Gade SK, 2012, BIOCHEM BIOPH RES CO, V419, P211, DOI 10.1016/j.bbrc.2012.01.149; Gasteiger J., 1990, TETRAHEDRON COMPUT M, V3, P537, DOI DOI 10.1016/0898-5529(90)90156-3; Gideon DA, 2012, CELL BIOCHEM BIOPHYS, V63, P35, DOI 10.1007/s12013-012-9339-0; Hutzler JM, 2002, DRUG METAB DISPOS, V30, P1194, DOI 10.1124/dmd.30.11.1194; Lake BG, 1987, BIOCH TOXICOLOGY PRA, P183; Locuson CW, 2004, BIOCHEMISTRY-US, V43, P6948, DOI 10.1021/bi049651o; Locuson CW, 2003, DRUG METAB DISPOS, V31, P967, DOI 10.1124/dmd.31.7.967; Manoj KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013272; Manoj KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010601; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Parashar A, 2012, BIOCHEM BIOPH RES CO, V417, P1041, DOI 10.1016/j.bbrc.2011.12.090; Peng CC, 2008, BIOORGAN MED CHEM, V16, P4064, DOI 10.1016/j.bmc.2008.01.021; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; REINKE LA, 1985, DRUG METAB DISPOS, V13, P548; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SAWYER DT, 1981, ACCOUNTS CHEM RES, V14, P393, DOI 10.1021/ar00072a005; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wester MR, 2004, J BIOL CHEM, V279, P35630, DOI 10.1074/jbc.M405427200; Williams PA, 2003, NATURE, V424, P464, DOI 10.1038/nature01862	29	16	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89967	10.1371/journal.pone.0089967	http://dx.doi.org/10.1371/journal.pone.0089967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594849	Green Submitted, Green Published, gold			2022-12-25	WOS:000332468900049
J	Quintino-dos-Santos, JW; Muller, CJT; Bernabe, CS; Rosa, CA; Tufik, S; Schenberg, LC				Quintino-dos-Santos, Jeyce Willig; Torres Mueller, Claudia Janaina; Bernabe, Cristie Setubal; Rosa, Caroline Azevedo; Tufik, Sergio; Schenberg, Luiz Carlos			Evidence That the Periaqueductal Gray Matter Mediates the Facilitation of Panic-Like Reactions in Neonatally-Isolated Adult Rats	PLOS ONE			English	Article							CHILDHOOD SEPARATION ANXIETY; HYPOXIC VENTILATORY RESPONSE; PITUITARY-ADRENAL AXIS; SEX-SPECIFIC AUGMENTATION; MATERNAL SEPARATION; ELECTRICAL-STIMULATION; DEFENSIVE BEHAVIORS; LIFE EVENTS; DISORDER; STRESS	Plenty of evidence suggests that childhood separation anxiety (CSA) predisposes the subject to adult-onset panic disorder (PD). As well, panic is frequently comorbid with both anxiety and depression. The brain mechanisms whereby CSA predisposes to PD are but completely unknown in spite of the increasing evidence that panic attacks are mediated at midbrain's dorsal periaqueductal gray matter (DPAG). Accordingly, here we examined whether the neonatal social isolation (NSI), a model of CSA, facilitates panic-like behaviors produced by electrical stimulations of DPAG of rats as adults. Eventual changes in anxiety and depression were also assessed in the elevated plus-maze (EPM) and forced-swimming test (FST) respectively. Male pups were subjected to 3-h daily isolations from post-natal day 2 (PN2) until weaning (PN21) allotting half of litters in individual boxes inside a sound-attenuated chamber (NSI, n = 26) whilst siblings (sham-isolated rats, SHAM, n = 27) and dam were moved to another box in a separate room. Non-handled controls (CTRL, n = 18) remained undisturbed with dams until weaning. As adults, rats were implanted with electrodes into the DPAG (PN60) and subjected to sessions of intracranial stimulation (PN65), EPM (PN66) and FST (PN67-PN68). Groups were compared by Fisher's exact test (stimulation sites), likelihood ratio chi-square tests (stimulus-response threshold curves) and Bonferroni's post hoc t-tests (EPM and FST), for P<0.05. Notably, DPAG-evoked panic-like responses of immobility, exophthalmus, trotting, galloping and jumping were markedly facilitated in NSI rats relative to both SHAM and CTRL groups. Conversely, anxiety and depression scores either did not change or were even reduced in neonatally-handled groups relative to CTRL, respectively. Data are the first behavioral evidence in animals that early-life separation stress produces the selective facilitation of panic-like behaviors in adulthood. Most importantly, results implicate the DPAG not only in panic attacks but also in separation-anxious children's predispositions to the late development of PD.	[Quintino-dos-Santos, Jeyce Willig; Torres Mueller, Claudia Janaina; Bernabe, Cristie Setubal; Rosa, Caroline Azevedo; Schenberg, Luiz Carlos] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil; [Quintino-dos-Santos, Jeyce Willig] Univ Fed Espirito Santo, Dept Sports, Vitoria, ES, Brazil; [Tufik, Sergio] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal de Sao Paulo (UNIFESP)	Schenberg, LC (corresponding author), Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil.	schenber@npd.ufes.br	Schenberg, Luiz/H-4816-2014	Schenberg, Luiz/0000-0003-3826-7010	Fundacao de Amparo a Pesquisa do Espirito Santo (FAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Associacao Fundo de Incentivo a Pesquisa (AFIP); Universidade Federal do Espirito Santo (UFES); FAPES [38.413.280/2007]; CNPq/FAPES [55203345/11]; UFES/AFIP [23068020409/2010-43]	Fundacao de Amparo a Pesquisa do Espirito Santo (FAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Associacao Fundo de Incentivo a Pesquisa (AFIP); Universidade Federal do Espirito Santo (UFES); FAPES(Fundacao de Amparo a Pesquisa do Estado de Espiritu Santo (FAPES)); CNPq/FAPES; UFES/AFIP	Research was funded by Fundacao de Amparo a Pesquisa do Espirito Santo (FAPES, www.fapes.es.gov.br), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, www.cnpq.br), Associacao Fundo de Incentivo a Pesquisa (AFIP, www.afip.com.br) and Universidade Federal do Espirito Santo (UFES, www.ufes.br), grants FAPES 38.413.280/2007, CNPq/FAPES 55203345/11 and UFES/AFIP (23068020409/2010-43). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JL, 1996, ARCH GEN PSYCHIAT, V53, P323; AMANO K, 1978, APPL NEUROPHYSIOL, V41, P66; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; Angst J, 1993, PSYCHOPHARMACOLOGY P, P7; BATTAGLIA M, 1995, AM J PSYCHIAT, V152, P1362; Battaglia M, 2008, AM J MED GENET B, V147B, P586, DOI 10.1002/ajmg.b.30647; Battaglia M, 2009, ARCH GEN PSYCHIAT, V66, P64, DOI 10.1001/archgenpsychiatry.2008.513; Bittencourt AS, 2005, NEUROSCIENCE, V133, P873, DOI 10.1016/j.neuroscience.2005.03.012; Bittencourt AS, 2004, NEUROSCIENCE, V125, P71, DOI 10.1016/j.neuroscience.2004.01.026; Brannan S, 2001, P NATL ACAD SCI USA, V98, P2029, DOI 10.1073/pnas.98.4.2029; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Collett D, 2002, MODELLING BINARY DAT; D'Amato FR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018637; Daniels WMU, 2004, METAB BRAIN DIS, V19, P3, DOI 10.1023/B:MEBR.0000027412.19664.b3; DEAKIN J F W, 1991, Journal of Psychopharmacology, V5, P305, DOI 10.1177/026988119100500414; Dumont FS, 2011, RESP PHYSIOL NEUROBI, V175, P288, DOI 10.1016/j.resp.2010.12.004; FARAVELLI C, 1989, AM J PSYCHIAT, V146, P622; Feinstein JS, 2013, NAT NEUROSCI, V16, P270, DOI 10.1038/nn.3323; Fournier S, 2007, J PHYSIOL-LONDON, V584, P951, DOI 10.1113/jphysiol.2007.141655; Fournier S, 2011, J APPL PHYSIOL, V111, P516, DOI 10.1152/japplphysiol.00370.2011; Francis DD, 1999, CURR OPIN NEUROBIOL, V9, P128, DOI 10.1016/S0959-4388(99)80016-6; Francis DD, 1999, ANN NY ACAD SCI, V896, P66, DOI 10.1111/j.1749-6632.1999.tb08106.x; Genest SE, 2004, J PHYSIOL-LONDON, V554, P543, DOI 10.1113/jphysiol.2003.052894; Genest SE, 2007, J PHYSIOL-LONDON, V583, P299, DOI 10.1113/jphysiol.2007.135160; Genest SE, 2007, J APPL PHYSIOL, V102, P1416, DOI 10.1152/japplphysiol.00454.2006; Goetz RR, 1996, NEUROPSYCHOPHARMACOL, V14, P355, DOI 10.1016/0893-133X(95)00147-6; GORMAN JM, 1984, AM J PSYCHIAT, V141, P857; Gorman JM, 1996, J CLIN PSYCHIAT, V57, P34; Grace L, 2009, METAB BRAIN DIS, V24, P643, DOI 10.1007/s11011-009-9162-5; Hayward LF, 2003, BRAIN RES, V974, P153, DOI 10.1016/S0006-8993(03)02573-3; Heim C, 2010, DEV PSYCHOBIOL, V52, P671, DOI 10.1002/dev.20494; HOFER MA, 1994, DEV PSYCHOBIOL, V27, P503, DOI 10.1002/dev.420270804; Hofer MA, 1996, PSYCHONEUROENDOCRINO, V21, P203, DOI 10.1016/0306-4530(95)00042-9; Hofer MA, 1996, BEHAV NEUROSCI, V110, P1158, DOI 10.1037/0735-7044.110.5.1158; Huot RL, 2001, PSYCHOPHARMACOLOGY, V158, P366, DOI 10.1007/s002130100701; JENCK F, 1995, PSYCHIAT RES, V57, P181, DOI 10.1016/0165-1781(95)02673-K; Kaufman J, 2000, DEPRESS ANXIETY, V12, P69, DOI 10.1002/1520-6394(2000)12:1+<69::AID-DA9>3.0.CO;2-K; Keay K.A., 2004, RAT NERVOUS SYSTEM, P243; Kent JM, 2001, AM J PSYCHIAT, V158, P58, DOI 10.1176/appi.ajp.158.1.58; Kinkead R, 2005, RESP PHYSIOL NEUROBI, V149, P313, DOI 10.1016/j.resp.2005.04.014; KLEIN DF, 1964, PSYCHOPHARMACOLOGIA, V5, P397, DOI 10.1007/BF02193476; KLEIN DF, 1993, ARCH GEN PSYCHIAT, V50, P306; Klein RG, 1995, CLIN NEUROPHARMACOL, V18, pS7; Kossowsky J, 2013, AM J PSYCHIAT, V170, P768, DOI 10.1176/appi.ajp.2012.12070893; Krout KE, 1998, J COMP NEUROL, V401, P437; Kuhn CM, 1998, INT J DEV NEUROSCI, V16, P261, DOI 10.1016/S0736-5748(98)00034-3; Kumar K, 1997, NEUROSURGERY, V40, P736, DOI 10.1097/00006123-199704000-00015; Lehmann J, 2000, REV NEUROSCIENCE, V11, P383; Levine S, 2001, PHYSIOL BEHAV, V73, P255, DOI 10.1016/S0031-9384(01)00496-6; MCGRATH PJ, 1988, PSYCHIAT RES, V25, P41, DOI 10.1016/0165-1781(88)90156-4; McIntosh J, 1999, DEV BRAIN RES, V113, P97, DOI 10.1016/S0165-3806(99)00005-X; Mobbs D, 2007, SCIENCE, V317, P1079, DOI 10.1126/science.1144298; NASHOLD BS, 1969, J NEUROSURG, V30, P14, DOI 10.3171/jns.1969.30.1.0014; Neumann ID, 2005, NEUROSCIENCE, V132, P867, DOI 10.1016/j.neuroscience.2005.01.034; Nixon RDV, 2004, J ANXIETY DISORD, V18, P193, DOI 10.1016/S0887-6185(02)00290-6; Nixon RDV, 2003, BEHAV RES THER, V41, P1237, DOI 10.1016/S0005-7967(03)00150-5; Ogliari A, 2010, J ANXIETY DISORD, V24, P433, DOI 10.1016/j.janxdis.2010.02.008; Ogliari A, 2010, PSYCHOTHER PSYCHOSOM, V79, P48, DOI 10.1159/000259417; Oreland S, 2009, BRAIN RES, V1305, pS37, DOI 10.1016/j.brainres.2009.08.069; Park HJ, 2005, NEUROSCI LETT, V377, P179, DOI 10.1016/j.neulet.2004.11.097; Pascual R, 2007, ACTA NEUROBIOL EXP, V67, P471; Casanova JP, 2013, BEHAV BRAIN RES, V253, P60, DOI 10.1016/j.bbr.2013.07.015; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PITTS FN, 1967, NEW ENGL J MED, V277, P1329, DOI 10.1056/NEJM196712212772502; Preter M, 2008, PROG NEURO-PSYCHOPH, V32, P603, DOI 10.1016/j.pnpbp.2007.07.029; Quintino-Dos-Santos JW, 2013, EUR J NEUROSCI, DOI [10.1111/ejn.12410, DOI 10.1111/EJN.12410)]; REIMAN EM, 1989, ARCH GEN PSYCHIAT, V46, P493; Rentesi G, 2010, NEUROSCI LETT, V480, P7, DOI 10.1016/j.neulet.2010.04.054; Roberson-Nay R, 2011, PSYCHOL MED, V41, P2411, DOI 10.1017/S0033291711000547; Roberson-Nay R, 2012, DEPRESS ANXIETY, V29, P320, DOI 10.1002/da.21931; Roberson-Nay R, 2010, BIOL PSYCHIAT, V67, P1171, DOI 10.1016/j.biopsych.2009.12.014; Roman E, 2006, HORM BEHAV, V50, P736, DOI 10.1016/j.yhbeh.2006.06.016; Rots NY, 1996, J NEUROENDOCRINOL, V8, P501, DOI 10.1046/j.1365-2826.1996.04843.x; ROYBYRNE PP, 1986, AM J PSYCHIAT, V143, P1424; Sampaio KN, 2012, NEUROSCIENCE, V210, P222, DOI 10.1016/j.neuroscience.2012.02.041; Savignac HM, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00013; Schenberg LC, 2005, NEUROSCI BIOBEHAV R, V29, P1279, DOI 10.1016/j.neubiorev.2005.05.006; Schenberg LC, 2001, NEUROSCI BIOBEHAV R, V25, P647, DOI 10.1016/S0149-7634(01)00060-4; SCHENBERG LC, 1990, NEUROSCI BIOBEHAV R, V14, P473, DOI 10.1016/S0149-7634(05)80070-3; SCHENBERG LC, 1993, BRAIN RES, V621, P50, DOI 10.1016/0006-8993(93)90296-Y; Schenberg LC, 2000, BEHAV BRAIN RES, V111, P175, DOI 10.1016/S0166-4328(00)00154-6; Schenberg LC, 1995, AM J PHYSIOL-REG I, V269, pR1378, DOI 10.1152/ajpregu.1995.269.6.R1378; Schenberg Luiz Carlos, 2010, Psychol. Neurosci., V3, P9, DOI 10.3922/j.psns.2010.1.003; Schimitel FG, 2012, NEUROSCIENCE, V200, P59, DOI 10.1016/j.neuroscience.2011.10.032; Schmidt M, 2002, J NEUROENDOCRINOL, V14, P450, DOI 10.1046/j.1365-2826.2002.00797.x; Schreiber W, 1996, NEUROPSYCHOPHARMACOL, V15, P7, DOI 10.1016/0893-133X(95)00146-5; Shalev U, 2002, PHARMACOL BIOCHEM BE, V73, P115, DOI 10.1016/S0091-3057(02)00756-6; Slotten HA, 2006, BRAIN RES, V1097, P123, DOI 10.1016/j.brainres.2006.04.066; Spatola CAM, 2011, AM J MED GENET B, V156B, P79, DOI 10.1002/ajmg.b.31144; SUCHECKI D, 1993, NEUROENDOCRINOLOGY, V57, P204, DOI 10.1159/000126361; Troakes C, 2009, STRESS, V12, P362, DOI 10.1080/10253890802506391; WHO, 2012, ICD 10 CLASS MENT BE; Wigger A, 1999, PHYSIOL BEHAV, V66, P293, DOI 10.1016/S0031-9384(98)00300-X; Wohr M, 2008, BEHAV NEUROSCI, V122, P310, DOI 10.1037/0735-7044.122.2.310	94	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90726	10.1371/journal.pone.0090726	http://dx.doi.org/10.1371/journal.pone.0090726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594924	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900139
J	Wei, Y; Li, LM; Wang, D; Zhang, CY; Zen, K				Wei, Yao; Li, Limin; Wang, Dong; Zhang, Chen-Yu; Zen, Ke			Importin 8 Regulates the Transport of Mature MicroRNAs into the Cell Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						MicroRNA; Nuclear Transport; Polymerase Chain Reaction (PCR); RNA Processing; siRNA	PORE COMPLEX; EXPORT; BIOGENESIS; CYTOPLASM; ARGONAUTE; SIRNAS	Background: The mechanism underlying the re-entering of mature miRNAs into the nucleus remains unknown. Results: IPO8 mediates the transport of mature miRNAs into the nucleus through binding to Ago2. Conclusion: IPO8 is a candidate carrier for nuclear import of mature miRNAs. Significance: This finding extends the gene regulatory network of miRNAs. Mature microRNAs (miRNAs), approximate to 22-nucleotide noncoding RNAs regulating target gene expression at the post-transcriptional level, have been recently shown to be transported into the nucleus where they modulate the biogenesis of other miRNAs or their own expression. However, the mechanism that governs the transport of mature miRNAs from cytoplasm to nucleus remains unknown. Here, we report that importin 8 (IPO8), a member of the karyopherin (also named the protein import receptor importin ) family, plays a critical role in mediating the cytoplasm-to-nucleus transport of mature miRNAs. Specifically knocking down IPO8 but not other karyopherin family proteins via siRNA significantly decreases the nuclear transport of various known nucleus-enriched miRNAs without affecting their total cellular levels. IPO8-mediated nuclear transport of mature miRNAs is also dependent on the association of IPO8 with the Argonaute 2 (Ago2) complex. Cross-immunoprecipitation and Western blot analysis show that IPO8 is physically associated with Ago2. Knocking down IPO8 via siRNA markedly decreases the nuclear transport of Ago2 but does not affect the total cellular Ago2 level. Furthermore, dissociating the binding of miRNAs with Ago2 by trypaflavine strongly reduces the IPO8-mediated nuclear transport of miRNAs.	[Wei, Yao; Li, Limin; Wang, Dong; Zhang, Chen-Yu; Zen, Ke] Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University	Li, LM (corresponding author), Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China.	bixuehan2005@163.com; cyzhang@nju.edu.cn; kzen@nju.edu.cn			National Basic Research Program of China [2012CB517603, 2011CB504803863]; National Natural Science Foundation of China [31301061, 30890044, 30800946]; Natural Science Foundation of Jiangsu Province [BK2011013, BK20130564]; Specialized Research Fund for the Doctoral Program of Higher Education [20130091120037]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Basic Research Program of China Grants 2012CB517603 and 2011CB504803863, National Natural Science Foundation of China Grants 31301061, 30890044, 30800946, the Natural Science Foundation of Jiangsu Province Grants BK2011013 and BK20130564), and Specialized Research Fund for the Doctoral Program of Higher Education Grant 20130091120037.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Foldes-Papp Z, 2009, CURR PHARM BIOTECHNO, V10, P569, DOI 10.2174/138920109789069332; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Okada C, 2009, SCIENCE, V326, P1275, DOI 10.1126/science.1178705; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Shibata S, 2006, NUCLEIC ACIDS RES, V34, P4711, DOI 10.1093/nar/gkl663; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Watashi K, 2010, J BIOL CHEM, V285, P24707, DOI 10.1074/jbc.M109.062976; Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023; Zisoulis DG, 2012, NATURE, V486, P541, DOI 10.1038/nature11134	22	86	87	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10270	10275		10.1074/jbc.C113.541417	http://dx.doi.org/10.1074/jbc.C113.541417			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24596094	Green Published, hybrid			2022-12-25	WOS:000334226400004
J	Jia, HG; Wang, N				Jia, Hongge; Wang, Nian			Targeted Genome Editing of Sweet Orange Using Cas9/sgRNA	PLOS ONE			English	Article							XANTHOMONAS-CITRI; TOBACCO PLANTS; MUTAGENESIS; GENE; RNA; ARABIDOPSIS; NUCLEASES; TALEN; EXPRESSION; MULTIPLEX	Genetic modification, including plant breeding, has been widely used to improve crop yield and quality, as well as to increase disease resistance. Targeted genome engineering is expected to contribute significantly to future varietal improvement, and genome editing technologies using zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9/single guide RNA ( sgRNA) have already been successfully used to genetically modify plants. However, to date, there has been no reported use of any of the current genome editing approaches in sweet orange, an important fruit crop. In this study, we first developed a novel tool, Xcc-facilitated agroinfiltration, for enhancing transient protein expression in sweet orange leaves. We then successfully employed Xcc-facilitated agroinfiltration to deliver Cas9, along with a synthetic sgRNA targeting the CsPDS gene, into sweet orange. DNA sequencing confirmed that the CsPDS gene was mutated at the target site in treated sweet orange leaves. The mutation rate using the Cas9/sgRNA system was approximately 3.2 to 3.9%. Off-target mutagenesis was not detected for CsPDS-related DNA sequences in our study. This is the first report of targeted genome modification in citrus using the Cas9/sgRNA system-a system that holds significant promise for the study of citrus gene function and for targeted genetic modification.	[Jia, Hongge; Wang, Nian] Univ Florida, Dept Microbiol & Cell Sci, Citrus Res & Educ Ctr, Lake Alfred, FL 33850 USA	State University System of Florida; University of Florida	Wang, N (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Citrus Res & Educ Ctr, Lake Alfred, FL 33850 USA.	nianwang@ufl.edu	Wang, Nian/HDM-2087-2022	Wang, Nian/0000-0001-7743-0728; Ren, Ning/0000-0001-9776-2471	Citrus Research and Development Foundation	Citrus Research and Development Foundation	This work was supported by the Citrus Research and Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen KL, 2013, J GENET GENOMICS, V40, P271, DOI 10.1016/j.jgg.2013.03.009; Christian M, 2013, TARGETED MUTAGENESIS, pG3; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Curtin SJ, 2013, METHODS MOL BIOL, V1069, P25, DOI 10.1007/978-1-62703-613-9_3; de Pater S, 2013, PLANT BIOTECHNOL J, V11, P510, DOI 10.1111/pbi.12040; DING SW, 1995, J GEN VIROL, V76, P459, DOI 10.1099/0022-1317-76-2-459; Febres V, 2011, CITRUS TRANSFORMATIO, DOI [10.5772/24526, DOI 10.5772/24526]; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Jia HG, 2007, PLANT CELL REP, V26, P1961, DOI 10.1007/s00299-007-0403-y; Jia HG, 2006, TRANSGENIC RES, V15, P375, DOI 10.1007/s11248-006-0011-6; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Liu ZZ, 2003, PLANTA, V216, P824, DOI 10.1007/s00425-002-0934-y; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Qi Y, 2013, TARGETED DELETION IN, pG3; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Strauss A, 2013, MOL PLANT, V6, P1384, DOI 10.1093/mp/sst075; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Sun Z, 2013, J INTEGR PLANT BIOL; SWARUP S, 1992, MOL PLANT MICROBE IN, V5, P204, DOI 10.1094/MPMI-5-204; Talon Manuel, 2008, Int J Plant Genomics, V2008, P528361, DOI 10.1155/2008/528361; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Wendt T, 2013, PLANT MOL BIOL, V83, P279, DOI 10.1007/s11103-013-0078-4; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Yan Q, 2012, MOL PLANT MICROBE IN, V25, P69, DOI 10.1094/MPMI-05-11-0121; Zhang F, 2011, METHODS MOL BIOL, V701, P167, DOI 10.1007/978-1-61737-957-4_9; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179	41	144	182	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93806	10.1371/journal.pone.0093806	http://dx.doi.org/10.1371/journal.pone.0093806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24603412	gold, Green Published, Green Submitted			2022-12-25	WOS:000334159800053
J	Chandrayan, SK; Prakash, S; Ahmed, S; Guptasarma, P				Chandrayan, Sanjeev Kumar; Prakash, Satya; Ahmed, Shubbir; Guptasarma, Purnananda			Hyperthermophile Protein Behavior: Partially-Structured Conformations of Pyrococcus furiosus Rubredoxin Monomers Generated through Forced Cold-Denaturation and Refolding	PLOS ONE			English	Article							HYPERTHERMOSTABILITY; APORUBREDOXINS; TEMPERATURE; STABILITY; NMR	Some years ago, we showed that thermo-chemically denatured, partially-unfolded forms of Pyrococcus furiosus triosephosphateisomerase (PfuTIM) display cold-denaturation upon cooling, and heat-renaturation upon reheating, in proportion with the extent of initial partial unfolding achieved. This was the first time that cold-denaturation was demonstrated for a hyperthermophile protein, following unlocking of surface salt bridges. Here, we describe the behavior of another hyperthermophile protein, the small, monomeric, 53 residues-long rubredoxin from Pyrococcus furiosus (PfRd), which is one of the most thermostable proteins known to man. Like PfuTIM, PfRd too displays cold-denaturation after initial thermo-chemical perturbation, however, with two differences: (i) PfRd requires considerably higher temperatures as well as higher concentrations of guanidium hydrochloride (Gdm. HCl) than PfuTIM; (ii) PfRd's cold-denaturation behavior during cooling after thermo-chemical perturbation is incompletely reversible, unlike PfuTIM's, which was clearly reversible (from each different conformation generated). Differential cold-denaturation treatments allow PfRd to access multiple partially-unfolded states, each of which is clearly highly kinetically-stable. We refer to these as 'Trishanku' unfolding intermediates (or TUIs). Fascinatingly, refolding of TUIs through removal of Gdm. HCl generates multiple partially-refolded, monomeric, kinetically-trapped, non-native 'Trishanku' refolding intermediates (or TRIs), which differ from each other and from native PfRd and TUIs, in structural content and susceptibility to proteolysis. We find that the occurrence of cold denaturation and observations of TUI and TRI states is contingent on the oxidation status of iron, with redox agents managing to modulate the molecule's behavior upon gaining access to PfRd's iron atom. Mass spectrometric examination provides no evidence of the formation of disulfide bonds, but other experiments suggest that the oxidation status of iron (and its extent of burial) together determine whether or not PfRd shows cold denaturation, and also whether redox agents are able to modulate its behavior.	[Prakash, Satya; Guptasarma, Purnananda] Indian Inst Sci Educ & Res IISER Mohali, Dept Biol Sci, Sect 81, Sas Nagar Mohali, Punjab, India; [Chandrayan, Sanjeev Kumar; Prakash, Satya; Ahmed, Shubbir; Guptasarma, Purnananda] Council Sci & Ind Res CSIR, Inst Microbial Technol, Prot Sci & Engn Div, IMTECH, Chandigarh, India	Indian Institute of Science Education & Research (IISER) - Mohali; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Guptasarma, P (corresponding author), Indian Inst Sci Educ & Res IISER Mohali, Dept Biol Sci, Sect 81, Sas Nagar Mohali, Punjab, India.	guptasarma@iisermohali.ac.in	Guptasarma, Purnananda/C-3976-2009; CHANDRAYAN, SANJEEV/M-1662-2016; Ahmed, Shubbir/AAC-4289-2019	Guptasarma, Purnananda/0000-0002-4801-3180; CHANDRAYAN, SANJEEV/0000-0003-2219-4654; Ahmed, Shubbir/0000-0003-1655-6735				BLAKE PR, 1991, BIOCHEMISTRY-US, V30, P10885, DOI 10.1021/bi00109a012; BLAKE PR, 1992, PROTEIN SCI, V1, P1508, DOI 10.1002/pro.5560011112; Bonomi F, 2008, J BIOL INORG CHEM, V13, P981, DOI 10.1007/s00775-008-0385-4; CAVAGNERO S, 1995, BIOCHEMISTRY-US, V34, P9865, DOI 10.1021/bi00031a007; Cavagnero S, 1998, BIOCHEMISTRY-US, V37, P3369, DOI 10.1021/bi9721795; Cavagnero S, 1998, BIOCHEMISTRY-US, V37, P3377, DOI 10.1021/bi9721804; Chandrayan SK, 2008, PROTEINS, V72, P539, DOI 10.1002/prot.22077; CHRISTENSEN HEM, 1994, EUR J BIOCHEM, V224, P97, DOI 10.1111/j.1432-1033.1994.tb19999.x; DAY MW, 1992, PROTEIN SCI, V1, P1494, DOI 10.1002/pro.5560011111; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Hernandez G, 2001, BIOCHEMISTRY-US, V40, P14384, DOI 10.1021/bi0112560; Hernandez G, 2000, P NATL ACAD SCI USA, V97, P3166, DOI 10.1073/pnas.040569697; Mukherjee S, 2005, ANAL BIOCHEM, V347, P49, DOI 10.1016/j.ab.2005.08.028; Scigelova M, 2001, EUR J MASS SPECTROM, V7, P29, DOI 10.1255/ejms.385; Sechi S, 1998, ANAL CHEM, V70, P5150, DOI 10.1021/ac9806005; Strop P, 2000, BIOCHEMISTRY-US, V39, P1251, DOI 10.1021/bi992257j; Vondrasek J, 2007, CHEM-EUR J, V13, P9022, DOI 10.1002/chem.200700428; Zartler ER, 2001, BIOCHEMISTRY-US, V40, P7279, DOI 10.1021/bi0026831	18	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e80014	10.1371/journal.pone.0080014	http://dx.doi.org/10.1371/journal.pone.0080014			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603413	Green Submitted, gold, Green Published			2022-12-25	WOS:000332483600001
J	Kooijman, E; Nijboer, CH; van Velthoven, CTJ; Mol, W; Dijkhuizen, RM; Kesecioglu, J; Heijnen, CJ				Kooijman, Elke; Nijboer, Cora H.; van Velthoven, Cindy T. J.; Mol, Wouter; Dijkhuizen, Rick M.; Kesecioglu, Jozef; Heijnen, Cobi J.			Long-Term Functional Consequences and Ongoing Cerebral Inflammation after Subarachnoid Hemorrhage in the Rat	PLOS ONE			English	Article							DIFFERENT BRAIN-REGIONS; NECROSIS-FACTOR-ALPHA; CEREBROSPINAL-FLUID; MOLECULAR-MECHANISMS; LEARNING-DEFICITS; HYPOXIA-ISCHEMIA; NEURONAL DEATH; BLOOD-FLOW; MYELOPEROXIDASE; INJURY	Subarachnoid hemorrhage (SAH) represents a considerable health problem with an incidence of 6-7 per 100.000 individuals per year in Western society. We investigated the long-term consequences of SAH on behavior, neuroinflammation and grayand white-matter damage using an endovascular puncture model in Wistar rats. Rats were divided into a mild or severe SAH group based on their acute neurological score at 24 h post-SAH. The degree of hemorrhage determined in post-mortem brains at 48 h strongly correlated with the acute neurological score. Severe SAH induced increased TNF-alpha, IL-1 beta, IL-10, MCP-1, MIP2, CINC-1 mRNA expression and cortical neutrophil influx at 48 h post-insult. Neuroinflammation after SAH was very long-lasting and still present at day 21 as determined by Iba-1 staining (microglia/macrophages) and GFAP (astrocytes). Long-term neuroinflammation was strongly associated with the degree of severity of SAH. Cerebral damage to gray-and white-matter was visualized by immunohistochemistry for MAP2 and MBP at 21 days after SAH. Severe SAH induced significant gray- and white-matter damage. MAP2 loss at day 21 correlated significantly with the acute neurological score determined at 24 h post-SAH. Sensorimotor behavior, determined by the adhesive removal task and von Frey test, was affected after severe SAH at day 21. In conclusion, we are the first to show that SAH induces ongoing cortical inflammation. Moreover, SAH induces mainly cortical long-term brain damage, which is associated with long-term sensorimotor damage.	[Kooijman, Elke; Kesecioglu, Jozef; Heijnen, Cobi J.] Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands; [Kooijman, Elke; Nijboer, Cora H.; van Velthoven, Cindy T. J.] Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands; [Mol, Wouter; Dijkhuizen, Rick M.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Heijnen, Cobi J.] Univ Texas MD Anderson Canc Ctr, Div Internal Med, Dept Symptom Res, Houston, TX 77030 USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Texas System; UTMD Anderson Cancer Center	Heijnen, CJ (corresponding author), Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands.	CJHeijnen@mdanderson.org		Dijkhuizen, Rick/0000-0002-4623-4078; van Velthoven, Cindy/0000-0001-5120-4546	Dirkzwager-Assink foundation; 'Friends of University Medical Center Utrecht' foundation	Dirkzwager-Assink foundation; 'Friends of University Medical Center Utrecht' foundation	This study was funded in part by the Dirkzwager-Assink foundation and by the 'Friends of University Medical Center Utrecht' foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2001, STROKE, V32, P212, DOI 10.1161/01.STR.32.1.212; Al-Tamimi YZ, 2010, WORLD NEUROSURG, V73, P654, DOI 10.1016/j.wneu.2010.02.005; Anderson C, 2000, STROKE, V31, P1843; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen G, 2013, NEUROSCIENCE, V231, P136, DOI 10.1016/j.neuroscience.2012.11.024; Chou SHY, 2012, J INVEST MED, V60, P1054, DOI 10.2310/JIM.0b013e3182686932; Dietmann A, 2012, CEREBROVASC DIS, V33, P16, DOI 10.1159/000331925; Dziurdzik P, 2004, INFLAMM RES, V53, P338, DOI 10.1007/s00011-004-1265-1; Fleiss B, 2012, LANCET NEUROL, V11, P556, DOI 10.1016/S1474-4422(12)70058-3; Flood C, 2001, J CEREBR BLOOD F MET, V21, P157, DOI 10.1097/00004647-200102000-00007; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Frontera JA, 2005, ACTA NEUROCHIR S, V95, P377; Hendryk S, 2004, NEUROENDOCRINOL LETT, V25, P141; Iseda K, 2007, J NEUROSURG, V107, P128, DOI 10.3171/JNS-07/07/0128; Jeon H, 2010, NEUROSCIENCE, V169, P1805, DOI 10.1016/j.neuroscience.2010.06.039; Kato H, 2009, ANESTH ANALG, V108, P288, DOI 10.1213/ane.0b013e318187bb93; Khalili MA, 2012, J STROKE CEREBROVASC, V21, P445, DOI 10.1016/j.jstrokecerebrovasdis.2010.10.005; Kimball MM, 2011, NEUROCRIT CARE, V15, P336, DOI 10.1007/s12028-011-9600-1; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Koenig Matthew A, 2012, Continuum (Minneap Minn), V18, P579, DOI 10.1212/01.CON.0000415429.99394.e8; KUBOTA T, 1993, STROKE, V24, P1993, DOI 10.1161/01.STR.24.12.1993; Lad SP, 2012, J STROKE CEREBROVASC, V21, P30, DOI 10.1016/j.jstrokecerebrovasdis.2010.04.004; Lu H, 2009, BRAIN RES, V1262, P73, DOI 10.1016/j.brainres.2009.01.017; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Mathiesen T, 1997, J NEUROSURG, V87, P215, DOI 10.3171/jns.1997.87.2.0215; Nijboer CHA, 2008, J NEUROSCI, V28, P3324, DOI 10.1523/JNEUROSCI.4769-07.2008; Nijboer CHA, 2007, J CEREBR BLOOD F MET, V27, P282, DOI 10.1038/sj.jcbfm.9600342; Ostrowski RP, 2006, NEUROL RES, V28, P399, DOI 10.1179/016164106X115008; Prunell GF, 2005, J NEUROSURG, V102, P1046, DOI 10.3171/jns.2005.102.6.1046; Prunell GF, 2005, NEUROSURGERY, V56, P1082, DOI 10.1227/01.NEU.0000157966.76590.39; Prunell GF, 2003, NEUROSURGERY, V52, P165, DOI 10.1097/00006123-200301000-00022; Rothwell NJ, 1999, J PHYSIOL-LONDON, V514, P3, DOI 10.1111/j.1469-7793.1999.003af.x; Schneider T, 1996, J IMMUNOL METHODS, V198, P1, DOI 10.1016/0022-1759(96)00143-3; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Sherchan P, 2011, J NEUROTRAUM, V28, P2503, DOI 10.1089/neu.2011.1864; Silasi G, 2009, BEHAV BRAIN RES, V198, P380, DOI 10.1016/j.bbr.2008.11.019; Simard JM, 2009, J CEREBR BLOOD F MET, V29, P317, DOI 10.1038/jcbfm.2008.120; Sozen T, 2009, STROKE, V40, P2519, DOI 10.1161/STROKEAHA.109.549592; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Suzuki H, 2010, STROKE, V41, P1783, DOI 10.1161/STROKEAHA.110.586537; Takata K, 2008, EXP NEUROL, V213, P336, DOI 10.1016/j.expneurol.2008.06.009; Takizawa T, 2001, NEUROL RES, V23, P724, DOI 10.1179/016164101101199243; Tiebosch IACW, 2013, NEUROCRIT CARE, V18, P96, DOI 10.1007/s12028-012-9692-2; van der Veen BS, 2009, ANTIOXID REDOX SIGN, V11, P2899, DOI [10.1089/ars.2009.2538, 10.1089/ARS.2009.2538]; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Wang Z, 2013, NEUROL SCI, V34, P1331, DOI 10.1007/s10072-012-1240-5; Willemen HLDM, 2010, PAIN, V150, P550, DOI 10.1016/j.pain.2010.06.015; Wu X, 2012, NEUROBIOL AGING, V33, P1364, DOI 10.1016/j.neurobiolaging.2010.11.002	51	63	69	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90584	10.1371/journal.pone.0090584	http://dx.doi.org/10.1371/journal.pone.0090584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603553	Green Submitted, Green Published, gold			2022-12-25	WOS:000332483600065
J	Bodicoat, DH; Gray, LJ; Henson, J; Webb, D; Guru, A; Misra, A; Gupta, R; Vikram, N; Sattar, N; Davies, MJ; Khunti, K				Bodicoat, Danielle H.; Gray, Laura J.; Henson, Joseph; Webb, David; Guru, Arvind; Misra, Anoop; Gupta, Rajeev; Vikram, Naval; Sattar, Naveed; Davies, Melanie J.; Khunti, Kamlesh			Body Mass Index and Waist Circumference Cut-Points in Multi-Ethnic Populations from the UK and India: The ADDITION-Leicester, Jaipur Heart Watch and New Delhi Cross-Sectional Studies	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; ABDOMINAL ADIPOSITY; REDEFINING OBESITY; ASIAN INDIANS; RISK; PEOPLE; RATIONALE; DIAGNOSIS; BMI	Aims: To derive cut-points for body mass index (BMI) and waist circumference (WC) for minority ethnic groups that are risk equivalent based on endogenous glucose levels to cut-points for white Europeans (BMI 30 kg/m(2); WC men 102 cm; WC women 88 cm). Materials and Methods: Cross-sectional data from participants aged 40-75 years: 4,672 white and 1,348 migrant South Asian participants from ADDITION-Leicester (UK) and 985 indigenous South Asians from Jaipur Heart Watch/New Delhi studies (India). Cut-points were derived using fractional polynomial models with fasting and 2-hour glucose as outcomes, and ethnicity, objectively-measured BMI/WC, their interaction and age as covariates. Results: Based on fasting glucose, obesity cut-points were 25 kg/m(2) (95% Confidence Interval: 24, 26) for migrant South Asian, and 18 kg/m(2) (16, 20) for indigenous South Asian populations. For men, WC cut-points were 90 cm (85, 95) for migrant South Asian, and 87 cm (82, 91) for indigenous South Asian populations. For women, WC cut-points were 77 cm (71, 82) for migrant South Asian, and 54 cm (20, 63) for indigenous South Asian populations. Cut-points based on 2-hour glucose were lower than these. Conclusions: These findings strengthen evidence that health interventions are required at a lower BMI and WC for South Asian individuals. Based on our data and the existing literature, we suggest an obesity threshold of 25 kg/m(2) for South Asian individuals, and a very high WC threshold of 90 cm for South Asian men and 77 cm for South Asian women. Further work is required to determine whether lower cut-points are required for indigenous, than migrant, South Asians.	[Bodicoat, Danielle H.; Henson, Joseph; Webb, David; Davies, Melanie J.; Khunti, Kamlesh] Univ Leicester, Diabet Res Ctr, Leicester, Leics, England; [Gray, Laura J.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Guru, Arvind] Postgrad Inst Med Educ & Res, Chandigarh 160012, Punjab, India; [Misra, Anoop] Fortis Hosp, Dept Diabet & Metab Dis, Delhi, India; [Gupta, Rajeev] Fortis Escorts Hosp, Dept Internal Med, Jaipur, Rajasthan, India; [Vikram, Naval] All India Inst Med Sci, Dept Med, Delhi, India; [Sattar, Naveed] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Leicester; University of Leicester; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Fortis Escorts Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Glasgow	Bodicoat, DH (corresponding author), Univ Leicester, Diabet Res Ctr, Leicester, Leics, England.	dhm6@le.ac.uk	/ABC-9527-2021	Sattar, Naveed/0000-0002-1604-2593; Gray, Laura/0000-0002-9284-9321; Webb, David/0000-0002-3932-3339; Henson, Joseph/0000-0002-3898-7053; Davies, Melanie/0000-0002-9987-9371; Khunti, Kamlesh/0000-0003-2343-7099	National Institute for Health and Care Excellence (NICE), Department of Health; University Hospitals of Leicester Diabetes Research Fund; Diabetes UK	National Institute for Health and Care Excellence (NICE), Department of Health; University Hospitals of Leicester Diabetes Research Fund; Diabetes UK(Diabetes UK)	This work was supported by funding from the National Institute for Health and Care Excellence (NICE), Department of Health, the University Hospitals of Leicester Diabetes Research Fund and Diabetes UK, and was conducted as part of activities supported by the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - Leicestershire, Northamptonshire and Rutland (NIHR CLAHRC - LNR), the NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit which is a partnership between University Hospitals of Leicester NHS Trust, Loughborough University and the University of Leicester, and by the Leicester Clinical Trials Unit. Analyses of the Addition-Leicester study with regards to BMI and waist circumference cut-points in black and minority ethnicity groups were commissioned by NICE during the development of their guidance on this topic. The researchers were independent from the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; BHATNAGAR D, 1995, LANCET, V345, P405; Chiu M, 2011, DIABETES CARE, V34, P1741, DOI 10.2337/dc10-2300; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Gholap N, 2011, PRIM CARE DIABETES, V5, P45, DOI 10.1016/j.pcd.2010.08.002; Gray LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026464; Gupta Rajeev, 2007, Indian Heart J, V59, P346; Gupta Rajeev, 2002, Indian Heart J, V54, P59; Kumar S, 2011, INT J CLIN PRACT, V65, P378, DOI 10.1111/j.1742-1241.2010.02548.x; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Low S, 2009, ANN ACAD MED SINGAP, V38, P66; Misra A, 2006, INT J OBESITY, V30, P106, DOI 10.1038/sj.ijo.0803111; Misra A, 2009, J Assoc Physicians India, V57, P163; Mostafa SA, 2010, POSTGRAD MED J, V86, P656, DOI 10.1136/pgmj.2009.091215; National Institute for Health and Clinical Excellence, 2006, OB GUID PREV ID ASS, V43; National Institute for Health and Clinical Excellence, 2009, TYP 2 DIAB MAN TYP 2; NICE, 2013, ASS BOD MASS IND WAI; Office for National Statistics, 2012, 2011 CENS KEY STAT L; Patel JV, 2010, ATHEROSCLEROSIS, V209, P579, DOI 10.1016/j.atherosclerosis.2009.10.010; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Rahman M, 2010, OBSTET GYNECOL, V115, P982, DOI 10.1097/AOG.0b013e3181da9423; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Webb DR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-16; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; World Health Organization, 1995, PHYS STAT US INT ANT	29	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90813	10.1371/journal.pone.0090813	http://dx.doi.org/10.1371/journal.pone.0090813			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599391	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000332479400135
J	Ocheretina, O; Escuyer, VE; Mabou, MM; Royal-Mardi, G; Collins, S; Vilbrun, SC; Pape, JW; Fitzgerald, DW				Ocheretina, Oksana; Escuyer, Vincent E.; Mabou, Marie-Marcelle; Royal-Mardi, Gertrude; Collins, Sean; Vilbrun, Stalz C.; Pape, Jean W.; Fitzgerald, Daniel W.			Correlation between Genotypic and Phenotypic Testing for Resistance to Rifampin in Mycobacterium tuberculosis Clinical Isolates in Haiti: Investigation of Cases with Discrepant Susceptibility Results	PLOS ONE			English	Article							PORT-AU-PRINCE; MULTIDRUG-RESISTANCE; SILENT MUTATION; RNA-POLYMERASE; RPOB GENE; DIAGNOSIS; STRAINS; ASSAY; BREAKPOINTS; PERFORMANCE	The World Health Organization has recommended use of molecular-based tests MTBDRplus and GeneXpert MTB/RIF to diagnose multidrug-resistant tuberculosis in developing and high-burden countries. Both tests are based on detection of mutations in the Rifampin (RIF) Resistance-Determining Region of DNA-dependent RNA Polymerase gene (rpoB). Such mutations are found in 95-98% of Mycobacterium tuberculosis strains determined to be RIF-resistant by the "gold standard" culture-based drug susceptibility testing (DST). We report the phenotypic and genotypic characterization of 153 consecutive clinical Mycobacterium tuberculosis strains diagnosed as RIF-resistant by molecular tests in our laboratory in Port-au-Prince, Haiti. 133 isolates (86.9%) were resistant to both RIF and Isoniazid and 4 isolates (2.6%) were RIF mono-resistant in MGIT SIRE liquid culture-based DST. However the remaining 16 isolates (10.5%) tested RIF-sensitive by the assay. Five strains with discordant genotypic and phenotypic susceptibility results had RIF minimal inhibitory concentration (MIC) close to the cut-off value of 1 mu g/ml used in phenotypic susceptibility assays and were confirmed as resistant by DST on solid media. Nine strains had sub-critical RIF MICs ranging from 0.063 to 0.5 mu g/ml. Finally two strains were pan-susceptible and harbored a silent rpoB mutation. Our data indicate that not only detection of the presence but also identification of the nature of rpoB mutation is needed to accurately diagnose resistance to RIF in Mycobacterium tuberculosis. Observed clinical significance of low-level resistance to RIF supports the re-evaluation of the present critical concentration of the drug used in culture-based DST assays.	[Ocheretina, Oksana; Collins, Sean; Pape, Jean W.; Fitzgerald, Daniel W.] Weill Cornell Med Coll, Ctr Global Hlth, Div Infect Dis, Dept Med, New York, NY 10021 USA; [Ocheretina, Oksana; Mabou, Marie-Marcelle; Royal-Mardi, Gertrude; Vilbrun, Stalz C.; Pape, Jean W.] Ctr GHESKIO, Port Au Prince, Haiti; [Escuyer, Vincent E.] New York State Dept Hlth, Wadsworth Ctr, Lab Mycobacteriol, Albany, NY USA	Cornell University; State University of New York (SUNY) System; Wadsworth Center	Ocheretina, O (corresponding author), Weill Cornell Med Coll, Ctr Global Hlth, Div Infect Dis, Dept Med, New York, NY 10021 USA.	oko2001@med.cornell.edu			Fogarty International Center [AITRP: TW000018-25]; NIAID [K24: AI098627-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069421, K24AI098627] Funding Source: NIH RePORTER	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding came from the Fogarty International Center - AITRP: TW000018-25;NIAID - K24: AI098627-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alonso M, 2011, J CLIN MICROBIOL, V49, P2688, DOI 10.1128/JCM.00659-11; Angr PK, 2012, J CLIN MICROBIOL, V50, P1233, DOI 10.1128/JCM.06479-11; [Anonymous], 2011, GLOB TUB CONTR 2011; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Campbell EA, 2005, EMBO J, V24, P674, DOI 10.1038/sj.emboj.7600499; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Dalhoff A, 2009, INFECTION, V37, P296, DOI 10.1007/s15010-009-7108-9; Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362, DOI 10.1128/JCM.36.2.362-366.1998; Gumbo T, 2010, ANTIMICROB AGENTS CH, V54, P1484, DOI 10.1128/AAC.01474-09; Huang WL, 2009, J CLIN MICROBIOL, V47, P2520, DOI 10.1128/JCM.02499-08; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KAPUR V, 1994, J CLIN MICROBIOL, V32, P1095, DOI 10.1128/JCM.32.4.1095-1098.1994; Kent PT, 1985, GUIDE LEVEL 3 LAB; Kim BJ, 1997, J CLIN MICROBIOL, V35, P492, DOI 10.1128/JCM.35.2.492-494.1997; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Mani C, 2001, J CLIN MICROBIOL, V39, P2987, DOI 10.1128/JCM.39.8.2987-2990.2001; Marlowe EM, 2011, J CLIN MICROBIOL, V49, P1621, DOI 10.1128/JCM.02214-10; Moure R, 2011, J CLIN MICROBIOL, V49, P3722, DOI 10.1128/JCM.05314-11; National Committee for Clinical Laboratory Standards, 2003, M24A NCCLS; Ocheretina O, 2013, J CLIN MICROBIOL, V51, P2232, DOI 10.1128/JCM.00268-13; Ocheretina O, 2012, REV PANAM SALUD PUBL, V31, P221, DOI 10.1590/S1020-49892012000300006; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Scott LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001061; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; TENOVER FC, 1993, J CLIN MICROBIOL, V31, P767, DOI 10.1128/JCM.31.4.767-770.1993; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Traore H, 2000, INT J TUBERC LUNG D, V4, P481; Turnidge J, 2007, CLIN MICROBIOL REV, V20, P391, DOI 10.1128/CMR.00047-06; Van Deun A, 2009, J CLIN MICROBIOL, V47, P3501, DOI 10.1128/JCM.01209-09; Van Rie A, 2012, INT J TUBERC LUNG D, V16, P206, DOI 10.5588/ijtld.11.0395; *WHO, 1994, WHOTB94178; Williamson DA, 2012, INT J TUBERC LUNG D, V16, P216, DOI 10.5588/ijtld.11.0178; Williamson DA, 2011, DIAGN MICROBIOL INFE, V74, P207; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2011, WHOHTMTB20112; Yang B, 1998, J ANTIMICROB CHEMOTH, V42, P621, DOI 10.1093/jac/42.5.621; Yuan XL, 2012, J CLIN MICROBIOL, V50, P2404, DOI 10.1128/JCM.06860-11	39	80	83	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90569	10.1371/journal.pone.0090569	http://dx.doi.org/10.1371/journal.pone.0090569			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599230	gold, Green Published, Green Submitted			2022-12-25	WOS:000332479400094
J	Dey, G; Gupta, GD; Ramalingam, B; Sathe, M; Mayor, S; Thattai, M				Dey, Gautam; Gupta, Gagan D.; Ramalingam, Balaji; Sathe, Mugdha; Mayor, Satyajit; Thattai, Mukund			Exploiting Cell-To-Cell Variability To Detect Cellular Perturbations	PLOS ONE			English	Article							GENE-EXPRESSION; ENDOCYTIC PATHWAYS; RNAI SCREEN; REVEALS; GENOME; NOISE	Any single-cell-resolved measurement generates a population distribution of phenotypes, characterized by a mean, a variance, and a shape. Here we show that changes in the shape of a phenotypic distribution can signal perturbations to cellular processes, providing a way to screen for underlying molecular machinery. We analyzed images of a Drosophila S2R+ cell line perturbed by RNA interference, and tracked 27 single-cell features which report on endocytic activity, and cell and nuclear morphology. In replicate measurements feature distributions had erratic means and variances, but reproducible shapes; RNAi down-regulation reliably induced shape deviations in at least one feature for 1072 out of 7131 genes surveyed, as revealed by a Kolmogorov-Smirnov-like statistic. We were able to use these shape deviations to identify a spectrum of genes that influenced cell morphology, nuclear morphology, and multiple pathways of endocytosis. By preserving single-cell data, our method was even able to detect effects invisible to a population-averaged analysis. These results demonstrate that cell-to-cell variability contains accessible and useful biological information, which can be exploited in existing cell-based assays.	[Dey, Gautam] Stanford Univ, Palo Alto, CA 94304 USA; [Gupta, Gagan D.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Ramalingam, Balaji] Ctr Cellular & Mol Platforms C CAMP, Bangalore, Karnataka, India; [Sathe, Mugdha; Mayor, Satyajit; Thattai, Mukund] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Stanford University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Thattai, M (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, UAS GKVK Campus, Bangalore, Karnataka, India.	thattai@ncbs.res.in	Dey, Gautam/GON-6083-2022; Dey, Gautam/AAQ-8917-2020	Dey, Gautam/0000-0003-1416-6223; Dey, Gautam/0000-0003-1416-6223; Gupta, Gagan/0000-0002-1089-965X; Sathe, Mugdha/0000-0002-1119-6542	Indo-US Science & Technology Forum through FOE Award [54-2006]; Natural Sciences and Engineering Research Council of Canada; WellcomeTrust-DBT India Alliance Intermediate Fellowship [500103/Z/09/Z]	Indo-US Science & Technology Forum through FOE Award; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); WellcomeTrust-DBT India Alliance Intermediate Fellowship(Wellcome Trust DBT India Alliance)	This project was initiated with support from the Indo-US Science & Technology Forum through FOE Award 54-2006. Support in developing the screening methodology was provided by the Nanoscience Mission of the Department of Science and Technology, Govt. of India, and the Department of Biotechnology, Govt. of India. GDG was partly supported by the Natural Sciences and Engineering Research Council of Canada. MT was partly supported by a WellcomeTrust-DBT India Alliance Intermediate Fellowship (500103/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Bakal C, 2007, SCIENCE, V316, P1753, DOI 10.1126/science.1140324; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Guha A, 2003, J CELL SCI, V116, P3373, DOI 10.1242/jcs.00637; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Gupta GD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006768; Gupta GD, 2014, PLOS ONE UNPUB; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Howes MT, 2010, CURR OPIN CELL BIOL, V22, P519, DOI 10.1016/j.ceb.2010.04.001; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; PRESS WH, 1992, NUMERICAL RECIPES C, P623; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Sacher R, 2008, CURR OPIN CELL BIOL, V20, P483, DOI 10.1016/j.ceb.2008.06.002; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	35	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90540	10.1371/journal.pone.0090540	http://dx.doi.org/10.1371/journal.pone.0090540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594940	gold, Green Published, Green Submitted			2022-12-25	WOS:000332475500063
J	Carrasco, JL; Castello, MJ; Naumann, K; Lassowskat, I; Navarrete-Gomez, M; Scheel, D; Vera, P				Luis Carrasco, Jose; Jose Castello, Maria; Naumann, Kai; Lassowskat, Ines; Navarrete-Gomez, Marisa; Scheel, Dierk; Vera, Pablo			Arabidopsis Protein Phosphatase DBP1 Nucleates a Protein Network with a Role in Regulating Plant Defense	PLOS ONE			English	Article							INNATE IMMUNITY; KINASE; MAPK; THALIANA; CALMODULINS; ACTIVATION; RESISTANCE; FAMILY; TARGET; ACID	Arabidopsis thaliana DBP1 belongs to the plant-specific family of DNA-binding protein phosphatases. Although recently identified as a novel host factor mediating susceptibility to potyvirus, little is known about DBP1 targets and partners and the molecular mechanisms underlying its function. Analyzing changes in the phosphoproteome of a loss-of-function dbp1 mutant enabled the identification of 14-3-3 lambda isoform (GRF6), a previously reported DBP1 interactor, and MAP kinase (MAPK) MPK11 as components of a small protein network nucleated by DBP1, in which GRF6 stability is modulated by MPK11 through phosphorylation, while DBP1 in turn negatively regulates MPK11 activity. Interestingly, grf6 and mpk11 loss-of-function mutants showed altered response to infection by the potyvirus Plum pox virus (PPV), and the described molecular mechanism controlling GRF6 stability was recapitulated upon PPV infection. These results not only contribute to a better knowledge of the biology of DBP factors, but also of MAPK signalling in plants, with the identification of GRF6 as a likely MPK11 substrate and of DBP1 as a protein phosphatase regulating MPK11 activity, and unveils the implication of this protein module in the response to PPV infection in Arabidopsis.	[Luis Carrasco, Jose; Jose Castello, Maria; Navarrete-Gomez, Marisa; Vera, Pablo] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain; [Naumann, Kai; Lassowskat, Ines; Scheel, Dierk; Vera, Pablo] Leibniz Inst Plant Biochem, Dept Stress & Dev Biol, Halle, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Leibniz Institut fur Pflanzenbiochemie	Vera, P (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain.	vera@ibmcp.upv.es	Carrasco, Jose Luis/M-5367-2015	Carrasco, Jose Luis/0000-0002-5905-8042; Vera, Pablo/0000-0002-7787-7519	Spanish MICINN [BFU2009-09771, EUI2009-04009]; Generalitat Valenciana [Prometeo2010/020]; German DFG [SCHE 235/15-1]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); German DFG(German Research Foundation (DFG))	This work was supported by the Spanish MICINN (Grants BFU2009-09771, EUI2009-04009 to PV), Generalitat Valenciana (Prometeo2010/020 to PV) and the German DFG (SCHE 235/15-1 to DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bethke G, 2012, MOL PLANT MICROBE IN, V25, P471, DOI 10.1094/MPMI-11-11-0281; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Carrasco JL, 2005, PLANT PHYSIOL, V137, P602, DOI 10.1104/pp.104.056002; Carrasco JL, 2003, EMBO J, V22, P3376, DOI 10.1093/emboj/cdg323; Carrasco JL, 2006, J BIOL CHEM, V281, P22875, DOI 10.1074/jbc.M512611200; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Denison FC, 2011, SEMIN CELL DEV BIOL, V22, P720, DOI 10.1016/j.semcdb.2011.08.006; Gokirmak T, 2010, CURR OPIN PLANT BIOL, V13, P527, DOI 10.1016/j.pbi.2010.06.001; Gupta R, 2003, PLANT PHYSIOL, V132, P1149, DOI 10.1104/pp.103.020792; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Castello MJ, 2011, PLANT PHYSIOL, V157, P2206, DOI 10.1104/pp.111.188953; Castello MJ, 2010, PLANT PHYSIOL, V153, P1521, DOI 10.1104/pp.110.158923; Katou S, 2005, J BIOL CHEM, V280, P39569, DOI 10.1074/jbc.M508115200; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kiegerl S, 2000, PLANT CELL, V12, P2247, DOI 10.1105/tpc.12.11.2247; Koroleva OA, 2005, PLANT J, V41, P162, DOI 10.1111/j.1365-313X.2004.02281.x; Kosetsu K, 2010, PLANT CELL, V22, P3778, DOI 10.1105/tpc.110.077164; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Sato T, 2011, PLANT J, V68, P137, DOI 10.1111/j.1365-313X.2011.04673.x; Schweighofer A, 2007, PLANT CELL, V19, P2213, DOI 10.1105/tpc.106.049585; Ulm R, 2001, GENE DEV, V15, P699, DOI 10.1101/gad.192601; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Wolschin F, 2005, PROTEOMICS, V5, P4389, DOI 10.1002/pmic.200402049; Yamakawa H, 2004, J BIOL CHEM, V279, P928, DOI 10.1074/jbc.M310277200	26	20	21	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90734	10.1371/journal.pone.0090734	http://dx.doi.org/10.1371/journal.pone.0090734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595057	Green Submitted, Green Published, gold			2022-12-25	WOS:000332475500094
J	Wang, XR; Lizier, JT; Nowotny, T; Berna, AZ; Prokopenko, M; Trowell, SC				Wang, X. Rosalind; Lizier, Joseph T.; Nowotny, Thomas; Berna, Amalia Z.; Prokopenko, Mikhail; Trowell, Stephen C.			Feature Selection for Chemical Sensor Arrays Using Mutual Information	PLOS ONE			English	Article							GENETIC ALGORITHM; PERFORMANCE	We address the problem of feature selection for classifying a diverse set of chemicals using an array of metal oxide sensors. Our aim is to evaluate a filter approach to feature selection with reference to previous work, which used a wrapper approach on the same data set, and established best features and upper bounds on classification performance. We selected feature sets that exhibit the maximal mutual information with the identity of the chemicals. The selected features closely match those found to perform well in the previous study using a wrapper approach to conduct an exhaustive search of all permitted feature combinations. By comparing the classification performance of support vector machines (using features selected by mutual information) with the performance observed in the previous study, we found that while our approach does not always give the maximum possible classification performance, it always selects features that achieve classification performance approaching the optimum obtained by exhaustive search. We performed further classification using the selected feature set with some common classifiers and found that, for the selected features, Bayesian Networks gave the best performance. Finally, we compared the observed classification performances with the performance of classifiers using randomly selected features. We found that the selected features consistently outperformed randomly selected features for all tested classifiers. The mutual information filter approach is therefore a computationally efficient method for selecting near optimal features for chemical sensor arrays.	[Wang, X. Rosalind; Lizier, Joseph T.; Prokopenko, Mikhail] CSIRO Computat Informat, Epping, NSW, Australia; [Nowotny, Thomas] Univ Sussex, Sch Engn & Informat, CCNR, Brighton, E Sussex, England; [Nowotny, Thomas; Berna, Amalia Z.; Trowell, Stephen C.] CSIRO Ecosyst Sci & Food Futures Flagship, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sussex; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Wang, XR (corresponding author), CSIRO Computat Informat, Epping, NSW, Australia.	Rosalind.Wang@csiro.au	Perez, Amalia Berna/C-2139-2008; Trowell, Stephen/AAG-8943-2019; Trowell, Stephen C/B-8043-2008; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008; Wang, X. Rosalind/AAY-2997-2021; Lizier, Joseph/B-8093-2008	Perez, Amalia Berna/0000-0003-4932-5415; Trowell, Stephen C/0000-0002-0505-8741; Prokopenko, Mikhail/0000-0002-4215-0344; Wang, X. Rosalind/0000-0001-5454-6197; Wang, X. Rosalind/0000-0001-5454-6197; Lizier, Joseph/0000-0002-9910-8972; Nowotny, Thomas/0000-0002-4451-915X	Science and Industry Endowment Fund	Science and Industry Endowment Fund	This research is supported by the Science and Industry Endowment Fund (http://www.sief.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleixandre M, 2004, SENSOR ACTUAT B-CHEM, V103, P122, DOI 10.1016/j.snb.2004.04.044; Avdiyenko Liliya, 2012, Proceedings of the 4th International Joint Conference on Computational Intelligence (IJCCI 2012), P474; BATTITI R, 1994, IEEE T NEURAL NETWOR, V5, P537, DOI 10.1109/72.298224; Berna AZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006406; Binions R, 2009, J ELECTROCHEM SOC, V156, pJ46, DOI 10.1149/1.3065436; Bishop C. M., 1995, NEURAL NETWORKS PATT; Breiman L., 2017, CLASSIFICATION REGRE; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cover T. M, 2006, ELEMENTS INFORM THEO, V2nd, DOI 10.1002/0471200611; Dacres H, 2011, BIOSENS BIOELECTRON, V29, P119, DOI 10.1016/j.bios.2011.08.004; Fano RM., 1961, TRANSMISSION INFORM; Fonollosa J, 2013, SENSOR ACTUAT B-CHEM, V187, P331, DOI 10.1016/j.snb.2012.12.026; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Gardner JW, 2005, SENSOR ACTUAT B-CHEM, V106, P114, DOI 10.1016/j.snb.2004.05.043; Guestrin C., 2005, P 22 INT C MACH LEAR, V22, P265; Guyon Isabelle, 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Krause A, 2008, J MACH LEARN RES, V9, P235; LIZIER JT, 2012, JIDT INFORM THEORETI; Llobet E, 2004, SENSOR ACTUAT B-CHEM, V99, P267, DOI 10.1016/j.snb.2003.11.019; Marco S, 2012, IEEE SENS J, V12, P3189, DOI 10.1109/JSEN.2012.2192920; Martinez S, 2006, AUTOMATICA, V42, P661, DOI 10.1016/j.automatica.2005.12.018; Muezzinoglu MK, 2010, SENSOR ACTUAT B-CHEM, V146, P472, DOI 10.1016/j.snb.2009.11.036; Murphy K, 2001, COMPUT SCI STAT, V33, P1024; Myung IJ, 2003, J MATH PSYCHOL, V47, P90, DOI 10.1016/S0022-2496(02)00028-7; NABNEY I, 2002, ADV PATTERN RECOGNIT; NELSON B, 1994, LECT NOTES CONTROL I, V200, P167, DOI DOI 10.1007/BFB0027593; Nowotny T, 2013, SENSOR ACTUAT B-CHEM, V187, P471, DOI 10.1016/j.snb.2013.01.088; OLSSON L, 2004, P 9 INT C ART LIF, P119; Pardo M, 2007, SENSOR ACTUAT B-CHEM, V123, P437, DOI 10.1016/j.snb.2006.09.041; Pardo M, 2005, SENSOR ACTUAT B-CHEM, V106, P136, DOI 10.1016/j.snb.2004.05.045; Pashami S, 2012, SENSORS-BASEL, V12, P16404, DOI 10.3390/s121216404; PEARCE TC, 2004, CHEM SENSOR ARRAY OP, P347, DOI DOI 10.1002/3527601597.CH14; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; PHIPPS MC, 1998, PRIMER STAT DATA ANA; Rakotomamonjy A., 2003, Journal of Machine Learning Research, V3, P1357, DOI 10.1162/153244303322753706; Raman B, 2009, SENSOR ACTUAT B-CHEM, V137, P617, DOI 10.1016/j.snb.2008.11.053; Rodriguez-Lujan I, 2014, CHEMOMETR INTELL LAB, V130, P123, DOI 10.1016/j.chemolab.2013.10.012; Rodriguez-Lujan I, 2010, J MACH LEARN RES, V11, P1491; Russell S., 1995, ARTIFICIAL INTELLIGE; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Vergara A, 2007, SENSOR ACTUAT B-CHEM, V123, P1002, DOI 10.1016/j.snb.2006.11.010; Vergara A., 2012, FRONTIERS NEUROENGIN, V4; Vergara A, 2012, SENSOR ACTUAT B-CHEM, V166, P320, DOI 10.1016/j.snb.2012.01.074; Vergara A, 2010, SENSOR ACTUAT B-CHEM, V148, P298, DOI 10.1016/j.snb.2010.04.040; Wang XR, 2009, INT CONF SELF SELF, P92, DOI 10.1109/SASO.2009.38; WILLIAMS PL, 2010, ABS10042515 CORR; Zheng HW, 2008, ADV SPACE RES, V41, P1960, DOI 10.1016/j.asr.2007.08.033	50	12	12	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89840	10.1371/journal.pone.0089840	http://dx.doi.org/10.1371/journal.pone.0089840			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595058	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000332475500023
J	Bertheleme, N; Strege, A; Bunting, SE; Dowell, SJ; Byrne, B				Bertheleme, Nicolas; Strege, Annette; Bunting, Sorrel E.; Dowell, Simon J.; Byrne, Bernadette			Arginine 199 and Leucine 208 Have Key Roles in the Control of Adenosine A(2A) Receptor Signalling Function	PLOS ONE			English	Article							CONSTITUTIVE ACTIVITY; NEUROTENSIN RECEPTOR; THERMOSTABILIZATION	One successful approach to obtaining high-resolution crystal structures of G-protein coupled receptors is the introduction of thermostabilising mutations within the receptor. This technique allows the generation of receptor constructs stabilised into different conformations suitable for structural studies. Previously, we functionally characterised a number of mutants of the adenosine A(2A) receptor, thermostabilised either in an agonist or antagonist conformation, using a yeast cell growth assay and demonstrated that there is a correlation between thermostability and loss of constitutive activity. Here we report the functional characterisation of 30 mutants intermediate between the Rag23 (agonist conformation mutant) and the wildtype receptor using the same yeast signalling assay with the aim of gaining greater insight into the role individual amino acids have in receptor function. The data showed that R199 and L208 have important roles in receptor function; substituting either of these residues for alanine abolishes constitutive activity. In addition, the R199A mutation markedly reduces receptor potency while L208A reduces receptor efficacy. A184L and L272A mutations also reduce constitutive activity and potency although to a lesser extent than the R199A and L208A. In contrast, the F79A mutation increases constitutive activity, potency and efficacy of the receptor. These findings shed new light on the role individual residues have on stability of the receptor and also provide some clues as to the regions of the protein responsible for constitutive activity. Furthermore, the available adenosine A(2A) receptor structures have allowed us to put our findings into a structural context.	[Bertheleme, Nicolas; Strege, Annette; Bunting, Sorrel E.; Byrne, Bernadette] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England; [Dowell, Simon J.] GlaxoSmithKline, Dept Mol Discovery Res, Stevenage, Herts, England	Imperial College London; GlaxoSmithKline	Byrne, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	b.byrne@imperial.ac.uk		Byrne, Bernadette/0000-0001-9598-9832; Dowell, Simon/0000-0001-6499-7573	Biotechnology and Biological Sciences Research Council; GlaxoSmithKline; Biotechnology and Biological Sciences Research Council [982182] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by the Biotechnology and Biological Sciences Research Council and GlaxoSmithKline. Dr. Simon Dowell, GSK, had a role in data analysis, decision to publish and preparation of the manuscript. However, the company (GSK) did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertheleme N, 2013, BRIT J PHARMACOL, V169, P988, DOI 10.1111/bph.12165; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Dowell SJ, 2009, METHODS MOL BIOL, V552, P213, DOI 10.1007/978-1-60327-317-6_15; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jiang QL, 1996, MOL PHARMACOL, V50, P512; Jiang QL, 1997, J MED CHEM, V40, P2588, DOI 10.1021/jm970084v; Klinger M, 2002, N-S ARCH PHARMACOL, V366, P287, DOI 10.1007/s00210-002-0617-z; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shibata Y, 2013, BBA-BIOMEMBRANES, V1828, P1293, DOI 10.1016/j.bbamem.2013.01.008; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	22	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89613	10.1371/journal.pone.0089613	http://dx.doi.org/10.1371/journal.pone.0089613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595172	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900025
J	Gerdin, M; Roy, N; Dharap, S; Kumar, V; Khajanchi, M; Tomson, G; Tsai, LF; Petzold, M; von Schreeb, J				Gerdin, Martin; Roy, Nobhojit; Dharap, Satish; Kumar, Vineet; Khajanchi, Monty; Tomson, Goran; Tsai, Li Fellander; Petzold, Max; von Schreeb, Johan			Early Hospital Mortality among Adult Trauma Patients Significantly Declined between 1998-2011: Three Single-Centre Cohorts from Mumbai, India	PLOS ONE			English	Article							SEVERELY INJURED PATIENTS; CARE; OUTCOMES; PERFORMANCE; MANAGEMENT; SYSTEMS; SERVICES; SURVIVAL; QUALITY; ICISS	Background: Traumatic injury causes more than five million deaths each year of which about 90% occur in low-and middle-income countries (LMIC). Hospital trauma mortality has been significantly reduced in high-income countries, but to what extent similar results have been achieved in LMIC has not been studied in detail. Here, we assessed if early hospital mortality in patients with trauma has changed over time in an urban lower middle-income setting. Methods: We conducted a retrospective study of patients admitted due to trauma in 1998, 2002, and 2011 to a large public hospital in Mumbai, India. Our outcome measure was early hospital mortality, defined as death between admission and 24-hours. We used multivariate logistic regression to assess the association between time and early hospital mortality, adjusting for patient case-mix. Injury severity was quantified using International Classification of Diseases-derived Injury Severity Score (ICISS). Major trauma was defined as ICISS, 0.90. Results: We analysed data on 4189 patients out of which 86.5% were males. A majority of patients were between 15 and 55 years old and 36.5% had major trauma. Overall early hospital mortality was 8.9% in 1998, 6.0% in 2002, and 8.1% in 2011. Among major trauma patients, early hospital mortality was 13.4%, in 1998, 11.3% in 2002, and 10.9% in 2011. Compared to trauma patients admitted in 1998, those admitted in 2011 had lower odds for early hospital mortality (OR = 0.56, 95% CI = 0.41-0.76) including those with major trauma (OR = 0.57, 95% CI = 0.41-0.78). Conclusions: We observed a significant reduction in early hospital mortality among patients with major trauma between 1998 and 2011. Improved survival was evident only after we adjusted for patient case-mix. This finding highlights the importance of risk-adjustment when studying longitudinal mortality trends.	[Gerdin, Martin; Roy, Nobhojit; Tomson, Goran; von Schreeb, Johan] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Roy, Nobhojit] Bhabha Atom Res Ctr Hosp, Dept Surg, Bombay, Maharashtra, India; [Roy, Nobhojit] Tata Inst Social Sci, Sch Habitat, Bombay, Maharashtra, India; [Dharap, Satish; Kumar, Vineet] Lokmanya Tilak Municipal Med Coll & Gen Hosp, Dept Surg, Bombay, Maharashtra, India; [Khajanchi, Monty] Seth GS Med Coll & King Edward Mem Hosp, Dept Surg, Bombay, Maharashtra, India; [Tomson, Goran] Karolinska Inst, Dept Learning Informat Management & Eth, Med Management Ctr, Stockholm, Sweden; [Tsai, Li Fellander] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Orthoped & Biotechnol, Stockholm, Sweden; [Petzold, Max] Univ Gothenburg, Sahlgrenska Acad, Ctr Appl Biostat Occupat & Environm Med, Gothenburg, Sweden	Karolinska Institutet; Bhabha Atomic Research Center (BARC); Tata Institute of Social Sciences; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Karolinska Institutet; Karolinska Institutet; University of Gothenburg	Gerdin, M (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	martin.gerdin@ki.se	Wärnberg, Martin Gerdin/D-7482-2019; Dharap, Satish/AAE-8565-2020	Wärnberg, Martin Gerdin/0000-0001-6069-4794; Dharap, Satish/0000-0002-9304-9617; Tomson, Goran/0000-0001-9222-3604; Fellander-Tsai, Li/0000-0003-0693-6080; Roy, Nobhojit/0000-0003-2022-7416	Swedish National Board of Health and Welfare	Swedish National Board of Health and Welfare	This research was funded through grants from the Second Assist and the Swedish National Board of Health and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balogh ZJ, 2012, LANCET, V380, P1109, DOI 10.1016/S0140-6736(12)60991-X; Blomberg H, 2013, J AM COLL SURGEONS, V217, P1010, DOI 10.1016/j.jamcollsurg.2013.08.002; Brennan PW, 2002, J TRAUMA, V53, P333, DOI 10.1097/00005373-200208000-00024; Cameron PA, 2008, MED J AUSTRALIA, V189, P546, DOI 10.5694/j.1326-5377.2008.tb02176.x; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Christensen MC, 2010, J TRAUMA, V69, P344, DOI 10.1097/TA.0b013e3181e74c69; Ciesla DJ, 2013, J AM COLL SURGEONS, V216, P687, DOI 10.1016/j.jamcollsurg.2012.12.033; Demyttenaere SV, 2009, CAN J SURG, V52, pE146; Diggs BS, 2008, J AM COLL SURGEONS, V206, P212, DOI 10.1016/j.jamcollsurg.2007.08.019; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; Gedeborg R, 2010, INJURY PREV, V16, P302, DOI 10.1136/ip.2009.024414; Glance LG, 2012, ARCH SURG-CHICAGO, V147, P732, DOI 10.1001/archsurg.2012.1138; Gliklich R, 2007, REGISTRIES EVALUATIN; Gould W, 1999, DO I IDENTIFY DUPLIC; Gruen RL, 2012, BRIT J SURG, V99, P97, DOI 10.1002/bjs.7754; Gruen RL, 2012, LANCET, V380, P1099, DOI 10.1016/S0140-6736(12)61224-0; Gruen RL, 2012, LANCET, V380, P1033, DOI 10.1016/S0140-6736(12)61418-4; Gururaj G, 2008, NATL MED J INDIA, V21, P14; Gururaj G, 2005, NATL COMMISSION MACR, P325; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Henry JA, 2012, J TRAUMA ACUTE CARE, V73, P261, DOI 10.1097/TA.0b013e31824bde1e; Ichikawa M, 2003, ACCIDENT ANAL PREV, V35, P183, DOI 10.1016/S0001-4575(01)00102-6; International Institute for Population Sciences and Macro International, 2008, NAT FAM HLTH SURV NF; Ker K, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-3; Kilgo PD, 2003, J TRAUMA, V55, P599, DOI 10.1097/01.TA.0000085721.47738.BD; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marson AC, 2001, J TRAUMA, V50, P917; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Meredith JW, 2002, J TRAUMA, V53, P621, DOI 10.1097/00005373-200210000-00001; Mock C, 2012, WORLD J SURG, V36, P959, DOI 10.1007/s00268-012-1459-6; Moore L, 2010, WORLD J SURG, V34, P2069, DOI 10.1007/s00268-010-0588-z; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; National Crime Records Bureau, 2011, ACC DEATHS SUIC IND; O'Reilly GM, 2012, INJURY, V43, P1148, DOI 10.1016/j.injury.2012.03.003; O'Reilly GM, 2013, INJURY; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Press Information Bureau, 2011, INDIA STATS MILL PLU; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Roy N, 2010, PREHOSP DISASTER MED, V25, P145, DOI 10.1017/S1049023X00007883; Rutledge R, 1998, J TRAUMA, V44, P41, DOI 10.1097/00005373-199801000-00003; RUTLEDGE R, 1995, SURG CLIN N AM, V75, P305, DOI 10.1016/S0039-6109(16)46590-4; Sample Registration System, 2011, SPEC B MAT MORT IND; Sample Registration System, 2000, SRS B, V33; SHACKFORD SR, 1986, J TRAUMA, V26, P812, DOI 10.1097/00005373-198609000-00006; Tohira H, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-63; WEST JG, 1979, ARCH SURG-CHICAGO, V114, P455; Wong Sydney S N, 2008, Mcgill J Med, V11, P9; World Bank, 2013, COUNTR LEND GROUPS; World Health Organization, 2004, WORLD REPORT ROAD TR; World Health Organization, 2010, INJ VIOL FACTS	51	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90064	10.1371/journal.pone.0090064	http://dx.doi.org/10.1371/journal.pone.0090064			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594775	Green Submitted, Green Published, gold			2022-12-25	WOS:000332468900062
J	Haye, A; Albert, J; Rooman, M				Haye, Alexandre; Albert, Jaroslav; Rooman, Marianne			Modeling the Drosophila Gene Cluster Regulation Network for Muscle Development	PLOS ONE			English	Article							TIME-SERIES DATA; EXPRESSION DATA; MICROARRAY; NORMALIZATION; INFERENCE; VARIANCE	The development of accurate and reliable dynamical modeling procedures that describe the time evolution of gene expression levels is a prerequisite to understanding and controlling the transcription process. We focused on data from DNA microarray time series for 20 Drosophila genes involved in muscle development during the embryonic stage. Genes with similar expression profiles were clustered on the basis of a translation-invariant and scale-invariant distance measure. The time evolution of these clusters was modeled using coupled differential equations. Three model structures involving a transcription term and a degradation term were tested. The parameters were identified in successive steps: network construction, parameter optimization, and parameter reduction. The solutions were evaluated on the basis of the data reproduction and the number of parameters, as well as on two biology-based requirements: the robustness with respect to parameter variations and the values of the expression levels not being unrealistically large upon extrapolation in time. Various solutions were obtained that satisfied all our evaluation criteria. The regulatory networks inferred from these solutions were compared with experimental data. The best solution has half of the experimental connections, which compares favorably with previous approaches. Biasing the network toward the experimental connections led to the identification of a model that is only slightly less good on the basis of the evaluation criteria. The non-uniqueness of the solutions and the variable agreement with experimental connections were discussed in the context of the different hypotheses underlying this type of approach.	[Haye, Alexandre; Albert, Jaroslav; Rooman, Marianne] Univ Libre Bruxelles, BioModeling BioInformat & BioProc Dept, Brussels, Belgium	Universite Libre de Bruxelles	Rooman, M (corresponding author), Univ Libre Bruxelles, BioModeling BioInformat & BioProc Dept, Brussels, Belgium.	mrooman@ulb.ac.be			Belgian Fund for Scientific Research (FNRS); Belgian Fund for Scientific Research (FRIA)	Belgian Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Belgian Fund for Scientific Research (FRIA)(Fonds de la Recherche Scientifique - FNRS)	This research was supported by the Belgian Fund for Scientific Research (FNRS and FRIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert Jaroslav, 2011, Syst Synth Biol, V5, P33, DOI 10.1007/s11693-011-9079-2; Androulakis IP, 2007, ANNU REV BIOMED ENG, V9, P205, DOI 10.1146/annurev.bioeng.9.060906.151904; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bar-Joseph Z, 2004, BIOINFORMATICS, V20, P2493, DOI 10.1093/bioinformatics/bth283; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Dufva Martin, 2009, V529, P1, DOI 10.1007/978-1-59745-538-1_1; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Goutsias J, 2007, CURR PHARM DESIGN, V13, P1415, DOI 10.2174/138161207780765945; Guo F., 2007, P 24 INT C MACH LEAR, P321; Hartigan J., 1975, CLUSTERING ALGORITHM; Haye Alexandre, 2012, BMC Res Notes, V5, P46, DOI 10.1186/1756-0500-5-46; Haye A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016004; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hempel S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-292; Hickman R, 2013, PLANT J, V75, P26, DOI 10.1111/tpj.12194; Ingold A, 2002, THESIS U AIX MARSEIL, P3; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Konopka T, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-123; Kramer R, 2008, J SIGNAL PROCESS SYS, V50, P321, DOI 10.1007/s11265-007-0122-1; Krishnan A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000562; Li P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S13; Motakis ES, 2006, BIOINFORMATICS, V22, P2547, DOI 10.1093/bioinformatics/btl412; Mueller HG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-60; Page Grier P., 2007, V404, P409, DOI 10.1007/978-1-59745-530-5_20; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rooman M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027948; Sima C, 2009, CURR GENOMICS, V10, P416, DOI 10.2174/138920209789177610; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Wu XW, 2006, METH MOL B, V316, P35; Yu JK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-461; Zhao WT, 2006, BIOINFORMATICS, V22, P2129, DOI 10.1093/bioinformatics/btl364; Zhou T, 2002, P NATL ACAD SCI USA, V99, P2049, DOI 10.1073/pnas.261714399	33	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90285	10.1371/journal.pone.0090285	http://dx.doi.org/10.1371/journal.pone.0090285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594656	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900089
J	Kocharunchitt, C; King, T; Gobius, K; Bowman, JP; Ross, T				Kocharunchitt, Chawalit; King, Thea; Gobius, Kari; Bowman, John P.; Ross, Tom			Global Genome Response of Escherichia coli O157:H7 Sakai during Dynamic Changes in Growth Kinetics Induced by an Abrupt Downshift in Water Activity	PLOS ONE			English	Article							CYCLOPROPANE FATTY-ACIDS; LAG PHASE DURATION; GENE-EXPRESSION; COLANIC-ACID; STRESS-RESPONSE; MESSENGER-RNA; SIGMA(S)-DEPENDENT GENES; MEMBRANE-PERMEABILITY; PHOSPHORELAY SYSTEM; MICROARRAY ANALYSIS	The present study was undertaken to investigate growth kinetics and time-dependent change in global expression of Escherichia coli O157:H7 Sakai upon an abrupt downshift in water activity (a(w)). Based on viable count data, shifting E. coli from a(w) 0.993 to a(w) 0.985 or less caused an apparent loss, then recovery, of culturability. Exponential growth then resumed at a rate characteristic for the a(w) imposed. To understand the responses of this pathogen to abrupt osmotic stress, we employed an integrated genomic and proteomic approach to characterize its cellular response during exposure to a rapid downshift but still within the growth range from a(w) 0.993 to a(w) 0.967. Of particular interest, genes and proteins with cell envelope-related functions were induced during the initial loss and subsequent recovery of culturability. This implies that cells undergo remodeling of their envelope composition, enabling them to adapt to osmotic stress. Growth at low a(w), however, involved up-regulating additional genes and proteins, which are involved in the biosynthesis of specific amino acids, and carbohydrate catabolism and energy generation. This suggests their important role in facilitating growth under such stress. Finally, we highlighted the ability of E. coli to activate multiple stress responses by transiently inducing the RpoE and RpoH regulons to control protein misfolding, while simultaneously activating the master stress regulator RpoS to mediate long-term adaptation to hyperosmolality. This investigation extends our understanding of the potential mechanisms used by pathogenic E. coli to adapt, survive and grow under osmotic stress, which could potentially be exploited to aid the selection and/or development of novel strategies to inactivate this pathogen.	[Kocharunchitt, Chawalit; Bowman, John P.; Ross, Tom] Univ Tasmania, Tasmanian Inst Agr, Food Safety Ctr, Hobart, Tas, Australia; [King, Thea] Commonwealth Sci & Ind Res Org Anim Food & Hlth S, N Ryde, NSW, Australia; [Gobius, Kari] Commonwealth Sci & Ind Res Org Anim Food & Hlth S, Werribee, Vic, Australia	University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Kocharunchitt, C (corresponding author), Univ Tasmania, Tasmanian Inst Agr, Food Safety Ctr, Hobart, Tas, Australia.	chawalit.kocharunchitt@utas.edu.au	Gobius, Kari/I-4700-2013; Bowman, John P./ABF-5108-2020; Bowman, John P/C-2414-2014	Gobius, Kari/0000-0002-3653-2581; Bowman, John P./0000-0002-4528-9333; Bowman, John P/0000-0002-4528-9333; Kocharunchitt, Chawalit/0000-0003-3919-2401; Ross, Tom/0000-0001-9916-7772	Meat and Livestock Australia	Meat and Livestock Australia(Meat and Livestock Australia)	This study was supported by Meat and Livestock Australia (http://www.mla.com.au/Home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertsen A, 2004, CRIT REV MICROBIOL, V30, P263, DOI 10.1080/10408410490884757; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; ALLEN PM, 1987, J MED MICROBIOL, V24, P363, DOI 10.1099/00222615-24-4-363; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BI E, 1993, J BACTERIOL, V175, P1118, DOI 10.1128/JB.175.4.1118-1125.1993; Bianchi AA, 1999, MOL MICROBIOL, V34, P1029, DOI 10.1046/j.1365-2958.1999.01664.x; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Brenner M, 1971, METABOLIC PATHWAYS; Brown JL, 1997, INT J FOOD MICROBIOL, V37, P163, DOI 10.1016/S0168-1605(97)00068-8; Busta F F, 1978, Adv Appl Microbiol, V23, P195, DOI 10.1016/S0065-2164(08)70069-8; Cagney C, 2004, FOOD MICROBIOL, V21, P203, DOI 10.1016/S0740-0020(03)00052-2; Canet S, 2003, FEMS MICROBIOL LETT, V225, P207, DOI 10.1016/S0378-1097(03)00515-9; CASADESUS J, 1989, MOL GEN GENET, V216, P210, DOI 10.1007/BF00334358; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Chen JR, 2004, INT J FOOD MICROBIOL, V93, P281, DOI 10.1016/j.ijfoodmicro.2003.12.004; CHIRIFE J, 1984, J FOOD SCI, V49, P1486, DOI 10.1111/j.1365-2621.1984.tb12827.x; Chung HJ, 2006, COMPR REV FOOD SCI F, V5, P52, DOI 10.1111/j.1541-4337.2006.00002.x; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; FITT PS, 1992, CURR MICROBIOL, V24, P251, DOI 10.1007/BF01577328; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; FRANDSEN N, 1993, MOL GEN GENET, V240, P348, DOI 10.1007/BF00280385; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Guillot A, 2000, INT J FOOD MICROBIOL, V55, P47, DOI 10.1016/S0168-1605(00)00193-8; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; Gur E, 2002, MOL MICROBIOL, V46, P1391, DOI 10.1046/j.1365-2958.2002.03257.x; Gyaneshwar P, 2005, P NATL ACAD SCI USA, V102, P3453, DOI 10.1073/pnas.0500141102; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hagiwara D, 2003, J BACTERIOL, V185, P5735, DOI 10.1128/JB.185.19.5735-5746.2003; Hatzimanikatis V, 1999, BIOTECHNOL PROGR, V15, P312, DOI 10.1021/bp990004b; Hatzimanikatis V, 1999, METAB ENG, V1, P275, DOI 10.1006/mben.1999.0115; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Horinouchi T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-579; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jung IL, 2003, ARCH BIOCHEM BIOPHYS, V418, P125, DOI 10.1016/j.abb.2003.08.003; KAWAMUKAI M, 1988, J BACTERIOL, V170, P3864, DOI 10.1128/jb.170.9.3864-3869.1988; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim YH, 2005, APPL MICROBIOL BIOT, V68, P786, DOI 10.1007/s00253-005-0053-3; King T, 2013, GLOBAL GENOME RESPON; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Kocharunchitt C, 2011, MOL CELL PROTEOMICS, DOI [10.1074/mcp.M1111.009019, DOI 10.1074/MCP.M1111.009019]; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; MACKEY BM, 1982, J APPL BACTERIOL, V53, P243, DOI 10.1111/j.1365-2672.1982.tb04683.x; Majdalani N, 2005, J BACTERIOL, V187, P6770, DOI 10.1128/JB.187.19.6770-6778.2005; Mao Y, 2006, LETT APPL MICROBIOL, V42, P642, DOI 10.1111/j.1472-765X.2006.01875.x; McClure P, 2000, WORLD J MICROB BIOT, V16, P749, DOI 10.1023/A:1008997310966; Mellefont LA, 2005, INT J FOOD MICROBIOL, V105, P399, DOI 10.1016/j.ijfoodmicro.2005.03.018; Mellefont LA, 2003, INT J FOOD MICROBIOL, V83, P281, DOI 10.1016/S0168-1605(02)00377-X; Mellefont LA, 2003, INT J FOOD MICROBIOL, V83, P295, DOI 10.1016/S0168-1605(02)00378-1; Meredith TC, 2007, J BIOL CHEM, V282, P7790, DOI 10.1074/jbc.M611034200; MEURY J, 1991, J BACTERIOL, V173, P4404, DOI 10.1128/JB.173.14.4404-4410.1991; MEURY J, 1994, FEMS MICROBIOL LETT, V121, P281, DOI 10.1016/0378-1097(94)90304-2; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; O'Byrne CP, 2002, INT J FOOD MICROBIOL, V74, P203, DOI 10.1016/S0168-1605(01)00681-X; OPHIR T, 1994, APPL ENVIRON MICROB, V60, P740, DOI 10.1128/AEM.60.2.740-745.1994; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Pham TV, 2010, BIOINFORMATICS, V26, P363, DOI 10.1093/bioinformatics/btp677; Pin C, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-108; Pratt LA, 1996, MOL MICROBIOL, V20, P911, DOI 10.1111/j.1365-2958.1996.tb02532.x; Price NL, 2009, J BACTERIOL, V191, P1798, DOI 10.1128/JB.00798-08; Rauch A, 2006, J PROTEOME RES, V5, P112, DOI 10.1021/pr0503533; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Ribeiro GF, 2006, MOL BIOL CELL, V17, P4584, DOI 10.1091/mbc.E06-05-0475; Robinson TP, 1998, INT J FOOD MICROBIOL, V44, P83, DOI 10.1016/S0168-1605(98)00120-2; Robinson TP, 2001, INT J FOOD MICROBIOL, V70, P163, DOI 10.1016/S0168-1605(01)00541-4; RON EZ, 1990, ANTON LEEUW INT J G, V58, P169, DOI 10.1007/BF00548929; Ross T, 2003, INT J FOOD MICROBIOL, V82, P33, DOI 10.1016/S0168-1605(02)00252-0; Rossouw D, 2010, APPL ENVIRON MICROB, V76, P3911, DOI 10.1128/AEM.00586-10; Russell NJ, 1995, INT J FOOD MICROBIOL, V28, P255, DOI 10.1016/0168-1605(95)00061-5; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shabala L, 2008, RES MICROBIOL, V159, P458, DOI 10.1016/j.resmic.2008.04.011; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; Sledjeski DD, 1996, J BACTERIOL, V178, P1204, DOI 10.1128/jb.178.4.1204-1206.1996; Thomas JG, 2000, MOL MICROBIOL, V36, P1360, DOI 10.1046/j.1365-2958.2000.01951.x; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Vaara M, 1999, ANTIMICROB AGENTS CH, V43, P1459, DOI 10.1128/AAC.43.6.1459; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; VUORIO R, 1992, ANTIMICROB AGENTS CH, V36, P826, DOI 10.1128/AAC.36.4.826; Watanabe H, 1996, LANCET, V348, P831, DOI 10.1016/S0140-6736(05)65257-9; Weber A, 2002, J BACTERIOL, V184, P5502, DOI 10.1128/JB.184.19.5502-5507.2002; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Wecker P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-410; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001; Zhou K, 2011, APPL ENVIRON MICROB, V77, P1758, DOI 10.1128/AEM.02629-10; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	95	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90422	10.1371/journal.pone.0090422	http://dx.doi.org/10.1371/journal.pone.0090422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594867	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900108
J	Riffel, P; Michaely, HJ; Morelli, JN; Pfeuffer, J; Attenberger, UI; Schoenberg, SO; Haneder, S				Riffel, Philipp; Michaely, Henrik J.; Morelli, John N.; Pfeuffer, Josef; Attenberger, Ulrike I.; Schoenberg, Stefan O.; Haneder, Stefan			Zoomed EPI-DWI of the Pancreas Using Two-Dimensional Spatially-Selective Radiofrequency Excitation Pulses	PLOS ONE			English	Article							DIFFUSION; REPRODUCIBILITY; EXPERIENCE; ABDOMEN	Background: Implementation of DWI in the abdomen is challenging due to artifacts, particularly those arising from differences in tissue susceptibility. Two-dimensional, spatially-selective radiofrequency (RF) excitation pulses for single-shot echo-planar imaging (EPI) combined with a reduction in the FOV in the phase-encoding direction (i.e. zooming) leads to a decreased number of k-space acquisition lines, significantly shortening the EPI echo train and potentially susceptibility artifacts. Purpose: To assess the feasibility and image quality of a zoomed diffusion-weighted EPI (z-EPI) sequence in MR imaging of the pancreas. The approach is compared to conventional single-shot EPI (c-EPI). Material and Methods: 23 patients who had undergone an MRI study of the abdomen were included in this retrospective study. Examinations were performed on a 3T whole-body MR system (Magnetom Skyra, Siemens) equipped with a two-channel fully dynamic parallel transmit array (TimTX TrueShape, Siemens). The acquired sequences consisted of a conventional EPI DWI of the abdomen and a zoomed EPI DWI of the pancreas. For z-EPI, the standard sinc excitation was replaced with a two-dimensional spatially-selective RF pulse using an echo-planar transmit trajectory. Images were evaluated with regard to image blur, respiratory motion artifacts, diagnostic confidence, delineation of the pancreas, and overall scan preference. Additionally ADC values of the pancreatic head, body, and tail were calculated and compared between sequences. Results: The pancreas was better delineated in every case (23/23) with z-EPI versus c-EPI. In every case (23/23), both readers preferred z-EPI overall to c-EPI. With z-EPI there was statistically significantly less image blur (p<0.0001) and respiratory motion artifact compared to c-EPI (p<0.0001). Diagnostic confidence was statistically significantly better with z-EPI (p<0.0001). No statistically significant differences in calculated ADC values were observed between the two sequences. Conclusion: Zoomed diffusion-weighted EPI leads to substantial image quality improvements with reduction of susceptibility artifacts in pancreatic DWI.	[Riffel, Philipp; Michaely, Henrik J.; Attenberger, Ulrike I.; Schoenberg, Stefan O.; Haneder, Stefan] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Inst Clin Radiol & Nucl Med, Mannheim, Germany; [Morelli, John N.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Pfeuffer, Josef] Siemens Healthcare Sect, Applicat Dev, Erlangen, Germany	Ruprecht Karls University Heidelberg; Johns Hopkins University; Siemens AG	Riffel, P (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Inst Clin Radiol & Nucl Med, Mannheim, Germany.	Philipp.Riffel@umm.de	Attenberger, Ulrike/HDN-2286-2022; Attenberger, Ulrike/ABD-8541-2020	Attenberger, Ulrike/0000-0002-8123-5447; Attenberger, Ulrike/0000-0002-8123-5447; Pfeuffer, Josef/0000-0001-9887-0458				Akisik MF, 2009, RADIOLOGY, V250, P103, DOI 10.1148/radiol.2493080160; [Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Barral M, 2013, Diagn Interv Imaging, V94, P619, DOI 10.1016/j.diii.2013.02.011; Barral M, 2013, Diagn Interv Imaging, V94, P418, DOI 10.1016/j.diii.2012.12.007; Bilgili MYK, 2012, EUR J RADIOL, V81, P2066, DOI 10.1016/j.ejrad.2011.06.045; Braithwaite AC, 2009, RADIOLOGY, V250, P459, DOI 10.1148/radiol.2502080849; Herrmann J, 2013, J MAGN RESON IMAGING, V37, P886, DOI 10.1002/jmri.23871; Ichikawa T, 1999, ABDOM IMAGING, V24, P456, DOI 10.1007/s002619900539; Kang KM, 2013, J MAGN RESON IMAGING; Kartalis N, 2009, EUR RADIOL, V19, P1981, DOI 10.1007/s00330-009-1384-8; Katscher U, 2003, MAGNET RESON MED, V49, P144, DOI 10.1002/mrm.10353; Klauss M, 2011, INVEST RADIOL, V46, P57, DOI 10.1097/RLI.0b013e3181fb3bf2; Kwee TC, 2008, J MAGN RESON IMAGING, V28, P1141, DOI 10.1002/jmri.21569; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Morelli J, 2013, ACTA RADIOL; MULLER MF, 1994, RADIOLOGY, V190, P475; Naganawa Shinji, 2005, Magn Reson Med Sci, V4, P175, DOI 10.2463/mrms.4.175; Pfeuffer J, 2002, NEUROIMAGE, V17, P272, DOI 10.1006/nimg.2002.1103; Rao RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032613; Rieseberg S, 2002, MAGN RESON MED, V47, P1186, DOI 10.1002/mrm.10157; Wang Y, 2011, J MAGN RESON IMAGING, V33, P136, DOI 10.1002/jmri.22414; Zhang JB, 2008, RADIOLOGY, V247, P458, DOI 10.1148/radiol.2472070823; Zhu YD, 2004, MAGNET RESON MED, V51, P775, DOI 10.1002/mrm.20011	23	43	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89468	10.1371/journal.pone.0089468	http://dx.doi.org/10.1371/journal.pone.0089468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594702	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900018
J	Schurek, EM; Volker, LA; Tax, J; Lamkemeyer, T; Rinschen, MM; Ungrue, D; Kratz, JE; Sirianant, L; Kunzelmann, K; Chalfie, M; Schermer, B; Benzing, T; Hohne, M				Schurek, Eva-Maria; Voelker, Linus A.; Tax, Judit; Lamkemeyer, Tobias; Rinschen, Markus M.; Ungrue, Denise; Kratz, John E., III; Sirianant, Lalida; Kunzelmann, Karl; Chalfie, Martin; Schermer, Bernhard; Benzing, Thomas; Hoehne, Martin			A Disease-causing Mutation Illuminates the Protein Membrane Topology of the Kidney-expressed Prohibitin Homology ( PHB) Domain Protein Podocin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caenorhabditis elegans; Cholesterol-binding Protein; Glycosylation; Lipid Raft; Protein Conformation; PHB Domain; Membrane Topology; Podocin; Steroid-resistant Nephrotic Syndrome; Stomatin Family Proteins	RESISTANT NEPHROTIC SYNDROME; MULTIPLE SEQUENCE ALIGNMENT; GLOMERULAR SLIT DIAPHRAGM; TURKISH CHILDREN; N-GLYCOSYLATION; NPHS2 MUTATIONS; NEPHRIN; MEC-2; TRPC6; GENE	Background: Mutations in the stomatin family protein podocin are the most common genetic cause of proteinuria. Results: A conserved proline residue of podocin is essential for its membrane topology. Conclusion: This study confirms a hairpin-like structure of the membrane-attached PHB domain protein and its significance for cholesterol recruitment. Significance: Podocin(P118L) elucidates the pathogenic implication in kidney disease and identifies a novel family of PHB domain proteins. Mutations in the NPHS2 gene are a major cause of steroid-resistant nephrotic syndrome, a severe human kidney disorder. The NPHS2 gene product podocin is a key component of the slit diaphragm cell junction at the kidney filtration barrier and part of a multiprotein-lipid supercomplex. A similar complex with the podocin ortholog MEC-2 is required for touch sensation in Caenorhabditis elegans. Although podocin and MEC-2 are membrane-associated proteins with a predicted hairpin-like structure and amino and carboxyl termini facing the cytoplasm, this membrane topology has not been convincingly confirmed. One particular mutation that causes kidney disease in humans (podocin(P118L)) has also been identified in C. elegans in genetic screens for touch insensitivity (MEC-2(P134S)). Here we show that both mutant proteins, in contrast to the wild-type variants, are N-glycosylated because of the fact that the mutant C termini project extracellularly. Podocin(P118L) and MEC-2(P134S) did not fractionate in detergent-resistant membrane domains. Moreover, mutant podocin failed to activate the ion channel TRPC6, which is part of the multiprotein-lipid supercomplex, indicative of the fact that cholesterol recruitment to the ion channels, an intrinsic function of both proteins, requires C termini facing the cytoplasmic leaflet of the plasma membrane. Taken together, this study demonstrates that the carboxyl terminus of podocin/MEC-2 has to be placed at the inner leaflet of the plasma membrane to mediate cholesterol binding and contribute to ion channel activity, a prerequisite for mechanosensation and the integrity of the kidney filtration barrier.	[Schurek, Eva-Maria; Voelker, Linus A.; Tax, Judit; Rinschen, Markus M.; Schermer, Bernhard; Benzing, Thomas; Hoehne, Martin] Univ Cologne, Dept Internal Med 2, D-50931 Cologne, Germany; [Schurek, Eva-Maria; Voelker, Linus A.; Tax, Judit; Rinschen, Markus M.; Schermer, Bernhard; Benzing, Thomas; Hoehne, Martin] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Lamkemeyer, Tobias; Ungrue, Denise; Schermer, Bernhard; Benzing, Thomas] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Schermer, Bernhard; Benzing, Thomas; Hoehne, Martin] Univ Cologne, Syst Biol Ageing Cologne, D-50931 Cologne, Germany; [Kratz, John E., III; Chalfie, Martin] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Sirianant, Lalida; Kunzelmann, Karl] Univ Regensburg, Dept Physiol, D-93053 Regensburg, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; Columbia University; University of Regensburg	Benzing, T (corresponding author), Univ Cologne, Dept Internal Med 2, D-50931 Cologne, Germany.	thomas.benzing@uk-koeln.de	Benzing, Thomas/X-5476-2019; Rinschen, Markus/N-7283-2019; Schermer, Bernhard/E-9972-2014; Völker, Linus Alexander/GLV-0326-2022	Rinschen, Markus/0000-0002-9252-1342; Schermer, Bernhard/0000-0002-5194-9000; Völker, Linus Alexander/0000-0002-4461-6128; Hohne, Martin/0000-0001-8698-5389	National Institutes of Health [GM30997]; Deutsche Forschungsgemeinschaft [SFB699, SFB572, SFB635, BE2212]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008798, R01GM030997, R37GM030997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM30997 (to M. C.). This work was also supported by Deutsche Forschungsgemeinschaft Grants SFB699 (to K. K.) and SFB572, SFB635, and BE2212 (to T. B.).	Anderson M, 2013, AM J PHYSIOL-CELL PH, V305, pC276, DOI 10.1152/ajpcell.00095.2013; Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Berdeli A, 2007, PEDIATR NEPHROL, V22, P2031, DOI 10.1007/s00467-007-0595-y; Bouchireb K, 2014, HUM MUTAT, V35, P178, DOI 10.1002/humu.22485; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Brand J, 2012, EMBO J, V31, P3635, DOI 10.1038/emboj.2012.203; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Caridi G, 2005, PEDIATR RES, V57, p54R, DOI 10.1203/01.PDR.0000160446.01907.B1; Eckhardt M, 2002, BIOCHEM J, V368, P317, DOI 10.1042/BJ20020946; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekim M, 2004, AM J KIDNEY DIS, V44, DOI 10.1053/j.ajkd.2004.04.044; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; HIEBLDIRSCHMIED CM, 1991, BIOCHIM BIOPHYS ACTA, V1090, P123, DOI 10.1016/0167-4781(91)90047-P; Hinkes BG, 2007, PEDIATRICS, V119, pE907, DOI 10.1542/peds.2006-2164; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Kadurin I, 2009, BIOCHEM J, V418, P587, DOI 10.1042/BJ20081662; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Ozer EA, 2004, NEPHROLOGY, V9, P310, DOI 10.1111/j.1440-1797.2004.00324.x; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rho SH, 2000, FEBS LETT, V478, P246, DOI 10.1016/S0014-5793(00)01863-9; Roselli S, 2004, TRAFFIC, V5, P37, DOI 10.1046/j.1600-0854.2003.00148.x; Roselli S, 2002, AM J PATHOL, V160, P131, DOI 10.1016/S0002-9440(10)64357-X; Schermer B, 2009, J AM SOC NEPHROL, V20, P473, DOI 10.1681/ASN.2008070694; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI200112849; Volker LA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-102; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weber S, 2004, KIDNEY INT, V66, P571, DOI 10.1111/j.1523-1755.2004.00776.x; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Zhang SF, 2004, CURR BIOL, V14, P1888, DOI 10.1016/j.cub.2004.10.030	38	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11262	11271		10.1074/jbc.M113.521773	http://dx.doi.org/10.1074/jbc.M113.521773			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596097	Green Published, hybrid			2022-12-25	WOS:000334638500029
J	Sousa, GR; Gomes, JAS; Fares, RCG; Damasio, MPD; Chaves, AT; Ferreira, KS; Nunes, MCP; Medeiros, NI; Valente, VAA; Correa-Oliveira, R; Rocha, MOD				Sousa, Giovane Rodrigo; Silva Gomes, Juliana Assis; Gomes Fares, Rafaelle Christine; de Souza Damasio, Marcos Paulo; Chaves, Ana Thereza; Ferreira, Karine Silvestre; Pereira Nunes, Maria Carmo; Medeiros, Nayara Ingrid; Azevedo Valente, Vanessa Alves; Correa-Oliveira, Rodrigo; da Costa Rocha, Manoel Otavio			Plasma Cytokine Expression Is Associated with Cardiac Morbidity in Chagas Disease	PLOS ONE			English	Article							DIFFERENT CLINICAL FORMS; NECROSIS-FACTOR-ALPHA; REGULATORY T-CELLS; IFN-GAMMA; FUNCTIONAL-CHARACTERISTICS; CARDIOMYOPATHY; INDETERMINATE; MOLECULES; MONOCYTES; DISPLAY	The expression of immune response appears to be associated with morbidity in Chagas disease. However, the studies in this field have usually employed small samples of patients and statistical analyses that do not consider the wide dispersion of cytokine production observed in these patients. The aim of this study was to evaluate the plasma cytokine levels in well-defined clinical polar groups of chagasic patients divided into categories that better reflect the wide cytokine profile and its relationship with morbidity. Patients infected with Trypanosoma cruzi (T. cruzi) were grouped as indeterminate (IND) and cardiac (CARD) forms ranging from 23 to 69 years of age (mean of 45.6 +/- 11.25). The IND group included 82 individuals, ranging from 24 to 66 years of age (mean of 39.6 +/- 10.3). The CARD group included 94 patients ranging from 23 to 69 years of age (mean of 48 +/- 12.52) presenting dilated cardiomyopathy. None of the patients have undergone chemotherapeutic treatment, nor had been previously treated for T. cruzi infection. Healthy non-chagasic individuals, ranging from 29 to 55 years of age (mean of 42.6 +/- 8.8) were included as a control group (NI). IND patients have a higher intensity of interleukin 10 (IL-10) expression when compared with individuals in the other groups. By contrast, inflammatory cytokine expression, such as interferon gamma (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), and interleukin 1 beta (IL-1 beta), proved to be the highest in the CARD group. Correlation analysis showed that higher IL-10 expression was associated with better cardiac function, as determined by left ventricular ejection fraction and left ventricular diastolic diameter values. Altogether, these findings reinforce the concept that a fine balance between regulatory and inflammatory cytokines represents a key element in the establishment of distinct forms of chronic Chagas disease.	[Sousa, Giovane Rodrigo; Silva Gomes, Juliana Assis; Pereira Nunes, Maria Carmo; da Costa Rocha, Manoel Otavio] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil; [Silva Gomes, Juliana Assis; de Souza Damasio, Marcos Paulo; Ferreira, Karine Silvestre; Azevedo Valente, Vanessa Alves] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Belo Horizonte, MG, Brazil; [Gomes Fares, Rafaelle Christine; Chaves, Ana Thereza; Medeiros, Nayara Ingrid; Correa-Oliveira, Rodrigo] Fundacao Oswaldo Cruz, Lab Imunol Celular & Mol, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Correa-Oliveira, Rodrigo] Inst Nacl Ciencia & Tecnol Doencas Tropicais, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Correa-Oliveira, R (corresponding author), Fundacao Oswaldo Cruz, Lab Imunol Celular & Mol, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	correa@cpqrr.fiocruz.br	Nunes, Maria Carmo/AAV-5185-2020; Damasio, Marcos/AAJ-7196-2021; Medeiros, Nayara I/F-3273-2018; Sousa, Giovane R./H-6102-2016; Gomes, Juliana A. S./M-4083-2017	Medeiros, Nayara I/0000-0002-5791-4802; Sousa, Giovane R./0000-0003-0085-3882; Gomes, Juliana A. S./0000-0002-8332-2907; Correa-Oliveira, Rodrigo/0000-0001-6419-9459; Fares Gusmao, Rafaelle/0000-0002-2186-4145	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [478846/2009-6]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ-02601-10]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant number: 478846/2009-6, http://www.cnpq.br) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, grant number: APQ-02601-10, http://www.fapemig.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel LCJ, 2001, J AUTOIMMUN, V17, P99, DOI 10.1006/jaut.2001.0523; Altman DG, 1991, PRACTICAL STAT MED R, P419; Araujo FF, 2007, FRONT BIOSCI-LANDMRK, V12, P2797, DOI 10.2741/2273; Bahia-Oliveira LMG, 1998, BRAZ J MED BIOL RES, V31, P127, DOI 10.1590/S0100-879X1998000100017; Chen R, 1999, CLIN CHEM, V45, P1693; Costa GC, 2009, J INFECT DIS, V199, P451, DOI 10.1086/596061; Crema E, 2006, CLIN IMMUNOL, V119, P213, DOI 10.1016/j.clim.2005.12.011; de Araujo FF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000992; de Araujo FF, 2011, HUM PATHOL, V42, P299, DOI 10.1016/j.humpath.2010.10.002; Dias J C, 1989, Rev Soc Bras Med Trop, V22, P147, DOI 10.1590/S0037-86821989000300007; Dutra WO, 2000, SCAND J IMMUNOL, V51, P91; Dutra WO, 1997, SCAND J IMMUNOL, V45, P74, DOI 10.1046/j.1365-3083.1997.d01-362.x; Gomes JAS, 2005, INFECT IMMUN, V73, P7960, DOI 10.1128/IAI.73.12.7960-7966.2005; Gomes JAS, 2003, INFECT IMMUN, V71, P1185, DOI 10.1128/IAI.71.3.1185-1193.2003; Menezes CAS, 2004, CLIN EXP IMMUNOL, V137, P129, DOI 10.1111/j.1365-2249.2004.02479.x; Reis MM, 1997, CLIN IMMUNOL IMMUNOP, V83, P165, DOI 10.1006/clin.1997.4335; Rocha MOC, 2003, FRONT BIOSCI-LANDMRK, V8, pE44, DOI 10.2741/926; Rocho MOC, 2007, EXPERT REV ANTI-INFE, V5, P727, DOI 10.1586/14787210.5.4.727; Souza PEA, 2007, INFECT IMMUN, V75, P1886, DOI 10.1128/IAI.01931-06; Souza PEA, 2004, INFECT IMMUN, V72, P5283, DOI 10.1128/IAI.72.9.5283-5291.2004; Talvani A, 2004, CLIN INFECT DIS, V38, P943, DOI 10.1086/381892; Vitelli-Avelar DM, 2008, SCAND J IMMUNOL, V68, P516, DOI 10.1111/j.1365-3083.2008.02167.x	24	69	72	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e87082	10.1371/journal.pone.0087082	http://dx.doi.org/10.1371/journal.pone.0087082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603474	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600004
J	Ntie-Kang, F; Onguene, PA; Fotso, GW; Andrae-Marobela, K; Bezabih, M; Ndom, JC; Ngadjui, BT; Ogundaini, AO; Abegaz, BM; Meva'a, LM				Ntie-Kang, Fidele; Onguene, Pascal Amoa; Fotso, Ghislain W.; Andrae-Marobela, Kerstin; Bezabih, Merhatibeb; Ndom, Jean Claude; Ngadjui, Bonaventure T.; Ogundaini, Abiodun O.; Abegaz, Berhanu M.; Meva'a, Luc Mbaze			Virtualizing the p-ANAPL Library: A Step towards Drug Discovery from African Medicinal Plants	PLOS ONE			English	Article							NATURAL-PRODUCTS; ALOE-EMODIN; ANTIINFLAMMATORY ACTIVITY; ANTIPLASMODIAL ACTIVITY; ANTIBACTERIAL ACTIVITY; SCAFFOLD ANALYSIS; ANTICANCER AGENT; IN-VITRO; PIPERINE; CANNABIDIOL	Background: Natural products play a key role in drug discovery programs, both serving as drugs and as templates for the synthesis of drugs, even though the quantities and availabilities of samples for screening are often limitted. Experimental approach: A current collection of physical samples of. 500 compound derived from African medicinal plants aimed at screening for drug discovery has been made by donations from several researchers from across the continent to be directly available for drug discovery programs. A virtual library of 3D structures of compounds has been generated and Lipinski's "Rule of Five" has been used to evaluate likely oral availability of the samples. Results: A majority of the compound samples are made of flavonoids and about two thirds (2/3) are compliant to the "Rule of Five". The pharmacological profiles of thirty six (36) selected compounds in the collection have been discussed. Conclusions and implications: The p-ANAPL library is the largest physical collection of natural products derived from African medicinal plants directly available for screening purposes. The virtual library is also available and could be employed in virtual screening campaigns.	[Ntie-Kang, Fidele] Univ Buea, Dept Chem, Chem & Bioact Informat Ctr, Fac Sci, Buea, Cameroon; [Onguene, Pascal Amoa; Ndom, Jean Claude; Meva'a, Luc Mbaze] Univ Douala, Dept Chem, Fac Sci, Douala, Cameroon; [Fotso, Ghislain W.] Univ Yaounde I, Dept Organ Chem, Yaounde, Cameroon; [Andrae-Marobela, Kerstin] Univ Botswana, Dept Biol Sci, Gaborone, Botswana; [Bezabih, Merhatibeb] Univ Botswana, Dept Chem, Gaborone, Botswana; [Ngadjui, Bonaventure T.] Univ Yaounde I, Fac Med & Biomed Sci, Dept Pharmaceut Sci & Tradit Pharmacopeia, Yaounde, Cameroon; [Ogundaini, Abiodun O.] Obafemi Awolowo Univ, Dept Pharmaceut Chem, Ife, Nigeria; [Abegaz, Berhanu M.] Acad Sci, Nairobi, Kenya	University of Yaounde I; University of Botswana; University of Botswana; University of Yaounde I; Obafemi Awolowo University	Andrae-Marobela, K (corresponding author), Univ Botswana, Dept Biol Sci, Gaborone, Botswana.	Marobelak@mopipi.ub.bw; lmbazze@yahoo.fr	Ntie-Kang, Fidele/B-5877-2013; Wabo, Ghislain Fotso/AAY-7266-2020	Ntie-Kang, Fidele/0000-0003-0795-394X; Ogundaini, Abiodun/0000-0001-9356-497X	Office of Research and Development (ORD) of the University of Botswana; Stellenbosch Institute for Advanced Studies (STIAS), Stellenbosch, South-Africa;  [K047]	Office of Research and Development (ORD) of the University of Botswana; Stellenbosch Institute for Advanced Studies (STIAS), Stellenbosch, South-Africa; 	We are grateful to the Office of Research and Development (ORD) of the University of Botswana which provided a Post-Doctoral position to GWF and a grant to KAM (K047) through which PAO was able to conduct the scientific work for this report. We are also grateful to the Stellenbosch Institute for Advanced Studies (STIAS), Stellenbosch, South-Africa which provided financial means for a stay of BMA in South-Africa during which he was able to write his contribution for this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegaz BM, 2000, CURR ORG CHEM, V4, P1079, DOI 10.2174/1385272003375905; Abegaz BM, 2002, J NAT PROD, V65, P1117, DOI 10.1021/np0201218; Abegaz BM, 2002, PHYTOCHEMISTRY, V59, P877, DOI 10.1016/S0031-9422(01)00483-6; Andrae-Marobela K, 2013, CURR DRUG METAB, V14, P392, DOI 10.2174/13892002113149990095; Bang JS, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2662; Banzouzi JT, 2002, J ETHNOPHARMACOL, V81, P399, DOI 10.1016/S0378-8741(02)00121-6; Basu S, 2005, PHYTOTHER RES, V19, P888, DOI 10.1002/ptr.1752; Bhardwaj RK, 2002, J PHARMACOL EXP THER, V302, P645, DOI 10.1124/jpet.102.034728; Bisogno T, 2001, BRIT J PHARMACOL, V134, P845, DOI 10.1038/sj.bjp.0704327; Blanco B, 2013, J AM CHEM SOC, V135, P12366, DOI 10.1021/ja405853p; Bringmann G, 1999, PLANTA MED, V65, P757, DOI 10.1055/s-2006-960859; Camarero S, 2008, ENVIRON SCI TECHNOL, V42, P6703, DOI 10.1021/es8008979; Cardenas C, 2006, CELL MOL LIFE SCI, V63, P3083, DOI 10.1007/s00018-006-6399-6; Chemical Computing Group Inc, 2010, MOL OP ENV SOFTW; Chen YY, 2010, INT J ONCOL, V36, P1113; Chibale K., 2012, DRUG DISCOVERY AFRIC, Vfirst; Coopoosamy RM, 2006, AFR J BIOTECHNOL, V5, P1092; DAGNE E, 1984, PHYTOCHEMISTRY, V23, P1729, DOI 10.1016/S0031-9422(00)83479-2; Daniel R, 2005, J VIROL, V79, P2058, DOI 10.1128/JVI.79.4.2058-2065.2005; DAVIS BD, 1951, J BIOL CHEM, V191, P315; Dobson CM, 2004, NATURE, V432, P824, DOI 10.1038/nature03192; Dunkel M, 2006, NUCLEIC ACIDS RES, V34, pD678, DOI 10.1093/nar/gkj132; Efange S. M. N., 2002, Ethnomedicine and drug discovery, P61; Fan GJ, 2001, BIOORG MED CHEM LETT, V11, P2361, DOI 10.1016/S0960-894X(01)00429-2; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Fullbeck M, 2006, NAT PROD REP, V23, P347, DOI 10.1039/b513504b; García-Sosa Karlina, 2006, J. Mex. Chem. Soc, V50, P76; Gu JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062839; Guimaraes LRC, 2010, PARASITOL RES, V107, P1075, DOI 10.1007/s00436-010-1973-0; Guo MX, 2013, EUR J PHARMACOL, V714, P56, DOI 10.1016/j.ejphar.2013.05.047; Habtemariam S, 2010, FITOTERAPIA, V81, P1013, DOI 10.1016/j.fitote.2010.06.021; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Ham A, 2013, BRAIN RES, V1524, P54, DOI 10.1016/j.brainres.2013.05.036; Hampson AJ, 1998, P NATL ACAD SCI USA, V95, P8268, DOI 10.1073/pnas.95.14.8268; Hann MM, 2004, CURR OPIN CHEM BIOL, V8, P255, DOI 10.1016/j.cbpa.2004.04.003; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Hostettmann K, 2000, CURR ORG CHEM, V4, P973, DOI 10.2174/1385272003375923; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jin J, 2011, J MED MICROBIOL, V60, P223, DOI 10.1099/jmm.0.025734-0; JURD L, 1971, PHYTOCHEMISTRY, V10, P2971, DOI 10.1016/S0031-9422(00)97334-5; Kakarala M, 2010, BREAST CANCER RES TR, V122, P777, DOI 10.1007/s10549-009-0612-x; Khanna V, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-30; Kim SJ, 2010, MOLECULES, V15, P6436, DOI 10.3390/molecules15096436; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kuete V, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00123; Kuete V, 2010, PLANTA MED, V76, P1479, DOI 10.1055/s-0030-1250027; Kuo PL, 2002, LIFE SCI, V71, P1879, DOI 10.1016/S0024-3205(02)01900-8; Lai YL, 2006, MOL CELL BIOCHEM, V292, P45, DOI 10.1007/s11010-006-9175-x; Lam KS, 2007, TRENDS MICROBIOL, V15, P279, DOI 10.1016/j.tim.2007.04.001; Lee MS, 2008, BIOL PHARM BULL, V31, P2154, DOI 10.1248/bpb.31.2154; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Lino CS, 1997, PHYTOTHER RES, V11, P211, DOI 10.1002/(SICI)1099-1573(199705)11:3<211::AID-PTR72>3.3.CO;2-N; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Lu CC, 2010, MOL NUTR FOOD RES, V54, P967, DOI 10.1002/mnfr.200900265; Magadula JJ, 2009, NAT PROD REP, V26, P1535, DOI 10.1039/b906089h; Malfait AM, 2000, P NATL ACAD SCI USA, V97, P9561, DOI 10.1073/pnas.160105897; Mbaveng AT, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-83; MORALES A, 1987, J UROLOGY, V137, P1168, DOI 10.1016/S0022-5347(17)44436-3; MUJUMDAR AM, 1990, JPN J MED SCI BIOL, V43, P95, DOI 10.7883/yoken1952.43.95; Mutanyatta J, 2005, TETRAHEDRON, V61, P8475, DOI 10.1016/j.tet.2005.06.055; Newman DJ, 2008, J MED CHEM, V51, P2589, DOI 10.1021/jm0704090; Ngameni B, 2007, ARKIVOC, P116, DOI 10.3998/ark.5550190.0008.d14; Ntie-Kang F, 2013, MALAR J UNPUB; Ntie-Kang F, 2014, RSC ADV, V4, P409, DOI 10.1039/c3ra43754j; Ntie-Kang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078085; Ntie-Kang F, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-147; Ntie-Kang F, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-88; Onguene PA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-449; Oprea TI, 2002, J COMPUT AID MOL DES, V16, P325, DOI 10.1023/A:1020877402759; Palomo JM, 2002, ENZYME MICROB TECH, V31, P775, DOI 10.1016/S0141-0229(02)00169-2; Pan L, 2013, FRONT BIOSCI, V4, P142, DOI DOI 10.2741/257; Pecere T, 2000, CANCER RES, V60, P2800; Quinn RJ, 2008, J NAT PROD, V71, P464, DOI 10.1021/np070526y; Ramesh B, 2006, J MED FOOD, V9, P562, DOI 10.1089/jmf.2006.9.562; Ramesh B, 2006, LIFE SCI, V79, P306, DOI 10.1016/j.lfs.2006.01.005; Schneider G, 2002, CURR MED CHEM, V9, P2095, DOI 10.2174/0929867023368755; Schwikkard S, 2002, NAT PROD REP, V19, P675, DOI 10.1039/b008980j; Seo EJ, 2012, J PHARMACOL SCI, V118, P245, DOI 10.1254/jphs.11123FP; Sharma S, 2010, J ANTIMICROB CHEMOTH, V65, P1694, DOI 10.1093/jac/dkq186; Silayo A, 1999, PHYTOCHEMISTRY, V52, P947, DOI 10.1016/S0031-9422(99)00267-8; Silvan AM, 1996, J NAT PROD, V59, P1183, DOI 10.1021/np960422f; Singh R, 2010, FOOD CHEM, V120, P825, DOI 10.1016/j.foodchem.2009.11.022; STARKE K, 1975, EUR J PHARMACOL, V34, P385, DOI 10.1016/0014-2999(75)90268-X; Sunila ES, 2004, J ETHNOPHARMACOL, V90, P339, DOI 10.1016/j.jep.2003.10.016; SUSSET JG, 1989, J UROLOGY, V141, P1360, DOI 10.1016/S0022-5347(17)41308-5; Teague SJ, 1999, ANGEW CHEM INT EDIT, V38, P3743, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U; Titanji VPK, 2008, AFR J TRADIT COMPLEM, V5, P302; Vasisht K., 2004, COMPENDIUM MED AROMA, V1, P23; Vasisht K, 2002, TRADE PRODUCTION HER, P3; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Volak LP, 2008, DRUG METAB DISPOS, V36, P1594, DOI 10.1124/dmd.108.020552; Yang J, 2010, J ASIAN NAT PROD RES, V12, P185, DOI 10.1080/10286020903427336; Yongye AB, 2012, CHEM BIOL DRUG DES, V80, P717, DOI 10.1111/cbdd.12011; Zofou D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079544; Zofou D, 2013, NAT PROD REP, V30, P1098, DOI 10.1039/c3np70030e; Zofou D, 2012, PARASITOL RES, V110, P539, DOI 10.1007/s00436-011-2519-9; Zuardi AW, 2006, BRAZ J MED BIOL RES, V39, P421, DOI 10.1590/S0100-879X2006000400001	99	42	42	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90655	10.1371/journal.pone.0090655	http://dx.doi.org/10.1371/journal.pone.0090655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599120	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400109
J	Leal, ECP; de Almeida, P; Tomazoni, SS; de Carvalho, PDC; Lopes-Martins, RAB; Frigo, L; Joensen, J; Johnson, MI; Bjordal, JM				Pinto Leal-Junior, Ernesto Cesar; de Almeida, Patricia; Tomazoni, Shaiane Silva; Camillo de Carvalho, Paulo de Tarso; Brandao Lopes-Martins, Rodrigo Alvaro; Frigo, Lucio; Joensen, Jon; Johnson, Mark I.; Bjordal, Jan Magnus			Superpulsed Low-Level Laser Therapy Protects Skeletal Muscle of mdx Mice against Damage, Inflammation and Morphological Changes Delaying Dystrophy Progression	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; SIGNALING PATHWAY; ORAL MUCOSITIS; LIGHT THERAPY; IN-VIVO; 660 NM; IRRADIATION; PAIN	Aim: To evaluate the effects of preventive treatment with low-level laser therapy (LLLT) on progression of dystrophy in mdx mice. Methods: Ten animals were rando mu ly divided into 2 experimental groups treated with superpulsed LLLT (904 nm, 15 mW, 700 Hz, 1 J) or placebo-LLLT at one point overlying the tibialis anterior muscle (bilaterally) 5 times per week for 14 weeks (from 6th to 20th week of age). Morphological changes, creatine kinase (CK) activity and mRNA gene expression were assessed in animals at 20th week of age. Results: Animals treated with LLLT showed very few morphological changes in skeletal muscle, with less atrophy and fibrosis than animals treated with placebo-LLLT. CK was significantly lower (p = 0.0203) in animals treated with LLLT (864.70 U.l(-1), SEM 226.10) than placebo (1708.00 U.l(-1), SEM 184.60). mRNA gene expression of inflammatory markers was significantly decreased by treatment with LLLT (p<0.05): TNF-alpha (placebo-control = 0.51 mu g/mu l [SEM 0.12], - LLLT = 0.048 mu g/mu l [SEM 0.01]), IL-1 beta (placebo-control = 2.292 mu g/mu l [SEM 0.74], - LLLT = 0.12 mu g/mu l [SEM 0.03]), IL-6 (placebo-control = 3.946 mu g/mu l [SEM 0.98], - LLLT = 0.854 mu g/mu l [SEM 0.33]), IL-10 (placebo-control = 1.116 mu g/mu l [SEM 0.22], - LLLT = 0.352 mu g/mu l [SEM 0.15]), and COX-2 (placebo-control = 4.984 mu g/mu l [SEM 1.18], LLLT = 1.470 mu g/mu l [SEM 0.73]). Conclusion: Irradiation of superpulsed LLLT on successive days five times per week for 14 weeks decreased morphological changes, skeletal muscle damage and inflammation in mdx mice. This indicates that LLLT has potential to decrease progression of Duchenne muscular dystrophy.	[Pinto Leal-Junior, Ernesto Cesar; de Almeida, Patricia; Camillo de Carvalho, Paulo de Tarso] Univ Nove de Julho UNINOVE, Postgrad Program Rehabil Sci, Sao Paulo, Brazil; [Pinto Leal-Junior, Ernesto Cesar; Camillo de Carvalho, Paulo de Tarso] Univ Nove de Julho UNINOVE, Postgrad Program Biophoton Appl Hlth Sci, Sao Paulo, Brazil; [Tomazoni, Shaiane Silva; Brandao Lopes-Martins, Rodrigo Alvaro] Univ Sao Paulo, Dept Pharmacol, Sao Paulo, Brazil; [Frigo, Lucio] Univ Cruzeiro Sul, Biol Sci & Hlth Ctr, Sao Paulo, Brazil; [Joensen, Jon] Bergen Univ Coll, Dept Physiotherapy Occupat Therapy & Radiog, Bergen, Norway; [Johnson, Mark I.] Leeds Metropolitan Univ, Fac Hlth & Social Sci, Leeds LS1 3HE, W Yorkshire, England; [Bjordal, Jan Magnus] Univ Bergen, Physiotherapy Res Grp, Bergen, Norway	Universidade Nove de Julho; Universidade Nove de Julho; Universidade de Sao Paulo; Universidade Cruzeiro do Sul; Western Norway University of Applied Sciences; Leeds Beckett University; University of Bergen	Leal, ECP (corresponding author), Univ Nove de Julho UNINOVE, Postgrad Program Rehabil Sci, Sao Paulo, Brazil.	ernesto.leal.junior@gmail.com	Tomazoni, Shaiane Silva/H-9000-2016; Lopes-Martins, Rodrigo A B/E-2013-2013; Bjordal, Jan Magnus/T-7122-2019; Frigo, Lucio/K-1564-2015; Frigo, Lucio/D-1708-2017; Leal-Junior, Ernesto Cesar/H-8920-2016; de Tarso C de Carvalho, Paulo/G-5333-2011	Tomazoni, Shaiane Silva/0000-0002-0822-4864; Lopes-Martins, Rodrigo A B/0000-0002-4533-1335; Frigo, Lucio/0000-0001-9131-1071; Leal-Junior, Ernesto Cesar/0000-0001-6393-7616; de Tarso C de Carvalho, Paulo/0000-0001-9624-4103; de Almeida Mattos, Patricia/0000-0001-6738-094X	FAPESP [2010/52404-0, 2012/06832-5]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Professor Ernesto Cesar Pinto Leal-Junior would like to thank FAPESP research grant number 2010/52404-0. Professor Lucio Frigo would like to thank FAPESP research grant number 2012/06832-5. FAPESP had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimbire F, 2007, PHOTOMED LASER SURG, V25, P112, DOI 10.1089/pho.2006.1041; Aimbire F, 2006, PHOTOMED LASER SURG, V24, P33, DOI 10.1089/pho.2006.24.33; Albertini R, 2007, J PHOTOCH PHOTOBIO B, V89, P50, DOI 10.1016/j.jphotobiol.2007.08.005; Albertini R, 2004, J PHOTOCH PHOTOBIO B, V74, P101, DOI 10.1016/j.jphotobiol.2004.03.002; Avni D, 2005, PHOTOMED LASER SURG, V23, P273, DOI 10.1089/pho.2005.23.273; Barber BJ, 2013, J PEDIATR-US, V163, P1080, DOI 10.1016/j.jpeds.2013.05.060; Basford JR, 1999, ARCH PHYS MED REHAB, V80, P647, DOI 10.1016/S0003-9993(99)90167-3; Bjordal JM, 2006, BRIT J SPORT MED, V40, P76, DOI 10.1136/bjsm.2005.020842; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Chow RT, 2006, PAIN, V124, P201, DOI 10.1016/j.pain.2006.05.018; Chow RT, 2009, LANCET, V374, P1897, DOI 10.1016/S0140-6736(09)61522-1; Cox GF, 1997, CURR OPIN CARDIOL, V12, P329; de Almeida P, 2012, LASER MED SCI, V27, P453, DOI 10.1007/s10103-011-0957-3; de Almeida P, 2011, PHOTOCHEM PHOTOBIOL, V87, P1159, DOI 10.1111/j.1751-1097.2011.00968.x; De Marchi T, 2012, LASER MED SCI, V27, P231, DOI 10.1007/s10103-011-0955-5; Emery A.E.H., 1993, DUCHENNE MUSCULAR DY; Emery AEH, 2003, DUCHENNE MUSCULAR DY; Fairclough RJ, 2011, EXP PHYSIOL, V96, P1101, DOI 10.1113/expphysiol.2010.053025; Gautam AP, 2012, RADIOTHER ONCOL, V104, P349, DOI 10.1016/j.radonc.2012.06.011; Goldman J A, 1980, Lasers Surg Med, V1, P93, DOI 10.1002/lsm.1900010110; Gur A, 2004, LASER SURG MED, V35, P229, DOI 10.1002/lsm.20082; Hayworth CR, 2010, PHOTOCHEM PHOTOBIOL, V86, P673, DOI 10.1111/j.1751-1097.2010.00732.x; Hegedus B, 2009, PHOTOMED LASER SURG, V27, P577, DOI 10.1089/pho.2008.2297; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lebel DE, 2013, J BONE JOINT SURG AM, V95A, P1057, DOI 10.2106/JBJS.L.01577; Li M, 2013, NEUROREPORT, V24, P924, DOI 10.1097/WNR.0000000000000028; Lim W, 2013, PHOTOCHEM PHOTOBIOL, V89, P199, DOI 10.1111/j.1751-1097.2012.01225.x; MCGEACHIE JK, 1993, J NEUROL SCI, V119, P169, DOI 10.1016/0022-510X(93)90130-Q; Moriyama Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P1351, DOI 10.1562/2005-02-28-RA-450; Ozcelik O, 2008, J CLIN PERIODONTOL, V35, P250, DOI 10.1111/j.1600-051X.2007.01194.x; Partridge TA, 2013, FEBS J, V280, P4177, DOI 10.1111/febs.12267; Leal ECP, 2008, PHOTOMED LASER SURG, V26, P419, DOI 10.1089/pho.2007.2160; Leal ECP, 2010, J ORTHOP SPORT PHYS, V40, P524, DOI 10.2519/jospt.2010.3294; Leal ECP, 2010, EUR J APPL PHYSIOL, V108, P1083, DOI 10.1007/s00421-009-1321-1; Leal ECP, 2009, LASER MED SCI, V24, P857, DOI 10.1007/s10103-008-0633-4; Leal ECP, 2009, LASER SURG MED, V41, P572, DOI 10.1002/lsm.20810; Leal ECP, 2009, PHOTOMED LASER SURG, V27, P617, DOI 10.1089/pho.2008.2350; Leal ECP, 2009, LASER MED SCI, V24, P425, DOI 10.1007/s10103-008-0592-9; Ramaswamy KS, 2011, J PHYSIOL-LONDON, V589, P1195, DOI 10.1113/jphysiol.2010.201921; Rao S, 2012, ARCH DIS CHILD, V97, P1000, DOI 10.1136/archdischild-2012-302457; Ricotti V, 2013, J NEUROL NEUROSUR PS, V84, P698, DOI 10.1136/jnnp-2012-303902; Rizzi CF, 2006, LASER SURG MED, V38, P704, DOI 10.1002/lsm.20371; Rochkind S, 2007, PHOTOMED LASER SURG, V25, P137, DOI 10.1089/pho.2007.2076; Schubert MM, 2007, SUPPORT CARE CANCER, V15, P1145, DOI 10.1007/s00520-007-0238-7; Serra F, 2012, MUSCLE NERVE, V46, P773, DOI 10.1002/mus.23432; Silveira PCL, 2009, J PHOTOCH PHOTOBIO B, V95, P89, DOI 10.1016/j.jphotobiol.2009.01.004; Stergioulas A, 2008, AM J SPORT MED, V36, P881, DOI 10.1177/0363546507312165; Takema T, 2000, LASER MED SCI, V15, P35, DOI 10.1007/s101030050045; Thomas GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049350; Tullberg M, 2003, PAIN, V105, P89, DOI 10.1016/S0304-3959(03)00166-0; Xu XY, 2008, PHOTOMED LASER SURG, V26, P197, DOI 10.1089/pho.2007.2125	53	28	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89453	10.1371/journal.pone.0089453	http://dx.doi.org/10.1371/journal.pone.0089453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599021	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000332479400013
J	Roberts, JD; Voss, JD; Knight, B				Roberts, Jennifer D.; Voss, Jameson D.; Knight, Brandon			The Association of Ambient Air Pollution and Physical Inactivity in the United States	PLOS ONE			English	Article							WITHIN-URBAN VARIABILITY; FINE PARTICULATE MATTER; LONG-TERM EXPOSURE; EXERCISE PERFORMANCE; DEPRESSIVE SYMPTOMS; HEART-DISEASE; LUNG-FUNCTION; OBESITY; MORTALITY; HEALTH	Background: Physical inactivity, ambient air pollution and obesity are modifiable risk factors for non-communicable diseases, with the first accounting for 10% of premature deaths worldwide. Although community level interventions may target each simultaneously, research on the relationship between these risk factors is lacking. Objectives: After comparing spatial interpolation methods to determine the best predictor for particulate matter (PM2.5; PM10) and ozone (O-3) exposures throughout the U. S., we evaluated the cross-sectional association of ambient air pollution with leisure-time physical inactivity among adults. Methods: In this cross-sectional study, we assessed leisure-time physical inactivity using individual self-reported survey data from the Centers for Disease Control and Prevention's 2011 Behavioral Risk Factor Surveillance System. These data were combined with county-level U. S. Environmental Protection Agency air pollution exposure estimates using two interpolation methods (Inverse Distance Weighting and Empirical Bayesian Kriging). Finally, we evaluated whether those exposed to higher levels of air pollution were less active by performing logistic regression, adjusting for demographic and behavioral risk factors, and after stratifying by body weight category. Results: With Empirical Bayesian Kriging air pollution values, we estimated a statistically significant 16-35% relative increase in the odds of leisure-time physical inactivity per exposure class increase of PM2.5 in the fully adjusted model across the normal weight respondents (p-value < 0.0001). Evidence suggested a relationship between the increasing dose of PM2.5 exposure and the increasing odds of physical inactivity. Conclusions: In a nationally representative, cross-sectional sample, increased community level air pollution is associated with reduced leisure-time physical activity particularly among the normal weight. Although our design precludes a causal inference, these results provide additional evidence that air pollution should be investigated as an environmental determinant of inactivity.	[Roberts, Jennifer D.; Voss, Jameson D.; Knight, Brandon] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Voss, Jameson D.] US Air Force Sch Aerosp Med, Epidemiol Consult Serv, Wright Patterson AFB, OH USA	Uniformed Services University of the Health Sciences - USA	Roberts, JD (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA.	jennifer.roberts@usuhs.edu	Voss, Jameson D/P-8392-2017	Voss, Jameson D/0000-0002-4104-1744; Knight, Brandon/0000-0003-4953-7194	Uniformed Services University of the Health Sciences	Uniformed Services University of the Health Sciences	Funding for this study was provided by a Uniformed Services University of the Health Sciences intramural start-up grant for newly appointed faculty. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeeff SE, 2007, CHEST, V132, P1890, DOI 10.1378/chest.07-1126; [Anonymous], 2012, EMPIRICAL BAYESIAN K; [Anonymous], 2008, SURVEY RES METHODS, DOI DOI 10.18148/SRM/2008.V2I1.597; Arsenault BJ, 2010, INT J OBESITY, V34, P340, DOI 10.1038/ijo.2009.229; Awatef M, 2011, CANCER EPIDEMIOL, V35, P540, DOI 10.1016/j.canep.2011.02.011; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Cakmak S, 2011, ENVIRON RES, V111, P1309, DOI 10.1016/j.envres.2011.09.016; Casazza K, 2013, NEW ENGL J MED, V368, P446, DOI 10.1056/NEJMsa1208051; CDC, 2012, MMWR-MORBID MORTAL W, P410; Centers for Disease Control and Prevention, 2011, OB RAT LOW INC PRESC; Cutrufello PT, 2011, INHAL TOXICOL, V23, P658, DOI 10.3109/08958378.2011.604106; Delfino RJ, 2010, EPIDEMIOLOGY, V21, P396, DOI 10.1097/EDE.0b013e3181d5e19b; EPA, 2008, APP G HLTH BAS COST; EPA, 2011, AQS DAT DICT; Fryar C., 2012, PREVALENCE OVERWEIGH; Gent JF, 2003, JAMA-J AM MED ASSOC, V290, P1859, DOI 10.1001/jama.290.14.1859; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Hankey S, 2012, ENVIRON HEALTH PERSP, V120, P247, DOI 10.1289/ehp.1103806; Herring MP, 2012, ARCH INTERN MED, V172, P101, DOI 10.1001/archinternmed.2011.696; Hystad P, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-22; Laden F, 2000, ENVIRON HEALTH PERSP, V108, P941, DOI 10.2307/3435052; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee IM, 2010, JAMA-J AM MED ASSOC, V303, P1173, DOI 10.1001/jama.2010.312; Marr LC, 2010, MED SCI SPORT EXER, V42, P585, DOI 10.1249/MSS.0b013e3181b84a85; Marshall JD, 2008, ATMOS ENVIRON, V42, P1359, DOI 10.1016/j.atmosenv.2007.08.012; Mokdad Ali H, 2003, MMWR Recomm Rep, V52, P1; Motl RW, 2004, PSYCHOSOM MED, V66, P336, DOI 10.1097/01.psy.0000126205.35683.0a; Nelson DE, 1998, AM STAT ASS 1998 P S, P214; Ogden CL, 2012, PREVALENCE OBESITY U; Peters A, 2000, EPIDEMIOLOGY, V11, P11, DOI 10.1097/00001648-200001000-00005; Pietilainen KH, 2008, OBESITY, V16, P409, DOI 10.1038/oby.2007.72; Pilz J, 2008, STOCH ENV RES RISK A, V22, P621, DOI 10.1007/s00477-007-0165-7; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Pratt M, 2012, LANCET, V380, P282, DOI 10.1016/S0140-6736(12)60736-3; Rundell KW, 2008, J STRENGTH COND RES, V22, P2, DOI 10.1519/JSC.0b013e31815ef98b; Singh GK, 2010, ARCH PEDIAT ADOL MED, V164, P598, DOI 10.1001/archpediatrics.2010.84; Son JY, 2010, ENVIRON RES, V110, P739, DOI 10.1016/j.envres.2010.08.003; United States Environmental Protection Agency (US EPA), 2004, DEV SPAT INT SURF ES; VDH, 2012, BRFSS METH; Voss JD, 2013, INT J OBES LOND, DOI [10.1038/ijo.2013.5, DOI 10.1038/IJ0.2013.5]; Wen XJ, 2009, J ENVIRON HEALTH, V72, P40	43	84	86	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90143	10.1371/journal.pone.0090143	http://dx.doi.org/10.1371/journal.pone.0090143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598907	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400049
J	Sousa-Ferreira, L; Aveleira, C; Botelho, M; Alvaro, AR; de Almeida, LP; Cavadas, C				Sousa-Ferreira, Ligia; Aveleira, Celia; Botelho, Mariana; Alvaro, Ana Rita; de Almeida, Luis Pereira; Cavadas, Claudia			Fluoxetine Induces Proliferation and Inhibits Differentiation of Hypothalamic Neuroprogenitor Cells In Vitro	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; NEUROPEPTIDE-Y; ENERGY-BALANCE; HIPPOCAMPAL NEUROGENESIS; ANTIDEPRESSANT EXPOSURE; PROGENITOR CELLS; RAT HIPPOCAMPUS; MESSENGER-RNA	A significant number of children undergo maternal exposure to antidepressants and they often present low birth weight. Therefore, it is important to understand how selective serotonin reuptake inhibitors (SSRIs) affect the development of the hypothalamus, the key center for metabolism regulation. In this study we investigated the proliferative actions of fluoxetine in fetal hypothalamic neuroprogenitor cells and demonstrate that fluoxetine induces the proliferation of these cells, as shown by increased neurospheres size and number of proliferative cells (Ki-67(+) cells). Moreover, fluoxetine inhibits the differentiation of hypothalamic neuroprogenitor cells, as demonstrated by decreased number of mature neurons (Neu-N+ cells) and increased number of undifferentiated cells (SOX-2(+) cells). Additionally, fluoxetine-induced proliferation and maintenance of hypothalamic neuroprogenitor cells leads to changes in the mRNA levels of appetite regulator neuropeptides, including Neuropeptide Y (NPY) and Cocaine-and-Amphetamine-Regulated-Transcript (CART). This study provides the first evidence that SSRIs affect the development of hypothalamic neuroprogenitor cells in vitro with consequent alterations on appetite neuropeptides.	[Sousa-Ferreira, Ligia; Aveleira, Celia; Botelho, Mariana; Alvaro, Ana Rita; de Almeida, Luis Pereira; Cavadas, Claudia] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Alvaro, Ana Rita] Univ Tras Os Montes & Alto Douro, Dept Biol & Environm, Vila Real, Portugal; [Sousa-Ferreira, Ligia; Botelho, Mariana; de Almeida, Luis Pereira; Cavadas, Claudia] Univ Coimbra, Fac Pharm, Coimbra, Portugal	Universidade de Coimbra; University of Tras-os-Montes & Alto Douro; Universidade de Coimbra	Cavadas, C (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.	ccavadas@uc.pt	de Almeida, Luis Pereira/A-4605-2009; Cavadas, Claudia/AAB-6904-2021; Sousa-Ferreira, Lígia/M-4181-2013; Alvaro, Ana Rita/A-8168-2013; de Almeida, Luis Pereira/O-8196-2019; Aveleira, Célia A/L-1325-2014; Aveleira, Célia/AAI-2455-2021	de Almeida, Luis Pereira/0000-0001-5831-3307; Cavadas, Claudia/0000-0001-8020-9266; Sousa-Ferreira, Lígia/0000-0002-7169-9491; Alvaro, Ana Rita/0000-0002-2387-374X; de Almeida, Luis Pereira/0000-0001-5831-3307; Aveleira, Célia A/0000-0002-2191-0682; Aveleira, Célia/0000-0002-2191-0682; Botelho da Rocha, Mariana/0000-0002-5197-7159	Portuguese Foundation for Science and Technology; FEDER; COMPETE [PEst-C/SAU/LA0001/2013-2014, PTDC/SAU-FCF/099082/2008, PTDC/BIM-MED/0775/2012, SFRH/BD/30608/2006, SFRH/BPD/73942/2010, SFRH/BPD/78424/2011]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FEDER(European Commission); COMPETE	This work was supported by grants from the Portuguese Foundation for Science and Technology, FEDER and COMPETE (PEst-C/SAU/LA0001/2013-2014; PTDC/SAU-FCF/099082/2008; PTDC/BIM-MED/0775/2012; SFRH/BD/30608/2006; SFRH/BPD/73942/2010; SFRH/BPD/78424/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnea A, 2001, BRAIN RES, V919, P57, DOI 10.1016/S0006-8993(01)02999-7; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Benninghoff J, 2010, NEUROPSYCHOPHARMACOL, V35, P893, DOI 10.1038/npp.2009.181; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; CHENG B, 1994, J NEUROCHEM, V62, P1319; Choi S, 2006, BRAIN RES, V1087, P83, DOI 10.1016/j.brainres.2006.02.129; Conti B, 2007, MOL PSYCHIATR, V12, P167, DOI 10.1038/sj.mp.4001897; Cottrell EC, 2009, AM J PHYSIOL-REG I, V296, pR631, DOI 10.1152/ajpregu.90690.2008; CROLL SD, 1994, EUR J NEUROSCI, V6, P1343, DOI 10.1111/j.1460-9568.1994.tb00325.x; Davidson S, 2009, PEDIATR RES, V65, P236, DOI 10.1203/PDR.0b013e318193594a; De Foubert G, 2004, NEUROSCIENCE, V128, P597, DOI 10.1016/j.neuroscience.2004.06.054; Desai M, 2011, ENDOCRINOLOGY, V152, P3192, DOI 10.1210/en.2010-1217; Desai M, 2011, BRAIN RES, V1378, P29, DOI 10.1016/j.brainres.2010.12.080; Dryden S, 1996, NEUROSCIENCE, V72, P557, DOI 10.1016/0306-4522(95)00566-8; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Gutierrez A, 2002, OBES RES, V10, P532, DOI 10.1038/oby.2002.72; Homberg JR, 2010, TRENDS PHARMACOL SCI, V31, P60, DOI 10.1016/j.tips.2009.11.003; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kohl Z, 2012, EUR J NEUROSCI, V35, P10, DOI 10.1111/j.1460-9568.2011.07933.x; Kristensen JH, 1999, BRIT J CLIN PHARMACO, V48, P521, DOI 10.1046/j.1365-2125.1999.00040.x; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Li JX, 2012, NAT CELL BIOL, V14, P999, DOI 10.1038/ncb2562; Loudes C, 2000, NEUROENDOCRINOLOGY, V72, P144, DOI 10.1159/000054581; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Manev H, 2001, EUR J PHARMACOL, V411, P67, DOI 10.1016/S0014-2999(00)00904-3; Marty S, 1996, NEURON, V16, P565, DOI 10.1016/S0896-6273(00)80075-6; Matrisciano F, 2008, NEUROPHARMACOLOGY, V54, P428, DOI 10.1016/j.neuropharm.2007.10.020; McNay DEG, 2012, J CLIN INVEST, V122, P142, DOI 10.1172/JCI43134; Mercer RE, 2011, FRONT NEUROENDOCRIN, V32, P398, DOI 10.1016/j.yfrne.2011.06.001; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nilsson I, 2005, DEV BRAIN RES, V155, P147, DOI 10.1016/j.devbrainres.2005.01.009; Oberlander TF, 2008, EARLY HUM DEV, V84, P689, DOI 10.1016/j.earlhumdev.2008.06.008; Olivier JDA, 2011, PSYCHOPHARMACOLOGY, V217, P419, DOI 10.1007/s00213-011-2299-z; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Pawluski JL, 2012, PSYCHONEUROENDOCRINO, V37, P1019, DOI 10.1016/j.psyneuen.2011.11.011; Pechnick RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027290; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Pinnock SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013652; Rampono J, 2004, INT J NEUROPSYCHOPH, V7, P329, DOI 10.1017/S1461145704004286; Rayen I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024003; Reibel S, 2000, EUR J NEUROSCI, V12, P595, DOI 10.1046/j.1460-9568.2000.00941.x; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Righi M, 2000, J NEUROSCI, V20, P3165, DOI 10.1523/JNEUROSCI.20-09-03165.2000; Saarelainen T, 2003, J NEUROSCI, V23, P349; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Simon GE, 2002, AM J PSYCHIAT, V159, P2055, DOI 10.1176/appi.ajp.159.12.2055; Sousa-Ferreira L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019745; Sugiyama N, 2003, MOL BRAIN RES, V115, P69, DOI 10.1016/S0169-328X(03)00184-0; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; TAPLEY P, 1992, ONCOGENE, V7, P371; Ververs T, 2006, EUR J CLIN PHARMACOL, V62, P863, DOI 10.1007/s00228-006-0177-0; Wisner KL, 2009, AM J PSYCHIAT, V166, P557, DOI 10.1176/appi.ajp.2008.08081170; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021; Zusso M, 2008, BIOCHEM PHARMACOL, V76, P391, DOI 10.1016/j.bcp.2008.05.014	58	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e88917	10.1371/journal.pone.0088917	http://dx.doi.org/10.1371/journal.pone.0088917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598761	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400007
J	Carlomagno, Y; Zhang, YJ; Davis, M; Lin, WL; Cook, C; Dunmore, J; Tay, W; Menkosky, K; Cao, XK; Petrucelli, L; DeTure, M				Carlomagno, Yari; Zhang, Yongjie; Davis, Mary; Lin, Wen-Lang; Cook, Casey; Dunmore, Judy; Tay, William; Menkosky, Kyle; Cao, Xiangkun; Petrucelli, Leonard; DeTure, Michael			Casein Kinase II Induced Polymerization of Soluble TDP-43 into Filaments Is Inhibited by Heat Shock Proteins	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN-43; MOLECULAR CHAPERONE; NEURONAL INCLUSIONS; ALZHEIMERS-DISEASE; TERMINAL FRAGMENTS; TAU-PROTEIN; AGGREGATION; MUTATIONS	Background: Trans-activation Response DNA-binding Protein-43 (TDP-43) lesions are observed in Amyotrophic Lateral (ALS), Frontotemporal Lobar Degeneration with ubiquitin inclusions (FTLD-TDP) and 25-50% of Alzheimer's Disease (AD) cases. These abnormal protein inclusions are composed of either amorphous TDP-43 aggregates or highly ordered filaments. The filamentous TDP-43 accumulations typically contain clean 10-12 nm filaments though wider 1820 nm coated filaments may be observed. The TDP-43 present within these lesions is phosphorylated, truncated and ubiquitinated, and these modifications appear to be abnormal as they are linked to both a cellular heat shock response and microglial activation. The mechanisms associated with this abnormal TDP-43 accumulation are believed to result in a loss of TDP-43 function, perhaps due to the post-translational modifications or resulting from physical sequestration of the TDP-43. The formation of TDP-43 inclusions involves cellular translocation and conversion of TDP-43 into fibrillogenic forms, but the ability of these accumulations to sequester normal TDP-43 and propagate this behavior between neurons pathologically is mostly inferred. The lack of methodology to produce soluble full length TDP-43 and recapitulate this polymerization into filaments as observed in disease has limited our understanding of these pathogenic cascades. Results: The protocols described here generate soluble, full-length and untagged TDP-43 allowing for a direct assessment of the impact of various posttranslational modifications on TDP-43 function. We demonstrate that Casein Kinase II (CKII) promotes the polymerization of this soluble TDP-43 into 10 nm diameter filaments that resemble the most common TDP-43 structures observed in disease. Furthermore, these filaments are recognized as abnormal by Heat Shock Proteins (HSPs) which can inhibit TDP-43 polymerization or directly promote TDP-43 filament depolymerization. Conclusion: These findings demonstrate CKII induces polymerization of soluble TDP-43 into filaments and Hsp90 promotes TDP-43 filament depolymerization. These findings provide rational for potential therapeutic intervention at these points in TDP-43 proteinopathies.	[Carlomagno, Yari; Zhang, Yongjie; Davis, Mary; Lin, Wen-Lang; Cook, Casey; Dunmore, Judy; Tay, William; Menkosky, Kyle; Cao, Xiangkun; Petrucelli, Leonard; DeTure, Michael] Maya Clin, Dept Neurosci, Jacksonville, FL 32224 USA		DeTure, M (corresponding author), Maya Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	deture.michael@mayo.edu			Mayo Clinic Foundation; National Institutes of Health/National Institute on Aging [R01AG026251]; National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01 NS 063964-01, R01 NS077402, ES20395-01, 1R21NS079807-01A1]; Amyotrophic Lateral Sclerosis Association; GHR Foundation; Department of Defense [W81XWH-10-1-0512-1, W81XWH-09-1-0315AL093108]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077402, R01NS063964, R21NS079807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026251] Funding Source: NIH RePORTER	Mayo Clinic Foundation; National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Amyotrophic Lateral Sclerosis Association; GHR Foundation; Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Mayo Clinic Foundation to L.P., National Institutes of Health/National Institute on Aging [R01AG026251 to L.P.], National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01 NS 063964-01 to L.P., R01 NS077402 to L.P., ES20395-01 to L.P., 1R21NS079807-01A1 to Y.Z.], Amyotrophic Lateral Sclerosis Association to L.P., GHR Foundation to Y.Z, and the Department of Defense [W81XWH-10-1-0512-1 to L.P. and W81XWH-09-1-0315AL093108 to L.P.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Brady OA, 2011, J NEUROCHEM, V116, P248, DOI 10.1111/j.1471-4159.2010.07098.x; Brettschneider J, 2012, ACTA NEUROPATHOL, V123, P395, DOI 10.1007/s00401-011-0932-x; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Choksi DK, 2013, HUMAN MOL GENETICS; Combs B, 2011, BIOCHEMISTRY-US, V50, P9446, DOI 10.1021/bi2010569; Dickey C, 2009, AM J PATHOL, V174, P228, DOI 10.2353/ajpath.2009.080764; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Gendron TF, 2012, J ALZHEIMERS DIS, V29, P29; Geser F, 2009, J NEUROL, V256, P1205, DOI 10.1007/s00415-009-5069-7; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Herman AM, 2011, BRAIN RES, V1386, P191, DOI 10.1016/j.brainres.2011.02.052; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; Higashi S, 2007, BRAIN RES, V1184, P284, DOI 10.1016/j.brainres.2007.09.048; IIMOTO DS, 1990, BRAIN RES, V507, P273, DOI 10.1016/0006-8993(90)90282-G; Jinwal UK, 2012, J BIOL CHEM, V287, P24814, DOI 10.1074/jbc.M112.367268; Jinwal UK, 2010, J BIOL CHEM, V285, P16798, DOI 10.1074/jbc.M110.113753; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; JOHNSON BS, 2009, J BIOL CHEM, V22, P22; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023075; Liachko NF, 2010, J NEUROSCI, V30, P16208, DOI 10.1523/JNEUROSCI.2911-10.2010; Lin WL, 2008, ACTA NEUROPATHOL, V116, P205, DOI 10.1007/s00401-008-0408-9; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; MASLIAH E, 1992, AM J PATHOL, V140, P263; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; Neumann M, 2007, ACTA NEUROPATHOL, V113, P543, DOI 10.1007/s00401-007-0221-x; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; Patterson KR, 2011, BIOCHEMISTRY-US, V50, P10300, DOI 10.1021/bi2009147; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Sahara N, 2007, J NEUROSCI RES, V85, P3098, DOI 10.1002/jnr.21417; Sarkar M, 2008, J NEUROSCI RES, V86, P2763, DOI 10.1002/jnr.21721; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Thorpe J, 2008, J NEURAL TRANSM, V115, P1661, DOI 10.1007/s00702-008-0137-1; Tsuji H, 2012, BRAIN, V135, P3380, DOI 10.1093/brain/aws230; Udan-Johns M, 2013, HUMAN MOL GENETICS; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Wu LS, 2012, J BIOL CHEM, V287, P27335, DOI 10.1074/jbc.M112.359000; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-33; Zhao M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-104	54	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90452	10.1371/journal.pone.0090452	http://dx.doi.org/10.1371/journal.pone.0090452			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595055	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500051
J	Carrier, B; Wen, S; Zigouras, S; Browne, RW; Li, ZY; Patel, MS; Williamson, DL; Rideout, TC				Carrier, Bradley; Wen, Shin; Zigouras, Sophia; Browne, Richard W.; Li, Zhuyun; Patel, Mulchand S.; Williamson, David L.; Rideout, Todd C.			Alpha-Lipoic Acid Reduces LDL-Particle Number and PCSK9 Concentrations in High-Fat Fed Obese Zucker Rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DENSITY-LIPOPROTEIN CHOLESTEROL; RANDOMIZED CONTROLLED-TRIAL; APOLIPOPROTEIN-E-DEFICIENT; SUBTILISIN/KEXIN TYPE 9; HEPATIC STEATOSIS; LIPID-METABOLISM; PLANT STEROLS; MONOCLONAL-ANTIBODY; INSULIN-RESISTANCE	We characterized the hypolipidemic effects of alpha-lipoic acid (LA, R-form) and examined the associated molecular mechanisms in a high fat fed Zucker rat model. Rats (n = 8) were assigned to a high fat (HF) diet or the HF diet with 0.25% LA (HF-LA) for 30 days and pair fed to remove confounding effects associated with the anorectic properties of LA. Compared with the HF controls, the HF-LA group was protected against diet-induced obesity (102.5 +/- 3.1 vs. 121.5 +/- 3.6,% change BW) and hypercholesterolemia with a reduction in total-C (-21%), non-HDL-C (-25%), LDL-C (-16%), and total LDL particle number (-46%) and an increase in total HDL particles (-22%). This cholesterol-lowering response was associated with a reduction in plasma PCSK9 concentration (-70%) and an increase in hepatic LDLr receptor protein abundance (2 fold of HF). Compared with the HF-fed animals, livers of LA-supplemented animals were protected against TG accumulation (-46%), likely through multiple mechanisms including: a suppressed lipogenic response (down-regulation of hepatic acetyl-CoA carboxylase and fatty acid synthase expression); enhanced hepatic fat oxidation (increased carnitine palmitoyl-transferase I alpha expression); and enhanced VLDL export (increased hepatic diacylglycerol acyltransferase and microsomal triglyceride transfer protein expression and elevated plasma VLDL particle number). Study results also support an enhanced fatty acid uptake (2.8 fold increase in total lipase activity) and oxidation (increased CPT1 beta protein abundance) in muscle tissue in LA-supplemented animals compared with the HF group. In summary, in the absence of a change in caloric intake, LA was effective in protecting against hypercholesterolemia and hepatic fat accumulation under conditions of strong genetic and dietary predisposition toward obesity and dyslipidemia.	[Carrier, Bradley; Wen, Shin; Zigouras, Sophia; Li, Zhuyun; Williamson, David L.; Rideout, Todd C.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Exercise Sci, Buffalo, NY 14260 USA; [Carrier, Bradley; Wen, Shin; Zigouras, Sophia; Li, Zhuyun; Williamson, David L.; Rideout, Todd C.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Nutr Sci, Buffalo, NY 14260 USA; [Browne, Richard W.] SUNY Buffalo, Buffalo, NY 14260 USA; [Patel, Mulchand S.] SUNY Buffalo, Sch Med & Biomed Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Rideout, TC (corresponding author), SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Exercise Sci, Buffalo, NY 14260 USA.	rideout@buffalo.edu	Li, Zhuyun/L-4792-2016	Rideout, Todd C/0000-0002-1834-7083	University at Buffalo; National Center for Complementary and Alternative Medicine [KO1]	University at Buffalo; National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This research was supported by University at Buffalo startup funding and a KO1 grant from the National Center for Complementary and Alternative Medicine (to TCR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Amom Z, 2008, J CLIN BIOCHEM NUTR, V43, P88, DOI 10.3164/jcbn.2008051; Bartels ED, 2002, DIABETES, V51, P1233, DOI 10.2337/diabetes.51.4.1233; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; Ben-Shlomo S, 2011, J HEPATOL, V54, P1214, DOI 10.1016/j.jhep.2010.09.032; Bjermo H, 2012, AM J CLIN NUTR, V95, P1003, DOI 10.3945/ajcn.111.030114; Brouwers MCGJ, 2011, CURR OPIN LIPIDOL, V22, P317, DOI 10.1097/MOL.0b013e328348a5df; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Butler JA, 2009, ARCH BIOCHEM BIOPHYS, V485, P63, DOI 10.1016/j.abb.2009.01.024; Cao AQ, 2011, J LIPID RES, V52, P518, DOI 10.1194/jlr.M010603; Carbonelli MG, 2010, CURR PHARM DESIGN, V16, P840, DOI 10.2174/138161210790883589; Cariou B, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-4; Castro MC, 2013, BBA-GEN SUBJECTS, V1830, P2226, DOI 10.1016/j.bbagen.2012.10.010; Chen WL, 2012, DIABETOLOGIA, V55, P1824, DOI 10.1007/s00125-012-2530-4; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; Farnier M, 2011, AM J CARDIOVASC DRUG, V11, P145, DOI 10.2165/11590330-000000000-00000; Fitzgerald KT, 2013, TOP COMPANION ANIM M, V28, P1, DOI 10.1053/j.tcam.2013.03.001; Ford I, 2001, METABOLISM, V50, P868, DOI 10.1053/meta.2001.24914; Giugliano RP, 2012, LANCET, V380, P2007, DOI 10.1016/S0140-6736(12)61770-X; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Harding SV, 2010, J NUTR, V140, P1249, DOI 10.3945/jn.109.120311; Hoekstra M, 2003, J BIOL CHEM, V278, P25448, DOI 10.1074/jbc.M301189200; Huong DTT, 2008, BRIT J NUTR, V100, P79, DOI 10.1017/S0007114507876227; Jeyarajah EJ, 2006, CLIN LAB MED, V26, P847, DOI 10.1016/j.cll.2006.07.006; Jung TS, 2012, LIVER INT, V32, P1565, DOI 10.1111/j.1478-3231.2012.02857.x; Kandeil MA, 2011, J DIABETES COMPLICAT, V25, P31, DOI 10.1016/j.jdiacomp.2009.09.007; Kim E, 2008, J CLIN PSYCHOPHARM, V28, P138, DOI 10.1097/JCP.0b013e31816777f7; Kim MS, 2004, NAT MED, V10, P727, DOI 10.1038/nm1061; Koh EH, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2010.08.005; Kuehl R, 2000, DESIGN EXPT STAT PRI; Lee WR, 2012, MOL BIOL REP, V39, P6857, DOI 10.1007/s11033-012-1511-5; Lee YN, 2006, BIOCHEM BIOPH RES CO, V344, P446, DOI 10.1016/j.bbrc.2006.03.062; LEWIS GF, 1995, J CLIN INVEST, V95, P158, DOI 10.1172/JCI117633; Lewis GF, 1996, DIABETES CARE, V19, P390, DOI 10.2337/diacare.19.4.390; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liang JJ, 2004, J BIOL CHEM, V279, P44938, DOI 10.1074/jbc.M408507200; Mackey RH, 2012, J AM COLL CARDIOL, V60, P508, DOI 10.1016/j.jacc.2012.03.060; Mater MK, 1999, J LIPID RES, V40, P1045; Moran-Ramos S, 2012, J NUTR, V142, P1956, DOI 10.3945/jn.112.165563; Nadeau KJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE90, DOI 10.1152/ajpendo.00543.2005; NESS GC, 1994, J BIOL CHEM, V269, P29168; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Parish S, 2012, CIRCULATION, V125, P2469, DOI 10.1161/CIRCULATIONAHA.111.073684; Park KG, 2008, HEPATOLOGY, V48, P1477, DOI 10.1002/hep.22496; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porasuphatana S, 2012, ASIA PAC J CLIN NUTR, V21, P12; Ratliff Joseph C, 2015, Clin Schizophr Relat Psychoses, V8, P196, DOI 10.3371/CSRP.RAPA.030113; Rector RS, 2008, WORLD J GASTROENTERO, V14, P185, DOI 10.3748/wjg.14.185; Richard C, 2012, BRIT J NUTR, V107, P705, DOI 10.1017/S0007114511003436; Rideout TC, 2007, J NUTR, V137, P568, DOI 10.1093/jn/137.3.568; Rideout TC, 2010, MOL NUTR FOOD RES, V54, pS7, DOI 10.1002/mnfr.201000027; Scoggan KA, 2009, J NUTR BIOCHEM, V20, P177, DOI 10.1016/j.jnutbio.2008.01.011; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seo EY, 2012, NUTR RES PRACT, V6, P195, DOI 10.4162/nrp.2012.6.3.195; Shay KP, 2009, BBA-GEN SUBJECTS, V1790, P1149, DOI 10.1016/j.bbagen.2009.07.026; Shrestha S, 2009, J NUTR, V139, P640, DOI 10.3945/jn.108.103341; Shukla A, 2006, BRIT J NUTR, V96, P674, DOI 10.1079/BJN20061895; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Sun YD, 2012, ANN NUTR METAB, V60, P293, DOI 10.1159/000338444; Timmers S, 2010, J LIPID RES, V51, P352, DOI 10.1194/jlr.M000992; TORNVALL P, 1995, ARTERIOSCL THROM VAS, V15, P1086, DOI 10.1161/01.ATV.15.8.1086; VANDERVUSSE GJ, 1985, J MOL CELL CARDIOL, V17, P527, DOI 10.1016/S0022-2828(85)80059-6; Xiao CT, 2011, AM J PHYSIOL-ENDOC M, V301, pE429, DOI 10.1152/ajpendo.00178.2011; Yamamoto T, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.16; Yang RL, 2008, NUTRITION, V24, P582, DOI 10.1016/j.nut.2008.02.002; Yi XW, 2011, J DIABETES COMPLICAT, V25, P193, DOI 10.1016/j.jdiacomp.2010.07.004; Ying ZK, 2010, LIFE SCI, V86, P95, DOI 10.1016/j.lfs.2009.11.009; Zhang WJ, 2008, CIRCULATION, V117, P421, DOI 10.1161/CIRCULATIONAHA.107.725275; Zhou YF, 2008, AM J PHYSIOL-RENAL, V295, pF662, DOI 10.1152/ajprenal.00046.2008; Zulkhairi A, 2008, BIOMED PHARMACOTHER, V62, P716, DOI 10.1016/j.biopha.2006.12.003	71	32	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90863	10.1371/journal.pone.0090863	http://dx.doi.org/10.1371/journal.pone.0090863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595397	gold, Green Published, Green Submitted			2022-12-25	WOS:000332475500107
J	Clay, CC; Maniar-Hew, K; Gerriets, JE; Wang, TT; Postlethwait, EM; Evans, MJ; Fontaine, JH; Miller, LA				Clay, Candice C.; Maniar-Hew, Kinjal; Gerriets, Joan E.; Wang, Theodore T.; Postlethwait, Edward M.; Evans, Michael J.; Fontaine, Justin H.; Miller, Lisa A.			Early Life Ozone Exposure Results in Dysregulated Innate Immune Function and Altered microRNA Expression in Airway Epithelium	PLOS ONE			English	Article							GENE-EXPRESSION; CELLS; LUNG; MORTALITY; LIPOPOLYSACCHARIDE; SUPPRESSION; ASSOCIATION; REGULATOR; INFECTION; POLLUTION	Exposure to ozone has been associated with increased incidence of respiratory morbidity in humans; however the mechanism(s) behind the enhancement of susceptibility are unclear. We have previously reported that exposure to episodic ozone during postnatal development results in an attenuated peripheral blood cytokine response to lipopolysaccharide (LPS) that persists with maturity. As the lung is closely interfaced with the external environment, we hypothesized that the conducting airway epithelium of neonates may also be a target of immunomodulation by ozone. To test this hypothesis, we evaluated primary airway epithelial cell cultures derived from juvenile rhesus macaque monkeys with a prior history of episodic postnatal ozone exposure. Innate immune function was measured by expression of the proinflammatory cytokines IL-6 and IL-8 in primary cultures established following in vivo LPS challenge or, in response to in vitro LPS treatment. Postnatal ozone exposure resulted in significantly attenuated IL-6 mRNA and protein expression in primary cultures from juvenile animals; IL-8 mRNA was also significantly reduced. The effect of antecedent ozone exposure was modulated by in vivo LPS challenge, as primary cultures exhibited enhanced cytokine expression upon secondary in vitro LPS treatment. Assessment of potential IL-6-targeting microRNAs miR-149, miR-202, and miR-410 showed differential expression in primary cultures based upon animal exposure history. Functional assays revealed that miR-149 is capable of binding to the IL-6 39 UTR and decreasing IL-6 protein synthesis in airway epithelial cell lines. Cumulatively, our findings suggest that episodic ozone during early life contributes to the molecular programming of airway epithelium, such that memory from prior exposures is retained in the form of a dysregulated IL-6 and IL-8 response to LPS; differentially expressed microRNAs such as miR-149 may play a role in the persistent modulation of the epithelial innate immune response towards microbes in the mature lung.	[Clay, Candice C.; Maniar-Hew, Kinjal; Gerriets, Joan E.; Wang, Theodore T.; Evans, Michael J.; Fontaine, Justin H.; Miller, Lisa A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Evans, Michael J.; Miller, Lisa A.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA; [Postlethwait, Edward M.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Environm Hlth Sci, Birmingham, AL 35294 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Alabama System; University of Alabama Birmingham	Miller, LA (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.	lmiller@ucdavis.edu			NIH [ES011617, ES000628, HL081286, HL097087, OD011107, T32 HL007013]; EPA STAR Grant [832947]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081286, R01HL097087, T32HL007013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011617] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPA STAR Grant(United States Environmental Protection Agency); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH ES011617, NIH ES000628, NIH HL081286, NIH HL097087, NIH OD011107, EPA STAR Grant 832947 and NIH T32 HL007013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hegelan M, 2011, IMMUNOL RES, V49, P173, DOI 10.1007/s12026-010-8180-z; Bai TR, 2005, CLIN SCI, V108, P463, DOI 10.1042/CS20040342; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bateson TF, 2008, J TOXICOL ENV HEAL A, V71, P238, DOI 10.1080/15287390701598234; Beane J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r201; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Burnett RT, 2001, AM J EPIDEMIOL, V153, P444, DOI 10.1093/aje/153.5.444; Chen LC, 2012, INT J BIOCHEM CELL B, V44, P1711, DOI 10.1016/j.biocel.2012.06.027; Delfino RJ, 1996, AM J RESP CRIT CARE, V154, P633, DOI 10.1164/ajrccm.154.3.8810598; DEVLIN RB, 1994, AM J PHYSIOL, V266, pL612, DOI 10.1152/ajplung.1994.266.6.L612; DEVLIN RB, 1991, AM J RESP CELL MOL, V4, P72, DOI 10.1165/ajrcmb/4.1.72; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Garg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077249; GILMOUR MI, 1993, EXP LUNG RES, V19, P299, DOI 10.3109/01902149309064348; GOLDSTEIN E, 1971, ARCH INTERN MED, V127, P1099, DOI 10.1001/archinte.127.6.1099; Goulding John, 2007, Proc Am Thorac Soc, V4, P618, DOI 10.1513/pats.200706-066TH; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gryparis A, 2004, AM J RESP CRIT CARE, V170, P1080, DOI 10.1164/rccm.200403-333OC; He Y, 2013, INFLAMMATION; Hollingsworth JW, 2004, AM J RESP CRIT CARE, V170, P126, DOI 10.1164/rccm.200311-1499OC; Holt PG, 2000, ALLERGY, V55, P688, DOI 10.1034/j.1398-9995.2000.00118.x; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; JAKAB GJ, 1995, ENVIRON HEALTH PERSP, V103, P77, DOI 10.2307/3432454; Jardim MJ, 2009, ENVIRON HEALTH PERSP, V117, P1745, DOI 10.1289/ehp.0900756; Jaspers I, 1997, AM J PHYSIOL-LUNG C, V272, pL504, DOI 10.1152/ajplung.1997.272.3.L504; Jin L, 2011, P NATL ACAD SCI USA, V108, P15840, DOI 10.1073/pnas.1019312108; KE Y, 1988, DIFFERENTIATION, V38, P60, DOI 10.1111/j.1432-0436.1988.tb00592.x; Kesic MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035108; Kleeberger SR, 1997, NAT GENET, V17, P475, DOI 10.1038/ng1297-475; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Lin RJ, 2010, MOL CARCINOGEN, V49, P719, DOI 10.1002/mc.20647; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Maniar-Hew K, 2010, AM J PHYSL LUNG CELL; Maniar-Hew K, 2013, AM J RESP CELL MOL, V49, P710, DOI 10.1165/rcmb.2012-0321OC; Manzer R, 2006, AM J RESP CELL MOL, V34, P158, DOI 10.1165/rcmb.2005-0205OC; Matsui H, 1998, J CLIN INVEST, V102, P1125, DOI 10.1172/JCI2687; Medina-Ramon M, 2006, AM J EPIDEMIOL, V163, P579, DOI 10.1093/aje/kwj078; Murphy SR, 2012, AM J RESP CELL MOL, V47, P815, DOI 10.1165/rcmb.2012-0110OC; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; PETERSON ML, 1978, ENVIRON RES, V15, P485, DOI 10.1016/0013-9351(78)90127-5; Pinkerton KE, 2000, ENVIRON HEALTH PERSP, V108, P457, DOI 10.2307/3454537; Plopper CG, 2000, ENVIRON HEALTH PERSP, V108, pA252, DOI 10.1289/ehp.108-a252; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Rossato M, 2012, P NATL ACAD SCI USA, V109, pE3101, DOI 10.1073/pnas.1209100109; Schelegle ES, 2003, TOXICOL APPL PHARM, V191, P74, DOI 10.1016/S0041-008X(03)00218-7; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Silveyra P, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13579; Sun YP, 2011, BLOOD, V117, P6172, DOI 10.1182/blood-2010-12-325647; Sweeney E, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011606, 10.1371/journal.pone.0009518]; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; VANLOVEREN H, 1988, TOXICOL APPL PHARM, V94, P374, DOI 10.1016/0041-008X(88)90279-7; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041693; Williams AS, 2007, J APPL PHYSIOL, V103, P1189, DOI 10.1152/japplphysiol.00172.2007; Xu Z, 2011, J BIOL CHEM, V286, P21401, DOI 10.1074/jbc.M110.198630; Yang X, 2013, HEPATOLOGY, V58, P158, DOI 10.1002/hep.26305; YANKASKAS JR, 1993, AM J PHYSIOL, V264, pC1219, DOI 10.1152/ajpcell.1993.264.5.C1219; Zhao YT, 2013, AM J PHYSIOL-LUNG C, V305, pL56, DOI 10.1152/ajplung.00417.2012	58	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90401	10.1371/journal.pone.0090401	http://dx.doi.org/10.1371/journal.pone.0090401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594710	gold, Green Published, Green Submitted			2022-12-25	WOS:000332475500048
J	Liu, MY; Blinn, C; McLeod, SM; Wiseman, JW; Newman, JV; Fisher, SL; Walkup, GK				Liu, Mingyu; Blinn, Christina; McLeod, Sarah M.; Wiseman, John W.; Newman, Joseph V.; Fisher, Stewart L.; Walkup, Grant K.			Secreted Gaussia princeps Luciferase as a Reporter of Escherichia coli Replication in a Mouse Tissue Cage Model of Infection	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; INTERLEUKIN-1 IL-1 PRODUCTION; FOREIGN-BODY INFECTION; IN-VIVO; FIREFLY LUCIFERASE; CHAMBER MODEL; GENE-EXPRESSION; BIOLUMINESCENCE; CELLS; MICE	Measurement of bacterial burden in animal infection models is a key component for both bacterial pathogenesis studies and therapeutic agent research. The traditional quantification means for in vivo bacterial burden requires frequent animal sacrifice and enumerating colony forming units (CFU) recovered from infection loci. To address these issues, researchers have developed a variety of luciferase-expressing bacterial reporter strains to enable bacterial detection in living animals. To date, all such luciferase-based bacterial reporters are in cell-associated form. Production of luciferase-secreting recombinant bacteria could provide the advantage of reporting CFU from both infection loci themselves and remote sampling (eg. body fluid and plasma). Toward this end, we have genetically manipulated a pathogenic Escherichia coli (E. coli) strain, ATCC25922, to secrete the marine copepod Gaussia princeps luciferase (Gluc), and assessed the use of Gluc as both an in situ and ex situ reporter for bacterial burden in mouse tissue cage infections. The E. coli expressing Gluc demonstrates in vivo imaging of bacteria in a tissue cage model of infection. Furthermore, secreted Gluc activity and bacterial CFUs recovered from tissue cage fluid (TCF) are correlated along 18 days of infection. Importantly, secreted Gluc can also be detected in plasma samples and serve as an ex situ indicator for the established tissue cage infection, once high bacterial burdens are achieved. We have demonstrated that Gluc from marine eukaryotes can be stably expressed and secreted by pathogenic E. coli in vivo to enable a facile tool for longitudinal evaluation of persistent bacterial infection.	[Liu, Mingyu; Blinn, Christina; McLeod, Sarah M.; Newman, Joseph V.; Fisher, Stewart L.; Walkup, Grant K.] AstraZeneca R&D Boston, Dept Biol, Infect Innovat Med, Waltham, MA 02451 USA; [Wiseman, John W.] AstraZeneca R&D, RAD Transgen, Discovery Sci, Molndal, Sweden	AstraZeneca; AstraZeneca	Liu, MY (corresponding author), AstraZeneca R&D Boston, Dept Biol, Infect Innovat Med, Waltham, MA 02451 USA.	Mingyu-mandy.liu@astrazeneca.com; Grant.walkup@astrazeneca.com			AstraZeneca RD	AstraZeneca RD(AstraZeneca)	This research was funded internally by AstraZeneca R&D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Andreu N, 2013, J ANTIMICROB CHEMOTH, V68, P2118, DOI 10.1093/jac/dkt155; Andreu N, 2011, FEMS MICROBIOL REV, V35, P360, DOI 10.1111/j.1574-6976.2010.00252.x; Andreu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010777; BAMBERGER DM, 1986, J ANTIMICROB CHEMOTH, V18, P51, DOI 10.1093/jac/18.1.51; Bamberger DM, 2002, ANTIMICROB AGENTS CH, V46, P2878, DOI 10.1128/AAC.46.9.2878-2884.2002; BAMBERGER DM, 1995, J ANTIMICROB CHEMOTH, V35, P623, DOI 10.1093/jac/35.5.623; BLASER J, 1995, ANTIMICROB AGENTS CH, V39, P1134, DOI 10.1128/AAC.39.5.1134; BOYLE VJ, 1973, ANTIMICROB AGENTS CH, V3, P418, DOI 10.1128/AAC.3.3.418; Chung E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008316; Contag CH, 2007, ANNU REV PATHOL-MECH, V2, P277, DOI 10.1146/annurev.pathol.2.010506.091930; Daniel C, 2013, APPL ENVIRON MICROB, V79, P1086, DOI 10.1128/AEM.03221-12; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAWSON J, 1993, AGENTS ACTIONS, V38, P255, DOI 10.1007/BF01976218; DAWSON J, 1993, AGENTS ACTIONS, V38, P247, DOI 10.1007/BF01976217; Degeling MH, 2013, ANAL CHEM, V85, P3006, DOI 10.1021/ac4003134; DEWET JR, 1985, P NATL ACAD SCI USA, V82, P7870; Enjalbert B, 2009, INFECT IMMUN, V77, P4847, DOI 10.1128/IAI.00223-09; Fernandez J, 1999, ANTIMICROB AGENTS CH, V43, P667, DOI 10.1128/AAC.43.3.667; Francis KP, 2001, INFECT IMMUN, V69, P3350, DOI 10.1128/IAI.69.5.3350-3358.2001; Galluzzi L, 2007, J BIOTECHNOL, V127, P188, DOI 10.1016/j.jbiotec.2006.06.019; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; GREEN AA, 1956, BIOCHIM BIOPHYS ACTA, V20, P170, DOI 10.1016/0006-3002(56)90275-X; Inouye S, 2008, BIOCHEM BIOPH RES CO, V365, P96, DOI 10.1016/j.bbrc.2007.10.152; Kim SB, 2011, ANAL CHEM, V83, P8732, DOI 10.1021/ac2021882; Koga K, 2005, MOL GENET GENOMICS, V274, P180, DOI 10.1007/s00438-005-0008-5; Kristian SA, 2004, MICROB PATHOGENESIS, V36, P237, DOI 10.1016/j.micpath.2003.12.004; Kristian SA, 2003, J INFECT DIS, V188, P414, DOI 10.1086/376533; LEMBERT N, 1995, BIOCHEM J, V305, P929, DOI 10.1042/bj3050929; Li CH, 2004, J ANTIMICROB CHEMOTH, V53, P297, DOI 10.1093/jac/dkh057; Lobo LA, 2013, MICROBIOLOGYOPEN, V2, P326, DOI 10.1002/mbo3.76; LUCET JC, 1990, ANTIMICROB AGENTS CH, V34, P2312, DOI 10.1128/AAC.34.12.2312; Maguire CA, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.25; Maguire CA, 2009, ANAL CHEM, V81, P7102, DOI 10.1021/ac901234r; McCallum N, 2006, ANTIMICROB AGENTS CH, V50, P2352, DOI 10.1128/AAC.00073-06; MEIGHEN EA, 1993, FASEB J, V7, P1016, DOI 10.1096/fasebj.7.11.8370470; MORRIS CE, 1986, GENE, V41, P193, DOI 10.1016/0378-1119(86)90098-3; Morse D, 2012, MOL THER, V20, P692, DOI 10.1038/mt.2012.38; Niers JM, 2011, MOL THER, V19, P1090, DOI 10.1038/mt.2011.17; Santos EB, 2009, NAT MED, V15, P338, DOI 10.1038/nm.1930; Shao N, 2008, CURR GENET, V53, P381, DOI 10.1007/s00294-008-0189-7; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Welsh JP, 2009, BIOCHEM BIOPH RES CO, V389, P563, DOI 10.1016/j.bbrc.2009.09.006; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wiles S, 2005, APPL ENVIRON MICROB, V71, P3427, DOI 10.1128/AEM.71.7.3427-3432.2005; Wille T, 2012, APPL ENVIRON MICROB, V78, P250, DOI 10.1128/AEM.06670-11; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305	49	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90382	10.1371/journal.pone.0090382	http://dx.doi.org/10.1371/journal.pone.0090382			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595353	gold, Green Submitted, Green Published			2022-12-25	WOS:000332475500045
J	Shen, FF; Yue, WB; Zhou, FY; Pan, Y; Zhao, XK; Jin, Y; Song, X; Li, B; Han, XN; Tang, S; Li, Y; Yuan, G; Chen, LS; Liu, YL; Hu, YL; Li, XM; Ren, JL; Wang, LD				Shen, Fang-Fang; Yue, Wen-Bin; Zhou, Fu-You; Pan, Ying; Zhao, Xue-Ke; Jin, Yan; Song, Xin; Li, Bei; Han, Xue-Na; Tang, Sa; Li, Yan; Yuan, Guo; Chen, Li-Sha; Liu, Ya-Li; Hu, Yan-Long; Li, Xiu-Min; Ren, Jing-Li; Wang, Li-Dong			Variations in the MHC Region Confer Risk to Esophageal Squamous Cell Carcinoma on the Subjects from High-Incidence Area in Northern China	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CLASS-I; SUSCEPTIBILITY LOCI; HLA-DR; EXPRESSION; GENES; PROTEIN; CANCER; COMPONENTS; PLCE1	Background: The human major histocompatibility complex (MHC) is the most important region in vertebrate genome, and is crucial in innate immunity. Recent studies have demonstrated the possible role of polymorphisms in the MHC region to high risk for esophageal squamous cell carcinoma (ESCC). Our previous genome-wide association study (GWAS) has indicated that the MHC region may confer important risk loci for ESCC, but without further fine mapping. The aim of this study is to further identify the risk loci in the MHC region for ESCC in Chinese population. Methods: Conditional logistic regression analysis (CLRA) was performed on 24 single nucleotide polymorphisms (SNPs) within the MHC region, which were obtained from the genetically matched 937 cases and 692 controls of Chinese Han population. The identified promising SNPs were further correlated with clinical and clinicopathology characteristics. Immunohistochemistry was performed to explore the protein expression pattern of the related genes in ESCC and neighboring normal tissues. Results: Of the 24 promising SNPs analyzed, we identified three independent SNPs in the MHC region associated with ESCC: rs35399661 (P = 6.07E-06, OR = 1.71, 95% CI = 1.36-2.17), rs3763338 (P = 1.62E-05, OR = 0.63, 95% CI = 0.50-0.78) and rs2844695 (P = 7.60E-05, OR = 0.74, 95% CI = 0.64-0.86). These three SNPs were located at the genes of HLA-DQA1, TRIM27, and DPCR1, respectively. Further analyses showed that rs2844695 was preferentially associated with younger ESCC cases (P = 0.009). The positive immunostaining rates both for HLA-DQA1 and TRIM27 were much higher in ESCC tissues than in neighboring normal tissues (69.4% vs. 26.8% for HLA-DQA1 and 77.6% vs. 47.8% for TRIM27, P<0.001). Furthermore, the overexpression of HLA-DQA1 is correlated significantly with age (P = 0.001) and family history (P<0.001). Conclusion: This study for the first time provides evidence that multiple genetic factors within the MHC region confer risk to ESCC on the subjects from high-risk area in northern China.	[Shen, Fang-Fang; Yue, Wen-Bin; Zhao, Xue-Ke; Jin, Yan; Song, Xin; Li, Bei; Han, Xue-Na; Tang, Sa; Li, Yan; Yuan, Guo; Chen, Li-Sha; Liu, Ya-Li; Hu, Yan-Long; Wang, Li-Dong] Zhengzhou Univ, Affiliated Hosp 1, Henan Key Lab Esophageal Canc Res, Zhengzhou 450052, Henan, Peoples R China; [Shen, Fang-Fang; Pan, Ying; Yuan, Guo; Chen, Li-Sha; Liu, Ya-Li; Hu, Yan-Long; Li, Xiu-Min] Xinxiang Med Univ, Canc Res Ctr, Xinxiang, Henan, Peoples R China; [Shen, Fang-Fang; Pan, Ying; Yuan, Guo; Chen, Li-Sha; Liu, Ya-Li; Hu, Yan-Long; Li, Xiu-Min] Xinxiang Med Univ, Affiliated Hosp 3, Xinxiang, Henan, Peoples R China; [Zhou, Fu-You] Anyang Tumor Hosp, Dept Thorac Surg, Anyang, Henan, Peoples R China; [Ren, Jing-Li] Zhengzhou Univ, Affiliated Hosp 2, Dept Pathol, Zhengzhou 450052, Henan, Peoples R China	Zhengzhou University; Xinxiang Medical University; Xinxiang Medical University; Zhengzhou University	Wang, LD (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Henan Key Lab Esophageal Canc Res, Zhengzhou 450052, Henan, Peoples R China.	ldwang2007@126.com	li, xiu/GXV-1745-2022	ren, jingli/0000-0001-9891-0579; Zhou, Fu-You/0000-0002-6548-4099	National Natural Science Foundations [30670956, 30971133]; 863 HighTech Key Projects [2006AA02A403, 2007AA02Z161]; China Key Program on Basic Research [2007CB516812]; Special Scientific Programs from Science and Technology Department of Henan Province; Health Department of Henan Province; Education Department of Henan Province	National Natural Science Foundations(National Natural Science Foundation of China (NSFC)); 863 HighTech Key Projects(National High Technology Research and Development Program of China); China Key Program on Basic Research; Special Scientific Programs from Science and Technology Department of Henan Province; Health Department of Henan Province; Education Department of Henan Province	his project was funded by National Natural Science Foundations (30670956, 30971133), 863 HighTech Key Projects (2006AA02A403, 2007AA02Z161), China Key Program on Basic Research (2007CB516812), Special Scientific Programs from Science and Technology Department (2009-8), Health Department (2009-10) and Education Department (2008-7) of Henan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Daly JM, 2000, J AM COLL SURGEONS, V190, P562, DOI 10.1016/S1072-7515(00)00238-6; Dho SH, 2003, J BIOL CHEM, V278, P31902, DOI 10.1074/jbc.M304062200; Dura P, 2013, INT J CANCER, V133, P1751, DOI 10.1002/ijc.28160; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Guo W, 2009, CURR GENOMICS, V10, P534, DOI 10.2174/138920209789503888; Haocai L, 1983, Ecol Dis, V2, P249; Hiyama T, 2007, INT J CANCER, V121, P1643, DOI 10.1002/ijc.23044; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Huang Li-ming, 2012, Zhonghua Zhong Liu Za Zhi, V34, P269, DOI 10.3760/cma.j.issn.0253-3766.2012.04.007; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jordanova ES, 2003, IMMUNOGENETICS, V55, P203, DOI 10.1007/s00251-003-0563-z; Kohno T, 2011, J THORAC ONCOL, V6, P813, DOI 10.1097/JTO.0b013e3181ee80ef; LAZARIS AC, 1995, DIS COLON RECTUM, V38, P739, DOI 10.1007/BF02048033; Liu Q, 2009, SCAND J GASTROENTERO, V44, P960, DOI 10.1080/00365520902998679; Matsuzaka Y, 2002, IMMUNOGENETICS, V54, P301, DOI 10.1007/s00251-002-0470-8; Morita M, 2010, INT J CLIN ONCOL, V15, P126, DOI 10.1007/s10147-010-0056-7; Nie Y, 2001, CARCINOGENESIS, V22, P1615, DOI 10.1093/carcin/22.10.1615; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rajendra S, 2006, J CLIN PATHOL, V59, P952, DOI 10.1136/jcp.2005.031575; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; TAKAHASHI M, 1988, ONCOGENE, V3, P571; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WANG LD, 1993, CANCER RES, V53, P1783; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; YANG CS, 1980, CANCER RES, V40, P2633	29	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90438	10.1371/journal.pone.0090438	http://dx.doi.org/10.1371/journal.pone.0090438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595008	Green Submitted, gold, Green Published			2022-12-25	WOS:000332475500049
J	Deng, Y; Chen, KR; Teng, W; Zhan, A; Tong, YP; Feng, G; Cui, ZL; Zhang, FS; Chen, XP				Deng, Yan; Chen, Keru; Teng, Wan; Zhan, Ai; Tong, Yiping; Feng, Gu; Cui, Zhenling; Zhang, Fusuo; Chen, Xinping			Is the Inherent Potential of Maize Roots Efficient for Soil Phosphorus Acquisition?	PLOS ONE			English	Article							PHOSPHATE TRANSPORTERS; ARABIDOPSIS-THALIANA; MYCORRHIZAL FUNGI; PLANT; RICE; DEFICIENCY; MANAGEMENT; RESPONSES; NITROGEN; SYSTEMS	Sustainable agriculture requires improved phosphorus (P) management to reduce the overreliance on P fertilization. Despite intensive research of root adaptive mechanisms for improving P acquisition, the inherent potential of roots for efficient P acquisition remains unfulfilled, especially in intensive agriculture, while current P management generally focuses on agronomic and environmental concerns. Here, we investigated how levels of soil P affect the inherent potential of maize (Zea mays L.) roots to obtain P from soil. Responses of root morphology, arbuscular mycorrhizal colonization, and phosphate transporters were characterized and related to agronomic traits in pot and field experiments with soil P supply from deficiency to excess. Critical soil Olsen-P level for maize growth approximated 3.2 mg kg(-1), and the threshold indicating a significant environmental risk was about 15 mg kg(-1), which represented the lower and upper levels of soil P recommended in current P management. However, most root adaptations involved with P acquisition were triggered when soil Olsen-P was below 10 mg kg(-1), indicating a threshold for maximum root inherent potential. Therefore, to maintain efficient inherent potential of roots for P acquisition, we suggest that the target upper level of soil P in intensive agriculture should be reduced from the environmental risk threshold to the point maximizing the inherent potential of roots.	[Deng, Yan; Chen, Keru; Feng, Gu; Cui, Zhenling; Zhang, Fusuo; Chen, Xinping] China Agr Univ, Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China; [Teng, Wan; Tong, Yiping] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Zhan, Ai] Chinese Acad Sci, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China; [Zhan, Ai] Minist Water Resource, Yangling, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS	Chen, XP (corresponding author), China Agr Univ, Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China.	chenxp@cau.edu.cn	Zhang, Fusuo/AAV-4517-2021; Feng, Gu/K-8367-2012	Feng, Gu/0000-0002-1052-5009	National Natural Science Foundation of China [30890133, 30971872]; National Maize Production System in China [CARS-02-24]; Innovative Group Grant of NSFC [30971892]; Innovation Fund for Graduate Student of China Agricultural University [KYCX2011032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Maize Production System in China; Innovative Group Grant of NSFC; Innovation Fund for Graduate Student of China Agricultural University	This work was supported by the National Natural Science Foundation of China (30890133, 30971872), National Maize Production System in China (CARS-02-24), the Innovative Group Grant of NSFC (30971892), and the Innovation Fund for Graduate Student of China Agricultural University (KYCX2011032). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ABBOTT LK, 1991, AGR ECOSYST ENVIRON, V35, P121, DOI 10.1016/0167-8809(91)90048-3; Bates TR, 1996, PLANT CELL ENVIRON, V19, P529, DOI 10.1111/j.1365-3040.1996.tb00386.x; BOLAN NS, 1991, PLANT SOIL, V134, P189, DOI 10.1007/BF00012037; Brown LK, 2013, ANN BOT-LONDON, V112, P317, DOI 10.1093/aob/mcs231; Calderon-Vazquez C, 2008, J EXP BOT, V59, P2479, DOI 10.1093/jxb/ern115; Chin JH, 2011, PLANT PHYSIOL, V156, P1202, DOI 10.1104/pp.111.175471; Coelho GTCP, 2010, PLANT MOL BIOL REP, V28, P717, DOI 10.1007/s11105-010-0199-8; Colomb B, 2007, EUR J AGRON, V26, P154, DOI 10.1016/j.eja.2006.09.004; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Cordell D, 2011, CHEMOSPHERE, V84, P747, DOI 10.1016/j.chemosphere.2011.02.032; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Covacevich F, 2007, APPL SOIL ECOL, V35, P1, DOI 10.1016/j.apsoil.2006.06.001; Elliott HA, 2007, SOIL BIOL BIOCHEM, V39, P1318, DOI 10.1016/j.soilbio.2006.12.007; Fan MS, 2003, FUNCT PLANT BIOL, V30, P493, DOI 10.1071/FP03046; Fernandez M, 2009, P INT PLANT NUTR C; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Gilbert N, 2009, NATURE, V461, P716, DOI 10.1038/461716a; Glassop D, 2007, CAN J BOT, V85, P644, DOI 10.1139/B07-070; Grant C, 2005, CAN J PLANT SCI, V85, P3, DOI 10.4141/P03-182; Grant CA, 2001, CAN J PLANT SCI, V81, P211, DOI 10.4141/P00-093; HECKRATH G, 1995, J ENVIRON QUAL, V24, P904, DOI 10.2134/jeq1995.00472425002400050018x; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Hesketh N, 2000, J ENVIRON QUAL, V29, P105, DOI 10.2134/jeq2000.00472425002900010013x; Higgs B, 2000, J ENVIRON QUAL, V29, P80, DOI 10.2134/jeq2000.00472425002900010010x; Hill JO, 2006, PLANT SOIL, V286, P7, DOI 10.1007/s11104-006-0014-3; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; Howard A. E., 2006, ALBERTA SOIL PHOSPHO, V5; Javot H, 2007, PLANT CELL ENVIRON, V30, P310, DOI 10.1111/j.1365-3040.2006.01617.x; Johnston A.E., 2005, PHOSPHORUS AGR RELAT; Kirkby Ernest A., 2008, V7, P177; Lambers H, 2006, ANN BOT-LONDON, V98, P693, DOI 10.1093/aob/mcl114; Li H, 2011, PLANT SOIL, V349, P157, DOI 10.1007/s11104-011-0909-5; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Lynch Jonathan P., 2008, V7, P83; Ma Z, 2001, PLANT CELL ENVIRON, V24, P459, DOI 10.1046/j.1365-3040.2001.00695.x; MacDonald GK, 2011, P NATL ACAD SCI USA, V108, P3086, DOI 10.1073/pnas.1010808108; Mallarino AP, 2005, SOIL SCI SOC AM J, V69, P266, DOI 10.2136/sssaj2005.0266; MALLARINO AP, 1992, AGRON J, V84, P850, DOI 10.2134/agronj1992.00021962008400050017x; Nagy R, 2006, PLANT BIOLOGY, V8, P186, DOI 10.1055/s-2005-873052; Nussaume L, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00083; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Pierzynski, 2000, METHODS PHOSPHORUS A, V396, P1; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Ramaekers L, 2010, FIELD CROP RES, V117, P169, DOI 10.1016/j.fcr.2010.03.001; Richardson AE, 2009, CROP PASTURE SCI, V60, P124, DOI 10.1071/CP07125; ROMER W, 1986, PLANT SOIL, V91, P221, DOI 10.1007/BF02181789; Sharpley A., 2003, AGR PHOSPHORUS EUTRO; SHARPLEY AN, 1994, J ENVIRON QUAL, V23, P437, DOI 10.2134/jeq1994.00472425002300030006x; Shi R., 1986, SOIL AGR CHEM ANAL; Smith SE, 2011, ANNU REV PLANT BIOL, V62, P227, DOI 10.1146/annurev-arplant-042110-103846; Tang X, 2009, PLANT SOIL, V323, P143, DOI 10.1007/s11104-009-9919-y; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; Vaccari DA, 2009, SCI AM, V300, P54, DOI 10.1038/scientificamerican0609-54; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558	57	39	41	5	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90287	10.1371/journal.pone.0090287	http://dx.doi.org/10.1371/journal.pone.0090287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594677	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900090
J	Grueber, CE; Wallis, GP; Jamieson, IG				Grueber, Catherine E.; Wallis, Graham P.; Jamieson, Ian G.			Episodic Positive Selection in the Evolution of Avian Toll-Like Receptor Innate Immunity Genes	PLOS ONE			English	Article							BALANCING SELECTION; NATURAL-SELECTION; STRUCTURAL BASIS; COMPLEX; IDENTIFICATION; RECOGNITION; LOCI; POPULATION; ACTIVATION; HOMOLOG	Toll-like receptors (TLRs) are a family of conserved pattern-recognition molecules responsible for initiating innate and acquired immune responses. Because they play a key role in host defence, these genes have received increasing interest in the evolutionary and population genetics literature, as their variation represents a potential target of adaptive evolution. However, the role of pathogen-mediated selection (i.e. episodic positive selection) in the evolution of these genes remains poorly known and has not been examined outside of mammals. A recent increase in the number of bird species for which TLR sequences are available has enabled us to examine the selective processes that have influenced evolution of the 10 known avian TLR genes. Specifically, we tested for episodic positive selection to identify codons that experience purifying selection for the majority of their evolution, interspersed with bursts of positive selection that may occur only in restricted lineages. We included up to 23 species per gene (mean = 16.0) and observed that, although purifying selection was evident, an average of 4.5% of codons experienced episodic positive selection across all loci. For four genes in which sequence coverage traversed both the extracellular leucine-rich repeat region (LRR) and transmembrane/intracellular domains of the proteins, increased positive selection was observed at the extracellular domain, consistent with theoretical predictions. Our results provide evidence that episodic positive selection has played an important role in the evolution of most avian TLRs, consistent with the role of these loci in pathogen recognition and a mechanism of host-pathogen coevolution.	[Grueber, Catherine E.; Jamieson, Ian G.] Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand; [Grueber, Catherine E.; Wallis, Graham P.; Jamieson, Ian G.] Univ Otago, Dept Zool, Dunedin, New Zealand	University of Otago	Grueber, CE (corresponding author), Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand.	catherine.grueber@otago.ac.nz	Grueber, Catherine E./H-4707-2011; Wallis, Graham/E-5410-2011	Grueber, Catherine E./0000-0002-8179-1822; Wallis, Graham/0000-0002-6408-7868	Allan Wilson Centre for Molecular Ecology and Evolution; Marsden Fund [UOO1009]; Landcare Research [C09X0503]; University of Otago	Allan Wilson Centre for Molecular Ecology and Evolution; Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Landcare Research; University of Otago	The authors' research received funding from the Allan Wilson Centre for Molecular Ecology and Evolution, the Marsden Fund (Contract no. UOO1009), Landcare Research (Contract no. C09X0503) and University of Otago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2006, TRENDS ECOL EVOL, V21, P433, DOI 10.1016/j.tree.2006.05.010; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alcaide M, 2011, MOL BIOL EVOL, V28, P1703, DOI 10.1093/molbev/msq351; Areal H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-368; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Boyd AC, 2012, J IMMUNOL, V189, P4930, DOI 10.4049/jimmunol.1101790; Brownlie R, 2011, CELL TISSUE RES, V343, P121, DOI 10.1007/s00441-010-1026-0; Brownlie R, 2009, MOL IMMUNOL, V46, P3163, DOI 10.1016/j.molimm.2009.06.002; Cadavid LF, 2013, IMMUNOGENETICS; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cormican P, 2009, DEV COMP IMMUNOL, V33, P967, DOI 10.1016/j.dci.2009.04.001; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Delport W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000885; Downing T, 2010, J IMMUNOL, V184, P6993, DOI 10.4049/jimmunol.0903092; Drummond AJ, 2010, GENEIOUS; Ellegren H, 2008, MOL ECOL, V17, P4586, DOI 10.1111/j.1365-294X.2008.03954.x; Ferrer-Admetlla A, 2008, J IMMUNOL, V181, P1315, DOI 10.4049/jimmunol.181.2.1315; Fornuskova A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-194; Gharib WH, 2013, MOL BIOL EVOL, V30, P1675, DOI 10.1093/molbev/mst062; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Grueber CE, 2013, CONSERV GENET RESOUR, V5, P1043, DOI 10.1007/s12686-013-9965-x; Grueber CE, 2013, MOL ECOL, V22, P4470, DOI 10.1111/mec.12404; Grueber CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045011; Hedrick PW, 1998, GENETICA, V104, P207, DOI 10.1023/A:1026494212540; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES AL, 1990, MOL BIOL EVOL, V7, P515; Jepson A, 1997, INFECT IMMUN, V65, P872, DOI 10.1128/IAI.65.3.872-876.1997; Keestra AM, 2008, J IMMUNOL, V181, P4354, DOI 10.4049/jimmunol.181.6.4354; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leulier F, 2008, NAT REV GENET, V9, P165, DOI 10.1038/nrg2303; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mukherjee S, 2009, P NATL ACAD SCI USA, V106, P7073, DOI 10.1073/pnas.0811357106; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; NEI M, 1986, MOL BIOL EVOL, V3, P418; Offord V, 2010, DEV COMP IMMUNOL, V34, P1035, DOI 10.1016/j.dci.2010.05.004; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; R Core Team R, 2022, R LANG ENV STAT COMP; Rech GE, 2012, PLANT SIGNAL BEHAV, V7, P1667, DOI 10.4161/psb.22362; Saponaro C, 2011, IMMUNOPHARM IMMUNOT, V33, P64, DOI 10.3109/08923971003739244; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Streicker DG, 2012, P NATL ACAD SCI USA, V109, P19715, DOI 10.1073/pnas.1203456109; Sundar D.R, 2009, BINOM BINOMIAL CONFI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Temperley ND, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-62; Tschirren B, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0364; Turner AK, 2012, MOL ECOL, V21, P1632, DOI 10.1111/j.1365-294X.2012.05501.x; Uematsu Satoshi, 2008, V183, P1; Villasenor-Cardoso MI, 2011, PARASITE IMMUNOL, V33, P643, DOI 10.1111/j.1365-3024.2011.01327.x; Vinkler M, 2009, TISSUE ANTIGENS, V74, P32, DOI 10.1111/j.1399-0039.2009.01273.x; Vinkler M, 2009, FOLIA ZOOL, V58, P15; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; Werling D, 2009, TRENDS IMMUNOL, V30, P124, DOI 10.1016/j.it.2008.12.001; Wlasiuk G, 2010, MOL BIOL EVOL, V27, P2172, DOI 10.1093/molbev/msq104; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010	61	74	78	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89632	10.1371/journal.pone.0089632	http://dx.doi.org/10.1371/journal.pone.0089632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595315	Green Submitted, gold, Green Published			2022-12-25	WOS:000332468900028
J	Lu, Y; Paraskevopoulos, E; Herholz, SC; Kuchenbuch, A; Pantev, C				Lu, Yao; Paraskevopoulos, Evangelos; Herholz, Sibylle C.; Kuchenbuch, Anja; Pantev, Christo			Temporal Processing of Audiovisual Stimuli Is Enhanced in Musicians: Evidence from Magnetoencephalography (MEG)	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; MISMATCH NEGATIVITY MMN; CORTICAL PLASTICITY; MUSICAL EXPERTISE; AUDITORY-CORTEX; BRAIN; INTEGRATION; PERCEPTION; REPRESENTATION; FMRI	Numerous studies have demonstrated that the structural and functional differences between professional musicians and non-musicians are not only found within a single modality, but also with regard to multisensory integration. In this study we have combined psychophysical with neurophysiological measurements investigating the processing of non-musical, synchronous or various levels of asynchronous audiovisual events. We hypothesize that long-term multisensory experience alters temporal audiovisual processing already at a non-musical stage. Behaviorally, musicians scored significantly better than non-musicians in judging whether the auditory and visual stimuli were synchronous or asynchronous. At the neural level, the statistical analysis for the audiovisual asynchronous response revealed three clusters of activations including the ACC and the SFG and two bilaterally located activations in IFG and STG in both groups. Musicians, in comparison to the non-musicians, responded to synchronous audiovisual events with enhanced neuronal activity in a broad left posterior temporal region that covers the STG, the insula and the Postcentral Gyrus. Musicians also showed significantly greater activation in the left Cerebellum, when confronted with an audiovisual asynchrony. Taken together, our MEG results form a strong indication that long-term musical training alters the basic audiovisual temporal processing already in an early stage (direct after the auditory N1 wave), while the psychophysical results indicate that musical training may also provide behavioral benefits in the accuracy of the estimates regarding the timing of audiovisual events.	[Lu, Yao; Paraskevopoulos, Evangelos; Kuchenbuch, Anja; Pantev, Christo] Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany; [Herholz, Sibylle C.] German Ctr Neurodegenerat Dis, Bonn, Germany	University of Munster; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Pantev, C (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany.	pantev@uni-muenster.de		Paraskevopoulos, Evangelos/0000-0003-4063-4182	Deutsche Forschungsgemeinschaft [PA392/12-2, HE6067-1/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft [PA392/12-2 and HE6067-1/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besle J, 2005, EXP BRAIN RES, V166, P337, DOI 10.1007/s00221-005-2375-x; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bushara KO, 2003, NAT NEUROSCI, V6, P190, DOI 10.1038/nn993; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Fujioka T, 2005, J COGNITIVE NEUROSCI, V17, P1578, DOI 10.1162/089892905774597263; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Gaser C, 2003, J NEUROSCI, V23, P9240; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Gonzalo D, 2000, NEUROIMAGE, V11, P243, DOI 10.1006/nimg.2000.0540; Haueisen J, 2001, J COGNITIVE NEUROSCI, V13, P786, DOI 10.1162/08989290152541449; Herholz SC, 2008, EUR J NEUROSCI, V28, P2352, DOI 10.1111/j.1460-9568.2008.06515.x; Hutchinson S, 2003, CEREB CORTEX, V13, P943, DOI 10.1093/cercor/13.9.943; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Ivry R, 1997, INT REV NEUROBIOL, V41, P555; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; IVRY RB, 1995, J EXP PSYCHOL HUMAN, V21, P3, DOI 10.1037/0096-1523.21.1.3; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Johnsrude IS, 1997, NEUROREPORT, V8, P1761, DOI 10.1097/00001756-199705060-00038; Lee H, 2011, P NATL ACAD SCI USA, V108, pE1441, DOI 10.1073/pnas.1115267108; Lewis R, 2010, J NEUROSCI, V30, P12329, DOI 10.1523/JNEUROSCI.5745-09.2010; Liegeois-Chauvel C, 2004, CEREB CORTEX, V14, P731, DOI 10.1093/cercor/bhh033; Love Scott A., 2012, Cognitive Behavioural Systems (COST 2012). International Training School. Revised Selected Papers, P304, DOI 10.1007/978-3-642-34584-5_27; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Musacchia G, 2009, HEARING RES, V258, P72, DOI 10.1016/j.heares.2009.06.018; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 2004, CLIN NEUROPHYSIOL, V115, P140, DOI 10.1016/j.clinph.2003.04.001; Noesselt T, 2008, BRAIN RES, V1220, P132, DOI 10.1016/j.brainres.2007.09.045; Noesselt T, 2007, J NEUROSCI, V27, P11431, DOI 10.1523/JNEUROSCI.2252-07.2007; NYMAN G, 1990, ELECTROEN CLIN NEURO, V77, P436, DOI 10.1016/0168-5597(90)90004-W; O'Reilly JX, 2008, J NEUROSCI, V28, P2252, DOI 10.1523/JNEUROSCI.2742-07.2008; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Pantev C, 2003, ANN NY ACAD SCI, V999, P438, DOI 10.1196/annals.1284.054; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Pantev C, 2009, ANN NY ACAD SCI, V1169, P143, DOI 10.1111/j.1749-6632.2009.04588.x; Paraskevopoulos E, 2012, J NEUROSCI, V32, P18196, DOI 10.1523/JNEUROSCI.1947-12.2012; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Penhune VB, 1998, J COGNITIVE NEUROSCI, V10, P752, DOI 10.1162/089892998563149; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; Petrini K, 2011, NEUROIMAGE, V56, P1480, DOI 10.1016/j.neuroimage.2011.03.009; Petrini K, 2009, EXP BRAIN RES, V198, P339, DOI 10.1007/s00221-009-1817-2; Powers AR, 2009, J NEUROSCI, V29, P12265, DOI 10.1523/JNEUROSCI.3501-09.2009; Rodrigues AC, 2013, BRAIN COGNITION, V82, P229, DOI 10.1016/j.bandc.2013.04.009; Schlaug G, 2001, ANN NY ACAD SCI, V930, P281, DOI 10.1111/j.1749-6632.2001.tb05739.x; Schon D, 2005, J COGNITIVE NEUROSCI, V17, P694, DOI 10.1162/0898929053467532; Schon D, 2003, ANN NY ACAD SCI, V999, P193, DOI 10.1196/annals.1284.028; Schon D, 2002, NEUROREPORT, V13, P2285, DOI 10.1097/01.wnr.0000044224.79663.f5; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stewart L, 2003, NEUROIMAGE, V20, P71, DOI 10.1016/S1053-8119(03)00248-9; Teder-Salejarvi WA, 2005, J COGNITIVE NEUROSCI, V17, P1396, DOI 10.1162/0898929054985383; Vuust P, 2005, NEUROIMAGE, V24, P560, DOI 10.1016/j.neuroimage.2004.08.039; Zatorre R, 2005, NATURE, V434, P312, DOI 10.1038/434312a; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	60	16	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90686	10.1371/journal.pone.0090686	http://dx.doi.org/10.1371/journal.pone.0090686			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595014	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900134
J	Song, JQ; Dong, F; Li, X; Xu, CP; Cui, Z; Jiang, N; Jia, JJ; Yu, B				Song, Jin-qi; Dong, Fu; Li, Xue; Xu, Chang-peng; Cui, Zhuang; Jiang, Nan; Jia, Jun-jie; Yu, Bin			Effect of Treadmill Exercise Timing on Repair of Full-Thickness Defects of Articular Cartilage by Bone-Derived Mesenchymal Stem Cells: An Experimental Investigation in Rats	PLOS ONE			English	Article							CONTINUOUS PASSIVE MOTION; AUTOGENOUS PERIOSTEAL GRAFTS; EARLY CONDITIONING EXERCISE; EXTRACELLULAR-MATRIX; OXYGEN-CONSUMPTION; MIDCARPAL JOINT; EQUINE CARPUS; KNEE-JOINT; OSTEOARTHRITIS; IMMOBILIZATION	Objective: Current medical practice for the treatment of articular cartilage lesions remains a clinical challenge due to the limited self-repair ability of articular cartilage. Both experimental and clinical researches show that moderate exercise can improve articular cartilage repair process. However, optimal timing of moderate exercise is unclear. We aimed to evaluate the effect of timing of moderate treadmill exercise on repair of full-thickness defects of articular cartilage. Design: Full-thickness cartilage defects were drilled in the patellar groove of bilateral femoral condyles in a total of 40 male SD rats before they were randomly assigned into four even groups. In sedentary control (SED) group, no exercise was given; in 2-week (2W), 4-week (4W) and 8-week groups, moderate treadmill exercise was initiated respectively two, four and eight weeks after operation. Half of the animals were sacrificed at week 10 after operation and half at week 14 after operation. Femoral condyles were harvested for gross observation and histochemical measurement by O'Driscoll scoring system. Collagen type II was detected by immunohistochemistry and mRNA expressions of aggrecan and collagen type II cartilage by RT-PCR. Results: Both 10 and 14 weeks post-operation, the best results were observed in 4W group and the worst results appeared in 2W group. The histochemistry scores and the expressions of collagen type II and aggrecan were significantly higher in 4W group than that in other three groups (P<0.05). Conclusions: Moderate exercise at a selected timing (approximately 4 weeks) after injury can significantly promote the healing of cartilage defects but may hamper the repair process if performed too early while delayed intervention by moderate exercise may reduce its benefits in repair of the defects.	[Song, Jin-qi; Li, Xue; Xu, Chang-peng; Cui, Zhuang; Jiang, Nan; Jia, Jun-jie; Yu, Bin] Southern Med Univ, Nanfang Hosp, Dept Orthopaed & Traumatol, Guangzhou, Guangdong, Peoples R China; [Dong, Fu] Beihai Peoples Hosp Guangxi Prov, Dept Orthopaed, Bei Hai, Guangxi Provinc, Peoples R China; [Yu, Bin] Southern Med Univ, Nanfang Hosp, Key Lab Bone & Cartilage Regenerat Med Guangdong, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Yu, B (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Orthopaed & Traumatol, Guangzhou, Guangdong, Peoples R China.	orthop@sohu.com	Jiang, Nan/AAD-9841-2019	Jiang, Nan/0000-0003-2416-1653	Production, Academy and Research Foundation of Guangdong Province [2011B090400016]	Production, Academy and Research Foundation of Guangdong Province	This study was financially supported by Production, Academy and Research Foundation of Guangdong Province (2011B090400016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albro MB, 2008, J BIOMECH, V41, P3152, DOI 10.1016/j.jbiomech.2008.08.023; BEDFORD TG, 1979, J APPL PHYSIOL, V47, P1278, DOI 10.1152/jappl.1979.47.6.1278; Carver SE, 1999, BIOTECHNOL BIOENG, V62, P166, DOI 10.1002/(SICI)1097-0290(19990120)62:2<166::AID-BIT6>3.3.CO;2-B; Chahine NO, 2009, BIOPHYS J, V97, P968, DOI 10.1016/j.bpj.2009.05.047; Chang NJ, 2012, BIOMATERIALS, V33, P3153, DOI 10.1016/j.biomaterials.2011.12.054; Dausse Y, 2003, OSTEOARTHR CARTILAGE, V11, P16, DOI 10.1053/joca.2002.0859; DUDEK BC, 1983, J COMP PSYCHOL, V97, P249, DOI 10.1037/0735-7036.97.3.249; Elsaid KA, 2012, OSTEOARTHR CARTILAGE, V20, P940, DOI 10.1016/j.joca.2012.04.021; Espanha MM, 2001, CONNECT TISSUE RES, V42, P97, DOI 10.3109/03008200109014252; Fransen M, 2003, COCHRANE DB SYST REV, V3, pD4286; FRENCH DA, 1989, VET SURG, V18, P312, DOI 10.1111/j.1532-950X.1989.tb01091.x; Galois L, 2004, OSTEOARTHR CARTILAGE, V12, P779, DOI 10.1016/j.joca.2004.06.008; Haapala J, 2000, INT J SPORTS MED, V21, P76; Haller JM, 2013, ORTHOP CLIN N AM, V44, P509, DOI 10.1016/j.ocl.2013.06.005; Huang AH, 2010, EUR CELLS MATER, V19, P72, DOI 10.22203/eCM.v019a08; HURTIG MB, 1988, CAN J VET RES, V52, P137; Kim W, 2012, AM J VET RES, V73, P498, DOI 10.2460/ajvr.73.4.498; Kim W, 2009, AM J VET RES, V70, P589, DOI 10.2460/ajvr.70.5.589; KINCAID SA, 1982, AM J VET RES, V43, P1218; KIVIRANTA I, 1988, J ORTHOPAED RES, V6, P188, DOI 10.1002/jor.1100060205; KREDER HJ, 1994, CLIN ORTHOP RELAT R, P288; Laforgia J, 2006, J SPORT SCI, V24, P1247, DOI 10.1080/02640410600552064; Lammi PE, 2001, HISTOCHEM CELL BIOL, V115, P301; Lee YJ, 2011, RHEUMATOL INT, V31, P1571, DOI 10.1007/s00296-010-1520-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANKIN HJ, 1974, NEW ENGL J MED, V291, P1285, DOI 10.1056/NEJM197412122912406; Moffat PA, 2008, EQUINE VET J, V40, P136, DOI 10.2746/042516408X253109; MORAN ME, 1992, J BONE JOINT SURG BR, V74, P659, DOI 10.1302/0301-620X.74B5.1527109; Ni GX, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4101; Ni GX, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3521; Nugent GE, 2004, OSTEOARTHR CARTILAGE, V12, P826, DOI 10.1016/j.joca.2004.07.001; O'Conor Christopher J, 2013, Stem Cell Res Ther, V4, P61, DOI 10.1186/scrt211; ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; PALMOSKI MJ, 1980, ARTHRITIS RHEUM, V23, P325, DOI 10.1002/art.1780230310; Reinold MM, 2006, J ORTHOP SPORT PHYS, V36, P774, DOI 10.2519/jospt.2006.2228; Roos EM, 2005, ARTHRITIS RHEUM-US, V52, P3507, DOI 10.1002/art.21415; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simon TM, 2006, SPORTS MED ARTHROSC, V14, P146, DOI 10.1097/00132585-200609000-00006; Soder S, 2011, PATHOLOGE, V32, P183, DOI 10.1007/s00292-011-1419-1; TODHUNTER RJ, 1993, J ORTHOPAED RES, V11, P782, DOI 10.1002/jor.1100110603; TROYER H, 1975, CLIN ORTHOP RELAT R, P249; van Weerew PR, 2008, EQUINE VET J, V40, P128, DOI 10.2746/042516408X253091; Vanwanseele B, 2002, OSTEOARTHR CARTILAGE, V10, P408, DOI 10.1053/joca.2002.0529; VIDEMAN T, 1981, BIOCHEM J, V200, P435, DOI 10.1042/bj2000435; VIDEMAN T, 1982, RHEUMATOL REHABIL, V21, P1, DOI 10.1093/rheumatology/21.1.1; Widuchowski W, 2008, ACTA CHIR ORTHOP TR, V75, P382; WILLIAMS JM, 1984, J ANAT, V139, P599; Zhuo Q, 2012, NAT REV RHEUMATOL, V8, P729, DOI 10.1038/nrrheum.2012.135	49	14	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90858	10.1371/journal.pone.0090858	http://dx.doi.org/10.1371/journal.pone.0090858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595327	Green Submitted, gold, Green Published			2022-12-25	WOS:000332468900153
J	Poore, KR; Hollis, LJ; Murray, RJS; Warlow, A; Brewin, A; Fulford, L; Cleal, JK; Lillycrop, KA; Burdge, GC; Hanson, MA; Green, LR				Poore, Kirsten R.; Hollis, Lisa J.; Murray, Robert J. S.; Warlow, Anna; Brewin, Andrew; Fulford, Laurence; Cleal, Jane K.; Lillycrop, Karen A.; Burdge, Graham C.; Hanson, Mark A.; Green, Lucy R.			Differential Pathways to Adult Metabolic Dysfunction following Poor Nutrition at Two Critical Developmental Periods in Sheep	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; INSULIN-RESISTANCE SYNDROME; PITUITARY-ADRENAL AXIS; MATERNAL UNDERNUTRITION; PRENATAL EXPOSURE; FETAL SHEEP; GLUCOSE-TOLERANCE; EARLY GESTATION; PERICONCEPTIONAL UNDERNUTRITION; POSTNATAL NUTRITION	Epidemiological and experimental studies suggest early nutrition has long-term effects on susceptibility to obesity, cardiovascular and metabolic diseases. Small and large animal models confirm the influence of different windows of sensitivity, from fetal to early postnatal life, on offspring phenotype. We showed previously that undernutrition in sheep either during the first month of gestation or immediately after weaning induces differential, sex-specific changes in adult metabolic and cardiovascular systems. The current study aims to determine metabolic and molecular changes that underlie differences in lipid and glucose metabolism induced by undernutrition during specific developmental periods in male and female sheep. Ewes received 100% (C) or 50% nutritional requirements (U) from 1-31 days gestation, and 100% thereafter. From weaning (12 weeks) to 25 weeks, offspring were then fed either ad libitum (CC, UC) or were undernourished (CU, UU) to reduce body weight to 85% of their individual target. From 25 weeks, all offspring were fed ad libitum. A cohort of late gestation fetuses were studied after receiving either 40% nutritional requirements (1-31 days gestation) or 50% nutritional requirements (104-127 days gestation). Post-weaning undernutrition increased in vivo insulin sensitivity, insulin receptor and glucose transporter 4 expression in muscle, and lowered hepatic methylation at the delta-like homolog 1/maternally expressed gene 3 imprinted cluster in adult females, but not males. Early gestational undernutrition induced lower hepatic expression of gluconeogenic factors in fetuses and reduced in vivo adipose tissue insulin sensitivity in adulthood. In males, undernutrition in early gestation increased adipose tissue lipid handling mechanisms (lipoprotein lipase, glucocorticoid receptor expression) and hepatic methylation within the imprinted control region of insulin-like growth factor 2 receptor in adulthood. Therefore, undernutrition during development induces changes in mechanisms of lipid and glucose metabolism which differ between tissues and sexes dependent on the period of nutritional restriction. Such changes may increase later life obesity and dyslipidaemia risk.	[Poore, Kirsten R.; Hollis, Lisa J.; Murray, Robert J. S.; Warlow, Anna; Brewin, Andrew; Fulford, Laurence; Cleal, Jane K.; Lillycrop, Karen A.; Burdge, Graham C.; Hanson, Mark A.; Green, Lucy R.] Univ Southampton, Fac Med, Acad Unit Human Dev & Hlth, Southampton SO9 5NH, Hants, England	University of Southampton	Poore, KR (corresponding author), Univ Southampton, Fac Med, Acad Unit Human Dev & Hlth, Southampton SO9 5NH, Hants, England.	kpoore@soton.ac.uk	Cleal, Jane/AAC-5062-2019; Hanson, Mark/AAE-8236-2019; Poore, Kirsten R/H-3949-2011; Cleal, Jane/AAC-9070-2019; Burdge, Graham/A-2370-2014	Cleal, Jane/0000-0001-7978-4327; Hanson, Mark/0000-0002-6907-613X; Poore, Kirsten R/0000-0002-1455-0615; Burdge, Graham/0000-0002-7665-2967; Lillycrop, Karen/0000-0001-7350-5489; Green, Lucy/0000-0001-7423-9696	Wessex Medical Research Innovation Fund [M13]; Biotechnology and Biosciences project grant [D17858]; Gerald Kerkut Trust; British Heart Foundation; Biotechnology and Biological Sciences Research Council [D17858] Funding Source: researchfish	Wessex Medical Research Innovation Fund; Biotechnology and Biosciences project grant; Gerald Kerkut Trust; British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wessex Medical Research Innovation Fund (M13) (www.wesmed.org.uk), a Biotechnology and Biosciences project grant (D17858) (http://www.bbsrc.ac.uk) and a Gerald Kerkut Trust PhD Studentship (http://www.southampton.ac.uk/similar to gktrust/). Professor Mark Hanson is funded by British Heart Foundation (http://www.bhf.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFRC (Agricultural and Food Research Council), 1993, EN PROT REQ RUM ADV, P100; Allender S, 2007, OBES REV, V8, P467, DOI 10.1111/j.1467-789X.2007.00394.x; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Bavdekar A, 1999, DIABETES, V48, P2422, DOI 10.2337/diabetes.48.12.2422; Brameld JM, 2000, J ENDOCRINOL, V167, P429, DOI 10.1677/joe.0.1670429; Brown J, 2009, TRENDS BIOCHEM SCI, V34, P612, DOI 10.1016/j.tibs.2009.07.003; Burdge GC, 2000, BRIT J NUTR, V84, P781; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Burrage DM, 2009, J PHYSIOL-LONDON, V587, P611, DOI 10.1113/jphysiol.2008.165944; Cleal JK, 2007, PEDIATR RES, V62, P422, DOI 10.1203/PDR.0b013e31813cbe60; Cleal JK, 2007, P NATL ACAD SCI USA, V104, P9529, DOI 10.1073/pnas.0610373104; Costello PM, 2008, J PHYSIOL-LONDON, V586, P2371, DOI 10.1113/jphysiol.2008.150987; Cottrell EC, 2008, PHYSIOL BEHAV, V94, P17, DOI 10.1016/j.physbeh.2007.11.017; Crowther NJ, 1998, DIABETOLOGIA, V41, P1163, DOI 10.1007/s001250051046; Darp RA, 2010, REPROD FERT DEVELOP, V22, P1188, DOI 10.1071/RD09292; Drake AJ, 2012, CLIN ENDOCRINOL, V77, P808, DOI 10.1111/j.1365-2265.2012.04453.x; Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662; Eriksson JG, 2002, DIABETOLOGIA, V45, P342, DOI 10.1007/s00125-001-0757-6; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gardner DS, 2005, AM J PHYSIOL-REG I, V289, pR947, DOI 10.1152/ajpregu.00120.2005; George LA, 2012, AM J PHYSIOL-REG I, V302, pR795, DOI 10.1152/ajpregu.00241.2011; Godfrey KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041759; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Gonzalez-Barranco J, 2003, METABOLISM, V52, P1005, DOI 10.1016/S0026-0495(03)00151-3; Haugen G, 2005, CIRC RES, V96, P12, DOI 10.1161/01.RES.0000152391.45273.A2; Hawkins P, 2000, EXP PHYSIOL, V85, P85, DOI 10.1111/j.1469-445X.2000.01914.x; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Lan Xianyong, 2013, Frontiers in Genetics, V4, P49, DOI 10.3389/fgene.2013.00049; LAW CM, 1992, J EPIDEMIOL COMMUN H, V46, P184, DOI 10.1136/jech.46.3.184; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Limesand SW, 2007, AM J PHYSIOL-ENDOC M, V293, pE1716, DOI 10.1152/ajpendo.00459.2007; MacLaughlin SM, 2005, J PHYSIOL-LONDON, V565, P111, DOI 10.1113/jphysiol.2005.084996; Mericq V, 2005, DIABETOLOGIA, V48, P2609, DOI 10.1007/s00125-005-0036-z; Micke GC, 2011, MOL CELL ENDOCRINOL, V332, P234, DOI 10.1016/j.mce.2010.10.018; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Morris TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007271; O'Connell J, 2011, J CLIN ENDOCR METAB, V96, pE680, DOI 10.1210/jc.2010-2026; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V271, pE1128, DOI 10.1152/ajpendo.1996.271.6.E1128; Ozanne SE, 1997, AM J PHYSIOL-ENDOC M, V273, pE46, DOI 10.1152/ajpendo.1997.273.1.E46; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V270, pE559, DOI 10.1152/ajpendo.1996.270.4.E559; PEDERSEN JF, 1980, BRIT MED J, V281, P1253, DOI 10.1136/bmj.281.6250.1253; Petry CJ, 2001, MOL CELL ENDOCRINOL, V185, P81, DOI 10.1016/S0303-7207(01)00627-X; PHILLIPS DIW, 1994, DIABETOLOGIA, V37, P150, DOI 10.1007/s001250050086; Poore KR, 2010, J PHYSIOL-LONDON, V588, P2219, DOI 10.1113/jphysiol.2010.187682; Poore KR, 2007, AM J PHYSIOL-ENDOC M, V292, P32; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Rosa AL, 2005, CHROMOSOME RES, V13, P809, DOI 10.1007/s10577-005-1015-4; Roseboom TJ, 2000, HEART, V84, P595, DOI 10.1136/heart.84.6.595; Roseboom TJ, 2000, AM J CLIN NUTR, V72, P1101; Rumball CWH, 2008, J PHYSIOL-LONDON, V586, P1399, DOI 10.1113/jphysiol.2007.144071; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; Spencer SJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00109; Tchirikov M, 2002, PLACENTA, V23, pS153, DOI 10.1053/plac.2002.0810; Thurston A, 2008, REPRODUCTION, V135, P29, DOI 10.1530/REP-07-0211; Waddell JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015055; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wiedmeier JE, 2011, NUTR REV, V69, P76, DOI 10.1111/j.1753-4887.2010.00370.x; Wylie AA, 2000, GENOME RES, V10, P1711, DOI 10.1101/gr.161600; Young LE, 2003, MECH DEVELOP, V120, P1433, DOI 10.1016/j.mod.2003.09.006; Zhang S, 2010, FASEB J, V24, P2772, DOI 10.1096/fj.09-154294	65	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90994	10.1371/journal.pone.0090994	http://dx.doi.org/10.1371/journal.pone.0090994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603546	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600120
J	Shukla, S; Bafna, K; Sundar, D; Thorat, SS				Shukla, Shantanu; Bafna, Khushboo; Sundar, Durai; Thorat, Sunil S.			The Bitter Barricading of Prostaglandin Biosynthesis Pathway: Understanding the Molecular Mechanism of Selective Cyclooxygenase-2 Inhibition by Amarogentin, a Secoiridoid Glycoside from Swertia chirayita	PLOS ONE			English	Article							SKIN CARCINOGENESIS MODEL; ASPIRIN-LIKE DRUGS; NF-KAPPA-B; ANTIHEPATOTOXIC ACTIVITY; INDUCED HEPATOTOXICITY; BINDING AFFINITIES; HIGH-THROUGHPUT; DOWN-REGULATION; LIGAND-BINDING; SOLVENT MODELS	Swertia chirayita, a medicinal herb inhabiting the challenging terrains and high altitudes of the Himalayas, is a rich source of essential phytochemical isolates. Amarogentin, a bitter secoiridoid glycoside from S. chirayita, shows varied activity in several patho-physiological conditions, predominantly in leishmaniasis and carcinogenesis. Experimental analysis has revealed that amarogentin downregulates the cyclooxygenase-2 (COX-2) activity and helps to curtail skin carcinogenesis in mouse models; however, there exists no account on selective inhibition of the inducible cyclooxygenase (COX) isoform by amarogentin. Hence the computer-aided drug discovery methods were used to unravel the COX-2 inhibitory mechanism of amarogentin and to check its selectivity for the inducible isoform over the constitutive one. The generated theoretical models of both isoforms were subjected to molecular docking analysis with amarogentin and twenty-one other Food and Drug Authority (FDA) approved lead molecules. The post-docking binding energy profile of amarogentin was comparable to the binding energy profiles of the FDA approved selective COX-2 inhibitors. Subsequent molecular dynamics simulation analysis delineated the difference in the stability of both complexes, with amarogentin-COX-2 complex being more stable after 40ns simulation. The total binding free energy calculated by MMGBSA for the amarogentin-COX-2 complex was - 52.35 KCal/mol against a binding free energy of -8.57 KCal/mol for amarogentin-COX-1 complex, suggesting a possible selective inhibition of the COX-2 protein by the natural inhibitor. Amarogentin achieves this potential selectivity by small, yet significant, structural differences inherent to the binding cavities of the two isoforms. Hypothetically, it might block the entry of the natural substrates in the hydrophobic binding channel of the COX-2, inhibiting the cyclooxygenation step. To sum up briefly, this work highlights the mechanism of the possible selective COX-2 inhibition by amarogentin and endorses the possibility of obtaining efficient, futuristic and targeted therapeutic agents for relieving inflammation and malignancy from this phytochemical source.	[Shukla, Shantanu; Thorat, Sunil S.] Reg Ctr Inst Bioresources & Sustainable Dev, Bioresource Database & Bioinformat Div, Tadong, Gangtok, India; [Bafna, Khushboo; Sundar, Durai] Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India; [Thorat, Sunil S.] Inst Bioresources & Sustainable Dev, Distributed Informat Sub Ctr, Imphal, Manipur, India	Department of Biotechnology (DBT) India; Institute of Bioresources & Sustainable Development (IBSD); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Department of Biotechnology (DBT) India; Institute of Bioresources & Sustainable Development (IBSD)	Sundar, D (corresponding author), Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India.	sundar@dbeb.iitd.ac.in; sunilsthorat.ibsd@nic.in	Sundar, Durai/F-7671-2012	Shukla, Shantanu/0000-0002-5473-0207; Sundar, Durai/0000-0002-6549-6663; Bafna, Khushboo/0000-0002-1893-1175	Department of Biotechnology, Government of India [102/IFD/SAN/3287/2005-2006]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The project was funded by the Department of Biotechnology, Government of India grant to Sub-Distributed Information Centre, IBSD, Imphal, SAN No. 102/IFD/SAN/3287/2005-2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeniyi AA, 2013, MOLECULES, V18, P3760, DOI 10.3390/molecules18043760; Alonso H, 2006, MED RES REV, V26, P531, DOI 10.1002/med.20067; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; Behrens M, 2009, J AGR FOOD CHEM, V57, P9860, DOI 10.1021/jf9014334; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Brahmachari G, 2004, CHEM BIODIVERS, V1, P1627, DOI 10.1002/cbdv.200490123; Calixto JB, 2003, PLANTA MED, V69, P973, DOI [10.1055/s-2003-45141, 10.1055/s-2004-815483]; Campanera JM, 2010, MOLECULES, V15, P2730, DOI 10.3390/molecules15042730; Cao Y, 2002, J CELL PHYSIOL, V190, P279, DOI 10.1002/jcp.10068; Chandrasekharan NV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-241; Claria J, 2003, CURR PHARM DESIGN, V9, P2177, DOI 10.2174/1381612033454054; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Corley DA, 2003, GASTROENTEROLOGY, V124, P47, DOI 10.1053/gast.2003.50008; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dirsch VM, 2001, BIOCHEM PHARMACOL, V61, P587, DOI 10.1016/S0006-2952(00)00580-3; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; FERREIRA SH, 1971, NATURE-NEW BIOL, V231, P237, DOI 10.1038/newbio231237a0; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Karan M, 1999, PHYTOTHER RES, V13, P24, DOI 10.1002/(SICI)1099-1573(199902)13:1&lt;24::AID-PTR378&gt;3.0.CO;2-L; Karan M, 1999, PHYTOTHER RES, V13, P95, DOI 10.1002/(SICI)1099-1573(199903)13:2&lt;95::AID-PTR379&gt;3.0.CO;2-4; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kimura A, 2000, PROSTAG LEUKOTR ESS, V63, P315, DOI 10.1054/plef.2000.0220; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuhn B, 2000, J MED CHEM, V43, P3786, DOI 10.1021/jm000241h; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Kurumbail RG, 2001, CURR OPIN STRUC BIOL, V11, P752, DOI 10.1016/S0959-440X(01)00277-9; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Mahdi JG, 2006, CELL PROLIFERAT, V39, P147, DOI 10.1111/j.1365-2184.2006.00377.x; Mahmud S, 2004, BRIT J CANCER, V90, P93, DOI 10.1038/sj.bjc.6601416; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Medda S, 1999, J ANTIMICROB CHEMOTH, V44, P791, DOI 10.1093/jac/44.6.791; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mouihate A, 2002, AM J PHYSIOL-REG I, V283, pR800, DOI 10.1152/ajpregu.00258.2002; Pal D, 2012, CARCINOGENESIS, V33, P2424, DOI 10.1093/carcin/bgs276; Pence HE, 2010, J CHEM EDUC, V87, P1123, DOI 10.1021/ed100697w; Phoboo S, 2013, PHYTOTHER RES, V27, P227, DOI 10.1002/ptr.4714; Price MLP, 2000, J AM CHEM SOC, V122, P9455, DOI 10.1021/ja001018c; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ray S, 1996, J NAT PROD, V59, P27, DOI 10.1021/np960018g; Riendeau D, 2001, J PHARMACOL EXP THER, V296, P558; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015; Saha P, 2004, PHYTOTHER RES, V18, P373, DOI 10.1002/ptr.1436; Saha P, 2006, CANCER LETT, V244, P252, DOI 10.1016/j.canlet.2005.12.036; Saklani A, 2008, DRUG DISCOV TODAY, V13, P161, DOI 10.1016/j.drudis.2007.10.010; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sheng HM, 1998, J BIOL CHEM, V273, P22120, DOI 10.1074/jbc.273.34.22120; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; SMITH JB, 1971, NATURE-NEW BIOL, V231, P235, DOI 10.1038/newbio231235a0; Subbaramaiah K, 2003, TRENDS PHARMACOL SCI, V24, P96, DOI 10.1016/S0165-6147(02)00043-3; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Turini ME, 2002, ANNU REV MED, V53, P35, DOI 10.1146/annurev.med.53.082901.103952; VANE JR, 1978, AGENTS ACTIONS, V8, P430, DOI 10.1007/BF01968671; Vane JR, 2003, THROMB RES, V110, P255, DOI 10.1016/S0049-3848(03)00379-7; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang WH, 2003, JNCI-J NATL CANCER I, V95, P1784, DOI 10.1093/jnci/djg106; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; Zimmermann KC, 1998, MOL PHARMACOL, V54, P536, DOI 10.1124/mol.54.3.536	67	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90637	10.1371/journal.pone.0090637	http://dx.doi.org/10.1371/journal.pone.0090637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603686	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600069
J	Fulop, A; Szijarto, A; Harsanyi, L; Budai, A; Pekli, D; Korsos, D; Horvath, I; Kovacs, N; Karlinger, K; Mathe, D; Szigeti, K				Fueloep, Andras; Szijarto, Attila; Harsanyi, Laszlo; Budai, Andras; Pekli, Damjan; Korsos, Diana; Horvath, Ildiko; Kovacs, Noemi; Karlinger, Kinga; Mathe, Domokos; Szigeti, Krisztian			Demonstration of Metabolic and Cellular Effects of Portal Vein Ligation Using Multi-Modal PET/MRI Measurements in Healthy Rat Liver	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; BRANCH LIGATION; HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; GLUCOSE-UTILIZATION; TISSUE; EMBOLIZATION; REGENERATION; F-18-FDG; GROWTH	Objectives: In the early recognition of portal vein ligation (PVL) induced tumor progression, positron emission tomography and magnetic resonance imaging (PET/MRI) could improve diagnostic accuracy of conventionally used methods. It is unknown how PVL affects metabolic patterns of tumor free hepatic tissues. The aim of this preliminary study is to evaluate the effect of PVL on glucose metabolism, using PET/MRI imaging in healthy rat liver. Materials and Methods: Male Wistar rats (n = 30) underwent PVL. 2/deoxy-2-(F-18)fluoro-D-glucose (FDG) PET/MRI imaging (nanoScan PET/MRI) and morphological/histological examination were performed before (Day 0) and 1, 2, 3, and 7 days after PVL. Dynamic PET data were collected and the standardized uptake values (SUV) for ligated and non-ligated liver lobes were calculated in relation to cardiac left ventricle (SUVVOI/SUVCLV) and mean liver SUV (SUVVOI/SUVLiver). Results: PVL induced atrophy of ligated lobes, while non-ligated liver tissue showed compensatory hypertrophy. Dynamic PET scan revealed altered FDG kinetics in both ligated and non-ligated liver lobes. SUVVOI/SUVCLV significantly increased in both groups of lobes, with a maximal value at the 2nd postoperative day and returned near to the baseline 7 days after the ligation. After PVL, ligated liver lobes showed significantly higher tracer uptake compared to the non-ligated lobes (significantly higher SUVVOI/SUVLiver values were observed at postoperative day 1, 2 and 3). The homogenous tracer biodistribution observed before PVL reappeared by 7th postoperative day. Conclusion: The observed alterations in FDG uptake dynamics should be taken into account during the assessment of PET data until the PVL induced atrophic and regenerative processes are completed.	[Fueloep, Andras; Szijarto, Attila; Harsanyi, Laszlo; Budai, Andras; Pekli, Damjan; Korsos, Diana] Semmelweis Univ, Dept Surg 1, H-1085 Budapest, Hungary; [Horvath, Ildiko; Szigeti, Krisztian] Semmelweis Univ, Dept Biophys & Radiat Biol, H-1085 Budapest, Hungary; [Kovacs, Noemi; Mathe, Domokos] CROmed Translat Res Ctr, Budapest, Hungary; [Karlinger, Kinga] Semmelweis Univ, Dept Radiol & Oncotherapy, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University; Semmelweis University	Fulop, A (corresponding author), Semmelweis Univ, Dept Surg 1, H-1085 Budapest, Hungary.	fulop.andras2@gmail.com		Mathe, Domokos/0000-0001-7343-0413	European Union [HEALTH-F2-2011-278850]; European Community FP7 Transnational Access grant QNANO	European Union(European Commission); European Community FP7 Transnational Access grant QNANO	The work leading to this invention has received funding from the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement nu HEALTH-F2-2011-278850 (INMiND). This study was supported in part by the European Community FP7 Transnational Access grant QNANO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other current funding sources were involved in this study.	Abdalla EK, 2002, ARCH SURG-CHICAGO, V137, P675, DOI 10.1001/archsurg.137.6.675; Abdalla EK, 2001, BRIT J SURG, V88, P165, DOI 10.1046/j.1365-2168.2001.01658.x; Abouzied MM, 2005, J NUCL MED TECHNOL, V33, P145; Alexander B, 2002, PFLUG ARCH EUR J PHY, V444, P291, DOI 10.1007/s00424-002-0815-z; Antoch G, 2005, J NUCL MED, V46, P520; Barbaro B, 2003, ACTA RADIOL, V44, P98, DOI 10.1034/j.1600-0455.2003.00016.x; BENGMARK S, 1988, ANN SURG, V207, P120, DOI 10.1097/00000658-198802000-00002; Bennink RJ, 2004, J NUCL MED, V45, P965; BRINKMANN A, 1978, H-S Z PHYSIOL CHEM, V359, P1561, DOI 10.1515/bchm2.1978.359.2.1561; Broering DC, 2002, J GASTROINTEST SURG, V6, P905, DOI 10.1016/S1091-255X(02)00122-1; Caraco C, 2000, J BIOL CHEM, V275, P18489, DOI 10.1074/jbc.M908096199; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; de Graaf W, 2011, BRIT J SURG, V98, P825, DOI 10.1002/bjs.7456; de Graaf W, 2009, ANN SURG ONCOL, V16, P423, DOI 10.1245/s10434-008-0222-6; Elias D, 1999, BRIT J SURG, V86, P784, DOI 10.1046/j.1365-2168.1999.01154.x; Gock M, 2011, MICROVASC RES, V81, P274, DOI 10.1016/j.mvr.2011.03.005; Hahn Oszkar, 2013, Magy Seb, V66, P21, DOI 10.1556/MaSeb.66.2013.1.3; Hammerstingl R, 2008, EUR RADIOL, V18, P457, DOI 10.1007/s00330-007-0716-9; Heinrich S, 2006, J HEPATOL, V45, P35, DOI 10.1016/j.jhep.2006.02.020; Ho CL, 2003, J NUCL MED, V44, P213; Hsiao IT, 2010, J HEPATOL, V52, P540, DOI 10.1016/j.jhep.2010.01.005; IKEDA K, 1995, ARCH HISTOL CYTOL, V58, P171, DOI 10.1679/aohc.58.171; Juweid ME, 2006, NEW ENGL J MED, V354, P496, DOI 10.1056/NEJMra050276; KAWASAKI S, 1994, SURGERY, V115, P674; Kokudo N, 2001, HEPATOLOGY, V34, P267, DOI 10.1053/jhep.2001.26513; KUBOTA K, 1991, J NUCL MED, V32, P2118; Mueller L, 2003, J SURG RES, V114, P146, DOI 10.1016/S0022-4804(03)00252-X; Pauwels EKJ, 1998, NUCL MED BIOL, V25, P317, DOI 10.1016/S0969-8051(97)00226-6; Pauwels EKJ, 2000, J CANCER RES CLIN, V126, P549, DOI 10.1007/PL00008465; Rocheleau B, 1999, AM J PHYSIOL-GASTR L, V277, pG1000, DOI 10.1152/ajpgi.1999.277.5.G1000; Rosa JL, 1997, HEPATOLOGY, V25, P324; ROZGA J, 1986, AM J PATHOL, V125, P300; Song SL, 2013, J NUCL MED, V54, P104, DOI 10.2967/jnumed.112.109397; Stewart EE, 2006, RADIOLOGY, V239, P740, DOI 10.1148/radiol.2393041382; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Takayama T, 2011, JPN J CLIN ONCOL, V41, P447, DOI 10.1093/jjco/hyr016; Takei T, 2005, J NUCL MED, V46, P794; Vogt FM, 2007, J NUCL MED, V48, P1836, DOI 10.2967/jnumed.107.042846; Willatt JM, 2008, RADIOLOGY, V247, P311, DOI 10.1148/radiol.2472061331; Zakko WF, 1998, AM J PHYSIOL-GASTR L, V275, pG717, DOI 10.1152/ajpgi.1998.275.4.G717	40	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90760	10.1371/journal.pone.0090760	http://dx.doi.org/10.1371/journal.pone.0090760			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599299	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400131
J	Selva, N; Berezowska-Cnota, T; Elguero-Claramunt, I				Selva, Nuria; Berezowska-Cnota, Teresa; Elguero-Claramunt, Isabel			Unforeseen Effects of Supplementary Feeding: Ungulate Baiting Sites as Hotspots for Ground-Nest Predation	PLOS ONE			English	Article							BOAR SUS-SCROFA; FOOD SUPPLEMENTATION; BREEDING SUCCESS; RED DEER; CONSERVATION; TOOL; CAPERCAILLIE; PRODUCTIVITY; POPULATION; CARCASSES	Despite the ubiquity and magnitude of food provision to wildlife, our understanding of its ecological effects and conservation implications is very limited. Supplementary feeding of ungulates, still one of the main paradigms of game management in Europe, occurs in natural areas on an enormous scale. We investigated the indirect effects of this practice on nest predation risk in the Polish Eastern Carpathians (Bieszczady Mountains). We hypothesized that the predators attracted to ungulate baiting sites would also forage for alternative prey nearby, increasing the nest predation risk for ground-nesting birds in the vicinity. We conducted a paired experiment by placing artificial nests (N = 120) in feeding and control sites (N = 12) at different distances from the ungulate feeding site. We also documented the use of three ungulate feeding sites by potential nest predators with automatic cameras. The proportion of depredated nests was 30% higher in the vicinity of feeding sites than at control sites (65%+/- 31.5 vs 35%+/- 32.1). The probability of a nest being depredated significantly increased with time and at shorter distances from the feeding site. We predicted that the area within 1-km distance from the feeding site would have a high risk (> 0.5) of nest predation. We recorded 13 species of potential ground-nest predators at ungulate baiting sites. Most frequent were Eurasian jays Garrulus glandarius, mice and voles Muroidea, ravens Corvus corax, brown bears Ursus arctos, and wild boar Sus scrofa. Nest predators made most use of supplementary feeding sites (82% pictures with predators vs 8% with ungulates, the target group). Our study alerts of the impacts of ungulate feeding on alternative prey; this is of special concern when affecting protected species. We urge for a sensible management of ungulate feeding, which considers potential indirect effects on other species and the spatial and temporal components of food provision.	[Selva, Nuria; Berezowska-Cnota, Teresa; Elguero-Claramunt, Isabel] Polish Acad Sci, Inst Nat Conservat, Krakow, Poland	Polish Academy of Sciences	Selva, N (corresponding author), Polish Acad Sci, Inst Nat Conservat, Krakow, Poland.	nuriselva@gmail.com	Selva, Nuria/J-6970-2013	Selva, Nuria/0000-0003-3389-201X; Berezowska-Cnota, Teresa/0000-0002-2566-6672	Polish Ministry of Science and Higher Education [NN304294037]; Institute of Nature Conservation PAS	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Institute of Nature Conservation PAS	This study was supported by the Polish Ministry of Science and Higher Education (project NN304294037) and by the budget of the Institute of Nature Conservation PAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apollonio M., 2010, EUROPEAN UNGULATES T; Barrios-Garcia MN, 2012, BIOL INVASIONS, V14, P2283, DOI 10.1007/s10530-012-0229-6; Bartos Ludek, 2010, P243; Bates D., 2013, LME4 LINEAR MIXED EF; Bonczar Z, 2007, ATLAS ROZMIESZCZENIA, P88; Borgmann KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065909; Brown RD, 2006, WILDLIFE SOC B, V34, P519, DOI 10.2193/0091-7648(2006)34[519:TNEAEA]2.0.CO;2; Brunnschweiler JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058522; Clout MN, 2002, BIOL CONSERV, V107, P13, DOI 10.1016/S0006-3207(01)00267-1; Cooper SM, 2000, WILDLIFE SOC B, V28, P660; Corcoran MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059235; Cortes-Avizanda A, 2009, ANIM CONSERV, V12, P85, DOI 10.1111/j.1469-1795.2008.00231.x; Cortes-Avizanda A, 2009, BASIC APPL ECOL, V10, P265, DOI 10.1016/j.baae.2008.03.009; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Darveau M, 1997, ECOL APPL, V7, P572, DOI 10.1890/1051-0761(1997)007[0572:FPATRO]2.0.CO;2; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Dunkley L., 2003, COMPREHENSIVE REV EC; Geisser H, 2005, J ZOOL, V267, P89, DOI 10.1017/S095283690500734X; Hamilton AM, 2002, AM MIDL NAT, V147, P123, DOI 10.1674/0003-0031(2002)147[0123:EODFHA]2.0.CO;2; Harrison TJE, 2010, OECOLOGIA, V164, P311, DOI 10.1007/s00442-010-1645-x; Hulme Philip E., 2007, V25, P56; Inslerman R.A., 2006, WILDLIFE SOC TECHNIC, V06-1; Jerina K, 2012, J MAMMAL, V93, P1139, DOI 10.1644/11-MAMM-A-136.1; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; Lambert BC, 2001, SOUTHWEST NAT, V46, P118, DOI 10.2307/3672387; Lopez-Bao JV, 2008, BIOL CONSERV, V141, P1857, DOI 10.1016/j.biocon.2008.05.002; Mandema FS, 2013, J COAST CONSERV, V17, P409, DOI 10.1007/s11852-013-0239-2; Margalida A, 2010, EUR J WILDLIFE RES, V56, P673, DOI 10.1007/s10344-010-0366-0; Gonzalez L, 2006, BIOL CONSERV, V129, P477, DOI 10.1016/j.biocon.2005.11.014; MARTIN TE, 1993, AM NAT, V141, P897, DOI 10.1086/285515; Martinson TJ, 2003, WILDLIFE SOC B, V31, P510; Marzec B, 2012, LOWIEC POLSKI, V10, P14; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; Miller R, 2003, J WILDLIFE DIS, V39, P84, DOI 10.7589/0090-3558-39.1.84; Moore RP, 2004, ECOLOGY, V85, P1562, DOI 10.1890/03-0088; Newey S, 2010, J ZOOL, V282, P214, DOI 10.1111/j.1469-7998.2010.00728.x; Newton I., 1998, POPULATION LIMITATIO; Orams MB, 2002, TOURISM MANAGE, V23, P281, DOI 10.1016/S0261-5177(01)00080-2; Orros ME, 2012, BASIC APPL ECOL, V13, P286, DOI 10.1016/j.baae.2012.03.001; Pedersen AO, 2009, EUR J WILDLIFE RES, V55, P371, DOI 10.1007/s10344-009-0253-8; Piper SE, 2005, P INT C CONS MAN VUL, P41; Plummer KE, 2013, SCI REP-UK, V3, DOI 10.1038/srep02002; Putman RJ, 2004, MAMMAL REV, V34, P285, DOI 10.1111/j.1365-2907.2004.00044.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Roodbergen M, 2012, J ORNITHOL, V153, P53, DOI 10.1007/s10336-011-0733-y; Saniga M, 2002, FOLIA ZOOL, V51, P205; Schoech SJ, 2008, BIOL CONSERV, V141, P162, DOI 10.1016/j.biocon.2007.09.009; Seibold S, 2013, BASIC APPL ECOL, V14, P687, DOI 10.1016/j.baae.2013.09.003; Selva N., 2009, VULTURES FEEDING STA, P452; Sikora A., 2007, ATLAS ROZMIESZCZENIA; Sorensen A, 2013, PREV VET ME IN PRESS; Storch I, 2007, WILDLIFE BIOL, V13, P5, DOI 10.2981/0909-6396(2007)13[5:CSOGWA]2.0.CO;2; Summers RW, 2004, J APPL ECOL, V41, P513, DOI 10.1111/j.0021-8901.2004.00891.x; SWENSON JE, 1994, J AVIAN BIOL, V25, P8, DOI 10.2307/3677289; UNEP, 2007, CARP ENV OUTL, P232; Walpole MJ, 2001, ANIM CONSERV, V4, P67, DOI 10.1017/S136794300100107X; Wawrzyniak Piotr, 2010, P223; Wilmers CC, 2003, ECOL LETT, V6, P996, DOI 10.1046/j.1461-0248.2003.00522.x; Winnicki T., 2009, NATURE BIESZCZADY NA; Zanette L, 2010, J ANIM ECOL, V79, P1172, DOI 10.1111/j.1365-2656.2010.01724.x	61	48	48	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90740	10.1371/journal.pone.0090740	http://dx.doi.org/10.1371/journal.pone.0090740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599216	gold, Green Submitted, Green Published			2022-12-25	WOS:000332479400128
J	Valdes, AL; Mc Laughlin, M; Viani, L; Walshe, P; Smith, J; Zeng, FG; Reilly, RB				Valdes, Alejandro Lopez; Mc Laughlin, Myles; Viani, Laura; Walshe, Peter; Smith, Jaclyn; Zeng, Fan-Gang; Reilly, Richard B.			Objective Assessment of Spectral Ripple Discrimination in Cochlear Implant Listeners Using Cortical Evoked Responses to an Oddball Paradigm	PLOS ONE			English	Article							MISMATCH NEGATIVITY; SPEECH RECOGNITION; NORMAL-HEARING; TRIPOLAR STIMULATION; CHILDREN; PERFORMANCE; POTENTIALS; MATURATION; RESOLUTION; ADULTS	Cochlear implants (CIs) can partially restore functional hearing in deaf individuals. However, multiple factors affect CI listener's speech perception, resulting in large performance differences. Non-speech based tests, such as spectral ripple discrimination, measure acoustic processing capabilities that are highly correlated with speech perception. Currently spectral ripple discrimination is measured using standard psychoacoustic methods, which require attentive listening and active response that can be difficult or even impossible in special patient populations. Here, a completely objective cortical evoked potential based method is developed and validated to assess spectral ripple discrimination in CI listeners. In 19 CI listeners, using an oddball paradigm, cortical evoked potential responses to standard and inverted spectrally rippled stimuli were measured. In the same subjects, psychoacoustic spectral ripple discrimination thresholds were also measured. A neural discrimination threshold was determined by systematically increasing the number of ripples per octave and determining the point at which there was no longer a significant difference between the evoked potential response to the standard and inverted stimuli. A correlation was found between the neural and the psychoacoustic discrimination thresholds (R-2 = 0.60, p < 0.01). This method can objectively assess CI spectral resolution performance, providing a potential tool for the evaluation and follow-up of CI listeners who have difficulty performing psychoacoustic tests, such as pediatric or new users.	[Valdes, Alejandro Lopez; Mc Laughlin, Myles; Reilly, Richard B.] Univ Dublin Trinity Coll, Trinity Ctr Bioengn, Dublin 2, Ireland; [Mc Laughlin, Myles; Zeng, Fan-Gang] Univ Calif Irvine, Hearing & Speech Lab, Irvine, CA USA; [Viani, Laura; Walshe, Peter; Smith, Jaclyn] Beaumont Hosp, Natl Cochlear Implant Programme, Dublin 9, Ireland	Trinity College Dublin; University of California System; University of California Irvine	Valdes, AL (corresponding author), Univ Dublin Trinity Coll, Trinity Ctr Bioengn, Dublin 2, Ireland.	lopezvaa@tcd.ie	Reilly, Richard/N-1080-2019; Reilly, Richard B/F-7034-2011; Mc Laughlin, Myles/G-3497-2015; Valdes, Alejandro Lopez/AAW-6341-2020	Reilly, Richard/0000-0001-8578-1245; Reilly, Richard B/0000-0001-8578-1245; Mc Laughlin, Myles/0000-0001-8574-1841; Valdes, Alejandro Lopez/0000-0002-5568-9808	Higher Education Authority (HEA) Graduate Research Education Program in Engineering (GREP-Eng) scholarship; EU FP7 Marie Curie International Outgoing Fellowship; National Institutes of Health; United States Department of Health and Human Services [P30 DC008369]	Higher Education Authority (HEA) Graduate Research Education Program in Engineering (GREP-Eng) scholarship; EU FP7 Marie Curie International Outgoing Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Health and Human Services	This work was supported by a Higher Education Authority (HEA) Graduate Research Education Program in Engineering (GREP-Eng) scholarship to Alejandro Lopez Valdes, an EU FP7 Marie Curie International Outgoing Fellowship to Myles Mc Laughlin and the National Institutes of Health, the United States Department of Health and Human Services (P30 DC008369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBAS PJ, 1988, HEARING RES, V36, P153, DOI 10.1016/0378-5955(88)90057-3; Blamey P, 1996, Audiol Neurootol, V1, P293; Brown CJ, 2008, EAR HEARING, V29, P704, DOI 10.1097/AUD.0b013e31817a98af; Brown CJ, 2000, EAR HEARING, V21, P151, DOI 10.1097/00003446-200004000-00009; BYRNE D, 1994, J ACOUST SOC AM, V96, P2108, DOI 10.1121/1.410152; Cheour M, 1998, INT J PSYCHOPHYSIOL, V29, P217, DOI 10.1016/S0167-8760(98)00017-8; Clark JH, 2012, J AM GERIATR SOC, V60, P1936, DOI 10.1111/j.1532-5415.2012.04150.x; Dimitrijevic A, 2004, EAR HEARING, V25, P68, DOI 10.1097/01.AUD.0000111545.71693.48; Firszt Jill B., 2002, Ear and Hearing, V23, P502, DOI 10.1097/00003446-200212000-00002; Franck KH, 2001, EAR HEARING, V22, P289, DOI 10.1097/00003446-200108000-00004; Friesen LM, 2010, HEARING RES, V259, P95, DOI 10.1016/j.heares.2009.10.012; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Fu QJ, 2002, NEUROREPORT, V13, P1635, DOI 10.1097/00001756-200209160-00013; Gilley PM, 2008, BRAIN RES, V1239, P56, DOI 10.1016/j.brainres.2008.08.026; Gilley PM, 2006, CLIN NEUROPHYSIOL, V117, P1772, DOI 10.1016/j.clinph.2006.04.018; He C, 2009, NEUROPSYCHOLOGIA, V47, P218, DOI 10.1016/j.neuropsychologia.2008.07.019; Henry BA, 2005, J ACOUST SOC AM, V118, P1111, DOI 10.1121/1.1944567; Henry BA, 2003, J ACOUST SOC AM, V113, P2861, DOI 10.1121/1.1561900; Hofmann M, 2010, JARO-J ASSOC RES OTO, V11, P267, DOI 10.1007/s10162-009-0201-z; Horn D, 2013, 36 ASS RES OT ANN MI, V36, P289; Hughes ML, 2000, EAR HEARING, V21, P164, DOI 10.1097/00003446-200004000-00010; Jones GL, 2011, J ACOUST SOC AM, V133, P425; Landsberger DM, 2009, HEARING RES, V254, P34, DOI 10.1016/j.heares.2009.04.007; Lazard DS, 2010, ACTA OTO-LARYNGOL, V130, P1267, DOI 10.3109/00016481003769972; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Litvak LM, 2007, J ACOUST SOC AM, V122, P982, DOI 10.1121/1.2749413; Loizou PC, 1999, IEEE ENG MED BIOL, V18, P32, DOI 10.1109/51.740962; Mc Laughlin M, 2013, HEARING RES, V302, P84, DOI 10.1016/j.heares.2013.05.006; Mc Laughlin M, 2012, IEEE T NEUR SYS REH, V20, P443, DOI 10.1109/TNSRE.2012.2186982; Naatanen R, 2012, CLIN NEUROPHYSIOL, V123, P424, DOI 10.1016/j.clinph.2011.09.020; Pantev C, 2006, CEREB CORTEX, V16, P31, DOI 10.1093/cercor/bhi081; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; Pisoni DB, 1999, VOLTA REV, V101, P111; Ponton CW, 1997, EVOKED POTENTIAL, V104, P143, DOI 10.1016/S0168-5597(97)96104-9; Ponton CW, 1996, EAR HEARING, V17, P430, DOI 10.1097/00003446-199610000-00009; Ponton CW, 2000, AUDIOL NEURO-OTOL, V5, P167, DOI 10.1159/000013878; Sharma A, 2009, J COMMUN DISORD, V42, P272, DOI 10.1016/j.jcomdis.2009.03.003; Supin AY, 1997, HEARING RES, V108, P17, DOI 10.1016/S0378-5955(97)00035-X; Torppa R, 2012, CLIN NEUROPHYSIOL, V123, P1966, DOI 10.1016/j.clinph.2012.03.008; Trainor L, 2003, INT J PSYCHOPHYSIOL, V51, P5, DOI 10.1016/S0167-8760(03)00148-X; van Dijk JE, 1999, AUDIOLOGY, V38, P109; Viola FC, 2011, PSYCHOPHYSIOLOGY, V48, P1470, DOI 10.1111/j.1469-8986.2011.01224.x; Waltzman SB, 2005, PEDIATRICS, V116, pE487, DOI 10.1542/peds.2005-0282; Won JH, 2007, JARO-J ASSOC RES OTO, V8, P384, DOI 10.1007/s10162-007-0085-8; Won JH, 2011, JARO-J ASSOC RES OTO, V12, P375, DOI 10.1007/s10162-011-0257-4; Wong DDE, 2009, IEEE T BIO-MED ENG, V56, P2851, DOI 10.1109/TBME.2009.2029239; Wu CC, 2013, JARO-J ASSOC RES OTO, V14, P213, DOI 10.1007/s10162-012-0366-8; Zeng Fan-Gang, 2004, Trends Amplif, V8, P1, DOI 10.1177/108471380400800102; Zeng Fan-Gang, 2008, IEEE Rev Biomed Eng, V1, P115, DOI 10.1109/RBME.2008.2008250; Zeng FG, 2002, J ACOUST SOC AM, V111, P377, DOI 10.1121/1.1423926; Zhu ZY, 2012, HEARING RES, V283, P45, DOI 10.1016/j.heares.2011.11.005	51	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90044	10.1371/journal.pone.0090044	http://dx.doi.org/10.1371/journal.pone.0090044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599314	Green Published, gold			2022-12-25	WOS:000332479400041
J	Kashdan, TB; DeWall, CN; Masten, CL; Pond, RS; Powell, C; Combs, D; Schurtz, DR; Farmer, AS				Kashdan, Todd B.; DeWall, C. Nathan; Masten, Carrie L.; Pond, Richard S., Jr.; Powell, Caitlin; Combs, David; Schurtz, David R.; Farmer, Antonina S.			Who Is Most Vulnerable to Social Rejection? The Toxic Combination of Low Self-Esteem and Lack of Negative Emotion Differentiation on Neural Responses to Rejection	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; EXCLUSION; ACCEPTANCE; MOOD; INTELLIGENCE; PERFORMANCE; RESILIENCE; VALIDATION; EXPERIENCE; ATTENTION	People have a fundamental need to belong that, when satisfied, is associated with mental and physical well-being. The current investigation examined what happens when the need to belong is thwarted-and how individual differences in self-esteem and emotion differentiation modulate neural responses to social rejection. We hypothesized that low self-esteem would predict heightened activation in distress-related neural responses during a social rejection manipulation, but that this relationship would be moderated by negative emotion differentiation-defined as adeptness at using discrete negative emotion categories to capture one's felt experience. Combining daily diary and neuroimaging methodologies, the current study showed that low self-esteem and low negative emotion differentiation represented a toxic combination that was associated with stronger activation during social rejection (versus social inclusion) in the dorsal anterior cingulate cortex and anterior insula-two regions previously shown to index social distress. In contrast, individuals with greater negative emotion differentiation did not show stronger activation in these regions, regardless of their level of self-esteem; fitting with prior evidence that negative emotion differentiation confers equanimity in emotionally upsetting situations.	[Kashdan, Todd B.; Farmer, Antonina S.] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Kashdan, Todd B.; Farmer, Antonina S.] George Mason Univ, Ctr Adv Well Being, Fairfax, VA 22030 USA; [DeWall, C. Nathan; Combs, David; Schurtz, David R.] Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA; [Masten, Carrie L.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Pond, Richard S., Jr.] Univ N Carolina, Dept Psychol, Wilmington, NC 28401 USA; [Powell, Caitlin] Georgia Coll & State Univ, Dept Psychol, Milledgeville, GA USA	George Mason University; George Mason University; University of Kentucky; University of California System; University of California Davis; University of North Carolina; University of North Carolina Wilmington; University System of Georgia; Georgia College & State University	Kashdan, TB (corresponding author), George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA.	tkashdan@gmu.edu	Farmer, Antonina/M-8914-2013	Farmer, Antonina/0000-0002-3305-8300	George Mason University Libraries Open Access Publishing Fund	George Mason University Libraries Open Access Publishing Fund	Publication of this article was funded in part by the George Mason University Libraries Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L.S., 1991, MULTIPLE REGRESSION; Barrett LF, 2006, J RES PERS, V40, P35, DOI 10.1016/j.jrp.2005.08.006; Barrett LF, 2004, PSYCHOL BULL, V130, P553, DOI 10.1037/0033-2909.130.4.553; Baumeister RF, 2005, J PERS SOC PSYCHOL, V88, P589, DOI 10.1037/0022-3514.88.4.589; Baumeister RF, 2003, PSYCHOL SCI, P1, DOI 10.1111/1529-1006.01431; Baumeister RF, 2002, J PERS SOC PSYCHOL, V83, P817, DOI 10.1037//0022-3514.83.4.817; Blackhart GC, 2007, BIOL PSYCHOL, V75, P267, DOI 10.1016/j.biopsycho.2007.03.005; Boden MT, 2013, COGNITION EMOTION, V27, P961, DOI 10.1080/02699931.2012.751899; Bolling DZ, 2011, NEUROIMAGE, V54, P2462, DOI 10.1016/j.neuroimage.2010.10.049; Brackett MA, 2006, J PERS SOC PSYCHOL, V91, P780, DOI 10.1037/0022-3514.91.4.780; Cacioppo JT, 2003, CURR DIR PSYCHOL SCI, V12, P71, DOI 10.1111/1467-8721.01232; Cutrona CE, 1982, LONELINESS SOURCEBOO, P291; DeWall CN, 2012, SOC COGN AFFECT NEUR, V7, P184, DOI 10.1093/scan/nsq107; DeWall CN, 2010, SOC PSYCHOL PERS SCI, V1, P168, DOI 10.1177/1948550610361387; DeWall CN, 2010, PSYCHOL SCI, V21, P931, DOI 10.1177/0956797610374741; DeWall CN, 2008, J PERS SOC PSYCHOL, V95, P1367, DOI 10.1037/a0012632; DeWall CN, 2009, J PERS SOC PSYCHOL, V96, P45, DOI 10.1037/a0013196; Dickerson SS, 2009, PSYCHOL SCI, V20, P1237, DOI 10.1111/j.1467-9280.2009.02437.x; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Ford MB, 2010, J PERS SOC PSYCHOL, V98, P405, DOI 10.1037/a0017345; Gohm CL, 2000, PERS SOC PSYCHOL B, V26, P679, DOI 10.1177/0146167200268004; Gohm CL, 2002, COGNITION EMOTION, V16, P495, DOI 10.1080/02699930143000374; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P895, DOI 10.1037/0022-3514.60.6.895; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Kang SM, 2004, J PERS, V72, P687, DOI 10.1111/j.0022-3506.2004.00277.x; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; Kashdan TB, 2010, PSYCHOL SCI, V21, P1341, DOI 10.1177/0956797610379863; Kross E, 2007, J COGNITIVE NEUROSCI, V19, P945, DOI 10.1162/jocn.2007.19.6.945; Larsen R.J., 1992, EMOTION, P25; Leary MR, 2000, ADV EXP SOC PSYCHOL, V32, P1, DOI 10.1016/S0065-2601(00)80003-9; LEARY MR, 1995, J PERS SOC PSYCHOL, V68, P518, DOI 10.1037/0022-3514.68.3.518; LEARY MR, 1990, J SOC CLIN PSYCHOL, V9, P221, DOI 10.1521/jscp.1990.9.2.221; Leary MR, 1995, PLENUM SERIES SOCIAL, P123; Lischetzke T, 2003, EMOTION, V3, P361, DOI 10.1037/1528-3542.3.4.361; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; Masten CL, 2011, J COGNITIVE NEUROSCI, V23, P1042, DOI 10.1162/jocn.2010.21520; Mayer JD, 2008, AM PSYCHOL, V63, P503, DOI 10.1037/0003-066X.63.6.503; Nezlek JB, 2007, EUR J PERSONALITY, V21, P789, DOI 10.1002/per.640; Ong AD, 2004, J GERONTOL B-PSYCHOL, V59, pP117, DOI 10.1093/geronb/59.3.P117; Onoda K, 2010, SOC COGN AFFECT NEUR, V5, P385, DOI 10.1093/scan/nsq002; Palmieri PA, 2009, J PERS ASSESS, V91, P560, DOI 10.1080/00223890903228539; Pond RS, 2012, EMOTION, V12, P326, DOI 10.1037/a0025762; Raudenbush SW, 2004, SSI; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Salovey P, 2002, PSYCHOL HEALTH, V17, P611, DOI 10.1080/08870440290025812; Salovey P., 1995, EMOTION DISCLOSURE H, P125; Schilbach L, 2010, J COGNITIVE NEUROSCI, V22, P2702, DOI 10.1162/jocn.2009.21401; Slavich GM, 2010, P NATL ACAD SCI USA, V107, P14817, DOI 10.1073/pnas.1009164107; Somerville LH, 2010, CEREB CORTEX, V20, P3005, DOI 10.1093/cercor/bhq049; Stone AA, 2007, SCI REAL TIME DATA C; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Thompson RJ, 2009, J RES PERS, V43, P875, DOI 10.1016/j.jrp.2009.07.006; Tugade MM, 2004, J PERS, V72, P1161, DOI 10.1111/j.1467-6494.2004.00294.x; Twenge JM, 2002, J PERS SOC PSYCHOL, V83, P606, DOI 10.1037//0022-3514.83.3.606; van Beest I, 2006, J PERS SOC PSYCHOL, V91, P918, DOI 10.1037/0022-3514.91.5.918; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WEGNER DM, 1993, J PERS SOC PSYCHOL, V65, P1093, DOI 10.1037/0022-3514.65.6.1093; Wild LG, 2004, J CHILD PSYCHOL PSYC, V45, P1454, DOI 10.1111/j.1469-7610.2004.00330.x; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 2009, ADV EXP SOC PSYCHOL, V41, P275, DOI 10.1016/S0065-2601(08)00406-1; Winkielman, 2007, SOCIAL NEUROSCIENCE, P106	61	31	35	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90651	10.1371/journal.pone.0090651	http://dx.doi.org/10.1371/journal.pone.0090651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4FD	24594689	Green Submitted, gold, Green Published			2022-12-25	WOS:000332475500082
J	Shah, AT; Beckler, MD; Walsh, AJ; Jones, WP; Pohlmann, PR; Skala, MC				Shah, Amy T.; Beckler, Michelle Demory; Walsh, Alex J.; Jones, William P.; Pohlmann, Paula R.; Skala, Melissa C.			Optical Metabolic Imaging of Treatment Response in Human Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							MULTIPHOTON MICROSCOPY; CANCER; CETUXIMAB; GROWTH; PATHWAY; THERAPY; NADH	Optical metabolic imaging measures fluorescence intensity and lifetimes from metabolic cofactors nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FAD). These molecular level measurements provide unique biomarkers for early cellular responses to cancer treatments. Head and neck squamous cell carcinoma (HNSCC) is an attractive target for optical imaging because of easy access to the site using fiber optic probes. Two HNSCC cell lines, SCC25 and SCC61, were treated with Cetuximab (anti-EGFR antibody), BGT226 (PI3K/mTOR inhibitor), or cisplatin (chemotherapy) for 24 hours. Results show increased redox ratio, NADH alpha(1) (contribution from free NADH), and FAD alpha(1) (contribution from protein-bound FAD) for malignant cells compared with the nonmalignant cell line OKF6 (p<0.05). In SCC25 and SCC61 cells, the redox ratio is unaffected by cetuximab treatment and decreases with BGT226 and cisplatin treatment (p<0.05), and these results agree with standard measurements of proliferation rates after treatment. For SCC25, NADH alpha(1) is reduced with BGT226 and cisplatin treatment. For SCC61, NADH alpha(1) is reduced with cetuximab, BGT226, and cisplatin treatment. Trends in NADH alpha(1) are statistically similar to changes in standard measurements of glycolytic rates after treatment. FAD alpha(1) is reduced with cisplatin treatment (p<0.05). These shifts in optical endpoints reflect early metabolic changes induced by drug treatment. Overall, these results indicate that optical metabolic imaging has potential to detect early response to cancer treatment in HNSCC, enabling optimal treatment regimens and improved patient outcomes.	[Shah, Amy T.; Walsh, Alex J.; Jones, William P.; Skala, Melissa C.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Beckler, Michelle Demory] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Beckler, Michelle Demory] Vanderbilt Univ, Med Ctr, Dept Radiol, Nashville, TN 37232 USA; [Pohlmann, Paula R.] Georgetown Univ, Med Ctr, Dept Med, Washington, DC 20007 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Georgetown University	Skala, MC (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.	m.skala@vanderbilt.edu		Walsh, Alex/0000-0003-3832-8207; Pohlmann, Paula/0000-0001-7914-5162	National Institutes of Health/National Cancer Institute [R00 CA142888]; National Science Foundation Graduate Research Fellowship [DGE-0909667]; NATIONAL CANCER INSTITUTE [R00CA142888] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by National Institutes of Health/National Cancer Institute R00 CA142888 and National Science Foundation Graduate Research Fellowship (DGE-0909667; A. T. Shah). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANERJEE S, 1989, Indian Journal of Cancer, V26, P21; Bernier J, 2009, NAT REV CLIN ONCOL, V6, P266, DOI 10.1038/nrclinonc.2009.40; Bird DK, 2005, CANCER RES, V65, P8766, DOI 10.1158/0008-5472.CAN-04-3922; BOARD M, 1990, BIOCHEM J, V265, P503, DOI 10.1042/bj2650503; CHANCE B, 1979, J BIOL CHEM, V254, P4764; Chang KY, 2011, CLIN CANCER RES, V17, P7116, DOI 10.1158/1078-0432.CCR-11-0796; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Drezek R, 2001, PHOTOCHEM PHOTOBIOL, V73, P636, DOI 10.1562/0031-8655(2001)073<0636:AMOFCT>2.0.CO;2; Eastman A., 1999, CISPLATIN CHEM BIOCH, P111, DOI [DOI 10.1002/9783906390420.CH4, 10.1002/9783906390420.ch4]; Eng J, 1989, SPECTROSCOPY, V55; Erlich RB, 2012, BRIT J CANCER, V106, P107, DOI 10.1038/bjc.2011.495; Fung C, 2010, EXPERT OPIN EMERG DR, V15, P355, DOI 10.1517/14728214.2010.497754; Georgakoudi I, 2012, ANNU REV BIOMED ENG, V14, P351, DOI 10.1146/annurev-bioeng-071811-150108; Gleysteen JP, 2007, CANCER BIOL THER, V6, P1181; Helman EE, 2010, CANCER BIOL THER, V10, P166, DOI 10.4161/cbt.10.2.12164; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; HU L, 1991, CANCER RES, V51, P3972; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Jabbour JM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046012; KIM KH, 1984, P NATL ACAD SCI-BIOL, V81, P4280, DOI 10.1073/pnas.81.14.4280; Kimura H, 2007, CANCER SCI, V98, P1275, DOI 10.1111/j.1349-7006.2007.00510.x; Kundu SK, 2012, TUMOR BIOL, V33, P707, DOI 10.1007/s13277-012-0350-2; LAKOWICZ JR, 1992, P NATL ACAD SCI USA, V89, P1271, DOI 10.1073/pnas.89.4.1271; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Levitt JM, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2401149; Machtay M, 2008, J CLIN ONCOL, V26, P3582, DOI 10.1200/JCO.2007.14.8841; Nestor M, 2010, TUMOR BIOL, V31, P141, DOI 10.1007/s13277-010-0018-8; Ostrander JH, 2010, CANCER RES, V70, P4759, DOI 10.1158/0008-5472.CAN-09-2572; Pavlova I, 2008, CLIN CANCER RES, V14, P2396, DOI 10.1158/1078-0432.CCR-07-1609; Pedrero JMG, 2005, INT J CANCER, V114, P242, DOI 10.1002/ijc.20711; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Rousseau a, 2012, ATLAS GENET CYTOGENE; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Seiwert TY, 2009, CANCER RES, V69, P3021, DOI 10.1158/0008-5472.CAN-08-2881; Skala MC, 2005, CANCER RES, V65, P1180, DOI 10.1158/0008-5472.CAN-04-3031; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Skala MC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717503; Sun J, 2004, OPT EXPRESS, V12, P2478, DOI 10.1364/OPEX.12.002478; Sun Y, 2009, OPT LETT, V34, P2081, DOI 10.1364/OL.34.002081; Walsh A, 2012, BIOMED OPT EXPRESS, V3, P75, DOI 10.1364/BOE.3.000075; Walsh AJ, 2013, CANCER RES, V73, P6164, DOI 10.1158/0008-5472.CAN-13-0527; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WEICHSELBAUM R, 1984, BRIT J CANCER, V49, P595, DOI 10.1038/bjc.1984.94; Wendt BTG, 2013, ALONE ADV HEAD NECK, V16, P1318; Yarbrough WG, 2007, INT J RADIAT ONCOL, V69, pS98, DOI 10.1016/j.ijrobp.2007.04.082; Zhang N, 2009, RADIOTHER ONCOL, V92, P388, DOI 10.1016/j.radonc.2009.04.019	46	51	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90746	10.1371/journal.pone.0090746	http://dx.doi.org/10.1371/journal.pone.0090746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595244	gold, Green Submitted, Green Published			2022-12-25	WOS:000332475500095
J	Galay, RL; Umemiya-Shirafuji, R; Bacolod, ET; Maeda, H; Kusakisako, K; Koyama, J; Tsuji, N; Mochizuki, M; Fujisaki, K; Tanaka, T				Galay, Remil Linggatong; Umemiya-Shirafuji, Rika; Bacolod, Eugene T.; Maeda, Hiroki; Kusakisako, Kodai; Koyama, Jiro; Tsuji, Naotoshi; Mochizuki, Masami; Fujisaki, Kozo; Tanaka, Tetsuya			Two Kinds of Ferritin Protect Ixodid Ticks from Iron Overload and Consequent Oxidative Stress	PLOS ONE			English	Article							LIPID-PEROXIDATION; CATTLE TICK; HARD TICK; HEME DETOXIFICATION; METABOLISM; MIDGUT; MALONDIALDEHYDE; REPRODUCTION	Ticks are obligate hematophagous parasites that have successfully developed counteractive means against their hosts' immune and hemostatic mechanisms, but their ability to cope with potentially toxic molecules in the blood remains unclear. Iron is important in various physiological processes but can be toxic to living cells when in excess. We previously reported that the hard tick Haemaphysalis longicornis has an intracellular (HlFER1) and a secretory (HlFER2) ferritin, and both are crucial in successful blood feeding and reproduction. Ferritin gene silencing by RNA interference caused reduced feeding capacity, low body weight and high mortality after blood meal, decreased fecundity and morphological abnormalities in the midgut cells. Similar findings were also previously reported after silencing of ferritin genes in another hard tick, Ixodes ricinus. Here we demonstrated the role of ferritin in protecting the hard ticks from oxidative stress. Evaluation of oxidative stress in Hlfer-silenced ticks was performed after blood feeding or injection of ferric ammonium citrate (FAC) through detection of the lipid peroxidation product, malondialdehyde (MDA) and protein oxidation product, protein carbonyl. FAC injection in Hlfer-silenced ticks resulted in high mortality. Higher levels of MDA and protein carbonyl were detected in Hlfer-silenced ticks compared to Luciferase-injected (control) ticks both after blood feeding and FAC injection. Ferric iron accumulation demonstrated by increased staining on native HlFER was observed from 72 h after iron injection in both the whole tick and the midgut. Furthermore, weak iron staining was observed after Hlfer knockdown. Taken together, these results show that tick ferritins are crucial antioxidant molecules that protect the hard tick from iron-mediated oxidative stress during blood feeding.	[Galay, Remil Linggatong; Maeda, Hiroki; Mochizuki, Masami; Tanaka, Tetsuya] Yamaguchi Univ, United Grad Sch Vet Sci, Dept Pathol & Prevent Vet Sci, Yamaguchi, Japan; [Galay, Remil Linggatong; Maeda, Hiroki; Kusakisako, Kodai; Mochizuki, Masami; Tanaka, Tetsuya] Kagoshima Univ, Joint Fac Vet Med, Lab Emerging Infect Dis, Kagoshima 890, Japan; [Umemiya-Shirafuji, Rika] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan; [Bacolod, Eugene T.] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan; [Bacolod, Eugene T.] Univ San Carlos, Coll Arts & Sci, Dept Chem, Cebu, Philippines; [Koyama, Jiro] Kagoshima Univ, Fac Fisheries, Educ & Res Ctr Marine Resources & Environm, Kagoshima 890, Japan; [Tsuji, Naotoshi; Fujisaki, Kozo] Natl Agr & Food Res Org, Tsukuba, Ibaraki, Japan	Yamaguchi University; Kagoshima University; Obihiro University of Agriculture & Veterinary Medicine; Kagoshima University; University of San Carlos; Kagoshima University; National Agriculture & Food Research Organization - Japan	Tanaka, T (corresponding author), Yamaguchi Univ, United Grad Sch Vet Sci, Dept Pathol & Prevent Vet Sci, Yamaguchi, Japan.	tetsuya@ms.kagoshima-u.ac.jp	Umemiya-Shirafuji, Rika/AFT-5139-2022; Galay, Remil/AAN-4392-2021	Umemiya-Shirafuji, Rika/0000-0001-7641-5526; Galay, Remil/0000-0001-9749-8308	National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine [25-joint-2]; Morinaga Foundation; Japan Society for the Promotion of Science (JSPS); Japanese Government Ministry of Education, Culture, Sports, Science, and Technology Scholarship (Monbukagakusho: MEXT)	National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine; Morinaga Foundation; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Government Ministry of Education, Culture, Sports, Science, and Technology Scholarship (Monbukagakusho: MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a joint research grant (25-joint-2) of the National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Morinaga Foundation, and grants-in-aid for Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS). RLG and ETB are supported by the Japanese Government Ministry of Education, Culture, Sports, Science, and Technology Scholarship (Monbukagakusho: MEXT) for doctoral fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Anderson JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-552; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Aung KM, 2011, PARASITOL RES, V108, P273, DOI 10.1007/s00436-010-2053-1; BRAUGHLER JM, 1986, J BIOL CHEM, V261, P282; Chauhan A, 2004, LIFE SCI, V75, P2539, DOI 10.1016/j.lfs.2004.04.038; Citelli M, 2007, MOL BIOCHEM PARASIT, V151, P81, DOI 10.1016/j.molbiopara.2006.10.008; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Dunkov Boris C, 2002, J Insect Sci, V2, P7; Fedorova M, 2013, MASS SPECTROM REV, DOI 10.1002/mas.21381; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; FUHRMAN B, 1994, ATHEROSCLEROSIS, V111, P65, DOI 10.1016/0021-9150(94)90192-9; FUJISAKI K, 1978, NATL I ANIM HEALTH Q, V18, P27; Galay RL, 2013, J EXP BIOL, V216, P1905, DOI 10.1242/jeb.081240; Geiser DL, 2006, INSECT BIOCHEM MOLEC, V36, P177, DOI 10.1016/j.ibmb.2005.12.001; Gkouvatsos K, 2012, BBA-GEN SUBJECTS, V1820, P188, DOI 10.1016/j.bbagen.2011.10.013; Grotto D, 2009, QUIM NOVA, V32, P169, DOI 10.1590/S0100-40422009000100032; Hajdusek O, 2009, P NATL ACAD SCI USA, V106, P1033, DOI 10.1073/pnas.0807961106; Ibrahim MA, 2013, COMP BIOCHEM PHYS B, V164, P221, DOI 10.1016/j.cbpb.2013.01.002; Lang ML, 2012, P NATL ACAD SCI USA, V109, P13337, DOI 10.1073/pnas.1208703109; Lara FA, 2003, J EXP BIOL, V206, P1707, DOI 10.1242/jeb.00334; Lara FA, 2005, J EXP BIOL, V208, P3093, DOI 10.1242/jeb.01749; Mandilaras K, 2013, NUTRIENTS, V5, P1622, DOI 10.3390/nu5051622; Mans BJ, 2004, INSECT BIOCHEM MOLEC, V34, P1, DOI 10.1016/j.ibmb.2003.09.002; Maya-Monteiro CM, 2000, J BIOL CHEM, V275, P36584, DOI 10.1074/jbc.M007344200; Missirlis F, 2006, P NATL ACAD SCI USA, V103, P5893, DOI 10.1073/pnas.0601471103; Niki E., 2013, BIOCH BIOPHYS ACTA; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; Ong ST, 2006, IMMUNOBIOLOGY, V211, P295, DOI 10.1016/j.imbio.2006.02.004; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; Pham DQD, 2010, BBA-GEN SUBJECTS, V1800, P824, DOI 10.1016/j.bbagen.2010.03.004; Pham DQD, 1999, EUR J BIOCHEM, V266, P236, DOI 10.1046/j.1432-1327.1999.00849.x; Qiu GF, 2008, COMP BIOCHEM PHYS B, V150, P320, DOI 10.1016/j.cbpb.2008.03.016; Tang X, 2013, FASEB J, V27, P1; Umemiya-Shirafuji R, 2012, INSECT BIOCHEM MOLEC, V42, P164, DOI 10.1016/j.ibmb.2011.12.001; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Wang D, 2009, COMP BIOCHEM PHYS B, V152, P20, DOI 10.1016/j.cbpb.2008.09.082; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Winzerling JJ, 2006, INSECT BIOCHEM MOLEC, V36, P310, DOI 10.1016/j.ibmb.2006.01.006	39	33	36	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90661	10.1371/journal.pone.0090661	http://dx.doi.org/10.1371/journal.pone.0090661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594832	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900131
J	Jonczyk, MS; Simon, M; Kumar, S; Fernandes, VE; Sylvius, N; Mallon, AM; Denny, P; Andrew, PW				Jonczyk, Magda S.; Simon, Michelle; Kumar, Saumya; Fernandes, Vitor E.; Sylvius, Nicolas; Mallon, Ann-Marie; Denny, Paul; Andrew, Peter W.			Genetic Factors Regulating Lung Vasculature and Immune Cell Functions Associate with Resistance to Pneumococcal Infection	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NECROSIS-FACTOR-ALPHA; AIRWAY SMOOTH-MUSCLE; PERIVASCULAR ADIPOSE-TISSUE; TRKB NEUROTROPHIN RECEPTOR; GROWTH-FACTOR-BETA; STREPTOCOCCUS-PNEUMONIAE; ACTIN GENE; DISEASE; SUSCEPTIBILITY	Streptococcus pneumoniae is an important human pathogen responsible for high mortality and morbidity worldwide. The susceptibility to pneumococcal infections is controlled by as yet unknown genetic factors. To elucidate these factors could help to develop new medical treatments and tools to identify those most at risk. In recent years genome wide association studies (GWAS) in mice and humans have proved successful in identification of causal genes involved in many complex diseases for example diabetes, systemic lupus or cholesterol metabolism. In this study a GWAS approach was used to map genetic loci associated with susceptibility to pneumococcal infection in 26 inbred mouse strains. As a result four candidate QTLs were identified on chromosomes 7, 13, 18 and 19. Interestingly, the QTL on chromosome 7 was located within S. pneumoniae resistance QTL (Spir1) identified previously in a linkage study of BALB/cOlaHsd and CBA/CaOlaHsd F2 intercrosses. We showed that only a limited number of genes encoded within the QTLs carried phenotype-associated polymorphisms (22 genes out of several hundred located within the QTLs). These candidate genes are known to regulate TGF beta signalling, smooth muscle and immune cells functions. Interestingly, our pulmonary histopathology and gene expression data demonstrated, lung vasculature plays an important role in resistance to pneumococcal infection. Therefore we concluded that the cumulative effect of these candidate genes on vasculature and immune cells functions as contributory factors in the observed differences in susceptibility to pneumococcal infection. We also propose that TGF beta-mediated regulation of fibroblast differentiation plays an important role in development of invasive pneumococcal disease. Gene expression data submitted to the NCBI Gene Expression Omnibus Accession No: GSE49533 SNP data submitted to NCBI dbSNP Short Genetic Variation http://www.ncbi.nlm.nih.gov/projects/SNP/snp_viewTable.cgi?handle = MUS PNEUMONIA.	[Jonczyk, Magda S.; Fernandes, Vitor E.; Andrew, Peter W.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Simon, Michelle; Kumar, Saumya; Mallon, Ann-Marie; Denny, Paul] MRC Harwell, Mammalian Genet Unit, Oxford, England; [Sylvius, Nicolas] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Leicester; MRC Harwell; University of Leicester	Andrew, PW (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.	pwa@le.ac.uk	Jonczyk, Magdalena/I-2153-2013; Andrew, Peter W/G-7526-2012	Jonczyk, Magdalena/0000-0003-2117-1143; Kumar, Saumya/0000-0001-9481-1944; E. Fernandes, Vitor/0000-0001-5179-2122; Sylvius, Nicolas/0000-0002-3470-3711; Denny, Paul/0000-0003-4659-6893	European Union [HEALTH-F3-2009-222983]; Medical Research Council [MC_U142684174, G0501416, MC_U142684171] Funding Source: researchfish; MRC [MC_U142684171, G0501416, MC_U142684174] Funding Source: UKRI	European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Union-funded Pneumopath Project HEALTH-F3-2009-222983. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behzad AR, 1996, MICROVASC RES, V51, P303, DOI 10.1006/mvre.1996.0029; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Besser M, 1999, J IMMUNOL, V162, P6303; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Blomberg C, 2009, J INFECT DIS, V199, P1032, DOI 10.1086/597205; Brenner D, 2008, CRIT REV ONCOL HEMAT, V66, P52, DOI 10.1016/j.critrevonc.2008.01.002; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Chapman SJ, 2010, GENES IMMUN, V11, P319, DOI 10.1038/gene.2009.76; Chapman SJ, 2007, AM J RESP CRIT CARE, V176, P181, DOI 10.1164/rccm.200702-169OC; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Chapman SJ, 2010, CRIT CARE, V14, DOI 10.1186/cc9377; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Cruse G, 2010, J IMMUNOL, V184, P7108, DOI 10.4049/jimmunol.0900802; Degn SE, 2011, AM J HUM GENET, V88, P689, DOI 10.1016/j.ajhg.2011.05.011; Denny P, 2003, MAMM GENOME, V14, P448, DOI 10.1007/S00335-002-2261-9; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Du WL, 2005, J BIOL CHEM, V280, P26287, DOI 10.1074/jbc.M502905200; Fernebro J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-65; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Flint J, 2013, CURR BIOL, V23, pR265, DOI 10.1016/j.cub.2013.01.040; Flint J, 2012, NAT REV GENET, V13, P807, DOI 10.1038/nrg3335; Gingles NA, 2001, INFECT IMMUN, V69, P426, DOI 10.1128/IAI.69.1.426-434.2001; Glavan BJ, 2011, AM J RESP CRIT CARE, V183, P356, DOI 10.1164/rccm.201003-0351OC; Guzik TJ, 2007, J PHYSIOL PHARMACOL, V58, P591; Halestrap AP, 2013, MOL ASPECTS MED, V34, P337, DOI 10.1016/j.mam.2012.05.003; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hollingsworth JW, 2007, IMMUNOGENETICS, V59, P713, DOI 10.1007/s00251-007-0242-6; Hunter KW, 2008, ANNU REV GENET, V42, P131, DOI 10.1146/annurev.genet.42.110807.091659; Ibarrola N, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-2; Ichikawa T, 2013, EXP CELL RES, V319, P1176, DOI 10.1016/j.yexcr.2013.02.014; Kadioglu A, 2004, INFECT IMMUN, V72, P2689, DOI 10.1128/IAI.72.5.2689-2697.2004; Kadioglu A, 2004, TRENDS IMMUNOL, V25, P143, DOI 10.1016/j.it.2003.12.006; Kadioglu A, 2000, INFECT IMMUN, V68, P492, DOI 10.1128/IAI.68.2.492-501.2000; Kadioglu A, 2011, J INFECT DIS, V204, P1971, DOI 10.1093/infdis/jir657; Kanayama S, 2007, J ENDOTOXIN RES, V13, P369, DOI 10.1177/0968051907086464; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kathiresan S, 2008, CURR OPIN LIPIDOL, V19, P122, DOI 10.1097/MOL.0b013e3282f70296; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kemp K, 2002, INFECT IMMUN, V70, P5019, DOI 10.1128/IAI.70.9.5019-5025.2002; Kermani P, 2005, J CLIN INVEST, V115, P653, DOI 10.1172/JCI200522655; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; Kerr AR, 2002, INFECT IMMUN, V70, P1547, DOI 10.1128/IAI.70.3.1547-1557.2002; Kirby A, 2010, GENETICS, V185, P1081, DOI 10.1534/genetics.110.115014; Koziol-White CJ, 2011, EXPERT REV RESP MED, V5, P767, DOI [10.1586/ERS.11.77, 10.1586/ers.11.77]; Kwapiszewska G, 2012, AM J PATHOL, V181, P2018, DOI 10.1016/j.ajpath.2012.08.028; Leduc MS, 2011, J LIPID RES, V52, P1139, DOI 10.1194/jlr.M009175; LeMessurier K, 2010, INFECT IMMUN, V78, P5287, DOI 10.1128/IAI.00431-10; Li L, 2011, WORLD J PEDIATR, V7, P250, DOI 10.1007/s12519-011-0285-5; Lingappa JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023413; Liu PY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000651; Liu XY, 2009, MOL BIOL CELL, V20, P2174, DOI 10.1091/mbc.E08-10-0994; Lloyd EE, 2011, HYPERTENSION, V58, P672, DOI 10.1161/HYPERTENSIONAHA.111.175349; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P571, DOI 10.1007/s00424-003-1141-9; MALO D, 1994, GENOMICS, V23, P51, DOI 10.1006/geno.1994.1458; Mandelkow E, 2002, TRENDS CELL BIOL, V12, P585, DOI 10.1016/S0962-8924(02)02400-5; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Maroder M, 1996, J IMMUNOL, V157, P2864; Marriott HM, 2006, INT J BIOCHEM CELL B, V38, P1848, DOI 10.1016/j.biocel.2006.06.001; Martens P, 2004, BMC INFECT DIS, V30, P4; Matsuzaki H, 2004, CLIN DIAGN LAB IMMUN, V11, P1140, DOI 10.1128/CDLI.11.6.1140-1147.2004; McGettrick HM, 2012, J LEUKOCYTE BIOL, V91, P385, DOI 10.1189/jlb.0911458; Meneghin A, 2007, J CLIN INVEST, V117, P530, DOI 10.1172/JCI30595; Miao CY, 2012, BRIT J PHARMACOL, V165, P643, DOI 10.1111/j.1476-5381.2011.01404.x; Mirakaj V, 2010, AM J RESP CRIT CARE, V181, P815, DOI 10.1164/rccm.200905-0717OC; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Mizrachi-Nebenzahl Y, 2003, CLIN EXP IMMUNOL, V134, P23, DOI 10.1046/j.1365-2249.2003.02261.x; Morote-Garcia JC, 2012, P NATL ACAD SCI USA, V109, P14146, DOI 10.1073/pnas.1202165109; Neill DR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002660; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pagiatakis C, 2012, J BIOL CHEM, V287, P8361, DOI 10.1074/jbc.M111.286203; Parsonage G, 2005, TRENDS IMMUNOL, V26, P150, DOI 10.1016/j.it.2004.11.014; Pechkovsky DV, 2010, AM J RESP CELL MOL, V43, P641, DOI 10.1165/rcmb.2009-0318OC; Prakash Ys, 2010, Expert Rev Respir Med, V4, P395, DOI 10.1586/ers.10.29; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ripoll VM, 2010, J LEUKOCYTE BIOL, V87, P735, DOI 10.1189/jlb.0509359; Romano V, 2012, J MOL MODEL, V18, P3617, DOI 10.1007/s00894-012-1370-y; Roy SG, 2001, INT J BIOCHEM CELL B, V33, P723, DOI 10.1016/S1357-2725(01)00041-3; Sanderson Michael J, 2008, Proc Am Thorac Soc, V5, P23, DOI 10.1513/pats.200704-050VS; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Su ZG, 2010, J LIPID RES, V51, P2706, DOI 10.1194/jlr.M008110; Suire S, 2012, EMBO J, V31, P3118, DOI 10.1038/emboj.2012.167; Sun K, 2011, INFECT IMMUN, V79, P1842, DOI 10.1128/IAI.01143-10; Szasz T, 2013, VASC HEALTH RISK MAN, V9, P105, DOI 10.2147/VHRM.S33760; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; van Rossum AMC, 2005, INFECT IMMUN, V73, P7718, DOI 10.1128/IAI.73.11.7718-7726.2005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wagner N, 2005, GENE DEV, V19, P2631, DOI 10.1101/gad.346405; Wakahara K, 2005, J INFECT DIS, V191, P930, DOI 10.1086/428134; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xia YXC, 2013, PULM PHARMACOL THER, V26, P64, DOI 10.1016/j.pupt.2012.05.006	92	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89831	10.1371/journal.pone.0089831	http://dx.doi.org/10.1371/journal.pone.0089831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594938	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900037
J	Ouyang, K; Woodiga, SA; Dwivedi, V; Buckwalter, CM; Singh, AK; Binjawadagi, B; Hiremath, J; Manickam, C; Schleappi, R; Khatri, M; Wu, JM; King, SJ; Renukaradhya, GJ				Ouyang, Kang; Woodiga, Shireen A.; Dwivedi, Varun; Buckwalter, Carolyn M.; Singh, Anirudh K.; Binjawadagi, Basavaraj; Hiremath, Jagadish; Manickam, Cordelia; Schleappi, Rose; Khatri, Mahesh; Wu, Jianmin; King, Samantha J.; Renukaradhya, Gourapura J.			Pretreatment of Epithelial Cells with Live Streptococcus pneumoniae Has No Detectable Effect on Influenza A Virus Replication In Vitro	PLOS ONE			English	Article							MDCK CELLS; SWINE; MODEL; EXOGLYCOSIDASES; SUSCEPTIBILITY; INFECTION; DISEASE; TRYPSIN; GROWTH; LINE	Influenza A virus (IAV) and Streptococcus pneumoniae (pneumococcus) are two major upper respiratory tract pathogens responsible for exacerbated disease in coinfected individuals. Despite several studies showing increased susceptibility to secondary bacterial infections following IAV infection, information on the direct effect of S. pneumoniae on IAV in vitro is unknown. This is an important area of investigation as S. pneumoniae is a common commensal of the human upper respiratory tract, present as an important coinfecting pathogen with IAV infection. A recent study showed that S. pneumoniae enhances human metapneumovirus infection in polarized bronchial epithelial cells in vitro. The aim of the current study was to determine whether treatment of epithelial cells with S. pneumoniae affects IAV replication using a standard immunofluorescence assay (IFA). For this study we used four IAV permissive epithelial cell lines including two human-derived cell lines, 12 pneumococcal strains including recent human clinical isolates which represent different genetic backgrounds and serotypes, and six IAV strains of varying genetic nature and pathogenic potential including the pandemic 2009 H1N1 virus. Our results suggested that pretreatment of MDCK cells with 7.5x10(6) colony-forming units (CFUs) of live S. pneumoniae resulted in gradual cell-death in a time-dependent manner (0.5 to 4 hr). But, pretreatment of cell lines with 7.5x10(5) and lower CFUs of S. pneumoniae had no detectable effect on either the morphology of cells or on the IAV replication. However, unlike in epithelial cell lines, due to influence of secreted host factors the effect of pneumococci on IAV replication may be different during coinfections in vivo in the human upper respiratory tract, and in vitro with primary human polarized bronchial epithelial cells.	[Ouyang, Kang; Wu, Jianmin] Guangxi Univ, Coll Anim Sci & Technol, Nanning 530004, Peoples R China; [Ouyang, Kang; Dwivedi, Varun; Binjawadagi, Basavaraj; Hiremath, Jagadish; Manickam, Cordelia; Schleappi, Rose; Khatri, Mahesh; Renukaradhya, Gourapura J.] Ohio State Univ, OARDC, Dept Vet Prevent Med, Food Anim Hlth Res Program FAHRP, Wooster, OH USA; [Woodiga, Shireen A.; Buckwalter, Carolyn M.; Singh, Anirudh K.; King, Samantha J.] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; [Buckwalter, Carolyn M.; King, Samantha J.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	Guangxi University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	King, SJ (corresponding author), Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA.	Samantha.King@nationwidechildrens.org; gourapura.1@osu.edu	king, samantha/AAS-4813-2021	Gourapura, Renukaradhya/0000-0003-2861-180X	National Center For Advancing Translational Sciences [UL1TR001070]; state and federal funds; China Scholarship Council (CSC) [2011666005]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	National Center For Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); state and federal funds; China Scholarship Council (CSC)(China Scholarship Council); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The project described was supported by award number grant UL1TR001070 from the National Center For Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Advancing Translational Sciences or the National Institutes of Health. Pilot funding from this grant was awarded to SJK and RJG. Salaries and research support were provided by state and federal funds appropriated to Ohio Agricultural Research and Development Center, The Ohio State University. The fellowship support by China Scholarship Council (CSC#2011666005) during KO's visit to OSU is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; Diavatopoulos DA, 2010, FASEB J, V24, P1789, DOI 10.1096/fj.09-146779; Garthoff LH, 2002, FOOD CHEM TOXICOL, V40, P487, DOI 10.1016/S0278-6915(01)00120-X; Genzel Y, 2006, VACCINE, V24, P6074, DOI 10.1016/j.vaccine.2006.05.023; Groves IJ, 2009, J GEN VIROL, V90, P2364, DOI 10.1099/vir.0.012526-0; Haynes L, 2012, J IMMUNOL, V189, P4921, DOI 10.4049/jimmunol.1201916; Huang YT, 2000, J CLIN MICROBIOL, V38, P422; Iannelli F, 1999, J BACTERIOL, V181, P2652, DOI 10.1128/JB.181.8.2652-2654.1999; Inman CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033707; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Khatri M, 2010, J VIROL, V84, P11210, DOI 10.1128/JVI.01211-10; Kim JO, 1999, INFECT IMMUN, V67, P2327, DOI 10.1128/IAI.67.5.2327-2333.1999; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Liu J, 2009, VACCINE, V27, P6460, DOI 10.1016/j.vaccine.2009.06.024; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; Marion C, 2009, INFECT IMMUN, V77, P1389, DOI 10.1128/IAI.01215-08; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; McCullers JA, 2010, J INFECT DIS, V202, P1287, DOI 10.1086/656333; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Pang XY, 2007, ISME J, V1, P156, DOI 10.1038/ismej.2007.23; PETERSON WD, 1971, P SOC EXP BIOL MED, V136, P1187; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sghir A, 2000, APPL ENVIRON MICROB, V66, P2263, DOI 10.1128/AEM.66.5.2263-2266.2000; Shakl JR, 2013, TRENDS MICROBIOL, V21, P129, DOI 10.1016/j.tim.2012.11.005; Short KR, 2012, FUTURE MICROBIOL, V7, P609, DOI [10.2217/FMB.12.29, 10.2217/fmb.12.29]; Smith AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003238; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; Verkaik NJ, 2011, CLIN MICROBIOL INFEC, V17, P1840, DOI 10.1111/j.1469-0691.2011.03480.x; Wang KC, 2008, BERL MUNCH TIERARZTL, V121, P198, DOI 10.2376/0005-9366-121-198; Yassine HM, 2009, VET MICROBIOL, V139, P132, DOI 10.1016/j.vetmic.2009.04.028	32	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90066	10.1371/journal.pone.0090066	http://dx.doi.org/10.1371/journal.pone.0090066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594847	gold, Green Published, Green Submitted			2022-12-25	WOS:000332468900064
J	Chai, Q; Singh, B; Peisker, K; Metzendorf, N; Ge, XL; Dasgupta, S; Sanyal, S				Chai, Qian; Singh, Bhupender; Peisker, Kristin; Metzendorf, Nicole; Ge, Xueliang; Dasgupta, Santanu; Sanyal, Suparna			Organization of Ribosomes and Nucleoids in Escherichia coli Cells during Growth and in Quiescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics; Cell Division; Cytoskeleton; DNA Replication; Ribosomes; Subcellular Organelles; Transcription; Translation; FtsZ Ring; Nucleoid	BACTERIAL CHROMOSOME; BACILLUS-SUBTILIS; RNA-POLYMERASE; ACTIVE TRANSCRIPTION; GENETIC INFORMATION; DNA-REPLICATION; E. COLI; Z-RING; TRANSLATION; PROTEIN	Background: We studied ribosome and nucleoid distribution in Escherichia coli under growth and quiescence. Results: Spatially segregated ribosomes and nucleoids show drastically altered distribution in stationary phase or when treated with drugs affecting translation, transcription, nucleoid-topology, or cytoskeleton. Ribosome inheritance in daughter cells is frequently unequal. Conclusion: Cellular growth processes modulate ribosome and nucleoid distribution. Significance: This provides insight into subcellular organization of molecular machines. We have examined the distribution of ribosomes and nucleoids in live Escherichia coli cells under conditions of growth, division, and in quiescence. In exponentially growing cells translating ribosomes are interspersed among and around the nucleoid lobes, appearing as alternative bands under a fluorescence microscope. In contrast, inactive ribosomes either in stationary phase or after treatment with translation inhibitors such as chloramphenicol, tetracycline, and streptomycin gather predominantly at the cell poles and boundaries with concomitant compaction of the nucleoid. However, under all conditions, spatial segregation of the ribosomes and the nucleoids is well maintained. In dividing cells, ribosomes accumulate on both sides of the FtsZ ring at the mid cell. However, the distribution of the ribosomes among the new daughter cells is often unequal. Both the shape of the nucleoid and the pattern of ribosome distribution are also modified when the cells are exposed to rifampicin (transcription inhibitor), nalidixic acid (gyrase inhibitor), or A22 (MreB-cytoskeleton disruptor). Thus we conclude that the intracellular organization of the ribosomes and the nucleoids in bacteria are dynamic and critically dependent on cellular growth processes (replication, transcription, and translation) as well as on the integrity of the MreB cytoskeleton.	[Chai, Qian; Singh, Bhupender; Peisker, Kristin; Metzendorf, Nicole; Ge, Xueliang; Dasgupta, Santanu; Sanyal, Suparna] Uppsala Univ, Dept Cell & Mol Biol, BMC, S-75124 Uppsala, Sweden	Uppsala University	Sanyal, S (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, BMC, Box 596, S-75124 Uppsala, Sweden.	suparna.sanyal@icm.uu.se	Singh, Bhupender/B-6817-2009	Singh, Bhupender/0000-0001-5634-6252; Ge, Xueliang/0000-0001-7954-3195	Swedish Research Council [2010-2619, 2011-6088, 2008-6593]; Carl-Tryggers Foundation [CTS 09:341, 10:330]; Wenner-Gren Foundation; Knut and Alice Wallenberg Foundation [KAW 2011.0081]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl-Tryggers Foundation; Wenner-Gren Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the research grants from the Swedish Research Council (2010-2619 (M), 2011-6088 (NT), and 2008-6593 (Linnaeus grant to Uppsala RNA Research Center)), the Carl-Tryggers Foundation (CTS 09:341 and 10: 330), the Wenner-Gren Foundation, and the Knut and Alice Wallenberg Foundation (KAW 2011.0081 to RiboCORE (to S. S.).	AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Azam TA, 2000, GENES CELLS, V5, P613, DOI 10.1046/j.1365-2443.2000.00350.x; Bakshi S, 2012, MOL MICROBIOL, V85, P21, DOI 10.1111/j.1365-2958.2012.08081.x; Bean GJ, 2009, BIOCHEMISTRY-US, V48, P4852, DOI 10.1021/bi900014d; Burmann BM, 2010, SCIENCE, V328, P501, DOI 10.1126/science.1184953; Cabrera JE, 2003, MOL MICROBIOL, V50, P1493, DOI 10.1046/j.1365-2958.2003.03805.x; Cabrera JE, 2009, J BACTERIOL, V191, P4180, DOI 10.1128/JB.01707-08; Campos M, 2013, CURR OPIN MICROBIOL, V16, P171, DOI 10.1016/j.mib.2013.01.007; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; DWORSKY P, 1973, J BACTERIOL, V116, P1364, DOI 10.1128/JB.116.3.1364-1374.1973; Ederth J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn992; English BP, 2011, P NATL ACAD SCI USA, V108, pE365, DOI 10.1073/pnas.1102255108; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Fishov I, 2012, CURR OPIN MICROBIOL, V15, P724, DOI 10.1016/j.mib.2012.11.001; Galli E, 2010, MOL MICROBIOL, V76, P1514, DOI 10.1111/j.1365-2958.2010.07183.x; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; Han XL, 2011, J ANTIMICROB CHEMOTH, V66, P323, DOI 10.1093/jac/dkq427; Herskovits AA, 2000, P NATL ACAD SCI USA, V97, P4621, DOI 10.1073/pnas.080077197; Hiraga S, 2000, ANNU REV GENET, V34, P21, DOI 10.1146/annurev.genet.34.1.21; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Konopka MC, 2006, J BACTERIOL, V188, P6115, DOI 10.1128/JB.01982-05; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; Llopis PM, 2010, NATURE, V466, P77, DOI 10.1038/nature09152; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Mascarenhas J, 2001, EMBO REP, V2, P685, DOI 10.1093/embo-reports/kve160; MILLER OL, 1970, SCIENCE, V169, P392, DOI 10.1126/science.169.3943.392; Mondal J, 2011, BIOPHYS J, V100, P2605, DOI 10.1016/j.bpj.2011.04.030; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Norris V, 2007, ANNU REV MICROBIOL, V61, P309, DOI 10.1146/annurev.micro.61.081606.103348; Ortiz JO, 2010, J CELL BIOL, V190, P613, DOI 10.1083/jcb.201005007; Osborn MJ, 2007, CURR OPIN MICROBIOL, V10, P606, DOI 10.1016/j.mib.2007.09.004; Pogliano J, 2001, P NATL ACAD SCI USA, V98, P4486, DOI 10.1073/pnas.081075798; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780; Soufo HJD, 2010, P NATL ACAD SCI USA, V107, P3163, DOI 10.1073/pnas.0911979107; Tao WT, 2000, MOL MICROBIOL, V38, P392, DOI 10.1046/j.1365-2958.2000.02138.x; Tao WT, 2000, PLASMID, V43, P200, DOI 10.1006/plas.1999.1457; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311; Woldringh CL, 2002, MOL MICROBIOL, V45, P17, DOI 10.1046/j.1365-2958.2002.02993.x; Zimmerman SB, 2006, J STRUCT BIOL, V156, P255, DOI 10.1016/j.jsb.2006.03.022	53	54	55	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11342	11352		10.1074/jbc.M114.557348	http://dx.doi.org/10.1074/jbc.M114.557348			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599955	Green Published, hybrid			2022-12-25	WOS:000334638500036
J	Gee, CE; Peterlik, D; Neuhauser, C; Bouhelal, R; Kaupmann, K; Laue, G; Uschold-Schmidt, N; Feuerbach, D; Zimmermann, K; Ofner, S; Cryan, JF; van der Putten, H; Fendt, M; Vranesic, I; Glatthar, R; Flor, PJ				Gee, Christine E.; Peterlik, Daniel; Neuhaeuser, Christoph; Bouhelal, Rochdi; Kaupmann, Klemens; Laue, Grit; Uschold-Schmidt, Nicole; Feuerbach, Dominik; Zimmermann, Kaspar; Ofner, Silvio; Cryan, John F.; van der Putten, Herman; Fendt, Markus; Vranesic, Ivo; Glatthar, Ralf; Flor, Peter J.			Blocking Metabotropic Glutamate Receptor Subtype 7 ( mGlu7) via the Venus Flytrap Domain ( VFTD) Inhibits Amygdala Plasticity, Stress, and Anxiety-related Behavior	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glutamate Receptors Metabotropic; Neurotransmitter Release; Pharmacology; Stress; Synaptic Plasticity; Elevated Plus-Maze; Fear Conditioning; XAP044	NEGATIVE ALLOSTERIC MODULATOR; CENTRAL-NERVOUS-SYSTEM; IN-VITRO; PHARMACOLOGICAL CHARACTERIZATION; MICE LACKING; ACTIVATION; PROTEIN; AGONIST; EXTINCTION; ANTIDEPRESSANT	Background: Behavioral genetics identified mGlu7 as a key regulator of brain emotion circuits. Results: An mGlu7-selective, Venus flytrap domain (VFTD)-directed antagonist inhibits fear, synaptic plasticity, stress, and anxiety in rodents. Conclusion: Pharmacological blockers of mGlu7 may represent promising future anxiolytics and antidepressants in man. Significance: The VFTD region of class C GPCRs provides a promising target for computer-assisted drug design. The metabotropic glutamate receptor subtype 7 (mGlu7) is an important presynaptic regulator of neurotransmission in the mammalian CNS. mGlu7 function has been linked to autism, drug abuse, anxiety, and depression. Despite this, it has been difficult to develop specific blockers of native mGlu7 signaling in relevant brain areas such as amygdala and limbic cortex. Here, we present the mGlu7-selective antagonist 7-hydroxy-3-(4-iodophenoxy)-4H-chromen-4-one (XAP044), which inhibits lateral amygdala long term potentiation (LTP) in brain slices from wild type mice with a half-maximal blockade at 88 nm. There was no effect of XAP044 on LTP of mGlu7-deficient mice, indicating that this pharmacological effect is mGlu7-dependent. Unexpectedly and in contrast to all previous mGlu7-selective drugs, XAP044 does not act via the seven-transmembrane region but rather via a binding pocket localized in mGlu7's extracellular Venus flytrap domain, a region generally known for orthosteric agonist binding. This was shown by chimeric receptor studies in recombinant cell line assays. XAP044 demonstrates good brain exposure and wide spectrum anti-stress and antidepressant- and anxiolytic-like efficacy in rodent behavioral paradigms. XAP044 reduces freezing during acquisition of Pavlovian fear and reduces innate anxiety, which is consistent with the phenotypes of mGlu7-deficient mice, the results of mGlu7 siRNA knockdown studies, and the inhibition of amygdala LTP by XAP044. Thus, we present an mGlu7 antagonist with a novel molecular mode of pharmacological action, providing significant application potential in psychiatry. Modeling the selective interaction between XAP044 and mGlu7's Venus flytrap domain, whose three-dimensional structure is already known, will facilitate future drug development supported by computer-assisted drug design.	[Gee, Christine E.; Bouhelal, Rochdi; Kaupmann, Klemens; Laue, Grit; Feuerbach, Dominik; Zimmermann, Kaspar; Ofner, Silvio; Cryan, John F.; van der Putten, Herman; Fendt, Markus; Vranesic, Ivo; Glatthar, Ralf; Flor, Peter J.] Novartis AG, Novartis Inst BioMed Res, CH-4057 Basel, Switzerland; [Gee, Christine E.] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol Hamburg, D-20249 Hamburg, Germany; [Peterlik, Daniel; Neuhaeuser, Christoph; Uschold-Schmidt, Nicole; Flor, Peter J.] Univ Regensburg, Fac Biol & Preclin Med, Lab Mol & Cellular Neurobiol, D-93053 Regensburg, Germany; [Cryan, John F.] Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland; [Fendt, Markus] Univ Magdeburg, Inst Pharmacol & Toxicol, D-39120 Magdeburg, Germany; [Fendt, Markus] Univ Magdeburg, Ctr Behav Brain Sci, D-39120 Magdeburg, Germany	Novartis; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Regensburg; University College Cork; Otto von Guericke University; Otto von Guericke University	Glatthar, R (corresponding author), Novartis Pharma AG, CH-4057 Basel, Switzerland.	ralf.glatthar@novartis.com; peter.flor@biologie.uni-regensburg.de	Cryan, John F./A-6950-2013; Fendt, Markus/G-1888-2013; Gee, Christine E/E-9241-2013	Cryan, John F./0000-0001-5887-2723; Fendt, Markus/0000-0002-3451-1226; Gee, Christine E/0000-0003-0345-3665; Kaupmann, Klemens/0000-0001-8903-2508	German Research Foundation [FL 729/2-1]	German Research Foundation(German Research Foundation (DFG))	Supported by Grant FL 729/2-1 from the German Research Foundation. To whom correspondence may be addressed: Faculty of Biology and Preclinical Medicine, University of Regensburg, D-93053 Regensburg, Germany. Tel.: 49-941-3079; Fax: 49-941-3052; E-mail: peter.flor@biologie.uni-regensburg.de.	Bessis AS, 2002, P NATL ACAD SCI USA, V99, P11097, DOI 10.1073/pnas.162138699; Bhattacharya S, 2013, PROTEINS, V81, P729, DOI 10.1002/prot.24195; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Callaerts-Vegh Z, 2006, J NEUROSCI, V26, P6573, DOI 10.1523/JNEUROSCI.1497-06.2006; Chaperon F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034963; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Cryan JF, 2003, EUR J NEUROSCI, V17, P2409, DOI 10.1046/j.1460-9568.2003.02667.x; Dobi A, 2013, NEUROPHARMACOLOGY, V66, P274, DOI 10.1016/j.neuropharm.2012.05.025; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Fendt M, 2008, MOL PSYCHIATR, V13, P970, DOI 10.1038/sj.mp.4002073; Fendt M, 2013, NEUROPHARMACOLOGY, V72, P215, DOI 10.1016/j.neuropharm.2013.04.052; Flor PJ, 2012, BIOCHEM PHARMACOL, V84, P414, DOI 10.1016/j.bcp.2012.04.013; Flor PJ, 1997, NEUROPHARMACOLOGY, V36, P153, DOI 10.1016/S0028-3908(96)00176-1; FLOR PJ, 1995, NEUROPHARMACOLOGY, V34, P149, DOI 10.1016/0028-3908(94)00149-M; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Gasparini F, 1999, J PHARMACOL EXP THER, V289, P1678; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; Goddyn H, 2008, NEUROBIOL LEARN MEM, V90, P103, DOI 10.1016/j.nlm.2008.01.001; Hikichi H, 2010, EUR J PHARMACOL, V639, P106, DOI 10.1016/j.ejphar.2009.08.047; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Kalinichev M, 2013, J PHARMACOL EXP THER, V344, P624, DOI 10.1124/jpet.112.200915; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lee OK, 2002, NEUROREPORT, V13, P685, DOI 10.1097/00001756-200204160-00030; Lin FF, 1997, NEUROPHARMACOLOGY, V36, P917, DOI 10.1016/S0028-3908(97)00078-6; Litschig S, 1999, MOL PHARMACOL, V55, P453; Maj M, 2003, NEUROPHARMACOLOGY, V45, P895, DOI 10.1016/S0028-3908(03)00271-5; Martin R, 2010, J BIOL CHEM, V285, P17907, DOI 10.1074/jbc.M109.080838; Masugi M, 1999, J NEUROSCI, V19, P955; Maurer TS, 2005, DRUG METAB DISPOS, V33, P175, DOI 10.1124/dmd.104.001222; Mitsukawa K, 2005, P NATL ACAD SCI USA, V102, P18712, DOI 10.1073/pnas.0508063102; Mitsukawa K, 2006, NEUROPSYCHOPHARMACOL, V31, P1112, DOI 10.1038/sj.npp.1300926; Muto T, 2007, ACTA CRYSTALLOGR F, V63, P627, DOI 10.1107/S1744309107030059; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nakamura M, 2010, BIOORG MED CHEM LETT, V20, P726, DOI 10.1016/j.bmcl.2009.11.070; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Niswender CM, 2010, MOL PHARMACOL, V77, P459, DOI 10.1124/mol.109.058768; O'Connor RM, 2013, NEUROPHARMACOLOGY, V72, P66, DOI 10.1016/j.neuropharm.2013.03.028; O'Connor RM, 2010, EUR J PHARMACOL, V639, P123, DOI 10.1016/j.ejphar.2010.02.059; Palazzo E, 2008, NEUROPHARMACOLOGY, V55, P537, DOI 10.1016/j.neuropharm.2008.05.007; Palucha A, 2007, PSYCHOPHARMACOLOGY, V194, P555, DOI 10.1007/s00213-007-0856-2; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; Pelkey KA, 2008, J PHYSIOL-LONDON, V586, P1495, DOI 10.1113/jphysiol.2007.148635; Pelkey KA, 2007, NEUROPHARMACOLOGY, V52, P108, DOI 10.1016/j.neuropharm.2006.07.020; Pelkey KA, 2006, NEURON, V52, P497, DOI 10.1016/j.neuron.2006.08.032; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Porsolt RD, 2000, REV NEUROSCIENCE, V11, P53; Reber SO, 2007, ENDOCRINOLOGY, V148, P670, DOI 10.1210/en.2006-0983; Rizzo SJS, 2011, J PHARMACOL EXP THER, V338, P345, DOI 10.1124/jpet.110.177378; Rodrigues SM, 2002, J NEUROSCI, V22, P5219, DOI 10.1523/JNEUROSCI.22-12-05219.2002; Rosemond E, 2004, MOL PHARMACOL, V66, P834, DOI 10.1124/mol.104.002956; Sansig G, 2001, J NEUROSCI, V21, P8734, DOI 10.1523/JNEUROSCI.21-22-08734.2001; Schoepp DD, 2001, J PHARMACOL EXP THER, V299, P12; Slattery DA, 2012, PSYCHONEUROENDOCRINO, V37, P702, DOI 10.1016/j.psyneuen.2011.09.002; Stachowicz K, 2008, BEHAV PHARMACOL, V19, P597, DOI 10.1097/FBP.0b013e32830cd839; Suzuki G, 2007, J PHARMACOL EXP THER, V323, P147, DOI 10.1124/jpet.107.124701; Tones MA, 1995, NEUROREPORT, V7, P117, DOI 10.1097/00001756-199512290-00028; Topiol S, 2011, NEUROPHARMACOLOGY, V60, P93, DOI 10.1016/j.neuropharm.2010.08.001; Toth I, 2012, NEUROPHARMACOLOGY, V62, P1619, DOI 10.1016/j.neuropharm.2011.10.021; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Wauson EM, 2013, MOL ENDOCRINOL, V27, P1188, DOI 10.1210/me.2013-1100; Weng K, 1997, J BIOL CHEM, V272, P33100, DOI 10.1074/jbc.272.52.33100; Wootten DL, 2010, PROG MOL BIOL TRANSL, V91, P53, DOI 10.1016/S1877-1173(10)91003-X; Yan F, 2008, BIOCHEMISTRY-US, V47, P1567, DOI 10.1021/bi701476b	63	55	59	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					10975	10987		10.1074/jbc.M113.542654	http://dx.doi.org/10.1074/jbc.M113.542654			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596089	Green Published, hybrid			2022-12-25	WOS:000334638500004
J	Huang, FF; Zhang, L; Wu, DS; Yuan, XY; Chen, FP; Zeng, H; Yu, YH; Zhao, XL				Huang, Fang-Fang; Zhang, Li; Wu, Deng-Shu; Yuan, Xiao-Yu; Chen, Fang-Ping; Zeng, Hui; Yu, Yan-Hui; Zhao, Xie-Lan			PTEN Regulates BCRP/ABCG2 and the Side Population through the PI3K/Akt Pathway in Chronic Myeloid Leukemia	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; CANCER RESISTANCE PROTEIN; HEMATOPOIETIC STEM-CELLS; ACUTE LYMPHOBLASTIC-LEUKEMIA; ABCG2 MULTIDRUG TRANSPORTER; ABL TYROSINE KINASE; IMATINIB MESYLATE; BCR-ABL; PHILADELPHIA-CHROMOSOME; IN-VITRO	A small population of cancer stem cells named the "side population'' (SP) has been demonstrated to be responsible for the persistence of many solid tumors. However, the role of the SP in leukemic pathogenesis remains controversial. The resistance of leukemic stem cells to targeted therapies, such as tyrosine kinase inhibitors (TKIs), results in therapeutic failure or refractory/relapsed disease in chronic myeloid leukemia (CML). The drug pump, ATP-binding cassette sub-family G member 2 (ABCG2), is well known as a specific marker of the SP and could be controlled by several pathways, including the PI3K/Akt pathway. Our data demonstrated that compared with wild-type K562 cells, the higher percentage of ABCG2+ cells corresponded to the higher SP fraction in K562/ABCG2 (ABCG2 overexpressing) and K562/IMR (resistance to imatinib) cells, which exhibited enhanced drug resistance along with downregulated phosphatase and tensin homologue deleted on chromosome - 10 (PTEN) and activated phosphorylated-Akt (p-Akt). PTEN and p-Akt downregulation could be abrogated by both the PI3K inhibitor LY294002 and the mTOR inhibitor rapamycin. Moreover, in CML patients in the accelerated phase/blastic phase (AP/BP), increased SP phenotype rather than ABCG2 expression was accompanied by the loss of PTEN protein and the up-regulation of p-Akt expression. These results suggested that the expression of ABCG2 and the SP may be regulated by PTEN through the PI3K/Akt pathway, which would be a potentially effective strategy for targeting CML stem cells.	[Huang, Fang-Fang; Wu, Deng-Shu; Yuan, Xiao-Yu; Chen, Fang-Ping; Zeng, Hui; Yu, Yan-Hui; Zhao, Xie-Lan] Cent S Univ, Xiang Ya Hosp, Dept Hematol, Changsha, Hunan, Peoples R China; [Zhang, Li] Sichuan Univ, Dept Hematol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China	Central South University; Sichuan University	Zeng, H (corresponding author), Cent S Univ, Xiang Ya Hosp, Dept Hematol, Changsha, Hunan, Peoples R China.	androps2011@hotmail.com			National Natural Science Foundation of China [81100328, 81170477]; Doctoral Fund of Ministry of Education of China [20110162120010]; Fundamental Research Funds for the Central Universities [2011QNZT151]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 81100328), the Doctoral Fund of Ministry of Education of China (Grant No. 20110162120010), and the Fundamental Research Funds for the Central Universities (Grant No. 2011QNZT151) to HZ and the National Natural Science Foundation of China (Grant No. 81170477) to F-PC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albano F, 2010, ONCOGENE, V29, P2509, DOI 10.1038/onc.2009.524; Barnes DJ, 2005, ONCOGENE, V24, P6432, DOI 10.1038/sj.onc.1208796; Bhatia R, 2003, BLOOD, V101, P4701, DOI 10.1182/blood-2002-09-2780; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Burger H, 2004, BLOOD, V104, P2940, DOI 10.1182/blood-2004-04-1398; Cortes J, 2005, CLIN CANCER RES, V11, P3425, DOI 10.1158/1078-0432.CCR-04-2139; Cortes J, 2004, BLOOD, V104, P2204, DOI 10.1182/blood-2004-04-1335; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Davies A, 2009, LEUKEMIA, V23, P1999, DOI 10.1038/leu.2009.166; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell Margaret A, 2005, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0918s34; Gronbaek K, 1998, BLOOD, V91, P4388; Hegedus C, 2012, BIOCHEM BIOPH RES CO, V420, P869, DOI 10.1016/j.bbrc.2012.03.090; Holyoake TL, 2001, BLOOD, V97, P720, DOI 10.1182/blood.V97.3.720; Houghton PJ, 2004, CANCER RES, V64, P2333, DOI 10.1158/0008-5472.CAN-03-3344; Huang FF, 2013, CANCER LETT, V336, P96, DOI 10.1016/j.canlet.2013.04.006; Illmer T, 2004, LEUKEMIA, V18, P401, DOI 10.1038/sj.leu.2403257; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jordanides NE, 2006, BLOOD, V108, P1370, DOI 10.1182/blood-2006-02-003145; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kantarjian HM, 2007, BLOOD, V110, P3540, DOI 10.1182/blood-2007-03-080689; Li HX, 2011, CANCER BIOL THER, V11, P950, DOI 10.4161/cbt.11.11.15531; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Nakanishi T, 2006, BLOOD, V108, P678, DOI 10.1182/blood-2005-10-4020; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; Ottmann O, 2007, BLOOD, V110, P2309, DOI 10.1182/blood-2007-02-073528; Ozvegy-Laczka C, 2004, MOL PHARMACOL, V65, P1485, DOI 10.1124/mol.65.6.1485; PEIFFER SL, 1995, CANCER RES, V55, P1922; Peng C, 2010, BLOOD, V115, P626, DOI 10.1182/blood-2009-06-228130; Ross DD, 2010, METHODS MOL BIOL, V596, P251, DOI 10.1007/978-1-60761-416-6_12; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Thomas J, 2004, BLOOD, V104, P3739, DOI 10.1182/blood-2003-12-4276; Weisberg E, 2003, DRUG RESIST UPDATE, V6, P231, DOI 10.1016/S1368-7646(03)00062-1; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zeng H, 2009, STEM CELLS, V27, P2435, DOI 10.1002/stem.192; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	42	39	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e88298	10.1371/journal.pone.0088298	http://dx.doi.org/10.1371/journal.pone.0088298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603487	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600005
J	Wang, CH; Wachholtz, M; Wang, J; Liao, XL; Lu, GQ				Wang, Chenghui; Wachholtz, Michael; Wang, Jun; Liao, Xiaolin; Lu, Guoqing			Analysis of the Skin Transcriptome in Two Oujiang Color Varieties of Common Carp	PLOS ONE			English	Article							CYPRINUS-CARPIO; GENOME DUPLICATION; RNA-SEQ; EVOLUTION; PIGMENTATION; GENE; PATHWAYS; DATABASE; TOOL	Background: Body color and coloration patterns are important phenotypic traits to maintain survival and reproduction activities. The Oujiang color varieties of common carp (Cyprinus carpio var. color), with a narrow distribution in Zhejiang Province of China and a history of aquaculture for over 1,200 years, consistently exhibit a variety of body color patterns. The molecular mechanism underlying diverse color patterns in these variants is unknown. To the practical end, it is essential to develop molecular markers that can distinguish different phenotypes and assist selective breeding. Methodology/Principal Findings: In this exploratory study, we conducted Roche 454 transcriptome sequencing of two pooled skin tissue samples of Oujiang common carp, which correspond to distinct color patterns, red with big black spots (RB) and whole white (WW), and a total of 737,525 sequence reads were generated. The reads obtained in this study were co-assembled jointly with common carp Roche 454 sequencing reads downloaded from NCBI SRA database, resulting in 43,923 isotigs and 546,676 singletons. Over 31 thousand (31,445; 71.6%) isotigs were found with significant BLAST matches (E<1e-10) to the nr protein database, which corresponds to 12,597 annotated zebrafish genes. A total of 70,947 isotigs and singletons (transcripts) were annotated with Gene Ontology, and 60,221 transcripts were found with corresponding EC numbers. Out of 145 zebrafish pigmentation genes, orthologs for 117 were recovered in Oujiang color carp transcriptome, including 18 found only among singletons. Our transcriptome analysis revealed over 52,902 SNPs in Oujiang common carp, and identified 63 SNP markers that are putatively unique either for RB or WW. Conclusions: The transcriptome of Oujiang color varieties of common carp obtained through this study, along with the pigmentation genes recovered and the color pattern-specific molecular markers developed, will facilitate future research on the molecular mechanism of color patterns and promote aquaculture of Oujiang color varieties of common carp through molecular marker assisted-selective breeding.	[Wang, Chenghui] Shanghai Ocean Univ, Minist Agr, Key Lab Freshwater Fisheries Germplasm Resources, Shanghai, Peoples R China; [Wang, Chenghui; Wachholtz, Michael; Wang, Jun; Liao, Xiaolin; Lu, Guoqing] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA; [Liao, Xiaolin] Minist Water Resources, Key Lab Ecol Impacts Hydraul Projects & Restorat, Inst Hydroecol, Wuhan, Peoples R China; [Liao, Xiaolin] Chinese Acad Sci, Wuhan, Peoples R China	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; University of Nebraska System; Chinese Academy of Sciences; Ministry of Water Resources; Chinese Academy of Sciences	Wang, CH (corresponding author), Shanghai Ocean Univ, Minist Agr, Key Lab Freshwater Fisheries Germplasm Resources, Shanghai, Peoples R China.	wangch@shou.edu.cn; glu3@unomaha.edu		wang, jun/0000-0002-6591-3316	Special Fund for Agro-Scientific Research in the Public Interest [200903045]; National Natural Science Foundation of China [30972250]; Shanghai University Knowledge Service Platform [ZF1206]	Special Fund for Agro-Scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai University Knowledge Service Platform	Funding was provided by grants from the Special Fund for Agro-Scientific Research in the Public Interest (No. 200903045), National Natural Science Foundation of China (No. 30972250), and by the Shanghai University Knowledge Service Platform (ZF1206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschmied J, 2002, GENETICS, V161, P259; Attwood TK, 2002, NUCLEIC ACIDS RES, V30, P239, DOI 10.1093/nar/30.1.239; Bagnara JT, 2007, PIGM CELL RES, V20, P14, DOI 10.1111/j.1600-0749.2006.00360.x; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; BALON EK, 1995, AQUACULTURE, V129, P3, DOI 10.1016/0044-8486(94)00227-F; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Braasch I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-74; Braasch I, 2009, GENOME BIOL EVOL, V1, P479, DOI 10.1093/gbe/evp050; Braasch I, 2009, PIGM CELL MELANOMA R, V22, P839, DOI 10.1111/j.1755-148X.2009.00614.x; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Chouvarine P, 2012, PLOS ONE, V7, P168, DOI 10.1371/journal.pone.0029850; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; David L, 2004, AQUACULTURE, V233, P129, DOI 10.1016/j.aquaculture.2003.10.033; David L, 2003, MOL BIOL EVOL, V20, P1425, DOI 10.1093/molbev/msg173; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Huan P, 2012, MAR BIOTECHNOL, V14, P69, DOI 10.1007/s10126-011-9389-0; Ji PF, 2012, INT J MOL SCI, V13, P9798, DOI 10.3390/ijms13089798; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li S, 2003, AGR DEV OPPORTUNITIE, V65, P17; Li SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036592; Liao XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062308; Logan DW, 2006, PIGM CELL RES, V19, P206, DOI 10.1111/j.1600-0749.2006.00307.x; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Ma YQ, 2011, FISHERIES SCI, V77, P591, DOI 10.1007/s12562-011-0359-2; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mellgren EM, 2002, TRENDS GENET, V18, P128, DOI 10.1016/S0168-9525(01)02614-2; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Protas ME, 2008, ANNU REV CELL DEV BI, V24, P425, DOI 10.1146/annurev.cellbio.24.110707.175302; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Richardson J, 2008, ZEBRAFISH, V5, P289, DOI 10.1089/zeb.2008.0541; Rodgers GM, 2010, ANIM BEHAV, V79, P1025, DOI 10.1016/j.anbehav.2010.01.017; Salem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036264; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Samanta MP, 2006, SCIENCE, V314, P960, DOI 10.1126/science.1131898; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Sugie A, 2004, GENE, V343, P337, DOI 10.1016/j.gene.2004.09.019; Visser WE, 2010, HUM MOL GENET, V19, P4189, DOI 10.1093/hmg/ddq337; Wang CH, 2008, J SHANGHAI FISH UNI, V4, P004; Wang CH, 2010, AQUAC RES, V41, P1339, DOI 10.1111/j.1365-2109.2009.02422.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xu F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2256; Zhu L, 2013, J SHANGHAI IN PRESS	49	36	45	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90074	10.1371/journal.pone.0090074	http://dx.doi.org/10.1371/journal.pone.0090074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603653	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600028
J	Sanz, AB; Aroeira, LS; Bellon, T; del Peso, G; Jimenez-Heffernan, J; Santamaria, B; Sanchez-Nino, MD; Blanco-Colio, LM; Lopez-Cabrera, M; Ruiz-Ortega, M; Egido, J; Selgas, R; Ortiz, A				Belen Sanz, Ana; Stark Aroeira, Luiz; Bellon, Teresa; del Peso, Gloria; Jimenez-Heffernan, Jose; Santamaria, Beatriz; Dolores Sanchez-Nino, Maria; Miguel Blanco-Colio, Luis; Lopez-Cabrera, Manuel; Ruiz-Ortega, Marta; Egido, Jesus; Selgas, Rafael; Ortiz, Alberto			TWEAK Promotes Peritoneal Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; TO-MESENCHYMAL TRANSITION; NECROSIS-FACTOR-ALPHA; MESOTHELIAL CELLS; WEAK INDUCER; APOPTOSIS; CYTOKINES; DIALYSIS; PATHWAY; PROLIFERATION	Peritoneal dialysis (PD) is complicated by peritonitis episodes that cause loss of mesothelium and eventually sclerosing peritonitis. An improved understanding of the molecular contributors to peritoneal injury and defense may increase the therapeutic armamentarium to optimize peritoneal defenses while minimizing peritoneal injury. There is no information on the expression and function of the cytokine TWEAK and its receptor Fn14 during peritoneal injury. Fn14 expression and soluble TWEAK levels were measured in human PD peritoneal effluent cells or fluids with or without peritonitis. Fn14 expression was also analyzed in peritoneal biopsies from PD patients. Actions of intraperitoneal TWEAK were studied in mice in vivo. sTWEAK levels were increased in peritoneal effluent in PD peritonitis. Effluent sTWEAK levels correlated with the number of peritoneal macrophages (r = 0.491, p = 0.002). Potential TWEAK targets that express the receptor Fn14 include mesothelial cells and macrophages, as demonstrated by flow cytometry of peritoneal effluents and by analysis of peritoneal biopsies. Peritoneal biopsy Fn14 correlated with mesothelial injury, fibrosis and inflammation, suggesting a potential deleterious effect of TWEAK/Fn14. In this regard, intraperitoneal TWEAK administration to mice promoted peritoneal inflammation characterized by increased peritoneal effluent MCP-1, Fn14 and Gr1(+) macrophages, increased mesothelial Fn14, MCP-1 and CCL21 expression and submesothelial tissue macrophage recruitment. Taken together these data suggest that the TWEAK/Fn14 system may promote inflammation and tissue injury during peritonitis and PD.	[Belen Sanz, Ana; Santamaria, Beatriz; Miguel Blanco-Colio, Luis; Ruiz-Ortega, Marta; Egido, Jesus; Ortiz, Alberto] IIS Fdn Jimenez Diaz, Lab Nephrol, Madrid, Spain; [Stark Aroeira, Luiz] IBIV, Dept Immunol, Vigo, Pontevedra, Spain; [Bellon, Teresa; del Peso, Gloria; Dolores Sanchez-Nino, Maria; Selgas, Rafael] IDIPAZ, Dept Nephrol, Madrid, Spain; [Belen Sanz, Ana; del Peso, Gloria; Dolores Sanchez-Nino, Maria; Lopez-Cabrera, Manuel; Ruiz-Ortega, Marta; Selgas, Rafael; Ortiz, Alberto] REDinREN, Madrid, Spain; [Jimenez-Heffernan, Jose] Hosp Univ Princesa, Madrid, Spain; [Lopez-Cabrera, Manuel] Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Ruiz-Ortega, Marta; Egido, Jesus; Selgas, Rafael; Ortiz, Alberto] Univ Autonoma Madrid, Madrid, Spain; [Egido, Jesus; Selgas, Rafael; Ortiz, Alberto] IRSIN, Madrid, Spain	Fundacion Jimenez Diaz; Hospital de La Princesa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Sanz, AB (corresponding author), IIS Fdn Jimenez Diaz, Lab Nephrol, Madrid, Spain.	asanz@fjd.es	Ortega, Marta Ruiz/AAN-2136-2020; Bellón, Teresa/ABF-4916-2020; Sanz, Ana Belen/C-9489-2013; Cabrera, Manuel López/AAA-5463-2019; Ruiz-Ortega, Marta/D-3584-2012; Santamaria, Beatriz/B-3469-2015; Blanco-Colio, Luis M./Z-2390-2019; Aroeira, Luiz Stark/D-7558-2014; Sanchez-Niño, Maria Dolores/B-7350-2019; ortiz, alberto/Y-7582-2018; ruiz-ortega, marta/D-3584-2012	Ortega, Marta Ruiz/0000-0002-1495-6535; Bellón, Teresa/0000-0002-0138-6879; Sanz, Ana Belen/0000-0002-0255-5689; Ruiz-Ortega, Marta/0000-0002-1495-6535; Santamaria, Beatriz/0000-0002-1990-2106; Aroeira, Luiz Stark/0000-0001-9391-1409; Sanchez-Niño, Maria Dolores/0000-0001-7110-6409; ortiz, alberto/0000-0002-9805-9523; ruiz-ortega, marta/0000-0002-1403-2690; Blanco-Colio, Luis Miguel/0000-0002-1560-6609; Lopez Cabrera, Manuel/0000-0002-0976-9719	FIS [PS09/00447, PI08/1564, PI10/00234, MS12/03262]; FEDER funds ISCIII-RETIC [REDinREN/RD06/0016, RD12/0021]; Comunidad de Madrid [S2010/BMD-2321, S2010/BMD-2378]; Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM); Programa Estabilizacion Investigadores; Miguel Servet; Sara Borrell	FIS(Instituto de Salud Carlos III); FEDER funds ISCIII-RETIC; Comunidad de Madrid(Comunidad de Madrid); Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM)(Instituto de Salud Carlos III); Programa Estabilizacion Investigadores; Miguel Servet; Sara Borrell	This work was supported by FIS PS09/00447, PI08/1564, PI10/00234, MS12/03262, FEDER funds ISCIII-RETIC REDinREN/RD06/0016, RD12/0021, Comunidad de Madrid (Fibroteam S2010/BMD-2321, S2010/BMD-2378). Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM) to AO, Programa Estabilizacion Investigadores to LB-C, Miguel Servet to ABS, Sara Borrell to BS, MDSN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroeira LS, 2008, PERITON DIALYSIS INT, V28, pS29; Sanz AB, 2011, KIDNEY INT, V80, P708, DOI 10.1038/ki.2011.180; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Blake PG, 2010, PERITON DIALYSIS INT, V30, P391, DOI 10.3747/pdi.2010.00142; Blanco-Colio LM, 2007, ARTERIOSCL THROM VAS, V27, P916, DOI 10.1161/01.ATV.0000258972.10109.ff; Brauner A, 1996, AM J KIDNEY DIS, V27, P402, DOI 10.1016/S0272-6386(96)90364-9; Campbell S, 2004, FRONT BIOSCI-LANDMRK, V9, P2273, DOI 10.2741/1395; Catalan MP, 2003, KIDNEY INT, V64, P321, DOI 10.1046/j.1523-1755.2003.00062.x; Chicheportiche Y, 2002, ARTHRITIS RES, V4, P126, DOI 10.1186/ar388; Cina D, 2009, NEPHROL DIAL TRANSPL, V24, P448, DOI 10.1093/ndt/gfn498; DASGUPTA MK, 1994, KIDNEY INT, V46, P475, DOI 10.1038/ki.1994.297; del Peso G, 2008, KIDNEY INT, V73, pS26, DOI 10.1038/sj.ki.5002598; Desplat-Jego S, 2002, J NEUROIMMUNOL, V133, P116, DOI 10.1016/S0165-5728(02)00368-5; Sanchez-Nino MD, 2010, J AM SOC NEPHROL, V21, P610, DOI 10.1681/ASN.2009020227; Sanchez-Nino MD, 2009, J AM SOC NEPHROL, V20, P353, DOI 10.1681/ASN.2008020194; Flessner MF, 2007, CLIN NEPHROL, V68, P341; Harada N, 2002, BIOCHEM BIOPH RES CO, V299, P488, DOI 10.1016/S0006-291X(02)02670-0; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Lai KN, 2010, NEPHRON CLIN PRACT, V116, pC11, DOI 10.1159/000314544; Loureiro J, 2011, J AM SOC NEPHROL, V22, P1682, DOI 10.1681/ASN.2010111197; Margetts PJ, 2002, AM J PATHOL, V160, P2285, DOI 10.1016/S0002-9440(10)61176-5; Margetts PJ, 2001, J AM SOC NEPHROL, V12, P2029, DOI 10.1681/ASN.V12102029; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; Merkle M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/709673; Michaelson JS, 2012, J AUTOIMMUN, V39, P130, DOI 10.1016/j.jaut.2012.05.003; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Munoz-Garcia B, 2011, CARDIOVASC RES, V89, P225, DOI 10.1093/cvr/cvq278; Munoz-Garcia B, 2009, ARTERIOSCL THROM VAS, V29, P2061, DOI 10.1161/ATVBAHA.109.194852; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Santamaria B, 2006, NEPHROL DIAL TRANSPL, V21, pii12; Santamaria B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006634; Sanz AB, 2009, J CELL MOL MED, V13, P3329, DOI 10.1111/j.1582-4934.2009.00766.x; Sanz AB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008955; Sanz AB, 2008, J AM SOC NEPHROL, V19, P695, DOI 10.1681/ASN.2007050577; Schwartz N, 2006, J AUTOIMMUN, V27, P242, DOI 10.1016/j.jaut.2006.12.003; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Xia YM, 2012, CLIN IMMUNOL, V145, P108, DOI 10.1016/j.clim.2012.08.008; Yilmaz MI, 2009, CLIN J AM SOC NEPHRO, V4, P1716, DOI 10.2215/CJN.02760409; Yung S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/484167; ZEMEL D, 1994, KIDNEY INT, V46, P1422, DOI 10.1038/ki.1994.414	43	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90399	10.1371/journal.pone.0090399	http://dx.doi.org/10.1371/journal.pone.0090399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599047	Green Submitted, Green Published, gold			2022-12-25	WOS:000332479400070
J	Sun, XJ; Fang, B; Zhao, X; Zhang, GW; Ma, H				Sun, Xuejun; Fang, Bo; Zhao, Xi; Zhang, Guangwei; Ma, Hong			Preconditioning of Mesenchymal Stem Cells by Sevoflurane to Improve Their Therapeutic Potential	PLOS ONE			English	Article							BONE-MARROW; STROMAL CELLS; IN-VITRO; MYOCARDIAL-INFARCTION; VOLATILE ANESTHETICS; INDUCED APOPTOSIS; PC12 CELLS; HYPOXIA; EXPRESSION; TRANSPLANTATION	Background: Bone marrow mesenchymal stem cells (MSCs) have been found to produce beneficial effects on ischemia-reperfusion injury. However, most of the MSCs died when transplanted into the ischemic tissue, which severely limit their therapeutic potential. Methods: Using an in vitro model of hypoxia and serum deprivation (H/SD), we investigated the hypothesis that sevoflurane preconditioning could protect MSCs against H/SD-induced apoptosis and improve their migration, proliferation, and therapeutic potential. The H/SD of MSCs and neuron-like PC12 cells were incubated in a serum-free medium and an oxygen concentration below 0.1% for 24 h. Sevoflurane preconditioning was performed through a 2-h incubation of MSCs in an airtight chamber filled with 2 vol% sevoflurane. Apoptosis of MSCs or neuron-like PC12 cells was assessed using Annexin V-FITC/propidium iodide (PI). Furthermore, the mitochondrial membrane potential was assessed using lipophilic cationic probe. The proliferation rate was evaluated through cell cycle analysis. Finally, HIF-1 alpha, HIF-2 alpha, VEGF and p-Akt/Akt levels were measured by western blot. Results: Sevoflurane preconditioning minimized the MSCs apoptosis and loss of mitochondrial membrane potential. Furthermore, it increased the migration and expression of HIF-1 alpha, HIF-2 alpha, VEGF, and p-Akt/Akt, reduced by H/SD. In addition, neuron-like PC12 cells were more resistant to H/SD-induced apoptosis when they were co-cultured with sevoflurane preconditioning MSCs. Conclusion: These findings suggest that sevoflurane preconditioning produces protective effects on survival and migration of MSCs against H/SD, as well as improving the therapeutic potential of MSCs. These beneficial effects might be mediated at least in part by upregulating HIF-1 alpha, HIF-2 alpha, VEGF, and p-Akt/Akt.	[Sun, Xuejun; Fang, Bo; Zhao, Xi; Ma, Hong] China Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Shenyang, Liaoning, Peoples R China; [Zhang, Guangwei] China Med Univ, Affiliated Hosp 1, Dept Cardiac Surg, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Ma, H (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Shenyang, Liaoning, Peoples R China.	mahong5466@yahoo.com	sun, xuejun/A-5561-2010; f, b/AGL-6241-2022; Zhang, Guang-Wei/GRN-9137-2022	sun, xuejun/0000-0003-2387-5531; Fang, Bo/0000-0002-4812-6919	Ministry of Education of China [20092104110009]; Science and Technology Plan Project of Liaoning Province, China [2012408002]; Fund for Scientific Research of the First Hospital of China Medical University [2014-07]	Ministry of Education of China(Ministry of Education, China); Science and Technology Plan Project of Liaoning Province, China; Fund for Scientific Research of the First Hospital of China Medical University	The study was supported by Doctoral Fund of Ministry of Education of China, No. 20092104110009; Science and Technology Plan Project of Liaoning Province, China, No. 2012408002; and Fund for Scientific Research of the First Hospital of China Medical University, No. 2014-07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Deng J, 2010, APOPTOSIS, V15, P463, DOI 10.1007/s10495-009-0434-7; Ding Q, 2009, ANESTH ANALG, V109, P1263, DOI 10.1213/ane.0b013e3181b2214c; Emerling BM, 2013, P NATL ACAD SCI USA, V110, P3483, DOI 10.1073/pnas.1222435110; Fan WW, 2013, STEM CELLS, V31, P203, DOI 10.1002/stem.1265; Fang B, 2013, J VASC SURG, V58, P1043, DOI 10.1016/j.jvs.2012.11.087; Gao Q, 2008, NEUROSCIENCE, V152, P646, DOI 10.1016/j.neuroscience.2007.10.069; Geng YJ, 2003, ANN NY ACAD SCI, V1010, P687, DOI 10.1196/annals.1299.126; Grau Cristina Malagelada, 2012, Methods Mol Biol, V846, P201, DOI 10.1007/978-1-61779-536-7_18; Holzwarth C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-11; Hung SP, 2012, J ORTHOP RES, V30, P260, DOI 10.1002/jor.21517; Kachooei E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041344; Li DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073334; Li QF, 2006, ANESTHESIOLOGY, V105, P1211, DOI 10.1097/00000542-200612000-00021; Li QF, 2008, BRAIN RES, V1245, P26, DOI 10.1016/j.brainres.2008.09.069; Li ZW, 2010, J CELL BIOCHEM, V111, P811, DOI 10.1002/jcb.22731; Li ZW, 2010, FEBS J, V277, P3688, DOI 10.1111/j.1742-4658.2010.07770.x; Liu HB, 2010, BIOCHEM BIOPH RES CO, V401, P509, DOI 10.1016/j.bbrc.2010.09.076; Liu XB, 2012, J ZHEJIANG UNIV-SC B, V13, P616, DOI 10.1631/jzus.B1201004; Lucchinetti E, 2009, ANESTH ANALG, V109, P1117, DOI 10.1213/ANE.0b013e3181b5a277; Mo SJ, 2012, NEUROSCI LETT, V522, P92, DOI 10.1016/j.neulet.2012.06.002; Muller-Edenborn B, 2012, ANESTHESIOLOGY, V117, P293, DOI 10.1097/ALN.0b013e3182605df1; Nabiuni M, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-8; Noiseux N, 2012, ENDOCRINOLOGY, V153, P5361, DOI 10.1210/en.2012-1402; Popescu Mihaela, 2011, Roum Arch Microbiol Immunol, V70, P109; Saller MM, 2012, BIOCHEM BIOPH RES CO, V423, P379, DOI 10.1016/j.bbrc.2012.05.134; Sarnowska A, 2009, EXP NEUROL, V215, P317, DOI 10.1016/j.expneurol.2008.10.023; Scheibe F, 2012, CELL MOL NEUROBIOL, V32, P567, DOI 10.1007/s10571-012-9798-2; Suzuki Y, 2010, AM J PHYSIOL-HEART C, V299, pH1077, DOI 10.1152/ajpheart.00212.2010; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Wang S, 2010, NEUROSCI BULL, V26, P437, DOI 10.1007/s12264-010-6024-4; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x; Williams AR, 2013, CIRCULATION, V127, P213, DOI 10.1161/CIRCULATIONAHA.112.131110; Xie XX, 2012, TOHOKU J EXP MED, V226, P29, DOI 10.1620/tjem.226.29; Xinaris C, 2013, CELL TRANSPLANT, V22, P423, DOI 10.3727/096368912X653246; Zhang J, 2008, J NEUROSCI RES, V86, P1501, DOI 10.1002/jnr.21617; Zhong Q, 2012, STEM CELLS DEV, V21, P2703, DOI 10.1089/scd.2011.0604; Zhu WQ, 2006, STEM CELLS, V24, P416, DOI 10.1634/stemcells.2005-0121; Zitta K, 2010, EUR J PHARMACOL, V645, P39, DOI 10.1016/j.ejphar.2010.07.017	39	29	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90667	10.1371/journal.pone.0090667	http://dx.doi.org/10.1371/journal.pone.0090667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599264	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400113
J	Carviel, JL; Wilson, DC; Isaacs, M; Carella, P; Catana, V; Golding, B; Weretilnyk, EA; Cameron, RK				Carviel, Jessie L.; Wilson, Daniel C.; Isaacs, Marisa; Carella, Philip; Catana, Vasile; Golding, Brian; Weretilnyk, Elizabeth A.; Cameron, Robin K.			Investigation of Intercellular Salicylic Acid Accumulation during Compatible and Incompatible Arabidopsis-Pseudomonas syringae Interactions Using a Fast Neutron-Generated Mutant Allele of EDS5 Identified by Genetic Mapping and Whole-Genome Sequencing	PLOS ONE			English	Article							AGE-RELATED RESISTANCE; ENHANCED DISEASE SUSCEPTIBILITY; DEFENSE RESPONSES; REVERSE GENETICS; AVIRULENCE GENE; PV. TOMATO; HYPERSENSITIVE RESPONSE; BASAL DEFENSE; THALIANA; LOCUS	A whole-genome sequencing technique developed to identify fast neutron-induced deletion mutations revealed that iap1-1 is a new allele of EDS5 (eds5-5). RPS2-AvrRpt2-initiated effector-triggered immunity (ETI) was compromised in iap1-1/eds5-5 with respect to in planta bacterial levels and the hypersensitive response, while intra-and intercellular free salicylic acid (SA) accumulation was greatly reduced, suggesting that SA contributes as both an intracellular signaling molecule and an antimicrobial agent in the intercellular space during ETI. During the compatible interaction between wild-type Col-0 and virulent Pseudomonas syringae pv. tomato (Pst), little intercellular free SA accumulated, which led to the hypothesis that Pst suppresses intercellular SA accumulation. When Col-0 was inoculated with a coronatine-deficient strain of Pst, high levels of intercellular SA accumulation were observed, suggesting that Pst suppresses intercellular SA accumulation using its phytotoxin coronatine. This work suggests that accumulation of SA in the intercellular space is an important component of basal/PAMP-triggered immunity as well as ETI to pathogens that colonize the intercellular space.	[Carviel, Jessie L.; Wilson, Daniel C.; Isaacs, Marisa; Carella, Philip; Catana, Vasile; Golding, Brian; Weretilnyk, Elizabeth A.; Cameron, Robin K.] McMaster Univ, Dept Biol, Hamilton, ON, Canada	McMaster University	Cameron, RK (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	rcamero@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada; Ontario Research Excellence Fund; Ontario Graduate Scholarships; McMaster University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Research Excellence Fund; Ontario Graduate Scholarships(Ontario Graduate Scholarship); McMaster University	This research was funded by a Natural Sciences and Engineering Research Council of Canada grant to RKC, an Ontario Research Excellence Fund grant to EAW, Ontario Graduate Scholarships to DW and MI, and McMaster University for growth chamber maintenance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Agrios G. N., 2005, PLANT PATHOL; Ashelford K, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r28; Austin RS, 2011, PLANT J, V67, P715, DOI 10.1111/j.1365-313X.2011.04619.x; Bruggemann E, 1996, PLANT J, V10, P755, DOI 10.1046/j.1365-313X.1996.10040755.x; Cameron RK, 2004, PHYSIOL MOL PLANT P, V65, P197, DOI 10.1016/j.pmpp.2005.02.002; Cameron RK, 1999, PHYSIOL MOL PLANT P, V55, P121, DOI 10.1006/pmpp.1999.0214; Carviel JL, 2009, MOL PLANT PATHOL, V10, P621, DOI [10.1111/j.1364-3703.2009.00557.x, 10.1111/J.1364-3703.2009.00557.X]; Clarke JD, 2000, PLANT CELL, V12, P2175, DOI 10.1105/tpc.12.11.2175; Comai L, 2006, PLANT J, V45, P684, DOI 10.1111/j.1365-313X.2006.02670.x; Cuperus JT, 2010, P NATL ACAD SCI USA, V107, P466, DOI 10.1073/pnas.0913203107; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Torres M, 2006, PLANT J, V47, P368, DOI 10.1111/j.1365-313X.2006.02798.x; DeFraia CT, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-28; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Dempsey D'Maris Amick, 2011, Arabidopsis Book, V9, pe0156, DOI 10.1199/tab.0156; Develey-Riviere MP, 2007, NEW PHYTOL, V175, P405, DOI 10.1111/j.1469-8137.2007.02130.x; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Fragniere C, 2011, FEBS LETT, V585, P1847, DOI 10.1016/j.febslet.2011.04.039; Garcion C, 2008, PLANT PHYSIOL, V147, P1279, DOI 10.1104/pp.108.119420; Gassmann W, 1999, PLANT J, V20, P265, DOI 10.1046/j.1365-313X.1999.t01-1-00600.x; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Glazebrook J, 1996, GENETICS, V143, P973; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Henikoff S, 2003, ANNU REV PLANT BIOL, V54, P375, DOI 10.1146/annurev.arplant.54.031902.135009; Hinsch M, 1996, MOL PLANT MICROBE IN, V9, P55, DOI 10.1094/MPMI-9-0055; Huang WE, 2006, PLANT J, V46, P1073, DOI 10.1111/j.1365-313X.2006.02758.x; Hunter CA, 2003, PLANT PHYSIOL, V132, P2135, DOI 10.1104/pp.103.023309; Jagadeeswaran G, 2007, PLANT J, V51, P234, DOI 10.1111/j.1365-313X.2007.03130.x; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; Jing BB, 2011, PLANT PHYSIOL, V157, P973, DOI 10.1104/pp.111.182089; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; KOORNNEEF M, 1982, MUTAT RES, V93, P109, DOI 10.1016/0027-5107(82)90129-4; KUNKEL BN, 1993, PLANT CELL, V5, P865, DOI 10.1105/tpc.5.8.865; Kus JV, 2002, PLANT CELL, V14, P479, DOI 10.1105/tpc.010481; Lee MW, 2007, MOL PLANT MICROBE IN, V20, P1192, DOI 10.1094/MPMI-20-10-1192; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li X, 2001, PLANT J, V27, P235, DOI 10.1046/j.1365-313x.2001.01084.x; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; MA SW, 1991, MOL PLANT MICROBE IN, V4, P69, DOI 10.1094/MPMI-4-069; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Pike SM, 2005, PLANT PHYSIOL, V138, P1009, DOI 10.1104/pp.104.047142; Rairdan GJ, 2002, GENETICS, V161, P803; Rogers C, 2009, PLANT PHYSIOL, V151, P1077, DOI 10.1104/pp.109.142919; Rogers EE, 1997, PLANT CELL, V9, P305, DOI 10.1105/tpc.9.3.305; Schneeberger K, 2011, TRENDS PLANT SCI, V16, P282, DOI 10.1016/j.tplants.2011.02.006; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Serrano M, 2013, PLANT PHYSIOL, V162, P1815, DOI 10.1104/pp.113.218156; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; van Wees S, 2008, CSH PROTOC, DOI [10.1101/pdb.prot4982, DOI 10.1101/PDB.PR0T4982]; Venugopal SC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000545; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Whalen MC, 2005, MOL PLANT PATHOL, V6, P347, DOI [10.1111/j.1364-3703.2005.00286.x, 10.1111/J.1364-3703.2005.00286.X]; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wolfe J, 2000, PHYSIOL MOL PLANT P, V56, P253, DOI 10.1006/pmpp.2000.0270; Yamasaki K, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23603; YU GL, 1993, MOL PLANT MICROBE IN, V6, P434, DOI 10.1094/MPMI-6-434; Zabala MD, 2009, PLANT J, V59, P375, DOI 10.1111/j.1365-313X.2009.03875.x; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zheng XY, 2012, CELL HOST MICROBE, V11, P587, DOI 10.1016/j.chom.2012.04.014; Zheng ZY, 2009, PLANT J, V57, P1040, DOI 10.1111/j.1365-313X.2008.03747.x; Zhu Y, 2012, GENETICS, V192, P139, DOI 10.1534/genetics.112.141986	74	16	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e88608	10.1371/journal.pone.0088608	http://dx.doi.org/10.1371/journal.pone.0088608			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594657	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500006
J	Li, ZJ; Tu, M; Han, B; Gu, YQ; Xue, XF; Sun, J; Ge, QQ; Miao, Y; Qian, ZY; Gao, WT				Li, Zhanjun; Tu, Min; Han, Bei; Gu, Yuqing; Xue, Xiaofeng; Sun, Jie; Ge, Qianqian; Miao, Yi; Qian, Zhuyin; Gao, Wentao			Vasohibin 2 Decreases the Cisplatin Sensitivity of Hepatocarcinoma Cell Line by Downregulating p53	PLOS ONE			English	Article							NEGATIVE FEEDBACK REGULATOR; HEPATOCELLULAR-CARCINOMA; ANGIOGENESIS INHIBITOR; RESISTANCE; ENDOTHELIUM; EXPRESSION; CANCER; LIVER; GENE; DIFFERENTIATION	Hepatocellular carcinoma (HCC) is a prevalent problem worldwide. Chemotherapy, especially cisplatin (CDDP)-based systemic chemotherapy, is the best option for advanced liver cancer. However, CDDP resistance is becoming common and hindering the clinical application of CDDP. Meanwhile, no consensus has been reached regarding the chemotherapeutic use of vasohibin 2 (VASH2), which promotes the angiogenesis and proliferation of cancer cells. In this work, a tissue microarray was used to observe VASH2 and its possible role in cancer treatment. Results showed that VASH2 was highly expressed in HCC tissues and was significantly correlated with cancer differentiation. To further investigate the efficacy and mechanism of the combination of VASH2 with anti-cancer drugs in liver cancer cells, we stably built VASH2 overexpression and knockdown cell lines. We found that VASH2 can influence the CDDP sensitivity and that the cell overexpression of VASH2 had a higher cell viability and lower apoptosis rate after CDDP exposure. We also observed that VASH2 overexpression downregulated wild-type p53, as well as suppressed the expression of the pro-apoptotic protein BCL2-associated X protein (Bax) and cleaved caspase-3 (CC-3) after treatment by CDDP. Conversely, the knockdown of VASH2 significantly inhibited these effects. In an in vivo chemosensitivity study, nude mice were subcutaneously injected with tumor cells and received CDDP treatment through intraperitoneal administration every 3 days. We found that VASH2 knockdown markedly limited the tumor growth and enhanced the CDDP toxicity and apoptosis of tumor cells. Western blot analysis revealed that tumor cells with downregulated VASH2 had a higher expression of wild-type p53, Bax, and CC-3 than control cells. Overall, our results indicated the novel roles of VASH2 in the chemoresistance of hepatocarcinoma cells to CDDP and suggested that VASH2 may be a promising anticancer target.	[Li, Zhanjun; Tu, Min; Ge, Qianqian; Miao, Yi] Nanjing Med Univ, Affiliated Hosp 1, Lab Gen Surg, Nanjing, Jiangsu, Peoples R China; [Miao, Yi; Qian, Zhuyin; Gao, Wentao] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Han, Bei] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Gu, Yuqing] Taicang City First Peoples Hosp, Dept Gen Surg, Suzhou, Peoples R China; [Xue, Xiaofeng] Suzhou Univ, Affiliated Hosp 1, Dept Gen Surg, Suzhou 215006, Peoples R China; [Sun, Jie] Fuyang Peoples Hosp, Dept Gen Surg, Fuyang, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Soochow University - China	Qian, ZY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.	qianzhusilver@163.com; gao11@hotmail.com			National Nature Science Foundation of China [81172267]; Public Welfare Industry of Health [201202007]; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Welfare Industry of Health; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants from the National Nature Science Foundation of China (No. 81172267), the Public Welfare Industry of Health (No. 201202007) and the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU and the Priority Academic Program Development of Jiangsu Higher Education Institutions (JX10231801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Chang CL, 2013, CANCER RES, V73, P119, DOI 10.1158/0008-5472.CAN-12-2225; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Dror N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073625; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandez-Sanchez M, 2006, MED ONCOL, V23, P171, DOI 10.1385/MO:23:2:171; Fuertes MA, 2003, CURR MED CHEM, V10, P257, DOI 10.2174/0929867033368484; Geng W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027362; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gu B, 2012, INT J BIOL SCI, V8, P672, DOI 10.7150/ijbs.4283; Gully CP, 2012, P NATL ACAD SCI USA, V109, pE1513, DOI 10.1073/pnas.1110287109; Hosaka T, 2009, AM J PATHOL, V175, P430, DOI 10.2353/ajpath.2009.080788; Hu RZ, 2011, CANCER RES, V71, P6524, DOI 10.1158/0008-5472.CAN-11-0853; Huang JT, 2013, J CANCER RES CLIN, V139, P1709, DOI 10.1007/s00432-013-1497-y; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kataria H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055316; Kimura H, 2009, BLOOD, V113, P4810, DOI 10.1182/blood-2008-07-170316; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lin XJ, 2001, CANCER RES, V61, P1508; Liu CL, 2013, MAR DRUGS, V11, P50, DOI 10.3390/md11010050; Martinez-Becerra P, 2012, MOL PHARMACEUT, V9, P1693, DOI 10.1021/mp300028a; Sato Y, 2007, ARTERIOSCL THROM VAS, V27, P37, DOI 10.1161/01.ATV.0000252062.48280.61; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Shen ZL, 2012, MED ONCOL, V29, P2718, DOI 10.1007/s12032-012-0212-1; Shibuya T, 2006, ARTERIOSCL THROM VAS, V26, P1051, DOI 10.1161/01.ATV.0000216747.66660.26; Shimizu K, 2005, BIOCHEM BIOPH RES CO, V327, P700, DOI 10.1016/j.bbrc.2004.12.073; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sun J, 2013, INT J ONCOL, V43, P255, DOI 10.3892/ijo.2013.1919; Takahashi Y, 2012, MOL CANCER RES, V10, P1135, DOI 10.1158/1541-7786.MCR-12-0098-T; Tamaki K, 2009, CANCER SCI, V100, P88, DOI 10.1111/j.1349-7006.2008.01015.x; Terry S, 2013, NEOPLASIA, V15, P761, DOI 10.1593/neo.122070; Vashchenko N, 2005, EUR UROL, V47, P147, DOI 10.1016/j.eururo.2004.09.007; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang G, 2004, CELL RES, V14, P303, DOI 10.1038/sj.cr.7290375; Warnock LJ, 2011, CANCER BIOL THER, V12, P1059, DOI 10.4161/cbt.12.12.18141; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Woo HG, 2011, GASTROENTEROLOGY, V140, P1063, DOI 10.1053/j.gastro.2010.11.034; Xue X, 2013, ONCOGENE, V32, P1724, DOI 10.1038/onc.2012.177; Xylinas E, 2013, EUR J CANCER, V49, P1889, DOI 10.1016/j.ejca.2013.02.001; Yoshinaga K, 2011, CANCER SCI, V102, P446, DOI 10.1111/j.1349-7006.2010.01812.x; Zhang Y, 2013, J HEPATOL, V59, P1255, DOI 10.1016/j.jhep.2013.07.009	44	13	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90358	10.1371/journal.pone.0090358	http://dx.doi.org/10.1371/journal.pone.0090358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595063	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500044
J	Mao, JJ; Zhao, Y; She, RP; Cao, BB; Xiao, P; Wu, QX; Guo, ZJ; Ma, LH; Soomro, MH				Mao, Jingjing; Zhao, Yue; She, Ruiping; Cao, Binbin; Xiao, Peng; Wu, Qiaoxing; Guo, Zhaojie; Ma, Longhuan; Soomro, Majid Hussain			Detection and Localization of Rabbit Hepatitis E Virus and Antigen in Systemic Tissues from Experimentally Intraperitoneally Infected Rabbits	PLOS ONE			English	Article							GENETIC IDENTIFICATION; CYNOMOLGUS MACAQUES; HEV INFECTION; UNITED-STATES; SWINE; REPLICATION; DIAGNOSIS; PREVALENT; CHICKENS; STRAINS	Rabbit hepatitis E virus (HEV) is a novel genotype of HEV, and is considered to pose a risk of zoonotic transmission. Research into the systemic distribution of rabbit HEV in rabbits during different periods of infection has rarely been reported. To better understand this virus, we infected rabbits with second-passage rabbit HEV via an intraperitoneal route. After inoculation, the infection showed two types, temporary and constant infection. The detection of HEV RNA in the feces varied with time, and serum antigen correlated with fecal HEV RNA. Viremia only appeared 72 days after inoculation. The rabbits remained antibody negative throughout the experimental period. When HEV was localized, several organs besides the liver were HEV RNA positive. Tissue antigen was observed immunohistochemically in the different cells of various organs, especially in parts of the small intestine and the characteristic rabbit gut-associated lymphoid tissue. These data provide valuable information for future research into the pathogenesis of HEV.	[Mao, Jingjing; Zhao, Yue; She, Ruiping; Cao, Binbin; Xiao, Peng; Wu, Qiaoxing; Guo, Zhaojie; Ma, Longhuan; Soomro, Majid Hussain] China Agr Univ, Key Lab Zoonosis, Lab Vet Pathol & Publ Hlth, Dept Vet Pathol,Coll Vet Med,Minist Agr, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	She, RP (corresponding author), China Agr Univ, Key Lab Zoonosis, Lab Vet Pathol & Publ Hlth, Dept Vet Pathol,Coll Vet Med,Minist Agr, Beijing 100094, Peoples R China.	sheruiping@126.com	Ma, Longhuan/AGL-2659-2022		National Natural Science Foundation of China [31072110, 31272515]; Program for Changjiang Scholars and Innovative Research Team in University of China [IRT0866]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (Grant No. 31072110, 31272515), and the Program for Changjiang Scholars and Innovative Research Team in University of China (Grant No. IRT0866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari IH, 2000, J MED VIROL, V60, P275, DOI 10.1002/(SICI)1096-9071(200003)60:3<275::AID-JMV5>3.3.CO;2-0; Beyaz F, 2010, VET RES COMMUN, V34, P255, DOI 10.1007/s11259-010-9349-6; Billam P, 2005, J VIROL, V79, P3429, DOI 10.1128/JVI.79.6.3429-3437.2005; Cossaboom CM, 2011, EMERG INFECT DIS, V17, P2047, DOI 10.3201/eid1711.110428; Geng YS, 2011, INFECT GENET EVOL, V11, P476, DOI 10.1016/j.meegid.2010.12.012; Haqshenas G, 2001, J GEN VIROL, V82, P2449, DOI 10.1099/0022-1317-82-10-2449; Huang F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-93; Huang FF, 2002, J CLIN MICROBIOL, V40, P1326, DOI 10.1128/JCM.40.4.1326-1332.2002; Huang YW, 2007, J VIROL, V81, P3018, DOI 10.1128/JVI.02259-06; Izopet J, 2012, EMERG INFECT DIS, V18, P1274, DOI 10.3201/eid1808.120057; Johne R, 2010, EMERG INFECT DIS, V16, P1452, DOI 10.3201/eid1609.100444; Lhomme S, 2013, J CLIN VIROLOGY; Li TC, 2001, VACCINE, V19, P3476, DOI 10.1016/S0264-410X(01)00059-7; Liu P, 2013, EMERG INFECT DIS, V19, P559, DOI 10.3201/eid1904.120827; Ma HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009160; Meng XJ, 1998, ARCH VIROL, V143, P1405, DOI 10.1007/s007050050384; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; NANDA SK, 1995, GASTROENTEROLOGY, V108, P225, DOI 10.1016/0016-5085(95)90028-4; Purcell R.H., 2001, FIELDS VIROLOGY, P3051; Purdy MA, 1993, HEPATITIS E VIRUS NO, P319; Purdy MA, 2011, VIRUS RES, V161, P31, DOI 10.1016/j.virusres.2011.04.030; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; Sonoda H, 2004, J CLIN MICROBIOL, V42, P5371, DOI 10.1128/JCM.42.11.5371-5374.2004; Takahashi M, 2011, J GEN VIROL, V92, P902, DOI 10.1099/vir.0.029470-0; TSAREV SA, 1994, J MED VIROL, V43, P135, DOI 10.1002/jmv.1890430207; van Cuyck-Gandre H, 1998, J MED VIROL, V55, P197, DOI 10.1002/(SICI)1096-9071(199807)55:3<197::AID-JMV3>3.0.CO;2-X; Williams TPE, 2001, J CLIN MICROBIOL, V39, P3040, DOI 10.1128/JCM.39.9.3040-3046.2001; Zhang F, 2006, J MED VIROL, V78, P1441, DOI 10.1002/jmv.20717; Zhang J, 2003, J MED VIROL, V71, P518, DOI 10.1002/jmv.10523; Zhao CY, 2007, J MED VIROL, V79, P1966, DOI 10.1002/jmv.21040; Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536	31	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e88607	10.1371/journal.pone.0088607	http://dx.doi.org/10.1371/journal.pone.0088607			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594631	Green Submitted, Green Published, gold			2022-12-25	WOS:000332475500005
J	Vanyushkina, AA; Fisunov, GY; Gorbachev, AY; Kamashev, DE; Govorun, VM				Vanyushkina, Anna A.; Fisunov, Gleb Y.; Gorbachev, Alexey Y.; Kamashev, Dmitri E.; Govorun, Vadim M.			Metabolomic Analysis of Three Mollicute Species	PLOS ONE			English	Article							T-STRAIN MYCOPLASMA; ACHOLEPLASMA-LAIDLAWII; UREAPLASMA-UREALYTICUM; ESCHERICHIA-COLI; COMPLETE GENOME; GALLISEPTICUM; PROTEIN; PATHOGENICITY; SPIROPLASMA; DATABASE	We present a systematic study of three bacterial species that belong to the class Mollicutes, the smallest and simplest bacteria, Spiroplasma melliferum, Mycoplasma gallisepticum, and Acholeplasma laidlawii. To understand the difference in the basic principles of metabolism regulation and adaptation to environmental conditions in the three species, we analyzed the metabolome of these bacteria. Metabolic pathways were reconstructed using the proteogenomic annotation data provided by our lab. The results of metabolome, proteome and genome profiling suggest a fundamental difference in the adaptation of the three closely related Mollicute species to stress conditions. As the transaldolase is not annotated in Mollicutes, we propose variants of the pentose phosphate pathway catalyzed by annotated enzymes for three species. For metabolite detection we employed high performance liquid chromatography coupled with mass spectrometry. We used liquid chromatography method - hydrophilic interaction chromatography with silica column - as it effectively separates highly polar cellular metabolites prior to their detection by mass spectrometer.	[Vanyushkina, Anna A.; Fisunov, Gleb Y.; Gorbachev, Alexey Y.; Kamashev, Dmitri E.; Govorun, Vadim M.] Russian Inst Physicochem Med, Moscow, Russia; [Kamashev, Dmitri E.] Russian Res Ctr, Kurchatov Inst, Moscow, Russia; [Govorun, Vadim M.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Govorun, Vadim M.] State Univ, Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia	National Research Centre - Kurchatov Institute; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Moscow Institute of Physics & Technology	Kamashev, DE (corresponding author), Russian Inst Physicochem Med, Moscow, Russia.	dkamashev@gmail.com	Govorun, Vadim M/A-9043-2018; Kamashev, Dmitri/K-6560-2017; Gorbachev, Alexey/ABH-4273-2020	Kamashev, Dmitri/0000-0003-4158-5300; Gorbachev, Alexey/0000-0002-2743-5835	Russian Foundation for Basic Research (RFBR) [12-04-31696]; Russian Science Foundation [14-24-00159] Funding Source: Russian Science Foundation	Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by a Grant (12-04-31696) from Russian Foundation for Basic Research (RFBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJELLO F, 1977, B I SIEROTER MILAN, V56, P343; Alexeev D, 2012, J PROTEOME RES, V11, P224, DOI 10.1021/pr2008626; Boer VM, 2010, MOL BIOL CELL, V21, P198, DOI 10.1091/mbc.E09-07-0597; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; Castanie-Cornet MP, 2001, MICROBIOL-UK, V147, P709, DOI 10.1099/00221287-147-3-709; Chernov VM, 2007, DOKL BIOCHEM BIOPHYS, V413, P57, DOI 10.1134/S1607672907020056; Cocaign-Bousquet M, 2002, APPL MICROBIOL BIOT, V60, P24, DOI 10.1007/s00253-002-1065-x; COLE RM, 1973, J BACTERIOL, V115, P367, DOI 10.1128/JB.115.1.367-386.1973; David SAW, 2010, APPL ENVIRON MICROB, V76, P2718, DOI 10.1128/AEM.02776-09; Folmsbee M, 2010, BIOLOGICALS, V38, P214, DOI 10.1016/j.biologicals.2009.11.001; Gorbachev AY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-726; HAHN RG, 1974, J BACTERIOL, V117, P611, DOI 10.1128/JB.117.2.611-618.1974; Kamashev D, 2011, BIOCHEMISTRY-US, V50, P8692, DOI 10.1021/bi2009097; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; KARADSHEH NS, 1973, BIOCHIM BIOPHYS ACTA, V327, P66, DOI 10.1016/0005-2744(73)90104-6; Laidlaw PP, 1936, PROC R SOC SER B-BIO, V120, P292, DOI 10.1098/rspb.1936.0036; Lazarev VN, 2011, J BACTERIOL, V193, P4943, DOI 10.1128/JB.05059-11; LEACH RH, 1967, ANN NY ACAD SCI, V143, P305, DOI 10.1111/j.1749-6632.1967.tb27670.x; Lee IM, 2000, ANNU REV MICROBIOL, V54, P221, DOI 10.1146/annurev.micro.54.1.221; Lehninger A, 2008, PRINCIOALS BIOL; Levitskiy SA, 2011, BIOCHIMIE, V93, P1102, DOI 10.1016/j.biochi.2011.03.005; Ley D., 2003, MYCOPLASMA GALLISEPT; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Maharjan RP, 2003, ANAL BIOCHEM, V313, P145; Maier T, 2013, MOL BIOSYST, V9, P1743, DOI 10.1039/c3mb70113a; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Moat A.G., 2002, MICROBIAL PHYSL; Papazisi L, 2003, MICROBIOL-SGM, V149, P2307, DOI 10.1099/mic.0.26427-0; Pereyre S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000677; POLLACK JD, 1986, J BACTERIOL, V165, P53, DOI 10.1128/jb.165.1.53-60.1986; POLLACK JD, 1983, YALE J BIOL MED, V56, P709; PONTREMO.S, 1965, J BIOL CHEM, V240, P3459; RAZIN S, 1964, J DENT RES, V43, P402, DOI 10.1177/00220345640430031101; Razin S, 1973, Adv Microb Physiol, V10, P1, DOI 10.1016/S0065-2911(08)60086-7; ROBERTSON J, 1976, J BACTERIOL, V128, P658, DOI 10.1128/JB.128.2.658-660.1976; Rohdich F, 2002, P NATL ACAD SCI USA, V99, P1158, DOI 10.1073/pnas.032658999; SCHIEFER HG, 1974, J BACTERIOL, V120, P81, DOI 10.1128/JB.120.1.81-88.1974; Scripal IG, 1988, MICROORGANISMS AGENT; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; STIPKOVITS L, 1979, ZBL BAKT-INT J MED M, V245, P171; Tautenhahn R, 2012, NAT BIOTECHNOL, V30, P826, DOI 10.1038/nbt.2348; TERRY TM, 1973, BIOCHIM BIOPHYS ACTA, V291, P144, DOI 10.1016/0005-2736(73)90069-2; TULLY JG, 1977, SCIENCE, V195, P892, DOI 10.1126/science.841314; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; van der Greef J, 2004, CURR OPIN CHEM BIOL, V8, P559, DOI 10.1016/j.cbpa.2004.08.013; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308; Vogl G, 2008, INFECT IMMUN, V76, P71, DOI 10.1128/IAI.00871-07; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263	49	19	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89312	10.1371/journal.pone.0089312	http://dx.doi.org/10.1371/journal.pone.0089312			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595068	Green Submitted, gold, Green Published			2022-12-25	WOS:000332475500012
J	Alcantara, S; Ree, RH; Martins, FR; Lohmann, LG				Alcantara, Suzana; Ree, Richard H.; Martins, Fernando R.; Lohmann, Lucia G.			The Effect of Phylogeny, Environment and Morphology on Communities of a Lianescent Clade (Bignonieae-Bignoniaceae) in Neotropical Biomes	PLOS ONE			English	Article							FUNCTIONAL TRAITS; RELATIVE IMPORTANCE; SEED PLANTS; EVOLUTION; ECOLOGY; POLLINATION; DIVERSITY; DIVERSIFICATION; BIOGEOGRAPHY; CONVERGENCE	The influence of ecological traits to the distribution and abundance of species is a prevalent issue in biodiversity science. Most studies of plant community assembly have focused on traits related to abiotic aspects or direct interactions among plants, with less attention paid to ignore indirect interactions, as those mediated by pollinators. Here, we assessed the influence of phylogeny, habitat, and floral morphology on ecological community structure in a clade of Neotropical lianas (tribe Bignonieae, Bignoniaceae). Our investigation was guided by the long-standing hypothesis that habitat specialization has promoted speciation in Bignonieae, while competition for shared pollinators influences species co-occurrence within communities. We analyzed a geo-referenced database for 94 local communities occurring across the Neotropics. The effect of floral morphological traits and abiotic variables on species co-occurrence was investigated, taking into account phylogenetic relationships. Habitat filtering seems to be the main process driving community assembly in Bignonieae, with environmental conditions limiting species distributions. Differing specialization to abiotic conditions might have evolved recently, in contrast to the general pattern of phylogenetic clustering found in communities of other diverse regions. We find no evidence that competition for pollinators affects species co-occurrence; instead, pollinator occurrence seems to have acted as an "environmental filter'' in some habitats.	[Alcantara, Suzana; Lohmann, Lucia G.] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, Brazil; [Alcantara, Suzana; Ree, Richard H.] Field Museum Nat Hist, Dept Bot, Chicago, IL 60605 USA; [Martins, Fernando R.] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Vegetal, Campinas, SP, Brazil	Universidade de Sao Paulo; Field Museum of Natural History (Chicago); Universidade de Sao Paulo; Universidade Estadual de Campinas	Alcantara, S (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	suzanaalcantara@gmail.com; llohmann@usp.br	Lohmann, Lucia G./AAF-7259-2021; Martins, Fernando R./F-5652-2012; Fapesp, Biota/F-8655-2017; Alcantara, Suzana/J-8225-2012	Lohmann, Lucia G./0000-0003-4960-0587; Martins, Fernando R./0000-0002-3068-7099; Fapesp, Biota/0000-0002-9887-8449; Alcantara, Suzana/0000-0001-9666-460X	FAPESP [2006/59916-0]; CCSD-Missouri Botanical Garden: Elizabeth E. Bascom Fellowships for Latin American Female Botanists	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CCSD-Missouri Botanical Garden: Elizabeth E. Bascom Fellowships for Latin American Female Botanists	This study has been funded by FAPESP: doctoral grant 2006/59916-0; and CCSD-Missouri Botanical Garden: Elizabeth E. Bascom Fellowships for Latin American Female Botanists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 1999, AM J BOT, V86, P1272, DOI 10.2307/2656775; Ackerly DD, 2003, INT J PLANT SCI, V164, pS1, DOI 10.1086/374729; Alcantara S, 2013, J EVOLUTION BIOL, V26, DOI 10.1111/jeb.12228; Alcantara S, 2011, BIOL J LINN SOC, V102, P378, DOI 10.1111/j.1095-8312.2010.01567.x; Alcantara S, 2010, AM J BOT, V97, P782, DOI 10.3732/ajb.0900182; [Anonymous], 1986, MULTIVARIATE STAT ME; Becerra JX, 2007, P NATL ACAD SCI USA, V104, P7483, DOI 10.1073/pnas.0608253104; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Buzato S, 2000, BIOTROPICA, V32, P824, DOI 10.1111/j.1744-7429.2000.tb00621.x; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Diamond J.M., 1975, P342; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Eaton DAR, 2012, ECOLOGY, V93, pS182, DOI 10.1890/11-0501.1; Environmental Systems Research Institute Inc. (ESRI), 2005, ARCGIS 9 1; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fine PVA, 2005, EVOLUTION, V59, P1464; GENTRY A H, 1974, Biotropica, V6, P64, DOI 10.2307/2989698; GENTRY A H, 1990, Memoirs of the New York Botanical Garden, V55, P118; GENTRY AH, 1974, ANN MO BOT GARD, V61, P728, DOI 10.2307/2395026; Gotelli NJ, 2003, ECOLOGY, V84, P532, DOI 10.1890/0012-9658(2003)084[0532:SAINMA]2.0.CO;2; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Hegland SJ, 2009, ECOL RES, V24, P929, DOI 10.1007/s11284-008-0572-3; HILL MO, 1976, TAXON, V25, P249, DOI 10.2307/1219449; Kay KM, 2009, ANNU REV ECOL EVOL S, V40, P637, DOI 10.1146/annurev.ecolsys.110308.120310; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Lohmann LG, 2006, AM J BOT, V93, P304, DOI 10.3732/ajb.93.2.304; Lohmann LG, 2014, ANN MISSOUR IN PRESS; Lohmann LG, 2003, THESIS U MISSOURI ST; Lohmann LG, 2013, BOT J LINN SOC, V171, P154, DOI 10.1111/j.1095-8339.2012.01311.x; Losos JB, 2003, NATURE, V424, P542, DOI 10.1038/nature01814; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; McCarthy MC, 2007, INT J PLANT SCI, V168, P751, DOI 10.1086/513491; MICHENER CD, 1979, ANN MO BOT GARD, V66, P277, DOI 10.2307/2398833; Moeller DA, 2004, ECOLOGY, V85, P3289, DOI 10.1890/03-0810; Nuismer SL, 2013, EVOLUTION, V67, P338, DOI 10.1111/j.1558-5646.2012.01801.x; Oliver P, 2002, GLOBAL PATTERNS PLAN; Olmstead RG, 2009, AM J BOT, V96, P1731, DOI 10.3732/ajb.0900004; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pausas JG, 2008, ECOLOGY, V89, P2181, DOI 10.1890/07-1737.1; Pausas JG, 2010, BIOSCIENCE, V60, P614, DOI 10.1525/bio.2010.60.8.7; Pennington RT, 2009, ANNU REV ECOL EVOL S, V40, P437, DOI 10.1146/annurev.ecolsys.110308.120327; PLEASANTS JM, 1980, ECOLOGY, V61, P1446, DOI 10.2307/1939053; Ricklefs RE, 2006, ECOLOGY, V87, pS3, DOI 10.1890/0012-9658(2006)87[3:EDATOO]2.0.CO;2; Sargent RD, 2008, TRENDS ECOL EVOL, V23, P123, DOI 10.1016/j.tree.2007.11.003; Sargent RD, 2011, AM J BOT, V98, P283, DOI 10.3732/ajb.1000329; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Sokal R. R., 2012, BIOMETRY; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Vamosi JC, 2006, P NATL ACAD SCI USA, V103, P956, DOI 10.1073/pnas.0507165103; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Walsh R.P.D., 1996, PW RICHARDS 1996 TRO, P159; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WEBB CO, 2008, PHYLOCOM SOFTWARE AN; Weiher E, 1998, OIKOS, V81, P309, DOI 10.2307/3547051; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011	64	11	11	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90177	10.1371/journal.pone.0090177	http://dx.doi.org/10.1371/journal.pone.0090177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594706	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900076
J	Chakraborty, S; Alhazzaa, M; Wasserman, JK; Sun, YY; Stotts, G; Hogan, MJ; Demchuk, A; Aviv, RI; Dowlatshahi, D				Chakraborty, Santanu; Alhazzaa, Mohammed; Wasserman, Jason K.; Sun, Yang Yang; Stotts, Grant; Hogan, Mathew J.; Demchuk, Andrew; Aviv, Richard I.; Dowlatshahi, Dar			Dynamic Characterization of the CT Angiographic 'Spot Sign'	PLOS ONE			English	Article							PRIMARY INTRACEREBRAL HEMORRHAGE; HEMATOMA EXPANSION; POSTCONTRAST CT; EXTRAVASATION	Background and purpose: Standard (static) CT angiography is used to identify the intracerebral hemorrhage (ICH) spot sign. We used dynamic CT-angiography to describe spot sign characteristics and measurement parameters over 60-seconds of image acquisition. Methods: We prospectively identified consecutive patients presenting with acute ICH within 4.5 hours of symptom onset, and collected whole brain dynamic CT-angiography (dCTA). Spot parameters (earliest appearance, duration, maximum Hounsfield unit (HU), time to maximum HU, time to spot diagnostic definition, spot volume and hematoma volumes) were measured using volumetric analysis software. Result: We enrolled 34 patients: three were excluded due to secondary causes of ICH. Of the remaining 31 patients there were 18 females (58%) with median age 70 (range 47-86) and baseline hematoma volume 33 ml (range 0.7-103 ml). Positive dCTA spot sign was present in 13 patients (42%) visualized as an expanding 3-dimensional structure temporally evolving its morphology over the scan period. Median time to spot appearance was 21 s (range 15-35 seconds). This method allowed tracking of spots evolution until the end of venous phase (active extravasation) with median duration of 39 s (range 25-45 seconds). The average density and time to maximum density was 204HU and 30.8 s (range 23-31 s) respectively. Median time to spot diagnosis was 20.8 s using either 100 or 120HU definitions. Conclusion: Dynamic CTA allows a 3-dimensional assessment of spot sign formation during acute ICH, and captured higher spot sign prevalence than previously reported. This is the first study to describe and quantify spot sign characteristics using dCTA; these can be used in ongoing and upcoming ICH studies.	[Chakraborty, Santanu] Ottawa Hosp Res Inst, Div Neuroradiol, Dept Med Imaging, Ottawa, ON, Canada; [Chakraborty, Santanu; Alhazzaa, Mohammed; Wasserman, Jason K.; Sun, Yang Yang; Stotts, Grant; Hogan, Mathew J.; Dowlatshahi, Dar] Univ Ottawa, Ottawa, ON K1N 6N5, Canada; [Alhazzaa, Mohammed; Sun, Yang Yang; Stotts, Grant; Hogan, Mathew J.; Dowlatshahi, Dar] Ottawa Hosp Res Inst, Dept Med, Ottawa, ON, Canada; [Dowlatshahi, Dar] Ottawa Hosp Res Inst, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Wasserman, Jason K.] Ottawa Hosp Res Inst, Dept Pathol, Ottawa, ON, Canada; [Alhazzaa, Mohammed] King Fahad Med City, Dept Neurol, Riyadh, Saudi Arabia; [Aviv, Richard I.] Univ Toronto, Div Neuroradiol, Toronto, ON, Canada; [Aviv, Richard I.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med Imaging, Toronto, ON, Canada; [Demchuk, Andrew] Calgary Hlth Reg, Foothills Med Ctr, Dept Clin Neurosci, Calgary, AB, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; King Fahad Medical City; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Calgary	Chakraborty, S (corresponding author), Ottawa Hosp Res Inst, Div Neuroradiol, Dept Med Imaging, Ottawa, ON, Canada.	santanoo@gmail.com	Alhazzaa, Mohammed/AAO-9581-2020; Demchuk, Andrew M/E-1103-2012; Hogan, Matthew/AAP-4735-2020	Demchuk, Andrew M/0000-0002-4930-7789; Hogan, Matthew/0000-0003-4660-8743; Dowlatshahi, Dar/0000-0003-1379-3612; Wasserman, Jason/0000-0003-3821-8956	Heart and Stroke Foundation of Ontario; Department of Medicine, University of Ottawa; Heart and Stroke Foundation of Canada	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Department of Medicine, University of Ottawa; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This study was funded by a Heart and Stroke Foundation of Ontario grant (DD and SC are Co-Principal Investigators), and by the Department of Medicine (DD), University of Ottawa. DD is supported by a New Investigator Award from the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almandoz JED, 2009, STROKE, V40, P2994, DOI 10.1161/STROKEAHA.109.554667; Becker KJ, 1999, STROKE, V30, P2025, DOI 10.1161/01.STR.30.10.2025; Chakraborty S, 2011, CASE REP NEUROL, V3, P154, DOI 10.1159/000330304; Chakraborty S, 2010, BRIT J RADIOL, V83, pE216, DOI 10.1259/bjr/74416385; Demchuk AM, 2012, LANCET NEUROL, V11, P307, DOI 10.1016/S1474-4422(12)70038-8; Dowlatshahi D, 2014, STROKE, V45, P277, DOI 10.1161/STROKEAHA.113.003387; Dowlatshahi D, 2013, LANCET, V381, P152, DOI 10.1016/S0140-6736(12)60829-0; Dowlatshahi D, 2012, STROKE, V43, P1961, DOI 10.1161/STROKEAHA.112.654970; Ederies A, 2009, STROKE, V40, P1672, DOI 10.1161/STROKEAHA.108.541201; Koculym A, 2013, AM J NEURORADIOL, V34, P965, DOI 10.3174/ajnr.A3338; Kosior JC, 2011, INT J STROKE, V6, P302, DOI 10.1111/j.1747-4949.2010.00579.x; Romero JM, 2012, NAT REV NEUROL, V8, P300, DOI 10.1038/nrneurol.2012.93; Salomon EJ, 2009, CLIN NEURORADIOL, V19, P187, DOI 10.1007/s00062-009-9019-7; Sun SJ, 2013, EUR RADIOL, V23, P1846, DOI 10.1007/s00330-013-2803-4; Thompson AL, 2009, CAN J NEUROL SCI, V36, P456, DOI 10.1017/S0317167100007782; Wada R, 2007, STROKE, V38, P1257, DOI 10.1161/01.STR.0000259633.59404.f3	16	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90431	10.1371/journal.pone.0090431	http://dx.doi.org/10.1371/journal.pone.0090431			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594897	gold, Green Submitted, Green Published			2022-12-25	WOS:000332468900109
J	Huang, YY; Harding, JCS				Huang, Yanyun; Harding, John C. S.			Attempted Experimental Reproduction of Porcine Periweaning-Failure-to-Thrive Syndrome Using Tissue Homogenates	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE PCR; EXPERIMENTAL-INFECTION; ASSAY; PIGS; DIFFERENTIATION; COLOSTRUM; TYPE-2; SERUM; MODEL; BIRTH	Porcine periweaning failure-to-thrive syndrome (PFTS) is characterized by anorexia and progressive debilitation of newly weaned pigs, of which some also demonstrate repetitive oral behaviour. Although no relevant porcine pathogens have been shown to be causally associated, inoculation of susceptible pigs using tissue homogenates is needed to rule out infectious etiologies. Eight snatched-farrowed porcine-colostrum-deprived (SF-pCD) pigs were inoculated with tissue homogenates made from PFTS-affected pigs orally, or combined orally, intraperitoneally (IP) and intramuscularly (IM) at day (D) 14 of age (INOC). On D21, IP and IM inoculation were repeated. Four sham-inoculated pigs served as control (CTRL). Three INOC pigs developed mixed bacterial septicemia between the first and second inoculation. All other pigs survived until termination on D49. Average daily gain (ADG) and the frequencies of diarrhea did not differ between INOC and CTRL pigs D14 and D29. Additionally, the progressive debilitation characteristic of PFTS was not observed in any pig, and repetitive oral behaviour was observed in both groups. In conclusion, PFTS was not experimentally reproduced by the current experimental approach providing evidence that PFTS may not have an infectious etiology.	[Huang, Yanyun; Harding, John C. S.] Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan	Harding, JCS (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK S7N 0W0, Canada.	John.harding@usask.ca			Saskatchewan Agricultural Development Fund [20090268]	Saskatchewan Agricultural Development Fund	This research was made possible with funding from Saskatchewan Agricultural Development Fund (www.agriculture.gov.sk.ca/ADF) (grant 20090268). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco I, 2004, VET MICROBIOL, V103, P21, DOI 10.1016/j.vetmic.2004.06.011; Butler JE, 2002, J IMMUNOL, V169, P6822, DOI 10.4049/jimmunol.169.12.6822; Chisholm SA, 2003, DIAGN MICR INFEC DIS, V46, P1, DOI 10.1016/S0732-8893(02)00547-3; Fowden AL, 1998, P NUTR SOC, V57, P113, DOI 10.1079/PNS19980017; Gagnon CA, 2008, J VET DIAGN INVEST, V20, P545, DOI 10.1177/104063870802000503; Hamel AL, 1999, J CLIN MICROBIOL, V37, P3767, DOI 10.1128/JCM.37.11.3767-3768.1999; Hellemans A, 2007, VET RES COMMUN, V31, P385, DOI 10.1007/s11259-006-3448-4; Huang YY, 2013, CAN J VET RES, V77, P81; Huang YY, 2012, J VET DIAGN INVEST, V24, P96, DOI 10.1177/1040638711425939; Huang YY, 2011, J SWINE HEALTH PROD, V19, P340; LAWRENCE AB, 1993, J ANIM SCI, V71, P2815, DOI 10.2527/1993.71102815x; MATTSSON JG, 1995, J CLIN MICROBIOL, V33, P893, DOI 10.1128/JCM.33.4.893-897.1995; McIntosh KA, 2009, VET MICROBIOL, V133, P23, DOI 10.1016/j.vetmic.2008.06.010; O'Sullivan TL, 2014, J SWINE HEALTH PROD, V22, P24; Oliveira S, 2003, CAN J VET RES, V67, P146; Pittman J. S., 2011, Evidence-based practice: how do we get there? American Association of Swine Veterinarians 42nd Annual Meeting Proceedings, 5-8 March, 2011, Phoenix, Arizona, USA, P367; Sangild PT, 1997, COMP BIOCHEM PHYS A, V118, P359, DOI 10.1016/S0300-9629(96)00319-2; Sekiguchi Y, 2004, J VET MED SCI, V66, P367, DOI 10.1292/jvms.66.367; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stelwagen K, 2009, J ANIM SCI, V87, P3, DOI 10.2527/jas.2008-1377; Tousignant S, 2013, 44 ANN M AM ASS SWIN, P421; Vemulapalli R, 2009, J VIROL METHODS, V162, P231, DOI 10.1016/j.jviromet.2009.08.016; Wang QH, 2005, EMERG INFECT DIS, V11, P1874, DOI 10.3201/eid1112.050485; Zell R, 2000, J VIROL METHODS, V88, P205, DOI 10.1016/S0166-0934(00)00189-0	24	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90065	10.1371/journal.pone.0090065	http://dx.doi.org/10.1371/journal.pone.0090065			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594806	Green Submitted, Green Published, gold			2022-12-25	WOS:000332468900063
J	Hulovatyy, Y; Solava, RW; Milenkovic, T				Hulovatyy, Yuriy; Solava, Ryan W.; Milenkovic, Tijana			Revealing Missing Parts of the Interactome via Link Prediction	PLOS ONE			English	Article							SCALE-FREE NETWORKS; PROTEIN-INTERACTION NETWORK; INTERACTION MAP; ALIGNMENT; TOPOLOGY; GENOMICS; BIOLOGY; YEAST	Protein interaction networks (PINs) are often used to "learn'' new biological function from their topology. Since current PINs are noisy, their computational de-noising via link prediction (LP) could improve the learning accuracy. LP uses the existing PIN topology to predict missing and spurious links. Many of existing LP methods rely on shared immediate neighborhoods of the nodes to be linked. As such, they have limitations. Thus, in order to comprehensively study what are the topological properties of nodes in PINs that dictate whether the nodes should be linked, we introduce novel sensitive LP measures that are expected to overcome the limitations of the existing methods. We systematically evaluate the new and existing LP measures by introducing "synthetic" noise into PINs and measuring how accurate the measures are in reconstructing the original PINs. Also, we use the LP measures to de-noise the original PINs, and we measure biological correctness of the de-noised PINs with respect to functional enrichment of the predicted interactions. Our main findings are: 1) LP measures that favor nodes which are both "topologically similar'' and have large shared extended neighborhoods are superior; 2) using more network topology often though not always improves LP accuracy; and 3) LP improves biological correctness of the PINs, plus we validate a significant portion of the predicted interactions in independent, external PIN data sources. Ultimately, we are less focused on identifying a superior method but more on showing that LP improves biological correctness of PINs, which is its ultimate goal in computational biology. But we note that our new methods outperform each of the existing ones with respect to at least one evaluation criterion. Alarmingly, we find that the different criteria often disagree in identifying the best method(s), which has important implications for LP communities in any domain, including social networks.	[Milenkovic, Tijana] Univ Notre Dame, ECK Inst Global Hlth, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; Univ Notre Dame, Interdisciplinary Ctr Network Sci & Applicat, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Milenkovic, T (corresponding author), Univ Notre Dame, ECK Inst Global Hlth, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA.	tmilenko@nd.edu			National Science Foundation [EAGER CCF-124329]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation EAGER CCF-124329 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic LA, 2003, SOC NETWORKS, V25, P211, DOI 10.1016/S0378-8733(03)00009-1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Edwards AM, 2002, TRENDS GENET, V18, P529, DOI 10.1016/S0168-9525(02)02763-4; Getoor L., 2005, ACM SIGKDD EXPLORATI, V7, P3, DOI DOI 10.1145/1117454.1117456; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Han JDJ, 2005, NAT BIOTECHNOL, V23, P839, DOI 10.1038/nbt1116; Ho H, 2010, BMC SYSTEMS BIOL, V4, P1; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Katz L., 1953, PSYCHOMETRIKA, V18, P39, DOI [DOI 10.1007/BF02289026, 10.1007/BF02289026]; Kuchaiev O, 2011, BIOINFORMATICS, V27, P1390, DOI 10.1093/bioinformatics/btr127; Kuchaiev O, 2010, J R SOC INTERFACE, V7, P1341, DOI 10.1098/rsif.2010.0063; Kuchaiev O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000454; Lei CW, 2013, BIOINFORMATICS, V29, P355, DOI 10.1093/bioinformatics/bts688; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lichtenwalter R.N., 2012, P 21 INT C WORLD WID, P1019, DOI [10.1145/2187836.2187973, DOI 10.1145/2187836.2187973]; Lichtenwalter R.N., 2010, P 16 ACM SIGKDD INT, P243; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Lu LY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046122; Marcus D, 2012, COMPUT NETW, V56, P810, DOI 10.1016/j.comnet.2011.08.019; Memisevic V, 2010, J INTEGR BIOINFORM, V7, P120; Milenkovic T, 2008, CANCER INFORM, V6, P257; Milenkovic T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-70; Milenkovic T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023016; Milenkovic T, 2010, CANCER INFORM, V9, P121, DOI 10.4137/CIN.S4744; Milenkovic T, 2010, J R SOC INTERFACE, V7, P423, DOI 10.1098/rsif.2009.0192; Milenkovic T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005967; Newman ME, 2001, PHYS REV E, V64; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Rattigan M., 2005, SIGKDD EXPLORATIONS, V7, P41, DOI DOI 10.1145/1117454.1117460; Salton Gerard, 1984, INTRO MODERN INFORM; Sarac OS, 2012, BIOINFORMATICS, V28, P2137, DOI 10.1093/bioinformatics/bts351; Sharan R, 2006, NAT BIOTECHNOL, V24, P427, DOI 10.1038/nbt1196; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Solava RW, 2012, BIOINFORMATICS, V28, pI480, DOI 10.1093/bioinformatics/bts376; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wodak SJ, 2009, MOL CELL PROTEOMICS, V8, P3, DOI 10.1074/mcp.R800014-MCP200; Xie YB, 2008, PHYSICA A, V387, P1683, DOI 10.1016/j.physa.2007.11.005; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055437; Zhong WC, 2012, PHYSICA A, V391, P2163, DOI 10.1016/j.physa.2011.10.025; Zhou T, 2009, EUR PHYS J B, V71, P623, DOI 10.1140/epjb/e2009-00335-8	53	37	37	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90073	10.1371/journal.pone.0090073	http://dx.doi.org/10.1371/journal.pone.0090073			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594900	gold, Green Published, Green Submitted			2022-12-25	WOS:000332468900065
J	Odek, WO; Githuka, GN; Avery, L; Njoroge, PK; Kasonde, L; Gorgens, M; Kimani, J; Gelmon, L; Gakii, G; Isac, S; Faran, E; Musyoki, H; Maina, W; Blanchard, JF; Moses, S				Odek, Willis Omondi; Githuka, George N.; Avery, Lisa; Njoroge, Peter K.; Kasonde, Lombe; Gorgens, Marelize; Kimani, Joshua; Gelmon, Lawrence; Gakii, Gloria; Isac, Shajy; Faran, Emmanuel; Musyoki, Helgar; Maina, William; Blanchard, James F.; Moses, Stephen			Estimating the Size of the Female Sex Worker Population in Kenya to Inform HIV Prevention Programming	PLOS ONE			English	Article							RISK; TRANSMISSION; HIGHWAY; AFRICA	Background: The high burden of HIV infections among female sex workers (FSW) in sub-Saharan Africa has been long recognised, but effective preventive interventions have largely not been taken to scale. We undertook a national geographical mapping exercise in 2011/2012 to assess the locations and population size of FSW in Kenya, to facilitate targeted HIV prevention services for this population. Methods and Findings: We used a geographical mapping approach, consisting of interviews with secondary key informants to identify "hot" spots frequented by FSW, their operational dynamics and the estimated numbers of FSW in those spots. This was followed by validation of the estimates through interviews with FSW at each spot identified. The mapping covered Nairobi, the capital city of Kenya, and 50 other major urban centres. In total, 11,609 secondary key informant interviews were conducted to identify FSW spots. Further, a total of 6,360 FSW were interviewed for spot validation purposes. A total of 10,670 spots where FSW congregate were identified. The estimated FSW population in all the towns mapped was 103,298 (range 77,878 to 128, 717). Size estimates in the towns mapped were extended to smaller towns that were not mapped, using a statistical model. The national urban FSW population estimate was 138,420 (range 107, 552 to 169, 288), covering all towns of over 5,000 population. We estimated that approximately 5% of the urban female population of reproductive age in Kenya could be sex workers, which is consistent with previous estimates from other sub-Saharan African countries. Conclusions: This study provides the first national level data on the size of the FSW population in Kenya. These data can be used to enhance HIV prevention programme planning and implementation for FSW, to form the basis for impact evaluations, and to improve programme coverage by directing efforts to locations with the greatest need.	[Odek, Willis Omondi; Avery, Lisa; Isac, Shajy; Faran, Emmanuel; Blanchard, James F.; Moses, Stephen] Univ Manitoba, Dept Community Hlth Sci, Ctr Global Publ Hlth, Winnipeg, MB R3T 2N2, Canada; [Githuka, George N.; Musyoki, Helgar; Maina, William] Minist Hlth, Natl AIDS STI Control Programme NASCOP, Nairobi, Kenya; [Njoroge, Peter K.] Univ Nairobi, Sch Publ Hlth, Nairobi, Kenya; [Kasonde, Lombe; Gorgens, Marelize] Int Bank Reconstruct & Dev, Washington, DC USA; [Kimani, Joshua; Gelmon, Lawrence; Gakii, Gloria] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; University of Nairobi; University of Manitoba	Odek, WO (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Ctr Global Publ Hlth, Winnipeg, MB R3T 2N2, Canada.	odekw@yahoo.co.uk	Odek, W./ABB-2958-2021; Maina, William/L-6650-2017	Maina, William/0000-0002-3184-9854; Blanchard, James/0000-0002-4701-590X	US President's Emergency Plan for AIDS Relief (PEPFAR), through the US Centres for Disease Control and Prevention (CDC); US Agency for International Development (USAID); World Bank; Bill & Melinda Gates Foundation	US President's Emergency Plan for AIDS Relief (PEPFAR), through the US Centres for Disease Control and Prevention (CDC); US Agency for International Development (USAID)(United States Agency for International Development (USAID)); World Bank(The World Bank India); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was implemented jointly with the following organisations: the Kenya AIDS Control Project, Universities of Manitoba and Nairobi (KACP); the Centre for HIV Prevention and Research, University of Nairobi (CHIVPR); Impact Research and Development Organisation (IRDO); Hope Worldwide Kenya (HWWK); and the International Centre for Reproductive Health, Kenya (ICRH-K). The study implementing partners were supported by the US President's Emergency Plan for AIDS Relief (PEPFAR), through the US Centres for Disease Control and Prevention (CDC) and the US Agency for International Development (USAID). The study was funded by The World Bank and the Bill & Melinda Gates Foundation. The technical approach adopted was developed in India by the Centre for Global Public Health, University of Manitoba (CGPH), with funding support from the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], KEN POP DAT SHEET 20; [Anonymous], STAT MODELS CAUSAL A; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Berchenko Y, 2011, SEX TRANSM INFECT, V87, P267, DOI 10.1136/sti.2011.049171; Blanchard JF, 2008, SEX TRANSM INFECT S2, V84, pii19; Cuadros DF, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-28; Emmanuel F, 2013, EXPERT REV ANTI-INFE, V11, P451, DOI [10.1586/ERI.13.33, 10.1586/eri.13.33]; Emmanuel F, 2010, AIDS, V24, pS77, DOI 10.1097/01.aids.0000386737.25296.c4; Ferguson AG, 2007, HEALTH PLACE, V13, P504, DOI 10.1016/j.healthplace.2006.05.009; Goitom M., 1998, THESIS ADDIS ABABA; Kimani J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054354; Kruse N, 2003, SEX TRANSM DIS, V30, P664, DOI 10.1097/01.OLQ.0000079523.04451.82; Ministry of Public Health and Sanitation Kenya (MOPHS), 2010, NAT GUID HIV STI PRO, P17; Morris CN, 2006, SEX TRANSM INFECT, V82, P368, DOI 10.1136/sti.2006.020933; Msisha WM, 2008, AIDS, V22, P741, DOI 10.1097/QAD.0b013e3282f3947f; National AIDS/ STI Control Programme Kenya (NASCOP), 2012, MOST RISK POP UNV NE; National Coordinating Agency for Population and Development (NCAPD), 2011, STAT KEN POP 2011 KE; NGUGI EN, 1988, LANCET, V2, P887, DOI 10.1016/S0140-6736(88)92480-4; Okal J, 2013, SEX TRANSM INFECT, V89, P366, DOI 10.1136/sextrans-2013-051071; Salganik MJ, 2012, EPIDEMIOLOGY, V23, P148, DOI 10.1097/EDE.0b013e31823b6979; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; Vuylsteke B, 2010, TROP MED INT HEALTH, V15, P1537, DOI 10.1111/j.1365-3156.2010.02654.x; World Health Organization (WHO) and The Joint United Nations Programme on HIV and AIDS (UNAIDS), 2010, GUID EST SIZ POP MOS	24	54	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89180	10.1371/journal.pone.0089180	http://dx.doi.org/10.1371/journal.pone.0089180			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595029	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900011
J	Wang, X; Fang, Y; Yang, SM; Jiang, MH; Yan, KK; Wu, LN; Lv, B; Shen, Q				Wang, Xiao; Fang, Yu; Yang, Shimin; Jiang, Minghuan; Yan, Kangkang; Wu, Lina; Lv, Bing; Shen, Qian			Access to Paediatric Essential Medicines: A Survey of Prices, Availability, Affordability and Price Components in Shaanxi Province, China	PLOS ONE			English	Article							CHILDREN; LIST	Objective: To evaluate the prices and availability of paediatric essential medicines in Shaanxi Province, China. Methods: Price and availability data for 28 paediatric essential medicines were collected from 60 public hospitals and 60 retail pharmacies in six areas of Shaanxi Province using a standardised methodology developed by the World Health Organization and Health Action International, during November to December 2012. Affordability was measured as the number of days' wages required for the lowest-paid unskilled government worker to purchase standard treatments for common conditions. Data on medicine price components were collected from hospitals, wholesalers and distributors to obtain price mark-ups. Findings: The mean availabilities of originator brands (OBs) and lowest-priced generics (LPGs) were 10.8% and 27.3% in the public hospitals and 11.9% and 20.6% in the private pharmacies. The public procurement and retail prices were 2.25 and 2.59 times the international reference prices (IRPs) for three OBs, and 0.52 and 0.93 times for 20 LPGs. In the private sector, the final prices for OBs and LPGs were 3.89 and 1.25 times their IRPs. The final price in the private sector was 2.7% lower than in the public sector for OBs, and 14.1% higher for LPGs. Generally, standard treatments cost less than 1 day's wages in both sectors. Distribution mark-ups applied to brand salbutamol in Xi'an was 65.5%, and up to 185.3% for generic. Cumulative mark-ups for LPGs in Ankang were also high, from 33% to 50%. The manufacturer's selling price is the largest contributor to the final price in both areas. Conclusions: The government should approve a list of national paediatric essential medicines. The availability, price and affordability of these should be improved in both public hospitals and private pharmacies to enable children to obtain effective treatment. Measures should be taken to improve the efficiency of the centralised medicine purchasing system.	[Wang, Xiao; Fang, Yu; Yang, Shimin; Jiang, Minghuan; Yan, Kangkang; Wu, Lina; Lv, Bing; Shen, Qian] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharm Adm, Xian 710049, Peoples R China; [Fang, Yu] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Fang, Yu] Harvard Pilgrim Hlth Care Inst, Boston, MA USA	Xi'an Jiaotong University; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Fang, Y (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharm Adm, Xian 710049, Peoples R China.	yufang@mail.xjtu.edu.cn; lvb1990@163.com			National Natural Science Fund [71103141/G0308]; Fundamental Research Funds for the Central Universities [2011jdhz62]; Shaanxi Provincial Social Science Fund [10E066]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Shaanxi Provincial Social Science Fund	This medicine price survey was conducted with financial support from the National Natural Science Fund (No: 71103141/G0308), the Fundamental Research Funds for the Central Universities (No: 2011jdhz62) and the Shaanxi Provincial Social Science Fund (No: 10E066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1977, WHO TECHN REP SER; [Anonymous], 2013, PEOPLES DAILY ONLINE; [Anonymous], 2004, INCR ACC ESS MED DEV; [Anonymous], 2011, RD WHO MOD LIST ESS; Anson A, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-22; Babar ZUD, 2007, PLOS MED, V4, P466, DOI 10.1371/journal.pmed.0040082; Balasubramaniam R., 2011, CEYLON MEDICAL JOURNAL, V56, P101, DOI 10.4038/cmj.v56i3.3597; Braine T, 2007, B WORLD HEALTH ORGAN, V85, P249; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Chen W, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-211; Department of Human Resources and Social Security of Shaanxi Province, 2012, LOW WAG REG SHAANX P; Fang Y, 2013, LANCET GLOB HEALTH, V1, pE227, DOI 10.1016/S2214-109X(13)70072-X; Finney E, 2011, CHILDRENS MED SITUAT; Gitanjali B, 2011, J PHARMACOL PHARMACO, V2, P95, DOI 10.4103/0976-500X.81900; Health Action International, 2012, MED PRIC AV AFF PRIC; Hu S., 2010, FINANCING PRICING UT; IMS Consulting Group, 2013, EXPL IMP REV EDL ASS; Jiang MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070836; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; Management Sciences for Health, 2011, INT DRUG PRIC IND GU; Niens LM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000333; Ravindran L, 2012, INDIAN J PHARMACOL, V44, P536, DOI 10.4103/0253-7613.99347; Robertson J, 2009, B WORLD HEALTH ORGAN, V87, P231, DOI 10.2471/BLT.08.053645; Seiter A, 2010, GENERIC DRUG POLICY; State Food and Drug Administration, 2011, NOT STOPP SAIL US AM; Sun Q., 2004, SURVEY MED PRICES AV; The Ministry of Health, 2012, CHIN NAT EML; The Shaanxi Provincial Government, 2012, IMPL OP SHAANX PROV; Tian X, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-401; WHO Health Action International, 2008, MEAS MED PRIC AV AFF, V2nd; World Health Organization, 2012, WORLD HLTH STAT 2012; World Health Organization, 2011, SEL ESS MED; World Health Organization, 2013, CHILDR RED MORT; World Health Organization, 2009, BETT MED CHILDR PROJ; World Health Organization and Health Action International, 2003, MED PRIC NEW APPR ME; Yang H, 2010, HEALTH POLICY PLANN, V25, P219, DOI 10.1093/heapol/czp056; Ye L., 2006, SURVEY MED PRICES AV	37	23	27	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90365	10.1371/journal.pone.0090365	http://dx.doi.org/10.1371/journal.pone.0090365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595099	gold, Green Published, Green Submitted			2022-12-25	WOS:000332468900098
J	Parente, J; Casabuono, A; Ferrari, MC; Paggi, RA; De Castro, RE; Couto, AS; Gimenez, MI				Parente, Juliana; Casabuono, Adriana; Celeste Ferrari, Maria; Alejandro Paggi, Roberto; Esther De Castro, Rosana; Susana Couto, Alicia; Ines Gimenez, Maria			A Rhomboid Protease Gene Deletion Affects a Novel Oligosaccharide N-Linked to the S-layer Glycoprotein of Haloferax volcanii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Archaea; Glycoprotein; Glycosylation; Mass Spectrometry (MS); Rhomboid Protease; Halophiles	INTRAMEMBRANE PROTEOLYSIS; GLYCOSYLATION PATHWAY; PROTEINS; IDENTIFICATION; BIOSYNTHESIS; GROWTH; SMART; RNA	Background: Rhomboid proteases are ubiquitous, and their role in Archaea has not been explored. Results: We generated a rhomboid deletion mutant that displayed a glycosylation defect. Conclusion: Deletion of a rhomboid protease gene altered S-layer glycoprotein N-glycosylation. Significance: This work provides structural characterization of a novel oligosaccharide bound to H. volcanii S-layer glycoprotein and relates a rhomboid protease with the protein glycosylation process. Rhomboid proteases occur in all domains of life; however, their physiological role is not completely understood, and nothing is known of the biology of these enzymes in Archaea. One of the two rhomboid homologs of Haloferax volcanii (RhoII) is fused to a zinc finger domain. Chromosomal deletion of rhoII was successful, indicating that this gene is not essential for this organism; however, the mutant strain (MIG1) showed reduced motility and increased sensitivity to novobiocin. Membrane preparations of MIG1 were enriched in two glycoproteins, identified as the S-layer glycoprotein and an ABC transporter component. The H. volcanii S-layer glycoprotein has been extensively used as a model to study haloarchaeal protein N-glycosylation. HPLC analysis of oligosaccharides released from the S-layer glycoprotein after PNGase treatment revealed that MIG1 was enriched in species with lower retention times than those derived from the parent strain. Mass spectrometry analysis showed that the wild type glycoprotein released a novel oligosaccharide species corresponding to GlcNAc-GlcNAc(Hex)(2)-(SQ-Hex)(6) in contrast to the mutant protein, which contained the shorter form GlcNAc(2)(Hex)(2)-SQ-Hex-SQ. A glycoproteomics approach of the wild type glycopeptide fraction revealed Asn-732 peptide fragments linked to the sulfoquinovose-containing oligosaccharide. This work describes a novel N-linked oligosaccharide containing a repeating SQ-Hex unit bound to Asn-732 of the H. volcanii S-layer glycoprotein, a position that had not been reported as glycosylated. Furthermore, this study provides the first insight on the biological role of rhomboid proteases in Archaea, suggesting a link between protein glycosylation and this protease family.	[Parente, Juliana; Casabuono, Adriana; Susana Couto, Alicia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Organ, Ctr Invest Hidratos Carbono, RA-1428 Buenos Aires, DF, Argentina; [Celeste Ferrari, Maria; Alejandro Paggi, Roberto; Esther De Castro, Rosana; Ines Gimenez, Maria] Univ Nacl Mar del Plata, Consejo Nacl Invest Cient & Tecn, Inst Invest Biol, RA-7600 Mar Del Plata, Buenos Aires, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata	Gimenez, MI (corresponding author), Univ Nacl Mar del Plata, Consejo Nacl Invest Cient & Tecn, Inst Invest Biol, Funes 3250 4To Nivel, RA-7600 Mar Del Plata, Buenos Aires, Argentina.	migimen@mdp.edu.ar		Paggi, Roberto/0000-0003-0059-9343	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP-1783, 1548]; Universidad Nacional de Mar del Plata Grant [Exa 454/09]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT-01824]; Universidad de Buenos Aires Grant [20020100100517]; ANPCyT [PME 125]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Mar del Plata Grant; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Universidad de Buenos Aires Grant; ANPCyT(ANPCyT)	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas Grants PIP-1783 and 1548, Universidad Nacional de Mar del Plata Grant Exa 454/09 (to R. E. D. C.), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) Grant PICT-01824 (to M. I. G.), and Universidad de Buenos Aires Grant 20020100100517 (to A. C.). The Ultraflex II (Bruker) TOF/TOF mass spectrometer was supported by ANPCyT Grant PME 125.	Abu-Qarn M, 2007, J MOL BIOL, V374, P1224, DOI 10.1016/j.jmb.2007.10.042; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Allers T, 2010, APPL ENVIRON MICROB, V76, P1759, DOI 10.1128/AEM.02670-09; Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113; Baker RP, 2012, NAT CHEM BIOL, V8, P759, DOI [10.1038/NCHEMBIO.1021, 10.1038/nchembio.1021]; Baxt LA, 2008, GENE DEV, V22, P1636, DOI 10.1101/gad.1667708; Burroughs AM, 2011, MOL BIOSYST, V7, P2261, DOI 10.1039/c1mb05061c; Calo D, 2010, GLYCOBIOLOGY, V20, P1065, DOI 10.1093/glycob/cwq055; DUBRAY G, 1982, ANAL BIOCHEM, V119, P325, DOI 10.1016/0003-2697(82)90593-0; Eichler J, 2005, MICROBIOL MOL BIOL R, V69, P393, DOI 10.1128/MMBR.69.3.393-425.2005; Guan ZQ, 2012, ENVIRON MICROBIOL, V14, P743, DOI 10.1111/j.1462-2920.2011.02625.x; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Jarrell Ken F, 2010, Int J Microbiol, V2010, P470138, DOI 10.1155/2010/470138; Kaminski L, 2013, MBIO, V4, DOI 10.1128/mBio.00716-13; Kandiba L, 2012, MOL MICROBIOL, V84, P578, DOI 10.1111/j.1365-2958.2012.08045.x; Kateete DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045741; Konrad Z, 2002, FEMS MICROBIOL LETT, V209, P197, DOI 10.1111/j.1574-6968.2002.tb11131.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2005, EMBO J, V24, P464, DOI 10.1038/sj.emboj.7600537; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Magidovich H, 2010, MOL MICROBIOL, V76, P190, DOI 10.1111/j.1365-2958.2010.07090.x; MARINUS MG, 1973, MOL GEN GENET, V127, P47, DOI 10.1007/BF00267782; Maupin-Furlow JA, 2005, CURR OPIN MICROBIOL, V8, P720, DOI 10.1016/j.mib.2005.10.005; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; MENGELE R, 1992, J BIOL CHEM, V267, P8182; Meyer BH, 2011, MOL MICROBIOL, V82, P1150, DOI 10.1111/j.1365-2958.2011.07875.x; Nieuwlandt D. T., 1995, P161; Paggi RA, 2010, LETT APPL MICROBIOL, V51, P36, DOI 10.1111/j.1472-765X.2010.02855.x; Palmieri G, 2013, J PROTEOME RES, V12, P2779, DOI 10.1021/pr400123z; Sambrook J, 2001, MOL CLONING LAB MANU; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Selman MHJ, 2011, ANAL CHEM, V83, P2492, DOI 10.1021/ac1027116; Shlay JC, 2007, JAIDS-J ACQ IMM DEF, V44, P506, DOI 10.1097/QAI.0b013e31804216cf; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; SUMPER M, 1990, J BACTERIOL, V172, P7111, DOI 10.1128/jb.172.12.7111-7118.1990; Tripepi M, 2012, J BACTERIOL, V194, P4876, DOI 10.1128/JB.00731-12; Urban S, 2006, GENE DEV, V20, P3054, DOI 10.1101/gad.1488606; Urban S, 2009, NAT REV MICROBIOL, V7, P411, DOI 10.1038/nrmicro2130; Wan CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037452; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; ZHU BCR, 1995, ARCH BIOCHEM BIOPHYS, V319, P355, DOI 10.1006/abbi.1995.1305	46	24	24	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11304	11317		10.1074/jbc.M113.546531	http://dx.doi.org/10.1074/jbc.M113.546531			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596091	hybrid, Green Published			2022-12-25	WOS:000334638500033
J	Goh, KM; Gan, HM; Chan, KG; Chan, GF; Shahar, S; Chong, CS; Kahar, UM; Chai, KP				Goh, Kian Mau; Gan, Han Ming; Chan, Kok-Gan; Chan, Giek Far; Shahar, Saleha; Chong, Chun Shiong; Kahar, Ummirul Mukminin; Chai, Kian Piaw			Analysis of Anoxybacillus Genomes from the Aspects of Lifestyle Adaptations, Prophage Diversity, and Carbohydrate Metabolism	PLOS ONE			English	Article							THERMOPHILIC BACTERIUM; BETA-GLUCOSIDASES; ESCHERICHIA-COLI; REVERSE GYRASE; ANNOTATION; STABILITY; PROTEINS; CLONING; GENE; SPORULATION	Species of Anoxybacillus are widespread in geothermal springs, manure, and milk-processing plants. The genus is composed of 22 species and two subspecies, but the relationship between its lifestyle and genome is little understood. In this study, two high-quality draft genomes were generated from Anoxybacillus spp. SK3-4 and DT3-1, isolated from Malaysian hot springs. De novo assembly and annotation were performed, followed by comparative genome analysis with the complete genome of Anoxybacillus flavithermus WK1 and two additional draft genomes, of A. flavithermus TNO-09.006 and A. kamchatkensis G10. The genomes of Anoxybacillus spp. are among the smaller of the family Bacillaceae. Despite having smaller genomes, their essential genes related to lifestyle adaptations at elevated temperature, extreme pH, and protection against ultraviolet are complete. Due to the presence of various competence proteins, Anoxybacillus spp. SK3-4 and DT3-1 are able to take up foreign DNA fragments, and some of these transferred genes are important for the survival of the cells. The analysis of intact putative prophage genomes shows that they are highly diversified. Based on the genome analysis using SEED, many of the annotated sequences are involved in carbohydrate metabolism. The presence of glycosyl hydrolases among the Anoxybacillus spp. was compared, and the potential applications of these unexplored enzymes are suggested here. This is the first study that compares Anoxybacillus genomes from the aspect of lifestyle adaptations, the capacity for horizontal gene transfer, and carbohydrate metabolism.	[Goh, Kian Mau; Shahar, Saleha; Chong, Chun Shiong; Kahar, Ummirul Mukminin; Chai, Kian Piaw] Univ Teknol Malaysia, Fac Biosci & Med Engn, Skudai, Johor, Malaysia; [Gan, Han Ming] Monash Univ Sunway Campus, Monash Sch Sci, Petaling Jaya, Selangor, Malaysia; [Chan, Kok-Gan] Univ Malaya, Fac Sci, Inst Biol Sci, Div Genet & Mol Biol, Kuala Lumpur, Malaysia; [Chan, Giek Far] Temasek Polytech, Sch Appl Sci, Singapore, Singapore	Universiti Teknologi Malaysia; Monash University; Monash University Sunway; Universiti Malaya	Goh, KM (corresponding author), Univ Teknol Malaysia, Fac Biosci & Med Engn, Skudai, Johor, Malaysia.	gohkianmau@utm.my	Goh, Kian Mau/C-7221-2011; Chong, Chun Shiong/F-8053-2013; Gan, Han Ming/AAF-9519-2019; Chan, Kok Gan/B-8347-2010; Kahar, Ummirul Mukminin/T-3689-2019	Goh, Kian Mau/0000-0002-2839-8722; Chong, Chun Shiong/0000-0003-2165-4030; Gan, Han Ming/0000-0001-7987-738X; Chan, Kok Gan/0000-0002-1883-1115; Kahar, Ummirul Mukminin/0000-0003-3041-985X; shahar, saleha/0000-0001-6393-4052	Universiti Teknologi Malaysia GUP [04H00]; University of Malaya-Ministry of Higher Education High Impact Research Grant (UMMOHE HIR) [H-50001-A000027]	Universiti Teknologi Malaysia GUP; University of Malaya-Ministry of Higher Education High Impact Research Grant (UMMOHE HIR)	This study was financially supported by the Universiti Teknologi Malaysia GUP Grant 04H00 and University of Malaya-Ministry of Higher Education High Impact Research Grant (UMMOHE HIR Grant No. H-50001-A000027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bhatia Y, 2002, CRIT REV BIOTECHNOL, V22, P375, DOI 10.1080/07388550290789568; Birge EA, 2006, BACTERIAL BACTERIOPH, P261; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Caspers MP, 2013, GENOME, V1; Chai YY, 2012, ENVIRON TECHNOL, V33, P1231, DOI 10.1080/09593330.2011.618935; Chai YY, 2012, J IND MICROBIOL BIOT, V39, P731, DOI 10.1007/s10295-011-1074-9; Cihan AC, 2013, INT J SYST IN PRESS; Cihan AC, 2011, J BASIC MICROB, V51, P136, DOI 10.1002/jobm.201000115; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davis BM, 2002, EMBO J, V21, P4240, DOI 10.1093/emboj/cdf427; Deep K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085493; Fouts DE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks757; Galperin MY, 2012, ENVIRON MICROBIOL, V14, P2870, DOI 10.1111/j.1462-2920.2012.02841.x; Giaquinto L, 2007, J BACTERIOL, V189, P5738, DOI 10.1128/JB.00395-07; Goh KM, 2013, APPL MICROBIOL BIOT, V97, P1475, DOI 10.1007/s00253-012-4663-2; Goosen N, 2008, DNA REPAIR, V7, P353, DOI 10.1016/j.dnarep.2007.09.002; Heine M, 2009, J MICROBIOL, V47, P229, DOI 10.1007/s12275-009-0019-8; HEINEN W, 1982, A VAN LEEUW J MICROB, V48, P265, DOI 10.1007/BF00400386; HOFFMANN T, 1995, FEMS MICROBIOL LETT, V131, P219, DOI 10.1111/j.1574-6968.1995.tb07780.x; Hosoya R, 2004, J GEN APPL MICROBIOL, V50, P271, DOI 10.2323/jgam.50.271; Hou MH, 2001, NUCLEIC ACIDS RES, V29, P5121, DOI 10.1093/nar/29.24.5121; Iguchi A, 2006, GENE, V372, P199, DOI 10.1016/j.gene.2006.01.005; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Kahar UM, 2013, INT J MOL SCI, V14, P11302, DOI 10.3390/ijms140611302; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Kramer N, 2007, MOL MICROBIOL, V65, P454, DOI 10.1111/j.1365-2958.2007.05799.x; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SJ, 2012, J BACTERIOL, V194, P6684, DOI 10.1128/JB.01877-12; Matsutani M, 2013, GENOME ANNOUNC, V1; Moumen B, 2012, GENET RES INT, V2012, DOI 10.1155/2012/543286; Mukherjee A, 2008, NUCLEIC ACIDS RES, V36, P3956, DOI 10.1093/nar/gkn348; OGAWA KI, 1995, J BACTERIOL, V177, P1409, DOI 10.1128/jb.177.5.1409-1413.1995; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Perugino G, 2009, BIOCHEM SOC T, V37, P69, DOI 10.1042/BST0370069; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Pikuta E, 2000, INT J SYST EVOL MICR, V50, P2109, DOI 10.1099/00207713-50-6-2109; Richardson DJ, 2001, CELL MOL LIFE SCI, V58, P165, DOI 10.1007/PL00000845; Saw JH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r161; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schirner K, 2009, MICROBIOL-SGM, V155, P3611, DOI 10.1099/mic.0.030692-0; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Sharon I, 2011, ISME J, V5, P1178, DOI 10.1038/ismej.2011.2; Singhania RR, 2013, BIORESOURCE TECHNOL, V127, P500, DOI 10.1016/j.biortech.2012.09.012; Smeesters PR, 2011, RES MICROBIOL, V162, P446, DOI 10.1016/j.resmic.2011.02.009; Takami H, 2004, NUCLEIC ACIDS RES, V32, P6292, DOI 10.1093/nar/gkh970; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trivedi Seema, 2005, Journal of Cell and Molecular Biology, V4, P61; Turner P, 2005, J BIOSCI BIOENG, V100, P380, DOI 10.1263/jbb.100.380; Turner P, 2005, PROTEIN EXPRES PURIF, V39, P54, DOI 10.1016/j.pep.2004.09.012; VANHALL CE, 1963, ANAL CHEM, V35, P315, DOI 10.1021/ac60196a014; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang XQ, 2013, INT J SYST IN PRESS; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	59	49	50	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90549	10.1371/journal.pone.0090549	http://dx.doi.org/10.1371/journal.pone.0090549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603481	Green Submitted, gold, Green Published			2022-12-25	WOS:000332483600063
J	Zhu, XY; Li, Q; Chang, RM; Yang, D; Song, ZB; Guo, QL; Huang, CS				Zhu, Xiaoyan; Li, Qian; Chang, Ruimin; Yang, Dong; Song, Zongbing; Guo, Qulian; Huang, Changsheng			Curcumin Alleviates Neuropathic Pain by Inhibiting p300/CBP Histone Acetyltransferase Activity-Regulated Expression of BDNF and Cox-2 in a Rat Model	PLOS ONE			English	Article							CHROMATIN REMODELING EVENTS; NEUROTROPHIC FACTOR; NERVE INJURY; SPINAL-CORD; MOUSE MODEL; DORSAL-ROOT; ACETYLATION; TRANSCRIPTION; ACTIVATION; CYCLOOXYGENASE-2	The management of neuropathic pain is still a major challenge because of its unresponsiveness to most common treatments. Curcumin has been reported to play an active role in the treatment of various neurological disorders, such as neuropathic pain. Curcumin has long been recognized as a p300/CREB-binding protein (CBP) inhibitor of histone acetyltransferase (HAT) activity. However, this mechanism has never been investigated for the treatment of neuropathic pain with curcumin. The aim of the present study was to investigate the anti-nociceptive role of curcumin in the chronic constriction injury (CCI) rat model of neuropathic pain. Furthermore, with this model we investigated the effect of curcumin on P300/CBP HAT activity-regulated release of the pro-nociceptive molecules, brain-derived neurotrophic factor (BDNF) and cyclooxygenase-2 (Cox-2). Treatment with 40 and 60 mg/kg body weight curcumin for 7 consecutive days significantly attenuated CCI-induced thermal hyperalgesia and mechanical allodynia, whereas 20 mg/kg curcumin showed no significant analgesic effect. Chromatin immunoprecipitation analysis revealed that curcumin dose-dependently reduced the recruitment of p300/CBP and acetyl-Histone H3/acetyl-Histone H4 to the promoter of BDNF and Cox-2 genes. A similar dose-dependent decrease of BDNF and Cox-2 in the spinal cord was also observed after curcumin treatment. These results indicated that curcumin exerted a therapeutic role in neuropathic pain by down-regulating p300/CBP HAT activity-mediated gene expression of BDNF and Cox-2.	[Zhu, Xiaoyan; Li, Qian; Song, Zongbing; Guo, Qulian; Huang, Changsheng] Cent S Univ, Dept Anesthesiol, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Chang, Ruimin] Cent S Univ, Liver Canc Lab, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Yang, Dong] Huazhong Univ Sci & Technol, Dept Anesthesiol, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Central South University; Central South University; Huazhong University of Science & Technology	Huang, CS (corresponding author), Cent S Univ, Dept Anesthesiol, Xiangya Hosp, Changsha, Hunan, Peoples R China.	docthuang2005@hotmail.com	Song, Zongbin/GYD-5863-2022; Chang, Ruiming/GWN-1856-2022; Changsheng, Huang/M-6033-2018; Yang, Dong/GSD-6859-2022	Song, Zongbin/0000-0002-0447-8648; Huang, Changsheng/0000-0003-0535-1865	National Natural Science Foundation of China [81000478, 81171053]; Science and Technology Planning Project of Hunan Province, China [2012WK3019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Hunan Province, China	This project was supported by National Natural Science Foundation of China (81000478, 81171053) and Science and Technology Planning Project of Hunan Province, China (2012WK3019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Moundhri MS, 2013, J MED TOXICOL, V9, P25, DOI 10.1007/s13181-012-0239-x; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bishnoi M, 2008, PHARMACOL BIOCHEM BE, V88, P511, DOI 10.1016/j.pbb.2007.10.009; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Caccamo A, 2010, P NATL ACAD SCI USA, V107, P22687, DOI 10.1073/pnas.1012851108; Chan HM, 2001, J CELL SCI, V114, P2363; Constandil L, 2008, BRAIN RES B, V86, P454; Crump NT, 2011, P NATL ACAD SCI USA, V108, P7814, DOI 10.1073/pnas.1100099108; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Di Pierro F, 2013, J PAIN RES, V6, P497, DOI 10.2147/JPR.S48432; Durrenberger PF, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-1; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Geng SJ, 2010, EXP NEUROL, V222, P256, DOI 10.1016/j.expneurol.2010.01.003; Goodman RH, 2000, GENE DEV, V14, P1553; Guo W, 2006, J NEUROSCI, V26, P126, DOI 10.1523/JNEUROSCI.3686-05.2006; Ha SO, 2001, NEUROSCIENCE, V107, P301, DOI 10.1016/S0306-4522(01)00353-0; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Huang CS, 2012, SPINE J, V12, P1154, DOI 10.1016/j.spinee.2012.10.036; IdanpaanHeikkila JJ, 1997, J PHARMACOL EXP THER, V282, P1366; Jean YH, 2009, BRIT J PHARMACOL, V158, P713, DOI 10.1111/j.1476-5381.2009.00323.x; Ji FT, 2013, CHINESE MED J-PEKING, V126, P1125, DOI 10.3760/cma.j.issn.0366-6999.20122095; Joshi RP, 2013, NANOMED-NANOTECHNOL, V9, P776, DOI 10.1016/j.nano.2013.01.001; Kobayashi H, 2008, BRAIN RES, V1206, P13, DOI 10.1016/j.brainres.2007.12.004; Kulkarni SK, 2008, PSYCHOPHARMACOLOGY, V201, P435, DOI 10.1007/s00213-008-1300-y; Li Y, 2013, INT J MED SCI, V10, P377, DOI 10.7150/ijms.5224; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Ma WY, 2002, BRAIN RES, V937, P94, DOI 10.1016/S0006-8993(02)02593-3; Marcu MG, 2006, MED CHEM, V2, P169, DOI 10.2174/157340606776056133; Martin TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034236; Miao F, 2004, J BIOL CHEM, V279, P18091, DOI 10.1074/jbc.M311786200; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Mishra S, 2008, ANN INDIAN ACAD NEUR, V11, P13, DOI 10.4103/0972-2327.40220; Mittal N, 2009, PHYTOTHER RES, V23, P507, DOI 10.1002/ptr.2662; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Mutskov V, 1998, MOL CELL BIOL, V18, P6293, DOI 10.1128/MCB.18.11.6293; Ohtori S, 2004, J PAIN, V5, P385, DOI 10.1016/j.jpain.2004.06.004; OSSIPOV MH, 1995, NEUROSCI LETT, V199, P83, DOI 10.1016/0304-3940(95)12026-Z; Piller Nicolas, 2013, BMC Res Notes, V6, P266, DOI 10.1186/1756-0500-6-266; Puglia C, 2012, EUR J PHARM BIOPHARM, V81, P288, DOI 10.1016/j.ejpb.2012.03.015; Quintao NLM, 2008, PAIN, V136, P125, DOI 10.1016/j.pain.2007.06.027; Reeta KH, 2010, EUR J PHARMACOL, V644, P106, DOI 10.1016/j.ejphar.2010.07.022; Renthal W, 2009, SEMIN CELL DEV BIOL, V20, P387, DOI 10.1016/j.semcdb.2009.01.005; Schmidt HD, 2012, J NEUROCHEM, V120, P202, DOI 10.1111/j.1471-4159.2011.07571.x; Seybold VS, 2003, PAIN, V105, P47, DOI 10.1016/S0304-3959(03)00254-9; Sharma S, 2006, EUR J PHARMACOL, V536, P256, DOI 10.1016/j.ejphar.2006.03.006; Sharma S, 2007, PHYTOTHER RES, V21, P278, DOI 10.1002/ptr.2070; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Soliman ML, 2013, LIPIDS, V48, P651, DOI 10.1007/s11745-013-3799-x; Tian F, 2009, J NEUROCHEM, V109, P1375, DOI 10.1111/j.1471-4159.2009.06058.x; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Ura K, 1997, EMBO J, V16, P2096, DOI 10.1093/emboj/16.8.2096; Valor LM, 2013, CURR PHARM DESIGN, V19, P5051, DOI 10.2174/13816128113199990382; Vivancos GG, 2004, BRAZ J MED BIOL RES, V37, P391, DOI 10.1590/S0100-879X2004000300017; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; Wall PD, 2006, CENTRAL CONSEQUENCES, P947; Wang DQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009853; Wang XD, 2009, J NEUROSCI, V29, P5508, DOI 10.1523/JNEUROSCI.4288-08.2009; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Yadav VS, 2005, IMMUNOPHARM IMMUNOT, V27, P485, DOI 10.1080/08923970500242244; Yajima Y, 2005, J NEUROCHEM, V93, P584, DOI 10.1111/j.1471-4159.2005.03045.x; Yeon KY, 2010, J DENT RES, V89, P170, DOI 10.1177/0022034509356169; Yuan H, 2013, AM J PHYSIOL-RENAL, V304, pF601, DOI 10.1152/ajprenal.00523.2012; Zhao FY, 2007, PAIN, V128, P78, DOI 10.1016/j.pain.2006.08.032; Zhao X, 2012, NEUROPHARMACOLOGY, V62, P843, DOI 10.1016/j.neuropharm.2011.08.050; Zhao Z, 2000, NEUROSCIENCE, V97, P743, DOI 10.1016/S0306-4522(00)00052-X; Zhu XY, 2013, CELL MOL NEUROBIOL, V33, P197, DOI 10.1007/s10571-012-9885-4; Zhu XY, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-84	70	73	76	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91303	10.1371/journal.pone.0091303	http://dx.doi.org/10.1371/journal.pone.0091303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603592	Green Submitted, Green Published, gold			2022-12-25	WOS:000332483600141
J	Mao, XD; Zheng, HC; Liu, ZW; Wu, Y; Na, RS; Wang, CP; Zheng, XL; Gao, J; Wu, LM; Shi, XH; Liu, C; Sheng, HG				Mao, Xudong; Zheng, Hongchao; Liu, Zhiwen; Wu, Yan; Na, Risu; Wang, Chunping; Zheng, Xulei; Gao, Jing; Wu, Liming; Shi, Xiaohong; Liu, Cong; Sheng, Hongguang			Analysis of 25(OH) D Serum Concentrations of Hospitalized Elderly Patients in the Shanghai Area	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; 25-HYDROXYVITAMIN D; GENE-EXPRESSION; D INSUFFICIENCY; US POPULATION; D-3	Objective: To find an association between basic characteristics, seasons as well as disease types and 25-Hydroxyvitamin D serum concentrations in Chinese patients. Methods: We randomly selected 5470 Chinese patients with various diseases, who were hospitalized between May 2012 and August 2013 in Shanghai and analyzed their serum 25-Hydroxyvitamin D2 (25 (OH) D2) and 25-Hydroxyvitamin D3 (25(OH) D3) concentrations with liquid chromatography-tandem mass spectrometry (LC-MS/MS) as well as their parathyroid hormone (PTH) and serum creatinine blood levels. The resulting data were analyzed by linear regression and variance analyses or multivariate analysis with covariance. Results: The 25(OH) D serum concentrations were lowest in December. Among the subjects with a median age of 83.0 +/- 16.0, the median 25(OH) D2, 25(OH) D3 and total 25(OH) D serum concentrations were 1.00 +/- 1.80 ng/ml, 12.20 +/- 8.50 ng/ml and 14.80 +/- 9.80 respectively, indicating a prevalent 25(OH) D deficiency. According to our multivariate analysis of covariance, the factors affecting 25(OH) D2 and 25(OH) D3 serum concentrations included age, creatinine, PTH, season and type of disease, whereas gender correlated only with 25(OH) D2 and 25(OH) D2 and D3 values correlated negatively with each other. Our results further revealed that 25(OH) D3 levels were low while 25(OH) D2 levels were high among patients with lung diseases, dyskinesia and coronary heart diseases. In addition, participants with diabetes and cerebral infarction had higher 25(OH) D3 serum concentrations compared with lung disease patients. Conclusion: Vitamin D intake particularly during winter and summer seasons is important especially for elderly lung disease, dyskinesia and coronary heart disease patients to improve their quality of life.	[Mao, Xudong; Liu, Zhiwen; Na, Risu; Wang, Chunping; Zheng, Xulei; Wu, Liming; Shi, Xiaohong; Liu, Cong; Sheng, Hongguang] Xuhui Dist Cent Hosp, Dept Endocrinol, Shanghai, Peoples R China; [Zheng, Hongchao] Xuhui Dist Cent Hosp, Dept Cardiol, Shanghai, Peoples R China; [Wu, Yan] Shanghai Mental Hlth Ctr, Dept Psychiat, Shanghai, Peoples R China; [Gao, Jing] Xuhui Dist Cent Hosp, Dept Informat, Shanghai, Peoples R China		Mao, XD (corresponding author), Xuhui Dist Cent Hosp, Dept Endocrinol, Shanghai, Peoples R China.	maoxud@sina.com; zhcmxd@163.com	Wu, liming/AAH-5415-2019		 [81170734]		This work was supported by Research Grants (81170734). Funder's website: http://www.nutrition.ac.cn/PI/PI_lihx.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davies P, 2010, AM J RESP CRIT CARE, V181, P94, DOI 10.1164/ajrccm.181.1.94a; Dawson-Hughes B, 2010, OSTEOPOROSIS INT, V21, P1151, DOI 10.1007/s00198-010-1285-3; Demetriou ETW, 2012, ENDOCR PRACT, V18, P399, DOI 10.4158/EP11268.OR; Dorjgochoo T, 2012, BRIT J NUTR, V108, P449, DOI 10.1017/S0007114511005745; Douglas AS, 1995, J EPIDEMIOL COMMUN H, V49, P575, DOI 10.1136/jech.49.6.575; Du XQ, 2001, AM J CLIN NUTR, V74, P494; Gibney KB, 2008, CLIN INFECT DIS, V46, P443, DOI 10.1086/525268; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hong W, 2011, CHIN J OSTEOPOROSIS, V4, P224; Jacques PF, 1997, AM J CLIN NUTR, V66, P929, DOI 10.1093/ajcn/66.4.929; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Mansoor S, 2010, CLIN BIOCHEM, V43, P1431, DOI 10.1016/j.clinbiochem.2010.09.022; MERKE J, 1989, J CLIN INVEST, V83, P1903, DOI 10.1172/JCI114097; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Nibbelink KA, 2007, J STEROID BIOCHEM, V103, P533, DOI 10.1016/j.jsbmb.2006.12.099; Pike JW, 2007, J BONE MINER RES, V22, pV16, DOI [10.1359/jbmr.07s207, 10.1359/JBMR.07S207]; Ralph AP, 2008, TRENDS MICROBIOL, V16, P336, DOI 10.1016/j.tim.2008.04.003; Ralph AR, 2013, LANCET INFECT DIS, V13, P77, DOI 10.1016/S1473-3099(12)70275-X; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Rucker D, 2002, CAN MED ASSOC J, V166, P1517; Sai AJ, 2011, J CLIN ENDOCR METAB, V96, pE436, DOI 10.1210/jc.2010-1886; Scragg R, 2008, AM J EPIDEMIOL, V168, P577, DOI 10.1093/aje/kwn163; Shin SY, 2013, J CLIN LAB ANAL, V27, P284, DOI 10.1002/jcla.21598; VANDERWIELEN RPJ, 1995, LANCET, V346, P207, DOI 10.1016/S0140-6736(95)91266-5; [汪纯 WANG Chun], 2011, [上海医学, Shanghai Medical Journal], V34, P166; Wu-Wong JR, 2006, ATHEROSCLEROSIS, V186, P20, DOI 10.1016/j.atherosclerosis.2005.06.046; Zhu H, 2010, CHIN J OSTEOPROSIS B, V3, P157	31	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90729	10.1371/journal.pone.0090729	http://dx.doi.org/10.1371/journal.pone.0090729			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599155	gold, Green Submitted, Green Published			2022-12-25	WOS:000332479400127
J	Miller, NA; Chen, X; Stillman, JH				Miller, Nathan A.; Chen, Xi; Stillman, Jonathon H.			Metabolic Physiology of the Invasive Clam, Potamocorbula amurensis: The Interactive Role of Temperature, Salinity, and Food Availability	PLOS ONE			English	Article							SAN-FRANCISCO ESTUARY; FRESH-WATER FLOW; CALIFORNIA; ENZYMES; PHYTOPLANKTON; ENERGETICS; RESPONSES; PROTEINS; PATTERNS; STRESS	In biological systems energy serves as the ultimate commodity, often determining species distributions, abundances, and interactions including the potential impact of invasive species on native communities. The Asian clam Potamocorbula amurensis invaded the San Francisco Estuary (SFE) in 1986 and is implicated in the decline of native fish species through resource competition. Using a combined laboratory/field study we examined how energy expenditure in this clam is influenced by salinity, temperature and food availability. Measures of metabolism were made at whole organism (metabolic rate) and biochemical (pyruvate kinase (PK) and citrate synthase (CS) enzyme activities) levels. We found in the field, over the course of a year, the ratio of PK to CS was typically 1.0 suggesting that aerobic and fermentative metabolism were roughly equivalent, except for particular periods characterized by low salinity, higher temperatures, and intermediate food availabilities. In a 30-day laboratory acclimation experiment, however, neither metabolic rate nor PK: CS ratio was consistently influenced by the same variables, though the potential for fermentative pathways did predominate. We conclude that in field collected animals, the addition of biochemical measures of energetic state provide little additional information to the previously measured whole organism metabolic rate. In addition, much of the variation in the laboratory remained unexplained and additional variables, including reproductive stage or body condition may influence laboratory-based results. Further study of adult clams must consider the role of organismal condition, especially reproductive state, in comparisons of laboratory experiments and field observations.	[Miller, Nathan A.; Chen, Xi; Stillman, Jonathon H.] San Francisco State Univ, Romberg Tiburon Ctr, Tiburon, CA USA; [Miller, Nathan A.; Chen, Xi; Stillman, Jonathon H.] San Francisco State Univ, Dept Biol, Tiburon, CA USA; [Stillman, Jonathon H.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	California State University System; San Francisco State University; California State University System; San Francisco State University; University of California System; University of California Berkeley	Miller, NA (corresponding author), San Francisco State Univ, Romberg Tiburon Ctr, Tiburon, CA USA.	natemiller77@gmail.com		Stillman, Jonathon/0000-0002-4783-3830	United States Department of the Interior, Bureau of Reclamation [R10AC-20074]	United States Department of the Interior, Bureau of Reclamation	This research was supported by the United States Department of the Interior, Bureau of Reclamation, Cooperative Agreement Number R10AC-20074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPINE AE, 1992, LIMNOL OCEANOGR, V37, P946, DOI 10.4319/lo.1992.37.5.0946; BAYNE B, 1973, Netherlands Journal of Sea Research, V7, P399, DOI 10.1016/0077-7579(73)90061-6; BLACKSTOCK J, 1980, J EXP MAR BIOL ECOL, V46, P197, DOI 10.1016/0022-0981(80)90031-3; CARLTON JT, 1990, MAR ECOL PROG SER, V66, P81, DOI 10.3354/meps066081; Castillo-Duran A, 2013, REV BIOL MAR OCEANOG, V48, P59, DOI 10.4067/S0718-19572013000100006; CHIH CP, 1987, COMP BIOCHEM PHYS B, V86, P541, DOI 10.1016/0305-0491(87)90445-7; Cullen M, 2003, DEEP-SEA RES PT II, V50, P1787, DOI 10.1016/S0967-0645(03)00088-2; Dahlhoff EP, 2004, ANNU REV PHYSIOL, V66, P183, DOI 10.1146/annurev.physiol.66.032102.114509; Dahlhoff EP, 2002, INTEGR COMP BIOL, V42, P862, DOI 10.1093/icb/42.4.862; Feyrer F, 2007, CAN J FISH AQUAT SCI, V64, P723, DOI 10.1139/F07-048; Fly EK, 2013, OECOLOGIA, V172, P35, DOI 10.1007/s00442-012-2486-6; Greene VE, 2011, MAR ECOL PROG SER, V431, P183, DOI 10.3354/meps09099; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Kearney MR, 2012, J EXP BIOL, V215, P922, DOI 10.1242/jeb.059634; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; Kimmerer WJ, 2009, ESTUAR COAST, V32, P375, DOI 10.1007/s12237-008-9124-x; KIMMERER WJ, 1994, MAR ECOL PROG SER, V113, P81, DOI 10.3354/meps113081; Kimmerer WJ, 2002, MAR ECOL PROG SER, V243, P39, DOI 10.3354/meps243039; Lesser MP, 2004, COMP BIOCHEM PHYS A, V137, P495, DOI 10.1016/j.cbpb.2003.10.022; Lockwood BL, 2011, J EXP MAR BIOL ECOL, V400, P167, DOI 10.1016/j.jembe.2011.02.022; Miller NA, 2013, MAR ECOL PROG SER, V476, P129, DOI 10.3354/meps10149; Moschino V, 2006, COMP BIOCHEM PHYS A, V145, P433, DOI 10.1016/j.cbpa.2006.07.021; Nisbet RM, 2012, J EXP BIOL, V215, P892, DOI 10.1242/jeb.059675; Orsi James J., 1996, P375; Paganini A, 2010, AQUAT BIOL, V11, P139, DOI 10.3354/ab00304; Parchaso Francis, 2002, Pacific Science, V56, P329, DOI 10.1353/psc.2002.0027; R Core Team, 2021, R LANG ENV STAT COMP; Somero GN, 2012, ANNU REV MAR SCI, V4, P39, DOI 10.1146/annurev-marine-120710-100935; Werner I, 2004, MAR ENVIRON RES, V58, P803, DOI 10.1016/j.marenvres.2004.03.097; WERNER I, 1993, LIMNOL OCEANOGR, V38, P949, DOI 10.4319/lo.1993.38.5.0949; Werner I, 2000, MAR ENVIRON RES, V50, P379, DOI 10.1016/S0141-1136(00)00058-1; Werner I, 1999, BIOMARKERS, V4, P473, DOI 10.1080/135475099230633; Wilkerson FP, 2006, ESTUAR COAST, V29, P401, DOI 10.1007/BF02784989; Zuur Alain F., 2009, P1	34	7	7	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e91064	10.1371/journal.pone.0091064	http://dx.doi.org/10.1371/journal.pone.0091064			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599347	gold, Green Published, Green Submitted			2022-12-25	WOS:000332479400153
J	Pons, C; Marti, C; Forment, J; Crisosto, CH; Dandekar, AM; Granell, A				Pons, Clara; Marti, Cristina; Forment, Javier; Crisosto, Carlos H.; Dandekar, Abhaya M.; Granell, Antonio			A Bulk Segregant Gene Expression Analysis of a Peach Population Reveals Components of the Underlying Mechanism of the Fruit Cold Response	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GENE; ABSCISIC-ACID RESPONSES; GAIN-OF-FUNCTION; FREEZING TOLERANCE; CHILLING INJURY; NEGATIVE REGULATOR; LOW-TEMPERATURE; NUCLEAR-PROTEIN; STRESS-RESPONSE; PLANT-GROWTH	Peach fruits subjected for long periods of cold storage are primed to develop chilling injury once fruits are shelf ripened at room temperature. Very little is known about the molecular changes occurring in fruits during cold exposure. To get some insight into this process a transcript profiling analyses was performed on fruits from a PopDG population segregating for chilling injury CI responses. A bulked segregant gene expression analysis based on groups of fruits showing extreme CI responses indicated that the transcriptome of peach fruits was modified already during cold storage consistently with eventual CI development. Most peach cold-responsive genes have orthologs in Arabidopsis that participate in cold acclimation and other stresses responses, while some of them showed expression patterns that differs in fruits according to their susceptibility to develop mealiness. Members of ICE1, CBF1/3 and HOS9 regulons seem to have a prominent role in differential cold responses between low and high sensitive fruits. In high sensitive fruits, an alternative cold response program is detected. This program is probably associated with dehydration/osmotic stress and regulated by ABA, auxins and ethylene. In addition, the observation that tolerant siblings showed a series of genes encoding for stress protective activities with higher expression both at harvest and during cold treatment, suggests that preprogrammed mechanisms could shape fruit ability to tolerate postharvest cold-induced stress. A number of genes differentially expressed were validated and extended to individual genotypes by medium-throughput RT-qPCR. Analyses presented here provide a global view of the responses of peach fruits to cold storage and highlights new peach genes that probably play important roles in the tolerance/sensitivity to cold storage. Our results provide a roadmap for further experiments and would help to develop new postharvest protocols and gene directed breeding strategies to better cope with chilling injury.	[Pons, Clara; Marti, Cristina; Forment, Javier; Granell, Antonio] Univ Politecn Valencia, Consejo Super Invest Cient, Plant Genom & Biotechnol Lab, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain; [Crisosto, Carlos H.; Dandekar, Abhaya M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); University of California System; University of California Davis	Granell, A (corresponding author), Univ Politecn Valencia, Consejo Super Invest Cient, Plant Genom & Biotechnol Lab, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain.	agranell@ibmcp.upv.es	Pons, Clara/AAA-6233-2020; Granell, Antonio/G-3664-2010; Marti, Cristina/I-4535-2015	Pons, Clara/0000-0002-8296-2937; Marti, Cristina/0000-0002-8918-8147; Dandekar, Abhaya/0000-0001-7925-4086	National Research Initiative of USDA's National Institute of Food and Agriculture (NIFA) [2008-35300-04432]; US-Israel Binational Agriculture Research and Development Fund (BARD) [US-4027-07]	National Research Initiative of USDA's National Institute of Food and Agriculture (NIFA); US-Israel Binational Agriculture Research and Development Fund (BARD)	This work was supported by the National Research Initiative of USDA's National Institute of Food and Agriculture (NIFA) grant # 2008-35300-04432 and US-Israel Binational Agriculture Research and Development Fund (BARD) Grant no. US-4027-07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amil-Ruiz F, 2011, PLANT CELL PHYSIOL, V52, P1873, DOI 10.1093/pcp/pcr136; Bassa C, 2012, PLANT CELL PHYSL; Begheldo M, 2008, POSTHARVEST BIOL TEC, V48, P84, DOI 10.1016/j.postharvbio.2007.09.023; Belin C, 2009, PLANT CELL, V21, P2253, DOI 10.1105/tpc.109.067702; BENARIE R, 1980, PHYTOCHEMISTRY, V19, P2553, DOI 10.1016/S0031-9422(00)83917-5; Bindon KA, 2012, J AGR FOOD CHEM, V60, P9249, DOI 10.1021/jf301552t; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Brummell DA, 2004, J EXP BOT, V55, P2041, DOI 10.1093/jxb/erh228; BUESCHER RW, 1978, J FOOD SCI, V43, P264, DOI 10.1111/j.1365-2621.1978.tb09788.x; Campos-Vargas R, 2006, SCI HORTIC-AMSTERDAM, V110, P79, DOI 10.1016/j.scienta.2006.06.019; Carvallo MA, 2011, J EXP BOT, V62, P3807, DOI 10.1093/jxb/err066; Catala R, 2011, P NATL ACAD SCI USA, V108, P16475, DOI 10.1073/pnas.1107161108; Cheung KJ, 2003, GENOME RES, V13, P206, DOI 10.1101/gr.401003; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Crisosto CH, 1999, HORTSCIENCE, V34, P1116, DOI 10.21273/HORTSCI.34.6.1116; Crisosto CH, 1997, HORTSCIENCE, V32, P820, DOI 10.21273/HORTSCI.32.5.820; Crisosto CH, 2002, POSTHARVEST BIOL TEC, V25, P151, DOI 10.1016/S0925-5214(01)00183-1; Dagar A, 2013, TREE GENET GENOMES, V9, P223, DOI 10.1007/s11295-012-0549-9; Dai F, 2009, BIOL PLANTARUM, V53, P257, DOI 10.1007/s10535-009-0048-5; Dhanaseely A. J., 2012, P INT C SOFTW ENG MO, P1; Doherty CJ, 2009, PLANT CELL, V21, P972, DOI 10.1105/tpc.108.063958; Dong CH, 2006, P NATL ACAD SCI USA, V103, P8281, DOI 10.1073/pnas.0602874103; El-Sharkawy I, 2004, PLANT CELL ENVIRON, V27, P1197, DOI 10.1111/j.1365-3040.2004.01218.x; Falara V, 2011, FUNCT INTEGR GENOMIC, V11, P357, DOI 10.1007/s10142-010-0204-1; Feng XM, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-22; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; GIOVANNONI JJ, 1991, NUCLEIC ACIDS RES, V19, P6553, DOI 10.1093/nar/19.23.6553; Gonzalez-Aguero M, 2008, J EXP BOT, V59, P1973, DOI 10.1093/jxb/em69; Guo Y, 2002, P NATL ACAD SCI USA, V99, P7786, DOI 10.1073/pnas.112040099; Han SK, 2012, PLANT CELL, V24, P4892, DOI 10.1105/tpc.112.105114; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; Hardenburg R.E., 1986, COMMERCIAL STORAGE F; HARDING PAUL L., 1934, PROC AMER SOC HORT SCI, V32, P160; Hugouvieux V, 2002, PLANT PHYSIOL, V130, P1276, DOI 10.1104/pp.009480; Huq E, 2000, P NATL ACAD SCI USA, V97, P9789, DOI 10.1073/pnas.170283997; Iriti M, 2009, INT J MOL SCI, V10, P3371, DOI 10.3390/ijms10083371; Jaglo KR, 2001, PLANT PHYSIOL, V127, P910, DOI 10.1104/pp.010548; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; JOHNSON E, 1994, PLANT PHYSIOL, V105, P141, DOI 10.1104/pp.105.1.141; Ju ZG, 2000, J HORTIC SCI BIOTECH, V75, P86, DOI 10.1080/14620316.2000.11511205; Jung C, 2007, PLANT CELL REP, V26, P1053, DOI 10.1007/s00299-007-0311-1; Jung S, 2008, NUCLEIC ACIDS RES, V36, pD1034, DOI 10.1093/nar/gkm803; KADER AA, 1989, PEACHES PLUMS NECTAR, P191; Kariola T, 2006, PLANT PHYSIOL, V142, P1559, DOI 10.1104/pp.106.086223; Kelley DR, 2012, PLANT PHYSIOL, V160, P47, DOI 10.1104/pp.112.200527; Kim DH, 2002, PLANT CELL, V14, P3043, DOI 10.1105/tpc.005306; Kim HJ, 2002, PLANT J, V29, P693, DOI 10.1046/j.1365-313X.2002.01249.x; Kitamura S, 2004, PLANT J, V37, P104, DOI 10.1046/j.1365-313X.2003.01943.x; Kitamura S, 2010, PLANT J, V62, P549, DOI 10.1111/j.1365-313X.2010.04174.x; KIYOSUE T, 1993, BIOCHEM BIOPH RES CO, V196, P1214, DOI 10.1006/bbrc.1993.2381; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; LAM HM, 1994, PLANT PHYSIOL, V106, P1347, DOI 10.1104/pp.106.4.1347; Lazzari B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S16; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lee BH, 2006, PLANT CELL, V18, P1736, DOI 10.1105/tpc.106.042184; Lee YP, 2009, PLANT BIOLOGY, V11, P273, DOI 10.1111/j.1438-8677.2008.00122.x; Lim GH, 2010, NEW PHYTOL, V185, P103, DOI 10.1111/j.1469-8137.2009.03032.x; Lin JF, 2004, PLANT J, V39, P612, DOI 10.1111/j.1365-313X.2004.02160.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYONS JM, 1973, ANNU REV PLANT PHYS, V24, P445, DOI 10.1146/annurev.pp.24.060173.002305; Martinez-Garcia PJ, 2012, EUPHYTICA, V185, P267, DOI 10.1007/s10681-011-0572-1; Medina J, 2011, PLANT SCI, V180, P3, DOI 10.1016/j.plantsci.2010.06.019; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Miura K, 2012, PLANT BIOTECHNOLOGY; Miura K, 2007, PLANT CELL, V19, P1403, DOI 10.1105/tpc.106.048397; Nakashima K, 1997, PLANT J, V12, P851, DOI 10.1046/j.1365-313X.1997.12040851.x; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Ogundiwin EA, 2008, TREE GENET GENOMES, V4, P543, DOI 10.1007/s11295-007-0130-0; Ogundiwin EA, 2008, PLANT MOL BIOL, V68, P379, DOI 10.1007/s11103-008-9378-5; Ogundiwin EA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-587; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; Peace CP, 2006, ACTA HORTIC, P489, DOI 10.17660/ActaHortic.2006.713.73; Peace CP, 2005, MOL BREEDING, V16, P21, DOI 10.1007/s11032-005-0828-3; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Provart NJ, 2003, PLANT PHYSIOL, V132, P893, DOI 10.1104/pp.103.021261; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rinaldi MA, 2012, PLANT MOL BIOL, V79, P359, DOI 10.1007/s11103-012-9917-y; Ruelland E, 2009, ADV BOT RES, V49, P35, DOI 10.1016/S0065-2296(08)00602-2; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Scott IM, 2004, PLANT PHYSIOL, V135, P1040, DOI 10.1104/pp.104.041293; Sevillano L, 2009, J SCI FOOD AGR, V89, P555, DOI 10.1002/jsfa.3468; Shi YT, 2012, PLANT CELL, V24, P2578, DOI 10.1105/tpc.112.098640; Soitamo AJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-13; Tacken E, 2010, PLANT PHYSIOL, V153, P294, DOI 10.1104/pp.109.151092; Takase T, 2003, PLANT CELL PHYSIOL, V44, P1071, DOI 10.1093/pcp/pcg130; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tittarelli A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-121; Trainotti L, 2007, J EXP BOT, V58, P3299, DOI 10.1093/jxb/erm178; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ueda A, 2008, PLANT MOL BIOL, V67, P683, DOI 10.1007/s11103-008-9348-y; Usadel B, 2008, PLANT CELL ENVIRON, V31, P518, DOI 10.1111/j.1365-3040.2007.01763.x; Vergne E., 2010, BMC PLANT BIOL, V10, P206, DOI DOI 10.1186/1471-2229-10-206; Vizoso P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-423; Von Mollendorf LJ, 1987, J HORTIC SCI, V5, P1; Wang YN, 2007, PLANT MOL BIOL, V64, P633, DOI 10.1007/s11103-007-9182-7; Wisniewski M, 2011, PLANTA, V233, P971, DOI 10.1007/s00425-011-1358-3; Xiong LM, 2002, P NATL ACAD SCI USA, V99, P10899, DOI 10.1073/pnas.162111599; Xiong LM, 1999, PLANT J, V19, P569, DOI 10.1046/j.1365-313X.1999.00558.x; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128; Zhang SC, 2011, J PLANT PHYSIOL, V168, P2093, DOI 10.1016/j.jplph.2011.06.010; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhao DY, 2009, J FOOD SCI, V74, pC348, DOI 10.1111/j.1750-3841.2009.01156.x; Zhao DY, 2009, FEBS LETT, V583, P3329, DOI 10.1016/j.febslet.2009.09.029; Zhao J, 2010, TRENDS PLANT SCI, V15, P72, DOI 10.1016/j.tplants.2009.11.006; Zhu JH, 2005, P NATL ACAD SCI USA, V102, P9966, DOI 10.1073/pnas.0503960102; Zhu JH, 2004, P NATL ACAD SCI USA, V101, P9873, DOI 10.1073/pnas.0403166101; Zhu J, 2008, P NATL ACAD SCI USA, V105, P4945, DOI 10.1073/pnas.0801029105	110	31	31	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90706	10.1371/journal.pone.0090706	http://dx.doi.org/10.1371/journal.pone.0090706			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598973	Green Published, gold			2022-12-25	WOS:000332479400123
J	Seabert, TA; Pal, S; Pinet, BM; Haman, F; Robidoux, MA; Imbeault, P; Krummel, EM; Kimpe, LE; Blais, JM				Seabert, Timothy A.; Pal, Shinjini; Pinet, Bernard M.; Haman, Francois; Robidoux, Michael A.; Imbeault, Pascal; Kruemmel, Eva M.; Kimpe, Linda E.; Blais, Jules M.			Elevated Contaminants Contrasted with Potential Benefits of omega-3 Fatty Acids in Wild Food Consumers of Two Remote First Nations Communities in Northern Ontario, Canada	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; POLYCHLORINATED-BIPHENYLS; ENVIRONMENTAL CONTAMINANTS; ORGANOCHLORINE PESTICIDES; MERCURY EXPOSURE; FISH CONSUMPTION; ADIPOSE-TISSUE; RISK-FACTORS; HUMAN HEALTH; FATTY-ACIDS	Indigenous communities in Boreal environments rely on locally-harvested wild foods for sustenance. These foods provide many nutritional benefits including higher levels of polyunsaturated fatty acids (PUFAs; such as omega-3) than what is commonly found in store-bought foods. However, wild foods can be a route of exposure to dietary mercury and persistent organic pollutants (POPs) such as polychlorinated biphenyls (PCBs). Here, we show a strong association between the frequency of wild food consumption in adults (N = 72) from two remote First Nations communities of Northern Ontario and environmental contaminants in blood (POPs) and hair (mercury). We observed that POPs and mercury were on average 3.5 times higher among those consuming wild foods more often, with many frequent wild food consumers exceeding Canadian and international health guidelines for PCB and mercury exposures. Contaminants in locally-harvested fish and game from these communities were sufficiently high that many participants exceeded the monthly consumption limits for methylmercury and PCBs. Those consuming more wild foods also had higher proportions of potentially beneficial omega-3 fatty acids including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). These results show that the benefits of traditional dietary choices in Boreal regions of Canada must be weighed against the inherent risks of contaminant exposure from these foods.	[Seabert, Timothy A.; Pal, Shinjini; Kruemmel, Eva M.; Kimpe, Linda E.; Blais, Jules M.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Pinet, Bernard M.; Haman, Francois; Robidoux, Michael A.] Univ Ottawa, Indigenous Hlth Res Grp, Ottawa, ON, Canada; [Imbeault, Pascal] Univ Ottawa, Fac Hlth Sci, Behav & Metab Res Unit, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa	Blais, JM (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	Jules.Blais@uottawa.ca	Blais, Jules/AAV-2321-2020	Blais, Jules/0000-0002-7188-3598	Canadian federal government, specifically Health Canada's National First Nations Environmental Contaminant Program	Canadian federal government, specifically Health Canada's National First Nations Environmental Contaminant Program	This research was supported by the Canadian federal government, specifically Health Canada's National First Nations Environmental Contaminant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, or did they assume any role in the generation or interpretation of results.	Arsenescu V, 2008, ENVIRON HEALTH PERSP, V116, P761, DOI 10.1289/ehp.10554; Belanger MC, 2008, METABOLISM, V57, P630, DOI 10.1016/j.metabol.2007.12.006; Bharadwaj L, 2006, J ENVIRON HEALTH, V68, P35; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; BLOOM NS, 1992, CAN J FISH AQUAT SCI, V49, P1010, DOI 10.1139/f92-113; Boucher O, 2012, ENVIRON HEALTH PERSP, V120, P1456, DOI 10.1289/ehp.1204976; Bourdon JA, 2010, FOOD CHEM TOXICOL, V48, P3093, DOI 10.1016/j.fct.2010.07.051; Burger J, 2008, SCI TOTAL ENVIRON, V390, P346, DOI 10.1016/j.scitotenv.2007.10.016; Chan HM, 1999, ENVIRON RES, V80, pS213, DOI 10.1006/enrs.1998.3930; Committee on the Toxicological Effects of Methylmercury Board on Environmental Studies and Toxicology National Research Council, 2000, TOX EFF METH; Das UN, 2000, PROSTAG LEUKOTR ESS, V63, P351, DOI 10.1054/plef.2000.0226; Dewailly E, 2002, AM J CLIN NUTR, V76, P85, DOI 10.1093/ajcn/76.1.85; Dewailly F, 2003, LIPIDS, V38, P359, DOI 10.1007/s11745-003-1070-4; Dietz R, 2004, SCI TOTAL ENVIRON, V331, P107, DOI 10.1016/j.scitotenv.2004.03.025; Dionex, 2011, SEL EXTR PCBS FISH T; Donaldson SG, 2010, SCI TOTAL ENVIRON, V408, P5165, DOI 10.1016/j.scitotenv.2010.04.059; Eaton SB, 1998, WORLD REV NUTR DIET, V83, P12; Eichelberger JW, 1994, DETERMINATION CHLORI; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gardner RM, 2010, ENVIRON RES, V110, P345, DOI 10.1016/j.envres.2010.02.001; Gardner RM, 2009, ENVIRON HEALTH PERSP, V117, P1932, DOI 10.1289/ehp.0900855; Garriguet Didier, 2008, Health Rep, V19, P21; Haman F, 2010, INT J OBESITY, V34, pS24, DOI 10.1038/ijo.2010.236; Hennig B, 2002, TOXICOL APPL PHARM, V181, P174, DOI 10.1006/taap.2002.9408; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Ibrahim MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025170; Imbeault P, 2012, PLOS ONE, V7; Imbeault P, 2011, J OBES, V2011, DOI 10.1155/2011/267509; Indian and Northern Affairs Canada, 2009, CAN ARCT CONT HLTH A, V2009; Iwasaki T, 2002, BIOCHEM BIOPH RES CO, V299, P384, DOI 10.1016/S0006-291X(02)02659-1; Jacobson JL, 2003, J PEDIATR-US, V143, P780, DOI 10.1067/S0022-3476(03)00577-8; JACOBSON JL, 1992, DEV PSYCHOL, V28, P297, DOI 10.1037/0012-1649.28.2.297; Jacobson JL, 1996, NEW ENGL J MED, V335, P783, DOI 10.1056/NEJM199609123351104; Kempuraj D, 2010, J NEUROINFLAMM, V7; Kim KY, 2010, ENVIRON HEALTH PERSP, V118, P370, DOI 10.1289/ehp.0901131; Kuhnlein H V, 2001, Int J Circumpolar Health, V60, P112; Kuhnlein HV, 2004, J NUTR, V134, P1447, DOI 10.1093/jn/134.6.1447; Kuhnlein HV, 2002, J FOOD COMPOS ANAL, V15, P545, DOI 10.1016/S0889-1575(02)91066-5; Lee D, 2011, PLOS ONE, V6; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Liberda EN, 2007, CAN J PUBLIC HEALTH, V98, P407, DOI 10.1007/BF03405429; LOCKHART WL, 1993, WATER SCI TECHNOL, V28, P43, DOI 10.2166/wst.1993.0602; Medehouenou TCM, 2011, ENVIRON RES, V111, P1313, DOI 10.1016/j.envres.2011.09.017; Mergler D, 2007, AMBIO, V36, P3, DOI 10.1579/0044-7447(2007)36[3:MEAHEI]2.0.CO;2; MILLER MA, 1995, B ENVIRON CONTAM TOX, V55, P96, DOI 10.1007/BF00212394; MITANI K, 1976, Eisei Kagaku, V22, P333; Munoz-de-Toro M, 2006, ENVIRON RES, V102, P107, DOI 10.1016/j.envres.2005.12.017; Myre M, 2013, OBESITY REV; Pal S, 2013, DIABETES METAB, V39, P497, DOI 10.1016/j.diabet.2013.01.006; Patterson D G Jr, 1991, IARC Sci Publ, P299; Patton M. Q., 1990, QUALITATIVE EVALUATI; PHILLIPS DL, 1989, ARCH ENVIRON CON TOX, V18, P495, DOI 10.1007/BF01055015; Plomgaard P, 2007, DIABETOLOGIA, V50, P2562, DOI 10.1007/s00125-007-0834-6; Receveur O, 1998, Int J Circumpolar Health, V57 Suppl 1, P219; Rice DC, 2003, RISK ANAL, V23, P107, DOI 10.1111/1539-6924.00294; Robidoux M. A., 2012, CAN J NATIVE STUD, V32, P59; Rylander L, 2005, ENV HLTH GLOBAL ACCE, V4; Seabert T, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.34; Seo T, 2005, CURR OPIN LIPIDOL, V16, P11, DOI 10.1097/00041433-200502000-00004; Tjepkema M, 2012, CHRON DIS INJ CAN, V32, P200; Turunen AW, 2013, ENVIRON RES, V120, P43, DOI 10.1016/j.envres.2012.09.007; U.S. Environmental Protection Agency, 2000, GUID ASS CHEM CONT D, V2; Uemura H, 2008, CHEMOSPHERE, V73, P30, DOI 10.1016/j.chemosphere.2008.05.066; *US EPA, 1994, 3640A US EPA; USEPA, 1996, 3630C USEPA; Vaillancourt E, 2007, J EXP BIOL, V210, P1161, DOI 10.1242/jeb.003012; Valera B, 2013, ENVIRON RES, V120, P102, DOI 10.1016/j.envres.2012.08.002; Van Oostdam J, 2005, SCI TOTAL ENVIRON, V351, P165, DOI 10.1016/j.scitotenv.2005.03.034; Van Oostdarn J., 2009, AMAP ASSESSMENT 2009, P61; Verbeke W, 2008, RISK ANAL, V28, P951, DOI 10.1111/j.1539-6924.2008.01075.x; VERDIER P, 1984, J CAN DIET ASSOC, V45, P52; Willows ND, 2005, CAN J PUBLIC HEALTH, V96, pS32, DOI 10.1007/BF03405199; Wilson K, 2003, HEALTH PLACE, V9, P83, DOI 10.1016/S1353-8292(02)00016-3; Zumbado M, 2005, SCI TOTAL ENVIRON, V339, P49, DOI 10.1016/j.scitotenv.2004.07.022	74	18	18	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90351	10.1371/journal.pone.0090351	http://dx.doi.org/10.1371/journal.pone.0090351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24598815	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400066
J	Sepp, D; Franz, D; Triftshaeuser, N; Ott, I; Esposito-Bauer, L; Feurer, R; Seifert, CL; Thaler, M; Hemmer, B; Poppert, H				Sepp, Dominik; Franz, Daniela; Triftshaeuser, Natalie; Ott, Ilka; Esposito-Bauer, Lorena; Feurer, Regina; Seifert, Christian L.; Thaler, Markus; Hemmer, Bernhard; Poppert, Holger			Mobilization of CD133(+) Progenitor Cells in Patients with Acute Cerebral Infarction	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; ACUTE ISCHEMIC-STROKE; COA REDUCTASE INHIBITORS; ENDOTHELIAL-CELLS; PERIPHERAL-BLOOD; IN-VITRO; INCREASE; CD34; INTERLEUKIN-8	Progenitor cells (PCs) contribute to the endogenous repair mechanism after ischemic events. Interleukin-8 (IL-8) as part of the acute inflammatory reaction may enhance PC mobilization. Also, statins are supposed to alter number and function of circulating PCs. We aimed to investigate PC mobilization after acute ischemic stroke as well as its association with inflammatory markers and statin therapy. Sixty-five patients with ischemic stroke were enrolled in the study. The number of CD133(+) PCs was analyzed by flow cytometry. Blood samples were drawn within 24 hours after symptom onset and after 5 days. The number of CD133(+) PCs increased significantly within 5 days (p < 0.001). We found no correlation between CD133(+) PCs and the serum levels of IL-8, IL-6, or C-reactive protein (CRP). Multivariate analysis revealed that preexisting statin therapy correlated independently with the increase of CD133(+) PCs (p = 0.001). This study showed a mobilization of CD133(+) PCs in patients with acute cerebral infarction within 5 days after symptom onset. The early systemic inflammatory response did not seem to be a decisive factor in the mobilization of PCs. Preexisting statin therapy was associated with the increase in CD133(+) PCs, suggesting a potentially beneficial effect of statin therapy in patients with stroke.	[Sepp, Dominik; Triftshaeuser, Natalie; Esposito-Bauer, Lorena; Feurer, Regina; Seifert, Christian L.; Hemmer, Bernhard; Poppert, Holger] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany; [Franz, Daniela] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, D-80290 Munich, Germany; [Ott, Ilka] Tech Univ Munich, Deutsch Herzzentrum, Dept Cardiovasc Dis, D-80290 Munich, Germany; [Thaler, Markus] Tech Univ Munich, Klinikum Rechts Isar, Inst Clin Chem & Pathobiochem, D-80290 Munich, Germany	Technical University of Munich; Technical University of Munich; German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; Technical University of Munich	Sepp, D (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany.	sepp@lrz.tum.de	Hemmer, Bernhard/GPX-8451-2022; Hemmer, Bernhard/AAT-8388-2021	Hemmer, Bernhard/0000-0001-5985-6784; Poppert, Holger/0000-0003-2189-7681; Junker, Daniela/0000-0002-7598-8485	MerckSerono; Bundesministerium fur Wirtschaft und Technologie; Bayer Schering; Novartis; Biogen Idec; Merck Serono; Teva Pharmaceutical Industries Ltd.; Roche and Genentech, Inc; Bayer Healthcare; Deutsche Stiftung Neurologie	MerckSerono(Merck & Company); Bundesministerium fur Wirtschaft und Technologie(Federal Ministry for Economic Affairs and Energy (BMWi)); Bayer Schering(Bayer AG); Novartis(Novartis); Biogen Idec(Biogen); Merck Serono(Merck & Company); Teva Pharmaceutical Industries Ltd.(Teva Pharmaceutical Industries); Roche and Genentech, Inc; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Deutsche Stiftung Neurologie	D. Sepp received government research support (Bundesministerium fur Wirtschaft und Technologie) and received funding for travel from MerckSerono. R. Feurer received government research support (Bundesministerium fur Wirtschaft und Technologie). C. L. Seifert received government research support (Bundesministerium fur Wirtschaft und Technologie). B. Hemmer has served on scientific advisory boards for Roche, Novartis, Bayer Schering, and Genzyme Corporation; received funding for travel from Bayer Schering, Novartis, Biogen Idec, Merck Serono, Teva Pharmaceutical Industries Ltd., Roche and Genentech, Inc; serves on the international advisory board of Archives of Neurology, Nervenarzt and Experimental Neurology; has received speaker honoraria from Bayer Schering, Novartis, Biogen Idec, Merck Serono, and Teva Pharmaceutical Industries Ltd; serves as consultant to Genentech Inc., Micromet Inc., Roche, Chugai, GlaxoSmithKline and Novartis; and receives research support from Biogen Idec, Bayer Schering, Merck Serono and Novartis. H. Poppert has served on a scientific advisory board for Bayer Healthcare, received speaker honoraria from Bayer Healthcare, Boehringer Ingelheim, Novartis and Roche, received funding for travel from Bayer Healthcare, received government research support (Bundesministerium fur Wirtschaft und Technologie) and received research support from Deutsche Stiftung Neurologie. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.	Anand N, 2005, CEREBROVASC DIS, V20, P213, DOI 10.1159/000087701; Bogoslovsky T, 2010, NEUROLOGY, V75, P2059, DOI 10.1212/WNL.0b013e318200d741; BROWN J, 1991, INT IMMUNOL, V3, P175, DOI 10.1093/intimm/3.2.175; Deschaseaux F, 2007, EUR J PHARMACOL, V562, P111, DOI 10.1016/j.ejphar.2007.01.045; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI200113152; Fan YF, 2008, J CEREBR BLOOD F MET, V28, P90, DOI 10.1038/sj.jcbfm.9600509; FINA L, 1990, BLOOD, V75, P2417; Gehling UM, 2000, BLOOD, V95, P3106; George J, 2004, EUR HEART J, V25, P1003, DOI 10.1016/j.ehj.2004.03.026; Grau AJ, 2001, J NEUROL SCI, V192, P41, DOI 10.1016/S0022-510X(01)00590-1; Grundmann F, 2007, CLIN RES CARDIOL, V96, P621, DOI 10.1007/s00392-007-0543-7; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hristov M, 2007, ATHEROSCLEROSIS, V192, P413, DOI 10.1016/j.atherosclerosis.2006.05.031; Paczkowska E, 2009, STROKE, V40, P1237, DOI 10.1161/STROKEAHA.108.535062; Pruijt J F, 1999, Curr Opin Hematol, V6, P152, DOI 10.1097/00062752-199905000-00005; Ren Guofeng, 2003, Current Drug Targets - Inflammation and Allergy, V2, P242, DOI 10.2174/1568010033484098; Schomig K, 2006, EUR HEART J, V27, P1032, DOI 10.1093/eurheartj/ehi761; Sepp Dominik, 2009, J Angiogenes Res, V1, P10, DOI 10.1186/2040-2384-1-10; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Taguchi A, 2004, CIRCULATION, V109, P2972, DOI 10.1161/01.CIR.0000133311.25587.DE; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Yip HK, 2008, STROKE, V39, P69, DOI 10.1161/STROKEAHA.107.489401; Zhou WJ, 2009, HYPERTENS RES, V32, P306, DOI 10.1038/hr.2009.16; Zohlnhofer D, 2006, JAMA-J AM MED ASSOC, V295, P1003, DOI 10.1001/jama.295.9.1003	26	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e70796	10.1371/journal.pone.0070796	http://dx.doi.org/10.1371/journal.pone.0070796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599235	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400001
J	Shim, U; Kim, HN; Roh, SJ; Cho, NH; Shin, C; Ryu, S; Sung, YA; Kim, HL				Shim, Unjin; Kim, Han-Na; Roh, Seung-Ju; Cho, Nam H.; Shin, Chol; Ryu, Seungho; Sung, Yeon-Ah; Kim, Hyung-Lae			Personality Traits and Body Mass Index in a Korean Population	PLOS ONE			English	Article							METABOLIC SYNDROME; 5-FACTOR MODEL; WAIST CIRCUMFERENCE; ABDOMINAL OBESITY; EATING BEHAVIOR; ALL-CAUSE; ADULTS; ASSOCIATION; NEUROTICISM; OVERWEIGHT	Background: Overweight and obesity is a serious problem worldwide related to cardiovascular and other diseases. Personality traits are associated with the abnormal body mass indices (BMIs) indicative of overweight and obesity. However, the links between personality traits and BMI have been little studied in Korea. Methods: We evaluated the association between personality traits and BMI in men and women using the rural Ansung and urban Ansan cohort from the Korean Genome Epidemiology Study, and the Kangbuk Samsung Hospital Cohort Study datasets. A shorter version of the original Revised Neuroticism-Extroversion-Openness Personality Inventory (NEO-PI-R) was used to measure the five-factor model of personality (neuroticism, extraversion, openness to experience, agreeableness, and conscientiousness). Results: Data from a total of 1,495 men (mean age 60.0 +/- 9.8 years; mean BMI 24.3 +/- 3.0 kg/m(2)) and 2,547 women (mean age 47.0 +/- 15.5 years; mean BMI 22.8 +/- 3.4 kg/m(2)) were included in the analysis. Compared with the normal weight groups, overweight and obese men scored higher on openness to experience and lower on conscientiousness. Overweight and obese women scored lower on neuroticism and openness to experience and higher on agreeableness. Extraversion was positively associated with BMI in men (beta = 0.032, P < 0.05). BMI and waist circumference were significantly increased in individuals who were less dutiful. In women, neuroticism was inversely associated with BMI (beta = -0.026, P < 0.05). Openness to experience was negatively, and agreeableness was positively, associated with BMI (openness to experience: beta = -0.072, agreeableness beta = 0.068) and waist circumference (openness to experience: beta = -0.202, agreeableness: beta = 0.227) (P < 0.05). Conclusion: Personality traits were associated with underweight, overweight, and obesity in men and women. Increased understanding of the underlying factors contributing to this association will aid in the prevention and treatment of abnormal BMI.	[Shim, Unjin] Ewha Womans Univ, Med Ctr, Dept Internal Med, Seoul Seonam Hosp, Seoul, South Korea; [Kim, Han-Na; Roh, Seung-Ju; Kim, Hyung-Lae] Ewha Womans Univ, Dept Biochem, Sch Med, Seoul, South Korea; [Cho, Nam H.] Ajou Univ, Sch Med, Dept Prevent Med, Suwon 441749, South Korea; [Shin, Chol] Korea Univ, Dept Internal Med, Ansan Hosp, Div Pulm & Crit Care Med, Ansan, South Korea; [Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Dept Occupat Med, Kangbuk Samsung Hosp, Seoul, South Korea; [Sung, Yeon-Ah] Ewha Womans Univ, Dept Internal Med, Sch Med, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ajou University; Korea University; Korea University Medicine (KU Medicine); Sungkyunkwan University (SKKU); Samsung Medical Center; Ewha Womans University	Kim, HN (corresponding author), Ewha Womans Univ, Dept Biochem, Sch Med, Seoul, South Korea.	o147942@gmail.com; hyung@ewha.ac.kr		Ryu, Seungho/0000-0002-3927-8646	National Research Foundation of Korea; Ministry of Education [NRF-2010-0026606]; Center for Disease Control and Prevention, Republic of Korea	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education; Center for Disease Control and Prevention, Republic of Korea	This research was supported by the National Research Foundation of Korea, which is funded by the Ministry of Education (NRF-2010-0026606). The Ansan/Ansung cohort data was obtained from the Korean Genome and Epidemiology Study (4851-302), which is supported by the Center for Disease Control and Prevention, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn C-K., 1997, KOREAN J COUNS PSYCH, V9, P443; Aitsi-Selmi A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-769; [Anonymous], 1995, PHYS STAT US INT ANT; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Bjornelv S, 2011, SOC PSYCH PSYCH EPID, V46, P353, DOI 10.1007/s00127-010-0197-z; Brummett BH, 2006, J RES PERS, V40, P222, DOI 10.1016/j.jrp.2004.12.002; Cassin SE, 2005, CLIN PSYCHOL REV, V25, P895, DOI 10.1016/j.cpr.2005.04.012; Chapman BP, 2009, HEALTH PSYCHOL, V28, P419, DOI 10.1037/a0015212; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Costa P.T., 1992, NEO FFI PERSONALITY; Daigre JL, 2012, DIABETES METAB, V38, P404, DOI 10.1016/j.diabet.2012.03.008; de Wit LM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-14; Dortland AKBV, 2012, PROG NEURO-PSYCHOPH, V36, P85, DOI 10.1016/j.pnpbp.2011.10.001; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; Elfhag Kristina, 2008, Eat Behav, V9, P285, DOI 10.1016/j.eatbeh.2007.10.003; Elovainio M, 2011, BIOL PSYCHOL, V87, P234, DOI 10.1016/j.biopsycho.2011.03.002; Goldbacher EM, 2009, PSYCHOSOM MED, V71, P266, DOI 10.1097/PSY.0b013e318197a4d5; Hagger-Johnson G, 2012, J PSYCHOSOM RES, V73, P98, DOI 10.1016/j.jpsychores.2012.05.007; Hernandez N, 2012, NUTR HOSP, V27, P1148, DOI 10.3305/nh.2012.27.4.5829; Human LJ, 2013, J PERS, V81, P249, DOI 10.1111/jopy.12002; International Association for the study of Obesity, 2000, AS PAC PERSP RED OB; Jokela M, 2013, OBES REV, V14, P315, DOI 10.1111/obr.12007; Jokela M, 2013, HLTH PSYCHOL; Jokela M, 2013, AM J EPIDEMIOL, V178, P667, DOI 10.1093/aje/kwt170; Jokela M, 2011, J AFFECT DISORDERS, V130, P454, DOI 10.1016/j.jad.2010.10.047; Jonassaint CR, 2010, ETHNIC DIS, V20, P11; Kakizaki M, 2008, J PSYCHOSOM RES, V64, P71, DOI 10.1016/j.jpsychores.2007.07.008; Koorevaar AML, 2013, J AFFECT DISORDERS, V151, P178, DOI 10.1016/j.jad.2013.05.075; Lawlor DA, 2005, AM J PUBLIC HEALTH, V95, P1245, DOI 10.2105/AJPH.2004.041129; Mase T, 2013, EAT WEIGHT DISORD-ST, V18, P125, DOI 10.1007/s40519-013-0019-x; McCann SJH, 2011, J PSYCHOL, V145, P419, DOI 10.1080/00223980.2011.584081; Miller Jessie L, 2006, Eat Behav, V7, P69, DOI 10.1016/j.eatbeh.2005.07.003; Mommersteeg PMC, 2012, J PSYCHOSOM RES, V73, P326, DOI 10.1016/j.jpsychores.2012.08.019; Ormel J, 2013, NEUROSCI BIOBEHAV R, V37, P59, DOI 10.1016/j.neubiorev.2012.09.004; Petry NM, 2008, PSYCHOSOM MED, V70, P288, DOI 10.1097/PSY.0b013e3181651651; Piedmont RL, 1997, J CROSS CULT PSYCHOL, V28, P131, DOI 10.1177/0022022197282001; Provencher Veronique, 2008, Eat Behav, V9, P294, DOI 10.1016/j.eatbeh.2007.10.004; Schneider TR, 2012, STRESS HEALTH, V28, P102, DOI 10.1002/smi.1409; Segerstrom SC, 2003, BRAIN BEHAV IMMUN, V17, pS92; Sutin AR, 2013, PSYCHOSOM MED, V75, P505, DOI 10.1097/PSY.0b013e3182919ff4; Sutin AR, 2011, J PERS SOC PSYCHOL, V101, P579, DOI 10.1037/a0024286; Sutin AR, 2010, AGE, V32, P513, DOI 10.1007/s11357-010-9153-9; Sutin AR, 2010, BIOL PSYCHOL, V84, P186, DOI 10.1016/j.biopsycho.2010.01.012; Terracciano A, 2008, PSYCHOSOM MED, V70, P621, DOI 10.1097/PSY.0b013e31817b9371; Terracciano A, 2009, PSYCHOSOM MED, V71, P682, DOI 10.1097/PSY.0b013e3181a2925b; Torres SJ, 2007, NUTRITION, V23, P887, DOI 10.1016/j.nut.2007.08.008; Wilson RS, 2005, PSYCHOSOM MED, V67, P841, DOI 10.1097/01.psy.0000190615.20656.83; Winograd RP, 2012, ALCOHOL CLIN EXP RES, V36, P1787, DOI 10.1111/j.1530-0277.2012.01796.x	49	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90516	10.1371/journal.pone.0090516	http://dx.doi.org/10.1371/journal.pone.0090516			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24598991	Green Submitted, Green Published, gold			2022-12-25	WOS:000332479400088
J	Spinner, M; Gorb, SN; Balmert, A; Bleckmann, H; Westhoff, G				Spinner, Marlene; Gorb, Stanislav N.; Balmert, Alexander; Bleckmann, Horst; Westhoff, Guido			Non-Contaminating Camouflage: Multifunctional Skin Microornamentation in the West African Gaboon Viper (Bitis rhinoceros)	PLOS ONE			English	Article							CONTACT ANGLES; SURFACE; LOTUS; WETTABILITY; TRANSITION; ROUGHNESS; POLAR; WINGS; WATER	The West African Gaboon viper (Bitis rhinoceros) has an extraordinary coloration of pale brown and velvety black markings. The velvety black appearance is caused by a unique hierarchical surface structures which was not found on the pale brown scales. In the present study we examined the wettability of the vipers scales by measuring contact angles of water droplets. Velvet black scale surfaces had high static contact angles beyond 160 degrees and low roll-off angles below 20 degrees indicating an outstanding superhydrophobicity. Our calculations showed that the Cassie-Baxter model describes well wettability effects for these surfaces. Self-cleaning capabilities were determined by contaminating the scales with particles and fogging them until droplets formed. Black scales were clean after fogging, while pale scales stayed contaminated. Black scales feature multifunctional structures providing not only water-repellent but also self-cleaning properties. The pattern of nanoridges can be used as a model for surface-active technical surfaces.	[Spinner, Marlene; Gorb, Stanislav N.] Univ Kiel, Inst Zool, D-24098 Kiel, Germany; [Balmert, Alexander; Bleckmann, Horst; Westhoff, Guido] Univ Bonn, Inst Zool, Bonn, Germany	University of Kiel; University of Bonn	Spinner, M (corresponding author), Univ Kiel, Inst Zool, D-24098 Kiel, Germany.	mspinner@zoologie.uni-kiel.de			German Science Foundation (DFG Graduiertenkolleg Bionik) [GRK 1572]; Federal Ministry of Education, Science and Technology, Germany (BMBF) [01RB0812]; German Science Foundation (DFG) 'Biomimetic Materials Research: Functionality by Hierarchical Structuring of Materials' [SPP 1420, GO 995/9-3]	German Science Foundation (DFG Graduiertenkolleg Bionik)(German Research Foundation (DFG)); Federal Ministry of Education, Science and Technology, Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); German Science Foundation (DFG) 'Biomimetic Materials Research: Functionality by Hierarchical Structuring of Materials'(German Research Foundation (DFG))	This work was partially supported by the German Science Foundation (DFG Graduiertenkolleg Bionik, GRK 1572) to GW and HB, by the Federal Ministry of Education, Science and Technology, Germany (BMBF project Biona 01RB0812) to GW, and by the SPP 1420 priority programme of German Science Foundation (DFG) 'Biomimetic Materials Research: Functionality by Hierarchical Structuring of Materials' (project GO 995/9-3) to SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autumn K, 2006, J COMP PHYSIOL A, V192, P1205, DOI 10.1007/s00359-006-0149-y; Balmert A, 2011, J MORPHOL, V272, P442, DOI 10.1002/jmor.10921; Barbieri L, 2007, LANGMUIR, V23, P1723, DOI 10.1021/la0617964; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Bhushan B, 2007, ULTRAMICROSCOPY, V107, P1033, DOI 10.1016/j.ultramic.2007.05.002; Bormashenko E, 2007, J COLLOID INTERF SCI, V311, P212, DOI 10.1016/j.jcis.2007.02.049; BURKEN RR, 1985, COMP BIOCHEM PHYS B, V81, P315, DOI 10.1016/0305-0491(85)90319-0; BUSSCHER HJ, 1984, COLLOID SURFACE, V9, P319, DOI 10.1016/0166-6622(84)80175-4; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Erbil HY, 1997, LANGMUIR, V13, P5484, DOI 10.1021/la9620521; Extrand CW, 2004, LANGMUIR, V20, P5013, DOI 10.1021/la036481s; Extrand CW, 2002, LANGMUIR, V18, P7991, DOI 10.1021/la025769z; FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008; Furstner R, 2005, LANGMUIR, V21, P956, DOI 10.1021/la0401011; Goodwyn PP, 2009, NATURWISSENSCHAFTEN, V96, P781, DOI 10.1007/s00114-009-0531-z; Hiller UN, 2009, FUNCTIONAL SURFACES IN BIOLOGY, VOL 1, P47, DOI 10.1007/978-1-4020-6697-9_4; HOLDGATE MW, 1955, J EXP BIOL, V32, P591; KAELBLE DH, 1970, J ADHESION, V2, P66, DOI 10.1080/0021846708544582; Klein MCG, 2012, J R SOC INTERFACE, V9, P3140, DOI 10.1098/rsif.2012.0479; Lafuma A, 2003, NAT MATER, V2, P457, DOI 10.1038/nmat924; Li W, 2008, SOFT MATTER, V4, P462, DOI 10.1039/b715731b; Li W, 2007, ADV COLLOID INTERFAC, V132, P51, DOI 10.1016/j.cis.2007.01.001; MADERSON PFA, 1978, J EXP ZOOL, V204, P11, DOI 10.1002/jez.1402040103; Marmur A, 2004, LANGMUIR, V20, P3517, DOI 10.1021/la036369u; Marmur A, 2006, SOFT MATTER, V2, P12, DOI 10.1039/b514811c; Nosonovsky M, 2007, LANGMUIR, V23, P3157, DOI 10.1021/la062301d; Oner D, 2000, LANGMUIR, V16, P7777, DOI 10.1021/la000598o; OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815; Patankar NA, 2004, LANGMUIR, V20, P8209, DOI 10.1021/la048629t; Patankar NA, 2004, LANGMUIR, V20, P7097, DOI 10.1021/la049329e; Rabel W., 1977, Physikalische Blaetter, V33, P151, DOI 10.1002/phbl.19770330402; SILBERGLIED R, 1980, SCIENCE, V207, P773, DOI 10.1126/science.207.4432.773; Spawls S., 1995, DANGEROUS SNAKES AFR; Spinner M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01846; Sun G, 2009, J BIONIC ENG, V6, P71, DOI 10.1016/S1672-6529(08)60094-3; Toni M, 2007, ZOOLOGY, V110, P41, DOI 10.1016/j.zool.2006.07.001; Voigt D, 2011, ZOOLOGY, V114, P265, DOI 10.1016/j.zool.2011.05.004; Wagner T, 1996, ACTA ZOOL-STOCKHOLM, V77, P213, DOI 10.1111/j.1463-6395.1996.tb01265.x; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI [10.1098/rstl.1805.0005, DOI 10.1098/RSTL.1805.0005]; Zenkiewicz M., 2007, J ACHIEV MAT MANUF E, V24, P137	41	21	21	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e91087	10.1371/journal.pone.0091087	http://dx.doi.org/10.1371/journal.pone.0091087			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599379	Green Submitted, gold, Green Published			2022-12-25	WOS:000332479400154
J	Sun, LP; Quan, HT; Xie, CY; Wang, L; Hu, YH; Lou, LG				Sun, Liping; Quan, Haitian; Xie, Chengying; Wang, Lei; Hu, Youhong; Lou, Liguang			Phosphodiesterase 3/4 Inhibitor Zardaverine Exhibits Potent and Selective Antitumor Activity against Hepatocellular Carcinoma Both In Vitro and In Vivo Independently of Phosphodiesterase Inhibition	PLOS ONE			English	Article							CELL-CYCLE; NUCLEOTIDE PHOSPHODIESTERASE; III INHIBITOR; APOPTOSIS; KINASE; CAMP; PROLIFERATION; PATHWAY; SUPPRESSION; SORAFENIB	Hepatocellular carcinoma (HCC) is the fifth common malignancy worldwide and the third leading cause of cancer-related death. Targeted therapies for HCC are being extensively developed with the limited success of sorafinib. In the present study, we investigated the potential antitumor activity of zardaverine, a dual-selective phosphodiesterase (PDE) 3/4 inhibitor in HCC cells both in vitro and in vivo. Although all zardaverine, PDE3 inhibitor trequinsin and PDE4 inhibitor rolipram increased intracellular cAMP levels through inhibiting PDE activity, only zardaverine significantly and selectively inhibited the proliferation of certain HCC cells, indicating that the antitumor activity of zardaverine is independent of PDE3/4 inhibition and intracellular cAMP levels. Further studies demonstrated that zardaverine induced G0/G1 phase cell cycle arrest of sensitive HCC cells through dysregulating cell cycle-associated proteins, including Cdk4, Cdk6, Cdk2, Cyclin A, Cyclin E, p21 and Rb. Notably, Rb expression was reversely related to the cell sensitivity to zardaverine. The present findings indicate that zardaverine may have potential as targeted therapies for some HCC, and the likely mechanism of action underlying its selective antitumor activity may be related to its regulation of Rb or Rb-associated signaling in cell cycles.	[Sun, Liping; Quan, Haitian; Xie, Chengying; Wang, Lei; Hu, Youhong; Lou, Liguang] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Lou, LG (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China.	lglou@mail.shcnc.ac.cn			National Natural Science Foundation of China [Y201181042, 81273546]; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China [2013ZX09102008, 2013ZX09402102-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China	This work was supported by research funding from the National Natural Science Foundation of China (numbers Y201181042 and 81273546) and the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China (numbers 2013ZX09102008 and 2013ZX09402102-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banner KH, 1995, BRIT J PHARMACOL, V116, P3169, DOI 10.1111/j.1476-5381.1995.tb15120.x; Chau BN, 2003, NAT REV CANCER, V3, P130, DOI 10.1038/nrc993; Chen TC, 1998, LAB INVEST, V78, P165; Conti M, 2000, PROG NUCLEIC ACID RE, V63, P1; DREES M, 1993, CANCER RES, V53, P3058; DUMONT JE, 1989, TRENDS BIOCHEM SCI, V14, P67, DOI 10.1016/0968-0004(89)90046-7; Gantner F, 1997, J ALLERGY CLIN IMMUN, V100, P527, DOI 10.1016/S0091-6749(97)70146-5; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; Grader-Beck T, 2003, BLOOD, V101, P998, DOI 10.1182/blood-2002-06-1665; Hamada Y, 1999, JPN CIRC J, V63, P605, DOI 10.1253/jcj.63.605; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Lee J, 1999, BBA-MOL CELL RES, V1449, P261, DOI 10.1016/S0167-4889(99)00019-1; Liu LH, 2005, CANCER BIOL THER, V4, P1240, DOI 10.4161/cbt.4.11.2099; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; MacKenzie SJ, 2000, BIOCHEM J, V347, P571, DOI 10.1042/0264-6021:3470571; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Marko D, 2000, CHEM RES TOXICOL, V13, P944, DOI 10.1021/tx000090l; McEwan DG, 2007, CANCER RES, V67, P5248, DOI 10.1158/0008-5472.CAN-07-0097; Merz KH, 1998, J MED CHEM, V41, P4733, DOI 10.1021/jm981021v; Molinari M, 2000, CELL PROLIFERAT, V33, P261, DOI 10.1046/j.1365-2184.2000.00191.x; Moon E, 2002, CLIN CANCER RES, V8, P589; Murata K, 1999, CLIN EXP METASTAS, V17, P525, DOI 10.1023/A:1006626529536; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Ogawa R, 2002, BLOOD, V99, P3390, DOI 10.1182/blood.V99.9.3390; Osinski MT, 2000, BIOCHEM PHARMACOL, V60, P381, DOI 10.1016/S0006-2952(00)00328-2; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Quan HT, 2009, J PHARMACOL EXP THER, V330, P326, DOI 10.1124/jpet.109.153320; RUPPERT D, 1982, LIFE SCI, V31, P2037, DOI 10.1016/0024-3205(82)90095-9; Schafer KA, 1998, VET PATHOL, V35, P461, DOI 10.1177/030098589803500601; Schmitt JM, 2001, MOL CELL BIOL, V21, P3671, DOI 10.1128/MCB.21.11.3671-3683.2001; SCHUDT C, 1991, BIOCHEM PHARMACOL, V42, P153, DOI 10.1016/0006-2952(91)90694-Z; Schudt C, 2011, HANDB EXP PHARMACOL, V204, P1, DOI 10.1007/978-3-642-17969-3_1; Sherr CJ, 2000, CANCER RES, V60, P3689; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Soderling SH, 2000, CURR OPIN CELL BIOL, V12, P174, DOI 10.1016/S0955-0674(99)00073-3; Swanton C, 2004, LANCET ONCOL, V5, P27, DOI 10.1016/S1470-2045(03)01321-4; Tan XQ, 1998, TRENDS CELL BIOL, V8, P116, DOI 10.1016/S0962-8924(97)01208-7; Timoshenko AV, 2003, EXP CELL RES, V289, P265, DOI 10.1016/S0014-4827(03)00269-6; Wei ZY, 2013, CLIN MED INSIGHTS-ON, V7, P87, DOI 10.4137/CMO.S7633; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Yamanaka Y, 2002, CANCER LETT, V176, P143, DOI 10.1016/S0304-3835(01)00764-9; Yang LH, 2007, CANCER RES, V67, P651, DOI 10.1158/0008-5472.CAN-06-2762	43	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90627	10.1371/journal.pone.0090627	http://dx.doi.org/10.1371/journal.pone.0090627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598942	Green Submitted, gold, Green Published			2022-12-25	WOS:000332479400105
J	Yao, Y; Marchal, K; Van de Peer, Y				Yao, Yao; Marchal, Kathleen; Van de Peer, Yves			Improving the Adaptability of Simulated Evolutionary Swarm Robots in Dynamically Changing Environments	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; ADAPTATION; GENES; LIFE	One of the important challenges in the field of evolutionary robotics is the development of systems that can adapt to a changing environment. However, the ability to adapt to unknown and fluctuating environments is not straightforward. Here, we explore the adaptive potential of simulated swarm robots that contain a genomic encoding of a bio-inspired gene regulatory network (GRN). An artificial genome is combined with a flexible agent-based system, representing the activated part of the regulatory network that transduces environmental cues into phenotypic behaviour. Using an artificial life simulation framework that mimics a dynamically changing environment, we show that separating the static from the conditionally active part of the network contributes to a better adaptive behaviour. Furthermore, in contrast with most hitherto developed ANN-based systems that need to re-optimize their complete controller network from scratch each time they are subjected to novel conditions, our system uses its genome to store GRNs whose performance was optimized under a particular environmental condition for a sufficiently long time. When subjected to a new environment, the previous condition-specific GRN might become inactivated, but remains present. This ability to store 'good behaviour' and to disconnect it from the novel rewiring that is essential under a new condition allows faster re-adaptation if any of the previously observed environmental conditions is reencountered. As we show here, applying these evolutionary-based principles leads to accelerated and improved adaptive evolution in a non-stable environment.	[Yao, Yao; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Yao, Yao; Marchal, Kathleen; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Yao, Yao; Marchal, Kathleen] Katholieke Univ Leuven, Dept Microbial & Mol Syst, Louvain, Belgium; [Marchal, Kathleen] Univ Ghent, iMinds, Dept Informat Technol, B-9000 Ghent, Belgium; [Van de Peer, Yves] Univ Pretoria, Dept Genet, Genom Res Inst, ZA-0002 Pretoria, South Africa	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; KU Leuven; Ghent University; IMEC; University of Pretoria	Marchal, K (corresponding author), Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium.	kathleen.marchal@intec.ugent.be; yves.vandepeer@psb.ugent.be	Van de Peer, Yves/D-4388-2009; Van de Peer, Yves/AAE-7666-2019; Marchal, Kathleen/B-5001-2013; Marchal, Kathleen/O-7936-2017	Van de Peer, Yves/0000-0003-4327-3730; Van de Peer, Yves/0000-0003-4327-3730; Marchal, Kathleen/0000-0002-2169-4588; Marchal, Kathleen/0000-0002-2169-4588	European Commission within the Work Program "Future and Emergent Technologies Proactive" [216342 (Symbrion)]; Ghent University; European Research Council under the European Union/ERC [322739 - DOUBLE-UP]; KU Leuven: project NATAR [GOA/08/011]; Agentschap voor Innovatie door Wetenschap en Technologie (IWT): SBONEMOA; Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO) [IOK-B9725-G.0329.09]	European Commission within the Work Program "Future and Emergent Technologies Proactive"; Ghent University(Ghent University); European Research Council under the European Union/ERC(European Research Council (ERC)); KU Leuven: project NATAR; Agentschap voor Innovatie door Wetenschap en Technologie (IWT): SBONEMOA; Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO)(FWO)	The authors acknowledge the support of the European Commission within the Work Program "Future and Emergent Technologies Proactive" under the grant agreement no. 216342 (Symbrion) and Ghent University (Multidisciplinary Research Partnership 'Bioinformatics: from nucleotides to networks'. YVdP acknowledges support from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Advanced Grant Agreement n. 322739 - DOUBLE-UP. KM acknowledges support from KU Leuven: GOA/08/011, project NATAR; Agentschap voor Innovatie door Wetenschap en Technologie (IWT): SBONEMOA; Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO) IOK-B9725-G.0329.09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed E, 2005, MANSOURA J MATH, V32, P6059; Bedau MA, 2003, TRENDS COGN SCI, V7, P505, DOI 10.1016/j.tics.2003.09.012; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Bentley P, 1999, GECCO-99: PROCEEDINGS OF THE GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P35; Bongard J, 2002, IEEE C EVOL COMPUTAT, P1872, DOI 10.1109/CEC.2002.1004528; Bredeche N, 2010, LECT NOTES COMPUT SC, V5975, P110, DOI 10.1007/978-3-642-14156-0_10; Conrad M, 1995, COMPUTERKULTUR, V2, P261; DOUGLAS HC, 1966, GENETICS, V54, P911; Draghi JA, 2011, NATURE, V474, P45, DOI 10.1038/474045a; Durr P, 2006, LECT NOTES COMPUT SC, V4193, P671; Floreano D, 2001, AUTON ROBOT, V11, P311, DOI 10.1023/A:1012459627968; Floreano D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000292; Floreano D, 2008, EVOL INTELL, V1, P47, DOI 10.1007/s12065-007-0002-4; Grefenstette JJ DR, 1996, SYMPOSIUM, P45; Guo HL, 2009, BIOSYSTEMS, V98, P193, DOI 10.1016/j.biosystems.2009.05.003; Hornby GS, 2002, ARTIF LIFE, V8, P223, DOI 10.1162/106454602320991837; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; James HA, 2004, RES LETT INFORM MATH, V6, P143; Kurakin A, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-6; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; Linksvayer TA, 2012, J EXP ZOOL PART B, V318B, P159, DOI 10.1002/jez.b.22001; Lynch M, 2010, MOL BIOL EVOL, V27, P1404, DOI 10.1093/molbev/msq020; Mattiussi C, 2011, J COMPUT SCI-NETH, V2, P165, DOI 10.1016/j.jocs.2011.01.007; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Polvichai J BU, 2011, SOFTWARE ENG, P166; Reil T, 1999, LECT NOTES ARTIF INT, V1674, P457; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Stanley KO, 2003, ARTIF LIFE, V9, P93, DOI 10.1162/106454603322221487; Stanley KO, 2002, EVOL COMPUT, V10, P99, DOI 10.1162/106365602320169811; Subagdja B, 2009, AAMAS 09 P 8 INT C A, V2, P1081; Tanner CJ, 2012, J ANIM ECOL, V81, P260, DOI 10.1111/j.1365-2656.2011.01879.x; Tononi G, 1999, P NATL ACAD SCI USA, V96, P3257, DOI 10.1073/pnas.96.6.3257; Wagner GP, 1996, EVOLUTION, V50, P967, DOI 10.1111/j.1558-5646.1996.tb02339.x; Weng JY, 2001, SCIENCE, V291, P599, DOI 10.1126/science.291.5504.599; Yao X, 1998, APPL MATH COMPUT, V91, P83, DOI 10.1016/S0096-3003(97)10005-4; Yu JB, 2008, NEUROCOMPUTING, V71, P1054, DOI 10.1016/j.neucom.2007.10.013	36	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90695	10.1371/journal.pone.0090695	http://dx.doi.org/10.1371/journal.pone.0090695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599485	gold, Green Published, Green Submitted			2022-12-25	WOS:000332479400118
J	Allenbach, Y; Chaara, W; Rosenzwajg, M; Six, A; Prevel, N; Mingozzi, F; Wanschitz, J; Musset, L; Charuel, JL; Eymard, B; Salomon, B; Duyckaerts, C; Maisonobe, T; Dubourg, O; Herson, S; Klatzmann, D; Benveniste, O				Allenbach, Yves; Chaara, Wahiba; Rosenzwajg, Michelle; Six, Adrien; Prevel, Nicolas; Mingozzi, Federico; Wanschitz, Julia; Musset, Lucile; Charuel, Jean-Luc; Eymard, Bruno; Salomon, Benoit; Duyckaerts, Charles; Maisonobe, Thierry; Dubourg, Odile; Herson, Serge; Klatzmann, David; Benveniste, Olivier			Th1 Response and Systemic Treg Deficiency in Inclusion Body Myositis	PLOS ONE			English	Article							REGULATORY T-CELLS; INFLAMMATION; CYTOKINES; BLOOD	Objective: Sporadic inclusion body myositis (sIBM), the most frequent myositis in elderly patients, is characterized by the presence muscle inflammation and degeneration. We aimed at characterizing immune responses and regulatory T cells, considered key players in the maintenance of peripheral immune tolerance, in sIBM. Methods: Serum and muscle tissue levels of 25 cytokines and phenotype of circulating immune cells were measured in 22 sIBM patients and compared with 22 healthy subjects. Cytokine data were analysed by unsupervised hierarchical clustering and principal components analysis. Results: Compared to healthy controls, sIBM patients had increased levels of Th-1 cytokines and chemokines such as IL-12 (261 +/- 138 pg/mL vs. 88 +/- 19 pg/mL; p<0.0001), CXCL-9 (186 +/- 12 pg/mL vs. 13 +/- 7 pg/mL; p<0.0001), and CXCL-10 (187 +/- 62 pg/mL vs. 13 +/- 6 pg/mL; p<0.0001). This was associated with an increased frequency of CD8(+)CD28(-) T cells (45.6 +/- 18.5% vs. 13.5 +/- 9.9%; p<0.0001), which were more prone to produce IFN-gamma (45.6 +/- 18.5% vs. 13.5 +/- 9.9%; p<0.0001). sIBM patients also had a decreased frequency of circulating regulatory T cells (CD4(+)CD25(+) CD127(low)FOXP3(+), 6.9 +/- 1.7%; vs. 5.2 +/- 1.1%, p = 0.01), which displayed normal suppressor function and were also present in affected muscle. Conclusion: sIBM patients present systemic immune activation with Th1 polarization involving the IFN-gamma pathway and CD8(+)CD28(-) T cells associated with peripheral regulatory T cell deficiency.	[Allenbach, Yves; Chaara, Wahiba; Rosenzwajg, Michelle; Six, Adrien; Prevel, Nicolas; Salomon, Benoit; Klatzmann, David] Univ Paris 06, Sorbonne Univ, Paris, France; [Allenbach, Yves; Chaara, Wahiba; Rosenzwajg, Michelle; Six, Adrien; Prevel, Nicolas; Salomon, Benoit; Klatzmann, David] CNRS, UMR 7211, Paris, France; [Allenbach, Yves; Chaara, Wahiba; Rosenzwajg, Michelle; Six, Adrien; Prevel, Nicolas; Klatzmann, David] INSERM, UMRS 959, Paris, France; [Allenbach, Yves; Chaara, Wahiba; Rosenzwajg, Michelle; Six, Adrien; Herson, Serge; Klatzmann, David; Benveniste, Olivier] Hop La Pitie Salpetriere, AP HP, Paris, France; [Allenbach, Yves; Herson, Serge; Benveniste, Olivier] Hop La Pitie Salpetriere, AP HP, Dept Internal Med 1, Ctr Reference Malad Neuromusculaire, Paris, France; [Mingozzi, Federico; Benveniste, Olivier] Univ Paris 06, Sorbonne Univ, U974, Paris, France; [Mingozzi, Federico; Benveniste, Olivier] INSERM, U974, Paris, France; [Mingozzi, Federico] Genethon, Evry, France; [Wanschitz, Julia] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Musset, Lucile; Charuel, Jean-Luc] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, Dept Immunochem, Paris, France; [Eymard, Bruno] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, Dept Neurol, Paris, France; [Duyckaerts, Charles; Maisonobe, Thierry; Dubourg, Odile] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, Dept Neuropathol, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Medical University of Innsbruck; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Allenbach, Y (corresponding author), Univ Paris 06, Sorbonne Univ, Paris, France.	yves.allenbach@psl.aphp.fr	Salomon, Benoit L/M-2421-2017; Salomon, Benoit/AAP-5209-2021; Rosenzwajg, Michelle/AAF-6276-2019	Salomon, Benoit L/0000-0001-9673-5578; Salomon, Benoit/0000-0001-9673-5578; Rosenzwajg, Michelle/0000-0001-5312-6203; Six, Adrien/0000-0001-5898-555X; Klatzmann, David/0000-0002-0054-3422; Allenbach, Yves/0000-0002-3185-7993	French state funds within the Investissementsd'Avenir programme [ANR-11-IDEX-0004-02]; association francaise contre les myopathies; Societe francaise nationale de medicine interne	French state funds within the Investissementsd'Avenir programme(French National Research Agency (ANR)); association francaise contre les myopathies(Association Francaise contre les Myopathies); Societe francaise nationale de medicine interne	This work was supported by French state funds within the Investissementsd'Avenir programme under reference ANR-11-IDEX-0004-02 (LabExTransimmunom), association francaise contre les myopathies, and Societe francaise nationale de medicine interne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antiga E, 2010, J AUTOIMMUN, V35, P342, DOI 10.1016/j.jaut.2010.07.006; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Askanas V, 2008, ACTA NEUROPATHOL, V116, P583, DOI 10.1007/s00401-008-0449-0; Baird GS, 2008, ARCH PATHOL LAB MED, V132, P232, DOI 10.1043/1543-2165(2008)132[232:MIAOCI]2.0.CO;2; Banica L, 2009, AUTOIMMUNITY, V42, P41, DOI 10.1080/08916930802282651; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Benveniste O, 2011, BRAIN, V134, P3176, DOI 10.1093/brain/awr213; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chi L, 2007, J NEUROIMMUNOL, V192, P206, DOI 10.1016/j.jneuroim.2007.09.034; De Paepe B, 2005, ACTA NEUROPATHOL, V109, P576, DOI 10.1007/s00401-005-0989-5; Dimitri D, 2006, BRAIN, V129, P986, DOI 10.1093/brain/awl020; Dubourg O, 2011, Acta Myol, V30, P103; Effros RB, 2005, IMMUNOL REV, V205, P147, DOI 10.1111/j.0105-2896.2005.00259.x; Greenberg SA, 2010, BRAIN, V133, DOI 10.1093/brain/awp275; Gregg R, 2005, CLIN EXP IMMUNOL, V140, P540, DOI 10.1111/j.1365-2249.2005.02798.x; GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504; Guillot-Delost M, 2008, J GENE MED, V10, P834, DOI 10.1002/jgm.1220; Hoogendijk Jessica E, 2004, Neuromuscul Disord, V14, P337, DOI 10.1016/j.nmd.2004.02.006; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Li X, 2008, CLIN IMMUNOL, V126, P180, DOI 10.1016/j.clim.2007.10.001; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Pandya JM, 2010, ARTHRITIS RHEUM-US, V62, P3457, DOI 10.1002/art.27665; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schmidt J, 2008, BRAIN, V131, P1228, DOI 10.1093/brain/awn053; Szodoray P, 2010, RHEUMATOLOGY, V49, P1867, DOI 10.1093/rheumatology/keq151; Taflin C, 2009, AM J PATHOL, V174, P497, DOI 10.2353/ajpath.2009.080580; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Terrier B, 2012, ARTHRITIS RHEUM-US, V64, P2001, DOI 10.1002/art.34327; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Zhang B, 2008, CLIN EXP IMMUNOL, V153, P182, DOI 10.1111/j.1365-2249.2008.03686.x	31	54	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e88788	10.1371/journal.pone.0088788	http://dx.doi.org/10.1371/journal.pone.0088788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594700	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500007
J	Cho, E; Kim, HC; Lee, JH; Yoo, JJ; Choi, WM; Cho, YY; Lee, MJ; Cho, Y; Lee, DH; Lee, YB; Yu, SJ; Kim, YJ; Yoon, JH; Chung, JW; Kim, CY; Lee, HS				Cho, Eunju; Kim, Hyo-Cheol; Lee, Jeong-Hoon; Yoo, Jeong-ju; Choi, Won-Mook; Cho, Young Youn; Lee, Min Jong; Cho, Yuri; Lee, Dong Hyeon; Lee, Yun Bin; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Chung, Jin Wook; Kim, Chung Yong; Lee, Hyo-Suk			Serum Insulin-Like Growth Factor-1 Predicts Disease Progression and Survival in Patients with Hepatocellular Carcinoma Who Undergo Transarterial Chemoembolization	PLOS ONE			English	Article							CANCER RISK; HEPATITIS-C; IGF-I; CIRRHOSIS; HCC; EXPRESSION; RESECTION; INFUSION; THERAPY; MRECIST	Insulin like-growth factor-1 (IGF-1) reflects hepatic synthetic function and plays a major role in the development and progression of various cancers. In the present study, we investigated whether baseline serum IGF-1 levels predict time-to-progression (TTP) and overall survival (OS) in hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization (TACE). A total of 155 consecutive treatment-naive patients with HCC who had undergone TACE as initial treatment were included from a prospective cohort. Baseline serum IGF-1 levels were analyzed with regard to their associations with disease progression and survival. During a median follow-up period of 41.8 months, patients with low IGF-1 levels showed significantly shorter TTP (median, 6.0 months; 95% confidence interval [CI], 4.5-7.6) than patients with high IGF-1 levels (median, 16.5 months; 95% CI, 4.9-28.1; p = 0.003). In the multivariate analysis, BCLC stage, serum vascular endothelial growth factorlevels, and IGF-1 levels were independent risk factors for disease progression. The hazard ratio (HR) of progression for each 10 ng/mL decrease in IGF-1 level was 1.072 (95% CI, 1.029-1.117; p = 0.001). Furthermore, together with tumor size, stage, and treatment response, IGF-1 levels were an independent predictor of poorer survival (for each 10 ng/mL decrease in IGF-1 level; HR, 1.057; 95% CI, 1.001-1.115; p = 0.045). In conclusion, low baseline IGF-1 levels independently correlated with shorter TTP and poorer OS in patients with HCC who underwent TACE.	[Cho, Eunju] Kangwon Natl Univ Hosp, Dept Internal Med, Chunchon, South Korea; [Kim, Hyo-Cheol; Chung, Jin Wook] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Lee, Jeong-Hoon; Yoo, Jeong-ju; Choi, Won-Mook; Cho, Young Youn; Lee, Min Jong; Cho, Yuri; Lee, Dong Hyeon; Lee, Yun Bin; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Kim, Chung Yong; Lee, Hyo-Suk] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Lee, Jeong-Hoon; Yoo, Jeong-ju; Choi, Won-Mook; Cho, Young Youn; Lee, Min Jong; Cho, Yuri; Lee, Dong Hyeon; Lee, Yun Bin; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Kim, Chung Yong; Lee, Hyo-Suk] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea	Kangwon National University; Kangwon National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	pindra@empal.com	Lee, Jeong-Hoon/Q-1055-2018	Lee, Jeong-Hoon/0000-0002-0315-2080; Chung, Jin Wook/0000-0002-1090-6872; Yu, Su Jong/0000-0001-8888-7977; , minjong/0000-0002-3159-5444; Cho, Eun Ju/0000-0002-2677-3189; Kim, Yoon Jun/0000-0001-9141-7773; Cho, Young Youn/0000-0002-9384-5357; Yoo, Jeong-Ju/0000-0002-7802-0381; Yoon, Jung-Hwan/0000-0002-9128-3610; Kim, Hyo-Cheol/0000-0002-6016-247X; Lee, Yun Bin/0000-0002-3193-9745	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-000-7381]; Kangwon National University Hospital Grant	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Kangwon National University Hospital Grant	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-000-7381) and Kangwon National University Hospital Grant (2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assy N, 2008, J HEPATOL, V49, P34, DOI 10.1016/j.jhep.2008.02.013; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; CastillaCortazar I, 1997, GASTROENTEROLOGY, V113, P1682, DOI 10.1053/gast.1997.v113.pm9352873; Catrina SB, 2006, CLIN CANCER RES, V12, P4506, DOI 10.1158/1078-0432.CCR-05-2473; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Cho EJ, 2013, CLIN CANC RES; Conchillo M, 2005, J HEPATOL, V43, P630, DOI 10.1016/j.jhep.2005.03.025; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Jung ES, 2013, J HEPATOL, V58, P1181, DOI 10.1016/j.jhep.2013.01.039; Kaseb AO, 2011, J CLIN ONCOL, V29, P3892, DOI 10.1200/JCO.2011.36.0636; Kaseb AO, 2011, ONCOLOGY-BASEL, V80, P373, DOI 10.1159/000329040; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Kim BK, 2013, EUR J CANCER, V49, P826, DOI 10.1016/j.ejca.2012.08.022; Kim HC, 2013, J VASC INTERV RADIOL, V24, P274, DOI 10.1016/j.jvir.2012.11.002; Lee HS, 2002, J CLIN ONCOL, V20, P4459, DOI 10.1200/JCO.2002.02.013; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Lorenzo-Zuniga V, 2007, DIGEST DIS SCI, V52, P3245, DOI 10.1007/s10620-006-9437-1; Maki RG, 2010, J CLIN ONCOL, V28, P4985, DOI 10.1200/JCO.2009.27.5040; Mazziotti G, 2002, CANCER, V95, P2539, DOI 10.1002/cncr.11002; Niizeki T, 2012, J GASTROENTEROL, V47, P686, DOI 10.1007/s00535-012-0555-6; Poon RTP, 2009, ANN SURG ONCOL, V16, P792, DOI 10.1245/s10434-009-0330-y; Poon RTP, 2003, CANCER RES, V63, P3121; Prajapati HJ, 2013, ANN ONCOL, V24, P965, DOI 10.1093/annonc/mds605; Shao YY, 2012, CLIN CANCER RES, V18, P3992, DOI 10.1158/1078-0432.CCR-11-2853; Sobrevals L, 2010, HEPATOLOGY, V51, P912, DOI 10.1002/hep.23412; Wu YP, 2002, CANCER RES, V62, P1030; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Zhu AX, 2011, NAT REV CLIN ONCOL, V8, P292, DOI 10.1038/nrclinonc.2011.30	31	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90862	10.1371/journal.pone.0090862	http://dx.doi.org/10.1371/journal.pone.0090862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595361	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500106
J	Hai, RT; Wang, YL; Wang, XH; Li, Y; Du, ZZ				Hai, Reti; Wang, Yulin; Wang, Xiaohui; Li, Yuan; Du, Zhize			Bacterial Community Dynamics and Taxa-Time Relationships within Two Activated Sludge Bioreactors	PLOS ONE			English	Article							WATER TREATMENT PLANTS; WASTE-WATER; RELATIVE ABUNDANCE; MICROBIAL ECOLOGY; AREA RELATIONSHIP; DIVERSITY; INSTABILITY; REACTORS; SYSTEMS; NITRIFICATION	Background: Biological activated sludge process must be functionally stable to continuously remove contaminants while relying upon the activity of complex microbial communities. However the dynamics of these communities are as yet poorly understood. A macroecology metric used to quantify community dynamic is the taxa-time relationship (TTR). Although the TTR of animal and plant species has been well documented, knowledge is still lacking in regard to TTR of microbial communities in activated sludge bioreactors. Aims: 1) To characterize the temporal dynamics of bacterial taxa in activated sludge from two bioreactors of different scale and investigate factors affecting such dynamics; 2) to evaluate the TTRs of activated sludge microbial communities in two bioreactors of different scale. Methods: Temporal variation of bacterial taxa in activated sludge collected from a full-and lab-scale activated sludge bioreactor was monitored over a one-year period using pyrosequencing of 16S rRNA genes. TTR was employed to quantify the bacterial taxa shifts based on the power law equation S = cT(w). Results: The power law exponent w for the full-scale bioreactor was 0.43 (R-2 = 0.970), which is lower than that of the lab-scale bioreactor (w = 0.55, R-2 = 0.971). The exponents for the dominant phyla were generally higher than that of the rare phyla. Canonical correspondence analysis (CCA) result showed that the bacterial community variance was significantly associated with water temperature, influent (biochemical oxygen demand) BOD, bioreactor scale and dissolved oxygen (DO). Variance partitioning analyses suggested that wastewater characteristics had the greatest contribution to the bacterial community variance, explaining 20.3% of the variance of bacterial communities independently, followed by operational parameters (19.9%) and bioreactor scale (3.6%). Conclusions: Results of this study suggest bacterial community dynamics were likely driven partly by wastewater and operational parameters and provide evidence that the TTR may be a fundamental ecological pattern in macro- and microbial systems.	[Hai, Reti; Wang, Yulin; Wang, Xiaohui; Li, Yuan; Du, Zhize] Beijing Univ Chem Technol, Dept Environm Sci & Engn, Beijing 100029, Peoples R China	Beijing University of Chemical Technology	Wang, XH (corresponding author), Beijing Univ Chem Technol, Dept Environm Sci & Engn, Beijing 100029, Peoples R China.	wangxiaohui2008@gmail.com	Yulin, Wang/AAL-3345-2021	Wang, Yulin/0000-0002-9899-7712	Fundamental Research Funds for the Central Universities [ZY1306]; special fund of State Key Joint Laboratory of Environment Simulation and Pollution Control [3K06ESPCT]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); special fund of State Key Joint Laboratory of Environment Simulation and Pollution Control	This study was supported by the Fundamental Research Funds for the Central Universities (ZY1306) and special fund of State Key Joint Laboratory of Environment Simulation and Pollution Control (3K06ESPCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2005, ECOLOGY, V86, P2032, DOI 10.1890/05-0067; Ayarza JM, 2011, MICROB ECOL, V61, P486, DOI 10.1007/s00248-010-9762-y; Briones A, 2003, CURR OPIN BIOTECH, V14, P270, DOI 10.1016/S0958-1669(03)00065-X; Cocolin L, 2000, FEMS MICROBIOL LETT, V189, P81, DOI 10.1016/S0378-1097(00)00257-3; Curtis TP, 2006, WATER SCI TECHNOL, V54, P227, DOI 10.2166/wst.2006.391; Fernandez AS, 2000, APPL ENVIRON MICROB, V66, P4058, DOI 10.1128/AEM.66.9.4058-4067.2000; Gentile ME, 2007, APPL ENVIRON MICROB, V73, P680, DOI 10.1128/AEM.01519-06; Gentile ME, 2007, ISME J, V1, P714, DOI 10.1038/ismej.2007.87; Graham DW, 2007, ISME J, V1, P385, DOI 10.1038/ismej.2007.45; Hu M, 2012, BIORESOURCE TECHNOL, V117, P72, DOI 10.1016/j.biortech.2012.04.061; Kim TS, 2013, APPL MICROBIOL BIOT, V97, P1755, DOI 10.1007/s00253-012-4002-7; Liu GQ, 2013, ENVIRON SCI TECHNOL, V47, P5109, DOI 10.1021/es304647y; Marzorati M, 2008, ENVIRON MICROBIOL, V10, P1571, DOI 10.1111/j.1462-2920.2008.01572.x; Matthews B, 2012, ECOLOGY, V93, P2435, DOI 10.1890/11-2289.1; Mcglinn DJ, 2009, ECOLOGY, V90, P836, DOI 10.1890/08-0377.1; Ofiteru ID, 2010, P NATL ACAD SCI USA, V107, P15345, DOI 10.1073/pnas.1000604107; Park HD, 2004, WATER RES, V38, P3275, DOI 10.1016/j.watres.2004.04.047; Pholchan MK, 2010, WATER RES, V44, P1341, DOI 10.1016/j.watres.2009.11.005; Rittmann BE, 2006, ENVIRON SCI TECHNOL, V40, P1096, DOI 10.1021/es062631k; Shade A, 2013, ISME J, V7, P1493, DOI 10.1038/ismej.2013.54; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; Siggins A, 2011, BIORESOURCE TECHNOL, V102, P7645, DOI 10.1016/j.biortech.2011.05.055; Slater FR, 2010, WATER RES, V44, P4908, DOI 10.1016/j.watres.2010.07.028; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; van der Gast CJ, 2008, ENVIRON MICROBIOL, V10, P1411, DOI 10.1111/j.1462-2920.2007.01550.x; van der Gast CJ, 2006, ENVIRON MICROBIOL, V8, P1048, DOI 10.1111/j.1462-2920.2006.00996.x; Wang XH, 2012, APPL ENVIRON MICROB, V78, P7042, DOI 10.1128/AEM.01617-12; Wang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036272; Wang XH, 2011, BIORESOURCE TECHNOL, V102, P2352, DOI 10.1016/j.biortech.2010.10.095; Wells GF, 2011, WATER RES, V45, P5476, DOI 10.1016/j.watres.2011.08.006; Wells GF, 2009, ENVIRON MICROBIOL, V11, P2310, DOI 10.1111/j.1462-2920.2009.01958.x; Werner JJ, 2011, P NATL ACAD SCI USA, V108, P4158, DOI 10.1073/pnas.1015676108; White EP, 2006, OIKOS, V112, P185; Wittebolle L, 2008, APPL ENVIRON MICROB, V74, P286, DOI 10.1128/AEM.01006-07; Ye L, 2011, WATER RES, V45, P4390, DOI 10.1016/j.watres.2011.05.028; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188	36	27	29	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90175	10.1371/journal.pone.0090175	http://dx.doi.org/10.1371/journal.pone.0090175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594695	Green Submitted, gold, Green Published			2022-12-25	WOS:000332475500036
J	Roy, I; Zimmerman, NP; Mackinnon, AC; Tsai, S; Evans, DB; Dwinell, MB				Roy, Ishan; Zimmerman, Noah P.; Mackinnon, A. Craig; Tsai, Susan; Evans, Douglas B.; Dwinell, Michael B.			CXCL12 Chemokine Expression Suppresses Human Pancreatic Cancer Growth and Metastasis	PLOS ONE			English	Article							ORGAN-SPECIFIC METASTASIS; RECEPTOR CXCR4; BREAST-CANCER; TUMOR-CELLS; DUCTAL ADENOCARCINOMA; SIGNALING PATHWAYS; CARCINOMA CELLS; FACTOR-I; MIGRATION; SURVIVAL	Pancreatic ductal adenocarcinoma is an unsolved health problem with nearly 75% of patients diagnosed with advanced disease and an overall 5-year survival rate near 5%. Despite the strong link between mortality and malignancy, the mechanisms behind pancreatic cancer dissemination and metastasis are poorly understood. Correlative pathological and cell culture analyses suggest the chemokine receptor CXCR4 plays a biological role in pancreatic cancer progression. In vivo roles for the CXCR4 ligand CXCL12 in pancreatic cancer malignancy were investigated. CXCR4 and CXCR7 were consistently expressed in normal and cancerous pancreatic ductal epithelium, established cell lines, and patient-derived primary cancer cells. Relative to healthy exocrine ducts, CXCL12 expression was pathologically repressed in pancreatic cancer tissue specimens and patient-derived cell lines. To test the functional consequences of CXCL12 silencing, pancreatic cancer cell lines stably expressingthe chemokine were engineered. Consistent with a role for CXCL12 as a tumor suppressor, cells producing the chemokine wereincreasingly adherent and migration deficient in vitro and poorly metastatic in vivo, compared to control cells. Further, CXCL12 reintroduction significantly reduced tumor growth in vitro, with significantly smaller tumors in vivo, leading to a pronounced survival advantage in a preclinical model. Together, these data demonstrate a functional tumor suppressive role for the normal expression of CXCL12 in pancreatic ducts, regulating both tumor growth andcellulardissemination to metastatic sites.	[Roy, Ishan; Zimmerman, Noah P.; Dwinell, Michael B.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Mackinnon, A. Craig] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Tsai, Susan; Evans, Douglas B.] Med Coll Wisconsin, Dept Surg, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Dwinell, MB (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA.	mdwinell@mcw.edu		Mackinnon, Alexander/0000-0002-2036-8529; Roy, Ishan/0000-0002-9109-0421	A Healthier Wisconsin; MCW Cancer Center	A Healthier Wisconsin; MCW Cancer Center	This work was supported in part by grants from the A Healthier Wisconsin and the MCW Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Abul K., 2010, BASIC IMMUNOLOGY FUN; Adams EJ, 1999, J CLIN PATHOL, V52, P75, DOI 10.1136/jcp.52.1.75; Arya M, 2003, CURR MED RES OPIN, V19, P557, DOI 10.1185/030079903125002216; Baumhoer D, 2012, MODERN PATHOL, V25, P522, DOI 10.1038/modpathol.2011.193; Billadeau DD, 2006, J GASTROINTEST CANC, V37, P110, DOI 10.1007/s12029-007-0011-7; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cabioglu N, 2007, ANN ONCOL, V18, P1021, DOI 10.1093/annonc/mdm060; Clatot F, 2011, ORAL ONCOL, V47, P1062, DOI 10.1016/j.oraloncology.2011.07.021; Cui K, 2010, J SURG RES; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Drury LJ, 2011, P NATL ACAD SCI USA, V108, P17655, DOI 10.1073/pnas.1101133108; Drury LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012895; Dwinell MB, 2004, AM J PHYSIOL-GASTR L, V286, pG844, DOI 10.1152/ajpgi.00112.2003; Dwinell MB, 2003, SURGERY, V133, P601, DOI 10.1067/msy.2003.143; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Haeno H, 2012, CELL, V148, P362, DOI 10.1016/j.cell.2011.11.060; Hassan S, 2009, AM J PATHOL, V175, P66, DOI 10.2353/ajpath.2009.080948; Heidemann J, 2004, AM J PHYSIOL-GASTR L, V286, pG1059, DOI 10.1152/ajpgi.00417.2003; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2005, METH MOLEC MED, V103, P1; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Hruban RH, 2001, CANCER J, V7, P251; Hwang S, 2012, J BIOL CHEM, V287, P22227, DOI 10.1074/jbc.M112.367979; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Katz MHG, 2008, J AM COLL SURGEONS, V206, P833, DOI 10.1016/j.jamcollsurg.2007.12.020; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Kobayashi T, 2010, BREAST CANCER RES TR, V123, P733, DOI 10.1007/s10549-009-0672-y; Koorstra JBM, 2008, PANCREATOLOGY, V8, P110, DOI 10.1159/000123838; Koshiba T, 2000, CLIN CANCER RES, V6, P3530; Liang JJ, 2010, CANCER EPIDEM BIOMAR, V19, P2598, DOI 10.1158/1055-9965.EPI-10-0405; Maitra A, 2005, ADV ANAT PATHOL, V12, P81, DOI 10.1097/01.pap.0000155055.14238.25; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Marchesi F, 2004, CANCER RES, V64, P8420, DOI 10.1158/0008-5472.CAN-04-1343; Mirisola V, 2009, EUR J CANCER, V45, P2579, DOI 10.1016/j.ejca.2009.06.026; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Ramos EAS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-23; Satoi S, 2012, J GASTROINTEST SURG, V16, P784, DOI 10.1007/s11605-011-1795-0; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smith JM, 2005, AM J PHYSIOL-GASTR L, V288, pG316, DOI 10.1152/ajpgi.00208.2004; Spicer JD, 2012, CANCER RES, V72, P3919, DOI 10.1158/0008-5472.CAN-11-2393; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tessema M, 2010, ONCOGENE, V29, P5159, DOI 10.1038/onc.2010.255; Veldkamp CT, 2009, PROTEIN SCI, V18, P1359, DOI 10.1002/pro.167; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; Wendt MK, 2008, ONCOGENE, V27, P1461, DOI 10.1038/sj.onc.1210751; Wendt MK, 2006, ONCOGENE, V25, P4986, DOI 10.1038/sj.onc.1209505; Wendt MK, 2008, GASTROENTEROLOGY, V135, P508, DOI 10.1053/j.gastro.2008.05.033; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zhi Y, 2012, DIGEST DIS SCI, V57, P650, DOI 10.1007/s10620-011-1922-5; Zhong WX, 2012, EXP THER MED, V4, P363, DOI 10.3892/etm.2012.631; Zimmerman NP, 2011, LAB INVEST, V91, P1040, DOI 10.1038/labinvest.2011.77; Zlotnik A, 2008, J PATHOL, V215, P211, DOI 10.1002/path.2350; Zlotnik A, 2004, SEMIN CANCER BIOL, V14, P181, DOI 10.1016/j.semcancer.2003.10.004; Zlotnik A, 2006, CONTRIB MICROBIOL, V13, P191, DOI 10.1159/000092973; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	62	59	62	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90400	10.1371/journal.pone.0090400	http://dx.doi.org/10.1371/journal.pone.0090400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594697	gold, Green Published, Green Submitted			2022-12-25	WOS:000332475500047
J	Gao, JL; Liu, Q; Liu, X; Ji, CY; Qu, SQ; Wang, SS; Luo, Y				Gao, Jinlan; Liu, Qi; Liu, Xing; Ji, Chunyan; Qu, Shengqiang; Wang, Shusen; Luo, Yang			Cyclin G2 Suppresses Estrogen-Mediated Osteogenesis through Inhibition of Wnt/beta-Catenin Signaling	PLOS ONE			English	Article							HIGH BONE MASS; POSTMENOPAUSAL WOMEN; PHOSPHOINOSITIDE 3-KINASE; NEGATIVE REGULATOR; SEX STEROIDS; EXPRESSION; DIFFERENTIATION; OSTEOPOROSIS; MARROW; TRANSCRIPTION	Estrogen plays an important role in the maintenance of bone formation, and deficiency in the production of estrogen is directly linked to postmenopausal osteoporosis. To date, the underlying mechanisms of estrogen-mediated osteogenic differentiation are not well understood. In this study, a pluripotent mesenchymal precursor cell line C2C12 was used to induce osteogenic differentiation and subjected to detection of gene expressions or to manipulation of cyclin G2 expressions. C57BL/6 mice were used to generate bilateral ovariectomized and sham-operated mice for analysis of bone mineral density and protein expression. We identified cyclin G2, an unconventional member of cyclin, is involved in osteoblast differentiation regulated by estrogen in vivo and in vitro. In addition, the data showed that ectopic expression of cyclin G2 suppressed expression of osteoblast transcription factor Runx2 and osteogenic differentiation marker genes, as well as ALP activity and in vitro extracellular matrix mineralization. Mechanistically, Wnt/beta-catenin signaling pathway is essential for cyclin G2 to inhibit osteogenic differentiation. To the best of our knowledge, the current study presents the first evidence that cyclin G2 serves as a negative regulator of both osteogenesis and Wnt/beta-catenin signaling. Most importantly, the basal and 17 beta-estradiol-induced osteogenic differentiation was restored by overexpression of cyclin G2. These results taken together suggest that cyclin G2 may function as an endogenous suppressor of estrogen-induced osteogenic differentiation through inhibition of Wnt/beta-catenin signaling.	[Gao, Jinlan; Liu, Qi; Liu, Xing; Ji, Chunyan; Qu, Shengqiang; Wang, Shusen; Luo, Yang] China Med Univ, Minist Educ, Key Lab Med Cell Biol, Res Ctr Med Genom,Key Lab Cell Biol,Minist Publ H, Shenyang, Peoples R China	China Medical University	Luo, Y (corresponding author), China Med Univ, Minist Educ, Key Lab Med Cell Biol, Res Ctr Med Genom,Key Lab Cell Biol,Minist Publ H, Shenyang, Peoples R China.	luoyang@mail.cmu.edu.cn			National Natural Science Foundation of China;  [81170543];  [81100419]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ; 	This work was supported by Grants 81170543 and 81100419 form the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar V, 2010, ENDOCRINOLOGY, V151, P5247, DOI 10.1210/en.2010-0461; Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005; Aubin JE, 1998, J CELL BIOCHEM, V147, P1531; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bates S, 1996, ONCOGENE, V13, P1103; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; BERESFORD JN, 1992, J CELL SCI, V102, P341; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Choi MG, 2009, J SURG RES, V157, P168, DOI 10.1016/j.jss.2008.06.020; Clements WM, 2002, CANCER RES, V62, P3503; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Fu G, 2011, ONCOGENE, V30, P3953, DOI 10.1038/onc.2011.127; Gambacciani M, 2001, MATURITAS, V39, P125, DOI 10.1016/S0378-5122(01)00194-3; Gao JL, 2011, AFR J BIOTECHNOL, V10, P14618; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Horne MC, 1997, J BIOL CHEM, V272, P12650, DOI 10.1074/jbc.272.19.12650; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Karsenty G, 2001, ENDOCRINOLOGY, V142, P2731, DOI 10.1210/en.142.7.2731; KITAZAWA R, 1994, J CLIN INVEST, V94, P2397, DOI 10.1172/JCI117606; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kulkarni NH, 2006, J BONE MINER RES, V21, P910, DOI 10.1359/JBMR.060316; Le XF, 2007, MOL CANCER THER, V6, P2843, DOI 10.1158/1535-7163.MCT-07-0109; Liu J, 2004, WORLD J GASTROENTERO, V10, P1357; Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; Masuda H, 2007, CIRC RES, V101, P598, DOI 10.1161/CIRCRESAHA.106.144006; Matsumoto Y, 2010, MOL CELL ENDOCRINOL, V325, P118, DOI 10.1016/j.mce.2010.05.004; NAKAMURA T, 1995, EXP CELL RES, V221, P534, DOI 10.1006/excr.1995.1406; Nuttall ME, 2000, BONE, V27, P177, DOI 10.1016/S8756-3282(00)00317-3; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Siris ES, 2001, JAMA-J AM MED ASSOC, V286, P2815, DOI 10.1001/jama.286.22.2815; Sowa H, 2004, J BIOL CHEM, V279, P40267, DOI 10.1074/jbc.M401312200; Spelsberg TC, 1999, MOL ENDOCRINOL, V13, P819, DOI 10.1210/me.13.6.819; Stossi F, 2006, J BIOL CHEM, V281, P16272, DOI 10.1074/jbc.M513405200; Wang Q, 2006, BIOCHEM BIOPH RES CO, V347, P117, DOI 10.1016/j.bbrc.2006.06.070; Waters KM, 2001, J CELL BIOCHEM, V83, P448, DOI 10.1002/jcb.1242; Yu HC, 2010, J BONE MINER RES, V25, P1128, DOI 10.1002/jbmr.9; Zhou S, 2001, BIOCHEM BIOPH RES CO, V210, P102	46	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89884	10.1371/journal.pone.0089884	http://dx.doi.org/10.1371/journal.pone.0089884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595300	gold, Green Published, Green Submitted			2022-12-25	WOS:000332468900042
J	Luchtmann, M; Steinecke, Y; Baecke, S; Lutzkendorf, R; Bernarding, J; Kohl, J; Jollenbeck, B; Tempelmann, C; Ragert, P; Firsching, R				Luchtmann, Michael; Steinecke, Yvonne; Baecke, Sebastian; Luetzkendorf, Ralf; Bernarding, Johannes; Kohl, Jana; Joellenbeck, Boris; Tempelmann, Claus; Ragert, Patrick; Firsching, Raimund			Structural Brain Alterations in Patients with Lumbar Disc Herniation: A Preliminary Study	PLOS ONE			English	Article							CHRONIC BACK-PAIN; VOXEL-BASED MORPHOMETRY; GRAY-MATTER DECREASE; RESEARCH TRIAL SPORT; NONSURGICAL MANAGEMENT; NONOPERATIVE TREATMENT; COST-EFFECTIVENESS; PREFRONTAL CORTEX; SCIATICA; SPINE	Chronic pain is one of the most common health complaints in industrial nations. For example, chronic low back pain (cLBP) disables millions of people across the world and generates a tremendous economic burden. While previous studies provided evidence of widespread functional as well as structural brain alterations in chronic pain, little is known about cortical changes in patients suffering from lumbar disc herniation. We investigated morphometric alterations of the gray and white matter of the brain in patients suffering from LDH. The volumes of the gray and white matter of 12 LDH patients were determined in a prospective study and compared to the volumes of healthy controls to distinguish local differences. High-resolution MRI brain images of all participants were performed using a 3 Tesla MRI scanner. Voxel-based morphometry was used to investigate local differences in gray and white matter volume between patients suffering from LDH and healthy controls. LDH patients showed significantly reduced gray matter volume in the right anterolateral prefrontal cortex, the right temporal lobe, the left premotor cortex, the right caudate nucleus, and the right cerebellum as compared to healthy controls. Increased gray matter volume, however, was found in the right dorsal anterior cingulate cortex, the left precuneal cortex, the left fusiform gyrus, and the right brainstem. Additionally, small subcortical decreases of the white matter were found adjacent to the left prefrontal cortex, the right premotor cortex and in the anterior limb of the left internal capsule. We conclude that the lumbar disk herniation can lead to specific local alterations of the gray and white matter in the human brain. The investigation of LDH-induced brain alterations could provide further insight into the underlying nature of the chronification processes and could possibly identify prognostic factors that may improve the conservative as well as the operative treatment of the LDH.	[Luchtmann, Michael; Steinecke, Yvonne; Kohl, Jana; Joellenbeck, Boris; Firsching, Raimund] Univ Magdeburg, Fac Med, Dept Neurosurg, D-39106 Magdeburg, Germany; [Baecke, Sebastian; Luetzkendorf, Ralf; Bernarding, Johannes] Univ Magdeburg, Fac Med, Inst Biometry & Med Informat, D-39106 Magdeburg, Germany; [Tempelmann, Claus] Univ Magdeburg, Fac Med, Dept Neurol, D-39106 Magdeburg, Germany; [Ragert, Patrick] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany	Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; Max Planck Society	Luchtmann, M (corresponding author), Univ Magdeburg, Fac Med, Dept Neurosurg, D-39106 Magdeburg, Germany.	Michael.Luchtmann@med.ovgu.de	Ragert, Patrick/AAI-7290-2020	Tempelmann, Claus/0000-0001-8570-4960; Luchtmann, Michael/0000-0002-9947-9095				Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Atlas SJ, 2005, SPINE, V30, P936, DOI 10.1097/01.brs.0000158953.57966.c0; Atlas SJ, 2001, SPINE, V26, P1179, DOI 10.1097/00007632-200105150-00017; Bingel U, 2007, PAIN, V131, P21, DOI 10.1016/j.pain.2006.12.005; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; Borsook D, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-27; Borsook D, 2010, NEUROSCIENTIST, V16, P171, DOI 10.1177/1073858409349902; Carragee EJ, 1997, SPINE, V22, P1650, DOI 10.1097/00007632-199707150-00025; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; Dichgans M, 2005, NEUROLOGY, V64, P608, DOI 10.1212/01.WNL.0000151855.98318.50; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Duerden EG, 2013, HUM BRAIN MAPP, V34, P109, DOI 10.1002/hbm.21416; Dunckley P, 2005, J NEUROSCI, V25, P7333, DOI 10.1523/JNEUROSCI.1100-05.2005; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; el Barzouhi A, 2013, NEW ENGL J MED, V368, P999, DOI 10.1056/NEJMoa1209250; Fairhurst M, 2007, PAIN, V128, P101, DOI 10.1016/j.pain.2006.09.001; Flor H, 2004, NEUROSCI LETT, V361, P147, DOI 10.1016/j.neulet.2003.12.064; Freund W, 2009, SOMATOSENS MOT RES, V26, P1, DOI 10.1080/08990220902738243; Freund W, 2007, SOMATOSENS MOT RES, V24, P203, DOI 10.1080/08990220701723636; Giesecke T, 2005, ARTHRITIS RHEUM-US, V52, P1577, DOI 10.1002/art.21008; Gracely RH, 2004, BRAIN, V127, P835, DOI 10.1093/brain/awh098; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Ingvar M, 1999, PHILOS T R SOC B, V354, P1347, DOI 10.1098/rstb.1999.0483; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Jin CW, 2013, NMR BIOMED, V26, P58, DOI 10.1002/nbm.2819; Karppinen J, 2001, SPINE, V26, P2587, DOI 10.1097/00007632-200112010-00013; Kattoor J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051149; Kim J, 2008, CEPHALALGIA, V28, P598, DOI 10.1111/j.1468-2982.2008.01550.x; KORTELAINEN P, 1985, SPINE, V10, P88, DOI 10.1097/00007632-198501000-00014; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Markham JA, 2004, NEURON GLIA BIOL, V1, P351, DOI 10.1017/S1740925X05000219; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; May A, 2011, NEUROSCIENTIST, V17, P209, DOI 10.1177/1073858410396220; Moschetti W, 2009, SEMIN SPINE SURG, V21, P223; Mysliwiec LW, 2010, EUR SPINE J, V19, P1087, DOI 10.1007/s00586-009-1274-4; Obermann M, 2013, NEUROIMAGE, V74, P352, DOI 10.1016/j.neuroimage.2013.02.029; Ohnmeiss DD, 1997, SPINE, V22, P1600, DOI 10.1097/00007632-199707150-00015; PETERS ML, 1989, PAIN, V39, P69, DOI 10.1016/0304-3959(89)90176-0; Petrovic P, 2002, PAIN, V95, P1, DOI 10.1016/S0304-3959(01)00467-5; Petrovic P, 2004, NEUROIMAGE, V22, P995, DOI 10.1016/j.neuroimage.2004.01.046; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; Rodriguez-Raecke R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054475; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Sandor PS, 2001, ANN NEUROL, V49, P668, DOI 10.1002/ana.1019; Schmidt-Wilcke T, 2007, PAIN, V132, pS109, DOI 10.1016/j.pain.2007.05.010; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; Schmidt-Wilcke T, 2005, NEUROLOGY, V65, P1483, DOI 10.1212/01.wnl.0000183067.94400.80; Schweinhardt P, 2008, PAIN, V140, P411, DOI 10.1016/j.pain.2008.09.014; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; SHVARTZMAN L, 1992, SPINE, V17, P176, DOI 10.1097/00007632-199202000-00010; Sonntag VKH, 2012, WORLD NEUROSURG, V77, P71, DOI 10.1016/j.wneu.2011.06.007; Sonntag VKH, 2010, WORLD NEUROSURG, V74, P574, DOI 10.1016/j.wneu.2010.08.006; Teutsch S, 2008, NEUROIMAGE, V42, P845, DOI 10.1016/j.neuroimage.2008.05.044; Ung H, 2012, CEREB CORTEX; Vlaeyen JWS, 2012, PAIN, V153, P1144, DOI 10.1016/j.pain.2011.12.009; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wand BM, 2011, MANUAL THER, V16, P15, DOI 10.1016/j.math.2010.06.008; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; Weinstein JN, 2008, SPINE, V33, P2789, DOI 10.1097/BRS.0b013e31818ed8f4; Wenig CM, 2009, EUR J PAIN, V13, P280, DOI 10.1016/j.ejpain.2008.04.005; Wiech K, 2006, J NEUROSCI, V26, P11501, DOI 10.1523/JNEUROSCI.2568-06.2006; Wood Patrick B, 2010, Curr Rheumatol Rep, V12, P462, DOI 10.1007/s11926-010-0129-7; Younger JW, 2011, PAIN, V152, P1803, DOI 10.1016/j.pain.2011.03.028	71	38	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90816	10.1371/journal.pone.0090816	http://dx.doi.org/10.1371/journal.pone.0090816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595036	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900150
J	Rastogi, N; Nagpal, N; Alam, H; Pandey, S; Gautam, L; Sinha, M; Shin, K; Manzoor, N; Virdi, JS; Kaur, P; Sharma, S; Singh, TP				Rastogi, Nilisha; Nagpal, Nitish; Alam, Hammad; Pandey, Sadanand; Gautam, Lovely; Sinha, Mau; Shin, Kouichirou; Manzoor, Nikhat; Virdi, Jugsharan S.; Kaur, Punit; Sharma, Sujata; Singh, Tej P.			Preparation and Antimicrobial Action of Three Tryptic Digested Functional Molecules of Bovine Lactoferrin	PLOS ONE			English	Article							2.6 ANGSTROM RESOLUTION; IRON-BINDING PROPERTIES; HUMAN-MILK; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; BUFFALO LACTOFERRIN; CANDIDA-ALBICANS; N-TERMINUS; PEPTIDES; APOLACTOFERRIN	Lactoferrin is an 80 kDa bilobal, iron binding glycoprotein which is primarily antimicrobial in nature. The hydrolysis of lactoferrin by various proteases in the gut produces several functional fragments of lactoferrin which have varying molecular sizes and properties. Here, bovine lactoferrin has been hydrolyzed by trypsin, the major enzyme present in the gut, to produce three functional molecules of sizes approximately 21 kDa, 38 kDa and 45 kDa. The molecules have been purified using ion exchange and gel filtration chromatography and identified using N-terminal sequencing, which reveals that while the 21 kDa molecule corresponds to the N2 domain (21LF), the 38 kDa represents the whole C-lobe (38LF) and the 45 kDa is a portion of N1 domain of N-lobe attached to the C-lobe (45LF). The iron binding and release properties of 21LF, 38LF and 45LF have been studied and compared. The sequence and structure analysis of the portions of the excision sites of LF from various species have been done. The antibacterial properties of these three molecules against bacterial strains, Streptococcus pyogenes, Escherichia coli, Yersinia enterocolitica and Listeria monocytogenes were investigated. The antifungal action of the molecules was also evaluated against Candida albicans. This is the first report on the antimicrobial actions of the trypsin cleaved functional molecules of lactoferrin from any species.	[Rastogi, Nilisha; Pandey, Sadanand; Gautam, Lovely; Sinha, Mau; Kaur, Punit; Sharma, Sujata; Singh, Tej P.] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Nagpal, Nitish; Virdi, Jugsharan S.] Univ Delhi, Dept Microbiol, New Delhi, India; [Alam, Hammad; Manzoor, Nikhat] Jamia Milia Islamia, Dept Biosci, New Delhi, India; [Shin, Kouichirou] Morinaga Milk Ind Co Ltd, Food Sci & Technol Inst, Zama, Kanagawa, Japan	All India Institute of Medical Sciences (AIIMS) New Delhi; University of Delhi; Jamia Millia Islamia; Morinaga Milk Industry Company, Ltd	Sharma, S (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	afrank2@gmail.com; tpsingh.aiims@gmail.com	; Virdi, Jugsharan Singh/L-8241-2015	SINHA, MAU/0000-0003-3011-9160; Virdi, Jugsharan Singh/0000-0002-6282-0018; Manzoor, Nikhat/0000-0002-6850-6142	Department of Biotechnology (DBT); Indian Council of Medical Research (ICMR), New Delhi; University Grant Commission (UGC); Council of Scientific and Industrial Research (CSIR)	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Indian Council of Medical Research (ICMR), New Delhi(Indian Council of Medical Research (ICMR)); University Grant Commission (UGC)(University Grants Commission, India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	TPS thanks the Department of Biotechnology (DBT), for the award of Distinguished Biotechnology Research Professorship to him. NR and SP thanks Indian Council of Medical Research (ICMR), New Delhi and University Grant Commission (UGC) for the award of fellowships. NN and HA thanks Council of Scientific and Industrial Research (CSIR) and Indian Council of Medical Research (ICMR), New Delhi for their fellowships. MS thanks Department of Science and Technology (DST), Ministry of Science and Technology, New Delhi and LG thanks Council of Scientific and Industrial Research (CSIR) for their fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrink M, 2000, KIDNEY INT, V57, P2004, DOI 10.1046/j.1523-1755.2000.00050.x; Ahmad A, 2010, J MED MICROBIOL, V59, P1178, DOI 10.1099/jmm.0.020693-0; ANDERSON BF, 1987, P NATL ACAD SCI USA, V84, P1769, DOI 10.1073/pnas.84.7.1769; ARNOLD RR, 1977, SCIENCE, V197, P263, DOI 10.1126/science.327545; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; BELLAMY W, 1992, J APPL BACTERIOL, V73, P472, DOI 10.1111/j.1365-2672.1992.tb05007.x; BELLAMY WR, 1993, J APPL BACTERIOL, V75, P478; BLUARDDECONINCK JM, 1978, BIOCHEM J, V171, P321, DOI 10.1042/bj1710321; BRINES RD, 1983, BIOCHIM BIOPHYS ACTA, V759, P229, DOI 10.1016/0304-4165(83)90317-3; BROCK JH, 1980, ARCH DIS CHILD, V55, P417, DOI 10.1136/adc.55.6.417; BROCK JH, 1976, BIOCHIM BIOPHYS ACTA, V446, P214, DOI 10.1016/0005-2795(76)90112-4; BROEKHUYSE RM, 1974, INVEST OPHTH VISUAL, V13, P550; Chierici R, 2001, ADV NUTR RES, V10, P247; DAVIDSSON L, 1994, PEDIATR RES, V35, P117, DOI 10.1203/00006450-199401000-00025; DAY CL, 1993, J MOL BIOL, V232, P1084, DOI 10.1006/jmbi.1993.1462; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; FOX PC, 1987, J GERONTOL, V42, P466, DOI 10.1093/geronj/42.5.466; GRIFFITHS E, 1977, INFECT IMMUN, V15, P396, DOI 10.1128/IAI.15.2.396-401.1977; Groenink J, 1999, FEMS MICROBIOL LETT, V179, P217, DOI 10.1016/S0378-1097(99)00414-0; Hagiwara S, 2003, J VET MED SCI, V65, P319, DOI 10.1292/jvms.65.319; HARIDAS M, 1994, ADV EXP MED BIOL, V357, P235; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; JONES EM, 1994, J APPL BACTERIOL, V77, P208, DOI 10.1111/j.1365-2672.1994.tb03065.x; Karthikeyan S, 1999, ACTA CRYSTALLOGR D, V55, P1805, DOI 10.1107/S0907444999010951; Khan JA, 2001, J MOL BIOL, V309, P751, DOI 10.1006/jmbi.2001.4692; KIRKPATRICK CH, 1971, J INFECT DIS, V124, P539, DOI 10.1093/infdis/124.6.539; KUROKAWA H, 1995, J MOL BIOL, V254, P196, DOI 10.1006/jmbi.1995.0611; LEGRAND D, 1986, BIOCHEM J, V236, P839, DOI 10.1042/bj2360839; Li KJ, 2006, J LEUKOCYTE BIOL, V80, P350, DOI 10.1189/jlb.1105668; LONGHI C, 1994, MED MICROBIOL IMMUN, V183, P77, DOI 10.1007/BF00277158; Lupetti A, 2000, ANTIMICROB AGENTS CH, V44, P3257, DOI 10.1128/AAC.44.12.3257-3263.2000; MASSON PL, 1968, FERTIL STERIL, V19, P679; MASSON PL, 1966, CLIN CHIM ACTA, V14, P735, DOI 10.1016/0009-8981(66)90004-0; MAZURIER J, 1980, BIOCHIM BIOPHYS ACTA, V629, P399, DOI 10.1016/0304-4165(80)90112-9; Mirza S, 2011, INFECT IMMUN, V79, P2440, DOI 10.1128/IAI.00489-10; Nibbering PH, 2001, INFECT IMMUN, V69, P1469, DOI 10.1128/IAI.69.3.1469-1476.2001; NIEMELA A, 1989, HUM REPROD, V4, P99, DOI 10.1093/oxfordjournals.humrep.a136854; NONNECKE BJ, 1984, J DAIRY SCI, V67, P606, DOI 10.3168/jds.S0022-0302(84)81345-4; Onyewu C, 2003, ANTIMICROB AGENTS CH, V47, P956, DOI 10.1128/AAC.47.3.956-964.2003; REITER B, 1975, IMMUNOLOGY, V28, P83; Sharma AK, 1999, J MOL BIOL, V289, P303, DOI 10.1006/jmbi.1999.2767; Sharma S, 1999, J DAIRY RES, V66, P81, DOI 10.1017/S0022029998003343; Sharma S, 2003, J MOL BIOL, V331, P485, DOI 10.1016/S0022-2836(03)00717-4; SHIMAZAKI K, 1993, J DAIRY SCI, V76, P946, DOI 10.3168/jds.S0022-0302(93)77421-4; Sinha Mau, 2013, Int J Pept, V2013, P390230, DOI 10.1155/2013/390230; Toma C, 1996, FEMS MICROBIOL LETT, V135, P143, DOI 10.1016/0378-1097(95)00463-7; TOMITA M, 1991, J DAIRY SCI, V74, P4137, DOI 10.3168/jds.S0022-0302(91)78608-6; TOMITA M, 1994, ADV EXP MED BIOL, V357, P209; Valenti P, 1998, ADV EXP MED BIOL, V443, P199; van der Does AM, 2012, J INNATE IMMUN, V4, P284, DOI 10.1159/000332941; YAMAUCHI K, 1993, INFECT IMMUN, V61, P719, DOI 10.1128/IAI.61.2.719-728.1993	51	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90011	10.1371/journal.pone.0090011	http://dx.doi.org/10.1371/journal.pone.0090011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595088	gold, Green Published, Green Submitted			2022-12-25	WOS:000332468900054
J	Tseng, YC; Glaser, JI; Caddigan, E; Lleras, A				Tseng, Yuan-Chi; Glaser, Joshua I.; Caddigan, Eamon; Lleras, Alejandro			Modeling the Effect of Selection History on Pop-Out Visual Search	PLOS ONE			English	Article							DIFFUSION-MODEL; SUPERIOR COLLICULUS; DISTRACTOR INHIBITION; INTERTRIAL INHIBITION; TARGET ACTIVATION; GUIDED SEARCH; NEURAL BASIS; REPETITION; SALIENCE; ATTENTION	While attentional effects in visual selection tasks have traditionally been assigned "top-down'' or "bottom-up'' origins, more recently it has been proposed that there are three major factors affecting visual selection: (1) physical salience, (2) current goals and (3) selection history. Here, we look further into selection history by investigating Priming of Pop-out (POP) and the Distractor Preview Effect (DPE), two inter-trial effects that demonstrate the influence of recent history on visual search performance. Using the Ratcliff diffusion model, we model observed saccadic selections from an oddball search experiment that included a mix of both POP and DPE conditions. We find that the Ratcliff diffusion model can effectively model the manner in which selection history affects current attentional control in visual inter-trial effects. The model evidence shows that bias regarding the current trial's most likely target color is the most critical parameter underlying the effect of selection history. Our results are consistent with the view that the 3-item color-oddball task used for POP and DPE experiments is best understood as an attentional decision making task.	[Tseng, Yuan-Chi; Caddigan, Eamon; Lleras, Alejandro] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Glaser, Joshua I.] Univ Illinois, Dept Math, Urbana, IL USA; [Tseng, Yuan-Chi; Caddigan, Eamon; Lleras, Alejandro] Univ Illinois, Dept Psychol, Urbana, IL USA; [Tseng, Yuan-Chi] Natl Cheng Kung Univ, Dept Ind Design, Tainan 70101, Taiwan; [Glaser, Joshua I.] Northwestern Univ, Interdept Neurosci Program, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; National Cheng Kung University; Northwestern University	Tseng, YC (corresponding author), Univ Illinois, Beckman Inst, Urbana, IL 61801 USA.	yuanchi.tseng@gmail.com	Lleras, Alejandro/AAA-5446-2020	Glaser, Joshua/0000-0003-2906-115X	National Science Council [NSC 101-2218-E-006-021]; National Science Foundation [BCS 07-46586 CAR]	National Science Council(Ministry of Science and Technology, Taiwan); National Science Foundation(National Science Foundation (NSF))	This work was funded with support from a grant (# NSC 101-2218-E-006-021) from National Science Council (YCT, PI; http://web1.nsc.gov.tw/mp.aspx?mp=7) and with a grant (# BCS 07-46586 CAR) from National Science Foundation (AL, PI; http://www.nsf.gov/div/index.jsp?div=BCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027926; Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Ariga A, 2004, J VISION, V4, P891, DOI 10.1167/4.10.5; Awh E, 2012, TRENDS COGNITIVE SCI; Bichot NP, 2002, J NEUROSCI, V22, P4675, DOI 10.1523/JNEUROSCI.22-11-04675.2002; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; Boucher L, 2007, PSYCHOL REV, V114, P376, DOI 10.1037/0033-295X.114.2.376; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Caddigan E, 2010, J VISION, P10; Chun MM, 2000, TRENDS COGN SCI, V4, P170, DOI 10.1016/S1364-6613(00)01476-5; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Eimer M, 2010, VISION RES, V50, P1353, DOI 10.1016/j.visres.2009.11.001; Fecteau JH, 2003, NAT REV NEUROSCI, V4, P435, DOI 10.1038/nrn1114; Fecteau JH, 2007, J VISION, V7, DOI 10.1167/7.6.1; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Found A, 1996, PERCEPT PSYCHOPHYS, V58, P88, DOI 10.3758/BF03205479; Geyer T, 2007, J EXP PSYCHOL HUMAN, V33, P788, DOI 10.1037/0096-1523.33.4.788; Goolsby BA, 2005, VISION RES, V45, P901, DOI 10.1016/j.visres.2004.10.003; Goolsby BA, 2001, PERCEPT PSYCHOPHYS, V63, P929, DOI 10.3758/BF03194513; Hastie TJ, 2011, ELEMENTS STAT LEARNI; Hickey C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014087; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Huang LQ, 2005, PERCEPT PSYCHOPHYS, V67, P150, DOI 10.3758/BF03195018; Huang LQ, 2004, MEM COGNITION, V32, P12, DOI 10.3758/BF03195816; HURVICH CM, 1991, BIOMETRIKA, V78, P499; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Krajbich I, 2011, P NATL ACAD SCI USA, V108, P13852, DOI 10.1073/pnas.1101328108; Kristjansson A, 2001, PERCEPTION, V30, P1375, DOI 10.1068/p3251; Kristjansson A, 2005, PRIMING COLOR POSITI; Kristjansson A, 2008, VISION RES, V48, P1217, DOI 10.1016/j.visres.2008.02.007; Kristjansson A, 2007, CEREB CORTEX, V17, P1612, DOI 10.1093/cercor/bhl072; Lamy D, 2013, VISION RES; Lamy D, 2008, VISION RES, V48, P30, DOI 10.1016/j.visres.2007.10.009; Lee H, 2009, ATTEN PERCEPT PSYCHO, V71, P1059, DOI 10.3758/APP.71.5.1059; Levinthal BR, 2008, J VISION, V8, DOI 10.1167/8.15.12; Lleras A, 2008, PERCEPT PSYCHOPHYS, V70, P114, DOI 10.3758/PP.70.1.114; Lleras A, 2009, PROG BRAIN RES, V176, P195, DOI 10.1016/S0079-6123(09)17611-2; Lleras A, 2009, J VISION, V9, DOI 10.1167/9.3.26; Maljkovic V, 1996, PERCEPT PSYCHOPHYS, V58, P977, DOI 10.3758/BF03206826; Maljkovic V, 2000, VIS COGN, V7, P571, DOI 10.1080/135062800407202; Maljkovic V, 1994, MEMORY COGNITION, V22; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; Meeter M, 2006, VIS COGN, V13, P202, DOI 10.1080/13506280500277488; Mozer M, 2006, NEURAL INFORM PROCES, V18, P923; Peremen Z, 2013, J VISION, V13, DOI 10.1167/13.5.1; Purcell BA, 2012, J NEUROSCI, V32, P3433, DOI 10.1523/JNEUROSCI.4622-11.2012; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; Ratcliff R, 2004, PSYCHOL AGING, V19, P278, DOI 10.1037/0882-7974.19.2.278; Ratcliff R, 2002, PSYCHON B REV, V9, P278, DOI 10.3758/BF03196283; Ratcliff R, 2002, PSYCHON B REV, V9, P438, DOI 10.3758/BF03196302; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2001, NATURE NEUROSCIENCE, V4; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Ratcliff R, 2007, J NEUROPHYSIOL, V97, P1756, DOI 10.1152/jn.00393.2006; Ratcliff R, 2006, PSYCHOL AGING, V21, P353, DOI 10.1037/0882-7974.21.2.353; Scalf PE, TRIAL HIST EFF UNPUB; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Schall JD, 2007, COGN AFFECT BEHAV NE, V7, P396, DOI 10.3758/CABN.7.4.396; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; Sigurdardottir HM, 2008, VIS COGN, V16, P643, DOI 10.1080/13506280701218364; Simen P, 2006, NEURAL NETWORKS, V19, P1013, DOI 10.1016/j.neunet.2006.05.038; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Tseng YC, 2004, PERCEPT PSYCHOPHYS, V66, P1363, DOI 10.3758/BF03195004; Tseng YC, 2013, ATTEN PERCEPT PSYCHO, V75, P287, DOI 10.3758/s13414-012-0400-2; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Vandekerckhove J, 2008, BEHAV RES METHODS, V40, P61, DOI 10.3758/BRM.40.1.61; Voss A, 2004, MEM COGNITION, V32, P1206, DOI 10.3758/BF03196893; Wan XA, 2010, VIS COGN, V18, P920, DOI 10.1080/13506280903507143; White CN, 2010, EMOTION, V10, P662, DOI 10.1037/a0019474; Wnuczko M, 2012, J GERONTOL B-PSYCHOL, V67, P325, DOI 10.1093/geronb/gbr114; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; Wolfe JM, 2003, J EXP PSYCHOL HUMAN, V29, P483, DOI 10.1037/0096-1523.29.2.483; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Yantis S., 1998, ATTENTION, V1, P223, DOI DOI 10.1037/0096-1523.16.4.812; Yashar A, 2010, J VISION, V10, DOI 10.1167/10.14.3	79	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89996	10.1371/journal.pone.0089996	http://dx.doi.org/10.1371/journal.pone.0089996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595032	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900053
J	Bill, A; Hall, ML; Borawski, J; Hodgson, C; Jenkins, J; Piechon, P; Popa, O; Rothwell, C; Tranter, P; Tria, S; Wagner, T; Whitehead, L; Gaither, LA				Bill, Anke; Hall, Michelle Lynn; Borawski, Jason; Hodgson, Catherine; Jenkins, Jeremy; Piechon, Philippe; Popa, Oana; Rothwell, Christopher; Tranter, Pamela; Tria, Scott; Wagner, Trixie; Whitehead, Lewis; Gaither, L. Alex			Small Molecule-facilitated Degradation of ANO1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; Cancer Biology; Cancer Therapy; Chloride Channels; Computational Biology; ER-associated Degradation; Ion Channels; Molecular Modeling; Protein Degradation; Small Molecules	ACTIVATED CHLORIDE CHANNEL; CA2+-ACTIVATED CL-CHANNEL; SQUAMOUS-CELL CARCINOMA; FINGERPRINT METHODS; CANCER PROGRESSION; BREFELDIN-A; TMEM16A; IDENTIFICATION; CONTRIBUTES; INHIBITORS	Background: The calcium-activated chloride channel ANO1 is highly expressed in cancer. Results: Inhibition of ANO1 activity alone is not sufficient to inhibit cancer cell proliferation, suggesting a novel function of ANO1 protein in cancer. Conclusion: The ANO1 inhibitor CaCCinh-A01 inhibits cancer cell proliferation by facilitating degradation of ANO1. Significance: Our results may provide a new targeting approach for antitumor therapy in ANO1-amplified cancers. ANO1, a calcium-activated chloride channel, is highly expressed and amplified in human cancers and is a critical survival factor in these cancers. The ANO1 inhibitor CaCCinh-A01 decreases proliferation of ANO1-amplified cell lines; however, the mechanism of action remains elusive. We explored the mechanism behind the inhibitory effect of CaCCinh-A01 on cell proliferation using a combined experimental and in silico approach. We show that inhibition of ANO1 function is not sufficient to diminish proliferation of ANO1-dependent cancer cells. We report that CaCCinh-A01 reduces ANO1 protein levels by facilitating endoplasmic reticulum-associated, proteasomal turnover of ANO1. Washout of CaCCinh-A01 rescued ANO1 protein levels and resumed cell proliferation. Proliferation of newly derived CaCCinh-A01-resistant cell pools was not affected by CaCCinh-A01 as compared with the parental cells. Consistently, CaCCinh-A01 failed to reduce ANO1 protein levels in these cells, whereas ANO1 currents were still inhibited by CaCCinh-A01, indicating that CaCCinh-A01 inhibits cell proliferation by reducing ANO1 protein levels. Furthermore, we employed in silico methods to elucidate novel biological functions of ANO1 inhibitors. Specifically, we derived a pharmacophore model to describe inhibitors capable of promoting ANO1 degradation and report new inhibitors of ANO1-dependent cell proliferation. In summary, our data demonstrate that inhibition of the channel activity of ANO1 is not sufficient to inhibit ANO1-dependent cell proliferation, indicating that the role of ANO1 in cancer only partially depends on its function as a channel. Our results provide an impetus for gaining a deeper understanding of ANO1 modulation in cells and introduce a new targeting approach for antitumor therapy in ANO1-amplified cancers.	[Bill, Anke; Hall, Michelle Lynn; Borawski, Jason; Jenkins, Jeremy; Rothwell, Christopher; Tria, Scott; Whitehead, Lewis; Gaither, L. Alex] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Hodgson, Catherine; Popa, Oana; Tranter, Pamela] Novartis Inst Biomed Res, Horsham RH12 5AB, W Sussex, England; [Piechon, Philippe; Wagner, Trixie] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland	Novartis; Novartis; Novartis	Gaither, LA (corresponding author), Novartis Inst Biomed Res, 500 Technology Sq, Cambridge, MA 02139 USA.	alex.gaither@novartis.com		Popa, Mariana Oana/0000-0002-2766-6801; Bill, Anke/0000-0003-1244-7574; Whitehead, Lewis/0000-0002-6125-0893				Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Bill A, 2010, CELL, V143, P201, DOI 10.1016/j.cell.2010.09.011; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; Cheeseright T, 2006, J CHEM INF MODEL, V46, P665, DOI 10.1021/ci050357s; Cheeseright TJ, 2008, J CHEM INF MODEL, V48, P2108, DOI 10.1021/ci800110p; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; Duan JX, 2010, J MOL GRAPH MODEL, V29, P157, DOI 10.1016/j.jmgm.2010.05.008; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Fallah G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004697; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Huang X, 2002, P NATL ACAD SCI USA, V99, P11369, DOI 10.1073/pnas.172285799; Jin X, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004184; Jonkers J, 2004, CANCER CELL, V6, P535, DOI 10.1016/j.ccr.2004.12.002; Kashyap MK, 2009, CANCER BIOL THER, V8, P36, DOI 10.4161/cbt.8.1.7090; Kumar S, 2012, BIOORGAN MED CHEM, V20, P4237, DOI 10.1016/j.bmc.2012.05.074; LINS L, 1995, FASEB J, V9, P535, DOI 10.1096/fasebj.9.7.7737462; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Mathes C, 2009, COMB CHEM HIGH T SCR, V12, P78, DOI 10.2174/138620709787047948; Mazzone A, 2012, BIOCHEM BIOPH RES CO, V427, P248, DOI 10.1016/j.bbrc.2012.09.022; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Neklesa TK, 2011, NAT CHEM BIOL, V7, P538, DOI [10.1038/NCHEMBIO.597, 10.1038/nchembio.597]; Perez-Cornejo P, 2012, P NATL ACAD SCI USA, V109, P10376, DOI 10.1073/pnas.1200174109; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Sastry M, 2010, J CHEM INF MODEL, V50, P771, DOI 10.1021/ci100062n; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Shi ZZ, 2013, CLIN CANCER RES, V19, P5867, DOI 10.1158/1078-0432.CCR-12-3753; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; Tian YM, 2013, BRIT J PHARMACOL, V168, P253, DOI 10.1111/j.1476-5381.2012.02193.x; Tien J, 2013, P NATL ACAD SCI USA, V110, P6352, DOI 10.1073/pnas.1303672110; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhang CH, 2013, AM J RESP CRIT CARE, V187, P374, DOI 10.1164/rccm.201207-1303OC; Zhang JH, 2009, PHARM RES-DORDR, V26, P2066, DOI 10.1007/s11095-009-9932-0	43	60	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11029	11041		10.1074/jbc.M114.549188	http://dx.doi.org/10.1074/jbc.M114.549188			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599954	hybrid, Green Published			2022-12-25	WOS:000334638500009
J	Mueller, A; Davis, A; Carlson, SS; Robinson, FR				Mueller, Adrienne; Davis, Adam; Carlson, Steven S.; Robinson, Farrel R.			N-Acetylgalactosamine Positive Perineuronal Nets in the Saccade-Related-Part of the Cerebellar Fastigial Nucleus Do Not Maintain Saccade Gain	PLOS ONE			English	Article							CHONDROITIN-SULFATE PROTEOGLYCANS; CENTRAL-NERVOUS-SYSTEM; EXTRACELLULAR-MATRIX; ADAPTATION; BRAIN; AGGRECAN; TERM; REGENERATION; DEPRIVATION; DEGRADATION	Perineuronal nets (PNNs) accumulate around neurons near the end of developmental critical periods. PNNs are structures of the extracellular matrix which surround synaptic contacts and contain chondroitin sulfate proteoglycans. Previous studies suggest that the chondroitin sulfate chains of PNNs inhibit synaptic plasticity and thereby help end critical periods. PNNs surround a high proportion of neurons in the cerebellar nuclei. These PNNs form during approximately the same time that movements achieve normal accuracy. It is possible that PNNs in the cerebellar nuclei inhibit plasticity to maintain the synaptic organization that produces those accurate movements. We tested whether or not PNNs in a saccade-related part of the cerebellar nuclei maintain accurate saccade size by digesting a part of them in an adult monkey performing a task that changes saccade size (long term saccade adaptation). We use the enzyme Chondroitinase ABC to digest the glycosaminoglycan side chains of proteoglycans present in the majority of PNNs. We show that this manipulation does not result in faster, larger, or more persistent adaptation. Our result indicates that intact perineuronal nets around saccade-related neurons in the cerebellar nuclei are not important for maintaining long-term saccade gain.	[Mueller, Adrienne; Davis, Adam; Robinson, Farrel R.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Carlson, Steven S.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Mueller, A (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	alm04@uw.edu	Mueller, Adrienne/AAU-3106-2021	Mueller, Adrienne/0000-0001-9161-5323; Robinson, Farrel/0000-0002-3903-8327	National Institutes of Health [EY018585, 3R01EY018585-02S1, 2T32EY007031-36]; NATIONAL EYE INSTITUTE [R01EY018585, P30EY001730, T32EY007031] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health grants EY018585, 3R01EY018585-02S1 and 2T32EY007031-36. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Bruckner G, 1998, EXP BRAIN RES, V121, P300, DOI 10.1007/s002210050463; Buzunov E, 2013, BRAIN RES, V1503, P33, DOI 10.1016/j.brainres.2013.02.001; Carlson SS, 1996, MATRIX BIOL, V15, P281, DOI 10.1016/S0945-053X(96)90118-3; Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; Corvetti L, 2005, J NEUROSCI, V25, P7150, DOI 10.1523/JNEUROSCI.0683-05.2005; Crook JD, 2007, NEUROSCIENCE, V149, P834, DOI 10.1016/j.neuroscience.2007.08.030; Deak A, 2012, NEUROSCI LETT, V513, P1, DOI 10.1016/j.neulet.2012.01.076; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; Foscarin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016666; FUCHS AF, 1993, J NEUROPHYSIOL, V70, P1723, DOI 10.1152/jn.1993.70.5.1723; FUCHS AF, 1966, J APPL PHYSIOL, V21, P1068, DOI 10.1152/jappl.1966.21.3.1068; Ghez C, 2000, PRINCIPLES NEURAL SC, P831; Goffart L, 2004, J NEUROPHYSIOL, V92, P3351, DOI 10.1152/jn.01199.2003; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Goldberg ME, 1993, CEREBELLUM BASAL GAN, P203; Hartig W, 1999, BRAIN RES, V842, P15, DOI 10.1016/S0006-8993(99)01784-9; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; HOCKFIELD S, 1990, COLD SPRING HARB SYM, V55, P505; Horn AK, 2003, J COMP NEUROL, V455, P341, DOI 10.1002/cne.10495; Inaba N, 2003, NEUROSCI RES, V46, P359, DOI 10.1016/S0168-0102(03)00098-1; Jager C, 2013, NEUROSCIENCE, V238, P168, DOI 10.1016/j.neuroscience.2013.02.014; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kwok JCF, 2012, INT J BIOCHEM CELL B, V44, P582, DOI 10.1016/j.biocel.2012.01.004; Kwok JCF, 2008, RESTOR NEUROL NEUROS, V26, P131; Matthews RT, 2002, J NEUROSCI, V22, P7536; McKay BE, 2004, J COMP NEUROL, V473, P86, DOI 10.1002/cne.20109; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; McRae PA, 2007, J NEUROSCI, V27, P5405, DOI 10.1523/JNEUROSCI.5425-06.2007; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Morawski M, 2012, INT J BIOCHEM CELL B, V44, P690, DOI 10.1016/j.biocel.2012.01.010; Mueller AL, 2012, NEUROSCIENCE, V224, P38, DOI 10.1016/j.neuroscience.2012.08.012; NODA H, 1988, J NEUROPHYSIOL, V60, P1036, DOI 10.1152/jn.1988.60.3.1036; OHTSUKA K, 1990, EXP BRAIN RES, V81, P659, DOI 10.1007/BF02423517; OIKE Y, 1980, BIOCHEM J, V191, P193, DOI 10.1042/bj1910193; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Robinson FR, 2006, J NEUROPHYSIOL, V96, P1030, DOI 10.1152/jn.01151.2005; ROBINSON FR, 1993, J NEUROPHYSIOL, V70, P1741, DOI 10.1152/jn.1993.70.5.1741; Romberg C, 2013, J NEUROSCI, V33, P7057, DOI 10.1523/JNEUROSCI.6267-11.2013; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Schmalfeldt M, 1998, J BIOL CHEM, V273, P15758, DOI 10.1074/jbc.273.25.15758; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; Seeberger T, 2002, BRAIN RES, V956, P374, DOI 10.1016/S0006-8993(02)03577-1; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; Wang DF, 2012, CELL TISSUE RES, V349, P147, DOI 10.1007/s00441-012-1375-y; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Zimmermann DR, 2008, HISTOCHEM CELL BIOL, V130, P635, DOI 10.1007/s00418-008-0485-9	52	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e86154	10.1371/journal.pone.0086154	http://dx.doi.org/10.1371/journal.pone.0086154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603437	gold, Green Submitted, Green Published			2022-12-25	WOS:000332483600002
J	Patel, N; Vogel, R; Chandra-Kuntal, K; Glasgow, W; Kelavkar, U				Patel, Nima; Vogel, Robert; Chandra-Kuntal, Kumar; Glasgow, Wayne; Kelavkar, Uddhav			A Novel Three Serum Phospholipid Panel Differentiates Normal Individuals from Those with Prostate Cancer	PLOS ONE			English	Article							PLASMA PHOSPHOLIPIDS; MEMBRANE-LIPIDS; FATTY-ACIDS; BIOMARKERS; LIPIDOMICS; LEVEL; RISK	Background: The results of prostate specific antigen (PSA) and digital rectal examination (DRE) screenings lead to both under and over treatment of prostate cancer (PCa). As such, there is an urgent need for the identification and evaluation of new markers for early diagnosis and disease prognosis. Studies have shown a link between PCa, lipids and lipid metabolism. Therefore, the aim of this study was to examine the concentrations and distribution of serum lipids in patients with PCa as compared with serum from controls. Method: Using Electrospray ionization mass spectrometry (ESI-MS/MS) lipid profiling, we analyzed serum phospholipids from age-matched subjects who were either newly diagnosed with PCa or healthy (normal). Results: We found that cholester (CE), dihydrosphingomyelin (DSM), phosphatidylcholine (PC), egg phosphatidylcholine (ePC) and egg phoshphatidylethanolamine (ePE) are the 5 major lipid groups that varied between normal and cancer serums. ePC 38: 5, PC 40: 3, and PC 42: 4 represent the lipids species most prevalent in PCa as compared with normal serum. Further analysis revealed that serum ePC 38: 5 >= 0.015 nmoles, PC 40.3 <= 0.001 nmoles and PC 42: 4 <= 0.0001 nmoles correlated with the absence of PCa at 94% prediction. Conversely, serum ePC 38: 5 <= 0.015 nmoles, PC 40: 3 >= 0.001 nmoles, and PC 42: 4 >= 0.0001 nmoles correlated with the presence of PCa. Conclusion: In summary, we have demonstrated that ePC 38: 5, PC 40: 3, and PC 42: 4 may serve as early predictive serum markers for the presence of PCa.	[Patel, Nima; Chandra-Kuntal, Kumar; Glasgow, Wayne; Kelavkar, Uddhav] Mem Univ, Dept Lab Oncol Res, Med Ctr MUMC, Savannah, GA 31404 USA; [Patel, Nima; Chandra-Kuntal, Kumar; Glasgow, Wayne; Kelavkar, Uddhav] Mercer Univ, Sch Med MUSM, Anderson Canc Inst, Savannah, GA USA; [Vogel, Robert] Georgia So Univ, Statesboro, GA 30460 USA	Mercer University; University System of Georgia; Georgia Southern University	Kelavkar, U (corresponding author), Mem Univ, Dept Lab Oncol Res, Med Ctr MUMC, Savannah, GA 31404 USA.	Kelavkar_U@mercer.edu						Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; [Anonymous], 2007, FOOD NUTR PHYS ACT P; Arab L, 2003, J NUTR, V133, p925S, DOI 10.1093/jn/133.3.925S; Awwad HM, 2012, CLIN BIOCH; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Benjamini Y, 2005, J AM STAT ASSOC, V100, P71, DOI 10.1198/016214504000001907; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brasky TM, AM J EPIDEMIOLOGY, V173, P1429; Brett AS, 2011, NEW ENGL J MED, V365, P1949, DOI 10.1056/NEJMp1112191; Bretz F, 2005, METHOD INFORM MED, V44, P423; Bretz F, 2005, METHOD INFORM MED, V44, P431; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Chan JM, 2004, J UROLOGY, V172, pS17; Chan June M, 2004, J Urol, V172, pS13, DOI 10.1097/01.ju.0000142068.66876.53; Clarke Raymond A, 2010, Cancers (Basel), V2, P1125, DOI 10.3390/cancers2021125; Crowe FL, 2008, AM J CLIN NUTR, V88, P1353, DOI 10.3945/ajcn.2008.26369; Cvetkovic B, 2012, MED ONCOL, V29, P809, DOI 10.1007/s12032-011-9914-z; DeMarzo AM, 2003, LANCET, V361, P955, DOI 10.1016/S0140-6736(03)12779-1; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Epstein MM, 2012, AM J EPIDEMIOL, V176, P240, DOI 10.1093/aje/kwr520; Greene KL, 2009, J UROLOGY, V182, P2232, DOI 10.1016/j.juro.2009.07.093; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Heidenreich A, 2010, GUIDELINES PROSTATE; Huang MG, 2012, PROSTATE, V72, P1779, DOI 10.1002/pros.22531; Jump DB, 2004, CRIT REV CL LAB SCI, V41, P41, DOI 10.1080/10408360490278341; Kelavkar UP, 2007, PROSTAG OTH LIPID M, V82, P185, DOI 10.1016/j.prostaglandins.2006.05.015; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Krzanowski WJ, 2009, MONOGR STAT APPL PRO, V111, P1; LEAF DA, 1995, AM J CLIN NUTR, V62, P68, DOI 10.1093/ajcn/62.1.68; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Min HK, 2011, ANAL BIOANAL CHEM, V399, P823, DOI 10.1007/s00216-010-4290-7; Norrish AE, 1999, BRIT J CANCER, V81, P1238, DOI 10.1038/sj.bjc.6690835; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Pepe MS, 2004, STAT EVALUATION MED; PUNNONEN K, 1989, J CANCER RES CLIN, V115, P575, DOI 10.1007/BF00391361; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Reynolds MA, 2003, CLIN CHEM, V49, P1733, DOI 10.1373/49.10.1733; Sartor MA, 2009, BIOINFORMATICS, V25, P211, DOI 10.1093/bioinformatics/btn592; Steele CB, 2000, AM J PUBLIC HEALTH, V90, P1595, DOI 10.2105/AJPH.90.10.1595; Tewari R, 2012, J ANDROL, V33, P763, DOI 10.2164/jandrol.111.015578; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Tsai CA, 2003, BIOMETRICS, V59, P1071, DOI 10.1111/j.0006-341X.2003.00123.x; Van AHT, 2012, BIOINFORMATICS, V28, P1766, DOI 10.1093/bioinformatics/bts238; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Yang YJ, 1999, CLIN BIOCHEM, V32, P405, DOI 10.1016/S0009-9120(99)00036-3; Zhou X, EXPT MOL PATHOLOGY, V92, P105; ZWEIG MH, 1993, CLIN CHEM, V39, P561	47	23	26	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e88841	10.1371/journal.pone.0088841	http://dx.doi.org/10.1371/journal.pone.0088841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603597	Green Submitted, Green Published, gold			2022-12-25	WOS:000332483600007
J	Yin, J; Liu, ZP; Li, HX; Sun, JY; Chang, XZ; Liu, J; He, SS; Li, BH				Yin, Jian; Liu, Zhipei; Li, Haixin; Sun, Jingyan; Chang, Xinzhong; Liu, Jing; He, Shanshan; Li, Binghui			Association of PKC zeta Expression with Clinicopathological Characteristics of Breast Cancer	PLOS ONE			English	Article							PROTEIN-KINASE-C; DOWN-REGULATION; INHIBITS MIGRATION; CELL-POLARITY; ACTIVATION; COMPLEX; PAR6; CHEMOTAXIS; INTERACTS; TISSUE	The protein kinase C (PKC) family has been functionally linked to cancer. It has been suggested that atypical PKCs contribute to cell proliferation and cancer progression. With respect to breast cancer, PKC zeta has been found to play a key role in intracellular transduction of mitogenic and apoptotic signals using mammary cell lines. However, little is known about its function in vivo. Here we examined the correlation between PKC zeta protein levels and important clinicopathologic factors in breast cancer using patient samples. To conduct the study, 30 invasive ductal carcinoma cases and their paired normal tissues were used for tissue microarray analysis (TMA) and 16 were used for western blot analysis. In addition, the correlation between PKC zeta expression levels and clinicopathologic characteristics was determined in 176 cases with relevant clinical data. Finally, the correlation between PKC zeta and epithelial growth factor receptor 2 (HER2) expressions was determined using three breast cancer cell lines by western blot analysis. Both TMA and western blot results showed that PKC zeta protein was highly expressed in primary tumors but not in paired normal tissue. The correlation study indicated that high PKC zeta levels were associated with premenopausal patients (p = 0.019) and worse prognostic factors, such as advanced clinical stage, more lymph node involvement and larger tumor size. Both disease-free survival and overall survival rates were lower in the high PKC zeta group than those in the low PKC zeta group. No correlation was observed between PKC zeta levels and age, histological grade, or estrogen or progesterone receptor expression status. A positive correlation between PKC zeta and HER2 levels was observed in both tumor samples and cell lines. Our observations link PKC zeta expression with factors pointing to worse prognosis, higher HER2 levels and a lower survival rate. This suggests that PKC zeta protein levels may serve as a prognostic marker of breast cancer.	[Yin, Jian; Sun, Jingyan; Chang, Xinzhong; Liu, Jing; He, Shanshan] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Breast Surg, Tianjin, Peoples R China; [Yin, Jian; Sun, Jingyan; Chang, Xinzhong; Liu, Jing; He, Shanshan] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Yin, Jian; Sun, Jingyan; Chang, Xinzhong; Liu, Jing; He, Shanshan] Tianjin Med Univ, Minist Educ, Key Lab Breast Canc Prevent & Therapy, Tianjin, Peoples R China; [Liu, Zhipei] Tianjin Binhai Union Gene Technol Co LTD, Prod & R&D Ctr, Tianjin, Peoples R China; [Liu, Zhipei] Union Stem Cell & Gene Engn Co LTD, Gene Bank, Tianjin, Peoples R China; [Li, Haixin] Tianjin Med Univ, Tumor Tissue Banking Facil, Dept Epidemiol & Biostat, Canc Inst & Hosp, Tianjin, Peoples R China; [Li, Binghui] Tianjin Med Univ, Canc Inst & Hosp, Canc Cell Biol Lab, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Yin, J (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Breast Surg, Tianjin, Peoples R China.	yinjian@tjmuch.com			Chinese National Natural Science Foundation [81202100]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The study has been supported by Chinese National Natural Science Foundation (No. 81202100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awadelkarim KD, 2012, INT J CANCER, V131, P2852, DOI 10.1002/ijc.27600; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Castoria G, 2004, MOL CELL BIOL, V24, P7643, DOI 10.1128/MCB.24.17.7643-7653.2004; Cheng W, 2012, J BIOL CHEM, V287, P26126, DOI 10.1074/jbc.M112.342170; Dong LQ, 1999, J BIOL CHEM, V274, P8117, DOI 10.1074/jbc.274.12.8117; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Fields Alan P, 2003, Methods Mol Biol, V233, P519; Guo H, 2009, J LEUKOCYTE BIOL, V85, P911, DOI 10.1189/jlb.0708429; Guo H, 2009, J NEUROCHEM, V109, P203, DOI 10.1111/j.1471-4159.2009.05946.x; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Iakoubov R, 2011, ENDOCRINOLOGY, V152, P1244, DOI 10.1210/en.2010-1352; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Li HY, 2012, ANTI-CANCER DRUG, V23, P691, DOI 10.1097/CAD.0b013e3283514cc1; Lin YM, 2012, CHINESE J PHYSIOL, V55, P55, DOI 10.4077/CJP.2012.AMM118; Liu XF, 2004, MOL CELL BIOL, V24, P6665, DOI 10.1128/mcb.24.15.6665-6675.2004; Liu Y, 2009, MOL CANCER RES, V7, P944, DOI 10.1158/1541-7786.MCR-08-0368; Liu Y, 2009, LUNG CANCER, V63, P210, DOI 10.1016/j.lungcan.2008.05.010; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; Nazarenko I, 2010, MOL CANCER RES, V8, P919, DOI 10.1158/1541-7786.MCR-09-0358; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; PAGE DL, 1991, AM J SURG PATHOL, V15, P334, DOI 10.1097/00000478-199104000-00002; Pu YS, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-39; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Valkov A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017507; Valkova C, 2010, MOL CANCER RES, V8, P783, DOI 10.1158/1541-7786.MCR-09-0164; Venkatachalam K, 2010, J NEUROSCI, V30, P11337, DOI 10.1523/JNEUROSCI.2709-10.2010; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Wu J, 2010, INVEST NEW DRUG, V28, P268, DOI 10.1007/s10637-009-9242-8; Zhang F, 2010, CANCER RES, V70, P9360, DOI 10.1158/0008-5472.CAN-10-0207	30	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90811	10.1371/journal.pone.0090811	http://dx.doi.org/10.1371/journal.pone.0090811			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603690	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600087
J	D'Arcangelo, D; Nicodemi, EM; Rossi, S; Giampietri, C; Facchiano, F; Facchiano, A				D'Arcangelo, Daniela; Nicodemi, Ezio M.; Rossi, Stefania; Giampietri, Claudia; Facchiano, Francesco; Facchiano, Antonio			Identification of Serum Regression Signs in Infantile Hemangioma	PLOS ONE			English	Article							CHEMOATTRACTANT PROTEIN-1 MCP-1; GROWTH FACTOR-BB; IN-VITRO; VASCULAR MALFORMATIONS; CLINICAL CHARACTERISTICS; RECEPTOR-ALPHA; CELLS; VIVO; EXPRESSION; MICE	Vessel proliferation underlies a number of serious pathological conditions. Infantile Hemangioma (IH) is a low-aggressive vascular tumor, interesting as an in vivo model of spontaneous tumor regression. Identifying mechanisms underlying IH spontaneous regression may then help to elucidate vessel-growth control, strongly deregulated in other serious conditions such as sarcoma, melanoma, diabetic retinopathy. The present study was aimed at identifying early regression indicators within hematological parameters. Thirty-four blood samples were collected from IH diagnosed babies (20-months median age), spontaneously regressing with age. Nineteen serum standard blood-tests were carried out using diagnostic reagents; in addition, serum-expression of 27 cytokine/chemokines was measured. Samples were divided in three age-groups, namely <= 12, 13 to 24 and >24 months-age, respectively. Red-cells count, Hemoglobin, Hematocrit, Neutrophils, Lymphocytes, MCP-1 and MIP-1beta were significantly different in the three age-groups, according to one-way ANOVA analysis. The same parameters showed a significant Pearson-correlation with age, supporting the direct link of age with IH-regression. ROC analysis showed that red-cells count, Hemoglobin, Hematocrit, MCP-1 and MIP-1beta levels significantly discriminate IH in the proliferating-phase from IH in the regressing-phase. Such data indicate for the first time that standard hematological tests and cytokine serum-expression values may effectively discriminate proliferating-from regressing-IH, unrevealing early regression signs, and demonstrate that standard blood-tests may have novel unsuspected diagnostic/prognostic relevance in altered vessel-growth conditions.	[D'Arcangelo, Daniela; Facchiano, Antonio] IRCCS, IDI, Rome, Italy; [Nicodemi, Ezio M.] IRCCS, IDI, Ctr Anomalie Vasc, Div Chirurg Plast, Rome, Italy; [Rossi, Stefania; Facchiano, Francesco] Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, I-00161 Rome, Italy; [Giampietri, Claudia] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped, Sect Histol & Med Embryol, I-00185 Rome, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Istituto Dermopatico dell'Immacolata (IDI); Istituto Superiore di Sanita (ISS); Sapienza University Rome	Facchiano, A (corresponding author), IRCCS, IDI, Rome, Italy.	a.facchiano@idi.it	Rossi, Stefania/J-8328-2016; D'Arcangelo, Daniela/K-6533-2016; Facchiano, Antonio/K-5984-2016; Facchiano, Antonio/J-4744-2012; Facchiano, Francesco/K-8716-2016	Rossi, Stefania/0000-0002-8854-7072; D'Arcangelo, Daniela/0000-0002-7862-3289; Facchiano, Antonio/0000-0002-4243-2392; Facchiano, Antonio/0000-0002-4243-2392; Facchiano, Francesco/0000-0003-4313-0617; Giampietri, Claudia/0000-0002-5025-5365	Italian Ministry of Health [RC12 3.5, RF07ONC-25/3]; Italy-USA Oncoproteomics Program	Italian Ministry of Health(Ministry of Health, Italy); Italy-USA Oncoproteomics Program	This work was funded by the Italian Ministry of Health [grant # RC12 3.5 and grant RF07ONC-25/3) and Italy-USA Oncoproteomics Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi MS, 2011, MOL THER, V19, P266, DOI 10.1038/mt.2010.211; Anghelina M, 2004, STEM CELLS DEV, V13, P665, DOI 10.1089/scd.2004.13.665; Bianchi G, 2000, Dev Immunol, V7, P143, DOI 10.1155/2000/39893; Bruckner AL, 2006, J AM ACAD DERMATOL, V55, P671, DOI 10.1016/j.jaad.2006.05.017; Cappuzzello C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-28; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Carvalho T, 2008, VET IMMUNOL IMMUNOP, V121, P344, DOI 10.1016/j.vetimm.2007.09.020; Chang LC, 2008, PEDIATRICS, V122, P360, DOI 10.1542/peds.2007-2767; Chiller KG, 2002, ARCH DERMATOL, V138, P1567, DOI 10.1001/archderm.138.12.1567; D'Amico G, 1998, BLOOD, V92, P207, DOI 10.1182/blood.V92.1.207.413a02_207_214; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Facchiano F, 2006, MOL ENDOCRINOL, V20, P2806, DOI 10.1210/me.2005-0322; Faraone D, 2006, BLOOD, V107, P1896, DOI 10.1182/blood-2005-04-1524; Faraone D, 2009, NEOPLASIA, V11, P732, DOI 10.1593/neo.09408; FRITZ E, 1986, BLOOD, V68, P514; Gonsalves C, 2010, J IMMUNOL, V185, P6253, DOI 10.4049/jimmunol.1000660; Gordillo GM, 2002, METHOD ENZYMOL, V352, P422; Greenberger S, 2010, ANGIOGENESIS, V13, P327, DOI 10.1007/s10456-010-9189-6; Haemmerling GJ, 2006, CELL CYCLE, V5, P509, DOI 10.4161/cc.5.5.2517; Haggstrom AN, 2006, PEDIATRICS, V118, P882, DOI 10.1542/peds.2006-0413; Holland KE, 2013, DERMATOL CLIN, V31, P289, DOI 10.1016/j.det.2012.12.006; Horuk R, 2001, CYTOKINE GROWTH F R, V12, P313, DOI 10.1016/S1359-6101(01)00014-4; Isik FF, 1996, J SURG RES, V61, P71, DOI 10.1006/jsre.1996.0083; Khan ZA, 2008, J CLIN INVEST, V118, P2592, DOI 10.1172/JCI33493; Kleiman A, 2012, EXP MOL PATHOL, V93, P264, DOI 10.1016/j.yexmp.2012.04.020; Krol A, 2005, ARCH FACIAL PLAST S, V7, P307, DOI 10.1001/archfaci.7.5.307; Landaw S, 1991, HEMATOLOGY BASIC PRI, P274; MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002; Nguyen J, 2009, SEMIN OPHTHALMOL, V24, P178, DOI 10.1080/08820530902805602; North PE, 2000, HUM PATHOL, V31, P11, DOI 10.1016/S0046-8177(00)80192-6; North PE, 2001, ARCH DERMATOL, V137, P1607; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; Pozzetto U, 2008, ANN CLIN BIOCHEM, V45, P213, DOI 10.1258/acb.2007.007155; Quinlivan EP, 2008, AM J CLIN NUTR, V87, P1537, DOI 10.1093/ajcn/87.5.1537; Ritter Matthew R., 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S146239940700052X; Roach EE, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.58; Rossler J, 2013, PEDIATR RES, V73, P409, DOI 10.1038/pr.2013.16; Russo K, 2002, J BIOL CHEM, V277, P1284, DOI 10.1074/jbc.M108858200; Spring H, 2005, P NATL ACAD SCI USA, V102, P18111, DOI 10.1073/pnas.0507158102; Tan ST, 2004, PLAST RECONSTR SURG, V113, P999, DOI 10.1097/01.PRS.0000105683.10752.A6; Tatara Y, 2009, J MOL CELL CARDIOL, V47, P104, DOI 10.1016/j.yjmcc.2009.03.012; Verdoliva V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057104; Zafra-Stone S, 2007, MOL NUTR FOOD RES, V51, P675, DOI 10.1002/mnfr.200700002	43	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e88545	10.1371/journal.pone.0088545	http://dx.doi.org/10.1371/journal.pone.0088545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599340	Green Submitted, Green Published, gold			2022-12-25	WOS:000332479400005
J	Flinspach, K; Kapitzke, C; Tocchetti, A; Sosio, M; Apel, AK				Flinspach, Katrin; Kapitzke, Claudia; Tocchetti, Arianna; Sosio, Margherita; Apel, Alexander K.			Heterologous Expression of the Thiopeptide Antibiotic GE2270 from Planobispora rosea ATCC 53733 in Streptomyces coelicolor Requires Deletion of Ribosomal Genes from the Expression Construct	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; NATURAL-PRODUCTS; CRE RECOMBINASE; MARKER REMOVAL; BIOSYNTHESIS; INHIBITOR; CLUSTER; CLONING; DNA	GE2270 is a thiopeptide antibiotic generated by extensive posttranslational modifications of a ribosomally generated precursor peptide. Thiopeptides are especially active against Gram-positive bacteria, including methicillin resistant Staphylococcus aureus (MRSA). In this study the GE2270 biosynthetic gene cluster (pbt) from Planobispora rosea ATCC 53733 was successfully expressed in the heterologous host strain Streptomyces coelicolor M1146. Notably, exconjugants containing the pbt gene cluster could only be obtained after deletion of the major part of the ribosomal genes flanking the gene cluster. This is a striking example that genes belonging to primary metabolism can prevent the successful conjugative transfer of DNA from phylogenetic distant species and thus complicate heterologous expression of secondary metabolite gene clusters. GE2270 production in the heterologous producer strain increased after introduction of the constitutive ermE* promoter upstream of the GE2270 resistance gene tuf from P. rosea. Insertion of the inducible tcp830 promoter resulted in inducible GE2270 production. When the regulatory gene pbtR was deleted, the resulting strain ceased to produce GE2270, suggesting an essential role of PbtR as a putative transcriptional activator of GE2270 expression.	[Flinspach, Katrin; Kapitzke, Claudia; Apel, Alexander K.] Univ Tubingen, Inst Pharmaceut, Tubingen, Germany; [Flinspach, Katrin; Apel, Alexander K.] Partner Site Tubingen, German Ctr Infect Res DZIF, Tubingen, Germany; [Tocchetti, Arianna; Sosio, Margherita] KtedoGen Srl, Milan, Italy; [Sosio, Margherita] NAICONS Srl, Milan, Italy	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; German Center for Infection Research	Apel, AK (corresponding author), Univ Tubingen, Inst Pharmaceut, Tubingen, Germany.	kristian.apel@uni-tuebingen.de		Sosio, Margherita/0000-0003-4297-6936; Tocchetti, Arianna/0000-0001-7004-7582	German Federal Ministry of Education and Research (ERA-IB GenoDrug) [FK20315930]; Italian MIUR; Regione Lombardia	German Federal Ministry of Education and Research (ERA-IB GenoDrug); Italian MIUR(Ministry of Education, Universities and Research (MIUR)); Regione Lombardia(Regione Lombardia)	Financial support was provided from the German Federal Ministry of Education and Research (ERA-IB GenoDrug, FK20315930). AT and MS were partially supported by grants from Italian MIUR and Regione Lombardia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANBORGH PH, 1991, EMBO J, V10, P779, DOI 10.1002/j.1460-2075.1991.tb08009.x; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Bagley MC, 2005, CHEM REV, V105, P685, DOI 10.1021/cr0300441; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; BIBB MJ, 1985, GENE, V38, P215, DOI 10.1016/0378-1119(85)90220-3; Butler MS, 2005, NAT PROD REP, V22, P162, DOI 10.1039/b402985m; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Dangel V, 2010, APPL MICROBIOL BIOT, V87, P261, DOI 10.1007/s00253-009-2435-4; Dey ES, 2004, APPL MICROBIOL BIOT, V64, P187, DOI 10.1007/s00253-003-1454-9; Donadio S, 2009, METHOD ENZYMOL, V458, P3, DOI 10.1016/S0076-6879(09)04801-0; Doumith M, 2000, MOL GEN GENET, V264, P477, DOI 10.1007/s004380000329; Fedoryshyn M, 2008, GENE, V419, P43, DOI 10.1016/j.gene.2008.04.011; Fedoryshyn M, 2008, APPL MICROBIOL BIOT, V78, P1065, DOI 10.1007/s00253-008-1382-9; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Flinspach K, 2010, BIOPOLYMERS, V93, P823, DOI 10.1002/bip.21493; Floriano B, 1996, MOL MICROBIOL, V21, P385, DOI 10.1046/j.1365-2958.1996.6491364.x; Gartel AL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00150; Gastaldo L, 2003, MICROBIOL-SGM, V149, P1523, DOI 10.1099/mic.0.26157-0; Gomez-Escribano JP, 2011, MICROB BIOTECHNOL, V4, P207, DOI 10.1111/j.1751-7915.2010.00219.x; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; IMADA A, 1978, J ANTIBIOT, V31, P7, DOI 10.7164/antibiotics.31.7; Jones AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069319; Khodakaramian G, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj019; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KING A, 1993, ANTIMICROB AGENTS CH, V37, P746, DOI 10.1128/AAC.37.4.746; LaMarche MJ, 2012, J MED CHEM, V55, P2376, DOI 10.1021/jm201685h; Li SM, 2006, PLANTA MED, V72, P1093, DOI 10.1055/s-2006-946699; Liao RJ, 2009, CHEM BIOL, V16, P141, DOI 10.1016/j.chembiol.2009.01.007; LOMINEK LA, 1972, ANTIMICROB AGENTS CH, V1, P123, DOI 10.1128/AAC.1.2.123; Malcolmson SJ, 2013, P NATL ACAD SCI USA, V110, P8483, DOI 10.1073/pnas.1307111110; McConkey GA, 1997, J BIOL CHEM, V272, P2046, DOI 10.1074/jbc.272.4.2046; Mohrle VG, 1997, BIOCHEM BIOPH RES CO, V230, P320, DOI 10.1006/bbrc.1996.5947; Morris RP, 2009, J AM CHEM SOC, V131, P5946, DOI 10.1021/ja900488a; Pozzi R, 2011, J ANTIBIOT, V64, P133, DOI 10.1038/ja.2010.149; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rodriguez-Garcia A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni086; Rogers MJ, 1998, ANTIMICROB AGENTS CH, V42, P715, DOI 10.1128/AAC.42.3.715; Saleh O, 2012, MEDCHEMCOMM, V3, P1009, DOI 10.1039/c2md20045g; Sambrook J, 2001, MOL CLONING LAB MANU; SEDMERA P, 1991, J NAT PROD, V54, P870, DOI 10.1021/np50075a022; SELVA E, 1991, J ANTIBIOT, V44, P693, DOI 10.7164/antibiotics.44.693; SELVA E, 1995, J ANTIBIOT, V48, P1039, DOI 10.7164/antibiotics.48.1039; Shima J, 1996, J BACTERIOL, V178, P3785, DOI 10.1128/jb.178.13.3785-3790.1996; Siebenberg S, 2010, J BIOSCI BIOENG, V109, P230, DOI 10.1016/j.jbiosc.2009.08.479; Sosio M, 2003, CHEM BIOL, V10, P541, DOI 10.1016/S1074-5521(03)00120-0; Sosio M, 1996, MOL MICROBIOL, V22, P43, DOI 10.1111/j.1365-2958.1996.tb02654.x; SU TL, 1948, BRIT J EXP PATHOL, V29, P473; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tocchetti A, 2013, CHEM BIOL, V20, P1067, DOI 10.1016/j.chembiol.2013.07.005; Young TS, 2011, P NATL ACAD SCI USA, V108, P13053, DOI 10.1073/pnas.1110435108; Zhang Q, 2013, NAT PROD REP, V30, P218, DOI 10.1039/c2np20107k	51	33	33	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90499	10.1371/journal.pone.0090499	http://dx.doi.org/10.1371/journal.pone.0090499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598591	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400082
J	Kolby, JE; Smith, KM; Berger, L; Karesh, WB; Preston, A; Pessier, AP; Skerratt, LF				Kolby, Jonathan E.; Smith, Kristine M.; Berger, Lee; Karesh, William B.; Preston, Asa; Pessier, Allan P.; Skerratt, Lee F.			First Evidence of Amphibian Chytrid Fungus (Batrachochytrium dendrobatidis) and Ranavirus in Hong Kong Amphibian Trade	PLOS ONE			English	Article							BULLFROGS RANA-CATESBEIANA; LONG-TERM; CHYTRIDIOMYCOSIS; DISEASE; INFECTION; PATHOGEN; ORIGIN; ASSAYS	The emerging infectious amphibian diseases caused by amphibian chytrid fungus (Batrachochytrium dendrobatidis, Bd) and ranaviruses are responsible for global amphibian population declines and extinctions. Although likely to have been spread by a variety of activities, transcontinental dispersal appears closely associated with the international trade in live amphibians. The territory of Hong Kong reports frequent, high volume trade in amphibians, and yet the presence of Bd and ranavirus have not previously been detected in either traded or free-ranging amphibians. In 2012, a prospective surveillance project was conducted to investigate the presence of these pathogens in commercial shipments of live amphibians exported from Hong Kong International Airport. Analysis of skin (Bd) and cloacal (ranavirus) swabs by quantitative PCR detected pathogen presence in 31/265 (11.7%) and in 105/185 (56.8%) of amphibians, respectively. In addition, the water in which animals were transported tested positive for Bd, demonstrating the risk of pathogen pollution by the disposal of untreated wastewater. It is uncertain whether Bd and ranavirus remain contained within Hong Kong's trade sector, or if native amphibians have already been exposed. Rapid response efforts are now urgently needed to determine current pathogen distribution in Hong Kong, evaluate potential trade-associated exposure to free-ranging amphibians, and identify opportunities to prevent disease establishment.	[Kolby, Jonathan E.; Berger, Lee; Skerratt, Lee F.] James Cook Univ, Hlth Res Grp 1, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia; [Kolby, Jonathan E.; Berger, Lee; Skerratt, Lee F.] James Cook Univ, Hlth Res Grp 1, Townsville, Qld 4811, Australia; [Kolby, Jonathan E.; Smith, Kristine M.; Karesh, William B.] EcoHlth Alliance, New York, NY USA; [Preston, Asa; Pessier, Allan P.] San Diego Zoo Global, Inst Conservat Res, Amphibian Dis Lab, San Diego, CA USA	James Cook University; James Cook University; EcoHealth Alliance	Kolby, JE (corresponding author), James Cook Univ, Hlth Res Grp 1, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia.	jonathan.kolby@my.jcu.edu.au	Kolby, Jonathan/GWV-5557-2022; Karesh, William/AAU-9084-2020; Kolby, Jonathan/GWZ-3092-2022	Karesh, William/0000-0001-6042-2860; Skerratt, Lee/0000-0003-3471-7512; Berger, Lee/0000-0001-9227-5439	EcoHealth Alliance through the New York Community Trust; James Cook University Australian Postgraduate Research Scholarship; Division Of Environmental Biology [0955897] Funding Source: National Science Foundation	EcoHealth Alliance through the New York Community Trust; James Cook University Australian Postgraduate Research Scholarship; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this project was provided by EcoHealth Alliance through the New York Community Trust and JEK is supported by a James Cook University Australian Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai CM, 2012, DIVERS DISTRIB, V18, P307, DOI 10.1111/j.1472-4642.2011.00878.x; Bai CM, 2010, ECOHEALTH, V7, P127, DOI 10.1007/s10393-010-0307-0; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Daszak P, 2004, HERPETOL J, V14, P201; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher Matthew C., 2007, Fungal Biology Reviews, V21, P2, DOI 10.1016/j.fbr.2007.02.002; Geng Y, 2011, J COMP PATHOL, V145, P95, DOI 10.1016/j.jcpa.2010.11.012; Gilbert M, 2012, ECOHEALTH, V9, P386, DOI 10.1007/s10393-013-0817-7; Gray MJ, 2012, DIS AQUAT ORGAN, V99, P1, DOI 10.3354/dao02436; Gray MJ, 2009, DIS AQUAT ORGAN, V87, P243, DOI 10.3354/dao02138; Hanselmann R, 2004, BIOL CONSERV, V120, P115, DOI 10.1016/j.biocon.2004.02.013; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Kirshtein JD, 2007, DIS AQUAT ORGAN, V77, P11, DOI 10.3354/dao01831; Kolby JE, 2010, DIS AQUAT ORGAN, V92, P245, DOI 10.3354/dao02055; Miller D, 2011, VIRUSES-BASEL, V3, P2351, DOI 10.3390/v3112351; Nazir J, 2012, DIS AQUAT ORGAN, V98, P177, DOI 10.3354/dao02443; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Pallister J, 2007, J FISH DIS, V30, P427, DOI 10.1111/j.1365-2761.2007.00828.x; Picco AM, 2008, CONSERV BIOL, V22, P1582, DOI 10.1111/j.1523-1739.2008.01025.x; RISCH JP, 1980, J HERPETOL, V14, P337, DOI 10.2307/1563687; Rowley J, 2010, BIOL LETTERS, V6, P336, DOI 10.1098/rsbl.2009.0793; Rowley JJL, 2007, DIS AQUAT ORGAN, V78, P87, DOI 10.3354/dao01861; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Schloegel LM, 2010, DIS AQUAT ORGAN, V92, P101, DOI 10.3354/dao02140; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; Skerratt LF, 2008, DIS AQUAT ORGAN, V80, P85, DOI 10.3354/dao01923; Skerratt LF, 2011, J HERPETOL, V45, P444, DOI 10.1670/10-193.1; Skerratt LF, 2010, EXPT RES OBTAIN BETT; Stohr AC, 2013, VET J, V197, P238, DOI 10.1016/j.tvjl.2013.02.014; Swei A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023179; Teacher AGF, 2010, ANIM CONSERV, V13, P514, DOI 10.1111/j.1469-1795.2010.00373.x; Thrusfield M., 2018, VET EPIDEMIOLOGY, DOI [10.1002/9781118280249, DOI 10.1002/9781118280249]; Une Y, 2009, EMERG INFECT DIS, V15, P1146, DOI 10.3201/eid1507.081636; Voros J, 2012, HERPETOL NOTES, V5, P519; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Xu K, 2010, ECOHEALTH, V7, P18, DOI 10.1007/s10393-010-0289-y	39	61	63	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90750	10.1371/journal.pone.0090750	http://dx.doi.org/10.1371/journal.pone.0090750			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599268	Green Published, Green Accepted, gold			2022-12-25	WOS:000332479400130
J	Lim, J; Liu, ZB; Apontes, P; Feng, DR; Pessin, JE; Sauve, AA; Angeletti, RH; Chi, YL				Lim, Jihyeon; Liu, Zhongbo; Apontes, Pasha; Feng, Daorong; Pessin, Jeffrey E.; Sauve, Anthony A.; Angeletti, Ruth H.; Chi, Yuling			Dual Mode Action of Mangiferin in Mouse Liver under High Fat Diet	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; ALPHA-KETOGLUTARATE DEHYDROGENASE; FUMARATE-HYDRATASE; HEPATIC TRIGLYCERIDE; RECEPTOR-ALPHA; ACID SYNTHESIS; PROTECTS MICE; MITOCHONDRIAL; DEFICIENCY; EXPRESSION	Chronic over-nutrition is a major contributor to the spread of obesity and its related metabolic disorders. Development of therapeutics has been slow compared to the speedy increase in occurrence of these metabolic disorders. We have identified a natural compound, mangiferin (MGF) (a predominant component of the plants of Anemarrhena asphodeloides and Mangifera indica), that can protect against high fat diet (HFD) induced obesity, hyperglycemia, insulin resistance and hyperlipidemia in mice. However, the molecular mechanisms whereby MGF exerts these beneficial effects are unknown. To understand MGF mechanisms of action, we performed unbiased quantitative proteomic analysis of protein profiles in liver of mice fed with HFD utilizing N-15 metabolically labeled liver proteins as internal standards. We found that out of 865 quantified proteins 87 of them were significantly differentially regulated by MGF. Among those 87 proteins, 50% of them are involved in two major processes, energy metabolism and biosynthesis of metabolites. Further classification indicated that MGF increased proteins important for mitochondrial biogenesis and oxidative activity including oxoglutarate dehydrogenase E1 (Dhtkd1) and cytochrome c oxidase subunit 6B1 (Cox6b1). Conversely, MGF reduced proteins critical for lipogenesis such as fatty acid stearoyl-CoA desaturase 1 (Scd1) and acetyl-CoA carboxylase 1 (Acac1). These mass spectrometry data were confirmed and validated by western blot assays. Together, data indicate that MGF upregulates proteins pivotal for mitochondrial bioenergetics and downregulates proteins controlling de novo lipogenesis. This novel mode of dual pharmacodynamic actions enables MGF to enhance energy expenditure and inhibit lipogenesis, and thereby correct HFD induced liver steatosis and prevent adiposity. This provides a molecular basis supporting development of MGF or its metabolites into therapeutics to treat metabolic disorders.	[Lim, Jihyeon; Angeletti, Ruth H.] Yeshiva Univ Albert Einstein Coll Med, Lab Macromol Anal & Prote, Bronx, NY 10461 USA; [Lim, Jihyeon; Angeletti, Ruth H.] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Liu, Zhongbo; Apontes, Pasha; Feng, Daorong; Pessin, Jeffrey E.; Chi, Yuling] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Pessin, Jeffrey E.] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Sauve, Anthony A.] Weill Cornell Med Coll, Dept, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Cornell University	Lim, J (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Lab Macromol Anal & Prote, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	yuling.chi@einstein.yu.edu	Liu, Zhongbo/U-3004-2017		American Heart Association [0735066N]; American Diabetes Association [1-11-JF-06]; NIH/NIDDK [DK41296]; NIH [RO1-DK-49688]; Laboratory for Macromolecular Analysis Proteomics [1S10RR15859., 1S10RR021056];  [NIH/5R01GM106072-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015859, S10RR021056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541, R01DK049688, R01DK098439, P30DK041296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106072] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laboratory for Macromolecular Analysis Proteomics; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the grants from the American Heart Association (0735066N to Yuling Chi), American Diabetes Association (1-11-JF-06 to Yuling Chi), and partially from NIH/NIDDK DK41296 to Einstein liver center and NIH RO1-DK-49688 to Einstein Liver center. This work was also partially supported by the Laboratory for Macromolecular Analysis & Proteomics grants 1S10RR15859 and 1S10RR021056. Additional support was from NIH/5R01GM106072-01 to Anthony A Sauve. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Andreu GP, 2005, EUR J PHARMACOL, V513, P47, DOI 10.1016/j.ejphar.2005.03.007; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133; BONNEFONT JP, 1992, J PEDIATR-US, V121, P255, DOI 10.1016/S0022-3476(05)81199-0; Bunik VI, 2009, BIOCHEM J, V422, P405, DOI 10.1042/BJ20090722; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; DANIEL J, 1986, BIOCHIMIE, V68, P303, DOI 10.1016/S0300-9084(86)80027-X; Dunckelmann RJ, 2000, NEUROPEDIATRICS, V31, P35, DOI 10.1055/s-2000-15295; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; ELSISSI HI, 1965, PLANTA MED, V13, P346, DOI 10.1055/s-0028-1100128; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Gazzana G, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-35; Goldberg IJ, 2006, GASTROENTEROLOGY, V130, P1343, DOI 10.1053/j.gastro.2006.02.040; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; GUFFON N, 1993, J INHERIT METAB DIS, V16, P821, DOI 10.1007/BF00714273; Guo FC, 2011, MOL NUTR FOOD RES, V55, P1809, DOI 10.1002/mnfr.201100392; Hodges M, 2002, J EXP BOT, V53, P905, DOI 10.1093/jexbot/53.370.905; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Johnson MT, 1997, P NATL ACAD SCI USA, V94, P14512, DOI 10.1073/pnas.94.26.14512; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Leiro JM, 2003, BIOCHEM PHARMACOL, V65, P1361, DOI 10.1016/S0006-2952(03)00041-8; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002; McLain AL, 2011, FREE RADICAL RES, V45, P29, DOI 10.3109/10715762.2010.534163; McLendon AN., 2013, J NUTR THER, V2, P53; Miura T, 2001, PHYTOMEDICINE, V8, P85, DOI 10.1078/0944-7113-00009; Miyazaki M, 2004, J BIOL CHEM, V279, P35017, DOI 10.1074/jbc.M405327200; Miyazaki M, 2004, J BIOL CHEM, V279, P25164, DOI 10.1074/jbc.M402781200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Monsalve FA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/549627; Muruganandan S, 2005, J ETHNOPHARMACOL, V97, P497, DOI 10.1016/j.jep.2004.12.010; Neufeld D S, 1997, Methods Mol Biol, V75, P145; Niu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030782; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Odievre MH, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9319; Pecina P, 2004, PHYSIOL RES, V53, pS213; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Ratcliffe PJ, 2007, CANCER CELL, V11, P303, DOI 10.1016/j.ccr.2007.03.015; Sanchez GM, 2000, PHARMACOL RES, V42, P565, DOI 10.1006/phrs.2000.0727; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Schmid GM, 2004, PROTEOMICS, V4, P2270, DOI 10.1002/pmic.200300810; Sellamuthu PS, 2009, J HEALTH SCI, V55, P206, DOI 10.1248/jhs.55.206; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Surendran S, 2002, AM J MED GENET, V113, P371, DOI 10.1002/ajmg.b.10804; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Toro JR, 2003, AM J HUM GENET, V73, P95, DOI 10.1086/376435; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Vyas A, 2012, MINI-REV MED CHEM, V12, P412, DOI 10.2174/138955712800493870; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Wu CC, 2004, ANAL CHEM, V76, P4951, DOI 10.1021/ac049208j; WU M, 1987, J BIOL CHEM, V262, P12275; Wu YF, 2002, J BIOL CHEM, V277, P8898, DOI 10.1074/jbc.M110761200; Xu WY, 2013, FEBS LETT, V587, P3587, DOI 10.1016/j.febslet.2013.08.047	61	43	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90137	10.1371/journal.pone.0090137	http://dx.doi.org/10.1371/journal.pone.0090137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598864	Green Submitted, Green Published, gold			2022-12-25	WOS:000332479400048
J	Moreno, B; Lopez, I; Fernandez-Diez, B; Gottlieb, M; Matute, C; Sanchez-Gomez, MV; Domercq, M; Giralt, A; Alberch, J; Collon, KW; Zhang, H; Parent, JM; Teixido, M; Giralt, E; Cena, V; Posadas, I; Martinez-Pinilla, E; Villoslada, P; Franco, R				Moreno, Beatriz; Lopez, Iciar; Fernandez-Diez, Begona; Gottlieb, Miroslav; Matute, Carlos; Sanchez-Gomez, Maria Victoria; Domercq, Maria; Giralt, Albert; Alberch, Jordi; Collon, Kevin W.; Zhang, Helen; Parent, Jack M.; Teixido, Meritxell; Giralt, Ernest; Cena, Valentin; Posadas, Inmaculada; Martinez-Pinilla, Eva; Villoslada, Pablo; Franco, Rafael			Differential Neuroprotective Effects of 5 '-Deoxy-5 '-Methylthioadenosine	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXCITOTOXICITY; BRAIN; PARKINSONS; METHYLTHIOADENOSINE; ACTIVATION; KYNURENINE; RECEPTORS; ISCHEMIA; SURVIVAL	Background: 5'-deoxy-5'-methylthioadenosine (MTA) is an endogenous compound produced through the metabolism of polyamines. The therapeutic potential of MTA has been assayed mainly in liver diseases and, more recently, in animal models of multiple sclerosis. The aim of this study was to determine the neuroprotective effect of this molecule in vitro and to assess whether MTA can cross the blood brain barrier (BBB) in order to also analyze its potential neuroprotective efficacy in vivo. Methods: Neuroprotection was assessed in vitro using models of excitotoxicity in primary neurons, mixed astrocyte-neuron and primary oligodendrocyte cultures. The capacity of MTA to cross the BBB was measured in an artificial membrane assay and using an in vitro cell model. Finally, in vivo tests were performed in models of hypoxic brain damage, Parkinson's disease and epilepsy. Results: MTA displays a wide array of neuroprotective activities against different insults in vitro. While the data from the two complementary approaches adopted indicate that MTA is likely to cross the BBB, the in vivo data showed that MTA may provide therapeutic benefits in specific circumstances. Whereas MTA reduced the neuronal cell death in pilocarpine-induced status epilepticus and the size of the lesion in global but not focal ischemic brain damage, it was ineffective in preserving dopaminergic neurons of the substantia nigra in the 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine (MPTP)-mice model. However, in this model of Parkinson's disease the combined administration of MTA and an A(2A) adenosine receptor antagonist did produce significant neuroprotection in this brain region. Conclusion: MTA may potentially offer therapeutic neuroprotection.	[Moreno, Beatriz; Fernandez-Diez, Begona; Villoslada, Pablo] Hosp Clin Barcelona, Ctr Neuroimmunol, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Lopez, Iciar; Martinez-Pinilla, Eva; Franco, Rafael] Univ Navarra, Div Neurosci, CIMA, E-31080 Pamplona, Spain; [Lopez, Iciar; Franco, Rafael] Ctr Biomed Res Rioja CIBIR, Lung Canc Unit, Oncol Area, Logrono, Spain; [Gottlieb, Miroslav; Matute, Carlos; Sanchez-Gomez, Maria Victoria; Domercq, Maria; Franco, Rafael] Univ Basque Country, Dept Neurosci, Achucarro Basque Ctr Neurosci, Leioa, Spain; [Gottlieb, Miroslav; Matute, Carlos; Franco, Rafael] Slovak Acad Sci, Inst Neurobiol, Kosice 04001, Slovakia; [Matute, Carlos; Giralt, Albert; Alberch, Jordi; Franco, Rafael] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Giralt, Albert; Alberch, Jordi; Franco, Rafael] Univ Barcelona, Sch Med, Dept Cellular Biol Immunol & Neurosci, Barcelona, Spain; [Collon, Kevin W.; Zhang, Helen; Parent, Jack M.; Franco, Rafael] Univ Michigan, Med Ctr, Dept Neurol, Ann Arbor, MI 48109 USA; [Teixido, Meritxell; Giralt, Ernest; Franco, Rafael] IRB, Barcelona, Spain; [Cena, Valentin; Posadas, Inmaculada; Franco, Rafael] Univ Castilla La Mancha, Albacete, Spain; [Franco, Rafael] Univ Barcelona, Sch Biol, Dept Biochem & Mol Biol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Navarra; University of Basque Country; Slovak Academy of Sciences; CIBERNED; University of Barcelona; University of Michigan System; University of Michigan; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universidad de Castilla-La Mancha; University of Barcelona	Moreno, B (corresponding author), Hosp Clin Barcelona, Ctr Neuroimmunol, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.	bmoreno@clinic.ub.es	Villoslada, Pablo/AAF-9547-2019; Giralt, Albert/AAA-5308-2020; Domercq, Maria/Z-2274-2019; Alberch, Jordi/K-5702-2014; Cena, Valentin/L-1751-2017; Giralt, Albert/M-7672-2015; Martínez-Pinilla, Eva/C-7907-2013; teixido, meritxell/I-3282-2015; Franco, Rafael/C-3694-2015; Sánchez-Gómez, M Victoria/AAU-9720-2021; Matute, Carlos/N-5559-2014; Posadas, Inmaculada/M-1124-2014	Domercq, Maria/0000-0002-4918-9276; Alberch, Jordi/0000-0002-8684-2721; Cena, Valentin/0000-0001-8928-3681; Giralt, Albert/0000-0001-5334-0963; Martínez-Pinilla, Eva/0000-0002-0572-0926; teixido, meritxell/0000-0002-7825-3695; Franco, Rafael/0000-0003-2549-4919; Sánchez-Gómez, M Victoria/0000-0001-5730-8194; Matute, Carlos/0000-0001-8672-711X; Posadas, Inmaculada/0000-0003-1854-3372	Instituto de Salud Carlos III RETICS program (Red Espanola de Esclerosis Multiple) [RD07/60/001]; FIMA (intramural); Digna Biotech;  [SK-VEGA 02/0092/12]	Instituto de Salud Carlos III RETICS program (Red Espanola de Esclerosis Multiple); FIMA (intramural); Digna Biotech; 	This work was supported by the Instituto de Salud Carlos III RETICS program (Red Espanola de Esclerosis Multiple (RD07/60/001) to PV), and funds from FIMA (intramural) and Digna Biotech. Models of focal and global ischemia in rat were supported by the project SK-VEGA 02/0092/12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHESON A, 1986, EMBO J, V5, P2799, DOI 10.1002/j.1460-2075.1986.tb04570.x; Alberdi E, 2002, NEUROBIOL DIS, V9, P234, DOI 10.1006/nbdi.2001.0457; Arbeloa J, 2012, NEUROBIOL DIS, V45, P954, DOI 10.1016/j.nbd.2011.12.014; Avila MA, 2004, INT J BIOCHEM CELL B, V36, P2125, DOI 10.1016/j.biocel.2003.11.016; BARRES BA, 1992, J NEUROBIOL, V23, P1221, DOI 10.1002/neu.480230912; Bruno V, 2001, EUR J NEUROSCI, V13, P1469, DOI 10.1046/j.0953-816x.2001.01541.x; di Penta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054722; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Doorn KJ, 2012, PROG NEUROBIOL, V98, P222, DOI 10.1016/j.pneurobio.2012.06.005; Greenwood J, 1996, J NEUROIMMUNOL, V71, P51, DOI 10.1016/S0165-5728(96)00130-0; Guillemin GJ, 2007, J NEUROSCI, V27, P12884, DOI 10.1523/JNEUROSCI.4101-07.2007; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Karadottir R, 2007, NEUROSCIENCE, V145, P1426, DOI 10.1016/j.neuroscience.2006.08.070; Klein C, 2013, NEUROPHARMACOLOGY, V70, P254, DOI 10.1016/j.neuropharm.2013.02.006; Kron MM, 2010, J NEUROSCI, V30, P2051, DOI 10.1523/JNEUROSCI.5655-09.2010; Latasa MU, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015690; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Moreno B, 2010, MULT SCLER J, V16, P1102, DOI 10.1177/1352458510375968; Moreno B, 2006, ANN NEUROL, V60, P323, DOI 10.1002/ana.20895; Neumann H, 1998, J NEUROPATH EXP NEUR, V57, P1, DOI 10.1097/00005072-199801000-00001; NOZAKI K, 1992, J CEREBR BLOOD F MET, V12, P400, DOI 10.1038/jcbfm.1992.57; OLSON L, 1994, J NEUROL, V242, pS12, DOI 10.1007/BF00939233; Panaro MA, 2012, CURR PHARM DESIGN, V18, P200; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Simile MM, 2001, J HEPATOL, V34, P386, DOI 10.1016/S0168-8278(00)00078-7; Stramentinoli G, 1984, U.S. patent, Patent No. 4454122; Vallejo-Illarramendi A, 2005, GLIA, V50, P276, DOI 10.1002/glia.20172; WILLIAMSASHMAN HG, 1982, BIOCHEM PHARMACOL, V31, P277, DOI 10.1016/0006-2952(82)90171-X	29	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90671	10.1371/journal.pone.0090671	http://dx.doi.org/10.1371/journal.pone.0090671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599318	gold, Green Published			2022-12-25	WOS:000332479400115
J	Peters, KR; Ray, LB; Fogel, S; Smith, V; Smith, CT				Peters, Kevin R.; Ray, Laura B.; Fogel, Stuart; Smith, Valerie; Smith, Carlyle T.			Age Differences in the Variability and Distribution of Sleep Spindle and Rapid Eye Movement Densities	PLOS ONE			English	Article							ELDERLY HUMAN-SUBJECTS; ALZHEIMERS-DISEASE; FREQUENCY ACTIVITY; OLD-AGE; PARAMETERS; PATTERNS; YOUNG; ORGANIZATION; PROBABILITY; VARIANCES	The present study had two main objectives. The first objective was to compare the sleep architecture of young and older adults, with an emphasis on sleep spindle density and REM density. The second objective was to examine two aspects of age differences that have not been considered in previous studies: age differences in the variability of sleep measures as well as the magnitude of age differences in phasic events across the distribution of values (i.e., at each decile rather than a single measure of location such as the mean or median. A total of 24 young (mean age = 20.75 +/- 1.78 years) and 24 older (mean age = 71.17 +/- 6.15 years) adults underwent in-home polysomnography. Whole-night spindle density was significantly higher in young adults than older adults. The two age groups did not differ significantly in whole-night REM density, although significant increases in REM density across the night were observed in both age groups. These results suggest that spindle density is more affected by age than REM density. Although age differences were observed in the degree of absolute variability (older adults had significantly larger variances than young adults for sleep efficiency and time spent awake after sleep onset), a similar pattern was also observed within the two age groups: the four sleep measures with the lowest degrees of relative variability were the same and included time spent in REM and Stage 2 sleep, total sleep time, and sleep efficiency. The distributional analysis of age differences in sleep spindle density revealed that the largest age differences were initially observed in the middle of the distributions, but as the night progressed, they were seen at the upper end of the distributions. The results reported here have potential implications for the causes and functional implications of age-related changes in sleep architecture.	[Peters, Kevin R.; Ray, Laura B.; Smith, Valerie; Smith, Carlyle T.] Trent Univ, Dept Psychol, Peterborough, ON K9J 7B8, Canada; [Fogel, Stuart] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Fogel, Stuart] Univ Western Ontario, Dept Psychol, London, ON, Canada	Trent University; Western University (University of Western Ontario); Western University (University of Western Ontario)	Peters, KR (corresponding author), Trent Univ, Dept Psychol, Peterborough, ON K9J 7B8, Canada.	kevinpeters@trentu.ca	Fogel, Stuart/F-7179-2017	Fogel, Stuart/0000-0002-3227-5370	Canadian Institutes of Health Research [178403]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was funded by an operating grant (#178403) from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca/e/?). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acion L, 2006, STAT MED, V25, P591, DOI 10.1002/sim.2256; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Beck AT., 1996, BECK DEPRESSION INVE; BLIWISE DL, 2000, PRINCIPLES PRACTICE; Boos DD, 2004, STAT SCI, V19, P571, DOI 10.1214/088342304000000503; Brunner E, 2000, BIOMETRICAL J, V42, P17, DOI 10.1002/(SICI)1521-4036(200001)42:1<17::AID-BIMJ17>3.0.CO;2-U; Crowley K, 2002, CLIN NEUROPHYSIOL, V113, P1615, DOI 10.1016/S1388-2457(02)00237-7; Crowley K, 2011, NEUROPSYCHOL REV, V21, P41, DOI 10.1007/s11065-010-9154-6; Curran-Everett D, 2009, ADV PHYSIOL EDUC, V33, P286, DOI 10.1152/advan.00062.2009; Dang-Vu TT, 2010, CURR BIOL, V20, pR626, DOI 10.1016/j.cub.2010.06.032; Darchia N, 2004, BRAIN RES BULL, V63, P433, DOI 10.1016/j.brainresbull.2003.12.017; Darchia N, 2003, SLEEP, V26, P973, DOI 10.1093/sleep/26.8.973; Dijk DJ, 1995, NEUROSCI LETT, V201, P13, DOI 10.1016/0304-3940(95)12118-N; DOUGLASS AB, 1994, SLEEP, V17, P160, DOI 10.1093/sleep/17.2.160; Dykierek P, 1998, J PSYCHIATR RES, V32, P1, DOI 10.1016/S0022-3956(97)00049-6; Efron B., 1994, INTRO BOOTSTRAP; EHLERS CL, 1989, ELECTROEN CLIN NEURO, V72, P118, DOI 10.1016/0013-4694(89)90172-7; Erceg-Hurn DM, 2008, AM PSYCHOL, V63, P591, DOI 10.1037/0003-066X.63.7.591; FEINBERG I, 1967, J PSYCHIAT RES, V5, P107, DOI 10.1016/0022-3956(67)90027-1; FEINBERG I, 1974, J PSYCHIATR RES, V10, P283, DOI 10.1016/0022-3956(74)90011-9; Ficca G, 1999, NEUROSCI LETT, V275, P219, DOI 10.1016/S0304-3940(99)00765-X; Fogel Stuart, 2012, Front Neurol, V3, P176, DOI 10.3389/fneur.2012.00176; GRISSOM RJ, 1994, J APPL PSYCHOL, V79, P314, DOI 10.1037/0021-9010.79.2.314; GUAZZELLI M, 1986, ELECTROEN CLIN NEURO, V63, P526, DOI 10.1016/0013-4694(86)90140-9; Iber C., 2007, AASM MANUAL SCORING; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; Landolt HP, 1996, BRAIN RES, V738, P205, DOI 10.1016/S0006-8993(96)00770-6; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lim TS, 1996, COMPUT STAT DATA AN, V22, P287, DOI 10.1016/0167-9473(95)00054-2; Martin N, 2013, NEUROBIOL AGING, V34, P468, DOI 10.1016/j.neurobiolaging.2012.05.020; Neikrug AB, 2010, GERONTOLOGY, V56, P181, DOI 10.1159/000236900; Nelson AE, 1992, GERONTOLOGIST, V32, P17; Nicolas A, 2001, CLIN NEUROPHYSIOL, V112, P521, DOI 10.1016/S1388-2457(00)00556-3; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; R Development Core Team, 2012, R LANG ENV STAT COMP; Rauchs G, 2008, NEUROREPORT, V19, P1159, DOI 10.1097/WNR.0b013e32830867c4; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Salzarulo P, 1997, ACTA NEUROL BELG, V97, P118; Spiegel R, 1999, BIOL PSYCHIAT, V45, P435, DOI 10.1016/S0006-3223(98)00042-0; STERIADE M, 1994, J PSYCHIATR NEUROSCI, V19, P354; Vegni C, 2001, NEUROSCI LETT, V297, P58, DOI 10.1016/S0304-3940(00)01636-0; WAUQUIER A, 1993, PHYSIOL BEHAV, V54, P803, DOI 10.1016/0031-9384(93)90095-W; Wei HG, 1999, NEUROSCI LETT, V260, P29, DOI 10.1016/S0304-3940(98)00851-9; Wilcox R. R., 2012, INTRO ROBUST ESTIMAT; YAMADORI A, 1971, Kobe Journal of Medical Sciences, V17, P97	47	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e91047	10.1371/journal.pone.0091047	http://dx.doi.org/10.1371/journal.pone.0091047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4GP	24599302	Green Submitted, Green Published, gold			2022-12-25	WOS:000332479400151
J	Roque, F; Soares, S; Breitenfeld, L; Gonzalez-Gonzalez, C; Figueiras, A; Herdeiro, MT				Roque, Fatima; Soares, Sara; Breitenfeld, Luiza; Gonzalez-Gonzalez, Cristian; Figueiras, Adolfo; Herdeiro, Maria Teresa			Portuguese Community Pharmacists' Attitudes to and Knowledge of Antibiotic Misuse: Questionnaire Development and Reliability	PLOS ONE			English	Article							INTRACLASS CORRELATION-COEFFICIENT; TEST-RETEST RELIABILITY; SELF-MEDICATION; RESISTANCE; EUROPE; SCALES	Objective: To develop and evaluate the reliability of a self-administered questionnaire designed to assess the attitudes and knowledge of community pharmacists in Portugal about microbial resistance and the antibiotic dispensing process. Methods: This study was divided into the following three stages: (1) design of the questionnaire, which included a literature review and a qualitative study with focus-group sessions; (2) assessment of face and content validity, using a panel of experts and a pre-test of community pharmacists; and, (3) pilot study and reliability analysis, which included a test-retest study covering fifty practising pharmacists based at community pharmacies in five districts situated in Northern Portugal. Questionnaire reproducibility was quantified using the intraclass correlation coefficient (ICC; 95% confidence interval) computed by means of one-way analysis of variance (ANOVA). Internal consistency was evaluated using Cronbach's alpha. Results: The correlation coefficients were fair to good (ICC > 0.4) for all statements (scale-items) regarding knowledge of and attitudes to antibiotic resistance, and ranged from fair to good to excellent for statements about situations in which pharmacists acknowledged that antibiotics were sometimes dispensed without a medical prescription (ICC > 0.8). Cronbach's alpha for this section was 0.716. Conclusions: The questionnaire designed in this study is valid and reliable in terms of content validity, face validity and reproducibility.	[Roque, Fatima; Breitenfeld, Luiza] Univ Beira Interior CICS UBI, Hlth Sci Res Ctr, Covilha, Portugal; [Roque, Fatima; Soares, Sara; Herdeiro, Maria Teresa] Univ Aveiro CBC UA, Ctr Cell Biol, Aveiro, Portugal; [Roque, Fatima] Polytech Inst Guarda UDI IPG, Res Unit Inland Dev, Guarda, Portugal; [Gonzalez-Gonzalez, Cristian; Figueiras, Adolfo] Univ Santiago de Compostela, Dept Prevent Med & Publ Hlth, Santiago De Compostela, Spain; [Figueiras, Adolfo] Univ Santiago de Compostela, Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Santiago De Compostela, Spain; [Herdeiro, Maria Teresa] Ctr Hlth Technol & Informat Syst Res CINTESIS FMU, Oporto, Portugal; [Herdeiro, Maria Teresa] Hlth Technol Res Ctr CITS CESPU, Gandra, Portugal	Universidade da Beira Interior; Universidade de Aveiro; Instituto Politecnico da Guarda; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidade de Santiago de Compostela; Universidade do Porto	Herdeiro, MT (corresponding author), Univ Aveiro CBC UA, Ctr Cell Biol, Aveiro, Portugal.	teresaherdeiro@ua.pt	Roque, Fatima Marques/H-1713-2013; Granadeiro, Luiza Breitenfeld/P-1852-2015; Figueiras, Adolfo/K-8563-2015; Soares, Sara/N-6285-2019; Herdeiro, Maria/H-8195-2013	Roque, Fatima Marques/0000-0003-0169-3788; Granadeiro, Luiza Breitenfeld/0000-0001-8550-1645; Figueiras, Adolfo/0000-0002-5766-8672; Herdeiro, Maria/0000-0002-0500-4049; Soares, Sara/0000-0002-7996-0519	Foundation for Science & Technology (Fundacao para a Ciencia e Tecnologia - FCT) from the Portuguese Ministry of Science Education [PTDC/SAU-ESA/105530/2008, Pest-OE/EGE/UI4056/2014]	Foundation for Science & Technology (Fundacao para a Ciencia e Tecnologia - FCT) from the Portuguese Ministry of Science Education	This work was supported by Foundation for Science & Technology (Fundacao para a Ciencia e Tecnologia - FCT) grants [PTDC/SAU-ESA/105530/2008] and [Pest-OE/EGE/UI4056/2014] from the Portuguese Ministry of Science & Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu A, 1999, J CLIN PHARM THER, V24, P181, DOI 10.1046/j.1365-2710.1999.00216.x; Alumran Arwa, 2012, J Infect Public Health, V5, P221, DOI 10.1016/j.jiph.2012.03.003; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Bonita R., 2006, BASIC EPIDEMIOLOGY, V2nd ed.; Bronzwaer SLAM, 2002, EMERG INFECT DIS, V8, P278, DOI 10.3201/eid0803.010192; Coenen S, 2004, J ANTIMICROB CHEMOTH, V54, P661, DOI 10.1093/jac/dkh374; COMMENGES D, 1994, BIOMETRICS, V50, P517, DOI 10.2307/2533395; de Melo MN, 2006, PHARM WORLD SCI, V28, P19, DOI 10.1007/s11096-005-2222-y; Pernas SID, 2012, INT J CLIN PHARM-NET, V34, P693, DOI 10.1007/s11096-012-9675-6; Du Toit R, 2002, OPTOMETRY VISION SCI, V79, P313, DOI 10.1097/00006324-200205000-00011; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Grigoryan L, 2010, CURR DRUG SAF, V5, P329, DOI 10.2174/157488610792246046; Gross R, 2001, CLIN INFECT DIS, V33, P289, DOI 10.1086/321880; Herdeiro MT, 2008, DRUG SAFETY, V31, P335, DOI 10.2165/00002018-200831040-00007; Herdeiro MT, 2006, DRUG SAFETY, V29, P331, DOI 10.2165/00002018-200629040-00004; Howard DH, 2005, CLIN INFECT DIS, V41, pS283, DOI 10.1086/430792; Johanson GA, 2010, EDUC PSYCHOL MEAS, V70, P394, DOI 10.1177/0013164409355692; Llor C, 2009, CLIN INFECT DIS, V48, P1345, DOI 10.1086/598183; Martins AP, 2002, PHARMACOEPIDEM DR S, V11, P409, DOI 10.1002/pds.711; Marx RG, 2003, J CLIN EPIDEMIOL, V56, P730, DOI 10.1016/S0895-4356(03)00084-2; Paul-Dauphin A, 1999, AM J EPIDEMIOL, V150, P1117, DOI 10.1093/oxfordjournals.aje.a009937; Plachouras D, 2010, EUROSURVEILLANCE, V15, P12; Roque F, 2013, INT J CLIN PHARM-NET, V35, P417, DOI 10.1007/s11096-013-9753-4; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Saengcharoen W, 2008, J CLIN PHARM THER, V33, P123, DOI 10.1111/j.1365-2710.2007.00890.x; Shen J, 2011, INT J CLIN PHARM-NET, V33, P929, DOI 10.1007/s11096-011-9577-z; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Yaghmaie F., 2003, J MED EDUC, V3, P25, DOI DOI 10.22037/JME.V3I1.870	29	14	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90470	10.1371/journal.pone.0090470	http://dx.doi.org/10.1371/journal.pone.0090470			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599387	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400080
J	Cebrian, R; Rodriguez-Ruano, S; Martinez-Bueno, M; Valdivia, E; Maqueda, M; Montalban-Lopez, M				Cebrian, Ruben; Rodriguez-Ruano, Sonia; Martinez-Bueno, Manuel; Valdivia, Eva; Maqueda, Mercedes; Montalban-Lopez, Manuel			Analysis of the Promoters Involved in Enterocin AS-48 Expression	PLOS ONE			English	Article							LACTOCOCCUS-LACTIS; BACTERIOCIN PRODUCTION; BACILLUS-SUBTILIS; ANTIBIOTIC AS-48; MODELING GROWTH; PLASMID; PH; TEMPERATURE; TRANSFORMATION; IMMUNITY	The enterocin AS-48 is the best characterized antibacterial circular protein in prokaryotes. It is a hydrophobic and cationic bacteriocin, which is ribosomally synthesized by enterococcal cells and post-translationally cyclized by a head-to-tail peptide bond. The production of and immunity towards AS-48 depend upon the coordinated expression of ten genes organized in two operons, as-48ABC (where genes encoding enzymes with processing, secretion, and immunity functions are adjacent to the structural as-48A gene) and as-48C(1)DD(1)EFGH. The current study describes the identification of the promoters involved in AS-48 expression. Seven putative promoters have been here amplified, and separately inserted into the promoter-probe vector pTLR1, to create transcriptional fusions with the mCherry gene used as a reporter. The activity of these promoter regions was assessed measuring the expression of the fluorescent mCherry protein using the constitutive pneumococcal promoter P-X as a reference. Our results revealed that only three promoters P-A, P-2(2) and P-D1 were recognized in Enterococcus faecalis, Lactococcus lactis and Escherichia coli, in the conditions tested. The maximal fluorescence was obtained with P-X in all the strains, followed by the P-2(2) promoter, which level of fluorescence was 2-fold compared to P-A and 4-fold compared to P-D1. Analysis of putative factors influencing the promoter activity in single and double transformants in E. faecalis JH2-2 demonstrated that, in general, a better expression was achieved in presence of pAM401-81. In addition, the P-2(2) promoter could be regulated in a negative fashion by genes existing in the native pMB-2 plasmid other than those of the as-48 cluster, while the pH seems to affect differently the as-48 promoter expression.	[Cebrian, Ruben; Rodriguez-Ruano, Sonia; Martinez-Bueno, Manuel; Valdivia, Eva; Maqueda, Mercedes; Montalban-Lopez, Manuel] Univ Granada, Fac Ciencias, Dept Microbiol, E-18071 Granada, Spain	University of Granada	Maqueda, M (corresponding author), Univ Granada, Fac Ciencias, Dept Microbiol, E-18071 Granada, Spain.	mmaqueda@ugr.es; m.montalban.lopez@rug.nl	CEBRIÁN, RUBÉN/M-3311-2014; Martínez-Bueno, Manuel/N-7021-2016; Montalban-Lopez, Manuel/AAA-2871-2019; Valdivia, Eva/R-9978-2018; Rodríguez-Ruano, Sonia María/AAA-9938-2020; Maqueda, Mercedes/K-9667-2014	CEBRIÁN, RUBÉN/0000-0003-1575-1846; Martínez-Bueno, Manuel/0000-0002-1488-5642; Montalban-Lopez, Manuel/0000-0002-2936-9077; Valdivia, Eva/0000-0002-9429-9634; Rodríguez-Ruano, Sonia María/0000-0001-6863-717X; Maqueda, Mercedes/0000-0002-5874-9343	Ministerio de Ciencia e Innovacion [BIO2008-01708]; Plan Propio from the University of Granada (Spain); Research Plan Group [BIO 160]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Plan Propio from the University of Granada (Spain); Research Plan Group	This work was supported in part by the Ministerio de Ciencia e Innovacion project BIO2008-01708, the Plan Propio from the University of Granada (Spain) and by the Research Plan Group (BIO 160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriouel F, 2005, SYST APPL MICROBIOL, V28, P383, DOI 10.1016/j.syapm.2005.01.007; Ananou S, 2008, INT DAIRY J, V18, P923, DOI 10.1016/j.idairyj.2008.02.001; Bourgeois PLF, 1991, GENETIC MOL BIOL STR, P301; Cebrian R, 2012, FOOD MICROBIOL, V30, P59, DOI 10.1016/j.fm.2011.12.002; Cebrian R, 2010, APPL ENVIRON MICROB, V76, P7268, DOI 10.1128/AEM.01154-10; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Diaz M, 2003, APPL ENVIRON MICROB, V69, P1229, DOI 10.1128/AEM.69.2.1229-1236.2003; Fernandez M, 2007, J APPL MICROBIOL, V102, P1350, DOI 10.1111/j.1365-2672.2006.03194.x; Fernandez M, 2008, J BACTERIOL, V190, P240, DOI 10.1128/JB.01528-07; FRIESENEGGER A, 1991, FEMS MICROBIOL LETT, V79, P323, DOI 10.1016/0378-1097(91)90106-K; GALVEZ A, 1986, CAN J MICROBIOL, V32, P765, DOI 10.1139/m86-141; Garcia-Cayuela T, 2011, Spanish patent, Patent No. [P201130356, 201130356]; Garcia-Cayuela T, 2012, APPL MICROBIOL BIOT, V96, P171, DOI 10.1007/s00253-012-4087-z; Goel A, 2012, APPL ENVIRON MICROB, V78, P134, DOI 10.1128/AEM.05276-11; GOMORI G, 1955, METHOD ENZYMOL, V1, P138, DOI 10.1016/0076-6879(55)01020-3; Guerra NP, 2003, LETT APPL MICROBIOL, V37, P51, DOI 10.1046/j.1472-765X.2003.01346.x; Holo H, 1995, Methods Mol Biol, V47, P195; Khan H, 2010, INT J FOOD MICROBIOL, V141, P1, DOI 10.1016/j.ijfoodmicro.2010.03.005; Leaes FL, 2013, ANTON LEEUW INT J G, V104, P149, DOI 10.1007/s10482-013-9935-z; Maqueda Abreu M, 2012, Spanish patent, Patent No. [P201231060-IPR-416- ES-2387425-B2, 201231060]; Maqueda M, 2004, CURR PROTEIN PEPT SC, V5, P399, DOI 10.2174/1389203043379567; Maqueda M, 2008, FEMS MICROBIOL REV, V32, P2, DOI 10.1111/j.1574-6976.2007.00087.x; Martinez-Bueno M, 1998, MOL MICROBIOL, V27, P347, DOI 10.1046/j.1365-2958.1998.00682.x; MARTINEZBUENO M, 1990, J BACTERIOL, V172, P2817, DOI 10.1128/jb.172.5.2817-2818.1990; Meng WM, 2001, NUCLEIC ACIDS RES, V29, P4166, DOI 10.1093/nar/29.20.4166; Messens W, 2002, APPL ENVIRON MICROB, V68, P1431, DOI 10.1128/AEM.68.3.1431-1435.2002; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Montalban-Lopez M, 2008, FEBS LETT, V582, P3237, DOI 10.1016/j.febslet.2008.08.018; Mu DD, 2013, APPL ENVIRON MICROB, V79, P4503, DOI 10.1128/AEM.00866-13; Mu F, 2013, J BIOSCI BIOENG, DOI [10.1016/j.jbiosc.2013.06.023, DOI 10.1016/J.JBI0SC.2013.06.023]; Nakano MM, 2000, J BACTERIOL, V182, P3274, DOI 10.1128/JB.182.11.3274-3277.2000; PEREZMARTIN J, 1994, MICROBIOL REV, V58, P268; POOLMAN B, 1988, J BACTERIOL, V170, P700, DOI 10.1128/jb.170.2.700-707.1988; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Ruiz-Cruz S, 2010, J MICROBIOL METH, V83, P156, DOI 10.1016/j.mimet.2010.08.004; Sanchez-Hidalgo M, 2011, CELL MOL LIFE SCI, V68, P2845, DOI 10.1007/s00018-011-0724-4; Seidman CE, 1997, CURRENT PROTOCOL S37; Solovjev V, 2011, METAGENOMICITAPP, P61; Strauch MA, 2007, J BACTERIOL, V189, P7720, DOI 10.1128/JB.01081-07; Tomita H, 1997, J BACTERIOL, V179, P7843, DOI 10.1128/jb.179.24.7843-7855.1997; Usui M, 2012, JPN J INFECT DIS, V65, P252, DOI 10.7883/yoken.65.252; Voskuil MI, 1998, NUCLEIC ACIDS RES, V26, P3584, DOI 10.1093/nar/26.15.3584; YAGI Y, 1980, J BACTERIOL, V143, P966, DOI 10.1128/JB.143.2.966-970.1980; Zhang J, 2012, APPL BIOCHEM BIOTECH, V166, P1388, DOI 10.1007/s12010-011-9532-4	44	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90603	10.1371/journal.pone.0090603	http://dx.doi.org/10.1371/journal.pone.0090603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594763	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500072
J	Gugerell, A; Kober, J; Laube, T; Walter, T; Nurnberger, S; Gronniger, E; Bronneke, S; Wyrwa, R; Schnabelrauch, M; Keck, M				Gugerell, Alfred; Kober, Johanna; Laube, Thorsten; Walter, Torsten; Nuernberger, Sylvia; Groenniger, Elke; Broenneke, Simone; Wyrwa, Ralf; Schnabelrauch, Matthias; Keck, Maike			Electrospun Poly(ester-Urethane)- and Poly(ester-Urethane-Urea) Fleeces as Promising Tissue Engineering Scaffolds for Adipose-Derived Stem Cells	PLOS ONE			English	Article							IN-VITRO; BIODEGRADABLE POLYURETHANES; FIBROUS SCAFFOLDS; NANOFIBER; MATRIX; BIOCOMPATIBILITY; BIOMATERIALS; DEGRADATION; SUBSTITUTE; EXPRESSION	An irreversible loss of subcutaneous adipose tissue in patients after tumor removal or deep dermal burns makes soft tissue engineering one of the most important challenges in biomedical research. The ideal scaffold for adipose tissue engineering has yet not been identified though biodegradable polymers gained an increasing interest during the last years. In the present study we synthesized two novel biodegradable polymers, poly(epsilon-caprolactone-co-urethane-co-urea) (PEUU) and poly[(L-lactide-co-epsilon-caprolactone)-co-(L-lysine ethyl ester diisocyanate)-block-oligo(ethylene glycol)-urethane] (PEU), containing different types of hydrolytically cleavable bondings. Solutions of the polymers at appropriate concentrations were used to fabricate fleeces by electrospinning. Ultrastructure, tensile properties, and degradation of the produced fleeces were evaluated. Adipose-derived stem cells (ASCs) were seeded on fleeces and morphology, viability, proliferation and differentiation were assessed. The biomaterials show fine micro-and nanostructures composed of fibers with diameters of about 0.5 to 1.3 mu m. PEUU fleeces were more elastic, which might be favourable in soft tissue engineering, and degraded significantly slower compared to PEU. ASCs were able to adhere, proliferate and differentiate on both scaffolds. Morphology of the cells was slightly better on PEUU than on PEU showing a more physiological appearance. ASCs differentiated into the adipogenic lineage. Gene analysis of differentiated ASCs showed typical expression of adipogenetic markers such as PPARgamma and FABP4. Based on these results, PEUU and PEU meshes show a promising potential as scaffold materials in adipose tissue engineering.	[Gugerell, Alfred; Kober, Johanna; Keck, Maike] Med Univ Vienna, Div Plast & Reconstruct Surg, Dept Surg, Vienna, Austria; [Laube, Thorsten; Walter, Torsten; Wyrwa, Ralf; Schnabelrauch, Matthias] INNOVENT eV, Biomat Dept, Jena, Germany; [Nuernberger, Sylvia] Austrian Cluster Tissue Regenerat, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria; [Nuernberger, Sylvia] Med Univ Vienna, Dept Traumatol, Vienna, Austria; [Groenniger, Elke; Broenneke, Simone] Beiersdorf AG, Res Dept Appl Skin Biol, Hamburg, Germany	Medical University of Vienna; Ludwig Boltzmann Institute; Medical University of Vienna; Beiersdorf AG	Gugerell, A (corresponding author), Med Univ Vienna, Div Plast & Reconstruct Surg, Dept Surg, Vienna, Austria.	alfred.gugerell@meduniwien.ac.at	Gugerell, Alfred/W-8542-2019	Gugerell, Alfred/0000-0002-5178-9967; Nurnberger, Sylvia/0000-0002-5175-5118	European Union Seventh Framework Programme (FP7) through the ArtiVasc 3D project [263416]	European Union Seventh Framework Programme (FP7) through the ArtiVasc 3D project	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7) through the ArtiVasc 3D project under grant agreement no263416. http://ec.europa.eu/research/fp7/index_en.cfm. http://www.artivasc.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashammakhi N, 2006, J NANOSCI NANOTECHNO, V6, P2693, DOI 10.1166/jnn.2006.485; Bottcher-Haberzeth S, 2010, BURNS, V36, P450, DOI 10.1016/j.burns.2009.08.016; BRUIN P, 1990, BIOMATERIALS, V11, P291, DOI 10.1016/0142-9612(90)90013-G; Casadei A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/462543; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Chen Q, 2012, BIOMATERIALS, V1; Chen SD, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-21; Chung S, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015019; Cohn D, 2005, BIOMATERIALS, V26, P2297, DOI 10.1016/j.biomaterials.2004.07.052; Cordewener FW, 2000, BIOMATERIALS, V21, P2433, DOI 10.1016/S0142-9612(00)00111-3; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Fan WW, 2013, STEM CELLS, V31, P203, DOI 10.1002/stem.1265; Fu XB, 2007, WOUND REPAIR REGEN, V15, P540, DOI 10.1111/j.1524-475X.2007.00262.x; Gentleman E, 2006, TISSUE ENG, V12, P1639, DOI 10.1089/ten.2006.12.1639; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Guelcher SA, 2008, TISSUE ENG PART B-RE, V14, P3, DOI 10.1089/teb.2007.0133; Gunatillake PA, 2003, EUR CELLS MATER, V5, P16; Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1; Halbleib M, 2003, BIOMATERIALS, V24, P3125, DOI 10.1016/S0142-9612(03)00156-X; Han JA, 2011, J BIOMED MATER RES A, V96A, P705, DOI 10.1002/jbm.a.33023; Hemmrich K, 2006, EXPERT REV MED DEVIC, V3, P635, DOI 10.1586/17434440.3.5.635; Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9; Jeun JP, 2007, J IND ENG CHEM, V13, P592; Jung Y, 2013, J BIOMAT SCI-POLYM E, V24, P386, DOI 10.1080/09205063.2012.690281; Kawaguchi N, 1998, P NATL ACAD SCI USA, V95, P1062, DOI 10.1073/pnas.95.3.1062; Keck M, 2011, BURNS, V37, P626, DOI 10.1016/j.burns.2010.07.016; Khil MS, 2005, J BIOMED MATER RES B, V72B, P117, DOI 10.1002/jbm.b.30122; Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1; Kim WS, 2009, ARCH DERMATOL RES, V301, P329, DOI 10.1007/s00403-009-0951-9; Kim YJ, 2013, WOUND REPAIR REGEN, V21, P456, DOI 10.1111/wrr.12041; Kluger PJ, 2010, J MATER SCI-MATER M, V21, P2665, DOI 10.1007/s10856-010-4128-z; Kral JG, 1999, PLAST RECONSTR SURG, V104, P1732, DOI 10.1097/00006534-199911000-00018; Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002; Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005; Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101; Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017; Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042; Mun CH, 2012, TISSUE ENG PT A, V18, P1608, DOI [10.1089/ten.tea.2011.0695, 10.1089/ten.TEA.2011.0695]; Park DJ, 2010, J PLAST RECONSTR AES, V63, P561, DOI 10.1016/j.bjps.2008.11.042; Ravichandran R, 2012, MACROMOL BIOSCI, V12, P286, DOI 10.1002/mabi.201100325; Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035; Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197; Rosen ED, 2000, GENE DEV, V14, P1293; Ruwald MH, 2013, J AM COLL CARDIOL, V61, P326; Schoeller T, 2001, AESTHET PLAST SURG, V25, P57, DOI 10.1007/s002660010096; Shanti RM, 2008, ANN PLAS SURG, V61, P566, DOI 10.1097/SAP.0b013e31816d9579; Shenaq SM, 2002, CLIN PLAST SURG, V29, P111, DOI 10.1016/S0094-1298(03)00089-0; Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011; SMAHEL J, 1989, BRIT J PLAST SURG, V42, P207, DOI 10.1016/0007-1226(89)90205-1; Stride N, 2013, EUR J HEART FAIL, V15, P150, DOI 10.1093/eurjhf/hfs172; Surrao DC, 2012, ACTA BIOMATER, V8, P3997, DOI 10.1016/j.actbio.2012.07.012; Tanzi MC, 2009, EXPERT REV MED DEVIC, V6, P533, DOI 10.1586/ERD.09.37; Tatai L, 2007, BIOMATERIALS, V28, P5407, DOI 10.1016/j.biomaterials.2007.08.035; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Traurig MT, 2006, DIABETES, V55, P3160, DOI 10.2337/db06-0373; Vermette M, 2007, BIOMATERIALS, V28, P2850, DOI 10.1016/j.biomaterials.2007.02.030; von Heimburg D, 2005, RESP PHYSIOL NEUROBI, V146, P107, DOI 10.1016/j.resp.2004.12.013; Wacker SA, 2011, J AM CHEM SOC, V133, P12386, DOI 10.1021/ja204561q; Wendorff J. H., 2012, ELECTROSPINNING; Wu HX, 2011, MOLECULES, V16, P6489, DOI 10.3390/molecules16086489; Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X; Young DA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024104; Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k; Zhang JY, 2002, TISSUE ENG, V8, P771, DOI 10.1089/10763270260424132; Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044; 付小兵, 2004, [中国修复重建外科杂志, Chinese Journal of Reparative and Reconstructive Surgery], V18, P447	66	17	17	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90676	10.1371/journal.pone.0090676	http://dx.doi.org/10.1371/journal.pone.0090676			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594923	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500085
J	Li, Z; Shen, JX; Qiu, GX; Yu, HQ; Wang, YP; Zhang, JG; Zhao, H; Zhao, Y; Li, SG; Weng, XS; Liang, JQ; Zhao, LJ				Li, Zheng; Shen, Jianxiong; Qiu, Guixing; Yu, Haiquan; Wang, Yipeng; Zhang, Jianguo; Zhao, Hong; Zhao, Yu; Li, Shugang; Weng, Xisheng; Liang, Jinqian; Zhao, Lijuan			Unplanned Reoperation within 30 Days of Fusion Surgery for Spinal Deformity	PLOS ONE			English	Article							ADOLESCENT IDIOPATHIC SCOLIOSIS; DEFINITIVE INSTRUMENTATION; COLORECTAL-CANCER; REVISION SURGERY; ADULT SCOLIOSIS; RISK-FACTORS; COMPLICATIONS; PSEUDOARTHROSIS; INFECTION; QUALITY	No recent studies have analyzed the rates of or reasons for unanticipated revision surgery within 30 days of primary surgery in spinal deformity patients. Our aim was to examine the incidence, characteristics, reasons, and risk factors for unplanned revision surgery in spinal deformity patients treated at one institution. All patients with a diagnosis of spinal deformity presenting for primary instrumented spinal fusion at a single institution from 1998 to 2012 were reviewed. All unplanned reoperations performed within 30 days after primary surgery were analyzed in terms of demographics, surgical data, and complications. Statistical analyses were performed to obtain correlations and risk factors for anticipated revision. Of 2758 patients [aged 16.07 years (range, 2-71), 69.8% female] who underwent spinal fusion surgery, 59 (2.1%) required reoperation within 30 days after primary surgery. The length of follow up for each patient was more than 30 days. Of those that required reoperation, 87.0% had posterior surgery only, 5.7% had anterior surgery, and 7.3% underwent an anteroposterior approach. The reasons for reoperation included implant failure (n = 20), wound infection (n = 12), neurologic deficit (n = 9), pulmonary complications (n = 17), and coronal plane imbalance (n = 1). The risk factors for reoperation were age, diagnosis, and surgical procedure with osteotomy.	[Shen, Jianxiong] Chinese Acad Med Sci, Dept Orthopaed Surg, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Shen, JX (corresponding author), Chinese Acad Med Sci, Dept Orthopaed Surg, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.	shenjianxiong@medmail.com.cn	Shen, Jianxiong/AAH-6200-2019; ZHAO, YU/GZL-3154-2022	ZHAO, YU/0000-0001-9025-2014; Qiu, Guixing/0000-0002-4597-9350; Wang, Yipeng/0000-0001-9769-9839; Weng, Xisheng/0000-0002-6021-1462	National Natural Science Foundation of P.R. China [81272053, 81330044]	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of P.R. China (Grant Number: 81272053 and 81330044; http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almoudaris AM, 2013, GUT, V62, P423, DOI 10.1136/gutjnl-2011-301489; Campos M, 2012, SPINE, V37, P1048, DOI 10.1097/BRS.0b013e31823ced6f; Carreon LY, 2007, J BONE JOINT SURG AM, V89A, P2427, DOI 10.2106/JBJS.F.00995; Charosky S, 2012, SPINE, V37, P693, DOI 10.1097/BRS.0b013e31822ff5c1; Csernatony Z, 2013, EUR SPINE J; Davis MA, 2009, SPINE, V34, P2318, DOI 10.1097/BRS.0b013e3181adb296; Froschl Uwe, 2006, Surg Infect (Larchmt), V7, P263, DOI 10.1089/sur.2006.7.263; Lehman RA, 2011, SPINE J, V11, P684, DOI 10.1016/j.spinee.2011.05.012; Liang CZ, 2012, J INT MED RES, V40, P399, DOI 10.1177/147323001204000201; Lykissas MG, 2013, SPINE, V38, pE113, DOI 10.1097/BRS.0b013e31827ae3d0; McSorley S, 2013, COLORECTAL DIS, V15, P689, DOI 10.1111/codi.12135; Mok JM, 2009, SPINE, V34, P578, DOI 10.1097/BRS.0b013e31819a827c; Mok JM, 2009, SPINE, V34, P832, DOI 10.1097/BRS.0b013e31819f2080; Mukerji N, 2012, J NEUROSURG-PEDIATR, V9, P665, DOI 10.3171/2012.2.PEDS11305; Muschik M, 2004, EUR SPINE J, V13, P645, DOI 10.1007/s00586-004-0694-4; Pateder DB, 2006, SPINE, V31, pE314, DOI 10.1097/01.brs.0000217619.57333.96; Pichelmann MA, 2010, SPINE, V35, P219, DOI 10.1097/BRS.0b013e3181c91180; Price JD, 2013, J AM COLL SURGEONS, V216, P412, DOI 10.1016/j.jamcollsurg.2012.11.009; Rama-Maceiras P, 2011, EUR J ANAESTH, V28, P10, DOI 10.1097/EJA.0b013e32833e33b0; Ramo BA, 2012, SPINE, V37, P1211, DOI 10.1097/BRS.0b013e31824b6b05; Richards BS, 2006, SPINE, V31, P3018, DOI 10.1097/01.brs.0000249553.22138.58; Sponseller PD, 2010, SPINE, V35, P2205, DOI 10.1097/BRS.0b013e3181e7d675; Sponseller PD, 2010, CLIN ORTHOP RELAT R, V468, P711, DOI 10.1007/s11999-009-0933-4; Theiss SM, 1996, ORTHOP CLIN N AM, V27, P105; Wiggins GC, 2001, J NEUROSURG, V95, P17, DOI 10.3171/spi.2001.95.1.0017	25	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e87172	10.1371/journal.pone.0087172	http://dx.doi.org/10.1371/journal.pone.0087172			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595145	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500002
J	Muster, C; Meyer, M; Sattler, T				Muster, Christoph; Meyer, Marc; Sattler, Thomas			Spatial Arrangement Overrules Environmental Factors to Structure Native and Non-Native Assemblages of Synanthropic Harvestmen	PLOS ONE			English	Article							ECOLOGICAL COMMUNITIES; BIOLOGICAL INVASIONS; NEIGHBOR MATRICES; HABITAT; URBANIZATION; FRAMEWORK; ALIEN; SCALE; BIODIVERSITY; DIVERSITY	Understanding how space affects the occurrence of native and non-native species is essential for inferring processes that shape communities. However, studies considering spatial and environmental variables for the entire community - as well as for the native and non-native assemblages in a single study - are scarce for animals. Harvestmen communities in central Europe have undergone drastic turnovers during the past decades, with several newly immigrated species, and thus provide a unique system to study such questions. We studied the wall-dwelling harvestmen communities from 52 human settlements in Luxembourg and found the assemblages to be largely dominated by non-native species (64% of specimens). Community structure was analysed using Moran's eigenvector maps as spatial variables, and landcover variables at different radii (500 m, 1000 m, 2000 m) in combination with climatic parameters as environmental variables. A surprisingly high portion of pure spatial variation (15.7% of total variance) exceeded the environmental (10.6%) and shared (4%) components of variation, but we found only minor differences between native and non-native assemblages. This could result from the ecological flexibility of both, native and non-native harvestmen that are not restricted to urban habitats but also inhabit surrounding semi-natural landscapes. Nevertheless, urban landcover variables explained more variation in the non-native community, whereas coverage of semi-natural habitats (forests, rivers) at broader radii better explained the native assemblage. This indicates that some urban characteristics apparently facilitate the establishment of non-native species. We found no evidence for competitive replacement of native by invasive species, but a community with novel combination of native and non-native species.	[Muster, Christoph] Ernst Moritz Arndt Univ Greifswald, Museum & Inst Zool, Greifswald, Germany; [Meyer, Marc] Musee Natl Hist Nat Luxembourg, Luxembourg, Luxembourg; [Sattler, Thomas] Swiss Fed Inst Forest Snow & Landscape Res WSL, Bellinzona, Switzerland; [Sattler, Thomas] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Sattler, Thomas] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	Ernst Moritz Arndt Universitat Greifswald; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute	Muster, C (corresponding author), Ernst Moritz Arndt Univ Greifswald, Museum & Inst Zool, Greifswald, Germany.	christoph.muster@uni-greifswald.de	Muster, Christoph/AAZ-1101-2021	Sattler, Thomas/0000-0001-5359-6387	Fonds National de la Recherche Luxembourg through an AMC2 - Mobility Mobility of researchers grant [FNR/09/AM2c/03]; Federal Office for the Environment Switzerland; Swiss National Science Foundation	Fonds National de la Recherche Luxembourg through an AMC2 - Mobility Mobility of researchers grant(Luxembourg National Research Fund); Federal Office for the Environment Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Field work of CM in Luxembourg was funded by the Fonds National de la Recherche Luxembourg through an AMC2 - Mobility Mobility of researchers grant (FNR/09/AM2c/03)(http://www.fnr.lu/). The salary of TS was funded by the Federal Office for the Environment Switzerland (http://www.bafu.admin.ch/index.html?lang = en) and the Swiss National Science Foundation (http://www.snf.ch/E/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta Luis E., 2007, P309; ADAMS J, 1984, OIKOS, V42, P361, DOI 10.2307/3544406; Anderson D.R., 2008, MODEL BASED INFERENC; Benedetti-Cecchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012946; Bennett AB, 2012, LANDSCAPE URBAN PLAN, V104, P26, DOI 10.1016/j.landurbplan.2011.09.007; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Blick T., 2004, CHECKLISTE WEBERKNEC; Boieiro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064591; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 1994, ENVIRON ECOL STAT, V1, P37, DOI 10.1007/BF00714196; Bossard M., 2000, 40 EUR ENV AG; Brunzel S, 2009, J BIOGEOGR, V36, P835, DOI 10.1111/j.1365-2699.2008.02044.x; Buczkowski G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041729; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Calcagno V., 2011, GLMULTI MODEL SELECT; Calcagno V, 2010, J STAT SOFTW, V34, P1; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Central Intelligence Agency, 2011, WORLD FACTB 2010; Chytry M, 2012, J BIOGEOGR, V39, P1101, DOI 10.1111/j.1365-2699.2011.02664.x; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Diamond J.M., 1975, P342; Dray S., 2013, SPACEMAKER SPATIAL M; Dray S., 2011, PACKFOR FORWARD SELE; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Dunlop J.A., 2007, HARVESTMEN BIOL OPIL, DOI [10.4159/9780674276833-007, DOI 10.4159/9780674276833-007]; Entling W, 2007, GLOBAL ECOL BIOGEOGR, V16, P440, DOI 10.1111/j.1466-8238.2006.00305.x; Gilbert B, 2010, J APPL ECOL, V47, P1071, DOI 10.1111/j.1365-2664.2010.01861.x; Griffith DA, 1998, J STAT PLAN INFER, V69, P153, DOI 10.1016/S0378-3758(97)00156-0; Hajek M, 2011, J BIOGEOGR, V38, P1683, DOI 10.1111/j.1365-2699.2011.02503.x; Hirzel AH, 2004, J APPL ECOL, V41, P1103, DOI 10.1111/j.0021-8901.2004.00980.x; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; JAROMCZYK JW, 1992, P IEEE, V80, P1502, DOI 10.1109/5.163414; Kobelt M, 2008, DIVERS DISTRIB, V14, P273, DOI 10.1111/j.1472-4642.2007.00426.x; Komposch C., 2002, NEOBIOTA STERREICH, P250; KOWARIK I, 1995, PLANT INVASIONS, P85; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Leprieur F, 2009, J BIOGEOGR, V36, P1899, DOI 10.1111/j.1365-2699.2009.02107.x; Lososova Z, 2011, J BIOGEOGR, V38, P1152, DOI 10.1111/j.1365-2699.2011.02475.x; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Muster C, 2014, NATURSCHUTZ IN PRESS; Muster Christoph, 2014, Ferrantia, V70, P5; Niedringhaus R, 2010, TEXTBAND FERRANTIA, V60, P5; Noordijk Jinze, 2007, Nederlandse Faunistische Mededelingen, V26, P65; Novak Tone, 2002, Acta Entomologica Slovenica, V10, P131; Oksanen J., 2016, R PACKAG; Pecarevic M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013222; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; Pysek P, 1998, J BIOGEOGR, V25, P155, DOI 10.1046/j.1365-2699.1998.251177.x; Pysek P, 2010, GLOBAL ECOL BIOGEOGR, V19, P317, DOI 10.1111/j.1466-8238.2009.00514.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sattler T, 2010, ECOLOGY, V91, P3343, DOI 10.1890/09-1810.1; Sattler T, 2010, LANDSCAPE ECOL, V25, P941, DOI 10.1007/s10980-010-9473-2; Sattler T, 2011, LANDSCAPE URBAN PLAN, V103, P347, DOI 10.1016/j.landurbplan.2011.08.008; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Sharma S, 2011, ECOGRAPHY, V34, P762, DOI 10.1111/j.1600-0587.2010.06811.x; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Toft S, 2004, MEJERNE; Toft Soren, 2011, Flora og Fauna, V117, P47; Von Holle B, 2013, BIOL INVASIONS, V15, P417, DOI 10.1007/s10530-012-0297-7; Wijnhoven H., 2009, ENTOMOL TABELLEN, V3, P1; Wijnhoven Hay, 2007, Arachnologische Mitteilungen, P27; Zar JH, 1999, BIOSTATISTICAL ANAL; Zulka P, 2009, MEJERNE, P397	70	10	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90474	10.1371/journal.pone.0090474	http://dx.doi.org/10.1371/journal.pone.0090474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595309	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500055
J	Do, BH; Ryu, HB; Hoang, P; Koo, BK; Choe, H				Do, Bich Hang; Ryu, Han-Bong; Hoang, Phuong; Koo, Bon-Kyung; Choe, Han			Soluble Prokaryotic Overexpression and Purification of Bioactive Human Granulocyte Colony-Stimulating Factor by Maltose Binding Protein and Protein Disulfide Isomerase	PLOS ONE			English	Article							FACTOR G-CSF; FACTOR HG-CSF; ESCHERICHIA-COLI; PERIPLASMIC PRODUCTION; EXTRACELLULAR DOMAIN; FACTOR-RECEPTOR; LIGAND-BINDING; FUSION PROTEIN; HUMAN PDI; EXPRESSION	Human granulocyte colony-stimulating factor (hGCSF), a neutrophil-promoting cytokine, is an effective therapeutic agent for neutropenia patients who have undergone several cancer treatments. Efficient production of hGCSF using E. coli is challenging because the hormone tends to aggregate and forms inclusion bodies. This study examined the ability of seven different N-terminal fusion tags to increase expression of soluble hGCSF in E. coli. Four tag proteins, namely maltose-binding protein (MBP), N-utilization substance protein A, protein disulfide isomerase (PDI), and the b'a' domain of PDI (PDIb'a'), increased the solubility of hGCSF under normal conditions. Lowering the expression temperature from 30 degrees C to 18 degrees C also increased the solubility of thioredoxin-tagged and glutathione S-transferase-tagged hGCSF. By contrast, hexahistidine-tagged hGCSF was insoluble at both temperatures. Simple conventional chromatographic methods were used to purify hGCSF from the overexpressed PDIb'a'-hGCSF and MBP-hGCSF proteins. In total, 11.3 mg or 10.2 mg of pure hGCSF were obtained from 500 mL cultures of E. coli expressing PDIb'a'-hGCSF or MBP-hGCSF, respectively. SDS-PAGE analysis and silver staining confirmed high purity of the isolated hGCSF proteins, and the endotoxin levels were less than 0.05 EU/mu g of protein. Subsequently, the bioactivity of the purified hGCSF proteins similar to that of the commercially available hGCSF was confirmed using the mouse M-NFS-60 myelogenous leukemia cell line. The EC(50)s of the cell proliferation dose-response curves for hGCSF proteins purified from MBP-hGCSF and PDIb'a'-hGCSF were 2.83 +/- 0.31 pM, and 3.38 +/- 0.41 pM, respectively. In summary, this study describes an efficient method for the soluble overexpression and purification of bioactive hGCSF in E. coli.	[Choe, Han] Univ Ulsan, Coll Med, Dept Physiol, Seoul, South Korea; Univ Ulsan, Coll Med, Biomed Inst Technol, Seoul, South Korea	University of Ulsan; University of Ulsan	Choe, H (corresponding author), Univ Ulsan, Coll Med, Dept Physiol, Seoul, South Korea.	hchoe@ulsan.ac.kr	Hang, Bich/AAI-6230-2021	Hang, Bich/0000-0002-8951-175X; choe, han/0000-0003-4604-647X	MRC [2008-0062286]; Priority Research Center Program of National Research Foundation [2009-0094054]; Ministry of Education, Science and Technology of Korea	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Priority Research Center Program of National Research Foundation; Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by MRC grant (2008-0062286) and Priority Research Center Program (2009-0094054) of National Research Foundation funded by the Ministry of Education, Science and Technology of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alrokayan S, 2011, GENET MOL RES, V10, P2671, DOI 10.4238/2011.October.31.18; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Bach H, 2001, J MOL BIOL, V312, P79, DOI 10.1006/jmbi.2001.4914; Bai Y, 2005, P NATL ACAD SCI USA, V102, P7292, DOI 10.1073/pnas.0500062102; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Bath PMW, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005207.pub2; Bonig H, 2001, BONE MARROW TRANSPL, V28, P259, DOI 10.1038/sj.bmt.1703136; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Chen X, 2010, PROTEIN SCI, V19, P449, DOI 10.1002/pro.323; Chung HK, 2011, BMB REP, V44, P686, DOI 10.5483/BMBRep.2011.44.10.686; Conzelmann Nadine, 2011, BMC Res Notes, V4, P194, DOI 10.1186/1756-0500-4-194; Cox GN, 2004, EXP HEMATOL, V32, P441, DOI 10.1016/j.exphem.2004.01.012; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; DEMETRI GD, 1991, BLOOD, V78, P2791; Diaz AA, 2010, BIOTECHNOL BIOENG, V105, P374, DOI 10.1002/bit.22537; Fahnert B, 2004, ADV BIOCHEM ENG BIOT, V89, P93; Ferrer M, 2004, APPL ENVIRON MICROB, V70, P4499, DOI 10.1128/AEM.70.8.4499-4504.2004; Gascon P, 2012, TARGET ONCOL, V7, pS29, DOI 10.1007/s11523-011-0190-9; Ghalaut P S, 2008, J Assoc Physicians India, V56, P942; Haniu M, 1995, ARCH BIOCHEM BIOPHYS, V324, P344, DOI 10.1006/abbi.1995.0047; HARA K, 1988, EXP HEMATOL, V16, P256; HOLLINGSHEAD LM, 1991, DRUGS, V42, P300, DOI 10.2165/00003495-199142020-00009; Horan T, 1996, BIOCHEMISTRY-US, V35, P4886, DOI 10.1021/bi9525841; Imsoonthornruksa S, 2011, J BIOTECHNOL, V151, P295, DOI 10.1016/j.jbiotec.2010.12.020; Jeong KJ, 2001, PROTEIN EXPRES PURIF, V23, P311, DOI 10.1006/prep.2001.1508; Jiang YP, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-28; Jin HF, 2011, PROTEIN EXPRES PURIF, V78, P69, DOI 10.1016/j.pep.2011.03.002; Kandror O, 1997, P NATL ACAD SCI USA, V94, P4978, DOI 10.1073/pnas.94.10.4978; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kim CW, 2007, PROTEIN SCI, V16, P635, DOI 10.1110/ps.062330907; Kim EE, 2012, CURR MED IMAGING REV, V8, P1; Kurokawa Y, 2001, J BIOL CHEM, V276, P14393, DOI 10.1074/jbc.M100132200; Lasnik MA, 2001, PFLUG ARCH EUR J PHY, V442, pR184, DOI 10.1007/s004240100018; Lefebvre J, 2009, MOL HUM REPROD, V15, P105, DOI 10.1093/molehr/gan077; Li M, 2012, APPL BIOCHEM BIOTECH, V166, P1264, DOI 10.1007/s12010-011-9512-8; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Liu Y, 2005, PROTEIN EXPRES PURIF, V44, P155, DOI 10.1016/j.pep.2005.03.030; Magistrelli G, 2005, BIOCHEM BIOPH RES CO, V334, P370, DOI 10.1016/j.bbrc.2005.06.091; Metcalf D, 2010, NAT REV CANCER, V10, P425, DOI 10.1038/nrc2843; Meuer K, 2006, J NEUROCHEM, V97, P675, DOI 10.1111/j.1471-4159.2006.03727.x; NICOLA NA, 1983, J BIOL CHEM, V258, P9017; NOMURA H, 1986, EMBO J, V5, P871, DOI 10.1002/j.1460-2075.1986.tb04297.x; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Pollari E, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-74; Rao DVK, 2008, BIOTECHNOL APPL BIOC, V50, P77, DOI 10.1042/BA20070130; Roberts AW, 2005, GROWTH FACTORS, V23, P33, DOI 10.1080/08977190500055836; Roessl U, 2012, BIOTECHNOL J, V7, P1014, DOI 10.1002/biot.201100436; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; SHIRANO Y, 1990, FEBS LETT, V271, P128, DOI 10.1016/0014-5793(90)80388-Y; Song JA, 2009, FEMS MICROBIOL LETT, V296, P60, DOI 10.1111/j.1574-6968.2009.01616.x; Song JA, 2013, APPL BIOCHEM BIOTECH, V170, P67, DOI 10.1007/s12010-013-0140-3; Vanz ALS, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-13; Vera A, 2007, BIOTECHNOL BIOENG, V96, P1101, DOI 10.1002/bit.21218; Villaverde A, 2003, BIOTECHNOL LETT, V25, P1385, DOI 10.1023/A:1025024104862; Wang CZ, 2008, BIOTECHNOL PROGR, V24, P209, DOI 10.1021/bp070263y; Wang Yanan, 2012, Sheng Wu Gong Cheng Xue Bao, V28, P1388; WEINSTEIN Y, 1986, P NATL ACAD SCI USA, V83, P5010, DOI 10.1073/pnas.83.14.5010; WINGFIELD P, 1988, BIOCHEM J, V256, P213, DOI 10.1042/bj2560213; Yamamoto A, 2002, VET IMMUNOL IMMUNOP, V90, P169, DOI 10.1016/S0165-2427(02)00259-3; Yi AR, 2009, J MICROBIOL BIOTECHN, V19, P829, DOI 10.4014/jmb.0812.683; Young DC, 1997, PROTEIN SCI, V6, P1228, DOI 10.1002/pro.5560060611; ZSEBO KM, 1986, IMMUNOBIOLOGY, V172, P175, DOI 10.1016/S0171-2985(86)80097-3	62	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89906	10.1371/journal.pone.0089906	http://dx.doi.org/10.1371/journal.pone.0089906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594699	Green Submitted, Green Published, gold			2022-12-25	WOS:000332468900045
J	Frings, L; Yew, B; Flanagan, E; Lam, BYK; Hull, M; Huppertz, HJ; Hodges, JR; Hornberger, M				Frings, Lars; Yew, Belinda; Flanagan, Emma; Lam, Bonnie Y. K.; Huell, Michael; Huppertz, Hans-Juergen; Hodges, John R.; Hornberger, Michael			Longitudinal Grey and White Matter Changes in Frontotemporal Dementia and Alzheimer's Disease	PLOS ONE			English	Article							BEHAVIORAL VARIANT; LOBAR DEGENERATION; DIAGNOSTIC-CRITERIA; SEMANTIC DEMENTIA; CEREBRAL ATROPHY; BRAIN ATROPHY; PATTERNS; MRI; AD; RATES	Behavioural variant frontotemporal dementia (bvFTD) and Alzheimer's disease (AD) dementia are characterised by progressive brain atrophy. Longitudinal MRI volumetry may help to characterise ongoing structural degeneration and support the differential diagnosis of dementia subtypes. Automated, observer-independent atlas-based MRI volumetry was applied to analyse 102 MRI data sets from 15 bvFTD, 14 AD, and 10 healthy elderly control participants with consecutive scans over at least 12 months. Anatomically defined targets were chosen a priori as brain structures of interest. Groups were compared regarding volumes at clinic presentation and annual change rates. Baseline volumes, especially of grey matter compartments, were significantly reduced in bvFTD and AD patients. Grey matter volumes of the caudate and the gyrus rectus were significantly smaller in bvFTD than AD. The bvFTD group could be separated from AD on the basis of caudate volume with high accuracy (79% cases correct). Annual volume decline was markedly larger in bvFTD and AD than controls, predominantly in white matter of temporal structures. Decline in grey matter volume of the lateral orbitofrontal gyrus separated bvFTD from AD and controls. Automated longitudinal MRI volumetry discriminates bvFTD from AD. In particular, greater reduction of orbitofrontal grey matter and temporal white matter structures after 12 months is indicative of bvFTD.	[Frings, Lars; Huell, Michael] Univ Med Ctr, Ctr Geriatr & Gerontol, Freiburg, Germany; [Frings, Lars] Univ Med Ctr, Dept Nucl Med, Freiburg, Germany; [Yew, Belinda; Flanagan, Emma; Lam, Bonnie Y. K.; Hodges, John R.; Hornberger, Michael] Neurosci Res Australia, Sydney, NSW, Australia; [Huppertz, Hans-Juergen] Swiss Epilepsy Ctr, Zurich, Switzerland; [Hodges, John R.; Hornberger, Michael] ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Lam, Bonnie Y. K.; Hodges, John R.; Hornberger, Michael] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	University of Freiburg; University of Freiburg; Neuroscience Research Australia; University of New South Wales Sydney	Hornberger, M (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	m.hornberger@neura.edu.au	Hornberger, Michael/C-9610-2011; Lam, Bonnie Yin Ka/J-7578-2016	Hornberger, Michael/0000-0002-2214-3788; Lam, Bonnie Yin Ka/0000-0002-1656-2433; Huppertz, Hans-Jurgen/0000-0003-3856-9094; Frings, Lars/0000-0001-9377-8935; Flanagan, Emma/0000-0003-1492-7061	Australian Research Council [DP110104202, FF0776229]; German Federal Ministry of Education and Research (BMBF) [01GW0662]	Australian Research Council(Australian Research Council); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Australian Research Council (DP110104202 to M Hornberger, FF0776229 to JR Hodges) and by the German Federal Ministry of Education and Research (BMBF grant 01GW0662 to M Hull). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2012, CEREB CORTEX, V22, P2705, DOI 10.1093/cercor/bhr288; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boccardi M, 2003, NEUROBIOL AGING, V24, P95, DOI 10.1016/S0197-4580(02)00045-3; Bocti C, 2006, DEMENT GERIATR COGN, V21, P364, DOI 10.1159/000091838; Broe M, 2003, NEUROLOGY, V60, P1005, DOI 10.1212/01.WNL.0000052685.09194.39; Chan D, 2001, NEUROLOGY, V57, P1756, DOI 10.1212/WNL.57.10.1756; Chow TW, 2008, DEMENT GERIATR COGN, V26, P79, DOI 10.1159/000144028; Dalton MA, 2013, NEUROIMAGE-CLIN, V2, P56, DOI 10.1016/j.nicl.2012.11.001; Davatzikos C, 2008, NEUROIMAGE, V41, P1220, DOI 10.1016/j.neuroimage.2008.03.050; Davies RR, 2009, NEURORADIOLOGY, V51, P491, DOI 10.1007/s00234-009-0521-z; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Du AT, 2007, BRAIN, V130, P1159, DOI 10.1093/brain/awm016; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Frings L, 2012, HUM BRAIN MAPP, V33, P1526, DOI 10.1002/hbm.21304; Hampel H, 2008, ALZHEIMERS DEMENT, V4, P38, DOI 10.1016/j.jalz.2007.08.006; Hornberger M, 2010, DEMENT GERIATR COGN, V30, P547, DOI 10.1159/000321670; Hornberger M, 2012, BRAIN, V135, P3015, DOI 10.1093/brain/aws239; Hornberger M, 2011, BRAIN, V134, P2502, DOI 10.1093/brain/awr173; Huppertz HJ, 2010, NEUROIMAGE, V49, P2216, DOI 10.1016/j.neuroimage.2009.10.066; Knopman DS, 2008, BRAIN, V131, P2957, DOI 10.1093/brain/awn234; Krueger CE, 2010, ALZ DIS ASSOC DIS, V24, P43, DOI 10.1097/WAD.0b013e3181a6f101; Lillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043993; Looi JCL, 2008, AM J NEURORADIOL, V29, P1537, DOI 10.3174/ajnr.A1168; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mioshi E, 2010, NEUROLOGY, V74, P1591, DOI 10.1212/WNL.0b013e3181e04070; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nestor PJ, 2003, EUR J NEUROSCI, V18, P2663, DOI 10.1046/j.1460-9568.2003.02999.x; O'Callaghan C, 2013, CORTEX, V49, P1833, DOI 10.1016/j.cortex.2012.12.003; Perry RJ, 2006, DEMENT GERIATR COGN, V22, P278, DOI 10.1159/000095128; Piguet O, 2009, NEUROLOGY, V72, P732, DOI 10.1212/01.wnl.0000343004.98599.45; Pleizier CM, 2012, J NEUROL NEUROSUR PS, V83, P1145, DOI 10.1136/jnnp-2012-302437; Rascovsky K, 2007, ALZ DIS ASSOC DIS, V21, pS14, DOI 10.1097/WAD.0b013e31815c3445; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Resnick SM, 2003, J NEUROSCI, V23, P3295; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Whitwell JL, 2007, BRAIN, V130, P1148, DOI 10.1093/brain/awm021; Yi Dong Seok, 2013, Dement. neuropsychol., V7, P75, DOI 10.1590/S1980-57642013DN70100012	42	47	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90814	10.1371/journal.pone.0090814	http://dx.doi.org/10.1371/journal.pone.0090814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595028	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000332468900149
J	Kunz, P; Fellenberg, J; Moskovszky, L; Sapi, Z; Krenacs, T; Poeschl, J; Lehner, B; Szendroi, M; Ewerbeck, V; Kinscherf, R; Fritzsching, B				Kunz, Pierre; Fellenberg, Joerg; Moskovszky, Linda; Sapi, Zoltan; Krenacs, Tibor; Poeschl, Johannes; Lehner, Burkhard; Szendroi, Miklos; Ewerbeck, Volker; Kinscherf, Ralf; Fritzsching, Benedikt			Osteosarcoma Microenvironment: Whole-Slide Imaging and Optimized Antigen Detection Overcome Major Limitations in Immunohistochemical Quantification	PLOS ONE			English	Article							INVASIVE BREAST-CARCINOMA; ENDOTHELIAL GROWTH-FACTOR; REGULATORY T-CELLS; SOLID HUMAN TUMORS; PROGNOSTIC-FACTORS; INTERNATIONAL CONSENSUS; DENDRITIC CELLS; ANGIOGENESIS; CANCER; RETRIEVAL	Background: In osteosarcoma survival rates could not be improved over the last 30 years. Novel biomarkers are warranted to allow risk stratification of patients for more individual treatment following initial diagnosis. Although previous studies of the tumor microenvironment have identified promising candidates, novel biomarkers have not been translated into routine histopathology. Substantial difficulties regarding immunohistochemical detection and quantification of antigens in decalcified and heterogeneous osteosarcoma might largely explain this translational short-coming. Furthermore, we hypothesized that conventional hot spot analysis is often not representative for the whole section when applied to heterogeneous tissues like osteosarcoma. We aimed to overcome these difficulties for major biomarkers of the immunovascular microenvironment. Methods: Immunohistochemistry was systematically optimized for cell surface (CD31, CD8) and intracellular antigens (FOXP3) including evaluation of 200 different antigen retrieval conditions. Distribution patterns of these antigens were analyzed in formalin-fixed and paraffin-embedded samples from 120 high-grade central osteosarcoma biopsies and computer-assisted whole-slide analysis was compared with conventional quantification methods including hot spot analysis. Results: More than 96% of osteosarcoma samples were positive for all antigens after optimization of immunohistochemistry. In contrast, standard immunohistochemistry retrieved false negative results in 35-65% of decalcified osteosarcoma specimens. Standard hot spot analysis was applicable for homogeneous distributed FOXP3(+) and CD8(+) cells. However, heterogeneous distribution of vascular CD31 did not allow reliable quantification with hot spot analysis in 85% of all samples. Computer-assisted whole-slide analysis of total CD31-immunoreactive area proved as the most appropriate quantification method. Conclusion: Standard staining and quantification procedures are not applicable in decalcified formalin-fixed and paraffin-embedded samples for major parameters of the immunovascular microenvironment in osteosarcoma. Whole-slide imaging and optimized antigen retrieval overcome these limitations.	[Kunz, Pierre; Fellenberg, Joerg; Lehner, Burkhard; Ewerbeck, Volker] Univ Heidelberg Hosp, Dept Orthoped & Traumatol, Heidelberg, Germany; [Moskovszky, Linda; Sapi, Zoltan; Krenacs, Tibor] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, Fac Med, H-1085 Budapest, Hungary; [Poeschl, Johannes; Fritzsching, Benedikt] Univ Heidelberg Hosp, Dept Pediat, Heidelberg, Germany; [Szendroi, Miklos] Semmelweis Univ, Dept Orthoped, H-1085 Budapest, Hungary; [Kinscherf, Ralf] Univ Marburg, Dept Med Cell Biol, Inst Anat & Cell Biol, Marburg, Germany; [Fritzsching, Benedikt] Heidelberg Univ, TLRC, Dept Translat Pulmonol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Semmelweis University; Ruprecht Karls University Heidelberg; Semmelweis University; Philipps University Marburg; Ruprecht Karls University Heidelberg	Kunz, P (corresponding author), Univ Heidelberg Hosp, Dept Orthoped & Traumatol, Heidelberg, Germany.	Pierre.Kunz@med.uni-heidelberg.de	Kinscherf, Ralf/AAV-7164-2021		Deutsche Kinderkrebsstifting [DKS2009.05, DKS2012.09]; Junior Group Leader "Airway Inflammation"; TLRC/German Center for Lung Research; EuroBoNeT; Stiftung Landesbank Baden-Wuerttemberg	Deutsche Kinderkrebsstifting; Junior Group Leader "Airway Inflammation"; TLRC/German Center for Lung Research; EuroBoNeT(European CommissionEuropean Commission Joint Research Centre); Stiftung Landesbank Baden-Wuerttemberg	This work was supported by the Deutsche Kinderkrebsstifting (http://www.kinderkrebsstiftung.de/ Grant number DKS2009.05, DKS2012.09), Junior Group Leader "Airway Inflammation", TLRC/German Center for Lung Research (http://www.dzl.de), EuroBoNeT (http://eurobonet.pathobiology.eu/cd/index.php), and Stiftung Landesbank Baden-Wuerttemberg, (http://www.lbbw.de/lbbwde/1000010859-de.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsat C, 2011, ISRN Obstet Gynecol, V2011, P354861, DOI 10.5402/2011/354861; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Chantrain CF, 2003, J HISTOCHEM CYTOCHEM, V51, P151, DOI 10.1177/002215540305100203; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; Curiel TJ, 2004, CANCER RES, V64, P5535, DOI 10.1158/0008-5472.CAN-04-1272; D'Amico F, 2009, J IMMUNOL METHODS, V341, P1, DOI 10.1016/j.jim.2008.11.007; Ek Eugene T H, 2006, Int Semin Surg Oncol, V3, P7, DOI 10.1186/1477-7800-3-7; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966; FOX SB, 1995, J PATHOL, V177, P275, DOI 10.1002/path.1711770310; FOX SB, 1994, BREAST CANCER RES TR, V29, P109, DOI 10.1007/BF00666186; Franz B, 2007, ARTHRITIS RHEUM-US, V56, P1910, DOI 10.1002/art.22699; Fritzsching B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017988; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Goldstein NS, 2007, APPL IMMUNOHISTO M M, V15, P124, DOI 10.1097/PAI.0b013e31804c7283; Gorlick R, 2003, CLIN CANCER RES, V9, P5442; Guo XJ, 2008, MODERN PATHOL, V21, P1101, DOI 10.1038/modpathol.2008.72; Haas J, 2008, BLOOD, V111, P761, DOI 10.1182/blood-2007-08-104877; Hammond MEH, 2000, ARCH PATHOL LAB MED, V124, P958; HASEGAWA T, 1991, HUM PATHOL, V22, P583, DOI 10.1016/0046-8177(91)90236-I; Hughes DPM, 2009, CURR OPIN ONCOL, V21, P332, DOI 10.1097/CCO.0b013e32832c94e2; Kaya M, 2000, CLIN CANCER RES, V6, P572; Kim NT, 2003, ANAL CELL PATHOL, V25, P63, DOI 10.1155/2003/473902; Klein MJ, 2006, AM J CLIN PATHOL, V125, P555, DOI 10.1309/UC6KQHLD9LV2KENN; Klemke CD, 2006, LEUKEMIA, V20, P1123, DOI 10.1038/sj.leu.2404182; Kreuter M, 2004, CLIN CANCER RES, V10, P8531, DOI 10.1158/1078-0432.CCR-04-0969; Kunz P, 2006, J NUCL MED, V47, P1515; Mangham DC, 2011, CLIN SARCOMA RES, V1, DOI 10.1186/2045-3329-1-6; Mantadakis E, 2001, J PEDIAT HEMATOL ONC, V23, P286, DOI 10.1097/00043426-200106000-00010; Mikulic D, 2004, PEDIATR HEMAT ONCOL, V21, P611, DOI 10.1080/08880010490501015; Osada T, 2008, CANCER IMMUNOL IMMUN, V57, P1115, DOI 10.1007/s00262-007-0441-x; Quintanilla-Martinez L, 2012, PATHOLOGE, V33, P481, DOI 10.1007/s00292-012-1647-z; Schoell WMJ, 1997, CANCER, V80, P2257; Shi SR, 1996, J PATHOL, V179, P347; SHI SR, 1992, J HISTOCHEM CYTOCHEM, V40, P787, DOI 10.1177/40.6.1588025; Shi SR, 2001, J HISTOCHEM CYTOCHEM, V49, P931, DOI 10.1177/002215540104900801; Simpson JF, 1996, CANCER, V77, P2077, DOI 10.1002/(SICI)1097-0142(19960515)77:10<2077::AID-CNCR17>3.3.CO;2-N; Sorensen Flemming Brandt, 2008, Sarcoma, V2008, P874075, DOI 10.1155/2008/874075; Sullivan CAW, 2009, HUM PATHOL, V40, P156, DOI 10.1016/j.humpath.2008.07.005; Tomlinson J, 1999, CLIN CANCER RES, V5, P3516; van Niekerk CG, 2009, PROSTATE, V69, P62, DOI 10.1002/pros.20855; Vermeulen PB, 1996, EUR J CANCER, V32A, P2474, DOI 10.1016/S0959-8049(96)00379-6; Vermeulen PB, 2002, EUR J CANCER, V38, P1564, DOI 10.1016/S0959-8049(02)00094-1; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Wilson E, 2007, J IMMUNOL METHODS, V322, P137, DOI 10.1016/j.jim.2007.01.020; Xu M, 2013, BONE, V57, P111, DOI 10.1016/j.bone.2013.07.035; Yamashita S, 2007, PROG HISTOCHEM CYTO, V41, P141, DOI 10.1016/j.proghi.2006.09.001; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	48	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90727	10.1371/journal.pone.0090727	http://dx.doi.org/10.1371/journal.pone.0090727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594971	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900140
J	Ma, QL; Deng, P; Zhu, G; Liu, C; Zhang, L; Zhou, Z; Luo, X; Li, M; Zhong, M; Yu, ZP; Chen, CH; Zhang, YW				Ma, Qinlong; Deng, Ping; Zhu, Gang; Liu, Chuan; Zhang, Lei; Zhou, Zhou; Luo, Xue; Li, Min; Zhong, Min; Yu, Zhengping; Chen, Chunhai; Zhang, Yanwen			Extremely Low-Frequency Electromagnetic Fields Affect Transcript Levels of Neuronal Differentiation-Related Genes in Embryonic Neural Stem Cells	PLOS ONE			English	Article							IN-VITRO; 50 HZ; MAGNETIC-FIELD; PRECURSOR CELLS; DNA-DAMAGE; EXPOSURE; PROLIFERATION; NEUROGENESIS; MAINTENANCE; MATURATION	Previous studies have reported that extremely low-frequency electromagnetic fields (ELF-EMF) can affect the processes of brain development, but the underlying mechanism is largely unknown. The proliferation and differentiation of embryonic neural stem cells (eNSCs) is essential for brain development during the gestation period. To date, there is no report about the effects of ELF-EMF on eNSCs. In this paper, we studied the effects of ELF-EMF on the proliferation and differentiation of eNSCs. Primary cultured eNSCs were treated with 50 Hz ELF-EMF; various magnetic intensities and exposure times were applied. Our data showed that there was no significant change in cell proliferation, which was evaluated by cell viability (CCK-8 assay), DNA synthesis (Edu incorporation), average diameter of neurospheres, cell cycle distribution (flow cytometry) and transcript levels of cell cycle related genes (P53, P21 and GADD45 detected by real-time PCR). When eNSCs were induced to differentiation, real-time PCR results showed a down-regulation of Sox2 and up-regulation of Math1, Math3, Ngn1 and Tuj1 mRNA levels after 50 Hz ELF-EMF exposure (2 mT for 3 days), but the percentages of neurons (Tuj1 positive cells) and astrocytes (GFAP positive cells) were not altered when detected by immunofluorescence assay. Although cell proliferation and the percentages of neurons and astrocytes differentiated from eNSCs were not affected by 50 Hz ELF-EMF, the expression of genes regulating neuronal differentiation was altered. In conclusion, our results support that 50 Hz ELF-EMF induce molecular changes during eNSCs differentiation, which might be compensated by post-transcriptional mechanisms to support cellular homeostasis.	[Ma, Qinlong; Deng, Ping; Zhu, Gang; Liu, Chuan; Zhang, Lei; Zhou, Zhou; Luo, Xue; Li, Min; Zhong, Min; Yu, Zhengping; Chen, Chunhai; Zhang, Yanwen] Third Mil Med Univ, Fac Prevent Med, Dept Occupat Hlth, Chongqing, Peoples R China	Army Medical University	Chen, CH (corresponding author), Third Mil Med Univ, Fac Prevent Med, Dept Occupat Hlth, Chongqing, Peoples R China.	chunhai2000@163.com; zhangyw20022002@aliyun.com		Chen, Chunhai/0000-0002-7549-213X	National Natural Science Foundation of China [30770507]; National Basic Research Program of China (National 973 Program) [2011CB503700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (National 973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (No. 30770507) and a grant from the National Basic Research Program of China (National 973 Program) (Grant No.: 2011CB503700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; BAE IS, 1995, CANCER RES, V55, P2387; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bodega G, 2005, ENVIRON RES, V98, P355, DOI 10.1016/j.envres.2004.12.010; Burdak-Rothkamm S, 2009, MUTAT RES-GEN TOX EN, V672, P82, DOI 10.1016/j.mrgentox.2008.10.016; Carlessi L, 2009, CELL DEATH DIFFER, V16, P795, DOI 10.1038/cdd.2009.10; Chen CH, 2011, NEUROTOX RES, V20, P15, DOI 10.1007/s12640-010-9214-y; Cuccurazzu B, 2010, EXP NEUROL, V226, P173, DOI 10.1016/j.expneurol.2010.08.022; Czyz J, 2004, MUTAT RES-GEN TOX EN, V557, P63, DOI 10.1016/j.mrgentox.2003.09.011; Das S, 2012, ELECTROMAGN BIOL MED, V31, P180, DOI 10.3109/15368378.2012.695706; Del Vecchio G, 2009, NEUROSCI LETT, V455, P173, DOI 10.1016/j.neulet.2009.03.061; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Focke F, 2010, MUTAT RES-FUND MOL M, V683, P74, DOI 10.1016/j.mrfmmm.2009.10.012; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Grassi C, 2004, CELL CALCIUM, V35, P307, DOI 10.1016/j.ceca.2003.09.001; Harry GJ, 2000, RADIAT RES, V153, P642; Hashimoto D, 2008, J CELL BIOL, V181, P1065, DOI 10.1083/jcb.200712156; Hirsch Matthew L., 2011, PLOS ONE, V6; Huang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030638; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Ivancsits S, 2002, MUTAT RES-GEN TOX EN, V519, P1, DOI 10.1016/S1383-5718(02)00109-2; Kheifets LI, 1995, J OCCUP ENVIRON MED, V37, P1327, DOI 10.1097/00043764-199512000-00002; Lacy-Hulbert A, 1998, FASEB J, V12, P395, DOI 10.1096/fasebj.12.6.395; Lisi A, 2005, J CELL PHYSIOL, V204, P532, DOI 10.1002/jcp.20322; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Liu Yun, 2003, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V21, P339; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis Sharon A, 2013, Methods Mol Biol, V946, P479, DOI 10.1007/978-1-62703-128-8_30; McFarlane EH, 2000, BIOELECTROCHEMISTRY, V52, P23, DOI 10.1016/S0302-4598(00)00078-7; Nam C, 2010, HISTOL HISTOPATHOL, V25, P485, DOI 10.14670/HH-25.485; Nikolova T, 2005, FASEB J, V19, P1686, DOI 10.1096/fj.04-3549fje; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Piacentini R, 2008, J CELL PHYSIOL, V215, P129, DOI 10.1002/jcp.21293; Qiu CX, 2004, EPIDEMIOLOGY, V15, P687, DOI 10.1097/01.ede.0000142147.49297.9d; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Ruzhynsky VA, 2007, J NEUROSCI, V27, P5926, DOI 10.1523/JNEUROSCI.1538-07.2007; Schuderer J, 2004, BIOELECTROMAGNETICS, V25, P582, DOI 10.1002/bem.20037; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Vanderluit JL, 2004, J CELL BIOL, V166, P853, DOI 10.1083/jcb.200403156; Vazquez-Garcia M, 2004, PHYSIOL BEHAV, V82, P685, DOI 10.1016/j.physbeh.2004.06.004; Yao L, 2012, MOL BIOL REP, V39, P569, DOI 10.1007/s11033-011-0772-8; Yoshimatsu T, 2006, DEVELOPMENT, V133, P2553, DOI 10.1242/dev.02419	43	40	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90041	10.1371/journal.pone.0090041	http://dx.doi.org/10.1371/journal.pone.0090041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595264	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900056
J	Vedam-Mai, V; Gardner, B; Okun, MS; Siebzehnrubl, FA; Kam, M; Aponso, P; Steindler, DA; Yachnis, AT; Neal, D; Oliver, BU; Rath, SJ; Faull, RLM; Reynolds, BA; Curtis, MA				Vedam-Mai, Vinata; Gardner, Bronwen; Okun, Michael S.; Siebzehnrubl, Florian A.; Kam, Monica; Aponso, Palingu; Steindler, Dennis A.; Yachnis, Anthony T.; Neal, Dan; Oliver, Brittany U.; Rath, Sean J.; Faull, Richard L. M.; Reynolds, Brent A.; Curtis, Maurice A.			Increased Precursor Cell Proliferation after Deep Brain Stimulation for Parkinson's Disease: A Human Study	PLOS ONE			English	Article							SUBVENTRICULAR ZONE; HUNTINGTONS-DISEASE; PROGENITOR CELLS; SUBTHALAMIC NUCLEUS; SUBEPENDYMAL LAYER; NEUROGENIC ZONES; BASAL GANGLIA; HIPPOCAMPUS; DISORDERS; ANATOMY	Objective: Deep brain stimulation (DBS) has been used for more than a decade to treat Parkinson's disease (PD); however, its mechanism of action remains unknown. Given the close proximity of the electrode trajectory to areas of the brain known as the "germinal niches," we sought to explore the possibility that DBS influences neural stem cell proliferation locally, as well as more distantly. Methods: We studied the brains of a total of 12 idiopathic Parkinson's disease patients that were treated with DBS (the electrode placement occurred 0.5-6 years before death), and who subsequently died of unrelated illnesses. These were compared to the brains of 10 control individuals without CNS disease, and those of 5 PD patients with no DBS. Results: Immunohistochemical analyses of the subventricular zone (SVZ) of the lateral ventricles, the third ventricle lining, and the tissue surrounding the DBS lead revealed significantly greater numbers of proliferating cells expressing markers of the cell cycle, plasticity, and neural precursor cells in PD-DBS tissue compared with both normal brain tissue and tissue from PD patients not treated with DBS. The level of cell proliferation in the SVZ in PD-DBS brains was 2-6 fold greater than that in normal and untreated PD brains. Conclusions: Our data suggest that DBS is capable of increasing cellular plasticity in the brain, and we hypothesize that it may have more widespread effects beyond the electrode location. It is unclear whether these effects of DBS have any symptomatic or other beneficial influences on PD.	[Vedam-Mai, Vinata; Okun, Michael S.; Siebzehnrubl, Florian A.; Steindler, Dennis A.; Oliver, Brittany U.; Rath, Sean J.; Reynolds, Brent A.] Univ Florida, Dept Neurosurg, McKnight Brain Inst, Gainesville, FL USA; [Vedam-Mai, Vinata] Univ Florida, Dept Neurol, UF Ctr Movement Disorders & Restorat, Gainesville, FL USA; [Gardner, Bronwen; Kam, Monica; Aponso, Palingu; Faull, Richard L. M.; Curtis, Maurice A.] Univ Auckland, Dept Anat Radiol, Auckland 1, New Zealand; [Gardner, Bronwen; Kam, Monica; Aponso, Palingu; Faull, Richard L. M.; Curtis, Maurice A.] Univ Auckland, Sch Med & Hlth Sci, Ctr Brain Res, Auckland 1, New Zealand; [Yachnis, Anthony T.] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Neal, Dan] Univ Florida, Dept Biostat, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Auckland; University of Auckland; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Curtis, MA (corresponding author), Univ Auckland, Dept Anat Radiol, Auckland 1, New Zealand.	m.curtis@auckland.ac.nz	Steindler, Dennis/AAJ-5811-2020; Siebzehnrubl, Florian/AAF-1496-2020	Siebzehnrubl, Florian/0000-0001-8411-8775; Okun, Michael/0000-0002-6247-9358; Curtis, Maurice/0000-0003-4496-0233; Gardner, Bronwen/0000-0001-6429-0535; Faull, Richard/0000-0003-3385-9498; Yachnis, Anthony/0000-0002-6971-0698	National Institute of Neurological Disorders and Stroke [U24 NS072026]; National Institute on Aging [P30 AG19610]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Health Research Council of New Zealand; Gus Fisher Trust; UF Foundation; National Parkinson Foundation Center of Excellence; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS072026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG019610] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Health Research Council of New Zealand(Health Research Council of New Zealand); Gus Fisher Trust; UF Foundation; National Parkinson Foundation Center of Excellence; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This program is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 the Michael J. Fox Foundation for Parkinson's Research. The Neurological Foundation of New Zealand for support of the brain bank, the Health Research Council of New Zealand Programme grant and the Gus Fisher Trust for research funding. Further funding was provided by the UF Foundation and the National Parkinson Foundation Center of Excellence located at the University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Beurrier C, 2001, J NEUROPHYSIOL, V85, P1351, DOI 10.1152/jn.2001.85.4.1351; Boekhoorn K, 2006, NEUROBIOL DIS, V24, P1, DOI 10.1016/j.nbd.2006.04.017; Butson CR, 2007, NEUROIMAGE, V34, P661, DOI 10.1016/j.neuroimage.2006.09.034; Castrioto A, 2011, ARCH NEUROL-CHICAGO, V68, P1550, DOI 10.1001/archneurol.2011.182; Chesselet MF, 1996, TRENDS NEUROSCI, V19, P417; Curtis MA, 2006, J CHEM NEUROANAT, V31, P210, DOI 10.1016/j.jchemneu.2006.01.005; Curtis MA, 2005, NEUROSCIENCE, V132, P777, DOI 10.1016/j.neuroscience.2004.12.051; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Curtis MA, 2007, NAT REV NEUROSCI, V8, P712, DOI 10.1038/nrn2216; DeLong MR, 2001, ANN NEUROL, V49, P142, DOI 10.1002/1531-8249(20010201)49:2<142::AID-ANA32>3.0.CO;2-O; Dostrovsky JO, 2000, J NEUROPHYSIOL, V84, P570, DOI 10.1152/jn.2000.84.1.570; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Halpern C, 2007, PARKINSONISM RELAT D, V13, P1, DOI 10.1016/j.parkreldis.2006.03.001; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Low VF, 2011, NEUROSCIENCE, V199, P577, DOI 10.1016/j.neuroscience.2011.09.010; Lozano AM, 2001, PARKINSONISM RELAT D, V7, P199, DOI 10.1016/S1353-8020(00)00057-2; Mai KM, 2008, ATLAS HUMAN BRAIN; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P589, DOI 10.1016/j.clinph.2003.10.033; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; Migaud M, 2010, EUR J NEUROSCI, V32, P2042, DOI 10.1111/j.1460-9568.2010.07521.x; Montgomery EB, 2000, NEUROL RES, V22, P259; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Nait-Oumesmar B, 2007, P NATL ACAD SCI USA, V104, P4694, DOI 10.1073/pnas.0606835104; Okun MS, 2010, EXPERT REV NEUROTHER, V10, P1847, DOI 10.1586/ERN.10.156; Song SJ, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/205878; Tattersfield AS, 2004, NEUROSCIENCE, V127, P319, DOI 10.1016/j.neuroscience.2004.04.061; Urbano Francisco J., 2002, Thalamus & Related Systems, V1, P371, DOI 10.1016/S1472-9288(02)00009-2; van den Berge SA, 2011, BRAIN, V134, P3249, DOI 10.1093/brain/awr256; Verwer RWH, 2007, BRAIN, V130, P3321, DOI 10.1093/brain/awm264	34	37	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e88770	10.1371/journal.pone.0088770	http://dx.doi.org/10.1371/journal.pone.0088770			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594681	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000332468900006
J	Walter, WD; Smith, R; Vanderklok, M; VerCauteren, KC				Walter, W. David; Smith, Rick; Vanderklok, Mike; VerCauteren, Kurt C.			Linking Bovine Tuberculosis on Cattle Farms to White-Tailed Deer and Environmental Variables Using Bayesian Hierarchical Analysis	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; MYCOBACTERIUM-BOVIS; ODOCOILEUS-VIRGINIANUS; WILDLIFE; MICHIGAN; CONVERGENCE; PREVALENCE; MANAGEMENT; INFECTION; EPIDEMIOLOGY	Bovine tuberculosis is a bacterial disease caused by Mycobacterium bovis in livestock and wildlife with hosts that include Eurasian badgers (Meles meles), brushtail possum (Trichosurus vulpecula), and white-tailed deer (Odocoileus virginianus). Risk-assessment efforts in Michigan have been initiated on farms to minimize interactions of cattle with wildlife hosts but research on M. bovis on cattle farms has not investigated the spatial context of disease epidemiology. To incorporate spatially explicit data, initial likelihood of infection probabilities for cattle farms tested for M. bovis, prevalence of M. bovis in white-tailed deer, deer density, and environmental variables for each farm were modeled in a Bayesian hierarchical framework. We used geo-referenced locations of 762 cattle farms that have been tested for M. bovis, white-tailed deer prevalence, and several environmental variables that may lead to long-term survival and viability of M. bovis on farms and surrounding habitats (i.e., soil type, habitat type). Bayesian hierarchical analyses identified deer prevalence and proportion of sandy soil within our sampling grid as the most supported model. Analysis of cattle farms tested for M. bovis identified that for every 1% increase in sandy soil resulted in an increase in odds of infection by 4%. Our analysis revealed that the influence of prevalence of M. bovis in white-tailed deer was still a concern even after considerable efforts to prevent cattle interactions with white-tailed deer through on-farm mitigation and reduction in the deer population. Cattle farms test positive for M. bovis annually in our study area suggesting that the potential for an environmental source either on farms or in the surrounding landscape may contributing to new or re-infections with M. bovis. Our research provides an initial assessment of potential environmental factors that could be incorporated into additional modeling efforts as more knowledge of deer herd factors and cattle farm prevalence is documented.	[Walter, W. David] Penn State Univ, US Geol Survey, Penn Cooperat Fish & Wildlife Res Unit, University Pk, PA 16802 USA; [Smith, Rick; Vanderklok, Mike] Michigan Dept Agr & Rural Dev, Anim Ind Div, Lansing, MI USA; [VerCauteren, Kurt C.] US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA)	Walter, WD (corresponding author), Penn State Univ, US Geol Survey, Penn Cooperat Fish & Wildlife Res Unit, University Pk, PA 16802 USA.	wdwalter@psu.edu			National Wildlife Research Center of the United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services	National Wildlife Research Center of the United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services	Funding for this research was provided by the National Wildlife Research Center of the United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, MODEL SELECTION MULT; [Anonymous], 2011, VET MED INT, DOI DOI 10.4061/2011/874924; Banerjee S., 2004, HIERARCHICAL MODELIN, P1; Berentsen AR, 2013, EUROPEAN J IN PRESS; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Brook RK, 2010, PREV VET MED, V94, P301, DOI 10.1016/j.prevetmed.2010.01.010; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Carstensen Michelle, 2011, Veterinary Medicine International, P413240, DOI 10.4061/2011/413240; CLIFTONHADLEY RS, 1993, EPIDEMIOL INFECT, V111, P9, DOI 10.1017/S0950268800056624; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Creed WA, 1984, WHITE TAILED DEER EC; de Lisle GW, 2002, REV SCI TECH OIE, V21, P317, DOI 10.20506/rst.21.2.1339; DUFFIELD BJ, 1985, VET MICROBIOL, V10, P193, DOI 10.1016/0378-1135(85)90021-5; Eberhardt LL, 1960, ESTIMATION VITAL CHA; Eberly LE, 2000, STAT MED, V19, P2279, DOI 10.1002/1097-0258(20000915/30)19:17/18<2279::AID-SIM569>3.0.CO;2-R; Farnsworth ML, 2006, ECOL APPL, V16, P1026, DOI 10.1890/1051-0761(2006)016[1026:LCWDTM]2.0.CO;2; Fine AE, 2011, VET MED INT, V2011, P1; Fine AE, 2011, ISRN VET SCI; Gelman A., 2004, BAYESIAN DATA ANAL, P1; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; GRIFFIN JM, 1993, PREV VET MED, V17, P145, DOI 10.1016/0167-5877(93)90025-O; Hill JA, 2005, THESIS UTAH STATE U; Hughey BD, 2003, THESIS MICHIGAN STAT; Hutchings MR, 1997, VET J, V153, P149, DOI 10.1016/S1090-0233(97)80035-4; Imrie CE, 2009, ENVIRON GEOCHEM HLTH, V31, P133, DOI 10.1007/s10653-008-9172-y; Jackson R, 1995, NEW ZEAL VET J, V43, P346, DOI 10.1080/00480169./1995.35918; Kaneene JB, 2004, JAVMA-J AM VET MED A, V224, P685, DOI 10.2460/javma.2004.224.685; Kaneene JB, 2002, J AM VET MED ASSOC, V221, P837, DOI 10.2460/javma.2002.221.837; Knust BM, 2011, AM J VET RES, V72, P924, DOI 10.2460/ajvr.72.7.924; Mathews F, 2006, BIOL LETTERS, V2, P271, DOI 10.1098/rsbl.2006.0461; Miller R, 2003, J WILDLIFE DIS, V39, P84, DOI 10.7589/0090-3558-39.1.84; Miller RA, 2006, AM J VET RES, V67, P604, DOI 10.2460/ajvr.67.4.604; Miller R, 2007, PREV VET MED, V82, P111, DOI 10.1016/j.prevetmed.2007.05.011; Mitscherlich E, 1984, MICROBIAL SURVIVAL E, P1; O'Brien DJ, 2011, VET MICROBIOL, V151, P179, DOI 10.1016/j.vetmic.2011.02.042; O'Brien DJ, 2004, J WILDLIFE DIS, V40, P42, DOI 10.7589/0090-3558-40.1.42; O'Brien DJ, 2002, PREV VET MED, V54, P47, DOI 10.1016/S0167-5877(02)00010-7; O'Brien DJ, 2006, VET MICROBIOL, V112; Osnas EE, 2009, ECOL APPL, V19, P1311, DOI 10.1890/08-0578.1; Phillips CJC, 2003, RES VET SCI, V74, P1, DOI 10.1016/S0034-5288(02)00145-5; Phillips Clive J. C., 2002, Animal Health Research Reviews, V3, P3, DOI 10.1079/AHRR200236; Smith BJ, 2007, J STAT SOFTW, V21, P1; Spiegelhalter D, 2003, WINBUGS VERSION 1 4; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; USDA NRCS, 2007, SOIL DAT VIEW 5 2 US; VANDONSEL DJ, 1977, J FOOD PROTECT, V40, P160, DOI 10.4315/0362-028X-40.3.160; Walter WD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1203; Walter WD., 2012, VET MED INT, V2012, P1, DOI [10.1155/2012/616318, DOI 10.1155/2012/616318]; Williams RS, 1930, J HYG-CAMBRIDGE, V30, P413, DOI 10.1017/S0022172400010561; Witmer G, 2010, J WILDLIFE DIS, V46, P368, DOI 10.7589/0090-3558-46.2.368; Young JS, 2005, APPL ENVIRON MICROB, V71, P1946, DOI 10.1128/AEM.71.4.1946-1952.2005	51	10	10	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90925	10.1371/journal.pone.0090925	http://dx.doi.org/10.1371/journal.pone.0090925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595231	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900158
J	Xiao, F; Ma, L; Zhao, M; Huang, GC; Mirenda, V; Dorling, A; Lechler, R; Lombardi, G				Xiao, Fang; Ma, Liang; Zhao, Min; Huang, Guocai; Mirenda, Vincenzo; Dorling, Anthony; Lechler, Robert; Lombardi, Giovanna			Ex Vivo Expanded Human Regulatory T Cells Delay Islet Allograft Rejection via Inhibiting Islet-Derived Monocyte Chemoattractant Protein-1 Production in CD34(+) Stem Cells-Reconstituted NOD-scid IL2r gamma(null) Mice	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IN-VITRO; RAG2(-/-)GAMMA(-/-)(C) MICE; INTERFERON-GAMMA; IMMUNE CELLS; TRANSPLANTATION; BLOOD; ENGRAFTMENT; MODEL; DIFFERENTIATION	Type 1 diabetes mellitus (T1DM) is an autoimmune disease caused by immune-mediated destruction of insulin-secreting beta cells of the pancreas. Near complete dependence on exogenous insulin makes T1DM very difficult to control, with the result that patients are exposed to high blood glucose and risk of diabetic complications and/or intermittent low blood glucose that can cause unconsciousness, fits and even death. Allograft transplantation of pancreatic islets restores normoglycemia with a low risk of surgical complications. However, although successful immediately after transplantation, islets are progressively lost, with most of the patients requiring exogenous insulin within 2 years post-transplant. Therefore, there is an urgent requirement for the development of new strategies to prevent islet rejection. In this study, we explored the importance of human regulatory T cells in the control of islets allograft rejection. We developed a pre-clinical model of human islet transplantation by reconstituting NOD-scid IL2r gamma(null) mice with cord blood-derived human CD34(+) stem cells and demonstrated that although the engrafted human immune system mediated the rejection of human islets, their survival was significantly prolonged following adoptive transfer of ex vivo expanded human T-regs. Mechanistically, T-regs inhibited the infiltration of innate immune cells and CD4(+) T cells into the graft by down-regulating the islet graft-derived monocyte chemoattractant protein-1. Our findings might contribute to the development of clinical strategies for T-reg therapy to control human islet rejection. We also show for the first time that CD34(+) cells-reconstituted NOD-scid IL2r gamma(null) mouse model could be beneficial for investigating human innate immunity in vivo.	[Xiao, Fang; Ma, Liang; Mirenda, Vincenzo; Dorling, Anthony; Lechler, Robert; Lombardi, Giovanna] Kings Coll London, Med Res Council MRC Transplantat, London WC2R 2LS, England; [Zhao, Min; Huang, Guocai] Kings Coll London, Dept Endocrinol & Diabet, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Lombardi, G (corresponding author), Kings Coll London, Med Res Council MRC Transplantat, London WC2R 2LS, England.	giovanna.lombardi@kcl.ac.uk		Dorling, Anthony/0000-0003-3102-2600	National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; National Institute for Health Research (NIHR) Biomedical Research Centre based at King's College London; Guy's and St Thomas' Charity Trust [R070723]; Medical Research Council in the UK [MR/J006742/1]; British Heart Foundation in the UK [RG/08/005/25303]; MRC [G0801965] Funding Source: UKRI; British Heart Foundation [RG/13/12/30395, RG/08/005/25303] Funding Source: researchfish; Medical Research Council [MR/J006742/1, G0801965] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; National Institute for Health Research (NIHR) Biomedical Research Centre based at King's College London(National Institute for Health Research (NIHR)); Guy's and St Thomas' Charity Trust; Medical Research Council in the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation in the UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research was funded by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The authors acknowledge financial support from Guy's and St Thomas' Charity Trust (R070723), Medical Research Council in the UK (MR/J006742/1), and British Heart Foundation in the UK (RG/08/005/25303). The funders had no role in study, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzali B, 2013, CLIN J AM SOC NEPHRO, V8, P1396, DOI 10.2215/CJN.12931212; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Brehm MA, 2012, BLOOD, V119, P2778, DOI 10.1182/blood-2011-05-353243; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; Chen DM, 2006, DIABETES, V55, P1011, DOI 10.2337/diabetes.55.04.06.db05-1048; Chen P, 2012, ACTA HISTOCHEM; Danner R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019826; Di Ianni M, 2012, TRANSFUS APHER SCI, V47, P213, DOI 10.1016/j.transci.2012.06.007; Ehrnfelt C, 2004, XENOTRANSPLANTATION, V11, P184, DOI 10.1046/j.1399-3089.2003.00104.x; Fiorina P, 2007, ENDOCRIN METAB CLIN, V36, px; Fiorina P, 2011, ENDOCR REV, V32, P725, DOI 10.1210/er.2011-0008; Florina P, 2007, ENDOCRIN METAB CLIN, V36, P999, DOI 10.1016/j.ecl.2007.07.004; Garcia S, 2012, IMMUNOL LETT, V146, P1, DOI 10.1016/j.imlet.2012.03.009; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; Harrison OJ, 2013, COLD SPRING HARB PER, V5; Hofer U, 2008, J VIROL, V82, P12145, DOI 10.1128/JVI.01105-08; Hu Z, 2012, CELL MOL IMMUNOL, V9, P232, DOI 10.1038/cmi.2011.63; Huang SJ, 2006, J REPROD IMMUNOL, V72, P60, DOI 10.1016/j.jri.2006.03.002; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Issa F, 2010, TRANSPLANTATION, V90, P1321, DOI 10.1097/TP.0b013e3181ff8772; Jacobson S, 2010, SCAND J IMMUNOL, V71, P83, DOI 10.1111/j.1365-3083.2009.02356.x; Jaiswal S, 2012, IMMUNOLOGY, V136, P334, DOI 10.1111/j.1365-2567.2012.03585.x; King M, 2008, CLIN IMMUNOL, V126, P303, DOI 10.1016/j.clim.2007.11.001; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Kolev M, 2013, SEMIN IMMUNOL, V25, P12, DOI 10.1016/j.smim.2013.04.012; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Lee YW, 2003, AM J PHYSIOL-HEART C, V284, pH185, DOI 10.1152/ajpheart.00524.2002; Li K, 2007, MOL IMMUNOL, V44, P3866, DOI 10.1016/j.molimm.2007.06.006; Maffi P, 2007, DIABETES CARE, V30, P1150, DOI 10.2337/dc06-1794; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Matsumura B, 2003, EXP HEMATOL, V31, P789, DOI 10.1016/S0301-472X(03)00193-0; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Nadig SN, 2010, NAT MED, V16, P809, DOI 10.1038/nm.2154; Piemonti L, 2002, DIABETES, V51, P55, DOI 10.2337/diabetes.51.1.55; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Sagoo P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002076; Sawitzki B, 2005, J EXP MED, V201, P1925, DOI 10.1084/jem.20050419; Schmidt A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00051; Scotta C, 2013, HAEMATOLOGICA, V98, P1291, DOI 10.3324/haematol.2012.074088; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tang QZ, 2012, CURR OPIN ORGAN TRAN, V17, P349, DOI 10.1097/MOT.0b013e328355a992; Tanriver Y, 2009, J IMMUNOL, V183, P2946, DOI 10.4049/jimmunol.0803953; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Tresoldi E, 2011, HAEMATOL-HEMATOL J, V96, P1357, DOI 10.3324/haematol.2011.041483; Vergani A, 2013, DIABETES, V62, P1665, DOI 10.2337/db12-0242; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; Watanabe S, 2007, J VIROL, V81, P13259, DOI 10.1128/JVI.01353-07; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227; Wood KJ, 2006, TRENDS IMMUNOL, V27, P183, DOI 10.1016/j.it.2006.02.008; Wu DC, 2013, TRANSPLANTATION; Yi SN, 2012, DIABETES, V61, P1180, DOI 10.2337/db11-1306; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022; Zhao M, 2002, TRANSPLANTATION, V73, P1454, DOI 10.1097/00007890-200205150-00015	63	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90387	10.1371/journal.pone.0090387	http://dx.doi.org/10.1371/journal.pone.0090387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594640	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900104
J	Bei, AK; Patel, SD; Volkman, SK; Ahouidi, AD; Ndiaye, D; Mboup, S; Wirth, DF				Bei, Amy K.; Patel, Saurabh D.; Volkman, Sarah K.; Ahouidi, Ambroise D.; Ndiaye, Daouda; Mboup, Souleymane; Wirth, Dyann F.			An Adjustable Gas-Mixing Device to Increase Feasibility of In Vitro Culture of Plasmodium falciparum Parasites in the Field	PLOS ONE			English	Article							MALARIA PARASITES; CULTIVATION; ERYTHROCYTES; INVITRO; CHLOROQUINE; INVASION; OXYGEN; VIVAX; CELLS; ASSAY	A challenge to conducting high-impact and reproducible studies of the mechanisms of P. falciparum drug resistance, invasion, virulence, and immunity is the lack of robust and sustainable in vitro culture in the field. While the technology exists and is routinely utilized in developed countries, various factors-from cost, to supply, to quality-make it hard to implement in malaria endemic countries. Here, we design and rigorously evaluate an adjustable gas-mixing device for the in vitro culture of P. falciparum parasites in the field to circumvent this challenge. The device accurately replicates the gas concentrations needed to culture laboratory isolates, short-term adapted field isolates, cryopreserved previously non-adapted isolates, as well as to adapt ex vivo isolates to in vitro culture in the field. We also show an advantage over existing alternatives both in cost and in supply. Furthermore, the adjustable nature of the device makes it an ideal tool for many applications in which varied gas concentrations could be critical to culture success. This adjustable gas-mixing device will dramatically improve the feasibility of in vitro culture of Plasmodium falciparum parasites in malaria endemic countries given its numerous advantages.	[Bei, Amy K.; Patel, Saurabh D.; Volkman, Sarah K.; Wirth, Dyann F.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Bei, Amy K.; Ahouidi, Ambroise D.; Mboup, Souleymane] Cheikh Anta Diop Univ, Fac Med & Pharm, Lab Bacteriol & Virol, Dakar, Senegal; [Patel, Saurabh D.] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA USA; [Volkman, Sarah K.; Wirth, Dyann F.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Volkman, Sarah K.] Simmons Coll, Sch Nursing & Hlth Sci, Boston, MA 02115 USA; [Ndiaye, Daouda] Cheikh Anta Diop Univ, Lab Parasitol & Mycol, Fac Med & Pharm, Dakar, Senegal	Harvard University; Harvard T.H. Chan School of Public Health; University Cheikh Anta Diop Dakar; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Simmons University; University Cheikh Anta Diop Dakar	Bei, AK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	abei@hsph.harvard.edu		Patel, Saurabh/0000-0002-5738-3175	Bill & Melinda Gates Foundation [OPP1053604]; National Institutes of Health [1R01AI099105-01A1]; American Society of Tropical Medicine & Hygiene (ASTMH) Centennial Award; Office of Faculty Development at Boston Children's Hospital; Shore fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099105] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Tropical Medicine & Hygiene (ASTMH) Centennial Award; Office of Faculty Development at Boston Children's Hospital; Shore fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Bill & Melinda Gates Foundation (grant OPP1053604) and the National Institutes of Health (grant 1R01AI099105-01A1). AKB is supported by an American Society of Tropical Medicine & Hygiene (ASTMH) Centennial Award. SDP is supported by a grant from the Office of Faculty Development at Boston Children's Hospital, and the Shore fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; Bei AK, 2010, AM J HEMATOL, V85, P234, DOI 10.1002/ajh.21642; BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428; Bopp SER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003293; Brackett R G, 1979, Bull World Health Organ, V57 Suppl 1, P33; Briolant S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-44; Butcher G A, 1979, Bull World Health Organ, V57 Suppl 1, P17; Cortes A, 2008, TRENDS PARASITOL, V24, P517, DOI 10.1016/j.pt.2008.08.005; DIVO AA, 1985, ANTIMICROB AGENTS CH, V27, P21, DOI 10.1128/AAC.27.1.21; Djimde A.A., 2007, Bulletin de la Societe de Pathologie Exotique, V100, P3, DOI 10.3185/pathexo2883; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; FAIRLAMB AH, 1985, ANN TROP MED PARASIT, V79, P379, DOI 10.1080/00034983.1985.11811935; Gysin J, 1999, INFECT IMMUN, V67, P6596; He SY, 2000, EXP PARASITOL, V94, P121, DOI 10.1006/expr.1999.4471; JENSEN JB, 1977, J PARASITOL, V63, P883, DOI 10.2307/3279900; JENSEN MD, 1983, J PARASITOL, V69, P1060, DOI 10.2307/3280864; LeRoux M, 2009, TRENDS PARASITOL, V25, P474, DOI 10.1016/j.pt.2009.07.005; Lin Q, 1999, Kansenshogaku Zasshi, V73, P1099; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; NGUYENDINH P, 1980, SCIENCE, V209, P1249, DOI 10.1126/science.6773146; Noulin F, 2013, TRENDS PARASITOL, V29, P286, DOI 10.1016/j.pt.2013.03.012; Nsobya SL, 2008, J INFECT DIS, V198, P1554, DOI 10.1086/592506; OSISANYA JOS, 1981, ANN TROP MED PARASIT, V75, P107, DOI 10.1080/00034983.1981.11687415; Ribacke U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069781; SOUTHWELL BR, 1989, T ROY SOC TROP MED H, V83, P464, DOI 10.1016/0035-9203(89)90248-4; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TRAGER W, 1977, B WORLD HEALTH ORGAN, V55, P363; TRAGER W, 1990, T ROY SOC TROP MED H, V84, P466, DOI 10.1016/0035-9203(90)90362-I; TRAGER W, 1982, BRIT MED BULL, V38, P129, DOI 10.1093/oxfordjournals.bmb.a071748; Trager W, 1979, Bull World Health Organ, V57 Suppl 1, P85; TRAGER W, 1979, J PROTOZOOL, V26, P125, DOI 10.1111/j.1550-7408.1979.tb02747.x; UDEINYA IJ, 1983, EXP PARASITOL, V56, P207, DOI 10.1016/0014-4894(83)90064-4	32	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90928	10.1371/journal.pone.0090928	http://dx.doi.org/10.1371/journal.pone.0090928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603696	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600106
J	Suzuki, M; Kirimoto, H; Sugawara, K; Oyama, M; Yamada, S; Yamamoto, J; Matsunaga, A; Fukuda, M; Onishi, H				Suzuki, Makoto; Kirimoto, Hikari; Sugawara, Kazuhiro; Oyama, Mineo; Yamada, Sumio; Yamamoto, Jun-ichi; Matsunaga, Atsuhiko; Fukuda, Michinari; Onishi, Hideaki			Motor Cortex-Evoked Activity in Reciprocal Muscles Is Modulated by Reward Probability	PLOS ONE			English	Article							TRANSCRANIAL-MAGNETIC-STIMULATION; LATENCY AFFERENT INHIBITION; SYNAPTIC PLASTICITY; INTRACORTICAL INHIBITION; MOVEMENT REPRESENTATIONS; CORTICAL PLASTICITY; PARKINSONS-DISEASE; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; DOPAMINE NEURONS	Horizontal intracortical projections for agonist and antagonist muscles exist in the primary motor cortex (M1), and reward may induce a reinforcement of transmission efficiency of intracortical circuits. We investigated reward-induced change in M1 excitability for agonist and antagonist muscles. Participants were 8 healthy volunteers. Probabilistic reward tasks comprised 3 conditions of 30 trials each: 30 trials contained 10% reward, 30 trials contained 50% reward, and 30 trials contained 90% reward. Each trial began with a cue (red fixation cross), followed by blue circle for 1 s. The subjects were instructed to perform wrist flexion and press a button with the dorsal aspect of middle finger phalanx as quickly as possible in response to disappearance of the blue circle without looking at their hand or the button. Two seconds after the button press, reward/non-reward stimulus was randomly presented for 2-s duration. The reward stimulus was a picture of Japanese 10-yen coin, and each subject received monetary reward at the end of experiment. Subjects were not informed of the reward probabilities. We delivered transcranial magnetic stimulation of the left M1 at the midpoint between center of gravities of agonist flexor carpi radialis (FCR) and antagonist extensor carpi radialis (ECR) muscles at 2 s after the red fixation cross and 1 s after the reward/non-reward stimuli. Relative motor evoked potential (MEP) amplitudes at 2 s after the red fixation cross were significantly higher for 10% reward probability than for 90% reward probability, whereas relative MEP amplitudes at 1 s after reward/non-reward stimuli were significantly higher for 90% reward probability than for 10% and 50% reward probabilities. These results implied that reward could affect the horizontal intracortical projections in M1 for agonist and antagonist muscles, and M1 excitability including the reward-related circuit before and after reward stimulus could be differently altered by reward probability.	[Suzuki, Makoto; Matsunaga, Atsuhiko; Fukuda, Michinari] Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa, Japan; [Kirimoto, Hikari; Sugawara, Kazuhiro; Oyama, Mineo; Onishi, Hideaki] Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan; [Yamada, Sumio] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Yamamoto, Jun-ichi] Keio Univ, Grad Sch Human Relat, Tokyo, Japan	Kitasato University; Niigata University; Nagoya University; Keio University	Suzuki, M (corresponding author), Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa, Japan.	maksuzu@gmail.com	Kirimoto, Hikari/O-6495-2016	Kirimoto, Hikari/0000-0003-3768-5907	Japan Society for the Promotion of Science (JSPS) [25350632]; Niigata University of Health and Welfare	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Niigata University of Health and Welfare	This work was supported by a Grant-in-Aid for Scientific Research (C) 25350632 from the Japan Society for the Promotion of Science (JSPS) and a Grant-in-Aid for Advanced Research from Niigata University of Health and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2006, NEUROIMAGE, V31, P790, DOI 10.1016/j.neuroimage.2006.01.001; Alle H, 2009, J PHYSIOL-LONDON, V587, P5163, DOI 10.1113/jphysiol.2009.179820; Awenowicz PW, 2002, J NEUROPHYSIOL, V88, P3439, DOI 10.1152/jn.00078.2002; Bertolasi L, 1998, J PHYSIOL-LONDON, V511, P947, DOI 10.1111/j.1469-7793.1998.947bg.x; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Campos M, 2005, J NEUROPHYSIOL, V94, P1325, DOI 10.1152/jn.00022.2005; Centonze D, 2003, J NEUROSCI, V23, P8506, DOI 10.1523/jneurosci.23-24-08506.2003; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; Chen R, 1999, EXP BRAIN RES, V129, P77, DOI 10.1007/s002210050938; Davis EJH, 2007, NEUROSCIENCE, V146, P784, DOI 10.1016/j.neuroscience.2007.01.039; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Di Lazzaro V, 2007, CLIN NEUROPHYSIOL, V118, P2207, DOI 10.1016/j.clinph.2007.07.005; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V569, P315, DOI 10.1113/jphysiol.2005.092155; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V564, P661, DOI 10.1113/jphysiol.2004.061747; Gao WJ, 2003, J NEUROSCI, V23, P1622; Gerachshenko T, 2007, EXP BRAIN RES, V183, P531, DOI 10.1007/s00221-007-1071-4; Giacobbe V, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-46; Gottlieb GL, 1998, J NEUROPHYSIOL, V80, P1860, DOI 10.1152/jn.1998.80.4.1860; Gottschalk JM, 2000, J APPL BEHAV ANAL, V33, P85, DOI 10.1901/jaba.2000.33-85; Gupta N, 2011, EUR J NEUROSCI, V33, P183, DOI 10.1111/j.1460-9568.2010.07510.x; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Hikosaka O, 2008, CURR OPIN NEUROBIOL, V18, P203, DOI 10.1016/j.conb.2008.07.002; Hortobagyi T, 2006, EXP BRAIN RES, V171, P322, DOI 10.1007/s00221-005-0274-9; Hosp JA, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00145; Hosp JA, 2011, J NEUROSCI, V31, P2481, DOI 10.1523/JNEUROSCI.5411-10.2011; Hulley S. B., 1988, DESIGNING CLIN RES; HUNTLEY GW, 1991, J NEUROPHYSIOL, V66, P390, DOI 10.1152/jn.1991.66.2.390; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Kapogiannis D, 2008, EUR J NEUROSCI, V27, P1836, DOI 10.1111/j.1460-9568.2008.06147.x; Kapogiannis D, 2011, MOVEMENT DISORD, V26, P1451, DOI 10.1002/mds.23701; Kleim JA, 2007, NAT PROTOC, V2, P1675, DOI 10.1038/nprot.2007.206; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lang N, 2008, BIOL PSYCHIAT, V63, P231, DOI 10.1016/j.biopsych.2007.04.033; Macaluso A, 2002, MUSCLE NERVE, V25, P858, DOI 10.1002/mus.10113; Mang CS, 2011, EXP BRAIN RES, V209, P355, DOI 10.1007/s00221-011-2556-8; Marconi B, 2011, NEUROREHAB NEURAL RE, V25, P48, DOI 10.1177/1545968310376757; Matsuzaka Y, 2007, J NEUROPHYSIOL, V97, P1819, DOI 10.1152/jn.00784.2006; Meesen RLJ, 2011, HUM BRAIN MAPP, V32, P872, DOI 10.1002/hbm.21075; Melgari JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003069; Michael J, 1988, Anal Verbal Behav, V6, P3; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; Murray EA, 2007, TRENDS COGN SCI, V11, P489, DOI 10.1016/j.tics.2007.08.013; Nudo RJ, 1996, J NEUROSCI, V16, P785; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ott DVM, 2011, NEUROIMAGE, V57, P617, DOI 10.1016/j.neuroimage.2011.04.038; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Pfann KD, 2001, MOVEMENT DISORD, V16, P1048, DOI 10.1002/mds.1220; Rioult-Pedotti MS, 2007, J NEUROPHYSIOL, V98, P3688, DOI 10.1152/jn.00164.2007; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rosenkranz K, 2007, J NEUROSCI, V27, P12058, DOI 10.1523/JNEUROSCI.2663-07.2007; Rosler KM, 2001, NEWS PHYSIOL SCI, V16, P297; Rossini PM, 2010, IEEE ENG MED BIOL, V29, P84, DOI 10.1109/MEMB.2009.935474; Rota S, 2014, J ELECTROMYOGR KINES, V24, P90, DOI 10.1016/j.jelekin.2013.10.007; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Siebner HR, 2003, EXP BRAIN RES, V148, P1, DOI 10.1007/s00221-002-1234-2; Smyth C, 2010, HUM MOVEMENT SCI, V29, P618, DOI 10.1016/j.humov.2010.02.006; Stowe AM, 2008, J NEUROSCI METH, V170, P317, DOI 10.1016/j.jneumeth.2008.01.031; Suzuki M, 2012, BRAIN RES, V1473, P114, DOI 10.1016/j.brainres.2012.07.043; Thabit MN, 2011, CLIN NEUROPHYSIOL, V122, P1764, DOI 10.1016/j.clinph.2011.02.021; Tokimura H, 2000, J PHYSIOL-LONDON, V523, P503, DOI 10.1111/j.1469-7793.2000.t01-1-00503.x; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wickens JR, 2003, CURR OPIN NEUROBIOL, V13, P685, DOI 10.1016/j.conb.2003.10.013; Yang HD, 2006, J CLIN NEUROSCI, V13, P245, DOI 10.1016/j.jocn.2004.12.011; Zald DH, 2004, J NEUROSCI, V24, P4105, DOI 10.1523/JNEUROSCI.4643-03.2004; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734	71	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90773	10.1371/journal.pone.0090773	http://dx.doi.org/10.1371/journal.pone.0090773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603644	gold, Green Submitted, Green Published			2022-12-25	WOS:000332483600085
J	Zhao, GJ; Mu, XM; Strehmel, A; Tian, P				Zhao, Guangju; Mu, Xingmin; Strehmel, Alex; Tian, Peng			Temporal Variation of Streamflow, Sediment Load and Their Relationship in the Yellow River Basin, China	PLOS ONE			English	Article							YANGTZE-RIVER; SOIL-EROSION; RAINFALL SIMULATION; DISCHARGE; IMPACTS; CLIMATE; VEGETATION; REACHES; FLOW	Variation of streamflow and sediment load in the Yellow River basin has received considerable attention due to its drastic reduction during the past several decades. This paper presents a detailed investigation on the changes of streamflow and sediment load from 1952 to 2011 using monthly observations at four gauging stations along the Yellow River. The results show significant decreasing trends for both streamflow and sediment load at all four gauging stations over the past 60 years. The wavelet transform demonstrated discontinuous periodicities from 1969 to 1973 and after 1986 due to the construction of large reservoirs and implementation of numerous soil and water conservations practices. The sediment rating curves with the power-law function was applied to investigate the relationship between discharge and sediment load. The results indicate distinct variations of the relationship between streamflow and sediment and implied significant hydro-morphological changes within different periods. The reducing sediment supply from the source region and the increased erosive power of the river are detected at Lanzhou station, while the decrease of the transport capacity at Toudaoguai is caused by severe siltation. Significant changes in the relationship between streamflow and sediment load are found at Huayuankou and Gaocun stations, which are largely induced by evident sediment income and trapping effects of large reservoirs. It is estimated that numerous reservoirs have strongly altered the regime and magnitude of streamflow and trapped large amount of sediment, leading to severe siltation and evident reduction of their total volumes. A decrease in precipitation, incoming water from the upper reaches, soil and water conservation measures as well as water consumption contribute most to the significant reduction of streamflow. The decrease of sediment load mainly resulted from various soil and water conservation measures and trapping in reservoirs from 1986 to 2011.	[Zhao, Guangju; Mu, Xingmin] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China; [Zhao, Guangju; Mu, Xingmin] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China; [Zhao, Guangju; Mu, Xingmin] Minist Water Resources, Yangling, Shaanxi Provinc, Peoples R China; [Strehmel, Alex] Univ Kiel, Inst Nat Resource Conservat, Dept Hydrol & Water Resources Management, Kiel, Germany; [Tian, Peng] Northwest A&F Univ, Coll Resource & Environm, Yangling, Shaanxi Provinc, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; University of Kiel; Northwest A&F University - China	Mu, XM (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China.	xmmu@ms.iswc.ac.cn		Zhao, Guangju/0000-0002-4233-9403; Zhao, Guangju/0000-0001-7756-4494	National Natural Sciences Foundation of China [41201266, 41271295]; Key Research Program of the Chinese Academy of Sciences [KZZD-EW-04]; Key Project of the National Science and Technology Ministry [2012BAB02B05]; Program for Excellent Youth Scholars in the Institute of Soil and Water Conservation [A315021394]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Key Project of the National Science and Technology Ministry; Program for Excellent Youth Scholars in the Institute of Soil and Water Conservation	This work was supported by the National Natural Sciences Foundation of China (Grant Nos.: 41201266, 41271295), the Key Research Program of the Chinese Academy of Sciences (No. KZZD-EW-04), the Key Project of the National Science and Technology Ministry (No. 2012BAB02B05) and the Program for Excellent Youth Scholars in the Institute of Soil and Water Conservation (A315021394). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselman NEM, 2000, J HYDROL, V234, P228, DOI 10.1016/S0022-1694(00)00253-5; Brown AE, 2013, J HYDROL, V483, P39, DOI 10.1016/j.jhydrol.2012.12.031; Cerda A, 2010, LAND DEGRAD DEV, V21, P71, DOI 10.1002/ldr.968; Cerda A, 1999, SOIL SCI SOC AM J, V63, P362, DOI 10.2136/sssaj1999.03615995006300020014x; Cerda A, 1998, CAN J SOIL SCI, V78, P321, DOI 10.4141/S97-060; Cerda A, 1998, J ARID ENVIRON, V38, P145, DOI 10.1006/jare.1997.0342; Fan X, 2012, LAND DEGRAD DEV, V23, P175, DOI 10.1002/ldr.1071; Gao P, 2011, HYDROL EARTH SYST SC, V15, P1, DOI 10.5194/hess-15-1-2011; Giordano M, 2004, 348 COMPR ASS WAT MA, V3, P48; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Hu BQ, 2011, QUATERN INT, V230, P34, DOI 10.1016/j.quaint.2009.08.018; Li XL, 2013, LAND DEGRAD DEV, V24, P72, DOI 10.1002/ldr.1108; Liu CM, 2004, HYDROL PROCESS, V18, P2337, DOI 10.1002/hyp.5534; Miao CY, 2011, GLOBAL PLANET CHANGE, V76, P196, DOI 10.1016/j.gloplacha.2011.01.008; Milliman JD, 2008, GLOBAL PLANET CHANGE, V62, P187, DOI 10.1016/j.gloplacha.2008.03.001; MILLIMAN JD, 1983, J GEOL, V91, P1, DOI 10.1086/628741; Morgan R. P. C., 1995, SOIL EROSION CONSERV; Mu XM, 2012, CLEAN-SOIL AIR WATER, V40, P303, DOI 10.1002/clen.201000319; PAN XT, 2006, RIVERBED PROCESS LOW; Peng J, 2010, CATENA, V83, P135, DOI 10.1016/j.catena.2010.08.006; Ran DC, 2006, TRAPPING EFFECTS SOI; Syvitski JP, 2000, WATER RESOUR RES, V36, P2747, DOI 10.1029/2000WR900133; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Valentin C, 2005, CATENA, V63, P132, DOI 10.1016/j.catena.2005.06.001; Walling DE, 2003, GLOBAL PLANET CHANGE, V39, P111, DOI 10.1016/S0921-8181(03)00020-1; Wang G., 2002, VARIATION STREAMFLOW; Wang HJ, 2010, J HYDROL, V391, P302, DOI 10.1016/j.jhydrol.2010.07.030; Wang SY, 2010, LAND USE POLICY, V27, P313, DOI 10.1016/j.landusepol.2009.04.002; Xu J. H., 1998, J SEDIMENT RES, V4, P36; Xu JX, 2009, QUATERN INT, V208, P85, DOI 10.1016/j.quaint.2008.11.003; Xu JX, 2005, ENVIRON MANAGE, V35, P620, DOI 10.1007/s00267-004-3094-y; Xu KH, 2010, GLOBAL PLANET CHANGE, V73, P219, DOI 10.1016/j.gloplacha.2010.07.002; Yang GF, 2007, GEOMORPHOLOGY, V85, P166, DOI 10.1016/j.geomorph.2006.03.016; Yao W.Y.., 2011, ANAL EVALUATION WATE; YRCC Yellow River Water Conservancy Committee, 2000, B YELL RIV; Zhang Q, 2007, J HYDROL, V333, P265, DOI 10.1016/j.jhydrol.2006.08.010; Zhang X., 2008, WATER RESOURCES RES, V44; Zhao GJ, 2013, HYDROL PROCESS, V27, P3852, DOI 10.1002/hyp.9504; Zhao GJ, 2013, LAND DEGRAD DEV, V24, P499, DOI 10.1002/ldr.2246; Zhao GJ, 2012, QUATERN INT, V282, P5, DOI 10.1016/j.quaint.2011.10.020; Zheng HX, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006665	42	39	41	2	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91048	10.1371/journal.pone.0091048	http://dx.doi.org/10.1371/journal.pone.0091048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603668	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600124
J	Grozinger, F; Thein, J; Feldhaar, H; Rodel, MO				Groezinger, Franziska; Thein, Juergen; Feldhaar, Heike; Roedel, Mark-Oliver			Giants, Dwarfs and the Environment - Metamorphic Trait Plasticity in the Common Frog	PLOS ONE			English	Article							PREY GROWTH-RATE; PHENOTYPIC PLASTICITY; RANA-TEMPORARIA; LARVAL DENSITY; PREDATION RISK; DEVELOPMENTAL PLASTICITY; ADAPTIVE PLASTICITY; MODEL SELECTION; LIFE-HISTORY; FOOD LEVEL	In order to understand adaptation processes and population dynamics, it is central to know how environmental parameters influence performance of organisms within populations, including their phenotypes. The impact of single or few particular parameters in concert was often assessed in laboratory and mesocosm experiments. However, under natural conditions, with many biotic and abiotic factors potentially interacting, outcomes on phenotypic changes may be different. To study the potential environmental impact on realized phenotypic plasticity within a natural population, we assessed metamorphic traits (developmental time, size and body mass) in an amphibian species, the European common frog Rana temporaria, since a) larval amphibians are known to exhibit high levels of phenotypic plasticity of these traits in response to habitat parameters and, b) the traits' features may strongly influence individuals' future performance and fitness. In 2007 we studied these metamorphic traits in 18 ponds spread over an area of 28 km 2. A subset of six ponds was reinvestigated in 2009 and 2010. This study revealed locally high variances in metamorphic traits in this presumed generalist species. We detected profound differences between metamorphing froglets (up to factor ten); both between and within ponds, on a very small geographic scale. Parameters such as predation and competition as well as many other pond characteristics, generally expected to have high impact on development, could not be related to the trait differences. We observed high divergence of patterns of mass at metamorphosis between ponds, but no detectable pattern when metamorphic traits were compared between ponds and years. Our results indicate that environment alone, i.e. as experienced by tadpoles sharing the same breeding pond, can only partly explain the variability of metamorphic traits observed. This emphasizes the importance to assess variability of reaction norms on the individual level to explain within-population variability.	[Groezinger, Franziska] Univ Wurzburg, Theodor Boveri Inst, Bioctr, Dept Anim Ecol & Trop Biol Zool 3, D-97070 Wurzburg, Germany; [Groezinger, Franziska; Roedel, Mark-Oliver] Museum Nat Kunde Berlin, Leibniz Inst Res Evolut & Biodivers, Berlin, Germany; [Thein, Juergen] Buro Faunist & Umweltbildung, Hassfurt, Germany; [Feldhaar, Heike] Univ Bayreuth, Bayreuth Ctr Ecol & Environm Res BayCEER, Bayreuth, Germany; [Groezinger, Franziska; Roedel, Mark-Oliver] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany	University of Wurzburg; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Bayreuth	Rodel, MO (corresponding author), Museum Nat Kunde Berlin, Leibniz Inst Res Evolut & Biodivers, Berlin, Germany.	mo.roedel@mfn-berlin.de	Feldhaar, Heike/AAB-8678-2020	Feldhaar, Heike/0000-0001-6797-5126	Cusanuswerk Bischofliche Studienforderung	Cusanuswerk Bischofliche Studienforderung	FG was supported by a scholarship of "Cusanuswerk Bischofliche Studienforderung'' (http://www.cusanuswerk.de/de/startseite/bischoeflichestudienfoerderung/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, EVOLUTION, V50, P1052, DOI 10.1111/j.1558-5646.1996.tb02346.x; Altwegg R, 2003, OECOLOGIA, V136, P46, DOI 10.1007/s00442-003-1248-x; Altwegg R, 2003, EVOLUTION, V57, P872; Alvarez D, 2002, FUNCT ECOL, V16, P640, DOI 10.1046/j.1365-2435.2002.00658.x; Atkinson D., 1996, Society for Experimental Biology Seminar Series, V59, P183; Barton K., 2013, MUMIN MULTI MODEL IN; Benard MF, 2004, ANNU REV ECOL EVOL S, V35, P651, DOI 10.1146/annurev.ecolsys.35.021004.112426; BERVEN KA, 1988, OECOLOGIA, V75, P67, DOI 10.1007/BF00378815; BERVEN KA, 1990, ECOLOGY, V71, P1599, DOI 10.2307/1938295; Berven KA, 2009, COPEIA, P328, DOI 10.1643/CH-08-052; Biek R, 2002, CONSERV BIOL, V16, P728, DOI 10.1046/j.1523-1739.2002.00433.x; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Borcard D, 2012, ECOLOGY, V93, P1473; Brady LD, 2000, J ZOOL, V252, P61; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burnham KP, 2003, MODEL SELECTION MULT; COLLINS JP, 1979, ECOLOGY, V60, P738, DOI 10.2307/1936611; Crawley M.J., 2007, R BOOK; Crisci C, 2012, ECOL MODEL, V240, P113, DOI 10.1016/j.ecolmodel.2012.03.001; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Denver RJ, 1997, AM ZOOL, V37, P172; Fordyce JA, 2006, J EXP BIOL, V209, P2377, DOI 10.1242/jeb.02271; Glos J, 2003, COPEIA, P650; GOTTHARD K, 1995, OIKOS, V74, P3, DOI 10.2307/3545669; Grozinger F, 2012, J ZOOL, V288, P103, DOI 10.1111/j.1469-7998.2012.00929.x; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hatch AC, 2003, ECOL APPL, V13, P1083, DOI 10.1890/1051-0761(2003)13[1083:CEOURA]2.0.CO;2; Hettyey A, 2011, J EVOLUTION BIOL, V24, P1007, DOI 10.1111/j.1420-9101.2011.02233.x; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; Indermaur L, 2010, ECOGRAPHY, V33, P887, DOI 10.1111/j.1600-0587.2010.06150.x; JOHNALDER HB, 1990, COPEIA, P856, DOI 10.2307/1446453; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; KAPLAN RH, 1984, AM NAT, V123, P393, DOI 10.1086/284211; Laurila A, 2002, EVOLUTION, V56, P617; Laurila A, 1998, OIKOS, V83, P307, DOI 10.2307/3546842; Laurila A, 1999, J ANIM ECOL, V68, P1123, DOI 10.1046/j.1365-2656.1999.00354.x; Laurila A, 2008, ECOLOGY, V89, P1399, DOI 10.1890/07-1521.1; Legendre P., 1998, NUMERICAL ECOLOGY, V24; LEIPS J, 1994, ECOLOGY, V75, P1345, DOI 10.2307/1937459; Loman J, 2006, J APPL ECOL, V43, P690, DOI 10.1111/j.1365-2664.2006.01172.x; Loman J, 2004, ECOLOGY, V85, P1611, DOI 10.1890/03-0179; Loman J, 1999, AMPHIBIA-REPTILIA, V20, P421, DOI 10.1163/156853899X00466; MANTEL N, 1967, CANCER RES, V27, P209; Melvin SD, 2012, OECOLOGIA, V169, P861, DOI 10.1007/s00442-012-2260-9; NEWMAN RA, 1989, ECOLOGY, V70, P1775, DOI 10.2307/1938111; NEWMAN RA, 1992, BIOSCIENCE, V42, P671, DOI 10.2307/1312173; Nicieza AG, 2000, OECOLOGIA, V123, P497, DOI 10.1007/s004420000343; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Peacor SD, 2002, ECOL LETT, V5, P77, DOI 10.1046/j.1461-0248.2002.00287.x; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Pierce Banjamin A., 1993, Ecotoxicology, V2, P65, DOI 10.1007/BF00058215; Pigliucci M., 2001, SYN ECO EVO; Pinheiro J, 2016, NLME LINEAR NONLINEA, DOI DOI 10.1016/S0006-3207(01)00201-4; R Core Team, 2021, R LANG ENV STAT COMP; R?del M.-O., 2009, METHODEN FELDHERPETO, P243; Ramos O, 2012, OECOLOGIA, V169, P535, DOI 10.1007/s00442-011-2208-5; Relyea RA, 2002, AM NAT, V159, P272, DOI 10.1086/338540; Relyea RA, 2003, OECOLOGIA, V134, P596, DOI 10.1007/s00442-002-1161-8; Relyea RA, 2007, OECOLOGIA, V152, P389, DOI 10.1007/s00442-007-0675-5; Richter-Boix A, 2010, MOL ECOL, V19, P716, DOI 10.1111/j.1365-294X.2009.04502.x; Ripley B., 2013, PACKAGE MASS; Rudolf VHW, 2007, EVOL ECOL, V21, P121, DOI 10.1007/s10682-006-0017-9; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Schlupmann M, 1996, AMPHIBIEN REPTILIEN, P412; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; Scott DE, 2007, OECOLOGIA, V153, P521, DOI 10.1007/s00442-007-0755-6; SCOTT DE, 1990, ECOLOGY, V71, P296, DOI 10.2307/1940269; SCOTT DE, 1994, ECOLOGY, V75, P1383, DOI 10.2307/1937462; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; SKELLY DK, 1992, ECOLOGY, V73, P704, DOI 10.2307/1940779; SKELLY DK, 1990, ECOLOGY, V71, P2313, DOI 10.2307/1938642; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; Stamper CE, 2008, HERPETOL J, V18, P187; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; Taylor BE, 1997, HERPETOLOGICA, V53, P132; TRAVIS J, 1980, EVOLUTION, V34, P40, DOI 10.1111/j.1558-5646.1980.tb04787.x; UCHMANSKI J, 1985, PHILOS T ROY SOC B, V310, P1, DOI 10.1098/rstb.1985.0099; Van Allen BG, 2010, OECOLOGIA, V164, P891, DOI 10.1007/s00442-010-1728-8; Van Buskirk J, 2000, ECOLOGY, V81, P2813, DOI 10.1890/0012-9658(2000)081[2813:TCOAID]2.0.CO;2; Van Buskirk J, 2005, ECOLOGY, V86, P1936, DOI 10.1890/04-1237; Van Buskirk J, 2005, J EVOLUTION BIOL, V18, P596, DOI 10.1111/j.1420-9101.2004.00869.x; Van Buskirk J, 1998, OIKOS, V82, P20; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305; WILBUR HM, 1977, ECOLOGY, V58, P206, DOI 10.2307/1935124; Winkler JD, 2012, FUNCT ECOL, V26, P513, DOI 10.1111/j.1365-2435.2012.01965.x	90	18	18	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89982	10.1371/journal.pone.0089982	http://dx.doi.org/10.1371/journal.pone.0089982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599256	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400038
J	Hauser, PM; Bernard, T; Greub, G; Jaton, K; Pagni, M; Hafen, GM				Hauser, Philippe M.; Bernard, Thomas; Greub, Gilbert; Jaton, Katia; Pagni, Marco; Hafen, Gaudenz M.			Microbiota Present in Cystic Fibrosis Lungs as Revealed by Whole Genome Sequencing	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; DATABASE; IDENTIFICATION; COMMUNITIES; CULTUROMICS; INFECTIONS; ALIGNMENT; ACCURATE; GENES; FUNGI	Determination of the precise composition and variation of microbiota in cystic fibrosis lungs is crucial since chronic inflammation due to microorganisms leads to lung damage and ultimately, death. However, this constitutes a major technical challenge. Culturing of microorganisms does not provide a complete representation of a microbiota, even when using culturomics (high-throughput culture). So far, only PCR-based metagenomics have been investigated. However, these methods are biased towards certain microbial groups, and suffer from uncertain quantification of the different microbial domains. We have explored whole genome sequencing (WGS) using the Illumina high-throughput technology applied directly to DNA extracted from sputa obtained from two cystic fibrosis patients. To detect all microorganism groups, we used four procedures for DNA extraction, each with a different lysis protocol. We avoided biases due to whole DNA amplification thanks to the high efficiency of current Illumina technology. Phylogenomic classification of the reads by three different methods produced similar results. Our results suggest that WGS provides, in a single analysis, a better qualitative and quantitative assessment of microbiota compositions than cultures and PCRs. WGS identified a high quantity of Haemophilus spp. (patient 1) or Staphylococcus spp. plus Streptococcus spp. (patient 2) together with low amounts of anaerobic (Veillonella, Prevotella, Fusobacterium) and aerobic bacteria (Gemella, Moraxella, Granulicatella). WGS suggested that fungal members represented very low proportions of the microbiota, which were detected by cultures and PCRs because of their selectivity. The future increase of reads' sizes and decrease in cost should ensure the usefulness of WGS for the characterisation of microbiota.	[Hauser, Philippe M.; Greub, Gilbert; Jaton, Katia] CHU Vaudois, Inst Microbiol, CH-1011 Lausanne, Switzerland; [Hauser, Philippe M.; Greub, Gilbert; Jaton, Katia; Hafen, Gaudenz M.] Univ Lausanne, Lausanne, Switzerland; [Bernard, Thomas; Pagni, Marco] SIB, Vital IT Grp, Lausanne, Switzerland; [Hafen, Gaudenz M.] CHU Vaudois, Pulm Unit, Dept Paediat, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Hafen, GM (corresponding author), CHU Vaudois, Pulm Unit, Dept Paediat, CH-1011 Lausanne, Switzerland.	gaudenz.hafen@chuv.ch	Jaton, Katia/A-2828-2016; Greub, Gilbert GG/K-5804-2017	Greub, Gilbert GG/0000-0001-9529-3317; Bernard, Thomas/0000-0003-3736-1507; Pagni, Marco/0000-0001-9292-9463; Hauser, Philippe/0000-0003-2834-7922; Jaton, Katia/0000-0001-8944-7295	Swiss Society for Cystic Fibrosis; Swiss Federal Government through the State Secretariat for Education and Research (SER)	Swiss Society for Cystic Fibrosis; Swiss Federal Government through the State Secretariat for Education and Research (SER)	This work was supported by the Swiss Society for Cystic Fibrosis (http://www.cfch.ch/). The computations were performed at the Vital-IT Center for high-performance computing (http://www.vital-it.ch) of the Swiss Institute of Bioinformatics (SIB). SIB receives financial support from the Swiss Federal Government through the State Secretariat for Education and Research (SER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Baquero F, 2012, CLIN MICROBIOL INFEC, V18, P2, DOI 10.1111/j.1469-0691.2012.03916.x; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Bittar F, 2010, CLIN MICROBIOL INFEC, V16, P809, DOI 10.1111/j.1469-0691.2010.03236.x; Blainey PC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004458; Bouchara JP, 2009, J CLIN MICROBIOL, V47, P142, DOI 10.1128/JCM.01668-08; Burns JL, 2013, J CYST FIBROS, pS1569; Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Gilchrist FJ, 2011, ARCH DIS CHILD, V96, P215, DOI 10.1136/adc.2009.177618; Greub G, 2012, CLIN MICROBIOL INFEC, V18, P1157, DOI 10.1111/1469-0691.12032; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Koetschan C, 2012, MOL PHYLOGENET EVOL, V63, P585, DOI 10.1016/j.ympev.2012.01.026; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; Lynch SV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009738; Madan JC, 2012, MBIO, V3, DOI 10.1128/mBio.00251-12; Meinicke P, 2011, BIOINFORMATICS, V27, P1618, DOI 10.1093/bioinformatics/btr266; Mowat E, 2010, FEMS MICROBIOL LETT, V313, P96, DOI 10.1111/j.1574-6968.2010.02130.x; Parkins MD, 2008, PEDIATR PULM, V43, P490, DOI 10.1002/ppul.20809; Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rogers GB, 2013, ISME J, V7, P697, DOI 10.1038/ismej.2012.145; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Santamaria M, 2012, BRIEF BIOINFORM, V13, P682, DOI 10.1093/bib/bbs036; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Sibley CD, 2011, CAN J MICROBIOL, V57, P69, DOI [10.1139/W10-105, 10.1139/w10-105]; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Wat D, 2008, J CYST FIBROS, V7, P320, DOI 10.1016/j.jcf.2007.12.002; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wong JK, 2013, PEDIAT PULMONOL, V43, P490; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	38	27	27	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90934	10.1371/journal.pone.0090934	http://dx.doi.org/10.1371/journal.pone.0090934			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599149	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400146
J	Kim, D; Song, S; Lee, M; Go, H; Shin, E; Yeom, JH; Ha, NC; Lee, K; Kim, YH				Kim, Daeyoung; Song, Saemee; Lee, Minho; Go, Hayoung; Shin, Eunkyoung; Yeom, Ji-Hyun; Ha, Nam-Chul; Lee, Kangseok; Kim, Yong-Hak			Modulation of RNase E Activity by Alternative RNA Binding Sites	PLOS ONE			English	Article							ESCHERICHIA-COLI-CELLS; CATALYTIC DOMAIN; MEMBRANE-BINDING; MUTATION; RRAA; AUTOREGULATION; COMPLEXES; ABUNDANCE; CLEAVAGE; GROWTH	Endoribonuclease E (RNase E) affects the composition and balance of the RNA population in Escherichia coli via degradation and processing of RNAs. In this study, we investigated the regulatory effects of an RNA binding site between amino acid residues 25 and 36 ((24)LYDLDIESPGHEQK(37)) of RNase E. Tandem mass spectrometry analysis of the N-terminal catalytic domain of RNase E (N-Rne) that was UV crosslinked with a 5'-P-32-end-labeled, 13-nt oligoribonucleotide (p-BR13) containing the RNase E cleavage site of RNA I revealed that two amino acid residues, Y25 and Q36, were bound to the cytosine and adenine of BR13, respectively. Based on these results, the Y25A N-Rne mutant was constructed, and was found to be hypoactive in comparison to wild-type and hyperactive Q36R mutant proteins. Mass spectrometry analysis showed that Y25A and Q36R mutations abolished the RNA binding to the uncompetitive inhibition site of RNase E. The Y25A mutation increased the RNA binding to the multimer formation interface between amino acid residues 427 and 433 ((427)LIEEEALK(433)), whereas the Q36R mutation enhanced the RNA binding to the catalytic site of the enzyme ((65)HGFLPL*K-71). Electrophoretic mobility shift assays showed that the stable RNA-protein complex formation was positively correlated with the extent of RNA binding to the catalytic site and ribonucleolytic activity of the N-Rne proteins. These mutations exerted similar effects on the ribonucleolytic activity of the full-length RNase E in vivo. Our findings indicate that RNase E has two alternative RNA binding sites for modulating RNA binding to the catalytic site and the formation of a functional catalytic unit.	[Kim, Daeyoung; Song, Saemee; Lee, Minho; Go, Hayoung; Shin, Eunkyoung; Yeom, Ji-Hyun; Lee, Kangseok] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Go, Hayoung] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Ha, Nam-Chul] Pusan Natl Univ, Dept Mfg Pharm, Pusan, South Korea; [Kim, Yong-Hak] Catholic Univ Daegu Sch Med, Dept Microbiol, Taegu, South Korea	Chung Ang University; Stanford University; Pusan National University; Catholic University of Daegu	Lee, K (corresponding author), Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea.	kangseok@cau.ac.kr; ykim@cu.ac.kr	Lee, Minho/AAK-4109-2021	Lee, Minho/0000-0002-8404-5702	NRF [2011-0028553, 2013R1A1A2061369]; Ministry of Education, Science and Technology, Republic of Korea	NRF; Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by NRF grants (2011-0028553 to K Lee and 2013R1A1A2061369 to YH Kim) funded by the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Callaghan AJ, 2004, J MOL BIOL, V340, P965, DOI 10.1016/j.jmb.2004.05.046; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gao JJ, 2006, MOL MICROBIOL, V61, P394, DOI 10.1111/j.1365-2958.2006.05246.x; Go H, 2011, RNA BIOL, V8, P1022, DOI 10.4161/rna.8.6.18063; GOLDBLUM K, 1981, J BACTERIOL, V146, P128, DOI 10.1128/JB.146.1.128-132.1981; Gorna MW, 2010, RNA, V16, P553, DOI 10.1261/rna.1858010; Jain C, 1995, Nucleic Acids Symp Ser, P85; Khemici V, 2008, MOL MICROBIOL, V70, P799, DOI 10.1111/j.1365-2958.2008.06454.x; Kido M, 1996, J BACTERIOL, V178, P3917, DOI 10.1128/jb.178.13.3917-3925.1996; Kime L, 2010, MOL MICROBIOL, V76, P590, DOI 10.1111/j.1365-2958.2009.06935.x; Koslover DJ, 2008, STRUCTURE, V16, P1238, DOI 10.1016/j.str.2008.04.017; Lee K, 2003, MOL MICROBIOL, V48, P349, DOI 10.1046/j.1365-2958.2003.03435.x; Lee K, 2002, MOL MICROBIOL, V43, P1445, DOI 10.1046/j.1365-2958.2002.02848.x; Lee KS, 2003, CELL, V114, P623, DOI 10.1016/j.cell.2003.08.003; LINCHAO S, 1994, J BIOL CHEM, V269, P10797; Liou GG, 2001, P NATL ACAD SCI USA, V98, P63, DOI 10.1073/pnas.011535498; Mackie GA, 2013, NAT REV MICROBIOL, V11, P45, DOI 10.1038/nrmicro2930; MCDOWALL KJ, 1995, NATURE, V374, P287, DOI 10.1038/374287a0; McDowall KJ, 1996, J MOL BIOL, V255, P349, DOI 10.1006/jmbi.1996.0027; MUDD EA, 1993, MOL MICROBIOL, V9, P557, DOI 10.1111/j.1365-2958.1993.tb01716.x; Murashko ON, 2012, P NATL ACAD SCI USA, V109, P7019, DOI 10.1073/pnas.1120181109; Shin E, 2008, GENETICS, V179, P1871, DOI 10.1534/genetics.108.088492; Sousa S, 2001, MOL MICROBIOL, V42, P867, DOI 10.1046/j.1365-2958.2001.02687.x; Tamura M, 2006, J BACTERIOL, V188, P5145, DOI 10.1128/JB.00367-06; Urlaub Henning, 2008, V488, P221, DOI 10.1007/978-1-60327-475-3_16; Wurtmann EJ, 2009, CRIT REV BIOCHEM MOL, V44, P34, DOI [10.1080/10409230802594043, 10.1080/10409230802594043 ]; Yeom JH, 2006, BIOCHEM BIOPH RES CO, V345, P1372, DOI 10.1016/j.bbrc.2006.05.018	29	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90610	10.1371/journal.pone.0090610	http://dx.doi.org/10.1371/journal.pone.0090610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598695	Green Submitted, Green Published, gold			2022-12-25	WOS:000332479400100
J	Janczur, MK; Solano, HJL; Ramos, LTS; Reyes, CHM; Cerro, MDO; Berasain, MDM; Manzano, IVR; Manjarrez, J; Benitez, JLV; Czarnoleski, M				Krzysztof Janczur, Mariusz; Leon Solano, Hector Javier; Solache Ramos, Lupita Tzenyatze; Mendoza Reyes, Citlalli Hypatia; Oro Cerro, Maria del Carmen; Mariezcurrena Berasain, Maria Dolores; Rivas Manzano, Irma Victoria; Manjarrez, Javier; Villareal Benitez, Jose Luis; Czarnoleski, Marcin			Chemical and Physical Defense Traits in Two Sexual Forms of Opuntia robusta in Central Eastern Mexico	PLOS ONE			English	Article							REPRODUCTION; HERBIVORY; PLANTS; COSTS; METAANALYSIS; ALLOCATION; PATTERNS; CLADODES; SPINES; GROWTH	Sexually dimorphic plants provide an excellent opportunity for examining the differences in the extent of their defense against herbivores because they exhibit sex-related differences in reproductive investment. Such differences enable comparison of the sex with high reproduction expenses with the sex that expends less. The more costly sex is usually also better defended against herbivores. Generally, females are considered more valuable than hermaphrodites in terms of fitness; however, hermaphrodites are more valuable if they can produce seed by autonomous selfing, provided that the inbreeding depression is low and pollen is limited. We studied a gynodioecious population of Opuntia robusta from Central-Eastern Mexico, which has been reported to be trioecious, dioecious, or hermaphrodite, and addressed the following questions: 1) Is the hermaphrodite's reproductive output higher than the female's, and are hermaphrodites thus better defended? 2) Are plant tissues differentially defended? 3) Do trade-offs exist among different physical defense traits? and 4) among physical and chemical defense traits? We found that 1) hermaphrodites had a higher seed output and more spines per areola than females and that their spines contained less moisture. Non-reproductive hermaphrodite cladodes contained more total phenolic compounds (TPCs) than female ones. In addition, 2) hermaphrodite reproductive cladodes bore more spines than female cladodes, and 3) and 4) we found a negative relationship between spine number per areola and areola number per cladode and a positive relationship between spine number per areola per plant and TPC concentration per plant. Non-reproductive hermaphrodite cladodes contained a higher concentration of TPCs than female cladodes, and parental cladodes contained fewer TPCs than both reproductive and empty cladodes.	[Krzysztof Janczur, Mariusz; Leon Solano, Hector Javier; Solache Ramos, Lupita Tzenyatze; Mendoza Reyes, Citlalli Hypatia; Oro Cerro, Maria del Carmen; Manjarrez, Javier] Autonomous Univ State Mexico, Res Grp Behav Biol & Conservat, Toluca, Estado De Mexic, Mexico; [Rivas Manzano, Irma Victoria] Autonomous Univ State Mexico, Res Grp Flora Composit & Ecol Trop & Template Sys, Toluca, Estado De Mexic, Mexico; [Mariezcurrena Berasain, Maria Dolores] Autonomous Univ State Mexico, Fac Agr Sci, Toluca, Estado De Mexic, Mexico; [Krzysztof Janczur, Mariusz; Czarnoleski, Marcin] Jagiellonian Univ, Inst Environm Sci, Res Grp Life Hist Evolut, Krakow, Poland; [Villareal Benitez, Jose Luis] Univ Nacl Autonoma Mexico, Div Comp Serv Informat & Commun Technol, Mexico City 04510, DF, Mexico	Universidad Autonoma del Estado de Mexico; Universidad Autonoma del Estado de Mexico; Universidad Autonoma del Estado de Mexico; Jagiellonian University; Universidad Nacional Autonoma de Mexico	Janczur, MK (corresponding author), Autonomous Univ State Mexico, Res Grp Behav Biol & Conservat, Carretera Toluca Tlachaloya, Toluca, Estado De Mexic, Mexico.	majmx@interia.pl	Janczur, Mariusz K/A-3964-2012; Manjarrez, Javier/S-3082-2019; Mariezcurrena Berasain, Maria/B-4923-2016; Czarnoleski, Marcin/H-2893-2015	Manjarrez, Javier/0000-0003-3053-3257; Mariezcurrena Berasain, Maria/0000-0003-1569-1783; Czarnoleski, Marcin/0000-0003-2645-0360; Janczur, Mariusz Krzysztof/0000-0002-3886-6710	UAEM project [2823/2009U]; CONACyT [180694/2012]; Secretaria de Investigacion, Autonomous University of the State of Mexico (UAEM); PIFI, Faculty of Agricultural Sciences, UAEM	UAEM project; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Investigacion, Autonomous University of the State of Mexico (UAEM); PIFI, Faculty of Agricultural Sciences, UAEM	The study was financed by the UAEM project 2823/2009U (partially) and by the CONACyT project 180694/2012 (http://www.conacyt.gob.mx/FondosyApoyos/Sectoriales/InvestigacionBasicaAplicada/SEP/Basica/Documents/Resultados_de_la_Convocatoria_de_Ciencia_Basica_2012.pdf). Article edition charge was financed by Secretaria de Investigacion, Autonomous University of the State of Mexico (UAEM). Article processing charge was financed by PIFI 2014, Faculty of Agricultural Sciences, UAEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinsoft, 2011, XLSTAT; Agren J., 1999, GENDER SEXUAL DIMORP, P217, DOI DOI 10.1007/978-3-662-03908-3_8; Alonso C, 2003, OIKOS, V101, P505, DOI 10.1034/j.1600-0706.2003.12115.x; Alonso C, 1996, J ECOL, V84, P495, DOI 10.2307/2261472; [Anonymous], INT J EVOL BIOL; Barton KE, 2010, AM NAT, V175, P481, DOI 10.1086/650722; Brailovsky-Alperowitz HU, 1981, CACTACEAS SUCULENTAS, V26, P86; Cornelissen T, 2005, OIKOS, V111, P488, DOI 10.1111/j.1600-0706.2005.14075.x; del Castillo R.F., 1988, AGROCIENCIA-MEXICO, V71, P185; del Castillo RF, 2009, AM J BOT, V96, P1148, DOI 10.3732/ajb.0800301; del Castillo RF, 1986, SELECCION NATURAL SI; Endara MJ, 2011, FUNCT ECOL, V25, P389, DOI 10.1111/j.1365-2435.2010.01803.x; Gershenzon J, 1994, INSECT PLANT INTERAC, P205; Gindl-Altmutter W, 2012, BIORESOURCES, V7, P1232; Koricheva J, 2004, AM NAT, V163, pE64, DOI 10.1086/382601; Janczur MK, 2009, EVOL ECOL RES, V11, P447; Malainine ME, 2003, CARBOHYD POLYM, V51, P77, DOI 10.1016/S0144-8617(02)00157-1; Marroquin JS, 1964, PUBLICACION ESPECIAL, V2; MAUSETH JD, 1984, AM J BOT, V71, P1283, DOI 10.2307/2443653; McCall AC, 2010, J ECOL, V98, P985, DOI 10.1111/j.1365-2745.2010.01693.x; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; Mutikainen P, 1996, OIKOS, V75, P353, DOI 10.2307/3545874; Mutikainen P., 1999, LIFE HIST EVOLUTION, P195; Nicotra AB, 1999, J ECOL, V87, P138, DOI 10.1046/j.1365-2745.1999.00337.x; Obeso JR, 1997, J ECOL, V85, P159, DOI 10.2307/2960648; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Peer 393, 2013, PEERAGE SCI; Peer 408, 2013, PEERAGE SCI; Pimienta-Barrios E, 2005, ANN BOT-LONDON, V95, P363, DOI 10.1093/aob/mci034; Quinn GP, 2003, EXPT DESIGN DATA ANA; SEMARNAT, 2013, AR NAT PROT DIAGN FI; Shykoff JA, 2003, OECOLOGIA, V135, P1, DOI 10.1007/s00442-002-1133-z; StatSoft, 2013, STATISTICA; Webb C.J., 1999, GENDER SEXUAL DIMORP, P61, DOI DOI 10.1007/978-3-662-03908-3_3	34	12	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89535	10.1371/journal.pone.0089535	http://dx.doi.org/10.1371/journal.pone.0089535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599143	Green Published, gold			2022-12-25	WOS:000332479400016
J	Phillips, M; Beatty, JD; Cataneo, RN; Huston, J; Kaplan, PD; Lalisang, RI; Lambin, P; Lobbes, MBI; Mundada, M; Pappas, N; Patel, U				Phillips, Michael; Beatty, J. David; Cataneo, Renee N.; Huston, Jan; Kaplan, Peter D.; Lalisang, Roy I.; Lambin, Philippe; Lobbes, Marc B. I.; Mundada, Mayur; Pappas, Nadine; Patel, Urvish			Rapid Point-Of-Care Breath Test for Biomarkers of Breast Cancer and Abnormal Mammograms	PLOS ONE			English	Article							OXIDATIVE STRESS; EXHALED BREATH; VOLATILE BIOMARKERS; PULMONARY TUBERCULOSIS; LUNG; PREDICTION; CLASSIFICATION; MARKERS; IMPACT; WOMEN	Background: Previous studies have reported volatile organic compounds (VOCs) in breath as biomarkers of breast cancer and abnormal mammograms, apparently resulting from increased oxidative stress and cytochrome p450 induction. We evaluated a six-minute point-of-care breath test for VOC biomarkers in women screened for breast cancer at centers in the USA and the Netherlands. Methods: 244 women had a screening mammogram (93/37 normal/abnormal) or a breast biopsy (cancer/no cancer 35/79). A mobile point-of-care system collected and concentrated breath and air VOCs for analysis with gas chromatography and surface acoustic wave detection. Chromatograms were segmented into a time series of alveolar gradients (breath minus room air). Segmental alveolar gradients were ranked as candidate biomarkers by C-statistic value (area under curve [AUC] of receiver operating characteristic [ROC] curve). Multivariate predictive algorithms were constructed employing significant biomarkers identified with multiple Monte Carlo simulations and cross validated with a leave-one-out (LOO) procedure. Results: Performance of breath biomarker algorithms was determined in three groups: breast cancer on biopsy versus normal screening mammograms (81.8% sensitivity, 70.0% specificity, accuracy 79% (73% on LOO) [C-statistic value], negative predictive value 99.9%); normal versus abnormal screening mammograms (86.5% sensitivity, 66.7% specificity, accuracy 83%, 62% on LOO); and cancer versus no cancer on breast biopsy (75.8% sensitivity, 74.0% specificity, accuracy 78%, 67% on LOO). Conclusions: A pilot study of a six-minute point-of-care breath test for volatile biomarkers accurately identified women with breast cancer and with abnormal mammograms. Breath testing could potentially reduce the number of needless mammograms without loss of diagnostic sensitivity.	[Phillips, Michael; Cataneo, Renee N.; Kaplan, Peter D.; Mundada, Mayur; Patel, Urvish] Menssana Res Inc, Breath Res Lab, Newark, NJ 07103 USA; [Phillips, Michael] New York Med Coll, Dept Med, Valhalla, NY 10595 USA; [Beatty, J. David] Swedish Canc Inst, Seattle, WA USA; [Huston, Jan] HackensackUMC Mountainside, Montclair, NJ USA; [Lalisang, Roy I.] Maastricht Univ Med Ctr, GROW Sch Oncol & Dev Biol, Dept Internal Med, Div Med Oncol, Maastricht, Netherlands; [Lambin, Philippe] Maastricht Univ Med Ctr, GROW Sch Oncol & Dev Biol, Dept Radiotherapy MAASTRO, Maastricht, Netherlands; [Lobbes, Marc B. I.] Maastricht Univ Med Ctr, GROW Sch Oncol & Dev Biol, Dept Radiol, Maastricht, Netherlands; [Pappas, Nadine] St Michaels Hosp, Newark, NJ USA	New York Medical College; Swedish Cancer Institute; Swedish Medical Center; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Phillips, M (corresponding author), Menssana Res Inc, Breath Res Lab, Newark, NJ 07103 USA.	mphillips@menssanaresearch.com		Kaplan, Peter/0000-0002-2292-6862; Lambin, Philippe/0000-0001-7961-0191	National Institutes of Health [1R43RR030689-01]; Dutch Pink Ribbon foundation; CTMM framework (AIRFORCE project) foundation [030-103]; NATIONAL CENTER FOR RESEARCH RESOURCES [R43RR030689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Pink Ribbon foundation; CTMM framework (AIRFORCE project) foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was funded in part by National Institutes of Health grant 1R43RR030689-01. In the Netherlands, this project was funded in part by the Dutch Pink Ribbon foundation and the CTMM framework (AIRFORCE project, grant 030-103) foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerson K, 2009, J ADV NURS, V65, P1130, DOI 10.1111/j.1365-2648.2009.04981.x; Amann A, 2011, EXPERT REV MOL DIAGN, V11, P207, DOI [10.1586/erm.10.112, 10.1586/ERM.10.112]; [Anonymous], BREAST CANC; Blanchard K, 2004, CANCER-AM CANCER SOC, V101, P495, DOI 10.1002/cncr.20392; Brett J, 2005, PSYCHO-ONCOLOGY, V14, P917, DOI 10.1002/pon.904; Bulun SE, 2009, ANN NY ACAD SCI, V1155, P121, DOI 10.1111/j.1749-6632.2009.03705.x; Centers for Disease Control and Prevention, CANC WOM; Consedine NS, 2004, CANCER EPIDEM BIOMAR, V13, P501; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; D'Amico Arnaldo, 2012, Expert Opin Med Diagn, V6, P175, DOI 10.1517/17530059.2012.665870; Gordon RT, 2008, J ALTERN COMPLEM MED, V14, P61, DOI 10.1089/acm.2006.6408; HIETANEN E, 1994, EUR J CLIN NUTR, V48, P575; Jansen-van der Weide MC, 2010, EUR RADIOL, V20, P2547, DOI 10.1007/s00330-010-1839-y; Jezierska-Drutel A, 2013, ADV CANCER RES, V119, P107, DOI 10.1016/B978-0-12-407190-2.00003-4; Jiang WY, 2007, STAT MED, V26, P5320, DOI 10.1002/sim.2968; Jiang YL, 2007, RADIOLOGY, V243, P360, DOI 10.1148/radiol.2432060253; Jorgensen KJ, 2013, DAN MED J, V60; KNEEPKENS CMF, 1994, FREE RADICAL BIO MED, V17, P127; Ludviksdottir D, 2012, CLIN RESPIR J, V6, P193, DOI 10.1111/crj.12001; Ma SG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-253; Mangler M, 2012, GINEKOL POL, V83, P730; Mathews JM, 1997, TOXICOL APPL PHARM, V146, P255, DOI 10.1006/taap.1997.8257; McCulloch M, 2006, INTEGR CANCER THER, V5, P30, DOI 10.1177/1534735405285096; Nelson HD, 2009, 1005142EF1 AHRQ; Patterson SG, 2011, AM SURGEON, V77, P747; Peng G, 2010, BRIT J CANCER, V103, P542, DOI 10.1038/sj.bjc.6605810; Phillips M, 2000, J LAB CLIN MED, V136, P243, DOI 10.1067/mlc.2000.108943; Phillips M, 2004, AM J CARDIOL, V94, P1593, DOI 10.1016/j.amjcard.2004.08.052; Phillips M, 2008, CLIN CHIM ACTA, V393, P76, DOI 10.1016/j.cca.2008.02.021; Phillips Michael, 2007, Cancer Biomarkers, V3, P95; Phillips M, 2007, TUBERCULOSIS, V87, P44, DOI 10.1016/j.tube.2006.03.004; Phillips M, 2006, BREAST CANCER RES TR, V99, P19, DOI 10.1007/s10549-006-9176-1; Phillips M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075274; Phillips Michael, 2003, Breast J, V9, P184, DOI 10.1046/j.1524-4741.2003.09309.x; Phillips M, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/3/036002; Phillips M, 2012, TUBERCULOSIS, V92, P314, DOI 10.1016/j.tube.2012.04.002; Phillips M, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/2/026003; Phillips M, 2010, TUBERCULOSIS, V90, P145, DOI 10.1016/j.tube.2010.01.003; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Schmalfuss F, 2013, BIOMARK INSIGHTS, V8, P9, DOI 10.4137/BMI.S11153; Shuster G, 2011, BREAST CANCER RES TR, V126, P791, DOI 10.1007/s10549-010-1317-x; Stolarek RA, 2010, J CANCER RES CLIN, V136, P923, DOI 10.1007/s00432-009-0734-x; Syhre M, 2009, TUBERCULOSIS, V89, P263, DOI 10.1016/j.tube.2009.04.003; Xu YW, 2013, J BIOMED NANOTECHNOL, V9, P1164, DOI 10.1166/jbn.2013.1651; Yang J, 2006, J ZHEJIANG UNIV-SC B, V7, P603	45	31	33	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90226	10.1371/journal.pone.0090226	http://dx.doi.org/10.1371/journal.pone.0090226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599224	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400056
J	Schwab, F; Gastmeier, P; Meyer, E				Schwab, Frank; Gastmeier, Petra; Meyer, Elisabeth			The Warmer the Weather, the More Gram-Negative Bacteria - Impact of Temperature on Clinical Isolates in Intensive Care Units	PLOS ONE			English	Article							BLOOD-STREAM INFECTION; SEASONAL-VARIATION; SERRATIA-MARCESCENS; DISEASES; PEAKS	Background: We investigated the relationship between average monthly temperature and the most common clinical pathogens causing infections in intensive care patients. Methods: A prospective unit-based study in 73 German intensive care units located in 41 different hospitals and 31 different cities with total 188,949 pathogen isolates (102,377 Gram-positives and 86,572 Gram-negatives) from 2001 to 2012. We estimated the relationship between the number of clinical pathogens per month and the average temperature in the month of isolation and in the month prior to isolation while adjusting for confounders and long-term trends using time series analysis. Adjusted incidence rate ratios for temperature parameters were estimated based on generalized estimating equation models which account for clustering effects. Results: The incidence density of Gram-negative pathogens was 15% (IRR 1.15, 95% CI 1.10-1.21) higher at temperatures >= 20 degrees C than at temperatures below 5 degrees C. E. cloacae occurred 43% (IRR = 1.43; 95% CI 1.31-1.56) more frequently at high temperatures, A. baumannii 37% (IRR = 1.37; 95% CI 1.11-1.69), S. maltophilia 32% (IRR = 1.32; 95% CI 1.12-1.57), K. pneumoniae 26% (IRR = 1.26; 95% CI 1.13-1.39), Citrobacter spp. 19% (IRR = 1.19; 95% CI 0.99-1.44) and coagulase-negative staphylococci 13% (IRR = 1.13; 95% CI 1.04-1.22). By contrast, S. pneumoniae 35% (IRR = 0.65; 95% CI 0.50-0.84) less frequently isolated at high temperatures. For each 5 degrees C increase, we observed a 3% (IRR = 1.03; 95% CI 1.02-1.04) increase of Gram-negative pathogens. This increase was highest for A. baumannii with 8% (IRR = 1.08; 95% CI 1.05-1.12) followed by K. pneumoniae, Citrobacter spp. and E. cloacae with 7%. Conclusion: Clinical pathogens vary by incidence density with temperature. Significant higher incidence densities of Gram-negative pathogens were observed during summer whereas S. pneumoniae peaked in winter. There is increasing evidence that different seasonality due to physiologic changes underlies host susceptibility to different bacterial pathogens. Even if the underlying mechanisms are not yet clear, the temperature-dependent seasonality of pathogens has implications for infection control and study design.	[Schwab, Frank; Gastmeier, Petra; Meyer, Elisabeth] Charite, Inst Hyg & Environm Med, D-13353 Berlin, Germany; [Schwab, Frank; Gastmeier, Petra; Meyer, Elisabeth] Natl Reference Ctr Surveillance Nosocomial Infect, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schwab, F (corresponding author), Charite, Inst Hyg & Environm Med, D-13353 Berlin, Germany.	frank.schwab@charite.de		Gastmeier, Petra/0000-0001-5520-4287; Meyer, Elisabeth/0000-0001-5590-2421	Federal Ministry of Education and Research [01Kl 9907]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	SARI (Surveillance of Antimicrobial use and antimicrobial Resistance in German Intensive Care Units) was supported until 2006 by a grant from the Federal Ministry of Education and Research (01Kl 9907). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hasan MN, 2011, CLIN MICROBIOL INFEC, V17, P539, DOI 10.1111/j.1469-0691.2010.03277.x; Al-Hasan MN, 2010, MAYO CLIN PROC, V85, P139, DOI 10.4065/mcp.2009.0410; Anderson DJ, 2008, J INFECT DIS, V197, P752, DOI 10.1086/527486; [Anonymous], 1930, LANCET, V216, P302; Chazan B, 2011, CLIN MICROBIOL INFEC, V17, P851, DOI 10.1111/j.1469-0691.2010.03327.x; (DAE) AEMdDAE, 2013, LEITL EMPF SICH GUT; Dowell SF, 2003, EMERG INFECT DIS, V9, P573, DOI 10.3201/eid0905.020556; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Eber MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025298; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Freeman JT, 2009, CLIN MICROBIOL INFEC, V15, P951, DOI 10.1111/j.1469-0691.2009.02866.x; Freeman J, 2009, INFECT CONT HOSP EP, V30, P813, DOI 10.1086/597506; Grundmann H, 2005, CRIT CARE MED, V33, P946, DOI 10.1097/01.CCM.0000163223.26234.56; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Leekha S, 2012, CLIN MICROBIOL INFEC, V18, P927, DOI 10.1111/j.1469-0691.2012.03955.x; McDonald LC, 1999, CLIN INFECT DIS, V29, P1133, DOI 10.1086/313441; Meyer E, 2003, INFECTION, V31, P208, DOI 10.1007/s15010-003-3201-7; Ostro B, 2010, AM J EPIDEMIOL, V172, P1053, DOI 10.1093/aje/kwq231; Paynter S, 2010, LANCET, V376, P1804, DOI 10.1016/S0140-6736(10)62141-1; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Perencevich EN, 2008, INFECT CONT HOSP EP, V29, P1124, DOI 10.1086/592698; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; Terletskaia-Ladwig E, 1946, DEUT MED WOCHENSCHR, V136, P69; Walter ND, 2010, CLIN INFECT DIS, V50, P175, DOI 10.1086/649208; Yang AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013728; YU VL, 1979, NEW ENGL J MED, V300, P887, DOI 10.1056/NEJM197904193001604; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	27	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e91105	10.1371/journal.pone.0091105	http://dx.doi.org/10.1371/journal.pone.0091105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599500	Green Submitted, Green Published, gold			2022-12-25	WOS:000332479400155
J	Tapiainen, T; Paalanne, N; Arkkola, T; Renko, M; Pokka, T; Kaijalainen, T; Uhari, M				Tapiainen, Terhi; Paalanne, Niko; Arkkola, Tuula; Renko, Marjo; Pokka, Tytti; Kaijalainen, Tarja; Uhari, Matti			Diet as a Risk Factor for Pneumococcal Carriage and Otitis Media: A Cross-Sectional Study among Children in Day Care Centers	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; STREPTOCOCCUS-PNEUMONIAE; DENTAL-CARIES; BEVERAGE CONSUMPTION; RANDOMIZED-TRIAL; NASOPHARYNGEAL; PREVENTION; XYLITOL; BIOFILMS; VACCINE	Background: Pharyngeal bacteria are exposed to different sugar conditions depending on the diet of the child. We hypothesized that dietary factors such as daily intake of carbohydrates could be associated with pneumococcal carriage and the occurrence of otitis media in children. Methods: Our study design was a cross-sectional study among 1006 children attending child day care centers. Parents filled in a food frequency questionnaire. Oropharyngeal swabs were collected from each child. The primary outcome was the occurrence of pneumococcal carriage and the secondary outcome the number of acute otitis media episodes during life. Principal component analysis was used to group dietary intake into nine factors. The models were adjusted for age, gender of the child and educational level of the mother. Results: The dietary factor which included high consumption of sweet pastries and jam was associated with an increased risk of pneumococcal carriage (OR 1.17, 95% CI 1.01 to 1.36, P-value 0.04). The factor including frequent consumption of fruit and berries was associated with a decreased risk of acute otitis (regression coefficient -0.51, 95% CI -0.98 to -0.03, P = 0.04). A high intake of consumption of sweets and snacks (OR 1.36, 95% CI 1.03 to 1.80, P = 0.03) was associated with an increased risk of caries. Conclusions: Diet was associated with a risk of pneumococcal carriage and the occurrence of otitis media. Diet may thus be a modifiable risk factor for the occurrence of acute otitis media.	[Tapiainen, Terhi; Paalanne, Niko; Arkkola, Tuula; Renko, Marjo; Pokka, Tytti; Uhari, Matti] Oulu Univ Hosp, Dept Pediat, Oulu, Finland; [Tapiainen, Terhi; Paalanne, Niko; Renko, Marjo; Pokka, Tytti; Uhari, Matti] Univ Oulu, Dept Pediat, SF-90100 Oulu, Finland; [Kaijalainen, Tarja] Natl Inst Hlth & Welf, Oulu, Finland	University of Oulu; University of Oulu; Finland National Institute for Health & Welfare	Tapiainen, T (corresponding author), Oulu Univ Hosp, Dept Pediat, Oulu, Finland.	terhi.tapiainen@oulu.fi	Renko, Marjo/F-7811-2014	Renko, Marjo/0000-0003-0507-4773	Foundation for Pediatric Research; Juho Vainio Foundation, Finland	Foundation for Pediatric Research; Juho Vainio Foundation, Finland	This work was financially supported by the Foundation for Pediatric Research, and the Juho Vainio Foundation, Finland. No other funding was used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Duarte S, 2006, FEMS MICROBIOL LETT, V257, P50, DOI 10.1111/j.1574-6968.2006.00147.x; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Garcia-Rodriguez JA, 2002, J ANTIMICROB CHEMOTH, V50, P59, DOI 10.1093/jac/dkf506; Greenberg D, 2004, J CLIN MICROBIOL, V42, P4604, DOI 10.1128/JCM.42.10.4604-4609.2004; Grimes CA, 2013, PEDIATRICS, V131, P14, DOI 10.1542/peds.2012-1628; Kilpi T, 2001, PEDIATR INFECT DIS J, V20, P654, DOI 10.1097/00006454-200107000-00004; Kontiokari T, 2003, AM J CLIN NUTR, V77, P600, DOI 10.1093/ajcn/77.3.600; Kontiokari T, 2001, BMJ-BRIT MED J, V322, P1571, DOI 10.1136/bmj.322.7302.1571; Koo H, 2010, CARIES RES, V44, P116, DOI 10.1159/000296306; Kurola P, 2011, APMIS, V119, P135, DOI 10.1111/j.1600-0463.2010.02703.x; Kyttala P., 2008, DIET FINNISH PRESCHO; Leino T, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-173; Makinen KK, 1995, J DENT RES, V74, P1904, DOI 10.1177/00220345950740121501; Marshall TA, 2003, PEDIATRICS, V112, pE184, DOI 10.1542/peds.112.3.e184; Ministry of Education and Culture Finland, 2010, SUOM VAEST KOUL VAHV; Mosby TT, 2012, ANTICANCER RES, V32, P4171; Niemela M, 2000, PEDIATRICS, V106, P483, DOI 10.1542/peds.106.3.483; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Rueda AM, 2010, J INFECTION, V60, P99, DOI 10.1016/j.jinf.2009.12.003; Salo J, 2012, CLIN INFECT DIS, V54, P340, DOI 10.1093/cid/cir801; SIPILA M, 1988, ACTA OTO-LARYNGOL, V106, P94, DOI 10.3109/00016488809107375; Syrjanen RK, 2001, J INFECT DIS, V184, P451, DOI 10.1086/322048; Touger-Decker R, 2003, AM J CLIN NUTR, V78, p881S, DOI 10.1093/ajcn/78.4.881S; Uhari M, 1996, BRIT MED J, V313, P1180, DOI 10.1136/bmj.313.7066.1180; Uhari M, 1996, CLIN INFECT DIS, V22, P1079, DOI 10.1093/clinids/22.6.1079; Vadeboncoeur C, 1997, FEMS MICROBIOL REV, V19, P187, DOI 10.1016/S0168-6445(96)00029-0; Veenhoven R, 2003, LANCET, V361, P2189, DOI 10.1016/S0140-6736(03)13772-5; Watt JP, 2004, J CLIN MICROBIOL, V42, P4974, DOI 10.1128/JCM.42.11.4974-4976.2004	28	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90585	10.1371/journal.pone.0090585	http://dx.doi.org/10.1371/journal.pone.0090585			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599395	Green Submitted, Green Published, gold			2022-12-25	WOS:000332479400099
J	Govender, S; Otwombe, K; Essien, T; Panchia, R; de Bruyn, G; Mohapi, L; Gray, G; Martinson, N				Govender, Sarishen; Otwombe, Kennedy; Essien, Thandekile; Panchia, Ravindre; de Bruyn, Guy; Mohapi, Lerato; Gray, Glenda; Martinson, Neil			CD4 Counts and Viral Loads of Newly Diagnosed HIV-Infected Individuals: Implications for Treatment as Prevention	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL TREATMENT; CELL COUNT; RNA LEVELS; AIDS; TRANSMISSION; SEROCONVERSION; PROGRESSION; THERAPY; MARKERS	Objective: To report the viral load and CD4 count in HIV-infected, antiretroviral naive, first - time HIV-testers, not immediately eligible for treatment initiation by current South Africa treatment guidelines. Design: This was a cross-sectional study in a high-volume, free-of-charge HIV testing centre in Soweto, South Africa. Methods: We enrolled first time HIV testers and collected demographic and risk-behaviour data and measured CD4 count and viral load. Results: Between March and October 2011, a total of 4793 adults attended VCT and 1062 (22%) tested positive. Of the 1062, 799 (75%) were ART naive and 348/799 (44%) were first-time HIV testers. Of this group of 348, 225 (65%) were female. Overall their median age, CD4 count and viral load was 34 years (IQR: 28-41), 364 (IQR: 238-542) cells/mm(3) and 13,000 (IQR: 2050-98171) copies/ml, respectively. Female first time HIV testers had higher CD4 counts (419 IQR: 262-582 vs. 303 IQR: 199418 cells/mm(3)) and lower viral loads (9,100 vs. 34,000 copies/ml) compared to males. Of 183 participants with CD4 count >350 cells/mm(3), 62 (34%) had viral loads. 10,000 copies/ml. Conclusions: A large proportion of HIV infected adults not qualifying for immediate ART at the CD4 count threshold of 350 cells/mm(3) have high viral loads. HIV-infected men at their first HIV diagnosis are more likely to have lower CD4 counts and higher viral loads than women.	[Govender, Sarishen; Otwombe, Kennedy; Essien, Thandekile; Panchia, Ravindre; de Bruyn, Guy; Mohapi, Lerato; Gray, Glenda; Martinson, Neil] Univ Witwatersrand, PHRU, Soweto, South Africa; [Govender, Sarishen; Otwombe, Kennedy; Essien, Thandekile; Panchia, Ravindre; de Bruyn, Guy; Mohapi, Lerato; Gray, Glenda; Martinson, Neil] Baragwanath Hosp, Soweto, South Africa; [Martinson, Neil] Johns Hopkins Univ, Ctr TB Res, Baltimore, MD USA; [Govender, Sarishen] Ottawa Hosp Gen Campus, Canada Africa Prevent Trials Network, Ottawa, ON, Canada	University of Witwatersrand; Johns Hopkins University; University of Ottawa; Ottawa Hospital Research Institute	Govender, S (corresponding author), Univ Witwatersrand, PHRU, Soweto, South Africa.	sarisheng@gmail.com		de Bruyn, Guy/0000-0002-8028-4474	Canadian African Prevention Trials Network (CAPT); Presidents Emergency Plan For AIDS Relief (PEPFAR)	Canadian African Prevention Trials Network (CAPT); Presidents Emergency Plan For AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by Canadian African Prevention Trials Network (CAPT) and Presidents Emergency Plan For AIDS Relief (PEPFAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KO has received research training from the Fogarty International Center (TW007373/0).	Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Department of Health,, S AFR ANT TREATM GUI; deWolf F, 1997, AIDS, V11, P1799, DOI 10.1097/00002030-199715000-00003; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Glencross D, 2002, CYTOMETRY, V50, P69, DOI 10.1002/cyto.10068; Granich R, 2010, CURR OPIN HIV AIDS, V5, P298, DOI 10.1097/COH.0b013e32833a6c32; Granich R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-1; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Meintjes G, 2012, S AFR J HIV MED, DOI 10.7196/SAJHIVMED.862; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Murnane PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051192; Prins M, 1999, AIDS, V13, P2361, DOI 10.1097/00002030-199912030-00007; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; Touloumi G, 2004, AIDS, V18, P1697, DOI 10.1097/01.aids.0000131395.14339.f5	16	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90754	10.1371/journal.pone.0090754	http://dx.doi.org/10.1371/journal.pone.0090754			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595317	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500097
J	Kadiyala, SB; Papandrea, D; Herron, BJ; Ferland, RJ				Kadiyala, Sridhar B.; Papandrea, Dominick; Herron, Bruce J.; Ferland, Russell J.			Segregation of Seizure Traits in C57 Black Mouse Substrains Using the Repeated-Flurothyl Model	PLOS ONE			English	Article							GENERALIZED TONICCLONIC SEIZURES; PONTINE TEGMENTAL LESIONS; TEMPORAL-LOBE EPILEPSY; BRAIN-STEM; INBRED MICE; C57BL/6 SUBSTRAINS; SPATIAL-PATTERNS; MITOTIC-ACTIVITY; TONIC SEIZURES; KINDLING MODEL	Identifying the genetic basis of epilepsy in humans is difficult due to its complexity, thereby underlying the need for preclinical models with specific aspects of seizure susceptibility that are tractable to genetic analyses. In the repeated-flurothyl model, mice are given 8 flurothyl-induced seizures, once per day (the induction phase), followed by a 28-day rest period (incubation phase) and final flurothyl challenge. This paradigm allows for the tracking of multiple phenotypes including: initial generalized seizure threshold, decreases in generalized seizure threshold with repeated flurothyl exposures, and changes in the complexity of seizures over time. Given the responses we previously reported in C57BL/6J mice, we analyzed substrains of the C57BL lineage to determine if any of these phenotypes segregated in these substrains. We found that the generalized seizure thresholds of C57BL/10SNJ and C57BL/10J mice were similar to C57BL/6J mice, whereas C57BL/6NJ and C57BLKS/J mice showed lower generalized seizure thresholds. In addition, C57BL/6J mice had the largest decreases in generalized seizure thresholds over the induction phase, while the other substrains were less pronounced. Notably, we observed only clonic seizures during the induction phase in all substrains, but when rechallenged with flurothyl after a 28-day incubation phase, similar to 80% of C57BL/6J and 25% of C57BL/10SNJ and C57BL/10J mice expressed more complex seizures with tonic manifestations with none of the C57BL/6NJ and C57BLKS/J mice having complex seizures with tonic manifestations. These data indicate that while closely related, the C57BL lineage has significant diversity in aspects of epilepsy that are genetically controlled. Such differences further highlight the importance of genetic background in assessing the effects of targeted deletions of genes in preclinical epilepsy models.	[Kadiyala, Sridhar B.; Papandrea, Dominick; Ferland, Russell J.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Herron, Bruce J.] Wadsworth Ctr, Albany, NY USA; [Herron, Bruce J.] SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY USA; [Ferland, Russell J.] Albany Med Coll, Dept Neurol, Albany, NY 12208 USA	Albany Medical College; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Albany Medical College	Ferland, RJ (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA.	ferlanr@mail.amc.edu	Ferland, Russell/Q-6793-2019	Ferland, Russell/0000-0002-8044-2479	National Institutes of Health [NS064283, AR054828]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health [NS064283 to R.J.F., AR054828 to B.J.H.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLEGATE CD, 1991, EPILEPSY RES, V10, P142, DOI 10.1016/0920-1211(91)90006-2; Applegate CD, 1997, EPILEPSIA, V38, P631, DOI 10.1111/j.1528-1157.1997.tb01231.x; Aydin-Abidin S, 2011, NEUROSCI LETT, V504, P165, DOI 10.1016/j.neulet.2011.09.030; Bankstahl M, 2012, BEHAV BRAIN RES, V230, P182, DOI 10.1016/j.bbr.2012.02.004; BLUM K, 1982, EXPERIENTIA, V38, P1469, DOI 10.1007/BF01955775; Blumenfeld H, 2009, BRAIN, V132, P999, DOI 10.1093/brain/awp028; BROWNING R, 1993, EPILEPSIA, V34, P393, DOI 10.1111/j.1528-1157.1993.tb02579.x; BROWNING RA, 1986, EXP NEUROL, V93, P546, DOI 10.1016/0014-4886(86)90174-3; BROWNING RA, 1985, EPILEPSIA, V26, P175, DOI 10.1111/j.1528-1157.1985.tb05402.x; BROWNING RA, 1981, EPILEPSIA, V22, P595, DOI 10.1111/j.1528-1157.1981.tb04131.x; BROWNING RA, 1981, EPILEPSIA, V22, P583, DOI 10.1111/j.1528-1157.1981.tb04130.x; Bryant CD, 2008, J NEUROGENET, V22, P315, DOI 10.1080/01677060802357388; Buono RJ, 2004, EPILEPSY RES, V58, P175, DOI 10.1016/j.eplepsyres.2004.02.003; Cortez Miguel A, 2006, Adv Neurol, V97, P293; DeSarro A, 1996, J ANTIMICROB CHEMOTH, V38, P475, DOI 10.1093/jac/38.3.475; ENGEL J, 1978, ANN NEUROL, V3, P538, DOI 10.1002/ana.410030615; Engel J Jr, 1996, Epilepsy Res Suppl, V12, P9; Ferland RJ, 1998, EXP NEUROL, V151, P124, DOI 10.1006/exnr.1998.6794; Ferland RJ, 1998, NEUROREPORT, V9, P3623, DOI 10.1097/00001756-199811160-00013; Ferland RJ, 2002, NEUROSCI LETT, V332, P131, DOI 10.1016/S0304-3940(02)00808-X; Ferland RJ, 2002, NEUROSCIENCE, V115, P669, DOI 10.1016/S0306-4522(02)00514-6; Ferland RJ, 1999, EPILEPSIA, V40, P144, DOI 10.1111/j.1528-1157.1999.tb02067.x; Ferland RJ, 1998, EPILEPSY RES, V30, P49, DOI 10.1016/S0920-1211(97)00093-4; Ferraro TN, 2011, GENES BRAIN BEHAV, V10, P309, DOI 10.1111/j.1601-183X.2010.00668.x; Ferraro TN, 2010, PHYSIOL GENOMICS, V42A, P1, DOI 10.1152/physiolgenomics.00096.2010; Ferraro TN, 2004, MAMM GENOME, V15, P239, DOI 10.1007/s00335-003-2270-3; GREEN RC, 1991, EPILEPSIA, V32, P22, DOI 10.1111/j.1528-1157.1991.tb05605.x; Holmes Gregory L, 2006, Adv Neurol, V97, P323; KREINDLER A, 1958, J NEUROPHYSIOL, V21, P430, DOI 10.1152/jn.1958.21.5.430; Kumar V, 2013, SCIENCE, V342, P1508, DOI 10.1126/science.1245503; LOTHMAN EW, 1985, BRAIN RES, V360, P92, DOI 10.1016/0006-8993(85)91224-7; MAGISTRIS MR, 1988, EPILEPSIA, V29, P379, DOI 10.1111/j.1528-1157.1988.tb03735.x; McKhann GM, 2003, NEUROSCIENCE, V122, P551, DOI 10.1016/S0306-4522(03)00562-1; Merrill MA, 2003, EPILEPSIA, V44, P305, DOI 10.1046/j.1528-1157.2003.31802.x; Mhyre TR, 2003, NEUROSCIENCE, V121, P1031, DOI 10.1016/S0306-4522(03)00475-5; Muller CJ, 2009, GENES BRAIN BEHAV, V8, P481, DOI 10.1111/j.1601-183X.2009.00490.x; Mulligan MK, 2008, GENES BRAIN BEHAV, V7, P677, DOI 10.1111/j.1601-183X.2008.00405.x; NAMBA H, 1991, EPILEPSIA, V32, P27, DOI 10.1111/j.1528-1157.1991.tb05606.x; Papandrea D, 2009, EPILEPSY RES, V87, P130, DOI 10.1016/j.eplepsyres.2009.08.003; Papandrea D, 2009, EXP NEUROL, V215, P60, DOI 10.1016/j.expneurol.2008.09.016; Pitkanen A, 2006, MODELS OF SEIZURES AND EPILEPSY, P1; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Radulovic J, 1998, BEHAV BRAIN RES, V95, P179, DOI 10.1016/S0166-4328(98)00039-4; RISE ML, 1991, SCIENCE, V253, P669, DOI 10.1126/science.1871601; Samoriski GM, 1998, NEUROSCIENCE, V84, P1209, DOI 10.1016/S0306-4522(97)00571-X; Samoriski GM, 1997, EXP NEUROL, V143, P255, DOI 10.1006/exnr.1996.6368; Samoriski GM, 1997, J NEUROSCI, V17, P5581; Stiedl O, 1999, BEHAV BRAIN RES, V104, P1, DOI 10.1016/S0166-4328(99)00047-9; Tsuchiya K, 2011, EPILEPSY RES, V95, P144, DOI 10.1016/j.eplepsyres.2011.03.015; Varghese GI, 2009, BRAIN, V132, P2102, DOI 10.1093/brain/awp027; Wang JR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S3-S13	51	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90506	10.1371/journal.pone.0090506	http://dx.doi.org/10.1371/journal.pone.0090506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594686	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900113
J	Lian, PW; Li, A; Li, Y; Liu, HC; Liang, D; Hu, B; Lin, D; Jiang, T; Moeckel, G; Qin, DH; Wu, GQ				Lian, Peiwen; Li, Ao; Li, Yuan; Liu, Haichao; Liang, Dan; Hu, Bo; Lin, De; Jiang, Tang; Moeckel, Gilbert; Qin, Dahui; Wu, Guanqing			Loss of Polycystin-1 Inhibits Bicc1 Expression during Mouse Development	PLOS ONE			English	Article							KIDNEY-DISEASE; BICAUDAL-C; EPITHELIAL-CELLS; PRIMARY CILIA; MDCK CELLS; KH-DOMAIN; PROTEIN; RNA; MUTATIONS; GENE	Bicc1 is a mouse homologue of Drosophila Bicaudal-C (dBic-C), which encodes an RNA-binding protein. Orthologs of dBic-C have been identified in many species, from C. elegans to humans. Bicc1-mutant mice exhibit a cystic phenotype in the kidney that is very similar to human polycystic kidney disease. Even though many studies have explored the gene characteristics and its functions in multiple species, the developmental profile of the Bicc1 gene product (Bicc1) in mammal has not yet been completely characterized. To this end, we generated a polyclonal antibody against Bicc1 and examined its spatial and temporal expression patterns during mouse embryogenesis and organogenesis. Our results demonstrated that Bicc1 starts to be expressed in the neural tube as early as embryonic day (E) 8.5 and is widely expressed in epithelial derivatives including the gut and hepatic cells at E10.5, and the pulmonary bronchi at E11.5. In mouse kidney development, Bicc1 appears in the early ureteric bud and mesonephric tubules at E11.5 and is also expressed in the metanephros at the same stage. During postnatal kidney development, Bicc1 expression gradually expands from the cortical to the medullary and papillary regions, and it is highly expressed in the proximal tubules. In addition, we discovered that loss of the Pkd1 gene product, polycystin-1 (PC1), whose mutation causes human autosomal dominant polycystic kidney disease (ADPKD), downregulates Bicc1 expression in vitro and in vivo. Our findings demonstrate that Bicc1 is developmentally regulated and reveal a new molecular link between Bicc1 and Pkd1.	[Lian, Peiwen; Li, Ao; Li, Yuan; Liu, Haichao; Wu, Guanqing] Chinese Acad Med Sci, Canc Hosp & Inst, State Key Lab Mol Oncol, Div Translat Canc Res & Therapy, Beijing 100730, Peoples R China; [Lian, Peiwen; Li, Ao; Li, Yuan; Liu, Haichao; Wu, Guanqing] Peking Union Med Coll, Beijing 100021, Peoples R China; [Lian, Peiwen; Li, Ao; Liang, Dan; Hu, Bo; Wu, Guanqing] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Wu, Guanqing] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37235 USA; [Lin, De] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Jiang, Tang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med, Guangzhou 510275, Guangdong, Peoples R China; [Moeckel, Gilbert] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Qin, Dahui] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Pathol, Tampa, FL 33682 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Vanderbilt University; Vanderbilt University; Vanderbilt University; Sun Yat Sen University; Yale University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Wu, GQ (corresponding author), Chinese Acad Med Sci, Canc Hosp & Inst, State Key Lab Mol Oncol, Div Translat Canc Res & Therapy, Beijing 100730, Peoples R China.	guanqing.wu@vanderbilt.edu	Li, Ao/W-2833-2019	Moeckel, Gilbert/0000-0002-6059-0837	National Institutes of Health of the USA [RR033682]; National 973 program [2012CB517700, 2011EG150311, 81173114, 81072688]	National Institutes of Health of the USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National 973 program(National Basic Research Program of China)	This work was supported by the National Institutes of Health of the USA (RR033682) to G. W and by National 973 program (2012CB517700) (2011EG150311) (81173114) (81072688). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Bouvrette DJ, 2008, NEPHRON EXP NEPHROL, V108, pE27, DOI 10.1159/000112913; Bouvrette DJ, 2010, COMPARATIVE MED, V60, P96; Chen TP, 1997, MOL CELL BIOL, V17, P5707, DOI 10.1128/MCB.17.10.5707; Cogswell C, 2003, MAMM GENOME, V14, P242, DOI 10.1007/s00335-002-2241-0; FLAHERTY L, 1995, KIDNEY INT, V47, P552, DOI 10.1038/ki.1995.69; Fu YL, 2010, EUR J CELL BIOL, V89, P428, DOI 10.1016/j.ejcb.2010.01.002; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hu B, 2011, EXP CELL RES, V317, P173, DOI 10.1016/j.yexcr.2010.09.012; Kim IY, 2008, J BIOL CHEM, V283, P31559, DOI 10.1074/jbc.M805452200; Kim IY, 2008, J AM SOC NEPHROL, V19, P455, DOI 10.1681/ASN.2007070770; Kim I, 2009, J AM SOC NEPHROL, V20, P2556, DOI 10.1681/ASN.2009030271; Kokot F, 2000, NEPHRON, V85, P97, DOI 10.1159/000045640; Kraus MRC, 2012, HUM MUTAT, V33, P86, DOI 10.1002/humu.21610; MAHONE M, 1995, EMBO J, V14, P2043, DOI 10.1002/j.1460-2075.1995.tb07196.x; Maisonneuve C, 2009, DEVELOPMENT, V136, P3019, DOI 10.1242/dev.038174; NAUTA J, 1995, PEDIATR RES, V37, P755, DOI 10.1203/00006450-199506000-00014; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Piazzon N, 2012, J MOL CELL BIOL; Streets AJ, 2009, J CELL SCI, V122, P1410, DOI 10.1242/jcs.045021; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Tran U, 2010, DEVELOPMENT, V137, P1107, DOI 10.1242/dev.046045; Wessely O, 2000, DEVELOPMENT, V127, P2053; Wessely O, 2001, MECH DEVELOP, V101, P267, DOI 10.1016/S0925-4773(00)00568-2; Wheatley DN, 1995, PATHOBIOLOGY, V63, P222, DOI 10.1159/000163955; Wilson PD, 2007, ANNU REV PATHOL-MECH, V2, P341, DOI 10.1146/annurev.pathol.2.010506.091850; Wu GQ, 2000, NAT GENET, V24, P75, DOI 10.1038/71724; Wu GQ, 2002, HUM MOL GENET, V11, P1845, DOI 10.1093/hmg/11.16.1845; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215; Zhang MZ, 2004, P NATL ACAD SCI USA, V101, P2311, DOI 10.1073/pnas.0400073101; Zhou L, 2008, INT J GENET, V31, P432	31	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e88816	10.1371/journal.pone.0088816	http://dx.doi.org/10.1371/journal.pone.0088816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594709	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900007
J	van Tussenbroek, BI; Cortes, J; Collin, R; Fonseca, AC; Gayle, PMH; Guzman, HM; Jacome, GE; Juman, R; Koltes, KH; Oxenford, HA; Rodriguez-Ramirez, A; Samper-Villarreal, J; Smith, SR; Tschirky, JJ; Weil, E				van Tussenbroek, Brigitta I.; Cortes, Jorge; Collin, Rachel; Fonseca, Ana C.; Gayle, Peter M. H.; Guzman, Hector M.; Jacome, Gabriel E.; Juman, Rahanna; Koltes, Karen H.; Oxenford, Hazel A.; Rodriguez-Ramirez, Alberto; Samper-Villarreal, Jimena; Smith, Struan R.; Tschirky, John J.; Weil, Ernesto			Caribbean-Wide, Long-Term Study of Seagrass Beds Reveals Local Variations, Shifts in Community Structure and Occasional Collapse	PLOS ONE			English	Article							CORAL-REEF; WATER-QUALITY; SEDIMENT NUTRIENTS; CARICOMP SITE; FLORIDA-KEYS; PATTERNS; PHOSPHORUS; HABITATS; MANGROVE; DYNAMICS	The CARICOMP monitoring network gathered standardized data from 52 seagrass sampling stations at 22 sites (mostly Thalassia testudinum-dominated beds in reef systems) across the Wider Caribbean twice a year over the period 1993 to 2007 (and in some cases up to 2012). Wide variations in community total biomass (285 to >2000 g dry m(-2)) and annual foliar productivity of the dominant seagrass T. testudinum (<200 and >2000 g dry m(-2)) were found among sites. Solar-cycle related intra-annual variations in T. testudinum leaf productivity were detected at latitudes > 16 degrees N. Hurricanes had little to no long-term effects on these well-developed seagrass communities, except for 1 station, where the vegetation was lost by burial below similar to 1 m sand. At two sites (5 stations), the seagrass beds collapsed due to excessive grazing by turtles or sea-urchins (the latter in combination with human impact and storms). The low-cost methods of this regional-scale monitoring program were sufficient to detect long-term shifts in the communities, and fifteen (43%) out of 35 long-term monitoring stations (at 17 sites) showed trends in seagrass communities consistent with expected changes under environmental deterioration.	[van Tussenbroek, Brigitta I.] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Cancun, Mexico; [Cortes, Jorge; Fonseca, Ana C.; Samper-Villarreal, Jimena] Univ Costa Rica, Ctr Invest Ciencias Mar & Limnol CIMAR, San Pedro, Costa Rica; [Collin, Rachel; Guzman, Hector M.; Jacome, Gabriel E.] Smithsonian Trop Res Inst, Panama City, Panama; [Gayle, Peter M. H.] Discovery Bay Marine Lab, Discovery Bay, Hong Kong, Peoples R China; [Juman, Rahanna] Inst Marine Affairs, Trinidad, Trinidad Tobago; [Koltes, Karen H.] Off Insular Affairs, Dept Interior, Washington, DC USA; [Oxenford, Hazel A.] Univ W Indies, CERMES, Wanstead, Barbados; [Rodriguez-Ramirez, Alberto] Inst Invest Marinas & Costeras INVEMAR, Santa Marta, Colombia; [Smith, Struan R.] Bermuda Biol Stn Res, St George, Bermuda; [Weil, Ernesto] Univ Puerto Rico, Dept Marine Sci, Mayaguez, PR 00709 USA	Universidad Nacional Autonoma de Mexico; Universidad Costa Rica; Smithsonian Institution; Smithsonian Tropical Research Institute; United States Department of the Interior; University of Puerto Rico; University of Puerto Rico Mayaguez	van Tussenbroek, BI (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Cancun, Mexico.	vantuss@cmarl.unam.mx	Collin, Rachel/G-2001-2010; Weil, Ernesto/AAI-3591-2020; van Tussenbroek, Brigitta/P-2517-2017; Cortés, Jorge/AAC-9782-2020; Collin, Rachel/Q-7100-2019; Weil, Ernesto/ABF-1290-2020	van Tussenbroek, Brigitta/0000-0002-6447-7479; Cortés, Jorge/0000-0001-7004-8649; Collin, Rachel/0000-0001-5103-4460; Weil, Ernesto/0000-0001-5275-1584; Rodriguez-Ramirez, Alberto/0000-0003-4855-7345; Samper-Villarreal, Jimena/0000-0002-7513-7293; Guzman, Hector M./0000-0001-9928-8523	John D. and Catherine T. MacArthur Foundation; UNESCO Environment and Development in Coastal Regions and in Small Islands (CSI); US National Science Foundation-Division of International Programs and Division of Ocean Sciences; CARICOMP data Management Centre; Centre for Marine Sciences; University of West Indies, Jamaica	John D. and Catherine T. MacArthur Foundation; UNESCO Environment and Development in Coastal Regions and in Small Islands (CSI); US National Science Foundation-Division of International Programs and Division of Ocean Sciences(National Science Foundation (NSF)); CARICOMP data Management Centre; Centre for Marine Sciences; University of West Indies, Jamaica	CARICOMP received support from the John D. and Catherine T. MacArthur Foundation, UNESCO Environment and Development in Coastal Regions and in Small Islands (CSI), US National Science Foundation-Division of International Programs and Division of Ocean Sciences, CARICOMP data Management Centre, Centre for Marine Sciences, University of West Indies, Jamaica, and the directors and administrators of the participating institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage AR, 2011, ECOSYSTEMS, V14, P430, DOI 10.1007/s10021-011-9421-2; Byron D, 2006, ESTUARIES COASTS, V29, P939, DOI 10.1007/BF02798654; CARICOMP, 1994, CARICOMP METH MAN LE; CARICOMP, 1997, P 8 INT COR REEF S, V1, P663; Carruthers TJB, 2005, ESTUAR COAST SHELF S, V64, P191, DOI 10.1016/j.ecss.2005.01.015; Chollett I, 2012, LIMNOL OCEANOGR, V57, P1233, DOI 10.4319/lo.2012.57.4.1233; Cortes J, 2010, REV BIOL TROP, V58, P1; Cruz-Palacios V, 2005, J EXP MAR BIOL ECOL, V324, P44, DOI 10.1016/j.jembe.2005.04.002; D'Croz L, 2005, CARIBB J SCI, V41, P414; Davis SE, 2004, J COASTAL RES, V20, P1198, DOI 10.2112/03-0072R.1; DENNISON WC, 1993, BIOSCIENCE, V43, P86, DOI 10.2307/1311969; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; DUARTE CM, 1991, AQUAT BOT, V40, P363, DOI 10.1016/0304-3770(91)90081-F; DUARTE CM, 1990, MAR ECOL PROG SER, V67, P201, DOI 10.3354/meps067201; Fonseca ACE, 2007, REV BIOL TROP, V55, P55; Fonseca M. S., 2000, P 4 INT SEAGR BIOL W, V7, P373; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Fourqurean JW, 2010, MAR ECOL PROG SER, V419, P223, DOI 10.3354/meps08853; Fourqurean JW, 2003, ECOL APPL, V13, P474, DOI 10.1890/1051-0761(2003)013[0474:FROSDT]2.0.CO;2; FOURQUREAN JW, 1992, LIMNOL OCEANOGR, V37, P162, DOI 10.4319/lo.1992.37.1.0162; Fourqurean JW, 2002, BIOGEOCHEMISTRY, V61, P229, DOI 10.1023/A:1020293503405; Fourqurean JW, 2001, MAR BIOL, V138, P341, DOI 10.1007/s002270000448; Gillanders BM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P503; Green E. E. P., 2003, WORLD ATLAS SEAGRASS; Heck KL, 2008, ECOSYSTEMS, V11, P1198, DOI 10.1007/s10021-008-9155-y; Jordan-Dahlgren E, 1997, P 8 INT COR REEF S 1, V1, P647; Kjerve B, 1998, COASTAL REGION SMALL; Koltes Karen H., 2009, Smithsonian Contributions to the Marine Sciences, P379; Liaw A., 2012, CRAN R RANDOMFOREST; Linton D, 2004, CARIBBEAN COASTAL MA; Linton DM, 2003, OCEAN COAST MANAGE, V46, P261, DOI 10.1016/S0964-5691(03)00007-3; Livingston RJ, 1998, AQUAT BOT, V60, P135, DOI 10.1016/S0304-3770(97)00079-X; Madsen JD, 2001, HYDROBIOLOGIA, V444, P71, DOI 10.1023/A:1017520800568; Marba N, 2003, AQUAT BOT, V77, P87, DOI 10.1016/S0304-3770(03)00079-2; McKenzie L.J., 2000, Biologia Marina Mediterranea, V7, P393; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Montcreiff CA, 1999, GULF RES REP, V11, P74; Murdoch TJT, 2007, MAR ECOL PROG SER, V339, P123, DOI 10.3354/meps339123; Nagelkerken I, 2001, MAR ECOL PROG SER, V214, P225, DOI 10.3354/meps214225; NELSEN JE, 1986, J SEDIMENT PETROL, V56, P622; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Rodriguez-Martinez RE, 2010, REV BIOL TROP, V58, P23; Rodriguez-Ramirez A, 2008, B INVESTIGACIONES MA, V37; Rodriguez-Ramirez A, 2010, REV BIOL TROP, V58, P45; Romero J, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P227; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; Short FT, 2006, MAR ECOL-EVOL PERSP, V27, P277, DOI 10.1111/j.1439-0485.2006.00095.x; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; SHORT FT, 1987, AQUAT BOT, V27, P41, DOI 10.1016/0304-3770(87)90085-4; Szmant AM, 1996, CORAL REEFS, V15, P21, DOI 10.1007/BF01626075; Udy JW, 1997, J EXP MAR BIOL ECOL, V217, P253, DOI 10.1016/S0022-0981(97)00060-9; Unsworth RKF, 2008, MAR ECOL PROG SER, V353, P213, DOI 10.3354/meps07199; van Tussenbroek BI, 2008, J COASTAL RES, V24, P278, DOI 10.2112/06-0777.1; van Tussenbroek BI, 2007, J PHYCOL, V43, P69, DOI 10.1111/j.1529-8817.2006.00307.x; van Tussenbroek BI, 2011, HIDROBIOLOGICA, V21, P293; Verweij MC, 2006, MAR ECOL PROG SER, V306, P257, DOI 10.3354/meps306257; WEFER G, 1980, NATURE, V285, P323, DOI 10.1038/285323a0; Whitfield PE, 2002, J COASTAL RES, V37, P68	58	53	55	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90600	10.1371/journal.pone.0090600	http://dx.doi.org/10.1371/journal.pone.0090600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594732	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900123
J	Oduwole, OO; Vydra, N; Wood, NEM; Samanta, L; Owen, L; Keevil, B; Donaldson, M; Naresh, K; Huhtaniemi, IT				Oduwole, Olayiwola O.; Vydra, Natalia; Wood, Nicholas E. M.; Samanta, Luna; Owen, Laura; Keevil, Brian; Donaldson, Mandy; Naresh, Kikkeri; Huhtaniemi, Ilpo T.			Overlapping dose responses of spermatogenic and extragonadal testosterone actions jeopardize the principle of hormonal male contraception	FASEB JOURNAL			English	Article						azoospermia; oligozoospermia; hypothalamic-pituitary-testicular axis	FOLLICLE-STIMULATING-HORMONE; LUTEINIZING-HORMONE; ENANTHATE; AZOOSPERMIA; INDUCTION; PLASMA; TESTIS	Testosterone (T), alone or in combination with progestin, provides a promising approach to hormonal male contraception. Its principle relies on enhanced negative feedback of exogenous T to suppress gonadotropins, thereby blocking the testicular T production needed for spermatogenesis, while simultaneously maintaining the extragonadal androgen actions, such as potency and libido, to avoid hypogonadism. A serious drawback of the treatment is that a significant proportion of men do not reach azoospermia or severe oligozoospermia, commensurate with contraceptive efficacy. We tested here, using hypogonadal luteinizing hormone/choriongonadotropin receptor (LHCGR) knockout (LHR-/-) mice, the basic principle of the T-based male contraceptive method, that a specific T dose could maintain extragonadal androgen actions without simultaneously activating spermatogenesis. LHR-/- mice were treated with increasing T doses, and the responses of their spermatogenesis and extragonadal androgen actions (including gonadotropin suppression and sexual behavior) were assessed. Conspicuously, all dose responses to T were practically superimposable, and no dose of T could be defined that would maintain sexual function and suppress gonadotropins without simultaneously activating spermatogenesis. This finding, never addressed in clinical contraceptive trials, is not unexpected in light of the same androgen receptor mediating androgen actions in all organs. When extrapolated to humans, our findings may jeopardize the current approach to hormonal male contraception and call for more effective means of inhibiting intratesticular T production or action, to achieve consistent spermatogenic suppression.	[Oduwole, Olayiwola O.; Vydra, Natalia; Wood, Nicholas E. M.; Samanta, Luna; Huhtaniemi, Ilpo T.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Dept Surg & Canc, London W12 0NN, England; [Naresh, Kikkeri] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Healthcare, Natl Hlth Serv Trust, Dept Histopathol, London W12 0NN, England; [Vydra, Natalia] Marie Curie Sklodowska Univ, Mem Canc Ctr, Gliwice, Poland; [Vydra, Natalia] Inst Oncol, Gliwice, Poland; [Samanta, Luna] Ravenshaw Univ, Sch Life Sci, Dept Zool, Biochem Lab, Cuttack, Orissa, India; [Owen, Laura; Keevil, Brian] Univ S Manchester Hosp, Dept Biochem, Manchester M20 8LR, Lancs, England; [Donaldson, Mandy] Charing Cross Hosp, Imperial Coll Healthcare, Natl Hlth Serv Trust, Dept Clin Biochem, London, England	Imperial College London; Imperial College London; Maria Curie-Sklodowska University; Maria Sklodowska-Curie National Research Institute of Oncology; Ravenshaw University; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Imperial College London	Huhtaniemi, IT (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Dept Surg & Canc, Hammersmith Campus,Cane Rd, London W12 0NN, England.	ilpo.huhtaniemi@imperial.ac.uk	Samanta, Luna/H-4206-2019; keevil, brian/AAP-6147-2020	Samanta, Luna/0000-0002-2969-0071; Oduwole, Olayiwola/0000-0003-3840-7335; Vydra, Natalia/0000-0001-7749-7770; Naresh, Kikkeri N/0000-0003-3807-3638	Wellcome Trust [082101/Z/07/Z]; MRC [0600002]	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Prof. Jimmy Bell [Metabolic and Molecular Imaging Group, Medical Research Council (MRC) Clinical Sciences Centre, Imperial College London] for his valuable advice on the body composition analysis. The authors also thank Jennifer H. Steel (Institute of Reproductive and Developmental Biology, Imperial College London) for advice on histology, and Tuula Hamalainen, Taina Kirjonen, and Anu Salminen (Department of Physiology, University of Turku, Turku, Finland) for the gonadotropin assay. This work was supported by the Wellcome Trust Programme, grant 082101/Z/07/Z, and the MRC, grant 0600002 to I.T.H.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; AMANN RP, 1962, AM J ANAT, V110, P69, DOI 10.1002/aja.1001100107; Anderson RA, 2002, ENDOCR REV, V23, P735, DOI 10.1210/er.2002-0002; [Anonymous], 1990, Lancet, V336, P955; Aribarg A, 1996, FERTIL STERIL, V65, P821; CUNNINGHAM GR, 1979, ENDOCRINOLOGY, V105, P177, DOI 10.1210/endo-105-1-177; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GEISSLER WM, 1994, NAT GENET, V7, P34, DOI 10.1038/ng0594-34; Gu XQ, 2003, J CLIN ENDOCR METAB, V88, P562, DOI 10.1210/jc.2002-020447; Gu YQ, 2009, J CLIN ENDOCR METAB, V94, P1910, DOI 10.1210/jc.2008-1846; Guerif F, 2002, INT J ANDROL, V25, P358, DOI 10.1046/j.1365-2605.2002.00382.x; HAAVISTO AM, 1993, ENDOCRINOLOGY, V132, P1687, DOI 10.1210/en.132.4.1687; HANDELSMAN DJ, 1995, FERTIL STERIL, V63, P125, DOI 10.1016/S0015-0282(16)57307-5; Handelsman DJ, 1999, ENDOCRINOLOGY, V140, P3938, DOI 10.1210/en.140.9.3938; HUHTANIEMI I, 1985, J CLIN ENDOCR METAB, V61, P698, DOI 10.1210/jcem-61-4-698; Huhtaniemi I, 2010, PROG BRAIN RES, V181, P273, DOI 10.1016/S0079-6123(08)81015-1; Ilani N, 2011, ASIAN J ANDROL, V13, P579, DOI 10.1038/aja.2010.133; KORENBROT CC, 1977, BIOL REPROD, V17, P298, DOI 10.1095/biolreprod17.2.298; Matthiesson KL, 2005, J CLIN ENDOCR METAB, V90, P5647, DOI 10.1210/jc.2005-0639; MCLACHLAN RI, 1995, TRENDS ENDOCRIN MET, V6, P95, DOI 10.1016/1043-2760(94)00215-P; McLachlan RI, 2002, J ANDROL, V23, P149; Meriggiola MC, 1996, J CLIN ENDOCR METAB, V81, P3018, DOI 10.1210/jc.81.8.3018; Mustonen MVJ, 1997, BIOCHEM J, V325, P199, DOI 10.1042/bj3250199; Narula A, 2002, J CLIN ENDOCR METAB, V87, P3399, DOI 10.1210/jc.87.7.3399; Nieschlag E, 2010, Handb Exp Pharmacol, P197, DOI 10.1007/978-3-642-02062-9_11; Nixon JP, 2010, OBESITY, V18, P1652, DOI 10.1038/oby.2009.471; O'Donnell L., 2012, TESTOSTERONE ACTION; Ogawa S, 1999, P NATL ACAD SCI USA, V96, P12887, DOI 10.1073/pnas.96.22.12887; Owen LJ, 2012, ANN CLIN BIOCHEM, V49, P600, DOI 10.1258/acb.2012.012037; ROBERTS KP, 1991, ANN NY ACAD SCI, V637, P90, DOI 10.1111/j.1749-6632.1991.tb27303.x; RUSSELL LD, 1977, ANAT RECORD, V187, P347, DOI 10.1002/ar.1091870307; SANTULLI R, 1990, ENDOCRINOLOGY, V126, P95, DOI 10.1210/endo-126-1-95; Segatelli TM, 2004, J ANDROL, V25, P872; Sharpe Richard M., 1994, P1363; Shetty G, 2000, ENDOCRINOLOGY, V141, P1735, DOI 10.1210/en.141.5.1735; SINGH J, 1995, ENDOCRINOLOGY, V136, P5311, DOI 10.1210/en.136.12.5311; STEINBERGER E, 1971, PHYSIOL REV, V51, P1, DOI 10.1152/physrev.1971.51.1.1; SUN YT, 1989, ENDOCRINOLOGY, V125, P1000, DOI 10.1210/endo-125-2-1000; TURNER TT, 1984, ENDOCRINOLOGY, V115, P1925, DOI 10.1210/endo-115-5-1925; van Casteren JIJ, 2000, BIOL REPROD, V62, P886, DOI 10.1095/biolreprod62.4.886; WALLACE EM, 1993, J CLIN ENDOCR METAB, V77, P290, DOI 10.1210/jc.77.1.290; Weiss J, 1999, LAB ANIM, V33, P192, DOI 10.1258/002367799780578417; WING TY, 1982, AM J ANAT, V165, P13, DOI 10.1002/aja.1001650103; Zhang FP, 2003, P NATL ACAD SCI USA, V100, P13692, DOI 10.1073/pnas.2232815100; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172	45	17	17	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2566	2576		10.1096/fj.13-249219	http://dx.doi.org/10.1096/fj.13-249219			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24599970	Green Published, hybrid			2022-12-25	WOS:000339883600016
J	Wu, XD; Qi, X; Liang, MF; Li, C; Cardona, CJ; Li, DX; Xing, Z				Wu, Xiaodong; Qi, Xian; Liang, Mifang; Li, Chuan; Cardona, Carol J.; Li, Dexin; Xing, Zheng			Roles of viroplasm-like structures formed by nonstructural protein NSs in infection with severe fever with thrombocytopenia syndrome virus	FASEB JOURNAL			English	Article						nucleoprotein; viral replication; bunyavirus	HEPATITIS-C VIRUS; LIPID DROPLETS; BUNYAMWERA-VIRUS; FATTY-ACID; VIRAL-RNA; ROTAVIRUS REPLICATION; DOWN-REGULATION; CORE PROTEIN; KINASE PKR; IN-VIVO	Severe fever with thrombocytopenia syndrome (SFTS) virus is an emerging bunyavirus that causes a hemorrhagic fever with a high mortality rate. The virus is likely tick-borne and replicates primarily in hemopoietic cells, which may lead to disregulation of proinflammatory cytokine induction and loss of leukocytes and platelets. The viral genome contains L, M, and S segments encoding a viral RNA polymerase, glycoproteins G(n) and G(c), nucleoprotein (NP), and a nonstructural S segment (NSs) protein. NSs protein is involved in the regulation of host innate immune responses and suppression of IFN beta-promoter activities. In this article, we demonstrate that NSs protein can form viroplasm-like structures (VLSs) in infected and transfected cells. NSs protein molecules interact with one another, interact with NP, and were associated with viral RNA in infected cells, suggesting that NSs protein may be involved in viral replication. Furthermore, we observed that NSs-formed VLS colocalized with lipid droplets and that inhibitors of fatty acid biosynthesis decreased VLS formation or viral replication in transfected and infected cells. Finally, we have demonstrated that viral dsRNAs were also localized in VLS in infected cells, suggesting that NSs-formed VLS may be implicated in the replication of SFTS bunyavirus. These findings identify a novel function of nonstructural NSs in SFTSV-infected cells where it is a scaffolding component in a VLS functioning as a virus replication factory. This function is in addition to the role of NSs protein in modulating host responses that will broaden our understanding of viral pathogenesis of phleboviruses.	[Wu, Xiaodong; Xing, Zheng] Nanjing Univ, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Wu, Xiaodong; Xing, Zheng] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Wu, Xiaodong; Xing, Zheng] Nanjing Univ, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China; [Qi, Xian] Jiangsu Prov Ctr Dis Prevent & Control, Nanjing, Jiangsu, Peoples R China; [Liang, Mifang; Li, Chuan; Li, Dexin] China Ctr Dis Prevent & Control, Beijing, Peoples R China; [Cardona, Carol J.; Xing, Zheng] Univ Minnesota, St Paul, MN 55108 USA	Nanjing University; Nanjing University; Nanjing University; Chinese Center for Disease Control & Prevention; University of Minnesota System; University of Minnesota Twin Cities	Xing, Z (corresponding author), Univ Minnesota, 300D Vet Sci Bldg,1971 Commonwealth Ave, St Paul, MN 55108 USA.	zxing@umn.edu	Xing, Zheng/G-8366-2011; Xing, Zheng/O-3137-2015	Xing, Zheng/0000-0002-7288-0268; Xing, Zheng/0000-0002-7288-0268	Minnesota Rapid Agricultural Response Fund (RARF); Vice President Office of Research (VPOR), University of Minnesota at Twin Cities; State Key Laboratory of Pharmaceutical Biotechnology of Nanjing University [KF-GN-201407]; Jiangsu Province Key Medical Talent Foundation [RC2011084]; Natural Science Foundation of Jiangsu Province [BK20131450]; 333 Projects of Jiangsu Province	Minnesota Rapid Agricultural Response Fund (RARF); Vice President Office of Research (VPOR), University of Minnesota at Twin Cities; State Key Laboratory of Pharmaceutical Biotechnology of Nanjing University; Jiangsu Province Key Medical Talent Foundation; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); 333 Projects of Jiangsu Province	This work was supported by the Minnesota Rapid Agricultural Response Fund (RARF) and a grant-in-aid (to Z.X.) from the Vice President Office of Research (VPOR), University of Minnesota at Twin Cities. It was also supported by the State Key Laboratory of Pharmaceutical Biotechnology of Nanjing University (grant KF-GN-201407 to Z.X.), and the Jiangsu Province Key Medical Talent Foundation (RC2011084), the Natural Science Foundation of Jiangsu Province (BK20131450), and the 333 Projects of Jiangsu Province (to X.Q.).	ALTENBURG BC, 1980, J GEN VIROL, V46, P75, DOI 10.1099/0022-1317-46-1-75; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Billecocq A, 2008, VIROLOGY, V378, P377, DOI 10.1016/j.virol.2008.05.033; BISHOP DHL, 1986, ADV VIRUS RES, V31, P1, DOI 10.1016/S0065-3527(08)60261-4; Blakqori G, 2003, J GEN VIROL, V84, P1207, DOI 10.1099/vir.0.18876-0; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; Cheung W, 2010, J VIROL, V84, P6782, DOI 10.1128/JVI.01757-09; Contin R, 2010, J GEN VIROL, V91, P1782, DOI 10.1099/vir.0.019133-0; Eichwald C, 2004, J GEN VIROL, V85, P625, DOI 10.1099/vir.0.19611-0; Fabbretti E, 1999, J GEN VIROL, V80, P333, DOI 10.1099/0022-1317-80-2-333; Fontana J, 2008, CELL MICROBIOL, V10, P2012, DOI 10.1111/j.1462-5822.2008.01184.x; Gai ZT, 2012, J INFECT DIS, V206, P1095, DOI 10.1093/infdis/jis472; Gaunt ER, 2013, J GEN VIROL, V94, P1576, DOI 10.1099/vir.0.049635-0; Gaunt ER, 2013, J GEN VIROL, V94, P1310, DOI 10.1099/vir.0.050146-0; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Habjan M, 2008, J GEN VIROL, V89, P2157, DOI 10.1099/vir.0.2008/002097-0; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2005, J VIROL, V79, P5606, DOI 10.1128/JVI.79.9.5606-5615.2005; Ikegami T, 2009, ANN NY ACAD SCI, V1171, pE75, DOI 10.1111/j.1749-6632.2009.05054.x; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; Kalveram B, 2013, VIROLOGY, V435, P415, DOI 10.1016/j.virol.2012.09.031; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Metcalfe MJ, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.70; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Netherton C, 2007, ADV VIRUS RES, V70, P101, DOI 10.1016/S0065-3527(07)70004-0; Netherton CL, 2011, CURR OPIN VIROL, V1, P381, DOI 10.1016/j.coviro.2011.09.008; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Pizer ES, 2000, CANCER RES, V60, P213; Qu BQ, 2012, J VIROL, V86, P8388, DOI 10.1128/JVI.00612-12; REED L. J., 1938, AMER JOUR HYG, V27, P493; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Schmaljohn C.S., 2007, FIELDS VIROLOGY, P1741; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; SIMONS JF, 1992, J VIROL, V66, P4233, DOI 10.1128/JVI.66.7.4233-4241.1992; Streitenfeld H, 2003, J VIROL, V77, P5507, DOI 10.1128/JVI.77.9.5507-5511.2003; Sun YL, 2012, J INFECT DIS, V206, P1085, DOI 10.1093/infdis/jis452; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; Weber F, 2002, J VIROL, V76, P7949, DOI 10.1128/JVI.76.16.7949-7955.2002; Weber F, 2001, VIROLOGY, V281, P67, DOI 10.1006/viro.2000.0774; Wu XD, 2014, J VIROL, V88, P3067, DOI 10.1128/JVI.03510-13; Xing Z, 2011, AM J RESP CELL MOL, V44, P24, DOI 10.1165/rcmb.2009-0120OC; Yadani FZ, 1999, J VIROL, V73, P5018, DOI 10.1128/JVI.73.6.5018-5025.1999; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang YZ, 2012, J VIROL, V86, P2864, DOI 10.1128/JVI.06192-11	51	48	55	1	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2504	2516		10.1096/fj.13-243857	http://dx.doi.org/10.1096/fj.13-243857			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24599967				2022-12-25	WOS:000339883600011
J	Di Jeso, B; Morishita, Y; Treglia, AS; Lofrumento, DD; Nicolardi, G; Beguinot, F; Kellogg, AP; Arvan, P				Di Jeso, Bruno; Morishita, Yoshiaki; Treglia, Antonella S.; Lofrumento, Dario D.; Nicolardi, Giuseppe; Beguinot, Francesco; Kellogg, Aaron P.; Arvan, Peter			Transient Covalent Interactions of Newly Synthesized Thyroglobulin with Oxidoreductases of the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Disulfide; Endoplasmic Reticulum (ER); Molecular Chaperone; Protein Folding; Thyroid	PROTEIN-DISULFIDE-ISOMERASE; CHOLINESTERASE-LIKE DOMAIN; MOLECULAR CHAPERONE; SECRETORY PATHWAY; ERP57; CALNEXIN; CELLS; CALRETICULIN; COMPLEXES; CATALYSIS	Background: Secretory proteins acquire their native three-dimensional conformation through repeated brief interactions with ER chaperones and oxidoreductases. Results: We have captured and defined previously unidentified disulfide adducts of newly synthesized thyroglobulin with ERp72 and CaBP1/P5. Conclusion: Multiple oxidoreductases simultaneously engage thyroglobulin during its early folding in the ER. Significance: Distinct chaperone/oxidoreductase partners coordinately engage this multi-domain secretory protein to promote its advancement to the native state. Newly synthesized thyroglobulin (Tg), the thyroid prohormone, forms detectable high molecular weight mixed disulfide adducts: until now, only Tg adduct B was identified as primarily engaging the endoplasmic reticulum oxidoreductases ERp57 and protein disulfide isomerase. Here, we demonstrate that the faster migrating Tg adduct C primarily engages the CaBP1/P5 oxidoreductase, whereas the slower migrating Tg adduct A primarily engages ERp72. Upon siRNA-mediated knockdown of CaBP1/P5 or ERp72, adducts C or A, respectively, are decreased. Within the three Tg adduct bands that do not exhibit a precursor-product relationship, Tg exhibits distinct oxidation patterns. We present evidence suggesting that disulfide maturation occurs within Tg monomers engaged in each of the adduct bands. Moreover, the same Tg substrate molecules can form simultaneous mixed disulfides with both CaBP1/P5 and protein disulfide isomerase, although these are generally viewed as components of distinct oxidoreductase-chaperone protein complexes. Such substrate-oxidoreductase combinations offer Tg the potential for simultaneous oxidative maturation along different parallel tracks leading to the native state.	[Di Jeso, Bruno; Treglia, Antonella S.] Univ Salento, Lab Patol Gen, Dipartimento Sci & Tecnol Biol & Ambientali, I-73100 Lecce, Italy; [Morishita, Yoshiaki; Kellogg, Aaron P.; Arvan, Peter] Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA; [Lofrumento, Dario D.; Nicolardi, Giuseppe] Univ Salento, Lab Anat Umana, Dipartimento Sci & Tecnol Biol & Ambientali, I-73100 Lecce, Italy; [Beguinot, Francesco] Univ Naples Federico II, Ctr Nazl Ric, Dipartimento Sci Med Traslaz, I-80131 Naples, Italy; [Beguinot, Francesco] Univ Naples Federico II, Ctr Nazl Ric, Ist Endocrinol & Oncol Sperimentale, I-80131 Naples, Italy	University of Salento; University of Michigan System; University of Michigan; University of Salento; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	Di Jeso, B (corresponding author), Univ Salento, Fac Sci MFN, Dipartimento Sci & Tecnol Biol & Ambientali, Lab Patol Gen,Ctr Ecotekne, I-73100 Lecce, Italy.	bruno.dijeso@unisalento.it; parvan@umich.edu	Morishita, Yoshiaki/AAX-6552-2021; lofrumento, dario domenico/K-9529-2015; Morishita, Yoshiaki/GWQ-6726-2022; Nicolardi, Giuseppe/N-7744-2015	Morishita, Yoshiaki/0000-0003-4733-7981; lofrumento, dario domenico/0000-0002-0106-3615; di jeso, bruno/0000-0001-8713-5984; Nicolardi, Giuseppe/0000-0003-3007-4468	Fondazione Cassa di Risparmio di Puglia; National Institutes of Health [R01 DK40344]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040344] Funding Source: NIH RePORTER	Fondazione Cassa di Risparmio di Puglia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant of "Fondazione Cassa di Risparmio di Puglia" (to B. D. J.) and National Institutes of Health Grant R01 DK40344 (to P. A.).	Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; BULLEID NJ, 1988, NATURE, V335, P649, DOI 10.1038/335649a0; Chong JM, 2001, J BIOL CHEM, V276, P5804, DOI 10.1074/jbc.M008839200; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; Di Jeso B, 2003, BIOCHEM J, V370, P449, DOI 10.1042/BJ20021257; DIJESO B, 1992, J BIOL CHEM, V267, P1938; DIJESO B, 2004, THYROID, P77; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; Kakihana T, 2012, ANTIOXID REDOX SIGN, V16, P763, DOI 10.1089/ars.2011.4238; KIM PS, 1991, J BIOL CHEM, V266, P12412; KIM PS, 1995, J CELL BIOL, V128, P29, DOI 10.1083/jcb.128.1.29; KIM PS, 1992, J CELL BIOL, V118, P541, DOI 10.1083/jcb.118.3.541; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; Lee J, 2008, J CLIN INVEST, V118, P2950, DOI 10.1172/JCI35164; Lee J, 2011, J BIOL CHEM, V286, P33045, DOI 10.1074/jbc.M111.281337; Lee J, 2011, J BIOL CHEM, V286, P26327, DOI 10.1074/jbc.M111.242099; Lee J, 2009, J BIOL CHEM, V284, P12752, DOI 10.1074/jbc.M806898200; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P619, DOI 10.1021/bi00217a005; Maattanen P, 2006, BIOCHEM CELL BIOL, V84, P881, DOI 10.1139/O06-186; Margittai E, 2011, TRAFFIC, V12, P1, DOI 10.1111/j.1600-0854.2010.01108.x; Menon S, 2007, J BIOL CHEM, V282, P6183, DOI 10.1074/jbc.M608863200; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Muresan Z, 1997, J BIOL CHEM, V272, P26095, DOI 10.1074/jbc.272.42.26095; Neumann GM, 1999, J BIOL CHEM, V274, P14587, DOI 10.1074/jbc.274.21.14587; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Rutkevich LA, 2010, MOL BIOL CELL, V21, P3093, DOI 10.1091/mbc.E10-04-0356; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Solda T, 2006, J BIOL CHEM, V281, P6219, DOI 10.1074/jbc.M513595200; Ulianich L, 2008, J CELL SCI, V121, P477, DOI 10.1242/jcs.017202; Wang XF, 2010, J BIOL CHEM, V285, P17564, DOI 10.1074/jbc.M110.111641; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Zhang Y, 2009, J BIOL CHEM, V284, P10160, DOI 10.1074/jbc.M808356200	41	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11488	11496		10.1074/jbc.M113.520767	http://dx.doi.org/10.1074/jbc.M113.520767			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599957	hybrid, Green Published			2022-12-25	WOS:000334638500049
J	Saha, K; Adhikary, G; Kanade, SR; Rorke, EA; Eckert, RL				Saha, Kamalika; Adhikary, Gautam; Kanade, Santosh R.; Rorke, Ellen A.; Eckert, Richard L.			p38 delta Regulates p53 to Control p21(Cip1) Expression in Human Epidermal Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Differentiation; Cell Proliferation; Cell Signaling; MAP Kinases (MAPKs); p38 MAPK	PROTEIN-KINASE-C; INVOLUCRIN GENE-EXPRESSION; CALCIUM-INDUCED DIFFERENTIATION; TUMOR SUPPRESSION; PROMOTER ACTIVITY; PKC-DELTA; PROLIFERATION; ACTIVATION; APOPTOSIS; SKIN	Background: Keratinocytes cease proliferation during differentiation, and the mechanism that mediates these events is not well understood. Results: PKC increases p38 activity, which increases p53 transcription and acts to increase p21(Cip1) promoter activity. Conclusion: PKC drives a MAPK cascade to increase p53 to control keratinocyte proliferation. Significance: This study provides detailed information regarding the mechanisms that control cell proliferation. PKC suppresses keratinocyte proliferation via a mechanism that involves increased expression of p21(Cip1). However, the signaling mechanism that mediates this regulation is not well understood. Our present studies suggest that PKC activates p38 leading to increased p21(Cip1) promoter activity and p21(Cip1) mRNA/protein expression. We further show that exogenously expressed p38 increases p21(Cip1) mRNA and protein and that p38 knockdown or expression of dominant-negative p38 attenuates this increase. Moreover, p53 is an intermediary in this regulation, as p38 expression increases p53 mRNA, protein, and promoter activity, and p53 knockdown attenuates the activation. We demonstrate a direct interaction of p38 with PKC and MEK3 and show that exogenous agents that suppress keratinocyte proliferation activate this pathway. We confirm the importance of this regulation using a stratified epidermal equivalent model, which mimics in vivo-like keratinocyte differentiation. In this model, PKC or p38 knockdown results in reduced p53 and p21(Cip1) levels and enhanced cell proliferation. We propose that PKC activates a MEKK1/MEK3/p38 MAPK cascade to increase p53 levels and p53 drives p21(Cip1) gene expression.	[Saha, Kamalika; Adhikary, Gautam; Kanade, Santosh R.; Eckert, Richard L.] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Dept Dermatol, Sch Med, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Dept Obstet & Gynecol, Sch Med, Baltimore, MD 21201 USA; [Rorke, Ellen A.] Univ Maryland, Dept Microbiol & Immunol, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Eckert, RL (corresponding author), Univ Maryland, Dept Biochem & Mol Biol, Sch Med, 108 N Greene St, Baltimore, MD 21201 USA.	reckert@umaryland.edu	Kanade, Santosh/V-7054-2019	Kanade, Santosh/0000-0002-2184-9973	National Institutes of Health [R01 AR046494, R01 AR053851, R21 AR065266]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046494, R01AR053851, R21AR065266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR046494, R01 AR053851, and R21 AR065266 (to R. E.).	Adhikary G, 2010, J INVEST DERMATOL, V130, P2017, DOI 10.1038/jid.2010.108; Aliouat-Denis CM, 2005, MOL CANCER RES, V3, P627, DOI 10.1158/1541-7786.MCR-05-0121; Balasubramanian S, 2002, J BIOL CHEM, V277, P1828, DOI 10.1074/jbc.M110376200; Balasubramanian S, 2006, J BIOL CHEM, V281, P36162, DOI 10.1074/jbc.M605368200; Bollag WB, 2004, DRUG NEWS PERSPECT, V17, P117, DOI 10.1358/dnp.2004.17.2.829045; Bollag WB, 2009, J INVEST DERMATOL, V129, P2330, DOI 10.1038/jid.2009.165; Cheng F, 2009, MOL BIOL CELL, V20, P319, DOI 10.1091/mbc.E08-07-0681; Chew YC, 2013, J BIOL CHEM, V288, P17759, DOI 10.1074/jbc.M113.477133; Chew YC, 2012, J BIOL CHEM, V287, P16168, DOI 10.1074/jbc.M111.305292; Chew YC, 2011, J BIOL CHEM, V286, P28772, DOI 10.1074/jbc.M110.205245; Dashti SR, 2001, J BIOL CHEM, V276, P27214, DOI 10.1074/jbc.M100465200; Dashti SR, 2001, J BIOL CHEM, V276, P8059, DOI 10.1074/jbc.C000862200; Denning MF, 2000, EXP DERMATOL, V9, P192, DOI 10.1034/j.1600-0625.2000.009003192.x; Denning MF, 2004, INT J BIOCHEM CELL B, V36, P1141, DOI 10.1016/j.biocel.2003.12.004; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; DLUGOSZ AA, 1992, MOL CARCINOGEN, V5, P286, DOI 10.1002/mc.2940050409; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Eckert RL, 2002, J INVEST DERM SYMP P, V7, P36, DOI 10.1046/j.1523-1747.2002.19634.x; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Efimova T, 2000, J BIOL CHEM, V275, P1601, DOI 10.1074/jbc.275.3.1601; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FISHER GJ, 1993, J INVEST DERMATOL, V101, P553, DOI 10.1111/1523-1747.ep12365967; GHERZI R, 1992, BIOCHEM BIOPH RES CO, V184, P283, DOI 10.1016/0006-291X(92)91190-2; Gorospe M, 1999, GENE EXPRESSION, V7, P377; Hara T, 2005, CANCER RES, V65, P7356, DOI 10.1158/0008-5472.CAN-04-4241; Hauser P, 2004, MOL CANCER RES, V2, P96; Kamioka N, 2010, BIOCHEM BIOPH RES CO, V394, P106, DOI 10.1016/j.bbrc.2010.02.125; Kraft CA, 2007, ARCH DERMATOL RES, V299, P71, DOI 10.1007/s00403-006-0727-4; Lee SJ, 2006, J BIOL CHEM, V281, P2215, DOI 10.1074/jbc.M509509200; Li JJ, 2000, MOL CARCINOGEN, V29, P159, DOI 10.1002/1098-2744(200011)29:3<159::AID-MC5>3.0.CO;2-W; Lin PY, 2009, VIROLOGY, V385, P323, DOI 10.1016/j.virol.2008.12.028; MATSUI MS, 1992, J INVEST DERMATOL, V99, P565, DOI 10.1111/1523-1747.ep12667411; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Niwa K, 2002, FREE RADICAL RES, V36, P1147, DOI 10.1080/1071576021000016409; Okuyama R, 2004, J INVEST DERM SYMP P, V9, P248, DOI 10.1111/j.1087-0024.2004.09308.x; OSADA S, 1990, J BIOL CHEM, V265, P22434; Papp H, 2004, CELL MOL LIFE SCI, V61, P1095, DOI 10.1007/s00018-004-4014-2; Poumay Y, 2004, ARCH DERMATOL RES, V296, P203, DOI 10.1007/s00403-004-0507-y; Praskova M, 2002, EXP DERMATOL, V11, P344, DOI 10.1034/j.1600-0625.2002.110408.x; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Ryer EJ, 2005, J BIOL CHEM, V280, P35310, DOI 10.1074/jbc.M507187200; Shen S, 2001, DIABETES, V50, P255, DOI 10.2337/diabetes.50.2.255; Sonkoly E, 2010, J INVEST DERMATOL, V130, P124, DOI 10.1038/jid.2009.294; Szegedi A, 2009, EXP DERMATOL, V18, P122, DOI 10.1111/j.1600-0625.2008.00771.x; Wheeler DL, 2002, ONCOGENE, V21, P3620, DOI 10.1038/sj.onc.1205451; Wong PP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008369; Wu HM, 2010, CANCER LETT, V298, P16, DOI 10.1016/j.canlet.2010.05.022	52	20	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11443	11453		10.1074/jbc.M113.543165	http://dx.doi.org/10.1074/jbc.M113.543165			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599959	hybrid, Green Published			2022-12-25	WOS:000334638500045
J	Gaetano, J; van der Zwan, R; Blair, D; Brooks, A				Gaetano, Justin; van der Zwan, Rick; Blair, Duncan; Brooks, Anna			Hands as Sex Cues: Sensitivity Measures, Male Bias Measures, and Implications for Sex Perception Mechanisms	PLOS ONE			English	Article							BIOLOGICAL MOTION PERCEPTION; FACE GENDER; FEMALE FACES; NEURAL BASIS; ADAPTATION; DISCRIMINATION; CATEGORIZATION; RECOGNITION; ACTIVATION; BRAIN	Sex perceptions, or more particularly, sex discriminations and sex categorisations, are high-value social behaviours. They mediate almost all inter-personal interactions. The two experiments reported here had the aim of exploring some of the basic characteristics of the processes giving rise to sex perceptions. Experiment 1 confirmed that human hands can be used as a cue to an individual's sex even when colour and texture cues are removed and presentations are brief. Experiment 1 also showed that when hands are sexually ambiguous observers tend to classify them as male more often than female. Experiment 2 showed that "male bias" arises not from sensitivity differences but from differences in response biases. Observers are conservative in their judgements of targets as female but liberal in their judgements of targets as male. These data, combined with earlier reports, suggest the existence of a sex-perception space that is cue-invariant.	[Gaetano, Justin; van der Zwan, Rick; Blair, Duncan; Brooks, Anna] So Cross Univ, Cognit Neurosci Res Cluster, Coffs Harbour, Australia	Southern Cross University	Gaetano, J (corresponding author), So Cross Univ, Cognit Neurosci Res Cluster, Coffs Harbour, Australia.	justin.gaetano@scu.edu.au	Blair, Duncan/G-2026-2014; Gaetano, Justin/E-9469-2012	Blair, Duncan/0000-0002-1654-9511; Gaetano, Justin/0000-0002-4200-163X				Agnihotri AK, 2006, INTERNET J FORENSIC, V2, P1; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Armann R, 2012, VISION RES, V63, P69, DOI 10.1016/j.visres.2012.05.005; Atkinson AP, 2011, PHILOS T R SOC B, V366, P1726, DOI 10.1098/rstb.2010.0349; Bachorowski JA, 1999, J ACOUST SOC AM, V106, P1054, DOI 10.1121/1.427115; BARCLAY CD, 1978, PERCEPT PSYCHOPHYS, V23, P145, DOI 10.3758/BF03208295; Bidet-Caulet A, 2005, NEUROIMAGE, V28, P132, DOI 10.1016/j.neuroimage.2005.06.018; Bigoni L, 2010, HOMO, V61, P16, DOI 10.1016/j.jchb.2009.09.004; Bonda E, 1996, J NEUROSCI, V16, P3737; Brooks A, 2008, CURR BIOL, V18, pR728, DOI 10.1016/j.cub.2008.06.054; BRUCE V, 1993, PERCEPTION, V22, P131, DOI 10.1068/p220131; BURTON AM, 1993, PERCEPTION, V22, P153, DOI 10.1068/p220153; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Cellerino A, 2004, BRAIN RES BULL, V63, P443, DOI 10.1016/j.brainresbull.2004.03.010; Chao LL, 1999, NEUROREPORT, V10, P2945, DOI 10.1097/00001756-199909290-00013; DAVIDENKO N, 2006, J VISION, V6, P1068; Davidenko N, 2007, J VISION, V7, DOI 10.1167/7.4.6; Davidenko N, 2008, VIS COGN, V16, P99; DeBruine LM, 2010, VIS COGN, V18, P816, DOI 10.1080/13506281003691357; Dzhelyova MP, 2011, J COGNITIVE NEUROSCI, V23, P2782, DOI 10.1162/jocn.2011.21604; FERRARIO VF, 1993, AM J ORTHOD DENTOFAC, V103, P327, DOI 10.1016/0889-5406(93)70013-E; Freeman JB, 2011, J EXP SOC PSYCHOL, V47, P259, DOI 10.1016/j.jesp.2010.08.018; Freeman JB, 2010, CEREB CORTEX, V20, P1314, DOI 10.1093/cercor/bhp195; Penton LG, 2010, NEURAL REGEN RES, V5, P1076, DOI 10.3969/j.issn.1673-5374.2010.14.007; Ghuman AS, 2010, CURR BIOL, V20, P32, DOI 10.1016/j.cub.2009.10.077; Grezes J, 1999, BRAIN, V122, P1875, DOI 10.1093/brain/122.10.1875; Hacker Graeme, 2013, BMC Psychol, V1, P10, DOI 10.1186/2050-7283-1-10; Hewig J, 2008, J NONVERBAL BEHAV, V32, P67, DOI 10.1007/s10919-007-0043-5; HILDEBRANDT KA, 1977, PERCEPT MOTOR SKILL, V45, P472, DOI 10.2466/pms.1977.45.2.472; Javadi AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046079; Jellema T, 2000, INT J PSYCHOL, V35, P205; Johnson KL, 2012, P ROY SOC B-BIOL SCI, V279, P4982, DOI 10.1098/rspb.2012.2060; Johnson KL, 2005, PSYCHOL SCI, V16, P890, DOI 10.1111/j.1467-9280.2005.01633.x; Jordan H, 2006, NAT NEUROSCI, V9, P738, DOI 10.1038/nn1710; Kovacs G, 2006, CEREB CORTEX, V16, P742, DOI 10.1093/cercor/bhj020; Kovacs G, 2004, NEUROREPORT, V15, P1275, DOI 10.1097/01.wnr.0000130234.51411.0e; KOZLOWSKI LT, 1977, PERCEPT PSYCHOPHYS, V21, P575, DOI 10.3758/BF03198740; LEINBACH MD, 1993, INFANT BEHAV DEV, V16, P317, DOI 10.1016/0163-6383(93)80038-A; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; LI XF, 1991, J ACOUST SOC AM, V90, P3036, DOI 10.1121/1.401778; LIPPA R, 1983, J PERS, V51, P667, DOI 10.1111/j.1467-6494.1983.tb00873.x; Little AC, 2005, P ROY SOC B-BIOL SCI, V272, P2283, DOI 10.1098/rspb.2005.3220; Maner JK, 2007, J PERS SOC PSYCHOL, V93, P389, DOI 10.1037/0022-3514.93.3.389; MATHER G, 1994, P ROY SOC B-BIOL SCI, V258, P273, DOI 10.1098/rspb.1994.0173; Millar JA, 1996, J HUM HYPERTENS, V10, P449; Morris JP, 2006, NEUROPSYCHOLOGIA, V44, P1919, DOI 10.1016/j.neuropsychologia.2006.01.035; Nagy E, 2000, PERCEPT MOTOR SKILL, V90, P102, DOI 10.2466/PMS.90.1.102-104; Napier J, 1993, HANDS, P13; Navarrete CD, 2009, PSYCHOL SCI, V20, P155, DOI 10.1111/j.1467-9280.2009.02273.x; Ng M, 2006, P NATL ACAD SCI USA, V103, P19552, DOI 10.1073/pnas.0605358104; Pelphrey KA, 2005, CEREB CORTEX, V15, P1866, DOI 10.1093/cercor/bhi064; Penn DJ, 2007, J R SOC INTERFACE, V4, P331, DOI 10.1098/rsif.2006.0182; Plant EA, 2011, PERS SOC PSYCHOL B, V37, P1274, DOI 10.1177/0146167211408617; Podrebarac SK, 2013, EXP BRAIN RES, V226, P241, DOI 10.1007/s00221-013-3429-0; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; Rhodes G, 2011, SCI SOCIAL VISION, P347; Schouten B, 2010, ATTEN PERCEPT PSYCHO, V72, P1256, DOI 10.3758/APP.72.5.1256; STANGOR C, 1992, J PERS SOC PSYCHOL, V62, P207, DOI 10.1037/0022-3514.62.2.207; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Thompson JC, 2007, NEUROIMAGE, V37, P966, DOI 10.1016/j.neuroimage.2007.05.058; Thompson P, 2009, CURR BIOL, V19, pR11, DOI 10.1016/j.cub.2008.10.014; THOMPSON SK, 1971, DEV PSYCHOL, V5, P181, DOI 10.1037/h0031427; Todorov A, 2013, CURR OPIN NEUROBIOL, V23, P373, DOI 10.1016/j.conb.2012.12.010; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; Toups MA, 2011, MOL BIOL EVOL, V28, P29, DOI 10.1093/molbev/msq234; Troje NF, 2006, J VISION, V6, P850, DOI 10.1167/6.8.7; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; van der Zwan R, 2009, EXP BRAIN RES, V198, P373, DOI 10.1007/s00221-009-1800-y; Veleminska J, 2012, HOMO, V63, P81, DOI 10.1016/j.jchb.2012.02.002; Walker PL, 2008, AM J PHYS ANTHROPOL, V136, P39, DOI 10.1002/ajpa.20776; Wang LB, 2012, NEUROIMAGE, V61, P931, DOI 10.1016/j.neuroimage.2012.03.080; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Wild HA, 2000, J EXP CHILD PSYCHOL, V77, P269, DOI 10.1006/jecp.1999.2554; Winer B.J., 1962, STAT PRINCIPLES EXPT; YAMAGUCHI MK, 1995, PERCEPTION, V24, P563, DOI 10.1068/p240563	76	9	9	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91032	10.1371/journal.pone.0091032	http://dx.doi.org/10.1371/journal.pone.0091032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4ID	24603615	Green Submitted, gold, Green Published			2022-12-25	WOS:000332483600122
J	Lopez-Fernandez, H; Arbour, J; Willis, S; Watkins, C; Honeycutt, RL; Winemiller, KO				Lopez-Fernandez, Hernan; Arbour, Jessica; Willis, Stuart; Watkins, Crystal; Honeycutt, Rodney L.; Winemiller, Kirk O.			Morphology and Efficiency of a Specialized Foraging Behavior, Sediment Sifting, in Neotropical Cichlid Fishes	PLOS ONE			English	Article							ECOMORPHOLOGICAL DIVERSIFICATION; FUNCTIONAL-MORPHOLOGY; CENTRARCHID FISHES; FEEDING MECHANISM; PREY CAPTURE; RIVER; ASSEMBLAGES; DIVERSITY; TELEOSTEI; EVOLUTION	Understanding of relationships between morphology and ecological performance can help to reveal how natural selection drives biological diversification. We investigate relationships between feeding behavior, foraging performance and morphology within a diverse group of teleost fishes, and examine the extent to which associations can be explained by evolutionary relatedness. Morphological adaptation associated with sediment sifting was examined using a phylogenetic linear discriminant analysis on a set of ecomorphological traits from 27 species of Neotropical cichlids. For most sifting taxa, feeding behavior could be effectively predicted by a linear discriminant function of ecomorphology across multiple clades of sediment sifters, and this pattern could not be explained by shared evolutionary history alone. Additionally, we tested foraging efficiency in seven Neotropical cichlid species, five of which are specialized benthic feeders with differing head morphology. Efficiency was evaluated based on the degree to which invertebrate prey could be retrieved at different depths of sediment. Feeding performance was compared both with respect to feeding mode and species using a phylogenetic ANCOVA, with substrate depth as a covariate. Benthic foraging performance was constant across sediment depths in non-sifters but declined with depth in sifters. The non-sifting Hypsophrys used sweeping motions of the body and fins to excavate large pits to uncover prey; this tactic was more efficient for consuming deeply buried invertebrates than observed among sediment sifters. Findings indicate that similar feeding performance among sediment-sifting cichlids extracting invertebrate prey from shallow sediment layers reflects constraints associated with functional morphology and, to a lesser extent, phylogeny.	[Lopez-Fernandez, Hernan; Willis, Stuart; Watkins, Crystal; Honeycutt, Rodney L.; Winemiller, Kirk O.] Texas A&M Univ, Program Ecol & Evolutionary Biol, College Stn, TX USA; [Lopez-Fernandez, Hernan; Willis, Stuart; Watkins, Crystal; Honeycutt, Rodney L.; Winemiller, Kirk O.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Lopez-Fernandez, Hernan; Arbour, Jessica] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Toronto	Lopez-Fernandez, H (corresponding author), Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada.	hernanl@rom.on.ca		Lopez-Fernandez, Hernan/0000-0003-0270-1671; Higgs, Dennis/0000-0002-0771-4642; Winemiller, Kirk/0000-0003-0236-5129	NSF Undergraduate Mentoring in Environmental Biology Program [0203992]; NSF DEB [0516831]; NSERC	NSF Undergraduate Mentoring in Environmental Biology Program(National Science Foundation (NSF)); NSF DEB(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this project was provided by the NSF Undergraduate Mentoring in Environmental Biology Program (grant #0203992), NSF DEB grant #0516831 to KOW, RLH and HLF, and by an NSERC Discovery Grant to HLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2004, EVOLUTION, V58, P495, DOI 10.1111/j.0014-3820.2004.tb01673.x; Arbour JH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0849; BAREL CDN, 1983, NETH J ZOOL, V33, P357; BARMUTA LA, 1984, HYDROBIOLOGIA, V112, P105, DOI 10.1007/BF00006913; Bastos RF, 2011, NEOTROP ICHTHYOL, V9, P825, DOI 10.1590/S1679-62252011005000049; Carroll AM, 2004, J EXP BIOL, V207, P3873, DOI 10.1242/jeb.01227; Cichocki, 1976, THESIS U MICHIGAN; Cochran-Biederman JL, 2010, ENVIRON BIOL FISH, V88, P143, DOI 10.1007/s10641-010-9624-y; Collar DC, 2006, EVOLUTION, V60, P2575; DRUCKER EG, 1991, J MORPHOL, V210, P267, DOI 10.1002/jmor.1052100306; Ferry-Graham LA, 2002, MAR BIOL, V141, P819, DOI 10.1007/s00227-002-0882-x; GARLAND T, 1993, SYST BIOL, V42, P265, DOI 10.2307/2992464; HEILIGENBERG W, 1965, ANIM BEHAV, V13, P163, DOI 10.1016/0003-3472(65)90087-4; Higham TE, 2007, J EVOLUTION BIOL, V20, P70, DOI 10.1111/j.1420-9101.2006.01227.x; Hulsey CD, 2002, P ROY SOC B-BIOL SCI, V269, P317, DOI 10.1098/rspb.2001.1874; Hulsey CD, 2005, FUNCT ECOL, V19, P487, DOI 10.1111/j.1365-2435.2005.00987.x; Kullander SO, 1986, CICHLID FISHES AMAZO; LAUDER GV, 1982, AM ZOOL, V22, P275; LIEM KF, 1980, AM ZOOL, V20, P295; Lopez-Fernandez H, 2005, ZOOL SCR, V34, P627, DOI 10.1111/j.1463-6409.2005.00209.x; Lopez-Fernandez H, 2013, EVOLUTION, V67, P1321, DOI 10.1111/evo.12038; Lopez-Fernandez H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033997; Lopez-Fernandez H, 2010, MOL PHYLOGENET EVOL, V55, P1070, DOI 10.1016/j.ympev.2010.02.020; Montana CG, 2010, ECOL FRESHW FISH, V19, P216, DOI 10.1111/j.1600-0633.2010.00406.x; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; SAZIMA I, 1986, J FISH BIOL, V29, P53, DOI 10.1111/j.1095-8649.1986.tb04926.x; Soria-Barreto M, 2008, ENVIRON BIOL FISH, V83, P459, DOI 10.1007/s10641-008-9368-0; Wainwright PC, 2005, INTEGR COMP BIOL, V45, P256, DOI 10.1093/icb/45.2.256; Wainwright PC, 1996, ECOLOGY, V77, P1336, DOI 10.2307/2265531; Wainwright PC, 2007, ANNU REV ECOL EVOL S, V38, P381, DOI 10.1146/annurev.ecolsys.38.091206.095706; Waltzek TB, 2003, J MORPHOL, V257, P96, DOI 10.1002/jmor.10111; Westneat MW, 2004, INTEGR COMP BIOL, V44, P378, DOI 10.1093/icb/44.5.378; Willis SC, 2005, OECOLOGIA, V142, P284, DOI 10.1007/s00442-004-1723-z; Winemiller KO, 2008, J BIOGEOGR, V35, P1551, DOI 10.1111/j.1365-2699.2008.01917.x; WINEMILLER KO, 1991, ECOL MONOGR, V61, P343, DOI 10.2307/2937046; WINEMILLER KO, 1995, ENVIRON BIOL FISH, V44, P235, DOI 10.1007/BF00005919	37	29	30	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89832	10.1371/journal.pone.0089832	http://dx.doi.org/10.1371/journal.pone.0089832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603485	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600024
J	Madl, T; Franklin, S; Chen, K; Montaldi, D; Trappl, R				Madl, Tamas; Franklin, Stan; Chen, Ke; Montaldi, Daniela; Trappl, Robert			Bayesian Integration of Information in Hippocampal Place Cells	PLOS ONE			English	Article							GRID CELLS; PATH-INTEGRATION; SPATIAL ORIENTATION; SPIKING NEURONS; NETWORKS; CA1; INFERENCE; DIRECTION; PHASE; RATS	Accurate spatial localization requires a mechanism that corrects for errors, which might arise from inaccurate sensory information or neuronal noise. In this paper, we propose that Hippocampal place cells might implement such an error correction mechanism by integrating different sources of information in an approximately Bayes-optimal fashion. We compare the predictions of our model with physiological data from rats. Our results suggest that useful predictions regarding the firing fields of place cells can be made based on a single underlying principle, Bayesian cue integration, and that such predictions are possible using a remarkably small number of model parameters.	[Madl, Tamas; Chen, Ke] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Franklin, Stan] Univ Memphis, Inst Intelligent Syst, Memphis, TN 38152 USA; [Montaldi, Daniela] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Madl, Tamas; Trappl, Robert] Austrian Res Inst Artificial Intelligence, Vienna, Austria	University of Manchester; University of Memphis; University of Manchester	Madl, T (corresponding author), Univ Manchester, Sch Comp Sci, Manchester, Lancs, England.	tamas.madl@gmail.com	, Ke/ABG-5874-2020; Chen, Ke/C-2560-2008; Franklin, Stan/AAI-5506-2020	Chen, Ke/0000-0001-9457-9364; 	EPSRC [EP/I028099/1]; FWF [P25380-N23]; Austrian Science Fund (FWF) [P 25380] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by EPSRC grant EP/I028099/1 (Engineering and Physical Sciences Research Council, http://www.epsrc.ac.uk), and FWF grant P25380-N23 (Austrian Science Fund, http://www.fwf.ac.at/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed OJ, 2009, TRENDS NEUROSCI, V32, P329, DOI 10.1016/j.tins.2009.01.009; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; Azzalini A, 2005, SCAND J STAT, V32, P159, DOI 10.1111/j.1467-9469.2005.00426.x; Barry C, 2006, REV NEUROSCIENCE, V17, P71; Barry Caswell, 2012, Neural Syst Circuits, V2, P6, DOI 10.1186/2042-1001-2-6; Baumann O, 2010, J NEUROSCI, V30, P12897, DOI 10.1523/JNEUROSCI.3077-10.2010; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Brette R, 2007, J COMPUT NEUROSCI, V23, P349, DOI 10.1007/s10827-007-0038-6; Brette R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002561; Bromiley P. A., 2003, 2003003 U MANCH MED, V3; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Buesing L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002211; Buhl EH, 1996, HIPPOCAMPUS, V6, P294; Burgess N, 2008, ANN NY ACAD SCI, V1124, P77, DOI 10.1196/annals.1440.002; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2011, CURR OPIN NEUROBIOL, V21, P734, DOI 10.1016/j.conb.2011.07.002; Burke SN, 2011, HIPPOCAMPUS, V21, P783, DOI 10.1002/hipo.20929; Canto C, 2008, NEURAL PLASTICITY, V2008; Cheng K, 1998, SPATIAL REPRESENTATION IN ANIMALS, P1; Cheng K, 2007, PSYCHOL BULL, V133, P625, DOI 10.1037/0033-2909.133.4.625; Cheung A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002651; Colombo M, 2012, BRIT J PHILOS SCI, V63, P697, DOI 10.1093/bjps/axr043; Deneve S, 2008, NEURAL COMPUT, V20, P91, DOI 10.1162/neco.2008.20.1.91; Deshmukh SS, 2013, HIPPOCAMPUS, V23, P253, DOI 10.1002/hipo.22101; Dickson CT, 2002, HIPPOCAMPUS, V12, P447, DOI 10.1002/hipo.10013; Dickson CT, 2000, ANN NY ACAD SCI, V911, P127; Doeller CF, 2012, NEUROSCIENTIST, V18, P556, DOI 10.1177/1073858411422115; Durrant-Whyte H, 2006, IEEE ROBOT AUTOM MAG, V13, P99, DOI 10.1109/MRA.2006.1638022; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Engel TA, 2008, J NEUROPHYSIOL, V100, P1576, DOI 10.1152/jn.01282.2007; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Etienne AS, 1996, J EXP BIOL, V199, P201; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; Fox C. W., 2010, IJCNN, P1, DOI DOI 10.1109/IJCNN.2010.5596681; Goodman DFM, 2009, FRONT NEUROSCI-SWITZ, V3, P192, DOI 10.3389/neuro.01.026.2009; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hancock PA., 1985, MOTOR BEHAV PROGRAMM, P153, DOI [DOI 10.1007/978-3-642-69749-4_5, 10.1007/978-3-642-69749-4_5]; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; Hoppensteadt F. C., 1997, APPL MATH SCI, V126; Hoyer PO, 2003, ADV NEURAL INFORM PR, V15, P293; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Jeffery KJ, 2007, CURR OPIN NEUROBIOL, V17, P684, DOI 10.1016/j.conb.2007.11.008; Joseph D, 2011, FRONTIERS COMPUTATIO, V5; Kajiwara R, 2008, HIPPOCAMPUS, V18, P266, DOI 10.1002/hipo.20385; Katz Y, 2007, PLOS COMPUT BIOL, V3, P2432, DOI 10.1371/journal.pcbi.0030234; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Koch C, 2000, NAT NEUROSCI, V3, P1171, DOI 10.1038/81444; Kording KP, 2004, J NEUROPHYSIOL, V92, P3161, DOI 10.1152/jn.00275.2004; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Lee SA, 2012, COGNITION, V123, P144, DOI 10.1016/j.cognition.2011.12.015; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; Lisman J, 2009, PHILOS T R SOC B, V364, P1193, DOI 10.1098/rstb.2008.0316; Ma WJ, 2008, CURR OPIN NEUROBIOL, V18, P217, DOI 10.1016/j.conb.2008.07.004; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; MacNeilage PR, 2008, J NEUROPHYSIOL, V100, P2981, DOI 10.1152/jn.90677.2008; Markus E, 2004, HIPPOCAMPUS, V4, P410; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; McNaughton BL, 1996, J EXP BIOL, V199, P173; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Montaldi D, 2010, HIPPOCAMPUS, V20, P1291, DOI 10.1002/hipo.20853; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Myung IJ, 1997, PSYCHON B REV, V4, P79, DOI 10.3758/BF03210778; Myung IJ, 2005, HDB COGNITION, P422; Nardini M, 2008, CURR BIOL, V18, P689, DOI 10.1016/j.cub.2008.04.021; Negenborn R., 2003, THESIS UTRECHT U; Nezis P, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/034005; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; Odobescu R, 2010, THESIS UCL; Okada K, 2011, IEEE IND ELEC; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; Pfuhl G, 2011, B MATH BIOL, V73, P951, DOI 10.1007/s11538-010-9547-y; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; Rao RPN, 2004, NEURAL COMPUT, V16, P1, DOI 10.1162/08997660460733976; Rapp PR, 1996, P NATL ACAD SCI USA, V93, P9926, DOI 10.1073/pnas.93.18.9926; Regier T, 2003, ENCY COGNITIVE SCI, P611; Rossant C, 2011, J NEUROSCI, V31, P17193, DOI 10.1523/JNEUROSCI.2482-11.2011; Samu D, 2009, BIOL CYBERN, V101, P19, DOI 10.1007/s00422-009-0311-z; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Sheynikhovich D, 2009, PSYCHOL REV, V116, P540, DOI 10.1037/a0016170; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Sreenivasan S, 2011, NAT NEUROSCI, V14, P1330, DOI 10.1038/nn.2901; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; Witter M, 2011, SCHOLARPEDIA J, V6, P4380, DOI DOI 10.4249/SCHOLARPEDIA.4380; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852; Yoshioka J.G., 1929, U CALIFORNIA PUBLICA, V4, P155; YOUNG BJ, 1994, J NEUROSCI, V14, P6553; Zemankovics R, 2010, J PHYSIOL-LONDON, V588, P2109, DOI 10.1113/jphysiol.2009.185975; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818; Zilli EA, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00016	101	19	20	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89762	10.1371/journal.pone.0089762	http://dx.doi.org/10.1371/journal.pone.0089762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603429	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600021
J	Monecke, T; Buschmann, J; Neumann, P; Wahle, E; Ficner, R				Monecke, Thomas; Buschmann, Juliane; Neumann, Piotr; Wahle, Elmar; Ficner, Ralf			Crystal Structures of the Novel Cytosolic 5 '-Nucleotidase IIIB Explain Its Preference for m(7)GMP	PLOS ONE			English	Article							PYRIMIDINE 5'-NUCLEOTIDASE; SUBSTRATE-SPECIFICITY; INSIGHTS; PROTEIN; 7-METHYLGUANINE; IDENTIFICATION; RECOGNITION; NUCLEOTIDE; SYSTEM; PYTHON	5'-nucleotidases catalyze the hydrolytic dephosphorylation of nucleoside monophosphates. As catabolic enzymes they contribute significantly to the regulation of cellular nucleotide levels; misregulation of nucleotide metabolism and nucleotidase deficiencies are associated with a number of diseases. The seven human 5'-nucleotidases differ with respect to substrate specificity and cellular localization. Recently, the novel cytosolic 5'-nucleotidase III-like protein, or cN-IIIB, has been characterized in human and Drosophila. cN-IIIB exhibits a strong substrate preference for the modified nucleotide 7-methylguanosine monophosphate but the structural reason for this preference was unknown. Here, we present crystal structures of cN-IIIB from Drosophila melanogaster bound to the reaction products 7-methylguanosine or cytidine. The structural data reveal that the cytosine-and 7-methylguanine moieties of the products are stacked between two aromatic residues in a coplanar but off-centered position. 7-methylguanosine is specifically bound through p-p interactions and distinguished from unmodified guanosine by additional cation-p coulomb interactions between the aromatic side chains and the positively charged 7-methylguanine. Notably, the base is further stabilized by T-shaped edge-to-face stacking of an additional tryptophan packing perpendicularly against the purine ring and forming, together with the other aromates, an aromatic slot. The structural data in combination with site-directed mutagenesis experiments reveal the molecular basis for the broad substrate specificity of cN-IIIB but also explain the substrate preference for 7-methylguanosine monophosphate. Analyzing the substrate specificities of cN-IIIB and the main pyrimidine 59-nucleotidase cN-IIIA by mutagenesis studies, we show that cN-IIIA dephosphorylates the purine m(7)GMP as well, hence redefining its substrate spectrum. Docking calculations with cN-IIIA and m(7)GMP as well as biochemical data reveal that Asn69 does not generally exclude the turnover of purine substrates thus correcting previous suggestions.	[Monecke, Thomas; Neumann, Piotr; Ficner, Ralf] Univ Gottingen, Inst Mikrobiol & Genet, Gottinger Zentrum Mol Biowissensch, Abt Mol Strukturbiol, D-37073 Gottingen, Germany; [Buschmann, Juliane; Wahle, Elmar] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06108 Halle, Saale, Germany	University of Gottingen; Martin Luther University Halle Wittenberg	Monecke, T (corresponding author), Univ Gottingen, Inst Mikrobiol & Genet, Gottinger Zentrum Mol Biowissensch, Abt Mol Strukturbiol, D-37073 Gottingen, Germany.	tmoneck@uni-goettingen.de		Wahle, Elmar/0000-0003-2504-0677	Gottingen University; DFG	Gottingen University; DFG(German Research Foundation (DFG))	Synchrotron data collection was supported by the Helmholtz-Zentrum Berlin. The authors acknowledge support by the Open Access Publication Funds of the Gottingen University, and EW acknowledges support by the DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allegrin S, 2001, J BIOL CHEM, V276, P33526, DOI 10.1074/jbc.M104088200; Allegrini S, 2004, EUR J BIOCHEM, V271, P4881, DOI 10.1111/j.1432-1033.2004.04457.x; Amici A, 2005, CELL MOL LIFE SCI, V62, P1613, DOI 10.1007/s00018-005-5135-y; Amici A, 2002, ARCH BIOCHEM BIOPHYS, V397, P184, DOI 10.1006/abbi.2001.2676; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Baxter NJ, 2008, J AM CHEM SOC, V130, P3952, DOI 10.1021/ja078000n; Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; Bitto E, 2006, J BIOL CHEM, V281, P20521, DOI 10.1074/jbc.M602000200; Bosse-Doenecke E, 2008, PROTEIN EXPRES PURIF, V58, P114, DOI 10.1016/j.pep.2007.10.012; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Buschmann J, 2013, J BIOL CHEM, V288, P2441, DOI 10.1074/jbc.M112.426700; Cliff MJ, 2010, J AM CHEM SOC, V132, P6507, DOI 10.1021/ja100974t; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grobosky CL, 2012, J MOL BIOL, V423, P540, DOI 10.1016/j.jmb.2012.08.014; HENDLER S, 1970, BIOCHEMISTRY-US, V9, P4141, DOI 10.1021/bi00823a017; Heuts DPHM, 2012, CHEMBIOCHEM, V13, P2384, DOI 10.1002/cbic.201200426; Hokari S, 1998, BIOL CHEM, V379, P329, DOI 10.1515/bchm.1998.379.3.329; Hsu PC, 2000, BIOCHEMISTRY-US, V39, P13730, DOI 10.1021/bi000623p; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Jordheim LP, 2013, BIOCHEM PHARMACOL, V85, P497, DOI 10.1016/j.bcp.2012.11.024; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knapp K, 2012, STRUCTURE, V20, P2161, DOI 10.1016/j.str.2012.10.001; Lahiri SD, 2003, SCIENCE, V299, P2067, DOI 10.1126/science.1082710; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002; Reaves ML, 2013, NATURE, V500, P237, DOI 10.1038/nature12445; Rees DC, 2003, BRIT J HAEMATOL, V120, P375, DOI 10.1046/j.1365-2141.2003.03980.x; Reichard P, 2010, BIOCHEM BIOPH RES CO, V396, P19, DOI 10.1016/j.bbrc.2010.02.108; Rinaldo-Matthis A, 2002, NAT STRUCT BIOL, V9, P779, DOI 10.1038/nsb846; Ruszczynska K, 2003, BIOPHYS J, V85, P1450, DOI 10.1016/S0006-3495(03)74577-9; Sambrook J., 2001, MOL CLONING; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Song MG, 2013, RNA, V19, P390, DOI 10.1261/rna.037309.112; Strasser A, 2005, EMBO J, V24, P2235, DOI 10.1038/sj.emboj.7600701; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; VALENTINE WN, 1974, J CLIN INVEST, V54, P866, DOI 10.1172/JCI107826; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; Wallden K, 2005, STRUCTURE, V13, P1081, DOI 10.1016/j.str.2005.04.023; Wallden K, 2007, BIOCHEMISTRY-US, V46, P13809, DOI 10.1021/bi7014794; Wallden K, 2007, J BIOL CHEM, V282, P17828, DOI 10.1074/jbc.M700917200; Wallden K, 2011, J MOL BIOL, V408, P684, DOI 10.1016/j.jmb.2011.02.059; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599; Wang ZZ, 2001, CELL, V107, P12; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	50	14	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90915	10.1371/journal.pone.0090915	http://dx.doi.org/10.1371/journal.pone.0090915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603684	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600105
J	Syamsunarno, MRAA; Iso, T; Yamaguchi, A; Hanaoka, H; Putri, M; Obokata, M; Sunaga, H; Koitabashi, N; Matsui, H; Maeda, K; Endo, K; Tsushima, Y; Yokoyama, T; Kurabayashi, M				Syamsunarno, Mas Rizky A. A.; Iso, Tatsuya; Yamaguchi, Aiko; Hanaoka, Hirofumi; Putri, Mirasari; Obokata, Masaru; Sunaga, Hiroaki; Koitabashi, Norimichi; Matsui, Hiroki; Maeda, Kazuhisa; Endo, Keigo; Tsushima, Yoshito; Yokoyama, Tomoyuki; Kurabayashi, Masahiko			Fatty Acid Binding Protein 4 and 5 Play a Crucial Role in Thermogenesis under the Conditions of Fasting and Cold Stress	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; INSULIN-RESISTANCE; BETA-OXIDATION; ENDOTHELIAL DYSFUNCTION; ENERGY-EXPENDITURE; OBESITY; MICE; EXPOSURE; DOMINANT; HUMANS	Hypothermia is rapidly induced during cold exposure when thermoregulatory mechanisms, including fatty acid (FA) utilization, are disturbed. FA binding protein 4 (FABP4) and FABP5, which are abundantly expressed in adipose tissues and macrophages, have been identified as key molecules in the pathogenesis of overnutrition-related diseases, such as insulin resistance and atherosclerosis. We have recently shown that FABP4/5 are prominently expressed in capillary endothelial cells in the heart and skeletal muscle and play a crucial role in FA utilization in these tissues. However, the role of FABP4/5 in thermogenesis remains to be determined. In this study, we showed that thermogenesis is severely impaired in mice lacking both FABP4 and FABP5 (DKO mice), as manifested shortly after cold exposure during fasting. In DKO mice, the storage of both triacylglycerol in brown adipose tissue (BAT) and glycogen in skeletal muscle (SkM) was nearly depleted after fasting, and a biodistribution analysis using I-125-BMIPP revealed that non-esterified FAs (NEFAs) are not efficiently taken up by BAT despite the robustly elevated levels of serum NEFAs. In addition to the severe hypoglycemia observed in DKO mice during fasting, cold exposure did not induce the uptake of glucose analogue F-18-FDG by BAT. These findings strongly suggest that DKO mice exhibit pronounced hypothermia after fasting due to the depletion of energy storage in BAT and SkM and the reduced supply of energy substrates to these tissues. In conclusion, FABP4/5 play an indispensable role in thermogenesis in BAT and SkM. Our study underscores the importance of FABP4/5 for overcoming life-threatening environments, such as cold and starvation.	[Syamsunarno, Mas Rizky A. A.; Iso, Tatsuya; Putri, Mirasari; Obokata, Masaru; Koitabashi, Norimichi; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Gunma, Japan; [Iso, Tatsuya; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Educ & Res Support Ctr, Gunma, Japan; [Yamaguchi, Aiko; Endo, Keigo] Gunma Univ, Grad Sch Med, Dept Bioimaging Informat Anal, Gunma, Japan; [Tsushima, Yoshito] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Gunma, Japan; [Putri, Mirasari] Gunma Univ, Grad Sch Med, Dept Publ Hlth, Gunma, Japan; [Sunaga, Hiroaki; Matsui, Hiroki; Yokoyama, Tomoyuki] Gunma Univ, Grad Sch Hlth Sci, Dept Lab Sci, Gunma, Japan; [Hanaoka, Hirofumi] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Imaging & Radiotherapy, Chiba, Japan; [Maeda, Kazuhisa] Osaka Univ Hosp, Grad Sch Med, Dept Complementary & Alternat Med, Osaka 553, Japan	Gunma University; Gunma University; Gunma University; Gunma University; Gunma University; Gunma University; Chiba University; Osaka University	Syamsunarno, MRAA (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Gunma, Japan.	isot@gunma-u.ac.jp	Koitabashi, Norimichi/AAM-8788-2020; Hanaoka, Hirofumi/T-6261-2019; Yamaguchi, Aiko/AAJ-1588-2021; Matsui, Hiroki/P-4033-2019; Putri, Mirasari/AAB-5217-2021	Hanaoka, Hirofumi/0000-0003-2421-7397; Matsui, Hiroki/0000-0003-3243-333X; Putri, Mirasari/0000-0003-0520-1373; Yamaguchi, Aiko/0000-0002-7631-3164; Iso, Tatsuya/0000-0001-5045-1676; Obokata, Masaru/0000-0002-5473-0688	Japan Society for the Promotion of Science; Japan Cardiovascular Foundation; Takeda Science Foundation; Therapeutic Research for Metabolic Syndrome; Astra Zeneca; Vehicle Racing Commemorative Foundation; Grants-in-Aid for Scientific Research [25504002] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Cardiovascular Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Therapeutic Research for Metabolic Syndrome; Astra Zeneca(AstraZeneca); Vehicle Racing Commemorative Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to MK and TI); a grant from the Japan Cardiovascular Foundation (to MK); and grants from the Takeda Science Foundation, Therapeutic Research for Metabolic Syndrome, Astra Zeneca, and the Vehicle Racing Commemorative Foundation (to TI). The listed funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerni-Flessner L, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-63; Baba S, 2007, J NUCL MED, V48, P1715, DOI 10.2967/jnumed.107.041715; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Boucher J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1905; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Garcia-Arcos I, 2013, J BIOL CHEM, V288, P14046, DOI 10.1074/jbc.M113.469270; Goto K, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004861; Guerra C, 1998, J CLIN INVEST, V102, P1724, DOI 10.1172/JCI4532; Hagberg CE, 2012, NATURE, V490, P426, DOI 10.1038/nature11464; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Haman F, 2006, J APPL PHYSIOL, V100, P1702, DOI 10.1152/japplphysiol.01088.2005; Haman F, 2005, J PHYSIOL-LONDON, V566, P247, DOI 10.1113/jphysiol.2005.086272; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Iso T, 2013, ARTERIOSCLER THROMB; Kanda T, 2009, J CLIN INVEST, V119, P110, DOI 10.1172/JCI36233; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Miinalainen IJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000543; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Schuler AM, 2005, MOL GENET METAB, V85, P7, DOI 10.1016/j.ymgme.2004.09.006; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Spiekerkoetter U, 2010, J INHERIT METAB DIS, V33, P539, DOI 10.1007/s10545-010-9121-7; Steinberg HO, 1996, J CLIN INVEST, V97, P2601, DOI 10.1172/JCI118709; Syamsunarno MR, 2013, PLOS ONE IN PRESS; Tolwani RJ, 2005, PLOS GENET, V1, P205, DOI 10.1371/journal.pgen.0010023; Vergnes L, 2011, J BIOL CHEM, V286, P380, DOI 10.1074/jbc.M110.184754; Yamamoto T, 2011, BIOTECHNOL LETT, V33, P237, DOI 10.1007/s10529-010-0444-0; Yamashita H, 2008, BIOCHEM BIOPH RES CO, V377, P632, DOI 10.1016/j.bbrc.2008.10.041; Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105	35	25	27	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90825	10.1371/journal.pone.0090825	http://dx.doi.org/10.1371/journal.pone.0090825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603714	Green Submitted, Green Published, gold			2022-12-25	WOS:000332483600089
J	Gorman, KB; Williams, TD; Fraser, WR				Gorman, Kristen B.; Williams, Tony D.; Fraser, William R.			Ecological Sexual Dimorphism and Environmental Variability within a Community of Antarctic Penguins (Genus Pygoscelis)	PLOS ONE			English	Article							STABLE-ISOTOPES; CLIMATE-CHANGE; WINTER DISTRIBUTION; SIZE DIMORPHISM; GENTOO PENGUINS; SEA-ICE; SEGREGATION; SPECIALIZATION; NITROGEN; CARBON	Background: Sexual segregation in vertebrate foraging niche is often associated with sexual size dimorphism (SSD), i.e., ecological sexual dimorphism. Although foraging behavior of male and female seabirds can vary markedly, differences in isotopic (carbon, delta C-13 and nitrogen, delta N-15) foraging niche are generally more pronounced within sexually dimorphic species and during phases when competition for food is greater. We examined ecological sexual dimorphism among sympatric nesting Pygoscelis penguins asking whether environmental variability is associated with differences in male and female pre-breeding foraging niche. We predicted that all Pygoscelis species would forage sex-specifically, and that higher quality winter habitat, i.e., higher or lower sea ice coverage for a given species, would be associated with a more similar foraging niche among the sexes. Results: P2/P8 primers reliably amplified DNA of all species. On average, male Pygoscelis penguins are structurally larger than female conspecifics. However, chinstrap penguins were more sexually dimorphic in culmen and flipper features than Adelie and gentoo penguins. Adelies and gentoos were more sexually dimorphic in body mass than chinstraps. Only male and female chinstraps and gentoos occupied separate delta N-15 foraging niches. Strong year effects in delta N-15 signatures were documented for all three species, however, only for Adelies, did yearly variation in delta N-15 signatures tightly correlate with winter sea ice conditions. There was no evidence that variation in sex-specific foraging niche interacted with yearly winter habitat quality. Conclusion: Chinstraps were most sexually size dimorphic followed by gentoos and Adelies. Pre-breeding sex-specific foraging niche was associated with overall SSD indices across species; male chinstrap and gentoo penguins were enriched in delta N-15 relative to females. Our results highlight previously unknown trophic pathways that link Pygoscelis penguins with variation in Southern Ocean sea ice suggesting that each sex within a species should respond similarly in pre-breeding trophic foraging to changes in future winter habitat.	[Gorman, Kristen B.; Williams, Tony D.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Gorman, Kristen B.; Fraser, William R.] Polar Oceans Res Grp, Sheridan, MT USA	Simon Fraser University	Gorman, KB (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	kgorman@sfu.ca		Chiaradia, Andre/0000-0002-6178-4211; Gorman, Kristen B./0000-0002-0258-9264	Palmer Station, Antarctica, Long-Term Ecological Research (LTER) program through the National Science Foundation (NSF), Office of Polar Programs (OPP) [0217282, 0823101]; NSF-OPP; SFU Graduate Fellowships; Glen Geen Graduate Scholarship in Marine Biology; Canada Natural Sciences and Engineering Research Council Discovery Grants;  [0741351]; Directorate For Geosciences [1440435] Funding Source: National Science Foundation	Palmer Station, Antarctica, Long-Term Ecological Research (LTER) program through the National Science Foundation (NSF), Office of Polar Programs (OPP); NSF-OPP(National Science Foundation (NSF)); SFU Graduate Fellowships; Glen Geen Graduate Scholarship in Marine Biology; Canada Natural Sciences and Engineering Research Council Discovery Grants; ; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Research was conducted as part of the Palmer Station, Antarctica, Long-Term Ecological Research (LTER) program (http://pal.lternet.edu) supported by grants #0217282 and #0823101 through the National Science Foundation (NSF), Office of Polar Programs (OPP) to WRF. Supplemental funds for this project were received by a separate grant #0741351 to WRF, also funded by NSF-OPP. KBG was partially supported by SFU Graduate Fellowships and the Glen Geen Graduate Scholarship in Marine Biology, in addition to Canada Natural Sciences and Engineering Research Council Discovery Grants to TDW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D.G., 2002, ADELIE PENGUIN BELLW, DOI DOI 10.7312/AINL12306; Andersson Malte, 1994; Baker AJ, 2006, P ROY SOC B-BIOL SCI, V273, P11, DOI 10.1098/rspb.2005.3260; Ballard G, 2010, ECOLOGY, V91, P2056, DOI 10.1890/09-0688.1; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Bearhop S, 2006, MAR ECOL PROG SER, V311, P157, DOI 10.3354/meps311157; Bertellotti M, 2002, WATERBIRDS, V25, P479, DOI 10.1675/1524-4695(2002)025[0479:DSOMPU]2.0.CO;2; Bestelmeyer BT, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00216.1; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bost CA, 2009, BIOL LETTERS, V5, P473, DOI 10.1098/rsbl.2009.0265; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chapman EW, 2010, DEEP-SEA RES PT II, V57, P543, DOI 10.1016/j.dsr2.2009.10.005; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; Clarke J, 2003, MAR ECOL PROG SER, V248, P267, DOI 10.3354/meps248267; Comiso J. C., 1999, BOOTSTRAP SEA ICE CO; Conradt Larissa, 2005, P11; Costantini V, 2008, ANIM REPROD SCI, V106, P162, DOI 10.1016/j.anireprosci.2007.12.013; Crawley MJ., 2007, R BOOK; Dall SRX, 2012, ECOL LETT, V15, P1189, DOI 10.1111/j.1461-0248.2012.01846.x; Darwin G., 1871, P423; Dehnhard N, 2011, POLAR BIOL, V34, P1763, DOI 10.1007/s00300-011-1026-x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Ducklow HW, 2013, OCEANOGRAPHY, V26, P190, DOI 10.5670/oceanog.2013.62; Dunn MJ, 2011, POLAR BIOL, V34, P205, DOI 10.1007/s00300-010-0870-4; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; FAIRBAIRN J, 1993, OIKOS, V68, P139, DOI 10.2307/3545319; Fargallo JA, 2004, POLAR BIOL, V27, P339, DOI 10.1007/s00300-004-0596-2; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; Forero MG, 2005, MAR ECOL PROG SER, V296, P107, DOI 10.3354/meps296107; Forero MG, 2002, MAR ECOL PROG SER, V234, P289, DOI 10.3354/meps234289; FRASER WR, 1992, POLAR BIOL, V11, P525; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gauthreaux S.A. Jr, 1978, Perspectives in Ethology, V3, P17; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hart T, 2009, WATERBIRDS, V32, P437, DOI 10.1675/063.032.0309; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Jacobs SS, 1997, J CLIMATE, V10, P697, DOI 10.1175/1520-0442(1997)010<0697:CVITAA>2.0.CO;2; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; LANDE R, 1980, EVOLUTION, V34, P292, DOI 10.1111/j.1558-5646.1980.tb04817.x; Lewis S, 2002, P ROY SOC B-BIOL SCI, V269, P1687, DOI 10.1098/rspb.2002.2083; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Lynch HJ, 2012, ECOLOGY, V93, P1367; Moline MA, 2008, ANN NY ACAD SCI, V1134, P267, DOI 10.1196/annals.1439.010; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Phillips RA, 2011, MAR BIOL, V158, P2199, DOI 10.1007/s00227-011-1725-4; Pinet P, 2012, ANIM BEHAV, V83, P979, DOI 10.1016/j.anbehav.2012.01.019; Polito Michael J., 2012, Marine Ornithology, V40, P89; Polito MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026642; Polito MJ, 2011, MAR ECOL PROG SER, V421, P265, DOI 10.3354/meps08863; R Core Team, 2012, R LANG ENV STAT COMP; Reis EC, 2011, GENET MOL RES, V10, P3731, DOI 10.4238/2011.December.5.7; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; SLATKIN M, 1984, EVOLUTION, V38, P622, DOI 10.1111/j.1558-5646.1984.tb00327.x; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; Stammerjohn S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL050874; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; Szekely Tamas, 2007, P27; Tanton JL, 2004, POLAR BIOL, V27, P299, DOI 10.1007/s00300-004-0592-6; Thiebot JB, 2012, ECOLOGY, V93, P122, DOI 10.1890/11-0385.1; Thiebot JB, 2011, MAR ECOL PROG SER, V421, P279, DOI 10.3354/meps08907; Trivelpiece WZ, 2007, POLAR BIOL, V30, P1231, DOI 10.1007/s00300-007-0283-1; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Weimerskirch H, 2009, OECOLOGIA, V161, P637, DOI 10.1007/s00442-009-1397-7; WILLIAMS TD, 1990, J ZOOL, V222, P247, DOI 10.1111/j.1469-7998.1990.tb05675.x; Williams TD, 1995, PENGUINS SPHENISCIDA	74	23	23	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90081	10.1371/journal.pone.0090081	http://dx.doi.org/10.1371/journal.pone.0090081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599330	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400042
J	Kuo, WL; Sharifi, MN; Lingen, MW; Ahmed, O; Liu, J; Nagilla, M; Macleod, KF; Cohen, EEW				Kuo, Wen-Liang; Sharifi, Marina N.; Lingen, Mark W.; Ahmed, Omar; Liu, Jing; Nagilla, Madhavi; Macleod, Kay F.; Cohen, Ezra E. W.			p62/SQSTM1 Accumulation in Squamous Cell Carcinoma of Head and Neck Predicts Sensitivity to Phosphatidylinositol 3-Kinase Pathway Inhibitors	PLOS ONE			English	Article							AUTOPHAGY; CANCER; ACTIVATION; SURVIVAL; DEATH; PI3K	The phosphoinositol-3 kinase (PI3K) pathway is highly dysregulated in squamous cell carcinoma of the head and neck (SCCHN). While inhibitors of the PI3K/AKT pathway are being developed in cancer, their efficacy does not appear to be related to the presence of mutations or amplification in pathway genes. The PI3K pathway is a major regulator of macro-autophagy, an evolutionarily conserved catabolic process that degrades cellular materials to promote cellular homeostasis and survival under stress. Employing a panel of SCCHN cell lines, we observed a significant correlation between the activity of PI3K/AKT inhibitors and their ability to induce autophagy. More specifically, resistance to these inhibitors was associated with accumulation of p62/SQSTM1, a pleotropic protein that is consumed during autophagy, while loss of autophagy was, for the first time, found to be due to silencing of an essential autophagy gene, ATG7. Moreover, modulating ATG7 and p62/SQSTM1 could regulate sensitivity to PI3K/AKT inhibitors, underscoring a mechanistic link between autophagy and drug sensitivity. Analysis of human tissues revealed progressive accumulation of p62/SQSTM1 in a significant proportion of cancer samples compared to normal tissue, suggesting that defective autophagy has relevance to SCCHN. These findings are further validated by analysis of TCGA data confirming homozygous deletion and mRNA down-regulation of ATG7 in 10.0% of SCCHN samples. Taken together, these data indicate that p62/SQSTM1 levels modulate sensitivity to PI3K/AKT inhibitors; cancers vary in their capacity to undergo autophagy through epigenetic modification and, when deficient, accumulate p62/SQSTM1; and expression of autophagy-related proteins may serve as markers for resistance to PI3K/AKT inhibitors in SCCHN.	[Kuo, Wen-Liang; Ahmed, Omar; Liu, Jing; Nagilla, Madhavi; Cohen, Ezra E. W.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Sharifi, Marina N.; Lingen, Mark W.; Macleod, Kay F.; Cohen, Ezra E. W.] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Sharifi, Marina N.; Macleod, Kay F.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Lingen, Mark W.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Lingen, Mark W.; Macleod, Kay F.; Cohen, Ezra E. W.] Univ Chicago, Comprehens Canc Ctr, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago	Cohen, EEW (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	ecohen@.ucsd.edu		Sharifi, Marina/0000-0003-0128-3033	Developmental Research Project University of Chicago Head and Neck Cancer Research Program; NCI [RO1 CA162405]; MSTP Training Program; NATIONAL CANCER INSTITUTE [R01CA162405] Funding Source: NIH RePORTER	Developmental Research Project University of Chicago Head and Neck Cancer Research Program; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MSTP Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Developmental Research Project University of Chicago Head and Neck Cancer Research Program (WLK, EEWC); Grant Achatz, Nick Kokonas; Alinea Restauran; NCI RO1 CA162405 (KFM); MSTP Training Program (MNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Bialik S, 2008, ADV EXP MED BIOL, V615, P177, DOI 10.1007/978-1-4020-6554-5_9; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cohen Y, 2011, ORAL ONCOL, V47, P946, DOI 10.1016/j.oraloncology.2011.07.013; COWAN JM, 1992, J NATL CANCER I, V84, P793, DOI 10.1093/jnci/84.10.793; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; EASTY DM, 1981, BRIT J CANCER, V43, P772, DOI 10.1038/bjc.1981.115; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Ghadimi MP, 2012, MOL CANCER THER, V11, P1758, DOI 10.1158/1535-7163.MCT-12-0015; Hayes JR David N., 2013, J CLIN ONCOL, V31; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Jaakkola PM, 2009, AUTOPHAGY, V5, P410, DOI 10.4161/auto.5.3.7823; Janku F, 2011, NATURE REV CLIN ONCO, V8; Janku F, 2011, MOL CANCER THER, V10, P558, DOI 10.1158/1535-7163.MCT-10-0994; Kaushik S, 2008, MOL BIOL CELL, V19, P2179, DOI 10.1091/mbc.E07-11-1155; Keck Michaela K., 2013, J CLIN ONCOL, V31; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kon M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003182; Kuo WL, 2010, MOL CANCER THER, V9, P2814, DOI 10.1158/1535-7163.MCT-10-0352; Kwon J, 2012, EMBO REP, V13, P150, DOI 10.1038/embor.2011.246; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Lee HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036221; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; Ma XH, 2011, CLIN CANCER RES, V17, P3478, DOI 10.1158/1078-0432.CCR-10-2372; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Pankiv S, 2010, J BIOL CHEM, V285, P5941, DOI 10.1074/jbc.M109.039925; Parzych K. R., 2013, ANTIOXID REDOX SIGNA; Puissant A, 2012, AM J CANCER RES, V2, P397; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Saman DM, 2012, HEAD NECK ONCOL, V4, DOI 10.1186/1758-3284-4-1; Sangai T, 2012, CLIN CANCER RES, V18, P5816, DOI 10.1158/1078-0432.CCR-12-1141; Shanware NP, 2013, ANNU REV PHARMACOL, V53, P89, DOI 10.1146/annurev-pharmtox-010611-134717; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Sridhar S, 2012, J PATHOL, V226, P255, DOI 10.1002/path.3025; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Young NR, 2013, MOL ONCOL, V7, P359, DOI 10.1016/j.molonc.2012.11.001; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645	48	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90171	10.1371/journal.pone.0090171	http://dx.doi.org/10.1371/journal.pone.0090171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599075	Green Submitted, Green Published, gold			2022-12-25	WOS:000332479400053
J	Liu, BG; Badeaux, MD; Choy, G; Chandra, D; Shen, I; Jeter, CR; Rycaj, K; Lee, CF; Person, MD; Liu, C; Chen, YP; Shen, JJ; Jung, SY; Qin, J; Tang, DG				Liu, Bigang; Badeaux, Mark D.; Choy, Grace; Chandra, Dhyan; Shen, Irvin; Jeter, Collene R.; Rycaj, Kiera; Lee, Chia-Fang; Person, Maria D.; Liu, Can; Chen, Yueping; Shen, Jianjun; Jung, Sung Yun; Qin, Jun; Tang, Dean G.			Nanog1 in NTERA-2 and Recombinant NanogP8 from Somatic Cancer Cells Adopt Multiple Protein Conformations and Migrate at Multiple M.W Species	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NF-KAPPA-B; SELF-RENEWAL; INITIATING CELLS; MARKER NANOG; EXPRESSION; PLURIPOTENCY; IDENTIFICATION; TRANSCRIPTION; BREAST	Human Nanog1 is a 305-amino acid (aa) homeodomain-containing transcription factor critical for the pluripotency of embryonic stem (ES) and embryonal carcinoma (EC) cells. Somatic cancer cells predominantly express a retrogene homolog of Nanog1 called NanogP8, which is similar to 99% similar to Nanog at the aa level. Although the predicted M. W of Nanog1/NanogP8 is similar to 35 kD, both have been reported to migrate, on Western blotting (WB), at apparent molecular masses of 29-80 kD. Whether all these reported protein bands represent authentic Nanog proteins is unclear. Furthermore, detailed biochemical studies on Nanog1/NanogpP8 have been lacking. By combining WB using 8 anti-Nanog1 antibodies, immunoprecipitation, mass spectrometry, and studies using recombinant proteins, here we provide direct evidence that the Nanog1 protein in NTERA-2 EC cells exists as multiple M.W species from similar to 22 kD to 100 kD with a major 42 kD band detectable on WB. We then demonstrate that recombinant NanogP8 (rNanogP8) proteins made in bacteria using cDNAs from multiple cancer cells also migrate, on denaturing SDS-PAGE, at similar to 28 kD to 180 kD. Interestingly, different anti-Nanog1 antibodies exhibit differential reactivity towards rNanogP8 proteins, which can spontaneously form high M.W protein species. Finally, we show that most long-term cultured cancer cell lines seem to express very low levels of or different endogenous NanogP8 protein that cannot be readily detected by immunoprecipitation. Altogether, the current study reveals unique biochemical properties of Nanog1 in EC cells and NanogP8 in somatic cancer cells.	[Liu, Bigang; Badeaux, Mark D.; Choy, Grace; Chandra, Dhyan; Shen, Irvin; Jeter, Collene R.; Rycaj, Kiera; Liu, Can; Chen, Yueping; Shen, Jianjun; Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA; [Lee, Chia-Fang; Person, Maria D.] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Jung, Sung Yun; Qin, Jun] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; [Tang, Dean G.] Tongji Univ, Sch Med, Canc Stem Cell Inst, Res Ctr Translat Med,East Hosp, Shanghai 200092, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; Baylor College of Medicine; Tongji University	Tang, DG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Sci Pk, Smithville, TX 78957 USA.	dtang@mdanderson.org	Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174; Jeter, Collene/0000-0002-9627-4529; Jung, Sung Yun/0000-0003-1521-7977; Chandra, Dhyan/0000-0001-7272-9384	NIH [R01-CA155693]; Department of Defense [W81XWH-13-1-0352]; CPRIT [RP120380, RP120394, RP110782]; MDACC Center for Cancer Epigenetics; RNA Center-Laura & John Arnold Foundation; DOD [PC121553];  [CCSG-5 P30 CA166672];  [ES007784]; NATIONAL CANCER INSTITUTE [R01CA166672, R01CA155693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); CPRIT; MDACC Center for Cancer Epigenetics; RNA Center-Laura & John Arnold Foundation; DOD(United States Department of Defense); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in part, by grants from NIH (R01-CA155693), Department of Defense (W81XWH-13-1-0352), CPRIT (RP120380), the MDACC Center for Cancer Epigenetics and RNA Center-Laura & John Arnold Foundation grant (D. G. Tang), and by two Center Grants (CCSG-5 P30 CA166672 and ES007784). C. Jeter, M. Person, and C. Liu were supported, in part, by CPRIT RP120394, CPRIT RP110782, and DOD post-doctoral fellowship (PC121553), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldridge L, 2008, J PROTEOME RES, V7, P1458, DOI 10.1021/pr7007829; Badeaux MA, 2013, CELL CYCLE, V12, P2395, DOI 10.4161/cc.25402; Booth HAF, 2004, GENOMICS, V84, P229, DOI 10.1016/j.ygeno.2004.02.014; Bourguignon LYW, 2012, ONCOGENE, V31, P149, DOI 10.1038/onc.2011.222; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chang DF, 2009, STEM CELLS, V27, P812, DOI 10.1634/stemcells.2008-0657; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Do HJ, 2007, BIOCHEM BIOPH RES CO, V353, P770, DOI 10.1016/j.bbrc.2006.12.100; Eberle I, 2010, NUCLEIC ACIDS RES, V38, P5384, DOI 10.1093/nar/gkq307; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Gorini G, 2010, FEBS LETT, V584, P845, DOI 10.1016/j.febslet.2009.12.061; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Ho BT, 2012, J BIOL CHEM, V287, P18656, DOI 10.1074/jbc.M111.322883; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Ibrahim EE, 2012, STEM CELLS, V30, P2076, DOI 10.1002/stem.1182; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Jung SY, 2005, MOL ENDOCRINOL, V19, P2451, DOI 10.1210/me.2004-0476; Kalbermatten DF, 2011, CELL TISSUE RES, V344, P251, DOI 10.1007/s00441-011-1142-5; Kim JS, 2005, EXP MOL MED, V37, P601, DOI 10.1038/emm.2005.73; Kochupurakkal BS, 2008, BIOCHEM BIOPH RES CO, V365, P846, DOI 10.1016/j.bbrc.2007.11.073; Kuijk EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010987; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liu M, 2010, CANCER RES, V70, P10464, DOI 10.1158/0008-5472.CAN-10-0732; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Meng HM, 2010, CANC BIOL THER, V9; Meyer MJ, 2010, CANCER RES, V70, P4624, DOI 10.1158/0008-5472.CAN-09-3619; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Mullin NP, 2008, BIOCHEM J, V411, P227, DOI 10.1042/BJ20080134; Noh KH, 2012, J CLIN INVEST, V122, P4077, DOI 10.1172/JCI64057; Noh KH, 2012, CANCER RES, V72, P1717, DOI 10.1158/0008-5472.CAN-11-3758; Oh JH, 2005, EXP MOL MED, V37, P250, DOI 10.1038/emm.2005.33; Palla AR, 2014, ONCOGENE, V33, P2513, DOI 10.1038/onc.2013.196; Pan GJ, 2005, J BIOL CHEM, V280, P1401, DOI 10.1074/jbc.M407847200; Pei DQ, 2009, J BIOL CHEM, V284, P3365, DOI 10.1074/jbc.R800063200; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; PERSSON H, 1984, SCIENCE, V225, P687, DOI 10.1126/science.6431612; Po A, 2010, EMBO J, V29, P2646, DOI 10.1038/emboj.2010.131; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; Ramakrishna S, 2011, STEM CELLS DEV, V20, P1512, DOI 10.1089/scd.2010.0410; RAMSAY G, 1984, P NATL ACAD SCI-BIOL, V81, P7742, DOI 10.1073/pnas.81.24.7742; Salmina K, 2010, EXP CELL RES, V316, P2099, DOI 10.1016/j.yexcr.2010.04.030; Santini R, 2012, STEM CELLS, V30, P1808, DOI 10.1002/stem.1160; Shan JJ, 2012, HEPATOLOGY, V56, P1004, DOI 10.1002/hep.25745; Siu MKY, 2013, ONCOGENE, V32, P3500, DOI 10.1038/onc.2012.363; Siu MKY, 2008, AM J PATHOL, V173, P1165, DOI 10.2353/ajpath.2008.080288; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Ye F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-108; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zhang J, 2013, ONCOGENE, V32, P4397, DOI 10.1038/onc.2012.461; Zhang JY, 2006, FEBS J, V273, P1723, DOI 10.1111/j.1742-4658.2006.05186.x; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhang X, 2009, J CELL BIOL, V184, P67, DOI 10.1083/jcb.200801009	68	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90615	10.1371/journal.pone.0090615	http://dx.doi.org/10.1371/journal.pone.0090615			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598770	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400101
J	Liu, YW; Su, CT; Chang, YT; Tsai, WC; Su, YR; Wang, SPH; Yang, CS; Tsai, LM; Chen, JH; Sung, JM				Liu, Yen-Wen; Su, Chi-Ting; Chang, Yu-Tzu; Tsai, Wei-Chuan; Su, Yu-Ru; Wang, Saprina P. H.; Yang, Chun-Shin; Tsai, Liang-Miin; Chen, Jyh-Hong; Sung, Junne-Ming			Elevated Serum Interleukin-18 Level Is Associated with All-Cause Mortality in Stable Hemodialysis Patients Independently of Cardiac Dysfunction	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; C-REACTIVE PROTEIN; NECROSIS-FACTOR-ALPHA; VENA-CAVA DIAMETER; TROPONIN-T; CARDIOVASCULAR MORTALITY; DIASTOLIC DYSFUNCTION; EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY	Background: High circulating interleukin (IL)-18 level predicts a higher hospitalization rate among dialysis patients, possibly through cardiovascular mechanisms; however, whether higher IL-18 level is associated with mortality in dialysis patients is less clear. In addition, its impacts on left ventricular (LV) function are also unknown. We conducted a cohort study to examine the impacts of IL-18 level on LV function and prognosis among clinically stable hemodialysis patients. Methods: Clinically stable patients undergoing maintenance hemodialysis (>= 3 months) were prospectively enrolled from December 2008 to January 2009, and were followed up for 31 months. The enrolled patients (41% male, 66.4 +/- 10.9 years of age) received 2-dimensional echocardiography and myocardial deformation (strain) analysis, including LV peak systolic longitudinal strain (GLS) and circumferential strain (CS). Laboratory measurements were also performed. Cox regression analysis was used to investigate prognostic factors. Results: Seventy-five patients were stratified into 2 groups by the median value of IL-18 (654.2 pg/ml). Between these 2 groups, there was no significant difference in baseline characteristics including LV ejection fraction. The high IL-18 group had a worse LV systolic function as demonstrated by reduced GLS and CS. Seventeen patients (22.7%) died during the follow-up period. Multivariate Cox regression analysis showed that low serum albumin, the presence of hypertension, high serum IL-18, and less negative GLS (>-15%) were independently associated with all-cause mortality. No significant interaction between IL-18 and less negative GLS was noted in the final Cox model. Conclusion: Hemodialysis patients with high IL-18 levels tend to have worse LV systolic function and higher mortality rate. However, elevated serum IL-18 level is predictive of poor prognosis among stable hemodialysis patients, independently of LV dysfunction. This suggests an additional value of IL-18 to echocardiographic study in predicting all-cause mortality, and IL-18 may be helpful in early risk stratification of hemodialysis patients.	[Liu, Yen-Wen; Tsai, Wei-Chuan; Tsai, Liang-Miin; Chen, Jyh-Hong] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Div Cardiol,Dept Internal Med, Tainan 70101, Taiwan; [Su, Chi-Ting] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Internal Med, Div Nephrol, Yunlin, Taiwan; [Chang, Yu-Tzu; Sung, Junne-Ming] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Div Nephrol, Dept Internal Med, Tainan 70101, Taiwan; [Su, Yu-Ru] Natl Cheng Kung Univ, Dept Stat, Tainan 70101, Taiwan; [Wang, Saprina P. H.] Natl Cheng Kung Univ, Grad Inst Biomed Engn, Tainan 70101, Taiwan; [Yang, Chun-Shin] Cathol Fu An Hosp, Dept Internal Med, Div Nephrol, Yunlin, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Taiwan University; National Taiwan University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University	Sung, JM (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Div Nephrol, Dept Internal Med, Tainan 70101, Taiwan.	jmsung@mail.ncku.edu.tw	Chang, Yu-Tzu/AAE-6781-2022	Chang, Yu-Tzu/0000-0003-1449-9431; Sung, Junne-Ming/0000-0003-1916-7815	National Science Council (NSC), Executive Yuan, Taipei, Taiwan [NSC 98-2314-B-006-051, 101-2314-B-006-035]	National Science Council (NSC), Executive Yuan, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council (NSC), Executive Yuan, Taipei, Taiwan: Grants NSC 98-2314-B-006-051 and 101-2314-B-006-035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akdag I, 2008, NEPHRON CLIN PRACT, V108, pC99, DOI 10.1159/000113526; Ando Y, 1995, ARTIF ORGANS, V19, P1237, DOI 10.1111/j.1525-1594.1995.tb02292.x; Blankenberg S, 2003, CIRCULATION, V108, P2453, DOI 10.1161/01.CIR.0000099509.76044.A2; Blankenberg S, 2002, CIRCULATION, V106, P24, DOI 10.1161/01.CIR.0000020546.30940.92; Cain BS, 1999, CRIT CARE MED, V27, P1309, DOI 10.1097/00003246-199907000-00018; Chandrasekar B, 2005, J BIOL CHEM, V280, P4553, DOI 10.1074/jbc.M411787200; Chiang CK, 2004, NEPHROL DIAL TRANSPL, V19, P2810, DOI 10.1093/ndt/gfh475; deFilippi C, 2003, JAMA-J AM MED ASSOC, V290, P353, DOI 10.1001/jama.290.3.353; Edwards NC, 2008, J AM SOC ECHOCARDIOG, V21, P1293, DOI 10.1016/j.echo.2008.09.013; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; Goicoechea M, 2005, KIDNEY INT, V67, pS35, DOI 10.1111/j.1523-1755.2005.09308.x; Ikizler TA, 1999, KIDNEY INT, V55, P1945, DOI 10.1046/j.1523-1755.1999.00410.x; Konopleva M, 1999, ADV EXP MED BIOL, V457, P217; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Leavey SF, 1998, AM J KIDNEY DIS, V31, P997, DOI 10.1053/ajkd.1998.v31.pm9631845; Li SH, 2007, AM J PHYSIOL-HEART C, V293, pH1847, DOI 10.1152/ajpheart.00578.2007; Liao XD, 2006, FASEB J, V20, P1883, DOI 10.1096/fj.06-5717fje; Liu YW, 2013, CLIN J AM SOC NEPHRO, V8, P1564, DOI 10.2215/CJN.10671012; Liu YW, 2011, AM J NEPHROL, V33, P84, DOI 10.1159/000322709; Liu YW, 2009, J CARD FAIL, V15, P782, DOI 10.1016/j.cardfail.2009.05.006; Mallat Z, 2001, CIRCULATION, V104, P1598, DOI 10.1161/hc3901.096721; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; Reddy VS, 2008, J CELL PHYSIOL, V215, P697, DOI 10.1002/jcp.21348; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sharma R, 2006, HEART, V92, P804, DOI 10.1136/hrt.2005.069666; Stanton T, 2009, CIRC-CARDIOVASC IMAG, V2, P356, DOI 10.1161/CIRCIMAGING.109.862334; Su CT, 2012, J AM SOC ECHOCARDIOG, V25, P895, DOI 10.1016/j.echo.2012.04.025; Tripepi G, 2005, J AM SOC NEPHROL, V16, pS83, DOI 10.1681/ASN.2004110972; Vanholder R, 2008, PEDIATR NEPHROL, V23, P1211, DOI 10.1007/s00467-008-0762-9; Wang AYM, 2006, KIDNEY INT, V70, P444, DOI 10.1038/sj.ki.5001605; Wang J, 2008, EUR HEART J, V29, P1283, DOI 10.1093/eurheartj/ehn141; Wang MJ, 2007, AM J PHYSIOL-HEART C, V292, pH1694, DOI 10.1152/ajpheart.01063.2006; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Whitman SC, 2002, CIRC RES, V90, pE34, DOI 10.1161/hh0202.105292; Woldbaek PR, 2005, AM J PHYSIOL-HEART C, V289, pH708, DOI 10.1152/ajpheart.01179.2004; Wong CK, 2007, IMMUNOL INVEST, V36, P47, DOI 10.1080/08820130600745505; Xing SS, 2010, MOL MED, V16, P465, DOI 10.2119/molmed.2010.00028; Yamagami H, 2005, ARTERIOSCL THROM VAS, V25, P1458, DOI 10.1161/01.ATV.0000168417.52486.56; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406; Yano A, 2005, NEPHROLOGY, V10, P576, DOI 10.1111/j.1440-1797.2005.00497.x; Yashiro M, 2007, THER APHER DIAL, V11, P131, DOI 10.1111/j.1744-9987.2007.00471.x; Yingchoncharoen T, 2013, J AM SOC ECHOCARDIOG, V26, P185, DOI 10.1016/j.echo.2012.10.008; Zoccali C, 2006, J AM SOC NEPHROL, V17, pS169, DOI 10.1681/ASN.2006080910	45	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89457	10.1371/journal.pone.0089457	http://dx.doi.org/10.1371/journal.pone.0089457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599060	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400014
J	Nwosu, BU; Maranda, L; Berry, R; Colocino, B; Flores, CD; Folkman, K; Groblewski, T; Ruze, P				Nwosu, Benjamin Udoka; Maranda, Louise; Berry, Rosalie; Colocino, Barbara; Flores, Carlos D., Sr.; Folkman, Kerry; Groblewski, Thomas; Ruze, Patricia			The Vitamin D Status of Prison Inmates	PLOS ONE			English	Article							D DEFICIENCY; MUSCLE STRENGTH; SKIN	Introduction: There is no comprehensive, systematic analysis of the vitamin D status of prisoners in the scientific literature. Objective: To investigate the vitamin D status and its determinants in US prison inmates. Hypothesis: Given the uniformity of dietary intake amongst inmates, vitamin D status will be determined by non-dietary factors such as skin pigmentation, security level-, and the duration of incarceration. Subjects and Methods: A retrospective study of 526 inmates (males, n = 502, age 48.6 +/- 12.5 years; females, n = 24, age 44.1 +/- 12.2) in Massachusetts prisons. Vitamin D sufficiency, insufficiency, and deficiency were respectively defined as a 25(OH)D concentration 75 nmol/L; 50 to 75 nmol/L; and,50 nmol/L. The Massachusetts Department of Correction Statement of Nutritional Adequacy stated that each inmate received the recommended daily allowance of vitamin D daily. Security level of incarceration was designated as minimum, medium, and maximum. Racial groups were categorized as Black, white, Asian, and Others. Results: Serum 25(OH)D levels peaked in summer and autumn, and decreased in winter and spring. Vitamin D deficiency occurred in 50.5% of blacks, 29.3% of whites, and 14.3% of Asian inmates (p = 0.007). Black inmates had significantly lower serum 25(OH)D level than white inmates at the maximum security level (p = 0.015), medium security level (p = 0.001), but not at the minimum security level (p = 0.40). After adjusting for covariates black inmates at a maximum security level had a four-fold higher risk for vitamin D deficiency than white inmates at the same security level (OR 3.9 [95% CI 1.3-11.7]. Conclusions: The vitamin D status of prison inmates is determined by skin pigmentation, seasons, and the security level of incarceration.	[Nwosu, Benjamin Udoka] Univ Massachusetts, Sch Med, Dept Pediat, Div Endocrinol, Worcester, MA 01655 USA; [Maranda, Louise] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA; [Berry, Rosalie; Colocino, Barbara; Flores, Carlos D., Sr.; Folkman, Kerry] Massachusetts Partnership Correct Healthcare, Dept Correct, Norton, MA USA; [Groblewski, Thomas; Ruze, Patricia] Univ Massachusetts, Sch Med, Dept Family & Community Med, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Nwosu, BU (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, Div Endocrinol, Worcester, MA 01655 USA.	Benjamin.Nwosu@umassmemorial.org			Faculty Diversity Scholars Program; Department of Pediatrics, University of Massachusetts Medical School; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	Faculty Diversity Scholars Program; Department of Pediatrics, University of Massachusetts Medical School; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the Faculty Diversity Scholars Program, and the Department of Pediatrics, University of Massachusetts Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Carson SA, 2008, J ECON HIST, V68, P1; CLEMENS TL, 1982, LANCET, V1, P74; Collins SA, 2012, J CORRECT HEALTH CAR, V18, P210, DOI 10.1177/1078345812444875; Cranney Ann, 2007, Evid Rep Technol Assess (Full Rep), P1; Cropsey KL, 2012, J NATL MED ASSOC, V104, P487, DOI 10.1016/S0027-9684(15)30214-5; Dhesi JK, 2002, J BONE MINER RES, V17, P891, DOI 10.1359/jbmr.2002.17.5.891; Eves A, 2003, J HUM NUTR DIET, V16, P167, DOI 10.1046/j.1365-277X.2003.00438.x; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Makimura H, 2012, CLIN ENDOCRINOL, V76, P220, DOI 10.1111/j.1365-2265.2011.04195.x; Pfeifer M, 2001, EXP CLIN ENDOCR DIAB, V109, P87, DOI 10.1055/s-2001-14831; Plum LA, 2010, NAT REV DRUG DISCOV, V9, P941, DOI 10.1038/nrd3318; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Sohl E, 2013, J CLIN ENDOCRINOL ME; Stewart R, 2010, PSYCHOSOM MED, V72, P608, DOI 10.1097/PSY.0b013e3181e9bf15; Strathdee A, 1994, J FORENSIC PSYCHIATR, V5, P83, DOI DOI 10.1080/09585189408410899; Svoren BM, 2009, J PEDIATR-US, V154, P132, DOI 10.1016/j.jpeds.2008.07.015; Visser M, 2003, J CLIN ENDOCR METAB, V88, P5766, DOI 10.1210/jc.2003-030604; Yetley EA, 2009, AM J CLIN NUTR, V89, P719, DOI 10.3945/ajcn.2008.26903	22	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90623	10.1371/journal.pone.0090623	http://dx.doi.org/10.1371/journal.pone.0090623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598840	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400103
J	Petiwala, SM; Berhe, S; Li, GB; Puthenveetil, AG; Rahman, O; Nonn, L; Johnson, JJ				Petiwala, Sakina M.; Berhe, Saba; Li, Gongbo; Puthenveetil, Angela G.; Rahman, Ozair; Nonn, Larisa; Johnson, Jeremy J.			Rosemary (Rosmarinus officinalis) Extract Modulates CHOP/GADD153 to Promote Androgen Receptor Degradation and Decreases Xenograft Tumor Growth	PLOS ONE			English	Article							PROSTATE-CANCER; DEPRIVATION THERAPY; MEDITERRANEAN DIET; CHEMOPREVENTION; POLYPHENOLS; PREVENTION; DITERPENE; CARNOSOL; TARGETS; CELLS	The Mediterranean diet has long been attributed to preventing or delaying the onset of cardiovascular disease, diabetes and various solid organ cancers. In this particular study, a rosemary extract standardized to carnosic acid was evaluated for its potential in disrupting the endoplasmic reticulum machinery to decrease the viability of prostate cancer cells and promote degradation of the androgen receptor. Two human prostate cancer cell lines, 22Rv1 and LNCaP, and prostate epithelial cells procured from two different patients undergoing radical prostatectomy were treated with standardized rosemary extract and evaluated by flow cytometry, MTT, BrdU, Western blot and fluorescent microscopy. A significant modulation of endoplasmic reticulum stress proteins was observed in cancer cells while normal prostate epithelial cells did not undergo endoplasmic reticulum stress. This biphasic response suggests that standardized rosemary extract may preferentially target cancer cells as opposed to "normal'' cells. Furthermore, we observed standardized rosemary extract to decrease androgen receptor expression that appears to be regulated by the expression of CHOP/GADD153. Using a xenograft tumor model we observed standardized rosemary extract when given orally to significantly suppress tumor growth by 46% compared to mice not receiving standardized rosemary extract. In the last several years regulatory governing bodies ( e. g. European Union) have approved standardized rosemary extracts as food preservatives. These results are especially significant as it is becoming more likely that individuals will be receiving standardized rosemary extracts that are a part of a natural preservative system in various food preparations. Taken a step further, it is possible that the potential benefits that are often associated with a "Mediterranean Diet'' in the future may begin to extend beyond the Mediterranean diet as more of the population is consuming standardized rosemary extracts.	[Petiwala, Sakina M.; Berhe, Saba; Li, Gongbo; Puthenveetil, Angela G.; Rahman, Ozair; Johnson, Jeremy J.] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL 60607 USA; [Nonn, Larisa; Johnson, Jeremy J.] Univ Illinois, Ctr Canc, Chicago, IL USA; [Nonn, Larisa] Univ Illinois, Coll Med, Dept Pathol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Johnson, JJ (corresponding author), Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL 60607 USA.	jjjohn@uic.edu	li, gongbo/C-6778-2008		University of Illinois at Chicago College of Pharmacy; American Cancer Society [RSG CNE - 122480]	University of Illinois at Chicago College of Pharmacy; American Cancer Society(American Cancer Society)	This work was supported by funding from the University of Illinois at Chicago College of Pharmacy and the American Cancer Society RSG CNE - 122480 (to J.J.J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar F, 2008, EFSA J, V8, P1; Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; Asoh S, 2000, J BIOL CHEM, V275, P37240, DOI 10.1074/jbc.M005841200; Doolaege EHA, 2011, PLANT FOOD HUM NUTR, V66, P196, DOI 10.1007/s11130-011-0233-5; Fortes C, 2003, NUTR CANCER, V46, P30, DOI 10.1207/S15327914NC4601_04; Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1; Haddad E, 2006, ANN UROL, V40, pS49, DOI 10.1016/S0003-4401(06)80021-5; Johnson JJ, 2010, PHYTOMEDICINE, V17, P3, DOI 10.1016/j.phymed.2009.09.011; Johnson JJ, 2011, CANCER LETT, V305, P1, DOI 10.1016/j.canlet.2011.02.005; Johnson JJ, 2010, CANCER PREV RES, V3, P1112, DOI 10.1158/1940-6207.CAPR-10-0168; Johnson JJ, 2008, PHARM RES-DORDR, V25, P2125, DOI 10.1007/s11095-008-9552-0; Johnson JJ, 2007, CANCER LETT, V255, P170, DOI 10.1016/j.canlet.2007.03.005; Johnson JJ, 2012, CARCINOGENESIS; Kawata H, 2010, PROSTATE, V70, P745, DOI 10.1002/pros.21107; KEYS A, 1986, AM J EPIDEMIOL, V124, P903, DOI 10.1093/oxfordjournals.aje.a114480; Li GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081572; Liu KC, 2012, ENV TOXICOL; Macvicar GR, 2013, CURR OPIN ONCOL; McLaughlin M, 2011, BRIT J PHARMACOL, V162, P328, DOI 10.1111/j.1476-5381.2010.01064.x; Nonn L, 2006, CANCER RES, V66, P4516, DOI 10.1158/0008-5472.CAN-05-3796; Petiwala SM, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00029; Piscopo S, 2009, PUBLIC HEALTH NUTR, V12, P1648, DOI 10.1017/S1368980009990504; Ramaiya A, 2012, CURR DRUG TARGETS, V13, P1698, DOI 10.2174/138945012804545524; Rodriguez-Gonzalez A, 2008, ONCOGENE, V27, P7201, DOI 10.1038/onc.2008.320; Ross RW, 2002, J UROLOGY, V167, P1952, DOI 10.1016/S0022-5347(05)65060-4; SANTEN RJ, 1992, J CLIN ENDOCR METAB, V75, P685, DOI 10.1210/jc.75.3.685; Savarese DM, 2001, J CLIN ONCOL, V19, P2509, DOI 10.1200/JCO.2001.19.9.2509; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Verfaillie T, 2010, CANC LETT; Yannucci J, 2006, J UROLOGY, V176, P520, DOI 10.1016/j.juro.2006.03.057	30	46	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89772	10.1371/journal.pone.0089772	http://dx.doi.org/10.1371/journal.pone.0089772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598693	gold, Green Published, Green Submitted			2022-12-25	WOS:000332479400026
J	Sabouri, S; Matene, E; Vinet, A; Richer, LP; Cardinal, R; Armour, JA; Page, P; Kus, T; Jacquemet, V				Sabouri, Sepideh; Matene, Elhacene; Vinet, Alain; Richer, Louis-Philippe; Cardinal, Rene; Armour, J. Andrew; Page, Pierre; Kus, Teresa; Jacquemet, Vincent			Simultaneous Epicardial and Noncontact Endocardial Mapping of the Canine Right Atrium: Simulation and Experiment	PLOS ONE			English	Article							REPOLARIZATION ALTERNANS; ACTIVATION; FIBRILLATION; TACHYARRHYTHMIAS; CONDUCTION; CATHETER; STIMULATION; PROPAGATION; VALIDATION; KINETICS	Epicardial high-density electrical mapping is a well-established experimental instrument to monitor in vivo the activity of the atria in response to modulations of the autonomic nervous system in sinus rhythm. In regions that are not accessible by epicardial mapping, noncontact endocardial mapping performed through a balloon catheter may provide a more comprehensive description of atrial activity. We developed a computer model of the canine right atrium to compare epicardial and noncontact endocardial mapping. The model was derived from an experiment in which electroanatomical reconstruction, epicardial mapping (103 electrodes), noncontact endocardial mapping (2048 virtual electrodes computed from a 64-channel balloon catheter), and direct-contact endocardial catheter recordings were simultaneously performed in a dog. The recording system was simulated in the computer model. For simulations and experiments (after atrio-ventricular node suppression), activation maps were computed during sinus rhythm. Repolarization was assessed by measuring the area under the atrial T wave (ATa), a marker of repolarization gradients. Results showed an epicardial-endocardial correlation coefficients of 0.80 and 0.63 (two dog experiments) and 0.96 (simulation) between activation times, and a correlation coefficients of 0.57 and 0.46 (two dog experiments) and 0.92 (simulation) between ATa values. Despite distance (balloon-atrial wall) and dimension reduction (64 electrodes), some information about atrial repolarization remained present in noncontact signals.	[Sabouri, Sepideh; Matene, Elhacene; Vinet, Alain; Cardinal, Rene; Kus, Teresa; Jacquemet, Vincent] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Sabouri, Sepideh; Matene, Elhacene; Vinet, Alain; Page, Pierre; Jacquemet, Vincent] Hop Sacre Coeur, Ctr Rech, Montreal, PQ H4J 1C5, Canada; [Richer, Louis-Philippe] Conseil Natl Rech Canada, Montreal, PQ, Canada; [Cardinal, Rene; Kus, Teresa] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Armour, J. Andrew] E Tennessee State Univ, Dept Pharmacol, Johnson City, TN 37614 USA; [Page, Pierre] Univ Montreal, Dept Chirurg, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; National Research Council Canada; Universite de Montreal; East Tennessee State University; Universite de Montreal	Jacquemet, V (corresponding author), Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada.	vincent.jacquemet@umontreal.ca			Heart and Stroke Foundation of Quebec; Natural Sciences and Engineering Research Council of Canada [386647-2010]; Fonds de Recherche du Quebec Sante	Heart and Stroke Foundation of Quebec; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de Recherche du Quebec Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Heart and Stroke Foundation of Quebec (www.heartandstroke.ca), by the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca, grant No 386647-2010) and by the Fonds de Recherche du Quebec Sante (www.frsq.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DJ, 2007, CIRCULATION, V115, P1738, DOI 10.1161/CIRCULATIONAHA.106.633982; Armour JA, 2005, AUTON NEUROSCI-BASIC, V118, P68, DOI 10.1016/j.autneu.2005.01.006; Armour JA, 2004, BASIC CLIN NEUROCARD; Bland M., 2000, INTRO MED STAT, V3rd; Botev ZI, 2010, ANN STAT, V38, P2916, DOI 10.1214/10-AOS799; Buzzard GT, 2008, SIAM J SCI COMPUT, V30, P837, DOI 10.1137/060653378; Cardinal R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P511, DOI 10.1161/CIRCEP.110.938050; Catanchin A, 2010, CLIN CARDIOL, V33, pE19, DOI 10.1002/clc.20421; Chen J, 2003, PACE, V26, P318, DOI 10.1046/j.1460-9592.2003.00041.x; DEMUNCK JC, 1992, IEEE T BIO-MED ENG, V39, P986, DOI 10.1109/10.256433; Dixit S, 2011, J CARDIOVASC ELECTR, V22, P422, DOI 10.1111/j.1540-8167.2010.01917.x; Dube B, 2009, PHYSIOL MEAS, V30, P1303, DOI 10.1088/0967-3334/30/12/002; Earley MJ, 2006, J AM COLL CARDIOL, V48, P485, DOI 10.1016/j.jacc.2006.04.069; Eckstein J, 2013, CIRC-ARRHYTHMIA ELEC, V6, P334, DOI 10.1161/CIRCEP.113.000342; Efimov IR, 2005, AM J PHYSIOL-HEART C, V289, pH977, DOI 10.1152/ajpheart.00456.2005; Everett TH, 2010, HEART RHYTHM, V7, P506, DOI 10.1016/j.hrthm.2009.12.030; Gornick CC, 1999, CIRCULATION, V99, P829, DOI 10.1161/01.CIR.99.6.829; Gulrajani R.M., 1998, BIOELECTRICITY BIOMA; Harley D, 2009, Patent US, Patent No. [7,505,810 B2, 7505810B2]; Herlin A, 2011, CHAOS, V21, DOI 10.1063/1.3670060; Hindricks G, 2001, CIRCULATION, V104, P297, DOI 10.1161/01.CIR.104.3.297; Jacquemet V, 2003, J CARDIOVASC ELECTR, V14, pS172, DOI 10.1046/j.1540.8167.90308.x; Jacquemet Vincent, 2008, IEEE Rev Biomed Eng, V1, P94, DOI 10.1109/RBME.2008.2008242; Jousset F, 2012, J CARDIOVASC ELECTR, V23, P1003, DOI 10.1111/j.1540-8167.2012.02336.x; Juneja R, 2009, CURR SCI INDIA, V97, P416; Kadish A, 1999, CIRCULATION, V99, P1906, DOI 10.1161/01.CIR.99.14.1906; Kawara T, 2001, CIRCULATION, V104, P3069, DOI 10.1161/hc5001.100833; Kneller J, 2002, CIRC RES, V90, pE73, DOI 10.1161/01.RES.0000019783.88094.BA; Krueger MW, 2011, LECT NOTES COMPUT SC, V6666, P223, DOI 10.1007/978-3-642-21028-0_28; Page P, 2006, AUTON NEUROSCI-BASIC, V128, P9, DOI 10.1016/j.autneu.2005.11.006; PAGE PL, 1995, J THORAC CARDIOV SUR, V109, P377, DOI 10.1016/S0022-5223(95)70400-0; Potse M, 2006, IEEE T BIO-MED ENG, V53, P2425, DOI 10.1109/TBME.2006.880875; Pruvot E, 2007, EUROPACE, V9, P83, DOI 10.1093/europace/eum211; Ramirez RJ, 2000, AM J PHYSIOL-HEART C, V279, pH1767, DOI 10.1152/ajpheart.2000.279.4.H1767; Rao LY, 2001, ANN BIOMED ENG, V29, P493, DOI 10.1114/1.1376389; Schilling RJ, 2000, EUR HEART J, V21, P550, DOI 10.1053/euhj.1999.1851; Schilling RJ, 1998, CIRCULATION, V98, P887, DOI 10.1161/01.CIR.98.9.887; Schilling RJ, 2001, J AM COLL CARDIOL, V38, P385, DOI 10.1016/S0735-1097(01)01401-2; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; SCHUESSLER RB, 1993, CIRCULATION, V88, P250, DOI 10.1161/01.CIR.88.1.250; Sharifov OF, 2000, J CARDIOVASC ELECTR, V11, P1029, DOI 10.1111/j.1540-8167.2000.tb00176.x; van Oosterom A, 2012, MED BIOL ENG COMPUT, V50, P1, DOI 10.1007/s11517-011-0837-9; Vigmond EJ, 2009, IEEE T BIO-MED ENG, V56, P1546, DOI 10.1109/TBME.2009.2014740; Vigmond EJ, 2004, HEART RHYTHM, V1, P334, DOI 10.1016/j.hrthm.2004.03.077; Voth E. J., 2005, IJBEM, V7, P191	45	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e91165	10.1371/journal.pone.0091165	http://dx.doi.org/10.1371/journal.pone.0091165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598778	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400157
J	Singh, S; Yang, GJ; Schluns, KS; Anthony, SM; Sastry, KJ				Singh, Shailbala; Yang, Guojun; Schluns, Kimberly S.; Anthony, Scott M.; Sastry, K. Jagannadha			Sublingual Vaccination Induces Mucosal and Systemic Adaptive Immunity for Protection against Lung Tumor Challenge	PLOS ONE			English	Article							KILLER T-CELLS; ANTIGEN IN-VIVO; ALPHA-GALACTOSYLCERAMIDE; NKT CELL; DENDRITIC CELLS; INTRANASAL; ADJUVANT; IMMUNIZATION; ACTIVATION; RESPONSES	Sublingual route offers a safer and more practical approach for delivering vaccines relative to other systemic and mucosal immunization strategies. Here we present evidence demonstrating protection against ovalbumin expressing B16 (B16-OVA) metastatic melanoma lung tumor formation by sublingual vaccination with the model tumor antigen OVA plus synthetic glycolipid alpha-galactosylceramide (aGalCer) for harnessing the adjuvant potential of natural killer T (NKT) cells, which effectively bridge innate and adaptive arms of the immune system. The protective efficacy of immunization with OVA plus aGalCer was antigen-specific as immunized mice challenged with parental B16 tumors lacking OVA expression were not protected. Multiple sublingual immunizations in the presence, but not in the absence of aGalCer, resulted in repeated activation of NKT cells in the draining lymph nodes, spleens, and lungs of immunized animals concurrent with progressively increasing OVA-specific CD8(+) T cell responses as well as serum IgG and vaginal IgA levels. Furthermore, sublingual administration of the antigen only in the presence of the aGalCer adjuvant effectively boosted the OVA-specific immune responses. These results support potential clinical utility of sublingual route of vaccination with aGalCer-for prevention of pulmonary metastases.	[Singh, Shailbala; Yang, Guojun; Schluns, Kimberly S.; Anthony, Scott M.; Sastry, K. Jagannadha] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Schluns, Kimberly S.; Anthony, Scott M.; Sastry, K. Jagannadha] Univ Texas Houston, Grad Sch Biomed Sci Houston, Grad Program Immunol, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Sastry, KJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	jsastry@mdanderson.org	Schluns, Kimberly/R-5635-2019	Sastry, Jagannadha/0000-0002-6987-4422; Anthony, Scott/0000-0002-1590-7401	National Institutes of Health (NIH) [R21 AI078898]; NATIONAL CANCER INSTITUTE [P30CA016672, T32CA009598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078898] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant R21 AI078898. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinis F, 2008, ALLERGY, V63, P1637, DOI 10.1111/j.1398-9995.2008.01742.x; Armstrong ME, 2005, J INFECT DIS, V192, P1628, DOI 10.1086/491739; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Chang DH, 2005, J EXP MED, V201, P1503, DOI 10.1084/jem.20042592; Choi JH, 2012, MOL PHARMACEUT, V9, P156, DOI 10.1021/mp200392g; Courtney AN, 2011, EUR J IMMUNOL, V41, P3312, DOI 10.1002/eji.201041359; Courtney AN, 2009, VACCINE, V27, P3335, DOI 10.1016/j.vaccine.2009.01.083; Cuburu N, 2007, VACCINE, V25, P8598, DOI 10.1016/j.vaccine.2007.09.073; Czerkinsky C, 2011, HUM VACCINES, V7, P110, DOI 10.4161/hv.7.1.13739; Fraser CK, 2010, CANCER BIOL THER, V10, P715, DOI 10.4161/cbt.10.7.12926; Fujihashi K, 2002, VACCINE, V20, P2431, DOI 10.1016/S0264-410X(02)00155-X; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Gonzalez-Aseguinolaza G, 2002, J EXP MED, V195, P617, DOI 10.1084/jem.20011889; Guillonneau C, 2009, P NATL ACAD SCI USA, V106, P3330, DOI 10.1073/pnas.0813309106; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Hervouet C, 2013, MUCOSAL IMMUNOL; Hervouet C, 2010, VACCINE, V28, P5582, DOI 10.1016/j.vaccine.2010.06.033; Hovav AH, 2013, MUCOSAL IMMUNOL; Kamijuku H, 2008, MUCOSAL IMMUNOL, V1, P208, DOI 10.1038/mi.2008.2; Kunii N, 2009, CANCER SCI, V100, P1092, DOI 10.1111/j.1349-7006.2009.01135.x; Kweon MN, 2011, CYTOKINE, V54, P1, DOI 10.1016/j.cyto.2010.12.014; Lemiale F, 2003, J VIROL, V77, P10078, DOI 10.1128/JVI.77.18.10078-10087.2003; Leong SPL, 2006, CANCER METAST REV, V25, P221, DOI 10.1007/s10555-006-8502-8; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Mascarell L, 2009, CLIN EXP ALLERGY, V39, P1910, DOI 10.1111/j.1365-2222.2009.03337.x; Matsuo K, 2011, J CONTROL RELEASE, V152, P310, DOI 10.1016/j.jconrel.2011.03.009; Moon JH, 2012, LARYNGOSCOPE, V122, P2442, DOI 10.1002/lary.23257; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Naz RK, 2012, J REPROD IMMUNOL, V93, P1, DOI 10.1016/j.jri.2011.09.005; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Papamichail M, 2004, CANCER IMMUNOL IMMUN, V53, P176, DOI 10.1007/s00262-003-0478-4; Parekh VV, 2005, J CLIN INVEST, V115, P2572, DOI 10.1172/JCI24762; PATEL JK, 1978, AM J SURG, V135, P807, DOI 10.1016/0002-9610(78)90171-X; Pedersen GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026973; Reilly EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037991; Sandoval F., 2013, SCI TRANSL MED, V5; Seino K, 2004, FRONT BIOSCI-LANDMRK, V9, P2577, DOI 10.2741/1418; Silk JD, 2004, J CLIN INVEST, V114, P1800, DOI 10.1172/JCI200422046; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105; Song JH, 2009, J IMMUNOL, V182, P6851, DOI 10.4049/jimmunol.0803568; Uldrich AP, 2005, J IMMUNOL, V175, P3092, DOI 10.4049/jimmunol.175.5.3092	42	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90001	10.1371/journal.pone.0090001	http://dx.doi.org/10.1371/journal.pone.0090001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599269	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400039
J	Bolivar, W; Antoniazzi, MM; Grant, T; Jared, C				Bolivar-G, Wilmar; Antoniazzi, Marta M.; Grant, Taran; Jared, Carlos			Discovery of a Novel Accessory Structure of the Pitviper Infrared Receptor Organ (Serpentes: Viperidae)	PLOS ONE			English	Article							FACIAL PIT; PHYLOGENY; SNAKES; HEAT	The facial pits of rattlesnakes, copperheads, lanceheads, bushmasters and other American and Asian pitvipers (Crotalinae) are highly innervated and densely vascularized infrared (IR) receptor organs. For over a century, studies have focused on a small sample of model species from North America and Asia. Based on an expanded survey of Central and South American crotalines, we report a conspicuous accessory structure composed of well-defined papillae that project from the anterior orbital adnexa. The papillae are continuous with the inner chamber of the IR receptor organ and our histological and ultrastructural data suggest that they possess a well-developed nervous network and extensive vascularization; however, they lack the characteristic IR-sensitive terminal nerve masses found in the IR-receptive pit membrane. The function of the IR receptor organ papillae is unknown.	[Bolivar-G, Wilmar] Univ Valle, Dept Biol, Programa Posgrad, Cali, Valle Del Cauca, Colombia; [Bolivar-G, Wilmar] Univ Valle, Grp Invest Ecol Anim, Cali, Valle Del Cauca, Colombia; [Antoniazzi, Marta M.; Jared, Carlos] Inst Butantan, Lab Biol Celular, Sao Paulo, Brazil; [Grant, Taran] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil	Universidad del Valle; Universidad del Valle; Instituto Butantan; Universidade de Sao Paulo	Grant, T (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil.	taran.grant@gmail.com; jared@butantan.gov.br	Antoniazzi, Marta/A-3495-2017; Jared, Carlos/D-3299-2012; Antoniazzi, Marta Maria/AAF-1942-2021; Grant, Taran/B-7703-2012; Grant, Taran/ABD-6313-2020	Jared, Carlos/0000-0002-9117-6276; Antoniazzi, Marta Maria/0000-0002-0575-7921; Grant, Taran/0000-0003-1726-999X; Grant, Taran/0000-0003-1726-999X	Programa de Postgrado en Ciencias-Biologia, Departamento de Biologia, Universidad del Valle; Conselho Nacional de Desenvolvimento Cientifico [307029/2009-3, 306529/2010-6, 307001/2011-3]; Instituto Nacional de Ciencia e Tecnologia em Toxinologia; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/10000-5]	Programa de Postgrado en Ciencias-Biologia, Departamento de Biologia, Universidad del Valle; Conselho Nacional de Desenvolvimento Cientifico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia em Toxinologia; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Programa de Postgrado en Ciencias-Biologia, Departamento de Biologia, Universidad del Valle, the Conselho Nacional de Desenvolvimento Cientifico (Proc. 307029/2009-3, 306529/2010-6, 307001/2011-3), the Instituto Nacional de Ciencia e Tecnologia em Toxinologia, and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Proc. 2012/10000-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya F, 1996, ANAT RECORD, V246, P135; Amemiya F, 1999, ANAT RECORD, V254, P107, DOI 10.1002/(SICI)1097-0185(19990101)254:1<107::AID-AR14>3.0.CO;2-Y; Amemiya F, 1995, BIOMED RES-TOKYO, V16, P411, DOI 10.2220/biomedres.16.411; BULLOCK TH, 1957, Q J MICROSC SCI, V98, P219; Carrasco PA, 2012, ZOOL SCR, V41, P109, DOI 10.1111/j.1463-6409.2011.00511.x; Castoe TA, 2006, MOL PHYLOGENET EVOL, V39, P91, DOI 10.1016/j.ympev.2005.12.014; Fenwick AM, 2009, ZOOL J LINN SOC-LOND, V156, P617, DOI 10.1111/j.1096-3642.2008.00495.x; Goris RC, 2007, MICROCIRCULATION, V14, P99, DOI 10.1080/10739680601131184; Goris RC, 2011, J HERPETOL, V45, P2, DOI 10.1670/10-238.1; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Jadin RC, 2011, ZOOL J LINN SOC-LOND, V163, P943, DOI 10.1111/j.1096-3642.2011.00748.x; Junqueira Luiz Carlos U., 1995, Ciencia e Cultura (Sao Paulo), V47, P92; Krochmal AR, 2004, J EXP BIOL, V207, P4231, DOI 10.1242/jeb.01278; Lynn WG, 1931, AM J ANAT, V49, P97, DOI 10.1002/aja.1000490105; NOBLE G. K., 1937, PROC AMER PHIL SOC, V77, P263; Terashima S-I, 1974, PROG NEUROBIOL, V2, P309; TERASHIMA SI, 1970, J ULTRA MOL STRUCT R, V31, P494, DOI 10.1016/S0022-5320(70)90165-6; Wuster W, 2008, MOL PHYLOGENET EVOL, V49, P445, DOI 10.1016/j.ympev.2008.08.019	18	1	1	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90622	10.1371/journal.pone.0090622	http://dx.doi.org/10.1371/journal.pone.0090622			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595025	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500075
J	Giesbrecht, CJ; Thornton, AE; Hall-Patch, C; Maan, EJ; Cote, HCF; Money, DM; Murray, M; Pick, N				Giesbrecht, Chantelle J.; Thornton, Allen E.; Hall-Patch, Clare; Maan, Evelyn J.; Cote, Helene C. F.; Money, Deborah M.; Murray, Melanie; Pick, Neora			Select Neurocognitive Impairment in HIV-Infected Women: Associations with HIV Viral Load, Hepatitis C Virus, and Depression, but Not Leukocyte Telomere Length	PLOS ONE			English	Article							NEUROPSYCHOLOGICAL PERFORMANCE; ANTIRETROVIRAL THERAPY; COGNITIVE FUNCTION; EXECUTIVE FUNCTION; INSTRUMENTAL ACTIVITIES; MEDICATION ADHERENCE; MEMORY PERFORMANCE; PREFRONTAL CORTEX; DECISION-MAKING; T-CELLS	Background: Through implementation of combination antiretroviral therapy (cART) remarkable gains have been achieved in the management of HIV infection; nonetheless, the neurocognitive consequences of infection remain a pivotal concern in the cART era. Research has often employed norm-referenced neuropsychological scores, derived from healthy populations (excluding many seronegative individuals at high risk for HIV infection), to characterize impairments in predominately male HIV-infected populations. Methods: Using matched-group methodology, we assessed 81 HIV-seropositive (HIV+) women with established neuropsychological measures validated for detection of HIV-related impairments, as well as additional detailed tests of executive function and decision-making from the Cambridge Neuropsychological Test Automated Battery (CANTAB). Results: On validated tests, the HIV+ women exhibited impairments that were limited to significantly slower information processing speed when compared with 45 HIV-seronegative (HIV-) women with very similar demographic backgrounds and illness comorbidities. Additionally, select executive impairments in shifting attention (i.e., reversal learning) and in decision-making quality were revealed in HIV+ participants. Modifiers of neurocognition in HIV-infected women included detectable HIV plasma viral load, active hepatitis C virus co-infection, and self-reported depression symptoms. In contrast, leukocyte telomere length (LTL), a marker of cellular aging, did not significantly differ between HIV+ and HIV- women, nor was LTL associated with overall neurocognition in the HIV+ group. Conclusions: The findings suggest that well-managed HIV infection may entail a more circumscribed neurocognitive deficit pattern than that reported in many norm-referenced studies, and that common comorbidities make a secondary contribution to HIV-related neurocognitive impairments.	[Giesbrecht, Chantelle J.; Thornton, Allen E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Giesbrecht, Chantelle J.; Thornton, Allen E.] British Columbia Mental Hlth & Addict Res Inst, Vancouver, BC, Canada; [Hall-Patch, Clare; Maan, Evelyn J.; Money, Deborah M.; Murray, Melanie; Pick, Neora] BC Womens Hosp, Oak Tree Clin, Vancouver, BC, Canada; [Hall-Patch, Clare; Maan, Evelyn J.; Cote, Helene C. F.; Money, Deborah M.; Murray, Melanie; Pick, Neora] CIHR Emerging Team HIV Therapy & Aging CARMA, Vancouver, BC, Canada; [Cote, Helene C. F.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Cote, Helene C. F.; Money, Deborah M.; Murray, Melanie; Pick, Neora] Womens Hlth Res Inst, Vancouver, BC, Canada; [Money, Deborah M.] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada; [Murray, Melanie; Pick, Neora] Univ British Columbia, Div Infect Dis, Vancouver, BC V5Z 1M9, Canada	Simon Fraser University; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Thornton, AE (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.	aethornt@sfu.ca		Thornton, Allen/0000-0002-9942-0122	Canadian Institute of Health Research (CIHR) [Het-85515]; CIHR [218622, YSH-80511, GXSR010]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institute of Health Research (CIHR) Emerging Team Grant (Het-85515 to HCFC and DMM), CIHR Catalyst Grant (218622 to NP), CIHR New Investigator Award (#YSH-80511 to HCFC), and CIHR Doctoral Research Award (GXSR010 to CJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khindi T, 2011, J INT NEUROPSYCH SOC, V17, P956, DOI 10.1017/S1355617711000968; Ances BM, 2012, JAIDS-J ACQ IMM DEF, V59, P469, DOI 10.1097/QAI.0b013e318249db17; Anthony IC, 2005, J NEUROPATH EXP NEUR, V64, P529, DOI 10.1093/jnen/64.6.529; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Becker JT, 2012, NEURORADIOLOGY, V54, P113, DOI 10.1007/s00234-011-0854-2; Bell-McGinty S, 2002, INT J GERIATR PSYCH, V17, P828, DOI 10.1002/gps.646; BENOWITZ NL, 1993, PHARMACOL TOXICOL, V72, P3, DOI 10.1111/j.1600-0773.1993.tb01331.x; Brandt J, 2001, HOPKINS VERBAL LEARN; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Cahn-Weiner Deborah A, 2002, Appl Neuropsychol, V9, P187, DOI 10.1207/S15324826AN0903_8; Carey CL, 2006, J CLIN EXP NEUROPSYC, V28, P536, DOI 10.1080/13803390590949494; Carey CL, 2004, CLIN NEUROPSYCHOL, V18, P234, DOI 10.1080/13854040490501448; Carter AJ, 2013, CAN J INFECT DIS MED, V24, p19A; Cattie JE, 2012, J CLIN EXP NEUROPSYC, V34, P906, DOI 10.1080/13803395.2012.692772; Chang L, 2002, NEUROIMAGE, V17, P1638, DOI 10.1006/nimg.2002.1254; Chang L, 2011, NEUROIMAGE, V58, P1017, DOI 10.1016/j.neuroimage.2011.07.010; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Clifford DB, 2005, AIDS, V19, pS64, DOI 10.1097/01.aids.0000192072.80572.43; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2003, APPL MULTIPLE REGRES, P302; Cote HCF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039266; Dawes S, 2008, J CLIN EXP NEUROPSYC, V30, P613, DOI 10.1080/13803390701565225; Devlin KN, 2012, J INT NEUROPSYCH SOC, V18, P68, DOI 10.1017/S1355617711001408; Durvasula RS, 2006, J CLIN EXP NEUROPSYC, V28, P383, DOI 10.1080/13803390590935408; Durvasula RS, 2001, J CLIN EXP NEUROPSYC, V23, P149, DOI 10.1076/jcen.23.2.149.1211; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; Ellis RJ, 2011, AIDS, V25, P1747, DOI 10.1097/QAD.0b013e32834a40cd; Ettenhofer ML, 2010, NEUROLOGY, V74, P1217, DOI 10.1212/WNL.0b013e3181d8c1ca; Ettenhofer ML, 2009, AM J GERIAT PSYCHIAT, V17, P281, DOI 10.1097/JGP.0b013e31819431bd; Failde-Garrido JM, 2008, PSYCHIAT CLIN NEUROS, V62, P494, DOI 10.1111/j.1440-1819.2008.01841.x; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Fray PJ, 1996, INT J GERIATR PSYCH, V11, P329; Fray PJ, 1996, NEUROTOXICOL TERATOL, V18, P499, DOI 10.1016/0892-0362(96)00027-X; Gatali Marene, 2004, BMC Womens Health, V4 Suppl 1, pS27; Gibbie T, 2006, HIV MED, V7, P112, DOI 10.1111/j.1468-1293.2006.00350.x; Gonzalez R, 2003, J INT NEUROPSYCH SOC, V9, P64, DOI 10.1017/S1355617703910071; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hampshire A, 2006, CEREB CORTEX, V16, P1679, DOI 10.1093/cercor/bhj116; Hardy DJ, 2006, NEUROPSYCHOLOGY, V20, P355, DOI 10.1037/0894-4105.20.3.355; HART RP, 1990, J CLIN EXP NEUROPSYC, V12, P72; Hearps AC, 2012, AIDS, V26, P843, DOI 10.1097/QAD.0b013e328351f756; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; HEDGES LV, 1984, PSYCHOL BULL, V96, P573, DOI 10.1037/0033-2909.96.3.573; Hestad KA, 2012, J NERV MENT DIS, V200, P336, DOI 10.1097/NMD.0b013e31824cc225; Hinkin CH, 2002, J INT NEUROPSYCH SOC, V8, P532, DOI 10.1017/S1355617702814278; Hinkin CH, 2008, J ADDICT DIS, V27, P11, DOI 10.1300/J069v27n02_02; Honig LS, 2006, ANN NEUROL, V60, P181, DOI 10.1002/ana.20894; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; Iudicello JE, 2008, J CLIN EXP NEUROPSYC, V30, P797, DOI 10.1080/13803390701779578; Iudicello JE, 2007, J INT NEUROPSYCH SOC, V13, P183, DOI 10.1017/S1355617707070221; Judd F, 2005, AUST NZ J PSYCHIAT, V39, P826, DOI 10.1111/j.1440-1614.2005.01659.x; Kyo S, 1999, CANCER RES, V59, P5917; Leeson VC, 2009, BIOL PSYCHIAT, V66, P586, DOI 10.1016/j.biopsych.2009.05.016; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Levine AJ, 2007, J CLIN EXP NEUROPSYC, V29, P669, DOI 10.1080/13803390600920471; Llorente AM, 1998, J CLIN EXP NEUROPSYC, V20, P60, DOI 10.1076/jcen.20.1.60.1489; Logie CH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001124; Lopez OL, 1999, EUR J NEUROL, V6, P205, DOI 10.1111/j.1468-1331.1999.tb00014.x; Maki PM, 2009, NEUROLOGY, V72, P1661, DOI 10.1212/WNL.0b013e3181a55f65; Maki PM, 2009, NEUROPSYCHOL REV, V19, P204, DOI 10.1007/s11065-009-9093-2; Malan-Muller S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058351; Manly JJ, 2011, J CLIN EXP NEUROPSYC, V33, P853, DOI 10.1080/13803395.2010.547662; Margolin A, 2002, AIDS PATIENT CARE ST, V16, P255, DOI 10.1089/10872910260066697; Martin EM, 2007, J CLIN EXP NEUROPSYC, V29, P496, DOI 10.1080/13803390600800970; Martin EM, 2004, J INT NEUROPSYCH SOC, V10, P931, DOI 10.1017/S1355617704107054; Martin-Ruiz C, 2006, ANN NEUROL, V60, P174, DOI 10.1002/ana.20869; Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180; Meyer JS, 2005, PSYCHOPHARMACOLOGY D, P276; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Munoz-Moreno JA, 2008, AIDS RES HUM RETROV, V24, P1301, DOI 10.1089/aid.2007.0310; Owsley C, 2002, GERONTOLOGY, V48, P254, DOI 10.1159/000058360; Palmer LD, 1997, J EXP MED, V185, P1381, DOI 10.1084/jem.185.7.1381; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Patel SH, 2002, AM J NEURORADIOL, V23, P543; Pathai S, 2013, AIDS, V27, P2375, DOI 10.1097/QAD.0b013e328363bf7f; Paul R, 2005, J NEUROPSYCH CLIN N, V17, P114, DOI 10.1176/appi.neuropsych.17.1.114; Paul R, 2002, NEUROSCI BIOBEHAV R, V26, P353, DOI 10.1016/S0149-7634(02)00006-4; PEAVY G, 1994, J CLIN EXP NEUROPSYC, V16, P508, DOI 10.1080/01688639408402662; Pommier JP, 1997, VIROLOGY, V231, P148, DOI 10.1006/viro.1997.8512; Potter GG, 2012, INT J GERIATR PSYCH, V27, P1172, DOI 10.1002/gps.3764; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Richardson JL, 2005, AIDS, V19, P1659, DOI 10.1097/01.aids.0000186824.53359.62; Richardson JL, 2002, J INT NEUROPSYCH SOC, V8, P781, DOI 10.1017/S1355617702860064; Rickabaugh TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016459; Robbins TW, 1998, J INT NEUROPSYCH SOC, V4, P474, DOI 10.1017/s1355617798455073; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Shimizu Sheri M, 2011, World J AIDS, V1, P139; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Spronk DB, 2013, NEUROSCI BIOBEHAV R, V37, P1838, DOI 10.1016/j.neubiorev.2013.07.003; Stern RA, 1998, J INT NEUROPSYCH SOC, V4, P172, DOI 10.1017/S1355617798001726; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; Testa R, 2012, ARCH CLIN NEUROPSYCH, V27, P213, DOI 10.1093/arclin/acr112; The Psychological Corporation, 2001, WECHSLER TEST ADULT; Thompson PM, 2005, P NATL ACAD SCI USA, V102, P15647, DOI 10.1073/pnas.0502548102; Towgood KJ, 2012, CORTEX, V48, P230, DOI 10.1016/j.cortex.2011.03.006; Tozzi V, 1999, AIDS, V13, P1889, DOI 10.1097/00002030-199910010-00011; Valdes AM, 2008, NEUROBIOL AGING, P1; Van der Molen MJW, 2012, BRAIN COGNITION, V78, P206, DOI 10.1016/j.bandc.2011.12.008; Vigil O, 2008, J CLIN EXP NEUROPSYC, V30, P805, DOI 10.1080/13803390701802354; Vitiello B, 2007, AIDS, V21, P1415, DOI 10.1097/QAD.0b013e328220e71a; von Zglinicki T, 2000, LAB INVEST, V80, P1739, DOI 10.1038/labinvest.3780184; Wang Xuetao, 2012, AIDS Res Treat, V2012, P560361, DOI 10.1155/2012/560361; Wechsler D., 2008, WAIS 4 ADM SCORING M; Woods SP, 2005, ARCH CLIN NEUROPSYCH, V20, P1061, DOI 10.1016/j.acn.2005.06.007; Yaffe K, 2011, NEUROBIOL AGING, V32, P2055, DOI 10.1016/j.neurobiolaging.2009.12.006; Zanet D L, 2012, CAN J INFECT DIS SA, V23; Zanet DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057787	110	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89556	10.1371/journal.pone.0089556	http://dx.doi.org/10.1371/journal.pone.0089556			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595021	gold, Green Submitted, Green Published			2022-12-25	WOS:000332475500017
J	Skaaby, T; Husemoen, LLN; Thuesen, BH; Pisinger, C; Jorgensen, T; Fenger, RV; Linneberg, A				Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Thuesen, Betina Heinsbaek; Pisinger, Charlotta; Jorgensen, Torben; Fenger, Runa Vavia; Linneberg, Allan			Vitamin D Status and Chronic Obstructive Pulmonary Disease: A Prospective General Population Study	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; 3RD NATIONAL-HEALTH; ACUTE EXACERBATIONS; D LEVEL; BLOOD; RISK; STABILITY	Objectives: Vitamin D deficiency is common among persons with chronic obstructive pulmonary disease (COPD). Whether vitamin D affects the development and deterioration of COPD or is a consequence of the disease lacks clarity. We investigated the association between vitamin D status and prevalent and incident COPD in the general population. Methods: We included a total of 12,041 individuals from three general population studies conducted in 1993-94, 1999-2001, and 2006-2008, respectively, with vitamin D measurements. Information on COPD was obtained from the Danish National Patient Register and The Danish Registry of Causes of Death. Results: There were 85 prevalent and 463 incident cases of COPD (median follow-up 9.7 years). We found a statistically significant inverse association between vitamin D status and prevalent COPD with odds ratio = 0.89 (95% confidence interval, CI: 0.79, 1.0), but no statistically significant association with incident COPD with a hazard ratio = 0.98 (95% CI: 0.94, 1.0), respectively, per 10 nmol/l higher vitamin D status, when adjusted for possible confounders. Conclusions: We found a statistically significant inverse cross-sectional association between vitamin D status and COPD, but no association between vitamin D status and incident COPD.	[Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Thuesen, Betina Heinsbaek; Pisinger, Charlotta; Jorgensen, Torben; Fenger, Runa Vavia; Linneberg, Allan] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, Aalborg, Denmark; [Linneberg, Allan] Glostrup Univ Hosp, Dept Clin Expt Res, Glostrup, Denmark; [Linneberg, Allan] Univ Copenhagen, Dept Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Aalborg University; University of Copenhagen; University of Copenhagen	Skaaby, T (corresponding author), Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark.	tea.skaaby.01@regionh.dk	Jørgensen, Torben/Z-1335-2018	Jorgensen, Torben/0000-0001-9453-2830; Pisinger, Charlotta/0000-0002-7970-3168; Skaaby, Tea/0000-0003-0031-5726; Linneberg, Allan/0000-0002-0994-0184; Thuesen, Betina/0000-0001-9772-4344	Health Insurance Foundation [2010 B 131]; Lundbeck Foundation [R108-2012-10225] Funding Source: researchfish	Health Insurance Foundation; Lundbeck Foundation(Lundbeckfonden)	The present study was financially supported by the Health Insurance Foundation (grant No. 2010 B 131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Andersen TF, 1999, DAN MED BULL, V46, P263; Bender AM, 2012, EUR J PREV CARDIOL; Berg ND, 2012, J ALLERGY CLIN IMMUN, V129, P374, DOI 10.1016/j.jaci.2011.08.045; Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; Carter GD, 2004, CLIN CHEM, V50, P2195, DOI 10.1373/clinchem.2004.040683; Davey Smith G, 2008, ANN MED, V40, P524, DOI 10.1080/07853890802010709; Dobak John, 1994, Journal of Dermatological Science, V8, P18, DOI 10.1016/0923-1811(94)90316-6; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; GOLD, 2011, GLOB STRAT DIAGN MAN; Grant WB, 2012, DERM-ENDOCRINOL, V4, P198, DOI 10.4161/derm.20514; Grant WB, 2011, DERM-ENDOCRINOL, V3, P199, DOI [10.4161/derm.3.3.15364, 10.4161/derm.15364]; Hersoug LG, 2010, RESPIROLOGY, V15, P993, DOI 10.1111/j.1440-1843.2010.01758.x; Holmgaard DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053670; Hoogendoorn M, 2011, EUR RESPIR J, V37, P508, DOI 10.1183/09031936.00043710; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Juel K, 1999, DAN MED BULL, V46, P354; Kunisaki KM, 2012, AM J RESP CRIT CARE, V185, P286, DOI 10.1164/rccm.201109-1644OC; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Nathell L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-89; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; OCKE MC, 1995, J CLIN EPIDEMIOL, V48, P1077, DOI 10.1016/0895-4356(94)00232-F; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Persson LJP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038934; Pfeffer PE, 2012, THORAX, V67, P1018, DOI 10.1136/thoraxjnl-2012-202139; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rasmussen SL, 1998, J HYPERTENS, V16, P1415, DOI 10.1097/00004872-199816100-00004; Romme EA, 2012, ANN MED; Sethi S, 2000, CHEST, V117, p380S, DOI 10.1378/chest.117.5_suppl_2.380S; Skaaby T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052423; Snellman G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011555; Strandhagen E, 2010, EUR J EPIDEMIOL, V25, P163, DOI 10.1007/s10654-010-9427-7; Thomsen RW, 2011, RESP MED, V105, P1063, DOI 10.1016/j.rmed.2011.01.012; Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016; Thyssen JP, 2012, J ALLERGY CLIN IMMUN; Wielders JPM, 2009, CLIN CHEM, V55, P1584, DOI 10.1373/clinchem.2008.117366	39	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90654	10.1371/journal.pone.0090654	http://dx.doi.org/10.1371/journal.pone.0090654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594696	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500083
J	Diaz, P; Wood, AM; Sibley, CP; Greenwood, SL				Diaz, Paula; Wood, Amber M.; Sibley, Colin P.; Greenwood, Susan L.			Intermediate Conductance Ca2+-Activated K+ Channels Modulate Human Placental Trophoblast Syncytialization	PLOS ONE			English	Article							REGULATORY VOLUME DECREASE; HUMAN CHORIONIC-GONADOTROPIN; CYTOTROPHOBLAST CELLS; SYNCYTIN EXPRESSION; INCREASED APOPTOSIS; POTASSIUM CHANNEL; IN-VITRO; DIFFERENTIATION; PROLIFERATION; PREECLAMPSIA	Regulation of human placental syncytiotrophoblast renewal by cytotrophoblast migration, aggregation/fusion and differentiation is essential for successful pregnancy. In several tissues, these events are regulated by intermediate conductance Ca2+-activated K+ channels (IKCa), in part through their ability to regulate cell volume. We used cytotrophoblasts in primary culture to test the hypotheses that IKCa participate in the formation of multinucleated syncytiotrophoblast and in syncytiotrophoblast volume homeostasis. Cytotrophoblasts were isolated from normal term placentas and cultured for 66 h. This preparation recreates syncytiotrophoblast formation in vivo, as mononucleate cells (15 h) fuse into multinucleate syncytia (66 h) concomitant with elevated secretion of human chorionic gonadotropin (hCG). Cells were treated with the IKCa inhibitor TRAM-34 (10 mu M) or activator DCEBIO (100 mu M). Culture medium was collected to measure hCG secretion and cells fixed for immunofluorescence with anti-IKCa and anti-desmoplakin antibodies to assess IKCa expression and multinucleation respectively. K+ channel activity was assessed by measuring Rb-86 efflux at 66 h. IKCa immunostaining was evident in nucleus, cytoplasm and surface of mono- and multinucleate cells. DCEBIO increased Rb-86 efflux 8.3-fold above control and this was inhibited by TRAM-34 (85%; p<0.0001). Cytotrophoblast multinucleation increased 12-fold (p<0.05) and hCG secretion 20-fold (p<0.05), between 15 and 66 h. Compared to controls, DCEBIO reduced multinucleation by 42% (p<0.05) and hCG secretion by 80% (p<0.05). TRAM-34 alone did not affect cytotrophoblast multinucleation or hCG secretion. Hyposmotic solution increased Rb-86 efflux 3.8-fold (p<0.0001). This effect was dependent on extracellular Ca2+, inhibited by TRAM-34 and 100 nM charybdotoxin (85% (p<0.0001) and 43% respectively) but unaffected by 100 nM apamin. In conclusion, IKCa are expressed in cytotrophoblasts and their activation inhibits the formation of multinucleated cells in vitro. IKCa are stimulated by syncytiotrophoblast swelling implicating a role in syncytiotrophoblast volume homeostasis. Inappropriate activation of IKCa in pathophysiological conditions could compromise syncytiotrophoblast turnover and volume homeostasis in pregnancy disease.	[Diaz, Paula; Wood, Amber M.; Sibley, Colin P.; Greenwood, Susan L.] Univ Manchester, Inst Human Dev, Fac Med & Human Sci, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Diaz, Paula; Wood, Amber M.; Sibley, Colin P.; Greenwood, Susan L.] Cent Manchester Univ Hosp Natl Hlth Serv NHS Fdn, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	University of Manchester; University of Manchester	Diaz, P (corresponding author), Univ Manchester, Inst Human Dev, Fac Med & Human Sci, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England.	pdiaztm@gmail.com	DIAZ, PAULA/ABG-5263-2021	DIAZ, PAULA/0000-0003-1479-7340; Greenwood, Susan/0000-0003-2867-4368	CONICYT-Becas Chile Doctoral Scholarship [72090593]; Tommy's the baby charity; Action Medical Research; Medical Research Council [1343194] Funding Source: researchfish	CONICYT-Becas Chile Doctoral Scholarship; Tommy's the baby charity; Action Medical Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	CONICYT-Becas Chile Doctoral Scholarship to Paula Diaz (72090593); Tommy's the baby charity; Action Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire AD, 2000, OBSTET GYNECOL, V96, P271, DOI 10.1016/S0029-7844(00)00895-4; ARNHOLDT H, 1991, VIRCHOWS ARCH B, V60, P365, DOI 10.1007/BF02899568; Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; Bakker WW, 2007, HYPERTENS PREGNANCY, V26, P227, DOI 10.1080/10641950701274896; Barfod ET, 2007, J BIOL CHEM, V282, P8984, DOI 10.1074/jbc.M607730200; Birdsey TJ, 1999, AM J PHYSIOL-REG I, V276, pR1479, DOI 10.1152/ajpregu.1999.276.5.R1479; Brown LM, 2005, HISTOCHEM CELL BIOL, V124, P499, DOI 10.1007/s00418-005-0051-7; Chen Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019257; Cheong A, 2005, MOL CELL, V20, P45, DOI 10.1016/j.molcel.2005.08.030; Clarson LH, 2002, AM J PHYSIOL-REG I, V282, pR1077, DOI 10.1152/ajpregu.00564.2001; Clarson LH, 2001, PLACENTA, V22, P328, DOI 10.1053/plac.2000.0622; Correa RRM, 2008, ARCH GYNECOL OBSTET, V277, P201, DOI 10.1007/s00404-007-0452-z; Correa SAL, 2009, J CELL SCI, V122, P4186, DOI 10.1242/jcs.058420; Crocker IP, 2004, J PATHOL, V204, P11, DOI 10.1002/path.1610; CRONIER L, 1994, ENDOCRINOLOGY, V135, P402, DOI 10.1210/en.135.1.402; Desforges M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.81; DOUGLAS GC, 1990, J CELL SCI, V96, P131; DOUGLAS GC, 1989, J IMMUNOL METHODS, V119, P259, DOI 10.1016/0022-1759(89)90405-5; Fioretti B, 2005, AM J PHYSIOL-CELL PH, V289, pC89, DOI 10.1152/ajpcell.00369.2004; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Gow IF, 2005, BBA-BIOMEMBRANES, V1712, P52, DOI 10.1016/j.bbamem.2005.04.002; Greenwood S, 1993, TROPHOBLAST RES, V7, P53; Grunnet M, 2002, PFLUG ARCH EUR J PHY, V444, P167, DOI 10.1007/s00424-002-0782-4; Higgins L, 2013, J MATERN-FETAL NEO M, V26, P783, DOI 10.3109/14767058.2012.760539; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Huppertz B, 2004, J SOC GYNECOL INVEST, V11, P353, DOI 10.1016/j.jsgi.2004.06.002; Huppertz B, 2002, FET MAT MED REV, V13, P103, DOI [10.1017/S0965539502000220, DOI 10.1017/S0965539502000220]; Huppertz B, 2011, ADV EXP MED BIOL, V713, P81, DOI 10.1007/978-94-007-0763-4_6; Ishihara N, 2002, AM J OBSTET GYNECOL, V186, P158, DOI 10.1067/mob.2002.119176; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Jensen BS, 1998, AM J PHYSIOL-CELL PH, V275, pC848, DOI 10.1152/ajpcell.1998.275.3.C848; Johnstone ED, 2005, BIOL REPROD, V73, P1282, DOI 10.1095/biolreprod.105.044206; Keith JC, 2002, AM J OBSTET GYNECOL, V187, P1122, DOI 10.1067/mob.2002.128512; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lang PA, 2003, AM J PHYSIOL-CELL PH, V285, pC1553, DOI 10.1152/ajpcell.00186.2003; Langbein M, 2008, MOL REPROD DEV, V75, P175, DOI 10.1002/mrd.20729; Lee X, 2001, PLACENTA, V22, P808, DOI 10.1053/plac.2001.0722; Leung DN, 2001, AM J OBSTET GYNECOL, V184, P1249, DOI 10.1067/mob.2001.112906; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; Li XY, 2013, IEEE T VIS COMPUT GR, V19, P344, DOI 10.1109/TVCG.2012.109; Liang Z, 2011, J PHYSIOL-LONDON, V589, P5965, DOI 10.1113/jphysiol.2011.219378; Lim KH, 1997, AM J PATHOL, V151, P1809; Longtine MS, 2012, PLACENTA, V33, P971, DOI 10.1016/j.placenta.2012.09.013; Longtine MS, 2012, REPRODUCTION, V143, P107, DOI 10.1530/REP-11-0340; MARUYAMA Y, 1995, PFLUG ARCH EUR J PHY, V430, P148, DOI 10.1007/BF00373851; Mauro T, 1997, J INVEST DERMATOL, V108, P864, DOI 10.1111/1523-1747.ep12292585; Mayhew TM, 2007, PLACENTA, V28, P233, DOI 10.1016/j.placenta.2006.02.011; Mayhew TM, 2009, J ANAT, V215, P77, DOI 10.1111/j.1469-7580.2008.00994.x; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Miller MJ, 2001, J BIOL CHEM, V276, P27753, DOI 10.1074/jbc.C100221200; Millership JE, 2011, AM J PHYSIOL-CELL PH, V300, pC792, DOI 10.1152/ajpcell.00274.2010; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Redel A, 2008, ANESTH ANALG, V106, P384, DOI 10.1213/ane.0b013e318160650f; Roberts VHJ, 2007, PLACENTA, V28, P270, DOI 10.1016/j.placenta.2006.04.008; ROBERTSON EG, 1972, J OBSTET GYN BR COMM, V79, P769; Sand P, 2004, ACTA PHYSIOL SCAND, V182, P361, DOI 10.1111/j.1365-201X.2004.01366.x; Schwab A, 2006, J CELL PHYSIOL, V206, P86, DOI 10.1002/jcp.20434; SCHWAB A, 1995, PFLUG ARCH EUR J PHY, V430, P802, DOI 10.1007/BF00386179; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; SHI QJ, 1993, ENDOCRINOLOGY, V132, P1387, DOI 10.1210/en.132.3.1387; Siman CM, 2001, AM J PHYSIOL-REG I, V280, pR1116, DOI 10.1152/ajpregu.2001.280.4.R1116; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P1395, DOI 10.1016/S0002-9378(97)70081-4; Tao R, 2008, AM J PHYSIOL-CELL PH, V295, pC1409, DOI 10.1152/ajpcell.00268.2008; van de Put FHMM, 1996, PLACENTA, V17, pA15; Vargas A, 2011, REPROD SCI, V18, P1085, DOI 10.1177/1933719111404608; Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025; Vazquez E, 2001, P NATL ACAD SCI USA, V98, P5329, DOI 10.1073/pnas.091096498; Wang J, 2003, AM J PHYSIOL-CELL PH, V284, pC77, DOI 10.1152/ajpcell.00132.2002; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Weskamp M, 2000, J MEMBRANE BIOL, V178, P11, DOI 10.1007/s002320010010; Williams JLR, 2008, AM J PHYSIOL-REG I, V295, pR1204, DOI 10.1152/ajpregu.00193.2008; Yang M, 2003, ENDOCRINOLOGY, V144, P1108, DOI 10.1210/en.2002-220922	74	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90961	10.1371/journal.pone.0090961	http://dx.doi.org/10.1371/journal.pone.0090961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595308	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900160
J	Mehl, A; Ghorbani, P; Douda, D; Huang, H; Palaniyar, N; Ratjen, F; Grasemann, H				Mehl, Anne; Ghorbani, Peyman; Douda, David; Huang, Hailu; Palaniyar, Nades; Ratjen, Felix; Grasemann, Hartmut			Effect of Arginase Inhibition on Pulmonary L-Arginine Metabolism in Murine Pseudomonas Pneumonia	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; AIRWAY HYPERRESPONSIVENESS; HELICOBACTER-PYLORI; MOUSE MODEL; AERUGINOSA; EXPRESSION; LOCALIZATION; INFECTION	Rationale: Infection of the lung with Pseudomonas aeruginosa results in upregulation of nitric oxide synthases (NOS) and arginase expression, and both enzymes compete for L-arginine as substrate. Nitric oxide (NO) production may be regulated by arginase as it controls L-arginine availability for NOS. We here studied the effect of systemic arginase inhibition on pulmonary L-arginine metabolism in Pseudomonas pneumonia in the mouse. Methods: Mice (C57BL/6, 8-10 weeks old, female) underwent direct tracheal instillation of Pseudomonas (PAO-1)-coated agar beads and were treated by repeated intra-peritoneal injections of the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) or PBS until lungs were harvested on day 3 of the infection. L-arginine metabolites were quantified using liquid chromatography-tandem mass spectrometry, NO metabolites nitrate and nitrite by Griess reagent and cytokines by ELISA. Results: NO metabolite concentrations (48.5 +/- 2.9 vs. 10.9 +/- 2.3 mu M, p<0.0001), as well as L-ornithine (29.6 +/- 1.7 vs 2.3 +/- 0.4 mu M, p<0.0001), the product of arginase activity, were increased in Pseudomonas infected lungs compared to naive controls. Concentrations of the NOS inhibitor asymmetric dimethylarginine (ADMA) were also increased (0.44 +/- 0.02 vs. 0.16 +/- 0.01 mu M, p<0.0001). Arginase inhibition in the infected animals resulted in a significant decrease in L-ornithine (14.6 +/- 1.6 mu M, p<0.0001) but increase in L-arginine concentration (p<0.001), L-arginine/ADMA ratio (p<0.001), L-arginine availability for NOS (p<0.001), and NO metabolite concentrations (67.3 +/- 5.7 mu M, p<0.05). Arginase inhibitor treatment also resulted in an increase in NO metabolite levels in animals following intratracheal injection of LPS (p=0.015). Arginase inhibition was not associated with an increase in inflammatory markers (IFN-gamma, IL-1 beta, IL-6, MIP-2, KC or TNF-alpha) in lung. Concentrations of the L-ornithine-dependent polyamines putrescine, spermidine and spermine were increased in Pseudomonas infected lungs (p<0.001, respectively) but were unaffected by ABH treatment. Conclusions: Systemic arginase inhibition with ABH during Pseudomonas pneumonia in mice results in an increase in pulmonary NO formation but no pro-inflammatory effect.	[Mehl, Anne; Ghorbani, Peyman; Douda, David; Huang, Hailu; Palaniyar, Nades; Ratjen, Felix; Grasemann, Hartmut] Hosp Sick Children, SickKids Res Inst, Program Physiol & Expt Med, Toronto, ON M5G 1X8, Canada; [Mehl, Anne; Ghorbani, Peyman; Douda, David; Huang, Hailu; Palaniyar, Nades; Ratjen, Felix; Grasemann, Hartmut] Univ Toronto, Toronto, ON, Canada; [Mehl, Anne; Ratjen, Felix; Grasemann, Hartmut] Hosp Sick Children, Dept Pediat, Div Resp Med, Toronto, ON M5G 1X8, Canada; [Mehl, Anne] Charite, Dept Pediat Pulmonol & Immunol, D-13353 Berlin, Germany; [Douda, David] Brigham & Womens Hosp, Pulm & Crit Care Med Div, Boston, MA 02115 USA; [Douda, David] Harvard Univ, Sch Med, Boston, MA USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Grasemann, H (corresponding author), Hosp Sick Children, SickKids Res Inst, Program Physiol & Expt Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	hartmut.grasemann@sickkids.ca		Ratjen, Felix/0000-0003-4057-6592; Ghorbani, Peyman/0000-0002-7398-5141; Palaniyar, Nades/0000-0002-2170-8548	Canadian Institute of Health Research [XNO-83101]; Cystic Fibrosis Canada; Lynne and Arnold Irwin Foundation; Canadian Foundation for Innovation (CFI)	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; Lynne and Arnold Irwin Foundation; Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This research was supported by grants from the Canadian Institute of Health Research (XNO-83101), Cystic Fibrosis Canada, and the Lynne and Arnold Irwin Foundation. Mass spectrometry analyses were performed at the Analytical Facility for Bioactive Molecules (AFBM) of the Centre for the Study of Complex Childhood Diseases (CSCCD), the Hospital for Sick Children, Toronto, Ontario. The CSCCD was supported by the Canadian Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belik J, 2008, AM J PHYSIOL-LUNG C, V294, pL498, DOI 10.1152/ajplung.00242.2007; Bussiere FI, 2005, J BIOL CHEM, V280, P2409, DOI 10.1074/jbc.C400498200; BUTTERY LDK, 1994, LAB INVEST, V71, P755; Chaturvedi R, 2012, AMINO ACIDS, V42, P627, DOI 10.1007/s00726-011-1038-4; Douda DN, 2011, J IMMUNOL, V187, P1856, DOI 10.4049/jimmunol.1004201; Dowling RB, 1998, AM J RESP CELL MOL, V19, P950, DOI 10.1165/ajrcmb.19.6.2904; Forte P, 1998, HYPERTENSION, V32, P730, DOI 10.1161/01.HYP.32.4.730; GASTON B, 1994, AM J RESP CRIT CARE, V149, P538, DOI 10.1164/ajrccm.149.2.7508323; Grasemann H, 2013, J CYST FIBROS, V12, P468, DOI 10.1016/j.jcf.2012.12.008; Grasemann H, 2003, AM J RESP CRIT CARE, V167, P1113, DOI 10.1164/rccm.200211-1342OC; Grasemann H, 2012, CURR PHARM DESIGN, V18, P726, DOI 10.2174/138161212799315911; Guilbault C, 2005, LAB ANIM-UK, V39, P336, DOI 10.1258/0023677054306944; Hopkins N, 2006, J PATHOL, V209, P198, DOI 10.1002/path.1963; Kenyon NJ, 2011, PHARMACEUTICALS, V4, P187, DOI 10.3390/ph4010187; Kim JH, 2009, J APPL PHYSIOL, V107, P1249, DOI 10.1152/japplphysiol.91393.2008; Lewis ND, 2010, J IMMUNOL, V184, P2572, DOI 10.4049/jimmunol.0902436; Liu SF, 1997, CRIT CARE MED, V25, P512, DOI 10.1097/00003246-199703000-00022; Maarsingh H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-23; Maarsingh H, 2011, EUR RESPIR J, V38, P318, DOI 10.1183/09031936.00057710; Maarsingh H, 2008, AM J RESP CRIT CARE, V178, P565, DOI 10.1164/rccm.200710-1588OC; Mehl A, 2010, PEDIATR PULM, V33, P134; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; North M.L., 2010, OPEN NITRIC OXIDE J, V2, P20, DOI DOI 10.2174/1875042701002020020; North ML, 2013, AM J RESP CELL MOL, V48, P694, DOI 10.1165/rcmb.2012-0323OC; North ML, 2009, AM J PHYSIOL-LUNG C, V296, pL911, DOI 10.1152/ajplung.00025.2009; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Rackef K., 2010, OPEN NITRIC OXIDE J, V2, P9, DOI [DOI 10.2174/1875042701002020009, 10.2174/1875042701002020009]; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; Scott JA, 2011, AM J RESP CRIT CARE, V184, P779, DOI 10.1164/rccm.201011-1810OC; Shatanawi A, 2011, AM J PHYSIOL-CELL PH, V300, pC1181, DOI 10.1152/ajpcell.00328.2010; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Tang WHW, 2009, J AM COLL CARDIOL, V53, P2061, DOI 10.1016/j.jacc.2009.02.036; Tsai WC, 1997, INFECT IMMUN, V65, P1870, DOI 10.1128/IAI.65.5.1870-1875.1997; Wang-Rosenke Y, 2012, J UROLOGY, V188, P316, DOI 10.1016/j.juro.2012.02.2552; Xu LY, 2003, IMMUNOLOGY, V110, P141, DOI 10.1046/j.1365-2567.2003.01713.x; Yoon SS, 2007, EMBO J, V26, P3662, DOI 10.1038/sj.emboj.7601787; Yu H, 2000, INFECT IMMUN, V68, P2142, DOI 10.1128/IAI.68.4.2142-2147.2000	39	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90232	10.1371/journal.pone.0090232	http://dx.doi.org/10.1371/journal.pone.0090232			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595185	Green Submitted, Green Published, gold			2022-12-25	WOS:000332468900085
J	Reed, CJ; Bushnell, S; Evilia, C				Reed, Christopher J.; Bushnell, Sarah; Evilia, Caryn			Circular Dichroism and Fluorescence Spectroscopy of Cysteinyl-tRNA Synthetase from Halobacterium salinarum ssp NRC-1 Demonstrates that Group I Cations Are Particularly Effective in Providing Structure and Stability to This Halophilic Protein	PLOS ONE			English	Article							AMINO-ACID DISCRIMINATION; STABILIZATION; ADAPTATION; TRYPTOPHAN; AMINOACYLATION; ORIGINS; ENZYMES	Proteins from extremophiles have the ability to fold and remain stable in their extreme environment. Here, we investigate the presence of this effect in the cysteinyl-tRNA synthetase from Halobacterium salinarum ssp. NRC-1 (NRC-1), which was used as a model halophilic protein. The effects of salt on the structure and stability of NRC-1 and of E. coli CysRS were investigated through far-UV circular dichroism (CD) spectroscopy, fluorescence spectroscopy, and thermal denaturation melts. The CD of NRC-1 CysRS was examined in different group I and group II chloride salts to examine the effects of the metal ions. Potassium was observed to have the strongest effect on NRC-1 CysRS structure, with the other group I salts having reduced strength. The group II salts had little effect on the protein. This suggests that the halophilic adaptations in this protein are mediated by potassium. CD and fluorescence spectra showed structural changes taking place in NRC-1 CysRS over the concentration range of 0-3 M KCl, while the structure of E. coli CysRS was relatively unaffected. Salt was also shown to increase the thermal stability of NRC-1 CysRS since the melt temperature of the CysRS from NRC-1 was increased in the presence of high salt, whereas the E. coli enzyme showed a decrease. By characterizing these interactions, this study not only explains the stability of halophilic proteins in extremes of salt, but also helps us to understand why and how group I salts stabilize proteins in general.	[Reed, Christopher J.; Bushnell, Sarah; Evilia, Caryn] Idaho State Univ, Dept Chem, Pocatello, ID 83209 USA	Idaho; Idaho State University	Evilia, C (corresponding author), Idaho State Univ, Dept Chem, Pocatello, ID 83209 USA.	evilcary@isu.edu		Reed, Christopher J/0000-0002-8774-5106	S-STEM program at Idaho State University; National Science Foundation (NSF) [0965939, 0730265]; BS/MS program through the Department of Chemistry at ISU	S-STEM program at Idaho State University; National Science Foundation (NSF)(National Science Foundation (NSF)); BS/MS program through the Department of Chemistry at ISU	C. Reed was supported through the S-STEM program at Idaho State University, which is funded through a grant from the National Science Foundation (NSF # 0965939) and through the BS/MS program through the Department of Chemistry at ISU. Part of this research was funded by a National Science Foundation start-up grant to C. Evilia (NSF #0730265). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADEA MG, 1978, BIOPHYS J, V24, P197, DOI 10.1016/S0006-3495(78)85356-9; Bae E, 2004, J BIOL CHEM, V279, P28202, DOI 10.1074/jbc.M401865200; CHRISTIAN JHB, 1962, BIOCHIM BIOPHYS ACTA, V65, P506, DOI 10.1016/0006-3002(62)90453-5; Ebel C, 1999, BIOCHEMISTRY-US, V38, P9039, DOI 10.1021/bi9900774; Ellis RJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0398; Engel MB, 2005, CELL BIOL INT, V29, P616, DOI 10.1016/j.cellbi.2005.03.024; Evilia C, 2003, RNA, V9, P794, DOI 10.1261/rna.5320603; Evilia C, 2006, BIOCHEMISTRY-US, V45, P6835, DOI 10.1021/bi0521386; Feller G, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/32/323101; Golynskiy MV, 2005, BIOCHEMISTRY-US, V44, P3380, DOI 10.1021/bi0480741; Hauenstein S, 2004, NAT STRUCT MOL BIOL, V11, P1134, DOI 10.1038/nsmb849; Karan Ram, 2012, Aquat Biosyst, V8, P4, DOI 10.1186/2046-9063-8-4; Kumar S, 2004, CHEMBIOCHEM, V5, P280, DOI 10.1002/cbic.200300627; Large AT, 2009, BIOCHEM SOC T, V37, P46, DOI 10.1042/BST0370046; Luke KA, 2007, FEBS J, V274, P4023, DOI 10.1111/j.1742-4658.2007.05955.x; Lund P, 2011, BIOCHEM SOC T, V39, P94, DOI 10.1042/BST0390094; Melo EP, 2001, PROTEINS, V42, P542, DOI 10.1002/1097-0134(20010301)42:4<542::AID-PROT120>3.3.CO;2-W; Mevarech M, 2000, BIOPHYS CHEM, V86, P155, DOI 10.1016/S0301-4622(00)00126-5; Mozo-Villarias A, 2002, J BIOCHEM BIOPH METH, V50, P163, DOI 10.1016/S0165-022X(01)00181-6; Muller-Santos M, 2009, BBA-MOL CELL BIOL L, V1791, P719, DOI 10.1016/j.bbalip.2009.03.006; Muino PL, 2009, J PHYS CHEM B, V113, P2572, DOI 10.1021/jp711513b; Newberry KJ, 2002, EMBO J, V21, P2778, DOI 10.1093/emboj/21.11.2778; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Piette F, 2010, MOL MICROBIOL, V76, P120, DOI 10.1111/j.1365-2958.2010.07084.x; Powers ET, 2013, NAT REV MOL CELL BIO, V14, P237, DOI 10.1038/nrm3542; Quinlan RA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0091; Reed C, 2013, ARCHAEA, V2013, P14; Siglioccolo A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-50; Tannous E, 2012, FEBS OPEN BIO, V2, P345, DOI 10.1016/j.fob.2012.10.003; Taupin CMJ, 1997, EUR J BIOCHEM, V243, P141, DOI 10.1111/j.1432-1033.1997.0141a.x; Tehei M, 2007, FEBS J, V274, P4034, DOI 10.1111/j.1742-4658.2007.05953.x; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Vrbka L, 2006, P NATL ACAD SCI USA, V103, P15440, DOI 10.1073/pnas.0606959103; Yamaguchi R, 2011, APPL MICROBIOL BIOT, V89, P673, DOI 10.1007/s00253-010-2882-y; ZACCAI G, 1989, J MOL BIOL, V208, P491, DOI 10.1016/0022-2836(89)90512-3; Zhang CM, 2003, BIOCHEMISTRY-US, V42, P10931, DOI 10.1021/bi034812u; Zhang CM, 2003, J MOL BIOL, V327, P911, DOI 10.1016/S0022-2836(03)00241-9; Zhang GY, 2013, PROTEIN J, V32, P239, DOI 10.1007/s10930-013-9484-3; Zhang GY, 2013, INT J BIOL MACROMOL, V53, P1, DOI 10.1016/j.ijbiomac.2012.10.031	39	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89452	10.1371/journal.pone.0089452	http://dx.doi.org/10.1371/journal.pone.0089452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594651	gold, Green Submitted, Green Published			2022-12-25	WOS:000332468900016
J	Ibrahim, N; Varricchio, DJ; Sereno, PC; Wilson, JA; Dutheil, DB; Martill, DM; Baidder, L; Zouhri, S				Ibrahim, Nizar; Varricchio, David J.; Sereno, Paul C.; Wilson, Jeff A.; Dutheil, Didier B.; Martill, David M.; Baidder, Lahssen; Zouhri, Samir			Dinosaur Footprints and Other Ichnofauna from the Cretaceous Kem Kem Beds of Morocco	PLOS ONE			English	Article							TRACE FOSSILS; MENISCATE BURROWS; ICHNOGENUS; MOUNTAINS; ICHNOLOGY; TRACKWAYS; DEPOSITS; RECORD; BASIN	We describe an extensive ichnofossil assemblage from the likely Cenomanian-age 'lower' and 'upper' units of the 'Kem Kem beds' in southeastern Morocco. In the lower unit, trace fossils include narrow vertical burrows in cross-bedded sandstones and borings in dinosaur bone, with the latter identified as the insect ichnotaxon Cubiculum ornatus. In the upper unit, several horizons preserve abundant footprints from theropod dinosaurs. Sauropod and ornithischian footprints are much rarer, similar to the record for fossil bone and teeth in the Kem Kem assemblage. The upper unit also preserves a variety of invertebrate traces including Conichnus (the resting trace of a sea-anemone), Scolicia (a gastropod trace), Beaconites (a probable annelid burrow), and subvertical burrows likely created by crabs for residence and detrital feeding on a tidal flat. The ichnofossil assemblage from the Upper Cretaceous Kem Kem beds contributes evidence for a transition from predominantly terrestrial to marine deposition. Body fossil and ichnofossil records together provide a detailed view of faunal diversity and local conditions within a fluvial and deltaic depositional setting on the northwestern coast of Africa toward the end of the Cretaceous.	[Ibrahim, Nizar; Sereno, Paul C.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Varricchio, David J.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Wilson, Jeff A.] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; [Wilson, Jeff A.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Martill, David M.] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England; [Baidder, Lahssen; Zouhri, Samir] Univ Hassan 2, Fac Sci Ain Chock, Lab Geosci, Casablanca, Morocco	University of Chicago; Montana State University System; Montana State University Bozeman; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Portsmouth; Hassan II University of Casablanca	Ibrahim, N (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	nibrahim@uchicago.edu	Zouhri, Samir/T-7894-2019	Zouhri, Samir/0000-0002-3811-9977; Martill, David/0000-0002-3208-5702; Dutheil, Didier/0000-0002-4856-0918; BAIDDER, Lahssen/0000-0001-5318-7102	David and Lucile Packard Foundation; National Geographic Society; Eppley Foundation for Research; University College Dublin Ad Astra Research Scholarship	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Geographic Society(National Geographic Society); Eppley Foundation for Research; University College Dublin Ad Astra Research Scholarship	This research was supported by The David and Lucile Packard Foundation, the National Geographic Society, the Eppley Foundation for Research (PCS) and a University College Dublin Ad Astra Research Scholarship (NI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggi R., 1954, NOTES SERVICE GEOLOG, V10, P43; Amiot Romain, 2004, Revue de Paleobiologie Volume Special, V9, P143; Avanzini M, 2005, ACTA PALAEONTOL POL, V50, P743; Avanzini M, 2012, LETHAIA, V45, P238, DOI 10.1111/j.1502-3931.2011.00276.x; Belvedere M, 2013, PALAEOGEOGR PALAEOCL, V383, P52, DOI 10.1016/j.palaeo.2013.04.026; CARPENTER K, 1984, CAN J EARTH SCI, V21, P1491, DOI 10.1139/e84-154; Cau A, 2012, ACTA PALAEONTOL POL, V57, P661, DOI 10.4202/app.2011.0043; Cau Andrea, 2009, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V150, P239; Cavin L, 2010, J AFR EARTH SCI, V57, P391, DOI 10.1016/j.jafrearsci.2009.12.007; Chamberlain C.K., 1975, STUDY TRACE FOSSILS, P431; CHRISTY JH, 1982, ANIM BEHAV, V30, P687, DOI 10.1016/S0003-3472(82)80139-5; DALESSANDRO A, 1987, PALAEONTOLOGY, V30, P743; Dalla Vecchia Fabio M., 2000, Gaia (Lisboa), V15, P355; de Broin FD, 2002, CR PALEVOL, V1, P275; de Souza Carvalho Ismar, 2004, Ichnos, V11, P311; Dutheil Didier B., 1999, P553; Eisawi AAM, 2011, J AFR EARTH SCI, V61, P233, DOI 10.1016/j.jafrearsci.2011.07.001; Ettachfini EM, 2004, CRETACEOUS RES, V25, P277, DOI [10.1016/j.cretres.2004.01.001, DOI 10.1016/J.CRETRES.2004.01.001]; Ettachfini M, 2008, STRATA SERIE, V2; Ettachfini M, 2005, GEOBIOS, V38, P57; Ezquerra R, 2007, GEOLOGY, V35, P507, DOI 10.1130/G23452A.1; Frey R. W., 1970, GEOL J, V2, P141; FREY RW, 1984, J PALEONTOL, V58, P511; FREY RW, 1981, J PALEONTOL, V55, P800; Gaffney ES, 2006, B AM MUS NAT HIST, P1; Gangloff Roland A., 2004, Ichnos, V11, P299, DOI 10.1080/10420940490442269; Gatesy SM, 1999, NATURE, V399, P141, DOI 10.1038/20167; Goldring R, 2005, CRETACEOUS RES, V26, P665, DOI 10.1016/j.cretres.2005.03.001; Hantzschel W, 1966, TREATISE INVERTEBRAT, VW, P177; Hasiotis S.T., 1992, Short Courses in Paleontology, P64; HASIOTIS S.T, 2002, SEPM SHORT COURSE NO, V51, P1; Hasiotis ST, 2005, ICHNOS, V2, P315; Hembree DI, 2005, J PALEONTOL, V79, P583, DOI 10.1666/0022-3360(2005)079<0583:TENIAI>2.0.CO;2; Ibrahim N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010875; Kennedy WJ, 2008, BULL INST R SC N B-S, V78, P149; Lavocat R., 1954, C GEOLOGIQUE INT ALG, V15, P65; Lavocat R., 1954, NOTES MEM SERV GEOL, V116, P1; Lee YN, 1997, J PALEONTOL, V71, P1147, DOI 10.1017/S0022336000036088; Li RH, 2008, NATURWISSENSCHAFTEN, V95, P185, DOI 10.1007/s00114-007-0310-7; Lockley Martin G., 2004, Ichnos, V11, P285, DOI 10.1080/10420940490428742; Lockley Martin G., 1994, Ichnos, V3, P213; Lockley Martin G., 1998, Modern Geology, V23, P331; Lockley MG, 1992, ASPECTS NONMARINE CR, P269; LOCKLEY MG, 1994, MESOZOIC SYSTEMS ROC, P95; Mahler L, 2005, J VERTEBR PALEONTOL, V25, P236, DOI 10.1671/0272-4634(2005)025[0236:ROADTF]2.0.CO;2; Martill DM, 2011, CRETACEOUS RES, V32, P433, DOI 10.1016/j.cretres.2011.01.005; Marty D, 2010, HIST BIOL, V22, P109, DOI 10.1080/08912960903503345; Masrour Moussa, 2013, Geogaceta, V53, P33; Mazzetta GV, 2001, ACTA PALAEONTOL POL, V46, P235; MCCARTHY B, 1979, J PALEONTOL, V53, P345; McGowan AJ, 2009, GEOLOGY, V37, P843, DOI 10.1130/G30188A.1; Mezga A, 1999, CRETACEOUS RES, V20, P735, DOI 10.1006/cres.1999.0180; Milan Jesper, 2010, Bulletin of the New Mexico Museum of Natural History and Science, V51, P15; Nicosia Umberto, 2007, Ichnos, V14, P69, DOI 10.1080/10420940601006859; Paczesna J, 2010, ACTA GEOL POL, V60, P93; PEMBERTON SG, 1988, CAN J EARTH SCI, V25, P866, DOI 10.1139/e88-085; PEMBERTON SG, 1988, J PALEONTOL, V62, P495; Perez-Lorente F., 2006, Geogaceta, V40, P159; Radley JD, 1998, CRETACEOUS RES, V19, P471, DOI 10.1006/cres.1997.0107; Roberts EM, 2007, J PALEONTOL, V81, P201, DOI 10.1666/0022-3360(2007)81[201:CIBIDB]2.0.CO;2; Russell Dale A., 1996, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V18, P349; Sarjeant WAS, 2008, ICHNOS, V6, P183; Savrda Charles E., 2002, Ichnos, V9, P33, DOI 10.1080/10420940190034058; Sereno PC, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.28.325; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Sidor C. A., 1997, Journal of Vertebrate Paleontology, V17, p76A; Smith JJ, 2008, J PALEONTOL, V82, P267, DOI 10.1666/06-023.1; Snow FH, 1887, T KANSAS ACAD SCI, V10, P3; Souto de PRF, 2010, NEW MEXICO MUSEUM NA, V51, P201; SQUIRES RL, 1984, J PALEONTOL, V58, P593; Sternberg CM, 1932, NATL MUSEUM CAN B, V42, P59; Taquet, 1984, ORME DINOSAURI, P165; Thulborn RA, 1990, DINOSAUR TRACES; TREWIN NH, 1994, PALAEONTOLOGY, V37, P811; VOSSLER SM, 1989, PALAEOGEOGR PALAEOCL, V74, P217, DOI 10.1016/0031-0182(89)90062-X; Wellnhofer Peter, 1999, Palaeontologische Zeitschrift, V73, P133; Whyte Martin A., 1994, Gaia, V10, P15; Wilson JA, 2005, PALEOBIOLOGY, V31, P400, DOI 10.1666/0094-8373(2005)031[0400:IIABFR]2.0.CO;2; Wright JL, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P252; Yabumoto Yoshitaka, 2005, Bulletin of the National Science Museum Series C (Geology & Paleontology), V31, P39; Zouhri S, 2008, CONTINENTAL EVOLUTIO, P331, DOI DOI 10.1007/978-3-540-77076-3_7	81	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90751	10.1371/journal.pone.0090751	http://dx.doi.org/10.1371/journal.pone.0090751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603467	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600080
J	Pallucca, R; Visconti, S; Camoni, L; Cesareni, G; Melino, S; Panni, S; Torreri, P; Aducci, P				Pallucca, Roberta; Visconti, Sabina; Camoni, Lorenzo; Cesareni, Giovanni; Melino, Sonia; Panni, Simona; Torreri, Paola; Aducci, Patrizia			Specificity of epsilon and Non-epsilon Isoforms of Arabidopsis 14-3-3 Proteins Towards the H+-ATPase and Other Targets	PLOS ONE			English	Article							PLANT PLASMA-MEMBRANE; SUCROSE-PHOSPHATE SYNTHASE; CRYSTAL-STRUCTURE; BINDING; PHOSPHORYLATION; 14-3-3-PROTEIN; PEPTIDE; YEAST; ACID; POLYAMINES	14-3-3 proteins are a family of ubiquitous dimeric proteins that modulate many cellular functions in all eukaryotes by interacting with target proteins. 14-3-3s exist as a number of isoforms that in Arabidopsis identifies two major groups named epsilon and non-epsilon. Although isoform specificity has been demonstrated in many systems, the molecular basis for the selection of specific sequence contexts has not been fully clarified. In this study we have investigated isoform specificity by measuring the ability of different Arabidopsis 14-3-3 isoforms to activate the H+-ATPase. We observed that GF14 isoforms of the non-epsilon group were more effective than epsilon group isoforms in the interaction with the H+-ATPase and in the stimulation of its activity. Kinetic and thermodynamic parameters of the binding of GF14 epsilon and GF14 omega isoforms, representative of epsilon and non-epsilon groups respectively, with the H+-ATPase, have been determined by Surface Plasmon Resonance analysis demonstrating that the higher affinity of GF14 omega is mainly due to slower dissociation. The role of the C-terminal region and of a Gly residue located in the loop 8 and conserved in all non-epsilon isoforms has also been studied by deletion and site-specific mutagenesis. The C-terminal domains, despite their high divergence, play an auto-inhibitory role in both isoforms and they, in addition to a specific residue located in the loop 8, contribute to isoform specificity. To investigate the generality of these findings, we have used the SPOT-synthesis technology to array a number of phosphopeptides matching known or predicted 14-3-3 binding sites present in a number of clients. The results of this approach confirmed isoform specificity in the recognition of several target peptides, suggesting that the isoform specificity may have an impact on the modulation of a variety of additional protein activities, as suggested by probing of a phosphopeptide array with members of the two 14-3-3 groups.	[Pallucca, Roberta; Visconti, Sabina; Camoni, Lorenzo; Cesareni, Giovanni; Aducci, Patrizia] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Melino, Sonia] Univ Roma Tor Vergata, Dept Sci & Chem Technol, Rome, Italy; [Panni, Simona] Univ Calabria, Dept DiBEST, I-87036 Arcavacata Di Rende, Italy; [Torreri, Paola] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Cesareni, Giovanni] Res Inst Fdn Santa Lucia, IRCSS, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Calabria; Istituto Superiore di Sanita (ISS); IRCCS Santa Lucia	Visconti, S (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	visconti@uniroma2.it	Cesareni, Gianni/AAW-1382-2020; TORRERI, PAOLA/A-6656-2015	TORRERI, PAOLA/0000-0002-0488-956X; panni, simona/0000-0002-7500-4028; MELINO, SONIA/0000-0001-7694-5279	Regione Lazio, Fondo per lo Sviluppo Economico, la Ricerca e l'Innovazione	Regione Lazio, Fondo per lo Sviluppo Economico, la Ricerca e l'Innovazione	This work has been supported by Regione Lazio, Fondo per lo Sviluppo Economico, la Ricerca e l'Innovazione. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aducci P, 2002, IUBMB LIFE, V53, P49, DOI 10.1080/15216540210813; Alsterfjord M, 2004, PLANT CELL PHYSIOL, V45, P1202, DOI 10.1093/pcp/pch136; Athwal GS, 2002, PLANT J, V29, P119, DOI 10.1046/j.0960-7412.2001.01200.x; Baunsgaard L, 1998, PLANT J, V13, P661, DOI 10.1046/j.1365-313X.1998.00083.x; Bornke F, 2005, J PLANT PHYSIOL, V162, P161, DOI 10.1016/j.jplph.2004.09.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bunney TD, 2001, P NATL ACAD SCI USA, V98, P4249, DOI 10.1073/pnas.061437498; Camoni L, 2000, J BIOL CHEM, V275, P9919, DOI 10.1074/jbc.275.14.9919; Camoni L, 1998, FEBS LETT, V430, P381, DOI 10.1016/S0014-5793(98)00696-6; Camoni L, 2001, J BIOL CHEM, V276, P31709, DOI 10.1074/jbc.M104194200; Camoni L, 2013, IUBMB LIFE, V65, P513, DOI 10.1002/iub.1167; Camoni L, 2012, IUBMB LIFE, V64, P710, DOI 10.1002/iub.1058; Chevalier D, 2009, ANNU REV PLANT BIOL, V60, P67, DOI 10.1146/annurev.arplant.59.032607.092844; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Denison FC, 2011, SEMIN CELL DEV BIOL, V22, P720, DOI 10.1016/j.semcdb.2011.08.006; Duby G, 2009, PFLUG ARCH EUR J PHY, V457, P645, DOI 10.1007/s00424-008-0457-x; FERL RJ, 1994, GENETICA, V92, P129, DOI 10.1007/BF00163762; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Fullone MR, 1998, J BIOL CHEM, V273, P7698, DOI 10.1074/jbc.273.13.7698; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Garufi A, 2007, PLANT CELL PHYSIOL, V48, P434, DOI 10.1093/pcp/pcm010; Harthill JE, 2006, PLANT J, V47, P211, DOI 10.1111/j.1365-313X.2006.02780.x; Huber SC, 2002, PLANT MOL BIOL, V50, P1053, DOI 10.1023/A:1021284002779; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kinoshita T, 2003, PLANT PHYSIOL, V133, P1453, DOI 10.1104/pp.103.029629; Kulma A, 2004, PLANT J, V37, P654, DOI 10.1111/j.1365-313X.2003.01992.x; Lambeck I, 2010, BIOCHEMISTRY-US, V49, P8177, DOI 10.1021/bi1003487; Latz A, 2007, PLANT J, V52, P449, DOI 10.1111/j.1365-313X.2007.03255.x; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; LU GH, 1994, PLANT CELL, V6, P501, DOI 10.1105/tpc.6.4.501; LU GH, 1994, PLANT PHYSIOL, V105, P1459, DOI 10.1104/pp.105.4.1459; Manak MS, 2007, BIOCHEMISTRY-US, V46, P1055, DOI 10.1021/bi061366c; Marra M, 2000, PLANT BIOLOGY, V2, P11, DOI 10.1055/s-2000-9458; Moorhead G, 1999, PLANT J, V18, P1, DOI 10.1046/j.1365-313X.1999.00417.x; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Oecking C, 2009, CURR OPIN PLANT BIOL, V12, P760, DOI 10.1016/j.pbi.2009.08.003; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Panni S, 2011, PROTEOMICS, V11, P128, DOI 10.1002/pmic.201000030; Paul AL, 2005, MOL BIOL CELL, V16, P1735, DOI 10.1091/mbc.E04-09-0839; Paul AL, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00190; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; Rienties IM, 2005, PLANTA, V221, P394, DOI 10.1007/s00425-004-1447-7; Rosenquist M, 2000, J MOL EVOL, V51, P446, DOI 10.1007/s002390010107; Rosenquist M, 2001, PLANT PHYSIOL, V127, P142, DOI 10.1104/pp.127.1.142; Sehnke PC, 2006, PLANT PHYSIOL, V140, P647, DOI 10.1104/pp.105.073916; Sehnke PC, 2000, PLANT PHYSIOL, V122, P235, DOI 10.1104/pp.122.1.235; Sehnke PC, 2002, PLANT MOL BIOL, V50, P1011, DOI 10.1023/A:1021289127519; Sehnke PC, 2001, P NATL ACAD SCI USA, V98, P765, DOI 10.1073/pnas.021304198; Shen W, 2003, PLANT J, V34, P473, DOI 10.1046/j.1365-313X.2003.01739.x; Sinnige MP, 2005, PLANT J, V44, P1001, DOI 10.1111/j.1365-313X.2005.02599.x; Sirichandra C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013935; Sullivan S, 2009, FEBS LETT, V583, P2187, DOI 10.1016/j.febslet.2009.06.011; Toroser D, 1998, FEBS LETT, V435, P110, DOI 10.1016/S0014-5793(98)01048-5; Truong AB, 2002, PROTEINS, V49, P321, DOI 10.1002/prot.10210; Tseng TS, 2012, PLANT CELL, V24, P1114, DOI 10.1105/tpc.111.092130; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341; Visconti S, 2003, J BIOL CHEM, V278, P8172, DOI 10.1074/jbc.M211039200; Visconti S, 2008, PLANT CELL PHYSIOL, V49, P1887, DOI 10.1093/pcp/pcn172; Vysotskii DA, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22672; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	69	38	40	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90764	10.1371/journal.pone.0090764	http://dx.doi.org/10.1371/journal.pone.0090764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603559	Green Submitted, gold, Green Published			2022-12-25	WOS:000332483600083
J	Wu, XD; Liang, HY; Tan, Y; Yuan, C; Li, SJ; Li, XW; Li, GP; Shi, YS; Zhang, XM				Wu, Xidong; Liang, Huiyu; Tan, Yan; Yuan, Chao; Li, Shuji; Li, Xiaowen; Li, Guiping; Shi, Yusheng; Zhang, Xingmei			Cell-SELEX Aptamer for Highly Specific Radionuclide Molecular Imaging of Glioblastoma In Vivo	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EGFRVIII	Glioblastoma (GBM) is the most frequent and aggressive primary adult brain tumor with poor prognosis. Epidermal growth factor receptor variant III (EGFRvIII) is the most common and highly oncogenic EGFR mutant in GBM. With the aim to generate specific molecular probes able to target EGFRvIII with high affinity, we selected four DNA aptamers (U2, U8, U19 and U31) specifically bound to U87-EGFRvIII cells that over expressed EGFRvIII with K-d values in the nanomole range by a cell-based systematic evolution of ligands by exponential enrichment (cell-SELEX) process. U87MG cells were introduced as control cells for counter selection. We further affirmed U2 and U8 identified EGFRvIII on the surface of target cells specifically. Then we radiolabeled U2 with 188Re to serve as a molecular imaging probe and observed 188Re -labeled U2 significantly targeted EGFRvIII over-expressing glioblastoma exnografts in mice. In conclusion, aptamers obtained from whole cell-SELEX strategy have great potential as molecular imaging probes that are probably beneficial to GBM diagnoses.	[Wu, Xidong; Liang, Huiyu; Tan, Yan; Li, Shuji; Li, Xiaowen; Zhang, Xingmei] Southern Med Univ, Sch Basic Med Sci, Dept Neurobiol, Guangzhou, Guangdong, Peoples R China; [Yuan, Chao] Southern Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Li, Guiping] Southern Med Univ, Nanfang Hosp, Dept Nucl Med, Guangzhou, Guangdong, Peoples R China; [Shi, Yusheng] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Shi, YS (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China.	390637670@qq.com; zxmray@hotmail.com		zhang, xingmei/0000-0001-9548-1289	National Science Foundation of China [30973481, 81272509]; Guangdong Natural Science Foundation [9151051501000053, 07005145]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from the National Science Foundation of China (No. 30973481 and No. 81272509) and the Guangdong Natural Science Foundation (No. 9151051501000053 and No. 07005145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyrou Maria, 2013, Int J Mol Imaging, V2013, P290750, DOI 10.1155/2013/290750; Boockvar JA, 2003, MOL CELL NEUROSCI, V24, P1116, DOI 10.1016/j.mcn.2003.09.011; Cheng Y, 2013, ADV DRUG DELIV REV; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Da Pieve C, 2009, NUCL MED BIOL, V36, P703, DOI 10.1016/j.nucmedbio.2009.04.004; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Gan HK, 2013, FEBS J, V280, P5350, DOI 10.1111/febs.12393; Gomes SD, 2012, BIOCONJUGATE CHEM, V23, P2192, DOI 10.1021/bc300146c; Hicke BJ, 2006, J NUCL MED, V47, P668; Hosseinimehr SJ, 2012, DRUG DISCOV TODAY, V17, P1224, DOI 10.1016/j.drudis.2012.07.002; Jeong JM, 2008, SEMIN NUCL MED, V38, pS19, DOI 10.1053/j.semnuclmed.2007.10.003; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Lambert B, 2005, J NUCL MED, V46, P60; Lambert B, 2009, Q J NUCL MED MOL IM, V53, P305; Lepareur Nicolas, 2012, Int J Mol Imaging, V2012, P278306, DOI 10.1155/2012/278306; MANKOFF DA, 2007, J NUCL MED, V48; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; Ramnarain DB, 2006, CANCER RES, V66, P867, DOI 10.1158/0008-5472.CAN-05-2753; Sefah K, 2010, NAT PROTOC, V5, P1169, DOI 10.1038/nprot.2010.66; Shi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070476; Shi H, 2010, CHEM-ASIAN J, V5, P2209, DOI 10.1002/asia.201000242; Tao F, 2010, DRUG DEVELOP RES, V71, P99, DOI 10.1002/ddr.20331; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Varmira K, 2013, J DRUG TARGET; Wykosky Jill, 2011, Chin J Cancer, V30, P5; Zhan Y, 2004, CANCER RES, V64, P8292, DOI 10.1158/0008-5472.CAN-03-3143	26	46	50	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90752	10.1371/journal.pone.0090752	http://dx.doi.org/10.1371/journal.pone.0090752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603483	Green Submitted, Green Published, gold			2022-12-25	WOS:000332483600081
J	Jamal, S; Cheriyan, VT; Muthu, M; Munie, S; Levi, E; Ashour, AE; Pass, HI; Wali, A; Singh, M; Rishi, AK				Jamal, Shazia; Cheriyan, Vino T.; Muthu, Magesh; Munie, Sara; Levi, Edi; Ashour, Abdelkader E.; Pass, Harvey I.; Wali, Anil; Singh, Mandip; Rishi, Arun K.			CARP-1 Functional Mimetics Are a Novel Class of Small Molecule Inhibitors of Malignant Pleural Mesothelioma Cells	PLOS ONE			English	Article							NF-KAPPA-B; APOPTOSIS-REGULATORY PROTEIN-1; ANAPHASE-PROMOTING COMPLEX; DNA-DAMAGE; CANCER CELLS; DEATH DOMAIN; IN-VITRO; RECEPTOR; PODOPLANIN; TRAIL	Malignant pleural mesothelioma (MPM) is an asbestos-related thoracic malignancy that is characterized by late metastases, and resistance to therapeutic modalities. The toxic side-effects of MPM therapies often limit their clinical effectiveness, thus necessitating development of new agents to effectively treat and manage this disease in clinic. CARP-1 functional mimetics (CFMs) are a novel class of compounds that inhibit growth of diverse cancer cell types. Here we investigated MPM cell growth suppression by the CFMs and the molecular mechanisms involved. CFM-1, -4, and -5 inhibited MPM cell growth, in vitro, in part by stimulating apoptosis. Apoptosis by CFM-4 involved activation of pro-apoptotic stress-activated protein kinases (SAPKs) p38 and JNK, elevated CARP-1 expression, cleavage of PARP1, and loss of the oncogene c-myc as well as mitotic cyclin B1. Treatments of MPM cells with CFM-4 resulted in depletion of NF-kappa B signaling inhibitor ABIN1 and Inhibitory kappa B (I kappa B) alpha and beta, while increasing expression of pro-apoptotic death receptor (DR) 4 protein. CFM-4 enhanced expression of serine-phosphorylated podoplanin and cleavage of vimetin. CFMs also attenuated biological properties of the MPM cells by blocking their abilities to migrate, form colonies in suspension, and invade through the matrix-coated membranes. Both podoplanin and vimentin regulate processes of cell motility and invasion, and their expression often correlates with metastatic disease, and poor prognosis. The fact that phosphorylation of serines in the cytoplasmic domain of podoplanin interferes with processes of cellular motility, CFM-4-dependent elevated phosphorylated podoplanin and cleavage of vimentin underscore a metastasis inhibitory property of these compounds, and suggest that CFMs and/or their future analogs have potential as anti-MPM agents.	[Jamal, Shazia; Cheriyan, Vino T.; Muthu, Magesh; Munie, Sara; Levi, Edi; Wali, Anil; Rishi, Arun K.] Wayne State Univ, John D Dingell VA Med Ctr, Detroit, MI 48202 USA; [Wali, Anil; Rishi, Arun K.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Jamal, Shazia; Cheriyan, Vino T.; Muthu, Magesh; Munie, Sara; Rishi, Arun K.] Wayne State Univ, Dept Oncol, Detroit, MI USA; [Levi, Edi] Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA; [Ashour, Abdelkader E.] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia; [Pass, Harvey I.] NYU, Ctr Canc, Div Cardiothorac Surg, New York, NY USA; [Singh, Mandip] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; King Saud University; New York University; State University System of Florida; Florida A&M University	Rishi, AK (corresponding author), Wayne State Univ, John D Dingell VA Med Ctr, Detroit, MI 48202 USA.	Rishia@Karmanos.org	Ashour, Abdelkader/ABH-8235-2020; muthu, magesh/N-6987-2017	Ashour, Abdelkader/0000-0003-3978-8045; muthu, magesh/0000-0003-3311-8120; jamal, shazia/0000-0003-4555-9513; Pass, Harvey/0000-0003-3222-3471; Levi, Edi/0000-0003-1809-2866	Department of Veterans Affairs Merit Review grant; NCI/NIH Cancer Center Support Grant; National Plan of Science, Technology and Innovation, King Saud University, Riyadh, Saudi Arabia [MED-1768-02]	Department of Veterans Affairs Merit Review grant(US Department of Veterans Affairs); NCI/NIH Cancer Center Support Grant; National Plan of Science, Technology and Innovation, King Saud University, Riyadh, Saudi Arabia	This work was supported by the Department of Veterans Affairs Merit Review grant (AKR), the NCI/NIH Cancer Center Support Grant to Karmanos Cancer Institute, Detroit, Michigan, and a grant from the National Plan of Science, Technology and Innovation, King Saud University, Riyadh, Saudi Arabia (Grant No. MED-1768-02; AEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2013, J IMMUNOL, V190, P6239, DOI 10.4049/jimmunol.1300448; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Ashour AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066733; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Berger R, 2011, MOL CANCER THER, V10, P1867, DOI 10.1158/1535-7163.MCT-11-0218; Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Fennell DA, 2008, NAT CLIN PRACT ONCOL, V5, P136, DOI 10.1038/ncponc1039; Gilles C, 1999, J CELL SCI, V112, P4615; Hendrix MJC, 1997, AM J PATHOL, V150, P483; Hoshino A, 2011, CANCER RES, V71, P4769, DOI 10.1158/0008-5472.CAN-10-3228; Jiang Yan, 2010, J Mol Signal, V5, P7, DOI 10.1186/1750-2187-5-7; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kamp DW, 2009, TRANSL RES, V153, P143, DOI 10.1016/j.trsl.2009.01.004; Karl S, 2009, J CELL MOL MED, V13, P4239, DOI 10.1111/j.1582-4934.2009.00888.x; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Kimura N, 2005, PATHOL INT, V55, P83, DOI 10.1111/j.1440-1827.2005.01791.x; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Krishnan H, 2013, J BIOL CHEM, V288, P12215, DOI 10.1074/jbc.C112.446823; Kunita A, 2007, AM J PATHOL, V170, P1337, DOI 10.2353/ajpath.2007.060790; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lang SH, 2002, PROSTATE, V52, P253, DOI 10.1002/pros.10088; Lehman NL, 2007, AM J PATHOL, V170, P1793, DOI 10.2353/ajpath.2007.060767; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Liu WK, 2004, BIOCHEM J, V378, P867, DOI 10.1042/BJ20031736; Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2; Martin-Villar E, 2010, MOL BIOL CELL, V21, P4387, DOI 10.1091/mbc.E10-06-0489; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Okada M, 2001, CANCER RES, V61, P6201; PASS HI, 1995, ANN THORAC SURG, V59, P835, DOI 10.1016/0003-4975(95)00045-M; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; Puliyappadamba VT, 2011, J BIOL CHEM, V286, P38000, DOI 10.1074/jbc.M111.222398; Ravi R, 2004, CANCER RES, V64, P9105, DOI 10.1158/0008-5472.CAN-04-2488; Rieser E, 2013, TRENDS BIOCHEM SCI, V38, P94, DOI 10.1016/j.tibs.2012.11.007; Rishi AK, 2006, J BIOL CHEM, V281, P13188, DOI 10.1074/jbc.M512279200; Rishi AK, 2003, J BIOL CHEM, V278, P33422, DOI 10.1074/jbc.M303173200; Schwenger P, 1998, MOL CELL BIOL, V18, P78, DOI 10.1128/MCB.18.1.78; Singh S, 2003, CANCER RES, V63, P2306; Su S, 2009, SEMIN THORAC CARDIOV, V21, P125, DOI 10.1053/j.semtcvs.2009.07.006; Tan JL, 2009, APOPTOSIS, V14, P764, DOI 10.1007/s10495-009-0345-7; Van TT, 2011, CANCER CHEMOTH PHARM, V68, P497, DOI 10.1007/s00280-010-1503-x; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; Verstrepen L, 2009, BIOCHEM PHARMACOL, V78, P105, DOI 10.1016/j.bcp.2009.02.009; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Yang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041214; Yuan BZ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-140; Yuan P, 2006, CANCER, V107, P563, DOI 10.1002/cncr.22061; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang LY, 2007, MOL CANCER THER, V6, P1661, DOI 10.1158/1535-7163.MCT-06-0653	57	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89146	10.1371/journal.pone.0089146	http://dx.doi.org/10.1371/journal.pone.0089146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598827	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400009
J	Naoumkina, M; Thyssen, G; Fang, DD; Hinchliffe, DJ; Florane, C; Yeater, KM; Page, JT; Udall, JA				Naoumkina, Marina; Thyssen, Gregory; Fang, David D.; Hinchliffe, Doug J.; Florane, Christopher; Yeater, Kathleen M.; Page, Justin T.; Udall, Joshua A.			The Li-2 Mutation Results in Reduced Subgenome Expression Bias in Elongating Fibers of Allotetraploid Cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							DUPLICATE GENE-EXPRESSION; PLANT-GROWTH SUBSTANCES; LIGON LINTLESS-2 MUTANT; IN-VITRO; TRANSCRIPTION FACTORS; CELL ELONGATION; RNA-SEQ; XYLOGLUCAN; EVOLUTION; LINKAGE	Next generation sequencing (RNA-seq) technology was used to evaluate the effects of the Ligon lintless-2 (Li-2) short fiber mutation on transcriptomes of both subgenomes of allotetraploid cotton (Gossypium hirsutum L.) as compared to its near-isogenic wild type. Sequencing was performed on 4 libraries from developing fibers of Li-2 mutant and wild type near-isogenic lines at the peak of elongation followed by mapping and PolyCat categorization of RNA-seq data to the reference D-5 genome (G. raimondii) for homeologous gene expression analysis. The majority of homeologous genes, 83.6% according to the reference genome, were expressed during fiber elongation. Our results revealed: 1) approximately two times more genes were induced in the A(T) subgenome comparing to the D-T subgenome in wild type and mutant fiber; 2) the subgenome expression bias was significantly reduced in the Li-2 fiber transcriptome; 3) Li-2 had a significantly greater effect on the D-T than on the A(T) subgenome. Transcriptional regulators and cell wall homeologous genes significantly affected by the Li-2 mutation were reviewed in detail. This is the first report to explore the effects of a single mutation on homeologous gene expression in allotetraploid cotton. These results provide deeper insights into the evolution of allotetraploid cotton gene expression and cotton fiber development.	[Naoumkina, Marina; Thyssen, Gregory; Fang, David D.; Florane, Christopher] USDA ARS, Cotton Fiber Biosci Res Unit, So Reg Res Ctr, New Orleans, LA USA; [Hinchliffe, Doug J.] USDA ARS, Cotton Chem & Utilizat Res Unit, So Reg Res Ctr, New Orleans, LA USA; [Yeater, Kathleen M.] USDA ARS, Southern Plains Area, College Stn, TX USA; [Page, Justin T.; Udall, Joshua A.] Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Brigham Young University	Naoumkina, M (corresponding author), USDA ARS, Cotton Fiber Biosci Res Unit, So Reg Res Ctr, New Orleans, LA USA.	marina.naoumkina@ars.usda.gov	Udall, Joshua A/A-7298-2009; FANG, DAVID/AAV-5774-2020	Udall, Joshua A/0000-0003-0978-4764; FANG, DAVID/0000-0003-0036-5459	United States Department of Agriculture-Agricultural Research Service [6435-21000-017-00D, 58-6435-2-663]	United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded by United States Department of Agriculture-Agricultural Research Service project number 6435-21000-017-00D and Cotton Incorporated project number 58-6435-2-663. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; BEASLEY CA, 1974, AM J BOT, V61, P188, DOI 10.2307/2441189; BEASLEY CA, 1973, AM J BOT, V60, P130, DOI 10.2307/2441099; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brubaker CL, 1999, GENOME, V42, P184, DOI 10.1139/gen-42-2-184; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chaudhary B, 2009, GENETICS, V182, P503, DOI 10.1534/genetics.109.102608; Chee Peng W., 2009, V3, P283, DOI 10.1007/978-0-387-70810-2_12; Cosgrove DJ, 2001, PLANT PHYSIOL, V125, P131, DOI 10.1104/pp.125.1.131; Dong SW, 2011, NEW PHYTOL, V190, P1045, DOI 10.1111/j.1469-8137.2011.03650.x; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Drenkard E, 2000, PLANT PHYSIOL, V124, P1483, DOI 10.1104/pp.124.4.1483; Flagel L, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-16; Flagel LE, 2010, NEW PHYTOL, V186, P184, DOI 10.1111/j.1469-8137.2009.03107.x; Friedrichsen DM, 2002, GENETICS, V162, P1445; FRY SC, 1992, BIOCHEM J, V282, P821, DOI 10.1042/bj2820821; Gilbert MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075268; Grover CE, 2004, GENOME RES, V14, P1474, DOI 10.1101/gr.2673204; Ha M, 2009, P NATL ACAD SCI USA, V106, P17835, DOI 10.1073/pnas.0907003106; HAYASHI T, 1988, CARBOHYD RES, V181, P273, DOI 10.1016/0008-6215(88)84047-3; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Hinchliffe DJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-445; Hovav R, 2008, P NATL ACAD SCI USA, V105, P6191, DOI 10.1073/pnas.0711569105; HUWYLER HR, 1979, PLANTA, V146, P635, DOI 10.1007/BF00388844; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kohel RJ, 2001, EUPHYTICA, V121, P163, DOI 10.1023/A:1012263413418; KOHEL RJ, 1992, CROP SCI, V32, P733, DOI 10.2135/cropsci1992.0011183X003200030031x; Kohel RJ, 2002, J HERED, V93, P130, DOI 10.1093/jhered/93.2.130; Kohno M, 2012, MOL BIOL REP, V39, P911, DOI 10.1007/s11033-011-0816-0; Lacape JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048855; Lee C, 2012, PLANT CELL PHYSIOL, V53, P135, DOI 10.1093/pcp/pcr158; Lee J, 2010, PLANTA, V232, P1191, DOI 10.1007/s00425-010-1246-2; Lee KJD, 2005, PLANT CELL, V17, P3051, DOI 10.1105/tpc.105.034413; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; Madson M, 2003, PLANT CELL, V15, P1662, DOI 10.1105/tpc.009837; Mei M, 2004, THEOR APPL GENET, V108, P280, DOI 10.1007/s00122-003-1433-7; Naoumkina M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-155; NARBUTH EV, 1990, J HERED, V81, P131; NISHITANI K, 1992, J BIOL CHEM, V267, P21058; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Page JT, 2013, G3-GENES GENOM GENET, V3, P517, DOI 10.1534/g3.112.005298; Papuga J, 2010, PLANT CELL, V22, P3034, DOI 10.1105/tpc.110.075960; Park YW, 2004, FEBS LETT, V564, P183, DOI 10.1016/S0014-5793(04)00346-1; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rong JK, 2005, THEOR APPL GENET, V111, P1137, DOI 10.1007/s00122-005-0041-0; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Shimizu Y, 1997, PLANT CELL PHYSIOL, V38, P375, DOI 10.1093/oxfordjournals.pcp.a029178; Takeda T, 2002, P NATL ACAD SCI USA, V99, P9055, DOI 10.1073/pnas.132080299; Taliercio EW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-22; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Ulloa M, 2005, J HERED, V96, P132, DOI 10.1093/jhered/esi020; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yang J, 2007, PLANTA, V226, P169, DOI 10.1007/s00425-007-0478-2; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; Yoo MJ, 2013, HEREDITY, V110, P171, DOI 10.1038/hdy.2012.94	62	21	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90830	10.1371/journal.pone.0090830	http://dx.doi.org/10.1371/journal.pone.0090830			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598808	Green Submitted, Green Published, gold			2022-12-25	WOS:000332479400139
J	Painer, J; Jewgenow, K; Dehnhard, M; Arnemo, JM; Linnell, JDC; Odden, J; Hildebrandt, TB; Goeritz, F				Painer, Johanna; Jewgenow, Katarina; Dehnhard, Martin; Arnemo, Jon M.; Linnell, John D. C.; Odden, John; Hildebrandt, Thomas B.; Goeritz, Frank			Physiologically Persistent Corpora lutea in Eurasian Lynx (Lynx lynx) - Longitudinal Ultrasound and Endocrine Examinations Intra-Vitam	PLOS ONE			English	Article							OVARIAN; CAT; PSEUDOPREGNANCY; MAINTENANCE; MORTALITY; EVOLUTION; PREGNANCY; PHENOLOGY; PATTERNS; RATES	Felids generally follow a poly-estrous reproductive strategy. Eurasian lynx (Lynx lynx) display a different pattern of reproductive cyclicity where physiologically persistent corpora lutea (CLs) induce a mono-estrous condition which results in highly seasonal reproduction. The present study was based around a sono-morphological and endocrine study of captive Eurasian lynx, and a control-study on free-ranging lynx. We verified that CLs persist after pregnancy and pseudo-pregnancy for at least a two-year period. We could show that lynx are able to enter estrus in the following year, while CLs from the previous years persisted in structure and only temporarily reduced their function for the period of estrus onset or birth, which is unique among felids. The almost constant luteal progesterone secretion (average of 5 ng/ml serum) seems to prevent folliculogenesis outside the breeding season and has converted a poly-estrous general felid cycle into a mono-estrous cycle specific for lynx. The hormonal regulation mechanism which causes lynx to have the longest CL lifespan amongst mammals remains unclear. The described non-felid like ovarian physiology appears to be a remarkably non-plastic system. The lynx's reproductive ability to adapt to environmental and anthropogenic changes needs further investigation.	[Painer, Johanna; Jewgenow, Katarina; Dehnhard, Martin; Hildebrandt, Thomas B.; Goeritz, Frank] Forsch Verbund Berlin eV, Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management & Reprod Biol, Berlin, Germany; [Arnemo, Jon M.] Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Dept Forestry & Wildlife Management, Elverum, Norway; [Arnemo, Jon M.] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, Fac Forest Sci, S-90183 Umea, Sweden; [Linnell, John D. C.; Odden, John] Norwegian Inst Nat Res, N-7004 Trondheim, Norway	Leibniz Institut fur Zoo und Wildtierforschung; Inland Norway University of Applied Sciences; Swedish University of Agricultural Sciences; Norwegian Institute Nature Research	Painer, J (corresponding author), Forsch Verbund Berlin eV, Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management & Reprod Biol, Berlin, Germany.	painer@izw-berlin.de	Odden, John/F-6088-2019; Linnell, John/V-4177-2019	Odden, John/0000-0002-6275-8648; Linnell, John/0000-0002-8370-5633; Jewgenow, Katarina/0000-0002-6173-840X; Painer - Gigler, Johanna/0000-0003-3929-511X	German ministry of education and research [BMBF 033L046]; Norwegian Research Council; Norwegian Directorate for Nature Management (DN); Nature Protection Division of the County Governor's Office for Troms and Finnmark; Regional Management Board of Region 8	German ministry of education and research(Federal Ministry of Education & Research (BMBF)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Directorate for Nature Management (DN); Nature Protection Division of the County Governor's Office for Troms and Finnmark; Regional Management Board of Region 8	The study on the captive population was funded by the German ministry of education and research (BMBF 033L046). Scandlynx is supported by the Norwegian Research Council, the Norwegian Directorate for Nature Management (DN), the Nature Protection Division of the County Governor's Office for Troms and Finnmark, and the Regional Management Board of Region 8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren H, 2006, BIOL CONSERV, V131, P23, DOI 10.1016/j.biocon.2006.01.025; [Anonymous], 2010, R LANG ENV STAT COMP; Apps Clayton D., 2000, P351; Arnemo J. M., 2012, BIOMEDICAL PROTOCOLS; Arnemo JM, 2006, WILDLIFE BIOL, V12, P109, DOI 10.2981/0909-6396(2006)12[109:ROCMIL]2.0.CO;2; BANKS DR, 1983, BIOL REPROD, V28, P923, DOI 10.1095/biolreprod28.4.923; Bischof R, 2012, J APPL ECOL, V49, P824, DOI 10.1111/j.1365-2664.2012.02167.x; Brown JL, 2011, ANIM REPROD SCI, V124, P155, DOI 10.1016/j.anireprosci.2010.08.024; Carnaby K, 2012, REPRODUCTION, V144, P477, DOI 10.1530/REP-12-0166; Crowe D.M., 1977, Proceedings of the Great Plains Wildlife Damage Control Workshop, V3, P40; DAWSON AB, 1946, ANAT REC, V95, P29, DOI 10.1002/ar.1090950105; Dehnhard M, 2010, GEN COMP ENDOCR, V167, P287, DOI 10.1016/j.ygcen.2010.03.023; Drews B, 2008, THERIOGENOLOGY, V69, P1120, DOI 10.1016/j.theriogenology.2008.01.026; Dupre SM, 2011, NEUROENDOCRINOLOGY, V94, P101, DOI 10.1159/000328971; Fanson KV, 2010, GEN COMP ENDOCR, V169, P217, DOI 10.1016/j.ygcen.2010.09.003; Ferguson SH, 2006, OIKOS, V114, P249; Finkenwirth C, 2010, THERIOGENOLOGY, V73, P530, DOI 10.1016/j.theriogenology.2009.10.008; Goeritz F, 2012, REPROD DOMEST ANIM, V47, P156, DOI 10.1111/rda.12026; Goritz F, 2009, REPROD DOMEST ANIM, V44, P87, DOI 10.1111/j.1439-0531.2009.01380.x; Goeritz Frank, 2009, P366; Hayssen V, 1993, ASDELLS PATTERN MAMM; Henriksen HB, 2005, EUR J WILDLIFE RES, V51, P151, DOI 10.1007/s10344-005-0104-1; Hermes R, 2000, ACTA THERIOL, V45, P559, DOI 10.4098/AT.arch.00-54; Jewgenow K, 2012, REPROD DOMEST ANIM, V47, P25, DOI 10.1111/rda.12033; Jewgenow K, REPROD SCI ANIMAL CO; Johnson WE, 2004, J HERED, V95, P19, DOI 10.1093/jhered/esh006; Kaczensky P, 1991, UNTERSUCHUNG RAUMNUT; KVAM T, 1991, Z SAUGETIERKD, V56, P146; Lane JE, 2012, NATURE, V489, P554, DOI 10.1038/nature11335; Linnell John D.C., 2009, P72, DOI 10.1002/9781444312034.ch4; Linnell JDC, 2010, ENVIRON MANAGE, V45, P1142, DOI 10.1007/s00267-010-9455-9; Logan K.A., 2001, DESERT PUMA EVOLUTIO; Lueders I, 2012, P ROY SOC B-BIOL SCI, V279, P3687, DOI 10.1098/rspb.2012.1038; Mattisson J, 2011, BIOL CONSERV, V144, P3009, DOI 10.1016/j.biocon.2011.09.004; Mejlgaard T, 2013, J ZOOL, V289, P222, DOI 10.1111/j.1469-7998.2012.00980.x; Nilsen EB, 2012, ACTA THERIOL, V57, P217, DOI 10.1007/s13364-011-0066-5; Nilsen EB, 2010, OECOLOGIA, V164, P943, DOI 10.1007/s00442-010-1713-2; Painer J., 2012, P63; Pau S, 2011, GLOBAL CHANGE BIOL, V17, P3633, DOI 10.1111/j.1365-2486.2011.02515.x; Pelican Katharine M., 2009, P340; Samelius G, 2012, J ZOOL, V286, P120, DOI 10.1111/j.1469-7998.2011.00857.x; Schadt S, 2002, J APPL ECOL, V39, P189, DOI 10.1046/j.1365-2664.2002.00700.x; SHILLE VM, 1979, BIOL REPROD, V21, P1217, DOI 10.1095/biolreprod21.5.1217; Weems CW, 2006, VET J, V171, P206, DOI 10.1016/j.tvjl.2004.11.014; WILDT DE, 1981, BIOL REPROD, V25, P15, DOI 10.1095/biolreprod25.1.15	45	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90469	10.1371/journal.pone.0090469	http://dx.doi.org/10.1371/journal.pone.0090469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599348	Green Published, gold			2022-12-25	WOS:000332479400079
J	Tsai, CH; Wu, JS; Chang, YF; Lu, FH; Yang, YC; Chang, CJ				Tsai, Chung-Hung; Wu, Jin-Shang; Chang, Yin-Fan; Lu, Feng-Hwa; Yang, Yi-Ching; Chang, Chih-Jen			The Number of Metabolic Abnormalities Associated with the Risk of Gallstones in a Non-diabetic Population	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INSULIN-RESISTANCE; GALLBLADDER-DISEASE; CHOLESTEROL GALLSTONES; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; UNITED-STATES; RAT-LIVER; PREVALENCE; INFECTION	Aim: To evaluate whether metabolic syndrome is associated with gallstones, independent of hepatitis C infection or chronic kidney disease (CKD), in a non-diabetic population. Materials and Methods: A total of 8,188 Chinese adult participants that underwent a self-motivated health examination were recruited into the final analysis after excluding the subjects who had a history of cholecystectomy, diabetes mellitus, or were currently using antihypertensive or lipid-lowering agents. Gallstones were defined by the presence of strong intraluminal echoes that were gravity-dependent or that attenuated ultrasound transmission. Results: A total of 447 subjects (5.5%) had gallstones, with 239 (5.1%) men and 208 (6.0%) women. After adjusting for age, gender, obesity, education level, and lifestyle factors, included current smoking, alcohol drinking, regular exercise, hepatitis B, hepatitis C, and CKD, there was a positive association between metabolic syndrome and gallstones. Moreover, as compared to subjects without metabolic abnormalities, subjects with one, two, and three or more suffered from a 35, 40, and 59% higher risk of gallstones, respectively. Conclusions: Non-diabetic subjects with metabolic syndrome had a higher risk of gallstones independent of hepatitis C or CKD, and a dose-dependent effect of metabolic abnormalities also exists.	[Tsai, Chung-Hung] China Med Univ, Tainan Municipal An Nan Hosp, Dept Family Med, Tainan, Taiwan; [Chang, Yin-Fan] Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan; [Wu, Jin-Shang; Lu, Feng-Hwa; Yang, Yi-Ching; Chang, Chih-Jen] Natl Cheng Kung Univ, Coll Med, Dept Family Med, Tainan 70101, Taiwan	China Medical University Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Chang, CJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Family Med, Tainan 70101, Taiwan.	em75210@email.ncku.edu.tw	Yang, Yi-Ching/C-7033-2014	Yang, Yi-Ching/0000-0003-1391-8040	Department of Family Medicine, National Cheng-Kung University Hospital [NCKUHFM-101-002]; National Sciene Council, Taiwan, R.O.C.	Department of Family Medicine, National Cheng-Kung University Hospital; National Sciene Council, Taiwan, R.O.C.	This study was supported by the grants from the Department of Family Medicine, National Cheng-Kung University Hospital (NCKUHFM-101-002). The authors would like to thank the National Sciene Council, Taiwan, R.O.C. for financially supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acalovschi M, 2009, J VIRAL HEPATITIS, V16, P860, DOI 10.1111/j.1365-2893.2009.01141.x; American College of Sports Medicine (ACSM), 2014, ACSMS GUIDELINES EXE; [Anonymous], 2010, DIABETES CARE; [Anonymous], 2002, AM J KIDNEY DIS OFFI, V39, pS1; Biddinger SB, 2008, NAT MED, V14, P778, DOI 10.1038/nm1785; Chang Y, 2008, J KOREAN MED SCI, V23, P644, DOI 10.3346/jkms.2008.23.4.644; Chen CH, 2006, J GASTROEN HEPATOL, V21, P1737, DOI 10.1111/j.1440-1746.2006.04381.x; DeSantis A, 1997, HEPATOLOGY, V25, P787, DOI 10.1002/hep.510250401; Eguchi Y, 2009, LIVER INT, V29, P213, DOI 10.1111/j.1478-3231.2008.01853.x; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fu D, 2011, P NATL ACAD SCI USA, V108, P1403, DOI 10.1073/pnas.1018376108; Grundy SM, 2004, AM J CLIN NUTR, V80, P1; HAFFNER SM, 1990, AM J EPIDEMIOL, V132, P327, DOI 10.1093/oxfordjournals.aje.a115662; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3; Kim Sang Soo, 2011, Korean Journal of Internal Medicine, V26, P285, DOI 10.3904/kjim.2011.26.3.285; Lai SW, 2009, MEDICINE, V88, P46, DOI 10.1097/MD.0b013e318194183f; Loriot MA, 1999, HEPATOLOGY, V29, P1587, DOI 10.1002/hep.510290527; Magi Lorenzo, 2005, Recenti Progressi in Medicina, V96, P280; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Mendez-Sanchez N, 2005, WORLD J GASTROENTERO, V11, P1653, DOI 10.3748/wjg.v11.i11.1653; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; NEPOKROEFF CM, 1974, ARCH BIOCHEM BIOPHYS, V160, P387, DOI 10.1016/0003-9861(74)90412-3; Nervi F, 2006, J HEPATOL, V45, P299, DOI 10.1016/j.jhep.2006.01.026; Ruhl CE, 2000, HEPATOLOGY, V31, P299, DOI 10.1002/hep.510310206; Stinton LM, 2010, GASTROENTEROL CLIN N, V39, P157, DOI 10.1016/j.gtc.2010.02.003; STORER GB, 1981, FEBS LETT, V136, P135, DOI 10.1016/0014-5793(81)81231-8; Uebi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037803; VanPatten S, 2001, AM J PHYSIOL-GASTR L, V281, pG393, DOI 10.1152/ajpgi.2001.281.2.G393; Weikert C, 2010, AM J EPIDEMIOL, V171, P447, DOI 10.1093/aje/kwp411; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Wittenburg H, 2003, GASTROENTEROLOGY, V125, P868, DOI 10.1016/S0016-5085(03)01053-9; Woods A, 2011, BIOCHEM J, V434, P49, DOI 10.1042/BJ20101721; World Health Organization, 2000, ASIA PACIFIC PERSPEC; Xie Y, 2009, J LIPID RES, V50, P977, DOI 10.1194/jlr.M800645-JLR200	35	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90310	10.1371/journal.pone.0090310	http://dx.doi.org/10.1371/journal.pone.0090310			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598574	gold, Green Published, Green Submitted			2022-12-25	WOS:000332479400062
J	Zhou, QM; Xu, F; Wu, QY; Gong, W; Xie, L; Wang, T; Fang, L; Yang, DY; Melgiri, ND; Xie, P				Zhou, Qinming; Xu, Fan; Wu, Qingyuan; Gong, Wei; Xie, Liang; Wang, Tao; Fang, Liang; Yang, Deyu; Melgiri, Narayan D.; Xie, Peng			The Mutual Influences between Depressed Macaca fascicularis Mothers and Their Infants	PLOS ONE			English	Article							NONHUMAN PRIMATE MODELS; POSTPARTUM-DEPRESSION; MATERNAL DEPRESSION; SOCIAL INTERACTIONS; BEHAVIOR; STRESS; CHILDREN; ANXIETY; PSYCHOPATHOLOGY; PHYSIOLOGY	Objective: To assess the influence of infant rearing on the behavior of depressed adult female Macaca fascicularis and the influence of depressed infant-rearing adult female Macaca fascicularis on their infants in a free enclosure environment. Methods: Here, 20 depressed subjects and then 20 healthy subjects were randomly selected from a total population of 1007 adult female Macaca fascicularis subjects. Four depressed subjects and eight healthy subjects were rearing infants. By focal observation, three trained observers video-recorded the selected subjects over a total observational period of 560 hours. The video footage was analyzed by qualified blinded analysts that coded the raw footage into quantitative behavioral data (i.e., durations of 53 pre-defined behavioral items across 12 behavioral categories) for statistical analysis. Results: Between infant-rearing and non-rearing healthy subjects, ten differential behaviors distributed across five behavioral categories were identified. Between infant-rearing and non-rearing depressed subjects, nine behaviors distributed across five behavioral categories were identified. Between infant-rearing healthy and infant-rearing depressed subjects, fifteen behaviors distributed across six behavioral categories were identified. Conclusion: Infant-rearing depressed adult female Macaca fascicularis subjects may have a worse psychological status as compared to non-rearing depressed counterparts. Infant rearing may negatively influence depressed Macaca fascicularis mothers. Infant-rearing depressed subjects were less adequate at raising infants as compared to infant-rearing healthy subjects. Thus, maternal depression in this macaque species may negatively impact infatile development, which is consistent with previous findings in humans.	[Zhou, Qinming; Xu, Fan; Wu, Qingyuan; Gong, Wei; Xie, Liang; Wang, Tao; Fang, Liang; Melgiri, Narayan D.; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Zhou, Qinming; Xu, Fan; Wu, Qingyuan; Gong, Wei; Xie, Liang; Wang, Tao; Fang, Liang; Melgiri, Narayan D.; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Zhou, Qinming; Wu, Qingyuan; Wang, Tao; Xie, Peng] Chongqing Med Univ, Dept Neurol, Affiliated Hosp 1, Chongqing, Peoples R China; [Yang, Deyu] Chongqing Med Univ, Yongchuan Hosp, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Xie, P (corresponding author), Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn	Zhou, Qinming/GWZ-7229-2022	Zhou, Qinming/0000-0001-6211-0588	National Basic Research Program of China (973 Program) [2009CB918300]; National Natural Science Foundation of China [31271189]; Chongqing Postdoctoral Science Foundation [XM20120010]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Postdoctoral Science Foundation	This work was supported by the National Basic Research Program of China (973 Program) (Grant No. 2009CB918300), the National Natural Science Foundation of China (Grant No. 31271189), and the Chongqing Postdoctoral Science Foundation (Grant No. XM20120010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Aureli F, 2010, BIOL LETTERS, V6, P27, DOI 10.1098/rsbl.2009.0513; Bardi M, 2002, DEV PSYCHOBIOL, V41, P364, DOI 10.1002/dev.10065; BOCCIA ML, 1989, PHYSIOL BEHAV, V45, P667, DOI 10.1016/0031-9384(89)90089-9; BURKE KC, 1991, ARCH GEN PSYCHIAT, V48, P789; Cabib S, 2000, BEHAV BRAIN RES, V112, P13, DOI 10.1016/S0166-4328(00)00157-1; Chance MRA, 1970, SOCIAL GROUPS MONKEY; Cooper PJ, 1998, BMJ-BRIT MED J, V316, P1884; Dietz PM, 2007, AM J PSYCHIAT, V164, P1515, DOI 10.1176/appi.ajp.2007.06111893; DRI M, 1991, FOLIA PRIMATOL, V57, P121; DUNBAR RIM, 1991, FOLIA PRIMATOL, V57, P121, DOI 10.1159/000156574; Eberhard-Gran M, 2003, SOC PSYCH PSYCH EPID, V38, P551, DOI 10.1007/s00127-003-0679-3; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; FAIRBANKS LA, 1989, DEV PSYCHOBIOL, V22, P669, DOI 10.1002/dev.420220703; FAIRBANKS LA, 1988, DEV PSYCHOBIOL, V21, P711, DOI 10.1002/dev.420210708; GOTLIB IH, 1995, J CONSULT CLIN PSYCH, V63, P90, DOI 10.1037/0022-006X.63.1.90; Guangmei Yan GZ, 2011, NATURE BIOTECHNOLOGY, V29; Herodin F, 2005, EUR CYTOKINE NETW, V16, P104; HOPKINS J, 1984, PSYCHOL BULL, V95, P498, DOI 10.1037/0033-2909.95.3.498; Kalin NH, 2003, ANN NY ACAD SCI, V1008, P189, DOI 10.1196/annals.1301.021; KESSLER RC, 1994, J AFFECT DISORDERS, V30, P15, DOI 10.1016/0165-0327(94)90147-3; Li J., 1994, CURRENT PRIMATOLOGY, VII, P185; Liang Bin, 2011, Zoological Research, V32, P91, DOI 10.3724/SP.J.1141.2011.01091; Maestripieri D, 2005, GESTURE, V5, P1; Maestripieri D, 2011, AM J PRIMATOL, V73, P516, DOI 10.1002/ajp.20882; Maestripieri D, 2009, PHYSIOL BEHAV, V96, P613, DOI 10.1016/j.physbeh.2008.12.016; Mbaya Albert Wulari, 2011, Pakistan Journal of Biological Sciences, V14, P709, DOI 10.3923/pjbs.2011.709.714; Michopoulos V, 2012, PSYCHONEUROENDOCRINO, V37, P1071, DOI 10.1016/j.psyneuen.2011.12.004; MingfeiHan DG, 2008, W CHINA MED; MORSE JM, 1992, CAN J PUBLIC HEALTH, V83, P213; MURRAY L, 1993, J CHILD PSYCHOL PSYC, V34, P1083, DOI 10.1111/j.1469-7610.1993.tb01775.x; Natl Acad Natl Res Council & Inst Med, 2009, DEPRESSION IN PARENTS, PARENTING, AND CHILDREN: OPPORTUNITIES TO IMPROVE IDENTIFICATION, TREATMENT, AND PREVENTION, P1; O'Hara M. W., 1988, MOTHERHOOD MENTAL IL, P17; OHARA MW, 1990, J ABNORM PSYCHOL, V99, P3, DOI 10.1037/0021-843X.99.1.3; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; ORVASCHEL H, 1988, J ABNORM CHILD PSYCH, V16, P17, DOI 10.1007/BF00910497; Poirier E., 1974, AM SOC ZOOLOGISTS, V14, P275; Radford AN, 2012, BIOL LETTERS, V8, P24, DOI 10.1098/rsbl.2011.0559; Rees W D, 1971, J R Coll Gen Pract, V21, P26; RUTTER M, 1990, DEV PSYCHOL, V26, P60, DOI 10.1037/h0092669; Sackett GP, 1973, DEV MONKEYS VARIED E; Schino G, 2001, DEV PSYCHOBIOL, V38, P186, DOI 10.1002/dev.1012; Shively CA, 1997, BIOL PSYCHIAT, V41, P871, DOI 10.1016/S0006-3223(96)00185-0; Shively CA, 2005, BIOL PSYCHOL, V69, P67, DOI 10.1016/j.biopsycho.2004.11.006; Sibal L R, 2001, ILAR J, V42, P74; SILK J B, 1980, Primates, V21, P100, DOI 10.1007/BF02383827; Simpson MJA, 1985, PRIMATES, V26, P57; Speranza AM, 2006, CLIN NEUROPSYCHIATR, V3, P57; SUOMI SJ, 1975, J ABNORM PSYCHOL, V84, P576, DOI 10.1037/h0077066; TETI DM, 1995, DEV PSYCHOL, V31, P364, DOI 10.1037/0012-1649.31.3.364; WEISBARD C, 1976, FOLIA PRIMATOL, V25, P95, DOI 10.1159/000155709; WEISSMAN MM, 1984, J AM ACAD CHILD PSY, V23, P78, DOI 10.1097/00004583-198401000-00011; WHIFFEN VE, 1993, J CONSULT CLIN PSYCH, V61, P485; WHIFFEN VE, 1991, J PSYCHIATR NEUROSCI, V16, P160; Willard SL, 2012, AM J PRIMATOL, V74, P528, DOI 10.1002/ajp.21013; Xia Houjun ZG, 2010, ZOOL RES, V31, P57; Xiaoqiu Li JX, 2002, J CHINESE J PSYCHIAT, V35, P184; Xu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037486	58	2	3	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89931	10.1371/journal.pone.0089931	http://dx.doi.org/10.1371/journal.pone.0089931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599092	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400034
J	BenMohamed, F; Medina, M; Wu, YZ; Maschalidi, S; Jouvion, G; Guillemot, L; Chignard, M; Manoury, B; Touqui, L				BenMohamed, Fatima; Medina, Mathieu; Wu, Yong-Zheng; Maschalidi, Sophia; Jouvion, Gregory; Guillemot, Laurent; Chignard, Michel; Manoury, Benedicte; Touqui, Lhousseine			Toll-Like Receptor 9 Deficiency Protects Mice against Pseudomonas aeruginosa Lung Infection	PLOS ONE			English	Article							NITRIC-OXIDE; EPITHELIAL-CELLS; INNATE IMMUNITY; TLR9; FLAGELLIN; DNA; RECOGNITION; MODULATION; MECHANISMS; INDUCTION	Pseudomonas aeruginosa is an opportunistic pathogen involved in nosocomial infections. While a number of studies have demonstrated the roles of TLR2, TLR4 and TLR5 in host defense againt P. aeruginosa infection, the implication of TLR9 in this process has been overlooked. Here, we show that P. aeruginosa DNA stimulates the inflammatory response through TLR9 pathway in both a cell line and primary alveolar macrophages (AMs). This activation requires asparagine endopeptidase-and endosomal acidification. Interestingly, TLR9(-/-) mice resisted to lethal lung infection by P. aeruginosa, compared to WT C57BL/6 mice. The resistance of TLR9(-/-) mice to P. aeruginosa infection was associated with: (i) a higher ability of TLR9(-/-) AMs to kill P. aeruginosa; (ii) a rapid increase in the pro-inflammatory cytokines such as TNF alpha, IL-1 beta and IL-6 production; and (iii) an increase in nitric oxide (NO) production and inductible NO synthase expression in AMs. In addition, inhibition of both IL-1 beta and NO production resulted in a significant decrease of P. aeruginosa clearance by AMs. Altogether these results indicate that TLR9 plays a detrimental role in pulmonary host defense toward P. aeruginosa by reducing the AMs clearance activity and production of IL-1 beta and NO necessary for bacteria killing.	[BenMohamed, Fatima; Medina, Mathieu; Wu, Yong-Zheng; Guillemot, Laurent; Chignard, Michel; Touqui, Lhousseine] Inst Pasteur, Unite Defense Innee & Inflammat, Paris, France; [BenMohamed, Fatima; Medina, Mathieu; Wu, Yong-Zheng; Guillemot, Laurent; Chignard, Michel; Touqui, Lhousseine] INSERM, U874, Paris, France; [Maschalidi, Sophia; Manoury, Benedicte] INSERM, U1013, Paris, France; [Jouvion, Gregory] Inst Pasteur, Unite Histopathol Humaine & Modeles Animaux, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Touqui, L (corresponding author), Inst Pasteur, Unite Defense Innee & Inflammat, Paris, France.	touqui@pasteur.fr	Jouvion, Grégory/AAL-2620-2021; Guillemot, Laurent/I-3166-2017	Guillemot, Laurent/0000-0002-5979-5501; Manoury, Benedicte/0000-0001-7784-3389	ANR [ANR 2010 MIDI 008 01]; Association Vaincre la Mucoviscidose [RF20120600716]	ANR(French National Research Agency (ANR)); Association Vaincre la Mucoviscidose	This work was supported by ANR (ANR 2010 MIDI 008 01) and the Association Vaincre la Mucoviscidose (RF20120600716). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Assis MC, 2006, INT J MOL MED, V18, P355; Balloy V, 2007, J INFECT DIS, V196, P289, DOI 10.1086/518610; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Bamboat ZM, 2010, HEPATOLOGY, V51, P621, DOI 10.1002/hep.23365; Ben Mohamed F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039888; Bhan U, 2007, J IMMUNOL, V179, P3937, DOI 10.4049/jimmunol.179.6.3937; Bhan U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009896; Darling KEA, 2003, INFECT IMMUN, V71, P2341, DOI 10.1128/IAI.71.5.2341-2349.2003; Descamps D, 2012, P NATL ACAD SCI USA, V109, P1619, DOI 10.1073/pnas.1108464109; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Gwinn MR, 2006, J TOXICOL ENV HEAL B, V9, P27, DOI 10.1080/15287390500196081; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hemmi Hiroaki, 2005, V86, P120, DOI 10.1159/000086657; Hiramatsu Y, 2013, MICROBES INFECT, V15, P96, DOI 10.1016/j.micinf.2012.11.003; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kasperkovitz PV, 2011, INFECT IMMUN, V79, P4858, DOI 10.1128/IAI.05626-11; Kleinbongard P, 2002, METHOD ENZYMOL, V359, P158; Kwon S, 1999, NITRIC OXIDE-BIOL CH, V3, P348, DOI 10.1006/niox.1999.0242; LaBaer J, 2004, GENOME RES, V14, P2190, DOI 10.1101/gr.2482804; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lau GW, 2005, TRENDS MICROBIOL, V13, P389, DOI 10.1016/j.tim.2005.05.011; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Loak K, 2003, BIOL CHEM, V384, P1239, DOI 10.1515/BC.2003.136; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P403, DOI 10.1513/pats.200508-090JS; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Parratt JR, 1998, J ANTIMICROB CHEMOTH, V41, P31, DOI 10.1093/jac/41.suppl_1.31; Ramphal R, 2008, J IMMUNOL, V181, P586, DOI 10.4049/jimmunol.181.1.586; Raoust E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007259; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Sodhi C, 2011, AM J PHYSIOL-GASTR L, V300, pG862, DOI 10.1152/ajpgi.00373.2010; Spitsin SV, 1996, MOL MED, V2, P226, DOI 10.1007/BF03401619; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Verma A, 2005, INFECT IMMUN, V73, P8237, DOI 10.1128/IAI.73.12.8237-8246.2005; XIE QW, 1994, J BIOL CHEM, V269, P4705	36	24	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90466	10.1371/journal.pone.0090466	http://dx.doi.org/10.1371/journal.pone.0090466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595157	gold, Green Published			2022-12-25	WOS:000332475500053
J	Evans, SE; Goult, BT; Fairall, L; Jamieson, AG; Ferrigno, PK; Ford, R; Schwabe, JWR; Wagner, SD				Evans, Sian E.; Goult, Benjamin T.; Fairall, Louise; Jamieson, Andrew G.; Ferrigno, Paul Ko; Ford, Robert; Schwabe, John W. R.; Wagner, Simon D.			The Ansamycin Antibiotic, Rifamycin SV, Inhibits BCL6 Transcriptional Repression and Forms a Complex with the BCL6-BTB/POZ Domain	PLOS ONE			English	Article							GERMINAL-CENTER FORMATION; NEGATIVE AUTOREGULATION; BTB DOMAIN; CELL; EXPRESSION; INFLAMMATION; GENE; ONCOPROTEIN; PREDICTION; MUTATIONS	BCL6 is a transcriptional repressor that is over-expressed due to chromosomal translocations, or other abnormalities, in similar to 40% of diffuse large B-cell lymphoma. BCL6 interacts with co-repressor, SMRT, and this is essential for its role in lymphomas. Peptide or small molecule inhibitors, which prevent the association of SMRT with BCL6, inhibit transcriptional repression and cause apoptosis of lymphoma cells in vitro and in vivo. In order to discover compounds, which have the potential to be developed into BCL6 inhibitors, we screened a natural product library. The ansamycin antibiotic, rifamycin SV, inhibited BCL6 transcriptional repression and NMR spectroscopy confirmed a direct interaction between rifamycin SV and BCL6. To further determine the characteristics of compounds binding to BCL6-POZ we analyzed four other members of this family and showed that rifabutin, bound most strongly. An X-ray crystal structure of the rifabutin-BCL6 complex revealed that rifabutin occupies a partly non-polar pocket making interactions with tyrosine58, asparagine21 and arginine24 of the BCL6-POZ domain. Importantly these residues are also important for the interaction of BLC6 with SMRT. This work demonstrates a unique approach to developing a structure activity relationship for a compound that will form the basis of a therapeutically useful BCL6 inhibitor.	[Evans, Sian E.; Goult, Benjamin T.; Fairall, Louise; Schwabe, John W. R.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Evans, Sian E.; Wagner, Simon D.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England; [Evans, Sian E.; Wagner, Simon D.] Univ Leicester, MRC Toxicol Unit, Leicester, Leics, England; [Jamieson, Andrew G.] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England; [Ferrigno, Paul Ko; Ford, Robert] Univ Leeds, Sect Expt Therapeut, Leeds Inst Mol Med, Leeds, W Yorkshire, England	University of Leicester; University of Leicester; University of Leicester; University of Leicester; University of Leeds	Wagner, SD (corresponding author), Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England.	sw227@le.ac.uk	Schwabe, John WR/A-9132-2008; Goult, Benjamin T/B-3127-2009	Schwabe, John WR/0000-0003-2865-4383; Goult, Benjamin T/0000-0002-3438-2807; Jamieson, Andrew/0000-0003-1726-7353; Wagner, Simon/0000-0002-8914-0370; Fairall, Louise/0000-0001-9456-3047; Ko Ferrigno, Paul/0000-0002-5922-4100	University of Leicester; Wellcome Trust [WT091820, WT100237]	University of Leicester; Wellcome Trust(Wellcome TrustEuropean Commission)	SEE is supported by a University of Leicester PhD Studentship (http://www.le.ac.uk). The work is supported by a Wellcome Trust Programme Grant WT091820 and Senior Investigator Grant WT100237 to JWRS (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Auld DS, 2008, J MED CHEM, V51, P2372, DOI 10.1021/jm701302v; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Cerchietti LC, 2010, J CLIN INVEST, V120, P4569, DOI 10.1172/JCI42869; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Cerchietti LC, 2009, BLOOD, V113, P3397, DOI 10.1182/blood-2008-07-168773; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dhordain P, 1998, NUCLEIC ACIDS RES, V26, P4645, DOI 10.1093/nar/26.20.4645; Dhordain P, 1995, ONCOGENE, V11, P2689; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Ghetu AF, 2008, MOL CELL, V29, P384, DOI 10.1016/j.molcel.2007.12.026; Huang CX, 2013, NAT IMMUNOL, V14, P380, DOI 10.1038/ni.2543; Iqbal J, 2007, LEUKEMIA, V21, P2332, DOI 10.1038/sj.leu.2404856; Kunin CM, 1996, CLIN INFECT DIS, V22, pS3, DOI 10.1093/clinids/22.Supplement_1.S3; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; OFFIT K, 1994, NEW ENGL J MED, V331, P74, DOI 10.1056/NEJM199407143310202; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang X, 2002, P NATL ACAD SCI USA, V99, P15018, DOI 10.1073/pnas.232581199; Woods LA, 2011, NAT CHEM BIOL, V7, P730, DOI [10.1038/nchembio.635, 10.1038/NCHEMBIO.635]; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161	41	18	19	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90889	10.1371/journal.pone.0090889	http://dx.doi.org/10.1371/journal.pone.0090889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595451	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500109
J	Guo, YS; Zhao, R; Ma, J; Cui, W; Sun, Z; Gao, B; He, S; Han, YH; Fan, J; Yang, L; Tang, J; Luo, ZJ				Guo, Yun-Shan; Zhao, Rui; Ma, Jie; Cui, Wei; Sun, Zhen; Gao, Bo; He, Shu; Han, Yue-Hu; Fan, Jing; Yang, Liu; Tang, Juan; Luo, Zhuo-Jing			beta ig-h3 Promotes Human Osteosarcoma Cells Metastasis by Interacting with Integrin alpha 2 beta 1 and Activating PI3K Signaling Pathway	PLOS ONE			English	Article							BREAST-CANCER CELLS; NUDE-MICE; OSTEOGENIC-SARCOMA; IN-VITRO; ADHESION; BETA; INVASION; PROTEIN; GROWTH; LUNG	Osteosarcoma, the most common primary bone tumor in children and young adolescents, is characterized by local invasion and distant metastasis. But the detailed mechanisms of osteosarcoma metastasis are not well known. In the present study, we found that beta ig-h3 promotes metastatic potential of human osteosarcoma cells in vitro and in vivo. Furthermore, beta ig-h3 co-localized with integrin alpha 2 beta 1 in osteosarcoma cells. But beta ig-h3 did not change integrin alpha 2 beta 1 expression in Saos-2 cells. Interaction of beta ig-h3 with integrin alpha 2 beta 1 mediates metastasis of human osteosarcoma cells. The second FAS1 domain of beta ig-h3 but not the first FAS1 domain, the third FAS1 domain or the fourth FAS1 domain mediates human osteosarcoma cells metastasis, which is the alpha 2 beta 1 integrin-interacting domain. We further demonstrated that PI3K/AKT signaling pathway is involved in beta ig-h3-induced human osteosarcoma cells metastasis process. Together, these results reveal beta ig-h3 enhances the metastasis potentials of human osteosarcoma cells via integrin alpha 2 beta 1-mediated PI3K/AKT signal pathways. The discovery of beta ig-h3-mediated pathway helps us to understand the mechanism of human osteosarcoma metastasis and provides evidence for the possibility that beta ig-h3 can be a potential therapeutic target for osteosarcoma treatment.	[Guo, Yun-Shan; Zhao, Rui; Sun, Zhen; Gao, Bo; He, Shu; Han, Yue-Hu; Fan, Jing; Yang, Liu; Luo, Zhuo-Jing] Fourth Mil Med Univ, Xijing Hosp, Dept Osteol, Xian 710032, Peoples R China; [Guo, Yun-Shan; Tang, Juan] Fourth Mil Med Univ, Cell Engn Res Ctr, Xian 710032, Peoples R China; [Guo, Yun-Shan; Tang, Juan] Fourth Mil Med Univ, Dept Cell Biol, State Key Lab Canc Biol, State Key Discipline Cell Biol, Xian 710032, Peoples R China; [Ma, Jie] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Cui, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol & Metab, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yang, L (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Osteol, Xian 710032, Peoples R China.	yangliu@fmmu.edu.cn; tangjuan1@fmmu.edu.cn; zjluo@fmmu.edu.cn			National Basic Research Program of China [2011CB964703]; National Natural Science Foundation of China [31101005]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Basic Research Program of China (2011CB964703) and the National Natural Science Foundation of China (31101005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JS, 2002, BIOCHEM BIOPH RES CO, V294, P940, DOI 10.1016/S0006-291X(02)00576-4; Bernstein Lori R., 1994, Current Opinion in Oncology, V6, P106, DOI 10.1097/00001622-199401000-00015; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris MB, 1998, J CLIN ONCOL, V16, P3641, DOI 10.1200/JCO.1998.16.11.3641; Izmailyan R, 2012, J VIROL, V86, P6677, DOI 10.1128/JVI.06860-11; Jin S, 2007, APOPTOSIS, V12, P1317, DOI 10.1007/s10495-007-0062-z; Kawamoto T, 1998, BBA-GENE STRUCT EXPR, V1395, P288, DOI 10.1016/S0167-4781(97)00172-3; Kim HJ, 2010, CURR OPIN PEDIATR, V22, P61, DOI 10.1097/MOP.0b013e328334581f; Kim JE, 2000, J BIOL CHEM, V275, P30907, DOI 10.1074/jbc.M002752200; Kim JE, 2002, J BIOL CHEM, V277, P46159, DOI 10.1074/jbc.M207055200; Kimura H, 2012, INT J CANCER, V131, P2027, DOI 10.1002/ijc.27475; Krishnamurthy M, 2011, ENDOCRINOLOGY, V152, P424, DOI 10.1210/en.2010-0877; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Ma J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037297; Messerschmitt PJ, 2009, J AM ACAD ORTHOP SUR, V17, P515, DOI 10.5435/00124635-200908000-00005; MEYERS PA, 1993, J CLIN ONCOL, V11, P449, DOI 10.1200/JCO.1993.11.3.449; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Murillo CA, 2004, SURGERY, V136, P143, DOI 10.1016/j.surg.2004.04.006; Nissinen L, 1998, EXP CELL RES, V243, P1, DOI 10.1006/excr.1998.4128; Park SW, 2004, EXP MOL MED, V36, P211, DOI 10.1038/emm.2004.29; Qin J, 2013, LIFE SCI, V93, P655, DOI 10.1016/j.lfs.2013.09.002; SCOTLANDI K, 1993, INT J ONCOL, V3, P963; Shah JN, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-284; Shaw LM, 2001, MOL CELL BIOL, V21, P5082, DOI 10.1128/MCB.21.15.5082-5093.2001; SKONIER J, 1994, DNA CELL BIOL, V13, P571, DOI 10.1089/dna.1994.13.571; Son HN, 2013, BBA-MOL CELL RES, V1833, P2378, DOI 10.1016/j.bbamcr.2013.06.012; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Tang J, 2008, CELL MOL LIFE SCI, V65, P2933, DOI 10.1007/s00018-008-8315-8; Tang J, 2012, CELL DEATH DIFFER, V19, P1779, DOI 10.1038/cdd.2012.60; Tang J, 2009, EXP BIOL MED, V234, P35, DOI 10.3181/0806-RM-187; Tome Y, 2013, ANTICANCER RES, V33, P3623; Tome Y, 2013, ANTICANCER RES, V33, P3021; Tsubaki M, 2012, TOXICOL APPL PHARM, V259, P402, DOI 10.1016/j.taap.2012.01.024; Uehara F, 2013, ANTICANCER RES, V33, P1361; Vihinen P, 1996, CELL GROWTH DIFFER, V7, P439; Ween MP, 2011, INT J CANCER, V128, P1570, DOI 10.1002/ijc.25494; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Zamilpa R, 2009, MATRIX BIOL, V28, P347, DOI 10.1016/j.matbio.2009.05.004	44	16	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90220	10.1371/journal.pone.0090220	http://dx.doi.org/10.1371/journal.pone.0090220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595049	gold, Green Published, Green Submitted			2022-12-25	WOS:000332475500038
J	Helland, O; Popa, M; Vintermyr, OK; Molven, A; Gjertsen, BT; Bjorge, L; McCormack, E				Helland, Oystein; Popa, Mihaela; Vintermyr, Olav K.; Molven, Anders; Gjertsen, Bjorn Tore; Bjorge, Line; McCormack, Emmet			First In-Mouse Development and Application of a Surgically Relevant Xenograft Model of Ovarian Carcinoma	PLOS ONE			English	Article							CYTOREDUCTIVE SURGERY; PRECLINICAL MODELS; PLUS PACLITAXEL; TUMOR-MODELS; PHASE-III; CANCER; CISPLATIN; GROWTH; SURVIVAL; DISEASE	Purpose: Preclinical models of epithelial ovarian cancer have not been exploited to evaluate the clinical standard combination therapy of surgical debulking with follow-up chemotherapy. As surgery is critical to patient survival, here we establish a combined surgical/chemotherapy xenograft model of epithelial ovarian cancer and demonstrate its translational relevance. Experimental Design: SKOV-3(luc+) ovary cancer cells were injected topically into the ovaries of immunodeficient mice. Disease development and effect of clinical standard treatment including hysterectomy, bilateral salpingoophorectomy and removal of metastasis with follow up chemotherapy (carboplatin 12 mg/kg + paclitaxel 15 mg/kg) was evaluated by clinical parameters. Tumor burden was quantified by bioluminescence imaging (BLI). Results: The xenograft ovarian tumors developed were poorly differentiated and multicystic and the disease disseminated into the peritoneal cavity. When compared to the controls with a mean survival time of 4.9 weeks, mice treated with surgery and chemotherapy, surgery or chemotherapy demonstrated significantly improved mean survival of 16.1 weeks (p = 0.0008), 12.7 weeks (p = 0.0008), or 10.4 weeks (p = 0.008), respectively. Conclusion: Combined surgical intervention and adjuvant chemotherapy was demonstrated for the first time in an orthotopic xenograft model of ovarian cancer. Similar to observation in human studies the combined approach resulted in the longest medial survival time, advocating application of this strategy in future preclinical therapeutic development for this disease.	[Helland, Oystein; Bjorge, Line] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Helland, Oystein; Gjertsen, Bjorn Tore; Bjorge, Line; McCormack, Emmet] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Popa, Mihaela] KinN Therapeut, Bergen, Norway; [Vintermyr, Olav K.; Molven, Anders] Univ Bergen, Gade Lab Pathol, Dept Clin Med, Bergen, Norway; [Vintermyr, Olav K.; Molven, Anders] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Gjertsen, Bjorn Tore; McCormack, Emmet] Haukeland Hosp, Dept Med, Hematol Sect, N-5021 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	McCormack, E (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	Emmet.Mc.Cormack@med.uib.no	Bjorge, Line/C-1307-2017; Gjertsen, Bjørn T/AAP-3281-2020; Bjorge, Line/AAD-6179-2021; Cormack, Emmet Mc/D-2922-2012; Gjertsen, Bjorn T/O-1542-2015	Bjorge, Line/0000-0002-0240-2770; Gjertsen, Bjørn T/0000-0001-9358-9704; Bjorge, Line/0000-0002-0240-2770; Cormack, Emmet Mc/0000-0002-7621-4625; Gjertsen, Bjorn T/0000-0001-9358-9704	Norwegian Cancer Society; Western Health Board of Norway; Bergen Research Foundation; MedViz; medical imaging and visualization R&D cluster in Western Norway founded by Haukeland University Hospital; University of Bergen; Christian Michelsen Research	Norwegian Cancer Society(Norwegian Cancer Society); Western Health Board of Norway; Bergen Research Foundation; MedViz; medical imaging and visualization R&D cluster in Western Norway founded by Haukeland University Hospital; University of Bergen; Christian Michelsen Research	This study has been supported by the Norwegian Cancer Society, Western Health Board of Norway, Bergen Research Foundation and MedViz (www.medviz.uib.no), a medical imaging and visualization R&D cluster in Western Norway founded by Haukeland University Hospital, University of Bergen, and Christian Michelsen Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; [Anonymous], 2009, INT J GYNECOL OBSTET, V105, P3; Bankert RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024420; Benencia F, 2005, MOL THER, V12, P789, DOI 10.1016/j.ymthe.2005.03.026; Bibby MC, 2004, EUR J CANCER, V40, P852, DOI 10.1016/j.ejca.2003.11.021; Bjorge L, 2005, BRIT J CANCER, V92, P895, DOI 10.1038/sj.bjc.6602334; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; Connolly DC, 2009, CANCER TREAT RES, V149, P353, DOI 10.1007/978-0-387-98094-2_17; Cordero A. B., 2010, J VIS EXP, DOI 10.3791/2125; CZERNOBILSKY B, 1985, EUR J CELL BIOL, V37, P175; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; du Bois A, 1999, ANN ONCOL, V10, P35, DOI 10.1023/A:1008355317514; FU XY, 1993, ANTICANCER RES, V13, P283; GRIFFITHS CT, 1975, NATL CANCER I MONOGR, P101; HACKER NF, 1983, OBSTET GYNECOL, V61, P413; Harlaar NJ, 2013, GYNECOL ONCOL, V128, P590, DOI 10.1016/j.ygyno.2012.12.011; Jarzabek MA, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2012.00029; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ke XS, 2011, EXP CELL RES, V317, P234, DOI 10.1016/j.yexcr.2010.10.009; Kerbel RS, 2003, CANCER BIOL THER, V2, pS134; Kiguchi K, 1998, CLIN EXP METASTAS, V16, P751, DOI 10.1023/A:1006537013317; Kotopoulis S, 2013, MOL IMAGING BIOL; Lorens JB, 2000, VIROLOGY, V272, P7, DOI 10.1006/viro.2000.0353; McCormack E, 2012, LEUKEMIA, V26, P910, DOI 10.1038/leu.2011.315; Mutch DG, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.31589; Nadeau ME, 2009, COMPARATIVE MED, V59, P553; Oliva P, 2012, BRIT J CANCER, V107, P360, DOI 10.1038/bjc.2012.261; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Morelli MP, 2012, J CLIN ONCOL, V30, pE45, DOI 10.1200/JCO.2011.36.9678; Piccart MJ, 2000, JNCI-J NATL CANCER I, V92, P699, DOI 10.1093/jnci/92.9.699; Ray P, 2011, NEOPLASIA, V13, P1152, DOI 10.1593/neo.111076; Ricci F, 2013, CANCER TREAT REV, V39, P561, DOI 10.1016/j.ctrv.2013.01.005; Schorge John O, 2010, Rev Obstet Gynecol, V3, P111; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Singer G, 2005, AM J SURG PATHOL, V29, P218, DOI 10.1097/01.pas.0000146025.91953.8d; Stewart JM, 2011, P NATL ACAD SCI USA, V108, P6468, DOI 10.1073/pnas.1005529108; Teefey P, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.03.012; Teicher BA, 2006, MOL CANCER THER, V5, P2435, DOI 10.1158/1535-7163.MCT-06-0391; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; van Scheltinga AGTT, 2011, J NUCL MED, V52, P1778, DOI 10.2967/jnumed.111.092833; Vidal A, 2012, CLIN CANCER RES, V18, P5399, DOI 10.1158/1078-0432.CCR-12-1513; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227; Wang J, 2011, NEUROPATH APPL NEURO, V37, P189, DOI 10.1111/j.1365-2990.2010.01119.x; Wimberger P, 2007, GYNECOL ONCOL, V106, P69, DOI 10.1016/j.ygyno.2007.02.026; Wu R, 2011, CLIN CANCER RES, V17, P7359, DOI 10.1158/1078-0432.CCR-11-1388; YANCIK R, 1993, CANCER, V71, P517; Zivanovic O, 2009, GYNECOL ONCOL, V114, pS3, DOI 10.1016/j.ygyno.2008.11.033	48	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89527	10.1371/journal.pone.0089527	http://dx.doi.org/10.1371/journal.pone.0089527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594904	Green Submitted, Green Published, gold			2022-12-25	WOS:000332475500016
J	Witztum, J; Persi, E; Horn, D; Pasmanik-Chor, M; Chor, B				Witztum, Jonathan; Persi, Erez; Horn, David; Pasmanik-Chor, Metsada; Chor, Benny			Hierarchical Partitioning of Metazoan Protein Conservation Profiles Provides New Functional Insights	PLOS ONE			English	Article							GENE ONTOLOGY; GAP-JUNCTIONS; GENOME; TOOL; ANNOTATION; METABOLISM; EVOLUTION; SEQUENCE	The availability of many complete, annotated proteomes enables the systematic study of the relationships between protein conservation and functionality. We explore this question based solely on the presence or absence of protein homologues (a.k.a. conservation profiles). We study 18 metazoans, from two distinct points of view: the human's and the fly's. Using the GOrilla gene ontology (GO) analysis tool, we explore functional enrichment of the "universal proteins'', those with homologues in all 17 other species, and of the "non-universal proteins''. A large number of GO terms are strongly enriched in both human and fly universal proteins. Most of these functions are known to be essential. A smaller number of GO terms, exhibiting markedly different properties, are enriched in both human and fly non-universal proteins. We further explore the non-universal proteins, whose conservation profiles are consistent with the "tree of life'' (TOL consistent), as well as the TOL inconsistent proteins. Finally, we applied Quantum Clustering to the conservation profiles of the TOL consistent proteins. Each cluster is strongly associated with one or a small number of specific monophyletic clades in the tree of life. The proteins in many of these clusters exhibit strong functional enrichment associated with the "life style'' of the related clades. Most previous approaches for studying function and conservation are "bottom up'', studying protein families one by one, and separately assessing the conservation of each. By way of contrast, our approach is "top down''. We globally partition the set of all proteins hierarchically, as described above, and then identify protein families enriched within different subdivisions. While supporting previous findings, our approach also provides a tool for discovering novel relations between protein conservation profiles, functionality, and evolutionary history as represented by the tree of life.	[Witztum, Jonathan; Pasmanik-Chor, Metsada] Tel Aviv Univ, Fac Life Sci, IL-69978 Tel Aviv, Israel; [Persi, Erez; Horn, David] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Chor, Benny] Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University	Chor, B (corresponding author), Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel.	benny@cs.tau.ac.il		Horn, David/0000-0003-2708-186X; Witztum, Jonathan/0000-0003-0092-2366				Alexopoulos H, 2004, CURR BIOL, V14, pR879, DOI 10.1016/j.cub.2004.09.067; Alibes A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-9; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; BERNACKI RJ, 1977, SCIENCE, V195, P577, DOI 10.1126/science.835014; Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Cooper GM, 2008, GENOME RES, V18, P201, DOI 10.1101/gr.7205808; de Bruyne M, 2006, BIOESSAYS, V28, P23, DOI 10.1002/bies.20338; DeVries ME, 2006, J IMMUNOL, V176, P401, DOI 10.4049/jimmunol.176.1.401; Dollo L., 1893, B SOC BELG GEOL, V7, P164; Eck R.V., 1966, ATLAS PROTEIN SEQUEN; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fang H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02015; Fox BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004933; Georgi B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003484; Getahun MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058889; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Horn D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.018702; KAM J, 2004, GENOME RES, V14, P109; Karabinos A, 2004, GENE, V326, P123, DOI 10.1016/j.gene.2003.10.019; Kimura MA, 1985, NEUTRAL THEORY MOL E; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Liu ZH, 2013, ACTA BIOCH BIOPH SIN, V45, P44, DOI 10.1093/abbs/gms105; Lopez-Bigas N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r33; Luz H, 2006, BIOINFORMATICS, V22, P1166, DOI 10.1093/bioinformatics/btl073; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Malagoli D, 2010, ISJ-INVERT SURVIV J, V7, P1; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Martin MJ, 2003, GENOME RES, V13, P991, DOI 10.1101/gr.678303; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Schultz U, 2004, DEV COMP IMMUNOL, V28, P499, DOI 10.1016/j.dci.2003.09.009; Shen HB, 2007, BIOCHEM BIOPH RES CO, V364, P53, DOI 10.1016/j.bbrc.2007.09.098; Tekaia F, 2005, PLOS COMPUT BIOL, V1, P604, DOI 10.1371/journal.pcbi.0010075; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102	39	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90282	10.1371/journal.pone.0090282	http://dx.doi.org/10.1371/journal.pone.0090282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594619	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500040
J	Zambrano, S; Bianchi, ME; Agresti, A				Zambrano, Samuel; Bianchi, Marco E.; Agresti, Alessandra			High-Throughput Analysis of NF-kappa B Dynamics in Single Cells Reveals Basal Nuclear Localization of NF-kappa B and Spontaneous Activation of Oscillations	PLOS ONE			English	Article							TEMPORAL CONTROL; SPECIFICITY; ROBUSTNESS; RESPONSES	NF-kappa B is a transcription factor that upon activation undergoes cycles of cytoplasmic-to-nuclear and nuclear-to-cytoplasmic transport, giving rise to so called "oscillations''. In turn, oscillations tune the transcriptional output. Since a detailed understanding of oscillations requires a systems biology approach, we developed a method to acquire and analyze large volumes of data on NF-kappa B dynamics in single cells. We measured the time evolution of the nuclear to total ratio of GFP-p65 in knock-in mouse embryonic fibroblasts using time-lapse imaging. We automatically produced a precise segmentation of nucleus and cytoplasm based on an accurate estimation of the signal and image background. Finally, we defined a set of quantifiers that describe the oscillatory dynamics, which are internally normalized and can be used to compare data recorded by different labs. Using our method, we analyzed NF-kappa B dynamics in over 2000 cells exposed to different concentrations of TNF-alpha alpha. We reproduced known features of the NF-kappa B system, such as the heterogeneity of the response in the cell population upon stimulation and we confirmed that a fraction of the responding cells does not oscillate. We also unveiled important features: the second and third oscillatory peaks were often comparable to the first one, a basal amount of nuclear NF-kappa B could be detected in unstimulated cells, and at any time a small fraction of unstimulated cells showed spontaneous random activation of the NF-kappa B system. Our work lays the ground for systematic, high-throughput, and unbiased analysis of the dynamics of transcription factors that can shuttle between the nucleus and other cell compartments.	[Zambrano, Samuel; Bianchi, Marco E.] San Raffaele Univ, Milan, Italy; [Bianchi, Marco E.; Agresti, Alessandra] Ist Sci San Raffaele, Genet & Cell Biol Div, I-20132 Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Agresti, A (corresponding author), Ist Sci San Raffaele, Genet & Cell Biol Div, I-20132 Milan, Italy.	agresti.alessandra@hsr.it	Bianchi, Marco Emilio/K-3417-2018; Agresti, Alessandra/Q-4394-2019; Zambrano, Samuel/K-5244-2016; Agresti, Alessandra/K-5228-2016	Bianchi, Marco Emilio/0000-0002-5329-6445; Agresti, Alessandra/0000-0001-5006-9506; Agresti, Alessandra/0000-0001-5006-9506; Zambrano, Samuel/0000-0002-9384-2017	Intra-European Fellowships for career development [2011-298447NonLinKB]; Italian AIRC [R0444];  [IEF-2011-298447]	Intra-European Fellowships for career development; Italian AIRC(Fondazione AIRC per la ricerca sul cancro); 	SZ is supported by the Intra-European Fellowships for career development-2011-298447NonLinKB. The work was supported by the IEF-2011-298447 research funding to SZ and the Italian AIRC 2010/2013 project No R0444 - to MEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Chazotte B, 2008, CSH PROTOCOLS; De Lorenzi R, 2009, GENESIS, V47, P323, DOI 10.1002/dvg.20468; Di Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052337; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Kalita MK, 2011, J BIOL CHEM, V286, P37741, DOI 10.1074/jbc.M111.280925; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Lipniacki T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-376; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Mora-Bermudez F, 2007, METHODS, V41, P158, DOI 10.1016/j.ymeth.2006.07.035; Nedelec F, 2001, PHYS REV LETT, V86, P3192, DOI 10.1103/PhysRevLett.86.3192; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Paszek P, 2010, P NATL ACAD SCI USA, V107, P11644, DOI 10.1073/pnas.0913798107; Purschke M, 2010, PHOTOCH PHOTOBIO SCI, V9, P1634, DOI 10.1039/c0pp00234h; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Schwarzfischer M, 2011, P MICR AN APPL BIOL; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Tay S, 2010, NATURE; Turner DA, 2010, J CELL SCI, V123, P2834, DOI 10.1242/jcs.069641; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Zambrano S, 2014, J THEORETIC IN PRESS	29	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90104	10.1371/journal.pone.0090104	http://dx.doi.org/10.1371/journal.pone.0090104			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595030	Green Submitted, Green Published, gold			2022-12-25	WOS:000332475500034
J	Das, S; Pal, U; Das, S; Bagga, K; Roy, A; Mrigwani, A; Maiti, NC				Das, Swagata; Pal, Uttam; Das, Supriya; Bagga, Khyati; Roy, Anupam; Mrigwani, Arpita; Maiti, Nakul C.			Sequence Complexity of Amyloidogenic Regions in Intrinsically Disordered Human Proteins	PLOS ONE			English	Article							MOLECULAR RECOGNITION FEATURES; FIBRIL-FORMING SEGMENTS; AGGREGATION-PRONE; ALPHA-SYNUCLEIN; UNSTRUCTURED PROTEINS; BINDING REGIONS; TAU-PROTEIN; WEB SERVER; PREDICTION; DETERMINANTS	An amyloidogenic region (AR) in a protein sequence plays a significant role in protein aggregation and amyloid formation. We have investigated the sequence complexity of AR that is present in intrinsically disordered human proteins. More than 80% human proteins in the disordered protein databases (DisProt+IDEAL) contained one or more ARs. With decrease of protein disorder, AR content in the protein sequence was decreased. A probability density distribution analysis and discrete analysis of AR sequences showed that similar to 8% residue in a protein sequence was in AR and the region was in average 8 residues long. The residues in the AR were high in sequence complexity and it seldom overlapped with low complexity regions (LCR), which was largely abundant in disorder proteins. The sequences in the AR showed mixed conformational adaptability towards alpha-helix, beta-sheet/strand and coil conformations.	[Das, Swagata; Pal, Uttam; Das, Supriya; Bagga, Khyati; Roy, Anupam; Mrigwani, Arpita; Maiti, Nakul C.] Indian Inst Chem Biol, Council Sci & Ind Res, Struct Biol & Bioinformat Div, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Maiti, NC (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Struct Biol & Bioinformat Div, Kolkata, India.	ncmaiti@iicb.res.in	Pal, Uttam/A-8544-2013; Maiti, Nakul/GLR-3207-2022; Mrigwani, Arpita/AAA-7227-2022	Pal, Uttam/0000-0003-2110-4610; Maiti, Nakul/0000-0002-8498-6502; 	grant GENESIS from the Council of Scientific & Industrial Research (CSIR), India [BSC0121]; grant miND from the Council of Scientific & Industrial Research (CSIR), India	grant GENESIS from the Council of Scientific & Industrial Research (CSIR), India; grant miND from the Council of Scientific & Industrial Research (CSIR), India	This work was supported by grants GENESIS (BSC0121) and miND from the Council of Scientific & Industrial Research (CSIR), India. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; Al-Ali H, 2010, BIOCHEM BIOPH RES CO, V391, P1104, DOI 10.1016/j.bbrc.2009.12.032; Alba MM, 2002, BIOINFORMATICS, V18, P672, DOI 10.1093/bioinformatics/18.5.672; Bemporad F, 2006, ACCOUNTS CHEM RES, V39, P620, DOI 10.1021/ar050067x; Bryson K, 2007, CURR PROTEIN PEPT SC, V8, P181, DOI 10.2174/138920307780363415; Burra PV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012069; Caflisch A, 2006, CURR OPIN CHEM BIOL, V10, P437, DOI 10.1016/j.cbpa.2006.07.009; Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dosztanyi Z, 2010, BRIEF BIOINFORM, V11, P225, DOI 10.1093/bib/bbp061; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Du ZQ, 2011, PRION, V5, P311, DOI [10.4161/pri.5.4.18304, 10.4161/pri.18304]; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dunker K, 2002, HUM GENOME NEWS, V12, P13; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Angarica VE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-316; Esteras-Chopo A, 2005, P NATL ACAD SCI USA, V102, P16672, DOI 10.1073/pnas.0505905102; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Frousios KK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-44; Fukuchi S, 2012, NUCLEIC ACIDS RES, V40, pD507, DOI 10.1093/nar/gkr884; Galzitskaya OV, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/28/285225; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Halfmann R, 2011, MOL CELL, V43, P72, DOI 10.1016/j.molcel.2011.05.013; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Hegyi H, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000552; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Huang K, 2006, BIOCHEMISTRY-US, V45, P10278, DOI 10.1021/bi060879g; Huntley MA, 2002, PROTEINS, V48, P134, DOI 10.1002/prot.10150; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karlin S, 1996, P NATL ACAD SCI USA, V93, P1560, DOI 10.1073/pnas.93.4.1560; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Lise S, 2005, PROTEINS, V58, P144, DOI 10.1002/prot.20279; Maestro B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056904; Magrane M, 2011, UNIPROT KNOWLEDGEBAS; Malinovska L, 2013, BBA-PROTEINS PROTEOM, V1834, P918, DOI 10.1016/j.bbapap.2013.01.003; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Mohan A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000497; Monsellier E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000199; Orosz F, 2011, BIOINFORMATICS, V27, P1449, DOI 10.1093/bioinformatics/btr175; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Pedersen JS, 2004, J MOL BIOL, V341, P575, DOI 10.1016/j.jmb.2004.06.020; Pietrosemoli N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055524; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Raghava G, 2000, APSSP ADV PROTEIN SE, V4, P75; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schad E, 2013, NUCLEIC ACIDS RES, V41, P4409, DOI 10.1093/nar/gkt110; Schlessinger A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004433; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Shin SW, 2005, BIOINFORMATICS, V21, P160, DOI 10.1093/bioinformatics/bth497; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tartaglia GG, 2005, PROTEIN SCI, V14, P2723, DOI 10.1110/ps.051471205; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Teng PK, 2009, PROTEIN ENG DES SEL, V22, P531, DOI 10.1093/protein/gzp037; Thompson A, 2000, J NEUROSCI RES, V62, P293, DOI 10.1002/1097-4547(20001015)62:2<293::AID-JNR14>3.0.CO;2-Y; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tian J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S45; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wang X, J BIOL CHEM, V285, P4951; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; WOOTTON JC, 1994, CURR OPIN STRUC BIOL, V4, P413, DOI 10.1016/S0959-440X(94)90111-2; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yagi H, 2010, BBA-PROTEINS PROTEOM, V1804, P2077, DOI 10.1016/j.bbapap.2010.07.007; Yoon S, 2004, PROTEIN SCI, V13, P2149, DOI 10.1110/ps.04790604; Zhang ZQ, 2007, BIOINFORMATICS, V23, P2218, DOI 10.1093/bioinformatics/btm325	89	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89781	10.1371/journal.pone.0089781	http://dx.doi.org/10.1371/journal.pone.0089781			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594841	Green Submitted, gold, Green Published			2022-12-25	WOS:000332468900035
J	Storm, MP; Kumpfmueller, B; Bone, HK; Buchholz, M; Ripoll, YS; Chaudhuri, JB; Niwa, H; Tosh, D; Welham, MJ				Storm, Michael P.; Kumpfmueller, Benjamin; Bone, Heather K.; Buchholz, Michael; Ripoll, Yolanda Sanchez; Chaudhuri, Julian B.; Niwa, Hitoshi; Tosh, David; Welham, Melanie J.			Zscan4 Is Regulated by PI3-Kinase and DNA-Damaging Agents and Directly Interacts with the Transcriptional Repressors LSD1 and CtBP2 in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							SELF-RENEWAL; SCAN DOMAIN; GENOMIC STABILITY; GENE-EXPRESSION; PLURIPOTENCY; ACTIVATION; DIFFERENTIATION; PROTEIN; PROLIFERATION; INVOLVEMENT	The Zscan4 family of genes, encoding SCAN-domain and zinc finger-containing proteins, has been implicated in the control of early mammalian embryogenesis as well as the regulation of pluripotency and maintenance of genome integrity in mouse embryonic stem cells. However, many features of this enigmatic family of genes are poorly understood. Here we show that undifferentiated mouse embryonic stem cell (ESC) lines simultaneously express multiple members of the Zscan4 gene family, with Zscan4c, Zscan4f and Zscan4-ps2 consistently being the most abundant. Despite this, between only 0.1 and 0.7% of undifferentiated mouse pluripotent stem cells express Zscan4 protein at a given time, consistent with a very restricted pattern of Zscan4 transcripts reported previously. Herein we demonstrate that Zscan4 expression is regulated by the p110 alpha catalytic isoform of phosphoinositide 3-kinases and is induced following exposure to a sub-class of DNA-damage-inducing agents, including Zeocin and Cisplatin. Furthermore, we observe that Zscan4 protein expression peaks during the G2 phase of the cell cycle, suggesting that it may play a critical role at this checkpoint. Studies with GAL4-fusion proteins suggest a role for Zscan4 in transcriptional regulation, further supported by the fact that protein interaction analyses demonstrate that Zscan4 interacts with both LSD1 and CtBP2 in ESC nuclei. This study advances and extends our understanding of Zscan4 expression, regulation and mechanism of action. Based on our data we propose that Zscan4 may regulate gene transcription in mouse ES cells through interaction with LSD1 and CtBP2.	[Storm, Michael P.; Kumpfmueller, Benjamin; Bone, Heather K.; Ripoll, Yolanda Sanchez; Welham, Melanie J.] Univ Bath, Ctr Regenerat Med, Bath BA2 7AY, Avon, England; [Storm, Michael P.; Kumpfmueller, Benjamin; Bone, Heather K.; Ripoll, Yolanda Sanchez; Welham, Melanie J.] Univ Bath, Dept Pharm, Bath BA2 7AY, Avon, England; [Storm, Michael P.; Kumpfmueller, Benjamin; Bone, Heather K.; Ripoll, Yolanda Sanchez; Welham, Melanie J.] Univ Bath, Dept Pharmacol, Bath BA2 7AY, Avon, England; [Buchholz, Michael; Tosh, David] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Kumpfmueller, Benjamin; Chaudhuri, Julian B.] Univ Bath, Dept Chem Engn, Bath, Avon, England; [Niwa, Hitoshi] RIKEN, Ctr Dev Biol, Kobe, Hyogo, Japan	University of Bath; University of Bath; University of Bath; University of Bath; University of Bath; RIKEN	Welham, MJ (corresponding author), Univ Bath, Ctr Regenerat Med, Bath BA2 7AY, Avon, England.	M.J.Welham@bath.ac.uk	Storm, Mike/AAC-8733-2020		Medical Research Council [G0801108]; Marie Curie Early Stage Training programme [MEST-CT-2005-019822]; MRC; MRC [G0801108] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie Early Stage Training programme(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by grant G0801108 from The Medical Research Council (http://www.mrc.ac.uk/index.htm). BK and MB were supported by the Marie Curie Early Stage Training programme MEST-CT-2005-019822. YSR was the recipient of an MRC Capacity Building Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2966; Boeuf H, 1997, J CELL BIOL, V138, P1207, DOI 10.1083/jcb.138.6.1207; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bone HK, 2009, CHEM BIOL, V16, P15, DOI 10.1016/j.chembiol.2008.11.003; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Costello I, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-54; Crabbe T, 2007, TRENDS BIOCHEM SCI, V32, P450, DOI 10.1016/j.tibs.2007.09.001; Craddock BL, 2001, J BIOL CHEM, V276, P24274, DOI 10.1074/jbc.M009098200; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; Era T, 2000, P NATL ACAD SCI USA, V97, P1737, DOI 10.1073/pnas.97.4.1737; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hirata T, 2012, SCI REPORTS, V2, P1; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Jiang J, 2013, CELL RES, V23, P92, DOI 10.1038/cr.2012.157; Kingham E, 2009, J CELL SCI, V122, P2311, DOI 10.1242/jcs.046557; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Marmorstein R, 2009, BIOCH BIOPHYS ACTA, V1789; Nagaria P, 2013, BBA-GEN SUBJECTS, V1830, P2345, DOI 10.1016/j.bbagen.2012.09.001; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Orlando L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030234; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SAVATIER P, 1994, ONCOGENE, V9, P809; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; Schumacher C, 2000, J BIOL CHEM, V275, P17173, DOI 10.1074/jbc.M000119200; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; SMITH AG, 1987, DEV BIOL, V121, P1, DOI 10.1016/0012-1606(87)90132-1; Stone JR, 2002, J BIOL CHEM, V277, P5448, DOI 10.1074/jbc.M109815200; Storm MP, 2009, STEM CELLS, V27, P764, DOI 10.1002/stem.3; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Turinetto V, 2012, STEM CELLS, V30, P1414, DOI 10.1002/stem.1133; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Welham MJ, 2011, BIOCHEM SOC T, V39, P674, DOI 10.1042/BST0390674; WELHAM MJ, 1994, J BIOL CHEM, V269, P21165; Williams AJ, 1999, MOL CELL BIOL, V19, P8526; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zhang W, 2006, NUCLEIC ACIDS RES, V34, P4780, DOI 10.1093/nar/gkl631	60	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89821	10.1371/journal.pone.0089821	http://dx.doi.org/10.1371/journal.pone.0089821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594919	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900036
J	Xiong, CR; Fang, FJ; Chen, L; Yang, QG; He, J; Zhou, D; Shen, B; Ma, L; Sun, Y; Zhang, DH; Zhu, CL				Xiong, Chunrong; Fang, Fujin; Chen, Lin; Yang, Qinggui; He, Ji; Zhou, Dan; Shen, Bo; Ma, Lei; Sun, Yan; Zhang, Donghui; Zhu, Changliang			Trypsin-Catalyzed Deltamethrin Degradation	PLOS ONE			English	Article							CHYMOTRYPSIN; METABOLISM; ABSORPTION; DIGESTION	To explore if trypsin could catalyze the degradation of non-protein molecule deltamethrin, we compared in vitro hydrolytic reactions of deltamethrin in the presence and absence of trypsin with ultraviolet-visible (UV/Vis) spectrophotometry and gas chromatography-mass spectrometry (GC/MS). In addition, acute oral toxicity of the degradation products was determined in Wistar rats. The results show that the absorption peak of deltamethrin is around 264 nm, while the absorption peaks of eltamethrin degradation products are around 250 nm and 296 nm. In our GC setting, the retention time of undegraded deltamethrin was 37.968 min, while those of deltamethrin degradation products were 15.289 min and 18.730 min. The LD50 of deltamethrin in Wistar rats is 55 mg/kg, while that of deltamethrin degradation products is 3358 mg/kg in female rats and 1045 mg/kg in male rates (61-fold and 19-fold reductions in toxicity), suggesting that trypsin could directly degrade deltamethrin, which significantly reduces the toxicity of deltamethrin. These results expand people's understanding of the functions of proteases and point to potential applications of trypsin as an attractive agent to control residual pesticides in the environment and on agricultural products.	[Xiong, Chunrong; Fang, Fujin; Chen, Lin; Yang, Qinggui; He, Ji; Zhou, Dan; Shen, Bo; Ma, Lei; Sun, Yan; Zhang, Donghui; Zhu, Changliang] Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Xiong, Chunrong; Fang, Fujin; Chen, Lin; Yang, Qinggui; He, Ji; Zhou, Dan; Shen, Bo; Ma, Lei; Sun, Yan; Zhang, Donghui; Zhu, Changliang] Jiangsu Prov Key Lab Modern Pathogen Biol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhang, DH (corresponding author), Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China.	donghuizhang2004@gmail.com			Academic Natural Science Foundation of Jiangsu Province [07KJD180137]; National Institutes of Health of the USA [R01AI075746]; National Natural Science Foundation of China [30972564, 81171900, 30901244]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075746] Funding Source: NIH RePORTER	Academic Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Institutes of Health of the USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Academic Natural Science Foundation of Jiangsu Province (No. 07KJD180137 to Donghui Zhang), the National Institutes of Health of the USA (No. R01AI075746 to Changliang Zhu) and the National Natural Science Foundation of China (Nos. 30972564 and 81171900 to Changliang Zhu, No. 30901244 to Yan Sun). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, World Health Organ Tech Rep Ser, V818, P1; Chen SH, 2011, APPL MICROBIOL BIOT, V90, P755, DOI 10.1007/s00253-010-3035-z; ERICKSON RH, 1990, ANNU REV MED, V41, P133; FREEMAN HJ, 1978, ANNU REV MED, V29, P99, DOI 10.1146/annurev.me.29.020178.000531; Gong MQ, 2005, ARCH BIOCHEM BIOPHYS, V438, P53, DOI 10.1016/j.abb.2005.03.021; Krem MM, 2001, EMBO J, V20, P3036, DOI 10.1093/emboj/20.12.3036; KUNDU N, 1970, NATURE, V226, P1171, DOI 10.1038/2261171a0; Kushida K, 2001, J CHROMATOGR B, V762, P137, DOI 10.1016/S0378-4347(01)00353-X; Leng G, 2005, J CHROMATOGR B, V814, P285, DOI 10.1016/j.jchromb.2004.10.044; MCLAREN AD, 1957, ARCH BIOCHEM BIOPHYS, V68, P157, DOI 10.1016/0003-9861(57)90336-3; Modi SJ, 2006, J CHROMATOGR A, V1118, P125, DOI 10.1016/j.chroma.2006.02.045; Muhlia-Almazan A, 2008, J COMP PHYSIOL B, V178, P655, DOI 10.1007/s00360-008-0263-y; Ramesh A, 2004, J CHROMATOGR B, V802, P371, DOI 10.1016/j.jchromb.2003.12.016; Rawlings N.D., 1998, HDB PROTEOLYTIC ENZY, P369; Ross MK, 2006, BIOCHEM PHARMACOL, V71, P657, DOI 10.1016/j.bcp.2005.11.020; Wu HW, 2004, PESTIC BIOCHEM PHYS, V79, P75, DOI 10.1016/j.pestbp.2004.04.004; Yang QG, 2008, TOXICOL IN VITRO, V22, P1528, DOI 10.1016/j.tiv.2008.05.007; Zheng YZ, 2007, APPL BIOCHEM BIOTECH, V136, P233, DOI 10.1007/s12010-007-9022-x	18	13	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89517	10.1371/journal.pone.0089517	http://dx.doi.org/10.1371/journal.pone.0089517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594869	Green Submitted, gold, Green Published			2022-12-25	WOS:000332468900021
J	Senatore, A; Guan, W; Boone, AN; Spafford, JD				Senatore, Adriano; Guan, Wendy; Boone, Adrienne N.; Spafford, J. David			T-type Channels Become Highly Permeable to Sodium Ions Using an Alternative Extracellular Turret Region ( S5-P) Outside the Selectivity Filter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Calcium Channels; Heart; Patch Clamp Electrophysiology; Permeability; Sodium Channels	CRYSTAL-STRUCTURE; CALCIUM-CHANNEL; K+ CHANNEL; POTASSIUM CHANNEL; CA2+ CHANNELS; MUSCLE CELLS; VOLTAGE; INHIBITOR; LYMNAEA; PORE	Background: Ion selectivity of voltage-gated channels is governed by selectivity filters. Results: Alternative turret region in domain II promotes highly sodium-permeable T-type channels without major changes to gating and kinetic features. Conclusion: T-type channels can generate variable sodium or calcium permeability by gene splicing. Significance: Ion selectivity in T-type channels can be altered using extracellular domains outside the ion selectivity filter. T-type (Ca(v)3) channels are categorized as calcium channels, but invertebrate ones can be highly sodium-selective channels. We illustrate that the snail LCa(v)3 T-type channel becomes highly sodium-permeable through exon splicing of an extracellular turret and descending helix in domain II of the four-domain Ca(v)3 channel. Highly sodium-permeable T-type channels are generated without altering the invariant ring of charged residues in the selectivity filter that governs calcium selectivity in calcium channels. The highly sodium-permeant T-type channel expresses in the brain and is the only splice isoform expressed in the snail heart. This unique splicing of turret residues offers T-type channels a capacity to serve as a pacemaking sodium current in the primitive heart and brain in lieu of Na(v)1-type sodium channels and to substitute for voltage-gated sodium channels lacking in many invertebrates. T-type channels would also contribute substantially to sodium leak conductances at rest in invertebrates because of their large window currents.	[Senatore, Adriano; Guan, Wendy; Boone, Adrienne N.; Spafford, J. David] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Spafford, JD (corresponding author), Univ Waterloo, Dept Biol, B1-173, Waterloo, ON N2L 3G1, Canada.	spafford@uwaterloo.ca			Heart and Stroke Foundation of Canada; Natural Sciences and Engineering Research Council of Canada; Natural Sciences and Engineering Research Council of Canada Graduate Scholarship; Ontario Graduate Scholarship award	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council of Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship award(Ontario Graduate Scholarship)	This work was supported in part by a Heart and Stroke Foundation of Canada grant-in-aid and Natural Sciences and Engineering Research Council of Canada discovery grant ( to J. D. S.).; Supported by Natural Sciences and Engineering Research Council of Canada Graduate Scholarship and Ontario Graduate Scholarship award.	Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Brezden BL, 1999, J NEUROPHYSIOL, V81, P1818, DOI 10.1152/jn.1999.81.4.1818; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Cheng RCK, 2010, EUR BIOPHYS J BIOPHY, V39, P839, DOI 10.1007/s00249-009-0574-2; Dawson T. F., 2014, PLOS ONE IN PRESS; Doering CJ, 2003, J BIOENERG BIOMEMBR, V35, P491, DOI 10.1023/B:JOBB.0000008022.50702.1a; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EISENMAN G, 1967, SCIENCE, V155, P965, DOI 10.1126/science.155.3765.965; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HESS P, 1986, J GEN PHYSIOL, V88, P293, DOI 10.1085/jgp.88.3.293; Hill, 2001, ION CHANNELS EXCITAB, P441; Hobert Oliver, 2013, WormBook, P1, DOI 10.1895/wormbook.1.161.1; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Huang X, 2010, J EXP BIOL, V213, P2094, DOI 10.1242/jeb.042242; Imredy JP, 1998, BIOCHEMISTRY-US, V37, P14867, DOI 10.1021/bi980929k; Jin WL, 1998, BIOCHEMISTRY-US, V37, P13291, DOI 10.1021/bi981178p; Khan N, 2008, J GEN PHYSIOL, V132, P223, DOI 10.1085/jgp.200809986; KOSTYUK PG, 1983, J MEMBRANE BIOL, V76, P83, DOI 10.1007/BF01871455; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Liebeskind BJ, 2011, P NATL ACAD SCI USA, V108, P9154, DOI 10.1073/pnas.1106363108; Lin YCJ, 2001, J EXP BIOL, V204, P3717; Lu Z, 1997, BIOCHEMISTRY-US, V36, P6936, DOI 10.1021/bi9702849; McComb C, 2005, J EXP BIOL, V208, P1459, DOI 10.1242/jeb.01544; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Nagle GT, 2001, EUR J BIOCHEM, V268, P1213, DOI 10.1046/j.1432-1327.2001.01972.x; Nikitin ES, 2008, CURR BIOL, V18, P1221, DOI 10.1016/j.cub.2008.07.030; Ono K, 2005, J PHARMACOL SCI, V99, P197, DOI 10.1254/jphs.FMJ05002X2; OPDYKE CA, 1994, J COMP PHYSIOL A, V175, P781; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Schlief T, 1996, EUR BIOPHYS J BIOPHY, V25, P75, DOI 10.1007/s002490050020; Senatore A, 2014, PFLUG ARCH EUR J PHY, V466, P645, DOI 10.1007/s00424-014-1449-7; Senatore A., 2012, WIRES MEMBR TRANSP S, V1, P467, DOI DOI 10.1002/WMTS.41; Senatore A, 2013, CHANNELS, V7, P60, DOI 10.4161/chan.23981; Senatore A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055088; Senatore A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037409; Senatore A, 2011, CHANNELS, V5, P173, DOI 10.4161/chan.5.2.15141; Senatore A, 2010, J BIOL CHEM, V285, P7447, DOI 10.1074/jbc.M109.090753; Shcheglovitov A, 2007, BBA-BIOMEMBRANES, V1768, P1406, DOI 10.1016/j.bbamem.2007.02.017; Spafford J. D., 2011, JOVE-J VIS EXP, V47, P2314; STRONG M, 1993, MOL BIOL EVOL, V10, P221; Talavera K, 2001, J BIOL CHEM, V276, P45628, DOI 10.1074/jbc.M103047200; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Thomas D, 2008, NEURON, V58, P859, DOI 10.1016/j.neuron.2008.04.016; Yeoman MS, 1999, J NEUROPHYSIOL, V82, P2428, DOI 10.1152/jn.1999.82.5.2428; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	49	18	18	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11952	11969		10.1074/jbc.M114.551473	http://dx.doi.org/10.1074/jbc.M114.551473			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24596098	Green Published, hybrid			2022-12-25	WOS:000335010600035
J	Buttner, FM; Zoll, S; Nega, M; Gotz, F; Stehle, T				Buettner, Felix Michael; Zoll, Sebastian; Nega, Mulugeta; Goetz, Friedrich; Stehle, Thilo			Structure-Function Analysis of Staphylococcus aureus Amidase Reveals the Determinants of Peptidoglycan Recognition and Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drug Design; Enzyme Mechanisms; Peptidoglycan; Staphylococcus aureus; X-ray Crystallography; Zinc; MRSA; Amidase; Autolysin; Complex Structure	MAJOR AUTOLYSIN; CELL-WALLS; BIOFILMS; EPIDERMIDIS; LYSOZYME; FEATURES; ENZYMES; ACID; AMPD	Background: Autolysins ensure the plasticity of bacterial cell walls, and deletion leads to impaired cell clusters. Results: High resolution structures of Staphylococcus aureus amidase AmiA shed light on peptidoglycan binding and cleavage. Conclusion: AmiA distinguishes peptidoglycan mostly by the peptide, and cleavage is facilitated by a zinc-activated water molecule. Significance: These structures will inform strategies to develop new therapeutics against MRSA. The bifunctional major autolysin AtlA of Staphylococcus aureus cleaves the bacterium's peptidoglycan network (PGN) at two distinct sites during cell division. Deletion of the enzyme results in large cell clusters with disordered division patterns, indicating that AtlA could be a promising target for the development of new antibiotics. One of the two functions of AtlA is performed by the N-acetylmuramyl-l-alanine amidase AmiA, which cleaves the bond between the carbohydrate and the peptide moieties of PGN. To establish the structural requirements of PGN recognition and the enzymatic mechanism of cleavage, we solved the crystal structure of the catalytic domain of AmiA (AmiA-cat) in complex with a peptidoglycan-derived ligand at 1.55 resolution. The peptide stem is clearly visible in the structure, forming extensive contacts with protein residues by docking into an elongated groove. Less well defined electron density and the analysis of surface features indicate likely positions of the carbohydrate backbone and the pentaglycine bridge. Substrate specificity analysis supports the importance of the pentaglycine bridge for fitting into the binding cleft of AmiA-cat. PGN of S. aureus with l-lysine tethered with d-alanine via a pentaglycine bridge is completely hydrolyzed, whereas PGN of Bacillus subtilis with meso-diaminopimelic acid directly tethered with d-alanine is not hydrolyzed. An active site mutant, H370A, of AmiA-cat was completely inactive, providing further support for the proposed catalytic mechanism of AmiA. The structure reported here is not only the first of any bacterial amidase in which both the PGN component and the water molecule that carries out the nucleophilic attack on the carbonyl carbon of the scissile bond are present; it is also the first peptidoglycan amidase complex structure of an important human pathogen.	[Buettner, Felix Michael; Zoll, Sebastian; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Nega, Mulugeta; Goetz, Friedrich] Univ Tubingen, Interfac Inst Microbiol & Infect Med, D-72076 Tubingen, Germany; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Vanderbilt University	Stehle, T (corresponding author), Univ Tubingen, Interfac Inst Biochem, Hoppe Seyler Str 4, D-72076 Tubingen, Germany.	thilo.stehle@uni-tuebingen.de		Zoll, Sebastian/0000-0001-5376-9698	Collaborative Research Center TRR34	Collaborative Research Center TRR34	This work was supported by the Collaborative Research Center TRR34.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht T, 2012, J BACTERIOL, V194, P2630, DOI 10.1128/JB.06609-11; [Anonymous], 2012, ACD CHEMSKETCH FREEW; Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baron Samuel, 1996, MED MICROBIOLOGY; Biswas R, 2006, FEMS MICROBIOL LETT, V259, P260, DOI 10.1111/j.1574-6968.2006.00281.x; Boneca IG, 2000, J BIOL CHEM, V275, P9910, DOI 10.1074/jbc.275.14.9910; Carrasco-Lopez C, 2011, J BIOL CHEM, V286, P31714, DOI 10.1074/jbc.M111.264366; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHENG XD, 1994, P NATL ACAD SCI USA, V91, P4034, DOI 10.1073/pnas.91.9.4034; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11255; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; European Antimicrobial Resistance Surveillance System, 2009, EARSS ANN REP 2008, P55; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Gotz F, 2000, INFECT ASS INDWELLIN, P55; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kerff F, 2010, J MOL BIOL, V397, P249, DOI 10.1016/j.jmb.2009.12.038; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; Kohlenberg A, 2008, CLIN MICROBIOL INFEC, V14, P93, DOI 10.1111/j.1469-0691.2007.01879.x; Kresken M., 2009, RESISTENZSITUATION B, P9; Liepinsh E, 2003, J MOL BIOL, V327, P833, DOI 10.1016/S0022-2836(03)00185-2; Low LY, 2011, J BIOL CHEM, V286, P34391, DOI 10.1074/jbc.M111.244160; Low LY, 2005, J BIOL CHEM, V280, P35433, DOI 10.1074/jbc.M502723200; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lutzner N, 2009, BIOCHEM BIOPH RES CO, V380, P554, DOI 10.1016/j.bbrc.2009.01.140; Martinez-Caballero S, 2013, J AM CHEM SOC, V135, P10318, DOI 10.1021/ja405464b; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Prigozhin DM, 2013, J BIOL CHEM, V288, P31549, DOI 10.1074/jbc.M113.510792; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stratagene, 2006, QUIKCHANGE SIT DIR M; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; WARTH AD, 1971, BIOCHEMISTRY-US, V10, P4349, DOI 10.1021/bi00800a001; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang DC, 2012, MOL MICROBIOL, V85, P768, DOI 10.1111/j.1365-2958.2012.08138.x; Zeller John L, 2007, JAMA, V298, P1826, DOI 10.1001/jama.298.15.1826; Zoll S, 2012, J BACTERIOL, V194, P3789, DOI 10.1128/JB.00331-12; Zoll S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000807	59	23	23	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11083	11094		10.1074/jbc.M114.557306	http://dx.doi.org/10.1074/jbc.M114.557306			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599952	hybrid, Green Published			2022-12-25	WOS:000334638500013
J	Yuan, G; Yan, SF; Xue, H; Zhang, P; Sun, JT; Li, G				Yuan, Guang; Yan, Shao-Feng; Xue, Hao; Zhang, Ping; Sun, Jin-Tang; Li, Gang			Cucurbitacin I Induces Protective Autophagy in Glioblastoma in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Autophagy; Glioblastoma; Hypoxia-inducible Factor (HIF); Signal Transduction; Chloroquine; Cucurbitacin I	CELL-CYCLE ARREST; SIGNAL TRANSDUCER; MEDIATED APOPTOSIS; CANCER-CELLS; STAT3; INHIBITION; ACTIVATION; INDUCTION; TARGET; DEATH	Background: Targeting disruption of STAT3 results in inhibition of tumor growth and survival in malignant glioma. Results: Cucurbitacin I triggers protective autophagy through the AMPK/mTOR/p70S6K pathway and down-regulates HIF-1. Conclusion: Autophagy blockade sensitizes glioblastoma to cucurbitacin I treatment. Significance: This study provides new insights into the biological and antiproliferative activities of cucurbitacin I against glioblastoma. There is an urgent need for new therapeutic avenues to improve the outcome of patients with glioblastoma multiforme (GBM). Current studies have suggested that cucurbitacin I, a natural selective inhibitor of JAK2/STAT3, has a potent anticancer effect on a variety of cancer cell types. This study showed that autophagy and apoptosis were induced by cucurbitacin I. Exposure of GBM cells to cucurbitacin I resulted in pronounced apoptotic cell death through activating bcl-2 family proteins. Cells treatment with cucurbitacin I up-regulated Beclin 1 and triggered autophagosome formation and accumulation as well as conversion of LC3I to LC3II. Activation of the AMP-activated protein kinase/mammalian target of rapamycin/p70S6K pathway, but not the PI3K/AKT pathway, occurred in autophagy induced by cucurbitacin I, which was accompanied by decreased hypoxia-inducible factor 1. Stable overexpression of hypoxia-inducible factor 1 induced by FG-4497 prevented cucurbitacin I-induced autophagy and down-regulation of bcl-2. Knockdown of beclin 1 or treatment with the autophagy inhibitor 3-methyladenine also inhibited autophagy induced by cucurbitacin I. A coimmunoprecipitation assay showed that the interaction of Bcl-2 and Beclin 1/hVps34 decreased markedly in cells treated with cucurbitacin I. Furthermore, knockdown of beclin 1 or treatment with the lysosome inhibitor chloroquine sensitized cancer cells to cucurbitacin I-induced apoptosis. Finally, a xenograft model provided additional evidence for the occurrence of cucurbitacin I-induced apoptosis and autophagy in vitro. Our findings provide new insights into the molecular mechanisms underlying cucurbitacin I-mediated GBM cell death and may provide an efficacious therapy for patients harboring GBM.	[Yuan, Guang; Yan, Shao-Feng; Xue, Hao; Zhang, Ping; Li, Gang] Shandong Univ, Dept Neurosurg, Qilu Hosp, Jinan 250012, Shandong, Peoples R China; [Yuan, Guang; Li, Gang] Shandong Univ, Brain Sci Res Inst, Jinan 250012, Shandong, Peoples R China; [Sun, Jin-Tang] Shandong Univ, Inst Basic Med Sci, Qilu Hosp, Jinan 250012, Shandong, Peoples R China; [Sun, Jin-Tang] Shandong Univ, Key Lab Cardiovasc Prote Shandong Prov, Qilu Hosp, Jinan 250012, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Li, G (corresponding author), Shandong Univ, Dept Neurosurg, Qilu Hosp, 107 Wenhua Western Rd, Jinan 250012, Shandong, Peoples R China.	doctorligang@126.com	Xue, Hao/GXV-4717-2022		Natural Science Foundation of China [81172403]; Independent Innovation Foundation of Shandong University [IIFSDU2009TS067]; Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province [BS2010YY022]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University; Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province	This work was supported by Natural Science Foundation of China Grant 81172403, by Independent Innovation Foundation of Shandong University Grant IIFSDU2009TS067, and by Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province Grant BS2010YY022.	Anglesio MS, 2011, CLIN CANCER RES, V17, P2538, DOI 10.1158/1078-0432.CCR-10-3314; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Banerjee S, 2010, CANCER RES, V70, P1356, DOI 10.1158/0008-5472.CAN-09-2178; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bommareddy A, 2009, CANCER RES, V69, P3704, DOI 10.1158/0008-5472.CAN-08-4344; Cao Yiting, 2010, Genes Cancer, V1, P50; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chan KS, 2008, ONCOGENE, V27, P1087, DOI 10.1038/sj.onc.1210726; Chen JC, 2005, NAT PROD REP, V22, P386, DOI 10.1039/b418841c; Chen N, 2011, CANCER BIOL THER, V11, P157, DOI 10.4161/cbt.11.2.14622; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Garner JM, 2013, J BIOL CHEM, V288, P26167, DOI 10.1074/jbc.M113.477950; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Horiguchi A, 2010, BRIT J CANCER, V102, P1592, DOI 10.1038/sj.bjc.6605691; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Huang SB, 2011, J BIOL CHEM, V286, P40002, DOI 10.1074/jbc.M111.297432; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Kandala PK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-9; Kim DJ, 2007, MOL CARCINOGEN, V46, P725, DOI 10.1002/mc.20342; Kim KW, 2006, J BIOL CHEM, V281, P36883, DOI 10.1074/jbc.M607094200; Kim RH, 2009, CANCER RES, V69, P700, DOI 10.1158/0008-5472.CAN-08-3157; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Li Y, 2007, CANCER RES, V67, P8494, DOI 10.1158/0008-5472.CAN-07-0647; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Livesey KM, 2009, CURR OPIN INVEST DR, V10, P1269; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marino ML, 2012, J BIOL CHEM, V287, P30664, DOI 10.1074/jbc.M112.339127; Maycotte P, 2011, CANCER BIOL THER, V11, P127, DOI 10.4161/cbt.11.2.14627; Meijer AJ, 2009, CRIT REV CL LAB SCI, V46, P210, DOI 10.1080/10408360903044068; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Molavi O, 2008, IMMUNOL CELL BIOL, V86, P506, DOI 10.1038/icb.2008.27; Ogier-Denis E, 2003, BBA-REV CANCER, V1603, P113, DOI 10.1016/S0304-419X(03)00004-0; Park JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040531; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Redell MS, 2011, BLOOD, V117, P5701, DOI 10.1182/blood-2010-04-280123; Reischl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084767; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; Roca H, 2008, J BIOL CHEM, V283, P25057, DOI 10.1074/jbc.M801073200; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Stechishin OD, 2013, NEURO-ONCOLOGY, V15, P198, DOI 10.1093/neuonc/nos302; Su YH, 2008, CANCER BIOL THER, V7, P1243, DOI 10.4161/cbt.7.8.6263; Sy LK, 2008, CANCER RES, V68, P10229, DOI 10.1158/0008-5472.CAN-08-1983; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Turkson J, 2005, J BIOL CHEM, V280, P32979, DOI 10.1074/jbc.M502694200; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Wang H, 2009, STEM CELLS, V27, P2393, DOI 10.1002/stem.188; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yu HC, 2013, J BIOL CHEM, V288, P18249, DOI 10.1074/jbc.M112.446385; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhao W, 2010, J BIOL CHEM, V285, P35855, DOI 10.1074/jbc.M110.154088	62	66	68	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10607	10619		10.1074/jbc.M113.528760	http://dx.doi.org/10.1074/jbc.M113.528760			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24599950	Green Published, hybrid			2022-12-25	WOS:000334226400032
J	Hendrickx, C; Mateus, O				Hendrickx, Christophe; Mateus, Octavio			Torvosaurus gurneyi n. sp., the Largest Terrestrial Predator from Europe, and a Proposed Terminology of the Maxilla Anatomy in Nonavian Theropods	PLOS ONE			English	Article							DINOSAURIA THEROPODA; CARCHARODONTOSAURID DINOSAURIA; ABELISAURIDAE DINOSAURIA; CRANIAL ANATOMY; CONSENSUS TREES; PHYLOGENY; OSTEOLOGY; SKULL; PORTUGAL; IDENTIFICATION	The Lourinha Formation (Kimmeridgian-Tithonian) of Central West Portugal is well known for its diversified dinosaur fauna similar to that of the Morrison Formation of North America; both areas share dinosaur taxa including the top predator Torvosaurus, reported in Portugal. The material assigned to the Portuguese T. tanneri, consisting of a right maxilla and an incomplete caudal centrum, was briefly described in the literature and a thorough description of these bones is here given for the first time. A comparison with material referred to Torvosaurus tanneri allows us to highlight some important differences justifying the creation of a distinct Eastern species. Torvosaurus gurneyi n. sp. displays two autapomorphies among Megalosauroidea, a maxilla possessing fewer than eleven teeth and an interdental wall nearly coincidental with the lateral wall of the maxillary body. In addition, it differs from T. tanneri by a reduced number of maxillary teeth, the absence of interdental plates terminating ventrally by broad V-shaped points and falling short relative to the lateral maxillary wall, and the absence of a protuberant ridge on the anterior part of the medial shelf, posterior to the anteromedial process. T. gurneyi is the largest theropod from the Lourinha Formation of Portugal and the largest land predator discovered in Europe hitherto. This taxon supports the mechanism of vicariance that occurred in the Iberian Meseta during the Late Jurassic when the proto-Atlantic was already well formed. A fragment of maxilla from the Lourinha Formation referred to Torvosaurus sp. is ascribed to this new species, and several other bones, including a femur, a tibia and embryonic material all from the Kimmeridgian-Tithonian of Portugal, are tentatively assigned to T. gurneyi. A standard terminology and notation of the theropod maxilla is also proposed and a record of the Torvosaurus material from Portugal is given.	[Hendrickx, Christophe; Mateus, Octavio] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencias Terra, Caparica, Portugal; [Hendrickx, Christophe; Mateus, Octavio] Museu Lourinha, Lourinha, Portugal	Universidade Nova de Lisboa	Hendrickx, C (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencias Terra, Caparica, Portugal.	christophe.hendrickx@hotmail.com	Mateus, Octávio/F-2910-2010; Hendrickx, Christophe/D-6120-2016	Mateus, Octávio/0000-0003-1253-3616; Hendrickx, Christophe/0000-0002-8500-2405	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/62979/2009]; Dinoeggs Project [PTDC/BIA-EVF/113222/2009]; FCT/MEC (PIDDAC)	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Dinoeggs Project; FCT/MEC (PIDDAC)	This research was supported by the Fundacao para a Ciencia e a Tecnologia (FCT) scholarship SFRH/BD/62979/2009 (Ministerio da Ciencia, Tecnologia e Ensino superior, Portugal) and the Dinoeggs Project (PTDC/BIA-EVF/113222/2009) financed by FCT/MEC (PIDDAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes MT, 2003, CR PALEVOL, V2, P77, DOI 10.1016/S1631-0683(03)00003-4; Araujo R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01924; Balanoff AM, 2012, B AM MUS NAT HIST, P1; Barsbold R, 1999, ACTA PALAEONTOL POL, V44, P189; Benson RBJ, 2008, ZOOTAXA, P57, DOI 10.11646/zootaxa.1931.1.5; Benson RBJ, 2010, ZOOL J LINN SOC-LOND, V158, P882, DOI 10.1111/j.1096-3642.2009.00569.x; Bever GS, 2009, AM MUS NOVIT, P1, DOI 10.1206/650.1; Bonaparte JF., 1980, MEMOIRES SOC GEOLOGI, V139, P19; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Britt B.B., 1991, Brigham Young University Geology Studies, V37, P1; Brusatte SL, 2007, J VERTEBR PALEONTOL, V27, P1052, DOI 10.1671/0272-4634(2007)27[1052:TSUOTE]2.0.CO;2; Brusatte SL, 2007, J VERTEBR PALEONTOL, V27, P902, DOI 10.1671/0272-4634(2007)27[902:ANSOCD]2.0.CO;2; Brusatte SL, 2010, ZOOTAXA, P1; Brusatte SL, 2012, B AM MUS NAT HIST, P1; Brusatte SL, 2010, ZOOL J LINN SOC-LOND, V158, P573, DOI 10.1111/j.1096-3642.2009.00563.x; Brusatte SL, 2009, NATURWISSENSCHAFTEN, V96, P1051, DOI 10.1007/s00114-009-0565-2; Carpenter K., 1992, ASPECTS NONMARINE CR, P250; Carr TD, 2005, J VERTEBR PALEONTOL, V25, P119, DOI 10.1671/0272-4634(2005)025[0119:ANGASO]2.0.CO;2; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Carrano MT, 2002, J VERTEBR PALEONTOL, V22, P510, DOI 10.1671/0272-4634(2002)022[0510:TOOMKA]2.0.CO;2; Castanhinha R, 2006, J VERTEBR PALEONTOL, V26, p48A; Choiniere JN, 2010, J VERTEBR PALEONTOL, V30, P1773, DOI 10.1080/02724634.2010.520779; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Clark James M., 1994, American Museum Novitates, V3115, P1; Clark JM, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)364<0001:CAOCOT>2.0.CO;2; Colbert E.H., 1990, P81, DOI 10.1017/CBO9780511608377.009; Coria RA, 2006, GEODIVERSITAS, V28, P71; Coria RA, 2002, J VERTEBR PALEONTOL, V22, P460, DOI 10.1671/0272-4634(2002)022[0460:ANCROC]2.0.CO;2; Currie Philip J., 2000, Geodiversitas, V22, P207; Currie PJ, 2004, LIFE O PAST, P112; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; CURRIE PJ, 1985, CAN J EARTH SCI, V22, P1643, DOI 10.1139/e85-173; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2037, DOI 10.1139/e93-179; Dal Sasso C, 2005, J VERTEBR PALEONTOL, V25, P888, DOI 10.1671/0272-4634(2005)025[0888:NIOTSO]2.0.CO;2; Eddy DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017932; Ezcurra Martin D., 2007, Historical Biology, V19, P185, DOI 10.1080/08912960600861467; Filla J., 1992, HUNTERIA, V2, P1; Fitzinger L, 1843, SYSTEMA REPTORILUSM; Galton P.M., 1979, Brigham Young University Geology Studies, V26, P1; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gilmore CW., 1920, B US NATL MUSEUM, V110, P1, DOI [10.5479/si.03629236.110.i, DOI 10.5479/SI.03629236.110.I]; Godefroit P, 2013, NATURE, DOI [10.1038/nature12168, DOI 10.1038/NATURE12168.101]; Godefroit P, 2008, J VERTEBR PALEONTOL, V28, P432, DOI 10.1671/0272-4634(2008)28[432:ANSOVD]2.0.CO;2; Gold MEL, 2013, AM MUS NOVIT, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hanson M, 2014, HIST BIOL, V26, P775, DOI 10.1080/08912963.2013.853056; Hendrickx C, 2014, ZOOTAXA, V 3759, P1, DOI 10.11646/zootaxa.3759.1.1; HILL G, 1989, J GEOL SOC LONDON, V146, P539, DOI 10.1144/gsjgs.146.3.0539; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P71; Hone DWE, 2011, CRETACEOUS RES, V32, P495, DOI 10.1016/j.cretres.2011.03.005; Hurum JH, 2003, ACTA PALAEONTOL POL, V48, P161; JENSEN JA, 1985, GREAT BASIN NAT, V45, P710; Kundrat M, 2008, ACTA ZOOL-STOCKHOLM, V89, P231, DOI 10.1111/j.1463-6395.2007.00311.x; Lamanna MC, 2002, J VERTEBR PALEONTOL, V22, P58, DOI 10.1671/0272-4634(2002)022[0058:ADATDF]2.0.CO;2; Larson Peter, 2008, P233; Madsen JH., 2000, UTAH GEOLOGICAL SURV, V2, P1; Madsen JH., 1976, UTAH GEOLOGICAL MINI, V109, P1; Mahler L, 2005, J VERTEBR PALEONTOL, V25, P236, DOI 10.1671/0272-4634(2005)025[0236:ROADTF]2.0.CO;2; Makovicky PJ, 2003, AM MUS NOVIT, P1; Malafaia E, 2007, CANTERA PALEONTOLOGI, P255; Malafaia E., 2009, ACT 4 JORN INT PAL D, P243; Malafaia E., 2008, PALAEONTOLOGICA NOVA, P273; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Mateus Isabel, 1998, Memorias de Academia de Ciencias de Lisboa, V37, P101; Mateus O., 2006, N MEX MUS NAT HIST S, V36, P223; Mateus O., 2000, 1 C IB PAL 16 JORN S, P115; Mateus O., 2006, PALEONTOLOGY GEOLOGY, V36, P123; Mateus O, 2013, CIENCEIAS TERRA SPEI; Mateus O, 2000, 31 INT GEOL C; Mateus Octavio, 1998, Memorias de Academia de Ciencias de Lisboa, V37, P111; Mateus O, 2010, LETHAIA, V43, P245, DOI 10.1111/j.1502-3931.2009.00190.x; MOLNAR R E, 1991, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V217, P137; Norell MA, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)446<0001:ATDFUT>2.0.CO;2; Norell MA, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3545[1:ANDTFU]2.0.CO;2; Osborn H. F., 1912, Memoirs of the American Museum of Natural History New York, V1; Osmolska H, 2004, DINOSAURIA, 2ND EDITION, P165; OSTROM J H, 1978, Zitteliana, V4, P73; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Paul G., 1988, PREDATORY DINOSAURS; Perez-Moreno BP, 1999, J GEOL SOC LONDON, V156, P449, DOI 10.1144/gsjgs.156.3.0449; Rauhut Oliver W.M., 1994, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V13, P179; Rauhut OWM, 2012, P NATL ACAD SCI USA, V109, P11746, DOI 10.1073/pnas.1203238109; Rauhut OWM, 2010, ZOOL J LINN SOC-LOND, V158, P155, DOI 10.1111/j.1096-3642.2009.00591.x; Rauhut Oliver W.M., 2000, P75; Rauhut OWM, 2005, P ROY SOC B-BIOL SCI, V272, P1179, DOI 10.1098/rspb.2005.3071; Rauhut OWM, 2004, J VERTEBR PALEONTOL, V24, P894, DOI 10.1671/0272-4634(2004)024[0894:PAAOGS]2.0.CO;2; Rauhut OWM, 2003, PALAEONTOLOGY, V46, P903, DOI 10.1111/1475-4983.00325; Ribeiro V, 2012, J VERTEBR PALEONTOL, V32, P161; Sadleir Rudyard W., 2008, Monograph of the Palaeontographical Society, P1; Sampson SD, 2007, J VERTEBR PALEONTOL, V27, P32, DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO;2; Seeley H.G., 1887, GEOL MAG, V5, P45, DOI [10.1017/s0016756800156006, DOI 10.1017/S0016756800156006]; Sereno PC, 2008, ACTA PALAEONTOL POL, V53, P15, DOI 10.4202/app.2008.0102; Sereno PC, 2012, J VERTEBR PALEONTOL, V32, P83, DOI 10.1080/02724634.2013.820113; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P451; Siegwarth J. D., 1997, CONTRIBUTIONS TATE M, V2, P1; Smith DK, 2010, J VERTEBR PALEONTOL, V30, P1466, DOI 10.1080/02724634.2010.501434; Smith JB, 2005, ANAT REC PART A, V285A, P699, DOI 10.1002/ar.a.20206; Sues HD, 2011, P ROY SOC B-BIOL SCI, V278, P3459, DOI 10.1098/rspb.2011.0410; Therrien F, 2007, J VERTEBR PALEONTOL, V27, P108, DOI 10.1671/0272-4634(2007)27[108:MTIBTY]2.0.CO;2; Turner AH, 2012, B AM MUS NAT HIST, P5; Turner AH, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3557[1:ASDTFS]2.0.CO;2; Tykoski RS, 2005, THESIS U TEXAS AUSTI; Weigert Andrea, 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V9, P562; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; Wiechmann Marc Filip, 2000, P83; Wilkinson M, 1996, MOL BIOL EVOL, V13, P437, DOI 10.1093/oxfordjournals.molbev.a025604; WILKINSON M, 1995, SYST BIOL, V44, P435, DOI 10.2307/2413604; WILKINSON M, 1994, SYST BIOL, V43, P343, DOI 10.2307/2413673; Witmer L.M., 1997, ENCY DINOSAURS, P151; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Xu X, 2009, NATURE, V459, P940, DOI 10.1038/nature08124; Zinke Jens, 1998, Palaeontologische Zeitschrift, V72, P179; Zinke Jens, 1994, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V13, P163	116	68	68	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e88905	10.1371/journal.pone.0088905	http://dx.doi.org/10.1371/journal.pone.0088905			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598585	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400006
J	Adler, BJ; Green, DE; Pagnotti, GM; Chan, ME; Rubin, CT				Adler, Benjamin J.; Green, Danielle E.; Pagnotti, Gabriel M.; Chan, M. Ete; Rubin, Clinton T.			High Fat Diet Rapidly Suppresses B Lymphopoiesis by Disrupting the Supportive Capacity of the Bone Marrow Niche	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; T-CELLS; CALORIC RESTRICTION; PROGENITOR CELLS; SELF-RENEWAL; OBESITY; MICE; ADIPOSITY; MICROENVIRONMENT; DIFFERENTIATION	The bone marrow (BM) niche is the primary site of hematopoiesis, and cues from this microenvironment are critical to maintain hematopoiesis. Obesity increases lifetime susceptibility to a host of chronic diseases, and has been linked to defective leukogenesis. The pressures obesity exerts on hematopoietic tissues led us to study the effects of a high fat diet (HFD: 60% Kcal from fat) on B cell development in BM. Seven week old male C57Bl/6J mice were fed either a high fat (HFD) or regular chow (RD) diet for periods of 2 days, 1 week and 6 weeks. B-cell populations (B220+) were not altered after 2 d of HFD, within 1 w B-cell proportions were reduced by -10%, and by 6 w by -25% as compared to RD (p<0.05). BM RNA was extracted to track the expression of B-cell development markers Il-7, Ebf-1 and Pax-5. At 2 d, the expression of Il-7 and Ebf-1 were reduced by -20% (p = 0.08) and -11% (p = 0.06) whereas Pax-5 was not significantly impacted. At one week, however, the expressions of Il-7, Ebf-1, and Pax-5 in HFD mice fell by -19%, -20% and -16%, and by six weeks were further reduced to -23%, -29% and -34% as compared to RD (p<0.05 for all), a suppression paralleled by a +363% increase in adipose encroachment within the marrow space (p<0.01). Il-7 is a critical factor in the early B-cell lineage which is secreted by supportive cells in the BM niche, and is necessary for B-cell commitment. These data indicate that BM Il-7 expression, and by extension B-cell differentiation, are rapidly impaired by HFD. The trend towards suppressed expression of Il-7 following only 2 d of HFD demonstrates how susceptible the BM niche, and the cells which rely on it, are to diet, which ultimately could contribute to disease susceptibility in metabolic disorders such as obesity.	[Adler, Benjamin J.; Green, Danielle E.; Pagnotti, Gabriel M.; Chan, M. Ete; Rubin, Clinton T.] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Rubin, CT (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	Clinton.Rubin@stonybrook.edu	Pagnotti, Gabriel/AAF-7280-2020	Pagnotti, Gabriel/0000-0003-0888-5117	National Institutes of Health (NIH) [AR 43498, EB 14351]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014351] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding provided by National Institutes of Health (NIH) AR 43498 and EB 14351. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila HL, 2012, J BONE MINER RES, V27, P1030, DOI 10.1002/jbmr.1553; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Biro FM, 2010, AM J CLIN NUTR, V91, p1499S, DOI 10.3945/ajcn.2010.28701B; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Challen GA, 2010, EXP HEMATOL, V38, P403, DOI 10.1016/j.exphem.2010.02.011; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chan ME, 2012, FASEB J, V26, P4855, DOI 10.1096/fj.12-209841; Cheshier SH, 2007, STEM CELLS DEV, V16, P707, DOI 10.1089/scd.2007.0017; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028; Feng J, 2009, BRIT J HAEMATOL, V145, P412, DOI 10.1111/j.1365-2141.2009.07632.x; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gottschling S, 2007, STEM CELLS, V25, P798, DOI 10.1634/stemcells.2006-0513; Green DE, 2011, J BONE MINER RES; Gyory I, 2012, GENE DEV, V26, P668, DOI 10.1101/gad.187328.112; Jacob B, 2010, BLOOD, V115, P1610, DOI 10.1182/blood-2009-07-232249; Kajkenova O, 1997, J BONE MINER RES, V12, P1772, DOI 10.1359/jbmr.1997.12.11.1772; Karlsson EA, 2010, EXP BIOL MED, V235, P1412, DOI 10.1258/ebm.2010.010227; Karlsson EA, 2010, J NUTR, V140, P1691, DOI 10.3945/jn.110.123653; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Lemieux ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024153; Lublinsky S, 2009, J DIGIT IMAGING, V22, P222, DOI 10.1007/s10278-008-9152-x; Luu YK, 2009, MED ENG PHYS, V31, P34, DOI 10.1016/j.medengphy.2008.03.006; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nieman DC, 1999, J AM DIET ASSOC, V99, P294, DOI 10.1016/S0002-8223(99)00077-2; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Noda S, 2009, BIOCHEM BIOPH RES CO, V383, P210, DOI 10.1016/j.bbrc.2009.03.153; Singh P, 2008, STEM CELLS, V26, P1009, DOI 10.1634/stemcells.2007-0461; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Telford WG, 2007, STEM CELLS, V25, P1029, DOI 10.1634/stemcells.2006-0567; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Trudel G, 2009, J APPL PHYSIOL, V107, P540, DOI 10.1152/japplphysiol.91530.2008; Tsapogas P, 2011, BLOOD, V118, P1283, DOI 10.1182/blood-2011-01-332189; Vilagos B, 2012, J EXP MED, V209, P775, DOI 10.1084/jem.20112422; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006; Wijga AH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-184; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yang H, 2009, BLOOD, V114, P3803, DOI 10.1182/blood-2009-03-213595; Zimmer SN, 2011, BLOOD, V118, P69, DOI 10.1182/blood-2010-09-307942	42	52	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90639	10.1371/journal.pone.0090639	http://dx.doi.org/10.1371/journal.pone.0090639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595332	gold, Green Published, Green Submitted			2022-12-25	WOS:000332475500080
J	Sheehy, EJ; Vinardell, T; Toner, ME; Buckley, CT; Kelly, DJ				Sheehy, Eamon J.; Vinardell, Tatiana; Toner, Mary E.; Buckley, Conor T.; Kelly, Daniel J.			Altering the Architecture of Tissue Engineered Hypertrophic Cartilaginous Grafts Facilitates Vascularisation and Accelerates Mineralisation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ENDOCHONDRAL OSSIFICATION; ARTICULAR-CARTILAGE; BONE-FORMATION; SCAFFOLD; CHONDROGENESIS; CANALS; HYDROGELS	Cartilaginous tissues engineered using mesenchymal stem cells (MSCs) can be leveraged to generate bone in vivo by executing an endochondral program, leading to increased interest in the use of such hypertrophic grafts for the regeneration of osseous defects. During normal skeletogenesis, canals within the developing hypertrophic cartilage play a key role in facilitating endochondral ossification. Inspired by this developmental feature, the objective of this study was to promote endochondral ossification of an engineered cartilaginous construct through modification of scaffold architecture. Our hypothesis was that the introduction of channels into MSC-seeded hydrogels would firstly facilitate the in vitro development of scaled-up hypertrophic cartilaginous tissues, and secondly would accelerate vascularisation and mineralisation of the graft in vivo. MSCs were encapsulated into hydrogels containing either an array of micro-channels, or into non-channelled 'solid' controls, and maintained in culture conditions known to promote a hypertrophic cartilaginous phenotype. Solid constructs accumulated significantly more sGAG and collagen in vitro, while channelled constructs accumulated significantly more calcium. In vivo, the channels acted as conduits for vascularisation and accelerated mineralisation of the engineered graft. Cartilaginous tissue within the channels underwent endochondral ossification, producing lamellar bone surrounding a hematopoietic marrow component. This study highlights the potential of utilising engineering methodologies, inspired by developmental skeletal processes, in order to enhance endochondral bone regeneration strategies.	[Sheehy, Eamon J.; Vinardell, Tatiana; Buckley, Conor T.; Kelly, Daniel J.] Univ Dublin Trinity Coll, Trinity Ctr Bioengn, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Sheehy, Eamon J.; Vinardell, Tatiana; Buckley, Conor T.; Kelly, Daniel J.] Univ Dublin Trinity Coll, Sch Engn, Dept Mech & Mfg Engn, Dublin 2, Ireland; [Kelly, Daniel J.] Univ Dublin Trinity Coll, Adv Mat & Bioengn Res Ctr AMBER, Dublin 2, Ireland; [Vinardell, Tatiana] Univ Coll Dublin, Sch Agr & Food Sci, Dublin 2, Ireland; [Toner, Mary E.] Univ Dublin Trinity Coll, Dept Pathol, Sch Dent Sci, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; University College Dublin; Trinity College Dublin	Kelly, DJ (corresponding author), Univ Dublin Trinity Coll, Trinity Ctr Bioengn, Trinity Biomed Sci Inst, Dublin 2, Ireland.	kellyd9@tcd.ie	Sheehy`, Eamon/AAR-8961-2020; Buckley, Conor/C-3575-2014	Sheehy`, Eamon/0000-0002-2902-4562; Vinardell, Tatiana/0000-0002-4902-6725; Buckley, Conor/0000-0001-7452-4534; Kelly, Daniel/0000-0003-4091-0992	Science Foundation Ireland [SFI/08/Y15/B1336]; European Research Council [258463]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	This work was supported by Science Foundation Ireland under the President of Ireland Young Researcher Award (Grant No. SFI/08/Y15/B1336) and a starter grant from the European Research Council (Stem Repair Project No. 258463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian L, 2009, OSTEOARTHR CARTILAGE, V17, P677, DOI 10.1016/j.joca.2008.10.003; Blumer MJF, 2008, ANN ANAT, V190, P305, DOI 10.1016/j.aanat.2008.02.004; Blumer MJF, 2006, J ANAT, V208, P695, DOI 10.1111/j.1469-7580.2006.00578.x; Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917; Buckley CT, 2012, TISSUE ENG PT A, V18, P382, DOI [10.1089/ten.tea.2011.0145, 10.1089/ten.TEA.2011.0145]; Buckley CT, 2009, TISSUE ENG PT A, V15, P3213, DOI [10.1089/ten.tea.2008.0531, 10.1089/ten.TEA.2008.0531]; Buckley CT, 2010, J BIOMED MATER RES B, V93B, P459, DOI 10.1002/jbm.b.31603; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Erickson IE, 2011, CLIN ORTHOP RELAT R, V469, P2744, DOI 10.1007/s11999-011-1869-z; Farrell E, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-31; Farrell E, 2009, TISSUE ENG PART C-ME, V15, P285, DOI 10.1089/ten.tec.2008.0297; GANEY TM, 1995, ANAT RECORD, V241, P425, DOI 10.1002/ar.1092410318; Gawlitta D, 2012, TISSUE ENG PT A, V18, P1957, DOI [10.1089/ten.tea.2011.0657, 10.1089/ten.TEA.2011.0657]; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Ignat'eva NY, 2007, J ANAL CHEM+, V62, P51, DOI 10.1134/S106193480701011X; Janicki P, 2010, ACTA BIOMATER, V6, P3292, DOI 10.1016/j.actbio.2010.01.037; Jukes JM, 2008, P NATL ACAD SCI USA, V105, P6840, DOI 10.1073/pnas.0711662105; Kafienah W, 2003, METH MOL B, V238, P217; Koh CJ, 2004, J AM SOC NEPHROL, V15, P1113, DOI 10.1097/01.ASN.0000119683.59068.F0; Langer R, 2000, MOL THER, V1, P12, DOI 10.1006/mthe.1999.0003; Lau TT, 2012, BIOMATERIALS, V33, P8406, DOI 10.1016/j.biomaterials.2012.08.025; Lee CH, 2009, TISSUE ENG PT A, V15, P3923, DOI 10.1089/ten.TEA.2008.0653; Lenas P, 2009, TISSUE ENG PART B-RE, V15, P381, DOI 10.1089/ten.TEB.2008.0575; Lennon DP, 2006, EXP HEMATOL, V34, P1604, DOI 10.1016/j.exphem.2006.07.014; Lyons FG, 2010, BIOMATERIALS, V31, P9232, DOI 10.1016/j.biomaterials.2010.08.056; Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001; Mauck RL, 2003, TISSUE ENG, V9, P597, DOI 10.1089/107632703768247304; Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656; Meijer GJ, 2007, PLOS MED, V4, P260, DOI 10.1371/journal.pmed.0040009; Mesallati T, 2012, BIOMECHANICS MODELIN, P1; Meyer EG, 2010, J BIOMECH, V43, P2516, DOI 10.1016/j.jbiomech.2010.05.020; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107; Scotti C, 2013, P NATL ACAD SCI USA, V110, P3997, DOI 10.1073/pnas.1220108110; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Sheehy EJ, 2013, ACTA BIOMATER, V9, P5484, DOI 10.1016/j.actbio.2012.11.008; Sheehy EJ, 2012, BIOCHEM BIOPH RES CO, V417, P305, DOI 10.1016/j.bbrc.2011.11.105; Sheehy EJ, 2011, J TISSUE ENG REGEN M, V5, P747, DOI 10.1002/term.385; Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027; Thorpe SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060764; Thorpe SD, 2010, ANN BIOMED ENG, V38, P2896, DOI 10.1007/s10439-010-0059-6; Tortelli F, 2010, BIOMATERIALS, V31, P242, DOI 10.1016/j.biomaterials.2009.09.038; Vinardell T, 2012, TISSUE ENG PT A, V18, P1161, DOI [10.1089/ten.tea.2011.0544, 10.1089/ten.TEA.2011.0544]; Weiss HE, 2012, TISSUE ENG PT A, V18, P1334, DOI [10.1089/ten.TEA.2011.0602, 10.1089/ten.tea.2011.0602]; Yang WX, 2013, ACTA BIOMATER, V9, P4505, DOI 10.1016/j.actbio.2012.10.003; Ytrehus B, 2004, BONE, V34, P454, DOI 10.1016/j.bone.2003.07.011; Zhang YY, 2012, BIOMATERIALS, V33, P2926, DOI 10.1016/j.biomaterials.2012.01.006	47	25	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90716	10.1371/journal.pone.0090716	http://dx.doi.org/10.1371/journal.pone.0090716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595316	gold, Green Published, Green Submitted			2022-12-25	WOS:000332475500091
J	Yan, YH; Li, JL; Zhang, XQ; Yang, WY; Wan, Y; Ma, YM; Zhu, YQ; Peng, Y; Huang, LK				Yan, Yan-Hong; Li, Jun-Lin; Zhang, Xin-Quan; Yang, Wen-Yu; Wan, Yan; Ma, Ying-Mei; Zhu, Yong-Qun; Peng, Yan; Huang, Lin-Kai			Effect of Naphthalene Acetic Acid on Adventitious Root Development and Associated Physiological Changes in Stem Cutting of Hemarthria compressa	PLOS ONE			English	Article							INDOLE-3-BUTYRIC ACID; DONOR PLANTS; AUXIN; PEROXIDASE; INDUCTION; SEEDLINGS; GROWTH; NAA; AGE	In order to find a way to induce rooting on cuttings of Hemarthria compressa cv. Ya'an under controlled conditions, a project was carried out to study the effect of naphthalene acetic acid (NAA) on rooting in stem cuttings and related physiological changes during the rooting process of Hemarthria compressa. The cuttings were treated with five concentrations of NAA (0, 100, 200 300, 400 mg/l) at three soaking durations (10, 20, 30 minutes), and cuttings without treatment were considered as control. Samples were planted immediately into pots after treatment. IAA-oxidase (IAAO) activity, peroxidase (POD) activity and polyphenol oxidase (PPO) activity were determined after planting. Results showed that NAA had positive effect on rooting at the concentration of 200 mg/l compared to other concentrations at 30 days after planting (DAP). Among the three soaking durations, 20 minutes (min) of 200 mg/l NAA resulted in higher percentages of rooting, larger numbers of adventitious roots and heavier root dry weight per cutting. The lowest IAAO activity was obtained when soaked at 200 mg/l NAA for 20 min soaking duration. This was consistent with the best rooting ability, indicating that the lower IAAO activity, the higher POD activity and PPO activity could be used as an indicator of better rooting ability for whip grass cuttings and might serve as a good marker for rooting ability in cuttings.	[Yan, Yan-Hong; Li, Jun-Lin; Zhang, Xin-Quan; Ma, Ying-Mei; Peng, Yan; Huang, Lin-Kai] Sichuan Agr Univ, Dept Grassland Sci, Coll Anim Sci & Technol, Yaan, Sichuan, Peoples R China; [Yang, Wen-Yu; Wan, Yan] Sichuan Agr Univ, Coll Agron, Wenjiang, Sichuan, Peoples R China; [Zhu, Yong-Qun] Sichuan Acad Agr Sci, Inst Soil & Fertilizer, Chengdu, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Academy of Agricultural Sciences (SAAS)	Zhang, XQ (corresponding author), Sichuan Agr Univ, Dept Grassland Sci, Coll Anim Sci & Technol, Yaan, Sichuan, Peoples R China.	zhangxq@sicau.edu.cn	Ma, Yingmei/J-7409-2019		earmarked fund for Modern Agro-Industry Technology Research System [CARS-35-05]; National Science & Technology Pillar Program in the Twelfth Five-Year Plan [2011BAD17B03]	earmarked fund for Modern Agro-Industry Technology Research System; National Science & Technology Pillar Program in the Twelfth Five-Year Plan	This work was supported by the earmarked fund for Modern Agro-Industry Technology Research System (#CARS-35-05) and the National Science & Technology Pillar Program in the Twelfth Five-Year Plan (#2011BAD17B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AESCHBACHER RA, 1994, ANNU REV PLANT PHYS, V45, P25, DOI 10.1146/annurev.pp.45.060194.000325; BEFFA R, 1990, PLANT PHYSIOL, V94, P485, DOI 10.1104/pp.94.2.485; Cui X. D., 2010, NO HORTIC, V2, P10; De Klerk GJ, 1999, IN VITRO CELL DEV-PL, V35, P189, DOI 10.1007/s11627-999-0076-z; DeKlerk GJ, 1996, AGRONOMIE, V16, P609, DOI 10.1051/agro:19961003; DEKLERK GJ, 1992, AGRONOMIE, V12, P747, DOI 10.1051/agro:19921002; Dick J, 1998, ACIAR P, V86, P188; GASPAR T, 1992, AGRONOMIE, V12, P757, DOI 10.1051/agro:19921003; Gaspar T., 1997, BIOL ROOT FORMATION, P57; Hartmann HT, 1968, PLANT PROPAGATION PR; Hausman JF, 1997, J APPL BOT-ANGEW BOT, V71, P104; Hentig W., 1987, ACTA HORTIC, V226, P479; [胡宗达 HU Zongda], 2008, [水土保持研究, Research of Soil and Water Conservation], V15, P120; Huang L., 2012, ADV SCI LETT, V7, P328, DOI [10.1166/asl.2012.2075, DOI 10.1166/ASL.2012.2075]; Hunt MA, 2011, NEW FOREST, V41, P349, DOI 10.1007/s11056-010-9227-7; Hunt RW, 2010, APPL BIOCHEM BIOTECH, V162, P2400, DOI 10.1007/s12010-010-9012-2; Husen A, 2006, NEW FOREST, V31, P57, DOI 10.1007/s11056-004-6794-5; Husen A, 2007, NEW FOREST, V33, P309, DOI 10.1007/s11056-006-9030-7; JAMES DJ, 1983, PHYSIOL PLANTARUM, V57, P154, DOI 10.1111/j.1399-3054.1983.tb00746.x; Kaur S, 2002, PLANT GROWTH REGUL, V37, P63, DOI 10.1023/A:1020355505105; Kevers C, 1997, J APPL BOT-ANGEW BOT, V71, P71; Khan S, 2012, PAK J BOT, V44, P1965; Khorsheduzzaman A. K. M., 2010, Bangladesh Journal of Agricultural Research, V35, P149, DOI 10.3329/bjar.v35i1.5876; Kowalczyk S, 2002, PLANT GROWTH REGUL, V38, P127, DOI 10.1023/A:1021232511258; LASKOWSKI MJ, 1995, DEVELOPMENT, V121, P3303; [李芳 LI Fang], 2009, [湖北农业科学, Hubei Agricultural Sciences], V48, P1210; Li Z, 2013, ACTA PHYSIOL PLANT, V35, P213, DOI 10.1007/s11738-012-1066-z; LIU JH, 1992, PHYSIOL PLANTARUM, V86, P285, DOI 10.1034/j.1399-3054.1992.860214.x; Liu ZH, 1996, BOT BULL ACAD SINICA, V37, P247; Mishra BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004502; Mori Y, 2011, PLANT GROWTH REGUL, V63, P271, DOI 10.1007/s10725-010-9524-3; Nag S, 2001, J PLANT GROWTH REGUL, V20, P182, DOI 10.1007/s003440010016; Raju NL, 2010, AGROFOREST SYST, V79, P249, DOI 10.1007/s10457-009-9251-9; Rivero RM, 2001, PLANT SCI, V160, P315, DOI 10.1016/S0168-9452(00)00395-2; Rout GR, 2006, PLANT GROWTH REGUL, V48, P111, DOI 10.1007/s10725-005-5665-1; SATO Y, 1993, PLANTA, V189, P584, DOI 10.1007/BF00198223; Srivastava L.M, 2002, PLANT GROWTH DEV HOR, DOI 10.1016/B978-012660570-9/50152-0; Sun YL, 2010, PLANT CELL TISS ORG, V100, P317, DOI 10.1007/s11240-009-9653-4; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068220; WIESMAN Z, 1988, PHYSIOL PLANTARUM, V74, P556, DOI 10.1111/j.1399-3054.1988.tb02018.x; Yan YH, 2013, RES CROP, V14, P907; Yang CH, 2010, TROP GRASSLANDS, V44, P47	42	50	56	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90700	10.1371/journal.pone.0090700	http://dx.doi.org/10.1371/journal.pone.0090700			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595064	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500087
J	Cannon, MV; Buchner, DA; Hester, J; Miller, H; Sehayek, E; Nadeau, JH; Serre, D				Cannon, Matthew V.; Buchner, David A.; Hester, James; Miller, Hadley; Sehayek, Ephraim; Nadeau, Joseph H.; Serre, David			Maternal Nutrition Induces Pervasive Gene Expression Changes but No Detectable DNA Methylation Differences in the Liver of Adult Offspring	PLOS ONE			English	Article							DIET-INDUCED OBESITY; ELEMENT-BINDING PROTEIN-1C; BOUND TRANSCRIPTION FACTOR; HIGH-FAT DIET; PRENATAL EXPOSURE; COMPLEX TRAITS; HUMAN GENOME; CROSS-TALK; LATER LIFE; MICE	Aims: Epidemiological and animal studies have shown that maternal diet can influence metabolism in adult offspring. However, the molecular mechanisms underlying these changes remain poorly understood. Here, we characterize the phenotypes induced by maternal obesity in a mouse model and examine gene expression and epigenetic changes induced by maternal diet in adult offspring. Methods: We analyzed genetically identical male mice born from dams fed a high-or low-fat diet throughout pregnancy and until day 21 postpartum. After weaning, half of the males of each group were fed a high-fat diet, the other half a low-fat diet. We first characterized the genome-wide gene expression patterns of six tissues of adult offspring - liver, pancreas, white adipose, brain, muscle and heart. We then measured DNA methylation patterns in liver at selected loci and throughout the genome. Results: Maternal diet had a significant effect on the body weight of the offspring when they were fed an obesogenic diet after weaning. Our analyses showed that maternal diet had a pervasive effect on gene expression, with a pronounced effect in liver where it affected many genes involved in inflammation, cholesterol synthesis and RXR activation. We did not detect any effect of the maternal diet on DNA methylation in the liver. Conclusions: Overall, our findings highlighted the persistent influence of maternal diet on adult tissue regulation and suggested that the transcriptional changes were unlikely to be caused by DNA methylation differences in adult liver.	[Cannon, Matthew V.; Hester, James; Miller, Hadley; Sehayek, Ephraim; Serre, David] Cleveland Clin, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44106 USA; [Buchner, David A.; Nadeau, Joseph H.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Nadeau, Joseph H.] Pacific Northwest Res Inst, Seattle, WA USA	Cleveland Clinic Foundation; Case Western Reserve University	Serre, D (corresponding author), Cleveland Clin, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44106 USA.	serred@ccf.org		Hester, James/0000-0002-2739-7082; Cannon, Matthew/0000-0002-3035-9490; Buchner, David/0000-0003-3920-4871	National Institutes of Health [R01 DK08824, DP1HD075624]; NIDDK [K01 DK084079]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD075624] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076174, K01DK084079, R01DK088824] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health awards to DS (R01 DK08824) and to JHN (DP1HD075624). DAB was supported by a NIDDK award (K01 DK084079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; Bayol SA, 2010, ENDOCRINOLOGY, V151, P1451, DOI 10.1210/en.2009-1192; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Bouchard L, 2010, DIABETES CARE, V33, P2436, DOI 10.2337/dc10-1024; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Buchner DA, 2012, MAMM GENOME, V23, P431, DOI 10.1007/s00335-012-9400-8; Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662; Erhuma A, 2007, BRIT J NUTR, V98, P517, DOI 10.1017/S0007114507721505; Giraudo SQ, 2010, PHARMACOL BIOCHEM BE, V97, P121, DOI 10.1016/j.pbb.2010.04.017; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; Hoile SP, 2012, J NUTR BIOCH; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hsiao A, 2005, NUCLEIC ACIDS RES, V33, pW627, DOI 10.1093/nar/gki443; Jones HN, 2009, FASEB J, V23, P271, DOI 10.1096/fj.08-116889; Kim TH, 2009, J BIOL CHEM, V284, P15071, DOI 10.1074/jbc.M109.006742; Kral JG, 2006, PEDIATRICS, V118, pE1644, DOI 10.1542/peds.2006-1379; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Levin BE, 1998, AM J PHYSIOL-REG I, V275, pR1374, DOI 10.1152/ajpregu.1998.275.4.R1374; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Millward CA, 2009, MAMM GENOME, V20, P71, DOI 10.1007/s00335-008-9165-2; Murphy SK, 2012, GENE, V494, P36, DOI 10.1016/j.gene.2011.11.062; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Plagemann A, 1997, INT J OBESITY, V21, P451, DOI 10.1038/sj.ijo.0800429; Plagemann A, 1997, DIABETOLOGIA, V40, P1094, DOI 10.1007/s001250050792; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rizzo TA, 1995, AM J OBSTET GYNECOL, V173, P1753, DOI 10.1016/0002-9378(95)90422-0; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roth A, 2008, MOL PHARMACOL, V73, P1282, DOI 10.1124/mol.107.041012; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Tamashiro KLK, 2009, DIABETES, V58, P1116, DOI 10.2337/db08-1129; Thompson RF, 2010, J BIOL CHEM, V285, P15111, DOI 10.1074/jbc.M109.095133; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Whitaker RC, 1998, J PEDIATR-US, V132, P768, DOI 10.1016/S0022-3476(98)70302-6; Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190	46	32	33	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90335	10.1371/journal.pone.0090335	http://dx.doi.org/10.1371/journal.pone.0090335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594983	Green Submitted, Green Published, gold			2022-12-25	WOS:000332468900095
J	Sun, ZY; Blanchard, JL				Sun, Zhiyi; Blanchard, Jeffrey L.			Strong Genome-Wide Selection Early in the Evolution of Prochlorococcus Resulted in a Reduced Genome through the Loss of a Large Number of Small Effect Genes	PLOS ONE			English	Article							CYANOBACTERIUM PROCHLOROCOCCUS; MICROBIAL GENOME; SEQUENCE; REDUCTION; ECOTYPES; ADAPTATION; EUKARYOTES; PROKARYOTE; SYMBIONT; DYNAMICS	The smallest genomes of any photosynthetic organisms are found in a group of free-living marine cyanobacteria, Prochlorococcus. To determine the underlying evolutionary mechanisms, we developed a new method to reconstruct the steps leading to the Prochlorococcus genome reduction using 12 Prochlorococcus and 6 marine Synechococcus genomes. Our results reveal that small genome sizes within Prochlorococcus were largely determined shortly after the split of Prochlorococcus and Synechococcus (an early big shrink) and thus for the first time decouple the genome reduction from Prochlorococcus diversification. A maximum likelihood approach was then used to estimate changes of nucleotide substitution rate and selection strength along Prochlorococcus evolution in a phylogenetic framework. Strong genome wide purifying selection was associated with the loss of many genes in the early evolutionary stage. The deleted genes were distributed around the genome, participated in many different functional categories and in general had been under relaxed selection pressure. We propose that shortly after Prochlorococcus diverged from its common ancestor with marine Synechococcus, its population size increased quickly thus increasing efficacy of selection. Due to limited nutrients and a relatively constant environment, selection favored a streamlined genome for maximum economy. Strong genome wide selection subsequently caused the loss of genes with small functional effect including the loss of some DNA repair genes. In summary, genome reduction in Prochlorococcus resulted in genome features that are similar to symbiotic bacteria and pathogens, however, the small genome sizes resulted from an increase in genome wide selection rather than a consequence of a reduced ecological niche or relaxed selection due to genetic drift.	[Sun, Zhiyi; Blanchard, Jeffrey L.] Univ Massachusetts, Grad Program Organism & Evolutionary Biol, Amherst, MA 01003 USA; [Blanchard, Jeffrey L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Blanchard, JL (corresponding author), Univ Massachusetts, Grad Program Organism & Evolutionary Biol, Amherst, MA 01003 USA.	jeffb@bio.umass.edu	Blanchard, Jeffrey/AAA-5173-2020	Blanchard, Jeffrey/0000-0002-7310-9678; Sun, Zhiyi/0000-0002-6106-5356	UMass Healy Foundation; USDA [MAS00898, MAS009582]	UMass Healy Foundation; USDA(United States Department of Agriculture (USDA))	We are grateful for funding from the UMass Healy Foundation (http://www.umass.edu/research/faculty-research-granthealey-endowment-grant) and USDA Hatch grants MAS00898 and MAS009582. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren NA, 2006, ENVIRON MICROBIOL, V8, P441, DOI 10.1111/j.1462-2920.2005.00910.x; Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson JO, 1999, MOL BIOL EVOL, V16, P1178, DOI 10.1093/oxfordjournals.molbev.a026208; Andersson JO, 2001, MOL BIOL EVOL, V18, P829, DOI 10.1093/oxfordjournals.molbev.a003864; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Coleman ML, 2010, P NATL ACAD SCI USA, V107, P18634, DOI 10.1073/pnas.1009480107; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Degnan PH, 2005, GENOME RES, V15, P1023, DOI 10.1101/gr.3771305; Dufresne A, 2003, P NATL ACAD SCI USA, V100, P10020, DOI 10.1073/pnas.1733211100; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Dufresne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r90; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Gil R, 2003, P NATL ACAD SCI USA, V100, P9388, DOI 10.1073/pnas.1533499100; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hu JH, 2009, MOL BIOL EVOL, V26, P5, DOI 10.1093/molbev/msn217; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Luo HW, 2011, MOL BIOL EVOL, V28, P2751, DOI 10.1093/molbev/msr081; Lynch M, 2006, ANNU REV MICROBIOL, V60, P327, DOI 10.1146/annurev.micro.60.080805.142300; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Marais Gabriel A B, 2008, Genetica, V134, P205; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Moran NA, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-12-research0054; Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Palenik B, 2006, P NATL ACAD SCI USA, V103, P13555, DOI 10.1073/pnas.0602963103; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Partensky F., 1999, B I OCEANOGRAPHIQUE, V19, P457; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Xu L, 2006, MOL BIOL EVOL, V23, P1107, DOI 10.1093/molbev/msk019; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zinser ER, 2003, GENETICS, V164, P1271	54	40	42	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e88837	10.1371/journal.pone.0088837	http://dx.doi.org/10.1371/journal.pone.0088837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594762	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900008
J	Liu-Helmersson, J; Stenlund, H; Wilder-Smith, A; Rocklov, J				Liu-Helmersson, Jing; Stenlund, Hans; Wilder-Smith, Annelies; Rocklov, Joacim			Vectorial Capacity of Aedes aegypti: Effects of Temperature and Implications for Global Dengue Epidemic Potential	PLOS ONE			English	Article							TRANSMISSION; IMPACT; FEVER; MODEL; FLUCTUATIONS; POPULATION; MOSQUITOS; CULICIDAE; DIPTERA; DISEASE	Dengue is a mosquito-borne viral disease that occurs mainly in the tropics and subtropics but has a high potential to spread to new areas. Dengue infections are climate sensitive, so it is important to better understand how changing climate factors affect the potential for geographic spread and future dengue epidemics. Vectorial capacity (VC) describes a vector's propensity to transmit dengue taking into account human, virus, and vector interactions. VC is highly temperature dependent, but most dengue models only take mean temperature values into account. Recent evidence shows that diurnal temperature range (DTR) plays an important role in influencing the behavior of the primary dengue vector Aedes aegypti. In this study, we used relative VC to estimate dengue epidemic potential (DEP) based on the temperature and DTR dependence of the parameters of A. aegypti. We found a strong temperature dependence of DEP; it peaked at a mean temperature of 29.3 degrees C when DTR was 0 degrees C and at 20 degrees C when DTR was 20 degrees C. Increasing average temperatures up to 29 degrees C led to an increased DEP, but temperatures above 29 degrees C reduced DEP. In tropical areas where the mean temperatures are close to 29 degrees C, a small DTR increased DEP while a large DTR reduced it. In cold to temperate or extremely hot climates where the mean temperatures are far from 29 degrees C, increasing DTR was associated with increasing DEP. Incorporating these findings using historical and predicted temperature and DTR over a two hundred year period (1901-2099), we found an increasing trend of global DEP in temperate regions. Small increases in DEP were observed over the last 100 years and large increases are expected by the end of this century in temperate Northern Hemisphere regions using climate change projections. These findings illustrate the importance of including DTR when mapping DEP based on VC.	[Liu-Helmersson, Jing; Stenlund, Hans; Wilder-Smith, Annelies; Rocklov, Joacim] Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, Umea, Sweden; [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore	Umea University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Liu-Helmersson, J (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, Umea, Sweden.	Jing.Helmersson@umu.se	Wilder-Smith, Annelies/F-8751-2015	Wilder-Smith, Annelies/0000-0003-0362-5375; Helmersson, Jing/0000-0001-9647-1015; Stenlund, Hans/0000-0001-9943-296X; Rocklov, Joacim/0000-0003-4030-0449	European Union [282589]	European Union(European Commission)	This study is part of the DengueTools project [33] funded by the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement no. 282589. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Astrom C, 2013, ECOHEALTH; Beebe NW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000429; Bhatt S, 2013, NATURE, V12060; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242; CMIP5, 2013, COUPL MOD INT PROJ P; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; European Centre for Disease Prevention and Control, 2012, EP UPD OUTBR DENG MA; European Centre for Disease Prevention and Control (ECDC), 2009, TECH REP DEV AED ALB; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; Gething PW, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-92; Goosse H, 2013, REPRESENTATIVE CONCE; Gosling S, 2009, INT J BIOMETEOROL, V53, P31, DOI 10.1007/s00484-008-0189-9; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Hempel S, 2013, EARTH SYST DYN DISCU, V4, DOI [DOI 10.5194/ESD-4-219-2013, 10.5194/esd-4-219-2013]; Huang ZJ, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-33; ISI-MIP, 2013, INT SECT IMP MOD INT; Jones P., 2008, CRU TIME SERIES TS H; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Liu-Helmersson J, 2012, THESIS; Mari R, 2012, INTECH; Massad E, 2011, PHYS LIFE REV, V8, P169, DOI 10.1016/j.plrev.2011.01.001; MCLEAN DM, 1974, CAN J MICROBIOL, V20, P255, DOI 10.1139/m74-040; Paaijmans K, 2010, INFLUENCE CLIMATE MA; Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Randolph SE, 2010, NAT REV MICROBIOL, V8, P361, DOI 10.1038/nrmicro2336; Reiter P, 2003, EMERG INFECT DIS, V9, P86; Reiter P, 2010, EUROSURVEILLANCE, V15, P11; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Sousa CA, 2012, EUROSURVEILLANCE, V17, P15; Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Warszawski L., 2013, P NATL ACAD SCI; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002; Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040	39	214	218	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89783	10.1371/journal.pone.0089783	http://dx.doi.org/10.1371/journal.pone.0089783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603439	gold, Green Published			2022-12-25	WOS:000332483600022
J	Matsushita, H; Sano, A; Wu, H; Jiao, JA; Kasinathan, P; Sullivan, EJ; Wang, ZD; Kuroiwa, Y				Matsushita, Hiroaki; Sano, Akiko; Wu, Hua; Jiao, Jin-an; Kasinathan, Poothappillai; Sullivan, Eddie J.; Wang, Zhongde; Kuroiwa, Yoshimi			Triple Immunoglobulin Gene Knockout Transchromosomic Cattle: Bovine Lambda Cluster Deletion and Its Effect on Fully Human Polyclonal Antibody Production	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN; PLASMA; EXPRESSION	Towards the goal of producing fully human polyclonal antibodies (hpAbs or hIgGs) in transchromosomic (Tc) cattle, we previously reported that Tc cattle carrying a human artificial chromosome (HAC) comprising the entire unrearranged human immunoglobulin (Ig) heavy-chain (hIGH), kappa-chain (hIGK), and lambda-chain (hIGL) germline loci produced physiological levels of hIgGs when both of the bovine immunoglobulin mu heavy-chains, bIGHM and bIGHML1, were homozygously inactivated (bIGHM(-/-), bIGHML1(-/-); double knockouts or DKO). However, because endogenous bovine immunoglobulin light chain loci are still intact, the light chains are produced both from the hIGK and hIGL genomic loci on the HAC and from the endogenous bovine kappa-chain (bIGK) and lambda-chain (bIGL) genomic loci, resulting in the production of fully hIgGs (both Ig heavy-chains and light-chains are of human origin: hIgG/hIgk or hIgG/hIg lambda) and chimeric hIgGs (Ig heavy-chains are of human origin while the Ig light-chains are of bovine origin: hIgG/bIgk or hIgG/bIg lambda). To improve fully hIgG production in Tc cattle, we here report the deletion of the entire bIGL joining (J) and constant (C) gene cluster (bIGLJ1-IGLC1 to bIGLJ5-IGLC5) by employing Cre/loxP mediated site-specific chromosome recombination and the production of triple knockout (bIGHM(-/-), bIGHML1(-/-) and bIGL(-/-); TKO) Tc cattle. We further demonstrate that bIGL cluster deletion greatly improves fully hIgGs production in the sera of TKO Tc cattle, with 51.3% fully hIgGs (hIgG/hIgk plus hIgG/hIg lambda).	[Matsushita, Hiroaki; Wu, Hua; Jiao, Jin-an; Sullivan, Eddie J.] Sanford Appl Biosci LLC, Sioux Falls, SD 57104 USA; [Sano, Akiko; Kuroiwa, Yoshimi] Kyowa Hakko Kirin Co Ltd, Chiyoda Ku, Tokyo, Japan; [Wang, Zhongde] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Kasinathan, Poothappillai] Trans Ova Genet, Sioux Ctr, IA USA; [Matsushita, Hiroaki; Sano, Akiko; Wu, Hua; Jiao, Jin-an; Kasinathan, Poothappillai; Sullivan, Eddie J.; Wang, Zhongde; Kuroiwa, Yoshimi] Hematech Inc, Sioux Falls, SD USA	Kyowa Kirin Ltd; Utah System of Higher Education; Utah State University	Sullivan, EJ (corresponding author), Sanford Appl Biosci LLC, Sioux Falls, SD 57104 USA.	eddie.sullivan@sanfordhealth.org; zonda.wang@usu.edu		Sullivan, Eddie/0000-0001-7468-2006; Wang, Zhongde/0000-0003-2441-4729	Hematech, Inc.	Hematech, Inc.	This work was financed by internal funding of Hematech, Inc., which no longer exists and no longer has financial interest in the work. Hematech has transferred all of its business to Sanford Applied Biosciences, LLC. No current external funding sources for this study. Financial interest in this work is currently owned by Sanford Applied Biosciences, who did have a role in the decision to publish as well as the preparation of the manuscript. While it is considered beneficial to the interests of Sanford Applied Biosciences to publish this work, this consideration played no role in the study design, data collection and analysis and preparation of the manuscript. This is evidenced by the inclusion of now independent authors with no affiliation to Sanford Applied Biosciences.	Arun SS, 1996, J VET MED A, V43, P573, DOI 10.1111/j.1439-0442.1996.tb00489.x; Boothpur R, 2010, AM J KIDNEY DIS, V55, P141, DOI 10.1053/j.ajkd.2009.06.017; Buchacher Andrea, 2006, Biotechnology Journal, V1, P148, DOI 10.1002/biot.200500037; Chen LM, 2008, VET IMMUNOL IMMUNOP, V124, P284, DOI 10.1016/j.vetimm.2008.04.012; Kumar A, 2006, INT ARCH ALLERGY IMM, V140, P185, DOI 10.1159/000093204; Kuroiwa Y, 2004, NAT GENET, V36, P775, DOI 10.1038/ng1373; Kuroiwa Y, 2009, NAT BIOTECHNOL, V27, P173, DOI 10.1038/nbt.1521; Lundquist AL, 2007, LIVER TRANSPLANT, V13, P647, DOI 10.1002/lt.21098; Newcombe C, 2007, J CHROMATOGR B, V848, P2, DOI 10.1016/j.jchromb.2006.07.004; Pasman Y, 2010, VET IMMUNOL IMMUNOP, V135, P306, DOI 10.1016/j.vetimm.2009.12.012; Sellahewa K. H., 1994, Ceylon Medical Journal, V39, P173; Sullivan EJ, 2004, BIOL REPROD, V70, P146, DOI 10.1095/biolreprod.103.021220; Tomizuka K, 2000, P NATL ACAD SCI USA, V97, P722, DOI 10.1073/pnas.97.2.722; Yeh KM, 2005, J ANTIMICROB CHEMOTH, V56, P919, DOI 10.1093/jac/dki346	14	40	45	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90383	10.1371/journal.pone.0090383	http://dx.doi.org/10.1371/journal.pone.0090383			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603704	Green Published, gold			2022-12-25	WOS:000332483600050
J	Aasebo, E; Opsahl, JA; Bjorlykke, Y; Myhr, KM; Kroksveen, AC; Berven, FS				Aasebo, Elise; Opsahl, Jill Anette; Bjorlykke, Yngvild; Myhr, Kjell-Morten; Kroksveen, Ann Cathrine; Berven, Frode S.			Effects of Blood Contamination and the Rostro-Caudal Gradient on the Human Cerebrospinal Fluid Proteome	PLOS ONE			English	Article							MASS-SPECTROMETRY; BARRIER FUNCTION; FLOW-RATE; PROTEINS; IDENTIFICATIONS; EXPRESSION; DYNAMICS; VARIABLES; LUMBAR; BRAIN	Over the last years there has been an increased focus on the importance of knowing the effect of pre-analytical influence on the proteomes under study, particularly in the field of biomarker discovery. We present three proteomics studies examining the effect of blood contamination and the rostro-caudal gradient (RCG) on the cerebrospinal fluid (CSF) proteome, in addition to plasma/CSF protein ratios. The studies showed that the central nervous system (CNS) derived proteins appeared to be unaffected by the RCG, while the plasma-derived proteins showed an increase in concentration towards the lumbar area. This implies that the concentration of the plasma-derived proteins in CSF will vary depending on the volume of CSF that is collected. In the CSF samples spiked with blood, 262 of 814 quantified proteins showed an abundance increase of more than 1.5 fold, while 403 proteins had a fold change of less than 1.2 and appeared to be unaffected by blood contamination. Proteins with a high plasma/CSF ratio appeared to give the largest effect on the CSF proteome upon blood contamination. The results give important background information on how factors like blood contamination, RCG and blood-CNS-barrier influences the CSF proteome. This information is particularly important in the field of biomarker discovery, but also for routine clinical measurements. The data from the blood contamination and RCG discovery studies have been deposited to the ProteomeXchange with identifier PXD000401.	[Aasebo, Elise; Opsahl, Jill Anette; Kroksveen, Ann Cathrine; Berven, Frode S.] Univ Bergen, Dept Biomed, Prote Unit PROBE, Bergen, Norway; [Aasebo, Elise; Opsahl, Jill Anette; Myhr, Kjell-Morten; Kroksveen, Ann Cathrine; Berven, Frode S.] Univ Bergen, Dept Clin Med, KG Jebsen Ctr MS Res, Bergen, Norway; [Bjorlykke, Yngvild] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Myhr, Kjell-Morten; Berven, Frode S.] Haukeland Hosp, Dept Neurol, Norwegian Multiple Sclerosis Competence Ctr, N-5021 Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Berven, FS (corresponding author), Univ Bergen, Dept Biomed, Prote Unit PROBE, Bergen, Norway.	Frode.berven@biomed.uib.no	Myhr, Kjell-Morten/H-1528-2018	Myhr, Kjell-Morten/0000-0002-0980-510X	National Program for Research in Functional Genomics (FUGE); Norwegian Research Council; Western Norway Regional Health Authority; Meltzer Foundation; Kjell Alme's Legacy for Research in Multiple Sclerosis; Kristian Gerhard Jebsen Foundation; PRIDE Team, EBI	National Program for Research in Functional Genomics (FUGE); Norwegian Research Council(Research Council of NorwayEuropean Commission); Western Norway Regional Health Authority; Meltzer Foundation; Kjell Alme's Legacy for Research in Multiple Sclerosis; Kristian Gerhard Jebsen Foundation; PRIDE Team, EBI	The study was supported by the National Program for Research in Functional Genomics (FUGE) funded by the Norwegian Research Council, Western Norway Regional Health Authority, the Meltzer Foundation, Kjell Alme's Legacy for Research in Multiple Sclerosis, and the Kristian Gerhard Jebsen Foundation. The data deposition to the ProteomeXchange Consortium was supported by PRIDE Team, EBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbatiello SE, 2010, CLIN CHEM, V56, P291, DOI 10.1373/clinchem.2009.138420; ATACK JR, 1990, NEUROCHEM INT, V16, P533, DOI 10.1016/0197-0186(90)90013-J; Aye TT, 2012, ANAL CHEM, V84, P4999, DOI 10.1021/ac300596r; Berven FS, 2007, PROTEOM CLIN APPL, V1, P699, DOI 10.1002/prca.200700126; Brandner S, 2013, EUR NEUROL, V70, P189, DOI 10.1159/000352032; CSERR HF, 1981, AM J PHYSIOL, V240, pF319, DOI 10.1152/ajprenal.1981.240.4.F319; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; FELGENHAUER K, 1974, KLIN WOCHENSCHR, V52, P1158, DOI 10.1007/BF01466734; Fenyo D, 2003, ANAL CHEM, V75, P768, DOI 10.1021/ac0258709; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Grijalva I, 2006, SPINAL CORD, V44, P280, DOI 10.1038/sj.sc.3101842; HELMAN LJ, 1988, J CLIN INVEST, V82, P686, DOI 10.1172/JCI113648; Jimenez CR, 2007, PROTEOM CLIN APPL, V1, P1385, DOI 10.1002/prca.200700330; Kirkpatrick LL, 2000, J BIOL CHEM, V275, P17786, DOI 10.1074/jbc.M002254200; Kroksveen AC, 2011, J PROTEOMICS, V74, P371, DOI 10.1016/j.jprot.2010.11.010; Kroksveen AC, 2013, J PROTEOMICS, V78, P312, DOI 10.1016/j.jprot.2012.09.037; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P79, DOI 10.1006/bbrc.1999.1638; MAY C, 1990, NEUROLOGY, V40, P500, DOI 10.1212/WNL.40.3_Part_1.500; Petzold A, 2006, NEUROCRIT CARE, V4, P153, DOI 10.1385/NCC:4:2:153; Portelius E, 2010, INT J ALZHEIMERS DIS; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; REIBER H, 1994, J NEUROL SCI, V122, P189, DOI 10.1016/0022-510X(94)90298-4; REIBER H, 1983, J CLIN CHEM CLIN BIO, V21, P199; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simonsen AH, 2013, J NEUROSCI METH, V215, P234, DOI 10.1016/j.jneumeth.2013.03.011; Simonsen AH, 2010, J NEUROSCI METH, V191, P244, DOI 10.1016/j.jneumeth.2010.06.017; Tarnaris A, 2011, NEUROCHEM RES, V36, P528, DOI 10.1007/s11064-010-0374-1; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Vaudel M, 2011, PROTEOMICS, V11, P996, DOI 10.1002/pmic.201000595; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; WEISNER B, 1978, J NEUROL SCI, V37, P205, DOI 10.1016/0022-510X(78)90204-6; You JS, 2005, PROTEOMICS, V5, P290, DOI 10.1002/pmic.200400889	33	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90429	10.1371/journal.pone.0090429	http://dx.doi.org/10.1371/journal.pone.0090429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599184	gold, Green Published, Green Submitted			2022-12-25	WOS:000332479400074
J	Clark, JT; Clark, MR; Shelke, NB; Johnson, TJ; Smith, EM; Andreasen, AK; Nebeker, JS; Fabian, J; Friend, DR; Kiser, PF				Clark, Justin T.; Clark, Meredith R.; Shelke, Namdev B.; Johnson, Todd J.; Smith, Eric M.; Andreasen, Andrew K.; Nebeker, Joel S.; Fabian, Judit; Friend, David R.; Kiser, Patrick F.			Engineering a Segmented Dual-Reservoir Polyurethane Intravaginal Ring for Simultaneous Prevention of HIV Transmission and Unwanted Pregnancy	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; IN-VITRO RELEASE; DRUG-DELIVERY; PREEXPOSURE PROPHYLAXIS; SUSTAINED DELIVERY; VIRUS-INFECTION; DAPIVIRINE; ADHERENCE; WOMEN; CHALLENGES	The HIV/AIDS pandemic and its impact on women prompt the investigation of prevention strategies to interrupt sexual transmission of HIV. Long-acting drug delivery systems that simultaneously protect womenfrom sexual transmission of HIV and unwanted pregnancy could be important tools in combating the pandemic. We describe the design, in silico, in vitro and in vivo evaluation of a dual-reservoir intravaginal ring that delivers the HIV-1 reverse transcriptase inhibitor tenofovir and the contraceptive levonorgestrel for 90 days. Two polyether urethanes with two different hard segment volume fractions were used to make coaxial extruded reservoir segments with a 100 mm thick rate controlling membrane and a diameter of 5.5 mm that contain 1.3 wt% levonorgestrel. A new mechanistic diffusion model accurately described the levonorgestrel burst release in early time points and pseudo-steady state behavior at later time points. As previously described, tenofovir was formulated as a glycerol paste and filled into a hydrophilic polyurethane, hollow tube reservoir that was melt-sealed by induction welding. These tenofovir-eluting segments and 2 cm long coaxially extruded levonorgestrel eluting segments were joined by induction welding to form rings that released an average of 7.5 mg tenofovir and 21 mg levonorgestrel per day in vitro for 90 days. Levonorgestrel segments placed intravaginally in rabbits resulted in sustained, dose-dependent levels of levonorgestrel in plasma and cervical tissue for 90 days. Polyurethane caps placed between segments successfully prevented diffusion of levonorgestrel into the tenofovir-releasing segment during storage. Hydrated rings endured between 152 N and 354 N tensile load before failure during uniaxial extension testing. In summary, this system represents a significant advance in vaginal drug delivery technology, and is the first in a new class of long-acting multipurpose prevention drug delivery systems.	[Clark, Justin T.; Shelke, Namdev B.; Johnson, Todd J.; Smith, Eric M.; Andreasen, Andrew K.; Nebeker, Joel S.; Fabian, Judit; Kiser, Patrick F.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Clark, Meredith R.; Friend, David R.] Eastern Virginia Med Sch, Dept Obstet & Gynecol, CONRAD, Arlington, VA USA; [Kiser, Patrick F.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA	Utah System of Higher Education; University of Utah; Eastern Virginia Medical School; Northwestern University	Kiser, PF (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.	patrick.kiser@northwestern.edu	Kiser, Patrick F/C-2843-2014	Kiser, Patrick F/0000-0002-3868-7122; Clark, Meredith/0000-0002-4476-8287	United States Agency for International Development (USAID) [GPO-A-00-08-00005-00, AID-OAA-A-10-0006]; Eastern Virginia Medical School [GPO-A-00-08-00005-00, AID-OAA-A-10-0006]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Eastern Virginia Medical School	Funding was provided under cooperative agreement (GPO-A-00-08-00005-00 and AID-OAA-A-10-0006) between the United States Agency for International Development (USAID) and the Eastern Virginia Medical School. This work was supported by a cooperative agreement from The United States Agency for International Development (USAID). USAID had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews C, 2013, 20 C RETR OPP INF AT; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Clark JT, 2012, J CONTROL RELEASE, V163, P240, DOI 10.1016/j.jconrel.2012.08.033; Clark MR, 2011, DRUG DELIV TRANSL RE, V1, P238, DOI 10.1007/s13346-011-0032-4; Clark MR, 2012, J PHARM SCI-US, V101, P576, DOI 10.1002/jps.22781; Connor J, 2004, B WORLD HEALTH ORGAN, V82, P935; Dobard C, 2012, J VIROL, V86, P718, DOI 10.1128/JVI.05842-11; DUSTERBERG B, 1981, CONTRACEPTION, V24, P673, DOI 10.1016/0010-7824(81)90018-4; Elabd YA, 2001, MACROMOLECULES, V34, P6268, DOI 10.1021/ma002107c; Fetherston SM, 2010, THER DELIV, V1, P785, DOI 10.4155/TDE.10.74; Folkers GK, 2010, JAMA-J AM MED ASSOC, V304, P350, DOI 10.1001/jama.2010.957; Friend DR, 2013, ANTIVIR RES, V99, P391, DOI 10.1016/j.antiviral.2013.06.021; Friend DR, 2012, EXPERT OPIN DRUG DEL, V9, P417, DOI 10.1517/17425247.2012.668183; Friend DR, 2011, DRUG DELIV TRANSL RE, V1, P185, DOI 10.1007/s13346-011-0024-4; Gupta KM, 2008, J PHARM SCI-US, V97, P4228, DOI 10.1002/jps.21331; Hankins CA, 2013, CURR OPIN HIV AIDS, V8, P50, DOI 10.1097/COH.0b013e32835b809d; Helbling IM, 2011, J CONTROL RELEASE, V149, P258, DOI 10.1016/j.jconrel.2010.10.018; Heneine W, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007419; Iskedjian M, 2002, CLIN THER, V24, P302, DOI 10.1016/S0149-2918(02)85026-3; Johnson TJ, 2012, ANTIMICROB AGENTS CH, V56, P6272, DOI 10.1128/AAC.01431-12; Johnson TJ, 2012, ANTIMICROB AGENTS CH, V56, P1291, DOI 10.1128/AAC.05721-11; Johnson TJ, 2010, EUR J PHARM SCI, V39, P203, DOI 10.1016/j.ejps.2009.11.007; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kiser PF, 2012, AIDS REV, V14, P62; Kiser PF, 2013, WO Patent Application, Patent No. [PCT/US2012/047649, 2012047649]; Kruk ME, 2006, CLIN THER, V28, P1989, DOI 10.1016/j.clinthera.2006.12.011; Malcolm K, 2003, J CONTROL RELEASE, V90, P217, DOI 10.1016/S0168-3659(03)00178-0; Malcolm RK, 2013, CONTRACEPTION, V88, P321, DOI 10.1016/j.contraception.2013.06.009; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Mesquita PMM, 2012, J ANTIMICROB CHEMOTH, V67, P1730, DOI 10.1093/jac/dks097; Nel A, 2009, JAIDS-J ACQ IMM DEF, V51, P416, DOI 10.1097/QAI.0b013e3181acb536; Rose S, 2009, ADV DRUG DELIVER REV, V61, P808, DOI 10.1016/j.addr.2009.04.022; ROWE PJ, 1990, CONTRACEPTION, V41, P105, DOI 10.1016/0010-7824(90)90141-H; Saltzman WM, 2001, ENG PRINCIPLES DRUG; Shattock RJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007385; Siepmann J, 2008, INT J PHARMACEUT, V364, P328, DOI 10.1016/j.ijpharm.2008.09.004; Siepmann J, 2012, J CONTROL RELEASE, V161, P351, DOI 10.1016/j.jconrel.2011.10.006; Singer R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003936; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Smith JM, 2013, P NATL ACAD SCI USA, V110, P16145, DOI 10.1073/pnas.1311355110; Szycher M, 1985, US patent, Patent No. [4,523,005, 4523005]; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; van Laarhoven JAH, 2002, INT J PHARM, V232, P163, DOI 10.1016/S0378-5173(01)00900-0; van Laarhoven JAH, 2002, J CONTROL RELEASE, V82, P309, DOI 10.1016/S0168-3659(02)00139-6; Vergnaud J.-M., 1993, CONTROLLED DRUG RELE; Wertheimer AI, 2013, CURR MED CHEM, V20, P1635	46	73	76	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e88509	10.1371/journal.pone.0088509	http://dx.doi.org/10.1371/journal.pone.0088509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599325	Green Submitted, gold, Green Published			2022-12-25	WOS:000332479400004
J	Ferrando, S; Castellano, L; Gallus, L; Ghigliotti, L; Masini, MA; Pisano, E; Vacchi, M				Ferrando, Sara; Castellano, Laura; Gallus, Lorenzo; Ghigliotti, Laura; Masini, Maria Angela; Pisano, Eva; Vacchi, Marino			A Demonstration of Nesting in Two Antarctic Icefish (Genus Chionodraco) Using a Fin Dimorphism Analysis and Ex Situ Videos	PLOS ONE			English	Article							PARENTAL CARE; EGG-MIMICRY; ROSS SEA; BEHAVIOR; EVOLUTION; FISH; REPRODUCTION; BIOLOGY; CHANNICHTHYIDAE; FERTILIZATION	Visual observations and videos of Chionodraco hamatus icefish at the "Acquario di Genova" and histological analyses of congeneric species C. hamatus and C. rastrospinosus adults sampled in the field provided new anatomical and behavioral information on the reproductive biology of these white blooded species that are endemic to the High-Antarctic region. During the reproductive season, mature males of both species, which are different from females and immature males, display fleshy, club-like knob modifications of their anal fin that consisted of a much thicker epithelium. Histology indicated that the knobs were without any specialized glandular or sensorial organization, thus suggesting a mechanical and/or ornamental role of the modified anal fin. In addition, the occurrence of necrotic regions at the base of the thickened epithelium and the detachment of the knobs in post-spawning C. hamatus males indicated the temporary nature of the knobs. The role of these structures was confirmed as mechanical and was clarified using visual observations and videos of the behavior of two C. hamatus during a reproductive event that occurred in an exhibit tank at the "Acquario di Genova". The reproductive process included pre-spawning activity, preparation of the nest, egg guarding and successfully ended with egg hatching. When the spawning event approached, the male prepared the nest. The nest was constructed on an accurately selected bottom surface, which was flattened and maintained free from sand or debris by a combination of radial body movements and continuous anal fin sweeping, thus demonstrating the important mechanical/abrasive function of the anal fin knobs. The present data are the first records of active nesting in icefish and clarify the meaning of dimorphic temporary structures, whose function would have been difficult to obtain in the field.	[Ferrando, Sara; Gallus, Lorenzo; Ghigliotti, Laura; Masini, Maria Angela; Pisano, Eva] Univ Genoa, Dept Earth Environm & Life Sci DiSTAV, Genoa, Italy; [Castellano, Laura] Acquario Genova, Costa Edutainment Spa, Genoa, Italy; [Vacchi, Marino] CNR, Inst Marine Sci ISMAR, Inst Environm Protect & Res ISPRA, Genoa, Italy	University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Italian Institute for Environmental Protection & Research (ISPRA)	Vacchi, M (corresponding author), CNR, Inst Marine Sci ISMAR, Inst Environm Protect & Res ISPRA, Genoa, Italy.	marino.vacchi@isprambiente.it	Ghigliotti, Laura/AAN-6843-2021; Ghigliotti, Laura/J-3076-2012; Ferrando, Sara/AAC-9934-2022; CNR, Ismar/P-1247-2014	Ghigliotti, Laura/0000-0003-2139-1381; Ferrando, Sara/0000-0002-5781-9709; CNR, Ismar/0000-0001-5351-1486	PNRA (Italian National Antarctic Research Programme) (PNRA Project) [2010_A1.11]	PNRA (Italian National Antarctic Research Programme) (PNRA Project)	The paper was finantially and logistically supported by PNRA (Italian National Antarctic Research Programme) (PNRA Project n. 2010_A1.11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balshine-Earn S, 1998, P ROY SOC B-BIOL SCI, V265, P2217, DOI 10.1098/rspb.1998.0562; Barrera-Oro ER, 2010, POLAR BIOL, V33, P1585, DOI 10.1007/s00300-010-0847-3; BART HL, 1991, COPEIA, P80, DOI 10.2307/1446250; Cheng CHC, 2007, PHILOS T R SOC B, V362, P2215, DOI 10.1098/rstb.2006.1946; COLLETTE BRUCE B., 1965, PROC U S NAT MUS, V117, P567; DANIELS RA, 1978, J FISH BIOL, V12, P465, DOI 10.1111/j.1095-8649.1978.tb04190.x; Detrich HW, 2005, POLAR BIOL, V28, P828, DOI 10.1007/s00300-005-0010-8; DEWITT H H, 1979, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V1, P775; Eastman JT, 2005, POLAR BIOL, V28, P93, DOI 10.1007/s00300-004-0667-4; Evans CW, 2005, ANTARCT SCI, V17, P319, DOI 10.1017/S0954102005002749; Fischer W., 1985, SO OCEAN FISHING ARE, V2, P233; GHERASIMCHOOK VV, 1989, ZOOL ZH, V68, P142; Giacomello E, 2006, BIOL LETTERS, V2, P330, DOI 10.1098/rsbl.2006.0492; Goodwin NB, 1998, P ROY SOC B-BIOL SCI, V265, P2265, DOI 10.1098/rspb.1998.0569; Gross MR, 2005, Q REV BIOL, V80, P37, DOI 10.1086/431023; GROSS MR, 1981, EVOLUTION, V35, P775, DOI 10.1111/j.1558-5646.1981.tb04937.x; GROSS MR, 1985, AM ZOOL, V25, P807; Helfman G, 2009, DIVERSITY FISHES BIO; Henning F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043695; HOURIGAN TF, 1989, MAR BIOL, V100, P277, DOI 10.1007/BF00391969; HUREAU JC, 1994, POLAR BIOL, V14, P307; Iwami T., 1990, P381; Jones CD, 2012, J FISH BIOL, V80, P2629, DOI 10.1111/j.1095-8649.2012.03282.x; KNAPP RA, 1989, BEHAV ECOL SOCIOBIOL, V25, P321, DOI 10.1007/BF00302989; Kock KH, 2006, ANTARCT SCI, V18, P223, DOI 10.1017/S0954102006000265; Kock K-H., 1992, ANTARCTIC FISH FISHE; Kock KH, 2008, POLAR BIOL, V31, P381, DOI 10.1007/s00300-007-0366-z; Kock KH, 2005, POLAR BIOL, V28, P897, DOI [10.1007/s00300-005-0019-z, 10.1007/s00300-005-0020-6]; KOCK KH, 1991, ANTARCT SCI, V3, P125, DOI 10.1017/S0954102091000172; Kuwamura T, 1997, ETHOLOGY, V103, P1015, DOI 10.1111/j.1439-0310.1997.tb00143.x; La Mesa M, 2003, POLAR BIOL, V26, P621, DOI 10.1007/s00300-003-0519-7; Lindstrom K, 2000, EVOLUTION, V54, P617, DOI 10.1111/j.0014-3820.2000.tb00063.x; LINQUIST DG, 1981, ENVIRON BIOL FISH, V6, P177; MORENO CA, 1980, COPEIA, P171; Moyle P. B., 1996, FISHES INTRO ICHTHYO; Near TJ, 2003, MOL PHYLOGENET EVOL, V28, P87, DOI 10.1016/S1055-7903(03)00029-0; Newman HH, 1909, BIOL BULL-US, V17, P170, DOI 10.2307/1536035; Noble GK, 1939, AM NAT, V73, P113, DOI 10.1086/280821; OLSEN STEINAR, 1955, NYTT MAG ZOOL OSLO, V3, P79; Pisano E., 2010, FISH ICE DVD; Porter BA, 2002, BEHAV ECOL SOCIOBIOL, V51, P350, DOI 10.1007/s00265-002-0456-4; ROBILLIARD GA, 1969, ANTARCT J U S, V4, P304; RUUD JT, 1954, NATURE, V173, P848, DOI 10.1038/173848a0; SMITH RL, 1974, B MAR SCI, V24, P595; St Mary CM, 2001, ETHOLOGY, V107, P1035, DOI 10.1046/j.1439-0310.2001.00747.x; Theis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029878; Vacchi M, 1996, ANTARCT SCI, V8, P185, DOI 10.1017/S0954102096000259; Weitzman Stanley H., 2005, Neotrop. ichthyol., V3, P329, DOI 10.1590/S1679-62252005000300002; WILEY M L, 1970, Bulletin of the American Museum of Natural History, V143, P147; WINN HE, 1958, ECOL MONOGR, V28, P156, DOI 10.2307/1942207; YAO ZX, 1995, AQUACULTURE, V130, P361, DOI 10.1016/0044-8486(94)00337-N; Zander C.D., 1975, Pubblicazioni Staz zool Napoli, V39, P717	52	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90512	10.1371/journal.pone.0090512	http://dx.doi.org/10.1371/journal.pone.0090512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598889	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400086
J	Moskwa, J; Borawska, MH; Markiewicz-Zukowska, R; Puscion-Jakubik, A; Naliwajko, SK; Socha, K; Soroczynska, J				Moskwa, Justyna; Borawska, Maria H.; Markiewicz-Zukowska, Renata; Puscion-Jakubik, Anna; Naliwajko, Sylwia K.; Socha, Katarzyna; Soroczynska, Jolanta			Polish Natural Bee Honeys Are Anti-Proliferative and Anti-Metastatic Agents in Human Glioblastoma multiforme U87MG Cell Line	PLOS ONE			English	Article							ANTINEOPLASTIC ACTIVITY; ANTIBACTERIAL ACTIVITY; PHENOLIC-COMPOUNDS; KAPPA-B; TEMOZOLOMIDE; PROPOLIS; ANTIOXIDANT; FLAVONOIDS; APOPTOSIS; GROWTH	Honey has been used as food and a traditional medicament since ancient times. However, recently many scientists have been concentrating on the anti-oxidant, anti-proliferative, anti-inflammatory and other properties of honey. In this study, we investigated for the first time an anticancer effect of different honeys from Poland on tumor cell line - glioblastoma multiforme U87MG. Anti-proliferative activity of honeys and its interferences with temozolomide were determined by a cytotoxicity test and DNA binding by [H-3]-thymidine incorporation. A gelatin zymography was used to conduct an evaluation of metalloproteinases (MMP-2 and MMP-9) expression in U87MG treatment with honey samples. The honeys were previously tested qualitatively (diastase activity, total phenolic content, lead and cadmium content). The data demonstrated that the examined honeys have a potent anti-proliferative effect on U87MG cell line in a time-and dose-dependent manner, being effective at concentrations as low as 0.5% (multifloral light honey - viability 53% after 72 h of incubation). We observed that after 48 h, combining honey with temozolomide showed a significantly higher inhibitory effect than the samples of honey alone. We observed a strong inhibition of MMP-2 and MMP-9 for the tested honeys (from 20 to 56% and from 5 to 58% compared to control, respectively). Our results suggest that Polish honeys have an anti-proliferative and anti-metastatic effect on U87MG cell line. Therefore, natural bee honey can be considered as a promising adjuvant treatment for brain tumors.	[Moskwa, Justyna; Borawska, Maria H.; Markiewicz-Zukowska, Renata; Puscion-Jakubik, Anna; Naliwajko, Sylwia K.; Socha, Katarzyna; Soroczynska, Jolanta] Med Univ Bialystok, Dept Bromatol, Bialystok, Poland	Medical University of Bialystok	Borawska, MH (corresponding author), Med Univ Bialystok, Dept Bromatol, Bialystok, Poland.	bromatos@umb.edu.pl	Naliwajko, Sylwia/AAR-8452-2021	Naliwajko, Sylwia/0000-0003-3340-6739; Markiewicz Zukowska, Renata/0000-0003-0716-9573; Moskwa, Justyna/0000-0003-2925-9916; Puscion-Jakubik, Anna/0000-0002-8526-8107; Borawska, Maria/0000-0003-0999-9650; Soroczynska, Jolanta/0000-0002-6262-8456; Socha, Katarzyna/0000-0002-5949-7061	Polish Ministry of Science and Higher Education of the Medical University in Bialystok [N 405 625438]; Medical University of Bialystok [POPW.01.03.00-20-022/09]	Polish Ministry of Science and Higher Education of the Medical University in Bialystok; Medical University of Bialystok	The presented work was supported financially by the Polish Ministry of Science and Higher Education (Grant project No N 405 625438 of the Medical University in Bialystok). This study was conducted with the use of the equipment purchased by the Medical University of Bialystok as part of the OP DEP 2007-2013, Priority Axis I.3, contract No. POPW.01.03.00-20-022/09. Founder's website: http://www.nauka.gov.pl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar MB, 2012, INT J MOL SCI, V13, P15054, DOI 10.3390/ijms131115054; [Anonymous], 2010, RD M JOINT FAO WHO E; Aso K, 2004, BIOL PHARM BULL, V27, P727, DOI 10.1248/bpb.27.727; Borges KS, 2011, GENET MOL BIOL, V34, P310, DOI 10.1590/S1415-47572011000200024; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Boukraa L, 2008, J MED FOOD, V11, P195, DOI 10.1089/jmf.2007.502; Codex Alimentarius Commission, 2001, 121981 FAO WHO COD A; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Estevinho L, 2008, FOOD CHEM TOXICOL, V46, P3774, DOI 10.1016/j.fct.2008.09.062; Fauzi AN, 2011, FOOD CHEM TOXICOL, V49, P871, DOI 10.1016/j.fct.2010.12.010; Fernandez-Cabezudo MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055993; Forsyth PA, 1999, BRIT J CANCER, V79, P1828, DOI 10.1038/sj.bjc.6690291; Frankfurt OS, 2003, ANTI-CANCER DRUG, V14, P555, DOI 10.1097/00001813-200308000-00008; Freitas M, 2011, METALLOMICS, V3, P1238, DOI 10.1039/c1mt00050k; Fukushima T, 2012, NEURO-ONCOLOGY, V14, P19, DOI 10.1093/neuonc/nor168; Galijatovic A, 2001, PHARMACEUT RES, V18, P374, DOI 10.1023/A:1011019417236; Ghashm AA, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-49; Gheldof N, 2002, J AGR FOOD CHEM, V50, P3050, DOI 10.1021/jf0114637; Guckenberger M, 2011, STRAHLENTHER ONKOL, V187, P548, DOI 10.1007/s00066-011-2242-6; Irish J, 2008, INT J ANTIMICROB AG, V32, P89, DOI 10.1016/j.ijantimicag.2008.02.012; Ishihara M, 2009, ONCOL REP, V22, P349, DOI 10.3892/or_00000444; Iurlina MO, 2009, FOOD CHEM, V115, P1141, DOI 10.1016/j.foodchem.2009.01.003; Jacinto FV, 2007, DNA REPAIR, V6, P1155, DOI 10.1016/j.dnarep.2007.03.013; Jaganathan SK, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/830616; Jo C, 2013, TOXICOL LETT, V222, P117, DOI 10.1016/j.toxlet.2013.07.015; Karali Y, 2012, PEDIATR HEMAT ONCOL, V29, P335, DOI 10.3109/08880018.2012.670368; Kim JT, 2006, ONCOL REP, V16, P33; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Markiewicz-Zukowska R, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-50; Nieder C, 2005, ANTICANCER RES, V25, P4605; Orsolic N, 2005, J SCI FOOD AGR, V85, P363, DOI 10.1002/jsfa.2041; Park MH, 2011, BIOCHEM BIOPH RES CO, V412, P710, DOI 10.1016/j.bbrc.2011.08.037; Pichichero E, 2009, J SCI FOOD AGR, V89, P609, DOI 10.1002/jsfa.3484; Posser T, 2007, ARCH TOXICOL, V81, P407, DOI 10.1007/s00204-007-0177-6; Pyrzynska K, 2009, TRAC-TREND ANAL CHEM, V28, P893, DOI 10.1016/j.trac.2009.03.015; Roomi MW, 2013, ONCOL REP, V29, P29, DOI 10.3892/or.2012.2110; Samarghandian S, 2011, PHARMACOGN MAG, V7, P46, DOI 10.4103/0973-1296.75901; Scrideli CA, 2008, J NEURO-ONCOL, V88, P281, DOI 10.1007/s11060-008-9579-4; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Swellam T, 2003, INT J UROL, V10, P213, DOI 10.1046/j.0919-8172.2003.00602.x; Van Nifterik KA, 2007, INT J RADIAT ONCOL, V69, P1246, DOI 10.1016/j.ijrobp.2007.07.2366; Wang MD, 2005, J NEURO-ONCOL, V72, P1, DOI 10.1007/s11060-004-1392-0; Wang XH, 2002, J AGR FOOD CHEM, V50, P6923, DOI 10.1021/jf025641n; Wang YB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060834, DOI 10.1371/J0URNAL.P0NE.0060834]; Yao LH, 2003, FOOD CHEM, V81, P159, DOI 10.1016/S0308-8146(02)00388-6; Zhang R, 2007, NEUROCHEM RES, V32, P2194, DOI 10.1007/s11064-007-9417-7; Zhao JX, 2007, EUR J NEUROL, V14, P510, DOI 10.1111/j.1468-1331.2006.01705.x; Zhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866	48	24	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90533	10.1371/journal.pone.0090533	http://dx.doi.org/10.1371/journal.pone.0090533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594866	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500061
J	Chen, JJ; Zhou, H; Xu, PF; Zhang, P; Ma, SN; Zhou, JY				Chen, Junjun; Zhou, Hua; Xu, Panfeng; Zhang, Pei; Ma, Shanni; Zhou, Jianying			Clinical and Radiographic Characteristics of Pulmonary Nocardiosis: Clues to Earlier Diagnosis	PLOS ONE			English	Article							TERTIARY MEDICAL-CENTER; UNITED-STATES; EXPERIENCE; FEATURES; INFECTIONS; SPECTRUM	Background and objectives: Pulmonary nocardiosis (PN) is a rare but life-threatening disease that is caused by Nocardia spp. The aim of this study was to characterize the common risk factors, clinical features, imaging findings, treatment and outcomes of PN, which are useful for an early diagnosis and patient management. Methods: From January 2009 to June 2013, a retrospective study was performed on all PN cases that were diagnosed at our hospital. Results: The study included 17 patients who were diagnosed with PN. Of these patients, 4 developed concomitant disseminated disease. A male predominance was observed among the patients with PN (76.47%). The most common risk factors were corticosteroid therapy (64.71%), diabetes mellitus (29.41) and chronic lung disease (23.53%). Cough and fever were the most common symptoms (94% and 71%, respectively). One or more nodules or masses (82.35%) and consolidations (58.82%) were the most frequent radiologic abnormalities, and cavitation mostly occurred within two weeks. The median time to diagnosis was 25 days. Overall, the mortality rate was 18.75% for PN, and death was most frequent among patients who received immunosuppressive drugs. For the patients with central nervous system involvement, the mortality rate was 50%. Conclusion: PN remains a rare opportunistic infection that mainly affects immunocompromised patients. A high clinical index of suspicion is necessary for an early diagnosis and timely treatment in immunocompromised patients who present with new nodules or masses evolving into cavitation in a short amount of time.	[Chen, Junjun; Zhou, Hua; Xu, Panfeng; Zhang, Pei; Ma, Shanni; Zhou, Jianying] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Resp Dis, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Zhou, JY (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Resp Dis, Hangzhou 310003, Zhejiang, Peoples R China.	zjyhz@zju.edu.cn		Zhou, Hua/0000-0001-6397-3203	National Natural Science Foundation of China [81170038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is funded by grants from the National Natural Science Foundation of China (grant number: 81170038) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosioni J, 2010, INFECTION, V38, P89, DOI 10.1007/s15010-009-9193-9; Bargehr J, 2013, CLIN RADIOL, V68, pE266, DOI 10.1016/j.crad.2012.11.021; BEAMAN BL, 1976, J INFECT DIS, V134, P286, DOI 10.1093/infdis/134.3.286; Blackmon KN, 2011, J THORAC IMAG, V26, P224, DOI 10.1097/RTI.0b013e3181f45dd5; Brown-Elliott BA, 2006, CLIN MICROBIOL REV, V19, P259, DOI 10.1128/CMR.19.2.259-282.2006; BUCKLEY JA, 1995, J COMPUT ASSIST TOMO, V19, P726, DOI 10.1097/00004728-199509000-00007; FEIGIN DS, 1986, RADIOLOGY, V159, P9, DOI 10.1148/radiology.159.1.3952335; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hardak E, 2012, AM J MED SCI, V343, P286, DOI 10.1097/MAJ.0b013e31822cb5dc; Kontoyiannis DP, 1998, MEDICINE, V77, P255, DOI 10.1097/00005792-199807000-00004; Lerner PI, 1996, CLIN INFECT DIS, V22, P891, DOI 10.1093/clinids/22.6.891; Tomas RM, 2007, RESPIROLOGY, V12, P394, DOI [10.1111/j.1440-1843.2007.01078.x, 10.1111/j.1400-1843.2007.01078.x]; Nocard ME, 1988, ANN I PASTEUR PARIS, P293; Riviere F, 2011, EUR RESPIR REV, V20, P210, DOI 10.1183/09059180.00002211; Rosman Y, 2013, EUR J INTERN MED, V24, P552, DOI 10.1016/j.ejim.2013.05.004; Saubolle MA, 2003, J CLIN MICROBIOL, V41, P4497, DOI 10.1128/JCM.41.10.4497-4501.2003; Uhde KB, 2010, CLIN INFECT DIS, V51, P1445, DOI 10.1086/657399; UTTAMCHANDANI RB, 1994, CLIN INFECT DIS, V18, P348, DOI 10.1093/clinids/18.3.348; Wilson JW, 2012, MAYO CLIN PROC, V87, P403, DOI 10.1016/j.mayocp.2011.11.016; Yildiz O, 2006, CURR OPIN PULM MED, V12, P228, DOI 10.1097/01.mcp.0000219273.57933.48	20	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90724	10.1371/journal.pone.0090724	http://dx.doi.org/10.1371/journal.pone.0090724			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594890	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900138
J	Strand, TA; Lale, R; Degnes, KF; Lando, M; Valla, S				Strand, Trine Aakvik; Lale, Rahmi; Degnes, Kristin Flogstad; Lando, Malin; Valla, Svein			A New and Improved Host-Independent Plasmid System for RK2-Based Conjugal Transfer	PLOS ONE			English	Article							RANGE; CLONING; VECTORS; CONSTRUCTION; EXPRESSION; GENES; RP4	Bacterial conjugation is a process that is mediated either by a direct cell-to-cell junction or by formation of a bridge between the cells. It is often used to transfer DNA constructs designed in Escherichia coli to recipient bacteria, yeast, plants and mammalian cells. Plasmids bearing the RK2/RP4 origin of transfer (oriT) are mostly mobilized using the E. coli S17-1/SM10 donor strains, in which transfer helper functions are provided from a chromosomally integrated RP4::Mu. We have observed that large plasmids were occasionally modified after conjugal transfer when using E. coli S17-1 as a donor. All modified plasmids had increased in size, which most probably was a result of co-transfer of DNA from the chromosomally located oriT. It has earlier also been demonstrated that the bacteriophage Mu is silently transferred to recipient cells by these donor strains, and both occurrences are very likely to lead to mutations within the recipient DNA. Here we report the construction of a new biological system addressing both the above mentioned problems in which the transfer helper functions are provided by a plasmid lacking a functional oriT. This system is compatible with all other replicons commonly used in conjugation experiments and further enables the use of diverse bacterial strains as donors. Plasmids containing large inserts were successfully conjugated and the plasmid modifications observed when E. coli S17-1 was used as donor were eliminated by the use of the new host-independent vector system.	[Strand, Trine Aakvik; Lale, Rahmi; Lando, Malin; Valla, Svein] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway; [Degnes, Kristin Flogstad] SINTEF Mat & Chem, Dept Biotechnol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); SINTEF	Lale, R (corresponding author), Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway.	rahmi.lale@ntnu.no		Lale, Rahmi/0000-0001-5460-3163	Research Council of Norway [192123, 157319]	Research Council of Norway(Research Council of Norway)	This work was supported by the Research Council of Norway, grant numbers 192123 and 157319. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakvik T, 2009, FEMS MICROBIOL LETT, V296, P149, DOI 10.1111/j.1574-6968.2009.01639.x; Babic A, 2008, RES MICROBIOL, V159, P545, DOI 10.1016/j.resmic.2008.06.004; Brautaset T, 2009, MICROB BIOTECHNOL, V2, P15, DOI 10.1111/j.1751-7915.2008.00048.x; BURKARDT HJ, 1979, J GEN MICROBIOL, V114, P341, DOI 10.1099/00221287-114-2-341; DELORENZO V, 1993, J BACTERIOL, V175, P6902, DOI 10.1128/jb.175.21.6902-6907.1993; Ferrieres L, 2010, J BACTERIOL, V192, P6418, DOI 10.1128/JB.00621-10; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HOTTE B, 1990, J BACTERIOL, V172, P2804; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; Lio P., 2012, NANO COMMUN NETW, V3, P36, DOI DOI 10.1016/J.NANC0M.2011.10.003; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; PANSEGRAU W, 1994, J MOL BIOL, V239, P623, DOI 10.1006/jmbi.1994.1404; PRIEFER UB, 1985, J BACTERIOL, V163, P324, DOI 10.1128/JB.163.1.324-330.1985; Sambrook J, 2001, MOL CLONING LAB MANU; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; VALLA S, 1992, APPL ENVIRON MICROB, V58, P1980, DOI 10.1128/AEM.58.6.1980-1985.1992; Wexler M, 2005, ENVIRON MICROBIOL, V7, P1917, DOI 10.1111/j.1462-2920.2005.00854.x; WIATER LA, 1994, PLASMID, V32, P280, DOI 10.1006/plas.1994.1067	21	34	36	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90372	10.1371/journal.pone.0090372	http://dx.doi.org/10.1371/journal.pone.0090372			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595202	Green Submitted, gold, Green Published			2022-12-25	WOS:000332468900100
J	Xia, ZF; Yang, TB; Wang, ZS; Dong, JP; Liang, CY				Xia, Zhenfang; Yang, Tubao; Wang, Zhuansuo; Dong, Jianping; Liang, Chunyan			GRK5 Intronic (CA)(n) Polymorphisms Associated with Type 2 Diabetes in Chinese Hainan Island	PLOS ONE			English	Article							RECEPTOR; GENE; DESENSITIZATION; EXPRESSION; REPEATS; BINDING	A genome-wide association study had showed G-protein-coupled receptor kinase 5 (GRK5) rs10886471 was related to the risk of type 2 diabetes mellitus (T2DM) through upregulated GRK5 mRNA expression. Rs10886471 is located in the intron region of GRK5. However, the mechanism by which intronic SNP affects gene expression remains unclear, whether the effect on gene expression depends on the intronic short tandem repeat (STR) (CA)(n) splicing regulator or not. Here we investigated the STR (CA)(n) polymorphism in rs10886471 and further discussed its role in the T2DM risk of Chinese Hainan Island individuals. A total of 1164 subjects were recruited and classified into a normal fasting glucose (NFG) group, an impaired fasting glucose (IFG) group, an impaired glucose tolerance (IGT) group, and a T2DM group. STR (CA)(n) polymorphisms were detected through polymerase chain reaction and sequencing. Five intronic (CA)(n) alleles, (CA)(15) to (CA)(19), were identified in GRK5 rs10886471. Only the (CA)(16) allele was significantly associated with increased prediabetes and T2DM risk [odds ratio (OR) > 1, P < 0.05]. Conversely, multiple alleles without any (CA)(16) protected against prediabetes and T2DM (0 < OR < 1, P < 0.05). In summary, rs10886471 acts as both an SNP and an STR. The rs10886471 intronic SNP causes GRK5 overexpression the subsequent risk of T2DM may be due to the rs10886471 intronic STR (CA)(n) splicing enhancer. Further studies should focus on verifying these finding using a large sample size and analyzing the splicing mechanism of intronic (CA)(n) in rs10886471.	[Xia, Zhenfang; Yang, Tubao] Cent S Univ, Sch Publ Hlth, Div Hlth Stat, Changsha, Hunan, Peoples R China; [Wang, Zhuansuo] Hainan Med Coll, Affiliated Hosp, Dept Endocrinol, City Of Haikou, Province Hainan, Peoples R China; [Dong, Jianping] Hainan Med Coll, Transgen Lab, City Of Haikou, Province Hainan, Peoples R China; [Liang, Chunyan] Community Hlth Serv Ctr Xiuying, Outpatients Dept, City Of Haikou, Province Hainan, Peoples R China	Central South University; Hainan Medical University; Hainan Medical University	Yang, TB (corresponding author), Cent S Univ, Sch Publ Hlth, Div Hlth Stat, Changsha, Hunan, Peoples R China.	1064960669@qq.com						Agrafioti I, 2007, NUCLEIC ACIDS RES, V35, pD71, DOI 10.1093/nar/gkl806; Chen HY, 2013, HUM MUTAT, V34, P1289, DOI 10.1002/humu.22363; Couvineau A, 2012, CURR DRUG TARGETS, V13, P103, DOI 10.2174/138945012798868434; Dou HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059495; Freedman NJ, 1997, J BIOL CHEM, V272, P17734, DOI 10.1074/jbc.272.28.17734; Ginter E, 2013, ADV EXP MED BIOL, V771, P42; Hamilton BJ, 2008, J BIOL CHEM, V283, P25606, DOI 10.1074/jbc.M802492200; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Hui JY, 2003, NAT STRUCT BIOL, V10, P33, DOI 10.1038/nsb875; KUNAPULI P, 1993, P NATL ACAD SCI USA, V90, P5588, DOI 10.1073/pnas.90.12.5588; Li HX, 2013, DIABETES, V62, P291, DOI 10.2337/db12-0454; Lin Y, 2010, J ENDOCRINOL, V204, P1, DOI 10.1677/JOE-09-0260; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Millar David S., 2010, Human Genomics, V4, P289; So CH, 2012, J BIOL CHEM, V287, P17088, DOI 10.1074/jbc.M112.353854; Tariq K, 2013, MOL VIS, V19, P710; TAUTZ D, 1994, CURR OPIN GENET DEV, V4, P832, DOI 10.1016/0959-437X(94)90067-1; Varela MA, 2010, GENOMICS, V95, P151, DOI 10.1016/j.ygeno.2009.12.003; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wang L, 2012, BIOCHEM BIOPH RES CO, V429, P99, DOI 10.1016/j.bbrc.2012.10.077; Wang WCH, 2008, PHARMACOGENET GENOM, V18, P729, DOI 10.1097/FPC.0b013e32830967e9; Wang Y, 2012, NAT STRUCT MOL BIOL, V19, P1044, DOI 10.1038/nsmb.2377; World Health Organization, 2006, DEF DIAGN DIAB MELL; Yilmaz-Aydogan H, 2013, GENE, V523, P20, DOI 10.1016/j.gene.2013.03.136; Yin YW, 2013, CYTOKINE, V62, P226, DOI 10.1016/j.cyto.2013.02.025; Zhang Wei, 2009, Human Genomics, V3, P236; Zhang WJ, 2013, J BIOL CHEM, V288, P22636, DOI 10.1074/jbc.M113.463901	27	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90597	10.1371/journal.pone.0090597	http://dx.doi.org/10.1371/journal.pone.0090597			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594703	Green Submitted, Green Published, gold			2022-12-25	WOS:000332468900122
J	Baba, T; Kashiwagi, Y; Arimitsu, N; Kogure, T; Edo, A; Maruyama, T; Nakao, K; Nakanishi, H; Kinoshita, M; Frohman, MA; Yamamoto, A; Tani, K				Baba, Takashi; Kashiwagi, Yuriko; Arimitsu, Nagisa; Kogure, Takeshi; Edo, Ayumi; Maruyama, Tomohiro; Nakao, Kazuki; Nakanishi, Hiroki; Kinoshita, Makoto; Frohman, Michael A.; Yamamoto, Akitsugu; Tani, Katsuko			Phosphatidic Acid ( PA)-preferring Phospholipase A1 Regulates Mitochondrial Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Membrane; Mitochondria; Phosphatidic Acid; Phospholipase A; Sperm	HEREDITARY SPASTIC PARAPLEGIA; MAMMALIAN SEC23P-INTERACTING PROTEIN; ENDOPLASMIC-RETICULUM; NUAGE FORMATION; A(1) KIAA0725P; FUSION; MEMBRANE; MUTATIONS; FISSION; TESTIS	Background: Phosphatidic acid (PA) is involved in membrane dynamics. Results: PA-preferring phospholipase A(1) (PA-PLA(1)) affects mitochondrial morphology in an activity-dependent manner. Gene disruption of PA-PLA(1) in mice causes sperm malformation due to mitochondrial organization defects. Conclusion: PA-PLA(1) regulates mitochondrial dynamics. Significance: We demonstrate an in vivo function of PA-PLA(1) and suggest a possible mechanism of PA regulation of the mitochondrial membrane. Recent studies have suggested that phosphatidic acid (PA), a cone-shaped phospholipid that can generate negative curvature of lipid membranes, participates in mitochondrial fusion. However, precise mechanisms underling the production and consumption of PA on the mitochondrial surface are not fully understood. Phosphatidic acid-preferring phospholipase A(1) (PA-PLA(1))/DDHD1 is the first identified intracellular phospholipase A(1) and preferentially hydrolyzes PA in vitro. Its cellular and physiological functions have not been elucidated. In this study, we show that PA-PLA(1) regulates mitochondrial dynamics. PA-PLA(1), when ectopically expressed in HeLa cells, induced mitochondrial fragmentation, whereas its depletion caused mitochondrial elongation. The effects of PA-PLA(1) on mitochondrial morphology appear to counteract those of MitoPLD, a mitochondrion-localized phospholipase D that produces PA from cardiolipin. Consistent with high levels of expression of PA-PLA(1) in testis, PA-PLA(1) knock-out mice have a defect in sperm formation. In PA-PLA(1)-deficient sperm, the mitochondrial structure is disorganized, and an abnormal gap structure exists between the middle and principal pieces. A flagellum is bent at that position, leading to a loss of motility. Our results suggest a possible mechanism of PA regulation of the mitochondrial membrane and demonstrate an in vivo function of PA-PLA(1) in the organization of mitochondria during spermiogenesis.	[Baba, Takashi; Kashiwagi, Yuriko; Arimitsu, Nagisa; Kogure, Takeshi; Edo, Ayumi; Maruyama, Tomohiro; Tani, Katsuko] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 1920392, Japan; [Nakao, Kazuki] RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Nakanishi, Hiroki] Akita Univ, Biosignal Res Ctr, Akita 0108543, Japan; [Kinoshita, Makoto] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Frohman, Michael A.] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; [Frohman, Michael A.] SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; [Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Fac Biosci, Nagahama, Shiga 5260829, Japan	Tokyo University of Pharmacy & Life Sciences; RIKEN; Akita University; Nagoya University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tani, K (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	tani@toyaku.ac.jp		Nakanishi, Hiroki/0000-0002-5108-1598; zhong wei, he gui/0000-0002-3066-3564	Ministry of Education, Culture, Sports, Science and Technology of Japan [23570239]; Grants-in-Aid for Scientific Research [25116702] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research 23570239 (to K. T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Arimitsu N, 2011, FEBS LETT, V585, P2171, DOI 10.1016/j.febslet.2011.05.050; Baba T, 2013, MOL CELL BIOCHEM, V376, P151, DOI 10.1007/s11010-013-1563-4; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; Cowell CF, 2009, J CELL SCI, V122, P919, DOI 10.1242/jcs.041061; Douglas DS, 2009, J NEUROSCI, V29, P12089, DOI 10.1523/JNEUROSCI.2029-09.2009; Fawcett D. W., 1970, Biol Reprod, V2, P90, DOI 10.1095/biolreprod2.Supplement_2.90; Gonzalez M, 2013, EUR J HUM GENET, V21, P1214, DOI 10.1038/ejhg.2013.29; Ha KD, 2012, BBA-MOL CELL BIOL L, V1821, P1078, DOI 10.1016/j.bbalip.2012.04.004; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Haucke V, 2007, CURR OPIN CELL BIOL, V19, P426, DOI 10.1016/j.ceb.2007.06.003; Higgs HN, 1998, J BIOL CHEM, V273, P5468, DOI 10.1074/jbc.273.10.5468; HIGGS HN, 1994, P NATL ACAD SCI USA, V91, P9574, DOI 10.1073/pnas.91.20.9574; Honda S, 2003, BIOCHEM BIOPH RES CO, V311, P424, DOI 10.1016/j.bbrc.2003.10.008; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; Iinuma T, 2007, J BIOL CHEM, V282, P17632, DOI 10.1074/jbc.M611237200; Imai H, 2009, J BIOL CHEM, V284, P32522, DOI 10.1074/jbc.M109.016139; Inoue H, 2012, BBA-MOL CELL RES, V1823, P930, DOI 10.1016/j.bbamcr.2012.02.002; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Jin JK, 2006, NEUROSCI LETT, V407, P263, DOI 10.1016/j.neulet.2006.08.062; Mul JD, 2011, J BIOL CHEM, V286, P26781, DOI 10.1074/jbc.M110.197947; Muliyil S, 2011, DEVELOPMENT, V138, P3043, DOI 10.1242/dev.060731; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nakajima K, 2002, J BIOL CHEM, V277, P11329, DOI 10.1074/jbc.M111092200; Pillai RS, 2012, DEV GROWTH DIFFER, V54, P78, DOI 10.1111/j.1440-169X.2011.01320.x; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Russell L.D., 1990, HISTOLOGICAL HISTOPA, P119; Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795; Schuurs-Hoeijmakers JHM, 2012, AM J HUM GENET, V91, P1073, DOI 10.1016/j.ajhg.2012.10.017; Shimoi W, 2005, J BIOL CHEM, V280, P10141, DOI 10.1074/jbc.M409673200; Shindou H, 2013, J BIOCHEM, V154, P21, DOI 10.1093/jb/mvt048; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Suzuki J, 2004, ONCOGENE, V23, P8527, DOI 10.1038/sj.onc.1207894; Tani K, 1999, J BIOL CHEM, V274, P20505, DOI 10.1074/jbc.274.29.20505; Tani K., 2013, BIOMOL CONCEPTS, V3, P471, DOI [10.1515/bmc-2012-0014, DOI 10.1515/BMC-2012-0014]; Tesson C, 2012, AM J HUM GENET, V91, P1051, DOI 10.1016/j.ajhg.2012.11.001; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Yang CY, 2012, INT J BIOCHEM CELL B, V44, P1346, DOI 10.1016/j.biocel.2012.05.006; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198	46	85	89	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11497	11511		10.1074/jbc.M113.531921	http://dx.doi.org/10.1074/jbc.M113.531921			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599962	hybrid, Green Published			2022-12-25	WOS:000334638500050
J	Fitzpatrick, P; Shattil, SJ; Ablooglu, AJ				Fitzpatrick, Paul; Shattil, Sanford J.; Ablooglu, Ararat J.			C-terminal COOH of Integrin beta 1 Is Necessary for beta 1 Association with the Kindlin-2 Adapter Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell-Cell Interaction; Development; Integrins; Protein-Protein Interactions; Zebrafish; FERM; PDZ; cd29; cd51; Kindlin	BINDING-LIKE DOMAIN; PDZ DOMAIN; CYTOPLASMIC DOMAIN; STRUCTURAL BASIS; ALPHA-V; TALIN; RECOGNITION; ACTIVATION; EXPRESSION; ZEBRAFISH	Background: Modulation of integrin/kindlin interactions can lead to human disease pathogenesis. Results: Interaction between integrin 1 and the kindlin-2 is mainly governed by the 1 C-terminal carboxylate moiety. Conclusion: The interaction chemistry identified here between integrin 1 and kindlin-2 appears to represent a novel protein-protein interaction mode. Significance: The unusual integrin 1/kindlin-2 association chemistry sheds new light on this aspect of integrin biology. Protein-protein interactions are driving forces in cellular processes. As a prime example, transmembrane integrins link extracellular matrix and intracellular proteins, resulting in bidirectional signaling that regulates cell migration, proliferation, differentiation, and survival. Here we provide the first evidence that interaction between the integrin 1 cytoplasmic tail and kindlin-2, a member of a family of adapters implicated in human disease pathogenesis, is mainly governed by the 1 C-terminal carboxylate moiety and is required for laterality organ development in zebrafish. Affinity measurements indicate that this unusual protein-protein interaction mode is coordinated by a putative carboxylate-binding motif in the kindlin-2 FERM subdomain F3. Contrary to the C terminus of proteins that engage PDZ domains, the C-terminal three residues of 1, per se, do not contribute to kindlin-2 binding or to laterality organ development. Thus, by employing zebrafish as an in situ physiological tool to correlate protein structure and function, we have discovered an unexpected association chemistry between an integrin and a key adapter involved in integrin signaling.	[Fitzpatrick, Paul; Shattil, Sanford J.; Ablooglu, Ararat J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ablooglu, AJ (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	aablooglu@ucsd.edu			National Institutes of Health [P30 NS047101]; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057900, P01HL078784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Jim Dowling for generously providing kindlin-2 MOs and the UCSD Fish Facility for animal maintenance. Confocal images were gathered at the UCSD Neuroscience Microscopy Shared Facility (supported by National Institutes of Health Grant P30 NS047101)	Ablooglu AJ, 2007, DEV DYNAM, V236, P2268, DOI 10.1002/dvdy.21229; Ablooglu AJ, 2010, DEVELOPMENT, V137, P3449, DOI 10.1242/dev.045310; Arias-Salgado EG, 2005, J BIOL CHEM, V280, P29699, DOI 10.1074/jbc.M503508200; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; BALZAC F, 1994, J CELL BIOL, V127, P557, DOI 10.1083/jcb.127.2.557; Bandyopadhyay A, 2012, J CELL SCI, V125, P2172, DOI 10.1242/jcs.096214; Bledzka K, 2012, J BIOL CHEM, V287, P24585, DOI 10.1074/jbc.M111.336743; Bledzka K, 2010, J BIOL CHEM, V285, P30370, DOI 10.1074/jbc.C110.134247; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; Dowling JJ, 2008, CIRC RES, V102, P423, DOI 10.1161/CIRCRESAHA.107.161489; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Lapidus LJ, 2002, J PHYS CHEM B, V106, P11628, DOI 10.1021/jp020829v; Lee KK, 2006, GLIA, V53, P836, DOI 10.1002/glia.20343; Luck K, 2012, FEBS LETT, V586, P2648, DOI 10.1016/j.febslet.2012.03.056; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pluskota E, 2011, BLOOD, V117, P4978, DOI 10.1182/blood-2010-11-321182; Relvas JB, 2001, CURR BIOL, V11, P1039, DOI 10.1016/S0960-9822(01)00292-5; Schneider I, 2008, DEVELOPMENT, V135, P75, DOI 10.1242/dev.004713; Senetar MA, 2005, GENE, V362, P141, DOI 10.1016/j.gene.2005.08.012; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Skelton NJ, 2003, J BIOL CHEM, V278, P7645, DOI 10.1074/jbc.M209751200; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Tsai WB, 2005, DEV BIOL, V277, P129, DOI 10.1016/j.ydbio.2004.08.052; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Weis SM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006478; Yates LA, 2012, J BIOL CHEM, V287, P43246, DOI 10.1074/jbc.M112.422089	39	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11183	11193		10.1074/jbc.M113.535369	http://dx.doi.org/10.1074/jbc.M113.535369			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24599960	hybrid, Green Published			2022-12-25	WOS:000334638500022
J	Viviant, M; Monestiez, P; Guinet, C				Viviant, Morgane; Monestiez, Pascal; Guinet, Christophe			Can We Predict Foraging Success in a Marine Predator from Dive Patterns Only? Validation with Prey Capture Attempt Data	PLOS ONE			English	Article							AREA-RESTRICTED SEARCH; ANTARCTIC FUR SEALS; OCEANOGRAPHIC HABITAT; ARCTOCEPHALUS-GAZELLA; KERGUELEN ISLANDS; DIVING BEHAVIOR; WEDDELL SEALS; ELEPHANT SEAL; TIME; STRATEGIES	Predicting how climatic variations will affect marine predator populations relies on our ability to assess foraging success, but evaluating foraging success in a marine predator at sea is particularly difficult. Dive metrics are commonly available for marine mammals, diving birds and some species of fish. Bottom duration or dive duration are usually used as proxies for foraging success. However, few studies have tried to validate these assumptions and identify the set of behavioral variables that best predict foraging success at a given time scale. The objective of this study was to assess if foraging success in Antarctic fur seals could be accurately predicted from dive parameters only, at different temporal scales. For this study, 11 individuals were equipped with either Hall sensors or accelerometers to record dive profiles and detect mouth-opening events, which were considered prey capture attempts. The number of prey capture attempts was best predicted by descent and ascent rates at the dive scale; bottom duration and descent rates at 30-min, 1-h, and 2-h scales; and ascent rates and maximum dive depths at the all-night scale. Model performances increased with temporal scales, but rank and sign of the factors varied according to the time scale considered, suggesting that behavioral adjustment in response to prey distribution could occur at certain scales only. The models predicted the foraging intensity of new individuals with good accuracy despite high inter-individual differences. Dive metrics that predict foraging success depend on the species and the scale considered, as verified by the literature and this study. The methodology used in our study is easy to implement, enables an assessment of model performance, and could be applied to any other marine predator.	[Viviant, Morgane; Guinet, Christophe] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France; [Monestiez, Pascal] INRA, Unite Biostat & Proc Spatiaux, Avignon, France	Centre National de la Recherche Scientifique (CNRS); INRAE	Guinet, C (corresponding author), CNRS, Ctr Etud Biol Chize, Villiers En Bois, France.	guinet@cebc.cnrs.fr	Guinet, Christophe/AAR-8457-2020	Monestiez, Pascal/0000-0001-5851-2699	French Polar Institute (Institut Paul Emile Victor, IPEV) [109]; Territoire des Terres Australes et Antarctiques Francaises (TAAF); French "Ministere de la Recherche'' through Pierre et Marie Curie University	French Polar Institute (Institut Paul Emile Victor, IPEV); Territoire des Terres Australes et Antarctiques Francaises (TAAF); French "Ministere de la Recherche'' through Pierre et Marie Curie University	This study is part of the national research program (no 109, H. Weimerskirch) supported by the French Polar Institute (Institut Paul Emile Victor, IPEV) and the Territoire des Terres Australes et Antarctiques Francaises (TAAF). MV was supported by a PhD grant from the French "Ministere de la Recherche'' through Pierre et Marie Curie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin D, 2006, J ANIM ECOL, V75, P408, DOI 10.1111/j.1365-2656.2006.01057.x; Austin D, 2006, ECOLOGY, V87, P3095, DOI 10.1890/0012-9658(2006)87[3095:LMDAHT]2.0.CO;2; Bailey H, 2009, MAR ECOL PROG SER, V378, P279, DOI 10.3354/meps07887; Bailleul F, 2007, PHILOS T R SOC B, V362, P2169, DOI 10.1098/rstb.2007.2109; Bastille-Rousseau G, 2010, J ANIM ECOL, V79, P1157, DOI 10.1111/j.1365-2656.2010.01737.x; Bestley S, 2010, ECOLOGY, V91, P2373, DOI 10.1890/08-2019.1; Bost CA, 2007, DEEP-SEA RES PT II, V54, P248, DOI 10.1016/j.dsr2.2006.11.007; BOYD IL, 1995, ANIM BEHAV, V50, P769, DOI 10.1016/0003-3472(95)80137-5; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Calambokidis J, 2007, MAR TECHNOL SOC J, V41, P19, DOI 10.4031/002533207787441980; Casper RM, 2010, ECOGRAPHY, V33, P748, DOI 10.1111/j.1600-0587.2009.06155.x; Cezilly F, 1996, REV ECOL-TERRE VIE, V51, P43; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Cherel Y, 1997, POLAR BIOL, V17, P87, DOI 10.1007/s003000050109; CROXALL JP, 1985, J ANIM ECOL, V54, P1, DOI 10.2307/4616; Duhamel G, 2000, POLAR BIOL, V23, P106, DOI 10.1007/s003000050015; Fedak MA, 2001, MAR MAMMAL SCI, V17, P94, DOI 10.1111/j.1748-7692.2001.tb00982.x; Fossette S, 2008, J ANIM ECOL, V77, P236, DOI 10.1111/j.1365-2656.2007.01344.x; Gales NJ, 1998, MAR MAMMAL SCI, V14, P355, DOI 10.1111/j.1748-7692.1998.tb00727.x; Goldbogen JA, 2006, J EXP BIOL, V209, P1231, DOI 10.1242/jeb.02135; Hanuise N, 2010, J EXP BIOL, V213, P3874, DOI 10.1242/jeb.044057; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Hooker SK, 2002, MAR MAMMAL SCI, V18, P680, DOI 10.1111/j.1748-7692.2002.tb01066.x; Horsburgh JM, 2008, MAR MAMMAL SCI, V24, P207, DOI 10.1111/j.1748-7692.2007.00156.x; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; KNOPPIEN P, 1985, J THEOR BIOL, V114, P273, DOI 10.1016/S0022-5193(85)80107-7; Kuhn CE, 2009, J ANIM ECOL, V78, P513, DOI 10.1111/j.1365-2656.2008.01509.x; Lea MA, 2002, MAR ECOL PROG SER, V245, P281, DOI 10.3354/meps245281; Lea MA, 2002, POLAR BIOL, V25, P269, DOI 10.1007/s00300-001-0339-6; Louzao M, 2006, ECOL APPL, V16, P1683, DOI 10.1890/1051-0761(2006)016[1683:OHOAEM]2.0.CO;2; Louzao M, 2011, J APPL ECOL, V48, P121, DOI 10.1111/j.1365-2664.2010.01910.x; Luque SP, 2007, BEHAVIOUR, V144, P1315, DOI 10.1163/156853907782418213; Marshall GJ, 1998, MAR TECHNOL SOC J, V32, P11; Mori Y, 2005, MAR ECOL PROG SER, V295, P257, DOI 10.3354/meps295257; Mori Y, 1998, J THEOR BIOL, V190, P187, DOI 10.1006/jtbi.1997.0550; Mori Y, 2007, ISR J ECOL EVOL, V53, P347, DOI 10.1560/IJEE.53.3.347; Morris DW, 2009, ANN NY ACAD SCI, V1162, P334, DOI 10.1111/j.1749-6632.2009.04494.x; Paiva VH, 2010, OIKOS, V119, P1423, DOI 10.1111/j.1600-0706.2010.18294.x; Peron C, 2010, MAR ECOL PROG SER, V416, P267, DOI 10.3354/meps08785; R Development Core Team, 2012, R LANG ENV STAT COMP; Robinson PW, 2007, DEEP-SEA RES PT II, V54, P356, DOI 10.1016/j.dsr2.2006.11.020; Ropert-Coudert Y, 2006, MAR BIOL, V149, P139, DOI 10.1007/s00227-005-0188-x; Ropert-Coudert Y, 2001, POLAR BIOL, V24, P467, DOI 10.1007/s003000100235; Shillinger GL, 2011, MAR ECOL PROG SER, V422, P275, DOI 10.3354/meps08884; Simeone A, 2003, MAR BIOL, V143, P825, DOI 10.1007/s00227-003-1114-8; Suryan RM, 2006, DEEP-SEA RES PT II, V53, P370, DOI 10.1016/j.dsr2.2006.01.012; Suzuki I, 2009, POLAR BIOL, V32, P667, DOI 10.1007/s00300-009-0596-3; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Takahashi A., 2004, Marine Ornithology, V32, P47; Thums M, 2008, J EXP MAR BIOL ECOL, V363, P75, DOI 10.1016/j.jembe.2008.06.024; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; Watanabe Y, 2003, MAR ECOL PROG SER, V252, P283, DOI 10.3354/meps252283; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Wilson RP, 2002, MAR BIOL, V140, P17, DOI 10.1007/s002270100659; WILSON RP, 1992, J EXP BIOL, V167, P267; Wilson RP, 2003, MAR ECOL PROG SER, V249, P305, DOI 10.3354/meps249305; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	58	32	32	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e88503	10.1371/journal.pone.0088503	http://dx.doi.org/10.1371/journal.pone.0088503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603534	Green Published, gold			2022-12-25	WOS:000332483600006
J	Wang, HS; Fan, XL; Owada, M; Wang, M; Nylin, S				Wang, Houshuai; Fan, Xiaoling; Owada, Mamoru; Wang, Min; Nylin, Soeren			Phylogeny, Systematics and Biogeography of the Genus Panolis (Lepidoptera: Noctuidae) Based on Morphological and Molecular Evidence	PLOS ONE			English	Article							PINE BEAUTY MOTH; OBLIGATE POLLINATION MUTUALISM; HISTORICAL BIOGEOGRAPHY; BUTTERFLIES; INFERENCE; EVOLUTION; FLAMMEA; TREE; DIVERGENCE; RADIATION	The genus Panolis is a small group of noctuid moths with six recognized species distributed from Europe to East Asia, and best known for containing the widespread Palearctic pest species P. flammea, the pine beauty moth. However, a reliable classification and robust phylogenetic framework for this group of potentially economic importance are currently lacking. Here, we use morphological and molecular data (mitochondrial genes cytochrome c oxidase subunit I and 16S ribosomal RNA, nuclear gene elongation factor-1 alpha) to reconstruct the phylogeny of this genus, with a comprehensive systematic revision of all recognized species and a new one, P. ningshan sp. nov. The analysis results of maximum parsimony, maximum likelihood and Bayesian inferring methods for the combined morphological and molecular data sets are highly congruent, resulting in a robust phylogeny and identification of two clear species groups, i.e., the P. flammea species group and the P. exquisita species group. We also estimate the divergence times of Panolis moths using two conventional mutation rates for the arthropod mitochondrial COI gene with a comparison of two molecular clock models, as well as reconstruct their ancestral areas. Our results suggest that 1) Panolis is a young clade, originating from the Oriental region in China in the Late Miocene (6-10Mya), with an ancestral species in the P. flammea group extending northward to the Palearctic region some 3-6 Mya; 2) there is a clear possibility for a representative of the Palearctic clade to become established as an invasive species in the Nearctic taiga.	[Wang, Houshuai; Fan, Xiaoling; Wang, Min] South China Agr Univ, Coll Nat Resources & Environm, Dept Entomol, Guangzhou, Guangdong, Peoples R China; [Wang, Houshuai; Nylin, Soeren] Univ Stockholm, Dept Zool, S-10691 Stockholm, Sweden; [Owada, Mamoru] Natl Museum Nat & Sci, Dept Zool, Tsukuba, Ibaraki, Japan	South China Agricultural University; Stockholm University; National Museum of Nature and Science	Wang, M (corresponding author), South China Agr Univ, Coll Nat Resources & Environm, Dept Entomol, Guangzhou, Guangdong, Peoples R China.	minwang@scau.edu.cn	Nylin, Soren/B-7375-2008	Nylin, Soren/0000-0003-4195-8920	Oversea Study Program of Guangzhou Elite Project [[2012] 59]; Swedish Research Council; National Natural Science Foundation of China [31172136]	Oversea Study Program of Guangzhou Elite Project; Swedish Research Council(Swedish Research CouncilEuropean Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Oversea Study Program of Guangzhou Elite Project (Sui jiaoke [2012] 59), a grant from the Swedish Research Council to SN (Grant 621-2011-5636) as well as a grant from National Natural Science Foundation of China to XF (31172136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Beck Herbert, 1996, Neue Entomologische Nachrichten, V36, P3; Brandley MC, 2006, SYST BIOL, V55, P138, DOI 10.1080/10635150500431155; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Canfield MR, 2008, MOL PHYLOGENET EVOL, V49, P477, DOI 10.1016/j.ympev.2008.07.003; Carter D. J., 1984, Pest Lepidoptera of Europe with special reference to the British Isles.; Chen Y.X., 1999, FAUNA SINICA INSECTA, V16, P52; CHO SW, 1995, MOL BIOL EVOL, V12, P650; Colston TJ, 2013, MOL PHYLOGENET EVOL, V66, P953, DOI 10.1016/j.ympev.2012.11.027; de Villers CJ, 1789, LINNAEI ENTOMOLOGIA; DeChaine EG, 2005, J BIOGEOGR, V32, P1943, DOI 10.1111/j.1365-2699.2005.01356.x; Denis JNCM, 1775, ANKUNDUNG SYSTEMATIS; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; DRAUDT M., 1950, MITTEIL MONCHNER ENT GES, V40, P1; Draudt M, 1935, MACROLEPIDOPTERA WOR, V3, P199; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Fabricius JC, 1787, MANTISSA INSECTORVM, VII; Farrell BD, 2001, MOL PHYLOGENET EVOL, V18, P467, DOI 10.1006/mpev.2000.0888; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Goeze JAE, 1781, ENTOMOLOGISCHE BEYTR, V3; Goloboff P, 1999, NONA TREE SEARCHING; Grant T, 2003, CLADISTICS, V19, P379, DOI 10.1111/j.1096-0031.2003.tb00311.x; Hacker H., 1996, ESPERIANA, V5, P7; Hampson GF, 1905, CATALOGUE LEPIDOPTER, V5; Hausmann A, 2011, SPIXIANA, V34, P47; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hicks BJ, 2001, AGR FOREST ENTOMOL, V3, P161, DOI 10.1046/j.1461-9555.2001.00106.x; Hicks BJ, 2008, AGR FOREST ENTOMOL, V10, P263, DOI 10.1111/j.1461-9563.2008.00382.x; Holder M, 2003, NAT REV GENET, V4, P275, DOI 10.1038/nrg1044; HOLLOWAY J D, 1986, Malayan Nature Journal, V40, P1; Hreblay M, 1997, ACTA ZOOL ACAD SCI H, V43, P21; Hubner J, 1826, VERZEICHNISS BEKANNT; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inoue H., 1958, P431; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kawakita A, 2009, P R SOC B, V276, P417, DOI 10.1098/rspb.2008.1226; Kononenko V.S., 1989, Nota Lepidopterologica, V12, P29; LEATHER SR, 1995, INT J PEST MANAGE, V41, P123, DOI 10.1080/09670879509371936; Molet T, 2011, CPHST PEST DATASHEET; Nazari V, 2007, INSECT SYST EVOL, V38, P121, DOI 10.1163/187631207788783996; Nixon K.C., 2002, WINCLADA VERSION 1 0; Oliver JC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002893; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Paykull G, 1786, VETENSKAPS ACAD NYA, V7, P60; Pfeiler Edward, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/423756; Poole R.W., 1989, P501; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1111/j.0014-3820.2004.tb01678.x; Rambaut A, 2007, TRACER V 1 5; Randle CP, 2010, CLADISTICS, V26, P550, DOI 10.1111/j.1096-0031.2009.00301.x; Randle CP, 2006, SYST BIOL, V55, P147, DOI 10.1080/10635150500481630; Ronkay Gabor, 2010, Esperiana, V15, P223; Ronkay L, 2001, HADENINAE 2 NOCTUIDA, V5; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2001, DIVA VERSION 1 2 COM; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simonov EA, 2008, AMUR HEILONG RIVER B; Sinev S.Yu., 2008, CATALOGUE LEPIDOPTER; Smith CI, 2008, EVOLUTION, V62, P2676, DOI 10.1111/j.1558-5646.2008.00500.x; Steel M, 2005, TRENDS GENET, V21, P307, DOI 10.1016/j.tig.2005.04.001; Sugi S, 1992, LEPIDOPTERA TAIWAN, VI, P198; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wahlberg N, 2006, SYST BIOL, V55, P703, DOI 10.1080/10635150600913235; Wang HS, 2010, FLA ENTOMOL, V93, P352, DOI 10.1653/024.093.0305; Wang M, 2011, MOTHS GUANGDONG NALI; Wiemers M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-300; Wileman A. E., 1914, Entomologist London, V47; Yamamoto M, 1987, LARVAE LARGER MOTHS, P197; Yu Y, 2011, PLANT SYST EVOL, V296, P179, DOI 10.1007/s00606-011-0486-3	75	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90598	10.1371/journal.pone.0090598	http://dx.doi.org/10.1371/journal.pone.0090598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603596	Green Published, Green Submitted, gold			2022-12-25	WOS:000332483600066
J	Beltran, WA; Cideciyan, AV; Guziewicz, KE; Iwabe, S; Swider, M; Scott, EM; Savina, SV; Ruthel, G; Stefano, F; Zhang, LL; Zorger, R; Sumaroka, A; Jacobson, SG; Aguirre, GD				Beltran, William A.; Cideciyan, Artur V.; Guziewicz, Karina E.; Iwabe, Simone; Swider, Malgorzata; Scott, Erin M.; Savina, Svetlana V.; Ruthel, Gordon; Stefano, Frank; Zhang, Lingli; Zorger, Richard; Sumaroka, Alexander; Jacobson, Samuel G.; Aguirre, Gustavo D.			Canine Retina Has a Primate Fovea-Like Bouquet of Cone Photoreceptors Which Is Affected by Inherited Macular Degenerations	PLOS ONE			English	Article							GANGLION-CELLS; AREA CENTRALIS; VISUAL-ACUITY; GENE-THERAPY; DENSITY; MODEL; EYE; PIT; RESOLUTION; MONKEYS	Retinal areas of specialization confer vertebrates with the ability to scrutinize corresponding regions of their visual field with greater resolution. A highly specialized area found in haplorhine primates (including humans) is the fovea centralis which is defined by a high density of cone photoreceptors connected individually to interneurons, and retinal ganglion cells (RGCs) that are offset to form a pit lacking retinal capillaries and inner retinal neurons at its center. In dogs, a local increase in RGC density is found in a topographically comparable retinal area defined as the area centralis. While the canine retina is devoid of a foveal pit, no detailed examination of the photoreceptors within the area centralis has been reported. Using both in vivo and ex vivo imaging, we identified a retinal region with a primate fovea-like cone photoreceptor density but without the excavation of the inner retina. Similar anatomical structure observed in rare human subjects has been named fovea-plana. In addition, dogs with mutations in two different genes, that cause macular degeneration in humans, developed earliest disease at the newly-identified canine fovea-like area. Our results challenge the dogma that within the phylogenetic tree of mammals, haplorhine primates with a fovea are the sole lineage in which the retina has a central bouquet of cones. Furthermore, a predilection for naturally-occurring retinal degenerations to alter this cone-enriched area fills the void for a clinically-relevant animal model of human macular degenerations.	[Beltran, William A.; Guziewicz, Karina E.; Iwabe, Simone; Scott, Erin M.; Savina, Svetlana V.; Aguirre, Gustavo D.] Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA; [Cideciyan, Artur V.; Swider, Malgorzata; Sumaroka, Alexander; Jacobson, Samuel G.] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ruthel, Gordon] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Stefano, Frank] Univ Penn, Sch Dent Med, Dept Biochem, Philadelphia, PA 19104 USA; [Zhang, Lingli; Zorger, Richard] Univ Penn, Dept Neurosci, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Beltran, WA (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA.	wbeltran@vet.upenn.edu; cideciya@mail.med.upenn.edu	Cideciyan, Artur V/A-1075-2007; Ruthel, Gordon/GYU-9133-2022	Cideciyan, Artur V/0000-0002-2018-0905; Ruthel, Gordon/0000-0001-9193-5589; Aguirre, Gustavo/0000-0002-5228-256X; Jacobson, Samuel/0000-0003-2122-169X; Scott, Erin/0000-0002-9702-7298	NIH [R24EY-022012, 2PNEY-018241, RO1EY-017549, RO1EY-06855, RO1EY-013203, P30EY-001583, P40-OD010939]; Foundation Fighting Blindness; Macula Vision Research Foundation; Hope for Vision; NATIONAL EYE INSTITUTE [R01EY013203, R01EY006855, R24EY022012, P30EY001583, R01EY017549] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010939] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Macula Vision Research Foundation; Hope for Vision; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants R24EY-022012, 2PNEY-018241, RO1EY-017549, -06855, -013203, P30EY-001583, P40-OD010939. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Eye Institute or the National Institutes of Health. Work was also funded by the Foundation Fighting Blindness, the Macula Vision Research Foundation, and Hope for Vision. AVC is a RPB Senior Scientific Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; Ahnelt PK, 1998, EYE, V12, P531, DOI 10.1038/eye.1998.142; [Anonymous], 1977, VISUAL SYSTEM VERTEB, DOI [DOI 10.1007/978-3-642-66468-7, 10.1007/978-3-642-66468-7_11, DOI 10.1007/978-3-642-66468-7_11]; Beltran WA, 2006, INVEST OPHTH VIS SCI, V47, P1669, DOI 10.1167/iovs.05-0845; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; Beltran WA, 2009, VET OPHTHALMOL, V12, P192, DOI 10.1111/j.1463-5224.2009.00694.x; BISHOP PO, 1962, J PHYSIOL-LONDON, V163, P466, DOI 10.1113/jphysiol.1962.sp006990; Boon CJF, 2009, PROG RETIN EYE RES, V28, P187, DOI 10.1016/j.preteyeres.2009.04.002; Bramall AN, 2010, ANNU REV NEUROSCI, V33, P441, DOI 10.1146/annurev-neuro-060909-153227; CALKINS DJ, 1994, NATURE, V371, P70, DOI 10.1038/371070a0; Carroll J, 2004, P NATL ACAD SCI USA, V101, P8461, DOI 10.1073/pnas.0401440101; Chievitz JH, 1889, ARCH ANAT PHYSL AN S, P139; Chui TYP, 2012, OPTOMETRY VISION SCI, V89, P602, DOI 10.1097/OPX.0b013e3182504227; Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110; Cideciyan AV, 2005, P NATL ACAD SCI USA, V102, P5233, DOI 10.1073/pnas.0408892102; Clark DL, 2013, EXP EYE RES, V116, P75, DOI 10.1016/j.exer.2013.08.004; COILE DC, 1988, OPHTHAL PHYSL OPT, V8, P215, DOI 10.1111/j.1475-1313.1988.tb01040.x; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Dawson W.W., 1989, Puerto Rico Health Sciences Journal, V8, P111; Dawson WW, 2008, VISION RES, V48, P360, DOI 10.1016/j.visres.2007.08.006; DOW BM, 1981, EXP BRAIN RES, V44, P213; Ezeh P. I., 1990, Progress in Veterinary Neurology, V1, P427; FISHMAN GA, 1988, ARCH OPHTHALMOL-CHIC, V106, P369; Francis PJ, 2008, HUM MOL GENET, V17, P2673, DOI 10.1093/hmg/ddn167; Franco ECS, 2000, BRAIN BEHAV EVOLUT, V56, P276, DOI 10.1159/000047211; Guziewicz KE, 2007, INVEST OPHTH VIS SCI, V48, P1959, DOI 10.1167/iovs.06-1374; HOGAN D, 1995, J COMP NEUROL, V352, P367, DOI 10.1002/cne.903520305; HOLLANDER H, 1972, BRAIN RES, V42, P497, DOI 10.1016/0006-8993(72)90549-5; HUGHES A, 1975, J COMP NEUROL, V163, P107, DOI 10.1002/cne.901630107; Lamb TD, 2007, NAT REV NEUROSCI, V8, P960, DOI 10.1038/nrn2283; Li KY, 2010, INVEST OPHTH VIS SCI, V51, P6858, DOI 10.1167/iovs.10-5499; Marmor MF, 2008, ARCH OPHTHALMOL-CHIC, V126, P907, DOI 10.1001/archopht.126.7.907; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; McAllister JT, 2010, VISION RES, V50, P810, DOI 10.1016/j.visres.2010.02.003; McGreevy P, 2004, BRAIN BEHAV EVOLUT, V63, P13, DOI 10.1159/000073756; MILLERET C, 1988, INVEST OPHTH VIS SCI, V29, P1299; Miyadera K, 2012, MAMM GENOME, V23, P40, DOI 10.1007/s00335-011-9361-3; Molday LL, 2000, NAT GENET, V25, P257, DOI 10.1038/77004; Moore AT, 2009, CURR OPIN OPHTHALMOL, V20, P363, DOI 10.1097/ICU.0b013e32832f8002; Mowat FM, 2008, MOL VIS, V14, P2518; Muller H, 1861, WURZBURGER NATURWISS, V2, P139; Murphy CJ, 1997, AM J VET RES, V58, P414; NEUHAUS W, 1967, Z VERGL PHYSIOL, V57, P137, DOI 10.1007/BF00303069; ODOM JV, 1983, AM J PHYSIOL, V245, pR637, DOI 10.1152/ajpregu.1983.245.5.R637; Oesterberg G, 1935, ACTA OPHTHALMOL    S, V6, P1; Ofri R., 1993, Progress in Veterinary & Comparative Ophthalmology, V3, P111; PEICHL L, 1992, J COMP NEUROL, V324, P603, DOI 10.1002/cne.903240412; PETTIGREW JD, 1988, BRAIN BEHAV EVOLUT, V32, P39, DOI 10.1159/000116531; Provis JM, 2013, PROG RETIN EYE RES, V35, P63, DOI 10.1016/j.preteyeres.2013.01.005; Putnam NM, 2005, J VISION, V5, P632, DOI 10.1167/5.7.3; RAPAPORT DH, 1984, NEUROSCIENCE, V11, P289, DOI 10.1016/0306-4522(84)90024-1; ROCHONDUVIGNEAU.A, 1907, ARCH ANAT MICROSC, V9, P315; Rossi EA, 2010, NAT NEUROSCI, V13, P156, DOI 10.1038/nn.2465; ROWE MH, 1982, BRAIN BEHAV EVOLUT, V21, P1, DOI 10.1159/000121611; Soemmerring DM, 1818, OCULORUM HOMINIS ANI; Springer AD, 2005, VISUAL NEUROSCI, V22, P171, DOI 10.1017/S095252380522206X; Springer AD, 2011, VISUAL NEUROSCI, V28, P473, DOI 10.1017/S0952523811000332; STEINBERG RH, 1973, J COMP NEUROL, V148, P229, DOI 10.1002/cne.901480209; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; VAKKUR GJ, 1963, VISION RES, V3, P357, DOI 10.1016/0042-6989(63)90009-9; Wagner-Schuman M, 2011, INVEST OPHTH VIS SCI, V52, P625, DOI 10.1167/iovs.10-5886; WIKLER KC, 1990, J COMP NEUROL, V297, P499, DOI 10.1002/cne.902970404; WIKLER KC, 1990, J NEUROSCI, V10, P3390; Zangerl B, 2010, MOL VIS, V16, P2791; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993; Zurn J., 1902, Arch Anat Suppl, P99	70	80	81	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90390	10.1371/journal.pone.0090390	http://dx.doi.org/10.1371/journal.pone.0090390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599007	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400069
J	Li, Y; Wang, NA; Zhang, CQ				Li, Yu; Wang, Nai'ang; Zhang, Chengqi			An Abrupt Centennial-Scale Drought Event and Mid-Holocene Climate Change Patterns in Monsoon Marginal Zones of East Asia	PLOS ONE			English	Article							HOLOCENE ENVIRONMENTAL-CHANGE; HIGH-RESOLUTION; MOISTURE EVOLUTION; TENGGER DESERT; QINGHAI LAKE; RECORD; DRY; SEDIMENTS; CHINA; STALAGMITE	The mid-latitudes of East Asia are characterized by the interaction between the Asian summer monsoon and the westerly winds. Understanding long-term climate change in the marginal regions of the Asian monsoon is critical for understanding the millennial-scale interactions between the Asian monsoon and the westerly winds. Abrupt climate events are always associated with changes in large-scale circulation patterns; therefore, investigations into abrupt climate changes provide clues for responses of circulation patterns to extreme climate events. In this paper, we examined the time scale and mid-Holocene climatic background of an abrupt dry mid-Holocene event in the Shiyang River drainage basin in the northwest margin of the Asian monsoon. Mid-Holocene lacustrine records were collected from the middle reaches and the terminal lake of the basin. Using radiocarbon and OSL ages, a centennial-scale drought event, which is characterized by a sand layer in lacustrine sediments both from the middle and lower reaches of the basin, was absolutely dated between 8.0-7.0 cal kyr BP. Grain size data suggest an abrupt decline in lake level and a dry environment in the middle reaches of the basin during the dry interval. Previous studies have shown mid-Holocene drought events in other places of monsoon marginal zones; however, their chronologies are not strong enough to study the mechanism. According to the absolutely dated records, we proposed a new hypothesis that the mid-Holocene dry interval can be related to the weakening Asian summer monsoon and the relatively arid environment in arid Central Asia. Furthermore, abrupt dry climatic events are directly linked to the basin-wide effective moisture change in semi-arid and arid regions. Effective moisture is affected by basin-wide precipitation, evapotranspiration, lake surface evaporation and other geographical settings. As a result, the time scales of the dry interval could vary according to locations due to different geographical features.	[Li, Yu; Wang, Nai'ang; Zhang, Chengqi] Lanzhou Univ, Coll Earth & Environm Sci, Ctr Hydrol Cycle & Water Resources Arid Reg, Lanzhou 730000, Peoples R China	Lanzhou University	Li, Y (corresponding author), Lanzhou Univ, Coll Earth & Environm Sci, Ctr Hydrol Cycle & Water Resources Arid Reg, Lanzhou 730000, Peoples R China.	liyu@lzu.edu.cn	zhang, chi/GRX-3610-2022	Li, Yu/0000-0003-3381-5372	National Natural Science Foundation of China [41371009, 41001116]; Fundamental Research Fund for the Central Universities [lzujbky-2013-127, lzujbky-2013-129]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Fund for the Central Universities	This research was supported by the National Natural Science Foundation of China (Grant No. 41371009 and 41001116) and the Fundamental Research Fund for the Central Universities (Grant No. lzujbky-2013-127 and lzujbky-2013-129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens CD, 1985, METEOROLOGY TODAY; Alley RB, 2000, P NATL ACAD SCI USA, V97, P1331, DOI 10.1073/pnas.97.4.1331; An CB, 2006, QUATERNARY SCI REV, V25, P351, DOI 10.1016/j.quascirev.2005.03.013; An CB, 2008, GLOBAL PLANET CHANGE, V63, P283, DOI 10.1016/j.gloplacha.2008.03.007; An ZS, 2000, QUATERNARY SCI REV, V19, P743, DOI 10.1016/S0277-3791(99)00031-1; [Anonymous], 1983, ACTA GEOGRAPHICA SIN, DOI DOI 10.3321/j.issn:0375-5444.1983.01.001; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Cai YJ, 2010, EARTH PLANET SC LETT, V291, P21, DOI 10.1016/j.epsl.2009.12.039; Chen CTA, 2003, PALAEOGEOGR PALAEOCL, V193, P181, DOI 10.1016/S0031-0182(03)00225-6; Chen FH, 2006, HOLOCENE, V16, P675, DOI 10.1191/0959683606hl951rp; Chen FH, 2008, QUATERNARY SCI REV, V27, P351, DOI 10.1016/j.quascirev.2007.10.017; Chen FH, 2003, CHINESE SCI BULL, V48, P1401, DOI 10.1360/03wd0245; Chen L.H., 1992, RATIONAL DEV USE LAN; Clemens SC, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2010PA001926; Cosford J, 2008, EARTH PLANET SC LETT, V275, P296, DOI 10.1016/j.epsl.2008.08.018; Dong JG, 2010, HOLOCENE, V20, P257, DOI 10.1177/0959683609350393; Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Fowell SJ, 2003, QUATERNARY RES, V59, P353, DOI 10.1016/S0033-5894(02)00020-0; GASSE F, 1991, NATURE, V353, P742, DOI 10.1038/353742a0; Guo ZT, 2000, GLOBAL PLANET CHANGE, V26, P97, DOI 10.1016/S0921-8181(00)00037-0; He Y, 2004, QUATERNARY RES, V61, P52, DOI 10.1016/j.yqres.2003.08.004; Herzschuh U, 2006, QUATERNARY SCI REV, V25, P163, DOI 10.1016/j.quascirev.2005.02.006; Hu CY, 2008, EARTH PLANET SC LETT, V266, P221, DOI 10.1016/j.epsl.2007.10.015; Huang DY, 1997, GANSU VEGETATION; Jiang WY, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD009050; Lerman A., 1978, LAKE CHEM GEOLOGY PH; Li J.J., 1990, QUATERNARY SCI, V3, P197; Li Y, 2012, J ASIAN EARTH SCI, V58, P78, DOI 10.1016/j.jseaes.2012.07.001; Li Y, 2010, CLIM DYNAM, V35, P1115, DOI 10.1007/s00382-010-0861-8; Li Y, 2009, BOREAS, V38, P349, DOI 10.1111/j.1502-3885.2008.00063.x; Li Y, 2009, REV PALAEOBOT PALYNO, V154, P54, DOI 10.1016/j.revpalbo.2008.12.005; Lin C, 1993, ATMOSPHERE CLIMATE C; Liu XQ, 2008, QUATERNARY RES, V70, P412, DOI 10.1016/j.yqres.2008.06.005; Liu XQ, 2007, CHINESE SCI BULL, V52, P539, DOI 10.1007/s11434-007-0086-3; Long H, 2010, QUATERNARY RES, V74, P46, DOI 10.1016/j.yqres.2010.03.009; MIDDLETON GV, 1976, J GEOL, V84, P405, DOI 10.1086/628208; Morrill C, 2006, QUATERNARY RES, V65, P232, DOI 10.1016/j.yqres.2005.02.014; PACHUR HJ, 1995, QUATERNARY RES, V44, P171, DOI 10.1006/qres.1995.1061; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Shen J, 2005, QUATERN INT, V136, P131, DOI 10.1016/j.quaint.2004.11.014; Sun DH, 2002, SEDIMENT GEOL, V152, P263, DOI 10.1016/S0037-0738(02)00082-9; [王可丽 Wang Keli], 2005, [水科学进展, Advances in Water Science], V16, P432; Wang W, 2011, QUATERN INT, V229, P74, DOI 10.1016/j.quaint.2010.06.005; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Wang YB, 2010, EARTH-SCI REV, V103, P135, DOI 10.1016/j.earscirev.2010.09.004; Wunnemann B, 2006, PALAEOGEOGR PALAEOCL, V234, P223, DOI 10.1016/j.palaeo.2005.10.016; Wunnemann B, 1998, QUATERNARY DESERTS AND CLIMATIC CHANGE, P381; Zhang HC, 2004, PALAEOGEOGR PALAEOCL, V211, P45, DOI 10.1016/j.palaeo.2004.04.006; Zhang HC, 2000, PALAEOGEOGR PALAEOCL, V162, P389, DOI 10.1016/S0031-0182(00)00139-5; Zhang J., 1992, CLIMATE CHINA; Zhao Y, 2008, J ARID ENVIRON, V72, P2054, DOI 10.1016/j.jaridenv.2008.06.016; Zhou WJ, 2004, QUATERNARY RES, V62, P39, DOI 10.1016/j.yqres.2004.05.004	53	2	2	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90241	10.1371/journal.pone.0090241	http://dx.doi.org/10.1371/journal.pone.0090241			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599259	gold, Green Published, Green Submitted			2022-12-25	WOS:000332479400057
J	Olson, SH; Parmley, J; Soos, C; Gilbert, M; Latorre-Margalef, N; Hall, JS; Hansbro, PM; Leighton, F; Munster, V; Joly, D				Olson, Sarah H.; Parmley, Jane; Soos, Catherine; Gilbert, Martin; Latorre-Margalef, Neus; Hall, Jeffrey S.; Hansbro, Phillip M.; Leighton, Frederick; Munster, Vincent; Joly, Damien			Sampling Strategies and Biodiversity of Influenza A Subtypes in Wild Birds	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; MIGRATORY BIRDS; VIRUS; SURVEILLANCE; WATERFOWL; PREVALENCE; PREDICTION; RICHNESS; PATTERNS	Wild aquatic birds are recognized as the natural reservoir of avian influenza A viruses (AIV), but across high and low pathogenic AIV strains, scientists have yet to rigorously identify most competent hosts for the various subtypes. We examined 11,870 GenBank records to provide a baseline inventory and insight into patterns of global AIV subtype diversity and richness. Further, we conducted an extensive literature review and communicated directly with scientists to accumulate data from 50 non-overlapping studies and over 250,000 birds to assess the status of historic sampling effort. We then built virus subtype sample-based accumulation curves to better estimate sample size targets that capture a specific percentage of virus subtype richness at seven sampling locations. Our study identifies a sampling methodology that will detect an estimated 75% of circulating virus subtypes from a targeted bird population and outlines future surveillance and research priorities that are needed to explore the influence of host and virus biodiversity on emergence and transmission.	[Olson, Sarah H.; Gilbert, Martin] Wildlife Conservat Soc, Bronx, NY USA; [Parmley, Jane] Univ Guelph, Dept Pathobiol, Canadian Cooperat Wildlife Hlth Ctr, Guelph, ON N1G 2W1, Canada; [Soos, Catherine] Environm Canada, Sci & Technol Branch, Saskatoon, SK, Canada; [Latorre-Margalef, Neus] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst EEMiS, Kalmar, Sweden; [Latorre-Margalef, Neus] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Southeastern Cooperat Wildlife Dis Study, Athens, GA USA; [Hall, Jeffrey S.] USGS, Natl Wildlife Hlth Ctr, Madison, WI USA; [Hansbro, Phillip M.] Univ Newcastle, Prior Res Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia; [Hansbro, Phillip M.] Hunter Med Res Inst, Newcastle, NSW, Australia; [Leighton, Frederick] Univ Saskatchewan, Western Coll Vet Med, Canadian Cooperat Wildlife Hlth Ctr, Saskatoon, SK S7N 0W0, Canada; [Munster, Vincent] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT USA; [Joly, Damien] Metabiota, Nanaimo, BC, Canada	Wildlife Conservation Society; University of Guelph; Environment & Climate Change Canada; Linnaeus University; University System of Georgia; University of Georgia; United States Department of the Interior; United States Geological Survey; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Saskatchewan; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Joly, D (corresponding author), Metabiota, Nanaimo, BC, Canada.	djoly@metabiota.com	Soos, Catherine/Q-4983-2019; Hansbro, Phil/G-7486-2013; Munster, Vincent/I-7607-2018	Soos, Catherine/0000-0003-4610-3614; Hansbro, Phil/0000-0002-4741-3035; Munster, Vincent/0000-0002-2288-3196; Hall, Jeffrey/0000-0001-5599-2826; Gilbert, Martin/0000-0002-9930-4383	Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); Department of Health and Human Services [HHSN266200700007C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001179] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Health and Human Services; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) Emerging Pandemic Threats program, PREDICT project. VJM is supported by the Division of Intramural Research, National Institute of Allergy and Infectious Disease, National Institutes of Health. Additional funding for this work was provided by the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), and the Department of Health and Human Services under contract HHSN266200700007C. Journal access was provided by in-kind support from the University of Wisconsin-Madison Center for Sustainability and the Global Environment (SAGE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00598-13; BirdLife International, 2013, DAT ZON; Brown JD, 2012, J WILDLIFE DIS, V48, P991, DOI 10.7589/2011-09-280; Brown JD, 2010, J WILDLIFE DIS, V46, P896, DOI 10.7589/0090-3558-46.3.896; Butler D, 2012, NATURE, V483, P520, DOI 10.1038/483520a; Chao A, 2009, ECOLOGY, V90, P1125, DOI 10.1890/07-2147.1; Cheng MC, 2010, AVIAN DIS, V54, P109, DOI 10.1637/8960-061709-Reg.1; Colwell R. K., 2006, ESTIMATES VERSION 8; DeLiberto TJ, 2009, INTEGR ZOOL, V4, P426, DOI 10.1111/j.1749-4877.2009.00180.x; Dove ADM, 2006, TRENDS PARASITOL, V22, P568, DOI 10.1016/j.pt.2006.09.008; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gilbert M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044097; Gotelli N. J., 2010, BIOL DIVERSITY FRONT, P39, DOI DOI 10.1016/J.BAAE.2011.07.002; Gunnarsson G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035679; Hansbro PM, 2010, EMERG INFECT DIS, V16, P1896, DOI 10.3201/eid1612.100776; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Henriques AM, 2011, AVIAN PATHOL, V40, P597, DOI 10.1080/03079457.2011.618943; Herrick KA, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-42; HINSHAW VS, 1985, B WORLD HEALTH ORGAN, V63, P711; HINSHAW VS, 1982, J VIROL, V42, P865, DOI 10.1128/JVI.42.3.865-872.1982; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Latorre-Margalef N, 2013, PLOS PATHOG, V9, DOI [10.1371/journal.ppat.1003443, DOI 10.1371/J0URNAL.PPAT.1003443]; Latorre-Margalef N, P R SOC B; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Morrison R. L., 2009, PROC OSA TOPICAL M C; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Munster VJ, 2009, J CLIN MICROBIOL, V47, P666, DOI 10.1128/JCM.01625-08; NCBI, INFL VIR DAT; Nolting Jacqueline, 2012, PLoS Curr, V4, pRRN1290; OIE, 2018, TERR AN HLTH COD; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Parmley JE, 2008, EMERG INFECT DIS, V14, P2005; R Development Core Team, 2012, R LANG ENV STAT COMP; Sivay MV, 2012, AVIAN DIS, V56, P456, DOI 10.1637/9868-080111-Reg.1; Soliman A, 2012, J WILDLIFE DIS, V48, P669, DOI 10.7589/0090-3558-48.3.669; Soos C, 2012, J WILDLIFE DIS, V48, P444, DOI 10.7589/0090-3558-48.2.444; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Turmelle AS, 2009, ECOHEALTH, V6, P522, DOI 10.1007/s10393-009-0263-8; United States Fish & Wildlife Service, 2012, N AM FLYW DIR 146; USDA, 2006, EARL DET SYST HIGHL; Wahlgren J, 2008, VECTOR-BORNE ZOONOT, V8, P783, DOI 10.1089/vbz.2007.0274; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Wallensten A, 2006, VACCINE, V24, P6734, DOI 10.1016/j.vaccine.2006.05.057; Wille M, 2011, ARCH VIROL, V156, P107, DOI 10.1007/s00705-010-0839-1	50	39	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90826	10.1371/journal.pone.0090826	http://dx.doi.org/10.1371/journal.pone.0090826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599502	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400137
J	Han, HM; Bai, L; Su, JJ; Zhang, JP; Song, LQ; Gao, AN; Yang, XM; Li, XQ; Liu, WH; Li, LH				Han, Haiming; Bai, Li; Su, Junji; Zhang, Jinpeng; Song, Liqiang; Gao, Ainong; Yang, Xinming; Li, Xiuquan; Liu, Weihua; Li, Lihui			Genetic Rearrangements of Six Wheat-Agropyron cristatum 6P Addition Lines Revealed by Molecular Markers	PLOS ONE			English	Article							TRITICUM-AESTIVUM L; CHROMOSOME BIN MAP; DISOMIC ADDITION; ASSISTED SELECTION; CONFERRING RESISTANCE; CRESTED WHEATGRASSES; BREAD WHEAT; IDENTIFICATION; HYBRIDS; HYBRIDIZATION	Agropyron cristatum (L.) Gaertn. (2n = 4x = 28, PPPP) not only is cultivated as pasture fodder but also could provide many desirable genes for wheat improvement. It is critical to obtain common wheat-A. cristatum alien disomic addition lines to locate the desired genes on the P genome chromosomes. Comparative analysis of the homoeologous relationships between the P genome chromosome and wheat genome chromosomes is a key step in transferring different desirable genes into common wheat and producing the desired alien translocation line while compensating for the loss of wheat chromatin. In this study, six common wheat-A. cristatum disomic addition lines were produced and analyzed by phenotypic examination, genomic in situ hybridization (GISH), SSR markers from the ABD genomes and STS markers from the P genome. Comparative maps, six in total, were generated and demonstrated that all six addition lines belonged to homoeologous group 6. However, chromosome 6P had undergone obvious rearrangements in different addition lines compared with the wheat chromosome, indicating that to obtain a genetic compensating alien translocation line, one should recombine alien chromosomal regions with homoeologous wheat chromosomes. Indeed, these addition lines were classified into four types based on the comparative mapping: 6P(I), 6P(II), 6P(III), and 6P(IV). The different types of chromosome 6P possessed different desirable genes. For example, the 6PI type, containing three addition lines, carried genes conferring high numbers of kernels per spike and resistance to powdery mildew, important traits for wheat improvement. These results may prove valuable for promoting the development of conventional chromosome engineering techniques toward molecular chromosome engineering.	[Han, Haiming; Bai, Li; Su, Junji; Zhang, Jinpeng; Song, Liqiang; Gao, Ainong; Yang, Xinming; Li, Xiuquan; Liu, Weihua; Li, Lihui] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Liu, WH (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China.	liuweihua@caas.cn; lilihui@caas.cn			National Basic Research Program of China [2011CB100104]; National High Technology Research and Development Program of China [2011AA100102]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The financial support was provided by the National Basic Research Program of China (Grant No. 2011CB100104; URL: http://www.973.gov.cn/AreaAppl.aspx) and the National High Technology Research and Development Program of China (Grant No. 2011AA100102; URL: http://www.863.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD F, 1991, PLANT BREEDING, V106, P275, DOI 10.1111/j.1439-0523.1991.tb00512.x; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Alkhimova AG, 1999, CHROMOSOME RES, V7, P205, DOI 10.1023/A:1009299300018; Bento M, 2010, THEOR APPL GENET, V121, P489, DOI 10.1007/s00122-010-1325-6; CHAPMAN V, 1955, NATURE, V175, P1091, DOI 10.1038/1751091a0; Chen HM, 2005, CHINESE SCI BULL, V50, P2328, DOI 10.1360/982005-379; CHEN Q, 1989, CR ACAD SCI III-VIE, V308, P425; CHEN Q, 1990, GENOME, V33, P663, DOI 10.1139/g90-098; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Conley EJ, 2004, GENETICS, V168, P625, DOI 10.1534/genetics.104.034801; Cuadrado A, 2000, THEOR APPL GENET, V101, P711, DOI 10.1007/s001220051535; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; Devos KM, 1997, PLANT MOL BIOL, V35, P3, DOI 10.1023/A:1005820229043; Dewey D.R., 1984, GENE MANIPULATION PL, P209, DOI DOI 10.1007/978-1-4613-2429-4_9; DONG YS, 1992, HEREDITAS, V116, P175, DOI 10.1111/j.1601-5223.1992.tb00224.x; Du WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053921; Fischer RA, 1998, CROP SCI, V38, P1467, DOI 10.2135/cropsci1998.0011183X003800060011x; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; Fu SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070483; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Gill BS, 2006, ADV AGRON, V89, P73, DOI 10.1016/S0065-2113(05)89002-9; HSIAO C, 1989, GENOME, V32, P1079, DOI 10.1139/g89-557; Hu LJ, 2012, GENES GENOM, P1; ISLAM AKMR, 1981, HEREDITY, V46, P161, DOI 10.1038/hdy.1981.24; Jahier J, 2001, PLANT BREEDING, V120, P125, DOI 10.1046/j.1439-0523.2001.00585.x; JAUHAR PP, 1992, HEREDITAS, V116, P107, DOI 10.1111/j.1601-5223.1992.tb00212.x; JOHNSON DA, 1986, CRESTED WHEATGRASS I, P65; Kishii M, 2004, THEOR APPL GENET, V109, P255, DOI 10.1007/s00122-004-1631-y; La Rota Mauricio, 2004, Functional & Integrative Genomics, V4, P34, DOI 10.1007/s10142-003-0098-2; LANDE R, 1990, GENETICS, V124, P743; Li L, 1990, SCI CHINA SER B, V34, P45; Li L.H., 1993, ACTA GENET SIN, V15, P45; Li L.H., 1997, ACTA GENET SIN, V24, P154; LI LH, 1991, THEOR APPL GENET, V81, P312, DOI 10.1007/BF00228669; Li LH, 2006, DESCRIPTORS DATA STA; Li Li-hui, 1998, Acta Genetica Sinica, V25, P538; Li Lihui, 1995, Acta Genetica Sinica, V22, P109; LIMIN AE, 1990, GENOME, V33, P581, DOI 10.1139/g90-085; Lin F, 2009, CAN J PLANT SCI, V89, P569, DOI 10.4141/CJPS08139; LIU CJ, 1992, THEOR APPL GENET, V83, P305, DOI 10.1007/BF00224276; Liu WH, 2010, GENOME, V53, P472, DOI [10.1139/G10-023, 10.1139/g10-023]; Liu WX, 2010, AGR SCI CHINA, V9, P463, DOI 10.1016/S1671-2927(09)60118-8; Luan Y, 2010, PLANTA, V232, P501, DOI 10.1007/s00425-010-1187-9; McArthur RI, 2012, CHROMOSOME RES, P1; McFADDEN EDGAR S., 1930, JOUR AMER SOC AGRON, V22, P1020; Mujeeb-Kazi A, 2013, ADV AGRON, V122, P179, DOI 10.1016/B978-0-12-417187-9.00004-8; Munkvold JD, 2004, GENETICS, V168, P639, DOI 10.1534/genetics.104.034819; Niu ZX, 2011, GENETICS, V187, P1011, DOI 10.1534/genetics.110.123588; Pestsova E, 2000, GENOME, V43, P689, DOI 10.1139/gen-43-4-689; POTVIN C, 1990, ECOLOGY, V71, P1389, DOI 10.2307/1938276; Qi LiLi, 2003, Functional & Integrative Genomics, V3, P39; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Qi ZJ, 2010, THEOR APPL GENET, V121, P589, DOI 10.1007/s00122-010-1332-7; Randhawa HS, 2004, GENETICS, V168, P677, DOI 10.1534/genetics.104.034843; Roder MS, 1998, GENETICS, V149, P2007; Schneider A, 2005, GENOME, V48, P1070, DOI 10.1139/G05-062; SHARP PJ, 1989, THEOR APPL GENET, V78, P342, DOI 10.1007/BF00265294; Smith DC, 1942, J AGRIC RES, V64, P0033; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Song LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069501; Sorrells ME, 2003, GENOME RES, V13, P1818, DOI 10.1101/gr.1113003; STEBBINS GL, 1947, ADV GENET, V1, P403, DOI 10.1016/S0065-2660(08)60490-3; Stuber CW, 1999, CROP SCI, V39, P1571, DOI 10.2135/cropsci1999.3961571x; Szakacs E, 2010, J APPL GENET, V51, P149, DOI 10.1007/BF03195723; Tomas D, 2012, INT J MOL SCI, V13, P8549, DOI 10.3390/ijms13078549; Uslu E, 1999, HEREDITAS, V131, P129, DOI 10.1111/j.1601-5223.1999.00129.x; Wang J, 2011, EUPHYTICA, P1; Wang QX, 2010, GENOME, V53, P241, DOI [10.1139/G09-098, 10.1139/g09-098]; Wang RRC, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P77, DOI 10.1007/978-3-642-14228-4_2; WHITE W. J., 1940, SCI AGRIC [OTTAWA], V21, P198; Wu J, 2006, THEOR APPL GENET, V114, P13, DOI 10.1007/s00122-006-0405-0; Yu JK, 2004, GENOME, V47, P805, DOI [10.1139/g04-057, 10.1139/G04-057]; Zhao RH, 2013, THEOR APPL GENET, V126, P2921, DOI 10.1007/s00122-013-2181-y	73	49	51	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e91066	10.1371/journal.pone.0091066	http://dx.doi.org/10.1371/journal.pone.0091066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595330	Green Submitted, Green Published, gold			2022-12-25	WOS:000332475500113
J	Ariza, A; Collado, D; Vida, Y; Montanez, MI; Perez-Inestrosa, E; Blanca, M; Torres, MJ; Canada, FJ; Perez-Sala, D				Ariza, Adriana; Collado, Daniel; Vida, Yolanda; Montanez, Maria I.; Perez-Inestrosa, Ezequiel; Blanca, Miguel; Jose Torres, Maria; Javier Canada, F.; Perez-Sala, Dolores			Study of Protein Haptenation by Amoxicillin Through the Use of a Biotinylated Antibiotic	PLOS ONE			English	Article							BETA-LACTAM ANTIBIOTICS; NF-KAPPA-B; IGE ANTIBODIES; ALLERGIC REACTIONS; CYSTIC-FIBROSIS; HYPERSENSITIVITY REACTIONS; BENZYL PENICILLOYL; SERUM-ALBUMIN; DRUG; IDENTIFICATION	Allergic reactions towards beta-lactam antibiotics pose an important clinical problem. The ability of small molecules, such as a beta-lactams, to bind covalently to proteins, in a process known as haptenation, is considered necessary for induction of a specific immunological response. Identification of the proteins modified by beta-lactams and elucidation of the relevance of this process in allergic reactions requires sensitive tools. Here we describe the preparation and characterization of a biotinylated amoxicillin analog (AX-B) as a tool for the study of protein haptenation by amoxicillin (AX). AX-B, obtained by the inclusion of a biotin moiety at the lateral chain of AX, showed a chemical reactivity identical to AX. Covalent modification of proteins by AX-B was reduced by excess AX and vice versa, suggesting competition for binding to the same targets. From an immunological point of view, AX and AX-B behaved similarly in RAST inhibition studies with sera of patients with non-selective allergy towards beta-lactams, whereas, as expected, competition by AX-B was poorer with sera of AX-selective patients, which recognize AX lateral chain. Use of AX-B followed by biotin detection allowed the observation of human serum albumin (HSA) modification by concentrations 100-fold lower that when using AX followed by immunological detection. Incubation of human serum with AX-B led to the haptenation of all of the previously identified major AX targets. In addition, some new targets could be detected. Interestingly, AX-B allowed the detection of intracellular protein adducts, which showed a cell type-specific pattern. This opens the possibility of following the formation and fate of AX-B adducts in cells. Thus, AX-B may constitute a valuable tool for the identification of AX targets with high sensitivity as well as for the elucidation of the mechanisms involved in allergy towards beta-lactams.	[Ariza, Adriana; Javier Canada, F.; Perez-Sala, Dolores] CSIC, Dept Chem & Phys Biol, Ctr Invest Biol, Madrid, Spain; [Ariza, Adriana; Montanez, Maria I.; Jose Torres, Maria] Carlos Haya Hosp IBIMA, Res Lab, Malaga, Spain; [Collado, Daniel; Vida, Yolanda; Perez-Inestrosa, Ezequiel] Univ Malaga, Dept Organ Chem, E-29071 Malaga, Spain; [Collado, Daniel; Vida, Yolanda; Montanez, Maria I.; Perez-Inestrosa, Ezequiel] BIONAND Andalusian Ctr Nanomed & Biotechnol, Malaga, Spain; [Blanca, Miguel] Hosp Carlos Haya, Allergy Serv, Malaga, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universidad de Malaga; Universidad de Malaga; Hospital Carlos Haya	Perez-Sala, D (corresponding author), CSIC, Dept Chem & Phys Biol, Ctr Invest Biol, Madrid, Spain.	dperezsala@cib.csic.es	Torres, María José/T-3518-2017; Vida, Yolanda/M-5662-2014; Montanez, Maria I/B-7194-2014; Cañada, Francisco J./D-5837-2014; Torres, Maria/GVU-3391-2022; Veguillas, Adriana Ariza/X-3696-2018; Perez-Sala, Dolores/L-5969-2014; Perez-Inestrosa, Ezequiel/H-9801-2015	Torres, María José/0000-0001-5228-471X; Montanez, Maria I/0000-0001-6641-5979; Cañada, Francisco J./0000-0003-4462-1469; Veguillas, Adriana Ariza/0000-0003-1524-9602; Perez-Sala, Dolores/0000-0003-0600-665X; Perez-Inestrosa, Ezequiel/0000-0001-7546-5273; Vida Pol, Yolanda/0000-0002-7004-4629	MINECO [SAF2012-36519]; RETIC [RD07/0064/0007, RD12/0013/0008]; Junta de Andalucia [CTS-6603]; ISCIII [PS09/01768, PI12/02529]; European Union under REA grant [300230]	MINECO(Spanish Government); RETIC; Junta de Andalucia(Junta de Andalucia); ISCIII(Instituto de Salud Carlos III); European Union under REA grant	This work was supported by grants SAF2012-36519 from MINECO and RETIC RD07/0064/0007 and RD12/0013/0008 to DPS, Junta de Andalucia CTS-6603 and ISCIII PS09/01768 and PI12/02529 to MJT, funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement no 300230, to MIM. The stay of A. A. at CIB-CSIC was funded in part by a fellowship from ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariza A, 2012, J PROTEOMICS, V77, P504, DOI 10.1016/j.jprot.2012.09.030; Ariza A, 2011, CURR OPIN ALLERGY CL, V11, P305, DOI 10.1097/ACI.0b013e3283489ae5; BATCHELOR FR, 1966, IMMUNOLOGY, V10, P21; Gomez MB, 2004, CURR OPIN ALLERGY CL, V4, P261, DOI 10.1097/01.all.0000136764.74065.15; BLANCA M, 1995, ALLERGY, V50, P777; BLANCA M, 1992, J IMMUNOL METHODS, V153, P99, DOI 10.1016/0022-1759(92)90311-G; Blanca M, 2009, ALLERGY, V64, P183, DOI [10.1111/j.1398-9995.2008.01924.x, 10.1111/j.1398-9995.2008.01916.x]; BLANCA M, 1994, J CLIN IMMUNOASSAY, V17, P166; BLANCA M, 1991, ALLERGY, V46, P632, DOI 10.1111/j.1398-9995.1991.tb00635.x; BLANCA M, 1988, ALLERGY, V43, P508, DOI 10.1111/j.1398-9995.1988.tb01628.x; BRANDER C, 1995, J IMMUNOL, V155, P2670; Brockow K, 2002, ALLERGY, V57, P45; Brooks BM, 2003, CLIN EXP IMMUNOL, V131, P268, DOI 10.1046/j.1365-2249.2003.02069.x; Carey MA, 2005, TOXICOLOGY, V216, P41, DOI 10.1016/j.tox.2005.07.015; Cernuda-Morollon E, 2002, J AM SOC NEPHROL, V13, P2223, DOI 10.1097/01.ASN.0000025786.87646.B1; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; DIAMANDIS EP, 1991, CLIN CHEM, V37, P625; EDWARDS RG, 1982, INT ARCH ALLER A IMM, V68, P352, DOI 10.1159/000233125; El-Ghaiesh S, 2012, J PHARMACOL EXP THER, V341, P597, DOI 10.1124/jpet.111.190900; ERLE DJ, 1994, J IMMUNOL, V153, P517; Fujiwara K, 2011, ANTIMICROB AGENTS CH, V55, P62, DOI 10.1128/AAC.01031-10; Garcia JJ, 1997, J CLIN LAB ANAL, V11, P251, DOI 10.1002/(SICI)1098-2825(1997)11:5<251::AID-JCLA3>3.0.CO;2-A; Garzon B, 2011, J PROTEOMICS, V74, P2243, DOI 10.1016/j.jprot.2011.03.028; Garzon B, 2010, CHEM-BIOL INTERACT, V183, P212, DOI 10.1016/j.cbi.2009.09.019; Jenkins RE, 2013, CHEM RES TOXICOL, V26, P963, DOI 10.1021/tx400124m; Jenkins RE, 2009, PROTEOM CLIN APPL, V3, P720, DOI 10.1002/prca.200800222; Torres MJ, 2010, J ALLERGY CLIN IMMUN, V125, P502, DOI 10.1016/j.jaci.2009.11.032; MAGI B, 1995, ELECTROPHORESIS, V16, P1190, DOI 10.1002/elps.11501601198; MAYORGA C, 1995, TOXICOLOGY, V97, P225, DOI 10.1016/0300-483X(94)02983-2; Morel E, 2007, ALLERGY, V62, P190, DOI 10.1111/j.1398-9995.2006.01285.x; MORENO F, 1995, INT ARCH ALLERGY IMM, V108, P74, DOI 10.1159/000237121; Pichler Werner J, 2006, Allergol Int, V55, P17, DOI 10.2332/allergolint.55.17; Praul CA, 1998, BIOCHEM BIOPH RES CO, V247, P312, DOI 10.1006/bbrc.1998.8757; Sala-Rabanal M, 2008, AM J PHYSIOL-RENAL, V294, pF1422, DOI 10.1152/ajprenal.00030.2008; Stamatakis K, 2006, ANN NY ACAD SCI, V1091, P548, DOI 10.1196/annals.1378.096; TAMAI I, 1985, J ANTIBIOT, V38, P1774, DOI 10.7164/antibiotics.38.1774; Torres MJ, 2010, MED CLIN N AM, V94, P805, DOI 10.1016/j.mcna.2010.04.006; Torres MJ, 2003, ALLERGY, V58, P961, DOI 10.1034/j.1398-9995.2003.00280.x; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Whitaker P, 2011, J IMMUNOL, V187, P200, DOI 10.4049/jimmunol.1100647; WIDE L, 1969, ACTA ENDOCRINOL-COP, VS 63, P207; YVON M, 1990, FEBS LETT, V263, P237, DOI 10.1016/0014-5793(90)81382-X; Zorrilla S, 2010, ANAL BIOCHEM, V399, P84, DOI 10.1016/j.ab.2009.12.021	43	38	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90891	10.1371/journal.pone.0090891	http://dx.doi.org/10.1371/journal.pone.0090891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595455	gold, Green Published			2022-12-25	WOS:000332468900156
J	Duivenvoorden, WCM; Paschos, A; Hopmans, SN; Austin, RC; Pinthus, JH				Duivenvoorden, Wilhelmina C. M.; Paschos, Athanasios; Hopmans, Sarah N.; Austin, Richard C.; Pinthus, Jehonathan H.			Endoplasmic Reticulum Protein ERp46 in Renal Cell Carcinoma	PLOS ONE			English	Article							BACTERIAL 2-HYBRID SYSTEM; SERUM ADIPONECTIN LEVELS; DISULFIDE-ISOMERASE; PROTEOMIC ANALYSIS; CANCER; EXPRESSION; THERAPY; PATHWAY; FAMILY	An established inverse clinical correlation between serum adiponectin levels and renal cell carcinoma (RCC) aggressiveness exists. We have recently demonstrated that adiponectin suppresses clear cell RCC (ccRCC) progression through interaction with its receptor, adiponectin receptor 1 (AdipoR1). ERp46 has been shown to inhibit adiponectin signaling via interaction with AdipoR1 in HeLa cells. However, the expression of ERp46 in RCC has not been described thus far. The objectives of this study were to investigate ERp46 in RCC, its expression, its effects on RCC growth in a mouse model and whether it interacts with AdipoR1. We demonstrated a higher ERp46/AdipoR1 expression ratio in metastatic compared to non-metastatic ccRCC, as determined by immunohistochemistry of tissue microarrays and subsequent image analysis. When ERp46 was stably knocked down using shRNA or overexpressed in murine RCC RAG cells, RCC growth after subcutaneous injection in BALB/c nude mice was inhibited and accelerated, respectively. In vitro analysis to determine the molecular interaction between AdipoR1 and ERp46 included co-immunoprecipitation using human ccRCC 786-O cells and a bacterial adenylate cyclase-based two hybrid system and demonstrated no sustained AdipoR1-ERp46 interaction. This is the first report to suggest a role for ERp46 as a potential therapeutic target in RCC given its expression profile in human RCC samples and its effect on in vivo RCC growth. Since a stable interaction with AdipoR1 could not be established, we suggest that the tumorigenic properties of ERp46 in RCC cells are not related to an inhibitory modulation of AdipoR1.	[Duivenvoorden, Wilhelmina C. M.] McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada; St Josephs Healthcare Hamilton, Hamilton, ON, Canada	McMaster University; McMaster University	Duivenvoorden, WCM (corresponding author), McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada.	duiven@mcmaster.ca	Duivenvoorden, Wilhelmina/F-1512-2016; Pinthus, Jehonathan/AAQ-1667-2021		Prostate Cancer Canada; McMaster Surgical Associates	Prostate Cancer Canada; McMaster Surgical Associates	This work was supported by Prostate Cancer Canada through a pilot grant and by McMaster Surgical Associates (to JHP and WCMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; [Anonymous], [No title captured]; Bastien L, 2009, BJU INT, V103, P1334, DOI 10.1111/j.1464-410X.2009.08454.x; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Benham AM, 2012, ANTIOXID REDOX SIGN, V16, P781, DOI 10.1089/ars.2011.4439; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Charlton HK, 2010, BIOCHEM BIOPH RES CO, V392, P234, DOI 10.1016/j.bbrc.2010.01.029; Chung H, 2013, BIOMARKERS, V18, P573, DOI 10.3109/1354750X.2013.827742; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Duivenvoorden WC, 2013, BRIT J CANCER, V108, P327, DOI 10.1038/bjc.2012.574; Funkner A, 2013, J MOL BIOL, V425, P1340, DOI 10.1016/j.jmb.2013.01.029; Gavrila A, 2003, J CLIN ENDOCR METAB, V88, P4823, DOI 10.1210/jc.2003-030214; Gu MX, 2012, J PROTEOME RES, V11, P2365, DOI 10.1021/pr300098f; Hannig G, 1998, TRENDS BIOTECHNOL, V16, P54, DOI 10.1016/S0167-7799(97)01155-4; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Horiguchi A, 2008, JPN J CLIN ONCOL, V38, P106, DOI 10.1093/jjco/hym158; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Karimova G, 2000, METHOD ENZYMOL, V328, P59, DOI 10.1016/S0076-6879(00)28390-0; Kleinmann N, 2014, CLIN EXP METASTAS, V31, P169, DOI 10.1007/s10585-013-9618-1; Klinghoffer Z, 2009, EXPERT REV ANTICANC, V9, P975, DOI [10.1586/era.09.51, 10.1586/ERA.09.51]; Knoblach B, 2003, MOL CELL PROTEOMICS, V2, P1104, DOI 10.1074/mcp.M300053-MCP200; Komatsubara AT, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-74; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Leys CM, 2007, SURGERY, V141, P41, DOI 10.1016/j.surg.2006.05.009; Lindquist JA, 2001, FASEB J, V15, P1448, DOI 10.1096/fj.00-0720fje; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Pace PE, 2013, BIOCHEM J, V453, P475, DOI 10.1042/BJ20130030; Paschos A, 2011, INFECT IMMUN, V79, P1033, DOI 10.1128/IAI.00993-10; Pinthus JH, 2008, EUR UROL, V54, P866, DOI 10.1016/j.eururo.2008.02.044; Rao DD, 2009, CANCER GENE THER, V16, P807, DOI 10.1038/cgt.2009.53; Rini BI, 2005, J CLIN ONCOL, V23, P1028, DOI 10.1200/JCO.2005.01.186; Rockstroh M MS, 2011, J INTEGR OMICS, V1, P135, DOI DOI 10.5584/JI0MICS; Sullivan DC, 2003, J BIOL CHEM, V278, P47079, DOI 10.1074/jbc.M308124200; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x; Vincent EE, 2011, ANTICANCER RES, V31, P1577; Wang YH, 2007, EXP BIOL MED, V232, P1152, DOI 10.3181/0701-RM-8; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; Yakovlev AA, 2009, NEUROCHEM J+, V3, P139, DOI 10.1134/S181971240902010X; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Zhang HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065277, 10.1371/journal.pone.0054510, 10.1371/journal.pone.0068634, 10.1371/journal.pone.0079454]; Zhang L, 2010, J CANCER RES CLIN, V136, P1497, DOI 10.1007/s00432-010-0807-x	44	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90389	10.1371/journal.pone.0090389	http://dx.doi.org/10.1371/journal.pone.0090389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594673	Green Submitted, gold, Green Published			2022-12-25	WOS:000332468900105
J	Leitman, J; Barak, B; Benyair, R; Shenkman, M; Ashery, U; Hartl, FU; Lederkremer, GZ				Leitman, Julia; Barak, Boaz; Benyair, Ron; Shenkman, Marina; Ashery, Uri; Hartl, F. Ulrich; Lederkremer, Gerardo Z.			ER Stress-Induced eIF2-alpha Phosphorylation Underlies Sensitivity of Striatal Neurons to Pathogenic Huntingtin	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; MUTANT-HUNTINGTIN; CELL-DEATH; DISEASE; INHIBITION; AGGREGATION; UBIQUITIN; TOXICITY; REPRESSION	A hallmark of Huntington's disease is the pronounced sensitivity of striatal neurons to polyglutamine-expanded huntingtin expression. Here we show that cultured striatal cells and murine brain striatum have remarkably low levels of phosphorylation of translation initiation factor eIF2 alpha, a stress-induced process that interferes with general protein synthesis and also induces differential translation of pro-apoptotic factors. EIF2 alpha phosphorylation was elevated in a striatal cell line stably expressing pathogenic huntingtin, as well as in brain sections of Huntington's disease model mice. Pathogenic huntingtin caused endoplasmic reticulum (ER) stress and increased eIF2 alpha phosphorylation by increasing the activity of PKR-like ER-localized eIF2 alpha kinase (PERK). Importantly, striatal neurons exhibited special sensitivity to ER stress-inducing agents, which was potentiated by pathogenic huntingtin. We could strongly reduce huntingtin toxicity by inhibiting PERK. Therefore, alteration of protein homeostasis and eIF2 alpha phosphorylation status by pathogenic huntingtin appears to be an important cause of striatal cell death. A dephosphorylated state of eIF2 alpha has been linked to cognition, which suggests that the effect of pathogenic huntingtin might also be a source of the early cognitive impairment seen in patients.	[Leitman, Julia; Benyair, Ron; Shenkman, Marina; Lederkremer, Gerardo Z.] Tel Aviv Univ, George Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Leitman, Julia; Barak, Boaz; Benyair, Ron; Shenkman, Marina; Ashery, Uri; Lederkremer, Gerardo Z.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Barak, Boaz; Ashery, Uri] Tel Aviv Univ, George Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Tel Aviv University; Tel Aviv University; Tel Aviv University; Max Planck Society	Lederkremer, GZ (corresponding author), Tel Aviv Univ, George Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	gerardo@post.tau.ac.il	Hartl, F. Ulrich/Y-8206-2019	Lederkremer, Gerardo/0000-0002-9857-7152; Benyair, Ron/0000-0003-0420-2649; Barak, Boaz/0000-0001-9724-4578; Ashery, Uri/0000-0001-6338-7888	Israel Science Foundation [1070/10]; German - Israeli Project Cooperation (Deutsch-Israelische Projektkooperation) [K 5-1]	Israel Science Foundation(Israel Science Foundation); German - Israeli Project Cooperation (Deutsch-Israelische Projektkooperation)	The work was supported by grants from the Israel Science Foundation (1070/10) and German - Israeli Project Cooperation (Deutsch-Israelische Projektkooperation K 5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Benyair R, 2011, INT REV CEL MOL BIO, V292, P197, DOI 10.1016/B978-0-12-386033-0.00005-0; Carnemolla A, 2009, J BIOL CHEM, V284, P18167, DOI 10.1074/jbc.M109.018325; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Gupta S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.74; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; Ill-Raga G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021456; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Kondratyev M, 2007, EXP CELL RES, V313, P3395, DOI 10.1016/j.yexcr.2007.07.006; Lajoie P, 2011, J CELL SCI, V124, P3332, DOI 10.1242/jcs.087510; Lee H, 2012, HUM MOL GENET, V21, P101, DOI 10.1093/hmg/ddr445; Leitman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3753; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Mitra S, 2008, THESCIENTIFICWORLDJO, V8, P421, DOI 10.1100/tsw.2008.60; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Reijonen S, 2008, EXP CELL RES, V314, P950, DOI 10.1016/j.yexcr.2007.12.025; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; Ron E, 2011, MOL BIOL CELL, V22, P3945, DOI 10.1091/mbc.E10-12-0944; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Roze E, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00055; Sakahira H, 2002, P NATL ACAD SCI USA, V99, P16412, DOI 10.1073/pnas.182426899; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Stout JC, 2011, NEUROPSYCHOLOGY, V25, P1, DOI 10.1037/a0020937; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Vidal R, 2011, CURR MOL MED, V11, P1, DOI 10.2174/156652411794474419; Vidal RL, 2012, HUM MOL GENET, V21, P2245, DOI 10.1093/hmg/dds040; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang H, 2010, CHEM BIOL DRUG DES, V76, P480, DOI 10.1111/j.1747-0285.2010.01048.x; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905	36	58	60	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90803	10.1371/journal.pone.0090803	http://dx.doi.org/10.1371/journal.pone.0090803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594939	Green Submitted, Green Published, gold			2022-12-25	WOS:000332468900147
J	van den Broek, NR; Jean-Baptiste, R; Neilson, JP				van den Broek, Nynke R.; Jean-Baptiste, Rachel; Neilson, James P.			Factors Associated with Preterm, Early Preterm and Late Preterm Birth in Malawi	PLOS ONE			English	Article							RURAL MALAWI; SYSTEMATIC ANALYSIS; TIME TRENDS; PREGNANCY; RISK; EPIDEMIOLOGY; COUNTRIES; MORTALITY; DELIVERY; WOMEN	Background: Assessment of risk factors for preterm birth in a population with high incidence of preterm birth and HIV infection. Methods: Secondary analysis of data for 2,149 women included in a community based randomized placebo controlled trial for the prevention of preterm birth (APPLe trial (ISRCTN84023116) with gestational age at birth determined through ultrasound measurement in early pregnancy. Multivariate Logistic Regression analyses to obtain models for three outcome variables: all preterm, early preterm, and late preterm birth. Findings: No statistical differences were noted for the prevalence of HIV infection (p = 0.30) or syphilis (p = 0.12) between women who delivered preterm versus term. BMI (Adjusted OR 0.91 (0.85-0.97); p = 0.005) and weight gain (Adjusted OR 0.89 (0.82-0.97); p = 0.006) had an independent, protective effect. Previous preterm birth doubled the odds of preterm birth (Adjusted OR 2.13 (1.198-3.80); p = 0.01). Persistent malaria (despite malaria prophylaxis) increased the risk of late preterm birth (Adjusted OR 1.99 (1.05-3.79); p = 0.04). Age <20 (Adjusted OR 1.73 (1.03-2.90); p = 0.04) and anemia (Adjusted OR 1.95 (1.08-3.52); p = 0.03) were associated with early preterm birth (<34 weeks). Conclusions: Despite claims that HIV infection is an important cause of preterm birth in Africa, we found no evidence of an association in this population (unexposed to anti-retroviral treatment). Persistent malaria was associated with late preterm birth. Maternal undernourishment and anemia were independently associated with early preterm birth. The study did not assess whether the link was direct or whether a common precursor such as chronic infection was responsible for both maternal effects and early labour.	[van den Broek, Nynke R.; Jean-Baptiste, Rachel] Univ Liverpool, Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Liverpool L3 5QA, Merseyside, England; [Neilson, James P.] Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool	van den Broek, NR (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	vdbroek@liv.ac.uk		van den Broek, Nynke/0000-0001-8523-2684	The Wellcome Trust, UK [065810/Z/01/Z]	The Wellcome Trust, UK(Wellcome Trust)	This study was funded by The Wellcome Trust, UK (project grant 065810/Z/01/Z) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Chang HH, 2013, LANCET, V381, P223, DOI 10.1016/S0140-6736(12)61856-X; Gladstone M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001121; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goldenberg RL, 2012, AM J OBSTET GYNECOL, V206, P113, DOI 10.1016/j.ajog.2011.10.865; Han Z, 2011, INT J EPIDEMIOL, V40, P65, DOI 10.1093/ije/dyq195; Huybregts L, 2009, AM J CLIN NUTR, V90, P1593, DOI 10.3945/ajcn.2009.28253; Kourtis AP, 2011, J INFECT DIS, V204, P493, DOI 10.1093/infdis/jir318; Kramer MS, 2012, AM J OBSTET GYNECOL, V206, P108, DOI 10.1016/j.ajog.2011.10.864; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; McGready R, 2011, BJOG-INT J OBSTET GY, V118, P123, DOI 10.1111/j.1471-0528.2010.02810.x; Ndirangu J, 2012, HUM REPROD, V27, P1846, DOI 10.1093/humrep/des090; Ota E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000032.pub2; Powis KM, 2011, J INFECT DIS, V204, P506, DOI 10.1093/infdis/jir307; Steer P, 2006, BJOG-INT J OBSTET GY, V113, P1, DOI [10.1111/j.1471-0528.2006.01116.x, 10.1111/j.1471-0528.2005.00837.x]; Steer P, 2005, J PERINAT MED, V33, P273, DOI 10.1515/JPM.2005.053; Taylor-Robinson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023163; van den Akker T, 2012, BJOG-INT J OBSTET GY, V119, P431, DOI 10.1111/j.1471-0528.2011.03229.x; van den Broek N, 2005, HUM REPROD, V20, P3235, DOI 10.1093/humrep/dei208; van den Broek NR, 2006, BJOG-INT J OBSTET GY, V113, P569, DOI 10.1111/j.1471-0528.2006.00891.x; van den Broek NR, 2000, AM J CLIN NUTR, V72, p247S, DOI 10.1093/ajcn/72.1.247S; van den Broek NR, 2003, BJOG-INT J OBSTET GY, V110, P902, DOI 10.1111/j.1471-0528.2003.02402.x; van den Broek NR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000191	25	52	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90128	10.1371/journal.pone.0090128	http://dx.doi.org/10.1371/journal.pone.0090128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595186	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900072
J	Djukic, M; Brzuszkiewicz, E; Funfhaus, A; Voss, J; Gollnow, K; Poppinga, L; Liesegang, H; Garcia-Gonzalez, E; Genersch, E; Daniel, R				Djukic, Marvin; Brzuszkiewicz, Elzbieta; Fuenfhaus, Anne; Voss, Joern; Gollnow, Kathleen; Poppinga, Lena; Liesegang, Heiko; Garcia-Gonzalez, Eva; Genersch, Elke; Daniel, Rolf			How to Kill the Honey Bee Larva: Genomic Potential and Virulence Mechanisms of Paenibacillus larvae	PLOS ONE			English	Article							AMERICAN FOULBROOD DISEASE; BACTERIAL PATHOGEN; SUBSP LARVAE; CLOSTRIDIUM-BOTULINUM; DIFFERENT GENOTYPES; SECRETED PROTEASES; SYNERGISTIC FACTOR; GRANULOSIS-VIRUS; ETIOLOGIC AGENT; APIS-MELLIFERA	Paenibacillus larvae, a Gram positive bacterial pathogen, causes American Foulbrood (AFB), which is the most serious infectious disease of honey bees. In order to investigate the genomic potential of P. larvae, two strains belonging to two different genotypes were sequenced and used for comparative genome analysis. The complete genome sequence of P. larvae strain DSM 25430 (genotype ERIC II) consisted of 4,056,006 bp and harbored 3,928 predicted protein-encoding genes. The draft genome sequence of P. larvae strain DSM 25719 (genotype ERIC I) comprised 4,579,589 bp and contained 4,868 protein-encoding genes. Both strains harbored a 9.7 kb plasmid and encoded a large number of virulence-associated proteins such as toxins and collagenases. In addition, genes encoding large multimodular enzymes producing nonribosomally peptides or polyketides were identified. In the genome of strain DSM 25719 seven toxin associated loci were identified and analyzed. Five of them encoded putatively functional toxins. The genome of strain DSM 25430 harbored several toxin loci that showed similarity to corresponding loci in the genome of strain DSM 25719, but were non-functional due to point mutations or disruption by transposases. Although both strains cause AFB, significant differences between the genomes were observed including genome size, number and composition of transposases, insertion elements, predicted phage regions, and strain-specific island-like regions. Transposases, integrases and recombinases are important drivers for genome plasticity. A total of 390 and 273 mobile elements were found in strain DSM 25430 and strain DSM 25719, respectively. Comparative genomics of both strains revealed acquisition of virulence factors by horizontal gene transfer and provided insights into evolution and pathogenicity.	[Djukic, Marvin; Brzuszkiewicz, Elzbieta; Voss, Joern; Gollnow, Kathleen; Liesegang, Heiko; Daniel, Rolf] Univ Gottingen, Dept Genom & Appl Microbiol, Inst Microbiol & Genet, D-37073 Gottingen, Germany; [Djukic, Marvin; Brzuszkiewicz, Elzbieta; Voss, Joern; Gollnow, Kathleen; Liesegang, Heiko; Daniel, Rolf] Univ Gottingen, Gottingen Genom Lab, Inst Microbiol & Genet, D-37073 Gottingen, Germany; [Fuenfhaus, Anne; Poppinga, Lena; Garcia-Gonzalez, Eva; Genersch, Elke] Inst Bee Res, Dept Mol Microbiol & Bee Dis, Hohen Neuendorf, Germany	University of Gottingen; University of Gottingen	Genersch, E (corresponding author), Inst Bee Res, Dept Mol Microbiol & Bee Dis, Hohen Neuendorf, Germany.	elke.genersch@rz.hu-berlin.de; rdaniel@gwdg.de	Daniel, Rolf/AAQ-5933-2021; Fünfhaus, Anne/AAD-4642-2022	Daniel, Rolf/0000-0002-8646-7925; Funfhaus, Anne/0000-0003-0990-5853; Liesegang, Heiko/0000-0003-1792-2047; Genersch, Elke/0000-0001-7906-4530	Ministry for Agriculture from Brandenburg, Germany; Ministry for Agriculture from Sachsen-Anhalt, Germany; German Research Foundation (DFG) [GE 1365/1-1, 1121]; Niedersachsisches Ministerium fur Wissenschaft und Kultur; Bundesministerium fur Bildung und Forschung	Ministry for Agriculture from Brandenburg, Germany; Ministry for Agriculture from Sachsen-Anhalt, Germany; German Research Foundation (DFG)(German Research Foundation (DFG)); Niedersachsisches Ministerium fur Wissenschaft und Kultur; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	EG was supported by grants from the Ministries for Agriculture from Brandenburg and Sachsen-Anhalt, Germany. AF and LP were supported by the German Research Foundation (DFG, grant GE 1365/1-1). EG-G was supported by the German Research Foundation (DFG, Graduate School 1121). The Gottingen group was supported by grants from the Niedersachsisches Ministerium fur Wissenschaft und Kultur and the Bundesministerium fur Bildung und Forschung. The funders had no role in study design, data collection, data analysis, data interpretation, writing of the report; and the decision to submit the article for publication.	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Alberts B, 2002, MOL BIOL CELL; Alippi AM, 2004, J APICULT RES, V43, P135, DOI 10.1080/00218839.2004.11101124; Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Antunez K, 2009, J INVERTEBR PATHOL, V102, P129, DOI 10.1016/j.jip.2009.07.010; Arrebola E, 2010, J APPL MICROBIOL, V108, P386, DOI 10.1111/j.1365-2672.2009.04438.x; BAIDA GE, 1995, BBA-GENE STRUCT EXPR, V1264, P151, DOI 10.1016/0167-4781(95)00150-F; Bailey L., 1991, HONEY BEE PATHOLOGY; Barrett AJ, 2004, CURR OPIN DRUG DISC, V7, P334; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Brodsgaard CJ, 1998, APIDOLOGIE, V29, P569, DOI 10.1051/apido:19980609; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chan QWT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-450; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Dancer BN, 1997, J INVERTEBR PATHOL, V70, P79, DOI 10.1006/jipa.1997.4672; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; Duitman EH, 1999, P NATL ACAD SCI USA, V96, P13294, DOI 10.1073/pnas.96.23.13294; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2004, J INVERTEBR PATHOL, V85, P105, DOI 10.1016/j.jip.2004.02.004; Fethiere J, 1999, J MOL BIOL, V288, P635, DOI 10.1006/jmbi.1999.2698; Forsgren E, 2008, VET MICROBIOL, V129, P342, DOI 10.1016/j.vetmic.2007.12.001; Funfhaus A, 2013, ENVIRON MICROBIOL, V15, P2951, DOI 10.1111/1462-2920.12229; Funfhaus A, 2009, ENV MICROBIOL REP, V1, P240, DOI 10.1111/j.1758-2229.2009.00039.x; Garcia-Gonzalez E, 2013, ENVIRON MICROBIOL, V15, P2894, DOI 10.1111/1462-2920.12167; Genersch E, 2006, INT J SYST EVOL MICR, V56, P501, DOI 10.1099/ijs.0.63928-0; Genersch E, 2005, APPL ENVIRON MICROB, V71, P7551, DOI 10.1128/AEM.71.11.7551-7555.2005; Genersch E, 2003, APIDOLOGIE, V34, P195, DOI 10.1051/apido:2003025; Genersch E, 2007, BERL MUNCH TIERARZTL, V120, P26, DOI 10.2376/0005-9366-120-26; Genersch E, 2010, APPL MICROBIOL BIOT, V87, P87, DOI 10.1007/s00253-010-2573-8; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; GILLIAM M, 1970, EXPERIENTIA, V26, P1006, DOI 10.1007/BF02114161; Graham J.M., 1999, HIVE HONEY BEE; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Holst EC, 1940, J BACTERIOL, V40, P723, DOI 10.1128/JB.40.5.723-731.1940; Hrabak J, 2007, J APICULT RES, V46, P160, DOI 10.1080/00218839.2007.11101388; JAROSZ J, 1990, J INVERTEBR PATHOL, V56, P143, DOI 10.1016/0022-2011(90)90096-O; Jung CM, 1999, J BACTERIOL, V181, P2816, DOI 10.1128/JB.181.9.2816-2822.1999; Keil B, 1992, Matrix Suppl, V1, P127; Khosla C, 1999, ANNU REV BIOCHEM, V68, P219, DOI 10.1146/annurev.biochem.68.1.219; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; Lindsay AM, 2009, MICROBIOL-SGM, V155, P443, DOI 10.1099/mic.0.020826-0; Loncaric I, 2009, J INVERTEBR PATHOL, V100, P44, DOI 10.1016/j.jip.2008.09.003; LOVGREN A, 1990, MOL MICROBIOL, V4, P2137, DOI 10.1111/j.1365-2958.1990.tb00575.x; Luquez C, 2009, APPL ENVIRON MICROB, V75, P6094, DOI 10.1128/AEM.01009-09; MAGETDANA R, 1994, TOXICOLOGY, V87, P151, DOI 10.1016/0300-483X(94)90159-7; Mahillon J, 1999, RES MICROBIOL, V150, P675, DOI 10.1016/S0923-2508(99)00124-2; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Matsushita O, 2001, J BIOL CHEM, V276, P8761, DOI 10.1074/jbc.M003450200; May JJ, 2001, J BIOL CHEM, V276, P7209, DOI 10.1074/jbc.M009140200; NAKANO H, 1990, JPN J MED SCI BIOL, V43, P183, DOI 10.7883/yoken1952.43.183; Neuendorf S, 2004, MICROBIOL-SGM, V150, P2381, DOI 10.1099/mic.0.27125-0; Peters M, 2006, J VET MED B, V53, P100, DOI 10.1111/j.1439-0450.2006.00920.x; Petit L, 2001, J BIOL CHEM, V276, P15736, DOI 10.1074/jbc.M010412200; Poppinga L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002716; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Qin X, 2006, INSECT MOL BIOL, V15, P715, DOI 10.1111/j.1365-2583.2006.00694.x; QUENTIN MJ, 1982, BIOCHIM BIOPHYS ACTA, V684, P207, DOI 10.1016/0005-2736(82)90007-4; Rauch S, 2009, APPL ENVIRON MICROB, V75, P3344, DOI 10.1128/AEM.02839-08; Rawlings ND, 2008, BIOCHIMIE, V90, P243, DOI 10.1016/j.biochi.2007.09.014; RAYMOND KN, 1979, ACCOUNTS CHEM RES, V12, P183, DOI 10.1021/ar50137a004; Schirmer J, 2002, J BIOL CHEM, V277, P11941, DOI 10.1074/jbc.M108463200; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Shah SA, 2011, RES MICROBIOL, V162, P27, DOI 10.1016/j.resmic.2010.09.001; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; Snowdon JA, 1996, INT J FOOD MICROBIOL, V31, P1, DOI 10.1016/0168-1605(96)00970-1; Staden R, 2000, Methods Mol Biol, V132, P115; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; STJULIAN G, 1971, J BACTERIOL, V108, P828, DOI 10.1128/JB.108.2.828-834.1971; Tamaki M, 2005, J ANTIBIOT, V58, P293, DOI 10.1038/ja.2005.37; THIMON L, 1995, FEMS MICROBIOL LETT, V128, P101, DOI 10.1111/j.1574-6968.1995.tb07507.x; Watanabe M, 2004, J BIOCHEM, V135, P471, DOI 10.1093/jb/mvh062; Wen YP, 2011, ENVIRON MICROBIOL, V13, P2726, DOI 10.1111/j.1462-2920.2011.02542.x; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Winkelmann G, 2002, BIOCHEM SOC T, V30, P691, DOI 10.1042/BST0300691; WOODRING J, 1993, J INSECT PHYSIOL, V39, P89, DOI 10.1016/0022-1910(93)90022-J; YAMAMOTO T, 1978, J INVERTEBR PATHOL, V31, P48, DOI 10.1016/0022-2011(78)90108-8; Yue D, 2008, ENVIRON MICROBIOL, V10, P1612, DOI 10.1111/j.1462-2920.2008.01579.x; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485; ZHU Y, 1989, J INVERTEBR PATHOL, V54, P49, DOI 10.1016/0022-2011(89)90139-0	88	71	71	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90914	10.1371/journal.pone.0090914	http://dx.doi.org/10.1371/journal.pone.0090914			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599066	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400144
J	Evans, LJ; Raine, NE				Evans, Lisa J.; Raine, Nigel E.			Changes in Learning and Foraging Behaviour within Developing Bumble Bee (Bombus terrestris) Colonies	PLOS ONE			English	Article							HONEY-BEES; DEFENSIVE BEHAVIOR; WORKER SIZE; FLOWER SIZE; BODY-SIZE; SPEED; HYMENOPTERA; PERFORMANCE; EVOLUTION; AGE	Organisation in eusocial insect colonies emerges from the decisions and actions of its individual members. In turn, these decisions and actions are influenced by the individual's behaviour (or temperament). Although there is variation in the behaviour of individuals within a colony, we know surprisingly little about how (or indeed if) the types of behaviour present in a colony change over time. Here, for the first time, we assessed potential changes in the behavioural type of foragers during colony development. Using an ecologically relevant foraging task, we measured the decision speed and learning ability of bumble bees (Bombus terrestris) at different stages of colony development. We determined whether individuals that forage early in the colony life cycle (the queen and early emerging workers) behaved differently from workers that emerge and forage at the end of colony development. Whilst we found no overall change in the foraging behaviour of workers with colony development, there were strong differences in foraging behaviour between queens and their workers. Queens appeared to forage more cautiously than their workers and were also quicker to learn. These behaviours could allow queens to maximise their nectar collecting efficiency whilst avoiding predation. Because the foundress queen is crucial to the survival and success of a bumble bee colony, more efficient foraging behaviour in queens may have strong adaptive value.	[Evans, Lisa J.; Raine, Nigel E.] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England	University of London; Royal Holloway University London	Evans, LJ (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England.	Lisa.evans.2011@live.rhul.ac.uk	Raine, Nigel/AAK-6425-2020; Evans, Lisa/E-7339-2018	Raine, Nigel/0000-0001-6343-2829; Evans, Lisa/0000-0001-7353-9750	Plant and Food Research Ltd New Zealand; C. Alma Baker Scholarship; Allan and Grace Kay Overseas Scholarship; Queen Elizabeth's Technicians Award	Plant and Food Research Ltd New Zealand; C. Alma Baker Scholarship; Allan and Grace Kay Overseas Scholarship; Queen Elizabeth's Technicians Award	There was no specific funding supporting this work. LJE was funded by Plant and Food Research Ltd New Zealand, a C. Alma Baker Scholarship, an Allan and Grace Kay Overseas Scholarship and a Queen Elizabeth's Technicians Award. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford DV, 1975, BUMBLEBEES; Anderson C, 2001, BIOL REV, V76, P211, DOI 10.1017/S1464793101005656; ARCHER ME, 1972, J ENTOMOL SER A-GEN, V46, P175; BENNETT PM, 1987, J ZOOL, V213, P327, DOI 10.1111/j.1469-7998.1987.tb03708.x; Bernasconi G, 1999, TRENDS ECOL EVOL, V14, P477, DOI 10.1016/S0169-5347(99)01722-X; Blarer A, 2002, ETHOLOGY, V108, P341, DOI 10.1046/j.1439-0310.2002.00778.x; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; BRIAN M. V., 1957, INSECTES SOCIAUX, V4, P177, DOI 10.1007/BF02222152; Burns JG, 2008, CURR BIOL, V18, pR953, DOI 10.1016/j.cub.2008.08.028; Burns James G., 2005, Animal Behaviour, V70, pe1, DOI 10.1016/j.anbehav.2005.06.002; CARTAR RV, 1991, CAN ENTOMOL, V123, P283, DOI 10.4039/Ent123283-2; Chapman BB, 2011, ANIM BEHAV, V82, P391, DOI 10.1016/j.anbehav.2011.05.019; Chittka L, 2004, POPUL ECOL, V46, P243, DOI 10.1007/s10144-004-0180-1; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; Chittka L, 2006, CURR OPIN PLANT BIOL, V9, P428, DOI 10.1016/j.pbi.2006.05.002; CLARK CW, 1994, AM NAT, V144, P542, DOI 10.1086/285693; COLE AC, 1948, AM MIDL NAT, V39, P641, DOI 10.2307/2421529; COLLINS AM, 1982, SCIENCE, V218, P72, DOI 10.1126/science.218.4567.72; Couvillon MJ, 2010, INSECT SOC, V57, P193, DOI 10.1007/s00040-010-0064-7; CROSLAND MWJ, 1990, J INSECT BEHAV, V3, P359, DOI 10.1007/BF01052114; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Dornhaus A, 2004, APIDOLOGIE, V35, P183, DOI 10.1051/apido:2004002; Drezner-Levy T, 2009, BEHAV ECOL SOCIOBIOL, V64, P135, DOI 10.1007/s00265-009-0829-z; DUCHATEAU MJ, 1988, BEHAVIOUR, V107, P186, DOI 10.1163/156853988X00340; DUKAS R, 1994, ANIM BEHAV, V48, P1001, DOI 10.1006/anbe.1994.1332; Dukas R, 2003, OIKOS, V101, P157, DOI 10.1034/j.1600-0706.2003.12143.x; Dukas R, 2001, ECOL LETT, V4, P327, DOI 10.1046/j.1461-0248.2001.00228.x; Dyer AG, 2004, J COMP PHYSIOL A, V190, P759, DOI 10.1007/s00359-004-0547-y; Foster DJ, 2011, J EXP BIOL, V214, P1896, DOI 10.1242/jeb.051730; Free JB, 1959, BUMBLEBEES; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Giurfa M, 1996, J COMP PHYSIOL A, V178, P699; Goulson D, 2010, BUMBLEBEES BEHAV ECO, V2; Guzman-Novoa E, 2004, APIDOLOGIE, V35, P15, DOI 10.1051/apido:2003061; HERBERS JM, 1981, J THEOR BIOL, V89, P175, DOI 10.1016/0022-5193(81)90184-3; Holldobler B., 1990, pi; Ings TC, 2008, CURR BIOL, V18, P1520, DOI 10.1016/j.cub.2008.07.074; Ings TC, 2009, BEHAV ECOL SOCIOBIOL, V63, P1207, DOI 10.1007/s00265-009-0731-8; Jandt JM, 2014, BIOL REV, V89, P48, DOI 10.1111/brv.12042; Jandt JM, 2009, ANIM BEHAV, V77, P641, DOI 10.1016/j.anbehav.2008.11.019; Jeanson R, 2014, BIOL REV, V89, P671, DOI 10.1111/brv.12074; Jones EI, 2011, BEHAV ECOL SOCIOBIOL, V65, P1505, DOI 10.1007/s00265-011-1160-z; Keller L, 1999, LEVELS SELECTION EVO; Laloi D, 2001, APIDOLOGIE, V32, P231, DOI 10.1051/apido:2001125; Latshaw JS, 2005, BEHAV ECOL SOCIOBIOL, V58, P200, DOI 10.1007/s00265-004-0904-4; Lin H, 2012, THESIS ROYAL HOLLOWA; Lye GC, 2009, BIOL CONSERV, V142, P2023, DOI 10.1016/j.biocon.2009.03.032; Mallon EB, 2001, BEHAV ECOL SOCIOBIOL, V50, P352, DOI 10.1007/s002650100377; MARDEN JH, 1987, J EXP BIOL, V130, P235; Matsuura K, 2002, ANIM BEHAV, V64, P167, DOI 10.1006/anbe.2002.3062; MIRENDA JT, 1981, ANIM BEHAV, V29, P410, DOI 10.1016/S0003-3472(81)80100-5; Molet M, 2009, NATURWISSENSCHAFTEN, V96, P213, DOI 10.1007/s00114-008-0465-x; Muller H, 2008, CURR BIOL, V18, pR961, DOI 10.1016/j.cub.2008.09.001; Muller H, 2010, ANIM BEHAV, V80, P1065, DOI 10.1016/j.anbehav.2010.09.016; Oster G.F., 1978, Monographs in Population Biology, pi; Ottoni EB, 2000, BEHAV RES METH INS C, V32, P446, DOI 10.3758/BF03200814; Pankiw T, 1999, J COMP PHYSIOL A, V185, P207, DOI 10.1007/s003590050379; PLOWRIGHT RC, 1977, CAN ENTOMOL, V109, P967, DOI 10.4039/Ent109967-7; POUVREAU A, 1974, Apidologie, V5, P39, DOI 10.1051/apido:19740103; Pruitt JN, 2011, P ROY SOC B-BIOL SCI, V278, P1209, DOI 10.1098/rspb.2010.1700; QUELLER DC, 1989, P NATL ACAD SCI USA, V86, P3224, DOI 10.1073/pnas.86.9.3224; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Raine NE, 2007, ENTOMOL GEN, V30, P191; Raine NE, 2006, ADV STUD BEHAV, V36, P305, DOI 10.1016/S0065-3454(06)36007-X; Raine NE, 2006, ENTOMOL GEN, V28, P241; Raine NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045096; Ray S, 1997, NEUROREPORT, V8, P789, DOI 10.1097/00001756-199702100-00042; ROBINSON GE, 1990, BEHAV ECOL SOCIOBIOL, V26, P315, DOI 10.1007/BF00171096; Rodriguez-Girones MA, 2012, OIKOS, V121, P1473, DOI 10.1111/j.1600-0706.2011.19473.x; Scharf I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033314; Scheiner R, 1999, J COMP PHYSIOL A, V185, P1, DOI 10.1007/s003590050360; Scheiner R, 2001, NEUROBIOL LEARN MEM, V76, P138, DOI 10.1006/nlme.2000.3996; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Spaethe J, 2003, J EXP BIOL, V206, P3447, DOI 10.1242/jeb.00570; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; SRINIVASAN MV, 1988, J COMP PHYSIOL A, V162, P159, DOI 10.1007/BF00606081; SUTCLIFFE GH, 1990, CAN J ZOOL, V68, P1120, DOI 10.1139/z90-166; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Willmer PG, 2004, ADV STUD BEHAV, V34, P347, DOI 10.1016/S0065-3454(04)34009-X; WITTER MS, 1994, ANIM BEHAV, V48, P201, DOI 10.1006/anbe.1994.1227; WOOD LA, 1981, INSECT SOC, V28, P117, DOI 10.1007/BF02223700; Worden BD, 2005, J EXP BIOL, V208, P2045, DOI 10.1242/jeb.01582; Wray MK, 2011, ANIM BEHAV, V81, P559, DOI 10.1016/j.anbehav.2010.11.027; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	85	11	11	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90556	10.1371/journal.pone.0090556	http://dx.doi.org/10.1371/journal.pone.0090556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599144	Green Submitted, Green Published, gold			2022-12-25	WOS:000332479400092
J	Rendall, AR; Sutherland, DR; Cooke, R; White, J				Rendall, Anthony R.; Sutherland, Duncan R.; Cooke, Raylene; White, John			Camera Trapping: A Contemporary Approach to Monitoring Invasive Rodents in High Conservation Priority Ecosystems	PLOS ONE			English	Article							RATS RATTUS-RATTUS; FERAL HOUSE MICE; BLACK RATS; POPULATION-DYNAMICS; RELATIVE ABUNDANCE; HABITAT STRUCTURE; ANIMAL DENSITY; SEABIRDS; ISLANDS; PREDATION	Invasive rodent species have established on 80% of the world's islands causing significant damage to island environments. Insular ecosystems support proportionally more biodiversity than comparative mainland areas, highlighting them as critical for global biodiversity conservation. Few techniques currently exist to adequately detect, with high confidence, species that are trap-adverse such as the black rat, Rattus rattus, in high conservation priority areas where multiple non-target species persist. This study investigates the effectiveness of camera trapping for monitoring invasive rodents in high conservation areas, and the influence of habitat features and density of colonial-nesting seabirds on rodent relative activity levels to provide insights into their potential impacts. A total of 276 camera sites were established and left in situ for 8 days. Identified species were recorded in discrete 15 min intervals, referred to as 'events'. In total, 19 804 events were recorded. From these, 31 species were identified comprising 25 native species and six introduced. Two introduced rodent species were detected: the black rat (90% of sites), and house mouse Mus musculus (56% of sites). Rodent activity of both black rats and house mice were positively associated with the structural density of habitats. Density of seabird burrows was not strongly associated with relative activity levels of rodents, yet rodents were still present in these areas. Camera trapping enabled a large number of rodents to be detected with confidence in site-specific absences and high resolution to quantify relative activity levels. This method enables detection of multiple species simultaneously with low impact (for both target and non-target individuals); an ideal strategy for monitoring trap-adverse invasive rodents in high conservation areas.	[Rendall, Anthony R.; Cooke, Raylene; White, John] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Melbourne, Vic, Australia; [Sutherland, Duncan R.] Phillip Isl Nat Pk, Res Dept, Cowes, Vic, Australia	Deakin University	Cooke, R (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Melbourne, Vic, Australia.	raylene.cooke@deakin.edu.au	White, John/A-4285-2008; Sutherland, Duncan/E-7763-2011	Sutherland, Duncan/0000-0003-0893-4425; White, John/0000-0002-7375-5944; Rendall, Anthony/0000-0002-7286-9288	Deakin University	Deakin University	Financial support was provided by Deakin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amori G., 2003, RATS MICE PEOPLE ROD, V96, P63; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Angel A, 2009, BIOL INVASIONS, V11, P1743, DOI 10.1007/s10530-008-9401-4; Arthur AD, 2005, OIKOS, V108, P562, DOI 10.1111/j.0030-1299.2005.13327.x; Arthur AD, 2004, J ANIM ECOL, V73, P867, DOI 10.1111/j.0021-8790.2004.00864.x; Banks PB, 2012, WILDLIFE RES, V39, P78, DOI 10.1071/WR11086; Barton K., 2012, MUMIN MULTIMODEL INF; Booth Andrea M., 1996, Notornis, V43, P147; Brooke M. de L., 2010, Endangered Species Research, V11, P47, DOI 10.3354/esr00249; Brown KP, 1996, NEW ZEAL J ECOL, V20, P271; Caut S, 2008, J APPL ECOL, V45, P428, DOI 10.1111/j.1365-2664.2007.01438.x; CHOWN SL, 1993, OECOLOGIA, V96, P508, DOI 10.1007/BF00320508; Cox CB, 2000, BIOGEOGRAPHY ECOLOGI; Cox GW, 1993, CONSERVATION ECOLOGY; Cox MPG, 2000, AUSTRAL ECOL, V25, P375, DOI 10.1111/j.1442-9993.2000.tb00043.x; CRAFFORD JE, 1987, BIOL CONSERV, V40, P255, DOI 10.1016/0006-3207(87)90119-4; De Bondi N, 2010, WILDLIFE RES, V37, P456, DOI 10.1071/WR10046; DICKMAN CR, 1986, OECOLOGIA, V70, P536, DOI 10.1007/BF00379900; DICKMAN CR, 1986, ECOL MONOGR, V56, P221, DOI 10.2307/2937075; Drake DR, 2011, DIRECT IMPACTS SEABI; Draper C, 2013, BIOL CONSERV, V158, P422, DOI 10.1016/j.biocon.2012.10.024; Dumont Y, 2010, NAT RESOUR MODEL, V23, P381, DOI 10.1111/j.1939-7445.2010.00068.x; ESRI, 2011, ARCGIS DESKT REL 10; Foster S, 2011, NEW ZEAL J ZOOL, V38, P285, DOI 10.1080/03014223.2011.599400; GRANT GS, 1981, J FIELD ORNITHOL, V52, P336; Grant-Hoffman MN, 2010, BIOL INVASIONS, V12, P805, DOI 10.1007/s10530-009-9503-7; Harper GA, 2010, BIOL INVASIONS, V12, P1449, DOI 10.1007/s10530-009-9560-y; Harper GA, 2005, NEW ZEAL J ECOL, V29, P251; Hines J. E, 2006, PRESENCE SOFTWARE ES; Igual JM, 2007, BIOL CONSERV, V137, P189, DOI 10.1016/j.biocon.2007.02.003; Igual JM, 2006, ANIM CONSERV, V9, P59, DOI 10.1111/j.1469-1795.2005.00005.x; Imber M, 2000, NEW ZEAL J ECOL, V24, P153; Jones H, 2008, POETRY WALES, V43, P22; Jones MGW, 2010, ANTARCT SCI, V22, P39, DOI 10.1017/S0954102009990459; Jouventin P, 2003, POLAR BIOL, V26, P371, DOI 10.1007/s00300-003-0497-9; King W.B., 1985, International Council for Bird Preservation Technical Publication, P3; Martin JL, 2000, CONSERV BIOL, V14, P1452, DOI 10.1046/j.1523-1739.2000.99190.x; McKelvey KS, 2001, CAN J ZOOL, V79, P1754, DOI 10.1139/cjz-79-10-1754; McMahon CR, 2012, BIOL CONSERV, V153, P254, DOI 10.1016/j.biocon.2012.05.004; Mitchell K., 2007, QUANTITATIVE ANAL PO; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oates A, 2011, SUMMERLAND PENINSULA; Paull DJ, 2012, WILDLIFE RES, V39, P546, DOI 10.1071/WR12034; PUTMAN RJ, 1995, BIODIVERS CONSERV, V4, P903, DOI 10.1007/BF00056197; Quillfeldt P, 2008, POLAR BIOL, V31, P333, DOI 10.1007/s00300-007-0363-2; R Core Team, 2012, R LANG ENV STAT COMP; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Rowcliffe JM, 2013, J WILDLIFE MANAGE, V77, P876, DOI 10.1002/jwmg.533; ROWEROWE DT, 1989, POLAR BIOL, V9, P457, DOI 10.1007/BF00443233; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Ruffino L, 2009, BIOL INVASIONS, V11, P1631, DOI 10.1007/s10530-008-9394-z; Ruffino L, 2011, POPUL ECOL, V53, P535, DOI 10.1007/s10144-011-0265-6; Ruscoe WA, 2001, WILDLIFE RES, V28, P173, DOI 10.1071/WR00035; Russell JC, 2011, OECOLOGIA, V167, P667, DOI 10.1007/s00442-011-2031-z; Russell JC, 2004, GLOBAL ECOL BIOGEOGR, V13, P497, DOI 10.1111/j.1466-822X.2004.00124.x; Smith JK, 2012, AUST MAMMAL, V34, P196, DOI 10.1071/AM11034; Stokes VL, 2013, AUST MAMMAL, V35, P49, DOI 10.1071/AM12002; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Venables W.N., 2002, MODERN APPL STAT S P, Vfourth, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2_10]; Wanless RM, 2007, BIOLOGY LETT, V3, P241, DOI 10.1098/rsbl.2007.0120; Wanless RM, 2009, BIOL CONSERV, V142, P1710, DOI 10.1016/j.biocon.2009.03.008; Whisson DA, 2005, WILDLIFE RES, V32, P239, DOI 10.1071/WR03128; Whisson DA, 2007, J MAMMAL, V88, P589, DOI 10.1644/06-MAMM-A-239R1.1; Williamson M. H., 1981, ISLAND POPULATIONS; Wilson D, 2004, EMU, V104, P37, DOI 10.1071/MU01054; Yabe Tatsuo, 2009, Marine Ornithology, V37, P293	66	42	44	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e86592	10.1371/journal.pone.0086592	http://dx.doi.org/10.1371/journal.pone.0086592			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599307	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400003
J	Zhang, ZJ; Ma, CT; Zhao, P; Duan, LT; Chen, WQ; Zhang, FS; Cui, ZZ				Zhang, Zhenjie; Ma, Chengtai; Zhao, Peng; Duan, Luntao; Chen, Wenqing; Zhang, Fushou; Cui, Zhizhong			Construction of Recombinant Marek's Disease Virus (rMDV) Co-Expressing AIV-H9N2-NA and NDV-F Genes under Control of MDV's Own Bi-Directional Promoter	PLOS ONE			English	Article							BACTERIAL ARTIFICIAL CHROMOSOME; KB-MESSENGER-RNA; RETICULOENDOTHELIOSIS VIRUS; NEWCASTLE-DISEASES; AVIAN INFLUENZA; FOWLPOX VIRUS; FIELD STRAIN; VACCINE; PROTECTION; CHICKENS	To qualitatively analyze and evaluate a bi-directional promoter transcriptional function in both transient and transgenic systems, several different plasmids were constructed and recombinant MDV type 1 strain GX0101 was developed to coexpress a Neuraminidase (NA) gene from Avian Influenza Virus H9N2 strain and a Fusion (F) gene from the Newcastle disease virus (NDV). The two foreign genes, NDV-F gene and AIV-NA gene, were inserted in the plasmid driven in each direction by the bi-directional promoter. To test whether the expression of pp38/pp24 heterodimers are the required activators for the expression of the foreign genes, the recombinant plasmid pPpp38-NA/1.8kb-F containing expression cassette for the two foreign genes was co-transfected with a pp38/pp24 expression plasmid, pBud-pp38-pp24, in chicken embryo fibroblast (CEF) cells. Alternatively, plasmid pPpp38-NA/1.8kb-F was transfected in GX0101-infected CEFs where the viral endogenous pp38/pp24 were expressed via virus infection. The expression of both foreign genes was activated by pp38/pp24 dimers either via virus infection, or co-expression. The CEFs transfected with pPpp38-NA/1.8kb-F alone had no expression. We chose to insert the expression cassette of Ppp38-NA/1.8kb-F in the non-essential region of GX0101 Delta Meq US2 gene, and formed a new rMDV named MZC13NA/F through homologous recombination. Indirect fluorescence antibody (IFA) test, ELISA and Western blot analyses indicated that F and NA genes were expressed simultaneously under control of the bi-directional promoter, but in opposite directions. The data also indicated the activity of the promoter in the 1.8-kb mRNA transcript direction was higher than that in the direction for the pp38 gene. The expression of pp38/pp24 dimers either via co-tranfection of the pBud-pp38-pp24 plasmid, or by GX0101 virus infection were critical to activate the bidirectional promoter for expression of two foreign genes in both directions. Therefore, the confirmed function of the bidirectional promoter provides better feasibilities to insert multiple foreign genes in MDV genome based vectors.	[Zhang, Zhenjie; Ma, Chengtai; Zhao, Peng; Duan, Luntao; Chen, Wenqing; Zhang, Fushou; Cui, Zhizhong] Shandong Agr Univ, Coll Vet Med, Tai An, Shandong, Peoples R China; [Zhang, Zhenjie; Ma, Chengtai; Zhao, Peng; Duan, Luntao; Chen, Wenqing; Zhang, Fushou; Cui, Zhizhong] Anim Dis Prevent Technol & Res Ctr Shandong Prov, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Cui, ZZ (corresponding author), Shandong Agr Univ, Coll Vet Med, Tai An, Shandong, Peoples R China.	zzcui@sdau.edu.cn	Zhao, Peng/HDO-7507-2022		National Natural Science Foundation [31072149]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The study was supported by a grant from National Natural Science Foundation Project (31072149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent SJ, 2006, J GEN VIROL, V87, P769, DOI 10.1099/vir.0.81498-0; Barlic-Maganja D, 2001, J VIROL METHODS, V95, P101, DOI 10.1016/S0166-0934(01)00302-0; BRADLEY G, 1989, J VIROL, V63, P2534, DOI 10.1128/JVI.63.6.2534-2542.1989; BRADLEY G, 1989, J VIROL, V63, P4129, DOI 10.1128/JVI.63.10.4129-4135.1989; Cui HY, 2009, J VIROL METHODS, V156, P66, DOI 10.1016/j.jviromet.2008.10.021; Cui HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053340; Cui Hongyu, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P569, DOI 10.1016/S1872-2075(08)60028-X; Cui Z., 1992, Proceedings 19th World's Poultry Congress Amsterdam 19-24 September 1992: Volume 1., P123; CUI ZZ, 1991, J VIROL, V65, P6509, DOI 10.1128/JVI.65.12.6509-6515.1991; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ding JB, 2006, VIRUS GENES, V32, P193, DOI 10.1007/s11262-005-6876-2; Ding JB, 2006, SCI CHINA SER C, V49, P53, DOI 10.1007/s11427-004-0119-y; Ding Jia-bo, 2005, Weishengwu Xuebao, V45, P363; Ding J, 2007, VIRUS GENES, V35, P643, DOI 10.1007/s11262-007-0129-5; Gimeno IM, 2005, J VIROL, V79, P4545, DOI 10.1128/JVI.79.7.4545-4549.2005; Jiang Shi-jin, 2005, Virologica Sinica, V20, P404; Lee LF, 2012, VACCINE, V30, P5151, DOI 10.1016/j.vaccine.2012.05.043; Lee LF, 2011, AVIAN DIS, V55, P172, DOI 10.1637/9575-101510-Reg.1; Lee LF, 2010, VACCINE, V28, P1294, DOI 10.1016/j.vaccine.2009.11.022; Li YP, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-2; Li YQ, 2011, VACCINE, V29, P8257, DOI 10.1016/j.vaccine.2011.08.115; Ma MX, 2006, VACCINE, V24, P4304, DOI 10.1016/j.vaccine.2006.03.006; McGeoch DJ, 2000, J VIROL, V74, P10401, DOI 10.1128/JVI.74.22.10401-10406.2000; MORGAN RW, 1990, AVIAN DIS, V34, P345, DOI 10.2307/1591417; MORGAN RW, 1992, AVIAN DIS, V36, P858, DOI 10.2307/1591544; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Narayanan K, 1999, GENE THER, V6, P442, DOI 10.1038/sj.gt.3300901; Petherbridge L, 2004, J VIROL, V78, P13376, DOI 10.1128/JVI.78.23.13376-13380.2004; Reddy SM, 2002, P NATL ACAD SCI USA, V99, P7054, DOI 10.1073/pnas.092152699; Sakaguchi M, 1998, VACCINE, V16, P472, DOI 10.1016/S0264-410X(97)80001-1; Schumacher D, 2000, J VIROL, V74, P11088, DOI 10.1128/JVI.74.23.11088-11098.2000; Shigekane H, 1999, ARCH VIROL, V144, P1893, DOI 10.1007/s007050050713; Sonoda K, 2000, J VIROL, V74, P3217, DOI 10.1128/JVI.74.7.3217-3226.2000; Su S, 2013, COMP BIOL CHARACTERI; Su S, 2012, J VIROL, V86, P13818, DOI 10.1128/JVI.02583-12; Su Shuai, 2010, Weishengwu Xuebao, V50, P380; Sun AJ, 2010, VIROLOGY, V397, P270, DOI 10.1016/j.virol.2009.11.017; Sun AJ, 2009, CHINESE SCI BULL, V54, P2641, DOI 10.1007/s11434-009-0364-3; [孙淑红 SUN Shuhong], 2007, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V38, P741; Swayne DE, 2000, VACCINE, V18, P1088, DOI 10.1016/S0264-410X(99)00369-2; TAYLOR J, 1990, J VIROL, V64, P1441, DOI 10.1128/JVI.64.4.1441-1450.1990; Tsukamoto K, 1999, VIROLOGY, V257, P352, DOI 10.1006/viro.1999.9641; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang Z, 2005, SCI CHINA SER C, V48, P81, DOI 10.1360/03yc0270; 丁家波, 2008, [中国科学. C辑, 生命科学, Science in China. Series C, Life Sciences], V38, P760	46	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90677	10.1371/journal.pone.0090677	http://dx.doi.org/10.1371/journal.pone.0090677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599338	Green Submitted, Green Published, gold			2022-12-25	WOS:000332479400116
J	Du, XR; Dong, YL; Shi, H; Li, J; Kong, SS; Shi, DH; Sun, LV; Xu, T; Deng, KJ; Tao, WF				Du, Xingrong; Dong, Yongli; Shi, Hao; Li, Jiang; Kong, Shanshan; Shi, Donghua; Sun, Ling V.; Xu, Tian; Deng, Kejing; Tao, Wufan			Mst1 and Mst2 Are Essential Regulators of Trophoblast Differentiation and Placenta Morphogenesis	PLOS ONE			English	Article							ORGAN SIZE CONTROL; CARDIOMYOCYTE PROLIFERATION; BRANCHING MORPHOGENESIS; HIPPO PATHWAY; MICE; RECEPTOR; PROTEIN; EXPRESSION; CLONING; GROWTH	The placenta is essential for survival and growth of the fetus because it promotes the delivery of nutrients and oxygen from the maternal circulation as well as fetal waste disposal. Mst1 and Mst2 (Mst1/2), key components of the mammalian hpo/Mst signaling pathway, encode two highly conserved Ser/Thr kinases and play important roles in the prevention of tumorigenesis and autoimmunity, control of T cell development and trafficking, and embryonic development. However, their functions in placental development are not fully understood, and the underlying cellular and molecular mechanisms remain elusive. Here, we investigated the functions of Mst1/2 in mouse placental development using both conventional and conditional (endothelial) Mst1/2 double knockout mice. We found that the number of trophoblast giant cells dramatically increased while spongiotrophoblast cells almost completely disappeared in Mst1/2 deficient placentas. We showed that Mst1/2 deficiency down regulated the expression of Mash2, which is required for suppressing the differentiation of trophoblast giant cells. Furthermore, we demonstrated that endothelial-specific deletion of Mst1/2 led to impaired placental labyrinthine vasculature and embryonic lethality at E11.5, but neither affected vasculature in yolk sac and embryo proper nor endocardium development. Collectively, our findings suggest that Mst1/2 regulate placental development by control of trophoblast cell differentiation and labyrinthine vasculature at midgestation and Mst1/2 control labyrinth morphogenesis in trophoblast-and fetal endothelial-dependent manners. Thus, our studies have defined novel roles of Mst1/2 in mouse placental development.	[Du, Xingrong; Dong, Yongli; Shi, Hao; Li, Jiang; Kong, Shanshan; Shi, Donghua; Sun, Ling V.; Xu, Tian; Deng, Kejing; Tao, Wufan] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Du, Xingrong; Dong, Yongli; Shi, Hao; Li, Jiang; Kong, Shanshan; Shi, Donghua; Sun, Ling V.; Xu, Tian; Deng, Kejing; Tao, Wufan] Fudan Univ, Sch Life Sci, Natl Ctr Int Res Dev & Dis, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China; [Xu, Tian] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA	Fudan University; Fudan University; Howard Hughes Medical Institute; Yale University	Deng, KJ (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	dengkj@fudan.edu.cn; wufan_tao@fudan.edu.cn	Du, Xinrong/GWU-9803-2022; SHI, HAO/ABE-4662-2020	SHI, HAO/0000-0002-2796-629X; Du, Xingrong/0000-0001-6427-9600	National Basic Research Program of China [2013CB945300, 2011CB510100, 2006CB806700]; National Natural Science Foundation of China [31171406, 30971666, 30630043]; Hi-tech Research and Development Program of China [2007AA022101]; Science and Technology Committee of Shanghai Municipality [12JC1400600]; Ministry of Education of China; NATIONAL CANCER INSTITUTE [R01CA069408] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-tech Research and Development Program of China(National High Technology Research and Development Program of China); Science and Technology Committee of Shanghai Municipality(Shanghai Science & Technology Committee); Ministry of Education of China(Ministry of Education, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Basic Research Program of China (2013CB945300, 2011CB510100, 2006CB806700); National Natural Science Foundation of China (31171406, 30971666, 30630043); Hi-tech Research and Development Program of China (2007AA022101); Key Projects Grant for Basic Research (12JC1400600) from the Science and Technology Committee of Shanghai Municipality and 985 projects of Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Chen JX, 2001, AM J PHYSIOL-CELL PH, V280, pC1475, DOI 10.1152/ajpcell.2001.280.6.C1475; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015; Dong YL, 2009, J IMMUNOL, V183, P3865, DOI 10.4049/jimmunol.0900678; Du Xingrong, 2014, J Immunol, V192, P1525, DOI 10.4049/jimmunol.1301060; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Harlow E., 1999, USING ANTIBODIES LAB; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hemberger M, 2001, TRENDS ENDOCRIN MET, V12, P162, DOI 10.1016/S1043-2760(01)00375-7; Hughes M, 2004, DEV BIOL, V271, P26, DOI 10.1016/j.ydbio.2004.03.029; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Katsanou V, 2009, MOL CELL BIOL, V29, P2762, DOI 10.1128/MCB.01393-08; Kong SS, 2013, CELL RES, V23, P835, DOI 10.1038/cr.2013.59; Lan Y, 2007, MOL CELL BIOL, V27, P7683, DOI 10.1128/MCB.00577-07; LESCISIN KR, 1988, GENE DEV, V2, P1639, DOI 10.1101/gad.2.12a.1639; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Mou F, 2012, J EXP MED, V209, P741, DOI 10.1084/jem.20111692; Navankasattusas S, 2008, DEVELOPMENT, V135, P659, DOI 10.1242/dev.013623; Oh S, 2009, MOL CELL BIOL, V29, P6309, DOI 10.1128/MCB.00551-09; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Schreiber J, 2000, MOL CELL BIOL, V20, P2466, DOI 10.1128/MCB.20.7.2466-2474.2000; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Takahashi T, 2003, MOL CELL BIOL, V23, P1817, DOI 10.1128/MCB.23.5.1817-1831.2003; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Tanaka M, 1997, DEV BIOL, V190, P55, DOI 10.1006/dbio.1997.8685; Ueda Y, 2012, PROC IUTAM, V5, P3, DOI 10.1016/j.piutam.2012.06.002; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Yang JH, 2000, NAT GENET, V24, P309, DOI 10.1038/73550; Yi J, 2010, DEV DYNAM, V239, P2005, DOI 10.1002/dvdy.22343; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang C, 2010, DEV DYNAM, V239, P2594, DOI 10.1002/dvdy.22391; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zheng-Fischhofer Q, 2007, DEV BIOL, V312, P258, DOI 10.1016/j.ydbio.2007.09.025; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	44	19	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90701	10.1371/journal.pone.0090701	http://dx.doi.org/10.1371/journal.pone.0090701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595170	Green Submitted, gold, Green Published			2022-12-25	WOS:000332475500088
J	Sasidharan, R; Keuskamp, DH; Kooke, R; Voesenek, LACJ; Pierik, R				Sasidharan, Rashmi; Keuskamp, Diederik H.; Kooke, Rik; Voesenek, Laurentius A. C. J.; Pierik, Ronald			Interactions between Auxin, Microtubules and XTHs Mediate Green Shade- Induced Petiole Elongation in Arabidopsis	PLOS ONE			English	Article							OUTER EPIDERMAL WALL; CORTICAL MICROTUBULES; PLASMA-MEMBRANE; CELL-WALL; MAIZE COLEOPTILES; DIFFERENTIAL GROWTH; AVOIDANCE RESPONSES; ABIOTIC STRESSES; PLANT-CELLS; CELLULOSE	Plants are highly attuned to translating environmental changes to appropriate modifications in growth. Such phenotypic plasticity is observed in dense vegetations, where shading by neighboring plants, triggers rapid unidirectional shoot growth (shade avoidance), such as petiole elongation, which is partly under the control of auxin. This growth is fuelled by cellular expansion requiring cell-wall modification by proteins such as xyloglucan endotransglucosylase/hydrolases (XTHs). Cortical microtubules (cMTs) are highly dynamic cytoskeletal structures that are also implicated in growth regulation. The objective of this study was to investigate the tripartite interaction between auxin, cMTs and XTHs in shade avoidance. Our results indicate a role for cMTs to control rapid petiole elongation in Arabidopsis during shade avoidance. Genetic and pharmacological perturbation of cMTs obliterated shade-induced growth and led to a reduction in XTH activity as well. Furthermore, the cMT disruption repressed the shade-induced expression of a specific set of XTHs. These XTHs were also regulated by the hormone auxin, an important regulator of plant developmental plasticity and also of several shade avoidance responses. Accordingly, the effect of cMT disruption on the shade enhanced XTH expression could be rescued by auxin application. Based on the results we hypothesize that cMTs can mediate petiole elongation during shade avoidance by regulating the expression of cell wall modifying proteins via control of auxin distribution.	[Sasidharan, Rashmi; Keuskamp, Diederik H.; Kooke, Rik; Voesenek, Laurentius A. C. J.; Pierik, Ronald] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands; [Keuskamp, Diederik H.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Kooke, Rik] Wageningen Univ, Lab Plant Physiol, NL-6700 AP Wageningen, Netherlands	Utrecht University; Wageningen University & Research; Wageningen University & Research	Sasidharan, R (corresponding author), Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands.	r.sasidharan@uu.nl	Pierik, Ronald/B-9591-2011; Voesenek, Laurentius A.C.J./B-9661-2011; Sasidharan, Rashmi/C-2088-2011	Pierik, Ronald/0000-0002-5320-6817; Sasidharan, Rashmi/0000-0002-6940-0657; Voesenek, Laurentius/0000-0002-3361-3837	Netherlands Organisation for Scientific Research (VENI) [86306001, 86312013]	Netherlands Organisation for Scientific Research (VENI)(Netherlands Organization for Scientific Research (NWO))	This work was supported with funds from the Netherlands Organisation for Scientific Research (www.nwo.nl; VENI grant no. 86306001 to R Pierik; VENI grant no. 86312013 to R Sasidharan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arioli T, 1998, SCIENCE, V279, P717, DOI 10.1126/science.279.5351.717; Baskin TI, 2001, PROTOPLASMA, V215, P150, DOI 10.1007/BF01280311; Bichet A, 2001, PLANT J, V25, P137, DOI 10.1046/j.1365-313x.2001.00946.x; Boutte Y, 2006, J CELL SCI, V119, P1255, DOI 10.1242/jcs.02847; Boutte Y, 2007, CELL BIOL INT, V31, P649, DOI 10.1016/j.cellbi.2007.01.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camilleri C, 2002, PLANT CELL, V14, P833, DOI 10.1105/tpc.010402; Casal JJ, 2012, ANONYMOUS ARABIDOPSI, pe0157; Catterou M, 2001, PLANTA, V212, P673, DOI 10.1007/s004250000467; Chuong SDX, 2004, MOL CELL PROTEOMICS, V3, P970, DOI 10.1074/mcp.M400053-MCP200; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Dixit R, 2004, PLANT CELL, V16, P2546, DOI 10.1105/tpc.104.161030; Djakovic-Petrovic T, 2007, PLANT J, V51, P117, DOI 10.1111/j.1365-313X.2007.03122.x; Feraru E, 2011, CURR BIOL, V21, P338, DOI 10.1016/j.cub.2011.01.036; Fischer K, 1997, PROTOPLASMA, V196, P108, DOI 10.1007/BF01281064; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Himmelspach R, 2003, PLANT J, V36, P565, DOI 10.1046/j.1365-313X.2003.01906.x; Himmelspach R, 2001, PLANTA, V212, P184, DOI 10.1007/s004250000378; Hornitschek P, 2012, PLANT J, V71, P699, DOI 10.1111/j.1365-313X.2012.05033.x; Hush JM, 1996, J MICROSC-OXFORD, V181, P129, DOI 10.1046/j.1365-2818.1996.106386.x; ISHIDA K, 1992, INT J PLANT SCI, V153, P155, DOI 10.1086/297017; Kakar K, 2013, NATURE, V495, P529, DOI 10.1038/nature11980; Keller MM, 2011, PLANT J, V67, P195, DOI 10.1111/j.1365-313X.2011.04598.x; Keuskamp DH, 2011, PLANT J, V67, P208, DOI 10.1111/j.1365-313X.2011.04597.x; Keuskamp DH, 2010, P NATL ACAD SCI USA, V107, P22740, DOI 10.1073/pnas.1013457108; Keuskamp DH, 2010, PLANT SIGNAL BEHAV, V5, P655, DOI 10.4161/psb.5.6.11401; Kozuka T, 2010, PLANT PHYSIOL, V153, P1608, DOI 10.1104/pp.110.156802; Lane DR, 2001, PLANT PHYSIOL, V126, P278, DOI 10.1104/pp.126.1.278; Li L, 2012, GENE DEV, V26, P785, DOI 10.1101/gad.187849.112; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd C, 2006, SCIENCE, V312, P1482, DOI 10.1126/science.1128903; Martinez-Garcia JF, 2010, ADV BOT RES, V53, P65, DOI 10.1016/S0065-2296(10)53003-9; Millenaar FF, 2005, PLANT PHYSIOL, V137, P998, DOI 10.1104/pp.104.053967; Morelli G, 2000, PLANT PHYSIOL, V122, P621, DOI 10.1104/pp.122.3.621; Mustroph A, 2006, CELL TYPE SPECIFIC A; Mustroph A, 2009, P NATL ACAD SCI USA, V106, P18843, DOI 10.1073/pnas.0906131106; NICK P, 1990, PLANTA, V181, P162, DOI 10.1007/BF02411533; NICK P, 1992, PLANT PHYSIOL, V99, P1302, DOI 10.1104/pp.99.4.1302; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Pagant S, 2002, PLANT CELL, V14, P2001, DOI 10.1105/tpc.002873; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Pierik R, 2009, PLANT PHYSIOL, V149, P1701, DOI 10.1104/pp.108.133496; Polko JK, 2012, NEW PHYTOL, V193, P339, DOI 10.1111/j.1469-8137.2011.03920.x; ROBERTS IN, 1985, PLANTA, V164, P439, DOI 10.1007/BF00395959; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Sasidharan R, 2008, PLANT PHYSIOL, V148, P1557, DOI 10.1104/pp.108.125518; Sasidharan R, 2011, CRIT REV PLANT SCI, V30, P548, DOI 10.1080/07352689.2011.615706; Sasidharan R, 2010, PLANT PHYSIOL, V154, P978, DOI 10.1104/pp.110.162057; SHIBAOKA H, 1994, ANNU REV PLANT PHYS, V45, P527, DOI 10.1146/annurev.pp.45.060194.002523; Soga K, 2006, PLANTA, V224, P1485, DOI 10.1007/s00425-006-0319-8; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Sugimoto K, 2003, PLANT CELL, V15, P1414, DOI 10.1105/tpc.011593; SULOVA Z, 1995, ANAL BIOCHEM, V229, P80, DOI 10.1006/abio.1995.1381; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Tatematsu K, 2004, PLANT CELL, V16, P379, DOI 10.1105/tpc.018630; Ueda K, 1999, PROTOPLASMA, V206, P201, DOI 10.1007/BF01279267; Vandenbussche F, 2005, CURR OPIN PLANT BIOL, V8, P462, DOI 10.1016/j.pbi.2005.07.007; Vissenberg K, 2005, J EXP BOT, V56, P673, DOI 10.1093/jxb/eri048; Wang C, 2011, BIOCHEMISTRY-MOSCOW+, V76, P320, DOI 10.1134/S0006297911030047; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; Williamson RE, 2001, PROTOPLASMA, V215, P116, DOI 10.1007/BF01280308; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Zadnikova P, 2010, DEVELOPMENT, V137, P607, DOI 10.1242/dev.041277; ZANDOMENI K, 1993, PROTOPLASMA, V173, P103, DOI 10.1007/BF01378999	66	27	30	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90587	10.1371/journal.pone.0090587	http://dx.doi.org/10.1371/journal.pone.0090587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594664	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500071
J	Tu, QC; He, ZL; Li, Y; Chen, YF; Deng, Y; Lin, L; Hemme, CL; Yuan, T; Van Nostrand, JD; Wu, LY; Zhou, XD; Shi, WY; Li, LJ; Xu, J; Zhou, JZ				Tu, Qichao; He, Zhili; Li, Yan; Chen, Yanfei; Deng, Ye; Lin, Lu; Hemme, Christopher L.; Yuan, Tong; Van Nostrand, Joy D.; Wu, Liyou; Zhou, Xuedong; Shi, Wenyuan; Li, Lanjuan; Xu, Jian; Zhou, Jizhong			Development of HuMiChip for Functional Profiling of Human Microbiomes	PLOS ONE			English	Article							CORE GUT MICROBIOME; PROBE DESIGN; COMMUNITY COMPOSITION; GENE MICROARRAYS; AMINO-ACIDS; PERIODONTITIS; METABOLISM; APOPTOSIS; HEALTH; METAGENOME	Understanding the diversity, composition, structure, function, and dynamics of human microbiomes in individual human hosts is crucial to reveal human-microbial interactions, especially for patients with microbially mediated disorders, but challenging due to the high diversity of the human microbiome. Here we have developed a functional gene-based microarray for profiling human microbiomes (HuMiChip) with 36,802 probes targeting 50,007 protein coding sequences for 139 key functional gene families. Computational evaluation suggested all probes included are highly specific to their target sequences. HuMiChip was used to analyze human oral and gut microbiomes, showing significantly different functional gene profiles between oral and gut microbiome. Obvious shifts of microbial functional structure and composition were observed for both patients with dental caries and periodontitis from moderate to advanced stages, suggesting a progressive change of microbial communities in response to the diseases. Consistent gene family profiles were observed by both HuMiChip and next generation sequencing technologies. Additionally, HuMiChip was able to detect gene families at as low as 0.001% relative abundance. The results indicate that the developed HuMiChip is a useful and effective tool for functional profiling of human microbiomes.	[Tu, Qichao; He, Zhili; Deng, Ye; Hemme, Christopher L.; Yuan, Tong; Van Nostrand, Joy D.; Wu, Liyou; Zhou, Jizhong] Univ Oklahoma, Dept Microbiol & Plant Biol, Inst Environm Genom, Norman, OK 73019 USA; [Li, Yan; Zhou, Xuedong] Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu 610064, Peoples R China; [Chen, Yanfei; Li, Lanjuan] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Lu; Xu, Jian] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Shandong, Peoples R China; [Shi, Wenyuan] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Zhou, Jizhong] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Zhou, Jizhong] Tsinghua Univ, State Key Joint Lab Environm Simulat & Pollut Con, Sch Environm, Beijing 100084, Peoples R China	University of Oklahoma System; University of Oklahoma - Norman; Sichuan University; Zhejiang University; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; University of California System; University of California Los Angeles; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Tsinghua University	He, ZL (corresponding author), Univ Oklahoma, Dept Microbiol & Plant Biol, Inst Environm Genom, Norman, OK 73019 USA.	zhili.he@ou.edu; jzhou@ou.edu	吴, 昊/AAB-1620-2020; ZHOU, XUE/F-6129-2013; He, Zhili/C-2879-2012; SHI, wen/GPW-9531-2022; Van Nostrand, Joy D/F-1740-2016; Deng, Ye/X-4358-2019; Xu, Jian/G-8430-2012	He, Zhili/0000-0001-8225-7333; Van Nostrand, Joy D/0000-0001-9548-6450; Deng, Ye/0000-0002-7584-0632; Xu, Jian/0000-0002-0548-8477; Tu, Qichao/0000-0002-3245-7545; Zhou, Xuedong/0000-0002-9319-7302	Oklahoma Center for the Advancement of Science and Technology (OCAST) through the Oklahoma Applied Research Support (OARS) [AR11-035]; ENIGMA-Ecosystems and Networks Integrated with Genes and Molecular Assemblies [DE-AC02-05CH11231]; International Science and Technology Cooperation Program of China [2011DFA30940]; National Basic Research Program of China "973 Pilot Research Program" [2011CB512108]; National Key Technologies R&D Program of the Twelfth Five-Year Plan, the Ministry of Science and Technology of China [2012BAI07B03]; National Natural Science Foundation of China [81170959, 30901689, 81172579]; Sichuan Provincial Department of science and technology project [2013SZ0039]	Oklahoma Center for the Advancement of Science and Technology (OCAST) through the Oklahoma Applied Research Support (OARS); ENIGMA-Ecosystems and Networks Integrated with Genes and Molecular Assemblies; International Science and Technology Cooperation Program of China; National Basic Research Program of China "973 Pilot Research Program"(National Basic Research Program of China); National Key Technologies R&D Program of the Twelfth Five-Year Plan, the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Provincial Department of science and technology project	This work was supported by the Oklahoma Center for the Advancement of Science and Technology (OCAST) through the Oklahoma Applied Research Support (OARS) Project AR11-035, ENIGMA-Ecosystems and Networks Integrated with Genes and Molecular Assemblies under Contract No. DE-AC02-05CH11231, the International Science and Technology Cooperation Program of China (grant number: 2011DFA30940), the National Basic Research Program of China ("973 Pilot Research Program", Grant Number: 2011CB512108), National Key Technologies R&D Program of the Twelfth Five-Year Plan, the Ministry of Science and Technology of China (grand 2012BAI07B03), the National Natural Science Foundation of China (81170959, 30901689 and 81172579), and the Sichuan Provincial Department of science and technology project(2013SZ0039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2012, J ORAL SCI, V54, P7, DOI 10.2334/josnusd.54.7; Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Cantarel BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028742; Comstock LE, 2006, CELL, V126, P847, DOI 10.1016/j.cell.2006.08.021; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Delzenne NM, 2011, ANNU REV NUTR, V31, P15, DOI 10.1146/annurev-nutr-072610-145146; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Hardie J M, 1982, Dent Update, V9, P199; He Z, 2012, CURRENT OPINION BIOT; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; He ZL, 2012, CURR OPIN BIOTECH, V23, P49, DOI 10.1016/j.copbio.2011.11.001; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; He ZL, 2005, APPL ENVIRON MICROB, V71, P3753, DOI 10.1128/AEM.71.7.3753-3760.2005; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Klaenhammer TR, 2008, J CLIN GASTROENTEROL, V42, pS160, DOI 10.1097/MCG.0b013e31817da140; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Lee Y-J, 2013, ISME J; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Li XY, 2005, NUCLEIC ACIDS RES, V33, P6114, DOI 10.1093/nar/gki914; Liang YT, 2010, APPL ENVIRON MICROB, V76, P1088, DOI 10.1128/AEM.02749-09; Liebich J, 2006, APPL ENVIRON MICROB, V72, P1688, DOI 10.1128/AEM.72.2.1688-1691.2006; Loscalzo J, 2011, CIRC RES, V109, P127, DOI 10.1161/RES.0b013e3182290620; Lu Rui-fang, 2008, Zhonghua Kou Qiang Yi Xue Za Zhi, V43, P664; Meng H, 2008, PERIODONTOLOGY, P156; Metges CC, 2000, J NUTR, V130, p1857S, DOI 10.1093/jn/130.7.1857S; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Ochiai K, 2011, J ORAL BIOSCI, V53, P213, DOI 10.2330/joralbiosci.53.213; Otte S, 1999, APPL ENVIRON MICROB, V65, P3148; Paliy O, 2009, APPL ENVIRON MICROB, V75, P3572, DOI 10.1128/AEM.02764-08; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qiqiang L, 2012, J PERIODONTAL RES; Quirynen M, 2001, J CLIN PERIODONTOL, V28, P499, DOI 10.1034/j.1600-051x.2001.028006499.x; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Reeds PJ, 2000, J NUTR, V130, p1835S; Rhee SK, 2004, APPL ENVIRON MICROB, V70, P4303, DOI 10.1128/AEM.70.7.4303-4317.2004; Roh SW, 2010, TRENDS BIOTECHNOL, V28, P291, DOI 10.1016/j.tibtech.2010.03.001; Salminen A, 2008, CELL MOL LIFE SCI, V65, P2979, DOI 10.1007/s00018-008-8103-5; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Sboner A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-125; Scholz MB, 2012, CURR OPIN BIOTECH, V23, P9, DOI 10.1016/j.copbio.2011.11.013; Siqueira JF, 2009, ORAL SURG ORAL MED O, V107, P870, DOI 10.1016/j.tripleo.2009.01.044; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Stehle HW, 2001, J PERIODONTOL, V72, P1059, DOI 10.1902/jop.2001.72.8.1059; Stralis-Pavese N, 2011, NAT PROTOC, V6, P609, DOI 10.1038/nprot.2010.191; Tanner ACR, 2007, J CLIN PERIODONTOL, V34, P917, DOI 10.1111/j.1600-051X.2007.01126.x; Tatakis Dimitris N, 2005, Dent Clin North Am, V49, P491, DOI 10.1016/j.cden.2005.03.001; Tatakis DN, 2005, DENT CLIN N AM, V49, pv; Tiquia SM, 2004, BIOTECHNIQUES, V36, P664, DOI 10.2144/04364RR02; Tottey W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062544; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Tsuda H, 2010, J PERIODONTAL RES, V45, P626, DOI 10.1111/j.1600-0765.2010.01277.x; Tu Q, 2013, GEOCHIP 4 0 HIGH DEN; Tu QC, 2013, APPL ENVIRON MICROB, V79, P5085, DOI 10.1128/AEM.01124-13; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; VERMEER C, 1990, BIOCHEM J, V266, P625, DOI 10.1042/bj2660625; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wu LY, 2006, APPL ENVIRON MICROB, V72, P4931, DOI 10.1128/AEM.02738-05; Wu LY, 2001, APPL ENVIRON MICROB, V67, P5780, DOI 10.1128/AEM.67.12.5780-5790.2001; XIE G, 2011, ORALGEN COMPREHENSIV; Zhou A, 2013, ENVIRON SCI TECHNOL, V13, P13; Zhou JZ, 2012, NAT CLIM CHANGE, V2, P106, DOI 10.1038/NCLIMATE1331	79	11	11	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90546	10.1371/journal.pone.0090546	http://dx.doi.org/10.1371/journal.pone.0090546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595026	gold, Green Submitted, Green Published			2022-12-25	WOS:000332475500065
J	Westermann, FL; Suckling, DM; Lester, PJ				Westermann, Fabian Ludwig; Suckling, David Maxwell; Lester, Philip John			Disruption of Foraging by a Dominant Invasive Species to Decrease Its Competitive Ability	PLOS ONE			English	Article							TRAIL PHEROMONE DISRUPTION; LINEPITHEMA-HUMILE MAYR; ARGENTINE ANT; NATIVE ANTS; NICHE DIFFERENTIATION; ECONOMIC COSTS; INTERFERENCE; CONSEQUENCES; EXPLOITATION; COMMUNITIES	Invasive species are a major threat to biodiversity when dominant within their newly established habitat. The globally distributed Argentine ant Linepithema humile has been reported to break the trade-off between interference and exploitative competition, achieve high population densities, and overpower nests of many endemic ant species. We have used the sensitivity of the Argentine ant to the synthetic trail pheromone (Z)-9-hexadecanal to investigate species interactions for the first time. We predicted that disrupting Argentine ant trail following behaviour would reduce their competitive ability and create an opportunity for three other resident species to increase their foraging success. Argentine ant success in the control was reduced with increasing pheromone concentration, as predicted, but interactions varied among competing resident species. These behavioural variations provide an explanation for observed differences in foraging success of the competing resident species and how much each of these individual competitors can increase their foraging if the competitive ability of the dominant invader is decreased. The mechanism for the observed increase in resource acquisition of resident species appears to be a decrease in aggressive behaviour displayed by the Argentine ant, which may create an opportunity for other resident species to forage more successfully. Our demonstration of species interactions with trail pheromone disruption is the first known case of reduced dominance under a pheromone treatment in ants.	[Westermann, Fabian Ludwig; Lester, Philip John] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Suckling, David Maxwell] New Zealand Inst Plant & Food Res, Christchurch, New Zealand	Victoria University Wellington; New Zealand Institute for Plant & Food Research Ltd	Westermann, FL (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	fabian.westermann@vuw.ac.nz	Suckling, David Maxwell/M-7730-2019; Lester, Phil/A-1296-2008; Suckling, David M/F-7005-2010; Westermann, Fabian Ludwig/N-2848-2013	Suckling, David Maxwell/0000-0001-7216-9348; Lester, Phil/0000-0002-1801-5687; Suckling, David M/0000-0001-7216-9348; Westermann, Fabian Ludwig/0000-0002-4709-6973	Victoria University of Wellington doctoral scholarship	Victoria University of Wellington doctoral scholarship	This research was funded by a Victoria University of Wellington doctoral scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI MF, 1990, BIOL REV, V65, P227, DOI 10.1111/j.1469-185X.1990.tb01425.x; Alowe S, 2000, ALIENS, V12, P2; ANDERSEN AN, 1994, OECOLOGIA, V98, P15, DOI 10.1007/BF00326085; ANDERSEN AN, 1992, AM NAT, V140, P401, DOI 10.1086/285419; Barbieri RF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2157; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Blancafort X, 2005, ACTA OECOL, V28, P49, DOI 10.1016/j.actao.2005.02.004; Buczkowski G, 2008, BIOL INVASIONS, V10, P1001, DOI 10.1007/s10530-007-9179-9; Cerda X, 1998, OIKOS, V82, P99, DOI 10.2307/3546920; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P159, DOI 10.1007/BF01417909; FELLERS JH, 1987, ECOLOGY, V68, P1466, DOI 10.2307/1939230; Gibb H, 2005, AUSTRAL ECOL, V30, P856, DOI 10.1111/j.1442-9993.2005.01528.x; Gomez C, 2003, ACTA OECOL, V24, P47, DOI 10.1016/S1146-609X(03)00042-0; Harris RJ, 2002, SURVEY CURRENT DISTR; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; HOLLDOBLER B, 1983, BIOTROPICA, V15, P241, DOI 10.2307/2387648; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; Human KG, 1996, OECOLOGIA, V105, P405, DOI 10.1007/BF00328744; KENWARD RE, 1993, P ROY SOC B-BIOL SCI, V251, P187; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McGrannachan CM, 2013, J APPL ENTOMOL, V137, P550, DOI 10.1111/jen.12032; McNatty A, 2009, OECOLOGIA, V160, P187, DOI 10.1007/s00442-009-1279-z; Morrison LW, 1996, OECOLOGIA, V107, P243, DOI 10.1007/BF00327909; Nishisue K, 2010, J ECON ENTOMOL, V103, P1784, DOI 10.1603/EC10008; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pintor LM, 2009, ECOLOGY, V90, P581, DOI 10.1890/08-0552.1; RACE MS, 1982, OECOLOGIA, V54, P337, DOI 10.1007/BF00380002; Roura-Pascual N, 2006, ECOL APPL, V16, P1832, DOI 10.1890/1051-0761(2006)016[1832:NDAFPF]2.0.CO;2; Rowles AD, 2007, BIOL INVASIONS, V9, P73, DOI 10.1007/s10530-006-9009-5; Rowles AD, 2009, AUSTRAL ECOL, V34, P239, DOI 10.1111/j.1442-9993.2008.01922.x; Ruther J, 2002, NATURWISSENSCHAFTEN, V89, P111, DOI 10.1007/s00114-001-0292-9; Sagata K, 2009, J APPL ECOL, V46, P19, DOI 10.1111/j.1365-2664.2008.01523.x; Sanders NJ, 2003, P NATL ACAD SCI USA, V100, P2474, DOI 10.1073/pnas.0437913100; Sanders NJ, 2001, OECOLOGIA, V127, P123, DOI 10.1007/s004420000572; SAVOLAINEN R, 1991, BEHAV ECOL SOCIOBIOL, V28, P1, DOI 10.1007/BF00172132; SAVOLAINEN R, 1989, OIKOS, V56, P3, DOI 10.2307/3566082; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Smith AA, 2009, CURR BIOL, V19, P78, DOI 10.1016/j.cub.2008.11.059; Sorrells TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018717; Stringer LD, 2007, ECOL ENTOMOL, V32, P732, DOI 10.1111/j.1365-2311.2007.00924.x; Suarez AV, 2001, P NATL ACAD SCI USA, V98, P1095, DOI 10.1073/pnas.98.3.1095; Suckling DM, 2008, J CHEM ECOL, V34, P1602, DOI 10.1007/s10886-008-9566-4; Suckling DM, 2011, J CHEM ECOL, V37, P1143, DOI 10.1007/s10886-011-0019-0; Suckling DM, 2010, J CHEM ECOL, V36, P122, DOI 10.1007/s10886-009-9734-1; Tsutsui ND, 2003, CONSERV BIOL, V17, P48, DOI 10.1046/j.1523-1739.2003.02018.x; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Vander Meer RK, 2002, BEHAV ECOL SOCIOBIOL, V51, P122, DOI 10.1007/s002650100417; VEPSALAINEN K, 1982, ANN ZOOL FENN, V19, P327; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Wild AL, 2004, ANN ENTOMOL SOC AM, V97, P1204, DOI 10.1603/0013-8746(2004)097[1204:TADOTA]2.0.CO;2; Wilson E, 2013, P I CIVIL ENG-CIV EN, V166, P2, DOI 10.1680/cien.2013.166.6.2; Zavaleta ES, 2001, TRENDS ECOL EVOL, V16, P454, DOI 10.1016/S0169-5347(01)02194-2	57	13	13	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90173	10.1371/journal.pone.0090173	http://dx.doi.org/10.1371/journal.pone.0090173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594633	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500035
J	Banerjee, J; Das Ghatak, P; Roy, S; Khanna, S; Sequin, EK; Bellman, K; Dickinson, BC; Suri, P; Subramaniam, VV; Chang, CJ; Sen, CK				Banerjee, Jaideep; Das Ghatak, Piya; Roy, Sashwati; Khanna, Savita; Sequin, Emily K.; Bellman, Karen; Dickinson, Bryan C.; Suri, Prerna; Subramaniam, Vish V.; Chang, Christopher J.; Sen, Chandan K.			Improvement of Human Keratinocyte Migration by a Redox Active Bioelectric Dressing	PLOS ONE			English	Article							EXTERNAL ELECTRIC-FIELD; HYDROGEN-PEROXIDE; OXIDATIVE-PHOSPHORYLATION; DIRECTIONAL MIGRATION; HUMAN-FIBROBLASTS; LIVING SYSTEMS; CELL-MIGRATION; IN-VIVO; STIMULATION; INTEGRIN	Exogenous application of an electric field can direct cell migration and improve wound healing; however clinical application of the therapy remains elusive due to lack of a suitable device and hence, limitations in understanding the molecular mechanisms. Here we report on a novel FDA approved redox-active Ag/Zn bioelectric dressing (BED) which generates electric fields. To develop a mechanistic understanding of how the BED may potentially influence wound reepithelialization, we direct emphasis on understanding the influence of BED on human keratinocyte cell migration. Mapping of the electrical field generated by BED led to the observation that BED increases keratinocyte migration by three mechanisms: (i) generating hydrogen peroxide, known to be a potent driver of redox signaling, (ii) phosphorylation of redox-sensitive IGF1R directly implicated in cell migration, and (iii) reduction of protein thiols and increase in integrin(alpha v) expression, both of which are known to be drivers of cell migration. BED also increased keratinocyte mitochondrial membrane potential consistent with its ability to fuel an energy demanding migration process. Electric fields generated by a Ag/Zn BED can cross-talk with keratinocytes via redox-dependent processes improving keratinocyte migration, a critical event in wound re-epithelialization.	[Banerjee, Jaideep; Das Ghatak, Piya; Roy, Sashwati; Khanna, Savita; Suri, Prerna; Sen, Chandan K.] Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA; [Sequin, Emily K.; Bellman, Karen; Subramaniam, Vish V.] Ohio State Univ, Dept Mech & Aerosp Engn, Columbus, OH 43210 USA; [Dickinson, Bryan C.; Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem & Mol & Cell Biol, Berkeley, CA 94720 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Sen, CK (corresponding author), Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA.	Chandan.sen@osumc.edu	Subramaniam, Vish/D-7013-2016; Roy, sashwati/E-3990-2011	Banerjee, Jaideep/0000-0002-8688-7137	Procellera(R), Vomaris Innovations; National Institutes of Health [GM077185, GM069589, DK076566, GM 79465]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077185, T32GM066698, R01GM069589, R01GM079465] Funding Source: NIH RePORTER	Procellera(R), Vomaris Innovations; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partly supported by the manufacturer of Procellera (R), Vomaris Innovations, by means of an unrestricted gift to The Ohio State University. The work was also supported by National Institutes of Health awards GM077185, GM069589 to CKS, DK076566 to SR and GM 79465 to CJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO Y, 1993, J CELL PHYSIOL, V156, P487, DOI 10.1002/jcp.1041560308; Borba GC, 2011, J SURG RES, V166, P324, DOI 10.1016/j.jss.2009.08.018; BORGENS RB, 1977, J EXP ZOOL, V200, P403, DOI 10.1002/jez.1402000310; BORGENS RB, 1977, P NATL ACAD SCI USA, V74, P4528, DOI 10.1073/pnas.74.10.4528; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BOURGUIGNON GJ, 1989, J CELL PHYSIOL, V140, P379, DOI 10.1002/jcp.1041400224; BOURGUIGNON GJ, 1987, FASEB J, V1, P398, DOI 10.1096/fasebj.1.5.3678699; Brooks PC, 1997, J CLIN INVEST, V99, P1390, DOI 10.1172/JCI119298; David E, 1983, Indian J Physiol Pharmacol, V27, P289; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; EBERHARDT A, 1986, Acta Physiologica Polonica, V37, P41; ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296; Fang KS, 1999, J CELL SCI, V112, P1967; Fang KS, 1998, J INVEST DERMATOL, V111, P751, DOI 10.1046/j.1523-1747.1998.00366.x; FOULDS IS, 1983, BRIT J DERMATOL, V109, P515, DOI 10.1111/j.1365-2133.1983.tb07673.x; Fu D, 2013, P NATL ACAD SCI USA, V110, P7288, DOI 10.1073/pnas.1304285110; Gest C, 2012, CANCER LETT, V317, P207, DOI 10.1016/j.canlet.2011.11.026; Haase I, 2003, J CELL SCI, V116, P3227, DOI 10.1242/jcs.00610; HAMAMOTO T, 1982, J BIOCHEM-TOKYO, V91, P1759, DOI 10.1093/oxfordjournals.jbchem.a133868; Hussain SRA, 2008, BLOOD, V111, P3190, DOI 10.1182/blood-2007-10-115733; JAFFE LF, 1977, ANNU REV BIOPHYS BIO, V6, P445, DOI 10.1146/annurev.bb.06.060177.002305; Junger M, 2008, WOUND REPAIR REGEN, V16, P480, DOI 10.1111/j.1524-475X.2008.00393.x; Khanna S, 2006, J NEUROCHEM, V98, P1474, DOI 10.1111/j.1471-4159.2006.04000.x; KIM JP, 1994, J BIOL CHEM, V269, P26926; Kim LT, 1998, J SURG RES, V76, P185, DOI 10.1006/jsre.1998.5331; Kloth Luther C, 2005, Int J Low Extrem Wounds, V4, P23; Kopidakis N, 2000, J PHYS CHEM B, V104, P3930, DOI 10.1021/jp9936603; Lampe K E, 1998, J Hand Ther, V11, P131; Lin VS, 2013, METHOD ENZYMOL, V526, P19, DOI 10.1016/B978-0-12-405883-5.00002-8; Lippert AR, 2011, ACCOUNTS CHEM RES, V44, P793, DOI 10.1021/ar200126t; Liu WK, 1997, J ANTIMICROB CHEMOTH, V39, P687, DOI 10.1093/jac/39.6.687; Liu XP, 2001, FREE RADICAL BIO MED, V31, P894, DOI 10.1016/S0891-5849(01)00665-7; MAILER K, 1990, BIOCHEM BIOPH RES CO, V170, P59, DOI 10.1016/0006-291X(90)91240-S; Manickam N, 2011, J THROMB HAEMOST, V9, P1207, DOI 10.1111/j.1538-7836.2011.04266.x; McCaig CD, 1997, BIOESSAYS, V19, P819, DOI 10.1002/bies.950190912; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Miller EW, 2010, J AM CHEM SOC, V132, P17071, DOI 10.1021/ja107783j; MOHR T, 1987, PHYS THER, V67, P526, DOI 10.1093/ptj/67.4.526; National Pressure Ulcer Advisory Panel European Pressure Ulcer Advisory Panel, 2009, PREV TREATM PRESS UL, P51; Nie YH, 2009, J CELL MOL MED, V13, P3051, DOI 10.1111/j.1582-4934.2008.00382.x; Nishimura KY, 1996, J CELL SCI, V109, P199; Nuccitelli R, 2003, CURR TOP DEV BIOL, V58, P1, DOI 10.1016/S0070-2153(03)58001-2; O'Toole EA, 2001, CLIN EXP DERMATOL, V26, P525, DOI 10.1046/j.1365-2230.2001.00891.x; Ohsaki Y, 2012, AM J PHYSIOL-RENAL, V302, pF95, DOI 10.1152/ajprenal.00469.2011; ORIDA N, 1982, CELL MOTIL CYTOSKEL, V2, P243, DOI 10.1002/cm.970020305; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; Rajnicek AM, 2006, J CELL SCI, V119, P1723, DOI 10.1242/jcs.02896; Reger SI, 1999, ARTIF ORGANS, V23, P460, DOI 10.1046/j.1525-1594.1999.06365.x; Reid AB, 2005, J PHARMACOL EXP THER, V312, P509, DOI 10.1124/jpet.104.075945; Reid B, 2005, FASEB J, V19, P379, DOI 10.1096/fj.04-2325com; RICE GC, 1986, CANCER RES, V46, P6105; Robinson KR, 2003, BIOESSAYS, V25, P759, DOI 10.1002/bies.10307; ROBINSON KR, 1985, J CELL BIOL, V101, P2023, DOI 10.1083/jcb.101.6.2023; Roy S, 2006, MOL THER, V13, P211, DOI 10.1016/j.ymthe.2005.07.684; Sato MJ, 2009, P NATL ACAD SCI USA, V106, P6667, DOI 10.1073/pnas.0809974106; Sen CK, 2002, J BIOL CHEM, V277, P33284, DOI 10.1074/jbc.M203391200; Sen CK, 1997, FREE RADICAL BIO MED, V22, P1241, DOI 10.1016/S0891-5849(96)00552-7; Shen MR, 2006, CARCINOGENESIS, V27, P962, DOI 10.1093/carcin/bgi336; Song B, 2002, P NATL ACAD SCI USA, V99, P13577, DOI 10.1073/pnas.202235299; Sta Iglesia Drina D., 1998, Wound Repair and Regeneration, V6, P531; Sutton G.W., 1965, ENG MAGNETOHYDRODYNA; Tirosh O, 2001, ANTIOXID REDOX SIGN, V3, P711, DOI 10.1089/15230860152543041; Torabi F, 2012, J ELECTROCHEM SOC, V159, pA1986, DOI 10.1149/2.038212jes; VINKLER C, 1982, P NATL ACAD SCI-BIOL, V79, P3183, DOI 10.1073/pnas.79.10.3183; WEISS DS, 1990, ARCH DERMATOL, V126, P222, DOI 10.1001/archderm.126.2.222; Yang HY, 2013, J CELL SCI, V126, P1942, DOI 10.1242/jcs.113225; YANG WP, 1984, EXP CELL RES, V155, P92, DOI 10.1016/0014-4827(84)90770-5; Yurko MA, 2001, J CELL PHYSIOL, V188, P24, DOI 10.1002/jcp.1093; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009	71	57	58	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89239	10.1371/journal.pone.0089239	http://dx.doi.org/10.1371/journal.pone.0089239			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595050	Green Published, gold			2022-12-25	WOS:000332468900012
J	Liu, XX; Chen, M; Collins, HL; Onstad, DW; Roush, RT; Zhang, QW; Earle, ED; Shelton, AM				Liu, Xiaoxia; Chen, Mao; Collins, Hilda L.; Onstad, David W.; Roush, Richard T.; Zhang, Qingwen; Earle, Elizabeth D.; Shelton, Anthony M.			Natural Enemies Delay Insect Resistance to Bt Crops	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; TRANSGENIC PLANTS; PINK-BOLLWORM; FIELD-RESISTANCE; POTENTIAL IMPACT; TOXIN CRY1AC; MANAGEMENT; LEPIDOPTERA; ADAPTATION; SUPPRESSION	We investigated whether development of resistance to a Bt crop in the presence of a natural enemy would be slower than without the natural enemy and whether biological control, in conjunction with a Bt crop, could effectively suppress the pest population. Additionally, we investigated whether insecticide-sprayed refuges of non-Bt crops would delay or accelerate resistance to the Bt crop. We used a system of Bt broccoli expressing Cry1Ac, a population of the pest Plutella xylostella with a low frequency of individuals resistant to Cry1Ac and the insecticide spinosad, and a natural enemy, Coleomegilla maculata, to conduct experiments over multiple generations. The results demonstrated that after 6 generations P. xylostella populations were very low in the treatment containing C. maculata and unsprayed non-Bt refuge plants. Furthermore, resistance to Bt plants evolved significantly slower in this treatment. In contrast, Bt plants with no refuge were completely defoliated in treatments without C. maculata after 4-5 generations. In the treatment containing sprayed non-Bt refuge plants and C. maculata, the P. xylostella population was low, although the speed of resistance selection to Cry1Ac was significantly increased. These data demonstrate that natural enemies can delay resistance to Bt plants and have significant implications for integrated pest management (IPM) with Bt crops.	[Liu, Xiaoxia; Zhang, Qingwen] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Liu, Xiaoxia; Chen, Mao; Collins, Hilda L.; Shelton, Anthony M.] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Onstad, David W.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Roush, Richard T.] Univ Melbourne, Melbourne Sch Land & Environm, Melbourne, Vic 3010, Australia; [Earle, Elizabeth D.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA	China Agricultural University; Cornell University; University of Illinois System; University of Illinois Urbana-Champaign; University of Melbourne; Cornell University	Shelton, AM (corresponding author), Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA.	ams5@cornell.edu			USDA National Institute of Food and Agriculture [2008-33120-19536]; Special Research Projects for Developing Transgenic Plants in China [2011zx08011-002]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Special Research Projects for Developing Transgenic Plants in China	This project was supported by the Biotechnology Risk Assessment Program Competitive Grant no. 2008-33120-19536 from the USDA National Institute of Food and Agriculture and the Special Research Projects for Developing Transgenic Plants (2011zx08011-002) in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia S, 1997, ENTOMOL EXP APPL, V82, P91, DOI 10.1023/A:1002935706990; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Chen M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002284; Chilcutt CF, 1999, ENVIRON ENTOMOL, V28, P505, DOI 10.1093/ee/28.3.505; Desneux N, 2010, ECOTOXICOLOGY, V19, P1642, DOI 10.1007/s10646-010-0550-8; Desneux N, 2010, ECOTOXICOLOGY, V19, P1183, DOI 10.1007/s10646-010-0502-3; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Gassmann AJ, 2006, J ECON ENTOMOL, V99, P920, DOI 10.1603/0022-0493-99.3.920; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GOULD F, 1991, ENTOMOL EXP APPL, V58, P1, DOI 10.1007/BF00163307; Heimpel GE, 2005, ENVIRON ENTOMOL, V34, P512, DOI 10.1603/0046-225X-34.3.512; Huang F, 2012, ENTOMOL EXP APPL, V140, P1; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Johnson MT, 1997, ENTOMOL EXP APPL, V83, P121, DOI 10.1023/A:1002961813014; Johnson MT, 1997, ENTOMOL EXP APPL, V82, P219, DOI 10.1023/A:1002900803649; Kathage J, 2012, P NATL ACAD SCI USA, V109, P11652, DOI 10.1073/pnas.1203647109; Liu XX, 2012, J ECON ENTOMOL, V105, P354, DOI 10.1603/EC11299; Liu XX, 2011, TRANSGENIC RES, V20, P887, DOI 10.1007/s11248-010-9471-9; Lovei GL, 2009, ENVIRON ENTOMOL, V38, P293, DOI 10.1603/022.038.0201; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Lundgren JG, 2009, CROP PROT, V28, P1017, DOI 10.1016/j.cropro.2009.06.001; Mallampalli N, 2005, ENTOMOL EXP APPL, V114, P47, DOI 10.1111/j.0013-8703.2005.00232.x; METZ TD, 1995, MOL BREEDING, V1, P309, DOI 10.1007/BF01248408; Naranjo S. E., 2009, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V4, P1, DOI 10.1079/PAVSNNR20094011; Onstad DW, 2008, INSECT RESISTANCE MA, P289; Qaim Matin, 2008, V5, P329, DOI 10.1007/978-1-4020-8373-0_12; Romeis J., 2008, INTEGRATION INSECT R; Romeis J, 2013, NAT BIOTECHNOL, V31, P386, DOI 10.1038/nbt.2578; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Shelton AM, 2000, NAT BIOTECHNOL, V18, P339, DOI 10.1038/73804; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Shelton AM, 2009, TRANSGENIC RES, V18, P317, DOI 10.1007/s11248-009-9260-5; SPSS, 1998, SPSS US GUID; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Tang JD, 2001, J ECON ENTOMOL, V94, P240, DOI 10.1603/0022-0493-94.1.240; Tian JC, 2012, TRANSGENIC RES, V21, P1303, DOI 10.1007/s11248-012-9604-4; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Zhao JZ, 2010, PEST MANAG SCI, V66, P1101, DOI 10.1002/ps.1985; Zhao JZ, 2005, P NATL ACAD SCI USA, V102, P8426, DOI 10.1073/pnas.0409324102	45	45	48	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90366	10.1371/journal.pone.0090366	http://dx.doi.org/10.1371/journal.pone.0090366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595158	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900099
J	Stoeva, MK; Aris-Brosou, S; Chetelat, J; Hintelmann, H; Pelletier, P; Poulain, AJ				Stoeva, Magdalena K.; Aris-Brosou, Stephane; Chetelat, John; Hintelmann, Holger; Pelletier, Philip; Poulain, Alexandre J.			Microbial Community Structure in Lake and Wetland Sediments from a High Arctic Polar Desert Revealed by Targeted Transcriptomics	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; CORNWALLIS-ISLAND; CHAR LAKE; PHYLOGENETIC ANALYSIS; ORGANIC-CARBON; SWISS-MODEL; METHANE; DIVERSITY; BACTERIAL; MERCURY	While microbial communities play a key role in the geochemical cycling of nutrients and contaminants in anaerobic freshwater sediments, their structure and activity in polar desert ecosystems are still poorly understood, both across heterogeneous freshwater environments such as lakes and wetlands, and across sediment depths. To address this question, we performed targeted environmental transcriptomics analyses and characterized microbial diversity across three depths from sediment cores collected in a lake and a wetland, located on Cornwallis Island, NU, Canada. Microbial communities were characterized based on 16S rRNA and two functional gene transcripts: mcrA, involved in archaeal methane cycling and glnA, a bacterial housekeeping gene implicated in nitrogen metabolism. We show that methane cycling and overall bacterial metabolic activity are the highest at the surface of lake sediments but deeper within wetland sediments. Bacterial communities are highly diverse and structured as a function of both environment and depth, being more diverse in the wetland and near the surface. Archaea are mostly methanogens, structured by environment and more diverse in the wetland. McrA transcript analyses show that active methane cycling in the lake and wetland corresponds to distinct communities with a higher potential for methane cycling in the wetland. Methanosarcina spp., Methanosaeta spp. and a group of uncultured Archaea are the dominant methanogens in the wetland while Methanoregula spp. predominate in the lake.	[Stoeva, Magdalena K.; Aris-Brosou, Stephane; Pelletier, Philip; Poulain, Alexandre J.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Aris-Brosou, Stephane] Univ Ottawa, Dept Math & Stat, Ottawa, ON, Canada; [Chetelat, John] Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada; [Hintelmann, Holger] Trent Univ, Dept Chem, Peterborough, ON K9J 7B8, Canada	University of Ottawa; University of Ottawa; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; Trent University	Poulain, AJ (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	apoulain@uottawa.ca	Hintelmann, Holger/AEV-0466-2022; Chételat, John/AAE-4711-2020	Hintelmann, Holger/0000-0002-5287-483X; Chételat, John/0000-0002-9380-7203; Stoeva, Magdalena/0000-0002-6974-6009; Aris-Brosou, Stephane/0000-0003-4987-0296; Poulain, Alexandre/0000-0002-0488-3993	NSERC; Northern Contaminants Program (Aboriginal Affairs and Northern Development Canada)	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Northern Contaminants Program (Aboriginal Affairs and Northern Development Canada)	This project was supported by Discovery Grants from NSERC and infrastructure support from CFI to AJP and SAB, as well as funding from the Northern Contaminants Program (Aboriginal Affairs and Northern Development Canada) awarded to JC and AJP. The Polar Shelf Continental Project provided logistical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Biddle JF, 2012, ISME J, V6, P1018, DOI 10.1038/ismej.2011.164; Borrel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043346; Castro H, 2004, APPL ENVIRON MICROB, V70, P6559, DOI 10.1128/AEM.70.11.6559-6568.2004; Cavicchioli R, 2006, NAT REV MICROBIOL, V4, P331, DOI 10.1038/nrmicro1390; Deison R, 2012, ENVIRON SCI TECHNOL, V46, P8748, DOI 10.1021/es300798w; DEMARCH L, 1978, J FISH RES BOARD CAN, V35, P1089, DOI 10.1139/f78-172; Drevnick PE, 2010, ENVIRON SCI TECHNOL, V44, P8415, DOI 10.1021/es101991p; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Freitag TE, 2010, FEMS MICROBIOL ECOL, V73, P157, DOI 10.1111/j.1574-6941.2010.00871.x; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gallon C, 2008, J N AM BENTHOL SOC, V27, P570, DOI 10.1899/07-132.1; Gentzel T, 2012, INLAND WATERS, V2, P77, DOI 10.5268/IW-2.2.416; Gilmour CC, 2013, ENVIRON SCI TECHNOL, V47, P11810, DOI 10.1021/es403075t; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Hales BA, 1996, APPL ENVIRON MICROB, V62, P668, DOI 10.1128/AEM.62.2.668-675.1996; Hallam SJ, 2003, APPL ENVIRON MICROB, V69, P5483, DOI 10.1128/AEM.69.9.5483-5491.2003; Hamelin S, 2011, ENVIRON SCI TECHNOL, V45, P7693, DOI 10.1021/es2010072; Hansen AA, 2007, ENVIRON MICROBIOL, V9, P2870, DOI 10.1111/j.1462-2920.2007.01403.x; Hirsch PR, 2010, SOIL BIOL BIOCHEM, V42, P878, DOI 10.1016/j.soilbio.2010.02.019; Hoj L, 2005, FEMS MICROBIOL ECOL, V53, P89, DOI 10.1016/j.femsec.2005.01.004; Hsu-Kim H, 2013, ENVIRON SCI TECHNOL, V47, P2441, DOI 10.1021/es304370g; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hurt RA, 2001, APPL ENVIRON MICROB, V67, P4495, DOI 10.1128/AEM.67.10.4495-4503.2001; Jorgenson MT, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024960; KALFF J, 1974, J FISH RES BOARD CAN, V31, P621, DOI 10.1139/f74-094; Kirk JL, 2011, ENVIRON SCI TECHNOL, V45, P964, DOI 10.1021/es102840u; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Kotsyurbenko OR, 2004, ENVIRON MICROBIOL, V6, P1159, DOI 10.1111/j.1462-2920.2004.00634.x; Labrenz M, 2004, APPL ENVIRON MICROB, V70, P4971, DOI 10.1128/AEM.70.8.4971-4979.2004; Lauro FM, 2011, ISME J, V5, P879, DOI 10.1038/ismej.2010.185; Lehours AC, 2007, APPL ENVIRON MICROB, V73, P2016, DOI 10.1128/AEM.01490-06; Liebner S, 2008, INT MICROBIOL, V11, P195, DOI 10.2436/20.1501.01.60; Loseto LL, 2004, ENVIRON TOXICOL CHEM, V23, P17, DOI 10.1897/02-644; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Luton PE, 2002, MICROBIOL-SGM, V148, P3521, DOI 10.1099/00221287-148-11-3521; Macdonald RW, 2005, SCI TOTAL ENVIRON, V342, P5, DOI 10.1016/j.scitotenv.2004.12.059; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; Michelutti N, 2003, GLOBAL PLANET CHANGE, V38, P257, DOI 10.1016/S0921-8181(02)00260-6; Nakagawa F, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2000GB001384; OREMLAND RS, 1991, APPL ENVIRON MICROB, V57, P130, DOI 10.1128/AEM.57.1.130-137.1991; Parks JM, 2013, SCIENCE, V339, P1332, DOI 10.1126/science.1230667; Pfaffl MW, 2001, BIOTECHNOL LETT, V23, P275, DOI 10.1023/A:1005658330108; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Purdy KJ, 2003, APPL ENVIRON MICROB, V69, P3181, DOI 10.1128/AEM.69.6.3181-3191.2003; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; SCHINDLE.DW, 1974, J FISH RES BOARD CAN, V31, P585, DOI 10.1139/f74-092; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Smith SL, 2012, CAN J EARTH SCI, V49, P914, DOI 10.1139/E2012-019; Smol JP, 2005, P NATL ACAD SCI USA, V102, P4397, DOI 10.1073/pnas.0500245102; Stibal M, 2012, GLOBAL CHANGE BIOL, V18, P3332, DOI 10.1111/j.1365-2486.2012.02763.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Wilhelm RC, 2011, CAN J MICROBIOL, V57, P303, DOI [10.1139/W11-004, 10.1139/w11-004]; Woo MK, 2003, WETLANDS, V23, P291, DOI 10.1672/8-20; Yavitt JB, 2012, BIOGEOCHEMISTRY, V109, P117, DOI 10.1007/s10533-011-9644-5; Young KL, 2011, WETLANDS, V31, P535, DOI 10.1007/s13157-011-0172-9; Young KL, 2003, PERMAFROST, VOLS 1 AND 2, P1265; Zemanick ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015101; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	69	21	26	6	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89531	10.1371/journal.pone.0089531	http://dx.doi.org/10.1371/journal.pone.0089531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594936	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900022
J	Ulak, M; Chandyo, RK; Adhikari, RK; Sharma, PR; Sommerfelt, H; Refsum, H; Strand, TA				Ulak, Manjeswori; Chandyo, Ram K.; Adhikari, Ramesh K.; Sharma, Pushpa R.; Sommerfelt, Halvor; Refsum, Helga; Strand, Tor A.			Cobalamin and Folate Status in 6 to 35 Months Old Children Presenting with Acute Diarrhea in Bhaktapur, Nepal	PLOS ONE			English	Article							METHYLMALONIC ACID LEVELS; TOTAL HOMOCYSTEINE; MICROBIOLOGICAL ASSAY; FOLIC-ACID; YOUNG-CHILDREN; SERUM; VITAMIN-B-12; DEFICIENCY; INFANTS; PLASMA	Background: Cobalamin and folate are essential micronutrients and are important in DNA and RNA synthesis, cell proliferation, growth, hematopoiesis, and cognitive function. However, data on cobalamin and folate status are lacking particularly from young children residing in low and middle income countries. Objective: To measure cobalamin and folate status and identifies their predictors among 6 to 35 months old children presenting with acute diarrhea. Design: This was a cross-sectional study in 823 children presenting with acute diarrhea. We measured plasma cobalamin, folate, methylmalonic acid and total homocysteine who sought treatment for acute diarrhea between June 1998 and August 2000. Results: The mean (SD) plasma concentrations of cobalamin, folate, total homocysteine and methylmalonic acid were 206 (124) pmol/L, 55 (32) nmol/L, 11.4 (5.6) mu mol/L and 0.79 (1.2) mmol/L, respectively. The prevalence of low plasma cobalamin (<150 pmol/L) was 41% but less than 2% (15) children had low folate concentration (<10 mu mol/L). Plasma homocysteine and methylmalonic acid concentrations were negatively associated with cobalamin concentration but not associated with folate status. The prevalence of cobalamin deficiency was higher in breastfed than non-breastfed children (44% vs 24%; p =<0.001). The prevalence of hyperhomocysteinemia (> 10 mu mol/L) and elevated methylmalonic acid (>0.28 mu mol/L) were 73% and 52%, respectively. In the regression analyses, the plasma cobalamin concentration was positively associated with age, and introduction of animal or formula milk. Conclusions: Our study indicated that poor cobalamin status was common particularly among breastfed children. Folate deficiency was virtually none existent. Possible consequences of cobalamin deficiency in young children need to be explored.	[Ulak, Manjeswori; Chandyo, Ram K.; Sommerfelt, Halvor; Strand, Tor A.] Univ Bergen, Ctr Int Hlth, N-5020 Bergen, Norway; [Ulak, Manjeswori] Inst Med, Dept Child Hlth, Kathmandu, Nepal; [Adhikari, Ramesh K.; Sharma, Pushpa R.] Kathmandu Med Coll, Dept Pediat, Kathmandu, Nepal; [Chandyo, Ram K.] Kathmandu Med Coll, Community Med, Kathmandu, Nepal; [Refsum, Helga] Univ Oslo, Inst Basic Med Sci, Dept Nutr, N-0316 Oslo, Norway; [Strand, Tor A.] Innlandet Hosp Trust, Lillehammer, Norway	University of Bergen; University of Oslo; Innlandet Hospital Trust	Ulak, M (corresponding author), Univ Bergen, Ctr Int Hlth, N-5020 Bergen, Norway.	manjeswori@gmail.com	Refsum, Helga/A-4073-2010; Strand, Tor/D-9836-2016; Sommerfelt, Halvor/ABD-3552-2020	Strand, Tor/0000-0002-4038-151X; Sommerfelt, Halvor/0000-0002-5670-9786	EU-INCO-DC [IC18-CT96-0045]; NUFU [PRO 52-53/96]	EU-INCO-DC; NUFU	The study was funded by EU-INCO-DC (contract number IC18-CT96-0045: "Effect of zinc and vitamin A supplementation on diarrhoea and physical growth in children" and NUFU (project number PRO 52-53/96: "Institutional capacity and competence building in research and education for promotion of child health and nutrition in South Asia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 2005, AM J CLIN NUTR, V81, p1206S; ALLEN LH, 1994, CLIN OBSTET GYNECOL, V37, P587, DOI 10.1097/00003081-199409000-00011; Allen LH, 2008, FOOD NUTR BULL, V29, pS20, DOI 10.1177/15648265080292S105; [Anonymous], 2012, SERUM RED BLOOD CELL; BAKER H, 1981, AM J OBSTET GYNECOL, V141, P792, DOI 10.1016/0002-9378(81)90706-7; Bjorke-Monsen AL, 2011, J INHERIT METAB DIS, V34, P111, DOI 10.1007/s10545-010-9119-1; Bondevik GT, 2001, EUR J CLIN NUTR, V55, P856, DOI 10.1038/sj.ejcn.1601236; Bostom AG, 1999, J AM SOC NEPHROL, V10, P164; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Chandra J, 2010, INDIAN J PEDIATR, V77, P795, DOI 10.1007/s12098-010-0121-2; Chandyo RK, 2002, COBALAMIN FOLATE STA; Clarke R, 2004, AGE AGEING, V33, P34, DOI 10.1093/ageing/afg109; dataset] National Institute of Statistics (NIS), 2011, POPULATION HOUSING C; DAVIS RE, 1986, ACTA PAEDIATR SCAND, V75, P402, DOI 10.1111/j.1651-2227.1986.tb10221.x; De Onis M, 2006, WHO CHILD GROWTH STA; Hannisdal R, 2010, J NUTR, V140, P522, DOI 10.3945/jn.109.116418; Hay G, 2008, AM J CLIN NUTR, V88, P105, DOI 10.1093/ajcn/88.1.105; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; HUSEK P, 1995, J CHROMATOGR B, V669, P352; IOM, 1998, DIET REF INT THIAM R; Jiang TN, 2005, J NUTR, V135, P1106, DOI 10.1093/jn/135.5.1106; Karademir F, 2007, J INT MED RES, V35, P384, DOI 10.1177/147323000703500313; KELLEHER BP, 1987, CLIN CHEM, V33, P52; Klee GG, 2000, CLIN CHEM, V46, P1277; LINDENBAUM J, 1990, AM J HEMATOL, V34, P99, DOI 10.1002/ajh.2830340205; Mackey AD, 1999, AM J CLIN NUTR, V69, P285; Ministry of Health and Population (MOHP) [Nepali] New ERA ICF International Inc., 2012, NEP DEM HLTH SURV 20; Molloy AM, 1997, METHOD ENZYMOL, V281, P43; Monsen ALB, 2003, AM J CLIN NUTR, V78, P7, DOI 10.1093/ajcn/78.1.7; Murphy SP, 2003, J NUTR, V133, p3932S, DOI 10.1093/jn/133.11.3932S; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Olivares JL, 2002, J AM COLL NUTR, V21, P109, DOI 10.1080/07315724.2002.10719202; Rimestad A. H., 2001, STORE MATVARETABELLE; SCOTT JM, 1981, LANCET, V2, P337; SHIPCHANDLER MT, 1995, CLIN CHEM, V41, P991; Snow CF, 1999, ARCH INTERN MED, V159, P1289, DOI 10.1001/archinte.159.12.1289; SPECKER BL, 1990, AM J CLIN NUTR, V52, P1073, DOI 10.1093/ajcn/52.6.1073; Strand TA, 2002, PEDIATRICS, V109, P898, DOI 10.1542/peds.109.5.898; TaneJa S, 2007, AM J CLIN NUTR, V86, P1302, DOI 10.1093/ajcn/86.5.1302; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; UELAND PM, 1993, CLIN CHEM, V39, P1764; Ulak M, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-1; USAID/INACG, 2002, ADJ HEM VAL PROGR SU; Vollset SE, 2000, AM J CLIN NUTR, V71, P962; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Yajnik CS, 2005, ASIA PAC J CLIN NUTR, V14, P179	46	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90079	10.1371/journal.pone.0090079	http://dx.doi.org/10.1371/journal.pone.0090079			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594935	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900066
J	Vendramin, E; Pea, G; Dondini, L; Pacheco, I; Dettori, MT; Gazza, L; Scalabrin, S; Strozzi, F; Tartarini, S; Bassi, D; Verde, I; Rossini, L				Vendramin, Elisa; Pea, Giorgio; Dondini, Luca; Pacheco, Igor; Dettori, Maria Teresa; Gazza, Laura; Scalabrin, Simone; Strozzi, Francesco; Tartarini, Stefano; Bassi, Daniele; Verde, Ignazio; Rossini, Laura			A Unique Mutation in a MYB Gene Cosegregates with the Nectarine Phenotype in Peach	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; MOLECULAR CHARACTERIZATION; TRANSPOSON INSERTION; TRICHOME DEVELOPMENT; IDENTIFIES GENES; READ ALIGNMENT; CANDIDATE GENE; CELL-TYPES; ARABIDOPSIS; EXPRESSION	Nectarines play a key role in peach industry; the fuzzless skin has implications for consumer acceptance. The peach/nectarine (G/g) trait was described as monogenic and previously mapped on chromosome 5. Here, the position of the G locus was delimited within a 1.1 cM interval (635 kb) based on linkage analysis of an F-2 progeny from the cross 'Contender' (C, peach) x 'Ambra' (A, nectarine). Careful inspection of the genes annotated in the corresponding genomic sequence (Peach v1.0), coupled with variant discovery, led to the identification of MYB gene PpeMYB25 as a candidate for trichome formation on fruit skin. Analysis of genomic re-sequencing data from five peach/nectarine accessions pointed to the insertion of a LTR retroelement in exon 3 of the PpeMYB25 gene as the cause of the recessive glabrous phenotype. A functional marker (indelG) developed on the LTR insertion cosegregated with the trait in the CxA F-2 progeny and was validated on a broad panel of genotypes, including all known putative donors of the nectarine trait. This marker was shown to efficiently discriminate between peach and nectarine plants, indicating that a unique mutational event gave rise to the nectarine trait and providing a useful diagnostic tool for early seedling selection in peach breeding programs.	[Vendramin, Elisa; Dettori, Maria Teresa; Gazza, Laura; Verde, Ignazio] Ctr Ric Frutticoltura CRA FRU, Consiglio Ric Sperimentaz Agr, Rome, Italy; [Pea, Giorgio; Strozzi, Francesco; Rossini, Laura] Parco Tecnol Padano, Lodi, Italy; [Dondini, Luca; Tartarini, Stefano] Univ Bologna, DipSA, Bologna, Italy; [Pacheco, Igor; Bassi, Daniele; Rossini, Laura] Univ Milan, DiSAA, Milan, Italy; [Scalabrin, Simone] IGA Technol Serv, Udine, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Bologna; University of Milan	Verde, I (corresponding author), Ctr Ric Frutticoltura CRA FRU, Consiglio Ric Sperimentaz Agr, Rome, Italy.	ignazio.verde@entecra.it; laura.rossini@unimi.it	gazza, laura/K-3927-2019; Rossini, Laura/J-7873-2012; Cruz, Igor Pacheco/J-1193-2019; Verde, Ignazio/K-6348-2019; Cruz, Igor Pacheco/A-8507-2015; Dondini, Luca/N-8797-2015; Bassi, Daniele/C-2952-2012; Vendramin, Elisa/AAI-8762-2020; Gazza, Laura/X-3266-2019	gazza, laura/0000-0003-2772-3199; Rossini, Laura/0000-0001-6509-9177; Cruz, Igor Pacheco/0000-0001-5057-0464; Cruz, Igor Pacheco/0000-0001-5057-0464; Dondini, Luca/0000-0002-3547-9731; Gazza, Laura/0000-0003-2772-3199; TARTARINI, STEFANO/0000-0002-3920-5658; Strozzi, Francesco/0000-0002-6845-6982; Vendramin, Elisa/0000-0002-7324-7237; Verde, Ignazio/0000-0002-9139-955X; Dettori, Maria Teresa/0000-0003-0528-2855; Bassi, Daniele/0000-0002-8966-3534	Ministero delle Politiche Agricole Alimentari e Forestali-Italy (MiPAAF) [DM14999/7303/08]; private and public agencies "MAS.PES: apricot and peach breeding by molecular-assisted selection"	Ministero delle Politiche Agricole Alimentari e Forestali-Italy (MiPAAF); private and public agencies "MAS.PES: apricot and peach breeding by molecular-assisted selection"	This work was supported by the Ministero delle Politiche Agricole Alimentari e Forestali-Italy (MiPAAF www.politicheagricole.it) through the project 'DRUPOMICS' (grant DM14999/7303/08) and by an Italian grant to DB funded by private and public agencies "MAS.PES: apricot and peach breeding by molecular-assisted selection". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami M, 2013, PLANT MOL BIOL REP, V31, P1166, DOI 10.1007/s11105-013-0628-6; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BHATTACHARYYA MK, 1990, CELL, V60, P115, DOI 10.1016/0092-8674(90)90721-P; BLAKE M. A., 1932, Proceedings. American Society for Horticultural Science, V29, P131; Botton A, 2006, PLANT SCI, V171, P106, DOI 10.1016/j.plantsci.2006.02.016; Cadle-Davidson MM, 2008, THEOR APPL GENET, V116, P1079, DOI 10.1007/s00122-008-0737-z; Creller MA, 1996, J AM SOC HORTIC SCI, V121, P198, DOI 10.21273/JASHS.121.2.198; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dirlewanger E, 2007, TREE GENET GENOMES, V3, P1, DOI 10.1007/s11295-006-0053-1; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Eduardo I, 2011, TREE GENET GENOMES, V7, P323, DOI 10.1007/s11295-010-0334-6; Esau K., 1977, Anatomy of seed plants.; Falchi R, 2013, PLANT J, V76, P175, DOI 10.1111/tpj.12283; Faust M, 1995, HORTTICULTURAL REV, V17; Fernandez V, 2011, PLANT PHYSIOL, V156, P2098, DOI 10.1104/pp.111.176305; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Glover BJ, 1998, DEVELOPMENT, V125, P3497; Harada E, 2010, PLANT CELL PHYSIOL, V51, P1627, DOI 10.1093/pcp/pcq118; Hauser MT, 2001, MOL BIOL EVOL, V18, P1754, DOI 10.1093/oxfordjournals.molbev.a003963; Hesse CO, 1975, ADV FRUIT BREEDING; Hulskamp M, 2004, NAT REV MOL CELL BIO, V5, P471, DOI 10.1038/nrm1404; Iijima Y, 2004, PLANT PHYSIOL, V136, P3724, DOI 10.1104/pp.104.051318; Jaffe FW, 2007, J EXP BOT, V58, P1515, DOI 10.1093/jxb/erm020; Jakoby MJ, 2008, PLANT PHYSIOL, V148, P1583, DOI 10.1104/pp.108.126979; Jeffree CE, 2006, ANNU PLANT REV, V23, P11; Jia L, 2004, PLANT PHYSIOL, V134, P575, DOI 10.1104/pp.103.027201; Aranzana MJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-69; Jurinke C, 2002, USE MASSARRAY TECHNO; Kawase M, 2005, MOL GENET GENOMICS, V274, P131, DOI 10.1007/s00438-005-0013-8; Kirik V, 2004, PLANT MOL BIOL, V55, P389, DOI 10.1007/s11103-004-0893-8; Kivimaki M, 2007, MOL ECOL, V16, P453, DOI 10.1111/j.1365-294X.2007.03109.x; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kumar A, 1996, TRENDS GENET, V12, P41, DOI 10.1016/0168-9525(96)81393-X; Lange BM, 2000, P NATL ACAD SCI USA, V97, P2934, DOI 10.1073/pnas.97.6.2934; Le Dantec L, 2010, TREE GENET GENOMES, V6, P995, DOI 10.1007/s11295-010-0308-8; Lee JJ, 2006, PLANTA, V223, P418, DOI 10.1007/s00425-005-0098-7; Li F, 2013, THEOR APPL GENET, V126, P1227, DOI 10.1007/s00122-013-2049-1; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lopez-Molina L, 2003, GENE DEV, V17, P410, DOI 10.1101/gad.1055803; Machado A, 2009, PLANT J, V59, P52, DOI 10.1111/j.1365-313X.2009.03847.x; Marchese A, 2005, J HORTIC SCI BIOTECH, V80, P121, DOI 10.1080/14620316.2005.11511902; Martin C, 2002, PHILOS T ROY SOC B, V357, P809, DOI 10.1098/rstb.2002.1089; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; NODA K, 1994, NATURE, V369, P661, DOI 10.1038/369661a0; Okie W.R., 1998, HDB PEACH NECTARINE; Okie WR, 2008, FRESH MARKET CULTIVA; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; Pastorello EA, 2011, INT ARCH ALLERGY IMM, V156, P362, DOI 10.1159/000324440; Payne CT, 2000, GENETICS, V156, P1349; Perez-Rodriguez M, 2005, DEVELOPMENT, V132, P359, DOI 10.1242/dev.01584; Pirona R, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-166; Rosinski JA, 1998, J MOL EVOL, V46, P74, DOI 10.1007/PL00006285; Schellmann S, 2002, EMBO J, V21, P5036, DOI 10.1093/emboj/cdf524; Shimazaki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021308; Stavrianakou S, 2010, PLANT STRESS, V4, P25; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Studer A, 2011, NAT GENET, V43, P1160, DOI 10.1038/ng.942; Tian JB, 2012, ACTA HORTIC, V962, P97, DOI 10.17660/ActaHortic.2012.962.12; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Uphof J.C.T., 1962, ENCYCL PLANT ANAT, V5, P1; Van Ooijen JW, 2002, JOINMAP 3 0 SOFTWARE; Venuto A, 1516, AGR OPUSCULUM; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Wang GD, 2008, PLANT PHYSIOL, V148, P1254, DOI 10.1104/pp.108.125187; Wang SC, 2008, PLANT CELL PHYSIOL, V49, P1792, DOI 10.1093/pcp/pcn159; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Wilkins TA, 2000, CRIT REV PLANT SCI, V19, P511, DOI 10.1016/S0735-2689(01)80007-1; Wu YR, 2006, PLANT CELL PHYSIOL, V47, P107, DOI 10.1093/pcp/pci228; Xia Y, 2010, PLANT PHYSIOL, V154, P833, DOI 10.1104/pp.110.161646; Yao JL, 2001, P NATL ACAD SCI USA, V98, P1306, DOI 10.1073/pnas.031502498; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yoon JH, 2006, J AM SOC HORTIC SCI, V131, P513, DOI 10.21273/JASHS.131.4.513; Yoshida M, 1994, PEACH, P32; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhang LC, 2012, J EXP BOT, V63, P203, DOI 10.1093/jxb/err264	86	62	68	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90574	10.1371/journal.pone.0090574	http://dx.doi.org/10.1371/journal.pone.0090574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595269	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900118
J	Zeng, Q; Dong, SY; Wang, ML; Xiang, H; Zhao, XL				Zeng, Qiang; Dong, Sheng-Yong; Wang, Man-Liu; Xiang, Hang; Zhao, Xiao-Lan			Association of EZSCAN Values with Arterial Stiffness in Individuals without Diabetes or Cardiovascular Disease	PLOS ONE			English	Article							ANKLE-BRACHIAL INDEX; SYMPATHETIC-NERVOUS-SYSTEM; CHRONIC KIDNEY-DISEASE; PULSE-WAVE VELOCITY; ALL-CAUSE MORTALITY; METABOLIC SYNDROME; AORTIC STIFFNESS; HEART-FAILURE; HYPERTENSION; EVENTS	Background: The EZSCAN test was recently developed to screen for early dysglycemia through an assessment of sudomotor function. Given the associations of dysglycemia and autonomic dysfunction with the development of arterial stiffness, EZSCAN may also detect early arterial stiffness. The aim of this study was to investigate the association of EZSCAN with arterial stiffness across blood glucose levels. Methodology and Principal Findings: A total of 5532 participants without diabetes or established cardiovascular disease were evaluated with EZSCAN. Their central systolic blood pressure (cSBP), brachial-ankle pulse wave velocity (baPWV), and ankle-brachial index (ABI) were also measured. Multivariate linear regression analyses were used to assess the association between the EZSCAN value and the cSBP, baPWV, and ABI measurements in all of the participants, with additional subgroup analysis that separated participants into a normal glucose tolerance (NGT) group and an impaired glucose regulation (IGR) group. The frequency of the IGRs increased with quartiles of the EZSCAN value (P for trend <0.0001). The levels of cSBP and baPWV increased while the levels of ABI decreased across quartiles of EZSCAN value in both NGT and IGR individuals (P for trend <0.0001 for all). In multivariable analyses, the EZSCAN value was positively associated with cSBP (log-transformed beta = 8.20, P<0.0001) and baPWV (log-transformed beta = 1.82, P<0.0001) but inversely associated with ABI (log-transformed beta = -0.043, P<0.0001) and was independent of conventional factors. Further adjustment for fasting and postprandial glucoses did not attenuate the associations. The results were also unchanged when stratified by IGR. Conclusions and Significance: The EZSCAN results were associated with arterial stiffness independent of conventional factors, blood glucose levels, and glucose tolerance status, suggesting a probable link between the EZSCAN value and arterial stiffness through autonomic dysfunction. The EZSCAN test may help us detect the development of arterial stiffness in high risk individuals to prevent unfavorable cardiovascular events.	[Zeng, Qiang; Dong, Sheng-Yong; Xiang, Hang] Chinese Peoples Liberat Army Gen Hosp, Int Med Ctr, Beijing, Peoples R China; [Wang, Man-Liu] Tsinghua Univ, Ctr Biomed Anal, Beijing 100084, Peoples R China; [Zhao, Xiao-Lan] Third Mil Med Univ, Southwest Hosp, Chongqing, Peoples R China	Chinese People's Liberation Army General Hospital; Tsinghua University; Army Medical University	Zeng, Q (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Int Med Ctr, Beijing, Peoples R China.	zq301@hotmail.com; 1021211982@qq.com	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Dong, Sheng-Yong/0000-0002-8395-4269	State Science and Technology Support Program [2012BAI37B04]; Military Eleventh Five Year Health Promotion Program [10BIZ18]	State Science and Technology Support Program; Military Eleventh Five Year Health Promotion Program	This study was supported by the State Science and Technology Support Program (No. 2012BAI37B04) and the Military Eleventh Five Year Health Promotion Program (No. 10BIZ18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bruno RM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00284; Bruno RM, 2011, HYPERTENSION, V57, P79, DOI 10.1161/HYPERTENSIONAHA.110.163584; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Chen LZ, 2013, DIABETES RES CLIN PR, V100, P210, DOI 10.1016/j.diabres.2013.03.001; Fink GD, 2009, HYPERTENSION, V53, P307, DOI 10.1161/HYPERTENSIONAHA.108.119990; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Gamboa A, 2012, AM J PHYSIOL-HEART C, V302, pH1438, DOI 10.1152/ajpheart.01020.2011; Ix JH, 2010, J AM COLL CARDIOL, V55, P342, DOI 10.1016/j.jacc.2009.11.010; Kaess BM, 2012, JAMA-J AM MED ASSOC, V308, P875, DOI 10.1001/2012.jama.10503; Kang S, 2010, EUR HEART J, V31, P2799, DOI 10.1093/eurheartj/ehq296; Korosoglou G, 2012, J AM COLL CARDIOL, V60, P167, DOI 10.1016/j.jacc.2012.02.056; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Licht CMM, 2013, J CLIN ENDOCR METAB, V98, P2484, DOI 10.1210/jc.2012-3104; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mayaudon H, 2010, DIABETES METAB, V36, P450, DOI 10.1016/j.diabet.2010.05.004; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Napoli C, 2012, CIRCULATION, V125, P2363, DOI 10.1161/CIRCULATIONAHA.111.085787; Neumann J, 2004, KIDNEY INT, V65, P1568, DOI 10.1111/j.1523-1755.2004.00552.x; Nilsson PM, 2014, BLOOD PRESSURE, V23, P17, DOI 10.3109/08037051.2013.796142; O'Rourke MF, 2005, CURR OPIN CARDIOL, V20, P275, DOI 10.1097/01.hco.0000166595.44711.6f; Okada Y, 2012, HYPERTENSION, V59, P98, DOI 10.1161/HYPERTENSIONAHA.111.176560; Parati G, 2012, EUR HEART J, V33, P1058, DOI 10.1093/eurheartj/ehs041; Ramachandran A, 2010, DIABETES RES CLIN PR, V88, P302, DOI 10.1016/j.diabres.2010.01.023; Sheng CS, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-36; Sun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043449; Swierblewska E, 2010, J HYPERTENS, V28, P979, DOI 10.1097/HJH.0b013e328336ed9a; Tentolouris N, 2008, NEUROMOL MED, V10, P169, DOI 10.1007/s12017-008-8022-5; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Theilade S, 2013, DIABETES CARE, V36, P715, DOI 10.2337/dc12-0850; Tomiyama H, 2010, J AM COLL CARDIOL, V55, P1979, DOI 10.1016/j.jacc.2009.12.042; Vlachopoulos C, 2012, HYPERTENSION, V60, P556, DOI 10.1161/HYPERTENSIONAHA.112.194779; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Webb DR, 2010, DIABETOLOGIA, V53, P1190, DOI 10.1007/s00125-010-1689-9; Yang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056480; Zeng Q, 2008, CLIN EXP PHARMACOL P, V35, P78, DOI 10.1111/j.1440-1681.2007.04749.x; Zeng Q, 2013, INT J CARDIOL, V167, P2311, DOI 10.1016/j.ijcard.2012.06.022; Zeng Q, 2012, BRAZ J MED BIOL RES, V45, P591, DOI 10.1590/S0100-879X2012007500059	39	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90854	10.1371/journal.pone.0090854	http://dx.doi.org/10.1371/journal.pone.0090854			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595279	Green Submitted, gold, Green Published			2022-12-25	WOS:000332468900152
J	Romero, MD; Roy, S; Pouillot, K; Feito, M; Esteve, M; Grasa, MD; Fernandez-Lopez, JA; Alemany, M; Remesar, X				del Mar Romero, Maria; Roy, Stephanie; Pouillot, Karl; Feito, Marisol; Esteve, Montserrat; del Mar Grasa, Maria; Fernandez-Lopez, Jose-Antonio; Alemany, Maria; Remesar, Xavier			Treatment of Rats with a Self-Selected Hyperlipidic Diet, Increases the Lipid Content of the Main Adipose Tissue Sites in a Proportion Similar to That of the Lipids in the Rest of Organs and Tissues	PLOS ONE			English	Article							ORAL OLEOYL-ESTRONE; OVERWEIGHT MALE RATS; ZUCKER OBESE RATS; WISTAR RATS; BODY-COMPOSITION; SKELETAL-MUSCLE; CAFETERIA DIET; ADIPOCYTES; FAT; ACCUMULATION	Adipose tissue (AT) is distributed as large differentiated masses, and smaller depots covering vessels, and organs, as well as interspersed within them. The differences between types and size of cells makes AT one of the most disperse and complex organs. Lipid storage is partly shared by other tissues such as muscle and liver. We intended to obtain an approximate estimation of the size of lipid reserves stored outside the main fat depots. Both male and female rats were made overweight by 4-weeks feeding of a cafeteria diet. Total lipid content was analyzed in brain, liver, gastrocnemius muscle, four white AT sites: subcutaneous, perigonadal, retroperitoneal and mesenteric, two brown AT sites (interscapular and perirenal) and in a pool of the rest of organs and tissues (after discarding gut contents). Organ lipid content was estimated and tabulated for each individual rat. Food intake was measured daily. There was a surprisingly high proportion of lipid not accounted for by the main macroscopic AT sites, even when brain, liver and BAT main sites were discounted. Muscle contained about 8% of body lipids, liver 1-1.4%, four white AT sites lipid 28-63% of body lipid, and the rest of the body (including muscle) 38-44%. There was a good correlation between AT lipid and body lipid, but lipid in "other organs" was highly correlated too with body lipid. Brain lipid was not. Irrespective of dietary intake, accumulation of body fat was uniform both for the main lipid storage and handling organs: large masses of AT (but also liver, muscle), as well as in the "rest" of tissues. These storage sites, in specialized (adipose) or not-specialized (liver, muscle) tissues reacted in parallel against a hyperlipidic diet challenge. We postulate that body lipid stores are handled and regulated coordinately, with a more centralized and overall mechanisms than usually assumed.	[del Mar Romero, Maria; Roy, Stephanie; Pouillot, Karl; Feito, Marisol; Esteve, Montserrat; del Mar Grasa, Maria; Fernandez-Lopez, Jose-Antonio; Alemany, Maria; Remesar, Xavier] Univ Barcelona, Fac Biol, Dept Nutr & Food Sci, Barcelona, Spain; [del Mar Romero, Maria; Esteve, Montserrat; del Mar Grasa, Maria; Fernandez-Lopez, Jose-Antonio; Alemany, Maria; Remesar, Xavier] Univ Barcelona, Inst Biomed, Barcelona, Spain; [del Mar Romero, Maria; Esteve, Montserrat; del Mar Grasa, Maria; Fernandez-Lopez, Jose-Antonio; Alemany, Maria; Remesar, Xavier] Inst Hlth Carlos III, CIBER Ctr Invest Biomed Red OBN Obesidad & Nutr, Madrid, Spain	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Remesar, X (corresponding author), Univ Barcelona, Fac Biol, Dept Nutr & Food Sci, Barcelona, Spain.	xremesar@ub.edu	López, José Antonio Fernández/C-5467-2017; Esteve, Montserrat/AAR-4146-2021; del Mar Romero, Maria/K-9004-2017; Remesar, Xavier/G-5703-2013; Alemany, Marià/H-5224-2011; Remesar, Xavier/L-4555-2019; Grasa Martínez, Maria del Mar/L-8031-2014; Esteve, Montserrat/L-6272-2014	López, José Antonio Fernández/0000-0002-2856-7223; Esteve, Montserrat/0000-0003-2128-7859; del Mar Romero, Maria/0000-0001-6274-5743; Remesar, Xavier/0000-0002-9707-7287; Alemany, Marià/0000-0002-9783-8293; Remesar, Xavier/0000-0002-9707-7287; Grasa Martínez, Maria del Mar/0000-0001-6362-0504; Esteve, Montserrat/0000-0003-2128-7859; Roy, Stephanie/0000-0002-5943-7106	Plan Nacional de Investigacion en Biomedicina [SAF2012-34895]; Plan Nacional de Ciencia y Tecnologia de los Alimentos of the Government of Spain [AGL-2011-23635]; CIBER-OBN (Institute of Health Carlos III, Spain)	Plan Nacional de Investigacion en Biomedicina; Plan Nacional de Ciencia y Tecnologia de los Alimentos of the Government of Spain; CIBER-OBN (Institute of Health Carlos III, Spain)	This study was funded by grants of the Plan Nacional de Investigacion en Biomedicina (SAF2012-34895) and the Plan Nacional de Ciencia y Tecnologia de los Alimentos (AGL-2011-23635) of the Government of Spain. CIBER-OBN (Institute of Health Carlos III, Spain) supported the salary of M.M. Romero. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2006, DIABETOLOGIA, V49, P755, DOI 10.1007/s00125-005-0125-z; Alemany M, 2006, CURR NUTR FOOD SCI, V2, P141, DOI 10.2174/157340106776818817; AROLA L, 1979, REV ESP FISIOL, V35, P215; Boettcher M, 2009, J MAGN RESON IMAGING, V29, P1340, DOI 10.1002/jmri.21754; Cabot C, 2012, J ENDOCRINOL METAB, V2, P21, DOI 10.4021/jem63w; Cinti S, 2001, P NUTR SOC, V60, P319, DOI 10.1079/PNS200192; Coatmellec-Taglioni G, 2003, J PHARMACOL EXP THER, V305, P362, DOI 10.1124/jpet.102.045682; Comizio R, 1998, AM J PHYSIOL-ENDOC M, V274, pE860, DOI 10.1152/ajpendo.1998.274.5.E860; Romero MD, 2009, EUR J NUTR, V48, P291, DOI 10.1007/s00394-009-0013-2; DEMING QB, 1958, J EXP MED, V107, P581, DOI 10.1084/jem.107.4.581; ESTEVE M, 1992, MOL CELL BIOCHEM, V118, P67, DOI 10.1007/BF00249696; Ferrer-Lorente R, 2005, LIFE SCI, V77, P2051, DOI 10.1016/j.lfs.2005.04.008; FIELD CJ, 1990, J BIOL CHEM, V265, P11143; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foster D. O., 1986, BROWN ADIPOSE TISSUE, P31; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; Gondret F, 2008, J ANIM SCI, V86, P2115, DOI 10.2527/jas.2007-0750; Goodpaster BH, 2004, PEDIATR DIABETES, V5, P219, DOI 10.1111/j.1399-543X.2004.00071.x; Gorski J, 1999, EUR J APPL PHYSIOL O, V79, P421, DOI 10.1007/s004210050532; Grasa MD, 2001, OBES RES, V9, P202; Grasa MM, 2001, DIABETES OBES METAB, V3, P203, DOI 10.1046/j.1463-1326.2001.00143.x; HIMMSHAGEN J, 1981, AM J PHYSIOL, V241, pE116, DOI 10.1152/ajpendo.1981.241.2.E116; KRIKETOS AD, 1995, AM J PHYSIOL-REG I, V269, pR1154, DOI 10.1152/ajpregu.1995.269.5.R1154; LASZLO J, 1965, SOUTHERN MED J, V58, P1099, DOI 10.1097/00007611-196509000-00007; Llado I, 1997, BIOCHEM MOL BIOL INT, V43, P1129; Malaisse WJ, 2006, NEUROSCI LETT, V409, P75, DOI 10.1016/j.neulet.2006.09.023; Martin S, 2005, SEMIN CELL DEV BIOL, V16, P163, DOI 10.1016/j.semcdb.2005.01.007; Massanes RM, 2003, INT J OBESITY, V27, P428, DOI 10.1038/sj.ijo.0802264; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; OBRIEN JS, 1965, J LIPID RES, V6, P537; OBrien SN, 1996, ANAL QUANT CYTOL, V18, P137; REES ED, 1966, J LIPID RES, V7, P396; Remesar X, 2002, INT J OBESITY, V26, P1092, DOI 10.1038/sj.ijo.0802056; Roelofsen B, 1982, CHEM ENZYMATIC LOCAL, P1; Romero MM, 2006, INT J OBESITY, V30, P1149, DOI 10.1038/sj.ijo.0803224; SCLAFANI A, 1976, PHYSIOL BEHAV, V17, P461, DOI 10.1016/0031-9384(76)90109-8; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; van Loon LJC, 2004, P NUTR SOC, V63, P301, DOI 10.1079/PNS2004347; Wang P, 2008, J CELL PHYSIOL, V216, P3, DOI 10.1002/jcp.21386; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21	40	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90995	10.1371/journal.pone.0090995	http://dx.doi.org/10.1371/journal.pone.0090995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603584	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600121
J	Schuster, S; Penke, M; Gorski, T; Petzold-Quinque, S; Damm, G; Gebhardt, R; Kiess, W; Garten, A				Schuster, Susanne; Penke, Melanie; Gorski, Theresa; Petzold-Quinque, Stefanie; Damm, Georg; Gebhardt, Rolf; Kiess, Wieland; Garten, Antje			Resveratrol Differentially Regulates NAMPT and SIRT1 in Hepatocarcinoma Cells and Primary Human Hepatocytes	PLOS ONE			English	Article							NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; P53 ACETYLATION; TRANSCRIPTION FACTORS; NAD(+) BIOSYNTHESIS; COLORECTAL-CANCER; TUMOR-GROWTH; DNA-DAMAGE; LIFE-SPAN; APOPTOSIS; INHIBITION	Resveratrol is reported to possess chemotherapeutic properties in several cancers. In this study, we wanted to investigate the molecular mechanisms of resveratrol-induced cell cycle arrest and apoptosis as well as the impact of resveratrol on NAMPT and SIRT1 protein function and asked whether there are differences in hepatocarcinoma cells (HepG2, Hep3B cells) and non-cancerous primary human hepatocytes. We found a lower basal NAMPT mRNA and protein expression in hepatocarcinoma cells compared to primary hepatocytes. In contrast, SIRT1 was significantly higher expressed in hepatocarcinoma cells than in primary hepatocytes. Resveratrol induced cell cycle arrest in the S-and G2/M- phase and apoptosis was mediated by activation of p53 and caspase-3 in HepG2 cells. In contrast to primary hepatocytes, resveratrol treated HepG2 cells showed a reduction of NAMPT enzymatic activity and increased p53 acetylation (K382). Resveratrol induced NAMPT release from HepG2 cells which was associated with increased NAMPT mRNA expression. This effect was absent in primary hepatocytes where resveratrol was shown to function as NAMPT and SIRT1 activator. SIRT1 inhibition by EX527 resembled resveratrol effects on HepG2 cells. Furthermore, a SIRT1 overexpression significantly decreased both p53 hyperacetylation and resveratrol-induced NAMPT release as well as S-phase arrest in HepG2 cells. We could show that NAMPT and SIRT1 are differentially regulated by resveratrol in hepatocarcinoma cells and primary hepatocytes and that resveratrol did not act as a SIRT1 activator in hepatocarcinoma cells.	[Schuster, Susanne; Penke, Melanie; Gorski, Theresa; Petzold-Quinque, Stefanie; Kiess, Wieland; Garten, Antje] Univ Leipzig, Fac Med, Ctr Pediat Res Leipzig, Univ Hosp Children & Adolescents, D-04109 Leipzig, Germany; [Damm, Georg] Charite, Dept Gen Visceral & Transplantat Surg, D-13353 Berlin, Germany; [Gebhardt, Rolf] Univ Leipzig, Fac Med, Inst Biochem, D-04109 Leipzig, Germany	Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University	Schuster, S (corresponding author), Univ Leipzig, Fac Med, Ctr Pediat Res Leipzig, Univ Hosp Children & Adolescents, D-04109 Leipzig, Germany.	Susanne.Schuster@medizin.uni-leipzig.de	Damm, Georg/ABD-7372-2021	Damm, Georg/0000-0002-2104-8076; Garten, Antje/0000-0002-5354-287X; Gaul, Susanne/0000-0003-4780-1844	German Research Foundation (DFG) [KFO 152]; DDG (Deutsche Diabetes Gesellschaft); LIFE (Leipzig Research Center for Civilization Diseases, University of Leipzig ); European Union; European Regional Development Fund (ERDF); German Federal Ministry of Education and Research; German Research Foundation (DFG); Leipzig University within the program of Open Access Publishing	German Research Foundation (DFG)(German Research Foundation (DFG)); DDG (Deutsche Diabetes Gesellschaft); LIFE (Leipzig Research Center for Civilization Diseases, University of Leipzig ); European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University within the program of Open Access Publishing	The work was supported by German Research Foundation (DFG) KFO 152 "Atherobesity" (to WK), DDG (Deutsche Diabetes Gesellschaft) (to SS and AG) and by LIFE (Leipzig Research Center for Civilization Diseases, University of Leipzig ) (to WK and SS). LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative. The "virtual liver" program is funded by the German Federal Ministry of Education and Research. We also acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Baarine M, 2011, GENES NUTR, V6, P161, DOI 10.1007/s12263-011-0232-z; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Bernhard D, 2000, CELL DEATH DIFFER, V7, P834, DOI 10.1038/sj.cdd.4400719; Bi TQ, 2010, CANCER BIOL THER, V10, P119, DOI 10.4161/cbt.10.2.12581; Bishayee A, 2010, CANCER TREAT REV, V36, P43, DOI 10.1016/j.ctrv.2009.10.002; Bjorklund M, 2011, CANCER CHEMOTH PHARM, V68, P1459, DOI 10.1007/s00280-011-1640-x; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cagnetta A, 2013, BLOOD, V122, P1243, DOI 10.1182/blood-2013-02-483511; Carbo N, 1999, BIOCHEM BIOPH RES CO, V254, P739, DOI 10.1006/bbrc.1998.9916; Chen HC, 2012, ANN SURG ONCOL, V19, P2011, DOI 10.1245/s10434-011-2159-4; Chen J, 2011, CANCER RES, V71, P4138, DOI 10.1158/0008-5472.CAN-10-4274; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Chini CC, 2013, CLIN CANC RES; De L, 2001, INT J ONCOL, V19, P83; Delmas D, 2006, CURR DRUG TARGETS, V7, P423, DOI 10.2174/138945006776359331; Delmas D, 2011, CURR MED CHEM, V18, P1100, DOI 10.2174/092986711795029708; Delmas D, 2000, ONCOL REP, V7, P847; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Dixit D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.10; Drevs J, 2003, ANTICANCER RES, V23, P4853; ELLIOTT GC, 1980, ANAL BIOCHEM, V107, P199, DOI 10.1016/0003-2697(80)90512-6; Flick F, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00029; Folgueira MAAK, 2005, CLIN CANCER RES, V11, P7434; Frazzi R., 2012, INT J CANCER; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Fukuhara A, 2007, SCIENCE, V318, P565, DOI 10.1126/science.318.5850.565b; Garten A, 2010, BIOCHEM BIOPH RES CO, V391, P376, DOI 10.1016/j.bbrc.2009.11.066; Gogada R, 2011, J BIOL CHEM, V286, P28749, DOI 10.1074/jbc.M110.202440; Hasmann M, 2003, CANCER RES, V63, P7436; Ho C, 2009, FEBS LETT, V583, P3081, DOI 10.1016/j.febslet.2009.08.031; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hu Y, 2011, FREE RADICAL BIO MED, V51, P250, DOI 10.1016/j.freeradbiomed.2011.04.034; Hufton SE, 1999, FEBS LETT, V463, P77, DOI 10.1016/S0014-5793(99)01578-1; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Joe AK, 2002, CLIN CANCER RES, V8, P893; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kai L, 2010, INT J CANCER, V126, P1538, DOI 10.1002/ijc.24928; Kang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006611; Kover K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058767; Kuo PL, 2002, LIFE SCI, V72, P23, DOI 10.1016/S0024-3205(02)02177-X; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Mahyar-Roemer M, 2001, INT J CANCER, V94, P615, DOI 10.1002/ijc.1516; Muruganandham M, 2005, CLIN CANCER RES, V11, P3503, DOI 10.1158/1078-0432.CCR-04-1399; NUSSLER AK, 2009, STRATEGIES REGENERAT, P283; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Pizarro JG, 2011, NEUROCHEM RES, V36, P187, DOI 10.1007/s11064-010-0296-y; Portmann S, 2013, MOL CANCER THER, V12, P499, DOI 10.1158/1535-7163.MCT-12-0700; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2007, CURR OPIN GASTROEN, V23, P164, DOI 10.1097/MOG.0b013e32801b3c8f; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; Thakur BK, 2013, INT J CANCER, V132, P766, DOI 10.1002/ijc.27726; Thakur BK, 2012, BIOCHEM BIOPH RES CO, V424, P371, DOI 10.1016/j.bbrc.2012.06.075; van Beijnum JR, 2002, INT J CANCER, V101, P118, DOI 10.1002/ijc.10584; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Venturelli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073097; Wang HN, 2012, ONCOL REP, V28, P311, DOI 10.3892/or.2012.1788; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Whitlock NC, 2012, NUTR CANCER, V64, P493, DOI 10.1080/01635581.2012.667862; Yang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070627; Zhang C, 2011, CARDIOVASC RES, V90, P538, DOI 10.1093/cvr/cvr022; Zhang Q, 2012, EMBO MOL MED, V4, P298, DOI 10.1002/emmm.201100211; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469; Zhou R, 2009, BRIT J PHARMACOL, V158, P462, DOI 10.1111/j.1476-5381.2009.00268.x	74	32	34	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91045	10.1371/journal.pone.0091045	http://dx.doi.org/10.1371/journal.pone.0091045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603648	Green Published, gold			2022-12-25	WOS:000332483600123
J	Apollonio, M; De Cena, F; Bongi, P; Ciuti, S				Apollonio, Marco; De Cena, Fabio; Bongi, Paolo; Ciuti, Simone			Female Preference and Predation Risk Models Can Explain the Maintenance of a Fallow Deer (Dama dama) Lek and Its 'Handy' Location	PLOS ONE			English	Article							SPATIAL SEXUAL SEGREGATION; MATE RETENTION; MATING SUCCESS; LEKKING; EVOLUTION; HARASSMENT; HOTSPOTS; CHOICE; MALES; SIZE	We tested the predictions of three models (female preference; hotspot; predator avoidance) on lek formation in the fallow deer population of San Rossore, Tuscany. We collected behavioural observations in two leks and radiotracking data on 67 deer over 7 years. Two deer sub-populations were present in the northern and southern sides of the area, respectively, the two sectors being delimited by a river and including one lek each. Predictions were tested for one lek (SG), located in the south-side where we set up our 7-year radiotracking program. Data from a second lek (FO, north-side) were used to test those predictions which imply the occurrence of multiple leks in the same population. We showed that the majority of females made one single visit to one lek, only during the rut. The lek was located outside areas of higher female traffic and home range overlap, and females increased home range sizes during the rut to reach it. Twilight routes of females never crossed the lek; instead, females walked atypical routes and at a faster pace to reach the lek and mate. The distance between the two leks was higher than the average diameter of female home ranges, and only one lek was present within female home ranges. Males reached the lek one month before the arrival of females, corroborating that lekking is a female-initiated process (females moving towards large clumped male aggregations) rather than a male-initiated process (males moving towards female hotspots). Our results supported the female preference model, and rejected the predictions of the hotspot model. Also, leks were located far from areas with higher predation risk, supporting the predator avoidance model. The position of lek SG resulted 'handy' at the sub-population level because of the optimal trade-off between travel costs for females to reach it and avoidance of human predators.	[Apollonio, Marco; De Cena, Fabio; Bongi, Paolo] Univ Sassari, Dept Sci Nat & Environm Resources, I-07100 Sassari, Italy; [Ciuti, Simone] Univ Freiburg, Dept Biometry & Environm Syst Anal, D-79106 Freiburg, Germany	University of Sassari; University of Freiburg	Ciuti, S (corresponding author), Univ Freiburg, Dept Biometry & Environm Syst Anal, Hugstetter Str 55, D-79106 Freiburg, Germany.	simone.ciuti@biom.uni-freiburg.de	Ciuti, Simone/D-7283-2013	Ciuti, Simone/0000-0003-1052-9509	EEC HUMAN CAPITAL AND MOBILITY [ERBCHRXCT940674]; Italian Ministry of Education PRIN [9705242520_010, 9905101114_002]	EEC HUMAN CAPITAL AND MOBILITY; Italian Ministry of Education PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This study was funded by EEC HUMAN CAPITAL AND MOBILITY (ERBCHRXCT940674; coordinator Dr. Rauno V. Alatalo University of Jyvaskyla, Finland); Italian Ministry of Education PRIN 1997 9705242520_010; Italian Ministry of Education PRIN 1999 9905101114_002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1992, BEHAV ECOL, V3, P53, DOI 10.1093/beheco/3.1.53; Alexander R.D., 1975, P35; APOLLONIO M, 1992, BEHAV ECOL, V3, P25, DOI 10.1093/beheco/3.1.25; Apollonio M, 2005, J MAMMAL, V86, P937, DOI 10.1644/1545-1542(2005)86[937:LIOHPO]2.0.CO;2; Apollonio M, 1998, ETHOLOGY, V104, P603, DOI 10.1111/j.1439-0310.1998.tb00095.x; APOLLONIO M, 1989, BEHAV ECOL SOCIOBIOL, V25, P89, DOI 10.1007/BF00302925; ARAK A, 1988, BEHAV ECOL SOCIOBIOL, V22, P317; BALMFORD A, 1992, BEHAV ECOL, V3, P112, DOI 10.1093/beheco/3.2.112; BALMFORD A, 1993, BEHAV ECOL SOCIOBIOL, V33, P57, DOI 10.1007/BF00164347; Bartos L, 2003, FOLIA ZOOL, V52, P1; BEEHLER BM, 1988, AM NAT, V131, P203, DOI 10.1086/284786; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; BRADBURY J, 1986, ANIM BEHAV, V34, P1694, DOI 10.1016/S0003-3472(86)80257-3; Bradbury J.W., 1981, P138; Bradbury J.W., 1983, P109; Bro-Jorgensen J, 2003, BEHAV ECOL SOCIOBIOL, V53, P324, DOI 10.1007/s00265-002-0573-0; Bro-Jorgensen J, 2002, P NATL ACAD SCI USA, V99, P9290, DOI 10.1073/pnas.142125899; Bro-Jorgensen J, 2008, ANIM BEHAV, V75, P1229, DOI 10.1016/j.anbehav.2007.06.010; Buzzard PJ, 2008, J ZOOL, V276, P330, DOI 10.1111/j.1469-7998.2008.00493.x; Carbone C, 1996, BEHAV ECOL, V7, P370, DOI 10.1093/beheco/7.3.370; Chapman D., 1997, FALLOW DEER THEIR HI; Ciuti S, 2006, J ZOOL, V268, P97, DOI 10.1111/j.1469-7998.2005.00003.x; Ciuti S, 2004, BEHAV ECOL SOCIOBIOL, V56, P552, DOI 10.1007/s00265-004-0819-0; Ciuti S, 2008, BEHAV ECOL SOCIOBIOL, V62, P1747, DOI 10.1007/s00265-008-0603-7; Ciuti S, 2011, BEHAVIOUR, V148, P435, DOI 10.1163/000579511X563981; CluttonBrock TH, 1996, BEHAV ECOL, V7, P373, DOI 10.1093/beheco/7.3.373; CLUTTONBROCK TH, 1992, BEHAV ECOL, V3, P234, DOI 10.1093/beheco/3.3.234; CLUTTONBROCK TH, 1993, ANIM BEHAV, V46, P1121, DOI 10.1006/anbe.1993.1302; Davini S, 2004, ACTA THERIOL, V49, P393, DOI 10.1007/BF03192537; DEUTSCH JC, 1992, BEHAV ECOL, V3, P223, DOI 10.1093/beheco/3.3.223; GOSLING LM, 1990, ANIM BEHAV, V40, P272, DOI 10.1016/S0003-3472(05)80922-4; HOGLUND J, 1990, BEHAV ECOL SOCIOBIOL, V26, P173; HOGLUND J, 1990, ANIM BEHAV, V40, P15, DOI 10.1016/S0003-3472(05)80661-X; HOGLUND J, 1993, BEHAV ECOL SOCIOBIOL, V32, P31; Hoglund J., 1995, LEKS, DOI DOI 10.1515/9781400864157; Hooge PN, 1999, ANIMAL MOVEMENT PROG; Isvaran K, 2005, BEHAV ECOL SOCIOBIOL, V57, P283, DOI 10.1007/s00265-004-0844-z; Jones TM, 2002, ANIM BEHAV, V63, P605, DOI 10.1006/anbe.2001.1946; MACHLIS L, 1985, Z TIERPSYCHOL, V68, P201; McElligott AG, 1999, ANIM BEHAV, V57, P1159, DOI 10.1006/anbe.1999.1076; NEFDT RJC, 1995, ANIM BEHAV, V49, P419, DOI 10.1006/anbe.1995.0055; Oring LW., 1982, AVIAN BIOL, P1; Pinheiro J, 2001, MIXED EFFECTS MODELS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ryder TB, 2006, AUK, V123, P247, DOI 10.1642/0004-8038(2006)123[0247:ATOTEH]2.0.CO;2; SCHAAL A, 1987, BIOL BEHAV, V12, P28; Stenstrom D, 2000, WILDLIFE BIOL, V6, P23, DOI 10.2981/wlb.2000.034; Stillman RA, 1996, ANIM BEHAV, V52, P891, DOI 10.1006/anbe.1996.0237; STILLMAN RA, 1993, BEHAV ECOL, V4, P1, DOI 10.1093/beheco/4.1.1; Westcott DA, 1997, ANIM BEHAV, V53, P235, DOI 10.1006/anbe.1996.0294; Wikelski M, 1996, ANIM BEHAV, V52, P581, DOI 10.1006/anbe.1996.0199; Wiley RH, 1973, TERRITORIALITY NONRA; Wiley RH, 1991, ADV STUD BEHAV, V20, P201; WITTENBERGER JF, 1978, CONDOR, V80, P126, DOI 10.2307/1367912; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Young KA, 2009, BEHAV ECOL, V20, P609, DOI 10.1093/beheco/arp038; [No title captured]	57	7	7	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89852	10.1371/journal.pone.0089852	http://dx.doi.org/10.1371/journal.pone.0089852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599036	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400032
J	Lashley, MA; Chitwood, MC; Biggerstaff, MT; Morina, DL; Moorman, CE; DePerno, CS				Lashley, Marcus A.; Chitwood, M. Colter; Biggerstaff, Michael T.; Morina, Daniel L.; Moorman, Christopher E.; DePerno, Christopher S.			White-Tailed Deer Vigilance: The Influence of Social and Environmental Factors	PLOS ONE			English	Article							PREDATION RISK; SEXUAL SEGREGATION; GROUP-SIZE; TEMPORAL VARIATION; ANTIPREDATOR BEHAVIOR; HABITAT SELECTION; RESPONSES; PREY; RUMINANTS; COSTS	Vigilance behavior may directly affect fitness of prey animals, and understanding factors influencing vigilance may provide important insight into predator-prey interactions. We used 40,540 pictures taken withcamera traps in August 2011 and 2012to evaluate factors influencing individual vigilance behavior of white-tailed deer (Odocoileus virginianus) while foraging at baited sites. We used binary logistic regression to determine if individual vigilance was affected by age, sex, and group size. Additionally, we evaluated whether the time of the day, moon phase, and presence of other non-predatorwildlife species impacted individual vigilance. Juveniles were 11% less vigilant at baited sites than adults. Females were 46% more vigilant when fawns were present. Males and females spent more time feeding as group size increased, but with each addition of 1 individual to a group, males increased feeding time by nearly double that of females. Individual vigilance fluctuated with time of day andwith moon phase but generally was least during diurnal and moonlit nocturnal hours, indicating deer have the ability to adjust vigilance behavior to changing predation risk associated with varyinglight intensity. White-tailed deer increased individual vigilance when other non-predator wildlife were present. Our data indicate that differential effects of environmental and social constraints on vigilance behavior between sexes may encourage sexual segregation in white-tailed deer.	[Lashley, Marcus A.; Chitwood, M. Colter; Biggerstaff, Michael T.; Morina, Daniel L.; Moorman, Christopher E.; DePerno, Christopher S.] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Lashley, MA (corresponding author), N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA.	marcus_lashley@ncsu.edu		Chitwood, Colter/0000-0001-7240-7430; Morina, Daniel/0000-0002-0743-0041	Fort Bragg Wildlife Branch; United States Department of Defense	Fort Bragg Wildlife Branch; United States Department of Defense(United States Department of Defense)	Funding was provided by Fort Bragg Wildlife Branch and the United States Department of Defense. The funders designed the sampling scheme and camera trap positions based on proper techniques for white-tailed deer population surveys as indicated by previous literature; however, the funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsky Z, 2002, ECOLOGY, V83, P1330, DOI 10.2307/3071947; Beier P., 1990, WILDLIFE MONOGRAPHS, V109, P3; Benoist S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082960; BERGERUD AT, 1983, J WILDLIFE MANAGE, V47, P977, DOI 10.2307/3808156; BERTRAM BCR, 1980, ANIM BEHAV, V28, P278, DOI 10.1016/S0003-3472(80)80030-3; Bleich VC, 1997, WILDLIFE MONOGR, P1; Blumstein DT, 2005, P ROY SOC B-BIOL SCI, V272, P1663, DOI 10.1098/rspb.2005.3147; Bowyer RT, 2004, J MAMMAL, V85, P1039, DOI 10.1644/BBL-002.1; Bro-Jorgensen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045769; Brown CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040505; Brown JS, 1999, EVOL ECOL RES, V1, P49; Cantrell M.A., 1995, RED COCKADED WOODPEC; Ciuti S, 2004, BEHAV ECOL SOCIOBIOL, V56, P552, DOI 10.1007/s00265-004-0819-0; Ciuti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050611; Creel S, 2005, ANIM BEHAV, V69, P1181, DOI 10.1016/j.anbehav.2004.07.022; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; FORMANOWICZ DR, 1989, AM MIDL NAT, V121, P379, DOI 10.2307/2426042; Fortin D, 2004, OIKOS, V107, P172, DOI 10.1111/j.0030-1299.2004.12976.x; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Hewitt D. G., 2011, NUTRITION, P75; Hewitt DG, 2011, ANATOMY PHYSL, P43; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; HUGHES JJ, 1993, ANIM BEHAV, V46, P1243, DOI 10.1006/anbe.1993.1320; Hunter LTB, 1998, BEHAVIOUR, V135, P195, DOI 10.1163/156853998793066320; Hwang S, 2013, PLOS ONE, V8; Jacobson HA, 1997, WILDLIFE SOC B, V25, P547; Kie JG, 1999, J MAMMAL, V80, P1004, DOI 10.2307/1383271; Kie JG, 1999, J MAMMAL, V80, P1114, DOI 10.2307/1383163; Kilgo JC, 2012, J WILDLIFE MANAGE, V76, P1420, DOI 10.1002/jwmg.393; Kuijper DPJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084607; Lark AM, 2008, AM MIDL NAT, V159, P67, DOI 10.1674/0003-0031(2008)159[67:VIVIWD]2.0.CO;2; Li CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032607; Li Z, 2009, J ZOOL, V277, P302, DOI 10.1111/j.1469-7998.2008.00541.x; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 1999, BEHAV ECOL SOCIOBIOL, V46, P110, DOI 10.1007/s002650050599; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Main MB, 1996, J MAMMAL, V77, P449, DOI 10.2307/1382821; METCALFE NB, 1984, ANIM BEHAV, V32, P986, DOI 10.1016/S0003-3472(84)80211-0; Nelson EH, 2004, ECOLOGY, V85, P1853, DOI 10.1890/03-3109; Pays O, 2012, OECOLOGIA, V169, P419, DOI 10.1007/s00442-011-2218-3; Prugh LR, 2014, J ANIM ECOL, V83, P504, DOI 10.1111/1365-2656.12148; Rhind SM, 2002, NUTR RES REV, V15, P43, DOI 10.1079/NRR200236; Ridley AR, 2014, FUNCT ECOL, V28, P197, DOI 10.1111/1365-2435.12153; Rieucau G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044801; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; Rockhill AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069213; Seiler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067397; Sih A, 2002, ANIM BEHAV, V63, P437, DOI 10.1006/anbe.2001.1921; Sonnichsen L, 2013, ETHOLOGY, V119, P233, DOI 10.1111/eth.12057; Stewart KM, 2011, BIOLOGY AND MANAGEMENT OF WHITE-TAILED DEER, P181; Tettamanti F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086004; Toigo C, 1999, CAN J ZOOL, V77, P1060, DOI 10.1139/cjz-77-7-1060; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; Vander Wal E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053777; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Winnie J, 2006, BEHAV ECOL SOCIOBIOL, V61, P277, DOI 10.1007/s00265-006-0258-1	56	45	48	2	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90652	10.1371/journal.pone.0090652	http://dx.doi.org/10.1371/journal.pone.0090652			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599090	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400108
J	Neuille, M; El Shamieh, S; Orhan, E; Michiels, C; Antonio, A; Lancelot, ME; Condroyer, C; Bujakowska, K; Poch, O; Sahel, JA; Audo, I; Zeitz, C				Neuille, Marion; El Shamieh, Said; Orhan, Elise; Michiels, Christelle; Antonio, Aline; Lancelot, Marie-Elise; Condroyer, Christel; Bujakowska, Kinga; Poch, Olivier; Sahel, Jose-Alain; Audo, Isabelle; Zeitz, Christina			Lrit3 Deficient Mouse (nob6): A Novel Model of Complete Congenital Stationary Night Blindness (cCSNB)	PLOS ONE			English	Article							RICH REPEAT PROTEIN; METABOTROPIC GLUTAMATE-RECEPTOR; OPTICAL COHERENCE TOMOGRAPHY; ROD BIPOLAR CELLS; CGMP PHOSPHODIESTERASE; SYNAPTIC-TRANSMISSION; RETINAL DEGENERATION; MAMMALIAN RETINA; LIGHT RESPONSE; BETA-SUBUNIT	Mutations in LRIT3, coding for a Leucine-Rich Repeat, immunoglobulin-like and transmembrane domains 3 protein lead to autosomal recessive complete congenital stationary night blindness (cCSNB). The role of the corresponding protein in the ON-bipolar cell signaling cascade remains to be elucidated. Here we genetically and functionally characterize a commercially available Lrit3 knock-out mouse, a model to study the function and the pathogenic mechanism of LRIT3. We confirm that the insertion of a Bgeo/Puro cassette in the knock-out allele introduces a premature stop codon, which presumably codes for a non-functional protein. The mouse line does not harbor other mutations present in common laboratory mouse strains or in other known cCSNB genes. Lrit3 mutant mice exhibit a so-called no b-wave (nob) phenotype with lacking or severely reduced b-wave amplitudes in the scotopic and photopic electroretinogram (ERG), respectively. Optomotor tests reveal strongly decreased optomotor responses in scotopic conditions. No obvious fundus auto-fluorescence or histological retinal structure abnormalities are observed. However, spectral domain optical coherence tomography (SD-OCT) reveals thinned inner nuclear layer and part of the retina containing inner plexiform layer, ganglion cell layer and nerve fiber layer in these mice. To our knowledge, this is the first time that SD-OCT technology is used to characterize an animal model for CSNB. This phenotype is noted at 6 weeks and at 6 months. The stationary nob phenotype of mice lacking Lrit3, which we named nob6, confirms the findings previously reported in patients carrying LRIT3 mutations and is similar to other cCSNB mouse models. This novel mouse model will be useful for investigating the pathogenic mechanism(s) associated with LRIT3 mutations and clarifying the role of LRIT3 in the ON-bipolar cell signaling cascade.	[Neuille, Marion; El Shamieh, Said; Orhan, Elise; Michiels, Christelle; Antonio, Aline; Lancelot, Marie-Elise; Condroyer, Christel; Bujakowska, Kinga; Sahel, Jose-Alain; Audo, Isabelle; Zeitz, Christina] INSERM, U968, Paris, France; [Neuille, Marion; El Shamieh, Said; Orhan, Elise; Michiels, Christelle; Antonio, Aline; Lancelot, Marie-Elise; Condroyer, Christel; Bujakowska, Kinga; Sahel, Jose-Alain; Audo, Isabelle; Zeitz, Christina] CNRS, UMR 7210, Paris, France; [Neuille, Marion; El Shamieh, Said; Orhan, Elise; Michiels, Christelle; Antonio, Aline; Lancelot, Marie-Elise; Condroyer, Christel; Bujakowska, Kinga; Sahel, Jose-Alain; Audo, Isabelle; Zeitz, Christina] Univ Paris 06, Univ Sorbonne, UMR S 968, Inst Vis, Paris, France; [Antonio, Aline; Sahel, Jose-Alain; Audo, Isabelle] Ctr Hosp Natl Ophtalmol Quinze Vingts, INSERM DHOS CIC 503, Paris, France; [Bujakowska, Kinga] Massachusetts Eye & Ear Infirm, Ocular Genom Inst, Boston, MA 02114 USA; [Poch, Olivier] CNRS, UMR 7357, ICube, Lab Bioinformat Integrat & Genom, Strasbourg, France; [Sahel, Jose-Alain; Audo, Isabelle] UCL, Inst Ophthalmol, London, England; [Sahel, Jose-Alain] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [Sahel, Jose-Alain] Acad Sci Inst France, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Harvard University; Massachusetts Eye & Ear Infirmary; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of London; University College London; Fondation Adolphe de Rothschild	Zeitz, C (corresponding author), INSERM, U968, Paris, France.	christina.zeitz@inserm.fr	Zeitz, Christina/F-2757-2017; Bujakowska, Kinga Maria/AGL-1293-2022; Shamieh, Said El/J-6343-2019; Sahel, Jose-Alain/F-3172-2017	Zeitz, Christina/0000-0002-3510-1712; Shamieh, Said El/0000-0002-8522-0445; Sahel, Jose-Alain/0000-0002-4831-1153; Bujakowska, Kinga/0000-0001-6809-9818; Orhan, Elise/0000-0002-8306-5250; Audo, Isabelle/0000-0003-0698-5309	Agence Nationale de la Recherche [ANR-12-BSVS1-0012-01_GPR179]; Foundation Voir et Entendre; Prix Dalloz for "la recherche en ophtalmologie''; Fondation pour la Recherche Medicale (FRM); Fondation Roland Bailly; Ville de Paris; Region Ile de France; Agence Nationale de la Recherche within the Investissements d'Avenir programme [ANR-11-IDEX-0004-0]; Foundation Fighting Blindness center grant [C-CMM-0907-0428-INSERM04]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Foundation Voir et Entendre; Prix Dalloz for "la recherche en ophtalmologie''; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation Roland Bailly; Ville de Paris; Region Ile de France(Region Ile-de-France); Agence Nationale de la Recherche within the Investissements d'Avenir programme(French National Research Agency (ANR)); Foundation Fighting Blindness center grant	The project was supported by Agence Nationale de la Recherche [ANR-12-BSVS1-0012-01_GPR179] (CZ), Foundation Voir et Entendre (CZ), Prix Dalloz for "la recherche en ophtalmologie'' (CZ), The Fondation pour la Recherche Medicale (FRM) in partnership with the Fondation Roland Bailly (CZ), Ville de Paris and Region Ile de France, LABEX LIFESENSES [reference ANR-10-LABX-65] supported by French state funds managed by the Agence Nationale de la Recherche within the Investissements d'Avenir programme [ANR-11-IDEX-0004-0], Foundation Fighting Blindness center grant [C-CMM-0907-0428-INSERM04]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Audo I, 2008, SURV OPHTHALMOL, V53, P16, DOI 10.1016/j.survophthal.2007.10.010; Audo I, 2012, AM J HUM GENET, V90, P321, DOI 10.1016/j.ajhg.2011.12.007; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bahadori R, 2006, EUR J NEUROSCI, V24, P1664, DOI 10.1111/j.1460-9568.2006.05053.x; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; BOWES C, 1993, P NATL ACAD SCI USA, V90, P2955, DOI 10.1073/pnas.90.7.2955; Cao Y, 2011, J NEUROSCI, V31, P11521, DOI 10.1523/JNEUROSCI.1682-11.2011; Chang B, 2006, INVEST OPHTH VIS SCI, V47, P5017, DOI 10.1167/iovs.05-1468; Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855; Dhingra A, 2000, J NEUROSCI, V20, P9053; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Godara P, 2012, AM J OPHTHALMOL, V154, P987, DOI 10.1016/j.ajo.2012.06.003; Gregg RG, 2003, INVEST OPHTH VIS SCI, V44, P378, DOI 10.1167/iovs.02-0501; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Iwakabe H, 1997, NEUROPHARMACOLOGY, V36, P135, DOI 10.1016/S0028-3908(96)00167-0; Kim KH, 2008, J VISION, V8, DOI 10.1167/8.1.17; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; LeFur N, 1996, GENOMICS, V37, P245; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Maddox DM, 2008, J PHYSIOL-LONDON, V586, P4409, DOI 10.1113/jphysiol.2008.157289; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Morgans CW, 2006, EUR J NEUROSCI, V23, P1163, DOI 10.1111/j.1460-9568.2006.04647.x; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; Nawy S, 1999, J NEUROSCI, V19, P2938; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; O'Connor E, 2005, HUM MOL GENET, V14, P1877, DOI 10.1093/hmg/ddi194; Orhan E, 2013, INVEST OPHTH VIS SCI, V54, P8041, DOI 10.1167/iovs.13-12610; Orlandi C, 2013, INVEST OPHTHALMOL VI; Orlandi C, 2012, J CELL BIOL, V197, P711, DOI 10.1083/jcb.201202123; Pardue MT, 1998, INVEST OPHTH VIS SCI, V39, P2443; Peachey NS, 2012, J NEUROPHYSIOL, V108, P2442, DOI 10.1152/jn.00137.2012; Peachey NS, 2012, AM J HUM GENET, V90, P331, DOI 10.1016/j.ajhg.2011.12.006; Pearring JN, 2011, J NEUROSCI, V31, P10060, DOI 10.1523/JNEUROSCI.1014-11.2011; Pinto LH, 2007, VISUAL NEUROSCI, V24, P111, DOI 10.1017/S0952523807070149; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Ruether K, 2000, INVEST OPHTH VIS SCI, V41, P4039; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; Slotnick S, 2012, OPTOMETRY VISION SCI, V89, pE575, DOI 10.1097/OPX.0b013e318250835d; Terry RB, 2004, ANIM GENET, V35, P134, DOI 10.1111/j.1365-2052.2004.01113.x; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Wycisk KA, 2006, INVEST OPHTH VIS SCI, V47, P3523, DOI 10.1167/iovs.06-0271; Xu Y, 2012, J NEUROPHYSIOL, V107, P948, DOI 10.1152/jn.00933.2011; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28; Zeitz C, 2005, INVEST OPHTH VIS SCI, V46, P4328, DOI 10.1167/iovs.05-0526; Zeitz C, 2003, INVEST OPHTH VIS SCI, V44, P4184, DOI 10.1167/iovs.03-0251; Zeitz C, 2007, EXPERT REV OPHTHALMO, V2, P467, DOI 10.1586/17469899.2.3.467; Zeitz C, 2013, AM J HUM GENET, V92, P67, DOI 10.1016/j.ajhg.2012.10.023	56	38	40	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90342	10.1371/journal.pone.0090342	http://dx.doi.org/10.1371/journal.pone.0090342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598786	gold, Green Published, Green Submitted			2022-12-25	WOS:000332479400065
J	Shi, SH; Cai, YP; Cai, XJ; Zheng, XY; Cao, DS; Ye, FQ; Xiang, Z				Shi, Shao-hua; Cai, Yue-piao; Cai, Xiao-jun; Zheng, Xiao-yong; Cao, Dong-sheng; Ye, Fa-qing; Xiang, Zheng			A Network Pharmacology Approach to Understanding the Mechanisms of Action of Traditional Medicine: Bushenhuoxue Formula for Treatment of Chronic Kidney Disease	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; UNILATERAL URETERAL OBSTRUCTION; ANGIOTENSIN-ALDOSTERONE SYSTEM; SALVIAE-MILTIORRHIZAE RADIX; INSULIN SIGNALING PATHWAY; TANSHINONE IIA; DIABETIC-NEPHROPATHY; MASS-SPECTROMETRY; TGF-BETA; GENE-EXPRESSION	Traditional Chinese medicine (TCM) has unique therapeutic effects for complex chronic diseases. However, for the lack of an effective systematic approach, the research progress on the effective substances and pharmacological mechanism of action has been very slow. In this paper, by incorporating network biology, bioinformatics and chemoinformatics methods, an integrated approach was proposed to systematically investigate and explain the pharmacological mechanism of action and effective substances of TCM. This approach includes the following main steps: First, based on the known drug targets, network biology was used to screen out putative drug targets; Second, the molecular docking method was used to calculate whether the molecules from TCM and drug targets related to chronic kidney diseases (CKD) interact or not; Third, according to the result of molecular docking, natural product-target network, main component-target network and compound-target network were constructed; Finally, through analysis of network characteristics and literature mining, potential effective multi-components and their synergistic mechanism were putatively identified and uncovered. Bu-shen-Huo-xue formula (BSHX) which was frequently used for treating CKD, was used as the case to demonstrate reliability of our proposed approach. The results show that BSHX has the therapeutic effect by using multi-channel network regulation, such as regulating the coagulation and fibrinolytic balance, and the expression of inflammatory factors, inhibiting abnormal ECM accumulation. Tanshinone IIA, rhein, curcumin, calycosin and quercetin may be potential effective ingredients of BSHX. This research shows that the integration approach can be an effective means for discovering active substances and revealing their pharmacological mechanisms of TCM.	[Shi, Shao-hua; Cai, Yue-piao; Cai, Xiao-jun; Zheng, Xiao-yong; Ye, Fa-qing; Xiang, Zheng] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou, Peoples R China; [Cao, Dong-sheng] Cent S Univ, Sch Pharmaceut Sci, Changsha, Hunan, Peoples R China	Wenzhou Medical University; Central South University	Ye, FQ (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou, Peoples R China.	yfq664340@163.com; XZH0077@126.com			National Natural Science Foundation of China [81001614]; Nature Foundation Committee of Zhejiang Province, China [Y2100317, LQ13H280001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Foundation Committee of Zhejiang Province, China	The authors acknowledge financial support from the National Natural Science Foundation of China (No. 81001614) and the Nature Foundation Committee of Zhejiang Province, China (Y2100317 and LQ13H280001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasian N, 2012, NEPHROL DIAL TRANSPL, V27, P241; Abdel-Rahman E, 2009, SEMIN DIALYSIS, V22, P532, DOI 10.1111/j.1525-139X.2009.00634.x; Agarwal SK, 2001, J SCI IND RES INDIA, V60, P1; Ahn YM, 2010, PHYTOTHER RES, V24, P1886, DOI 10.1002/ptr.3347; Akgul T, 2011, KAOHSIUNG J MED SCI, V27, P15, DOI 10.1016/j.kjms.2010.03.001; Alasbahi RH, 2012, PHARMAZIE, V67, P5, DOI 10.1691/ph.2012.1642; [Anonymous], KIDNEY INT, V73, P269; Azuaje FJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00052; Bailey JL, 2002, J AM SOC NEPHROL, V13, p522A; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Biggar PH, 2011, PEDIATR NEPHROL, V26, P7, DOI 10.1007/s00467-010-1526-x; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brophy D, 2009, AM J KIDNEY DIS, V53, pA30; Cao J, 2008, BIOMED CHROMATOGR, V22, P164, DOI 10.1002/bmc.911; Chea E, 2007, BMC BIOINFORMATICS, V8; Chen XH, 2012, J CHROMATOGR A, V1263, P34, DOI 10.1016/j.chroma.2012.09.074; Chen XM, 2011, J CHROMATOGR B, V879, P2339, DOI 10.1016/j.jchromb.2011.06.019; [陈修平 CHEN Xiu-ping], 2010, [中草药, Chinese Traditional and Herbal Drugs], V41, P1; Chevalier RL, 1999, J UROLOGY, V161, P309, DOI 10.1016/S0022-5347(01)62137-2; Cho DY, 2012, PLOS COMPUTATIONAL B, V8; Choi ME, 2012, SEMIN NEPHROL, V32, P244, DOI 10.1016/j.semnephrol.2012.04.003; Chuang CC, 2010, AM J CLIN NUTR, V92, P1511, DOI 10.3945/ajcn.2010.29807; Chuang PY, 2010, KIDNEY INT, V78, P231, DOI 10.1038/ki.2010.158; CHUNG HY, 1988, CHEM PHARM BULL, V36, P274; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Dubey RK, 1999, HYPERTENSION, V33, P177, DOI 10.1161/01.HYP.33.1.177; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eybl V, 2008, HUM EXP TOXICOL, V27, P347, DOI 10.1177/0960327108094508; Fernand VE, 2011, CHEM-BIOL INTERACT, V192, P220, DOI 10.1016/j.cbi.2011.03.013; Fujimoto H, 1998, CHEM PHARM BULL, V46, P1506; Gaedeke J, 2004, KIDNEY INT, V66, P112, DOI 10.1111/j.1523-1755.2004.00713.x; Gao S, 2012, ATHEROSCLEROSIS, V220, P3, DOI 10.1016/j.atherosclerosis.2011.06.041; Gao ZhiQing, 2010, China Journal of Traditional Chinese Medicine and Pharmacy, V25, P296; Garcia-Mediavilla V, 2007, EUR J PHARMACOL, V557, P221, DOI 10.1016/j.ejphar.2006.11.014; Gold MR, 2000, IMMUNOL REV, V176, P47; Gong ZW, 2009, ENDOCRINOLOGY, V150, P104, DOI 10.1210/en.2008-0322; Gonzalez-Salazar A, 2011, CARDIOVASC TOXICOL, V11, P357, DOI 10.1007/s12012-011-9128-9; Greenbaum D, 2003, GENOME BIOL, V4; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Guan XH, 2009, TRANSPL INT, V22, P232, DOI 10.1111/j.1432-2277.2008.00770.x; Ha MK, 2011, BIOL PHARM BULL, V34, P1432, DOI 10.1248/bpb.34.1432; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; He DY, 2011, BIOL PHARM BULL, V34, P1219, DOI 10.1248/bpb.34.1219; Heyman SN, 2008, AM J NEPHROL, V28, P998, DOI 10.1159/000146075; Hong JY, 2006, J FOOD SCI, V71, pS626, DOI 10.1111/j.1750-3841.2006.00194.x; Hsieh CL, 2013, J AGR FOOD CHEM, V61, P7258, DOI 10.1021/jf304595p; Hu YB, 2012, ACTA PHYS-CHIM SIN, V28, P1257, DOI 10.3866/PKU.WHXB201202212; Hu Y, 2010, AM J NEPHROL, V31, P332, DOI 10.1159/000287230; Huang LM, 2006, ACTA PHARMACOL SIN, V27, P321; Huang XZ, 2008, CANCER BIOL THER, V7, P468, DOI 10.4161/cbt.7.3.5457; Hwang JS, 2005, ARCH PHARM RES, V28, P190, DOI 10.1007/BF02977714; Hwang WC, 2008, CLIN PHARMACOL THER, V84, P563, DOI 10.1038/clpt.2008.129; Hwang W, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-24; Iqbal M, 2009, MOL CELL BIOCHEM, V324, P157, DOI 10.1007/s11010-008-9994-z; Jariyawat S, 2009, J NAT MED-TOKYO, V63, P430, DOI 10.1007/s11418-009-0345-5; Jha V, 2010, NEPHROLOGY, V15, P10, DOI 10.1111/j.1440-1797.2010.01305.x; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Jin RF, 2011, INT J QUANTUM CHEM, V111, P1064, DOI 10.1002/qua.22466; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Kang DG, 2002, AM J CHINESE MED, V30, P87, DOI 10.1142/S0192415X02000107; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Khan SS, 2012, AM J KIDNEY DIS, V59, pA47; Khorsandi L, 2008, DARU, V16, P155; Kim SK, 2009, BIOL PHARM BULL, V32, P220, DOI 10.1248/bpb.32.220; Kim W, 2006, NY TIMES BK REV, P1; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Ko JC, 2011, BIOCHEM PHARMACOL, V81, P680, DOI 10.1016/j.bcp.2010.12.008; Kong LD, 2004, J ETHNOPHARMACOL, V91, P351, DOI 10.1016/j.jep.2004.01.013; Koyama J, 2007, J CHROMATOGR A, V1145, P183, DOI 10.1016/j.chroma.2007.01.076; KUPPUSAMY UR, 1994, BIOCHEM PHARMACOL, V47, P521, DOI 10.1016/0006-2952(94)90184-8; Lai PB, 2012, RENAL FAILURE, V34, P83, DOI 10.3109/0886022X.2011.623564; Lee KJ, 2012, PHARM BIOL, V50, P591; Lee S, 2009, EXPERT OPIN DRUG DIS, V4, P1177, DOI 10.1517/17460440903322234; Lee W, 2012, BMB REP, V45, P141, DOI 10.5483/BMBRep.2012.45.3.141; Letavernier E, 2005, J AM SOC NEPHROL, V16, P2395, DOI 10.1681/ASN.2004090802; Li BH, 2012, INT J MOL SCI, V13, P13501, DOI 10.3390/ijms131013501; Li FM, 2010, HYPERTENSION, V56, pE123; Li JH, 2002, J AM SOC NEPHROL, V13, p287A; Li JX, 2005, CHINESE J PHYSIOL, V48, P101; Li LS, 1996, NEPHROLOGY, V2, pS146, DOI 10.1111/j.1440-1797.1996.tb00160.x; Li M, 2013, J ETHNOPHARMACOL, V146, P614, DOI 10.1016/j.jep.2013.01.038; Li R, 2011, FOOD CHEM, V126, P1890, DOI 10.1016/j.foodchem.2010.12.014; Li S, 2006, J ASIAN NAT PROD RES, V8, P281, DOI 10.1080/10286020412331286434; Li Shao, 2011, Zhongguo Zhong Yao Za Zhi, V36, P2017; Li SG, 2009, CARBOHYD POLYM, V78, P343, DOI 10.1016/j.carbpol.2009.04.013; Li XM, 2005, ADV CHRONIC KIDNEY D, V12, P276, DOI 10.1016/j.ackd.2005.03.007; Li YG, 2009, J CHROMATOGR A, V1216, P1941, DOI 10.1016/j.chroma.2008.12.032; Li YS, 2009, J HUAZHONG U SCI-MED, V29, P476, DOI 10.1007/s11596-009-0417-5; Lin SL, 2011, AM J PATHOL, V178, P911, DOI 10.1016/j.ajpath.2010.10.012; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu F, 2012, KIDNEY BLOOD PRESS R, V35, P182, DOI 10.1159/000331054; Liu Y, 2010, J PHARMACEUT BIOMED, V53, P698, DOI 10.1016/j.jpba.2010.03.041; Luyckx VA, 2012, ADV CHRONIC KIDNEY D, V19, P129, DOI 10.1053/j.ackd.2012.04.005; Lv ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022806; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Martin A, 2010, BMC BIOINFORMATICS, V11; Matsuura S, 2011, J HISTOCHEM CYTOCHEM, V59, P864, DOI 10.1369/0022155411413929; Mencher Simon K, 2005, BMC Clin Pharmacol, V5, P3, DOI 10.1186/1472-6904-5-3; Morphy R, 2007, DRUG DISCOV TODAY, V12, P156, DOI 10.1016/j.drudis.2006.12.006; Nabavi SM, 2012, RENAL FAILURE, V34, P901, DOI 10.3109/0886022X.2012.687347; Nagao S, 2008, KIDNEY INT, V73, P269, DOI 10.1038/sj.ki.5002629; Nagler EV, 2012, NEPHROL DIAL TRANSPL, V27, P3736, DOI 10.1093/ndt/gfs295; Navab KD, 2011, CURR PHARM DESIGN, V17, P17; Navaneethan SD, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-3; Ozturk M, 2007, FOOD CHEM, V103, P623, DOI 10.1016/j.foodchem.2006.09.005; PALYA A, 2008, AM J KIDNEY DIS, V51, pA77; Pan HJ, 2005, J ETHNOPHARMACOL, V99, P99, DOI 10.1016/j.jep.2005.02.007; Pei LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057414; Qi LW, 2009, J CHROMATOGR A, V1216, P2087, DOI 10.1016/j.chroma.2008.02.095; Qin Y, 2011, AM J PATHOL, V179, P2766, DOI 10.1016/j.ajpath.2011.08.025; Remuzzi G, 2005, KIDNEY INT, V68, P57; Sheng BW, 2005, CHINESE MED J-PEKING, V118, P43; Shi CS, 2007, THROMB RES, V119, P769, DOI 10.1016/j.thromres.2006.06.008; Siragy HM, 2010, AM J NEPHROL, V31, P541, DOI 10.1159/000313363; Skupien J, 2009, DIABETES, V58, pA219; Soetikno V, 2011, NUTR METAB, V8; Stinghen AEM, 2010, BLOOD PURIFICAT, V29, P114, DOI 10.1159/000245636; Stone R, 2008, SCIENCE, V319, P709, DOI 10.1126/science.319.5864.709; Tang FT, 2011, EUR J PHARMACOL, V650, P275, DOI 10.1016/j.ejphar.2010.07.038; Tang JL, 2008, LANCET, V372, P1938, DOI 10.1016/S0140-6736(08)61354-9; Tang JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011822; Tang JH, 2008, J HUAZHONG U SCI-MED, V28, P539, DOI 10.1007/s11596-008-0511-0; Tang SCW, 2006, J AM SOC NEPHROL, V17, P1633, DOI 10.1681/ASN.2005101113; Tapmeier TT, 2008, KIDNEY INT, V73, P885, DOI 10.1038/sj.ki.5002797; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsukiyama F, 2006, BIOCHEM BIOPH RES CO, V351, P234, DOI 10.1016/j.bbrc.2006.10.025; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang D, 2006, J SEP SCI, V29, P2012, DOI 10.1002/jssc.200500486; Wang H, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008000.pub2; Wang JX, 2012, IEEE ACM T COMPUT BI, V9, P1070, DOI 10.1109/TCBB.2011.147; Wang JP, 2006, EUR J PHARMACOL, V553, P297, DOI 10.1016/j.ejphar.2006.08.087; Wang R, 2007, LIFE SCI, V80, P2481, DOI 10.1016/j.lfs.2007.04.010; Wang SP, 2010, RAPID COMMUN MASS SP, V24, P1641, DOI 10.1002/rcm.4561; Wang YJ, 2012, J ETHNOPHARMACOL, V139, P757, DOI 10.1016/j.jep.2011.12.009; Wasserman RL, 2012, J CLIN IMMUNOL, V32, P1153, DOI 10.1007/s10875-012-9740-x; Wichitnithad W, 2009, PHYTOCHEM ANALYSIS, V20, P314, DOI 10.1002/pca.1129; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wu LC, 2012, ACTA PHARMACOL SIN, V33, P1254, DOI 10.1038/aps.2012.84; Wu XL, 2012, PLANTA MED, V78, P866, DOI 10.1055/s-0031-1298487; Xavier S, 2012, EUR J PHARMACOL, V687, P14, DOI 10.1016/j.ejphar.2012.02.050; Xiang Z, 2011, PHYTOCHEM ANALYSIS, V22, P411, DOI 10.1002/pca.1296; Xiao HB, 2004, J CHROMATOGR A, V1032, P117, DOI 10.1016/j.chroma.2003.09.032; Xiao-hong D, 2011, CHIN J INTEGR TRAD W, V31, P765; Yang FQ, 2006, J CHROMATOGR A, V1134, P226, DOI 10.1016/j.chroma.2006.09.048; Yang JX, 2008, J ETHNOPHARMACOL, V119, P166, DOI 10.1016/j.jep.2008.06.027; Yang KY, 2007, J CHROMATOGR B, V853, P183, DOI 10.1016/j.jchromb.2007.03.010; Ye M, 2005, RAPID COMMUN MASS SP, V19, P1469, DOI 10.1002/rcm.1944; Yon JM, 2011, REPROD TOXICOL, V31, P513, DOI 10.1016/j.reprotox.2011.02.011; Yongzheng H., 2011, COMPREHENSIVE NATURA; Zhang G, 1996, NEPHROL DIAL TRANSPL, V11, P186, DOI 10.1093/oxfordjournals.ndt.a027039; Zhang HX, 2004, J CHROMATOGR B, V812, P175, DOI 10.1016/j.jchromb.2004.08.010; ZHANG JH, 1992, KIDNEY INT, V42, P498; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang P, 2008, PHYSICA A, V387, P6869, DOI 10.1016/j.physa.2008.09.006; Zhang Q, 2012, EXP BIOL MED, V237, P903, DOI 10.1258/ebm.2012.012032; Zhang X, 2007, ANAL CHIM ACTA, V602, P252, DOI 10.1016/j.aca.2007.09.033; Zhao YL, 2011, FOOD CHEM TOXICOL, V49, P1705, DOI 10.1016/j.fct.2011.04.011; Zhong F, 2011, BIOL PHARM BULL, V34, P226, DOI 10.1248/bpb.34.226; Zhu B, 2011, MOL MED REP, V4, P505, DOI 10.3892/mmr.2011.444; Zhu M, 2009, J DRUG TARGET, V17, P524, DOI 10.1080/10611860903046610; Zuo C, 2009, J ZHEJIANG UNIV-SC B, V10, P380, DOI 10.1631/jzus.B0820230	166	70	73	4	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89123	10.1371/journal.pone.0089123	http://dx.doi.org/10.1371/journal.pone.0089123			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598793	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400008
J	Wei, XL; Qiu, MZ; Lin, HX; Zhang, Y; Liu, JX; Yu, HM; Liang, WP; Jin, Y; Ren, C; He, MM; Chen, WW; Luo, HY; Wang, ZQ; Zhang, DS; Wang, FH; Li, YH; Xu, RH				Wei, Xiao-li; Qiu, Miao-zhen; Lin, Huan-xin; Zhang, Ying; Liu, Jian-xin; Yu, Hong-mei; Liang, Wei-ping; Jin, Ying; Ren, Chao; He, Ming-ming; Chen, Wei-wei; Luo, Hui-yan; Wang, Zhi-qiang; Zhang, Dong-sheng; Wang, Feng-hua; Li, Yu-hong; Xu, Rui-hua			Patients with Old Age or Proximal Tumors Benefit from Metabolic Syndrome in Early Stage Gastric Cancer	PLOS ONE			English	Article							PRIMARY LIVER-CANCER; BODY-MASS INDEX; RISK-FACTORS; INSULIN-RESISTANCE; BREAST-CANCER; PROSPECTIVE COHORT; PROGNOSTIC-FACTOR; MORTALITY; ADENOCARCINOMA; ASSOCIATION	Background: Metabolic syndrome and/or its components have been demonstrated to be risk factors for several cancers. They are also found to influence survival in breast, colon and prostate cancer, but the prognostic value of metabolic syndrome in gastric cancer has not been investigated. Methods: Clinical data and pre-treatment information of metabolic syndrome of 587 patients diagnosed with early stage gastric cancer were retrospectively collected. The associations of metabolic syndrome and/or its components with clinical characteristics and overall survival in early stage gastric cancer were analyzed. Results: Metabolic syndrome was identified to be associated with a higher tumor cell differentiation (P = 0.036). Metabolic syndrome was also demonstrated to be a significant and independent predictor for better survival in patients aged.50 years old (P = 0.009 in multivariate analysis) or patients with proximal gastric cancer (P = 0.047 in multivariate analysis). No association was found between single metabolic syndrome component and overall survival in early stage gastric cancer. In addition, patients with hypertension might have a trend of better survival through a good control of blood pressure (P = 0.052 in univariate analysis). Conclusions: Metabolic syndrome was associated with a better tumor cell differentiation in patients with early stage gastric cancer. Moreover, metabolic syndrome was a significant and independent predictor for better survival in patients with old age or proximal tumors.	[Wei, Xiao-li; Qiu, Miao-zhen; Jin, Ying; Ren, Chao; He, Ming-ming; Chen, Wei-wei; Luo, Hui-yan; Wang, Zhi-qiang; Zhang, Dong-sheng; Wang, Feng-hua; Li, Yu-hong; Xu, Rui-hua] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Huan-xin; Zhang, Ying; Liu, Jian-xin; Yu, Hong-mei; Liang, Wei-ping] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Prevent Care,Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Xu, RH (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China.	xurh@sysucc.org.cn	骆, 卉妍/GWR-3383-2022; xu, rui/GRX-5734-2022; Xu, Rui-Hua/AAW-4766-2021	骆, 卉妍/0000-0001-6312-9299; Xu, Rui-Hua/0000-0001-9771-8534	National High Technology Research and Development Program of China (863 Program), China [2012AA02A506]; National Natural Science Foundation of China [81372570]; Science and Technology Department of Guangdong Province, China [2012B031800088]; Medical Scientific Research Foundation of Guangdong Province, China [C2011019]	National High Technology Research and Development Program of China (863 Program), China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Guangdong Province, China; Medical Scientific Research Foundation of Guangdong Province, China	This work was supported by the National High Technology Research and Development Program of China (863 Program), China (NO. 2012AA02A506), the National Natural Science Foundation of China (No. 81372570), The Science and Technology Department of Guangdong Province, China (No. 2012B031800088), and the Medical Scientific Research Foundation of Guangdong Province, China (No. C2011019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almquist M, 2011, CANCER CAUSE CONTROL, V22, P743, DOI 10.1007/s10552-011-9747-2; Barresi V, 2009, J CLIN PATHOL, V62, P705, DOI 10.1136/jcp.2009.066175; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Bickenbach KA, 2013, ANN SURG ONCOL, V20, P780, DOI 10.1245/s10434-012-2653-3; Bjorge T, 2011, INT J EPIDEMIOL, V40, P1667, DOI 10.1093/ije/dyr130; Borena W, 2012, INT J CANCER, V131, P193, DOI 10.1002/ijc.26338; Colonna SV, 2012, BREAST CANCER RES TR, V131, P325, DOI 10.1007/s10549-011-1790-x; Cowey S, 2006, AM J PATHOL, V169, P1505, DOI 10.2353/ajpath.2006.051090; Da Li Q, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-315; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Friedenreich CM, 2011, CANCER EPIDEM BIOMAR, V20, P2384, DOI 10.1158/1055-9965.EPI-11-0715; Haggstrom C, 2011, INT J CANCER, V128, P1890, DOI 10.1002/ijc.25521; Healy LA, 2012, COLORECTAL DIS, V14, P157, DOI 10.1111/j.1463-1318.2011.02562.x; Healy LA, 2010, CLIN ONCOL-UK, V22, P281, DOI 10.1016/j.clon.2010.02.001; Jaggers JR, 2009, EUR J CANCER, V45, P1831, DOI 10.1016/j.ejca.2009.01.031; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jinjuvadia R, 2013, J CLIN GASTROENTEROL, V47, P33, DOI 10.1097/MCG.0b013e3182688c15; Konings IRHM, 2010, EUR J CANCER, V46, P3200, DOI 10.1016/j.ejca.2010.07.036; Lee JS, 2010, ANN ONCOL, V21, P640, DOI 10.1093/annonc/mdp344; MacInnis RJ, 2006, INT J CANCER, V118, P2628, DOI 10.1002/ijc.21638; Merry AHH, 2007, GUT, V56, P1503, DOI 10.1136/gut.2006.116665; Nagel G, 2012, BRIT J DERMATOL, V167, P59, DOI 10.1111/j.1365-2133.2012.10974.x; Nagel G, 2012, ANN HEMATOL, V91, P1519, DOI 10.1007/s00277-012-1489-z; Nozoe T, 2012, SURG TODAY, V42, P945, DOI 10.1007/s00595-012-0183-z; O'Doherty MG, 2012, GUT, V61, P1261, DOI 10.1136/gutjnl-2011-300551; Otani K, 2008, GASTRIC CANCER, V11, P86, DOI 10.1007/s10120-008-0459-6; Pasanisi P, 2006, INT J CANCER, V119, P236, DOI 10.1002/ijc.21812; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Reeves KW, 2012, CANCER CAUSE CONTROL, V23, P1241, DOI 10.1007/s10552-012-0002-2; Rosato V, 2011, METABOLISM, V60, P1372, DOI 10.1016/j.metabol.2011.03.005; Shebl FM, 2011, BRIT J CANCER, V105, P1424, DOI 10.1038/bjc.2011.363; Shen ZL, 2010, AM J SURG, V200, P59, DOI 10.1016/j.amjsurg.2009.05.005; Shin E, 2013, J CANCER RES CLIN, V139, P709, DOI 10.1007/s00432-013-1379-3; Stebbing J, 2012, ANN ONCOL, V23, P860, DOI 10.1093/annonc/mdr347; Tamura T, 2012, J GASTROEN HEPATOL, V27, P1635, DOI 10.1111/j.1440-1746.2012.07189.x; Tian T, 2012, EXP CLIN ENDOCR DIAB, V120, P217, DOI 10.1055/s-0031-1297969; Tseng CH, 2011, GUT, V60, P774, DOI 10.1136/gut.2010.226522; Tsukada T, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-107; Ulaganathan V, 2012, ASIAN PAC J CANCER P, V13, P3873, DOI 10.7314/APJCP.2012.13.8.3873; Ulmer H, 2012, GYNECOL ONCOL, V125, P330, DOI 10.1016/j.ygyno.2012.01.052; Welzel TM, 2011, HEPATOLOGY, V54, P463, DOI 10.1002/hep.24397; Wu Q, 2012, DIGESTION, V86, P294, DOI 10.1159/000341397; Xiang YZ, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-9; Yang Y, 2013, CANCER-AM CANCER SOC, V119, P1512, DOI 10.1002/cncr.27923	44	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e89965	10.1371/journal.pone.0089965	http://dx.doi.org/10.1371/journal.pone.0089965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599168	Green Published, gold, Green Submitted			2022-12-25	WOS:000332479400036
J	Beltran, LM; Hernandez, RM; Bernal, RSD; Morillo, JSG; Egido, J; Noval, ML; Ferrando-Martinez, S; Blanco-Colio, LM; Genebat, M; Villar, JR; Moreno-Luna, R; Moreno, JA				Beltran, Luis M.; Munoz Hernandez, Rocio; de Pablo Bernal, Rebeca S.; Garcia Morillo, Jose S.; Egido, Jesus; Leal Noval, Manuel; Ferrando-Martinez, Sara; Blanco-Colio, Luis M.; Genebat, Miguel; Villar, Jose R.; Moreno-Luna, Rafael; Antonio Moreno, Juan			Reduced sTWEAK and Increased sCD163 Levels in HIV-Infected Patients: Modulation by Antiretroviral Treatment, HIV Replication and HCV Co-Infection	PLOS ONE			English	Article							SOLUBLE CD163; ASYMMETRIC DIMETHYLARGININE; MYOCARDIAL-INFARCTION; WEAK INDUCER; TWEAK; INFLAMMATION; MARKERS; RISK; ACTIVATION; THERAPY	Background: Patients infected with the human immunodeficiency virus (HIV) have an increased risk of cardiovascular disease due to increased inflammation and persistent immune activation. CD163 is a macrophage scavenger receptor that is involved in monocyte-macrophage activation in HIV-infected patients. CD163 interacts with TWEAK, a member of the TNF superfamily. Circulating levels of sTWEAK and sCD163 have been previously associated with cardiovascular disease, but no previous studies have fully analyzed their association with HIV. Objective: The aim of this study was to analyze circulating levels of sTWEAK and sCD163 as well as other known markers of inflammation (hsCRP, IL-6 and sTNFRII) and endothelial dysfunction (sVCAM-1 and ADMA) in 26 patients with HIV before and after 48 weeks of antiretroviral treatment (ART) and 23 healthy subjects. Results: Patients with HIV had reduced sTWEAK levels and increased sCD163, sVCAM-1, ADMA, hsCRP, IL-6 and sTNFRII plasma concentrations, as well as increased sCD163/sTWEAK ratio, compared with healthy subjects. Antiretroviral treatment significantly reduced the concentrations of sCD163, sVCAM-1, hsCRP and sTNFRII, although they remained elevated when compared with healthy subjects. Antiretroviral treatment had no effect on the concentrations of ADMA and sTWEAK, biomarkers associated with endothelial function. The use of protease inhibitors as part of antiretroviral therapy and the presence of HCV-HIV co-infection and/or active HIV replication attenuated the ART-mediated decrease in sCD163 plasma concentrations. Conclusion: HIV-infected patients showed a proatherogenic profile characterized by increased inflammatory, immune-activation and endothelial-dysfunction biomarkers that partially improved after ART. HCV-HIV co-infection and/or active HIV replication enhanced immune activation despite ART.	[Beltran, Luis M.; Munoz Hernandez, Rocio; Garcia Morillo, Jose S.; Villar, Jose R.; Moreno-Luna, Rafael] Univ Seville, Inst Biomed Sevilla, Hosp Univ Virgen del Rocio, Ctr Super Invest Cient,Unidad Clin Expt Riesgo Va, Seville, Spain; [Beltran, Luis M.] Hosp Univ La Paz, Unidad Metab Vasc, Fdn Invest, IdiPAZ, Madrid, Spain; [de Pablo Bernal, Rebeca S.; Leal Noval, Manuel; Ferrando-Martinez, Sara; Genebat, Miguel] Univ Seville, Lab Inmunovirol, Unidad Clin Enfermedades Infecciosas Microbiol &, Inst Biomed Sevilla,Hosp Univ Virgen del Rocio,Ct, Seville, Spain; [Egido, Jesus; Blanco-Colio, Luis M.; Antonio Moreno, Juan] Fdn Jimenez Diaz, Lab Patol Vasc, Inst Invest Sanitaria, E-28040 Madrid, Spain; [Egido, Jesus] Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain; [Ferrando-Martinez, Sara] Hosp Gen Univ Gregorio Maranon, Lab Inmunobiol Mol, Madrid, Spain; [Ferrando-Martinez, Sara] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Ferrando-Martinez, Sara] Networking Res Ctr Bioengn Biomat & Nanomed, Madrid, Spain; [Moreno-Luna, Rafael] Hosp Nacl Paraplejicos, Dept Vasc Physiopathol, Serv Salud Castilla La Mancha, Toledo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Universitario La Paz; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Fundacion Jimenez Diaz; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Hospital Nacional de Paraplejicos	Moreno-Luna, R (corresponding author), Univ Seville, Inst Biomed Sevilla, Hosp Univ Virgen del Rocio, Ctr Super Invest Cient,Unidad Clin Expt Riesgo Va, Seville, Spain.	rmluna@sescam.jccm.es; jamoreno@fjd.es	MORENO-LUNA, RAFAEL/AFP-3358-2022; Blanco-Colio, Luis M./Z-2390-2019; Garcia Morillo, Salvador/C-9364-2015; Beltrán-Romero, Luis M./H-5479-2017; Genebat, Miguel/F-3072-2015; García-Morillo, José-Salvador/L-8365-2018; Moreno, Juan Antonio/B-3487-2018; IBIS, HIPERCOLESTERO/P-3953-2015; de Pablo-Bernal, Rebeca S/E-9923-2015	MORENO-LUNA, RAFAEL/0000-0002-9840-5078; Garcia Morillo, Salvador/0000-0001-9969-1881; Beltrán-Romero, Luis M./0000-0001-8048-9106; García-Morillo, José-Salvador/0000-0003-1311-5483; Moreno, Juan Antonio/0000-0002-7468-2871; Blanco-Colio, Luis Miguel/0000-0002-1560-6609; de Pablo-Bernal, Rebeca S/0000-0002-8026-2857	Unidad Clinico-Experimental de Riesgo Vascular [RIMON_ L_01031]; Redes Tematicas de Investigacion en SIDA [ISCIII RETIC RD12/0017/0029, RD12/0017/0037]; Junta de Andalucia, Incentivos a proyectos de investigacion de excelencia [CTS-6313]; Consejeria de Salud [PI-0278]; FIS [PI10/00234]; Programa Miguel Servet [CP10/00479, PI13/00802]; Fundacion Lilly; FRIAT; ISCIII fund [PI10/00072]; Incentivos a proyectos de investigacion de excelencia [CTS-6313]	Unidad Clinico-Experimental de Riesgo Vascular; Redes Tematicas de Investigacion en SIDA; Junta de Andalucia, Incentivos a proyectos de investigacion de excelencia(Junta de Andalucia); Consejeria de Salud; FIS(Instituto de Salud Carlos III); Programa Miguel Servet; Fundacion Lilly; FRIAT; ISCIII fund; Incentivos a proyectos de investigacion de excelencia	This study was supported by grants from the Unidad Clinico-Experimental de Riesgo Vascular (RIMON_ L_01031, to Jose Villar), Redes Tematicas de Investigacion en SIDA (ISCIII RETIC RD12/0017/0029 and RD12/0017/0037), Junta de Andalucia, Incentivos a proyectos de investigacion de excelencia (CTS-6313, to Manolo Leal), Consejeria de Salud (PI-0278), FIS PI10/00234 to LMBC and Programa Miguel Servet: CP10/00479 and PI13/00802 to JAM. Fundacion Lilly, FRIAT and ISCIII fund PI10/00072 to JE. RSPB is supported by Incentivos a proyectos de investigacion de excelencia (CTS-6313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristoteli LP, 2006, ATHEROSCLEROSIS, V184, P342, DOI 10.1016/j.atherosclerosis.2005.05.004; Baker JV, 2012, JAIDS-J ACQ IMM DEF, V60, P128, DOI 10.1097/QAI.0b013e318252f99f; Baker JV, 2011, EUR HEART J, V32, P945, DOI 10.1093/eurheartj/ehq483; Blanco-Colio LM, 2007, FRONT BIOSCI-LANDMRK, V12, P3648, DOI 10.2741/2341; Blanco-Colio LM, 2007, ARTERIOSCL THROM VAS, V27, P916, DOI 10.1161/01.ATV.0000258972.10109.ff; Bover LC, 2007, J IMMUNOL, V178, P8183, DOI 10.4049/jimmunol.178.12.8183; Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Calza L, 2009, JAIDS-J ACQ IMM DEF, V50, P430, DOI 10.1097/QAI.0b013e31819a292c; Carrero JJ, 2009, CLIN J AM SOC NEPHRO, V4, P110, DOI 10.2215/CJN.02790608; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Chorianopoulos E, 2010, ATHEROSCLEROSIS, V211, P322, DOI 10.1016/j.atherosclerosis.2010.02.016; Chorianopoulos E, 2009, EUR J HEART FAIL, V11, P1050, DOI 10.1093/eurjhf/hfp139; Currier Judith S, 2008, Circulation, V118, pe29, DOI 10.1161/CIRCULATIONAHA.107.189624; Davis BH, 2005, CYTOM PART B-CLIN CY, V63B, P16, DOI 10.1002/cyto.b.20031; Dube Michael P, 2008, Circulation, V118, pe36, DOI 10.1161/CIRCULATIONAHA.107.189625; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fick A, 2012, J BIOL CHEM, V287, P484, DOI 10.1074/jbc.M111.287656; Funderburg NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083514; Hearps AC, 2012, AIDS, V26, P843, DOI 10.1097/QAD.0b013e328351f756; Hsue PY, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000422; Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x; Jang JJ, 2011, ATHEROSCLEROSIS, V217, P514, DOI 10.1016/j.atherosclerosis.2011.03.035; Jelic-Ivanovic Z, 2009, CLIN BIOCHEM, V42, P1381, DOI 10.1016/j.clinbiochem.2009.06.001; Jong E, 2010, THROMB HAEMOSTASIS, V104, P1228, DOI 10.1160/TH10-04-0233; Kalayjian RC, 2010, J INFECT DIS, V201, P1796, DOI 10.1086/652750; Kim SH, 2004, CIRC J, V68, P396, DOI 10.1253/circj.68.396; Kralisch S, 2008, ATHEROSCLEROSIS, V199, P440, DOI 10.1016/j.atherosclerosis.2007.10.022; Kristoffersen US, 2009, HIV MED, V10, P79, DOI 10.1111/j.1468-1293.2008.00661.x; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Kurz K, 2009, PHARMACOL RES, V60, P508, DOI 10.1016/j.phrs.2009.07.009; Law MG, 2006, HIV MED, V7, P218, DOI 10.1111/j.1468-1293.2006.00362.x; Levy AP, 2007, CIRC RES, V101, P106, DOI 10.1161/CIRCRESAHA.107.149435; Martin GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055279; Martin-Ventura JL, 2011, ATHEROSCLEROSIS, V214, P486, DOI 10.1016/j.atherosclerosis.2010.11.009; McComsey GA, 2012, AIDS, V26, P1371, DOI 10.1097/QAD.0b013e328354f4fb; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Moller HJ, 2002, BLOOD, V99, P378, DOI 10.1182/blood.V99.1.378; Moreno JA, 2010, ARTERIOSCL THROM VAS, V30, P1253, DOI 10.1161/ATVBAHA.110.203364; Moreno JA, 2009, ATHEROSCLEROSIS, V207, P103, DOI 10.1016/j.atherosclerosis.2009.04.033; Moreno JA, 2012, EUR HEART J, V33, P252, DOI 10.1093/eurheartj/ehr123; Munoz-Garcia B, 2006, STROKE, V37, P2044, DOI 10.1161/01.STR.0000230648.00027.00; Munoz-Garcia B, 2009, ARTERIOSCL THROM VAS, V29, P2061, DOI 10.1161/ATVBAHA.109.194852; Nakayama M, 2003, BIOCHEM BIOPH RES CO, V306, P819, DOI 10.1016/S0006-291X(03)01051-9; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Panel de expertos de Gesida y Plan Nacional sobre el Sida, 2012, Enferm Infecc Microbiol Clin, V30, pe1, DOI 10.1016/j.eimc.2012.03.006; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Sandler NG, 2014, CURR OPIN HIV AIDS, V9, P72, DOI 10.1097/COH.0000000000000020; Sosner P, 2012, ATHEROSCLEROSIS, V222, P274, DOI 10.1016/j.atherosclerosis.2012.02.027; Stein JH, 2001, CIRCULATION, V104, P257, DOI 10.1161/01.CIR.104.3.257; Subramanian S, 2012, JAMA-J AM MED ASSOC, V308, P379, DOI 10.1001/jama.2012.6698; Tippett E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019968; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Triant VA, 2009, JAIDS-J ACQ IMM DEF, V51, P268, DOI 10.1097/QAI.0b013e3181a9992c; Urbonaviciene G, 2011, ATHEROSCLEROSIS, V219, P892, DOI 10.1016/j.atherosclerosis.2011.09.016; Valdivielso JM, 2013, J NEPHROL, V26, P1105, DOI 10.5301/jn.5000245; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Yilmaz MI, 2011, CLIN J AM SOC NEPHRO, V6, P785, DOI 10.2215/CJN.09231010	58	44	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90541	10.1371/journal.pone.0090541	http://dx.doi.org/10.1371/journal.pone.0090541			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594990	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500064
J	Caruso, R; Botta, L; Verde, A; Milazzo, F; Vecchi, I; Trivella, MG; Martinelli, L; Paino, R; Frigerio, M; Parodi, O				Caruso, Raffaele; Botta, Luca; Verde, Alessandro; Milazzo, Filippo; Vecchi, Irene; Trivella, Maria Giovanna; Martinelli, Luigi; Paino, Roberto; Frigerio, Maria; Parodi, Oberdan			Relationship between Pre-Implant Interleukin-6 Levels, Inflammatory Response, and Early Outcome in Patients Supported by Left Ventricular Assist Device: A Prospective Study	PLOS ONE			English	Article							HEART-FAILURE; INTENSIVE-CARE; TASK-FORCE; ASSOCIATION; GUIDELINES; DIAGNOSIS; PEROXYNITRITE; MORTALITY; NEOPTERIN; SOCIETY	Purpose: The immune response is crucial in the development of multi-organ failure (MOF) and complications in end-stage heart failure patients supported by left ventricular assist device (LVAD). However, at pre-implant, the association between inflammatory state and post-LVAD outcome is not yet clarified. Aim of the study was to assess the relationship among pre-implant levels of immune-related cytokines, postoperative inflammatory response and 3-month outcome in LVAD-patients. Methods: In 41 patients undergoing LVAD implantation, plasma levels of interleukin (IL)-6, IL-8, crucial for monocyte modulation, and urine neopterin/creatinine ratio (Neo/Cr), marker of monocyte activation, were assessed preoperatively, at 3 days, 1 and 4 weeks post-LVAD. MOF was evaluated by total sequential organ failure assessment (tSOFA) score. Intensive care unit (ICU)-death and/or post-LVAD tSOFA >= 11 was considered as main adverse outcome. Length of ICU-stay, 1 week-tSOFA score, hospitalisation and 3-month survival were considered additional end-points. Results: During ICU-stay, 8 patients died of MOF, while 8 of the survivors experienced severe MOF with postoperative tSOFA score >= 11. Pre-implant level of IL-6 >= 8.3 pg/mL was identified as significant marker of discrimination between patients with or without adverse outcome (OR 6.642, 95% Cl 1.201-36.509, p = 0.030). Patients were divided according to pre-implant IL-6 cutoff of 8.3 pg/ml in A [3.5 (1.2-6.1) pg/mL] and B [24.6 (16.4-38.0) pg/mL] groups. Among pre-implant variables, only white blood cells count was independently associated with pre-implant IL-6 levels higher than 8.3 pg/ml (OR 1.491, 95% CI 1.004-2.217, p = 0.048). The ICU-stay and hospitalisation resulted longer in B-group (p = 0.001 and p = 0.030, respectively). Postoperatively, 1 week-tSOFA score, IL-8 and Neo/Cr levels were higher in B-group. Conclusions: LVAD-candidates with elevated pre-implant levels of IL-6 are associated, after intervention, to higher release of monocyte activation related-markers, a clue for the development of MOF, longer clinical course and poor outcome.	[Caruso, Raffaele; Parodi, Oberdan] Osped Niguarda Ca Granda, CNR Inst Clin Physiol, CardioThorac & Vasc Dept, Milan, Italy; [Botta, Luca; Verde, Alessandro; Milazzo, Filippo; Vecchi, Irene; Martinelli, Luigi; Paino, Roberto; Frigerio, Maria] Osped Niguarda Ca Granda, CardioThorac & Vasc Dept, Milan, Italy; [Trivella, Maria Giovanna] CNR Inst Clin Physiol, Pisa, Italy; [Trivella, Maria Giovanna] Univ Pisa, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Pisa	Caruso, R (corresponding author), Osped Niguarda Ca Granda, CNR Inst Clin Physiol, CardioThorac & Vasc Dept, Milan, Italy.	raffaele.caruso@ospedaleniguarda.it	Vecchi, Irene/Y-5084-2019; Botta, Luca/A-1090-2015	Vecchi, Irene/0000-0002-7836-7430; Botta, Luca/0000-0002-5674-3861; Verde, Alessandro/0000-0003-3917-2355; Trivella, Maria Giovanna/0000-0001-8702-2859	 [24863]		This study was partially supported by FP7-ICT-2009 project grant agreement 24863 (SensorART - A Remote Controlled Sensorized ARTificial Heart Enabling Patients Empowerment and New Therapy Approaches). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Caruso R, 2012, J HEART LUNG TRANSPL, V31, P625, DOI 10.1016/j.healun.2012.02.006; Caruso R, 2010, ASAIO J, V56, P313, DOI 10.1097/MAT.0b013e3181de3049; Castellani ML, 2012, J BIOL REGUL HOMEOST, V24, P1; De Rosa S, 2011, CURR VASC PHARMACOL, V9, P188, DOI 10.2174/157016111794519372; Deng MC, 2005, J HEART LUNG TRANSPL, V24, P1182, DOI 10.1016/j.healun.2005.07.002; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Ferdinandy P, 2000, CIRC RES, V87, P241, DOI 10.1161/01.RES.87.3.241; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Herpfer I, 2002, FREE RADICAL RES, V36, P509, DOI 10.1080/10715760290025898; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Kirsch M, 2012, INT J ARTIF ORGANS, V35, P169, DOI 10.5301/ijao.5000053; Kobold ACM, 2000, INTENS CARE MED, V26, P883, DOI 10.1007/s001340051277; Levey AS, 2000, J AM SOC NEPHROL, V11, pA0828; Lund LH, 2010, EUR J HEART FAIL, V12, P434, DOI 10.1093/eurjhf/hfq006; Masai T, 2002, ANN THORAC SURG, V73, P549, DOI 10.1016/S0003-4975(01)03510-X; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Nieminen MS, 2005, EUR HEART J, V26, P384; Palardy M, 2010, J CARD FAIL, V16, P218, DOI 10.1016/j.cardfail.2009.11.002; Ploder M, 2006, SHOCK, V25, P129, DOI 10.1097/01.shk.0000191379.62897.1d; Shiga T, 2011, CIRC J, V75, P121, DOI 10.1253/circj.CJ-10-0770; Walsh DS, 2005, J SURG RES, V129, P221, DOI 10.1016/j.jss.2005.05.003; Wiel E, 2005, CRIT CARE CLIN, V21, P403, DOI 10.1016/j.ccc.2005.03.001; Wilson SR, 2009, CIRCULATION, V119, P2225, DOI 10.1161/CIRCULATIONAHA.109.850610	24	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90802	10.1371/journal.pone.0090802	http://dx.doi.org/10.1371/journal.pone.0090802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594915	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500102
J	de Oliveira, DN; Ferreira, MS; Catharino, RR				de Oliveira, Diogo N.; Ferreira, Monica S.; Catharino, Rodrigo R.			Rapid and Simultaneous In Situ Assessment of Aflatoxins and Stilbenes Using Silica Plate Imprinting Mass Spectrometry Imaging	PLOS ONE			English	Article							SOLID-PHASE EXTRACTION; LIQUID-CHROMATOGRAPHY; SMALL MOLECULES; FOOD SAFETY; RESVERATROL; MYCOTOXIN; MALDI; URINE; HPLC; OCHRATOXIN	A fast and direct combination of techniques for simultaneous mycotoxin and phytoalexin identification in peanut skin and kernel is described. Silica Plate Imprinting Laser Desorption/Ionization Mass Spectrometry Imaging (SPILDI-MSI) is a powerful technique that exhibits great advantages, such as solvent-free and matrix-free characteristics, as well as no sample preparation or separation steps. It also permits accurate identification of mycotoxins and phytoalexins with unique fingerprint profiles in just a few seconds. Results are expressed as chemical images of the 4 identified types of aflatoxins (B1, B2, G1 and G2) and a stilbenoid (resveratrol). Also, SPILDI-MSI allows the comparison between the spatial distribution of aflatoxins and resveratrol found in kernel and skin. This novel application has proven to be useful for instantaneous qualitative assessment of aflatoxins and stilbenoids both in the peanut skin and kernel and offers precise tracking of fungal contamination in nuts and other foodstuffs.	[de Oliveira, Diogo N.; Ferreira, Monica S.; Catharino, Rodrigo R.] Univ Estadual Campinas, UNICAMP, Sch Med Sci, INNOVARE Biomarkers Lab, Campinas, SP, Brazil	Universidade Estadual de Campinas	Catharino, RR (corresponding author), Univ Estadual Campinas, UNICAMP, Sch Med Sci, INNOVARE Biomarkers Lab, Campinas, SP, Brazil.	rrc@fcm.unicamp.br	Catharino, Rodrigo/AAH-4333-2021; de Oliveira, Diogo Noin/C-3939-2013; Siqueira Ferreira, Mônica/B-8718-2014; Catharino, Rodrigo/G-1487-2013	Catharino, Rodrigo/0000-0001-7219-2644; de Oliveira, Diogo Noin/0000-0002-2725-476X; Catharino, Rodrigo/0000-0001-7219-2644	CAPES, FAPESP [2011/50400-0]; INCT	CAPES, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INCT	The authors would like to thanks CAPES, FAPESP (process number 2011/50400-0) and INCT for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali WH, 2010, J CHROMATOGR A, V1217, P6668, DOI 10.1016/j.chroma.2010.04.071; Ayed-Boussema I, 2008, TOXICOL IN VITRO, V22, P1671, DOI 10.1016/j.tiv.2008.06.016; Belli P, 2010, FOOD CHEM TOXICOL, V48, P2818, DOI 10.1016/j.fct.2010.07.012; Bicchi C, 2007, J CHROMATOGR A, V1148, P137, DOI 10.1016/j.chroma.2007.03.007; Bouhet S, 2005, VET IMMUNOL IMMUNOP, V108, P199, DOI 10.1016/j.vetimm.2005.08.010; Bryden WL, 2012, ANIM FEED SCI TECH, V173, P134, DOI 10.1016/j.anifeedsci.2011.12.014; Catharino RR, 2005, ANAL CHEM, V77, P8155, DOI 10.1021/ac051111p; Cavaliere C, 2006, J CHROMATOGR A, V1135, P135, DOI 10.1016/j.chroma.2006.07.048; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; de Melo FT, 2012, FOOD CHEM TOXICOL, V50, P3548, DOI 10.1016/j.fct.2011.12.022; de Oliveira D, 2013, INT J COSMETIC SCI; Drexler Dieter M., 2007, Journal of Pharmacological and Toxicological Methods, V55, P279, DOI 10.1016/j.vascn.2006.11.004; Fabiani A, 2010, TALANTA, V83, P281, DOI 10.1016/j.talanta.2010.08.027; Ferreira MS, 2014, ANAL CHIM ACTA, V807, P96, DOI 10.1016/j.aca.2013.11.033; Galezowska A, 2013, RAPID COMMUN MASS SP, V27, P964, DOI 10.1002/rcm.6536; Garrett TJ, 2007, INT J MASS SPECTROM, V260, P166, DOI 10.1016/j.ijms.2006.09.019; Grove KJ, 2011, J AM SOC MASS SPECTR, V22, P192, DOI 10.1007/s13361-010-0013-8; Holcomb M, 1996, J SUPERCRIT FLUID, V9, P118, DOI 10.1016/S0896-8446(96)90007-8; Jeannot E, 2012, INT J CANCER, V130, P1347, DOI 10.1002/ijc.26140; KUSSAK A, 1993, J CHROMATOGR-BIOMED, V616, P235, DOI 10.1016/0378-4347(93)80391-G; Lee SS, 2004, FOOD RES INT, V37, P247, DOI 10.1016/j.foodres.2003.11.007; Moss MO, 1996, MYCOL RES, V100, P513, DOI 10.1016/S0953-7562(96)80001-3; Norris JL, 2013, CHEM REV, V113, P2309, DOI 10.1021/cr3004295; Pascual-Marti MC, 2001, TALANTA, V54, P735, DOI 10.1016/S0039-9140(01)00319-8; Pitt JI, 2013, FOOD CONTROL, V32, P205, DOI 10.1016/j.foodcont.2012.11.023; Reiter E, 2009, MOL NUTR FOOD RES, V53, P508, DOI 10.1002/mnfr.200800145; Rodriguez-Carrasco Y, 2012, J CHROMATOGR A, V1270, P28, DOI 10.1016/j.chroma.2012.10.061; Scott E, 2012, MOL NUTR FOOD RES, V56, P7, DOI 10.1002/mnfr.201100400; Sherma J, 2000, J CHROMATOGR A, V880, P129, DOI 10.1016/S0021-9673(99)01132-2; Shindler KS, 2010, J NEURO-OPHTHALMOL, V30, P328, DOI 10.1097/WNO.0b013e3181f7f833; Sobolev VS, 2007, J AGR FOOD CHEM, V55, P2195, DOI 10.1021/jf063478g; Sobolev VS, 2011, J AGR FOOD CHEM, V59, P1673, DOI 10.1021/jf104742n; Sobolev VS, 2009, J AGR FOOD CHEM, V57, P62, DOI 10.1021/jf802891v; Somogyi A, 2007, MACROMOLECULES, V40, P5311, DOI 10.1021/ma062200m; Tokusoglu O, 2005, J AGR FOOD CHEM, V53, P5003, DOI 10.1021/jf050496+; Ungvari Z, 2007, AM J PHYSIOL-HEART C, V292, pH2417, DOI 10.1152/ajpheart.01258.2006; Urayama S, 2010, RAPID COMMUN MASS SP, V24, P613, DOI 10.1002/rcm.4420; Vatinno R, 2008, J CHROMATOGR A, V1201, P215, DOI 10.1016/j.chroma.2008.05.079; Wagacha JM, 2008, INT J FOOD MICROBIOL, V124, P1, DOI 10.1016/j.ijfoodmicro.2008.01.008; Wang SH, 2010, RECENT ADVANCES IN FOOD AND FLAVOR CHEMISTRY: FOOD FLAVORS AND ENCAPSULATION, HEALTH BENEFITS, ANALYTICAL METHODS, AND MOLECULAR BIOLOGY OF FUNCTIONAL FOODS, P322; Wang Y, 2002, J AGR FOOD CHEM, V50, P431, DOI 10.1021/jf010812u; Xu H, 2007, J CHROMATOGR B, V852, P529, DOI 10.1016/j.jchromb.2007.02.057; Youssef M, 2013, THER DRUG MONIT, V35, P698	43	23	23	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90901	10.1371/journal.pone.0090901	http://dx.doi.org/10.1371/journal.pone.0090901			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595464	gold, Green Published, Green Submitted			2022-12-25	WOS:000332475500110
J	Gavilan, HS; Kulikauskas, RM; Gutmann, DH; Fehon, RG				Gavilan, Heather S.; Kulikauskas, Rima M.; Gutmann, David H.; Fehon, Richard G.			In Vivo Functional Analysis of the Human NF2 Tumor Suppressor Gene in Drosophila	PLOS ONE			English	Article							REGULATE CELL-PROLIFERATION; EXPANDED FUNCTION; EPITHELIAL-CELLS; ERM PROTEINS; MERLIN; HIPPO; MOESIN; TUMORIGENESIS; NF2/MERLIN; GROWTH	The proper control of tissue growth is essential during normal development and an important problem in human disease. Merlin, the product of the Neurofibromatosis 2 tumor suppressor gene, has been extensively studied to understand its functions in growth control. Here we describe experiments in which we used Drosophila as an in vivo system to test the functions of the normal human NF2 gene products and patient-derived mutant alleles. Although the predominant NF2 gene isoform, isoform 1, could functionally replace the Drosophila Merlin gene, a second isoform with a distinct C-terminal tail could not. Immunofluorescence studies show that the two isoforms have distinct subcellular localizations when expressed in the polarized imaginal epithelium, and function in genetic rescue assays correlates with apical localization of the NF2 protein. Interestingly, we found that a patient-derived missense allele, NF2(L64P), appears to be temperature sensitive. These studies highlight the utility of Drosophila for in vivo functional analysis of highly conserved human disease genes.	[Fehon, Richard G.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Gavilan, Heather S.; Kulikauskas, Rima M.] Duke Univ, Dept Biol, Durham, NC USA; [Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	University of Chicago; Duke University; Washington University (WUSTL)	Fehon, RG (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA.	rfehon@uchicago.edu		Gutmann, David/0000-0002-3127-5045	National Institutes of Health [NS034783]; U.S. Army Neurofibromatosis Research Program [DAMD17-97-1-7345]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Neurofibromatosis Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (NS034783) and the U.S. Army Neurofibromatosis Research Program (DAMD17-97-1-7345) to RGF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cockburn K, 2013, CURR BIOL, V23, P1195, DOI 10.1016/j.cub.2013.05.044; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Denholm B, 2005, DEVELOPMENT, V132, P2389, DOI 10.1242/dev.01829; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Giovannini M, 1999, GENE DEV, V13, P978, DOI 10.1101/gad.13.8.978; Goutebroze L, 2000, MOL CELL BIOL, V20, P1699, DOI 10.1128/MCB.20.5.1699-1712.2000; Gronholm M, 1999, J CELL SCI, V112, P895; Guilgur LG, 2012, DEVELOPMENT, V139, P503, DOI 10.1242/dev.071027; Gutmann DH, 1999, HUM MOL GENET, V8, P267, DOI 10.1093/hmg/8.2.267; Gutmann DH, 1998, HUM MOL GENET, V7, P335, DOI 10.1093/hmg/7.3.335; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; HARA T, 1994, CANCER RES, V54, P330; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; Hughes SC, 2006, J CELL BIOL, V175, P305, DOI 10.1083/jcb.200608009; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; LaJeunesse DR, 2001, GENETICS, V158, P667; Li W, 2012, EMBO REP, V13, P204, DOI 10.1038/embor.2012.11; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; McCartney BM, 2000, DEVELOPMENT, V127, P1315; McCartney BM, 1996, J CELL BIOL, V133, P843, DOI 10.1083/jcb.133.4.843; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; MCCLATCHEY AI, 1992, CELL, V68, P769, DOI 10.1016/0092-8674(92)90151-2; McClatchey AI, 2009, TRENDS CELL BIOL, V19, P198, DOI 10.1016/j.tcb.2009.02.006; Neisch AL, 2013, MOL BIOL CELL, V24, P1420, DOI 10.1091/mbc.E12-11-0800; Nguyen R, 2001, J BIOL CHEM, V276, P7621, DOI 10.1074/jbc.M006708200; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Schulz A, 2013, NAT NEUROSCI, V16, P426, DOI 10.1038/nn.3348; Scoles DR, 1998, NAT GENET, V18, P354, DOI 10.1038/ng0498-354; Sher I, 2012, DEV CELL, V22, P703, DOI 10.1016/j.devcel.2012.03.008; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; WILDER EL, 1995, DEVELOPMENT, V121, P477; Yang K, 2005, FEBS LETT, V579, P4113, DOI 10.1016/j.febslet.2005.06.039; Yi CL, 2010, GENE DEV, V24, P1673, DOI 10.1101/gad.1964810; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015	39	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90853	10.1371/journal.pone.0090853	http://dx.doi.org/10.1371/journal.pone.0090853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595234	Green Published, gold			2022-12-25	WOS:000332475500105
J	Li, JJ; Dolios, G; Wang, R; Liao, FF				Li, Jing Jing; Dolios, Georgia; Wang, Rong; Liao, Francesca-Fang			Soluble Beta-Amyloid Peptides, but Not Insoluble Fibrils, Have Specific Effect on Neuronal MicroRNA Expression	PLOS ONE			English	Article							LONG-TERM POTENTIATION; IMPAIR SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; A-BETA; POSTSYNAPTIC DENSITY-95; SECRETED OLIGOMERS; OXIDATIVE STRESS; SMALL RNAS; IN-VIVO; PROTEIN	Recent studies indicate that soluble beta-amyloid (sA beta) oligomers, rather than their fibrillar aggregates, contribute to the pathogenesis of Alzheimer's disease (AD), though the mechanisms of their neurotoxicity are still elusive. Here, we demonstrate that sA beta derived from 7PA2 cells exert a much stronger effect on the regulation of a set of functionally validated microRNAs (miRNAs) in primary cultured neurons than the synthetic insoluble A beta fibrils (fA beta). Synthetic sA beta peptides at a higher concentration present comparable effect on these miRNAs in our neuronal model. Further, the sA beta-induced miR-134, miR-145 and miR-210 expressions are fully reversed by two selective N-methyl-d-aspartate (NMDA) receptor inhibitors, but are neither reversed by insulin nor by forskolin, suggesting an NMDA receptor-dependent, rather than PI3K/AKT or PKA/CREB signaling dependent regulatory mechanism. In addition, the repression of miR-107 expression by the sA beta containing 7PA2 CM is likely involved multiple mechanisms and multiple players including NMDA receptor, N-terminally truncated A beta and reactive oxygen species (ROS).	[Li, Jing Jing; Liao, Francesca-Fang] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; [Dolios, Georgia; Wang, Rong] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	University of Tennessee System; University of Tennessee Health Science Center; Icahn School of Medicine at Mount Sinai	Li, JJ (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA.	jli43@uthsc.edu; fliao@uthsc.edu	Wang, Rong/A-8721-2009		NIH [R01AG031893, R21AG041934, R21NS083908]; Alzheimer's Association [IIRG-11-204030]; NIH/NINDS [P30 NS061777]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061777, R21NS083908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031893, R21AG041934] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by research grants from NIH (R01AG031893, R21AG041934, R21NS083908); Alzheimer's Association (IIRG-11-204030 for F. F. L.); and NIH/NINDS P30 NS061777 for W. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschrafi A, 2008, J NEUROSCI, V28, P12581, DOI 10.1523/JNEUROSCI.3338-08.2008; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Boissonneault V, 2009, J BIOL CHEM, V284, P1971, DOI 10.1074/jbc.M807530200; Brouillette J, 2012, J NEUROSCI, V32, P7852, DOI 10.1523/JNEUROSCI.5901-11.2012; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Cui JG, 2010, J BIOL CHEM, V285, P38951, DOI 10.1074/jbc.M110.178848; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; delaMonte SM, 1997, J NEUROL SCI, V152, P73, DOI 10.1016/S0022-510X(97)00131-7; Eacker SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025068; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2013, J ALZHEIMERS DIS, V35, P335, DOI 10.3233/JAD-122350; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kitamura Y, 1997, BIOCHEM BIOPH RES CO, V232, P418, DOI 10.1006/bbrc.1997.6301; Klein WL, 2013, J ALZHEIMERS DIS, V33, pS49, DOI 10.3233/JAD-2012-129039; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Kwak YD, 2012, J NEUROSCI, V32, P10971, DOI 10.1523/JNEUROSCI.1836-12.2012; Kye MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024682; Lambert TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015182; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lau P, 2013, EMBO MOL MED, V5, P1613, DOI 10.1002/emmm.201201974; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Li YY, 2011, NEUROSCI LETT, V487, P94, DOI 10.1016/j.neulet.2010.09.079; Lin Q, 2011, NAT NEUROSCI, V14, P1115, DOI 10.1038/nn.2891; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Lukiw Walter J, 2012, Int J Biochem Mol Biol, V3, P105; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Mok YF, 2006, METHOD ENZYMOL, V413, P199, DOI 10.1016/S0076-6879(06)13011-6; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Muller M, 2014, NEUROBIOL AGING, V35, P152, DOI 10.1016/j.neurobiolaging.2013.07.005; Nakanishi N, 2013, J NEUROSCI, V33, P14170, DOI 10.1523/JNEUROSCI.4646-10.2013; Portelius E, 2013, J ALZHEIMERS DIS, V33, P85, DOI 10.3233/JAD-2012-120994; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Schonrock N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011070; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shao NY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-409; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; Su D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054505; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Uljon SN, 2000, METH MOL B, V146, P439, DOI 10.1385/1-59259-045-4:439; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HL, 2010, BRAIN RES, V1357, P166, DOI 10.1016/j.brainres.2010.08.023; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202; Wang XY, 2009, BRAIN RES BULL, V80, P268, DOI 10.1016/j.brainresbull.2009.08.006; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Wong HKA, 2013, HUM MOL GENET, V22, P3077, DOI 10.1093/hmg/ddt164; Xie L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0001.2002; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yoon SO, 2012, NEURON, V75, P824, DOI 10.1016/j.neuron.2012.06.024	75	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90770	10.1371/journal.pone.0090770	http://dx.doi.org/10.1371/journal.pone.0090770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595404	gold, Green Submitted, Green Published			2022-12-25	WOS:000332475500100
J	Schmer, MR; Vogel, KP; Varvel, GE; Follett, RF; Mitchell, RB; Jin, VL				Schmer, Marty R.; Vogel, Kenneth P.; Varvel, Gary E.; Follett, Ronald F.; Mitchell, Robert B.; Jin, Virginia L.			Energy Potential and Greenhouse Gas Emissions from Bioenergy Cropping Systems on Marginally Productive Cropland	PLOS ONE			English	Article							LAND-USE CHANGE; CELLULOSIC ETHANOL; CARBON DEBT; CORN STOVER; NET ENERGY; SWITCHGRASS; BIOMASS; BIOFUELS; US; GRASSLANDS	Low-carbon biofuel sources are being developed and evaluated in the United States and Europe to partially offset petroleum transport fuels. Current and potential biofuel production systems were evaluated from a long-term continuous no-tillage corn (Zea mays L.) and switchgrass (Panicum virgatum L.) field trial under differing harvest strategies and nitrogen (N) fertilizer intensities to determine overall environmental sustainability. Corn and switchgrass grown for bioenergy resulted in near-term net greenhouse gas (GHG) reductions of -29 to -396 grams of CO2 equivalent emissions per megajoule of ethanol per year as a result of direct soil carbon sequestration and from the adoption of integrated biofuel conversion pathways. Management practices in switchgrass and corn resulted in large variation in petroleum offset potential. Switchgrass, using best management practices produced 3919 +/- 117 liters of ethanol per hectare and had 74 +/- 2.2 gigajoules of petroleum offsets per hectare which was similar to intensified corn systems (grain and 50% residue harvest under optimal N rates). Co-locating and integrating cellulosic biorefineries with existing dry mill corn grain ethanol facilities improved net energy yields (GJ ha(-1)) of corn grain ethanol by >70%. A multi-feedstock, landscape approach coupled with an integrated biorefinery would be a viable option to meet growing renewable transportation fuel demands while improving the energy efficiency of first generation biofuels.	[Schmer, Marty R.; Varvel, Gary E.; Jin, Virginia L.] Univ Nebraska, USDA ARS, Agroecosyst Management Res Unit, Lincoln, NE 68583 USA; [Vogel, Kenneth P.; Mitchell, Robert B.] Univ Nebraska, USDA ARS, Grain Forage & Bioenergy Res Unit, Lincoln, NE 68583 USA; [Follett, Ronald F.] USDA ARS, Soil Plant Nutrient Res Unit, Ft Collins, CO 80522 USA	United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA)	Schmer, MR (corresponding author), Univ Nebraska, USDA ARS, Agroecosyst Management Res Unit, Lincoln, NE 68583 USA.	marty.schmer@ars.usda.gov			U.S. Department of Agriculture (USDA), Agricultural Research Service (ARS); USDA-ARS GRACEnet effort; USDA Natural Resources Conservation Service	U.S. Department of Agriculture (USDA), Agricultural Research Service (ARS)(United States Department of Agriculture (USDA)); USDA-ARS GRACEnet effort; USDA Natural Resources Conservation Service(United States Department of Agriculture (USDA))	This research was funded by the U.S. Department of Agriculture (USDA), Agricultural Research Service (ARS) including funds from the USDA-ARS GRACEnet effort, and partly by the USDA Natural Resources Conservation Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PR, 2007, ECOL APPL, V17, P675, DOI 10.1890/05-2018; California Air Resources Board, 2013, LOW CARB FUEL STAND, P13; Claassen R., 2011, ERR120; Davis SC, 2012, FRONT ECOL ENVIRON, V10, P69, DOI 10.1890/110003; DOE US, 2011, ORNLTM2011224 DOE US; Donner SD, 2008, P NATL ACAD SCI USA, V105, P4513, DOI 10.1073/pnas.0708300105; Dunn JB, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-51; Energy Information Agency, 2013, DOEEIA0383; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Follett RF, 2013, SOIL SCI SOC AM J, V77, P951, DOI 10.2136/sssaj2012.0413; Follett RF, 2012, BIOENERG RES, V5, P866, DOI 10.1007/s12155-012-9198-y; Frank AB, 2004, CROP SCI, V44, P1391, DOI 10.2135/cropsci2004.1391; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Gelfand I, 2011, P NATL ACAD SCI USA, V108, P13864, DOI 10.1073/pnas.1017277108; GRABOSKI MS, 2002, FOSSIL ENERGY USE MA; Humbird D, 2011, NRELTP510047764 USDO, P136; Jin VL, 2011, ASA CSSA SSSA INT AN; Liebig MA, 2008, BIOENERG RES, V1, P215, DOI 10.1007/s12155-008-9019-5; Liska A. J., 2008, BESS BIOFUEL ENERGY; Liska AJ, 2008, J BIOBASED MATER BIO, V2, P187, DOI 10.1166/jbmb.2008.402; Liska AJ, 2009, J IND ECOL, V13, P58, DOI 10.1111/j.1530-9290.2008.00105.x; MacLean HL, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014001; Mitchell R, 2012, BIOFUELS-UK, V3, P47, DOI 10.4155/BFS.11.153; Plevin RJ, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/2/024003; Renewable and Applicable Energy Laboratory, 2007, EN RES GROUP BIOF AN; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Sheehan John, 2003, Journal of Industrial Ecology, V7, P117; Spatari S, 2010, BIORESOURCE TECHNOL, V101, P654, DOI 10.1016/j.biortech.2009.08.067; Templeton DW, 2009, CELLULOSE, V16, P621, DOI 10.1007/s10570-009-9325-x; Uden DR, 2013, BIOENERG RES, V6, P930, DOI 10.1007/s12155-013-9311-x; Unger N, 2010, P NATL ACAD SCI USA, V107, P3382, DOI 10.1073/pnas.0906548107; USDA-NASS, 2013, US CORN YIELDS; Varvel GE, 2008, BIOMASS BIOENERG, V32, P18, DOI 10.1016/j.biombioe.2007.07.003; Vogel KP, 2011, BIOENERG RES, V4, P96, DOI 10.1007/s12155-010-9104-4; Vogel KP, 2008, CROP SCI, V48, P2159, DOI 10.2135/cropsci2008.02.0117; Vogel KP, 2002, AGRON J, V94, P413, DOI 10.2134/agronj2002.0413; Wallace R, 2005, NREPTP51037092 USDOE; Wallander S., 2011, USDA ERS EC INFORM B, V79; Wang M, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045905; Wang M, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/2/024001; Wiens J, 2011, ECOL APPL, V21, P1085, DOI 10.1890/09-0673.1; Wilhelm WW, 2007, AGRON J, V99, P1665, DOI 10.2134/agronj2007.0150; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110	45	44	45	3	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89501	10.1371/journal.pone.0089501	http://dx.doi.org/10.1371/journal.pone.0089501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594783	Green Submitted, Green Published, gold			2022-12-25	WOS:000332475500015
J	Breitbach, S; Tug, S; Helmig, S; Zahn, D; Kubiak, T; Michal, M; Gori, T; Ehlert, T; Beiter, T; Simon, P				Breitbach, Sarah; Tug, Suzan; Helmig, Susanne; Zahn, Daniela; Kubiak, Thomas; Michal, Matthias; Gori, Tommaso; Ehlert, Tobias; Beiter, Thomas; Simon, Perikles			Direct Quantification of Cell-Free, Circulating DNA from Unpurified Plasma	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROME; MATERNAL PLASMA; CANCER-PATIENTS; PROGNOSTIC MARKER; QUANTITATIVE PCR; NUCLEIC-ACIDS; BREAST-CANCER; HUMAN GENOME; HUMAN-BLOOD	Cell-free DNA (cfDNA) in body tissues or fluids is extensively investigated in clinical medicine and other research fields. In this article we provide a direct quantitative real-time PCR (qPCR) as a sensitive tool for the measurement of cfDNA from plasma without previous DNA extraction, which is known to be accompanied by a reduction of DNA yield. The primer sets were designed to amplify a 90 and 222 bp multi-locus L1PA2 sequence. In the first module, cfDNA concentrations in unpurified plasma were compared to cfDNA concentrations in the eluate and the flow-through of the QIAamp DNA Blood Mini Kit and in the eluate of a phenol-chloroform isoamyl (PCI) based DNA extraction, to elucidate the DNA losses during extraction. The analyses revealed 2.79-fold higher cfDNA concentrations in unpurified plasma compared to the eluate of the QIAamp DNA Blood Mini Kit, while 36.7% of the total cfDNA were found in the flow-through. The PCI procedure only performed well on samples with high cfDNA concentrations, showing 87.4% of the concentrations measured in plasma. The DNA integrity strongly depended on the sample treatment. Further qualitative analyses indicated differing fractions of cfDNA fragment lengths in the eluate of both extraction methods. In the second module, cfDNA concentrations in the plasma of 74 coronary heart disease patients were compared to cfDNA concentrations of 74 healthy controls, using the direct L1PA2 qPCR for cfDNA quantification. The patient collective showed significantly higher cfDNA levels (mean (SD) 20.1 (23.8) ng/ml; range 5.1-183.0 ng/ml) compared to the healthy controls (9.7 (4.2) ng/ml; range 1.6-23.7 ng/ml). With our direct qPCR, we recommend a simple, economic and sensitive procedure for the quantification of cfDNA concentrations from plasma that might find broad applicability, if cfDNA became an established marker in the assessment of pathophysiological conditions.	[Breitbach, Sarah; Tug, Suzan; Helmig, Susanne; Ehlert, Tobias; Simon, Perikles] Johannes Gutenberg Univ Mainz, Dept Sports Med Rehabil & Prevent, D-55122 Mainz, Germany; [Zahn, Daniela; Kubiak, Thomas] Johannes Gutenberg Univ Mainz, Dept Hlth Psychol, D-55122 Mainz, Germany; [Michal, Matthias] Johannes Gutenberg Univ Mainz, Dept Psychosomat Med & Psychotherapy, D-55122 Mainz, Germany; [Gori, Tommaso] Johannes Gutenberg Univ Mainz, Dept Cardiol Angiol & Internal Med, D-55122 Mainz, Germany; [Beiter, Thomas] Univ Tubingen, Dept Sports Med, Med Clin, Tubingen, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Eberhard Karls University of Tubingen	Simon, P (corresponding author), Johannes Gutenberg Univ Mainz, Dept Sports Med Rehabil & Prevent, D-55122 Mainz, Germany.	simonpe@uni-mainz.de	Gori, Tommaso/F-1575-2012; Kubiak, Thomas/D-4655-2009; Simon, Perikles D/B-2293-2013	Kubiak, Thomas/0000-0003-0095-9265; Simon, Perikles D/0000-0002-7996-4034; Zahn, Daniela/0000-0002-0477-1369; Beiter, Thomas/0000-0001-7299-7303	Johannes Gutenberg University of Mainz	Johannes Gutenberg University of Mainz	This work was supported by the internal research funding of the Johannes Gutenberg University of Mainz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKER P, 1975, CANCER RES, V35, P2375; Antonatos D, 2006, ANN NY ACAD SCI, V1075, P278, DOI 10.1196/annals.1368.037; Atamaniuk J, 2004, CLIN CHEM, V50, P1668, DOI 10.1373/clinchem.2004.034553; Atamaniuk J, 2008, EUR J APPL PHYSIOL, V104, P711, DOI 10.1007/s00421-008-0827-2; Atamaniuk J, 2010, EUR J APPL PHYSIOL, V110, P695, DOI 10.1007/s00421-010-1532-5; Balta S, 2013, CARDIOLOGY, V126, P122, DOI 10.1159/000353266; Beck J, 2009, CLIN CHEM, V55, P730, DOI 10.1373/clinchem.2008.113597; Beiter T, 2011, CLIN CHEM, V57, P633, DOI 10.1373/clinchem.2010.158030; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Breitbach S, 2012, SPORTS MED, V42, P565, DOI 10.2165/11631380-000000000-00000; Brojer E, 2005, TRANSFUSION, V45, P1473, DOI 10.1111/j.1537-2995.2005.00559.x; Buzdin A, 2003, HUM GENET, V112, P527, DOI 10.1007/s00439-002-0904-2; Chan KCA, 2008, CLIN CANCER RES, V14, P4141, DOI 10.1158/1078-0432.CCR-08-0182; Chang CPY, 2003, CLIN CHIM ACTA, V327, P95, DOI 10.1016/S0009-8981(02)00337-6; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Clausen FB, 2007, PRENATAL DIAG, V27, P6, DOI 10.1002/pd.1605; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cui M, 2013, CARDIOLOGY, V126, P124, DOI 10.1159/000353665; Deligezer U, 2008, CLIN CHEM LAB MED, V46, P311, DOI 10.1515/CCLM.2008.080; Destouni A, 2009, ACTA CARDIOL, V64, P51, DOI 10.2143/AC.64.1.2034362; Esser KH, 2006, NAT METHODS, V3, pI, DOI 10.1038/NMETH853; Fatouros IG, 2006, CLIN CHEM, V52, P1820, DOI 10.1373/clinchem.2006.070417; Fatouros IG, 2010, CLIN BIOCHEM, V43, P1368, DOI 10.1016/j.clinbiochem.2010.08.020; Fleischhacker M, 2011, CLIN CHIM ACTA, V412, P2085, DOI 10.1016/j.cca.2011.07.011; Fong SL, 2009, CLIN CHEM, V55, P587, DOI 10.1373/clinchem.2008.110122; Heitzer E, 2013, INT J CANCER, V133, P346, DOI 10.1002/ijc.28030; Herrera LJ, 2005, CLIN CHEM, V51, P113, DOI 10.1373/clinchem.2004.039263; Huang DJ, 2005, CLIN CHEM, V51, P2419, DOI 10.1373/clinchem.2005.056010; Huggett Jim F, 2008, BMC Res Notes, V1, P70, DOI 10.1186/1756-0500-1-70; Jahr S, 2001, CANCER RES, V61, P1659; Jensen MK, 2013, J AM HEART ASS, V2, P1; Jiang F, 2013, INT UROL NEPHROL, V45, P1023, DOI 10.1007/s11255-013-0491-2; Lee YJ, 2011, CLIN CANCER RES, V17, P5179, DOI 10.1158/1078-0432.CCR-11-0400; Lehner J, 2013, INT J CLIN PHARM TH, V51, P59, DOI 10.5414/CPP51059; LOPAREV VN, 1991, J VIROL METHODS, V34, P105, DOI 10.1016/0166-0934(91)90126-K; Macher H, 2012, CLIN CHIM ACTA, V414, P12, DOI 10.1016/j.cca.2012.08.001; Mamon H, 2008, CLIN CHEM, V54, P1582, DOI 10.1373/clinchem.2008.104612; Mygind T, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-17; Parida SK, 2006, ADV COLLOID INTERFAC, V121, P77, DOI 10.1016/j.cis.2006.05.028; Pavlicek A, 2001, GENE, V276, P39, DOI 10.1016/S0378-1119(01)00645-X; Puszyk WM, 2009, CLIN BIOCHEM, V42, P736, DOI 10.1016/j.clinbiochem.2008.11.006; Rozen S, 2000, Methods Mol Biol, V132, P365; Sai S, 2007, ANTICANCER RES, V27, P2747; Salvianti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049843; Schmidt B, 2005, CLIN CHEM, V51, P1561, DOI 10.1373/clinchem.2005.051003; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; Tamkovich SN, 2006, ANN NY ACAD SCI, V1075, P191, DOI 10.1196/annals.1368.026; Tangkijvanich P, 2007, CLIN CHIM ACTA, V379, P127, DOI 10.1016/j.cca.2006.12.029; Umetani N, 2006, J CLIN ONCOL, V24, P4270, DOI 10.1200/JCO.2006.05.9493; Umetani N, 2006, CLIN CHEM, V52, P1062, DOI 10.1373/clinchem.2006.068577; Umetani N, 2006, ANN NY ACAD SCI, V1075, P299, DOI 10.1196/annals.1368.040; van der Vaart M, 2008, ANN NY ACAD SCI, V1137, P18, DOI 10.1196/annals.1448.022; Yun DD, 1997, CARDIOLOGY, V88, P223, DOI 10.1159/000177335	55	96	101	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e87838	10.1371/journal.pone.0087838	http://dx.doi.org/10.1371/journal.pone.0087838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595313	Green Published, gold			2022-12-25	WOS:000332468900003
J	Hira, ZM; Trigeorgis, G; Gillies, DF				Hira, Zena M.; Trigeorgis, George; Gillies, Duncan F.			An Algorithm for Finding Biologically Significant Features in Microarray Data Based on A Priori Manifold Learning	PLOS ONE			English	Article							CLASSIFICATION; DISCOVERY; SELECTION; CANCER; ISOMAP	Microarray databases are a large source of genetic data, which, upon proper analysis, could enhance our understanding of biology and medicine. Many microarray experiments have been designed to investigate the genetic mechanisms of cancer, and analytical approaches have been applied in order to classify different types of cancer or distinguish between cancerous and non-cancerous tissue. However, microarrays are high-dimensional datasets with high levels of noise and this causes problems when using machine learning methods. A popular approach to this problem is to search for a set of features that will simplify the structure and to some degree remove the noise from the data. The most widely used approach to feature extraction is principal component analysis (PCA) which assumes a multivariate Gaussian model of the data. More recently, non-linear methods have been investigated. Among these, manifold learning algorithms, for example Isomap, aim to project the data from a higher dimensional space onto a lower dimension one. We have proposed a priori manifold learning for finding a manifold in which a representative set of microarray data is fused with relevant data taken from the KEGG pathway database. Once the manifold has been constructed the raw microarray data is projected onto it and clustering and classification can take place. In contrast to earlier fusion based methods, the prior knowledge from the KEGG databases is not used in, and does not bias the classification process-it merely acts as an aid to find the best space in which to search the data. In our experiments we have found that using our new manifold method gives better classification results than using either PCA or conventional Isomap.	[Hira, Zena M.; Trigeorgis, George; Gillies, Duncan F.] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England	Imperial College London	Hira, ZM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England.	zena.hira09@imperial.ac.uk	Trigeorgis, George/Y-8208-2019		Imperial College, Department of Computing	Imperial College, Department of Computing	George Trigeorgis and Zena Hira have been receiving PhD student funding from Imperial College, Department of Computing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian M, 2002, SCIENCE, V295; BELLMAN R, 1966, SCIENCE, V153, P34, DOI 10.1126/science.153.3731.34; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Cayton L., 2005, 12 U CAL, P1; Cayton L, 2005, CS20080923 U CAL; Chen X, 2008, BIOINFORMATICS; Chen X, 2009, J COMPUT BIOL, V16, P265, DOI 10.1089/cmb.2008.12TT; Chen Y, 2004, NUCLEIC ACIDS RES, V32, P6414, DOI 10.1093/nar/gkh978; Cheng Jill, 2004, J Biopharm Stat, V14, P687, DOI 10.1081/BIP-200025659; Choudhary A, 2006, BIOINFORMATICS, V22, P837, DOI 10.1093/bioinformatics/btl008; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Cobaleda C, 2009, BIOESSAYS, V31, P600, DOI 10.1002/bies.200800234; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dawson K, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-195; Dijkstra E. W., 1959, NUMER MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Evangelista PF, 2005, P EUR S ART NEUR NET; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Jaccard P., 1901, B SOC VAUD SCI NAT, V37, P547, DOI DOI 10.5169/SEALS-266450; Jonnalagadda S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-267; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Kung S, 2009, MACHINE LEARNING BIO; Kustra R, 2010, IEEE ACM T COMPUT BI, V7, P50, DOI 10.1109/TCBB.2007.70267; Landgrebe J, 2002, GENOME BIOL, V3; Li C, 2008, BIOINFORMATICS; Liu H, 2008, CH CRC DATA MIN KNOW, P3; Liu QZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008250; McLachlan G, 2005, WILEY SERIES PROBABI; Misra J, 2002, GENOME RES, V12, P1112, DOI 10.1101/gr.225302; Nikulin Vladimir, 2009, Computational Intelligence Methods for Bioinformatics and Biostatistics. 6th International Meeting, CIBB 2009. Revised Selected Papers, P82; Orsenigo C, 2012, PATTERN RECOGN LETT, V33, P9, DOI 10.1016/j.patrec.2011.09.016; Osareh A, 2010, 2010 5 INT S HLTH IN, P114, DOI 10.1109/HIBIT.2010.5478895; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; Tai F, 2007, BIOINFORMATICS, V23, P1775, DOI 10.1093/bioinformatics/btm234; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319	38	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90562	10.1371/journal.pone.0090562	http://dx.doi.org/10.1371/journal.pone.0090562			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595155	gold, Green Published, Green Submitted			2022-12-25	WOS:000332468900117
J	Raza, FA; Rehman, SU; Khalid, R; Ahmad, J; Ashraf, S; Iqbal, M; Hasnain, S				Raza, Faiz Ahmed; Rehman, Shafiq Ur; Khalid, Ruqyya; Ahmad, Jameel; Ashraf, Sajjad; Iqbal, Mazhar; Hasnain, Shahida			Demographic and Clinico-Epidemiological Features of Dengue Fever in Faisalabad, Pakistan	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; RISK-FACTORS; VIRUS; SEVERITY; CHILDREN; KARACHI; ADULTS	This cross-sectional study was carried out to explore the epidemiological and clinical features of dengue fever in Faisalabad, Pakistan during 2011 and 2012. During the study period, anti-dengue IgM positive cases were reported in the post-monsoon period during the months of August-December. Certain hotspots for the dengue infection were identified in the city that coincide with the clusters of densely populated urban regions of the city. Out of total 299 IgM positive patients (male 218 and female 81); there were 239 dengue fever (DF) and 60 dengue hemorrhagic fever (DHF) patients. There was decrease in the median age of dengue patients from 31 years in 2011 to 21.5 years in 2012 (p<0.001). Abdominal pain was seen in 35% DHF patients followed by nausea in 28.3%, epistaxis in 25% and rash in 20% patients (p<0.05). Patients reported to be suffering from high-grade fever for an average of 8.83 days in DHF as compared to 5.82 days in DF before being hospitalized. Co-morbidities were found to be risk factor for the development of DHF in dengue patients. Clinical and laboratory features of dengue cases studied could be used for the early identification of patients at risk of severe dengue fever.	[Raza, Faiz Ahmed; Iqbal, Mazhar] Punjab Med Coll, Res Ctr, Pakistan Med Res Council, Faisalabad, Pakistan; [Raza, Faiz Ahmed; Rehman, Shafiq Ur; Hasnain, Shahida] Univ Punjab, Dept Microbiol & Mol Genet, Lahore, Pakistan; [Khalid, Ruqyya] Univ Punjab, Sch Biol Sci, Lahore, Pakistan; [Ahmad, Jameel] Allied Hosp, Dept Pathol, Faisalabad, Pakistan; [Ashraf, Sajjad] Chung Ang Univ, Nano Bio Energy Engn Sch Integrat Engn, Seoul 156756, South Korea	Punjab Medical College; University of Punjab; University of Punjab; Chung Ang University	Raza, FA (corresponding author), Punjab Med Coll, Res Ctr, Pakistan Med Res Council, Faisalabad, Pakistan.	faiz.raza@gmail.com	Ashraf, Sajjad/A-7479-2019; Rehman, shafiq ur/AAE-9102-2019; Hasnain, Shahida/I-6924-2015; Raza, Faiz Ahmed/N-5177-2014	Rehman, shafiq ur/0000-0002-1265-3442; Raza, Faiz Ahmed/0000-0002-8748-7741; Hasnain, Shahida/0000-0002-5916-7759; Ashraf, Sajjad/0000-0001-7987-4816; Khalid, Ruqyya/0000-0001-5658-3506	Pakistan Medical Research Council [4-23-4/11/Dengue/RDC/PMC/3495]	Pakistan Medical Research Council	This work was supported by Pakistan Medical Research Council (www.pmrc.org.pk) via Grant No. 4-23-4/11/Dengue/RDC/PMC/3495. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram Dure Samin, 1998, Indian Journal of Pediatrics, V65, P735, DOI 10.1007/BF02731055; Anker M, 2011, WEST PAC SURVEILL RE, V2, P17, DOI [10.5365/WPSAR.2011.2.1.002, 10.5365/wpsar.2011.2.1.002]; [Anonymous], 2003, INT WORKSH DEV REG S, p21e23; Barraud PJ., 1934, FAUNA BRIT INDIA INC, P420; Bhatty Shaheen, 2009, JPMA Journal of the Pakistan Medical Association, V59, P519; Carlos CC, 2005, AM J TROP MED HYG, V73, P435, DOI 10.4269/ajtmh.2005.73.435; da Rosa APAT, 2000, EMERG INFECT DIS, V6, P298; de Souza LJ, 2007, BRAZ J INFECT DIS, V11, P407, DOI 10.1590/S1413-86702007000400007; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Figueiredo MAA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000699; García-Rivera Enid J., 2003, Rev Panam Salud Publica, V13, P362, DOI 10.1590/S1020-49892003000500004; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Gulati S, 2007, TROP MED INT HEALTH, V12, P1087, DOI 10.1111/j.1365-3156.2007.01891.x; Gunther J, 2009, J CLIN VIROL, V45, P218, DOI 10.1016/j.jcv.2009.05.007; Guzman Maria G., 2002, International Journal of Infectious Diseases, V6, P118, DOI 10.1016/S1201-9712(02)90072-X; Hammond SN, 2005, AM J TROP MED HYG, V73, P1063; Jamil B, 2007, EMERG INFECT DIS, V13, P182, DOI 10.3201/eid1301.060376; Khan E, 2008, J CLIN VIROL, V43, P176, DOI 10.1016/j.jcv.2008.06.003; Khan E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012505; Laughlin CA, 2012, J INFECT DIS, V206, P1121, DOI 10.1093/infdis/jis351; Murgue B, 1999, TROP MED INT HEALTH, V4, P765, DOI 10.1046/j.1365-3156.1999.00478.x; Nishtar S, 2013, LANCET, V381, P2193, DOI 10.1016/S0140-6736(13)60019-7; Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/eid1206.051210; Pang JX, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001641; Rasheed SB, 2013, PUBLIC HEALTH, V127, P11, DOI 10.1016/j.puhe.2012.09.006; Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007; Shekhar K C, 1992, Asia Pac J Public Health, V6, P126; Thein TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081060; WHO, 2009, WHO TECH REP SER, V958, P1; World-Gazetteer, WORLD GAZETTEER; Yew YW, 2009, ANN ACAD MED SINGAP, V38, P667	31	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89868	10.1371/journal.pone.0089868	http://dx.doi.org/10.1371/journal.pone.0089868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595236	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900041
J	Siawaya, JFD				Siawaya, Joel Fleury Djoba			Chlamydia trachomatis, Human Immunodeficiency Virus (HIV) Distribution and Sexual Behaviors across Gender and Age Group in an African Setting	PLOS ONE			English	Article							DRINKING INCARCERATED WOMEN; ADOLESCENT HEALTH; RISK-TAKING; PREVALENCE; PREVENTION; INFECTION; POPULATION; COUNTRIES; PATTERNS; STUDENTS	Objective: The purpose of this study was to (1) describe the distribution of Chlamydia trachomatis (CT) and Human Immunodeficiency Virus (HIV) cases across gender and age groups in Libreville (Gabon); (2) examine Gabonese Sexually Transmitted Infections (STIs)-related risk behaviour. Methods: The sampled population was people attending the "Laboratoire National de Sante Plublique''. Between 2007 and 2011, 14 667 and 9 542 people respectively, were tested for CT and HIV infections. 1 854 of them were tested for both infections. We calculated CT and HIV rates across gender and age groups. Also analysed was the groups' contribution to the general CT and HIV epidemiology. STIs-related risk behaviours were assessed in 224 men and 795 women (between July 2011 and March 2013) who agreed and answered a questionnaire including questions on their marital status, number of sex partners, sexual practices, history of STIs, sex frequency and condom use. Results: Data showed a 24% dropped in the CT infection rate between 2007 and 2010, followed by a 14% increase in 2011. The HIV infection rates for the same period were between 15% and 16%. The risk of a CT-positive subject getting HIV is about 0.71 times the risk of a CT-negative subject. Young adult aged between 18 and 35 years old represented 65.2% of people who had STIs. 80% of women and 66% of men confessed to an inconsistent use of condoms. 11.6% of women and 48% of men declared having multiple sex partners. 61% of questioned women and 67% of men declared knowing their HIV status. Conclusions: In this Gabonese setting, the population-aged from 18 to 35 years is the most affected by STIs. Other matters of concern are the inconsistent use of protection and sex with non-spousal or non-life partners.	LNSP, Unite Rech & Diagnost Specialise, Libreville, Gabon		Siawaya, JFD (corresponding author), LNSP, Unite Rech & Diagnost Specialise, BP 10736, Libreville, Gabon.	joelfleury@yahoo.com	Siawaya, Joel Fleury Djoba/N-3156-2019	Siawaya, Joel Fleury Djoba/0000-0002-0369-0153				Adams EJ, 2004, SEX TRANSM INFECT, V80, P354, DOI 10.1136/sti.2003.005454; Agency HP, 2008, SEX TRANSM INF YOUNG; Annang L, 2010, PUBLIC HEALTH REP, V125, P110, DOI 10.1177/00333549101250S415; [Anonymous], 2011, UNAIDS WORLD AIDS DA; [Anonymous], 2011, B RES SURV INF SEX T; Awusabo-Asare K, 2008, APPL HEALTH ECON HEA, V6, P27, DOI 10.2165/00148365-200806010-00003; Banandur P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S13; BERHAN A, 2012, WORLD J AIDS, V2, P78, DOI DOI 10.4236/WJA.2012.22011; Berhan Y, 2013, AIDS CARE, V25, P151, DOI 10.1080/09540121.2012.689812; Bertozzi SM, 2008, LANCET, V372, P831, DOI 10.1016/S0140-6736(08)60889-2; Bingenheimer JB, 2010, STUD FAMILY PLANN, V41, P1, DOI 10.1111/j.1728-4465.2010.00220.x; Blum RW, 2012, LANCET, V379, P1567, DOI 10.1016/S0140-6736(12)60407-3; Blum RW, 2009, LANCET, V374, P853, DOI 10.1016/S0140-6736(09)61607-X; Carael MaG J.R, 2007, HIV INFECT YOUNG ADU, P123; Catalano RF, 2012, LANCET, V379, P1653, DOI 10.1016/S0140-6736(12)60238-4; Caviness CM, 2012, WOMEN HEALTH, V52, P119, DOI 10.1080/03630242.2011.649396; CDC, 2011, HIV YOUTH; Direction Generale de la Statistique (DGS) International eI, 2013, ENQ DEM SANT GAB 201; Doyle AM, 2012, TROP MED INT HEALTH, V17, P796, DOI 10.1111/j.1365-3156.2012.03005.x; Eaton D., 2011, MORB MORTAL, V59, P1; Goulet V, 2010, SEX TRANSM INFECT, V86, P263, DOI 10.1136/sti.2009.038752; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Johnson WD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001230.pub2; Jonason PK, 2007, J SOC PSYCHOL, V147, P5, DOI 10.3200/SOCP.147.1.5-14; Jonason P, 2009, SEX ROLES, V60, P151, DOI 10.1007/s11199-008-9506-3; Kohli Ruchika, 2013, BMC Res Notes, V6, P44, DOI 10.1186/1756-0500-6-44; Le Marchand C, 2013, DRUG ALCOHOL DEPEND; Marangoni A, 2012, NEW MICROBIOL, V35, P215; McCoy SI, 2010, AIDS BEHAV, V14, P469, DOI 10.1007/s10461-009-9644-9; Mengistu TS, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-38; Neema S, 2006, ADOLESCENT SEXUAL RE; Ngandjio A, 2003, J CLIN MICROBIOL, V41, P4404, DOI 10.1128/JCM.41.9.4404-4407.2003; Nys S, 2004, J ANTIMICROB CHEMOTH, V54, P952, DOI 10.1093/jac/dkh448; Opio A, 2008, JAIDS-J ACQ IMM DEF, V49, P320, DOI 10.1097/QAI.0b013e3181893eb0; Pettifor A, LANCET, V379, P1280; Stein MD, 2009, J STUD ALCOHOL DRUGS, V70, P508, DOI 10.15288/jsad.2009.70.508; UNIAIDS WHO, 2009, GAB EP FACT SHEET HI; van der Helm JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068698; Wand H, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000005	40	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90174	10.1371/journal.pone.0090174	http://dx.doi.org/10.1371/journal.pone.0090174			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4CT	24594663	gold, Green Published			2022-12-25	WOS:000332468900075
J	Thaker, TM; Sarwar, M; Preininger, AM; Hamm, HE; Iverson, TM				Thaker, Tarjani M.; Sarwar, Maruf; Preininger, Anita M.; Hamm, Heidi E.; Iverson, T. M.			A Transient Interaction between the Phosphate Binding Loop and Switch I Contributes to the Allosteric Network between Receptor and Nucleotide in G alpha(i1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; G Protein-coupled Receptors (GPCR); G Proteins; Heterotrimeric G Proteins; Rhodopsin; Signal Transduction	HETEROTRIMERIC G-PROTEIN; LIGHT-ACTIVATED RHODOPSIN; COVALENT CROSS-LINKING; ALPHA-SUBUNIT; CRYSTAL-STRUCTURE; STRUCTURAL DETERMINANTS; COMPLEX-FORMATION; AMINO-TERMINUS; CONTACT SITES; C-TERMINUS	Background: G proteins couple receptor binding to nucleotide release via an allosteric network. Results: Mutation of allosteric sites of G(i1) stabilizes a transient signaling conformation and may highlight an allosteric connection between receptor and nucleotide. Conclusion: The P-loop interacts with Switch I in the K345L variant of G(i1). Significance: G protein signaling is critical for numerous cellular functions, and GDP release is the rate-limiting step of the cycle. Receptor-mediated activation of the G subunit of heterotrimeric G proteins requires allosteric communication between the receptor binding site and the guanine nucleotide binding site, which are separated by >30 . Structural changes in the allosteric network connecting these sites are predicted to be transient in the wild-type G subunit, making studies of these connections challenging. In the current work, site-directed mutants that alter the energy barriers between the activation states are used as tools to better understand the transient features of allosteric signaling in the G subunit. The observed differences in relative receptor affinity for intact G(i1) subunits versus C-terminal G(i1) peptides harboring the K345L mutation are consistent with this mutation modulating the allosteric network in the protein subunit. Measurement of nucleotide exchange rates, affinity for metarhodopsin II, and thermostability suggest that the K345L G(i1) variant has reduced stability in both the GDP-bound and nucleotide-free states as compared with wild type but similar stability in the GTPS-bound state. High resolution x-ray crystal structures reveal conformational changes accompanying the destabilization of the GDP-bound state. Of these, the conformation for Switch I was stabilized by an ionic interaction with the phosphate binding loop. Further site-directed mutagenesis suggests that this interaction between Switch I and the phosphate binding loop is important for receptor-mediated nucleotide exchange in the wild-type G(i1) subunit.	[Thaker, Tarjani M.; Iverson, T. M.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Sarwar, Maruf; Preininger, Anita M.; Hamm, Heidi E.; Iverson, T. M.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Hamm, HE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 442 Robinson Res Bldg, Nashville, TN 37232 USA.	Heidi.hamm@vanderbilt.edu; tina.iverson@vanderbilt.edu	Hamm, Heidi E/G-2374-2014	Preininger, Anita/0000-0001-8011-9391	United States Department of Energy [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL EYE INSTITUTE [P30EY008126, R01EY006062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095633] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Ali I. Kaya both for assistance with the rhodopsin binding studies and for informative discussions, James Gilbert for assistance with G beta<INF>1</INF>gamma<INF>1</INF> preparation, and Dr. Kathryn McCulloch and Chrystal Starbird for critical reading of this manuscript. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor (Grant 085P1000817).	Abdulaev NG, 2006, BIOCHEMISTRY-US, V45, P12986, DOI 10.1021/bi061088h; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aris L, 2001, J BIOL CHEM, V276, P2333, DOI 10.1074/jbc.M002533200; Bae H, 1999, J BIOL CHEM, V274, P14963, DOI 10.1074/jbc.274.21.14963; Bae H, 1997, J BIOL CHEM, V272, P32071, DOI 10.1074/jbc.272.51.32071; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Cai K, 2001, P NATL ACAD SCI USA, V98, P4877, DOI 10.1073/pnas.051632898; Ceruso MA, 2004, J MOL BIOL, V338, P469, DOI 10.1016/j.jmb.2004.02.064; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Coleman DE, 1999, J BIOL CHEM, V274, P16669, DOI 10.1074/jbc.274.24.16669; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; DRATZ EA, 1993, NATURE, V363, P276, DOI 10.1038/363276a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Grishina G, 2000, MOL PHARMACOL, V57, P1081; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hamm HE, 2013, J STRUCT BIOL, V184, P63, DOI 10.1016/j.jsb.2013.02.016; Herrmann R, 2006, VISION RES, V46, P4582, DOI 10.1016/j.visres.2006.07.027; Herrmann R, 2006, J BIOL CHEM, V281, P30234, DOI 10.1074/jbc.M600797200; Ho MKC, 2004, BIOCHEM J, V380, P361, DOI 10.1042/BJ20040231; Itoh Y, 2001, P NATL ACAD SCI USA, V98, P4883, DOI 10.1073/pnas.051632998; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Kapoor N, 2009, J MOL BIOL, V393, P882, DOI 10.1016/j.jmb.2009.08.043; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kling RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067244; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li JN, 2011, PROTEINS, V79, P2794, DOI 10.1002/prot.23106; Lichtarge O, 1996, P NATL ACAD SCI USA, V93, P7507, DOI 10.1073/pnas.93.15.7507; Marin EP, 2002, BIOCHEMISTRY-US, V41, P6988, DOI 10.1021/bi025514k; Marin EP, 2001, J BIOL CHEM, V276, P23873, DOI 10.1074/jbc.M101197200; Marin EP, 2001, J BIOL CHEM, V276, P27400, DOI 10.1074/jbc.C100198200; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; Mazzoni MR, 1996, J BIOL CHEM, V271, P30034, DOI 10.1074/jbc.271.47.30034; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Morikawa T, 2007, ACTA CRYSTALLOGR F, V63, P139, DOI 10.1107/S1744309107003363; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2007, P NATL ACAD SCI USA, V104, P7927, DOI 10.1073/pnas.0702623104; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Posner BA, 1998, J BIOL CHEM, V273, P21752, DOI 10.1074/jbc.273.34.21752; Preininger AM, 2008, BIOCHEMISTRY-US, V47, P10281, DOI 10.1021/bi800741r; Preininger AM, 2013, J MOL BIOL, V425, P2288, DOI 10.1016/j.jmb.2013.04.011; Preininger AM, 2012, BIOCHEMISTRY-US, V51, P1911, DOI 10.1021/bi201472c; Preininger AM, 2009, BIOCHEMISTRY-US, V48, P2630, DOI 10.1021/bi801853a; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ridge KD, 2006, VISION RES, V46, P4482, DOI 10.1016/j.visres.2006.07.024; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Singh G, 2012, BIOCHEMISTRY-US, V51, P3232, DOI 10.1021/bi3001984; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; TAYLOR JM, 1994, J BIOL CHEM, V269, P27618; Thaker TM, 2012, METHODS MOL BIOL, V796, P133, DOI 10.1007/978-1-61779-334-9_8; Thomas CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023197; Thomas CJ, 2004, P NATL ACAD SCI USA, V101, P7560, DOI 10.1073/pnas.0304091101; Van Eps N, 2006, P NATL ACAD SCI USA, V103, P16194, DOI 10.1073/pnas.0607972103; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Zelent B, 2001, BIOCHEMISTRY-US, V40, P9647, DOI 10.1021/bi010272u	79	7	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11331	11341		10.1074/jbc.M113.539064	http://dx.doi.org/10.1074/jbc.M113.539064			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596087	hybrid, Green Published			2022-12-25	WOS:000334638500035
J	Tsvetkov, P; Myers, N; Eliav, R; Adamovich, Y; Hagai, T; Adler, J; Navon, A; Shaul, Y				Tsvetkov, Peter; Myers, Nadav; Eliav, Raz; Adamovich, Yaarit; Hagai, Tzachi; Adler, Julia; Navon, Ami; Shaul, Yosef			NADH Binds and Stabilizes the 26S Proteasomes Independent of ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-dependent Protease; ATPases; Magnesium; NADH; Proteasome; Protein Degradation; Psmc1; Rotenone	DNA-BINDING; PROTEIN; COMPLEX; NAD(+); 20S; SPECIFICITY; ACTIVATION; MECHANISMS; ATPASES; TERMINI	Background: 26S proteasome complex is highly dependent on ATP. Results: NADH binds the proteasome via the Psmc1 subunit resulting in ATP-independent stabilization of the 26S proteasome complex, in vitro and in cells. Conclusion: NADH is a novel regulator of the 26S proteasome. Significance: NADH can maintain proteasomal integrity in the absence of ATP, linking cellular redox state to protein degradation. The 26S proteasome is the end point of the ubiquitin- and ATP-dependent degradation pathway. The 26S proteasome complex (26S PC) integrity and function has been shown to be highly dependent on ATP and its homolog nucleotides. We report here that the redox molecule NADH binds the 26S PC and is sufficient in maintaining 26S PC integrity even in the absence of ATP. Five of the 19S proteasome complex subunits contain a putative NADH binding motif (GxGxxG) including the AAA-ATPase subunit, Psmc1 (Rpt2). We demonstrate that recombinant Psmc1 binds NADH via the GxGxxG motif. Introducing the GxGxxG Psmc1 mutant into cells results in reduced NADH-stabilized 26S proteasomes and decreased viability following redox stress induced by the mitochondrial inhibitor rotenone. The newly identified NADH binding of 26S proteasomes advances our understanding of the molecular mechanisms of protein degradation and highlights a new link between protein homeostasis and the cellular metabolic/redox state.	[Tsvetkov, Peter; Myers, Nadav; Eliav, Raz; Adamovich, Yaarit; Adler, Julia; Shaul, Yosef] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Navon, Ami] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Hagai, Tzachi] Univ Calif San Francisco, San Francisco Sch Med, Dept Microbiol & Immunol, San Francisco, CA 94158 USA	Weizmann Institute of Science; Weizmann Institute of Science; University of California System; University of California San Francisco	Tsvetkov, P (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	petert@wi.mit.edu; yosef.shaul@weizmann.ac.il	Tsvetkov, Peter/J-9878-2019; Hagai, Tzachi/AAL-8758-2021	Tsvetkov, Peter/0000-0002-7577-2342; Adamovich, Yaarit/0000-0001-9583-0338; Tzachi, Hagai/0000-0002-4575-6624	Israel Science Foundation [551/11]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation Grant 551/11.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ansari HR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-160; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bajorek M, 2003, CURR BIOL, V13, P1140, DOI 10.1016/S0960-9822(03)00417-2; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Berko D, 2012, MOL CELL, V48, P601, DOI 10.1016/j.molcel.2012.08.029; Cho-Park PF, 2013, CELL, V153, P614, DOI 10.1016/j.cell.2013.03.040; Chou AP, 2010, NEUROTOXICOLOGY, V31, P367, DOI 10.1016/j.neuro.2010.04.006; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Fang M, 2010, CELL, V143, P711, DOI 10.1016/j.cell.2010.10.010; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Hoglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x; HOUGH R, 1987, J BIOL CHEM, V262, P8303; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; McLure KG, 2004, MOL CELL BIOL, V24, P9958, DOI 10.1128/MCB.24.22.9958-9967.2004; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Reinheckel T, 2000, ARCH BIOCHEM BIOPHYS, V377, P65, DOI 10.1006/abbi.2000.1717; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Tai H. C., 2010, FRONT MOL NEUROSCI, DOI [10.3389/fnmol.2010.00012, DOI 10.3389/FNMOL. 2010. 00012]; Tsvetkov P, 2009, J BIOL CHEM, V284, P26234, DOI 10.1074/jbc.M109.040493; Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223; Um JW, 2010, J NEUROSCI, V30, P11805, DOI 10.1523/JNEUROSCI.2862-09.2010; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232; Wolff EC, 2000, J BIOL CHEM, V275, P9170, DOI 10.1074/jbc.275.13.9170; Yi CH, 2011, CELL, V146, P607, DOI 10.1016/j.cell.2011.06.050; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	41	26	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11272	11281		10.1074/jbc.M113.537175	http://dx.doi.org/10.1074/jbc.M113.537175			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596095	Green Published, hybrid			2022-12-25	WOS:000334638500030
J	Landrum, E; Wetzel, R				Landrum, Elizabeth; Wetzel, Ronald			Biophysical Underpinnings of the Repeat Length Dependence of Polyglutamine Amyloid Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Huntington Disease; Kinetics; Polyglutamine; Protein Aggregation; Protein Stability; Nucleation; Repeat Length	HUNTINGTONS-DISEASE; AGGREGATION NUCLEATION; MUTANT HUNTINGTIN; IN-VITRO; MOLECULAR-MECHANISMS; PROTEIN AGGREGATION; FIBRIL ELONGATION; OLIGOMERS; PEPTIDES; TOXICITY	Background: The molecular basis for the repeat length dependence of disease risk in polyglutamine diseases is not known. Results: We show here a nonlinear dependence of aggregation propensity versus polyglutamine repeat length that qualitatively mirrors how age of onset depends on repeat length. Conclusion: This provides further support for a role for aggregation in these diseases. Significance: This lends support to therapeutic strategies targeting aggregation. There are now 10 expanded CAG repeat diseases in which both disease risk and age of onset are strongly dependent on the repeat length of the polyglutamine (polyQ) sequence in the disease protein. Large, polyQ-rich inclusions in patient brains and in cell and animal models are consistent with the involvement of polyQ aggregation in the disease mechanism. This possibility is reinforced by studies showing strong repeat length dependence to the aggregation process, qualitatively mirroring the repeat length dependence of disease risk. Our understanding of the underlying biophysical principles that mediate the repeat length dependence of aggregation, however, is far from complete. A previous study of simple polyQ peptides showed that N*, the size of the critical nucleus that controls onset of aggregation, decreases from unfavorable tetramer to favorable monomer over the range Q(23) to Q(26). These data, however, do not explain why, for all peptides exhibiting N* approximate to 1, spontaneous aggregation rates continue to increase with increasing repeat length. Here we describe a novel kinetics analyses that maps out the nonlinear dependence with repeat length of a nucleation efficiency term that is likely related to aspects of nucleus structure. This trend accounts for why nucleus size increases to tetrameric at repeat lengths of Q(23) or below. Intriguingly, both aggregation and age of onset trend with repeat length in similar ways, exhibiting large changes per added Gln at low repeat lengths and small changes per added Gln at relatively long repeat lengths. Fibril stability also increases with repeat length in a nonlinear fashion.	[Wetzel, Ronald] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wetzel, R (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Biomed Sci Tower 3,3501 Fifth Ave, Pittsburgh, PA 15260 USA.	rwetzel@pitt.edu	Wetzel, Ronald/G-7453-2011		National Institutes of Health [R01 AG019322, R01 GM099718]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG019322 and R01 GM099718.	Andresen JM, 2007, ANN HUM GENET, V71, P295, DOI 10.1111/j.1469-1809.2006.00335.x; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; BATES G, 2002, HUNTINGTONS DIS; Bates G. P., 2002, HUNTINGTONS DIS, P429; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Bhattacharyya AM, 2005, P NATL ACAD SCI USA, V102, P15400, DOI 10.1073/pnas.0501651102; Blum ES, 2013, TRENDS CELL BIOL, V23, P168, DOI 10.1016/j.tcb.2012.11.003; Cannon MJ, 2004, ANAL BIOCHEM, V328, P67, DOI 10.1016/j.ab.2004.01.014; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Davranche A, 2011, HUM MOL GENET, V20, P2795, DOI 10.1093/hmg/ddr178; Dragatsis I, 2009, NEUROBIOL DIS, V33, P315, DOI 10.1016/j.nbd.2008.10.009; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Hughes A, 2014, HUNTINGTONS DIS, P323; Jayaraman M, 2011, METHODS, V53, P246, DOI 10.1016/j.ymeth.2011.01.001; Jimenez-Sanchez M, 2012, PROG NEUROBIOL, V97, P67, DOI 10.1016/j.pneurobio.2011.08.013; Kar K, 2013, J MOL BIOL, V425, P1183, DOI 10.1016/j.jmb.2013.01.016; Kar K, 2011, NAT STRUCT MOL BIOL, V18, P328, DOI 10.1038/nsmb.1992; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kurouski D, 2013, FEBS LETT, V587, P1638, DOI 10.1016/j.febslet.2013.03.038; Labbadia J, 2013, TRENDS BIOCHEM SCI, V38, P378, DOI 10.1016/j.tibs.2013.05.003; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Michalik A, 2003, HUM MOL GENET, V12, pR173, DOI 10.1093/hmg/ddg295; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Nakano M, 2013, J MOL MODEL, V19, P1627, DOI 10.1007/s00894-012-1712-9; Nakano M, 2010, J PHYS CHEM B, V114, P7056, DOI 10.1021/jp9122024; O'Nuallain B, 2005, BIOCHEMISTRY-US, V44, P12709, DOI 10.1021/bi050927h; O'Nuallain B, 2006, METHOD ENZYMOL, V413, P34, DOI 10.1016/S0076-6879(06)13003-7; Orr HT, 2012, CURR OPIN GENET DEV, V22, P251, DOI 10.1016/j.gde.2012.01.001; Ossato G, 2010, BIOPHYS J, V98, P3078, DOI 10.1016/j.bpj.2010.02.058; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rudnicki DD, 2008, J NEUROPATH EXP NEUR, V67, P366, DOI 10.1097/NEN.0b013e31816b4aee; Sahl SJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00895; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Slepko N, 2006, P NATL ACAD SCI USA, V103, P14367, DOI 10.1073/pnas.0602348103; Snowden J., 2014, HUNTINGTONS DIS, P36; Takahashi T, 2010, J MOL CELL BIOL, V2, P180, DOI 10.1093/jmcb/mjq005; Takahashi Y, 2007, J BIOL CHEM, V282, P24039, DOI 10.1074/jbc.M704789200; Thakur AK, 2002, P NATL ACAD SCI USA, V99, P17014, DOI 10.1073/pnas.252523899; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; van Eyk CL, 2012, ADV EXP MED BIOL, V769, P55; Vitalis A, 2011, BIOPHYS CHEM, V159, P14, DOI 10.1016/j.bpc.2011.04.006; Wetzel R., 2014, HUNTINGTONS DIS, P274; Wilburn B, 2011, NEURON, V70, P427, DOI 10.1016/j.neuron.2011.03.021; Williams AD, 2006, J MOL BIOL, V357, P1283, DOI 10.1016/j.jmb.2006.01.041; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	54	30	30	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10254	10260		10.1074/jbc.C114.552943	http://dx.doi.org/10.1074/jbc.C114.552943			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24596088	Green Published, hybrid			2022-12-25	WOS:000334226400001
J	Du, YJ; Lu, Y; Wang, XL; Qi, J; Liu, JY; Hu, Y; Li, F; Wu, JQ; Guo, LH; Liu, JZ; Tao, HY; Sun, WB; Chen, L; Cong, XY; Ren, SF; Shi, JL; Li, J; Wang, JB; Huang, BH; Wan, RZ				Du, Yijun; Lu, Yu; Wang, Xinglong; Qi, Jing; Liu, Jiyu; Hu, Yue; Li, Feng; Wu, Jiaqiang; Guo, Lihui; Liu, Junzhen; Tao, Haiying; Sun, Wenbo; Chen, Lei; Cong, Xiaoyan; Ren, Sufang; Shi, Jianli; Li, Jun; Wang, Jinbao; Huang, Baohua; Wan, Renzhong			Highly Efficient Expression of Interleukin-2 under the Control of Rabbit beta-Globin Intron II Gene Enhances Protective Immune Responses of Porcine Reproductive and Respiratory Syndrome (PRRS) DNA Vaccine in Pigs	PLOS ONE			English	Article							SYNDROME VIRUS PRRSV; UNITED-STATES; GP5; SWINE; CHINA; PROTEINS; STRAIN; IMMUNOGENICITY; EMERGENCE; OUTBREAKS	Highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) had caused catastrophic losses in swine industry in China. The current inactivated vaccine provided only limited protection, and the attenuated live vaccine could protect piglets against the HP-PRRSV but there was a possibility that the attenuated virus returned to high virulence. In this study, the eukaryotic expression vector pVAX1 (c) was modified under the control of rabbit beta-globin intron II gene and the modified vector pMVAX1 (c) was constructed. Porcine interleukin-2 (IL-2) and GP3-GP5 fusion protein of HP-PRRSV strain SD-JN were highly expressed by pMVAX1 (c). Mice inoculated with pMVAX1 (c)-GP35 developed significantly higher PRRSV-specific antibody responses and T cell proliferation than those vaccinated with pVAX1 (c)-GP35. pMVAX1 (c)-GP35 was selected as PRRS DNA vaccine candidate and co-administrated with pVAX1 (c)-IL-2 or pMVAX1 (c)-IL-2 in pigs. pMVAX1 (c) -IL-2+pMVAX1 (c)-GP35 could provide enhanced PRRSV-specific antibody responses, T cell proliferation, Th1-type and Th2-type cytokine responses and CTL responses than pMVAX1 (c)-GP35 and pVAX1 (c)-IL-2+pMVAX1 (c)-GP35. Following homologous challenge with HP-PRRSV strain SD-JN, similar with attenuated PRRS vaccine group, pigs inoculated with pMVAX1 (c)-IL-2+pMVAX1 (c)-GP35 showed no clinical signs, almost no lung lesions and no viremia, as compared to those in pMVAX1 (c)-GP35 and pVAX1 (c)-IL-2+pMVAX1 (c)-GP35 groups. It indicated that pMVAX1 (c)-IL-2 effectively increases humoral and cell mediated immune responses of pMVAX1 (c)-GP35. Co-administration of pMVAX1 (c)-IL-2 and pMVAX1 (c)-GP35 might be attractive candidate vaccines for preventing HP-PRRSV infections.	[Du, Yijun; Qi, Jing; Chen, Lei; Cong, Xiaoyan; Wang, Jinbao] Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China; [Du, Yijun; Qi, Jing; Liu, Jiyu; Wu, Jiaqiang; Guo, Lihui; Liu, Junzhen; Tao, Haiying; Sun, Wenbo; Chen, Lei; Cong, Xiaoyan; Ren, Sufang; Shi, Jianli; Li, Jun; Wang, Jinbao; Huang, Baohua] Shandong Acad Agr Sci, Shandong Key Lab Anim Dis Control & Breeding, Inst Anim Sci & Vet Med, Jinan, Peoples R China; [Lu, Yu] Jiangsu Acad Agr Sci, Natl Res Ctr Vet Biol Engn & Technol, Nanjing, Jiangsu, Peoples R China; [Wang, Xinglong] Northwest A&F Univ, Coll Vet Med, Yangling, Peoples R China; [Hu, Yue; Wang, Jinbao] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China; [Li, Feng] S Dakota State Univ, Dept Vet & Biomed Sci, Dept Biol & Microbiol, Brookings, SD 57007 USA	Shandong University; Shandong Academy of Agricultural Sciences; Jiangsu Academy of Agricultural Sciences; Northwest A&F University - China; Shandong Agricultural University; South Dakota State University	Wang, JB (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China.	wangjb@saas.ac.cn; jn-hbh@163.com; wrzh63@163.com		Li, Feng/0000-0002-8904-2893	National Natural Science Foundation [31170146, 31100119, 31370189]; Special Fund for Agro-scientific Research in the Public Interest [201303046]; Research Award Fund for Outstanding Young Scientist of Shandong Province [BS2012NY012]; China Postdoctoral Science Foundation [2012M521341]; Shandong Province Postdoctoral Special Fund for Innovative Projects [201203036]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Research Award Fund for Outstanding Young Scientist of Shandong Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shandong Province Postdoctoral Special Fund for Innovative Projects	This work was supported by the National Natural Science Foundation (31170146, 31100119 and 31370189), Special Fund for Agro-scientific Research in the Public Interest (201303046), Research Award Fund for Outstanding Young Scientist of Shandong Province (BS2012NY012), a grant from the China Postdoctoral Science Foundation (2012M521341), and Shandong Province Postdoctoral Special Fund for Innovative Projects (201203036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann MF, 2007, EMBO REP, V8, P1142, DOI 10.1038/sj.embor.7401099; Bastos RG, 2004, VACCINE, V22, P467, DOI 10.1016/S0264-410X(03)00572-3; Cavanagh D, 1997, ARCH VIROL, V142, P629; Charerntantanakul W, 2009, VET IMMUNOL IMMUNOP, V129, P1, DOI 10.1016/j.vetimm.2008.12.018; Cho JG, 2006, THERIOGENOLOGY, V66, P655, DOI 10.1016/j.theriogenology.2006.04.024; Chow YH, 1997, J VIROL, V71, P169, DOI 10.1128/JVI.71.1.169-178.1997; de Lima M, 2006, VIROLOGY, V353, P410, DOI 10.1016/j.virol.2006.05.036; DEA S, 1991, J VET DIAGN INVEST, V3, P275, DOI 10.1177/104063879100300401; Du YJ, 2012, VIRUS GENES, V45, P474, DOI 10.1007/s11262-012-0790-1; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Guo BQ, 2013, VIROLOGY, V446, P238, DOI 10.1016/j.virol.2013.08.008; HALBUR PG, 1995, VET PATHOL, V32, P200, DOI 10.1177/030098589503200218; Hou YH, 2008, VACCINE, V26, P1438, DOI 10.1016/j.vaccine.2007.12.057; Jiang WM, 2008, VIRUS RES, V136, P50, DOI 10.1016/j.virusres.2008.04.016; Jiang YB, 2006, VACCINE, V24, P2869, DOI 10.1016/j.vaccine.2005.12.049; Jiang YB, 2007, VACCINE, V25, P547, DOI 10.1016/j.vaccine.2006.07.032; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Li JX, 2009, VACCINE, V27, P825, DOI 10.1016/j.vaccine.2008.11.088; Li XM, 1998, J EXP MED, V188, P681, DOI 10.1084/jem.188.4.681; Li YF, 2007, VET J, V174, P577, DOI 10.1016/j.tvjl.2007.07.032; Montiel-Equihua CA, 2012, MOL THER, V20, P1400, DOI 10.1038/mt.2012.50; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; NUNBERG JH, 1989, P NATL ACAD SCI USA, V86, P4240, DOI 10.1073/pnas.86.11.4240; Opriessnig T, 2002, J VIROL, V76, P11837, DOI 10.1128/JVI.76.23.11837-11844.2002; Plagemann PGW, 2004, VET IMMUNOL IMMUNOP, V102, P263, DOI 10.1016/j.vetimm.2004.09.011; Rompato G, 2006, VET IMMUNOL IMMUNOP, V109, P151, DOI 10.1016/j.vetimm.2005.08.015; Shen GS, 2007, VACCINE, V25, P4193, DOI 10.1016/j.vaccine.2007.03.010; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Tian ZJ, 2009, VET MICROBIOL, V138, P34, DOI 10.1016/j.vetmic.2009.03.003; Tong GZ, 2007, EMERG INFECT DIS, V13, P1434, DOI 10.3201/eid1309.070399; Wang XL, 2009, VIRUS RES, V143, P24, DOI 10.1016/j.virusres.2009.02.017; Wootton S, 2000, ARCH VIROL, V145, P2297, DOI 10.1007/s007050070022; Wu J, 2009, ARCH VIROL, V154, P1589, DOI 10.1007/s00705-009-0478-6; Zhou JY, 2005, MOL IMMUNOL, V42, P589, DOI 10.1016/j.molimm.2004.09.014; Zhou L, 2012, VIROLOGY, V434, P96, DOI 10.1016/j.virol.2012.09.005; Zhou YJ, 2008, TRANSBOUND EMERG DIS, V55, P152, DOI 10.1111/j.1865-1682.2008.01020.x	36	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90326	10.1371/journal.pone.0090326	http://dx.doi.org/10.1371/journal.pone.0090326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603502	Green Published, gold, Green Submitted			2022-12-25	WOS:000332483600043
J	Pusceddu, A; Gambi, C; Corinaldesi, C; Scopa, M; Danovaro, R				Pusceddu, Antonio; Gambi, Cristina; Corinaldesi, Cinzia; Scopa, Mariaspina; Danovaro, Roberto			Relationships between Meiofaunal Biodiversity and Prokaryotic Heterotrophic Production in Different Tropical Habitats and Oceanic Regions	PLOS ONE			English	Article							SPECIES-DIVERSITY; MARINE BIODIVERSITY; POSIDONIA-OCEANICA; ORGANIC-MATTER; MANGROVE; COMMUNITIES; SEDIMENT; BACTERIA; BED; ASSEMBLAGES	Tropical marine ecosystems are among the most diverse of the world oceans, so that assessing the linkages between biodiversity and ecosystem functions (BEF) is a crucial step to predict consequences of biodiversity loss. Most BEF studies in marine ecosystems have been carried out on macrobenthic diversity, whereas the influence of the meiofauna on ecosystem functioning has received much less attention. We compared meiofaunal and nematode biodiversity and prokaryotic heterotrophic production across seagrass, mangrove and reef sediments in the Caribbean, Celebes and Red Seas. For all variables we report the presence of differences among habitats within the same region, and among regions within the same habitat. In all regions, the richness of meiofaunal taxa in reef and seagrass sediments is higher than in mangrove sediments. The sediments of the Celebes Sea show the highest meiofaunal biodiversity. The composition of meiofaunal assemblages varies significantly among habitats in the same region. The nematode beta diversity among habitats within the same region is higher than the beta diversity among regions. Although one site per habitat was considered in each region, these results suggest that the composition of meiofaunal assemblages varies primarily among biogeographic regions, whereas the composition of nematode assemblages varies more considerably among habitats. Meiofauna and nematode biodiversity and prokaryotic heterotrophic production, even after the removal of covariate effects linked with longitude and the quantity and nutritional quality of organic matter, are positively and linearly linked both across regions and within each habitat type. Our results confirm that meiofauna and nematode biodiversity may influence benthic prokaryotic activity, which, in turn, implies that diversity loss could have negative impacts on ecosystem functioning in these systems.	[Pusceddu, Antonio; Gambi, Cristina; Corinaldesi, Cinzia; Scopa, Mariaspina; Danovaro, Roberto] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy; [Scopa, Mariaspina] Expt Reg Ctr Fishery & Acquacolture, Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Termoli, Italy; [Danovaro, Roberto] Stn Zool Anton Dohrn, Naples, Italy	Marche Polytechnic University; IZS Dell'abruzzo E Del Molise Giuseppe Caporale; Stazione Zoologica Anton Dohrn di Napoli	Pusceddu, A (corresponding author), Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy.	a.pusceddu@univpm.it		Gambi, Cristina/0000-0001-6160-6004	Polytechnic University of Marche; MIUR Italy	Polytechnic University of Marche; MIUR Italy(Ministry of Education, Universities and Research (MIUR))	This study was carried out in the framework of the projects Ricerca di Ateneo 2004-2011 financed by the Polytechnic University of Marche. This study is a contribution to the FIRB Project EXPLODIVE financially supported by MIUR Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONGI DM, 1987, MAR ECOL PROG SER, V40, P103, DOI 10.3354/meps040103; ALONGI DM, 1988, J MAR RES, V46, P349, DOI 10.1357/002224088785113630; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Armenteros M, 2006, ESTUAR COAST, V29, P124, DOI 10.1007/BF02784704; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barnes N, 2011, BIODIVERS CONSERV, V20, P2075, DOI 10.1007/s10531-011-0076-2; Beck M. W., 2009, SHELLFISH REEFS RISK; Benedetti-Cecchi L, 2012, MARINE BIODIVERSITY AND ECOSYSTEM FUNCTIONING: FRAMEWORKS, METHODOLOGIES, AND INTEGRATION, P73; Bulling MT, 2010, PHILOS T R SOC B, V365, P2107, DOI 10.1098/rstb.2010.0022; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chinnadurai G, 2007, ESTUAR COAST SHELF S, V72, P329, DOI 10.1016/j.ecss.2006.11.004; Claudet J, 2010, BIOL CONSERV, V143, P2195, DOI 10.1016/j.biocon.2010.06.004; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Danovaro R, 2002, MAR BIOL, V141, P667, DOI 10.1007/s00227-002-0857-y; Danovaro R, 2002, MAR ECOL PROG SER, V234, P95, DOI 10.3354/meps234095; Danovaro R, 1996, MAR BIOL, V127, P1, DOI 10.1007/BF00993638; Danovaro R, 2001, MICROB ECOL, V42, P177; Danovaro R, 1995, OLSEN INT S, P115; Danovaro R., 2010, METHODS STUDY DEEP S; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Danovaro R, 2009, NEMATODES AS ENVIRONMENTAL INDICATORS, P146, DOI 10.1079/9781845933852.0146; De Mesel I, 2006, POLAR BIOL, V29, P860, DOI 10.1007/s00300-006-0124-7; De Troch M, 2001, J SEA RES, V45, P45, DOI 10.1016/S1385-1101(00)00055-1; DEMORAIS LT, 1984, MAR BIOL, V82, P209, DOI 10.1007/BF00394104; Duarte CM, 2008, ESTUAR COAST, V31, P233, DOI 10.1007/s12237-008-9038-7; Ehrlich P.R., 1981, EXTINCTION; Feller R.J., 1988, P181; Fry J. C., 1990, METHODS AQUATIC BACT, P27; Gambi C, 2014, GLOBAL ECOL BIOGEOGR, V23, P24, DOI 10.1111/geb.12094; Giere, 2009, MEIOBENTHOLOGY THE M; Gingold R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066653; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; LAWTON JH, 1994, OIKOS, V71, P367, DOI 10.2307/3545824; Leduc D, 2013, MAR ECOL-EVOL PERSP, V34, P334, DOI 10.1111/maec.12019; Loreau M, 2008, CURR BIOL, V18, pR126, DOI 10.1016/j.cub.2007.11.060; Loreau M, 2010, PHILOS T R SOC B, V365, P49, DOI 10.1098/rstb.2009.0155; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Max LM, 2013, MAR ECOL PROG SER, V482, P181, DOI 10.3354/meps10259; MONTAGNA PA, 1984, MAR ECOL PROG SER, V18, P119, DOI 10.3354/meps018119; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Netto SA, 2003, HYDROBIOLOGIA, V505, P159, DOI 10.1023/B:HYDR.0000007304.22992.b2; OLAFSSON E, 1995, HYDROBIOLOGIA, V312, P47, DOI 10.1007/BF00018886; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Pinto TK, 2013, MAR ECOL-EVOL PERSP, V34, P257, DOI 10.1111/maec.12011; Pusceddu A, 2009, ESTUAR COAST SHELF S, V84, P227, DOI 10.1016/j.ecss.2009.06.019; Pusceddu A, 2009, MAR ECOL PROG SER, V375, P41, DOI 10.3354/meps07735; Quang Ngo Xuan, 2007, Ocean Science Journal, V42, P135; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; SOETAERT K, 1990, MAR ECOL PROG SER, V59, P305, DOI 10.3354/meps059305; Solan M, 2006, MAR ECOL PROG SER, V311, P175, DOI 10.3354/meps311175; Somerfield PJ, 1998, J MAR BIOL ASSOC UK, V78, P717, DOI 10.1017/S0025315400044738; Stephens MP, 1997, GEOCHIM COSMOCHIM AC, V61, P4605, DOI 10.1016/S0016-7037(97)00358-X; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; van Oevelen D, 2006, LIMNOL OCEANOGR, V51, P1302, DOI 10.4319/lo.2006.51.3.1302; VANDUYL FC, 1994, MAR BIOL, V120, P323, DOI 10.1007/BF00349694; Vanreusel A, 2010, MAR ECOL-EVOL PERSP, V31, P6, DOI 10.1111/j.1439-0485.2009.00352.x; WATZIN MC, 1983, OECOLOGIA, V59, P163, DOI 10.1007/BF00378833; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; WIESER W., 1953, ARKIV ZOOL, V4, P439; Wilkinson C, 2008, STATUS CORAL REEFS W; Wilson M, 2009, NEMATODES AS ENVIRONMENTAL INDICATORS, pXI, DOI 10.1079/9781845933852.0000; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	72	39	40	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e91056	10.1371/journal.pone.0091056	http://dx.doi.org/10.1371/journal.pone.0091056			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603709	gold, Green Published, Green Submitted			2022-12-25	WOS:000332483600127
J	Scalzo, RL; Peltonen, GL; Giordano, GR; Binns, SE; Klochak, AL; Paris, HLR; Schweder, MM; Szallar, SE; Wood, LM; Larson, DG; Luckasen, GJ; Hickey, MS; Bell, C				Scalzo, Rebecca L.; Peltonen, Garrett L.; Giordano, Gregory R.; Binns, Scott E.; Klochak, Anna L.; Paris, Hunter L. R.; Schweder, Melani M.; Szallar, Steve E.; Wood, Lacey M.; Larson, Dennis G.; Luckasen, Gary J.; Hickey, Matthew S.; Bell, Christopher			Regulators of Human White Adipose Browning: Evidence for Sympathetic Control and Sexual Dimorphic Responses to Sprint Interval Training	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; INCREASES INSULIN SENSITIVITY; PGC-1-ALPHA MESSENGER-RNA; SKELETAL-MUSCLE; ADRENERGIC-STIMULATION; THERMOGENIC RESPONSE; NERVE ACTIVITY; PPAR-ALPHA; FAT-CELL; TISSUE	The conversion of white adipose to the highly thermogenic beige adipose tissue has been proposed as a potential strategy to counter the unfavorable consequences of obesity. Three regulators of this conversion have recently emerged but information regarding their control is limited, and contradictory. We present two studies examining the control of these regulators. Study 1: In 10 young men, the plasma concentrations of irisin and fibroblast growth factor 21 (FGF21) were determined prior to and during activation of the sympathetic nervous system via hypoxic gas breathing (FIO2 = 0.11). The measurements were performed twice, once with and once without prior/concurrent sympathetic inhibition via transdermal clonidine administration. FGF21 was unaffected by basal sympathetic inhibition (338 +/- 113 vs. 295 +/- 680 pg/mL; P = 0.43; mean +/- SE), but was increased during hypoxia mediated sympathetic activation (368 +/- 135); this response was abrogated (P = 0.035) with clonidine (269 +/- 693). Irisin was unaffected by sympathetic inhibition and/or hypoxia (P>0.21). Study 2: The plasma concentration of irisin and FGF21, and the skeletal muscle protein content of fibronectin type III domain containing 5 (FNDC5) was determined in 19 young adults prior to and following three weeks of sprint interval training (SIT). SIT decreased FGF21 (338 +/- 78 vs. 251 +/- 36; P = 0.046) but did not affect FNDC5 (P = 0.79). Irisin was decreased in males (127 +/- 18 vs. 90 +/- 23 ng/mL; P = 0.045) and increased in females (139 +/- 14 vs. 170 +/- 18). Collectively, these data suggest a potential regulatory role of acute sympathetic activation pertaining to the browning of white adipose; further, there appears to be a sexual dimorphic response of irisin to SIT.d	[Scalzo, Rebecca L.; Peltonen, Garrett L.; Giordano, Gregory R.; Binns, Scott E.; Klochak, Anna L.; Paris, Hunter L. R.; Schweder, Melani M.; Szallar, Steve E.; Wood, Lacey M.; Hickey, Matthew S.; Bell, Christopher] Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA; [Larson, Dennis G.; Luckasen, Gary J.] Univ Colorado Hlth, Heart Ctr Rockies, Ft Collins, CO USA	Colorado State University; University of Colorado System; University of Colorado Anschutz Medical Campus	Bell, C (corresponding author), Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA.	christopher.bell@colostate.edu			Defense Advanced Research Projects Agency (DARPA) [N66001-10-c-2134]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The Defense Advanced Research Projects Agency (DARPA: N66001-10-c-2134) provided support for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GE, 2002, CIRCULATION, V106, P2533, DOI 10.1161/01.CIR.0000041244.79165.25; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bell C, 2011, EXERC SPORT SCI REV, V39, P187, DOI 10.1097/JES.0b013e31822673f0; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Chartoumpekis DV, 2011, MOL MED, V17, P736, DOI 10.2119/molmed.2011.00075; Cuevas-Ramos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038022; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; Fain JN, 2013, METABOLISM; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fletcher JA, 2012, APPL PHYSIOL NUTR ME, V37, P1054, DOI [10.1139/H2012-091, 10.1139/h2012-091]; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; GRASSI G, 1995, HYPERTENSION, V25, P560, DOI 10.1161/01.HYP.25.4.560; Grassi G, 1998, CIRCULATION, V97, P2037, DOI 10.1161/01.CIR.97.20.2037; Grassi G, 2001, HYPERTENSION, V38, P1316, DOI 10.1161/hy1201.096117; Hecht R, 2012, PLOS ONE; Hecksteden A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-235; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jenkins Alicia, 2008, Diabetes Res Clin Pract, V82, pe5, DOI 10.1016/j.diabres.2008.06.019; Jocken JWE, 2008, DIABETOLOGIA, V51, P320, DOI 10.1007/s00125-007-0866-y; Jones PP, 1997, AM J PHYSIOL-ENDOC M, V272, pE976, DOI 10.1152/ajpendo.1997.272.6.E976; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063517; Kralisch S, 2013, J ENDOCRINOL, V216, P135, DOI 10.1530/JOE-12-0367; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Kurosu H, 2009, MOL CELL ENDOCRINOL, V299, P72, DOI 10.1016/j.mce.2008.10.052; Lichtenbelt WDV, 2011, AM J PHYSIOL-REG I, V301, pR285, DOI 10.1152/ajpregu.00652.2010; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Macpherson REK, 2011, MED SCI SPORT EXER, V43, P115, DOI 10.1249/MSS.0b013e3181e5eacd; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Matsumoto T, 1999, INT J OBESITY, V23, P793, DOI 10.1038/sj.ijo.0800928; Matsumoto T, 2001, OBES RES, V9, P78, DOI 10.1038/oby.2001.10; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Miura S, 2007, ENDOCRINOLOGY, V148, P3441, DOI 10.1210/en.2006-1646; Monroe MB, 2001, AM J PHYSIOL-ENDOC M, V280, pE740, DOI 10.1152/ajpendo.2001.280.5.E740; Muise ES, 2008, MOL PHARMACOL, V74, P403, DOI 10.1124/mol.108.044826; Navegantes LCC, 2003, J CLIN ENDOCR METAB, V88, P5515, DOI 10.1210/jc.2003-030445; Newsom SA, 2010, J ENDOCRINOL, V206, P307, DOI 10.1677/JOE-10-0152; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Pekkala S, 2013, J PHYSIOL-LONDON, V591, P5393, DOI 10.1113/jphysiol.2013.263707; Peltonen GL, 2012, J PHYSIOL-LONDON, V590, P2801, DOI 10.1113/jphysiol.2011.227090; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Richards JC, 2010, J PHYSIOL-LONDON, V588, P2961, DOI 10.1113/jphysiol.2010.189886; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Sanchez J.A.G., 2013, MOL NUTR FOOD RES, P1; Sandvei M, 2012, ARCH PHYSIOL BIOCHEM, V118, P139, DOI 10.3109/13813455.2012.677454; SCHERRER U, 1994, CIRCULATION, V89, P2634, DOI 10.1161/01.CIR.89.6.2634; SCHWARTZ RS, 1990, METABOLISM, V39, P733, DOI 10.1016/0026-0495(90)90109-P; Seale P, 2009, DIABETES, V58, P1482, DOI 10.2337/db09-0622; Soderlund V, 2007, EUR J NUCL MED MOL I, V34, P1018, DOI 10.1007/s00259-006-0318-9; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Stuckey MI, 2012, SCAND J MED SCI SPOR, V22, P756, DOI 10.1111/j.1600-0838.2011.01320.x; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang H, 2008, MOL CELL BIOL, V28, P188, DOI 10.1128/MCB.00992-07; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	61	39	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90696	10.1371/journal.pone.0090696	http://dx.doi.org/10.1371/journal.pone.0090696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603718	Green Published, gold			2022-12-25	WOS:000332483600072
J	Barboza, P; Vaillant, L; Le Strat, Y; Hartley, DM; Nelson, NP; Mawudeku, A; Madoff, LC; Linge, JP; Collier, N; Brownstein, JS; Astagneau, P				Barboza, Philippe; Vaillant, Laetitia; Le Strat, Yann; Hartley, David M.; Nelson, Noele P.; Mawudeku, Abla; Madoff, Lawrence C.; Linge, Jens P.; Collier, Nigel; Brownstein, John S.; Astagneau, Pascal			Factors Influencing Performance of Internet-Based Biosurveillance Systems Used in Epidemic Intelligence for Early Detection of Infectious Diseases Outbreaks	PLOS ONE			English	Article							EARLY WARNING SYSTEM; PROMED-MAIL; SURVEILLANCE; IMPORTATION; BIOCASTER	Background: Internet-based biosurveillance systems have been developed to detect health threats using information available on the Internet, but system performance has not been assessed relative to end-user needs and perspectives. Method and Findings: Infectious disease events from the French Institute for Public Health Surveillance (InVS) weekly international epidemiological bulletin published in 2010 were used to construct the gold-standard official dataset. Data from six biosurveillance systems were used to detect raw signals (infectious disease events from informal Internet sources): Argus, BioCaster, GPHIN, HealthMap, MedISys and ProMED-mail. Crude detection rates (C-DR), crude sensitivity rates (C-Se) and intrinsic sensitivity rates (I-Se) were calculated from multivariable regressions to evaluate the systems' performance (events detected compared to the gold-standard) 472 raw signals (Internet disease reports) related to the 86 events included in the gold-standard data set were retrieved from the six systems. 84 events were detected before their publication in the gold-standard. The type of sources utilised by the systems varied significantly (p < 0001). I-Se varied significantly from 43% to 71% (p = 0001) whereas other indicators were similar (C-DR: p = 020; C-Se, p = 013). I-Se was significantly associated with individual systems, types of system, languages, regions of occurrence, and types of infectious disease. Conversely, no statistical difference of C-DR was observed after adjustment for other variables. Conclusion: Although differences could result from a biosurveillance system's conceptual design, findings suggest that the combined expertise amongst systems enhances early detection performance for detection of infectious diseases. While all systems showed similar early detection performance, systems including human moderation were found to have a 53% higher I-Se (p = 00001) after adjustment for other variables. Overall, the use of moderation, sources, languages, regions of occurrence, and types of cases were found to influence system performance.	[Barboza, Philippe; Vaillant, Laetitia] Inst Veille Sanit, French Inst Publ Hlth Surveillance, Int Dept, St Maurice, France; [Le Strat, Yann] Inst Veille Sanit, French Inst Publ Hlth Surveillance, Infect Dept, St Maurice, France; [Hartley, David M.] Georgetown Univ, Dept Microbiol & Immunol, Med Ctr, Washington, DC USA; [Hartley, David M.] Georgetown Univ, Sch Med, Imaging Sci & Informat Syst Ctr, Washington, DC USA; [Nelson, Noele P.] Georgetown Univ, Med Ctr, Dept Pediat, Washington, DC 20007 USA; [Mawudeku, Abla] Publ Hlth Agcy Canada, Ctr Emergency Preparedness & Response, Ottawa, ON, Canada; [Madoff, Lawrence C.] Int Soc Infect Dis, ProMED Mail, Boston, MA USA; [Linge, Jens P.] Commiss European Communities, Joint Res Ctr, I-21020 Ispra, Italy; [Collier, Nigel] Natl Inst Informat, Tokyo, Japan; [Collier, Nigel] European Bioinformat Inst, Cambridge, England; [Brownstein, John S.] Harvard Univ, Sch Med, Boston Childrens Hosp, Boston, MA USA; [Astagneau, Pascal] PRES Sorbonne Cite, Univ Sch Publ Hlth, EHESP, Paris, France	Institute of Public Health Surveillance; Institute of Public Health Surveillance; Georgetown University; Georgetown University; Georgetown University; Public Health Agency of Canada; European Commission Joint Research Centre; EC JRC ISPRA Site; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; European Molecular Biology Laboratory (EMBL); Harvard University; Boston Children's Hospital; Harvard Medical School; Ecole des Hautes Etudes en Sante Publique (EHESP)	Barboza, P (corresponding author), Inst Veille Sanit, French Inst Publ Hlth Surveillance, Int Dept, St Maurice, France.	barbozap@who.int	Le Strat, Yann/C-9848-2013; Astagneau, Pascal/AAF-3473-2020	Le Strat, Yann/0000-0002-6180-4200; Hartley, David/0000-0003-2589-2538; Collier, Nigel/0000-0002-7230-4164				[Anonymous], 2010, W NIL VIR CIRC EPISO; Barboza P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057252; Barboza Philippe, 2007, Rev Prat, V57, P867; Bitar D, 2009, B ACAD NAT MED PARIS, V193, P1847, DOI 10.1016/S0001-4079(19)32418-5; Brownstein J., 2007, EUROSURVEILLANCE, V12, DOI DOI 10.2807/ESW.12.48.03322-EN5; Collier N, 2008, BIOINFORMATICS, V24, P2940, DOI 10.1093/bioinformatics/btn534; Cowen P, 2006, JAVMA-J AM VET MED A, V229, P1090, DOI 10.2460/javma.229.7.1090; Formenty P, 2006, MED MALADIES INFECT, V36, P9, DOI 10.1016/j.medmal.2005.06.009; Hartley DM, 2013, CLIN MICROBIOL INFEC, V19, P1006, DOI 10.1111/1469-0691.12273; Hartley Dm, 2010, Emerg Health Threats J, V3, pe3, DOI 10.3134/ehtj.10.003; Heymann D L, 2001, Lancet Infect Dis, V1, P345, DOI 10.1016/S1473-3099(01)00148-7; Institut de Veille Sanitaire website, EP INT I VEILL SAN I; Institut de Veille Sanitaire website, B HEBD INT; Josseran L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011984; Ledrans M, 2007, EUROSURVEILLANCE, V12; Linge JP, 2009, EUROSURVEILLANCE, V14; Lyon A, 2012, TRANSBOUND EMERG DIS, V59, P223, DOI 10.1111/j.1865-1682.2011.01258.x; Madoff LC, 2004, CLIN INFECT DIS, V39, P227, DOI 10.1086/422003; Mawudeku A, 2008, P 7 C ASS MACH TRANS; Morse SS, 2012, BIOSECUR BIOTERROR, V10, P6, DOI 10.1089/bsp.2011.0088; Nelson NP, 2010, EUROSURVEILLANCE, V15, P7; Paquet C, 2012, EUROSURVEILLANCE, V12, P212; Rotureau B, 2007, EMERG INFECT DIS, V13, P1590, DOI 10.3201/eid1310.070522; Woodall J P, 2001, Cad Saude Publica, V17 Suppl, P147, DOI 10.1590/S0102-311X2001000700024; Zhang ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015314; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	26	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90536	10.1371/journal.pone.0090536	http://dx.doi.org/10.1371/journal.pone.0090536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599062	Green Published, Green Submitted, gold			2022-12-25	WOS:000332479400090
J	Gaidenko, TA; Price, CW				Gaidenko, Tatiana A.; Price, Chester W.			Genetic Evidence for a Phosphorylation-Independent Signal Transduction Mechanism within the Bacillus subtilis Stressosome	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SIGMA(B); IN-VIVO PHOSPHORYLATION; LIGHT RECEPTOR YTVA; ENVIRONMENTAL-STRESS; PATHWAY; RSBR; ACTIVATION; COMPLEX; KINASE; OUTPUT	The stressosome is a 1.8 MDa cytoplasmic complex that controls diverse bacterial signaling pathways. Its role is best understood in Bacillus subtilis, where it activates the sigma(B) transcription factor in response to a variety of sharp environmental challenges, including acid, ethanol, heat or salt stress. However, details of the signaling mechanism within the stressosome remain uncertain. The core of the complex comprises one or more members of the RsbR co-antagonist family together with the RsbS antagonist protein, which binds the RsbT kinase in the absence of stress. As part of the response, RsbT first phosphorylates the RsbRA co-antagonist on T171 and then RsbS on S59; this latter event correlates with the stress-induced release of RsbT to activate downstream signaling. Here we examine the in vivo consequence of S59 phosphorylation in a model strain whose stressosome core is formed solely with the RsbRA co-antagonist and RsbS. A phosphorylation-deficient S59A substitution in RsbS blocked response to mild stress but had declining impact as stress increased: with strong ethanol challenge response with S59A was 60% as robust as with wild type RsbS. Genetic analysis narrowed this S59-independent activation to the stressosome and established that significant signaling still occurred in a strain bearing both the T171A and S59A substitutions. We infer that S59 phosphorylation increases signaling efficiency but is not essential, and that a second (or underlying) mechanism of signal transduction prevails in its absence. This interpretation nullifies models in which stressosome signaling is solely mediated by control of RsbT kinase activity toward S59.	[Gaidenko, Tatiana A.; Price, Chester W.] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA	University of California System; University of California Davis	Price, CW (corresponding author), Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA.	cwprice@ucdavis.edu	Price, Chester/M-6900-2019		National Institute of General Medical Sciences of the National Institutes of Health [RO1 GM42077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042077] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number RO1 GM42077. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar S, 1997, MOL MICROBIOL, V24, P567, DOI 10.1046/j.1365-2958.1997.3631732.x; Akbar S, 2001, J BACTERIOL, V183, P1329, DOI 10.1128/JB.183.4.1329-1338.2001; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Avila-Perez M, 2010, J BACTERIOL, V192, P755, DOI 10.1128/JB.00826-09; Avila-Perez M, 2009, J BIOL CHEM, V284, P24958, DOI 10.1074/jbc.M109.033316; BOYLAN SA, 1992, J BACTERIOL, V174, P3695, DOI 10.1128/JB.174.11.3695-3706.1992; Brigulla M, 2003, J BACTERIOL, V185, P4305, DOI 10.1128/JB.185.15.4305-4314.2003; Chen CC, 2004, J BACTERIOL, V186, P6830, DOI 10.1128/JB.186.20.6830-6836.2004; Chen CC, 2003, MOL MICROBIOL, V49, P1657, DOI 10.1046/j.1365-2958.2003.03663.x; Cybulski RJ, 2009, INFECT IMMUN, V77, P274, DOI 10.1128/IAI.00515-08; Delumeau O, 2004, J BIOL CHEM, V279, P40927, DOI 10.1074/jbc.M405464200; Delumeau O, 2006, J BACTERIOL, V188, P7885, DOI 10.1128/JB.00892-06; Diensthuber RP, 2013, STRUCTURE, V21, P1127, DOI 10.1016/j.str.2013.04.024; DUBNAU D, 1971, J MOL BIOL, V56, P209, DOI 10.1016/0022-2836(71)90460-8; Eymann C, 2011, MOL MICROBIOL, V80, P798, DOI 10.1111/j.1365-2958.2011.07609.x; Gaidenko TA, 1999, J MOL BIOL, V288, P29, DOI 10.1006/jmbi.1999.2665; Gaidenko TA, 2006, J BACTERIOL, V188, P6387, DOI 10.1128/JB.00691-06; Gaidenko TA, 2012, J BACTERIOL, V194, P3913, DOI 10.1128/JB.00583-12; Gaidenko TA, 2011, J BACTERIOL, V193, P3588, DOI 10.1128/JB.00060-11; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Hoper D, 2005, J BACTERIOL, V187, P2810, DOI 10.1128/JB.187.8.2810-2826.2005; Jurk M, 2013, BIOCHEM BIOPH RES CO, V432, P499, DOI 10.1016/j.bbrc.2013.02.025; Kang CM, 1996, J BACTERIOL, V178, P3846, DOI 10.1128/jb.178.13.3846-3853.1996; Kim TJ, 2004, J BACTERIOL, V186, P6124, DOI 10.1128/jb.186.18.6124-6132.2004; Kim TJ, 2004, J MOL BIOL, V341, P135, DOI 10.1016/j.jmb.2004.05.043; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Liebal UW, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-3; Losi A, 2002, BIOPHYS J, V82, P2627, DOI 10.1016/S0006-3495(02)75604-X; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Marles-Wright J, 2008, SCIENCE, V322, P92, DOI 10.1126/science.1159572; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Moglich A, 2009, J MOL BIOL, V385, P1433, DOI 10.1016/j.jmb.2008.12.017; Murray JW, 2005, P NATL ACAD SCI USA, V102, P17320, DOI 10.1073/pnas.0506599102; Pane-Farre J, 2005, J MOL MICROB BIOTECH, V9, P65, DOI 10.1159/000088837; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; PIGGOT PJ, 1973, J BACTERIOL, V114, P1241, DOI 10.1128/JB.114.3.1241-1253.1973; Price CW, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P301; Purcell EB, 2010, BIOCHEMISTRY-US, V49, P6761, DOI 10.1021/bi1006404; Quin MB, 2012, STRUCTURE, V20, P350, DOI 10.1016/j.str.2012.01.003; Reeves A, 2010, MICROBIOL-SGM, V156, P990, DOI 10.1099/mic.0.036095-0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; STEINMETZ M, 1994, GENE, V142, P79, DOI 10.1016/0378-1119(94)90358-1; Van der Steen JB, 2012, J BACTERIOL, V194, P1708, DOI 10.1128/JB.06705-11; Vijay K, 2000, MOL MICROBIOL, V35, P180, DOI 10.1046/j.1365-2958.2000.01697.x; Yang XF, 1996, GENE DEV, V10, P2265, DOI 10.1101/gad.10.18.2265; Young JW, 2013, P NATL ACAD SCI USA, V110, P4140, DOI 10.1073/pnas.1213060110	48	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90741	10.1371/journal.pone.0090741	http://dx.doi.org/10.1371/journal.pone.0090741			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24599254	Green Published, gold			2022-12-25	WOS:000332479400129
J	Kim, YW; Jeong, YJ; Kim, AY; Son, HH; Lee, JA; Jung, CH; Kim, CH; Kim, J				Kim, Young-Wook; Jeong, Young-Ju; Kim, Ah-Young; Son, Hyun-Hee; Lee, Jong-Am; Jung, Cheong-Hwan; Kim, Chae-Hyun; Kim, Jaeman			Lactobacillus brevis Strains from Fermented Aloe vera Survive Gastroduodenal Environment and Suppress Common Food Borne Enteropathogens	PLOS ONE			English	Article							GLUTAMATE-DECARBOXYLASE; ACID; MICROENCAPSULATION; BACTERIA; BARBADENSIS; CLONING; SAFETY; GENE	Five novel Lactobacillus brevis strains were isolated from naturally fermented Aloe vera leaf flesh. Each strain was identified by Random Amplified Polymorphic DNA (RAPD) analysis and 16S rRNA sequence comparison. These strains were highly tolerant to acid, surviving in pH2.5 for up to 4 hours, and resistant to 5% bile salts at 37 degrees C for 18 hours. Due to its tolerance to acid and bile salts, one strain passed through the gastric barrier and colonised the intestine after oral administration. All five strains inhibited the growth of many harmful enteropathogens without restraining most of normal commensals in the gut and hence named POAL (Probiotics Originating from Aloe Leaf) strains. Additionally, each strain exhibited discriminative resistance to a wide range of antibiotics. The L. brevis POAL strains, moreover, expressed high levels of the glutamate decarboxylase (GAD) gene which produces a beneficial neurotransmitter, gamma-aminobutyric acid (GABA). These characteristics in all suggest that the novel L. brevis strains should be considered as potential food additives and resources for pharmaceutical research.	[Kim, Young-Wook; Jeong, Young-Ju; Son, Hyun-Hee; Lee, Jong-Am; Jung, Cheong-Hwan; Kim, Chae-Hyun] KBNP Inc, KBNP Technol Inst, Yesan, South Korea; [Kim, Ah-Young] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju, South Korea; [Kim, Jaeman] Mokpo Natl Univ, Dept Biol, Muan, South Korea	Chonnam National University; Mokpo National University	Kim, J (corresponding author), Mokpo Natl Univ, Dept Biol, Muan, South Korea.	jkim@mokpo.ac.kr			KBNP Inc.	KBNP Inc.	This study was supported by KBNP Inc., a manufacturing company specialising in animal health products for providing funding in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcroft M, 2003, ALOE VERA NATURES SE; Betoret N, 2003, J FOOD ENG, V56, P273, DOI 10.1016/S0260-8774(02)00268-6; Chandramouli V, 2004, J MICROBIOL METH, V56, P27, DOI 10.1016/j.mimet.2003.09.002; Cho JK, 2007, KOREAN J FOOD SCI AN, V27, P363, DOI 10.5851/kosfa.2007.27.3.363; Chou LS, 1999, J DAIRY SCI, V82, P23, DOI 10.3168/jds.S0022-0302(99)75204-5; Collado MC, 2007, LETT APPL MICROBIOL, V45, P454, DOI 10.1111/j.1472-765X.2007.02212.x; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Deng Xinhua, 1999, Journal of Plant Resources and Environment, V8, P26; Ding WK, 2009, J FOOD SCI, V74, pM53, DOI 10.1111/j.1750-3841.2008.01030.x; ERLANDER MG, 1991, NEUROCHEM RES, V16, P215, DOI 10.1007/BF00966084; Esteban-Carrasco A, 2001, PLANT PHYSIOL BIOCH, V39, P521, DOI 10.1016/S0981-9428(01)01270-0; Ezendam J, 2006, NUTR REV, V64, P1, DOI [10.1301/nr.2006.jan.1-14, 10.1111/j.1753-4887.2006.tb00168.x]; Farnell MB, 2005, J APPL MICROBIOL, V99, P1043, DOI 10.1111/j.1365-2672.2005.02712.x; Favaro-Trindade CS, 2002, J MICROENCAPSUL, V19, P485, DOI 10.1080/02652040210140715; Ferro VA, 2003, ANTIMICROB AGENTS CH, V47, P1137, DOI 10.1128/AAC.47.3.1137-1139.2003; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; Kang TK, 2010, KOREAN J FOOD SCI AN, V30, P795, DOI 10.5851/kosfa.2010.30.5.795; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kim TW, 2009, INT J FOOD MICROBIOL, V131, P265, DOI 10.1016/j.ijfoodmicro.2009.03.001; Makras L, 2006, INT DAIRY J, V16, P1049, DOI 10.1016/j.idairyj.2005.09.006; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Morelli L, 2000, Curr Issues Intest Microbiol, V1, P59; National Committee for Clinical Laboratory Standards, 2004, M11A6 NCCLS CLIN LAB; Park KB, 2007, BIORESOURCE TECHNOL, V98, P312, DOI 10.1016/j.biortech.2006.01.004; Park Ki-Bum, 2004, Preventive Nutrition and Food Science, V9, P324; Park S. Y., 1996, KOR J APPL MICROBIOL, V24, P304; 강효진, 2004, [Korean Journal of Microbiology, 미생물학회지], V40, P1; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Salminen S, 1993, LACTIC ACID BACTERIA; Saxelin M, 2005, CURR OPIN BIOTECH, V16, P204, DOI 10.1016/j.copbio.2005.02.003; Shahzad K., 2009, PHARMACOLOGYONLINE, V1, P416; Shamim S, 2004, PHARM BIOL, V42, P491, DOI 10.3109/13880200490891845; 이윤미, 2004, [Korean Journal of Food Science and Technology, 한국식품과학회지], V36, P129; Takahashi N, 2004, J DAIRY RES, V71, P340, DOI 10.1017/S0022029904000251; Ueno H, 2000, J MOL CATAL B-ENZYM, V10, P67, DOI 10.1016/S1381-1177(00)00114-4; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; Vernazza CL, 2006, J APPL MICROBIOL, V100, P846, DOI 10.1111/j.1365-2672.2006.02832.x; Vesterlund S, 2007, INT J FOOD MICROBIOL, V116, P325, DOI 10.1016/j.ijfoodmicro.2007.02.002; VIDGREN G, 1992, J BACTERIOL, V174, P7419, DOI 10.1128/jb.174.22.7419-7427.1992; YAMADA K, 1977, BIOTECHNOL BIOENG, V19, P1563, DOI 10.1002/bit.260191102	40	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90866	10.1371/journal.pone.0090866	http://dx.doi.org/10.1371/journal.pone.0090866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598940	Green Submitted, Green Published, gold			2022-12-25	WOS:000332479400141
J	Okuda, DT; Siva, A; Kantarci, O; Inglese, M; Katz, I; Tutuncu, M; Keegan, BM; Donlon, S; Hua, LH; Vidal-Jordana, A; Montalban, X; Rovira, A; Tintore, M; Amato, MP; Brochet, B; de Seze, J; Brassat, D; Vermersch, P; De Stefano, N; Sormani, MP; Pelletier, D; Lebrun, C				Okuda, Darin T.; Siva, Aksel; Kantarci, Orhun; Inglese, Matilde; Katz, Ilana; Tutuncu, Melih; Keegan, B. Mark; Donlon, Stacy; Hua, Le H.; Vidal-Jordana, Angela; Montalban, Xavier; Rovira, Alex; Tintore, Mar; Amato, Maria Pia; Brochet, Bruno; de Seze, Jerome; Brassat, David; Vermersch, Patrick; De Stefano, Nicola; Sormani, Maria Pia; Pelletier, Daniel; Lebrun, Christine		RISC; CFSEP	Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; CONVERSION; LESIONS; DISABILITY; MRI; AGE	Objective: To report the 5-year risk and to identify risk factors for the development of a seminal acute or progressive clinical event in a multi-national cohort of asymptomatic subjects meeting 2009 RIS Criteria. Methods: Retrospectively identified RIS subjects from 22 databases within 5 countries were evaluated. Time to the first clinical event related to demyelination (acute or 12-month progression of neurological deficits) was compared across different groups by univariate and multivariate analyses utilizing a Cox regression model. Results: Data were available in 451 RIS subjects (F: 354 (78.5%)). The mean age at from the time of the first brain MRI revealing anomalies suggestive of MS was 37.2 years (y) (median: 37.1 y, range: 11-74 y) with mean clinical follow-up time of 4.4 y (median: 2.8 y, range: 0.01-21.1 y). Clinical events were identified in 34% (standard error = 3%) of individuals within a 5-year period from the first brain MRI study. Of those who developed symptoms, 9.6% fulfilled criteria for primary progressive MS. In the multivariate model, age [hazard ratio (HR): 0.98 (95% CI: 0.96-0.99); p = 0.03], sex (male) [HR: 1.93 (1.24-2.99); p = 0.004], and lesions within the cervical or thoracic spinal cord [HR: 3.08 (2.06-4.62); p =< 0.001] were identified as significant predictors for the development of a first clinical event. Interpretation: These data provide supportive evidence that a meaningful number of RIS subjects evolve to a first clinical symptom. An age <37 y, male sex, and spinal cord involvement appear to be the most important independent predictors of symptom onset.	[Okuda, Darin T.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Clin Ctr Multiple Sclerosis, Dallas, TX 75390 USA; [Siva, Aksel; Tutuncu, Melih] Istanbul Univ, Dept Neurol, Cerrahpasa Med Sch, Istanbul, Turkey; [Kantarci, Orhun; Keegan, B. Mark] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN USA; [Inglese, Matilde; Katz, Ilana] Mt Sinai Sch Med, Dept Neurol Radiol & Neurosci, New York, NY USA; [Donlon, Stacy] Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA; [Hua, Le H.] Cleveland Clin, Dept Neurol, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA; [Vidal-Jordana, Angela; Montalban, Xavier; Rovira, Alex; Tintore, Mar] Vall dHebron Hosp, MS Ctr Catalunya Cemcat, Barcelona, Spain; [Vidal-Jordana, Angela; Montalban, Xavier; Rovira, Alex; Tintore, Mar] Vall dHebron Hosp, Magnet Resonance Unit, Barcelona, Spain; [Amato, Maria Pia] Univ Florence, Dept Neurol, Florence, Italy; [Brochet, Bruno] Ctr Hosp Univ Bordeaux, Bordeaux, France; [de Seze, Jerome] Ctr Hosp Univ Strasbourg, Strasbourg, France; [Brassat, David] Ctr Hosp Univ Purpan, Toulouse, France; [Vermersch, Patrick] Ctr Hosp Univ Salengro, Lille, France; [De Stefano, Nicola] Univ Siena, Dept Med Surg & Neurosci, I-53100 Siena, Italy; [Sormani, Maria Pia] Univ Genoa, Dept Hlth Sci DISSAL, Genoa, Italy; [Pelletier, Daniel] Yale Univ, Dept Neurol, New Haven, CT USA; [Pelletier, Daniel] Yale Univ, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Lebrun, Christine] Hop Louis Pasteur, Serv Neurol, F-06002 Nice, France	University of Texas System; University of Texas Southwestern Medical Center Dallas; Istanbul University; Istanbul University - Cerrahpasa; Mayo Clinic; Icahn School of Medicine at Mount Sinai; Barrow Neurological Institute; Cleveland Clinic Foundation; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; University of Florence; CHU Bordeaux; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Toulouse; Universite de Lille - ISITE; CHU Lille; University of Siena; University of Genoa; Yale University; Yale University; CHU Nice	Okuda, DT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Clin Ctr Multiple Sclerosis, Dallas, TX 75390 USA.	darin.okuda@utsouthwestern.edu	Amato, Maria Pia/AAC-5940-2022; Donlon, Stacy/AAL-9460-2020; Inglese, Matilde/AAH-3189-2020; Tütüncü, Melih/AAF-1702-2021; De Stefano, Nicola/AHE-3052-2022; Siva, Aksel/A-5132-2016; Sormani, Maria Pia/ABH-8756-2020; amato, Maria Pia/AAL-5998-2020; Rovira, Alex/AAX-3973-2020; De Seze, Jerome/M-8316-2016; Montalban, Xavier/J-5938-2016; lebrun-frenay, christine/AAP-9539-2021; Brassat, David/L-2173-2014; Hua, Le/S-4930-2019	Inglese, Matilde/0000-0002-9610-0297; Tütüncü, Melih/0000-0002-9851-7002; De Stefano, Nicola/0000-0003-4930-7639; Siva, Aksel/0000-0002-8340-6641; amato, Maria Pia/0000-0003-3325-3760; De Seze, Jerome/0000-0002-7197-7578; Montalban, Xavier/0000-0002-0098-9918; lebrun-frenay, christine/0000-0002-3713-2416; Vidal-Jordana, Angela/0000-0002-7270-5507; Okuda, Darin/0000-0002-6499-1523; Hua, Le/0000-0002-0535-3978; Tintore, Mar/0000-0001-9999-5359; SORMANI, MARIA PIA/0000-0001-6892-104X	Acorda Therapeutics; Biogen IDEC; Genzyme; Ipsen Pharmaceuticals; Teva Neuroscience; Bayer-Schering AG; Novartis; Allergan; Merck-Serono; Gen Ilac; Celgene; Vaccinex; National MS Society; eMedicine; Bristol Meyers Squibb; Bionest; Terumo BCT; EMD Serono; Almirall; Bayer; Merck; Genentech; GeNeuro; Neurotec; Sanofi-Aventis; AdvanceCell Bayer-Schering Pharma; OLEA Medical; Siemens AG; Merck Serono; Bayer-Schering; Caridian; GSK; Novartis Pharma AG; Actelion; Synthon; Allozyne; Roche	Acorda Therapeutics; Biogen IDEC(Biogen); Genzyme(Sanofi-AventisGenzyme Corporation); Ipsen Pharmaceuticals(Ipsen); Teva Neuroscience(Teva Pharmaceutical Industries); Bayer-Schering AG; Novartis(Novartis); Allergan(AbbVieAllergan); Merck-Serono(Merck & Company); Gen Ilac; Celgene(Bristol-Myers SquibbCelgene Corporation); Vaccinex; National MS Society(National Multiple Sclerosis Society); eMedicine; Bristol Meyers Squibb(Bristol-Myers Squibb); Bionest; Terumo BCT; EMD Serono; Almirall(Almirall); Bayer(Bayer AG); Merck(Merck & Company); Genentech(Roche HoldingGenentech); GeNeuro; Neurotec; Sanofi-Aventis(Sanofi-Aventis); AdvanceCell Bayer-Schering Pharma; OLEA Medical; Siemens AG(Siemens AG); Merck Serono(Merck & Company); Bayer-Schering(Bayer AG); Caridian; GSK(GlaxoSmithKline); Novartis Pharma AG; Actelion; Synthon; Allozyne; Roche(Roche Holding)	Dr. Okuda reports personal fees for consulting, advisory board, and speaking activities from Acorda Therapeutics, Biogen IDEC, Genzyme, Ipsen Pharmaceuticals, and Teva Neuroscience, outside the submitted work. Professor Siva reports personal fees for consulting and serving on a scientific advisory board from Bayer-Schering AG, Novartis, Biogen IDEC and Allergan within the last year, and travel and registration coverage for congresses or symposia from Bayer-Schering AG, Merck-Serono, Gen Ilac, and Allergan. Professor Siva received research support from Bayer-Schering AG, outside the submitted work. Dr. Kantarci has nothing to disclose. Dr. Inglese reports personal fees from Celgene, and Vaccinex. Dr. Katz reports grants from Acorda Therapeutics and from the National MS Society, outside the submitted work. Dr. Tutuncu has nothing to disclose. Dr. Keegan reports personal fees from eMedicine, Bristol Meyers Squibb, Novartis, Bionest, and grants from Terumo BCT, outside the submitted work. Dr. Donlon has nothing to disclose. Dr. Hua has nothing to disclose. Dr. Vidal-Jordana reports personal fees from EMD Serono, outside the submitted work. Dr. Montalban reports personal fees from Almirall, Bayer, Biogen IDEC, EMD Serono, Merck, Genentech, GeNeuro, Genzyme, Neurotec, Novartis, Sanofi-Aventis, and Teva Neuroscience, outside the submitted work. Dr. Rovira reports personal fees from AdvanceCell Bayer-Schering Pharma, Novartis, OLEA Medical, Sanofi-Aventis, Teva Neuroscience, Biogen IDEC, grants from Siemens AG, outside the submitted work. Dr. Tintore reports personal fees from Genzyme, Biogen IDEC, Teva Neuroscience, Novartis, Sanofi-Aventis, Bayer, and Merck Serono, outside the submitted work. Dr. Amato reports grants and personal fees from Biogen IDEC, Merck Serono, Bayer-Schering, Teva Neuroscience, Sanofi-Aventis, and Novartis, outside the submitted work. Dr. Brochet reports personal fees from Novartis, Genzyme, and Bayer, grants from Bayer and Teva Neuroscience, Merck-Serono, and Caridian, outside the submitted work. Dr. de Seze has nothing to disclose. Dr. Brassat reports personal fees from Bayer-Schering, Biogen IDEC, Merck-Serono, Novartis, Sanofi-Aventis, and Teva Neuroscience, outside the submitted work. Dr. Vermersch reports grants and personal fees from Biogen IDEC, Sanofi-Aventis, Bayer, Merck-Serono, personal fees from Novartis, GSK, and Almirall, outside the submitted work. Dr. De Stefano reports personal fees from Merck-Serono, Novartis Pharma AG, Teva Neuroscience, Sanofi-Aventis, Bayer-Schering AG, and Biogen IDEC, outside the submitted work. Dr. Sormani reports personal fees from Biogen IDEC, Merck-Serono, Actelion, Synthon, and Allozyne, outside the submitted work. Dr. Pelletier reports personal fees from Teva Neuroscience, Biogen IDEC, and Roche, grants from Biogen IDEC, outside the submitted work. Dr. Lebrun has nothing to disclose. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bot JCJ, 2002, RADIOLOGY, V223, P46, DOI 10.1148/radiol.2231010707; Cohen AB, 2012, J NEUROIMAGING, V22, P122, DOI 10.1111/j.1552-6569.2011.00589.x; Comi G, 2009, LANCET, V374, P1503, DOI 10.1016/S0140-6736(09)61259-9; Confavreux C, 2003, BRAIN, V126, P770, DOI 10.1093/brain/awg081; De Stefano N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019452; Gabelic T, 2012, ACTA NEUROL BELG; Gabelic T, 2013, AJNR AM J NEURORADIO; Giorgio A, 2011, NEUROLOGY, V77, P1896, DOI 10.1212/WNL.0b013e318238ee9b; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Kappos L, 2006, NEUROLOGY, V67, P1242, DOI 10.1212/01.wnl.0000237641.33768.8d; Koch-Henriksen N, 2010, LANCET NEUROL, V9, P520, DOI 10.1016/S1474-4422(10)70064-8; Kruit MC, 2010, CEPHALALGIA, V30, P129, DOI 10.1111/j.1468-2982.2009.01904.x; Lebrun C, 2008, J NEUROL NEUROSUR PS, V79, P195, DOI 10.1136/jnnp.2006.108274; Lebrun C, 2012, MULT SCLER J, V18, P1297, DOI 10.1177/1352458511435931; Lebrun C, 2010, MULT SCLER J, V16, P919, DOI 10.1177/1352458510375707; Lebrun C, 2009, ARCH NEUROL-CHICAGO, V66, P841, DOI 10.1001/archneurol.2009.119; Liu S, 2013, MULT SCLER J, V19, P1101, DOI 10.1177/1352458512471874; McDonnell GV, 2003, MULT SCLER J, V9, P204, DOI 10.1191/1352458503ms890cr; Oh J, 2013, NEUROLOGY; Okuda DT, 2011, NEUROLOGY, V76, P686, DOI 10.1212/WNL.0b013e31820d8b1d; Okuda DT, 2009, NEUROLOGY, V72, P800, DOI 10.1212/01.wnl.0000335764.14513.1a; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Scalfari A, 2011, NEUROLOGY, V77, P1246, DOI 10.1212/WNL.0b013e318230a17d; Siva A, 2009, MULT SCLER J, V15, P918, DOI 10.1177/1352458509106214; Sombekke MH, 2013, NEUROLOGY, V80, P69, DOI 10.1212/WNL.0b013e31827b1a67; Stromillo ML, 2013, NEUROLOGY; Tintore M, 2010, NEUROLOGY, V75, P1933, DOI 10.1212/WNL.0b013e3181feb26f; Tutuncu M, 2013, MULT SCLER J, V19, P188, DOI 10.1177/1352458512451510; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972	29	179	184	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2014	9	3							e90509	10.1371/journal.pone.0090509	http://dx.doi.org/10.1371/journal.pone.0090509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4GP	24598783	Green Submitted, Green Published, gold			2022-12-25	WOS:000332479400084
J	Gong, G; Xiang, L; Yuan, LB; Hu, L; Wu, W; Cai, L; Yin, L; Dong, HL				Gong, Gu; Xiang, Lei; Yuan, Libang; Hu, Ling; Wu, Wei; Cai, Lin; Yin, Liang; Dong, Hailong			Protective Effect of Glycyrrhizin, a Direct HMGB1 Inhibitor, on Focal Cerebral Ischemia/Reperfusion-Induced Inflammation, Oxidative Stress, and Apoptosis in Rats	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; ISCHEMIA-REPERFUSION INJURY; CHROMATIN PROTEIN HMGB1; POSTISCHEMIC BRAIN; LIVER-INJURY; IN-VIVO; MEDIATOR; CELLS; HMG-1; STROKE	Aim: Glycyrrhizin (GL) has been reported to protect against ischemia and reperfusion (I/R)-induced injury by inhibiting the cytokine activity of high mobility group box 1 (HMGB1). In the present study, the protective effects of GL against I/R injury, as well as the related molecular mechanisms, were investigated in rat brains. Methods: Focal cerebral I/R injury was induced by intraluminal filamentous occlusion of the middle cerebral artery (MCA) in Male Sprague-Dawley rats. GL alone or GL and rHMGB1 were administered intravenously at the time of reperfusion. Serum levels of HMGB1 and inflammatory mediators were quantified via enzyme-linked immunosorbent assay (ELISA). Histopathological examination, immunofluorescence, RT-PCR and western blotting analyses were performed to investigate the protective and anti-apoptotic effects and related molecular mechanisms of GL against I/R injury in rat brains. Results: Pre-treatment with GL significantly reduced infarct volume and improved the accompanying neurological deficits in locomotor function. The release of HMGB1 from the cerebral cortex into the serum was inhibited by GL administration. Moreover, pre-treatment with GL alleviated apoptotic injury resulting from cerebral I/R through the inhibition of cytochrome C release and caspase 3 activity. The expression levels of inflammation-and oxidative stress-related molecules including TNF-alpha, iNOS, IL-1 beta, and IL-6, which were over-expressed in I/R, were decreased by GL. P38 and P-JNK signalling were involved in this process. All of the protective effects of GL could be reversed by rHMGB1 administration. Conclusions: GL has a protective effect on ischemia-reperfusion injury in rat brains through the inhibition of inflammation, oxidative stress and apoptotic injury by antagonising the cytokine activity of HMGB1.	[Gong, Gu; Hu, Ling; Wu, Wei; Cai, Lin; Yin, Liang] Peoples Liberat Army, Gen Hosp, Dept Anaesthesiol, Chengdu, Sichuan, Peoples R China; [Xiang, Lei] Tianjin Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China; [Yuan, Libang; Dong, Hailong] Fourth Mil Med Univ, Xijing Hosp, Dept Anaesthesiol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Dong, HL (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Anaesthesiol, Xian 710032, Shaanxi, Peoples R China.	hldong2012_12@163.com		Dong, Hailong/0000-0001-8984-9067	State Key Program of the National Natural Science Foundation of China, Sichuan Province [110469]; Chengdu military area command general hospital [2011YG-A06]	State Key Program of the National Natural Science Foundation of China, Sichuan Province; Chengdu military area command general hospital	This study was supported by the State Key Program of the National Natural Science Foundation of China (Grant NO. 110469), Sichuan Province and Chengdu military area command general hospital Awards Fund (2011YG-A06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Arase Y, 1997, CANCER, V79, P1494, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Ceulemans AG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-74; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Goldstein RS, 2006, SHOCK, V25, P571, DOI 10.1097/01.shk.0000209540.99176.72; Gong G, 2012, ACTA PHARMACOL SIN, V33, P11, DOI 10.1038/aps.2011.151; Gursoy-Ozdemir Y, 2004, STROKE, V35, P1449, DOI 10.1161/01.STR.0000126044.83777.f4; Gwak GY, 2012, WORLD J GASTROENTERO, V18, P679, DOI 10.3748/wjg.v18.i7.679; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286, DOI 10.1152/ajpregu.1995.268.1.R286; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kim I, 2012, SPACE, P20; Kim JB, 2008, J NEUROSCI RES, V86, P1125, DOI 10.1002/jnr.21555; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kim SW, 2011, ANAT CELL BIOL, V44, P304, DOI 10.5115/acb.2011.44.4.304; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; LANDSMAN D, 1993, BIOESSAYS, V15, P539, DOI 10.1002/bies.950150807; Lee ST, 2005, BRAIN RES, V1058, P120, DOI 10.1016/j.brainres.2005.07.076; Li J, 2007, STROKE, V38, P2992, DOI 10.1161/STROKEAHA.107.490904; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Ogiku M, 2011, J PHARMACOL EXP THER, V339, P93, DOI 10.1124/jpet.111.182592; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Oozawa S, 2008, CIRC J, V72, P1178, DOI 10.1253/circj.72.1178; Piao CS, 2003, J NEUROSCI RES, V73, P537, DOI 10.1002/jnr.10671; Ren D, 2006, INFLAMM RES, V55, P207, DOI 10.1007/s00011-006-0072-2; Sato H, 1996, ANTIVIR RES, V30, P171, DOI 10.1016/0166-3542(96)00942-4; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sitia G, 2007, J LEUKOCYTE BIOL, V81, P100, DOI 10.1189/jlb.0306173; van Rossum TGJ, 2001, AM J GASTROENTEROL, V96, P2432, DOI 10.1111/j.1572-0241.2001.04049.x; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Yang QW, 2010, J CEREBR BLOOD F MET, V30, P243, DOI 10.1038/jcbfm.2009.202; Yoshida T, 2007, EUR J PHARMACOL, V576, P136, DOI 10.1016/j.ejphar.2007.08.012; Zhai C, 2012, ACTA PHARM SIN, V10, P1	43	133	145	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89450	10.1371/journal.pone.0089450	http://dx.doi.org/10.1371/journal.pone.0089450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594628	Green Submitted, Green Published, gold			2022-12-25	WOS:000332475500014
J	Gong, JH; Wang, ZD; Polejaeva, I; Salgia, R; Kao, CM; Chen, CT; Chen, GC; Chen, LH				Gong, Jianhua; Wang, Zhongde; Polejaeva, Irina; Salgia, Ravi; Kao, Chien-Min; Chen, Chin-Tu; Chen, Guangchun; Chen, Liaohai			Activating the Expression of Human K-ras(G12D) Stimulates Oncogenic Transformation in Transgenic Goat Fetal Fibroblast Cells	PLOS ONE			English	Article							K-RAS; CONDITIONAL EXPRESSION; CAPRA-HIRCUS; TUMOR; GENE; MUTATIONS; TUMORIGENESIS; GROWTH; CANCER; KRAS	Humane use of preclinical large animal cancer models plays a critical role in understanding cancer biology and developing therapeutic treatments. Among the large animal candidates, goats have great potentials as sustainable sources for large animal cancer model development. Goats are easier to handle and cheaper to raise. The genome of the goats has been sequenced recently. It has been known that goats develop skin, adrenal cortex, breast and other types of cancers. Technically, goats are subject to somatic cell nuclear transfer more efficiently and exhibit better viability through the cloning process. Towards the development of a goat cancer model, we created a transgenic goat fetal fibroblast (GFF) cell as the donor cell for SCNT. Human mutated K-ras (hK-ras(G12D)) was chosen as the transgene, as it is present in 20% of cancers. Both hK-ras(G12D) and a herpes simplex viral thymidine kinase (HSV1-tk) reporter genes, flanked by a pair of LoxP sites, were knocked in the GFF endogenous K-ras locus through homologous recombination. Following Cre-mediated activation (with a 95% activation efficiency), hK-ras(G12D) and HSV1-tk were expressed in the transgenic GFF cells, evidently through the presence of corresponding mRNAs, and confirmed by HSV1-tk protein function assay. The hK-ras(G12D) expressing GFF cells exhibited enhanced proliferation rates and an anchorage-independent growth behavior. They were able to initiate tumor growth in athymic nude mice. In conclusion, after activating hK-ras(G12D) gene expression, hK-ras(G12D) transgenic GFF cells were transformed into tumorgenesis cells. Transgenic goats via SCNT using the above-motioned cells as the donor cells have been established.	[Gong, Jianhua; Chen, Guangchun; Chen, Liaohai] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Wang, Zhongde; Polejaeva, Irina] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Salgia, Ravi; Kao, Chien-Min; Chen, Chin-Tu] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; University of Chicago	Chen, LH (corresponding author), Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA.	l.chen@usu.edu	Chen, Chin-Tu/K-3393-2014; Kao, Chien-Min/CAI-0648-2022; Gong, Jian-Hua/L-5284-2019; Polejaeva, Irina/G-4881-2012	Kao, Chien-Min/0000-0002-8785-5225; Wang, Zhongde/0000-0003-2441-4729; Polejaeva, Irina/0000-0002-0858-5889	Utah Science Technology and Research Initiative at Utah State University	Utah Science Technology and Research Initiative at Utah State University	This work was supported by Utah Science Technology and Research Initiative at Utah State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr SM, 2001, J CELL BIOCHEM, V81, P621, DOI 10.1002/jcb.1099; BOS JL, 1989, CANCER RES, V49, P4682; Brose MS, 2002, CANCER RES, V62, P6997; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hatada S, 2000, P NATL ACAD SCI USA, V97, P13807, DOI 10.1073/pnas.240462897; Hospers GAP, 2000, CANCER RES, V60, P1488; Hu YM, 2012, CELL RES, V22, P399, DOI 10.1038/cr.2011.145; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Lohr CV, 2013, VET PATHOL, V50, P668, DOI 10.1177/0300985812471544; Lu ZH, 2003, BLOOD, V102, P1531, DOI 10.1182/blood-2003-03-0708; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; Reed SD, 2009, J VET DIAGN INVEST, V21, P262, DOI 10.1177/104063870902100217; Reggio BC, 2001, BIOL REPROD, V65, P1528, DOI 10.1095/biolreprod65.5.1528; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Scocco P, 2001, VET PATHOL, V38, P98, DOI 10.1354/vp.38-1-98; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; SINGH B, 1972, VET PATHOL, V9, P441, DOI 10.1177/030098587200900604; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vizan P, 2005, CANCER RES, V65, P5512, DOI 10.1158/0008-5472.CAN-05-0074; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Wang SH, 2013, J BIOTECHNOL, V163, P377, DOI 10.1016/j.jbiotec.2012.10.018; WINTER E, 1986, MOL CELL BIOL, V6, P2562, DOI 10.1128/MCB.6.7.2562; Yaghoubi SS, 2006, NAT PROTOC, V1, P3069, DOI 10.1038/nprot.2006.459; YAMAMOTO F, 1988, ONCOGENE RES, V3, P125	33	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90059	10.1371/journal.pone.0090059	http://dx.doi.org/10.1371/journal.pone.0090059			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594684	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500031
J	Hrvatin, S; Deng, F; O'Donnell, CW; Gifford, DK; Melton, DA				Hrvatin, Sinisa; Deng, Francis; O'Donnell, Charles W.; Gifford, David K.; Melton, Douglas A.			MARIS: Method for Analyzing RNA following Intracellular Sorting	PLOS ONE			English	Article							STEM-CELL LINES; CAPTURE; QUANTIFICATION; EXPRESSION; GENE; FACS	Transcriptional profiling is a key technique in the study of cell biology that is limited by the availability of reagents to uniquely identify specific cell types and isolate high quality RNA from them. We report a Method for Analyzing RNA following Intracellular Sorting (MARIS) that generates high quality RNA for transcriptome profiling following cellular fixation, intracellular immunofluorescent staining and FACS. MARIS can therefore be used to isolate high quality RNA from many otherwise inaccessible cell types simply based on immunofluorescent tagging of unique intracellular proteins. As proof of principle, we isolate RNA from sorted human embryonic stem cell-derived insulin-expressing cells as well as adult human beta cells. MARIS is a basic molecular biology technique that could be used across several biological disciplines.	[Hrvatin, Sinisa; Deng, Francis; O'Donnell, Charles W.; Melton, Douglas A.] Harvard Univ, Harvard Stem Cell Inst, Harvard Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [O'Donnell, Charles W.; Gifford, David K.] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Melton, Douglas A.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Howard Hughes Medical Institute	Melton, DA (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Harvard Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	dmelton@harvard.edu	Young, Richard A/F-6495-2012; Deng, Francis/X-9840-2019	Young, Richard A/0000-0001-8855-8647; Deng, Francis/0000-0003-3117-5076; Hrvatin, Sinisa/0000-0001-7303-4218; O'donnell, Colm/0000-0002-8004-450X	Sternlicht Director's Fund Fellowship; Howard Hughes Medical Institute; Harvard Stem Cell Institute; National Institutes of Health [2U01DK07247307, RL1DK081184, 1U01HL10040804]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RL1DK081184] Funding Source: NIH RePORTER	Sternlicht Director's Fund Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Harvard Stem Cell Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SH is supported by the Sternlicht Director's Fund Fellowship. This project is funded by the Howard Hughes Medical Institute, Harvard Stem Cell Institute and National Institutes of Health grants (2U01DK07247307, RL1DK081184, 1U01HL10040804) and the Harvard Stem Cell Institute. DM Is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS S, 2010, GENOME BIOL, V11; Auer H, 2003, NAT GENET, V35, P292, DOI 10.1038/ng1203-292; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dobson JT, 2009, BRIT J HAEMATOL, V144, P732, DOI 10.1111/j.1365-2141.2008.07527.x; Fend F, 1999, AM J PATHOL, V154, P61, DOI 10.1016/S0002-9440(10)65251-0; Goldsworthy SM, 1999, MOL CARCINOGEN, V25, P86, DOI 10.1002/(SICI)1098-2744(199906)25:2<86::AID-MC2>3.3.CO;2-W; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Jeyapalan JC, 2013, AGING-US, V5, P120, DOI 10.18632/aging.100536; Lindeman N, 2002, DIAGN MOL PATHOL, V11, P187, DOI 10.1097/00019606-200212000-00001; Pan Y, 2011, PLOS ONE, V6; Pechhold S, 2009, NAT BIOTECHNOL, V27, P1038, DOI 10.1038/nbt.1579; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; ROOZEMOND RC, 1976, HISTOCHEM J, V8, P625, DOI 10.1007/BF01003963; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Yamada H, 2010, BIOCHEM BIOPH RES CO, V397, P425, DOI 10.1016/j.bbrc.2010.05.112	19	69	71	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89459	10.1371/journal.pone.0089459	http://dx.doi.org/10.1371/journal.pone.0089459			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24594682	Green Submitted, Green Published, gold			2022-12-25	WOS:000332468900017
J	Liu, TW; Chen, JA; Wang, WH; Simon, M; Wu, FH; Hu, WJ; Chen, JB; Zheng, HL				Liu, Tingwu; Chen, Juan A.; Wang, Wenhua; Simon, Martin; Wu, Feihua; Hu, Wenjun; Chen, Juan B.; Zheng, Hailei			A Combined Proteomic and Transcriptomic Analysis on Sulfur Metabolism Pathways of Arabidopsis thaliana under Simulated Acid Rain	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; SERINE ACETYLTRANSFERASE; DIFFERENTIAL EXPRESSION; SULFATE TRANSPORTERS; GLUTAMINE-SYNTHETASE; SIGNALING PATHWAY; OXIDATIVE BURST; PLANT-RESPONSES; GENE-EXPRESSION; CELL-DEATH	With rapid economic development, most regions in southern China have suffered acid rain (AR) pollution. In our study, we analyzed the changes in sulfur metabolism in Arabidopsis under simulated AR stress which provide one of the first case studies, in which the systematic responses in sulfur metabolism were characterized by high-throughput methods at different levels including proteomic, genomic and physiological approaches. Generally, we found that all of the processes related to sulfur metabolism responded to AR stress, including sulfur uptake, activation and also synthesis of sulfur-containing amino acid and other secondary metabolites. Finally, we provided a catalogue of the detected sulfur metabolic changes and reconstructed the coordinating network of their mutual influences. This study can help us to understand the mechanisms of plants to adapt to AR stress.	[Liu, Tingwu; Chen, Juan A.; Wang, Wenhua; Simon, Martin; Wu, Feihua; Hu, Wenjun; Chen, Juan B.; Zheng, Hailei] Xiamen Univ, Coll Environm & Ecol, Minist Educ Coastal & Wetland Ecosyst, Key Lab, Xiamen, Fujian, Peoples R China; [Liu, Tingwu] Huaiyin Normal Univ, Dept Biol, Huaian, Jiangsu, Peoples R China; [Wang, Wenhua] Duke Univ, Dept Biol, Durham, NC USA; [Zheng, Hailei] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China	Xiamen University; Huaiyin Normal University; Duke University; Xiamen University	Zheng, HL (corresponding author), Xiamen Univ, Coll Environm & Ecol, Minist Educ Coastal & Wetland Ecosyst, Key Lab, Xiamen, Fujian, Peoples R China.	zhenghl@xmu.edu.cn	Zheng, Hai-Lei/G-3432-2010	Zheng, Hai-Lei/0000-0001-8588-1529; Wu, Feihua/0000-0002-5817-3831	Natural Science Foundation of China (NSFC) [30930076, 31260057, 30770192, 30670317]; Ministry of Education; Foundation of the Chinese Ministry of Education [20070384033, 209084]; Program for New Century Excellent Talents in Xiamen University [NCETXMU X07115]; Changjiang Scholarship [X09111]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Education; Foundation of the Chinese Ministry of Education(Ministry of Education, China); Program for New Century Excellent Talents in Xiamen University(Program for New Century Excellent Talents in University (NCET)); Changjiang Scholarship	This study was financially supported by the Natural Science Foundation of China (NSFC) (30930076, 31260057, 30770192 and 30670317), the Scholarship Award for Excellent Doctoral Student granted by Ministry of Education, the Foundation of the Chinese Ministry of Education (20070384033, 209084), the Program for New Century Excellent Talents in Xiamen University (NCETXMU X07115) and a Changjiang Scholarship (X09111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada K, 2004, PLANT CELL PHYSIOL, V45, pS11; Bandurska H, 2009, ACTA BIOL CRACOV BOT, V51, P37; Bick JA, 1998, CURR OPIN PLANT BIOL, V1, P240, DOI 10.1016/S1369-5266(98)80111-8; Brychkova G, 2007, PLANT J, V50, P696, DOI 10.1111/j.1365-313X.2007.03080.x; Carpentier SC, 2005, PROTEOMICS, V5, P2497, DOI 10.1002/pmic.200401222; Cordwell SJ, 2010, PROTEOMICS, V10, P611, DOI 10.1002/pmic.200900521; Dixon DP, 2010, PHYTOCHEMISTRY, V71, P338, DOI 10.1016/j.phytochem.2009.12.012; Fabio F, 2007, SULFUR METABOLISM CA; Fan HB, 2000, FOREST ECOL MANAG, V132, P285, DOI 10.1016/S0378-1127(00)00392-3; Gallardo K, 2007, MOL CELL PROTEOMICS, V6, P2165, DOI 10.1074/mcp.M700171-MCP200; Ge CM, 2006, CELL RES, V16, P446, DOI 10.1038/sj.cr.7310056; Gorg A, 2009, ELECTROPHORESIS, V30, pS122, DOI 10.1002/elps.200900051; Goto DB, 2002, GENES GENET SYST, V77, P89, DOI 10.1266/ggs.77.89; Harms K, 2000, PLANT J, V22, P335, DOI 10.1046/j.1365-313x.2000.00743.x; Hatzios KK, 1999, ABSTR PAP AM CHEM S, V218, pU117; Hawkesford MJ, 2006, PLANT CELL ENVIRON, V29, P382, DOI 10.1111/j.1365-3040.2005.01470.x; Hawkesford MJ, 2003, PHYSIOL PLANTARUM, V117, P155, DOI 10.1034/j.1399-3054.2003.00034.x; Hell R, 1997, PLANTA, V202, P138, DOI 10.1007/s004250050112; Hesse H, 2001, AMINO ACIDS, V20, P281, DOI 10.1007/s007260170044; Hirai MY, 2005, J BIOL CHEM, V280, P25590, DOI 10.1074/jbc.M502332200; KARNI L, 1984, ARCH MICROBIOL, V140, P215, DOI 10.1007/BF00454930; Karnosky DF, 2001, ENVIRON POLLUT, V115, P317, DOI 10.1016/S0269-7491(01)00224-X; Klikocka H, 2005, J PLANT NUTR, V28, P819, DOI 10.1081/PLN-200055547; Kopriva S, 2004, J EXP BOT, V55, P1831, DOI 10.1093/jxb/erh203; Koralewska A, 2009, J PLANT PHYSIOL, V166, P168, DOI 10.1016/j.jplph.2008.03.005; Langebartels C, 2002, PLANT PHYSIOL BIOCH, V40, P567, DOI 10.1016/S0981-9428(02)01416-X; Larssen T, 2006, ENVIRON SCI TECHNOL, V40, P418, DOI 10.1021/es0626133; Lee Y, 2006, PLANT PHYSIOL BIOCH, V44, P38, DOI 10.1016/j.plaphy.2006.01.003; Li LY, 2007, J PROTEOME RES, V6, P759, DOI 10.1021/pr060383l; Likens GE, 1998, SCIENCE, V282, P1991; Likens GE, 1996, SCIENCE, V272, P244, DOI 10.1126/science.272.5259.244; Liu TW, 2011, J PROTEOME RES, V10, P2579, DOI 10.1021/pr200056a; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loudet O, 2007, NAT GENET, V39, P896, DOI 10.1038/ng2050; Marmagne A, 2010, NEW PHYTOL, V186, P216, DOI 10.1111/j.1469-8137.2009.03139.x; Maruyama-Nakashita A, 2003, PLANT PHYSIOL, V132, P597, DOI 10.1104/pp.102.019802; Mitchell P, 2010, NAT BIOTECHNOL, V28, P665, DOI 10.1038/nbt0710-665; Moons A, 2005, VITAM HORM, V72, P155, DOI 10.1016/S0083-6729(05)72005-7; Nikiforova V, 2003, PLANT J, V33, P633, DOI 10.1046/j.1365-313X.2003.01657.x; Noctor G, 1998, PLANT PHYSIOL, V118, P471, DOI 10.1104/pp.118.2.471; Oliveira IC, 1999, PLANT PHYSIOL, V121, P301, DOI 10.1104/pp.121.1.301; PETERMAN TK, 1991, MOL GEN GENET, V230, P145, DOI 10.1007/BF00290662; Rausch T, 2005, TRENDS PLANT SCI, V10, P503, DOI 10.1016/j.tplants.2005.08.006; Rennenberg H, 2007, PLANT BIOLOGY, V9, P620, DOI 10.1055/s-2007-965248; Resch A, 2006, PROTEOMICS, V6, P1867, DOI 10.1002/pmic.200500531; Rogasik J, 2002, PHYTON-ANN REI BOT A, V42, P171; Saito K, 2004, PLANT PHYSIOL, V136, P2443, DOI 10.1104/pp.104.046755; Shibagaki N, 2002, PLANT J, V29, P475, DOI 10.1046/j.0960-7412.2001.01232.x; Toda K, 2001, J PLANT RES, V114, P291, DOI 10.1007/PL00013990; Tomlinson GH, 2003, BIOGEOCHEMISTRY, V65, P51, DOI 10.1023/A:1026069927380; Walters DR, 2003, PHYTOCHEMISTRY, V64, P97, DOI 10.1016/S0031-9422(03)00329-7; Winfield MO, 2010, PLANT BIOTECHNOL J, V8, P749, DOI 10.1111/j.1467-7652.2010.00536.x; Yano A, 1999, PLANT J, V18, P105, DOI 10.1046/j.1365-313X.1999.00421.x; Yoshimoto N, 2002, PLANT J, V29, P465, DOI 10.1046/j.0960-7412.2001.01231.x; Youssefian S, 2001, PLANT PHYSIOL, V126, P1001, DOI 10.1104/pp.126.3.1001; Zhu GH, 2006, J INTEGR PLANT BIOL, V48, P1177, DOI 10.1111/j.1744-7909.2006.00332.x	56	15	16	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90120	10.1371/journal.pone.0090120	http://dx.doi.org/10.1371/journal.pone.0090120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595051	gold, Green Submitted, Green Published			2022-12-25	WOS:000332468900069
J	Zhuang, JY; Zhang, S; Xu, J; Hu, D				Zhuang, Jin-Ying; Zhang, Sen; Xu, Jing; Hu, Die			Discriminating Males and Unpredictable Females: Males Differentiate Self-Similar Facial Cues More than Females in the Judgment of Opposite-Sex Attractiveness	PLOS ONE			English	Article							MALE MATE CHOICE; MENSTRUAL-CYCLE; MALE FACES; GOOD GENES; WOMENS PREFERENCES; SPERM COMPETITION; MARRIED-COUPLES; APPARENT HEALTH; JAPANESE-QUAIL; IMMUNE-SYSTEM	Attractiveness judgment in the context of mate preferences is thought to reflect an assessment of mate quality in relation to an absolute scale of genetic fitness and a relative scale of self-similarity. In this study, subjects judged the attractiveness and trustworthiness of faces in composite images that were manipulated to produce self-similar (self-resemblance) and dissimilar (other-resemblance) images. Males differentiated between self- and other-resemblance as well as among different degrees of self-resemblance in their attractiveness ratings; females did not. Specifically, in Experiment 1, using a morphing technique, we created previously unseen face images possessing different degrees (0%, 30%, 40%, or 50%) of incorporation of the subject's images (different degrees of self-resemblance) and found that males preferred images that were closer to average (0%) rather than more self-similar, whereas females showed no preference for any degree of self-similarity. In Experiment 2, we added a pro-social question about trustworthiness. We replicated the Experiment 1 attractiveness rating results and further found that males differentiated between self- and other-resemblance for the same degree of composites; women did not. Both males and females showed a similar preference for self-resemblances when judging trustworthiness. In conclusion, only males factored self-resemblance into their attractiveness ratings of opposite-sex individuals in a manner consistent with cues of reproductive fitness, although both sexes favored self-resemblance when judging trustworthiness.	[Zhuang, Jin-Ying] E China Normal Univ, Key Lab Brain Funct Genom, MOE, Shanghai 200062, Peoples R China; E China Normal Univ, STCSM, Sch Psychol & Cognit Sci, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University; Science & Technology Commission of Shanghai Municipality (STCSM)	Zhuang, JY (corresponding author), E China Normal Univ, Key Lab Brain Funct Genom, MOE, Shanghai 200062, Peoples R China.	jinyingzhuang@gmail.com						AHMED SA, 1990, BAILLIERE CLIN RHEUM, V4, P13, DOI 10.1016/S0950-3579(05)80241-9; Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; Amundsen T, 2001, P NATL ACAD SCI USA, V98, P13155, DOI 10.1073/pnas.211439298; Bailenson JN, 2006, POLIT PSYCHOL, V27, P373, DOI 10.1111/j.1467-9221.2006.00505.x; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BATESON P, 1982, NATURE, V295, P236, DOI 10.1038/295236a0; BATESON P, 1980, Z TIERPSYCHOL, V53, P231; Bateson P, 1978, SEXUAL IMPRINTING OP; Bereczkei T, 2002, PERS INDIV DIFFER, V33, P677, DOI 10.1016/S0191-8869(01)00182-9; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Bonilla MM, 2011, ETHOLOGY, V117, P740, DOI 10.1111/j.1439-0310.2011.01928.x; Brooks R, 2011, P ROY SOC B-BIOL SCI, V278, P810, DOI 10.1098/rspb.2010.0964; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Darwin Charles, 1871, DESCENT MAN; DeBruine LM, 2008, ARCH SEX BEHAV, V37, P64, DOI 10.1007/s10508-007-9266-0; DeBruine LM, 2011, P ROY SOC B-BIOL SCI, V278, P813, DOI 10.1098/rspb.2010.2200; DeBruine LM, 2010, P ROY SOC B-BIOL SCI, V277, P2405, DOI 10.1098/rspb.2009.2184; DeBruine LM, 2002, P ROY SOC B-BIOL SCI, V269, P1307, DOI 10.1098/rspb.2002.2034; DeBruine LM, 2005, P ROY SOC B-BIOL SCI, V272, P919, DOI 10.1098/rspb.2004.3003; DeBruine LM, 2005, HORM BEHAV, V47, P379, DOI 10.1016/j.yhbeh.2004.11.006; DeBruine LM, 2004, P ROY SOC B-BIOL SCI, V271, P2085, DOI 10.1098/rspb.2004.2824; Enlow DH, 1990, FACIAL GROWTH, P240; EPSTEIN E, 1984, SOC BIOL, V31, P243; Espinedo CM, 2010, EVOL ECOL, V24, P865, DOI 10.1007/s10682-009-9343-z; Fink B, 2007, AM J HUM BIOL, V19, P82, DOI 10.1002/ajhb.20583; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; GRIFFITHS RW, 1973, SOC BIOL, V20, P448, DOI 10.1080/19485565.1973.9988075; HINSZ VB, 1989, J SOC PERS RELAT, V6, P223, DOI 10.1177/026540758900600205; Hughes SM, 2004, EVOL HUM BEHAV, V25, P295, DOI 10.1016/j.evolhumbehav.2004.06.001; Johnston VS, 2001, EVOL HUM BEHAV, V22, P251, DOI 10.1016/S1090-5138(01)00066-6; Jones BC, 2005, HORM BEHAV, V48, P283, DOI 10.1016/j.yhbeh.2005.03.010; Jones BC, 2001, EVOL HUM BEHAV, V22, P417, DOI 10.1016/S1090-5138(01)00083-6; Keller MC, 1996, PERS INDIV DIFFER, V21, P217, DOI 10.1016/0191-8869(96)00066-9; Kocsor F, 2011, ARCH SEX BEHAV, V40, P1263, DOI 10.1007/s10508-010-9723-z; Kokko H, 2008, J EVOLUTIONARY BIOL, V21, P259; Krupp DB, 2008, EVOL HUM BEHAV, V29, P49, DOI 10.1016/j.evolhumbehav.2007.08.002; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; Lass-Hennemann J, 2010, P ROY SOC B-BIOL SCI, V277, P2175, DOI 10.1098/rspb.2010.0258; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Lebas NR, 2006, TRENDS ECOL EVOL, V21, P170, DOI 10.1016/j.tree.2006.01.007; Lihoreau M, 2010, ANIM BEHAV, V80, P303, DOI 10.1016/j.anbehav.2010.05.011; Lihoreau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003365; Little AC, 2006, PERS INDIV DIFFER, V40, P973, DOI 10.1016/j.paid.2005.09.016; Little AC, 2001, P ROY SOC B-BIOL SCI, V268, P39, DOI 10.1098/rspb.2000.1327; MITTON JB, 1984, ANNU REV ECOL SYST, V15, P479; Morse DH, 2010, BEHAV ECOL, V21, P250, DOI 10.1093/beheco/arp183; Murphy TG, 2009, BEHAV ECOL, V20, P1000, DOI 10.1093/beheco/arp089; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; Penton-Voak IS, 1999, CURR PSYCHOL, V18, P104; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Penton-Voak IS, 2003, J COMP PSYCHOL, V117, P264, DOI 10.1037/0735-7036.117.3.264; Penton-Voak IS, 2001, ADV STUD BEHAV, V30, P219, DOI 10.1016/S0065-3454(01)80008-5; Penton-Voak IS, 2000, EVOL HUM BEHAV, V21, P39, DOI 10.1016/S1090-5138(99)00033-1; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Perrett DI, 1999, EVOL HUM BEHAV, V20, P295, DOI 10.1016/S1090-5138(99)00014-8; Pizzari T, 2003, NATURE, V426, P70, DOI 10.1038/nature02004; Provost MP, 2008, EVOL HUM BEHAV, V29, P65, DOI 10.1016/j.evolhumbehav.2007.07.007; Quist MC, 2012, J EXP SOC PSYCHOL, V48, P770, DOI 10.1016/j.jesp.2011.12.018; READ AF, 1988, HUMAN MATING PATTERN, P115; Reading KL, 2007, ANIM BEHAV, V74, P867, DOI 10.1016/j.anbehav.2006.09.025; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; ROWLAND DA, 1995, IEEE COMPUT GRAPH, V15, P70, DOI 10.1109/38.403830; RUSHTON JP, 1988, ETHOL SOCIOBIOL, V9, P329, DOI 10.1016/0162-3095(88)90025-8; Saxton TK, 2009, BEHAV ECOL, V20, P1133, DOI 10.1093/beheco/arp107; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Seli E, 2002, IMMUNOL ALLERGY CLIN, V22, P407, DOI 10.1016/S0889-8561(02)00017-6; THIESSEN D, 1980, ETHOL SOCIOBIOL, V1, P111, DOI 10.1016/0162-3095(80)90003-5; Thiessen D, 1999, SOCIAL INFLUENCES HU, P311; Thomas ML, 2007, AM NAT, V170, P190, DOI 10.1086/519404; Thomas ML, 2009, P R SOC B, V276, P383, DOI 10.1098/rspb.2008.1206; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; THORNHILL R, 1993, HUM NATURE-INT BIOS, V4, P237, DOI 10.1007/BF02692201; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Tobias JA, 2011, J EVOLUTION BIOL, V24, P2118, DOI 10.1111/j.1420-9101.2011.02345.x; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Vukovic J, 2010, BEHAV ECOL, V21, P767, DOI 10.1093/beheco/arq051; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Willians G. C., 1966, ADAPTATION NATURAL S; ZAJONC RB, 1987, MOTIV EMOTION, V11, P335, DOI 10.1007/BF00992848; Zentner M, 2012, PSYCHOL SCI, V23, P1176, DOI 10.1177/0956797612441004	81	1	2	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e90493	10.1371/journal.pone.0090493	http://dx.doi.org/10.1371/journal.pone.0090493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC4CT	24594644	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900112
J	Vieira, LD; Faoro, H; Fraga, HPD; Rogalski, M; de Souza, EM; Pedrosa, FD; Nodari, RO; Guerra, MP				Vieira, Leila do Nascimento; Faoro, Helisson; de Freitas Fraga, Hugo Pacheco; Rogalski, Marcelo; de Souza, Emanuel Maltempi; Pedrosa, Fabio de Oliveira; Nodari, Rubens Onofre; Guerra, Miguel Pedro			An Improved Protocol for Intact Chloroplasts and cpDNA Isolation in Conifers	PLOS ONE			English	Article							INVERTED REPEAT COPIES; PLASTID GENOME; DNA EXTRACTION; EVOLUTION; NUCLEAR; GENES; SEQUENCE; PROTEIN; BIOTECHNOLOGY; PINACEAE	Background: Performing chloroplast DNA (cpDNA) isolation is considered a major challenge among different plant groups, especially conifers. Isolating chloroplasts in conifers by such conventional methods as sucrose gradient and high salt has not been successful. So far, plastid genome sequencing protocols for conifer species have been based mainly on long-range PCR, which is known to be time-consuming and difficult to implement. Methodology/Principal Findings: We developed a protocol for cpDNA isolation using three different conifer families: Araucaria angustifolia and Araucaria bidwilli (Araucariaceae), Podocarpus lambertii (Podocarpaceae) and Pinus patula (Pinaceae). The present protocol is based on high salt isolation buffer followed by saline Percoll gradient. Combining these two strategies allowed enhanced chloroplast isolation, along with decreased contamination caused by polysaccharides, polyphenols, proteins, and nuclear DNA in cpDNA. Microscopy images confirmed the presence of intact chloroplasts in high abundance. This method was applied to cpDNA isolation and subsequent sequencing by Illumina MiSeq (2x250 bp), using only 50 ng of cpDNA. Reference-guided chloroplast genome mapping showed that high average coverage was achieved for all evaluated species: 24.63 for A. angustifolia, 135.97 for A. bidwilli, 1196.10 for P. lambertii, and 64.68 for P. patula. Conclusion: Results show that this improved protocol is suitable for enhanced quality and yield of chloroplasts and cpDNA isolation from conifers, providing a useful tool for studies that require isolated chloroplasts and/or whole cpDNA sequences.	[Vieira, Leila do Nascimento; de Freitas Fraga, Hugo Pacheco; Nodari, Rubens Onofre; Guerra, Miguel Pedro] Univ Fed Santa Catarina, Programa Pos Grad Recursos Genet Vegetais, Dept Fitotecnia, Florianopolis, SC, Brazil; [Faoro, Helisson; de Souza, Emanuel Maltempi; Pedrosa, Fabio de Oliveira] Univ Fed Parana, Nucleo Fixacao Biol Nitrogenio, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil; [Rogalski, Marcelo] Univ Fed Vicosa, Dept Biol Vegetal, Vicosa, MG, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal do Parana; Universidade Federal de Vicosa	Guerra, MP (corresponding author), Univ Fed Santa Catarina, Programa Pos Grad Recursos Genet Vegetais, Dept Fitotecnia, Florianopolis, SC, Brazil.	miguel.guerra@ufsc.br	Faoro, Helisson/F-7163-2012; Pedrosa, Fabio 0/C-1938-2013; Vieira, Leila N/F-9934-2012; ROGALSKI, MARCELO/ABA-3940-2020; Rogalski, Marcelo/AAA-5192-2020; Nodari, Rubens O/B-7006-2014; Fraga, Hugo PF/F-9049-2012; Fraga, Hugo/L-7275-2019	Faoro, Helisson/0000-0002-0146-8639; ROGALSKI, MARCELO/0000-0002-1990-5243; Nodari, Rubens O/0000-0002-8884-2426; Fraga, Hugo PF/0000-0002-7363-5213; Guerra, Miguel/0000-0002-5319-3446; do Nascimento Vieira, Leila/0000-0001-8413-2155	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC) [14848/2011-2, 3770/2012, 2780/2012-4]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC)(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPq) with fellowships, and by Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC) under project number 14848/2011-2, 3770/2012, and 2780/2012-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkatib S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003076; Arif IA, 2010, INT J MOL SCI, V11, P3149, DOI 10.3390/ijms11093149; Atherton RA, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-22; AYLIFFE MA, 1992, THEOR APPL GENET, V85, P229, DOI 10.1007/BF00222864; Ayliffe MA, 1998, MOL BIOL EVOL, V15, P738, DOI 10.1093/oxfordjournals.molbev.a025977; Bock R, 2013, PLANT MOL BIOL, V83, P21, DOI 10.1007/s11103-013-0045-0; BOOKJANS G, 1984, ANAL BIOCHEM, V141, P244, DOI 10.1016/0003-2697(84)90452-4; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Clarke JL, 2011, PLANT MOL BIOL, V76, P207, DOI 10.1007/s11103-011-9792-y; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Diekmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002813; Gargano D, 2013, PLANT MOL BIOL, V81, P235, DOI 10.1007/s11103-012-9994-y; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Greiner S, 2013, BIOESSAYS, V35, P354, DOI 10.1002/bies.201200137; He ZH, 2013, J PLANT PHYSIOL, V170, P1139, DOI 10.1016/j.jplph.2013.03.016; Hirao T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-70; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kaneko T, 1996, DNA Res, V3, P109; Keeling CI, 2006, PHYTOCHEMISTRY, V67, P2415, DOI 10.1016/j.phytochem.2006.08.019; Kubis Sybille E., 2008, V425, P171, DOI 10.1007/978-1-60327-210-0_16; Lin CP, 2010, GENOME BIOL EVOL, V2, P504, DOI 10.1093/gbe/evq036; Maliga P, 2011, PLANT PHYSIOL, V155, P1501, DOI 10.1104/pp.110.170969; Mastroberti Alexandra A., 2003, Braz. J. Bot., V26, P343, DOI 10.1590/S0100-84042003000300007; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; PALMER JD, 1986, CURR GENET, V10, P823, DOI 10.1007/BF00418529; Rogalski M, 2008, PLANT CELL, V20, P2221, DOI 10.1105/tpc.108.060392; Rogalski M, 2011, PLANT BIOTECHNOL J, V9, P554, DOI 10.1111/j.1467-7652.2011.00621.x; Rousseau-Gueutin M, 2011, PLANT PHYSIOL, V157, P2181, DOI 10.1104/pp.111.185074; Shi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031468; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; WALKER DA, 1987, METHOD ENZYMOL, V148, P145; Werner O, 2009, BRYOLOGIST, V112, P315, DOI 10.1639/0007-2745-112.2.315; Wolf PG, 2010, GENOME, V53, P731, DOI [10.1139/G10-061, 10.1139/g10-061]; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Wu CS, 2007, MOL BIOL EVOL, V24, P1366, DOI 10.1093/molbev/msm059; Wu CS, 2011, GENOME BIOL EVOL, V3, P1284, DOI 10.1093/gbe/evr095; Yamamoto S, 2004, J MASS SPECTROM, V39, P1337, DOI 10.1002/jms.726; Yi X, 2013, GENOME BIOL EVOL, V5, P688, DOI 10.1093/gbe/evt042	41	71	74	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84792	10.1371/journal.pone.0084792	http://dx.doi.org/10.1371/journal.pone.0084792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392157	gold, Green Published, Green Submitted			2022-12-25	WOS:000329460100080
J	Zheng, Z; Lee, KS; Zhang, XL; Nguyen, C; Hsu, CY; Wang, JZ; Rackohn, TM; Enjamuri, DR; Murphy, M; Ting, K; Soo, C				Zheng, Zhong; Lee, Kevin S.; Zhang, Xinli; Nguyen, Calvin; Hsu, Chingyun; Wang, Joyce Z.; Rackohn, Todd Matthew; Enjamuri, Dwarak Reddy; Murphy, Maxwell; Ting, Kang; Soo, Chia			Fibromodulin-Deficiency Alters Temporospatial Expression Patterns of Transforming Growth Factor-beta Ligands and Receptors during Adult Mouse Skin Wound Healing	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; TGF-BETA; EXTRACELLULAR-MATRIX; SCAR FORMATION; COLLAGEN FIBRILLOGENESIS; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; DECORIN; LUMICAN; GROWTH-FACTOR-BETA-1	Fibromodulin (FMOD) is a small leucine-rich proteoglycan required for scarless fetal cutaneous wound repair. Interestingly, increased FMOD levels have been correlated with decreased transforming growth factor (TGF)-beta 1 expression in multiple fetal and adult rodent models. Our previous studies demonstrated that FMOD-deficiency in adult animals results in delayed wound closure and increased scar size accompanied by loose package collagen fiber networks with increased fibril diameter. In addition, we found that FMOD modulates in vitro expression and activities of TGF-beta ligands in an isoform-specific manner. In this study, temporospatial expression profiles of TGF-beta ligands and receptors in FMOD-null and wild-type (WT) mice were compared by immunohistochemical staining and quantitative reverse transcriptase-polymerase chain reaction using a full-thickness, primary intention wound closure model. During the inflammatory stage, elevated inflammatory infiltration accompanied by increased type I TGF-beta receptor levels in individual inflammatory cells was observed in FMOD-null wounds. This increased inflammation was correlated with accelerated epithelial migration during the proliferative stage. On the other hand, significantly more robust expression of TGF-beta 3 and TGF-beta receptors in FMOD-null wounds during the proliferative stage was associated with delayed dermal cell migration and proliferation, which led to postponed granulation tissue formation and wound closure and increased scar size. Compared with WT controls, expression of TGF-beta ligands and receptors by FMOD-null dermal cells was markedly reduced during the remodeling stage, which may have contributed to the declined collagen synthesis capability and unordinary collagen architecture. Taken together, this study demonstrates that a single missing gene, FMOD, leads to conspicuous alternations in TGF-beta ligand and receptor expression at all stages of wound repair in various cell types. Therefore, FMOD critically coordinates temporospatial distribution of TGF-beta ligands and receptors in vivo, suggesting that FMOD modulates TGF-beta bioactivity in a complex way beyond simple physical binding to promote proper wound healing.	[Zheng, Zhong; Lee, Kevin S.; Zhang, Xinli; Nguyen, Calvin; Hsu, Chingyun; Rackohn, Todd Matthew; Murphy, Maxwell; Ting, Kang] Univ Calif Los Angeles, Sch Dent, Dent & Craniofacial Res Inst, Los Angeles, CA 90024 USA; [Zheng, Zhong; Lee, Kevin S.; Zhang, Xinli; Nguyen, Calvin; Hsu, Chingyun; Rackohn, Todd Matthew; Murphy, Maxwell; Ting, Kang] Univ Calif Los Angeles, Sch Dent, Sect Orthodont, Los Angeles, CA 90024 USA; [Wang, Joyce Z.] SUNY Downstate, Kings Country Hosp Ctr, Dept Emergency Med, New York, NY USA; [Enjamuri, Dwarak Reddy] Univ Calif Los Angeles, Dept Psychobiol, Los Angeles, CA USA; [Soo, Chia] Univ Calif Los Angeles, Los Angeles, CA USA; [Soo, Chia] Univ Calif Los Angeles, Orthopaed Hosp Dept Orthopaed Surg, Los Angeles, CA USA; [Soo, Chia] Univ Calif Los Angeles, Orthopaed Hosp Res Ctr, Los Angeles, CA USA; [Soo, Chia] Univ Calif Los Angeles, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ting, K (corresponding author), Univ Calif Los Angeles, Sch Dent, Dent & Craniofacial Res Inst, Los Angeles, CA 90024 USA.	kting@dentistry.ucla.edu; bsoo@ucla.edu	Liu, Chunji/B-5243-2009; Zheng, Zhi/C-4110-2017; Zheng, Zhong/AAZ-9647-2020; Yan, Guijun/A-9809-2011	Zheng, Zhi/0000-0002-1493-1995; Yan, Guijun/0000-0001-9628-1211; Kilian, Andrzej/0000-0002-2730-7462	Plastic Surgery Research Foundation; NIH-NIAMS (SBIR grant) [1R43-AR064126]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R43AR064126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R44DE024692] Funding Source: NIH RePORTER	Plastic Surgery Research Foundation; NIH-NIAMS (SBIR grant); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the Plastic Surgery Research Foundation (2013 National Endowment for Plastic Surgery Research Grant Program) and NIH-NIAMS (SBIR grant 1R43-AR064126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN A, 2002, NOVEL TECHNIQUE COMP; [Anonymous], 2011, JUV FAILS LAT STAG T; Baghy K, 2012, J HISTOCHEM CYTOCHEM, V60, P262, DOI 10.1369/0022155412438104; Bandyopadhyay B, 2006, J CELL BIOL, V172, P1093, DOI 10.1083/jcb.200507111; Beanes Steven R., 2003, Expert Reviews in Molecular Medicine, V5, P1, DOI 10.1017/S1462399403005817; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Bossi F, 2011, MOL IMMUNOL, V48, P1676, DOI 10.1016/j.molimm.2011.06.254; BRANDES ME, 1991, J BIOL CHEM, V266, P19697; BRANDES ME, 1991, J IMMUNOL, V147, P1600; Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2; Chaudhury A, 2009, IUBMB LIFE, V61, P929, DOI 10.1002/iub.239; Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3; Clark R. A. F., 1988, MOL CELLULAR BIOL WO; CUI W, 1995, GENE DEV, V9, P945, DOI 10.1101/gad.9.8.945; DANIELPOUR D, 1990, J BIOL CHEM, V265, P6973; Decline F, 2003, CELL MOTIL CYTOSKEL, V54, P64, DOI 10.1002/cm.10086; Denton CP, 2009, J INVEST DERMATOL, V129, P194, DOI 10.1038/jid.2008.171; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Frank S, 1996, J BIOL CHEM, V271, P10188, DOI 10.1074/jbc.271.17.10188; Goldberg M, 2006, J HISTOCHEM CYTOCHEM, V54, P525, DOI 10.1369/jhc.5A6650.2005; GRANDE J, 1993, LAB INVEST, V69, P387; GRAYCAR JL, 1989, MOL ENDOCRINOL, V3, P1977, DOI 10.1210/mend-3-12-1977; Han GW, 2012, INT J BIOL SCI, V8, P228, DOI 10.7150/ijbs.8.228; HEBDA PA, 1988, J INVEST DERMATOL, V91, P440, DOI 10.1111/1523-1747.ep12476480; Heegaard AM, 2004, J CELL BIOCHEM, V93, P463, DOI 10.1002/jcb.20189; Henry G, 2003, SURG CLIN N AM, V83, P483, DOI 10.1016/S0039-6109(02)00200-1; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Honardoust D, 2012, J BURN CARE RES, V33, P218, DOI 10.1097/BCR.0b013e3182335980; Honardoust D, 2011, WOUND REPAIR REGEN, V19, P368, DOI 10.1111/j.1524-475X.2011.00677.x; Ikushima H, 2012, CELL TISSUE RES, V347, P37, DOI 10.1007/s00441-011-1179-5; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Iozzo RV, 2011, BIOL EXTRACELL MATR, P197, DOI 10.1007/978-3-642-16555-9_6; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Isaka Y, 1996, NAT MED, V2, P418, DOI 10.1038/nm0496-418; Jian J, 2013, BIOCH BIOPHYSICAL RE, V436; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Khorasani H, 2011, AM J PATHOL, V178, P621, DOI 10.1016/j.ajpath.2010.10.019; Kolb M, 2001, AM J PHYSIOL-LUNG C, V280, pL1327, DOI 10.1152/ajplung.2001.280.6.L1327; Lagraoui M, 1997, CELL MOL BIOL, V43, P313; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Levens E, 2005, MOL HUM REPROD, V11, P489, DOI 10.1093/molehr/gah187; LEVINE JH, 1993, AM J PATHOL, V143, P368; Li X, 2006, POULTRY SCI, V85, P326, DOI 10.1093/ps/85.2.326; LIN RY, 1995, ANN SURG, V222, P146, DOI 10.1097/00000658-199508000-00006; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; Lorenz HP, 2008, WOUNDS BIOL PATHOLOG; Mariano JM, 1998, INT J DEV BIOL, V42, P1125; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mayr C, 2005, BLOOD, V105, P1566, DOI 10.1182/blood-2004-04-1233; Merline R, 2009, J CELL COMMUN SIGNAL, V3, P323, DOI 10.1007/s12079-009-0066-2; Mikaelsson E, 2005, BLOOD, V105, P4828, DOI 10.1182/blood-2004-10-3941; Murata H, 1997, J INVEST DERMATOL, V108, P258, DOI 10.1111/1523-1747.ep12286451; Niewiarowska J, 2011, THROMB RES, V128, P452, DOI 10.1016/j.thromres.2011.06.011; Occleston NL, 2008, J BIOMAT SCI-POLYM E, V19, P1047, DOI 10.1163/156856208784909345; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; Oldberg A, 2007, P NATL ACAD SCI USA, V104, P13966, DOI 10.1073/pnas.0702014104; PARALKAR VM, 1991, DEV BIOL, V143, P303, DOI 10.1016/0012-1606(91)90081-D; Penn JW, 2012, INT J BURNS TRAUMA, V2, P18; Qian H, 2004, ORAL DIS, V10, P233, DOI 10.1111/j.1601-0825.2004.00996.x; Ranjzad P, 2009, GENE THER, V16, P1154, DOI 10.1038/gt.2009.63; ROBERTS AB, 1996, MOL CELLULAR BIOL WO, P275; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; SHAH M, 1995, J CELL SCI, V108, P985; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sinno H, 2013, J DERMATOL TREAT, V24, P141, DOI 10.3109/09546634.2011.631977; Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200; Soo C, 2003, AM J PATHOL, V163, P2459, DOI 10.1016/S0002-9440(10)63601-2; Soo C, 2000, AM J PATHOL, V157, P423, DOI 10.1016/S0002-9440(10)64555-5; Soo C, 2001, SURG FORUM, V52, P578; Stoff A, 2007, J MOL MED-JMM, V85, P481, DOI 10.1007/s00109-006-0148-z; Sun T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008515; Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Viola M, 2007, CONNECT TISSUE RES, V48, P141, DOI 10.1080/03008200701276133; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; Wu LC, 1997, ARCH SURG-CHICAGO, V132, P753; Xiao YQ, 2009, INVEST OPHTH VIS SCI, V50, P1698, DOI 10.1167/iovs.08-1675; Yamanaka O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082730; Zhang Z, 2007, BURNS, V33, P634, DOI 10.1016/j.burns.2006.08.018; Zhang Z, 2009, BURNS, V35, P527, DOI 10.1016/j.burns.2008.08.021; Zheng Z, 2012, BIOMATERIALS, V33, P5821, DOI 10.1016/j.biomaterials.2012.04.049; Zheng Z, 2011, J INVEST DERMATOL, V131, P769, DOI 10.1038/jid.2010.381	86	56	61	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e90817	10.1371/journal.pone.0090817	http://dx.doi.org/10.1371/journal.pone.0090817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603701	gold, Green Submitted, Green Published			2022-12-25	WOS:000332483600088
J	Dai, LL; Mao, YY; Luo, XM; Shen, YP				Dai, Lin-Lin; Mao, Yuan-Yuan; Luo, Xiao-Ming; Shen, Yue-Ping			Prenatal Care in Combination with Maternal Educational Level Has a Synergetic Effect on the Risk of Neonatal Low Birth Weight: New Findings in a Retrospective Cohort Study in Kunshan City, China	PLOS ONE			English	Article							PRETERM BIRTH; ASSOCIATION; OUTCOMES; INEQUALITIES; ADEQUACY; INDEXES; VISITS	Objectives: To investigate the dose-response relationship and synergetic effect of the maternal educational level and two measures of prenatal care on neonatal low birth weight (LBW) risk. Methods: Data were derived from the Perinatal Health Care Surveillance System (PHCSS) from January 2001 to September 2009 in Kunshan City, Jiangsu province, eastern China, which included data on 31412 women with a normal birth weight delivery and 640 women with a LBW delivery. Logistic modelling was performed to estimate the association including the joint effects with odds ratio (OR) and 95% confidence interval (CI) between the prenatal care measures and LBW risk after adjusting for the potential confounders. The dose-response relationship between the number of prenatal care visits and the risk of LBW was investigated by modeling the quantitative exposure with restricted cubic splines (RCS). Results: There was a significant synergetic effect on the LBW risk between maternal educational attainment and the number of prenatal care visits (chi(2)=4.98, P=0.0257), whereas no significant maternal educational attainment interaction was found with the week of initiation of prenatal care after adjusting for relevant confounding factors (chi(2)=2.04, P=0.1530), and the LBW risk displayed a 'U-shape' curve tendency among the different number of prenatal care visits (P for nonlinearity=0.0002) using RCS. In particular, the ORs were approaching the curve's bottom when the women had 9 or 10 prenatal care visits. Comparing with 5 prenatal care visits, the ORs and 95% CI of LBW risk for 7, 9, 11 and >= 13 visits were 0.92 (0.82-1.03), 0.50 (0.38-0.66), 0.62 (0.47-0.82), and 0.99 (0.61-1.60), respectively. Conclusions: Our findings suggest that appropriate prenatal care, in combination with a higher maternal educational level, can produce a protective interaction effect on LBW risk. Reasonable health resource assignment for different social statuses should be taken into account by policy-makers in developing countries.	[Dai, Lin-Lin; Shen, Yue-Ping] Soochow Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Coll Med, Suzhou, Jiangsu, Peoples R China; [Mao, Yuan-Yuan] Kunshan First Peoples Hosp, Suzhou, Jiangsu, Peoples R China; [Luo, Xiao-Ming] Kunshan Fourth Peoples Hosp, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Shen, YP (corresponding author), Soochow Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Coll Med, Suzhou, Jiangsu, Peoples R China.	shenyueping@suda.edu.cn	Dai, Yun/AAG-4040-2019	Dai, Yun/0000-0003-2285-0818; Orlowski, Robert/0000-0002-5723-4129; Takabatake, Yukie/0000-0003-0540-3610	Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL CANCER INSTITUTE [R01CA100866, P50CA142509, P30CA016672, R01CA093738] Funding Source: NIH RePORTER	Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to gratefully acknowledge the work and support of the leaders and health care professionals at all levels responsible for the operation of the Perinatal Health Care Surveillance System in Kunshan City, Jiangsu Province, China. This study was supported by a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Alexander GR, 2001, PUBLIC HEALTH REP, V116, P306; Alibekova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084237; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barros H, 1996, J PUBLIC HEALTH MED, V18, P321, DOI 10.1093/oxfordjournals.pubmed.a024513; Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012; Breslow NE, 1980, IARC SCI PUBL, P5; Cano-Serral Gemma, 2006, Gac Sanit, V20, P25, DOI 10.1157/13084124; Collins JW, 1997, J NATL MED ASSOC, V89, P198; Goldani MZ, 2004, AM J PUBLIC HEALTH, V94, P1366, DOI 10.2105/AJPH.94.8.1366; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; Hien NT, 2005, TROP DOCT, V35, P103, DOI 10.1258/0049475054036823; Jefferis BJMH, 2002, BRIT MED J, V325, P305, DOI 10.1136/bmj.325.7359.305; Jewell RT, 2006, HEALTH ECON, V15, P1245, DOI 10.1002/hec.1121; Khan-Neelofur D, 1998, PAEDIATR PERINAT EP, V12, P7, DOI 10.1046/j.1365-3016.12.s2.6.x; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1486, DOI 10.2105/AJPH.84.9.1486; Krans EE, 2012, AM J OBSTET GYNECOL, V206, P398, DOI 10.1016/j.ajog.2011.06.082; Lauderdale Diane S, 2010, Med Care Res Rev, V67, P609, DOI 10.1177/1077558709351530; Li CY, 2008, PUBLIC HEALTH, V122, P243, DOI 10.1016/j.puhe.2007.05.011; Liu Ying-hui, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P1029; Liu YH, 2008, AM J PUBLIC HEALTH, V98, P687, DOI 10.2105/AJPH.2006.088716; Lu M C, 2003, J Matern Fetal Neonatal Med, V13, P362, DOI 10.1080/713605924; Nwaru BI, 2012, EUR J PUBLIC HEALTH, V22, P776, DOI 10.1093/eurpub/ckr182; Orsini N, 2011, STATA J, V11, P1; PANETH NS, 1995, FUTURE CHILD, V5, P19, DOI 10.2307/1602505; Pathak PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013593; Petrou S, 2003, EUR J OBSTET GYN R B, V106, P40, DOI 10.1016/S0301-2115(02)00215-4; RUTTER DR, 1990, SOC SCI MED, V30, P553, DOI 10.1016/0277-9536(90)90154-K; VanderWeele TJ, 2009, J CLIN EPIDEMIOL, V62, P438, DOI 10.1016/j.jclinepi.2008.08.001; Wehby GL, 2009, HEALTH POLICY PLANN, V24, P175, DOI 10.1093/heapol/czp005	29	63	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113377	10.1371/journal.pone.0113377	http://dx.doi.org/10.1371/journal.pone.0113377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CZ	24594907	gold, Green Published, Green Submitted			2022-12-25	WOS:000349145400046
J	Crichton, GE; Elias, MF; Davey, A; Alkerwi, A				Crichton, Georgina E.; Elias, Merrill F.; Davey, Adam; Alkerwi, Ala'a			Cardiovascular Health and Cognitive Function: The Maine-Syracuse Longitudinal Study	PLOS ONE			English	Article							BLOOD-PRESSURE; RISK SCORE; SERUM-CHOLESTEROL; PHYSICAL-ACTIVITY; SEDENTARY TIME; DEMENTIA RISK; HEART-DISEASE; DIET QUALITY; PERFORMANCE; MORTALITY	Background: Smoking, physical inactivity, and poor diet, along with obesity, fasting glucose and blood pressure have been independently associated with poorer cognitive performance. Few studies have related scales representing a combination of these variables to multiple domains of cognitive performance. The aim of this study was to investigate the association between overall cardiovascular health, incorporating seven components, and cognitive function. Methods: A cross-sectional analysis employing 972 participants, from the Maine-Syracuse Longitudinal Study was undertaken. Four health behaviors (body mass index, physical activity, diet, smoking) and three health factors (total cholesterol, blood pressure, and fasting plasma glucose) were measured. Each was categorized according to the American Heart Association definitions for ideal cardiovascular health, except diet, for which two food scores were calculated. A Cardiovascular Health Score was determined by summing the number of cardiovascular metrics at ideal levels. Cognitive function was assessed using a thorough neuropsychological test battery. Results: Cardiovascular Health Score was positively associated with seven out of eight measures of cognitive function, with adjustment for age, education, and gender. With further adjustment for cardiovascular and psychological variables, these associations remained significant for Visual-Spatial Memory, Working Memory, Scanning and Tracking, Executive Function and the Global Composite score (p<0.05 for all). Ideal levels of a number of health factors and behaviors were positively associated with global cognitive performance. Conclusion: Increasing cardiovascular health, indexed by a higher number of metrics at ideal levels, is associated with greater cognitive performance. Smoking, physical activity, and diet are important components of cardiovascular health that impact upon cognition.	[Crichton, Georgina E.] Univ S Australia, Nutr Physiol Res Ctr, Adelaide, SA 5001, Australia; [Crichton, Georgina E.; Alkerwi, Ala'a] Ctr Etud Sante, Ctr Rech Publ Sante, Strassen, Luxembourg; [Elias, Merrill F.] Univ Maine, Dept Psychol, Orono, ME 04469 USA; [Elias, Merrill F.] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME USA; [Davey, Adam] Temple Univ, Dept Publ Hlth, Philadelphia, PA 19122 USA	University of South Australia; Luxembourg Institute of Health; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Crichton, GE (corresponding author), Univ S Australia, Nutr Physiol Res Ctr, Adelaide, SA 5001, Australia.	whige003@mymail.unisa.edu.au		Alkerwi, Ala'a/0000-0002-7448-3936	National Heart, Lung and Blood Institute, National Institutes of Health (USA) [R01HL067358, R01HL081290]; National Institute on Aging, National Institutes of Health (USA) [R01AG03055]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067358, R01HL081290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG003055] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute, National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging, National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Maine Syracuse Longitudinal Study was supported by grants R01HL067358, and R01HL081290 from the National Heart, Lung and Blood Institute, National Institutes of Health (USA), and research grant R01AG03055 from the National Institute on Aging, National Institutes of Health (USA). GC is a National Health and Medical Research Council (NHMRC) Sidney Sax Research Fellow (GNT1054567) (Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Appel LJ, 2012, CIRCULATION, V125, P973, DOI 10.1161/CIRCULATIONAHA.111.088542; Baik I, 2013, EUR J CLIN NUTR, V67, P25, DOI 10.1038/ejcn.2012.175; Bambs C, 2011, CIRCULATION, V123, P850, DOI 10.1161/CIRCULATIONAHA.110.980151; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Crawford AG, 2010, POPUL HEALTH MANAG, V13, P151, DOI 10.1089/pop.2009.0039; D'Agostino RB, 2008, CIRCULATION, V118, pE86, DOI 10.1161/CIRCULATIONAHA.108.190154; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Dore GA, 2008, ANN BEHAV MED, V35, P341, DOI 10.1007/s12160-008-9038-7; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Elias MF, 2007, HYPERTENSION, V49, P439, DOI 10.1161/01.HYP.0000256361.68158.24; Elias Merrill F, 2005, Neurobiol Aging, V26 Suppl 1, P11, DOI 10.1016/j.neurobiolaging.2005.08.019; Elias MF, 2006, PSYCHOSOM MED, V68, P547, DOI 10.1097/01.psy.0000221380.92521.51; Elias MF, 2012, J ALZHEIMERS DIS, V30, pS113, DOI 10.3233/JAD-2011-111175; Elias MF, 2009, HYPERTENSION, V53, P668, DOI 10.1161/HYPERTENSIONAHA.108.126342; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; Elias MF, 2004, STROKE, V35, P404, DOI 10.1161/01.STR.0000103141.82869.77; Elias PK, 2005, PSYCHOSOM MED, V67, P24, DOI 10.1097/01.psy.0000151745.67285.c2; Elias PK, 1997, DIABETES CARE, V20, P1388, DOI 10.2337/diacare.20.9.1388; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ford ES, 2012, CIRCULATION, V125, P1955, DOI 10.1161/CIRCULATIONAHA.112.102327; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Francis H, 2013, APPETITE, V63, P119, DOI 10.1016/j.appet.2012.12.018; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gunstad John, 2005, J Cardiopulm Rehabil, V25, P173, DOI 10.1097/00008483-200505000-00009; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Jaccard J, 2010, THEORY CONSTRUCTION; Kaffashian S, 2013, NEUROLOGY, V80, P1300, DOI 10.1212/WNL.0b013e31828ab370; Kaluza J, 2009, EUR J CLIN NUTR, V63, P451, DOI 10.1038/sj.ejcn.1602968; Kanoski SE, 2011, PHYSIOL BEHAV, V103, P59, DOI 10.1016/j.physbeh.2010.12.003; Kant AK, 2000, JAMA-J AM MED ASSOC, V283, P2109, DOI 10.1001/jama.283.16.2109; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Kroke A, 1999, AM J CLIN NUTR, V70, P439; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Michels KB, 2002, INT J EPIDEMIOL, V31, P847, DOI 10.1093/ije/31.4.847; Middleton LE, 2009, ARCH NEUROL-CHICAGO, V66, P1210, DOI 10.1001/archneurol.2009.201; Muldoon MF, 1997, PSYCHOSOM MED, V59, P382, DOI 10.1097/00006842-199707000-00008; Muldoon MF, 2001, NEUROPSYCHOLOGY OF CARDIOVASCULAR DISEASE, P37; Office of the Surgeon General (US) Office on Smoking and Health (US), 2004, HLTH CONS SMOK REP S; Petretta M, 2012, EUR J NUCL MED MOL I, V39, P1959, DOI 10.1007/s00259-012-2254-1; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reis JP, 2013, ANN NEUROL, V73, P170, DOI 10.1002/ana.23836; Robbins MA, 2005, PSYCHOSOM MED, V67, P707, DOI 10.1097/01.psy.0000171164.50990.80; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Sacco RL, 2011, CIRCULATION, V123, P2653, DOI 10.1161/CIR.0b013e318220dec1; SCHULTZ NR, 1979, J GERONTOL, V34, P246, DOI 10.1093/geronj/34.2.246; Singh-Manoux A, 2012, NEUROLOGY, V79, P755, DOI 10.1212/WNL.0b013e3182661f63; Tangney CC, 2011, AM J CLIN NUTR, V93, P601, DOI 10.3945/ajcn.110.007369; US Department of Agriculture & US Department of Health and Human Services, 2010, DIET GUID AM 2010; Waldstein S.R., 2001, NEUROPSYCHOLOGY CARD; WALDSTEIN SR, 1995, EXP AGING RES, V21, P321, DOI 10.1080/03610739508253989; Weiner H, 1976, PSYCHOL BULL, V2, P213; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; World Health Organization and Alzheimers Disease International, 2012, DEM PUBL HLTH PRIOR; Wright CB, 2008, STROKE, V39, P800, DOI 10.1161/STROKEAHA.107.484147; Yaffe K, 2004, NEUROLOGY, V63, P658, DOI 10.1212/01.WNL.0000134666.64593.BA; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339	67	70	71	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89317	10.1371/journal.pone.0089317	http://dx.doi.org/10.1371/journal.pone.0089317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595096	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000332468900013
J	Wang, Q; Tikhonenko, M; Bozack, SN; Lydic, TA; Yan, L; Panchy, NL; Mcsorley, KM; Faber, MS; Yan, YQ; Boulton, ME; Grant, MB; Busik, JV				Wang, Qi; Tikhonenko, Maria; Bozack, Svetlana N.; Lydic, Todd A.; Yan, Lily; Panchy, Nicholas L.; Mcsorley, Kelly M.; Faber, Matthew S.; Yan, Yuanqing; Boulton, Michael E.; Grant, Maria B.; Busik, Julia V.			Changes in the Daily Rhythm of Lipid Metabolism in the Diabetic Retina	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; CIRCADIAN CLOCK; MOLECULAR CLOCKS; LIVER; MOUSE; TIME; MELATONIN; INSULIN; PROTEIN-1; SYSTEM	Disruption of circadian regulation was recently shown to cause diabetes and metabolic disease. We have previously demonstrated that retinal lipid metabolism contributed to the development of diabetic retinopathy. The goal of this study was to determine the effect of diabetes on circadian regulation of clock genes and lipid metabolism genes in the retina and retinal endothelial cells (REC). Diabetes had a pronounced inhibitory effect on the negative clock arm with lower amplitude of the period (per) 1 in the retina; lower amplitude and a phase shift of per2 in the liver; and a loss of cryptochrome (cry) 2 rhythmic pattern in suprachiasmatic nucleus (SCN). The positive clock arm was increased by diabetes with higher amplitude of circadian locomotor output cycles kaput (CLOCK) and brain and muscle aryl-hydrocarbon receptor nuclear translocator-like 1 (bmal1) and phase shift in bmal1 rhythmic oscillations in the retina; and higher bmal1 amplitude in the SCN. Peroxisome proliferator-activated receptor (PPAR) alpha exhibited rhythmic oscillation in retina and liver; PPAR gamma had lower amplitude in diabetic liver; sterol regulatory element-binding protein (srebp) 1c had higher amplitude in the retina but lower in the liver in STZ-induced diabetic animals. Both of Elongase (Elovl) 2 and Elovl4 had a rhythmic oscillation pattern in the control retina. Diabetic retinas lost Elovl4 rhythmic oscillation and had lower amplitude of Elovl2 oscillations. In line with the in vivo data, circadian expression levels of CLOCK, bmal1 and srebp1c had higher amplitude in rat REC (rREC) isolated from diabetic rats compared with control rats, while PPAR gamma and Elovl2 had lower amplitude in diabetic rREC. In conclusion, diabetes causes dysregulation of circadian expression of clock genes and the genes controlling lipid metabolism in the retina with potential implications for the development of diabetic retinopathy.	[Wang, Qi; Bozack, Svetlana N.; Mcsorley, Kelly M.; Faber, Matthew S.; Busik, Julia V.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Tikhonenko, Maria; Panchy, Nicholas L.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Lydic, Todd A.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Yan, Lily] Michigan State Univ, Dept Psychol Social Sci, E Lansing, MI 48824 USA; [Yan, Yuanqing; Grant, Maria B.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA; [Boulton, Michael E.] Indiana Univ, Dept Ophthalmol, Indianapolis, IN 46204 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; State University System of Florida; University of Florida; Indiana University System; Indiana University-Purdue University Indianapolis	Busik, JV (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	busik@msu.edu	Busik, Julia V/A-2698-2010; Lydic, Todd A./ADB-0177-2022	Busik, Julia V/0000-0003-3453-7124; Yan, Lily/0000-0002-6261-2542; Faber, Matthew/0000-0002-5583-5115	National Institutes of Health (NIH) [EY016077]; MEAS [MICL02163, EY07739, EY12601, EY021626, DK090730]; NATIONAL EYE INSTITUTE [R01EY016077, R01EY007739, R01EY012601, R21EY021626, R29EY007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090730, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEAS; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) Grants EY016077; and MEAS grant MICL02163 to JVB, EY07739 and EY12601 to MBG, EY021626 to MEB and DK090730 to MBG and JVB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Ando H, 2009, DIABETOLOGIA, V52, P329, DOI 10.1007/s00125-008-1194-6; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bhatwadekar AD, 2013, DIABETES, V62, P273, DOI 10.2337/db12-0172; Botolin D, 2003, J BIOL CHEM, V278, P6959, DOI 10.1074/jbc.M212846200; Brewer M, 2005, J BIOL RHYTHM, V20, P195, DOI 10.1177/0748730405275952; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Busik J, 2009, DIABETES, V58, pA229; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Deng X, 2007, J BIOL CHEM, V282, P17517, DOI 10.1074/jbc.M702228200; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dinet V, 2007, J PINEAL RES, V42, P83, DOI 10.1111/j.1600-079X.2006.00387.x; Grace MS, 1996, BRAIN RES, V735, P93; Herichova I, 2005, MOL CELL BIOCHEM, V270, P223, DOI 10.1007/s11010-005-5323-y; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Hofmann K, 2013, HORM METAB RES, V45, P629, DOI 10.1055/s-0033-1343462; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Kohsaka A, 2007, TRENDS ENDOCRIN MET, V18, P4, DOI 10.1016/j.tem.2006.11.005; Kudo T, 2004, DIABETOLOGIA, V47, P1425, DOI 10.1007/s00125-004-1461-0; Kuriyama K, 2004, FEBS LETT, V572, P206, DOI 10.1016/j.febslet.2004.07.036; Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764; Lowden A, 2010, SCAND J WORK ENV HEA, V36, P150, DOI 10.5271/sjweh.2898; Maeda A, 2006, INVEST OPHTH VIS SCI, V47, P4050, DOI 10.1167/iovs.06-0183; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Mater MK, 1999, J BIOL CHEM, V274, P32725, DOI 10.1074/jbc.274.46.32725; Matsumoto E, 2010, J BIOL CHEM, V285, P33028, DOI 10.1074/jbc.M109.089391; Maywood ES, 2003, J NEUROENDOCRINOL, V15, P329, DOI 10.1046/j.1365-2826.2003.00971.x; Monteleone P, 2008, NEUROSCI LETT, V435, P30, DOI 10.1016/j.neulet.2008.02.003; Mulligan JD, 2008, EXP GERONTOL, V43, P146, DOI 10.1016/j.exger.2007.10.011; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Oishi K, 2004, BIOCHEM BIOPH RES CO, V317, P330, DOI 10.1016/j.bbrc.2004.03.055; Organisciak DT, 2000, INVEST OPHTH VIS SCI, V41, P3694; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pavan B, 2006, BIOCHEM BIOPH RES CO, V350, P169, DOI 10.1016/j.bbrc.2006.09.015; Paxinos G, 1999, CHEMOARCHITECTONIC A; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; Peschke E, 2008, J PINEAL RES, V45, P439, DOI 10.1111/j.1600-079X.2008.00612.x; Prasai MJ, 2008, DIABETES VASC DIS RE, V5, P89, DOI 10.3132/dvdr.2008.015; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sakamoto K, 2000, NEUROREPORT, V11, P3995, DOI 10.1097/00001756-200012180-00018; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sookoian S, 2008, AM J CLIN NUTR, V87, P1606, DOI 10.1093/ajcn/87.6.1606; Stamenkovic JA, 2012, METABOLISM, V61, P978, DOI 10.1016/j.metabol.2011.11.013; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Straume M, 2004, METHOD ENZYMOL, V383, P149; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Xue JF, 2010, FITOTERAPIA, V81, P173, DOI 10.1016/j.fitote.2009.08.020; Yamazaki S, 1999, J BIOL RHYTHM, V14, P197, DOI 10.1177/074873099129000605; Yang GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038117; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	61	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95028	10.1371/journal.pone.0095028	http://dx.doi.org/10.1371/journal.pone.0095028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736612	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600131
J	Zheng, Z; Kilian, A; Yan, GJ; Liu, CJ				Zheng, Zhi; Kilian, Andrzej; Yan, Guijun; Liu, Chunji			QTL Conferring Fusarium Crown Rot Resistance in the Elite Bread Wheat Variety EGA Wylie	PLOS ONE			English	Article							HEAD BLIGHT RESISTANCE; DISEASE; BARLEY; MAP; IDENTIFICATION; GRAMINEARUM; SEEDLINGS; SEVERITY	Fusarium crown rot (FCR) is one of the most damaging cereal diseases in semi-arid regions worldwide. The genetics of FCR resistance in the bread wheat (Triticum eastivum L.) variety EGA Wylie, the most resistant commercial variety available, was studied by QTL mapping. Three populations of recombinant inbred lines were developed with this elite variety as the resistant parent. Four QTL conferring FCR resistance were detected and resistance alleles of all of them were derived from the resistant parent EGA Wylie. One of these loci was located on the short arm of chromosome 5D (designated as Qcrs.cpi-5D). This QTL explains up to 31.1% of the phenotypic variance with an LOD value of 9.6. The second locus was located on the long arm of chromosome 2D (designated as Qcrs.cpi-2D) and explained up to 20.2% of the phenotypic variance with an LOD value of 4.5. Significant effects of both Qcrs.cpi-5D and Qcrs.cpi-2D were detected in each of the three populations assessed. Another two QTL (designated as Qcrs.cpi-4B. 1 and Qcrs.cpi-4B.2, respectively) were located on the short arm of chromosome 4B. These two QTL explained up to 16.9% and 18.8% of phenotypic variance, respectively. However, significant effects of Qcrs.cpi-4B.1 and Qcrs.cpi-4B.2 were not detected when the effects of plant height was accounted for by covariance analysis. The elite characteristics of this commercial variety should facilitate the incorporation of the resistance loci it contains into breeding programs.	[Zheng, Zhi; Liu, Chunji] Commenwealth Sci & Ind Res Org CSIRO Plant Ind, St Lucia, Qld, Australia; [Zheng, Zhi; Yan, Guijun; Liu, Chunji] Univ Western Australia, Sch Plant Biol, Fac Sci, Perth, WA 6009, Australia; [Zheng, Zhi; Yan, Guijun; Liu, Chunji] Univ Western Australia, UWA Inst Agr, Perth, WA 6009, Australia; [Zheng, Zhi] Hebei Acad Agr & Forestry Sci, Inst Millet Crops, Natl Foxtail Millet Improvement Ctr, Shijiazhuang, Peoples R China; [Kilian, Andrzej] Divers Arrays Technol Pty Ltd, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; University of Western Australia; Hebei Academy of Agricultural & Forestry Sciences	Liu, CJ (corresponding author), Commenwealth Sci & Ind Res Org CSIRO Plant Ind, St Lucia, Qld, Australia.	Chunji.liu@csiro.au	Liu, Chunji/B-5243-2009; Zheng, Zhi/C-4110-2017; Zheng, Zhong/AAZ-9647-2020; Yan, Guijun/A-9809-2011	Zheng, Zhi/0000-0002-1493-1995; Yan, Guijun/0000-0001-9628-1211; Kilian, Andrzej/0000-0002-2730-7462	Commonwealth Scientific & Industrial Organisation of Australia (CSIRO); University of Western Australia; China Scholarship Council (CSC); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R43AR064126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R44DE024692] Funding Source: NIH RePORTER	Commonwealth Scientific & Industrial Organisation of Australia (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); University of Western Australia; China Scholarship Council (CSC)(China Scholarship Council); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding for the study was provided by the Commonwealth Scientific & Industrial Organisation of Australia (CSIRO). Z. Zheng is grateful to the University of Western Australia and China Scholarship Council (CSC) for his PhD scholarships. No additional external funding was received or used for this study. CSIRO determines the research priorities of all research that it funds. Publication of research is subject to review by CSIRO officials. Specific study design, data collection, data analysis, and preparation of the manuscript is under the control of the individual researchers.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Akinsanmi OA, 2004, AUST J AGR RES, V55, P97, DOI 10.1071/AR03090; Anderson JA, 1992, THEOR APPL GENET, V83, P1035, DOI 10.1007/BF00232969; [Anonymous], 2013, QUEENSLAND WHEAT VAR; Bovill WD, 2006, PLANT BREEDING, V125, P538, DOI 10.1111/j.1439-0523.2006.01251.x; Bovill WD, 2010, THEOR APPL GENET, V121, P127, DOI 10.1007/s00122-010-1296-7; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Chakraborty S, 2006, AUSTRALAS PLANT PATH, V35, P643, DOI 10.1071/AP06068; Chen GD, 2014, BMC PLANT BIOL, V14, DOI [10.1186/1471-2229-14-22, 10.1186/1471-2458-14-754]; Chen GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058040; Li HB, 2009, THEOR APPL GENET, V118, P903, DOI 10.1007/s00122-008-0948-3; Li HB, 2010, THEOR APPL GENET, V121, P941, DOI 10.1007/s00122-010-1363-0; Li XM, 2008, J PHYTOPATHOL, V156, P751, DOI 10.1111/j.1439-0434.2008.01425.x; Liu CJ, 2011, CZECH J GENET PLANT, V47, pS109, DOI 10.17221/3264-CJGPB; Liu YX, 2010, PHYTOPATHOLOGY, V100, P1276, DOI 10.1094/PHYTO-05-10-0142; Ma J, 2010, THEOR APPL GENET, V120, P1119, DOI 10.1007/s00122-009-1239-3; Mudge AM, 2006, PHYSIOL MOL PLANT P, V69, P73, DOI 10.1016/j.pmpp.2007.01.003; Murray GM, 2009, AUSTRALAS PLANT PATH, V38, P558, DOI 10.1071/AP09053; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Poole GJ, 2012, THEOR APPL GENET, V125, P91, DOI 10.1007/s00122-012-1818-6; PURSS G. S., 1966, Queensland Journal of Agricultural and Animal Sciences, V23, P475; Smiley RW, 2005, PLANT DIS, V89, P595, DOI 10.1094/PD-89-0595; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Van Ooijen JW, 2004, MAPQTL 5; Van Ooijen JW, 2006, JOINTMAP 4; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wallwork H, 2004, AUSTRALAS PLANT PATH, V33, P1, DOI 10.1071/AP03073; WILDERMUTH GB, 1994, PLANT DIS, V78, P949, DOI 10.1094/PD-78-0949; Xie GQ, 2007, AUST J EXP AGR, V47, P603, DOI 10.1071/EA05250; Yan W, 2011, PLANT PATHOL, V60, P506, DOI 10.1111/j.1365-3059.2011.02426.x	30	56	61	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e96011	10.1371/journal.pone.0096011	http://dx.doi.org/10.1371/journal.pone.0096011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24603701	Green Submitted, gold, Green Published			2022-12-25	WOS:000346241800024
J	Huang, YL; Chen, HW; Han, BC; Liu, CW; Chuang, HC; Lin, LY; Chuang, KJ				Huang, Ya-Li; Chen, Hua-Wei; Han, Bor-Cheng; Liu, Chien-Wei; Chuang, Hsiao-Chi; Lin, Lian-Yu; Chuang, Kai-Jen			Personal Exposure to Household Particulate Matter, Household Activities and Heart Rate Variability among Housewives	PLOS ONE			English	Article							AIR-POLLUTION; ENVIRONMENTAL EXPOSURE; DISEASE; ASSOCIATION; INFLAMMATION; PARTICLES; WORKERS; SMOKE; PM2.5; RISK	Background: The association between indoor air pollution and heart rate variability (HRV) has been well-documented. Little is known about effects of household activities on indoor air quality and HRV alteration. To investigate changes in HRV associated with changes in personal exposure to household particulate matter (PM) and household activities. Methods: We performed 24-h continuous monitoring of electrocardiography and measured household PM exposure among 50 housewives. The outcome variables were log(10)-transformed standard deviation of normal-to-normal (NN) intervals (SDNN) and the square root of the mean of the sum of the squares of differences between adjacent NN intervals (r-MSSD). ,Household PM was measured as the mass concentration of PM with an aerodynamic diameter <2.5 mu m (PM2.5). We used mixed-effects models to examine the association between household PM2.5 exposure and log(10)-transformed HRV indices. Results: After controlling for potential confounders, an interquartile range change in household PM2.5 with 1- to 4-h mean was associated with 1.25-4.31% decreases in SDNN and 0.12-3.71% decreases in r-MSSD. Stir-frying, cleaning with detergent and burning incense may increase household PM2.5 concentrations and modify the effects of household PM2.5 on HRV indices among housewives. Conclusions: Indoor PM2.5 exposures were associated with decreased SDNN and r-MSSD among housewives, especially during stir-frying, cleaning with detergent and burning incense.	[Huang, Ya-Li; Chuang, Kai-Jen] Taipei Med Univ, Coll Med, Sch Med, Dept Publ Hlth, Taipei, Taiwan; [Huang, Ya-Li; Han, Bor-Cheng; Chuang, Kai-Jen] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan; [Chen, Hua-Wei] St Marys Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Yilan, Taiwan; [Liu, Chien-Wei] St Marys Jr Coll Med Nursing & Management, Dept Informat Management, Yilan, Taiwan; [Chuang, Hsiao-Chi] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Chuang, Hsiao-Chi] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan; [Lin, Lian-Yu] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; National Taiwan University; National Taiwan University Hospital	Chuang, KJ (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Publ Hlth, Taipei, Taiwan.	kjc@tmu.edu.tw	Chuang, Hsiao-Chi/E-7912-2010	Chuang, Hsiao-Chi/0000-0003-4651-5192; Han, Bor-Cheng/0000-0002-8493-8199; LIN, LIAN-YU/0000-0001-7505-6429; Huang, Yan-Ping/0000-0002-3301-2847	National Science Council of Taiwan [NSC 101-2314-B-038-053-MY3, TMU101-AE1-B08]; Taipei Medical University	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University	This study was supported by grants (NSC 101-2314-B-038-053-MY3 and TMU101-AE1-B08) from the National Science Council of Taiwan and Taipei Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behera D, 2006, CANCER RES, V66, P4961; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Chan CC, 2004, ENVIRON HEALTH PERSP, V112, P1063, DOI 10.1289/ehp.6897; Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC; Chuang KJ, 2007, J OCCUP ENVIRON MED, V49, P610, DOI 10.1097/JOM.0b013e318058205b; Chuang KJ, 2005, ENVIRON HEALTH PERSP, V113, P1693, DOI 10.1289/ehp.8145; Gold DR, 2000, CIRCULATION, V101, P1267, DOI 10.1161/01.CIR.101.11.1267; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Lanki T, 2007, J EXPO SCI ENV EPID, V17, P124, DOI 10.1038/sj.jes.7500470; Lee GS, 2010, AUTON NEUROSCI-BASIC, V155, P94, DOI 10.1016/j.autneu.2009.12.008; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin LY, 2012, SCI TOTAL ENVIRON, V414, P68, DOI 10.1016/j.scitotenv.2011.08.050; Lung SC, 1999, COMMUNITY AIR QUALIT; Magari SR, 2002, EPIDEMIOLOGY, V13, P305, DOI 10.1097/00001648-200205000-00011; Magari SR, 2001, CIRCULATION, V104, P986, DOI 10.1161/hc3401.095038; McCracken J, 2011, ENVIRON HEALTH PERSP, V119, P1562, DOI 10.1289/ehp.1002834; Pan CH, 2008, CANCER EPIDEM BIOMAR, V17, P3351, DOI 10.1158/1055-9965.EPI-08-0075; Polidori A, 2006, J EXPO SCI ENV EPID, V16, P321, DOI 10.1038/sj.jes.7500476; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Svendsen K, 2003, AM J IND MED, V43, P436, DOI 10.1002/ajim.10197; Syazwan AI, 2012, DRUG HEALTHC PATIENT, V4, P107, DOI 10.2147/DHPS.S33400; Tse LA, 2011, ENVIRON HEALTH PERSP, V119, P1641, DOI 10.1289/ehp.1002790; WHO-Europe, 2006, AIR QUAL GUID GLOB U	24	36	37	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89969	10.1371/journal.pone.0089969	http://dx.doi.org/10.1371/journal.pone.0089969			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24667838	Green Published, gold, Green Submitted			2022-12-25	WOS:000332468900050
J	Pei, XY; Dai, Y; Felthousen, J; Chen, S; Takabatake, Y; Zhou, L; Youssefian, LE; Sanderson, MW; Bodie, WW; Kramer, LB; Orlowski, RZ; Grant, S				Pei, Xin-Yan; Dai, Yun; Felthousen, Jessica; Chen, Shuang; Takabatake, Yukie; Zhou, Liang; Youssefian, Leena E.; Sanderson, Michael W.; Bodie, Wesley W.; Kramer, Lora B.; Orlowski, Robert Z.; Grant, Steven			Circumvention of Mcl-1-Dependent Drug Resistance by Simultaneous Chk1 and MEK1/2 Inhibition in Human Multiple Myeloma Cells	PLOS ONE			English	Article							DOWN-REGULATION; BONE-MARROW; INDUCE APOPTOSIS; UP-REGULATION; FACTOR-I; MCL-1; PHOSPHORYLATION; SURVIVAL; PROTEIN; BIM	The anti-apoptotic protein Mcl-1 plays a major role in multiple myeloma (MM) cell survival as well as bortezomib- and microenvironmental forms of drug resistance in this disease. Consequently, there is a critical need for strategies capable of targeting Mcl-1-dependent drug resistance in MM. The present results indicate that a regimen combining Chk1 with MEK1/2 inhibitors effectively kills cells displaying multiple forms of drug resistance stemming from Mcl-1 up-regulation in association with direct transcriptional Mcl-1 down-regulation and indirect disabling of Mcl-1 anti-apoptotic function through Bim up-regulation and increased Bim/Mcl-1 binding. These actions release Bak from Mcl-1, accompanied by Bak/Bax activation. Analogous events were observed in both drug-naive and acquired bortezomib-resistant MM cells displaying increased Mcl-1 but diminished Bim expression, or cells ectopically expressing Mcl-1. Moreover, concomitant Chk1 and MEK1/2 inhibition blocked Mcl-1 up-regulation induced by IL-6/IGF-1 or co-culture with stromal cells, effectively overcoming microenvironment-related drug resistance. Finally, this regimen down-regulated Mcl-1 and robustly killed primary CD138(+) MM cells, but not normal hematopoietic cells. Together, these findings provide novel evidence that this targeted combination strategy could be effective in the setting of multiple forms of Mcl-1-related drug resistance in MM.	[Pei, Xin-Yan; Dai, Yun; Felthousen, Jessica; Chen, Shuang; Takabatake, Yukie; Zhou, Liang; Youssefian, Leena E.; Sanderson, Michael W.; Bodie, Wesley W.; Kramer, Lora B.; Grant, Steven] Virginia Commonwealth Univ, Dept Med, Div Hematol Oncol, Richmond, VA 23298 USA; [Pei, Xin-Yan; Dai, Yun; Felthousen, Jessica; Chen, Shuang; Takabatake, Yukie; Zhou, Liang; Youssefian, Leena E.; Sanderson, Michael W.; Bodie, Wesley W.; Kramer, Lora B.; Grant, Steven] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA; [Orlowski, Robert Z.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA; [Grant, Steven] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA USA; [Grant, Steven] Inst Mol Med, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Texas System; UTMD Anderson Cancer Center; Virginia Commonwealth University	Grant, S (corresponding author), Virginia Commonwealth Univ, Dept Med, Div Hematol Oncol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	stgrant@vcu.edu	Dai, Yun/AAG-4040-2019	Dai, Yun/0000-0003-2285-0818; Orlowski, Robert/0000-0002-5723-4129; Takabatake, Yukie/0000-0003-0540-3610	National Institutes of Health [CA100866, CA93738, P50 CA142509-01]; MMRF; NATIONAL CANCER INSTITUTE [R01CA100866, P50CA142509, P30CA016672, R01CA093738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MMRF; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by awards CA100866, CA93738, and P50 CA142509-01 from the National Institutes of Health and the MMRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat UG, 2010, LEUKEMIA, V24, P851, DOI 10.1038/leu.2010.3; Bhat UG, 2010, MOL CANCER THER, V9, P1688, DOI 10.1158/1535-7163.MCT-09-0919; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chen S, 2012, CANCER RES, V72, P4225, DOI 10.1158/0008-5472.CAN-12-1118; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Dai Y, 2002, BLOOD, V100, P3333, DOI 10.1182/blood-2002-03-0940; Dai Y, 2008, BLOOD, V112, P2439, DOI 10.1182/blood-2008-05-159392; Dai Y, 2011, J BIOL CHEM, V286, P34036, DOI 10.1074/jbc.M111.284216; Dai Y, 2011, BLOOD, V117, P1947, DOI 10.1182/blood-2010-06-291146; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Eichhorn JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.411; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Ewings KE, 2007, EMBO J, V26, P2856, DOI 10.1038/sj.emboj.7601723; Fulda S, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00121; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Gores GJ, 2012, GENE DEV, V26, P305, DOI 10.1101/gad.186189.111; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; Hazlehurst LA, 2003, ONCOGENE, V22, P7396, DOI 10.1038/sj.onc.1206943; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hu JS, 2012, BLOOD, V119, P826, DOI 10.1182/blood-2011-07-366492; Jourdan M, 2003, ONCOGENE, V22, P2950, DOI 10.1038/sj.onc.1206423; Kale AJ, 2012, J MED CHEM, V55, P10317, DOI 10.1021/jm300434z; Kawabata T, 2012, J BIOL CHEM, V287, P10289, DOI 10.1074/jbc.M111.319426; Khoury JD, 2003, J PATHOL, V199, P90, DOI 10.1002/path.1254; Kim KH, 2010, BIOMAT PROP PROD DEV, P149; Konopleva M, 2012, LEUKEMIA, V26, P778, DOI 10.1038/leu.2011.287; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuhn DJ, 2012, BLOOD, V120, P3260, DOI 10.1182/blood-2011-10-386789; Laubach JP, 2011, J NATL COMPR CANC NE, V9, P1209, DOI 10.6004/jnccn.2011.0098; Le Gouill S, 2004, CELL CYCLE, V3, P1259; Le Gouill S, 2004, BLOOD, V104, P2886, DOI 10.1182/blood-2004-05-1760; Ley R, 2004, J BIOL CHEM, V279, P8837, DOI 10.1074/jbc.M311578200; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Mahindra A, 2012, NAT REV CLIN ONCOL, V9, P135, DOI 10.1038/nrclinonc.2012.15; Manier S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/157496; Mazumder S, 2012, CANCER RES, V72, P3069, DOI 10.1158/0008-5472.CAN-11-4106; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Mitsiades CS, 2006, EUR J CANCER, V42, P1564, DOI 10.1016/j.ejca.2005.12.025; MOALLI PA, 1993, CANCER RES, V53, P3877; Morales AA, 2011, BLOOD, V118, P1329, DOI 10.1182/blood-2011-01-327197; Nair RR, 2012, ADV PHARMACOL, V65, P143, DOI 10.1016/B978-0-12-397927-8.00006-3; Nefedova Y, 2003, LEUKEMIA, V17, P1175, DOI 10.1038/sj.leu.2402924; Nencioni A, 2005, BLOOD, V105, P3255, DOI 10.1182/blood-2004-10-3984; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Nifoussi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047060; Pagnucco G, 2004, ANN NY ACAD SCI, V1028, P390, DOI 10.1196/annals.1322.047; Pei XY, 2007, BLOOD, V110, P2092, DOI 10.1182/blood-2007-04-083204; Pei XY, 2011, BLOOD, V118, P5189, DOI 10.1182/blood-2011-02-339432; Perez-Galan P, 2007, BLOOD, V109, P4441, DOI 10.1182/blood-2006-07-034173; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Schmidmaier R., 2006, Experimental Oncology, V28, P12; Schmidmaier R, 2004, BLOOD, V104, P1825, DOI 10.1182/blood-2003-12-4218; Senderowicz AM, 2000, ONCOGENE, V19, P6600, DOI 10.1038/sj.onc.1204085; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Tai YT, 2007, BLOOD, V110, P1656, DOI 10.1182/blood-2007-03-081240; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; Yang-Yen HF, 2006, J BIOMED SCI, V13, P201, DOI 10.1007/s11373-005-9064-4; Yasui H, 2006, BRIT J HAEMATOL, V132, P385, DOI 10.1111/j.1365-2141.2005.05860.x; Zhang B, 2003, ONCOGENE, V22, P1848, DOI 10.1038/sj.onc.1206358; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885; Zhang J, 2003, ONCOGENE, V22, P6289, DOI 10.1038/sj.onc.1206718	64	63	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89064	10.1371/journal.pone.0089064	http://dx.doi.org/10.1371/journal.pone.0089064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24594907	Green Submitted, Green Published, gold			2022-12-25	WOS:000332475500008
J	Graversen, L; Sorensen, TIA; Petersen, L; Sovio, U; Kaakinen, M; Sandbaek, A; Laitinen, J; Taanila, A; Pouta, A; Jarvelin, MR; Obel, C				Graversen, Lise; Sorensen, Thorkild I. A.; Petersen, Liselotte; Sovio, Ulla; Kaakinen, Marika; Sandbaek, Annelli; Laitinen, Jaana; Taanila, Anja; Pouta, Anneli; Jarvelin, Marjo-Riitta; Obel, Carsten			Preschool Weight and Body Mass Index in Relation to Central Obesity and Metabolic Syndrome in Adulthood	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; CORONARY-HEART-DISEASE; FINLAND BIRTH COHORT; AGE 31 YEARS; CHILDHOOD OBESITY; RISK-FACTORS; CARDIOVASCULAR RISK; ABERDEEN CHILDREN; LIFE; INFANCY	Background: If preschool measures of body size routinely collected at preventive health examinations are associated with adult central obesity and metabolic syndrome, a focused use of these data for the identification of high risk children is possible. The aim of this study was to test the associations between preschool weight and body mass index (BMI) and adult BMI, central obesity and metabolic alterations. Methods: The Northern Finland Birth Cohort 1966 (NFBC1966) (N = 4111) is a population-based cohort. Preschool weight (age 5 months and 1 year) and BMI (age 2-5 years) were studied in relation to metabolic syndrome as well as BMI, waist circumference, lipoproteins, blood pressure, and fasting glucose at the age of 31 years. Linear regression models and generalized linear regression models with log link were used. Results: Throughout preschool ages, weight and BMI were significantly linearly associated with adult BMI and waist circumference. Preschool BMI was inversely associated with high-density lipoprotein levels from the age of 3 years. Compared with children in the lower half of the BMI range, the group of children with the 5% highest BMI at the age of 5 years had a relative risk of adult obesity of 6.2(95% CI: 4.2-9.3), of adult central obesity of 2.4(95% CI:2.0-2.9), and of early onset adult metabolic syndrome of 2.5(95% CI:1.7-3.8). Conclusions: High preschool BMI is consistently associated with adult obesity, central obesity and early onset metabolic syndrome. Routinely collected measures of body size in preschool ages can help to identify children in need of focused prevention due to their increased risk of adverse metabolic alterations in adulthood.	[Graversen, Lise; Sandbaek, Annelli; Obel, Carsten] Aarhus Univ, Dept Publ Hlth, Sect Gen Med Practice, Aarhus, Denmark; [Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Petersen, Liselotte] Aarhus Univ, Natl Ctr Register Based Res, Fac Social Sci, Aarhus, Denmark; [Sovio, Ulla] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England; [Sovio, Ulla; Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Kaakinen, Marika; Taanila, Anja; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Oulu, Finland; [Taanila, Anja; Jarvelin, Marjo-Riitta] Univ Hosp Oulu, Primary Hlth Care Unit, Oulu, Finland; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Oulu, Finland; [Pouta, Anneli] Univ Oulu, Dept Obstet & Gynecol, SF-90220 Oulu, Finland; [Pouta, Anneli] Oulu Univ Hosp, Oulu, Finland	Aarhus University; University of Copenhagen; Bispebjerg Hospital; Novo Nordisk Foundation; University of Copenhagen; Aarhus University; University of Cambridge; Imperial College London; University of Oulu; University of Oulu; Finnish Institute of Occupational Health; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu	Graversen, L (corresponding author), Aarhus Univ, Dept Publ Hlth, Sect Gen Med Practice, Aarhus, Denmark.	lgra@alm.au.dk; m.jarvelin@imperial.ac.uk	Sovio, Ulla/H-8532-2019; Obel, Carsten/H-9605-2016	Sovio, Ulla/0000-0002-0799-1105; Obel, Carsten/0000-0001-5004-1933; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Petersen, Liselotte Vogdrup/0000-0002-0479-5379; Kaakinen, Marika/0000-0002-9228-0462	Nordic Council of Ministers research program 'Longitudinal Epidemiology' [020056]; Academy of Finland; Oulu University Hospital; Biocenter Oulu, University of Oulu, Finland; The Finnish Ministry of Health and Social Affairs; European Commission Quality of Life and Management of Living Resources Programme [QLG1-CT-2000-01643]; Medical Research Council, UK [G0500539, G0600705, PrevMetSyn/SALVE, PS0476]; Danish Tryg Foundation, the Health Foundation, Denmark; Aarhus University, Denmark; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705] Funding Source: researchfish	Nordic Council of Ministers research program 'Longitudinal Epidemiology'; Academy of Finland(Academy of Finland); Oulu University Hospital; Biocenter Oulu, University of Oulu, Finland; The Finnish Ministry of Health and Social Affairs; European Commission Quality of Life and Management of Living Resources Programme(European CommissionEuropean Commission Joint Research Centre); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Tryg Foundation, the Health Foundation, Denmark; Aarhus University, Denmark; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was financially supported by the Nordic Council of Ministers research program 'Longitudinal Epidemiology' (020056), the Academy of Finland, Oulu University Hospital, Biocenter Oulu, University of Oulu, Finland, The Finnish Ministry of Health and Social Affairs, the European Commission Quality of Life and Management of Living Resources Programme Contract QLG1-CT-2000-01643, the Medical Research Council, UK (G0500539, G0600705, PrevMetSyn/SALVE, PS0476), the Danish Tryg Foundation, the Health Foundation, Denmark, and Aarhus University, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Carmienke S, 2013, EUR J CLIN NUTR; de Kroon MLA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013966; Fall CHD, 2008, DIABETES CARE, V31, P2349, DOI 10.2337/dc08-0911; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; Gamborg M, 2007, AM J EPIDEMIOL, V166, P634, DOI 10.1093/aje/kwm042; Gamborg M, 2009, AM J EPIDEMIOL, V169, P1167, DOI 10.1093/aje/kwp047; Jarvelin MR, 2004, HYPERTENSION, V44, P838, DOI 10.1161/01.HYP.0000148304.33869.ee; Lawlor DA, 2006, DIABETOLOGIA, V49, P2614, DOI 10.1007/s00125-006-0408-z; Lawlor DA, 2005, CIRCULATION, V112, P1414, DOI 10.1161/CIRCULATIONAHA.104.528356; Lawlor DA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6224; Leitzmann MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018582; Liddle K, 2012, J PAEDIATR CHILD H, V48, P424, DOI 10.1111/j.1440-1754.2011.02247.x; Lloyd LJ, 2012, INT J OBESITY, V36, P1, DOI 10.1038/ijo.2011.186; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Park MH, 2012, OBES REV, V13, P985, DOI 10.1111/j.1467-789X.2012.01015.x; RANTAKALLIO P, 1969, ACTA PAEDIATR SC S, V0193; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Sovio U, 2013, INT J OBES LOND; Sovio U, 2007, J HEALTH PSYCHOL, V12, P371, DOI 10.1177/1359105307074301; Tzoulaki I, 2010, AM J EPIDEMIOL, V171, P989, DOI 10.1093/aje/kwq027; Zimmermann E, 2011, INT J OBESITY, V35, P1193, DOI 10.1038/ijo.2010.274	28	32	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89986	10.1371/journal.pone.0089986	http://dx.doi.org/10.1371/journal.pone.0089986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24748033	Green Published, Green Submitted, gold			2022-12-25	WOS:000332468900052
J	Li, X; Zhang, Y; Xia, M; Gulbins, E; Boini, KM; Li, PL				Li, Xiang; Zhang, Yang; Xia, Min; Gulbins, Erich; Boini, Krishna M.; Li, Pin-Lan			Activation of Nlrp3 Inflammasomes Enhances Macrophage Lipid-Deposition and Migration: Implication of a Novel Role of Inflammasome in Atherogenesis	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; NALP3 INFLAMMASOME; SIGNALING PATHWAY; OXIDATIVE STRESS; CHOLESTEROL; CELLS; ATHEROSCLEROSIS; CONTRIBUTE; CRYSTALS	Although Nlrp3 inflammasome activation in macrophages has been shown to be critical for the development of atherosclerosis upon atherogenic stimuli, it remains unknown whether activated Nlrp3 inflammasomes by other non-atherogenic stimuli induce alterations in macrophages that may contribute in the concert with other factors to atherogenesis. Thus, the present study tested the hypothesis that activation of Nlrp3 inflammasomes by ATP, which is a classical non-lipid danger stimulus, enhances the migration of macrophage and increases lipids deposition in macrophages accelerating foam cell formation. We first demonstrated that extracellular ATP (2.5 mM) markedly increased the formation and activation of Nlrp3 inflammasomes in bone marrow macrophages (BMMs) from wild type (Asc(+/+)) mice resulting in activation of caspase-1 and IL-1 beta production. In these Asc(+/+) macrophages, such stimulation of inflammasomes by non-lipid ATP was similar to those induced by atherogenic stimuli such as cholesterol crystals or 7-ketocholesterol. Both non-lipid and lipid forms of stimuli induced formation and activation of Nlrp3 inflammasomes, which were prevented by Asc gene deletion. Interestingly, Asc(+/+) BMMs had dramatic lipids accumulation after stimulation with ATP. Further, we demonstrated that large amount of cholesterol was accumulated in lysosomes of Asc(+/+) BMMs when inflammasomes were activated by ATP. Such intracellular and lysosomal lipids deposition was not observed in Asc(-/-) BMMs and also prevented by caspase-1 inhibitor WEHD. In addition, in vitro and in vivo experiments revealed that migration of Asc(+/+) BMMs increased due to stimulation of Nlrp3 inflammasomes, which was markedly attenuated in Asc(-/-) BMMs. Together, these results suggest that activation of Nlrp3 inflammasomes remarkably increases the susceptibility of macrophages to lipid deposition and their migration ability. Such novel action of inflammasomes may facilitate entry or retention of macrophages into the arterial wall, where they form foam cells and ultimately induce atherosclerosis.	[Li, Xiang; Zhang, Yang; Xia, Min; Boini, Krishna M.; Li, Pin-Lan] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; [Gulbins, Erich] Univ Duisburg Essen, Med Sch Essen, Dept Mol Biol, Essen, Germany	Virginia Commonwealth University; University of Duisburg Essen	Li, PL (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	pli@vcu.edu	Xia, Min/C-2084-2012; Gulbins, Erich/L-6989-2014; Han, Zhong Chao/D-7157-2016	Gulbins, Erich/0000-0002-3117-1342; Han, Zhong Chao/0000-0002-2687-7682	National Institutes of Health [HL-57244, HL-075316, HL-091464]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL057244, R01HL075316, R01HL091464, R01HL057244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Institutes of Health (HL-57244, HL-075316, and HL-091464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel A, 2005, J BIOL CHEM, V280, P43079, DOI 10.1074/jbc.M509796200; Busso N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2952; CHABRAOUI F, 1993, J IMMUNOL METHODS, V165, P225, DOI 10.1016/0022-1759(93)90348-B; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Dinarello CA, 2010, CURR OPIN ENDOCRINOL, V17, P314, DOI 10.1097/MED.0b013e32833bf6dc; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Fearon WF, 2008, CIRCULATION, V117, P2577, DOI 10.1161/CIRCULATIONAHA.108.772491; HALEY NJ, 1977, LAB INVEST, V37, P287; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Herijgers N, 2000, ARTERIOSCL THROM VAS, V20, P1961, DOI 10.1161/01.ATV.20.8.1961; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Jerome WG, 1998, J LIPID RES, V39, P1362; Johnston TP, 2006, EUR J PHARMACOL, V536, P232, DOI 10.1016/j.ejphar.2006.03.019; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Nour AM, 2009, INFECT IMMUN, V77, P1262, DOI 10.1128/IAI.01032-08; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rodriguez G, 2009, INVEST CLIN, V50, P109; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Rudel LL, 2001, CURR OPIN LIPIDOL, V12, P121, DOI 10.1097/00041433-200104000-00005; Silverstein RL, 2000, CURR OPIN LIPIDOL, V11, P483, DOI 10.1097/00041433-200010000-00006; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Stienstra R, 2012, CELL METAB, V15, P10, DOI 10.1016/j.cmet.2011.10.011; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Wei YM, 2013, CELL PHYSIOL BIOCHEM, V31, P925, DOI 10.1159/000350111; Wei YM, 2013, J PHARMACOL EXP THER, V345, P170, DOI 10.1124/jpet.112.201442; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Xia M, 2011, CARDIOVASC RES, V89, P401, DOI 10.1093/cvr/cvq286; Xu SW, 2010, CYTOTECHNOLOGY, V62, P473, DOI 10.1007/s10616-010-9290-0; Yancey PG, 1998, J LIPID RES, V39, P1349; Zhang AY, 2006, HYPERTENSION, V47, P74, DOI 10.1161/01.HYP.0000196727.53300.62; Zhang F, 2011, AM J PHYSIOL-CELL PH, V301, pC421, DOI 10.1152/ajpcell.00393.2010; Zhang Y, 2011, NAT MED, V17, P341, DOI 10.1038/nm.2296; Zheng Y, 2011, ARTERIOSCL THROM VAS, V31, P2781, DOI 10.1161/ATVBAHA.111.224907; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	39	142	149	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2014	9	1							e87552	10.1371/journal.pone.0087552	http://dx.doi.org/10.1371/journal.pone.0087552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301BI	24475307	Green Published, gold			2022-12-25	WOS:000330507300200
J	Wang, H; Liu, B; Liu, X; Li, ZL; Yu, XF; Zhang, WY				Wang, Hong; Liu, Bin; Liu, Xin; Li, Zhaolong; Yu, Xiao-Fang; Zhang, Wenyan			Identification of HIV-1 Vif Regions Required for CBF-beta Interaction and APOBEC3 Suppression	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 VIF; LIGASE COMPLEX; HCCH MOTIF; SOCS-BOX; BINDING; DEGRADATION; INFECTION; DETERMINANTS; RESTRICTION	Human immunodeficiency virus type 1 (HIV-1) Vif requires core binding factor beta (CBF-beta) to degrade the host APOBEC3 restriction factors. Although a minimum domain and certain amino acids of HIV-1 Vif, including hydrophobic residues at the N-terminal, have been identified as critical sites for binding with CBF-beta, other regions that potentially mediate this interaction need to be further investigated. Here, we mapped two new regions of HIV-1 Vif that are required for interaction with CBF-beta by generating a series of single-site or multiple-site Vif mutants and testing their effect on the suppression of APOBEC3G (A3G) and APOBEC3F (A3F). A number of the mutants, including G84A/SIEW86-89AAAA (84/86-89), E88A/W89A (88/89), G84A, W89A, L106S and I107S in the (84)GxSIEW(89) and L(102)ADQLI(107) regions, affected Vif function by disrupting CBF-beta binding. These Vif mutants also had altered interactions with CUL5, since CBF-beta is known to facilitate the binding of Vif to CUL5. We further showed that this effect was not due to misfolding or conformational changes in Vif, as the mutants still maintained their interactions with other factors such as ElonginB, A3G and A3F. Notably, G84D and D104A had stronger effects on the Vif-CUL5 interaction than on the Vif-CBF-beta interaction, indicating that they mainly influenced the CUL5 interaction and implying that the interaction of Vif with CUL5 contributes to the binding of Vif to CBF-beta. These new binding interfaces with CBF-beta in HIV-1 Vif provide novel targets for the development of HIV-1 inhibitors.	[Wang, Hong; Liu, Bin; Liu, Xin; Li, Zhaolong; Yu, Xiao-Fang; Zhang, Wenyan] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun 130023, Jilin Province, Peoples R China; [Liu, Bin] Jilin Univ, Hosp 1, Dept Hand Surg, Changchun 130023, Jilin Province, Peoples R China; [Yu, Xiao-Fang] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Jilin University; Jilin University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhang, WY (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun 130023, Jilin Province, Peoples R China.	zhangwenyan@jlu.edu.cn			National Natural Science Foundation of China [31270202]; Chinese Ministry of Science and Technology [2012CB911102, 2013ZX10001-005]; Chinese Ministry of Education [IRT1016]; Key Laboratory of Molecular Virology, Jilin Province [20102209]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Ministry of Education(Ministry of Education, China); Key Laboratory of Molecular Virology, Jilin Province	This work was supported in part by funding from National Natural Science Foundation of China (No. 31270202), the Chinese Ministry of Science and Technology (2012CB911102 and No. 2013ZX10001-005), the Chinese Ministry of Education (IRT1016), and the Key Laboratory of Molecular Virology, Jilin Province (20102209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chackerian B, 1997, J VIROL, V71, P3932, DOI 10.1128/JVI.71.5.3932-3939.1997; Chen GY, 2009, J VIROL, V83, P8674, DOI 10.1128/JVI.00653-09; Dang Y, 2010, J VIROL, V84, P5741, DOI 10.1128/JVI.00079-10; Dang Y, 2009, J VIROL, V83, P8544, DOI 10.1128/JVI.00651-09; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Du J, 2013, J VIROL, V87, P1906, DOI 10.1128/JVI.02199-12; Fribourgh JL, 2014, J VIROL; Guo YY, 2014, NATURE, V505, P229, DOI 10.1038/nature12884; He ZW, 2008, J MOL BIOL, V381, P1000, DOI 10.1016/j.jmb.2008.06.061; Hultquist JF, 2012, J VIROL, V86, P2874, DOI 10.1128/JVI.06950-11; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kim DY, 2013, MOL CELL, V49, P632, DOI 10.1016/j.molcel.2012.12.012; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Matsui Y, 2014, VIROLOGY, V449, P82, DOI 10.1016/j.virol.2013.11.004; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Paul I, 2006, P NATL ACAD SCI USA, V103, P18475, DOI 10.1073/pnas.0604150103; Pery E, 2009, J VIROL, V83, P2374, DOI 10.1128/JVI.01898-08; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Tian CJ, 2006, J VIROL, V80, P3112, DOI 10.1128/JVI.80.6.3112-3115.2006; Wang XD, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-94; Wissing S, 2011, J BIOL CHEM, V286, P36427, DOI 10.1074/jbc.M111.251058; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zhang WY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003963; Zhen AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038771; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004; Zhou XH, 2014, J VIROL, V88, P2555, DOI 10.1128/JVI.03604-13; Zhou XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033495	31	50	51	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2014	9	5							e95738	10.1371/journal.pone.0095738	http://dx.doi.org/10.1371/journal.pone.0095738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1XT	24595218	gold, Green Published, Green Submitted			2022-12-25	WOS:000338213300014
J	Wang, ST; Sun, XL; Hoshino, Y; Yu, Y; Jia, B; Sun, ZW; Sun, MZ; Duan, XB; Zhu, YM				Wang, Sun-ting; Sun, Xiao-li; Hoshino, Yoichiro; Yu, Yang; Jia, Bei; Sun, Zhong-wen; Sun, Ming-zhe; Duan, Xiang-bo; Zhu, Yan-ming			MicroRNA319 Positively Regulates Cold Tolerance by Targeting OsPCF6 and OsTCP21 in Rice (Oryza sativa L.)	PLOS ONE			English	Article							APOPLASTIC OXIDATIVE BURST; PLANT MICRORNAS; TRANSCRIPTION FACTORS; LOW-TEMPERATURE; GENE-REGULATION; SMALL RNAS; STRESS; ARABIDOPSIS; EXPRESSION; LANCEOLATE	The microRNA319 (miR319) family is conserved among diverse plant species. In rice (Oryza sativa L.), the miR319 gene family is comprised of two members, Osa-miR319a and Osa-miR319b. We found that overexpressing Osa-miR319b in rice resulted in wider leaf blades and delayed development. Here, we focused on the biological function and potential molecular mechanism of the Osa-miR319b gene in response to cold stress in rice. The expression of Osa-miR319b was down-regulated by cold stress, and the overexpression of Osa-miR319b led to an enhanced tolerance to cold stress, as evidenced by higher survival rates and proline content. Also, the expression of a handful of cold stress responsive genes, such as DREB1A/B/C, DREB2A, TPP1/2, was increased in Osa-miR319b transgenic lines. Furthermore, we demonstrated the nuclear localization of the transcription factors, OsPCF6 and OsTCP21, which may be Osa-miR319b-targeted genes. We also showed that OsPCF6 and OsTCP21 expression was largely induced by cold stress, and the degree of induction was obviously repressed in plants overexpressing Osa-miR319b. As expected, the down-regulation of OsPCF6 and OsTCP21 resulted in enhanced tolerance to cold stress, partially by modifying active oxygen scavenging. Taken together, our findings suggest that Osa-miR319b plays an important role in plant response to cold stress, maybe by targeting OsPCF6 and OsTCP21.	[Wang, Sun-ting; Sun, Xiao-li; Yu, Yang; Jia, Bei; Sun, Zhong-wen; Sun, Ming-zhe; Duan, Xiang-bo; Zhu, Yan-ming] Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin, Peoples R China; [Hoshino, Yoichiro] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Kita Ku, Sapporo, Hokkaido, Japan	Northeast Agricultural University - China; Hokkaido University	Zhu, YM (corresponding author), Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin, Peoples R China.	ymzhu2001@neau.edu.cn	Hoshino, Yoichiro/A-5115-2012; han, xiao/HDN-9782-2022; Sun, Xiaoli/AAH-2265-2020	Hoshino, Yoichiro/0000-0003-3828-0696; Sun, Xiaoli/0000-0003-1134-3976; Sun, Mingzhe/0000-0001-7557-623X	National Natural Science Foundation of China [31171578]; "863" project [2008AA10Z153]; Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program [2011TD005]; National basic scientific talent training fund projects [J1210069]; Graduate student innovation research project in Heilongjiang province [YJSCX2012-047HLJ]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "863" project(National High Technology Research and Development Program of China); Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program; National basic scientific talent training fund projects; Graduate student innovation research project in Heilongjiang province	This work was supported by the National Natural Science Foundation of China (31171578), the "863" project (2008AA10Z153), Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program (2011TD005), National basic scientific talent training fund projects (J1210069), Graduate student innovation research project in Heilongjiang province (YJSCX2012-047HLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Andaya VC, 2003, THEOR APPL GENET, V106, P1084, DOI 10.1007/s00122-002-1126-7; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Armengaud P, 2004, PHYSIOL PLANTARUM, V120, P442, DOI 10.1111/j.0031-9317.2004.00251.x; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Ben-Gera H, 2012, PLANT SIGNAL BEHAV, V7, P1255, DOI 10.4161/psb.21550; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Chinnusamy V, 2010, METHODS MOL BIOL, V639, P39, DOI 10.1007/978-1-60761-702-0_3; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Efroni I, 2008, PLANT CELL, V20, P2293, DOI 10.1105/tpc.107.057521; Eldem V, 2013, TURK J AGRIC FOR, V37, P1, DOI 10.3906/tar-1206-50; Fattash I, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-13; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; GLASZMANN JC, 1990, EUPHYTICA, V45, P95; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hsieh TH, 2002, PLANT PHYSIOL, V129, P1086, DOI 10.1104/pp.003442; Huang J, 2009, BIOCHEM BIOPH RES CO, V389, P556, DOI 10.1016/j.bbrc.2009.09.032; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Liu Q, 2009, FEBS LETT, V583, P723, DOI 10.1016/j.febslet.2009.01.020; Lou QJ, 2007, EUPHYTICA, V158, P87, DOI 10.1007/s10681-007-9431-5; Lv DK, 2010, GENE, V459, P39, DOI 10.1016/j.gene.2010.03.011; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mao DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047275; Martin-Trillo M, 2010, TRENDS PLANT SCI, V15, P31, DOI 10.1016/j.tplants.2009.11.003; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Nonogaki H, 2010, PLANT CELL PHYSIOL, V51, P1840, DOI 10.1093/pcp/pcq154; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Ozhuner E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059543; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Peyman S, 2010, RICE SCI, V1, P77; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Saini A., 2012, MICRORNAS PLANT DEV, P219, DOI [10.1016/j.tplants.2012.01.010, DOI 10.1016/J.TPLANTS.2012.01.010]; Schommer C., 2012, SIGNAL COMMUN PLANTS, V15, P29, DOI [DOI 10.1007/978-3-642-27384-1_2, 10.1007/978-3-642-27384-1_2]; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Sharma R., 2010, J PLANT MOL BIOL BIO, V1, P24; Song SY, 2011, PLANTA, V234, P331, DOI 10.1007/s00425-011-1403-2; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; Talmor-Neiman M, 2006, PLANT J, V47, P25, DOI 10.1111/j.1365-313X.2006.02768.x; Thiebaut F, 2012, PLANT CELL ENVIRON, V35, P502, DOI 10.1111/j.1365-3040.2011.02430.x; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Ueno M, 2003, PLANT J, V36, P215, DOI 10.1046/j.1365-313X.2003.01875.x; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Warthmann N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001829; Xin Z, 2000, PLANT CELL ENVIRON, V23, P893, DOI 10.1046/j.1365-3040.2000.00611.x; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yanai O, 2011, PLANT J, V68, P571, DOI 10.1111/j.1365-313X.2011.04716.x; Yang CH, 2013, PLANT CELL ENVIRON, V36, P2207, DOI 10.1111/pce.12130; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zhao K, 2013, PLANT CELL PHYSIOL, V54, P1415, DOI 10.1093/pcp/pct087	61	207	241	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e91357	10.1371/journal.pone.0091357	http://dx.doi.org/10.1371/journal.pone.0091357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24595136	Green Published, gold, Green Submitted			2022-12-25	WOS:000333675600005
J	Wang, S; Han, XH; Wang, JF; Yao, JR; Shi, YK				Wang, Shuai; Han, Xiaohong; Wang, Jianfei; Yao, Jiarui; Shi, Yuankai			Antitumor Effects of a Novel Chromosome Region Maintenance 1 (CRM1) Inhibitor on Non-Small Cell Lung Cancer Cells In Vitro and in Mouse Tumor Xenografts	PLOS ONE			English	Article							NUCLEAR EXPORT SIGNAL; SELECTIVE INHIBITORS; PROGNOSTIC-FACTOR; TRANSPORT; RECEPTOR; APOPTOSIS; EGFR	Background: Chromosome Region Maintenance 1 (CRM1) is a nuclear exporter and its inhibitor has anti-tumor activity in various cancers. This study assessed the therapeutic efficiency of the novel CRM1 inhibitor KPT-185 on non-small cell lung cancer (NSCLC). Methods: NSCLC cell lines were treated with KPT-185 to assess changes in cell viability, cell cycle, apoptosis, and protein expression. NOD-SCID mice carrying NSCLC cell xenografts were orally treated with KPT-276, a clinical analog of KPT-185, to examine the efficacy and side effects of KPT-276 in vivo. Results: KPT-185 significantly reduced the viability of six NSCLC cell lines in a time-and dose-dependent manner, including epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-resistant H1975 and H1650GR cell lines. In addition, KPT-185 induced these NSCLC cells to arrest at G1 phase of the cell cycle and caused apoptosis in a dose-dependent manner. KPT-185 treatment also reduced CRM1 protein levels in six NSCLC cell lines, and the reduction could be completely abolished by the proteasome inhibitor bortezomib. KPT-185 activated caspase 3, 8, and 9, but inhibited survivin expression in NSCLC cells. In a mouse H1975 cell xenograft model, tumor growth was significantly inhibited by oral KPT-276 administration, and there was no significant mouse body weight loss or other side effects. Conclusions: The current study demonstrated the anti-tumor effects of KPT-185 in NSCLC cells, including EGFR-TKI-resistant NSCLC cell lines. Further studies will assess anti-tumor activity of KPT-185 in a clinical trial for NSCLC patients.	[Shi, Yuankai] Chinese Acad Med Sci, Dept Med Oncol, Canc Inst Hosp, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China; Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Shi, YK (corresponding author), Chinese Acad Med Sci, Dept Med Oncol, Canc Inst Hosp, Beijing 100730, Peoples R China.	syuankai@cicams.ac.cn	Hoshino, Yoichiro/A-5115-2012; han, xiao/HDN-9782-2022; Sun, Xiaoli/AAH-2265-2020	Hoshino, Yoichiro/0000-0003-3828-0696; Sun, Xiaoli/0000-0003-1134-3976; Sun, Mingzhe/0000-0001-7557-623X				Azmi AS, 2013, GASTROENTEROLOGY, V144, P447, DOI 10.1053/j.gastro.2012.10.036; Bartholomeusz G, 2006, MOL CARCINOGEN, V45, P73, DOI 10.1002/mc.20156; Bonazzi S, 2010, J AM CHEM SOC, V132, P1432, DOI 10.1021/ja9097093; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Etchin J, 2013, LEUKEMIA, V27, P66, DOI 10.1038/leu.2012.219; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Keller Shannon A., 2000, Blood, V96, P2537; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Meissner T, 2004, FEBS LETT, V576, P27, DOI 10.1016/j.febslet.2004.08.056; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Murakami N, 2002, BIOORG MED CHEM LETT, V12, P2807, DOI 10.1016/S0960-894X(02)00624-8; Mutka SC, 2009, CANCER RES, V69, P510, DOI 10.1158/0008-5472.CAN-08-0858; Newlands ES, 1996, BRIT J CANCER, V74, P648, DOI 10.1038/bjc.1996.415; Noske A, 2008, CANCER-AM CANCER SOC, V112, P1733, DOI 10.1002/cncr.23354; Noske A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-294; Phelps RM, 1996, J CELL BIOCHEM, P32; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Sakakibara K, 2011, BLOOD, V118, P3922, DOI 10.1182/blood-2011-01-333138; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Turner JG, 2012, BIOCHEM PHARMACOL, V83, P1021, DOI 10.1016/j.bcp.2011.12.016; Van Neck T, 2008, BIOORGAN MED CHEM, V16, P9487, DOI 10.1016/j.bmc.2008.09.051; Wach JY, 2010, BIOORG MED CHEM LETT, V20, P2843, DOI 10.1016/j.bmcl.2010.03.049; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Zhang KJ, 2013, EXP HEMATOL, V41, P67, DOI 10.1016/j.exphem.2012.09.002	31	207	241	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89848	10.1371/journal.pone.0089848	http://dx.doi.org/10.1371/journal.pone.0089848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24595136	Green Published, Green Submitted, gold			2022-12-25	WOS:000332475500025
J	Wang, SL; Yang, H; Yu, LJ; Jin, JL; Qian, L; Zhao, H; Xu, Y; Zhu, XL				Wang, Sulei; Yang, Hui; Yu, Linjie; Jin, Jiali; Qian, Lai; Zhao, Hui; Xu, Yun; Zhu, Xiaolei			Oridonin Attenuates A beta(1-42)-Induced Neuroinflammation and Inhibits NF-kappa B Pathway	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OXIDATIVE STRESS; IN-VITRO; PROINFLAMMATORY CYTOKINES; INFLAMMATION; ACTIVATION; HYPOTHESIS; PROTECTS; NEURONS	Neuroinflammation induced by beta-amyloid (A beta) plays a critical role in the pathogenesis of Alzheimer's disease (AD), and inhibiting A beta-induced neuroinflammation serves as a potential strategy for the treatment of AD. Oridonin (Ori), a compound of Rabdosia rubescens, has been shown to exert anti-inflammatory effects. In this study, we demonstrated that Ori inhibited glial activation and decreased the release of inflammatory cytokines in the hippocampus of A beta(1-42)-induced AD mice. In addition, Ori inhibited the NF-kappa B pathway and A beta(1-42)-induced apoptosis. Furthermore, Ori could attenuate memory deficits in A beta(1-42)-induced AD mice. In conclusion, our study demonstrated that Ori inhibited the neuroinflammation and attenuated memory deficits induced by A beta(1-42), suggesting that Ori might be a promising candidate for AD treatment.	[Wang, Sulei; Yang, Hui; Xu, Yun] Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Yu, Linjie; Jin, Jiali; Qian, Lai; Zhao, Hui; Xu, Yun; Zhu, Xiaolei] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University of Chinese Medicine; Nanjing University	Xu, Y (corresponding author), Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Dept Neurol, Nanjing, Jiangsu, Peoples R China.	xuyun20042001@aliyun.com; zhuquelee@126.com	Hoshino, Yoichiro/A-5115-2012; han, xiao/HDN-9782-2022; Sun, Xiaoli/AAH-2265-2020	Hoshino, Yoichiro/0000-0003-3828-0696; Sun, Xiaoli/0000-0003-1134-3976; Sun, Mingzhe/0000-0001-7557-623X	National Nature Science Foundation of China [81200839, 81230026, 81171085]; Natural Science Foundation [BL2012013]; Bureau of Health of the Jiangsu Province of China [LJ201101]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Bureau of Health of the Jiangsu Province of China	This study was supported by the National Nature Science Foundation of China (81200839, 81230026, and 81171085), the Natural Science Foundation (BL2012013) and the Bureau of Health (LJ201101) of the Jiangsu Province of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae S, 2014, INT J MOL MED, V33, P185, DOI 10.3892/ijmm.2013.1561; Batsch N., 2012, WORLD ALZHEIMER REPO; Boissiere F, 1997, NEUROREPORT, V8, P2849, DOI 10.1097/00001756-199709080-00009; Bu HQ, 2014, ONCOL REP, V31, P975, DOI 10.3892/or.2013.2888; Capiralla H, 2012, J NEUROCHEM, V120, P461, DOI 10.1111/j.1471-4159.2011.07594.x; Couturier J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-72; Fan H, 2013, J BIOMED RES, V27, P296, DOI 10.7555/JBR.27.20120100; Gubandru M, 2013, FOOD CHEM TOXICOL, V61, P209, DOI 10.1016/j.fct.2013.07.013; Han LJ, 2013, NEUROCHEM INT, V62, P913, DOI 10.1016/j.neuint.2013.03.003; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; Huang Y, 2005, NEUROSCI LETT, V373, P115, DOI 10.1016/j.neulet.2004.09.074; Jaturapatporn D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006378.pub2; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim HG, 2014, NEUROTOXICOLOGY, V40, P23, DOI 10.1016/j.neuro.2013.10.004; Ku CM, 2013, FOOD CHEM, V141, P1104, DOI 10.1016/j.foodchem.2013.04.044; Kurt MA, 1997, NEUROSCI LETT, V239, P41, DOI 10.1016/S0304-3940(97)00876-8; Lawrence T, 2010, INT J BIOCHEM CELL B, V42, P519, DOI 10.1016/j.biocel.2009.12.016; Leung CH, 2005, MOL PHARMACOL, V68, P286, DOI 10.1124/mol.105.012765; Llano DA, 2012, ALZ DIS ASSOC DIS, V26, P322, DOI 10.1097/WAD.0b013e31823b2728; Lyman M, 2014, NEUROSCI RES, V79, P1, DOI 10.1016/j.neures.2013.10.004; McGeer PL, 2013, ACTA NEUROPATHOL, V126, P479, DOI 10.1007/s00401-013-1177-7; Meng QH, 2013, PHARMAZIE, V68, P904, DOI 10.1691/ph.2013.3571; Overmyer M, 1999, DEMENT GERIATR COGN, V10, P252, DOI 10.1159/000017128; Paris D, 2007, NEUROSCI LETT, V415, P11, DOI 10.1016/j.neulet.2006.12.029; PRICE DL, 1995, CURR OPIN NEUROL, V8, P268, DOI 10.1097/00019052-199508000-00004; Rozemuller AJM, 2012, NEURODEGENER DIS, V10, P301, DOI 10.1159/000335380; Thangavel R, 2012, NEUROPATH APPL NEURO, V38, P572, DOI 10.1111/j.1365-2990.2011.01232.x; Valerio A, 2006, EUR J NEUROSCI, V23, P1711, DOI 10.1111/j.1460-9568.2006.04722.x; Wang C, 2011, NEUROSCI LETT, V491, P127, DOI 10.1016/j.neulet.2011.01.022; Wu J, 2011, BIOCHEM BIOPH RES CO, V408, P382, DOI 10.1016/j.bbrc.2011.04.013; Xu Y, 2009, INT IMMUNOPHARMACOL, V9, P360, DOI 10.1016/j.intimp.2009.01.002; Zhang J, 2013, BEHAV BRAIN RES, V244, P70, DOI 10.1016/j.bbr.2013.01.037; Zhang YY, 2013, CLIN INTERV AGING, V8, DOI 10.2147/CIA.S40405; Zhao H, 2013, CNS NEUROSCI THER, V19, P117, DOI 10.1111/cns.12043; Zhu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035823	37	207	241	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104745	10.1371/journal.pone.0104745	http://dx.doi.org/10.1371/journal.pone.0104745			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	24595136	gold, Green Submitted, Green Published			2022-12-25	WOS:000341017000058
